PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Pascual, M; Rodo, X; Ellner, SP; Colwell, R; Bouma, MJ				Pascual, M; Rodo, X; Ellner, SP; Colwell, R; Bouma, MJ			Cholera dynamics and El Nino-Southern Oscillation	SCIENCE			English	Article							INTRASEASONAL OSCILLATIONS; GLOBAL ATMOSPHERE; TIME-SERIES; HEMISPHERE; CHAOS; LIMA; PERU	Analysis of a monthly 18-year cholera time series from Bangladesh shows that the temporal variability of cholera exhibits an interannual component at the dominant frequency of El Nino-Southern Oscillation (ENSO). Results from nonlinear time series analysis support a role for both ENSO and previous disease Levels in the dynamics of cholera. Cholera patterns are Linked to the previously described changes in the atmospheric circulation of south Asia and, consistent with these changes, to regional temperature anomalies.	Univ Maryland, Ctr Marine Biotechnol, Inst Biotechnol, Columbus Ctr, Baltimore, MD 21202 USA; Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; Univ Barcelona, Dept Ecol, E-08028 Barcelona, Catalunya, Spain; PCB Univ Barcelona, Climat Res Grp, E-08028 Barcelona, Catalunya, Spain; Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; Univ Maryland, Dept Cell & Mol Biol, College Pk, MD 20742 USA; Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England	University System of Maryland; University of Maryland Baltimore; Woods Hole Oceanographic Institution; University of Barcelona; Cornell University; University System of Maryland; University of Maryland College Park; University of London; London School of Hygiene & Tropical Medicine	Pascual, M (corresponding author), Univ Maryland, Ctr Marine Biotechnol, Inst Biotechnol, Columbus Ctr, 701 E Pratt St,Suite 236, Baltimore, MD 21202 USA.		Rodó, Xavier/F-7663-2017	Rodó, Xavier/0000-0003-4843-6180				BROOMHEAD DS, 1986, PHYSICA D, V20, P217, DOI 10.1016/0167-2789(86)90031-X; BRYDEN JL, 1871, EPIDEMIC CHOLERA BEN; Casdagli M., 1992, NONLINEAR MODELING F; Checkley W, 2000, LANCET, V355, P442, DOI 10.1016/S0140-6736(00)82010-3; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; ELLNER S, 1995, AM NAT, V145, P343, DOI 10.1086/285744; EPSTEIN PR, 1993, LANCET, V342, P1216, DOI 10.1016/0140-6736(93)92191-U; Finkenstadt B, 1998, P ROY SOC B-BIOL SCI, V265, P753, DOI 10.1098/rspb.1998.0357; Franco AA, 1997, AM J EPIDEMIOL, V146, P1067, DOI 10.1093/oxfordjournals.aje.a009235; GHIL M, 1991, J ATMOS SCI, V48, P752, DOI 10.1175/1520-0469(1991)048<0752:IOITGA>2.0.CO;2; GHIL M, 1991, J ATMOS SCI, V48, P780, DOI 10.1175/1520-0469(1991)048<0780:IOITGA>2.0.CO;2; HARRISON EF, 1990, J GEOPHYS RES-ATMOS, V95, P18687, DOI 10.1029/JD095iD11p18687; Klein SA, 1999, J CLIMATE, V12, P917, DOI 10.1175/1520-0442(1999)012<0917:RSSTVD>2.0.CO;2; Lobitz B, 2000, P NATL ACAD SCI USA, V97, P1438, DOI 10.1073/pnas.97.4.1438; NYCHKA D, 1992, J ROY STAT SOC B MET, V54, P399; ROSSOW WB, 1991, B AM METEOROL SOC, V72, P2, DOI 10.1175/1520-0477(1991)072<0002:ICDP>2.0.CO;2; SalazarLindo E, 1997, LANCET, V350, P1597, DOI 10.1016/S0140-6736(05)64013-5; SCHAFFER WM, 1990, UBIQUITY OF CHAOS, P138; SCHMETZ J, 1995, ADV SPACE RES, V16, P69, DOI 10.1016/0273-1177(95)00382-O; SCHWARTZ IB, 1992, J MATH BIOL, V30, P473, DOI 10.1007/BF00160532; SCHWARTZ IB, 1983, J MATH BIOL, V18, P233, DOI 10.1007/BF00276090; Soden BJ, 1996, J GEOPHYS RES-ATMOS, V101, P9333, DOI 10.1029/96JD00280; Takens F., 1981, LECT NOTES MATH, V898,, P366, DOI [DOI 10.1007/BFB0091924, 10.1007/BFb0091924]; VAUTARD R, 1989, PHYSICA D, V35, P395, DOI 10.1016/0167-2789(89)90077-8	24	360	369	3	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 8	2000	289	5485					1766	1769		10.1126/science.289.5485.1766	http://dx.doi.org/10.1126/science.289.5485.1766			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352BT	10976073				2022-12-24	WOS:000089195200051
J	Sinervo, B; Svensson, E; Comendant, T				Sinervo, B; Svensson, E; Comendant, T			Density cycles and an offspring quantity and quality game driven by natural selection	NATURE			English	Article							SIZE; POPULATION; EVOLUTION; FINCHES; NUMBER; TESTS	A long-standing hypothesis(1,2) posits that natural selection can favour two female strategies when density cycles. At low density, females producing many smaller progeny are favoured when the intrinsic rate of increase, r, governs population growth. At peak density, females producing fewer, high-quality, progeny are favoured when the carrying capacity, K, is exceeded and the population crashes. Here we report on the first example of a genetic r versus K selection(3-5) game that promotes stable population cycles in lizards. Decade-long fitness studies and game theory demonstrated that two throat-colour morphs were refined by selection in which the strength of natural selection varied with density. Orange-throated females, r strategists, produced many eggs and were favoured at low density. Conversely, yellow-throated females, K strategists, produced large eggs and were favoured at high density. Progeny size should also be under negative frequency-dependent selection in that large progeny will have a survival advantage when rare, but the advantage disappears when they become common. We confirmed this prediction by seeding field plots with rare and common giant hatchlings. Thus, intrinsic causes of frequency- and density-dependent selection promotes an evolutionary game with two-generation oscillations.	Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Sinervo, B (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Earth & Marine Sci Bldg, Santa Cruz, CA 95064 USA.	sinervo@biology.ucsc.edu	Svensson, Erik/E-8324-2010	Svensson, Erik/0000-0001-9006-016X				BOAG PT, 1981, SCIENCE, V214, P82, DOI 10.1126/science.214.4516.82; BROCKELMAN WY, 1975, AM NAT, V109, P677, DOI 10.1086/283037; BRODIE ED, 1992, EVOLUTION, V46, P1284, DOI 10.1111/j.1558-5646.1992.tb01124.x; Chatfield C, 1992, ANAL TIME SERIES INT, P62; Chitty D, 1960, COLD SPRING HARB SYM, V22, P277; CHITTY DENNIS, 1960, CANADIAN JOUR ZOOL, V38, P99, DOI 10.1139/z60-011; Cooper W.E. Jr, 1992, P298; Endler J.A., 1986, Monographs in Population Biology, pviii; GIBBS HL, 1987, NATURE, V327, P511, DOI 10.1038/327511a0; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; MAC ARTHUR ROBERT H., 1967; Maynard Smith J., 1982, pi; PIANKA ER, 1970, AM NAT, V104, P592, DOI 10.1086/282697; RICE WR, 1990, BIOMETRICS, V46, P303, DOI 10.2307/2531435; Sinervo B, 1998, MATERNAL EFFECTS AS ADAPTATIONS, P288; SINERVO B, 1990, SCIENCE, V248, P1106, DOI 10.1126/science.248.4959.1106; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Sinervo B, 1996, EVOLUTION, V50, P1299, DOI 10.1111/j.1558-5646.1996.tb02370.x; SINERVO B, 1991, SCIENCE, V252, P1300, DOI 10.1126/science.252.5010.1300; SINERVO B, 1992, SCIENCE, V258, P1927, DOI 10.1126/science.258.5090.1927; Sinervo B, 2000, ADAPTIVE GENETIC VARIATION IN THE WILD, P41; SINERVO B, 1996, ADAPTATION, P148; SINERVO B, MODEL SYSTEMS BEHAV; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Stearns S.C., 1992, pi; SVENSSON E, IN PRESS EVOLUTION; Wallace B., 1970, GENETIC LOAD ITS BIO; Zeng Z, 1998, ECOLOGY, V79, P2193, DOI 10.1890/0012-9658(1998)079[2193:CPDITR]2.0.CO;2	28	322	323	1	138	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 31	2000	406	6799					985	988		10.1038/35023149	http://dx.doi.org/10.1038/35023149			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	348ZW	10984050				2022-12-24	WOS:000089020200042
J	Galko, MJ; Tessier-Lavigne, M				Galko, MJ; Tessier-Lavigne, M			Function of an axonal chemoattractant modulated by metalloprotease activity	SCIENCE			English	Article							NECROSIS-FACTOR-ALPHA; NEURONAL GROWTH CONE; PLASMINOGEN-ACTIVATOR; NERVOUS-SYSTEM; SURFACE PROTEIN; GUIDANCE; DISINTEGRIN; DROSOPHILA; NETRIN-1; PEPTIDE	The axonal chemoattractant netrin-1 guides spinal commissural axons by activating its receptor DCC (Deleted in Colorectal Cancer). We have found that chemical inhibitors of metalloproteases potentiate netrin-mediated axon outgrowth in vitro. We have also found that DCC is a substrate for metalloprotease-dependent ectodomain shedding, and that the inhibitors block proteolytic processing of DCC and cause an increase in DCC protein levels on axons within spinal cord explants, Thus, potentiation of netrin activity by inhibitors may result from stabilization of DCC on the axons, and proteolytic activity may regulate axon migration by controlling the number of functional extracellular axon guidance receptors.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Tessier-Lavigne, M (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA.			Galko, Michael/0000-0002-3759-2017				Arribas J, 1996, J BIOL CHEM, V271, P11376, DOI 10.1074/jbc.271.19.11376; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Black RA, 1998, CURR OPIN CELL BIOL, V10, P654, DOI 10.1016/S0955-0674(98)80042-2; BLOBEL CP, 1992, NATURE, V356, P248, DOI 10.1038/356248a0; Fambrough D, 1996, P NATL ACAD SCI USA, V93, P13233, DOI 10.1073/pnas.93.23.13233; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Galko MJ, 2000, J BIOL CHEM, V275, P7832, DOI 10.1074/jbc.275.11.7832; GALKO MJ, UNPUB; GROBELNY D, 1992, BIOCHEMISTRY-US, V31, P7152, DOI 10.1021/bi00146a017; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; KRYSTOSEK A, 1981, P NATL ACAD SCI-BIOL, V78, P7810, DOI 10.1073/pnas.78.12.7810; KRYSTOSEK A, 1981, SCIENCE, V213, P1532, DOI 10.1126/science.7197054; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Nishiwaki K, 2000, SCIENCE, V288, P2205, DOI 10.1126/science.288.5474.2205; Oxford Rhodes Library, COMMUNICATION; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; PITTMAN RN, 1985, DEV BIOL, V110, P91, DOI 10.1016/0012-1606(85)90067-3; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; PRIMAKOFF P, 1987, J CELL BIOL, V104, P141, DOI 10.1083/jcb.104.1.141; Rooke J, 1996, SCIENCE, V273, P1227, DOI 10.1126/science.273.5279.1227; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Shirasaki R, 1996, NEURON, V17, P1079, DOI 10.1016/S0896-6273(00)80241-X; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; YAMAMOTO M, 1986, J NEUROSCI, V6, P3576	32	143	148	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 25	2000	289	5483					1365	1367		10.1126/science.289.5483.1365	http://dx.doi.org/10.1126/science.289.5483.1365			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347RF	10958786				2022-12-24	WOS:000088942400043
J	Ban, N; Nissen, P; Hansen, J; Moore, PB; Steitz, TA				Ban, N; Nissen, P; Hansen, J; Moore, PB; Steitz, TA			The complete atomic structure of the large ribosomal subunit at 2.4 angstrom resolution	SCIENCE			English	Article							PEPTIDYL TRANSFERASE CENTER; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; THERMUS-THERMOPHILUS; ELONGATION-FACTORS; 70S RIBOSOME; TRANSFER-RNA; PROTEIN; BINDING; LOOP	The large ribosomal subunit catalyzes peptide bond formation and binds initiation, termination, and elongation factors. We have determined the crystal structure of the Large ribosomal subunit from Haloarcula marismortui at 2.4 angstrom resolution, and it includes 2833 of the subunit's 3045 nucleotides and 27 of its 31 proteins. The domains of its RNAs all have irregular shapes and fit together in the ribosome Like the pieces of a three-dimensional jigsaw puzzle to form a Large, monolithic structure. Proteins are abundant everywhere on its surface except in the active site where peptide bond formation occurs and where it contacts the small subunit. Most of the proteins stabilize the structure by interacting with several RNA domains, often using idiosyncratically folded extensions that reach into the subunit's interior.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Chem, New Haven, CT 06520 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.		Nissen, Poul/D-5774-2014; Steitz, Thomas A./C-6559-2009	Nissen, Poul/0000-0003-0948-6628	NIGMS NIH HHS [GM54216, GM22778] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Agrawal RK, 1999, J BIOL CHEM, V274, P8723, DOI 10.1074/jbc.274.13.8723; Agrawal RK, 1998, P NATL ACAD SCI USA, V95, P6134, DOI 10.1073/pnas.95.11.6134; Ban N, 1998, CELL, V93, P1105, DOI 10.1016/S0092-8674(00)81455-5; Ban N, 1999, NATURE, V400, P841, DOI 10.1038/23641; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; CHITTUM HS, 1994, J BACTERIOL, V176, P6192, DOI 10.1128/jb.176.20.6192-6198.1994; Clemons WM, 1999, NATURE, V400, P833, DOI 10.1038/23631; Conn GL, 1999, SCIENCE, V284, P1171, DOI 10.1126/science.284.5417.1171; Correll CC, 1997, CELL, V91, P705, DOI 10.1016/S0092-8674(00)80457-2; Correll CC, 1998, P NATL ACAD SCI USA, V95, P13436, DOI 10.1073/pnas.95.23.13436; Culver GM, 1999, SCIENCE, V285, P2133, DOI 10.1126/science.285.5436.2133; David L., 1996, Fizika A, V5, P55; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Dube P, 1998, STRUCTURE, V6, P389, DOI 10.1016/S0969-2126(98)00040-9; Garrett R. A., 2000, RIBOSOME STRUCTURE F; Garrett R. A., 1996, RIBOSOMAL RNA STRUCT, P327; Gerbi S.A., 1996, RIBOSOMAL RNA STRUCT, P71; GOLDEN BL, 1993, EMBO J, V12, P4901, DOI 10.1002/j.1460-2075.1993.tb06184.x; GUTELL RR, 1996, RIBOSOMAL RNA STRUCT, P111; GUTELL RR, UNPUB; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LEFFERS H, 1987, J MOL BIOL, V195, P43, DOI 10.1016/0022-2836(87)90326-3; LEIJONMARCK M, 1980, NATURE, V286, P824, DOI 10.1038/286824a0; LILJAS A, 1991, INT REV CYTOL, V124, P103; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mao HY, 1999, NAT STRUCT BIOL, V6, P1139; Markus MA, 1997, NAT STRUCT BIOL, V4, P70, DOI 10.1038/nsb0197-70; MOAZED D, 1988, NATURE, V334, P362, DOI 10.1038/334362a0; Moller W., 1986, STRUCTURE FUNCTION G, P309; Moore PB, 1999, ANNU REV BIOCHEM, V68, P287, DOI 10.1146/annurev.biochem.68.1.287; Mueller F, 2000, J MOL BIOL, V298, P35, DOI 10.1006/jmbi.2000.3635; Nakagawa A, 1999, EMBO J, V18, P1459, DOI 10.1093/emboj/18.6.1459; Nevskaya N, 2000, STRUCTURE, V8, P363, DOI 10.1016/S0969-2126(00)00116-7; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; NOLLER HF, 1990, RIBOSOME, P73; OAKES M, 1986, STRUCTURE FUNCTION G, P47; Ostergaard P, 1998, J MOL BIOL, V284, P227, DOI 10.1006/jmbi.1998.2185; OTWINOWSKI Z, 1993, DATA COLLECTION PROC, P52; Puglisi EV, 1997, NAT STRUCT BIOL, V4, P775; ROSSMANN MG, 1989, ANNU REV BIOCHEM, V58, P533, DOI 10.1146/annurev.bi.58.070189.002533; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; SHEVACK A, 1985, FEBS LETT, V184, P68, DOI 10.1016/0014-5793(85)80655-4; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; STOEFFLER G, 1986, STRUCTURE FUNCTION G, P28; SZEWCZAK AA, 1995, J MOL BIOL, V247, P81, DOI 10.1006/jmbi.1994.0124; Szymanski M, 1998, NUCLEIC ACIDS RES, V26, P156, DOI 10.1093/nar/26.1.156; Tocilj A, 1999, P NATL ACAD SCI USA, V96, P14252, DOI 10.1073/pnas.96.25.14252; TRAKHANOV SD, 1987, FEBS LETT, V220, P319, DOI 10.1016/0014-5793(87)80838-4; Tronrud DE, 1997, METHOD ENZYMOL, V277, P306, DOI 10.1016/S0076-6879(97)77017-4; Unge J, 1998, STRUCTURE, V6, P1577, DOI 10.1016/S0969-2126(98)00155-5; VONBOHLEN K, 1991, J MOL BIOL, V222, P11, DOI 10.1016/0022-2836(91)90730-T; WALLECZEK J, 1988, EMBO J, V7, P3571, DOI 10.1002/j.1460-2075.1988.tb03234.x; WARE VC, 1983, NUCLEIC ACIDS RES, V11, P7795, DOI 10.1093/nar/11.22.7795; Westhof E, 2000, STRUCTURE, V8, pR55, DOI 10.1016/S0969-2126(00)00112-X; WILSON KS, 1986, P NATL ACAD SCI USA, V83, P7251, DOI 10.1073/pnas.83.19.7251; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; Wittmann-Liebold Brigitte, 1986, STRUCTURE FUNCTION G, P326; WITTMANNLIEBOLD B, 1990, RIBOSOME, P598; WOOL IG, 1992, TRENDS BIOCHEM SCI, V17, P266, DOI 10.1016/0968-0004(92)90407-Z; Wool IG, 1995, BIOCHEM CELL BIOL, V73, P933, DOI 10.1139/o95-101; Worbs M, 2000, EMBO J, V19, P807, DOI 10.1093/emboj/19.5.807; YONATH AE, 1980, BIOCHEM INT, V1, P428	67	2611	2706	5	268	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2000	289	5481					905	920		10.1126/science.289.5481.905	http://dx.doi.org/10.1126/science.289.5481.905			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343KH	10937989				2022-12-24	WOS:000088701200023
J	MacBeth, CE; Golombek, AP; Young, VG; Yang, C; Kuczera, K; Hendrich, MP; Borovik, AS				MacBeth, CE; Golombek, AP; Young, VG; Yang, C; Kuczera, K; Hendrich, MP; Borovik, AS			O-2 activation by nonheme iron complexes: A monomeric Fe(III)-oxo complex derived from O-2	SCIENCE			English	Article							BOND-DISSOCIATION ENERGIES; HEME-CONTAINING OXYGENASES; HORSERADISH-PEROXIDASE; EXAFS SPECTROSCOPY; COMPOUND-I; OXO; MANGANESE(III); RECOGNITION; HEMOGLOBIN; MECHANISMS	Iron species with terminal oxo Ligands are implicated as key intermediates in several synthetic and biochemical catalytic cycles. However, there is a dearth of structural information regarding these types of complexes because their instability has precluded isolation under ambient conditions. The isolation and structural characterization of an iron(III) complex with a terminal oxo Ligand, derived directly from dioxygen (O-2), is reported. A stable structure resulted from placing the oxoiron unit within a synthetic cavity Lined with hydrogen-bonding groups. The cavity creates a microenvironment around the iron center that aids in regulating O-2 activation and stabilizing the oxoiron unit. These cavities share properties with the active sites of metalloproteins, where function is correlated strongly with site structure.	Univ Kansas, Dept Chem, Lawrence, KS 66045 USA; Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA; Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA	University of Kansas; University of Kansas; Carnegie Mellon University; University of Minnesota System; University of Minnesota Twin Cities	Borovik, AS (corresponding author), Univ Kansas, Dept Chem, Lawrence, KS 66045 USA.		Golombek, Adina/Q-1789-2019	Golombek, Adina/0000-0001-7176-7071	NIGMS NIH HHS [GM49970, GM50781] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM050781, R01GM050781, R01GM049970, R29GM049970, R37GM050781] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSSON LA, 1991, STRUCT BOND, V74, P1; BALCH AL, 1985, J AM CHEM SOC, V107, P3003, DOI 10.1021/ja00297a001; BORDWELL FG, 1990, J ORG CHEM, V55, P3337, DOI 10.1021/jo00297a064; BORDWELL FG, 1991, J AM CHEM SOC, V113, P9790, DOI 10.1021/ja00026a012; Collman JP, 1999, ACCOUNTS CHEM RES, V32, P455, DOI 10.1021/ar9603064; Debrunner P. G., 1989, IRON PORPHYRINS 3, P139; FULOP V, 1994, STRUCTURE, V2, P201, DOI 10.1016/S0969-2126(00)00021-6; Hammes BS, 1999, ANGEW CHEM INT EDIT, V38, P666, DOI 10.1002/(SICI)1521-3773(19990301)38:5<666::AID-ANIE666>3.0.CO;2-X; HERBER RH, 1979, INORG CHEM, V18, P2786, DOI 10.1021/ic50200a030; HOLM RH, 1987, CHEM REV, V87, P1401, DOI 10.1021/cr00082a005; HOPPER ML, 1982, ACTA CRYSTALLOGR B, V32, P2237; KICKHAM JE, 1993, J AM CHEM SOC, V115, P7031, DOI 10.1021/ja00068a094; KITAJIMA N, 1994, J AM CHEM SOC, V116, P11596, DOI 10.1021/ja00104a061; KURTZ DM, 1990, CHEM REV, V90, P585, DOI 10.1021/cr00102a002; Lange SJ, 1999, J AM CHEM SOC, V121, P6330, DOI 10.1021/ja990233u; Lipscomb WN, 1996, CHEM REV, V96, P2375, DOI 10.1021/cr950042j; Lu Y, 1997, CURR OPIN STRUC BIOL, V7, P495, DOI 10.1016/S0959-440X(97)80112-1; MAYER JM, 1985, J AM CHEM SOC, V107, P7454, DOI 10.1021/ja00311a039; MOMENTEAU M, 1994, CHEM REV, V94, P659, DOI 10.1021/cr00027a006; MORRIS RJ, 1988, POLYHEDRON, V7, P2001, DOI 10.1016/S0277-5387(00)80715-9; Mukai M, 1997, J AM CHEM SOC, V119, P1758, DOI 10.1021/ja962551o; Mukerjee S, 1997, J AM CHEM SOC, V119, P8097, DOI 10.1021/ja9709482; Ogo S, 1998, ANGEW CHEM INT EDIT, V37, P2102, DOI 10.1002/(SICI)1521-3773(19980817)37:15<2102::AID-ANIE2102>3.0.CO;2-A; PENNERHAHN JE, 1986, J AM CHEM SOC, V108, P7819, DOI 10.1021/ja00284a054; PERUTZ MF, 1987, ACCOUNTS CHEM RES, V20, P309, DOI 10.1021/ar00141a001; QUE L, 1990, PROG INORG CHEM, V38, P97; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Shirin Z, 2000, J AM CHEM SOC, V122, P1836, DOI 10.1021/ja993818x; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; Sono M, 1996, CHEM REV, V96, P2841, DOI 10.1021/cr9500500; SPALTENSTEIN E, 1989, J AM CHEM SOC, V111, P8741, DOI 10.1021/ja00205a038; SPRINGER BA, 1994, CHEM REV, V94, P699, DOI 10.1021/cr00027a007; WU YD, 1992, INORG CHEM, V31, P718, DOI 10.1021/ic00031a002	33	337	339	1	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2000	289	5481					938	941		10.1126/science.289.5481.938	http://dx.doi.org/10.1126/science.289.5481.938			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343KH	10937994				2022-12-24	WOS:000088701200028
J	Heim, C; Newport, DJ; Heit, S; Graham, YP; Wilcox, M; Bonsall, R; Miller, AH; Nemeroff, CB				Heim, C; Newport, DJ; Heit, S; Graham, YP; Wilcox, M; Bonsall, R; Miller, AH; Nemeroff, CB			Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORTICOTROPIN-RELEASING-FACTOR; FACTOR-LIKE IMMUNOREACTIVITY; EARLY PARENTAL SEPARATION; MAJOR DEPRESSION; PARAVENTRICULAR NUCLEUS; CEREBROSPINAL-FLUID; ANXIETY DISORDERS; BIPOLAR DISORDER; MESSENGER-RNA; COMMUNITY	Context Evidence suggests that early adverse experiences play a preeminent role in development of mood and anxiety disorders and that corticotropin-releasing factor (CRF) systems may mediate this association. Objective To determine whether early-life stress results in a persistent sensitization of the hypothalamic-pituitary-adrenal axis to mild stress in adulthood, thereby contributing to vulnerability to psychopathological conditions, Design and Setting Prospective controlled study conducted from May 1997 to July 1999 at the General Clinical Research Center of Emery University Hospital, Atlanta, Ga. Participants Forty-nine healthy women aged 18 to 45 years with regular menses, with no history of mania or psychosis, with no active substance abuse or eating disorder within 6 months, and who were free of hormonal and psychotropic medications were recruited into 4 study groups (n = 12 with no history of childhood abuse or psychiatric disorder [controls]; n =13 with diagnosis of current major depression who were sexually or physically abused as children; n = 14 without current major depression who were sexually or physically abused as children; and n = 10 with diagnosis of current major depression and no history of childhood abuse). Main Outcome Measures Adrenocorticotropic hormone (ACTH) and cortisol levels and heart rate responses to a standardized psychosocial laboratory stressor compared among the 4 study groups. Results Women with a history of childhood abuse exhibited increased pituitary-adrenal and autonomic responses to stress compared with controls. This effect was particularly robust in women with current symptoms of depression and anxiety. Women with a history of childhood abuse and a current major depression diagnosis exhibited a more than 6-fold greater ACTH response to stress than age-matched controls (net peak of 9.0 pmol/L [41.0 pg/ml]; 95% confidence interval [CI], 4.7-13.3 pmol/L [21.6-60.4 pg/mL]; vs net peak of 1.4 pmol/L [6.19 pg/ml]; 95% CI, 0.2-2.5 pmol/L [1.0-11.4 pg/mL]; difference, 8.6 pmol/L [38.9 pg/ml]; 95% CI, 4.6-12.6 pmol/L [20.8-57.1 pg/mL]; P < .001). Conclusions Our findings suggest that hypothalamic-pituitary-adrenal axis and autonomic nervous system hyperreactivity, presumably due to CRF hypersecretion, is a persistent consequence of childhood abuse that may contribute to the diathesis for adulthood psychopathological conditions. Furthermore, these results imply a role for CRF receptor antagonists in the prevention and treatment of psychopathological conditions related to early-life stress.	Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; Univ Trier, Ctr Psychobiol & Psychosomat Res, Trier, Germany	Emory University; Universitat Trier	Nemeroff, CB (corresponding author), Emory Univ, Sch Med, Dept Psychiat & Behav Sci, 1639 Pierce Dr,WMRB,Suite 4000, Atlanta, GA 30322 USA.	cnemero@emory.edu	Newport, D. Jeffrey/AAN-5036-2020; Heim, Christine/J-4693-2014; Heim, Christine/A-1183-2009; Newport, Donald Jeffrey/H-9846-2013	Newport, D. Jeffrey/0000-0003-1695-9710; Heim, Christine/0000-0002-6580-6326; Nemeroff, Charles/0000-0001-7867-1160	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000039] Funding Source: NIH RePORTER	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Agid O, 1999, MOL PSYCHIATR, V4, P163, DOI 10.1038/sj.mp.4000473; ALTEMUS M, 1992, ARCH GEN PSYCHIAT, V49, P9; [Anonymous], 1994, SEMIN NEUROSCI; Baker DG, 1999, AM J PSYCHIAT, V156, P585; BANKI CM, 1987, AM J PSYCHIAT, V144, P873; BREMNER JD, 1993, AM J PSYCHIAT, V150, P235; Bremner JD, 1997, AM J PSYCHIAT, V154, P624; BREMNER JD, IN PRESS J TRAUMA ST; BRITTON DR, 1982, LIFE SCI, V31, P363, DOI 10.1016/0024-3205(82)90416-7; BROWNE MAO, 1995, AUST NZ J PSYCHIAT, V29, P437; BUTLER PD, 1990, COMORBIDITY OF MOOD AND ANXIETY DISORDERS, P413; Cohen J., 1988, STAT POWER ANAL BEHA; Coplan JD, 1996, P NATL ACAD SCI USA, V93, P1619, DOI 10.1073/pnas.93.4.1619; DUNN AJ, 1990, BRAIN RES REV, V15, P71, DOI 10.1016/0165-0173(90)90012-D; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; FARAVELLI C, 1986, BRIT J PSYCHIAT, V148, P288, DOI 10.1192/bjp.148.3.288; FRIST MB, 1997, STRUCTURED CLIN INTE, V4; Furukawa TA, 1999, J AFFECT DISORDERS, V52, P85, DOI 10.1016/S0165-0327(98)00054-8; GULLEY LR, 1993, J CLIN PSYCHIAT, V54, P16; HALLSTROM T, 1987, ACTA PSYCHIAT SCAND, V75, P212, DOI 10.1111/j.1600-0447.1987.tb02777.x; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hartline KM, 1996, ANN NY ACAD SCI, V780, P96, DOI 10.1111/j.1749-6632.1996.tb15114.x; Holsboer F, 1999, J PSYCHIATR RES, V33, P181, DOI 10.1016/S0022-3956(98)90056-5; KENDLER KS, 1992, ARCH GEN PSYCHIAT, V49, P109; KENDLER KS, 1993, AM J PSYCHIAT, V150, P1139; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Ladd CO, 1996, ENDOCRINOLOGY, V137, P1212, DOI 10.1210/en.137.4.1212; Levene H., 1960, CONTRIBUTIONS PROBAB, P278; McCauley J, 1997, JAMA-J AM MED ASSOC, V277, P1362, DOI 10.1001/jama.277.17.1362; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Mullen PE, 1996, CHILD ABUSE NEGLECT, V20, P7, DOI 10.1016/0145-2134(95)00112-3; Nemeroff CB, 1999, MOL PSYCHIATR, V4, P106, DOI 10.1038/sj.mp.4000512; NEMEROFF CB, 1984, SCIENCE, V226, P1342, DOI 10.1126/science.6334362; OWENS MJ, 1991, PHARMACOL REV, V43, P425; PLOTSKY PM, 1993, MOL BRAIN RES, V18, P195, DOI 10.1016/0169-328X(93)90189-V; Portegijs PJM, 1996, FAM PRACT, V13, P1, DOI 10.1093/fampra/13.1.1; RAADSHEER FC, 1995, AM J PSYCHIAT, V152, P1372; RAADSHEER FC, 1994, NEUROENDOCRINOLOGY, V60, P436, DOI 10.1159/000126778; ROSENBLUM LA, 1984, CHILD DEV, V55, P305, DOI 10.1111/j.1467-8624.1984.tb00293.x; ROY A, 1985, ARCH GEN PSYCHIAT, V42, P987; SAUNDERS BE, 1992, J INTERPERS VIOLENCE, V7, P189, DOI 10.1177/088626092007002005; SIRINATHSINGHJI DJS, 1983, NATURE, V305, P232, DOI 10.1038/305232a0; Stein MB, 1996, AM J PSYCHIAT, V153, P275; SUTTON RE, 1982, NATURE, V297, P331, DOI 10.1038/297331a0; WIDERLOV E, 1988, J AFFECT DISORDERS, V14, P99, DOI 10.1016/0165-0327(88)90051-1; Zobel AW, 2000, J PSYCHIATR RES, V34, P171, DOI 10.1016/S0022-3956(00)00016-9	46	1372	1396	0	168	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 2	2000	284	5					592	597		10.1001/jama.284.5.592	http://dx.doi.org/10.1001/jama.284.5.592			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	337WG	10918705	Bronze			2022-12-24	WOS:000088385400028
J	Burris, S; Lurie, P; Abrahamson, D; Rich, JD				Burris, S; Lurie, P; Abrahamson, D; Rich, JD			Physician prescribing of sterile injection equipment to prevent HIV infection: Time for action	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							IMMUNODEFICIENCY-VIRUS INFECTION; SYRINGE-EXCHANGE PROGRAMS; UNITED-STATES; DRUG-USERS; CARE	Injection drug users, their sex partners, and their children are at high risk for acquiring HIV infection and other bloodborne diseases. The risk for disease transmission in the United States is partly the result of restricted access to sterile injection equipment. Physicians and pharmacists can play an important role in providing syringe access by prescribing and dispensing syringes to patients who use injection drugs and cannot or will not enter drug treatment. Prescribing and dispensing injection equipment are ethical, clinically appropriate, and fully consistent with current public health guidelines on disease prevention. An analysis of the laws of the 50 U.S. states, the District of Columbia, and Puerto Rico finds that physicians in nearly all these jurisdictions may legally prescribe sterile injection equipment to prevent disease transmission among drug-using patients and that pharmacists in most states have a clear or reasonable legal basis for filling the prescriptions. Given these medical and legal findings, physicians may wish to take a larger role in improving access to sterile injection equipment by prescribing this equipment for their patients where this practice is legal, and by joining efforts to change the law where it poses a barrier.	Temple Univ, Sch Law, Philadelphia, PA 19122 USA; Publ Citizens Hlth Res Grp, Washington, DC USA; Lindsmith Ctr W, San Francisco, CA USA; Brown Univ, Miriam Hosp, Sch Med, Providence, RI USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Brown University; Lifespan Health Rhode Island; Miriam Hospital	Burris, S (corresponding author), Temple Univ, Sch Law, 1719 N Broad St, Philadelphia, PA 19122 USA.	burris@vm.temple.edu		Burris, Scott/0000-0002-6013-5842	NIDA NIH HHS [K20 DA00268, DA 09712] Funding Source: Medline; CSAT SAMHSA HHS [KD1 TI12037-01] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA009712, K20DA000268] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); CSAT SAMHSA HHS; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Alter MJ, 1998, J ACQ IMMUN DEF SYND, V18, pS6, DOI 10.1097/00042560-199802001-00003; Beauchamp TL., 1994, PRINCIPLES BIOMEDICA; BRIDGES FS, 1998, FLORIDA J PHARM, V1, P12; Brooner R, 1998, Public Health Rep, V113 Suppl 1, P129; Burris S, 1996, AM J PUBLIC HEALTH, V86, P1161, DOI 10.2105/AJPH.86.8_Pt_1.1161; Case P, 1998, J ACQ IMMUN DEF SYND, V18, pS94, DOI 10.1097/00042560-199802001-00017; COMPTON WM, 1992, AM J PUBLIC HEALTH, V82, P595, DOI 10.2105/AJPH.82.4.595; Costarides AH, 1998, TOP LANG DISORD, V18, P1, DOI 10.1097/00011363-199805000-00004; FERGUSON LK, 1998, TEMPLE POLITICAL CIV, V8, P41; FRIEDLAND GH, 1998, HARRISONS PRINCIPLES, P831; FURROW BR, 1995, HLTH LAW, P139; Garfein RS, 1998, J ACQ IMMUN DEF SYND, V18, pS11, DOI 10.1097/00042560-199802001-00004; Gleghorn AA, 1998, J ACQ IMMUN DEF SYND, V18, pS89, DOI 10.1097/00042560-199802001-00016; Gostin L O, 1997, Emory Law J, V46, P587; Heimer R, 1996, AIDS PUBLIC POLICY J, V11, P169; Holmberg SD, 1996, AM J PUBLIC HEALTH, V86, P642, DOI 10.2105/AJPH.86.5.642; Hurley SF, 1997, LANCET, V349, P1797, DOI 10.1016/S0140-6736(96)11380-5; JARLAIS DCD, 1988, AM PSYCHOL, V43, P865, DOI 10.1037/0003-066X.43.11.865; Jarlais DCD, 1996, LANCET, V348, P987, DOI 10.1016/S0140-6736(96)02536-6; JONES TS, 1999, J AM PHARM ASSOC, V39, P1; Kapp M B, 1997, Univ Toledo Law Rev, V28, P521; KOESTER SK, 1994, HUM ORGAN, V53, P286; Lazzarini Z, 1998, J ACQ IMMUN DEF SYND, V18, pS141, DOI 10.1097/00042560-199802001-00025; LIURIE P, 1993, PUBLIC HLTH IMPACT N; Loue S, 1995, J LAW MED ETHICS, V23, P382, DOI 10.1111/j.1748-720X.1995.tb01383.x; Lurie P, 1998, J ACQ IMMUN DEF SYND, V18, pS45, DOI 10.1097/00042560-199802001-00009; Macalino GE, 1998, J ACQ IMMUN DEF SYND, V18, pS111, DOI 10.1097/00042560-199802001-00019; MCCLELLAN FM, 1994, MED MALPRACTICE LAW; NELSON KE, 1991, JAMA-J AM MED ASSOC, V266, P2259, DOI 10.1001/jama.266.16.2259; NORMAND J, 1995, PREVENTING HIV TRANS; Novick A, 1996, AIDS PUBLIC POLICY J, V11, P63; OCONNOR PG, 1994, NEW ENGL J MED, V331, P450, DOI 10.1056/NEJM199408183310707; Osterholm MT, 2000, PRINCIPLES PRACTICE, V5th, P156; RENO J, 1998, COMMUNICATION   0605; Satterfield D, 1991, Diabetes Educ, V17, P321, DOI 10.1177/014572179101700412; Singer M, 1998, Public Health Rep, V113 Suppl 1, P81; Stolberg Sheryl Gay, 1998, N Y Times Web, pA21; STONE SE, 1983, DRUG ENFORCEMENT, V21, P23; STRAUSS S, 1980, PHARM LAW, P29; TOEWS DW, 1995, AM J PUBLIC HEALTH, V85, P1447; *US PHS, 1997, HIV PREV B MED ADV P; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; VAETH C, 1994, AM LAW REPORTS, V13, P1; Vlahov D, 1997, J ACQ IMMUN DEF SYND, V16, P400, DOI 10.1097/00042560-199712150-00014; WEILER PC, 1991, MEASURE MALPRACTICE; Wortley PM, 1997, JAMA-J AM MED ASSOC, V278, P911, DOI 10.1001/jama.278.11.911; 1998, MMWR MORB MORTAL WKL, V47, P652	47	31	31	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	2000	133	3					218	226		10.7326/0003-4819-133-3-200008010-00015	http://dx.doi.org/10.7326/0003-4819-133-3-200008010-00015			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	338XW	10906838				2022-12-24	WOS:000088449400008
J	Marek, K; Seibyl, J				Marek, K; Seibyl, J			Imaging - A molecular map for neurodegeneration	SCIENCE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; DOPAMINE TRANSPORTERS; PROGRESSION; BRAIN; PET		Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA	Yale University	Marek, K (corresponding author), Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA.	Ken.Marek@yale.edu; jseibyl@calvin.med.yale.edu		Marek, Kenneth/0000-0002-4197-5627				Baird AE, 1999, CURR OPIN NEUROL, V12, P65, DOI 10.1097/00019052-199902000-00011; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Brooks DJ, 2000, ANN NEUROL, V47, pS154; Brooks DJ, 1998, NEUROSURG CLIN N AM, V9, P263; Dezutter NA, 1999, EUR J NUCL MED, V26, P1392, DOI 10.1007/s002590050470; Doder M, 2000, NEUROLOGY, V54, pA112; Frey K A, 1998, Adv Pharmacol, V42, P269; Holloway R, 2000, CLIN NEUROPHARMACOL, V23, P34; Hussey D, 1998, J NUCL MED, V39, p209P; INNIS RB, 1993, P NATL ACAD SCI USA, V90, P11965, DOI 10.1073/pnas.90.24.11965; KENNEDY AM, 1995, NEUROSCI LETT, V186, P17, DOI 10.1016/0304-3940(95)11270-7; LEENDERS KL, 1995, NEUROLOGY, V45, pA220; Marek KL, 1999, NEUROLOGY, V52, pA91; Marek KL, 1996, NEUROLOGY, V46, P231, DOI 10.1212/WNL.46.1.231; MORRISH P, 1998, J NEUROL NEUROSUR PS, V59, P597; Morrish PK, 1996, BRAIN, V119, P585, DOI 10.1093/brain/119.2.585; Parkinson J, 1819, ESSAY SHAKING PALSY; Piccini P, 1999, NAT NEUROSCI, V2, P1137, DOI 10.1038/16060; Piccini P, 1999, ANN NEUROL, V45, P577, DOI 10.1002/1531-8249(199905)45:5<577::AID-ANA5>3.0.CO;2-O; Rascol O, 2000, NEW ENGL J MED, V342, P1484, DOI 10.1056/NEJM200005183422004; Reiman EM, 1996, NEW ENGL J MED, V334, P752, DOI 10.1056/NEJM199603213341202; Skovronsky DM, 2000, P NATL ACAD SCI USA, V97, P7609, DOI 10.1073/pnas.97.13.7609	22	15	17	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2000	289	5478					409	411		10.1126/science.289.5478.409	http://dx.doi.org/10.1126/science.289.5478.409			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336ME	10939953				2022-12-24	WOS:000088305500031
J	Hattori, M; Osterfield, M; Flanagan, JG				Hattori, M; Osterfield, M; Flanagan, JG			Regulated cleavage of a contact-mediated axon repellent	SCIENCE			English	Article							LYMPHOCYTE L-SELECTIN; GUIDANCE; RECEPTOR; GROWTH; SYSTEM; DROSOPHILA; EXPRESSION; EPHRIN-A5; LIGANDS; NEURONS	Contact-mediated axon repulsion by ephrins raises an unresolved question: these cell surface Ligands form a high-affinity multivalent complex with their receptors present on axons, yet rather than being bound, axons can be rapidly repelled. We show here that ephrin-A2 forms a stable complex with the metalloprotease Kuzbanian, involving interactions outside the cleavage region and the protease domain. Eph receptor binding triggered ephrin-A2 cleavage in a Localized reaction specific to the cognate Ligand. A cleavage-inhibiting mutation in ephrin-A2 delayed axon withdrawal. These studies reveal mechanisms for protease recognition and control of cell surface proteins, and, for ephrin-A2, they may provide a means for efficient axon detachment and termination of signaling.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Flanagan, JG (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.		Flanagan, John/AAM-2995-2020; Hattori, Mitsuharu/F-3859-2010	Hattori, Mitsuharu/0000-0002-0503-4969	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029417, R37HD029417] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011559] Funding Source: NIH RePORTER; NEI NIH HHS [EY11559] Funding Source: Medline; NICHD NIH HHS [HD29417] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		COX EC, 1990, NEURON, V2, P31; Davenport RW, 1998, J NEUROSCI, V18, P975; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; Drescher U, 1997, CURR OPIN NEUROBIOL, V7, P75, DOI 10.1016/S0959-4388(97)80123-7; Fambrough D, 1996, P NATL ACAD SCI USA, V93, P13233, DOI 10.1073/pnas.93.23.13233; Feehan C, 1996, J BIOL CHEM, V271, P7019, DOI 10.1074/jbc.271.12.7019; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Gale NW, 1997, CELL TISSUE RES, V290, P227, DOI 10.1007/s004410050927; Gao PP, 1996, P NATL ACAD SCI USA, V93, P11161, DOI 10.1073/pnas.93.20.11161; GODEMENT P, 1994, J NEUROSCI, V14, P704; Grundy WN, 1996, COMPUT APPL BIOSCI, V12, P303; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; Lackmann M, 1997, J BIOL CHEM, V272, P16521, DOI 10.1074/jbc.272.26.16521; MASSAGUE J, 1993, ANNU REV BIOCHEM, V62, P515, DOI 10.1146/annurev.bi.62.070193.002503; Meima L, 1997, EUR J NEUROSCI, V9, P177, DOI 10.1111/j.1460-9568.1997.tb01365.x; Murray MJ, 1999, J NEUROSCI, V19, P7901; NAKAMURA H, 1989, J NEUROSCI, V9, P3776; Pan DJ, 1997, CELL, V90, P271, DOI 10.1016/S0092-8674(00)80335-9; Primakoff P, 2000, TRENDS GENET, V16, P83, DOI 10.1016/S0168-9525(99)01926-5; Schlondorff J, 1999, J CELL SCI, V112, P3603; SHOCKETT P, 1995, P NATL ACAD SCI USA, V92, P6522, DOI 10.1073/pnas.92.14.6522; Swarte VVR, 1998, CELL ADHES COMMUN, V6, P311, DOI 10.3109/15419069809010790; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Vecchi M, 1998, J BIOL CHEM, V273, P20589, DOI 10.1074/jbc.273.32.20589; Werb Z, 1998, SCIENCE, V282, P1279, DOI 10.1126/science.282.5392.1279; Wroblewski M, 1997, INT IMMUNOL, V9, P555, DOI 10.1093/intimm/9.4.555; Yavari R, 1998, HUM MOL GENET, V7, P1161, DOI 10.1093/hmg/7.7.1161; Zhang JH, 1996, J NEUROSCI, V16, P7182	31	448	455	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 25	2000	289	5483					1360	1365		10.1126/science.289.5483.1360	http://dx.doi.org/10.1126/science.289.5483.1360			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347RF	10958785				2022-12-24	WOS:000088942400042
J	Serio, TR; Cashikar, AG; Kowal, AS; Sawicki, GJ; Moslehi, JJ; Serpell, L; Arnsdorf, MF; Lindquist, SL				Serio, TR; Cashikar, AG; Kowal, AS; Sawicki, GJ; Moslehi, JJ; Serpell, L; Arnsdorf, MF; Lindquist, SL			Nucleated conformational conversion and the replication of conformational information by a prion determinant	SCIENCE			English	Article							YEAST PRION; PROTEIN; PROPAGATION; DISEASE; SCRAPIE; INHERITANCE; MECHANISM; HSP104; PSI(+); SUP35	Prion proteins can serve as genetic elements by adopting distinct physical and functional states that are self-perpetuating and heritable. The critical region of one prion protein, Sup35, is initially unstructured in solution and then forms self-seeded amyloid fibers. We examined in vitro the mechanism by which this state is attained and replicated. Structurally fluid oligomeric complexes appear to be crucial intermediates in de novo amyloid nucleus formation. Rapid assembly ensues when these complexes conformationally convert. upon association with nuclei. This model for replicating protein-based genetic information. nucleated conformational conversion, may be applicable to other protein assembly processes.	Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Cardiol Sect, Chicago, IL 60637 USA; MRC Ctr, Div Neurobiol, Mol Biol Lab, Cambridge CB2 2QH, England	University of Chicago; Howard Hughes Medical Institute; University of Chicago; University of Chicago; MRC Laboratory Molecular Biology	Lindquist, SL (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58th St, Chicago, IL 60637 USA.		Cashikar, Anil G/F-5968-2011; Serio, Tricia/GPP-7129-2022	Serio, Tricia/0000-0003-2687-7372; Serpell, Louise/0000-0001-9335-7751	NCRR NIH HHS [P41-RR017777] Funding Source: Medline; NIGMS NIH HHS [GM57840, GM025874] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM025874, R01GM057840, R37GM025874] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BEAVEN GH, 1969, EUR J BIOCHEM, V11, P37, DOI 10.1111/j.1432-1033.1969.tb00735.x; CASHIKAR AG, UNPUB; CASPAR DLD, 1980, BIOPHYS J, V32, P103, DOI 10.1016/S0006-3495(80)84929-0; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; COX BS, 1965, HEREDITY, V20, P505, DOI 10.1038/hdy.1965.65; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Dill KA, 1999, PROTEIN SCI, V8, P1166, DOI 10.1110/ps.8.6.1166; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; HOFRICHTER J, 1974, P NATL ACAD SCI USA, V71, P4864, DOI 10.1073/pnas.71.12.4864; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Lansbury PT, 1999, P NATL ACAD SCI USA, V96, P3342, DOI 10.1073/pnas.96.7.3342; LINDQUIST S, 1999, MOL CHAPERONES FOLDI, P347; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; Mayo KH, 2000, TRENDS BIOTECHNOL, V18, P212, DOI 10.1016/S0167-7799(00)01439-6; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1997, SCIENCE, V277, P381, DOI 10.1126/science.277.5324.381; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Serio TR, 1999, ANNU REV CELL DEV BI, V15, P661, DOI 10.1146/annurev.cellbio.15.1.661; Serio TR, 1999, METHOD ENZYMOL, V309, P649; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; URATANI Y, 1972, J MOL BIOL, V67, P85, DOI 10.1016/0022-2836(72)90388-9; WALL JS, 1986, ANNU REV BIOPHYS BIO, V15, P355; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481	28	793	806	1	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 25	2000	289	5483					1317	1321		10.1126/science.289.5483.1317	http://dx.doi.org/10.1126/science.289.5483.1317			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347RF	10958771				2022-12-24	WOS:000088942400028
J	Chai, JJ; Du, CY; Wu, JW; Kyin, S; Wang, XD; Shi, YG				Chai, JJ; Du, CY; Wu, JW; Kyin, S; Wang, XD; Shi, YG			Structural and biochemical basis of apoptotic activation by Smac/DIABLO	NATURE			English	Article							PROGRAMMED CELL-DEATH; CYTOCHROME-C; PROCASPASE-9 ACTIVATION; DNA FRAGMENTATION; PROTEIN XIAP; INHIBITOR; OLIGOMERIZATION; CASPASES; APAF-1; DATP	Apoptosis (programmed cell death), an essential process in the development and homeostasis of metazoans, is carried out by caspases. The mitochondrial protein Smac/DIABLO performs a critical function in apoptosis by eliminating the inhibitory effect of IAPs (inhibitor of apoptosis proteins) on caspases. Here we show that Smac/DIABLO promotes not only the proteolytic activation of procaspase-3 but also the enzymatic activity of mature caspase-3, both of which depend upon its ability to interact physically with IAPs. The crystal structure of Smac/DIABLO at 2.2 Angstrom resolution reveals that it homodimerizes through an extensive hydrophobic interface. Missense mutations inactivating this dimeric interface significantly compromise the function of Smac/DIABLO. As in the Drosophila proteins Reaper, Grim and Hid, the amino-terminal amino acids of Smac/DIABLO are indispensable for its function, and a seven-residue peptide derived from the amino terminus promotes procaspase-3 activation in vitro. These results establish an evolutionarily conserved structural and biochemical basis for the activation of apoptosis by Smac/DIABLO.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75235 USA	Princeton University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Shi, YG (corresponding author), Princeton Univ, Dept Mol Biol, Washington Rd, Princeton, NJ 08544 USA.	yshi@molbio.princeton.edu		Shi, Yigong/0000-0003-2030-168X; Chai, Jijie/0000-0001-7591-3873				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chinnaiyan AM, 1996, CURR BIOL, V6, P555; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Deveraux QL, 1999, EMBO J, V18, P5242, DOI 10.1093/emboj/18.19.5242; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; GREEN DR, 1995, CURR OPIN IMMUNOL, V7, P694, DOI 10.1016/0952-7915(95)80079-4; Hengartner MO, 1996, CURR OPIN GENET DEV, V6, P34, DOI 10.1016/S0959-437X(96)90007-6; HIREL PH, 1989, P NATL ACAD SCI USA, V86, P8247, DOI 10.1073/pnas.86.21.8247; Horvitz HR, 1999, CANCER RES, V59, p1701S; Hozak RR, 2000, MOL CELL BIOL, V20, P1877, DOI 10.1128/MCB.20.5.1877-1885.2000; Hu YM, 1998, J BIOL CHEM, V273, P33489, DOI 10.1074/jbc.273.50.33489; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KLAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Miller LK, 1999, TRENDS CELL BIOL, V9, P323, DOI 10.1016/S0962-8924(99)01609-8; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Rotonda J, 1996, NAT STRUCT BIOL, V3, P619, DOI 10.1038/nsb0796-619; Saleh A, 1999, J BIOL CHEM, V274, P17941, DOI 10.1074/jbc.274.25.17941; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; Sun CH, 1999, NATURE, V401, P818, DOI 10.1038/44617; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; Terwilliger TC, 1996, ACTA CRYSTALLOGR D, V52, P749, DOI 10.1107/S0907444996000832; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; Yang XL, 1998, SCIENCE, V281, P1355, DOI 10.1126/science.281.5381.1355; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	37	637	725	18	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2000	406	6798					855	862		10.1038/35022514	http://dx.doi.org/10.1038/35022514			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347AG	10972280				2022-12-24	WOS:000088903600034
J	Churchill, D; Allen, J; Pringle, M; Hippisley-Cox, J; Ebdon, D; Macpherson, M; Bradley, S				Churchill, D; Allen, J; Pringle, M; Hippisley-Cox, J; Ebdon, D; Macpherson, M; Bradley, S			Consultation patterns and provision of contraception in general practice before teenage pregnancy: case-control study	BRITISH MEDICAL JOURNAL			English	Article							ADOLESCENTS; CARE	Objectives To determine patterns of consultation in general practice and provision of contraception before teenage pregnancy. Design Case-control study, with retrospective analysis of case notes. Setting 14 general practices in Trent region. Subjects 240 registered patients (cases) with a recorded conception before the age of 20. Three controls per case were matched by age and practice. Main outcome measures Consultations in general practice and provision of contraception in the 12 months before conception and recorded provision of contraception at any time before conception. Results Overall, 223 cases (93%) had consulted a health professional at least once in the year before conception, 171 (71%) had discussed contraception in this time, and 121 (50%) had been prescribed oral contraception. Cases were more likely to have consulted in the year before: conception than controls (odds ratio 2.70, 95% confidence interval 1.56 to 4.66). (odds ratio 2.70, 95% confidence interval 1.56 to 4.66). Most Of the difference was owing to consultation for contraception. Overall, 53 cases (22%,) resulted in a termination of pregnancy. Cases whose pregnancy ended in a termination were more likely to have received emergency contraception than either their controls (3.21, 1.32 to 7.79) or cases resulting in other outcomes (3.01, 1.06 to 8.51). Conclusions Most teenagers who became pregnant attended general practice in the year before pregnancy, and many had sought contraceptive advice. The reluctance of teenagers to attend general practice for contraception may be less than previously supposed. The association between provision of emergency contraception and pregnancy ending in termination emphasises the need for continuing follow up of teenagers consulting for this form of contraception.	Univ Nottingham, Sch Med, Queens Med Ctr, Div Gen Practice, Nottingham NG7 2UH, England; Univ Nottingham, Dept Geog, Nottingham NG7 2RD, England; Queens Med Ctr, Dept Obstet & Gynaecol, Nottingham NG7 2UH, England; Queens Med Ctr, Sch Nursing, Nottingham NG7 2UH, England	University of Nottingham; University of Nottingham; University of Nottingham; University of Nottingham	Churchill, D (corresponding author), Univ Nottingham, Sch Med, Queens Med Ctr, Div Gen Practice, Nottingham NG7 2UH, England.		Hippisley-Cox, Julia/AAY-2788-2020	Hippisley-Cox, Julia/0000-0002-2479-7283; Bethea, Jane/0000-0003-0297-0468; Churchill, Richard/0000-0003-0049-8200				COLEMAN J, 1999, KEY DATA ADOLESCENCE; Donovan C, 1997, BRIT J GEN PRACT, V47, P715; JACOBSON LD, 1994, FAM PRACT, V11, P296, DOI 10.1093/fampra/11.3.296; JACOBSON LD, 1994, BRIT J GEN PRACT, V44, P420; Kramer T, 1997, BRIT J GEN PRACT, V47, P327; MELVILLE AWT, 1989, FAM PRACT, V6, P245, DOI 10.1093/fampra/6.4.245; NHS Centre for Reviews and Dissemination University of York, 1997, EFFECTIVE HLTH CARE, V3, P1; PEARSON VAH, 1995, J ROY SOC MED, V88, P384; PEARSON VAH, 1995, BRIT J FAM PLAN, V21, P45; *SECR STAT HLTH, 1992, HLTH NAT; *SOC EXCL UN, 1999, CMND 4342; Stevenson J, 1996, BRIT J FAM PLAN, V22, P75	12	42	45	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 19	2000	321	7259					486	489		10.1136/bmj.321.7259.486	http://dx.doi.org/10.1136/bmj.321.7259.486			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	347MC	10948031	Bronze, Green Published			2022-12-24	WOS:000088932800023
J	Kawasaki, Y; Senda, T; Ishidate, T; Koyama, R; Morishita, T; Iwayama, Y; Higuchi, O; Akiyama, T				Kawasaki, Y; Senda, T; Ishidate, T; Koyama, R; Morishita, T; Iwayama, Y; Higuchi, O; Akiyama, T			Asef, a link between the tumor suppressor APC and G-protein signaling	SCIENCE			English	Article							BETA-CATENIN; DROSOPHILA HOMOLOG; CELL-MIGRATION; GENE-PRODUCT; AXIN; IDENTIFICATION; ASSOCIATION; LOCALIZATION; GSK-3-BETA; GSK3-BETA	The adenomatous polyposis coli gene (APC) is mutated in familiar adenomatous polyposis and in sporadic colorectal tumors. Here the APC gene product is shown to bind through its armadillo repeat domain to a Rac-specific guanine nucleotide exchange factor (GEF), termed Asef. Endogenous APC colocalized with Asef in mouse colon epithelial cells and neuronal cells. Furthermore, APC enhanced the CEF activity of Asef and stimulated Asef-mediated cell flattening, membrane ruffling, and Lamellipodia formation in MDCK cells. These results suggest that the APC-Asef complex may regulate the actin cytoskeletal network, cell morphology and migration, and neuronal function.	Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Bunkyo Ku, Tokyo 113, Japan; Nagoya Univ, Sch Med, Dept Anat 1, Showa Ku, Nagoya, Aichi 466, Japan; Osaka Univ, Inst Microbial Dis, Dept Oncogene Res, Suita, Osaka 565, Japan	University of Tokyo; Nagoya University; Osaka University	Akiyama, T (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 113, Japan.							BAEG GH, 1995, EMBO J, V14, P5618, DOI 10.1002/j.1460-2075.1995.tb00249.x; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Bienz M, 1999, CURR OPIN GENET DEV, V9, P595, DOI 10.1016/S0959-437X(99)00016-7; Brakeman JSF, 1999, NEUROSCIENCE, V91, P661, DOI 10.1016/S0306-4522(98)00605-8; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hamada F, 1999, GENES CELLS, V4, P465, DOI 10.1046/j.1365-2443.1999.00272.x; Hamada F, 1999, SCIENCE, V283, P1739, DOI 10.1126/science.283.5408.1739; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; KAWASAKI Y, UNPUB; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Matsumine A, 1996, SCIENCE, V272, P1020, DOI 10.1126/science.272.5264.1020; McCartney BM, 1999, J CELL BIOL, V146, P1303, DOI 10.1083/jcb.146.6.1303; MIKI T, 1993, NATURE, V362, P462, DOI 10.1038/362462a0; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Nakagawa H, 1998, CANCER RES, V58, P5176; Nakamura T, 1998, GENES CELLS, V3, P395, DOI 10.1046/j.1365-2443.1998.00198.x; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Polakis P, 1997, BBA-REV CANCER, V1332, pF127, DOI 10.1016/S0304-419X(97)00008-5; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Senda T, 1998, NEUROSCIENCE, V83, P857, DOI 10.1016/S0306-4522(97)00459-4; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; SU LK, 1995, CANCER RES, V55, P2972; VAN AL, 1997, GENE DEV, V11, P2295; van Es JH, 1999, CURR BIOL, V9, P105, DOI 10.1016/S0960-9822(99)80024-4; Whitehead IP, 1997, BBA-REV CANCER, V1332, pF1, DOI 10.1016/S0304-419X(96)00040-6; Wong MH, 1996, P NATL ACAD SCI USA, V93, P9588, DOI 10.1073/pnas.93.18.9588; Yu X, 1999, NAT CELL BIOL, V1, P144, DOI 10.1038/11064	30	284	296	2	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 18	2000	289	5482					1194	1197		10.1126/science.289.5482.1194	http://dx.doi.org/10.1126/science.289.5482.1194			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346JE	10947987				2022-12-24	WOS:000088866600043
J	Vanrenterghem, Y				Vanrenterghem, Y			Cautious approach to use of non-heart-beating donors	LANCET			English	Editorial Material							TRANSPLANTATION; KIDNEYS		Univ Hosp Gasthuisberg, Dept Nephrol, B-3000 Louvain, Belgium	KU Leuven; University Hospital Leuven	Vanrenterghem, Y (corresponding author), Univ Hosp Gasthuisberg, Dept Nephrol, B-3000 Louvain, Belgium.							Balupuri S, 2000, TRANSPLANTATION, V69, P842; BOS MA, 1995, TRANSPLANT P, V27, P2929; Cho YW, 1998, NEW ENGL J MED, V338, P221, DOI 10.1056/NEJM199801223380403; Daemen JWHC, 1997, TRANSPLANTATION, V63, P89, DOI 10.1097/00007890-199701150-00017; *I MED NAT AC SCI, 1997, NONH BEAT ORG TRANSP; Kootstra G, 1997, TRANSPLANTATION, V63, P917, DOI 10.1097/00007890-199704150-00001; KOOTSTRA G, 1995, TRANSPLANT P, V27, P2893; *PMC, 1993, KENNEDY INST ETHIC J, V3, pA1; WIJNEN RMH, 1995, LANCET, V345, P1067, DOI 10.1016/S0140-6736(95)90815-3	9	25	25	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 12	2000	356	9229					528	528		10.1016/S0140-6736(00)02575-7	http://dx.doi.org/10.1016/S0140-6736(00)02575-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	345MY	10950227				2022-12-24	WOS:000088820800007
J	Angelucci, E; Brittenham, GM; McLaren, CE; Ripalti, M; Baronciani, D; Giardini, C; Galimberti, M; Polchi, P; Lucarelli, G				Angelucci, E; Brittenham, GM; McLaren, CE; Ripalti, M; Baronciani, D; Giardini, C; Galimberti, M; Polchi, P; Lucarelli, G			Hepatic iron concentration and total body iron stores in thalassemia major.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE-MARROW TRANSPLANTATION; STORAGE IRON; OVERLOAD; SELECTION	Background and Methods: We tested the usefulness of measuring the hepatic iron concentration to evaluate total body iron stores in patients who had been cured of thalassemia major by bone marrow transplantation and who were undergoing phlebotomy treatment to remove excess iron. Results: We began treatment with phlebotomy a mean (+/-SD) of 4.3+/-2.7 years after transplantation in 48 patients without hepatic cirrhosis. In the group of 25 patients with liver-biopsy samples that were at least 1.0 mg in dry weight, there was a significant correlation between the decrease in the hepatic iron concentration and total body iron stores (r=0.98, P<0.001). Assuming that the hepatic iron concentration is reduced to zero with complete removal of body iron stores during phlebotomy, the amount of total body iron stores (in milligrams per kilogram of body weight) is equivalent to 10.6 times the hepatic iron concentration (in milligrams per gram of liver, dry weight). With the use of this equation, we could reliably estimate total body iron stores as high as 250 mg per kilogram of body weight, with a standard error of less than 7.9. Conclusions: The hepatic iron concentration is a reliable indicator of total body iron stores in patients with thalassemia major. In patients with transfusion-related iron overload, repeated determinations of the hepatic iron concentration can provide a quantitative means of measuring the long-term iron balance. (N Engl J Med 2000;343:327-31.) (C) 2000, Massachusetts Medical Society.	Azienda Osped Pesaro, Unita Operat Ematol, Pesaro, Italy; Azienda Osped Pesaro, Ctr Trapianto Midollo Osseo Muraglia, Pesaro, Italy; Columbia Univ Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; Univ Calif Irvine, Dept Med, Div Epidemiol, Irvine, CA 92717 USA	Columbia University; Columbia University; University of California System; University of California Irvine	Angelucci, E (corresponding author), Azienda Osped Pesaro, Unita Operat Ematol Muraglia, I-61100 Pesaro, Italy.		Angelucci, Emanuele/AAC-1855-2021	Baronciani, Donatella/0000-0001-6087-2431; Angelucci, Emanuele/0000-0002-6512-6080	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK049108, R01DK049108] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL61219, HL62882] Funding Source: Medline; NIDDK NIH HHS [DK49108] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLEN DM, 1974, TECHNOMETRICS, V16, P125, DOI 10.2307/1267500; Angelucci E, 1997, BLOOD, V90, P4736, DOI 10.1182/blood.V90.12.4736.4736_4736_4742; Angelucci E, 1997, BLOOD, V90, P994, DOI 10.1182/blood.V90.3.994.994_994_998; ANGELUCCI E, 1995, BRIT J HAEMATOL, V89, P757; BARRY M, 1974, BMJ-BRIT MED J, V2, P16, DOI 10.1136/bmj.2.5909.16; BARRY M, 1974, GUT, V15, P411, DOI 10.1136/gut.15.5.411; Bonkovsky HL, 1999, RADIOLOGY, V212, P227, DOI 10.1148/radiology.212.1.r99jl35227; BOTHWELL T. H., 1964, S AFR J MED SCI, V29, P21; BRITTENHAM G, IN PRESS SEMIN HEMAT; Brittenham GM, 1998, BLOOD, V92, p38B; BRITTENHAM GM, 1982, NEW ENGL J MED, V307, P1671, DOI 10.1056/NEJM198212303072703; BRITTENHAM GM, 1994, NEW ENGL J MED, V331, P567, DOI 10.1056/NEJM199409013310902; Brittenham GM, 2000, HEMATOLOGY BASIC PRI, P397; Fischer R., 1998, MAGNETISM MED HDB, P286; GEISSER S, 1979, J AM STAT ASSOC, V74, P153, DOI 10.2307/2286745; HALLBERG L, 1966, ACTA OBSTET GYN SCAN, V45, P320, DOI 10.3109/00016346609158455; Jandl J.H., 1996, BLOOD TXB HEMATOLOGY; LUCARELLI G, 1993, LANCET, V342, P1388, DOI 10.1016/0140-6736(93)92753-G; MCCULLAGH P., 1991, GEN LINEAR MODELS; MURETTO P, 1994, LIVER, V14, P14; Oelckers S, 1996, PHYS MED BIOL, V41, P1149, DOI 10.1088/0031-9155/41/7/006; Pippard M J, 1989, Prog Clin Biol Res, V309, P85; SMITH N, 1991, J APPL PHYS, V69, P5082, DOI 10.1063/1.348130; Soriano-Cubells MJ, 1984, ATOM SPECTROSC, V5, P217; VALBERG LS, 1975, J LAB CLIN MED, V86, P479; Wang ZYJ, 1999, J MAGN RESON, V140, P477, DOI 10.1006/jmre.1999.1873; Weisberg S., 1985, APPL LINEAR REGRESSI; Worwood M, 1994, IRON METABOLISM HLTH, P449	28	432	461	3	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 3	2000	343	5					327	331		10.1056/NEJM200008033430503	http://dx.doi.org/10.1056/NEJM200008033430503			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	340GR	10922422				2022-12-24	WOS:000088525200003
J	Sharma, K; Leonard, AE; Lettieri, K; Pfaff, SL				Sharma, K; Leonard, AE; Lettieri, K; Pfaff, SL			Genetic and epigenetic mechanisms contribute to motor neuron pathfinding	NATURE			English	Article							MOTONEURON PROJECTION PATTERNS; EMBRYONIC STEM-CELLS; SPINAL-CORD; INNERVATION; EXPRESSION; REQUIREMENT; MUSCULATURE; IDENTITY; SUBTYPES; WINGS	Many lines of evidence indicate that genetically distinct subtypes of motor neurons are specified during development(1), with each type having characteristic properties of axon guidance and cell-body migration(2). Motor neuron subtypes express unique combinations of LIM-type homeodomain factors that may act as intrinsic genetic regulators of the cytoskeletal events that mediate cell migration, axon navigation or both(3-7). Although experimentally displaced motor neurons can pioneer new routes to their targets(8-11), in many cases the axons of motor neurons in complete isolation from their normal territories passively follow stereotypical pathways dictated by the environment(12-16). To investigate the nonspecific versus genetically controlled regulation of motor connectivity we forced all motor neurons to express ectopically a LIM gene combination appropriate for the subgroup that innervates axial muscles. Here we show that this genetic alteration is sufficient to convert the cell body settling pattern, gene-expression profile and axonal projections of all motor neurons to that of the axial subclass. Nevertheless, elevated occupancy of the axial pathway can override their genetic program, causing some axons to project to alternative targets.	Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	Salk Institute	Pfaff, SL (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.							Appel B, 1995, DEVELOPMENT, V121, P4117; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Bell E, 1999, SCIENCE, V284, P2168, DOI 10.1126/science.284.5423.2168; FERGUSON BA, 1983, J NEUROSCI, V3, P1760; FERNS MJ, 1993, J NEUROSCI, V13, P2463, DOI 10.1523/JNEUROSCI.13-06-02463.1993; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Goodhill GJ, 1999, TRENDS NEUROSCI, V22, P529, DOI 10.1016/S0166-2236(99)01469-1; Jurata LW, 2000, CURR OPIN NEUROBIOL, V10, P72, DOI 10.1016/S0959-4388(99)00053-7; LANCEJONES C, 1980, J PHYSIOL-LONDON, V302, P559; LANCEJONES C, 1980, J PHYSIOL-LONDON, V302, P581; LANCEJONES CC, 1986, DEV BIOL, V116, P387, DOI 10.1016/0012-1606(86)90141-7; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P391, DOI 10.1113/jphysiol.1978.sp012546; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; OBRIEN MK, 1990, J NEUROBIOL, V21, P341, DOI 10.1002/neu.480210208; Pfaff S, 1998, CURR OPIN NEUROBIOL, V8, P27, DOI 10.1016/S0959-4388(98)80005-6; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; STRAZNICKY C, 1983, ANAT EMBRYOL, V167, P247, DOI 10.1007/BF00298514; SUMMERBELL D, 1981, J EMBRYOL EXP MORPH, V61, P233; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; VarelaEchavarria A, 1996, MOL CELL NEUROSCI, V8, P242, DOI 10.1006/mcne.1996.0061; WETTS R, 1994, NEUROSCIENCE, V63, P1117, DOI 10.1016/0306-4522(94)90577-0; WHITELAW V, 1983, J NEUROSCI, V3, P1216	27	102	103	0	7	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2000	406	6795					515	519		10.1038/35020078	http://dx.doi.org/10.1038/35020078			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952312				2022-12-24	WOS:000088538000046
J	Scolnick, DM; Halazonetis, TD				Scolnick, DM; Halazonetis, TD			Chfr defines a mitotic stress checkpoint that delays entry into metaphase	NATURE			English	Article							HUMAN CANCERS; DNA-DAMAGE; CELL-LINES; IDENTIFICATION; MITOSIS; MUTATION; TARGETS; FINGER; DOMAIN; GENES	Chemicals that target microtubules induce mitotic stress by affecting several processes that occur during mitosis. These processes include separation of the centrosomes in prophase, alignment of the chromosomes on the spindle in metaphase and sister-chromatid separation in anaphase(1,2). Many human cancers are sensitive to mitotic stress. This sensitivity is being exploited for therapy and implies checkpoint defects(2-8). The known mitotic checkpoint genes, which prevent entry into anaphase when the chromosomes are not properly aligned on the mitotic spindle, are, however, rarely inactivated in human cancer(9-13). Here we describe the chfr gene, which is inactivated owing to lack of expression or by mutation in four out of eight human cancer cell lines examined. Normal primary cells and tumour cell lines that express wild-type chfr exhibited delayed entry into metaphase when centrosome separation was inhibited by mitotic stress. In contrast, the tumour cell lines that had lost chfr function entered metaphase without delay. Ectopic expression of wild-type chfr restored the cell cycle delay and increased the ability of the cells to survive mitotic stress. Thus, chfr defines a checkpoint that delays entry into metaphase in response to mitotic stress.	Wistar Inst, Philadelphia, PA 19104 USA; Univ Penn, Grad Program Biochem, Philadelphia, PA 19104 USA	The Wistar Institute; University of Pennsylvania	Halazonetis, TD (corresponding author), Wistar Inst, 3601 Spruce St, Philadelphia, PA 19104 USA.		Halazonetis, Thanos/D-7923-2011					Amon A, 1999, CURR OPIN GENET DEV, V9, P69, DOI 10.1016/S0959-437X(99)80010-0; BORDEN KLB, 1995, EMBO J, V14, P1532, DOI 10.1002/j.1460-2075.1995.tb07139.x; Cahill DP, 1999, GENOMICS, V58, P181, DOI 10.1006/geno.1999.5831; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; Elledge SJ, 1998, SCIENCE, V279, P999, DOI 10.1126/science.279.5353.999; Furuno N, 1999, J CELL BIOL, V147, P295, DOI 10.1083/jcb.147.2.295; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; HOFMANN K, 1995, TRENDS BIOCHEM SCI, V20, P347, DOI 10.1016/S0968-0004(00)89072-6; HOLLIDAY R, 1993, MUTAT RES, V285, P61, DOI 10.1016/0027-5107(93)90052-H; Janss AJ, 1998, EXP CELL RES, V243, P29, DOI 10.1006/excr.1998.4122; Jin DY, 1998, CELL, V93, P81, DOI 10.1016/S0092-8674(00)81148-4; Jordan MA, 1998, CURR OPIN CELL BIOL, V10, P123, DOI 10.1016/S0955-0674(98)80095-1; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Li Y, 1996, SCIENCE, V274, P246, DOI 10.1126/science.274.5285.246; LOVERING R, 1993, P NATL ACAD SCI USA, V90, P2112, DOI 10.1073/pnas.90.6.2112; MCINTOSH JR, 1989, SCIENCE, V246, P622; Muhua L, 1998, NATURE, V393, P487, DOI 10.1038/31014; Murone M, 1996, EMBO J, V15, P6605, DOI 10.1002/j.1460-2075.1996.tb01051.x; Weinert T, 1998, CELL, V94, P555, DOI 10.1016/S0092-8674(00)81597-4; Yamaguchi K, 1999, CANCER LETT, V139, P183, DOI 10.1016/S0304-3835(99)00035-X; Zimmerman W, 1999, CURR OPIN CELL BIOL, V11, P122, DOI 10.1016/S0955-0674(99)80015-5; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	24	319	333	0	40	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					430	435		10.1038/35019108	http://dx.doi.org/10.1038/35019108			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935642				2022-12-24	WOS:000088383800052
J	Brittle, EE; Waters, MG				Brittle, EE; Waters, MG			Cell biology - ER-to-Golgi traffic - This bud's for you	SCIENCE			English	Editorial Material							ENDOPLASMIC-RETICULUM; TRANSPORT; ENDOSOME; DOCKING; COMPLEX		Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Brittle, EE (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.			Zumbrun, Elizabeth/0000-0002-9897-7201				Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Cao XC, 2000, J CELL BIOL, V149, P55, DOI 10.1083/jcb.149.1.55; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Guo W, 2000, TRENDS CELL BIOL, V10, P251, DOI 10.1016/S0962-8924(00)01754-2; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; NUOFFER C, 1994, J CELL BIOL, V125, P225, DOI 10.1083/jcb.125.2.225; Peterson MR, 1999, CURR BIOL, V9, P159, DOI 10.1016/S0960-9822(99)80071-2; Rowe T, 1998, SCIENCE, V279, P696, DOI 10.1126/science.279.5351.696; Sonnichsen B, 1998, J CELL BIOL, V140, P1013, DOI 10.1083/jcb.140.5.1013; Springer S, 1998, SCIENCE, V281, P698, DOI 10.1126/science.281.5377.698; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; Waters MG, 1999, CURR OPIN CELL BIOL, V11, P453, DOI 10.1016/S0955-0674(99)80065-9; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X	14	7	7	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2000	289	5478					403	404		10.1126/science.289.5478.403	http://dx.doi.org/10.1126/science.289.5478.403			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336ME	10939952				2022-12-24	WOS:000088305500028
J	Takakura, N; Watanabe, T; Suenobu, S; Yamada, Y; Noda, T; Ito, Y; Satake, M; Suda, T				Takakura, N; Watanabe, T; Suenobu, S; Yamada, Y; Noda, T; Ito, Y; Satake, M; Suda, T			A role for hematopoietic stem cells in promoting angiogenesis	CELL			English	Article							RECEPTOR TYROSINE KINASE; BLOOD-VESSEL FORMATION; DEFINITIVE HEMATOPOIESIS; TIE2 RECEPTOR; YOLK-SAC; VASCULAR DEVELOPMENT; MOUSE EMBRYOS; ANGIOPOIETIN-1; MICE; LEUKEMIA	Angiogenesis is an important event for embryonic organogenesis as well as for tissue repair in the adult. Here, we show that hematopoietic stem cells (HSCs) play important roles for angiogenesis during embryogenesis. To investigate the role of HSCs in endothelial cell (EC) development, we analyzed AML1-deficient embryos, which lack definitive hematopoiesis. These embryos showed defective angiogenesis in the head and pericardium. Pars-aortic splanchnopleural (P-Sp) explant cultures on stromal cells (P-Sp culture) did not generate definitive hematopoietic cells and showed defective angiogenesis in the AML1 null embryo. Disrupted angiogenesis in P-Sp cultures from AML1 null embryos was rescued by addition of HSCs or angiopoietin-1 (Ang1). HSCs, which express Ang1, directly promoted migration of ECs in vivo and in vitro. These results indicate that HSCs are critical for angiogenesis.	Kumamoto Univ, Sch Med, Inst Mol Embryol & Genet, Dept Cell Differentiat, Kumamoto 8600811, Japan; Tohoku Univ, Inst Dev Aging & Canc, Dept Mol Immunol, Sendai, Miyagi 9800872, Japan; Inst Canc Res, Dept Cell Biol, Toshima Ku, Tokyo 1708455, Japan; Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Sakyo Ku, Kyoto 6068507, Japan	Kumamoto University; Tohoku University; Kyoto University	Takakura, N (corresponding author), Kumamoto Univ, Sch Med, Inst Mol Embryol & Genet, Dept Cell Differentiat, 2-2-1 Honjo, Kumamoto 8600811, Japan.	ntakaku@gpo.kumamoto-u.ac.jp; sudato@gpo.kumamoto-u.ac.jp	Suda, Toshio/H-6761-2013; Noda, Tetsuo/B-1667-2016	Suda, Toshio/0000-0001-7540-1771; 				Asahara T, 1998, CIRC RES, V83, P233, DOI 10.1161/01.RES.83.3.233; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Dumont DJ, 1998, SCIENCE, V282, P946, DOI 10.1126/science.282.5390.946; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Gale NW, 1999, GENE DEV, V13, P1055, DOI 10.1101/gad.13.9.1055; GODIN I, 1995, P NATL ACAD SCI USA, V92, P773, DOI 10.1073/pnas.92.3.773; Hanahan D, 1997, SCIENCE, V277, P48, DOI 10.1126/science.277.5322.48; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Janowska-Wieczorek A, 1999, BLOOD, V93, P3379, DOI 10.1182/blood.V93.10.3379.410k09_3379_3390; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; North T, 1999, DEVELOPMENT, V126, P2563; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Okada H, 1998, ONCOGENE, V17, P2287, DOI 10.1038/sj.onc.1202151; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; PASSANITI A, 1992, LAB INVEST, V67, P519; PURI MC, 1995, EMBO J, V14, P5884, DOI 10.1002/j.1460-2075.1995.tb00276.x; ROBB L, 1995, P NATL ACAD SCI USA, V92, P7075, DOI 10.1073/pnas.92.15.7075; Sato A, 1998, INT IMMUNOL, V10, P1217, DOI 10.1093/intimm/10.8.1217; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; SHIVDASANI RA, 1995, CELL, V81, P695, DOI 10.1016/0092-8674(95)90531-6; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Suri C, 1998, SCIENCE, V282, P468, DOI 10.1126/science.282.5388.468; Takakura N, 1996, J EXP MED, V184, P2301, DOI 10.1084/jem.184.6.2301; Takakura N, 1998, IMMUNITY, V9, P677, DOI 10.1016/S1074-7613(00)80665-2; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; Visvader JE, 1998, GENE DEV, V12, P473, DOI 10.1101/gad.12.4.473; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Witzenbichler B, 1998, J BIOL CHEM, V273, P18514, DOI 10.1074/jbc.273.29.18514; Yano M, 1997, BLOOD, V89, P4317, DOI 10.1182/blood.V89.12.4317; Yoder MC, 1997, IMMUNITY, V7, P335, DOI 10.1016/S1074-7613(00)80355-6	39	425	457	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 21	2000	102	2					199	209		10.1016/S0092-8674(00)00025-8	http://dx.doi.org/10.1016/S0092-8674(00)00025-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	337NA	10943840	Bronze			2022-12-24	WOS:000088366800010
J	Maritan, A; Micheletti, C; Trovato, A; Banavar, JR				Maritan, A; Micheletti, C; Trovato, A; Banavar, JR			Optimal shapes of compact strings	NATURE			English	Article							SECONDARY STRUCTURE; KNOTS; GEOMETRY	Optimal geometrical arrangements, such as the stacking of atoms, are of relevance in diverse disciplines(1-5). A classic problem is the determination of the optimal arrangement of spheres in three dimensions in order to achieve the highest packing fraction; only recently has it been proved(1,2) that the answer for infinite systems is a face-centred-cubic lattice. This simply stated problem has had a profound impact in many areas(3-5), ranging from the crystallization and melting of atomic systems, to optimal packing of objects and the sub-division of space. Here we study an analogous problem-that of determining the optimal shapes of closely packed compact strings. This problem is a mathematical idealization of situations commonly encountered in biology, chemistry and physics, involving the optimal structure of folded polymeric chains. We rnd that, in cases where boundary effects(6) are not dominant, helices with a particular pitch-radius ratio are selected. Interestingly, the same geometry is observed in helices in naturally occurring proteins.	Penn State Univ, Dept Phys, University Pk, PA 16802 USA; Penn State Univ, Ctr Phys Mat, Davey Lab 104, University Pk, PA 16802 USA; Scuola Int Super Studi Avanzati, I-34014 Trieste, Italy; Ist Nazl Fis Mat, Trieste, Italy; Abdus Salam Int Ctr Theoret Phys, Trieste, Italy	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; International School for Advanced Studies (SISSA); Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); University of Padua; Abdus Salam International Centre for Theoretical Physics (ICTP)	Banavar, JR (corresponding author), Penn State Univ, Dept Phys, University Pk, PA 16802 USA.	jayanth@phys.psu.edu	Trovato, Antonio/A-3471-2009	Trovato, Antonio/0000-0002-1596-9477; Micheletti, Cristian/0000-0002-1022-1638; Maritan, Amos/0000-0002-3535-7873				Buck G, 1998, NATURE, V392, P238, DOI 10.1038/32561; BUCK G, 1995, TOPOL APPL, V61, P205, DOI 10.1016/0166-8641(94)00024-W; Cantarella J, 1998, NATURE, V392, P237, DOI 10.1038/32558; Car R, 1997, NATURE, V385, P115, DOI 10.1038/385115a0; Cipra B, 1998, SCIENCE, V281, P1267, DOI 10.1126/science.281.5381.1267; CREIGHTON TE, 1993, PROTEINS STRUCTURES, P182; Gonzalez O, 1999, P NATL ACAD SCI USA, V96, P4769, DOI 10.1073/pnas.96.9.4769; Katritch V, 1997, NATURE, V388, P148, DOI 10.1038/40582; Katritch V, 1996, NATURE, V384, P142, DOI 10.1038/384142a0; Mackenzie D, 1999, SCIENCE, V285, P1338, DOI 10.1126/science.285.5432.1338; Maritan A, 2000, PHYS REV LETT, V84, P3009, DOI 10.1103/PhysRevLett.84.3009; Micheletti C, 1999, PHYS REV LETT, V82, P3372, DOI 10.1103/PhysRevLett.82.3372; ROSE GD, 1977, J MOL BIOL, V113, P153, DOI 10.1016/0022-2836(77)90046-8; SALI A, 1994, NATURE, V369, P248, DOI 10.1038/369248a0; Sloane NJA, 1998, NATURE, V395, P435, DOI 10.1038/26609; SOCCI ND, 1994, PHYS REV E, V49, P3440, DOI 10.1103/PhysRevE.49.3440; Sokal AD, 1996, NUCL PHYS B, P172, DOI 10.1016/0920-5632(96)00042-4; STEWART I, 1998, SCI AM           FEB, P80; Woodcock LV, 1997, NATURE, V385, P141, DOI 10.1038/385141a0; YEE DP, 1994, J MOL BIOL, V241, P557, DOI 10.1006/jmbi.1994.1531	20	236	235	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2000	406	6793					287	290		10.1038/35018538	http://dx.doi.org/10.1038/35018538			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917526	Green Submitted			2022-12-24	WOS:000088251900044
J	Margolis, KL; Ensrud, KE; Schreiner, PJ; Tabor, HK				Margolis, KL; Ensrud, KE; Schreiner, PJ; Tabor, HK		Study Osteoporotic Fractures Res	Body size and risk for clinical fractures in older women	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	21st Annual Meeting of the Society-of-General-Internal-Medicine	APR 23-25, 1998	CHICAGO, IL	Soc Gen Internal Med			HIP FRACTURE; ELDERLY WOMEN; OSTEOPOROTIC FRACTURES; BONE-DENSITY	Background: Small body size predicts hip fractures in older women. Objective: To test the hypothesis that small body size predicts the risk for other clinical fractures. Design: Prospective cohort study, Setting: Population-based listings in four areas of the United States. Patients: 8059 ambulatory nonblack women 65 years of age or older. Measurements: Weight, weight change since 25 years of age, body mass index, lean body mass and percent body fat, and nonspine fractures during 6.4 years of follow-up. Results: Compared with women in the highest quartile of weight, women in the lowest quartile had relative risks of 2.0 (95% CI, 1.5 to 2.8) for hip fractures, 2.3 (CI, 1.1 to 4.7) for pelvis fractures, and 2.4 (CI, 1.5 to 3.9) for rib fractures. Adjustment for total-hip bone mineral density eliminated the elevated risk. Results were similar for other body size measures. Smaller body size was not a risk factor for humerus, elbow, wrist, ankle, or foot fractures, Conclusions: Total body weight is useful in the prediction of hip, pelvis, and rib fractures when bone mineral density has not been measured.	Univ Minnesota, Hennepin Cty Med Ctr, Minneapolis Med Res Fdn, Vet Affairs Med Ctr, Minneapolis, MN 55415 USA; Univ Minnesota, Sch Publ Hlth, Minneapolis, MN 55415 USA	Hennepin County Medical Center; Minneapolis Medical Research Foundation; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities	Margolis, KL (corresponding author), Univ Minnesota, Hennepin Cty Med Ctr, Minneapolis Med Res Fdn, Vet Affairs Med Ctr, 701 Pk Ave, Minneapolis, MN 55415 USA.			Ensrud, Kristine/0000-0002-9069-3036; Margolis, Karen/0000-0003-1862-7402; Schreiner, Pamela/0000-0002-9920-6257	NIA NIH HHS [5-R01-AG-05395] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG005395] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		CUMMINGS SR, 1990, JAMA-J AM MED ASSOC, V263, P665, DOI 10.1001/jama.263.5.665; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Ensrud KE, 1997, ARCH INTERN MED, V157, P857, DOI 10.1001/archinte.157.8.857; Ensrud KE, 1997, AM J MED, V103, P274, DOI 10.1016/S0002-9343(97)00025-9; Ettinger B, 1998, J CLIN ENDOCR METAB, V83, P2239, DOI 10.1210/jc.83.7.2239; FARMER ME, 1989, J AM GERIATR SOC, V37, P9, DOI 10.1111/j.1532-5415.1989.tb01562.x; KIEL DP, 1987, NEW ENGL J MED, V317, P1169, DOI 10.1056/NEJM198711053171901; Lohman TG, 1988, ANTHROPOMETRIC STAND, P177, DOI DOI 10.1002/AJHB.1310040323; LOHMAN TG, 1992, ADV BODY COMPOSITION, P119; *NAT OST FDN, 1998, OSTEOPOROS INT S4, V8, pS3; NEVITT MC, 1992, AM J EPIDEMIOL, V135, P490, DOI 10.1093/oxfordjournals.aje.a116315; Paganini-Hill A, 1991, Epidemiology, V2, P16; Ray NF, 1997, J BONE MINER RES, V12, P24, DOI 10.1359/jbmr.1997.12.1.24; SEELEY DG, 1991, ANN INTERN MED, V115, P837, DOI 10.7326/0003-4819-115-11-837; Seeley DG, 1996, J BONE MINER RES, V11, P1347; 1994, NIH TECHNOLOGY  1212, V1	16	72	74	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2000	133	2					123	127		10.7326/0003-4819-133-2-200007180-00011	http://dx.doi.org/10.7326/0003-4819-133-2-200007180-00011			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	335RL	10896638				2022-12-24	WOS:000088258500005
J	Agami, R; Bernards, R				Agami, R; Bernards, R			Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage	CELL			English	Article							MAMMALIAN-CELLS; C-ABL; D1; PROTEOLYSIS; PROGRESSION; P53; SEQUESTRATION; DEGRADATION; ACTIVATION; UBIQUITIN	DNA damage causes stabilization of p53, leading to G1 arrest through induction of p21(cip1). As this process requires transcription, several hours are needed to exert this response. We show that DNA damage causes an immediate and p53-independent G1 arrest, caused by rapid proteolysis of cyclin D1. Degradation is mediated through a previously unrecognized destruction box in cyclin D1 and leads to a release of p21(cip1) from CDK4 to inhibit CDK2. Interference with cyclin D1 degradation prevents initiation of G1 arrest and renders cells more susceptible to DNA damage, indicating that cyclin D1 degradation is an essential component of the cellular response to genotoxic stress. Thus, induction of G1 arrest in response to DNA damage is minimally a two step process: a fast p53-independent initiation of G1 arrest mediated by cyclin D1 proteolysis and a slower maintenance of arrest resulting from increased p53 stability.	Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Bernards, R (corresponding author), Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands.		agami, reuven/GOG-8289-2022	Agami, Reuven/0000-0002-2848-2473; Bernards, Rene/0000-0001-8677-3423				Agami R, 1999, NATURE, V399, P809; Bouchard C, 1999, EMBO J, V18, P5321, DOI 10.1093/emboj/18.19.5321; Brandeis M, 1996, EMBO J, V15, P5280, DOI 10.1002/j.1460-2075.1996.tb00913.x; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cooper KF, 1997, EMBO J, V16, P4665, DOI 10.1093/emboj/16.15.4665; Diehl JA, 1997, GENE DEV, V11, P957, DOI 10.1101/gad.11.8.957; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Geng Y, 1999, CELL, V97, P767, DOI 10.1016/S0092-8674(00)80788-6; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; IMIGER S, 1995, CELL, V81, P269; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Kramer ER, 1998, CURR BIOL, V8, P1207, DOI 10.1016/S0960-9822(07)00510-6; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Lipinski MM, 1999, ONCOGENE, V18, P7873, DOI 10.1038/sj.onc.1203244; Meek DW, 1999, ONCOGENE, V18, P7666, DOI 10.1038/sj.onc.1202951; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; Perez-Roger I, 1999, EMBO J, V18, P5310, DOI 10.1093/emboj/18.19.5310; QUELLE DE, 1995, CELL, V83, P993; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Sionov RV, 1999, ONCOGENE, V18, P6145, DOI 10.1038/sj.onc.1203130; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; WALDMAN T, 1995, CANCER RES, V55, P5187; Weinert T, 1998, CELL, V94, P555, DOI 10.1016/S0092-8674(00)81597-4; Yuan ZM, 1996, NATURE, V382, P272, DOI 10.1038/382272a0; Zwijsen RML, 1997, CELL, V88, P405, DOI 10.1016/S0092-8674(00)81879-6	34	312	327	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 7	2000	102	1					55	66		10.1016/S0092-8674(00)00010-6	http://dx.doi.org/10.1016/S0092-8674(00)00010-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	332UL	10929713	Green Published, Bronze			2022-12-24	WOS:000088091700008
J	Hardin, J				Hardin, J			Development - A degrading way to make an organ	SCIENCE			English	Editorial Material							CAENORHABDITIS-ELEGANS; CELL-MIGRATION		Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; Univ Wisconsin, Program Mol & Cellular Biol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Hardin, J (corresponding author), Univ Wisconsin, Dept Zool, 1117 W Johnson St, Madison, WI 53706 USA.							Blelloch R, 1999, CURR OPIN CELL BIOL, V11, P608, DOI 10.1016/S0955-0674(99)00028-9; Blelloch R, 1999, DEV BIOL, V216, P382, DOI 10.1006/dbio.1999.9491; Blelloch R, 1999, NATURE, V399, P586, DOI 10.1038/21196; Colavita A, 1998, SCIENCE, V281, P706, DOI 10.1126/science.281.5377.706; Hardin J, 1996, CURR TOP DEV BIOL, V33, P159, DOI 10.1016/S0070-2153(08)60339-7; HEDGECOCK EM, 1987, DEVELOPMENT, V100, P365; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; Murphy G, 1999, CURR OPIN CELL BIOL, V11, P614, DOI 10.1016/S0955-0674(99)00022-8; Nishiwaki K, 2000, SCIENCE, V288, P2205, DOI 10.1126/science.288.5474.2205; Nishiwaki K, 1999, GENETICS, V152, P985; Shapiro SD, 1998, CURR OPIN CELL BIOL, V10, P602, DOI 10.1016/S0955-0674(98)80035-5	12	2	11	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 23	2000	288	5474					2142	2143		10.1126/science.288.5474.2142	http://dx.doi.org/10.1126/science.288.5474.2142			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FH	10896589				2022-12-24	WOS:000087782900026
J	Lundblad, V				Lundblad, V			Molecular biology - Telomeres keep on rappin'	SCIENCE			English	Editorial Material							LENGTH REGULATION; TRF1; END		Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine	Lundblad, V (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.							Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Cohn M, 1998, CURR GENET, V33, P83, DOI 10.1007/s002940050312; Evans SK, 1999, SCIENCE, V286, P117, DOI 10.1126/science.286.5437.117; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Murti KG, 1999, P NATL ACAD SCI USA, V96, P14436, DOI 10.1073/pnas.96.25.14436; Shore D, 1997, BIOL CHEM, V378, P591; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0	11	6	7	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 23	2000	288	5474					2141	2142		10.1126/science.288.5474.2141	http://dx.doi.org/10.1126/science.288.5474.2141			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FH	10896588				2022-12-24	WOS:000087782900025
J	Barber, PA; Demchuk, AM; Zhang, JJ; Buchan, AM				Barber, PA; Demchuk, AM; Zhang, JJ; Buchan, AM		ASPECTS Study Grp	Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy	LANCET			English	Article							ACUTE ISCHEMIC STROKE; TISSUE-PLASMINOGEN ACTIVATOR; CT; ECASS	Background Computed tomography (CT) must be done before thrombolytic treatment of hyperacute ischaemic stroke, but the significance of early ischaemic change on CT is unclear. We tested a quantitative CT score, the Alberta Stroke Programme Early CT Score (ASPECTS). Methods 203 consecutive patients with ischaemic stroke were treated with intravenous alteplase within 3 h of symptom onset in two North American teaching hospitals. All pretreatment CT scans were prospectively scored. The score divides the middle-cererbral-artery territory into ten regions of interest. Primary outcomes were symptomatic intracerebral haemorrhage and 3-month functional outcome. The sensitivity and specificity of ASPECTS for the primary outcomes were calculated. Logistic regression was used to test the association between the score on ASPECTS and the primary outcomes. Findings Ischaemic changes on the baseline CT were seen in 117 (75%) of 156 treated patients with anterior-circulation ischaemia included in the analysis (23 had ischaemia in the posterior circulation and 24 were treated outside the protocol). Baseline ASPECTS value correlated inversely with the severity of stroke on the National institutes of Health Stroke Scale (r=-0.56, p<0.001). Baseline ASPECTS value predicted functional outcome and symptomatic intracerebral haemorrhage (p<0.001, p=0.012, respectively). The sensitivity of ASPECTS for functional outcome was 0.78 and specificity 0.96; the values for symptomatic intracerebral haemorrhage were 0.90 and 0.62, Agreement between observers for ASPECTS, with knowledge of the affected hemisphere, was good (kappa statistic 0.71-0.89). Interpretation This CT score is simple and reliable and identifies stroke patients unlikely to make an independent recovery despite thrombolytic treatment.	Univ Calgary, Dept Clin Neurosci, Alberta Stroke Programme, Calgary, AB, Canada; Univ Texas, Stroke Program, Houston, TX USA	University of Calgary; University of Texas System	Buchan, AM (corresponding author), Foothills Hosp, Dept Clin Neurosci, Room 1162,1403 29th St NW, Calgary, AB T2N 2T9, Canada.		Barber, Philip A/C-7108-2016; Buchan, Alastair M/B-9095-2009; Demchuk, Andrew M/E-1103-2012; Hill, Michael D/C-9073-2012	Buchan, Alastair M/0000-0002-2918-5200; Demchuk, Andrew M/0000-0002-4930-7789; Hill, Michael D/0000-0002-6269-1543				Armitage P., 1987, STAT METHODS MED RES; Baird AE, 1998, J CEREBR BLOOD F MET, V18, P583, DOI 10.1097/00004647-199806000-00001; BARON JC, 1995, STROKE, V26, P2219, DOI 10.1161/01.STR.26.12.2219; Brott T, 1997, STROKE, V28, P2109, DOI 10.1161/01.STR.28.11.2109; Buchan AM, 2000, NEUROLOGY, V54, P679, DOI 10.1212/WNL.54.3.679; del Zoppo GJ, 1998, J NEUROL NEUROSUR PS, V65, P1, DOI 10.1136/jnnp.65.1.1; Demchuk AM, 1999, STROKE, V30, P34, DOI 10.1161/01.STR.30.1.34; DIPPEL DWJ, 1997, CEREBROVASC DIS, V7, P15; Grotta JC, 1999, STROKE, V30, P1528, DOI 10.1161/01.STR.30.8.1528; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017; Kasner SE, 1999, STROKE, V30, P1534, DOI 10.1161/01.STR.30.8.1534; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Schriger DL, 1998, JAMA-J AM MED ASSOC, V279, P1293, DOI 10.1001/jama.279.16.1293; vonKummer R, 1997, RADIOLOGY, V205, P327, DOI 10.1148/radiology.205.2.9356611; Wardlaw JM, 1999, J NEUROL NEUROSUR PS, V67, P651, DOI 10.1136/jnnp.67.5.651; Wardlaw JM, 1999, COCHRANE LIB	17	1543	1620	3	68	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 13	2000	355	9216					1670	1674		10.1016/S0140-6736(00)02237-6	http://dx.doi.org/10.1016/S0140-6736(00)02237-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	313CY	10905241				2022-12-24	WOS:000086983800008
J	Bartolazzi, A				Bartolazzi, A			Improving accuracy of cytology for nodular thyroid lesions	LANCET			English	Editorial Material							FINE-NEEDLE ASPIRATION; GALECTIN-3; EXPERIENCE; EXPRESSION; MARKER		Karolinska Hosp, Canc Ctr Karolinska, S-17176 Stockholm, Sweden; NCI Regina Elena, Dept Pathol, Rome, Italy	Karolinska Institutet; Karolinska University Hospital	Bartolazzi, A (corresponding author), Karolinska Hosp, Canc Ctr Karolinska, S-17176 Stockholm, Sweden.		Bartolazzi, Armando/K-9708-2016	Bartolazzi, Armando/0000-0001-7820-5127				Baloch ZW, 1998, THYROID, V8, P565, DOI 10.1089/thy.1998.8.565; CHIARIOTTI L, 1992, ONCOGENE, V7, P2507; ERMAK G, 1995, CANCER RES, V55, P4594; Gasbarri A, 1999, J CLIN ONCOL, V17, P3494, DOI 10.1200/JCO.1999.17.11.3494; Inohara H, 1999, CANCER, V85, P2475, DOI 10.1002/(SICI)1097-0142(19990601)85:11<2475::AID-CNCR25>3.3.CO;2-T; Kini SR, 1987, GUIDE CLIN ASPIRATIO, V3; Lowhagen T, 1981, World J Surg, V5, P61; Orlandi F, 1998, CANCER RES, V58, P3015; Raber W, 1997, WIEN KLIN WOCHENSCHR, V109, P116; ROSAI J, 1992, ATLAS TUMOR PATHOL, P343; Schlinkert RT, 1997, MAYO CLIN PROC, V72, P913, DOI 10.1016/S0025-6196(11)63360-0; Tuttle RM, 1998, THYROID, V8, P377, DOI 10.1089/thy.1998.8.377	12	33	40	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 13	2000	355	9216					1661	1662		10.1016/S0140-6736(00)02233-9	http://dx.doi.org/10.1016/S0140-6736(00)02233-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	313CY	10905237				2022-12-24	WOS:000086983800004
J	Olowokure, B; Hawker, J; Blair, I; Spencer, N				Olowokure, B; Hawker, J; Blair, I; Spencer, N			Decrease in effectiveness of routine surveillance of Haemophilus influenzae disease after introduction of conjugate vaccine: comparison of routine reporting with active surveillance system	BRITISH MEDICAL JOURNAL			English	Article								In October 1992 routine immunisation with Haemophilus influenzae type b conjugate vaccine was introduced in the United Kingdom, and the incidence of disease was subsequently reported to have decreased 15-fold.(1) The surveillance systems in place were primarily routine and were known to underestimate the burden of invasive H influenzae disease.(2) This study aimed to determine whether underreporting continued after introduction of the conjugate vaccine, and how this might affect the reported success of the vaccine. Results of routine surveillance were compared with active surveillance for invasive H influenzae disease in the West Midlands health region of England.	Univ Birmingham, Dept Epidemiol & Publ Hlth, Birmingham B15 2TT, W Midlands, England; Sandwell Hlth Author, Dept Publ Hlth, W Bromwich B70 9LD, W Midlands, England; Univ Warwick, Postgrad Med Sch, Sect Child Hlth, Coventry CV4 7AL, W Midlands, England	University of Birmingham; University of Warwick	Olowokure, B (corresponding author), W Midlands Heartlands Hosp, Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, Birmingham B9 5SS, W Midlands, England.							Hargreaves RM, 1996, BRIT MED J, V312, P160; Macleod C A, 1994, Commun Dis Rep CDR Rev, V4, pR13; Nazareth B, 1992, Commun Dis Rep CDR Rev, V2, pR13; Salisbury DM, 1998, PEDIATR INFECT DIS J, V17, pS136, DOI 10.1097/00006454-199809001-00009; Wise J, 1999, BRIT MED J, V319, P278, DOI 10.1136/bmj.319.7205.278	5	11	11	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	SEP 23	2000	321	7263					731	732		10.1136/bmj.321.7263.731	http://dx.doi.org/10.1136/bmj.321.7263.731			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FE	10999903	Green Published, Bronze			2022-12-24	WOS:000089546600020
J	Yen, AS; Kim, SS; Hecht, MH; Frant, MS; Murray, B				Yen, AS; Kim, SS; Hecht, MH; Frant, MS; Murray, B			Evidence that the reactivity of the martian soil is due to superoxide ions	SCIENCE			English	Article							OXIDE SURFACES; OXYGEN; PHOTOFORMATION; RESONANCE	The Viking Landers were unable to detect evidence of Life on Mars but, instead, found a chemically reactive soil capable of decomposing organic molecules. This reactivity was attributed to the presence of one or more as-yet-unidentified inorganic superoxides or peroxides in the martian soil. Using electron paramagnetic resonance spectroscopy, we show that superoxide radical ions (O-2(-)) form directly on Mars-analog mineral surfaces exposed to ultraviolet radiation under a simulated martian atmosphere. These oxygen radicals can explain the reactive nature of the soil and the apparent absence of organic material at the martian surface.	CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Chemot Consulting, Newton, MA 02458 USA; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); California Institute of Technology	Yen, AS (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.			Hecht, Michael/0000-0002-4114-4583				ANPO M, 1985, J PHYS CHEM-US, V89, P5689, DOI 10.1021/j100272a023; BALLOU EV, 1978, NATURE, V271, P644, DOI 10.1038/271644a0; Bandfield JL, 2000, SCIENCE, V287, P1626, DOI 10.1126/science.287.5458.1626; Biemann K., 1977, Journal of Geophysical Research, V82, P4641, DOI 10.1029/JS082i028p04641; CHE M, 1982, ADV CATAL, V31, P77, DOI 10.1016/S0360-0564(08)60453-8; CHE M, 1983, ADV CATAL, V32, P1, DOI 10.1016/S0360-0564(08)60439-3; Christensen PR, 1998, SCIENCE, V279, P1692, DOI 10.1126/science.279.5357.1692; CHUN SFS, 1978, NATURE, V274, P875, DOI 10.1038/274875a0; CLARKSON RB, 1978, SURF SCI, V74, P325, DOI 10.1016/0039-6028(78)90029-8; COTTON FA, 1995, BASIC INORGANIC CHEM, P435; GASYMOV AM, 1984, KINET KATAL, V25, P358; HOROWITZ NH, 1986, UTOPIA BACK SEARCH L, P136; HOWE RF, 1982, ADV COLLOID INTERFAC, V18, P1, DOI 10.1016/0001-8686(82)85030-6; HOWE RF, 1993, COLLOID SURFACE A, V72, P353, DOI 10.1016/0927-7757(93)80485-W; HOWE RF, 1986, J CHEM PHYS, V85, P6129, DOI 10.1063/1.451478; HUNTEN DM, 1979, J MOL EVOL, V14, P71, DOI 10.1007/BF01732369; ITO T, 1985, J CHEM SOC FARAD T 1, V81, P2835, DOI 10.1039/f19858102835; Johnston C.L., 1991, GEMS GEMOL, V27, P220, DOI [10.5741/GEMS.27.4.220, DOI 10.5741/GEMS.27.4.220]; Kieffer H. H., 1977, Journal of Geophysical Research, V82, P4249, DOI 10.1029/JS082i028p04249; KLEIN HP, 1978, ICARUS, V34, P666, DOI 10.1016/0019-1035(78)90053-2; KLEIN HP, 1976, SCIENCE, V194, P99, DOI 10.1126/science.194.4260.99; KUHN WR, 1979, J MOL EVOL, V14, P57, DOI 10.1007/BF01732367; Levin G. V., 1977, Journal of Geophysical Research, V82, P4663, DOI 10.1029/JS082i028p04663; LUNSFORD JH, 1973, CATAL REV, V8, P135; LUNSFORD JH, 1984, ACS SYM SER, V248, P127; Oyama V. I., 1977, Journal of Geophysical Research, V82, P4669, DOI 10.1029/JS082i028p04669; OYAMA VI, 1977, NATURE, V265, P110, DOI 10.1038/265110a0; ZENT AP, 1994, ICARUS, V108, P146, DOI 10.1006/icar.1994.1047; [No title captured]	29	199	205	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 15	2000	289	5486					1909	1912		10.1126/science.289.5486.1909	http://dx.doi.org/10.1126/science.289.5486.1909			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354XD	10988066				2022-12-24	WOS:000089355800038
J	Reid, RP; Visscher, PT; Decho, AW; Stolz, JF; Bebout, BM; Dupraz, C; Macintyre, LG; Paerl, HW; Pinckney, JL; Prufert-Bebout, L; Steppe, TF; DesMarais, DJ				Reid, RP; Visscher, PT; Decho, AW; Stolz, JF; Bebout, BM; Dupraz, C; Macintyre, LG; Paerl, HW; Pinckney, JL; Prufert-Bebout, L; Steppe, TF; DesMarais, DJ			The role of microbes in accretion, lamination and early lithification of modern marine stromatolites	NATURE			English	Article							SUBTIDAL STROMATOLITES; EXUMA-CAYS; BAHAMAS; MATS; COMMUNITIES	For three billion years, before the Cambrian diversification of life, laminated carbonate build-ups called stromatolites were widespread in shallow marine seas(1,2). These ancient structures are generally thought to be microbial in origin and potentially preserve evidence of the Earth's earliest biosphere(1-3). Despite their evolutionary significance, little is known about stromatolite formation, especially the relative roles of microbial and environmental factors in stromatolite accretion(1,3). Here we show that growth of modern marine stromatolites represents a dynamic balance between sedimentation and intermittent lithification of cyanobacterial mats. Periods of rapid sediment accretion, during which stromatolite surfaces are dominated by pioneer communities of gliding filamentous cyanobacteria, alternate with hiatal intervals. These discontinuities in sedimentation are characterized by development of surface films of exopolymer and subsequent heterotrophic bacterial decomposition, forming thin crusts of microcrystalline carbonate. During prolonged hiatal periods, climax communities develop, which include endolithic coccoid cyanobacteria. These coccoids modify the sediment, forming thicker lithified laminae. Preservation of lithified layers at depth creates millimetre-scale lamination. This simple model of modern marine stromatolite growth may be applicable to ancient stromatolites.	Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, MGG, Miami, FL 33149 USA; Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; Univ S Carolina, Sch Publ Hlth, Columbia, SC 29208 USA; Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15282 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA; Univ N Carolina, Inst Marine Sci, Morehead City, NC 28557 USA; Texas A&M Univ, Dept Oceanog, College Stn, TX 77843 USA	University of Miami; University of Connecticut; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Duquesne University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Smithsonian Institution; Smithsonian National Museum of Natural History; University of North Carolina; University of North Carolina Chapel Hill; Texas A&M University System; Texas A&M University College Station	Reid, RP (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, MGG, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	preid@rsmas.miami.edu	Decho, Alan W/F-9510-2010; Visscher, Pieter/T-7464-2017	Pinckney, James/0000-0002-6056-6511; Visscher, Pieter/0000-0001-6911-1532				AWRAMIK SM, 1988, P NATL ACAD SCI USA, V85, P1327, DOI 10.1073/pnas.85.5.1327; Bartley JK, 1996, PALAIOS, V11, P571, DOI 10.2307/3515192; CHAFETZ H S, 1992, Palaios, V7, P277, DOI 10.2307/3514973; Decho AW, 1999, BIOTECHNIQUES, V27, P1246; DECHO AW, UNPUB AQUAT MICROB E; DILL RF, 1986, NATURE, V324, P55, DOI 10.1038/324055a0; DRAVIS JJ, 1983, SCIENCE, V219, P385, DOI 10.1126/science.219.4583.385; Golubic S, 2000, MICROBIAL SEDIMENTS, P57; Golubic S., 1996, ALGOLOGICAL STUDIES, P273; Grotzinger JP, 1999, ANNU REV EARTH PL SC, V27, P313, DOI 10.1146/annurev.earth.27.1.313; KRUMBEIN WE, 1977, LIMNOL OCEANOGR, V22, P635, DOI 10.4319/lo.1977.22.4.0635; Lee SJ, 2000, MICROBIAL SEDIMENTS, P16; LOGAN BW, 1961, J GEOL, V69, P517, DOI 10.1086/626769; MACINTYRE IG, IN PRESS SEDIMENTOLO; Monty C.L.V., 1976, STROMATOLITES DEV SE, P193, DOI DOI 10.1016/S0070-4571(08)71137-3; PAERL HW, 1993, LIMNOL OCEANOGR, V38, P1150, DOI 10.4319/lo.1993.38.6.1150; Pinckney JL, 1997, FACIES, V36, P204; REID RP, 1995, FACIES, V33, P1, DOI 10.1007/BF02537442; Reid RP, 2000, J SEDIMENT RES, V70, P24, DOI 10.1306/2DC408FA-0E47-11D7-8643000102C1865D; REID RP, 1999, ATOLL RES B, V466, P1; Riding R, 1994, BIOSTABILIZATION SED, V84, P183; STAL LJ, 1985, FEMS MICROBIOL ECOL, V31, P111, DOI 10.1111/j.1574-6968.1985.tb01138.x; VANGEMERDEN H, 1993, MAR GEOL, V113, P3, DOI 10.1016/0025-3227(93)90146-M; Visscher PT, 1999, APPL ENVIRON MICROB, V65, P3272; Visscher PT, 1998, AM MINERAL, V83, P1482, DOI 10.2138/am-1998-11-1236; VISSCHER PT, IN PRESS GEOLOGY; Walter M. R., 1976, DEV SEDIMENTOL, V20, P251; Walter M.R., 1983, EARTHS EARLIEST BIOS, P187; WALTER MR, 1992, PROTEROZOIC BIOSPHER, P335; [No title captured]	30	562	613	8	161	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2000	406	6799					989	992		10.1038/35023158	http://dx.doi.org/10.1038/35023158			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	348ZW	10984051				2022-12-24	WOS:000089020200043
J	Rask-Nissila, L; Jokinen, E; Terho, P; Tammi, A; Lapinleimu, H; Ronnemaa, T; Viikari, J; Seppanen, R; Korhonen, T; Tuominen, J; Valimaki, I; Simell, O				Rask-Nissila, L; Jokinen, E; Terho, P; Tammi, A; Lapinleimu, H; Ronnemaa, T; Viikari, J; Seppanen, R; Korhonen, T; Tuominen, J; Valimaki, I; Simell, O			Neurological development of 5-year-old children receiving a low-saturated fat, low-cholesterol diet since infancy - A randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY HEART-DISEASE; SERUM-CHOLESTEROL; RISK-FACTORS; GROWTH; REDUCTION; AGE; ATHEROSCLEROSIS; INTERVENTION; ASSOCIATION; CHILDHOOD	Context Early childhood introduction of nutritional habits aimed at atherosclerosis prevention is compatible with normal growth, but its effect on neurological development is unknown. Objective To analyze how parental counseling aimed at keeping children's diets low in saturated fat and cholesterol influences neurodevelopment during the first 5 years of life. Design Randomized controlled trial conducted between February 1990 and November 1996. Setting Outpatient clinic of a university department in Turku, Finland. Participants A total of 1062 seven-month-old infants and their parents, recruited at well-baby clinics between 1990 and 1992. At age 5 years, 496 children still living in the city of Turku were available to participate in neurodevelopmental testing. Intervention Participants were randomly assigned to receive individualized counseling aimed at limiting the child's fat intake to 30% to 35% of daily energy, with a saturated: monounsaturated:polyunsaturated fatty acid ratio of 1:1:1 and a cholesterol intake of less than 200 mg/d (n = 540) or usual health education (control group, n = 522). Main Outcome Measures Nutrient intake, serum lipid concentrations, and neurological development at 5 years, among children in the intervention vs control groups. Results Absolute and relative intakes of fat, saturated fatty acids, and cholesterol among children in the intervention group were markedly less than the respective values of control children. Mean (SD) percentages of daily energy at age 5 years for the intervention vs control groups were as follows: for total fat, 30.6% (4.5%) vs 33.4% (4.4%) (P<.001); and for saturated fat, 11.7% (2.3%) vs 14.5% (2.4%) (P<.001). Mean intakes of cholesterol were 164.2 mg (60.1 mg) and 192.5 mg (71.9 mg) (P<.001) for the intervention and control groups, respectively Serum cholesterol concentrations were continuously 3% to 5% lower in children in the intervention group than in children in the control group. At age 5 years, mean (SD) serum cholesterol concentration of the intervention group was 4.27 (0.63) mmol/L (165 [24] mg/dL) and of the control group, 4.41 (0.74) mmol/L (170 [29] mg/dL) (P=.04). Neurological development of children in the intervention group was at least as good as that of children in the control group. Relative risks for children in the intervention group to fail tests of speech and language skills, gross motor functioning plus perception, and visual motor skills were 0.95 (90% confidence interval [CI], 0.60-1.49), 0.95 (90% CI, 0.58-1.55), and 0.65 (90% CI, 0.39-1.08), respectively (P=.85, .86, and .16, respectively, vs control children). Conclusion Our data indicate that repeated child-targeted dietary counseling of parents during the first 5 years of a child's life lessens age-associated increases in children's serum cholesterol and is compatible with normal neurological development.	Univ Turku, Cardiovasc Res Unit, FIN-20520 Turku, Finland; Univ Turku, Dept Pediat, FIN-20520 Turku, Finland; Univ Turku, Dept Med, FIN-20520 Turku, Finland; Univ Turku, Dept Biostat, FIN-20520 Turku, Finland; Univ Turku, Dept Child Psychiat & Psychol, FIN-20520 Turku, Finland; City Turku, Social Insurance Inst, Res & Dev Unit, Turku, Finland; City Turku, Child & Adolescent Hlth Care, Turku, Finland; Univ Helsinki, Hosp Children & Adolescents, Helsinki, Finland	University of Turku; University of Turku; University of Turku; University of Turku; University of Turku; University of Helsinki	Rask-Nissila, L (corresponding author), Univ Turku, Cardiovasc Res Unit, Kiinamyllynkatu 10, FIN-20520 Turku, Finland.	leena.rask-nissila@utu.fi	Lapinleimu, Helena/AAT-8415-2021					AGGETT PJ, 1994, J PEDIATR GASTR NUTR, V19, P261; Altman DG., 1995, PRACTICAL STAT MED R; American Academy of Pediatrics. Committee on Nutrition, 1998, Pediatrics, V101, P141; [Anonymous], 1995, JAMA, V273, P1429; AYRES JA, 1980, SO CALIFORNIA SENSOR; BAX M, 1987, DEV MED CHILD NEUROL, V29, P40; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; BOULTON TJC, 1995, ACTA PAEDIATR, V84, P146, DOI 10.1111/j.1651-2227.1995.tb13597.x; DiGeorge AM., 1996, NELSON TXB PEDIAT, P1640; *EUR AG EV MED PRO, 2000, POINTS CONS BIOST ME; Fisher EA, 1997, CIRCULATION, V95, P2332, DOI 10.1161/01.CIR.95.9.2332; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; FRIEDMAN G, 1976, PEDIATRICS, V58, P655; GALLER JR, 1987, J PEDIATR GASTR NUTR, V6, P847, DOI 10.1097/00005176-198711000-00005; Hakala P, 1996, FOOD CHEM, V57, P71, DOI 10.1016/0308-8146(96)00077-5; HAND D, 1996, PRACTICAL LONGITUDIN; Harris, 1963, CHILDRENS DRAWINGS M; KLAG MJ, 1993, NEW ENGL J MED, V328, P313, DOI 10.1056/NEJM199302043280504; KOPPITZ EM, 1963, BENDER GESTALT TEST; LAPINLEIMU H, 1995, LANCET, V345, P471, DOI 10.1016/S0140-6736(95)90580-4; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; LIFSHITZ F, 1989, AM J DIS CHILD, V143, P537, DOI 10.1001/archpedi.1989.02150170035015; LIUKSILA PR, 1993, TURUN KAUPUNGIN TERV, V8, P1; Miller L. J, 1988, MILLER ASSESSMENT PR; NEURINGER M, 1994, J PEDIATR-US, V125, pS39, DOI 10.1016/S0022-3476(06)80735-3; NEWMAN WP, 1986, NEW ENGL J MED, V314, P138, DOI 10.1056/NEJM198601163140302; Niinikoski H, 1997, PEDIATRICS, V99, P687, DOI 10.1542/peds.99.5.687; Niinikoski H, 1997, PEDIATRICS, V100, P810, DOI 10.1542/peds.100.5.810; Niinikoski H, 1996, CIRCULATION, V94, P1386, DOI 10.1161/01.CIR.94.6.1386; POLONSKY SM, 1993, PEDIATRICS, V91, P92; PUGLIESE MT, 1987, PEDIATRICS, V80, P175; RASTAS M, 1993, NUTR COMP FOODS; Salo P, 1999, EUR J CLIN NUTR, V53, P927, DOI 10.1038/sj.ejcn.1600872; SAS, 1996, SAS STAT SOFTW CHANG; SHANNON BM, 1994, PEDIATRICS, V94, P923; SHEA S, 1993, PEDIATRICS, V92, P579; Stott D.H., 1984, TEST MOTOR IMPAIRMEN; WALTER HJ, 1988, NEW ENGL J MED, V318, P1093, DOI 10.1056/NEJM198804283181704; WEBBER LS, 1991, AM J EPIDEMIOL, V133, P884, DOI 10.1093/oxfordjournals.aje.a115968; WISSLER RW, 1993, ARTERIOSCLER THROMB, V13, P1291	40	61	62	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 23	2000	284	8					993	1000		10.1001/jama.284.8.993	http://dx.doi.org/10.1001/jama.284.8.993			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344PX	10944645				2022-12-24	WOS:000088769000026
J	Djulbegovic, B; Lacevic, M; Cantor, A; Fields, KK; Bennett, CL; Adams, JR; Kuderer, NM; Lyman, GH				Djulbegovic, B; Lacevic, M; Cantor, A; Fields, KK; Bennett, CL; Adams, JR; Kuderer, NM; Lyman, GH			The uncertainty principle and industry-sponsored research	LANCET			English	Article; Proceedings Paper	VII Cochrane Colloquium	OCT 05-09, 1999	ROME, ITALY				RANDOMIZED CLINICAL-TRIALS; CONFLICT-OF-INTEREST; ETHICS; EQUIPOISE; QUALITY; DESIGN; DRUGS	Background Reporting of pharmaceutical-industry-sponsored randomised clinical trials often result in biased findings, either due to selective reporting of studies with non-equivalent arms or publication of low-quality papers, wherein unfavourable results are incompletely described. A randomised trial should be conducted only if there is substantial uncertainty about the relative value of one treatment versus another. Studies in which intervention and control are thought to be non-equivalent violates the uncertainty principle. Methods We examined the quality of 136 published randomised trials that focused on one disease category (multiple myeloma) and adherence to the uncertainty principle. To evaluate whether the uncertainty principle was upheld, we compared the number of studies favouring experimental treatments over standard ones. We analysed data according to the source of funding. Findings Trials funded solely or in part by 35 profit-making organisations had a trend toward higher quality scores (mean 2.94 [SD 1.3]; median 3) than randomised trials supported by 95 governmental or other non-profit organisations (2.4 [0.8]; 2; p=0.06). Overall, the uncertainty principle was upheld, with 44% of randomised trials favouring standard treatments and 56% innovative treatments (p=0.17); mean and median preference evaluation scores were 3.7 (1.0) and 4. However, when the analysis was done according to the source of funding, studies funded by non-profit organisations maintained equipoise favouring new therapies over standard ones (47% vs 53%; p=0.608) to a greater extent than randomised trials supported solely or in part by profit-making organisations (74% vs 26%; p=0.004). Interpretation The reported bias in research sponsored by the pharmaceutical industry may be a consequence of violations of the uncertainty principle. Sponsors of clinical trials should be encouraged to report all results and to choose appropriate comparative controls.	Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Div Blood & Bone Marrow Transplantat, Tampa, FL 33612 USA; Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Div Biostat, Tampa, FL 33612 USA; VA Chicago Hlth Care Syst, Lakeside Div, Chicago, IL USA; Northwestern Univ, Sch Med, Div Hematol Oncol, Chicago, IL USA; Albany Med Coll, Div Hematol Oncol, Albany, NY 12208 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Northwestern University; Albany Medical College	Djulbegovic, B (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr & Res Inst, Div Blood & Bone Marrow Transplantat, 12902 Magnolia Dr, Tampa, FL 33612 USA.	djulbebm@moffitt.usf.edu	Lyman, Gary H/K-5227-2019; Bennett, Charles L/C-2050-2008; Djulbegovic, Benjamin/I-3661-2012	Lyman, Gary H/0000-0002-0823-8086; Djulbegovic, Benjamin/0000-0003-0671-1447				ATKINS H, 1966, BRIT MED J, V2, P377, DOI 10.1136/bmj.2.5510.377; CHALMERS I, 1990, JAMA-J AM MED ASSOC, V263, P1405, DOI 10.1001/jama.263.10.1405; Chalmers I, 1997, BRIT MED J, V314, P74, DOI 10.1136/bmj.314.7073.74a; CLARK PI, 1994, ANNU REV PUBL HEALTH, V15, P19; COLDITZ GA, 1989, STAT MED, V8, P441, DOI 10.1002/sim.4780080408; DICKERSIN K, 1994, BMJ-BRIT MED J, V309, P1286, DOI 10.1136/bmj.309.6964.1286; Dickersin K, 1997, AIDS EDUC PREV, V9, P15; Dieppe P, 1999, LANCET, V353, P1626, DOI 10.1016/S0140-6736(05)75755-X; Djulbegovic B, 1999, BLOOD, V94, p399A; Doll R, 1998, BMJ-BRIT MED J, V317, P1217, DOI 10.1136/bmj.317.7167.1217; Edwards SJ., 1998, HEALTH TECHNOL ASSES, V2, P1; FREEDMAN B, 1987, NEW ENGL J MED, V317, P141, DOI 10.1056/NEJM198707163170304; Friedberg M, 1999, JAMA-J AM MED ASSOC, V282, P1453, DOI 10.1001/jama.282.15.1453; GILBERT JP, 1977, SCIENCE, V198, P684, DOI 10.1126/science.333585; HILL AB, 1987, BRIT MED J, V294, P1419, DOI 10.1136/bmj.294.6584.1419; HILL AB, 1963, BMJ-BRIT MED J, V2, P1043; Horton R, 1999, LANCET, V354, P1138, DOI 10.1016/S0140-6736(99)00328-1; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Johansen HK, 1999, JAMA-J AM MED ASSOC, V282, P1752, DOI 10.1001/jama.282.18.1752; Kjaergard LL, 1999, HEPATOLOGY, V30, P1134, DOI 10.1002/hep.510300510; Lilford RJ, 1995, J ROY SOC MED, V88, P552; Machin D, 1997, Clin Oncol (R Coll Radiol), V9, P100; MOHER D, 1999, HLTH TECHNOL ASSES, V3, P19; Peto R, 1998, BMJ-BRIT MED J, V317, P1170, DOI 10.1136/bmj.317.7167.1170; Rennie D, 1999, JAMA-J AM MED ASSOC, V282, P1766, DOI 10.1001/jama.282.18.1766; ROCHON PA, 1994, ARCH INTERN MED, V154, P157, DOI 10.1001/archinte.154.2.157; ROTHMAN KJ, 1994, NEW ENGL J MED, V331, P394, DOI 10.1056/NEJM199408113310611; Sackett DL, 2000, CAN MED ASSOC J, V162, P1311; Stelfox HT, 1998, NEW ENGL J MED, V338, P101, DOI 10.1056/NEJM199801083380206; Zivin JA, 2000, SCI AM, V282, P69, DOI 10.1038/scientificamerican0400-69; 2000, N ENGL J MED, V342, P42	31	331	339	1	42	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 19	2000	356	9230					635	638		10.1016/S0140-6736(00)02605-2	http://dx.doi.org/10.1016/S0140-6736(00)02605-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	346RD	10968436				2022-12-24	WOS:000088884100011
J	Zhu, YY; Chen, HR; Fan, JH; Wang, YY; Li, Y; Chen, JB; Fan, JX; Yang, SS; Hu, LP; Leung, H; Mew, TW; Teng, PS; Wang, ZH; Mundt, CC				Zhu, YY; Chen, HR; Fan, JH; Wang, YY; Li, Y; Chen, JB; Fan, JX; Yang, SS; Hu, LP; Leung, H; Mew, TW; Teng, PS; Wang, ZH; Mundt, CC			Genetic diversity and disease control in rice	NATURE			English	Article							GREEN-REVOLUTION; RESISTANCE; MIXTURES; PATHOGEN; SPREAD	Crop heterogeneity is a possible solution to the vulnerability of monocultured crops to disease(1-3). Both theory(4) and observation(2,3) indicate that genetic heterogeneity provides greater disease suppression when used over large areas, though experimental data are lacking. Here we report a unique cooperation among farmers, researchers and extension personnel in Yunnan Province, China-genetically diversified rice crops were planted in all the rice fields in five townships in 1998 and ten townships in 1999. Control plots of monocultured crops allowed us to calculate the effect of diversity on the severity of rice blast, the major disease of rice(5). Disease-susceptible rice varieties planted in mixtures with resistant varieties had 89% greater yield and blast was 94% less severe than when they were grown in monoculture. The experiment was so successful that fungicidal sprays were no longer applied by the end of the two-year programme. Our results support the view that intraspecific crop diversification provides an ecological approach to disease control that can be highly effective over a large area and contribute to the sustainability of crop production.	Int Rice Res Inst, Div Entomol & Plant Pathol, Makati City 1271, Philippines; Yunnan Agr Univ, Phytopathol Lab Yunnan Prov, Kunming 650201, Yunnan, Peoples R China; Honghe Prefecture Plant Protect Stn Yunnan Prov, Kaiyuan 661400, Peoples R China; Jianshui Cty Plant Protect Stn Yunnan Prov, Jianshui 654300, Peoples R China; Shiping Cty Plant Protect Stn Yunnan Prov, Shiping 662200, Peoples R China; Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	CGIAR; International Rice Research Institute (IRRI); Yunnan Agricultural University; Oregon State University	Mundt, CC (corresponding author), Int Rice Res Inst, Div Entomol & Plant Pathol, MCPO Box 3127, Makati City 1271, Philippines.							Baker B, 1997, SCIENCE, V276, P726, DOI 10.1126/science.276.5313.726; BONMAN JM, 1992, ANNU REV PHYTOPATHOL, V30, P507, DOI 10.1146/annurev.py.30.090192.002451; BOUDREAU MA, 1997, ENV SAFE APPROACHES, P33; Browning J. A., 1981, Strategies for the control of cereal disease, P37; BROWNING JA, 1969, ANNU REV PHYTOPATHOL, V7, P355, DOI 10.1146/annurev.py.07.090169.002035; Calonnec A, 1996, EUR J PLANT PATHOL, V102, P733, DOI 10.1007/BF01877147; CHIN KM, 1984, PLANT PATHOL, V33, P89, DOI 10.1111/j.1365-3059.1984.tb00592.x; Dwyer G, 1998, AM NAT, V152, P485, DOI 10.1086/286185; Francis C. A., 1986, Multiple cropping systems, P1; Garrett KA, 1999, PHYTOPATHOLOGY, V89, P984, DOI 10.1094/PHYTO.1999.89.11.984; George MLC, 1998, PHYTOPATHOLOGY, V88, P223, DOI 10.1094/PHYTO.1998.88.3.223; *INT RIC RES I, 1997, IRRI RIC FACTS; KIYOSAWA S, 1982, ANNU REV PHYTOPATHOL, V20, P93, DOI 10.1146/annurev.py.20.090182.000521; Mann C, 1997, SCIENCE, V277, P1038, DOI 10.1126/science.277.5329.1038; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; Mundt C.C., 1985, CEREAL RUSTS, V2, P527, DOI DOI 10.1016/B978-0-12-148402-6.50025-0; MUNDT CC, 1994, RICE BLAST DISEASE, P293; MUNDT CC, 1989, PLANT DIS EPIDEMIOLO, V2, P150; OU SH, 1980, ANNU REV PHYTOPATHOL, V18, P167, DOI 10.1146/annurev.py.18.090180.001123; Ou SH, 1985, RICE DIS; *PEOPL REP CHIN, 1996, 157901995 GBT PEOPL, P1; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; SCHMIDT RA, 1978, PLANT DIS ADV TREATI, P287; Schwartz MW, 1999, ANNU REV ECOL SYST, V30, P83, DOI 10.1146/annurev.ecolsys.30.1.83; STASKAWICZ BJ, 1995, SCIENCE, V268, P661, DOI 10.1126/science.7732374; Tilman D, 1998, NATURE, V396, P211, DOI 10.1038/24254; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; WOLFE MS, 1985, ANNU REV PHYTOPATHOL, V23, P251, DOI 10.1146/annurev.py.23.090185.001343; WOLFE MS, 1992, BARLEY GENET, V6, P1055	29	889	1218	29	629	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2000	406	6797					718	722		10.1038/35021046	http://dx.doi.org/10.1038/35021046			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963595				2022-12-24	WOS:000088767700042
J	Delgado, P; Fernandez, E; Dave, V; Kappes, D; Alarcon, B				Delgado, P; Fernandez, E; Dave, V; Kappes, D; Alarcon, B			CD3 delta couples T-cell receptor signalling to ERK activation and thymocyte positive selection	NATURE			English	Article							ALPHA-BETA; LINEAGE COMMITMENT; ENGAGEMENT; PATHWAY; MICE; PHOSPHORYLATION; REQUIREMENT; INVOLVEMENT; LAT	Thymocytes from mice lacking the CD3 delta chain of the T-cell receptor (TCR), unlike those of other CD3-deficient mice(1,2), progress from a CD4(-)CD8(-) double-negative to a CD4(+)CD8(+) double-positive stage. However, CD3 delta(-/-) double-positive cells fail to undergo positive selection, by which double-positive cells differentiate into more mature thymocytes(3). Positive selection is also impaired in mice expressing inactive components of the Ras/mitogen activated protein (MAP) kinase signalling pathway(4-6). Here we show that CD3 delta(-/-) thymocytes are defective in the induction of extracellular signal-regulated protein kinase (ERK) MAP kinases upon TCR engagement, whereas activation of other MAP kinases is unaffected. The requirement for CD3d maps to its extracellular or transmembrane domains, or both, as expression of a tail-less CD3d rescues both ERK activation and positive selection in CD3 delta(-/-) mice. Furthermore, the defect correlates with severely impaired tyrosine phosphorylation of the linker protein LAT, and of the CD3 zeta chain that is localized to membrane lipid rafts upon TCR engagement. Our data indicate that the blockade of positive selection of CD3 delta(-/-) thymocytes may derive from defective tyrosine phosphorylation of CD3z in lipid rafts, resulting in impaired activation of the LAT/Ras/ERK pathway.	Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Fox Chase Cancer Center	Alarcon, B (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain.		Delgado, Pilar/F-3365-2016; Alarcon, Balbino/N-9648-2016	Delgado, Pilar/0000-0002-8431-8002; Alarcon, Balbino/0000-0001-7820-1070				ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; Backstrom BT, 1998, SCIENCE, V281, P835, DOI 10.1126/science.281.5378.835; Bommhardt U, 1999, J IMMUNOL, V163, P715; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; Clements JL, 1998, SCIENCE, V281, P416, DOI 10.1126/science.281.5375.416; DAMBROSIO D, 1994, EUR J IMMUNOL, V24, P616, DOI 10.1002/eji.1830240319; Dave VP, 1998, INT IMMUNOL, V10, P1481, DOI 10.1093/intimm/10.10.1481; Dave VP, 1997, EMBO J, V16, P1360, DOI 10.1093/emboj/16.6.1360; DAVE VP, UNPUB IMMUNITY; DUTZ JP, 1995, J IMMUNOL, V154, P2588; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Haks MC, 1998, EMBO J, V17, P1871, DOI 10.1093/emboj/17.7.1871; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; Kersh EN, 1998, SCIENCE, V281, P572, DOI 10.1126/science.281.5376.572; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; MILISSEN B, 1999, ADV IMMUNOL, V72, P103; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; Neel BG, 1997, CURR OPIN IMMUNOL, V9, P405, DOI 10.1016/S0952-7915(97)80088-X; OShea CC, 1996, EUR J IMMUNOL, V26, P2350, DOI 10.1002/eji.1830261012; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Rudd CE, 1999, CELL, V96, P5, DOI 10.1016/S0092-8674(00)80953-8; Sahuquillo AG, 1998, J EXP MED, V187, P1179, DOI 10.1084/jem.187.8.1179; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Sharp LL, 1997, IMMUNITY, V7, P609, DOI 10.1016/S1074-7613(00)80382-9; SWAN KA, 1995, EMBO J, V14, P276, DOI 10.1002/j.1460-2075.1995.tb07001.x; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Zhang WG, 1999, IMMUNITY, V10, P323, DOI 10.1016/S1074-7613(00)80032-1; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8	28	114	115	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					426	430		10.1038/35019102	http://dx.doi.org/10.1038/35019102			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935641				2022-12-24	WOS:000088383800051
J	Garman, SC; Wurzburg, BA; Tarchevskaya, SS; Kinet, JP; Jardetzky, TS				Garman, SC; Wurzburg, BA; Tarchevskaya, SS; Kinet, JP; Jardetzky, TS			Structure of the Fc fragment of human IgE bound to its high-affinity receptor Fc epsilon RI alpha	NATURE			English	Article							HUMAN-IMMUNOGLOBULIN-E; MEDIATED EFFECTOR FUNCTIONS; BINDING-SITE; CRYSTAL-STRUCTURE; GAMMA-RII; MONOCLONAL-ANTIBODY; IDENTIFICATION; SUBUNIT; COMPLEX; GLYCOSYLATION	The initiation of immunoglobulin-E (IgE)-mediated allergic responses requires the binding of IgE antibody to its high-affinity receptor, Fc epsilon RI. Crosslinking of Fc epsilon RI initiates an intracellular signal transduction cascade that triggers the release of mediators of the allergic response. The interaction of the crystallizable fragment (Fc) of IgE (IgE-Fc) with Fc epsilon RI is a key recognition event of this process and involves the extracellular domains of the Fc epsilon RI alpha-chain. To understand the structural basis for this interaction, we have solved the crystal structure of the human IgE-Fc-Fc epsilon RI alpha complex to 3.5-Angstrom resolution. The crystal structure reveals that one receptor binds one dimeric IgE-Fc molecule asymmetrically through interactions at two sites, each involving one C epsilon 3 domain of the IgE-Fc. The interaction of one receptor with the IgE-Fc blocks the binding of a second receptor, and features of this interaction are conserved in other members of the Fc receptor family. The structure suggests new approaches to inhibiting the binding of IgE to Fc epsilon RI for the treatment of allergy and asthma.	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; Beth Israel Deaconness Med Ctr, Dept Pathol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Northwestern University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Jardetzky, TS (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	tedj@northwestern.edu						ANDERSON CL, 1987, J IMMUNOL, V138, P2254; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BASU M, 1993, J BIOL CHEM, V268, P13118; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang TW, 2000, NAT BIOTECHNOL, V18, P157, DOI 10.1038/72601; CHAPPEL MS, 1991, P NATL ACAD SCI USA, V88, P9036, DOI 10.1073/pnas.88.20.9036; Cook JPD, 1997, BIOCHEMISTRY-US, V36, P15579, DOI 10.1021/bi9713005; Cookson W, 1999, NATURE, V402, pB5, DOI 10.1038/35037002; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; DEISENHOFER J, 1976, H-S Z PHYSIOL CHEM, V357, P1421, DOI 10.1515/bchm2.1976.357.2.1421; DORRINGTON KJ, 1978, IMMUNOL REV, V41, P3, DOI 10.1111/j.1600-065X.1978.tb01458.x; DUNCAN AR, 1988, NATURE, V332, P563, DOI 10.1038/332563a0; Garman SC, 1998, CELL, V95, P951, DOI 10.1016/S0092-8674(00)81719-5; GRANATO DA, 1987, MOL IMMUNOL, V24, P849, DOI 10.1016/0161-5890(87)90187-8; Harris LJ, 1999, ADV IMMUNOL, V72, P191; Harris LJ, 1997, BIOCHEMISTRY-US, V36, P1581, DOI 10.1021/bi962514+; Henry AJ, 1997, BIOCHEMISTRY-US, V36, P15568, DOI 10.1021/bi971299+; HULETT MD, 1995, J BIOL CHEM, V270, P21188, DOI 10.1074/jbc.270.36.21188; HULETT MD, 1993, EUR J IMMUNOL, V23, P640, DOI 10.1002/eji.1830230310; Hulett MD, 1999, J BIOL CHEM, V274, P13345, DOI 10.1074/jbc.274.19.13345; HULETT MD, 1994, J BIOL CHEM, V269, P15287; Jardieu PM, 1999, INT ARCH ALLERGY IMM, V118, P112, DOI 10.1159/000024043; Jefferis R, 1998, IMMUNOL REV, V163, P59, DOI 10.1111/j.1600-065X.1998.tb01188.x; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KANELLOPOULOS JM, 1980, J BIOL CHEM, V255, P9060; KEEGAN AD, 1991, MOL IMMUNOL, V28, P1149, DOI 10.1016/0161-5890(91)90030-N; Keown MB, 1997, EUR BIOPHYS J BIOPHY, V25, P471, DOI 10.1007/s002490050062; KEOWN MB, 1995, P NATL ACAD SCI USA, V92, P1841, DOI 10.1073/pnas.92.6.1841; Keown MB, 1998, BIOCHEMISTRY-US, V37, P8863, DOI 10.1021/bi972354h; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LETOURNEUR O, 1995, J BIOL CHEM, V270, P8249, DOI 10.1074/jbc.270.14.8249; MALLAMACI MA, 1993, J BIOL CHEM, V268, P22076; Maxwell KF, 1999, NAT STRUCT BIOL, V6, P437; METZGER H, 1992, IMMUNOL REV, V125, P37, DOI 10.1111/j.1600-065X.1992.tb00624.x; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NISSIM A, 1991, EMBO J, V10, P101, DOI 10.1002/j.1460-2075.1991.tb07925.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PRESTA L, 1994, J BIOL CHEM, V269, P26368; Ravetch JV, 1998, ANNU REV IMMUNOL, V16, P421, DOI 10.1146/annurev.immunol.16.1.421; ROBERTSON MW, 1993, J BIOL CHEM, V268, P12736; Sanchez LM, 1999, BIOCHEMISTRY-US, V38, P9471, DOI 10.1021/bi9907330; Sayers I, 1998, BIOCHEMISTRY-US, V37, P16152, DOI 10.1021/bi981456k; Schreiber SL, 2000, SCIENCE, V287, P1964, DOI 10.1126/science.287.5460.1964; Shi JG, 1997, BIOCHEMISTRY-US, V36, P2112, DOI 10.1021/bi961231e; Sondermann P, 1999, BIOCHEMISTRY-US, V38, P8469, DOI 10.1021/bi982889q; Sondermann P, 1999, EMBO J, V18, P1095, DOI 10.1093/emboj/18.5.1095; Turner H, 1999, NATURE, V402, pB24, DOI 10.1038/35037021; ZHENG Y, 1992, BIOCHEMISTRY-US, V31, P7446, DOI 10.1021/bi00148a004	50	282	345	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2000	406	6793					259	266		10.1038/35018500	http://dx.doi.org/10.1038/35018500			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917520				2022-12-24	WOS:000088251900038
J	Avorn, J; Solomon, DH				Avorn, J; Solomon, DH			Cultural and economic factors that (Mis)Shape antibiotic use: The nonpharmacologic basis of therapeutics	ANNALS OF INTERNAL MEDICINE			English	Article							RESISTANT STREPTOCOCCUS-PNEUMONIAE; RANDOMIZED CONTROLLED TRIAL; DAY-CARE-CENTER; ACUTE BRONCHITIS; DECISION-SUPPORT; DRUG-RESISTANCE; VANCOMYCIN USE; ORDER FORM; PHYSICIANS; IMPACT	The use of antibiotics in both ambulatory and inpatient settings is heavily shaped by cultural and economic factors as well as by microbiological considerations. These nonpharmacologic factors are relevant to clinicians and policymakers because of the clinical and fiscal toll of inappropriate antibiotic prescribing, including excessive use, preventable adverse effects, and the increasing prevalence of resistant organisms. An understanding of the determinants of antibiotic consumption is critical to explain current patterns of use and to devise programs to reduce inappropriate use. Patient motivations include the desire for a tangible product of the clinical encounter coupled with incorrect perceptions of the effectiveness of antibiotics, particularly in viral infections. Physician behavior can be explained by such factors as lack of information, a desire to satisfy patient demand, and pressure from managed care organizations to speed throughput. Marketing campaigns directed at both physicians and patients further serve to increase demand, especially for newer, costlier products. Studies of antibiotic use patterns in inpatient and outpatient care consistently demonstrate considerable inappropriate prescribing, which is likely to exacerbate the emergence of resistant organisms. Several approaches have been shown to improve the rationality of antibiotic use. Computer-based algorithms or reminders can prompt physicians to improve antibiotic choices at the time of prescribing; paper-based order entry forms can achieve the same goal. Interactive educational outreach ("academic detailing") is a practical implementation of social marketing principles to improve antibiotic use. Public education programs directed at consumers can help to reduce the inappropriate patient demand that helps to drive much improper antibiotic prescribing.	Brigham & Womens Hosp, Div Pharmaco Epidemiol & Pharmacoeconom, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Avorn, J (corresponding author), Brigham & Womens Hosp, Div Pharmaco Epidemiol & Pharmacoeconom, 221 Longwood Ave,BLI-341, Boston, MA 02115 USA.							Austin DJ, 1999, P NATL ACAD SCI USA, V96, P1152, DOI 10.1073/pnas.96.3.1152; AVOM J, 1987, REV INFECT DIS, V9, pS286; AVORN J, 1988, ARCH INTERN MED, V148, P1720, DOI 10.1001/archinte.148.8.1720; AVORN J, 1983, NEW ENGL J MED, V308, P1457, DOI 10.1056/NEJM198306163082406; Bell RA, 1999, J GEN INTERN MED, V14, P651, DOI 10.1046/j.1525-1497.1999.01049.x; BRICKFIELD FX, 1986, J FAM PRACTICE, V23, P119; CLASSEN DC, 1991, JAMA-J AM MED ASSOC, V266, P2847, DOI 10.1001/jama.266.20.2847; COHEN ML, 1992, SCIENCE, V257, P1050, DOI 10.1126/science.257.5073.1050; DAVIS DA, 1995, JAMA-J AM MED ASSOC, V274, P700; Dowell SF, 1997, AM FAM PHYSICIAN, V55, P1647; DUCHIN JS, 1995, PEDIATR INFECT DIS J, V14, P745, DOI 10.1097/00006454-199509000-00004; ECHOLS RM, 1984, J INFECT DIS, V150, P803, DOI 10.1093/infdis/150.6.803; EVANS RS, 1994, ARCH INTERN MED, V154, P878, DOI 10.1001/archinte.154.8.878; EVERITT DE, 1990, INFECT CONT HOSP EP, V11, P578; Farmer P, 1997, SOC SCI MED, V44, P347, DOI 10.1016/S0277-9536(96)00143-8; FARYNA A, 1987, J GEN INTERN MED, V2, P102, DOI 10.1007/BF02596306; Freidson E., 1970, PROFESSION MED STUDY; Gonzales R, 1998, J GEN INTERN MED, V13, P541, DOI 10.1046/j.1525-1497.1998.00165.x; Gonzales R, 1999, JAMA-J AM MED ASSOC, V281, P1512, DOI 10.1001/jama.281.16.1512; Gonzales R, 1997, JAMA-J AM MED ASSOC, V278, P901, DOI 10.1001/jama.278.11.901; HOWIE JGR, 1976, BRIT MED J, V2, P1061, DOI 10.1136/bmj.2.6043.1061; Jernigan DB, 1996, JAMA-J AM MED ASSOC, V275, P206, DOI 10.1001/jama.275.3.206; KATON W, 1980, RELEVANCE SOCIAL SCI, P253; Levy S.B., 1992, ANTIBIOTIC PARADOX H; Lipsky BA, 1999, AM J INFECT CONTROL, V27, P84, DOI 10.1016/S0196-6553(99)70086-6; MCCAIG LF, 1995, JAMA-J AM MED ASSOC, V273, P214, DOI 10.1001/jama.273.3.214; MCGOWAN JE, 1983, REV INFECT DIS, V5, P1033; McIsaac WJ, 2000, MED DECIS MAKING, V20, P33, DOI 10.1177/0272989X0002000104; Metlay JP, 1998, ARCH INTERN MED, V158, P1813, DOI 10.1001/archinte.158.16.1813; *OFF TECHN ASS, 1995, IMP ANT RES BACT; OSLER W, 1920, AECQUANIMITAS, P254; Parsons T, 1951, SOCIAL SYSTEM, P428; Pestotnik SL, 1996, ANN INTERN MED, V124, P884, DOI 10.7326/0003-4819-124-10-199605150-00004; PESTOTNIK SL, 1990, AM J MED, V88, P43, DOI 10.1016/0002-9343(90)90126-X; PHELPS CE, 1989, MED CARE, V27, P194, DOI 10.1097/00005650-198902000-00009; RADETSKY MS, 1981, LANCET, V2, P771; RAY WA, 1985, JAMA-J AM MED ASSOC, V253, P1774, DOI 10.1001/jama.253.12.1774; REICHLER MR, 1992, J INFECT DIS, V166, P1346, DOI 10.1093/infdis/166.6.1346; ROBINSBROWNE RM, 1984, J HYG-CAMBRIDGE, V93, P9, DOI 10.1017/S0022172400060873; Shojania KG, 1998, J AM MED INFORM ASSN, V5, P554, DOI 10.1136/jamia.1998.0050554; SOUMERAI SB, 1986, MED CARE, V24, P313, DOI 10.1097/00005650-198604000-00003; Starr P, 1982, SOCIAL TRANSFORMATIO; STOTT NCH, 1976, BRIT MED J, V2, P556, DOI 10.1136/bmj.2.6035.556; UTTLEY AHC, 1988, LANCET, V1, P57; Watson RL, 1999, PEDIATRICS, V104, P1251, DOI 10.1542/peds.104.6.1251; Wilson AA, 1999, J GEN INTERN MED, V14, P658, DOI 10.1046/j.1525-1497.1999.08118.x; ZENNI MK, 1995, J PEDIATR-US, V127, P533, DOI 10.1016/S0022-3476(95)70108-7	47	195	196	0	25	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2000	133	2					128	135		10.7326/0003-4819-133-2-200007180-00012	http://dx.doi.org/10.7326/0003-4819-133-2-200007180-00012			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	335RL	10896639				2022-12-24	WOS:000088258500006
J	Williams, TL; Baker, TA				Williams, TL; Baker, TA			Molecular biology - Transposase team puts a headlock on DNA	SCIENCE			English	Editorial Material							SARCOMA VIRUS INTEGRASE; ACTIVE-SITE; TRANSPOSITIONAL RECOMBINATION; CATALYTIC DOMAIN; DIVALENT-CATIONS; STRAND TRANSFER; MU TRANSPOSASE; RESOLUTION; RESIDUES; CLEAVAGE		MIT, Dept Chem, Off 68 517, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Williams, TL (corresponding author), MIT, Dept Chem, Off 68 517, Cambridge, MA 02139 USA.							Aldaz H, 1996, CELL, V85, P257, DOI 10.1016/S0092-8674(00)81102-2; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Bhasin A, 1999, J BIOL CHEM, V274, P37021, DOI 10.1074/jbc.274.52.37021; Bujacz G, 1997, J BIOL CHEM, V272, P18161, DOI 10.1074/jbc.272.29.18161; Bujacz G, 1996, STRUCTURE, V4, P89, DOI 10.1016/S0969-2126(96)00012-3; CRAIG NL, 1995, SCIENCE, V270, P253, DOI 10.1126/science.270.5234.253; Davies DR, 2000, SCIENCE, V289, P77, DOI 10.1126/science.289.5476.77; Davies DR, 1999, J BIOL CHEM, V274, P11904, DOI 10.1074/jbc.274.17.11904; KATAYANAGI K, 1993, PROTEINS, V17, P337, DOI 10.1002/prot.340170402; Kennedy AK, 1998, CELL, V95, P125, DOI 10.1016/S0092-8674(00)81788-2; KULKOSKY J, 1992, MOL CELL BIOL, V12, P2331, DOI 10.1128/MCB.12.5.2331; Maignan S, 1998, J MOL BIOL, V282, P359, DOI 10.1006/jmbi.1998.2002; MIZUUCHI K, 1992, ANNU REV BIOCHEM, V61, P1011; Mizuuchi K, 1997, GENES CELLS, V2, P1, DOI 10.1046/j.1365-2443.1997.970297.x; Namgoong SY, 1998, EMBO J, V17, P3775, DOI 10.1093/emboj/17.13.3775; Rice P, 1996, CURR OPIN STRUC BIOL, V6, P76, DOI 10.1016/S0959-440X(96)80098-4; Savilahti H, 1996, CELL, V85, P271, DOI 10.1016/S0092-8674(00)81103-4; WANG Y, 1995, STRUCTURE, V3, P131; Williams TL, 1999, GENE DEV, V13, P2725, DOI 10.1101/gad.13.20.2725	19	4	4	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 7	2000	289	5476					73	74		10.1126/science.289.5476.73	http://dx.doi.org/10.1126/science.289.5476.73			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332TW	10928934				2022-12-24	WOS:000088090400033
J	Halliday, HL				Halliday, HL			Towards earlier neonatal extubation	LANCET			English	Editorial Material									Queens Univ Belfast, Nuffield Dept Child Hlth, Belfast BT12 6BJ, Antrim, North Ireland	Queens University Belfast	Halliday, HL (corresponding author), Queens Univ Belfast, Nuffield Dept Child Hlth, Belfast BT12 6BJ, Antrim, North Ireland.			Halliday, Henry/0000-0001-7978-4992				Bancalari Eduardo, 1992, P200; DAVIES MW, 2000, COCHRANE LIB; DAVIS PG, 2000, COCHRANE LIB; Dimitriou G, 2000, BRIT J RADIOL, V73, P156, DOI 10.1259/bjr.73.866.10884728; FLENADY VJ, 2000, COCHRANE LIB; HENDERSONSMART DJ, 2000, COCHRANE LIB; SPENCE K, 2000, COCHRANE LIB; Verder H, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.2.e24	8	6	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 17	2000	355	9221					2091	2092		10.1016/S0140-6736(00)02372-2	http://dx.doi.org/10.1016/S0140-6736(00)02372-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325QD	10902619				2022-12-24	WOS:000087687100005
J	Richards, F; Hopkins, D; Cupp, E				Richards, F; Hopkins, D; Cupp, E			Programmatic goals and approaches to onchocerciasis	LANCET			English	Editorial Material							IVERMECTIN; VOLVULUS; TRANSMISSION		Carter Ctr, Atlanta, GA 30307 USA; Auburn Univ, Auburn, AL 36849 USA	Auburn University System; Auburn University	Richards, F (corresponding author), Carter Ctr, Atlanta, GA 30307 USA.							ABIOSE AO, 1995, WHO TECH REP SER, V852, P1; Burnham G, 1998, LANCET, V351, P1341, DOI 10.1016/S0140-6736(97)12450-3; CLINE BL, 1992, AM J TROP MED HYG, V47, P512, DOI 10.4269/ajtmh.1992.47.512; CUPP EW, 1986, SCIENCE, V231, P740, DOI 10.1126/science.3753801; CUPP EW, 1989, AM J TROP MED HYG, V40, P501, DOI 10.4269/ajtmh.1989.40.501; CUPP EW, 1992, AM J TROP MED HYG, V47, P170, DOI 10.4269/ajtmh.1992.47.170; Dean M, 2000, LANCET, V355, P385, DOI 10.1016/S0140-6736(05)74012-5; DUKE BOL, 1993, TROP MED PARASITOL, V44, P61; Dull HB, 1998, ANN TROP MED PARASIT, V92, pS69, DOI 10.1080/00034983.1998.11813368; Guderian RH, 1997, TROP MED INT HEALTH, V2, P982, DOI 10.1046/j.1365-3156.1997.d01-158.x; KHABIR A, 1999, LANCET, V354, P1455; REMME JHF, 1995, PARASITOL TODAY, V11, P403, DOI 10.1016/0169-4758(95)80017-4; Richards F O, 1998, Bull World Health Organ, V76 Suppl 2, P147; Stevenson P, 1999, LANCET, V354, P2143, DOI 10.1016/S0140-6736(05)77052-5; *WHO, 1999, WKLY EPIDEMIOL REC, V74, P12	15	45	45	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 13	2000	355	9216					1663	1664		10.1016/S0140-6736(00)02235-2	http://dx.doi.org/10.1016/S0140-6736(00)02235-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	313CY	10905239				2022-12-24	WOS:000086983800006
J	Shretta, R; Brugha, R; Robb, A; Snow, RW				Shretta, R; Brugha, R; Robb, A; Snow, RW			Sustainability, affordability, and equity of corporate drug donations: the case of Malarone	LANCET			English	Editorial Material							PROGRAM; AFRICA		Kenya Govt Med Res Ctr, Wellcome Trust Collaborat Programme, Nairobi, Kenya; London Sch Hyg & Trop Med, Hlth Policy Unit, London WC1, England; WHO, Malaria Unit AFRO, Harare, Zimbabwe; Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Ctr Trop Med, Oxford OX3 9DU, England	Kenya Medical Research Institute; University of London; London School of Hygiene & Tropical Medicine; World Health Organization; University of Oxford	Shretta, R (corresponding author), Kenya Govt Med Res Ctr, Wellcome Trust Collaborat Programme, POB 43460, Nairobi, Kenya.	rima@wtrl.or.ke	Snow, Robert William/AFR-1436-2022; Brugha, Ruairi/C-8420-2012	Snow, Robert William/0000-0003-3725-6088; Brugha, Ruairi/0000-0003-0729-0197				BATES JA, 1998, OPTIONS PROMOTING FI, P1; Bloland PB, 1997, LANCET, V350, P1624, DOI 10.1016/S0140-6736(97)06082-0; BRUNDTLAND GH, 1999, WHO WAY AHEAD; BUSE K, IN PRESS B WHO; Foege WH, 1997, LANCET, V350, P1628, DOI 10.1016/S0140-6736(05)64045-7; Nabarro DN, 1998, SCIENCE, V280, P2067, DOI 10.1126/science.280.5372.2067; Nzila AM, 2000, ANTIMICROB AGENTS CH, V44, P991, DOI 10.1128/AAC.44.4.991-996.2000; Radloff PD, 1996, LANCET, V347, P1511, DOI 10.1016/S0140-6736(96)90671-6; RAPUODA BA, 1998, MALARIA INFECT DIS A, V8, P25; RIDLEY R, 1999, 3 GLOB FOR HLTH RES; Ringwald P, 1998, LANCET, V351, P673, DOI 10.1016/S0140-6736(05)78458-0; SACHS J, 1999, ECONOMIST       0814, P17; Sharp D, 1996, LANCET, V348, P1575, DOI 10.1016/S0140-6736(05)66177-6; Snow RW, 1998, T ROY SOC TROP MED H, V92, P601, DOI 10.1016/S0035-9203(98)90781-7; Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624; W.H.O, 1999, GUID TREATM DENG FEV, P1	16	17	18	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 13	2000	355	9216					1718	1720		10.1016/S0140-6736(00)02251-0	http://dx.doi.org/10.1016/S0140-6736(00)02251-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	313CY	10905260				2022-12-24	WOS:000086983800040
J	Neumann, CJ; Nuesslein-Volhard, C				Neumann, CJ; Nuesslein-Volhard, C			Patterning of the zebrafish retina by a wave of sonic hedgehog activity	SCIENCE			English	Article							POLARITY GENE HEDGEHOG; TRANSGENIC ZEBRAFISH; DROSOPHILA EYE; FLOOR PLATE; DIFFERENTIATION; EXPRESSION; ACTIVATION; INDUCTION; TISSUES; CELLS	The Drosophila retina is patterned by a morphogenetic wave driven by the Hedgehog signaling protein. Hedgehog, secreted by the first neurons, induces neuronal differentiation and hedgehog expression in nearby uncommitted cells, thereby propagating the wave. Evidence is presented here that the zebrafish Hedgehog homolog, Sonic Hedgehog, is also expressed in the first retinal neurons, and that Sonic Hedgehog drives a wave of neurogenesis across the retina, strikingly similar to the wave in Drosophila. The conservation of this patterning mechanism is unexpected, given the highly divergent structures of vertebrate and invertebrate eyes, and supports a common evolutionary origin of the animal visual system.	Max Planck Inst Entwicklungsbiol, D-72076 Tubingen, Germany	Max Planck Society	Neumann, CJ (corresponding author), Max Planck Inst Entwicklungsbiol, Spemannstr 35-III, D-72076 Tubingen, Germany.							Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Currie PD, 1996, NATURE, V382, P452, DOI 10.1038/382452a0; EKKER SC, 1995, CURR BIOL, V5, P944, DOI 10.1016/S0960-9822(95)00185-0; Gabay L, 1997, SCIENCE, V277, P1103, DOI 10.1126/science.277.5329.1103; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Greenwood S, 1999, DEVELOPMENT, V126, P5795; HEBERLEIN U, 1993, CELL, V75, P913, DOI 10.1016/0092-8674(93)90535-X; HEBERLEIN U, 1995, NATURE, V373, P709, DOI 10.1038/373709a0; HO RK, 1990, NATURE, V348, P728, DOI 10.1038/348728a0; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Jensen AM, 1997, DEVELOPMENT, V124, P363; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; Levine EM, 1997, J NEUROSCI, V17, P6277; Long QM, 1997, DEVELOPMENT, V124, P4105; MA CY, 1993, CELL, V75, P927, DOI 10.1016/0092-8674(93)90536-Y; Malicki J, 1996, DEVELOPMENT, V123, P263; McCabe KL, 1999, DEVELOPMENT, V126, P5713; Muller F, 1999, DEVELOPMENT, V126, P2103; Neumann C.C M., UNPUB; Neumann CJ, 1999, DEVELOPMENT, V126, P4817; Schauerte HE, 1998, DEVELOPMENT, V125, P2983; Schmitt EA, 1996, J COMP NEUROL, V371, P222, DOI 10.1002/(SICI)1096-9861(19960722)371:2<222::AID-CNE3>3.0.CO;2-4; Stenkamp DL, 2000, DEV BIOL, V220, P238, DOI 10.1006/dbio.2000.9629; Takabatake T, 1997, FEBS LETT, V410, P485, DOI 10.1016/S0014-5793(97)00645-5; Treisman JE, 1998, CURR TOP DEV BIOL, V39, P119, DOI 10.1016/S0070-2153(08)60454-8; WESTERFIELD M, 1992, GENE DEV, V6, P591, DOI 10.1101/gad.6.4.591	26	282	284	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2000	289	5487					2137	2139		10.1126/science.289.5487.2137	http://dx.doi.org/10.1126/science.289.5487.2137			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11000118				2022-12-24	WOS:000089430900048
J	Mulac-Jericevic, B; Mullinax, RA; DeMayo, FJ; Lydon, LP; Conneely, OM				Mulac-Jericevic, B; Mullinax, RA; DeMayo, FJ; Lydon, LP; Conneely, OM			Subgroup of reproductive functions of progesterone mediated by progesterone receptor-B isoform	SCIENCE			English	Article							HUMAN-BREAST-CANCER; EMBRYONIC STEM-CELLS; MOUSE UTERUS; ESTROGEN-RECEPTOR; GENE-EXPRESSION; A-ISOFORM; IMPLANTATION; FORM; ACTIVATION; PROMOTERS	Progesterone regulates reproductive function through two intracellular receptors, progesterone receptor-A (PR-A) and progesterone receptor-B (PR-B), that arise from a single gene and function as transcriptional regulators of progesterone-responsive genes. Although in vitro studies show that PR isoforms can display different transcriptional regulatory activities, their physiological significance is unknown. By selective ablation of PR-A in mice, we show that the PR-B isoform modulates a subset of reproductive functions of progesterone by regulation of a subset of progesterone-responsive target genes. Thus, PR-A and PR-B are functionally distinct mediators of progesterone action in vivo and should provide suitable targets for generation of tissue-selective progestins.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine	Conneely, OM (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, 1 Baylor Plaza, Houston, TX 77030 USA.		DeMayo, Francesco/C-6255-2019; Mulac-Jericevic, Biserka/S-6034-2018	DeMayo, Francesco/0000-0002-9480-7336; Mulac-Jericevic, Biserka/0000-0001-8418-0712	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD032007, R01HD032007] Funding Source: NIH RePORTER; NICHD NIH HHS [HD32007] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abuin A, 1996, MOL CELL BIOL, V16, P1851; BECK CA, 1993, P NATL ACAD SCI USA, V90, P4441, DOI 10.1073/pnas.90.10.4441; BRANDON DD, 1993, AM J OBSTET GYNECOL, V169, P78, DOI 10.1016/0002-9378(93)90135-6; CONNEELY OM, 1989, J BIOL CHEM, V264, P14062; DAS SK, 1995, MOL ENDOCRINOL, V9, P691, DOI 10.1210/me.9.6.691; Duffy DM, 1997, BIOL REPROD, V57, P693, DOI 10.1095/biolreprod57.4.693; Giangrande PH, 1999, RECENT PROG HORM RES, V54, P291; Giangrande PH, 1997, J BIOL CHEM, V272, P32889, DOI 10.1074/jbc.272.52.32889; Graham JD, 1997, ENDOCR REV, V18, P502, DOI 10.1210/er.18.4.502; Graham JD, 1996, J STEROID BIOCHEM, V56, P93; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Hovland AR, 1998, J BIOL CHEM, V273, P5455, DOI 10.1074/jbc.273.10.5455; KASTNER P, 1990, EMBO J, V9, P1603, DOI 10.1002/j.1460-2075.1990.tb08280.x; LESSEY BA, 1983, ENDOCRINOLOGY, V112, P1267, DOI 10.1210/endo-112-4-1267; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; MCDONNELL DP, 1994, J STEROID BIOCHEM, V48, P425, DOI 10.1016/0960-0760(94)90190-2; MCMASTER MT, 1992, MOL ENDOCRINOL, V6, P101, DOI 10.1210/me.6.1.101; MEYER ME, 1992, J BIOL CHEM, V267, P10882; MULACJERICEVIC B, UNPUB; MUSGROVE EA, 1993, MOL CELL BIOL, V13, P3577, DOI 10.1128/MCB.13.6.3577; Norris JD, 1999, SCIENCE, V285, P744, DOI 10.1126/science.285.5428.744; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Paria BC, 1998, ENDOCRINOLOGY, V139, P3958, DOI 10.1210/en.139.9.3958; SARTORIUS CA, 1994, MOL ENDOCRINOL, V8, P1347, DOI 10.1210/me.8.10.1347; SARTORIUS CA, 1994, CANCER RES, V54, P3868; SHYAMALA G, 1990, ENDOCRINOLOGY, V126, P2882, DOI 10.1210/endo-126-6-2882; Tibbetts TA, 1998, BIOL REPROD, V59, P1143, DOI 10.1095/biolreprod59.5.1143; Tibbetts TA, 1999, P NATL ACAD SCI USA, V96, P12021, DOI 10.1073/pnas.96.21.12021; TORA L, 1988, NATURE, V333, P185, DOI 10.1038/333185a0; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.biochem.63.1.451; VEGETO E, 1993, MOL ENDOCRINOL, V7, P1244, DOI 10.1210/me.7.10.1244; WEIGEL NL, 1993, HORMONES HLTH DIS, P309; Zhu LJ, 1998, ENDOCRINOLOGY, V139, P3923, DOI 10.1210/en.139.9.3923	33	527	553	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 8	2000	289	5485					1751	1754		10.1126/science.289.5485.1751	http://dx.doi.org/10.1126/science.289.5485.1751			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352BT	10976068				2022-12-24	WOS:000089195200046
J	Gelber, AC; Hochberg, MC; Mead, LA; Wang, NY; Wigley, FM; Klag, MJ				Gelber, AC; Hochberg, MC; Mead, LA; Wang, NY; Wigley, FM; Klag, MJ			Joint injury in young adults and risk for subsequent knee and hip osteoarthritis	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	60th National Scientific Meeting of the American-College-of-Rheumatology	OCT 18-22, 1996	ORLANDO, FL	Amer Coll Rheumatol			ARTICULAR-CARTILAGE; UNITED-STATES; ARTHRITIS; WOMEN; MEN; EPIDEMIOLOGY; MENISCECTOMY; ASSOCIATION; PREVALENCE; OBESITY	Background: Knee and hip injuries have been linked with osteoarthritis in cross-sectional and case-control studies, but few prospective studies have examined the relation between injuries in young adults and risk for later osteoarthritis. Objective: To prospectively examine the relation between joint injury and incident knee acid hip osteoarthritis. Design: Prospective cohort study. Setting: Johns Hopkins Precursors Study. Participants: 1321 former medical students. Measurements: Injury status at cohort entry was recorded when the mean age of participants was 22 years. Injury during followup and incident osteoarthritis were determined by using self-administered questionnaires. Osteoarthritis was confirmed by symptoms and radiographic findings. Results: Over a median follow-up of 36 years, 141 participants reported joint injuries (knee alone [n = 111], hip alone [n = 16], or knee and hip [n = 14]) and 96 developed osteoarthritis (knee alone [n = 64], hip alone [n = 27], or knee and hip [n = 5]). The cumulative incidence of knee osteoarthritis by 65 years of age was 13.9% in participants who had a knee injury during adolescence and young adulthood and 6.0% in those who did not (P = 0.0045) (relative risk, 2.95 [95% CI, 1.35 to 6.45]). Joint injury at cohort entry or during follow-up substantially increased the risk for subsequent osteoarthritis at that site (relative risk, 5.17 [CI, 3.07 to 8.71] and 3.50 [CI, 0.84 to 14.69] for knee and hip, respectively). Results were similar for persons with osteoarthritis confirmed by radiographs and symptoms. Conclusions: Young adults with knee injuries are at considerably increased risk for osteoarthritis later in life and should be targeted in the primary prevention of osteoarthritis.	Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA; Univ Maryland, Baltimore, MD 21201 USA; Vet Affairs Med Ctr, Baltimore, MD USA	Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Gelber, AC (corresponding author), Johns Hopkins Univ, Sch Med, 1830 E Monument St,Suite 7500, Baltimore, MD 21205 USA.			Wang, Nae-Yuh/0000-0001-6513-9730	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR001939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG001760] Funding Source: NIH RePORTER; NIAMS NIH HHS [KO8 AR-01939] Funding Source: Medline; NIA NIH HHS [AG-01760] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALTMAN RD, 1991, J RHEUMATOL, V18, P10; ALTMAN RD, 1992, ANN RHEUM DIS, V51, P1056, DOI 10.1136/ard.51.9.1056; COMONIHUNTLEY J, 1990, HLTH STATUS WELL BEI; COOPER C, 1994, ANN RHEUM DIS, V53, P90, DOI 10.1136/ard.53.2.90; Cooper C, 1998, AM J EPIDEMIOL, V147, P516; Creamer P, 1997, LANCET, V350, P503, DOI 10.1016/S0140-6736(97)07226-7; CREAMER P, 1993, J RHEUMATOL, V20, P1461; CUNNINGHAM LS, 1984, AM J PUBLIC HEALTH, V74, P574, DOI 10.2105/AJPH.74.6.574; DAVIS MA, 1989, AM J EPIDEMIOL, V130, P278, DOI 10.1093/oxfordjournals.aje.a115334; DECKERS JW, 1990, CIRCULATION, V82, P259; *DEP HLTH HUM SERV, 1980, INT CLASS DIS, V1; Felson DT, 1997, ARTHRITIS RHEUM, V40, P728, DOI 10.1002/art.1780400420; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1343, DOI 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9; Gabriel SE, 1997, J RHEUMATOL, V24, P719; Gabriel SE, 1997, J RHEUMATOL, V24, P43; Gelber AC, 1999, AM J MED, V107, P542, DOI 10.1016/S0002-9343(99)00292-2; GUCCIONE AA, 1994, AM J PUBLIC HEALTH, V84, P351, DOI 10.2105/AJPH.84.3.351; Hart DJ, 1999, ARTHRITIS RHEUM, V42, P17, DOI 10.1002/1529-0131(199901)42:1<17::AID-ANR2>3.0.CO;2-E; HELIOVAARA M, 1993, ACTA ORTHOP SCAND, V64, P513, DOI 10.3109/17453679308993681; Hochberg M.C., 1997, OSTEOARTHRITIS PUBLI, P169; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; KLAG MJ, 1993, NEW ENGL J MED, V328, P313, DOI 10.1056/NEJM199302043280504; KUJALA UM, 1995, ARTHRITIS RHEUM, V38, P539, DOI 10.1002/art.1780380413; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; LEQUESNE M, 1994, J RHEUMATOL, V21, P65; Little C, 1997, J RHEUMATOL, V24, P2199; MANKIN HJ, 1974, NEW ENGL J MED, V291, P1285, DOI 10.1056/NEJM197412122912406; MANKIN HJ, 1974, NEW ENGL J MED, V291, P1335, DOI 10.1056/NEJM197412192912507; March LM, 1998, OSTEOARTHR CARTILAGE, V6, P87, DOI 10.1053/joca.1997.0098; *NAT HLTH NUTR EX, 1979, BAS DAT ARTHR KNEE H; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; RADIN EL, 1972, LANCET, V1, P519; RALL K L, 1964, Mo Med, V61, P435; Roos H, 1998, ARTHRITIS RHEUM, V41, P687, DOI 10.1002/1529-0131(199804)41:4<687::AID-ART16>3.0.CO;2-2; ROUBENOFF R, 1991, JAMA-J AM MED ASSOC, V266, P3004, DOI 10.1001/jama.266.21.3004; Slemenda C, 1998, ARTHRITIS RHEUM, V41, P1951, DOI 10.1002/1529-0131(199811)41:11<1951::AID-ART9>3.0.CO;2-9; Slemenda C, 1997, ANN INTERN MED, V127, P97, DOI 10.7326/0003-4819-127-2-199707150-00001; Sowers M, 1999, ARTHRITIS RHEUM, V42, P483, DOI 10.1002/1529-0131(199904)42:3<483::AID-ANR13>3.0.CO;2-O; TEPPER S, 1993, AM J EPIDEMIOL, V137, P1081, DOI 10.1093/oxfordjournals.aje.a116611; THOMAS CB, 1951, B JOHNS HOPKINS HOSP, V89, P419; YELIN EH, 1990, ARTHRITIS RHEUM, V33, P750, DOI 10.1002/art.1780330520	42	466	481	0	30	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 5	2000	133	5					321	328		10.7326/0003-4819-133-5-200009050-00007	http://dx.doi.org/10.7326/0003-4819-133-5-200009050-00007			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	350QD	10979876				2022-12-24	WOS:000089111900001
J	Schieber, J; Krinsley, D; Riciputi, L				Schieber, J; Krinsley, D; Riciputi, L			Diagenetic origin of quartz silt in mudstones and implications for silica cycling	NATURE			English	Article							FOSSIL RECORD; PROVENANCE; DEPOSITION; MUDROCKS; ISOTOPES; OXYGEN	Mudstone-the most abundant sedimentary rock type(1), composed primarily of clay- or silt-sized particles-contains most of the quartz found in sedimentary rocks(2). These quartz grains, which are chemically and mechanically resistant and therefore preserve their characteristics well, have long been considered to be derived from the continental crust(1). Here we analyse quartz silt from black shales in the eastern USA, dating back to the Late Devonian period (about 370 million years ago), using backscattered electron and cathodoluminescence imaging and measure oxygen isotopes with an ion probe. Our results indicate that up to 100% of the quartz silt in our samples does not originate from the continental crust. Instead, it appears to have precipitated early in diagenesis in algal cysts and other pore spaces(3), with silica derived from the dissolution of opaline skeletons of planktonic organisms, such as radiolaria and diatoms. Transformation of early diatoms into in situ quartz silt might explain the time gap between the earliest fossil occurrences of diatoms about 120 Myr ago(4) and molecular evidence for a much earlier appearance between 266 or even 500 Myr ago(5,6). Moreover, if many other mudstone successions show similarly high proportions of in situ precipitated-rather than detrital-quartz silt, the sedimentary record in mudstones may have been misinterpreted in the past, with consequences for our estimates of palaeoproductivity as well as our perceptions of the dynamics and magnitude of global biogeochemical cycling of silica.	Univ Texas, Dept Geol, Arlington, TX 76019 USA; Univ Oregon, Dept Geol Sci, Eugene, OR 97403 USA; Oak Ridge Natl Lab, Div Chem & Analyt Sci, Oak Ridge, TN 37831 USA	University of Texas System; University of Texas Arlington; University of Oregon; United States Department of Energy (DOE); Oak Ridge National Laboratory	Schieber, J (corresponding author), Univ Texas, Dept Geol, Arlington, TX 76019 USA.	schieber@uta.edu	Schieber, Juergen Schieber/A-3001-2013					[Anonymous], 1992, PRODUCTIVITY ACCUMUL; BLATT H, 1987, J SEDIMENT PETROL, V57, P373, DOI 10.1306/212F8B34-2B24-11D7-8648000102C1865D; BLATT H, 1985, J SEDIMENT PETROL, V55, P69; BLATT H, 1981, J SEDIMENT PETROL, V51, P1259; Carroll AR, 1998, GEOLOGY, V26, P1023, DOI 10.1130/0091-7613(1998)026<1023:EDSITU>2.3.CO;2; Ettensohn F.R, 1988, DEVONIAN WORLD, V2, P323; Ettensohn F.R., 1998, SHALES MUDSTONES, VVolume I, P109; FUCHBAUER H, 1988, SEDIMENTE SEDIMENTGE; Hallam A., 1992, PHANEROZOIC SEA LEVE; HATHON C, 1980, FE234661 US DEP EN; Kepferle R. C., 1993, USGS BULL, V1909, pF1, DOI [10.3133 /b1909, DOI 10.3133/B1909]; Kooistra WHCF, 1996, MOL PHYLOGENET EVOL, V6, P391, DOI 10.1006/mpev.1996.0088; MALIVA R G, 1989, Palaios, V4, P519, DOI 10.2307/3514743; MATTER A, 1985, PROVENANCE ARENITES, P191; MILLIKEN KL, 1994, J SEDIMENT RES A, V64, P567, DOI 10.1306/D4267E0B-2B26-11D7-8648000102C1865D; OBrien N.R., 1990, ARGILLACEOUS ROCK AT; Parrish J.T., 1998, INTERPRETING PREQUAT; PHILIPPE H, 1994, J EVOLUTION BIOL, V7, P247, DOI 10.1046/j.1420-9101.1994.7020247.x; Potter P.E., 1980, SEDIMENTOLOGY SHALE; Riciputi LR, 1998, INT J MASS SPECTROM, V178, P81, DOI 10.1016/S1387-3806(98)14088-5; Round F.E., 1990, DIATOMS BIOL MORPHOL, P747, DOI 10.1017/S0025315400059245; Schieber J, 1999, J SEDIMENT RES, V69, P909, DOI 10.2110/jsr.69.909; Schieber J, 1996, J SEDIMENT RES, V66, P175; Schieber J., 1998, SHALES AND MUDSTONES, V1, P187; Seyedolali A, 1997, GEOLOGY, V25, P787, DOI 10.1130/0091-7613(1997)025<0787:PIOQBS>2.3.CO;2; Tappan H, 1980, PALEOBIOLOGY PLANT P; Tyson R.V., 1991, Geological Society Special Publication, V58, P1; Wollast R., 1983, SILICON GEOCHEMISTRY, P39; WOODROW DL, 1985, CATSKILL DELTA, P51; ZINKERNAGEL U, 1978, CONTRIB SEDIMENTOL, V8	30	164	188	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2000	406	6799					981	985		10.1038/35023143	http://dx.doi.org/10.1038/35023143			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	348ZW	10984049				2022-12-24	WOS:000089020200041
J	Taylor, G; Lehrer, MS; Jensen, PJ; Sun, TT; Lavker, RM				Taylor, G; Lehrer, MS; Jensen, PJ; Sun, TT; Lavker, RM			Involvement of follicular stem cells in forming not only the follicle but also the epidermis	CELL			English	Article							LABEL-RETAINING CELLS; CORNEAL EPITHELIAL-CELLS; OCULAR SURFACE DISORDERS; HAIR FOLLICLE; IN-VITRO; AUTOGRAFT TRANSPLANTATION; MOUSE EPIDERMIS; SMALL-INTESTINE; CLONAL ANALYSIS; EARLY ANAGEN	The location of follicular and epidermal stem cells in mammalian skin is a crucial issue in cutaneous biology. We demonstrate that hair follicular stem cells, located in the bulge region, can give rise to several cell types of the hair follicle as well as upper follicular cells. Moreover, we devised a double-label technique to show that upper follicular keratinocytes emigrate into the epidermis in normal newborn mouse skin, and in adult mouse skin in response to a penetrating wound. These findings indicate that the hair follicle represents a major repository of keratinocyte stem cells in mouse skin, and that follicular bulge stem cells are potentially bipotent as they can give rise to not only the hair follicle, but also the epidermis.	NYU, Sch Med, Ronald O Perelman Dept Dermatol, Epithelial Biol Unit, New York, NY 10016 USA; NYU, Sch Med, Kaplan Canc Ctr, Dept Pharmacol, New York, NY 10016 USA; NYU, Sch Med, Kaplan Canc Ctr, Dept Urol, New York, NY 10016 USA; Univ Penn, Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA	New York University; New York University; New York University; University of Pennsylvania	Lavker, RM (corresponding author), NYU, Sch Med, Ronald O Perelman Dept Dermatol, Epithelial Biol Unit, New York, NY 10016 USA.	sunt0l@med.nyu.edu; lavker@mail.med.upenn.edu	Sun, Tung-Tien/J-4425-2015	Sun, Tung-Tien/0000-0002-6841-1063; Taylor, Gina/0000-0002-3611-5286	NEI NIH HHS [EY06769] Funding Source: Medline; NIAMS NIH HHS [AR42998] Funding Source: Medline; NIDDK NIH HHS [DK39753] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039753] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARGYRIS TS, 1976, AM J PATHOL, V83, P329; AURAN JD, 1995, OPHTHALMOLOGY, V102, P33; BICKENBACH JR, 1981, J DENT RES, V60, P1611, DOI 10.1177/002203458106000311011; Bickenbach JR, 1998, EXP CELL RES, V244, P184, DOI 10.1006/excr.1998.4163; Binder RL, 1998, CANCER RES, V58, P4314; BUCK RC, 1985, INVEST OPHTH VIS SCI, V26, P1296; BURNS ER, 1975, CELL TISSUE KINET, V8, P61, DOI 10.1111/j.1365-2184.1975.tb01207.x; Buschke W, 1943, B JOHNS HOPKINS HOSP, V73, P143; Chen TT, 1997, MOL CELL BIOL, V17, P3056, DOI 10.1128/MCB.17.6.3056; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; DAVANGER M, 1971, NATURE, V229, P560, DOI 10.1038/229560a0; EBATO B, 1988, INVEST OPHTH VIS SCI, V29, P1533; FOGLE JA, 1980, A GRAEF ARCH KLIN EX, V213, P143, DOI 10.1007/BF00410983; Fuchs E, 2000, CELL, V100, P143, DOI 10.1016/S0092-8674(00)81691-8; FUCHS E, 1990, J CELL BIOL, V111, P2807, DOI 10.1083/jcb.111.6.2807; Ghazizadeh S, 1999, GENE THER, V6, P1267, DOI 10.1038/sj.gt.3300956; HANSEN LA, 1994, P NATL ACAD SCI USA, V91, P7822, DOI 10.1073/pnas.91.16.7822; HARDY MH, 1992, TRENDS GENET, V8, P55, DOI 10.1016/0168-9525(92)90350-D; Hodson S, 1997, NATURE, V387, P449, DOI 10.1038/387449a0; HUANG AJW, 1991, INVEST OPHTH VIS SCI, V32, P96; Jensen PJ, 1999, J INVEST DERMATOL, V112, P240, DOI 10.1046/j.1523-1747.1999.00494.x; Kamimura J, 1997, J INVEST DERMATOL, V109, P534, DOI 10.1111/1523-1747.ep12336704; KAUR P, 1986, CELL TISSUE KINET, V19, P601, DOI 10.1111/j.1365-2184.1986.tb00761.x; KENYON KR, 1989, OPHTHALMOLOGY, V96, P709; KRUSE FE, 1990, INVEST OPHTH VIS SCI, V31, P1903; LAVKER RM, 1983, J INVEST DERMATOL, V81, pS121, DOI 10.1111/1523-1747.ep12540880; LAVKER RM, 1993, J INVEST DERMATOL, V101, pS16, DOI 10.1111/1523-1747.ep12362556; Lavker RM, 1998, INVEST OPHTH VIS SCI, V39, P301; LAVKER RM, 1999, FITZPATRICKS DERMATO, P230; Lehrer MS, 1998, J CELL SCI, V111, P2867; Li A, 1998, P NATL ACAD SCI USA, V95, P3902, DOI 10.1073/pnas.95.7.3902; LINDBERG K, 1993, INVEST OPHTH VIS SCI, V34, P2672; Lyle S, 1998, J CELL SCI, V111, P3179; Mackenzie IC, 1997, J INVEST DERMATOL, V109, P377, DOI 10.1111/1523-1747.ep12336255; MILLER SJ, 1993, J INVEST DERMATOL, V101, P591, DOI 10.1111/1523-1747.ep12366045; MILLER SJ, 1993, SEMIN DEV BIOL, V4, P217; Morris RJ, 1997, CANCER RES, V57, P3436; Morris RJ, 2000, CANCER RES, V60, P226; MORRIS RJ, 1994, CELL PROLIFERAT, V27, P279, DOI 10.1111/j.1365-2184.1994.tb01425.x; Morris RJ, 1999, J INVEST DERMATOL, V112, P470, DOI 10.1046/j.1523-1747.1999.00537.x; OLIVER RF, 1966, J EMBRYOL EXP MORPH, V15, P331; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769; Pizzarello LD, 1978, OCULAR ADNEXAL TUMOR, P553; POTTEN CS, 1987, VIRCHOWS ARCH B, V53, P279, DOI 10.1007/BF02890254; POTTEN CS, 1982, CELL TISSUE KINET, V15, P305, DOI 10.1111/j.1365-2184.1982.tb01050.x; QUESENBERRY P, 1979, NEW ENGL J MED, V301, P819, DOI 10.1056/NEJM197910113011505; ROCHAT A, 1994, CELL, V76, P1063, DOI 10.1016/0092-8674(94)90383-2; RODRIGUES M, 1987, DIFFERENTIATION, V34, P60, DOI 10.1111/j.1432-0436.1987.tb00051.x; RUSSELL WO, 1956, CANCER, V9, P1, DOI 10.1002/1097-0142(195601/02)9:1&lt;1::AID-CNCR2820090102&gt;3.0.CO;2-Z; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; SCHEVING LE, 1967, J CELL BIOL, V32, P677, DOI 10.1083/jcb.32.3.677; Schmitt A, 1996, J VIROL, V70, P1912, DOI 10.1128/JVI.70.3.1912-1922.1996; STENBACK F, 1981, BRIT J CANCER, V44, P1, DOI 10.1038/bjc.1981.141; Suter MM, 1997, VET DERMATOL, V8, P67, DOI 10.1046/j.1365-3164.1997.d01-5.x; SZABO G, 1967, PHILOS T ROY SOC B, V252, P447, DOI 10.1098/rstb.1967.0029; TSAI RJF, 1990, OPHTHALMOLOGY, V97, P446, DOI 10.1016/S0161-6420(90)32575-7; TSENG SCG, 1989, EYE, V3, P141, DOI 10.1038/eye.1989.22; TSENG SCG, 1999, CORNEAL SURG THEORY, P9; TSUBOTA K, 1995, OPHTHALMOLOGY, V102, P1486; Voelker R, 1997, JAMA-J AM MED ASSOC, V278, P1477, DOI 10.1001/jama.278.18.1477; Watt FM, 1998, PHILOS T R SOC B, V353, P831, DOI 10.1098/rstb.1998.0247; WEI ZG, 1993, INVEST OPHTH VIS SCI, V34, P1814; WEI ZG, 1995, INVEST OPHTH VIS SCI, V36, P236; WILSON C, 1994, DIFFERENTIATION, V55, P127, DOI 10.1046/j.1432-0436.1994.5520127.x; YANG JS, 1993, J INVEST DERMATOL, V101, P652, DOI 10.1111/1523-1747.ep12371671	68	843	950	2	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 18	2000	102	4					451	461		10.1016/S0092-8674(00)00050-7	http://dx.doi.org/10.1016/S0092-8674(00)00050-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	347BX	10966107	Bronze			2022-12-24	WOS:000088908000007
J	Wilson, JE; Pestova, TV; Hellen, CUT; Sarnow, P				Wilson, JE; Pestova, TV; Hellen, CUT; Sarnow, P			Initiation of protein synthesis from the A site of the ribosome	CELL			English	Article							PICORNA-LIKE VIRUS; MESSENGER-RNA; TRANSLATION INITIATION; EUKARYOTIC RIBOSOMES; NUCLEOTIDE-SEQUENCE; BINDING; INHIBITION; IDENTIFICATION; SUBUNITS; COMPLEX	Positioning of the translation initiation complex on mRNAs requires interaction between the anticodon of initiator Met-tRNA, associated with elF2-GTP and 40S ribosomal subunit, and the cognate start codon of the mRNA. We show that an internal ribosome entry site located in the genome of cricket paralysis virus can form 80S ribosomes without initiator Met-tRNA, elF2, or GTP hydrolysis, with a CCU triplet in the ribosomal P site and a GCU triplet in the A site. P-site mutagenesis revealed that the P site was not decoded, and protein sequence analysis showed that translation initiates at the triplet in the A site. Translational initiation from the A site of the ribosome suggests that the repertoire of translated open reading frames in eukaryotic mRNAs may be greater than anticipated.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; SUNY Hlth Sci Ctr, Morse Inst Mol Genet, Dept Microbiol & Immunol, Brooklyn, NY 11203 USA	Stanford University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Sarnow, P (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.			Sarnow, Peter/0000-0002-2043-2770	NIAID NIH HHS [AI44108] Funding Source: Medline; NIGMS NIH HHS [GM55979] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055979] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANTHONY DD, 1992, J BIOL CHEM, V267, P1554; Carrasco L, 1974, Methods Enzymol, V30, P282; CHEN CY, 1995, SCIENCE, V268, P415, DOI 10.1126/science.7536344; Domier LL, 2000, VIROLOGY, V268, P264, DOI 10.1006/viro.2000.0189; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; GRAY NK, 1994, EMBO J, V13, P3882, DOI 10.1002/j.1460-2075.1994.tb06699.x; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; HOLSCHUH K, 1980, BIOCHEMISTRY-US, V19, P5857, DOI 10.1021/bi00566a030; JACKSON RJ, 1996, TRANSLATIONAL CONTRO, P71; Johannes G, 1999, P NATL ACAD SCI USA, V96, P13118, DOI 10.1073/pnas.96.23.13118; Johnson KN, 1998, J GEN VIROL, V79, P191, DOI 10.1099/0022-1317-79-1-191; Joseph S, 1998, EMBO J, V17, P3478, DOI 10.1093/emboj/17.12.3478; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; KOZAK M, 1978, J BIOL CHEM, V253, P6568; LAZARO E, 1991, BIOCHEMISTRY-US, V30, P9642, DOI 10.1021/bi00104a011; Merrick WC., 1996, TRANSLATION CONTROL, P31; Moon JS, 1998, VIROLOGY, V243, P54, DOI 10.1006/viro.1998.9043; Murali N, 1997, BIOPHYS J, V72, P2275, DOI 10.1016/S0006-3495(97)78872-6; Muto A, 1998, TRENDS BIOCHEM SCI, V23, P25, DOI 10.1016/S0968-0004(97)01159-6; Nakashima N, 1999, ARCH VIROL, V144, P2051, DOI 10.1007/s007050050726; ODOM OW, 1978, J BIOL CHEM, V253, P1807; Pestova TV, 2000, NATURE, V403, P332, DOI 10.1038/35002118; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pestova TV, 1998, NATURE, V394, P854, DOI 10.1038/29703; Pestova TV, 1996, MOL CELL BIOL, V16, P6859, DOI 10.1128/mcb.16.12.6859; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; Sasaki J, 2000, P NATL ACAD SCI USA, V97, P1512, DOI 10.1073/pnas.010426997; Sasaki J, 1999, J VIROL, V73, P1219, DOI 10.1128/JVI.73.2.1219-1226.1999; Sasaki J, 1998, VIROLOGY, V244, P50, DOI 10.1006/viro.1998.9094; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; SZER W, 1970, Biochimica et Biophysica Acta, V224, P477, DOI 10.1016/0005-2787(70)90580-0; WALTER R, 1980, MOL CELL BIOCHEM, V30, P111; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000; WONG WL, 1993, BIOCHEM J, V289, P71, DOI 10.1042/bj2890071	34	340	347	0	16	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 18	2000	102	4					511	520		10.1016/S0092-8674(00)00055-6	http://dx.doi.org/10.1016/S0092-8674(00)00055-6			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	347BX	10966112	Bronze			2022-12-24	WOS:000088908000012
J	Nader, K; Schafe, GE; Le Doux, JE				Nader, K; Schafe, GE; Le Doux, JE			Fear memories require protein synthesis in the amygdala for reconsolidation after retrieval	NATURE			English	Article							ELEMENT-BINDING PROTEIN; LONG-TERM-MEMORY; CONSOLIDATION; PHASE	'New' memories are initially labile and sensitive to disruption before being consolidated into stable long-term memories(1-5). Much evidence indicates that this consolidation involves the synthesis of new proteins in neurons(6-9). The lateral and basal nuclei of the amygdala (LBA) are believed to be a site of memory storage in fear learning(10). Infusion of the protein synthesis inhibitor anisomycin into the LBA shortly after training prevents consolidation of fear memories(11). Here we show that consolidated fear memories, when reactivated during retrieval, return to a labile state in which infusion of anisomycin shortly after memory reactivation produces amnesia on later tests, regardless of whether reactivation was performed 1 or 14 days after conditioning. The same treatment with anisomycin, in the absence of memory reactivation, left memory intact. Consistent with a time-limited role for protein synthesis production in consolidation, delay of the infusion until six hours after memory reactivation produced no amnesia. Our data show that consolidated fear memories, when reactivated, return to a labile state that requires de novo protein synthesis for reconsolidation. These findings are not predicted by traditional theories of memory consolidation.	NYU, Ctr Neural Sci, WM Keck Fdn, Neurobiol Lab, New York, NY 10003 USA	New York University	Nader, K (corresponding author), NYU, Ctr Neural Sci, WM Keck Fdn, Neurobiol Lab, New York, NY 10003 USA.							Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Agranoff BW, 1981, BASIC NEUROCHEMISTRY, P801; Bartlett F. C., 1932, REMEMBERING; BLANCHARD RJ, 1969, J COMP PHYSIOL PSYCH, V67, P370, DOI 10.1037/h0026779; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; BRADY JV, 1952, J COMP PHYSIOL PSYCH, V45, P9, DOI 10.1037/h0062178; Burnham WH, 1903, AM J PSYCHOL, V14, P382; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Davis M, 1997, J NEUROPSYCH CLIN N, V9, P382; Dudai Y, 1996, NEURON, V17, P367, DOI 10.1016/S0896-6273(00)80168-3; DUNCAN CP, 1949, J COMP PHYSIOL PSYCH, V42, P32, DOI 10.1037/h0058173; Fanselow MS, 1998, NEURON, V20, P625, DOI 10.1016/S0896-6273(00)81002-8; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; FLEXNER LB, 1965, EXP NEUROL, V13, P264, DOI 10.1016/0014-4886(65)90114-7; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; Guzowski JF, 1997, P NATL ACAD SCI USA, V94, P2693, DOI 10.1073/pnas.94.6.2693; Hebb D.O., 1949, ORG BEHAV; JUDGE ME, 1982, PHYSIOL BEHAV, V28, P585, DOI 10.1016/0031-9384(82)90034-8; Lamprecht R, 1997, J NEUROSCI, V17, P8443; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; MACTUTUS CF, 1979, SCIENCE, V204, P1319, DOI 10.1126/science.572083; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Misanin JR, 1968, SCIENCE, V160, P203; MULLER GE, 2000, Z PSYCHOL S, V1; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; SCHAFE GE, IN PRESS J NEUROSCI; SCHOLEY AB, 1993, NEUROSCIENCE, V55, P499, DOI 10.1016/0306-4522(93)90519-L	30	1807	1858	6	227	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2000	406	6797					722	726		10.1038/35021052	http://dx.doi.org/10.1038/35021052			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	344PH	10963596				2022-12-24	WOS:000088767700043
J	Wakefield, MA; Chaloupka, FJ; Kaufman, NJ; Orleans, CT; Barker, DC; Ruel, EE				Wakefield, MA; Chaloupka, FJ; Kaufman, NJ; Orleans, CT; Barker, DC; Ruel, EE			Effect of restrictions on smoking at home, at school, and in public places on teenage smoking: cross sectional study	BRITISH MEDICAL JOURNAL			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; POLICY IMPLICATIONS; WORKPLACE SMOKING; UNITED-STATES; ADOLESCENTS; HOUSEHOLD; AUSTRALIA	Objective To determine the relation between extent of restrictions on smoking at home, at school, and in public places and smoking uptake and smoking prevalence among school students, Design Cross sectional survey with merged records of extent of restrictions on smoking in public places. Setting United States. Participants 17 287 high school students, Main outcome measures Five point scale of smoking uptake; 30 day smoking prevalence, Results More restrictive arrangements on smoking at home were associated with a greater likelihood of being in an earlier stage of smoking uptake (P < 0.05) and a lower 30 day prevalence (odds ratio 0.79 (95% confidence interval 0.67 to 0.91), P < 0.001). These findings applied even when parents were smokers. More pervasive restrictions on smoking in public places were associated with a higher probability of being in a earlier stage of smoking uptake (P < 0.05) and lower 30 day prevalence (0.91 (0.83 to 0.99), P = 0.03). School smoking bans were related to a greater likelihood of being in an earlier stage of smoking uptake (0.89 (0.85 to 0.99), P < 0.05) and lower prevalence (0.86 (0.77 to 0.91), P< 0.001) only when the ban was strongly enforced, as measured by instances when teenagers perceived that most or ail students obeyed the rule. Conclusions These findings suggest that restrictions on smoking at home, more extensive bans on smoking in public places, and enforced bans on smoking at school may reduce teenage smoking.	Univ Illinois, Hlth Res Ctr, Chicago, IL 60607 USA; Univ Illinois, Policy Ctr, Chicago, IL 60607 USA; Univ Illinois, Dept Econ, Chicago, IL 60680 USA; Robert Wood Johnson Fdn, Princeton, NJ 08543 USA; Barker Bi Coastal Hlth Consultants, Calabasas, CA 91302 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Robert Wood Johnson Foundation (RWJF)	Wakefield, MA (corresponding author), Univ Illinois, Hlth Res Ctr, 850 W Jackson Blvd, Chicago, IL 60607 USA.		Wakefield, Melanie/E-5019-2012					AARO LE, 1981, SCAND J PSYCHOL, V22, P297, DOI 10.1111/j.1467-9450.1981.tb00404.x; Biener L, 1997, PREV MED, V26, P358, DOI 10.1006/pmed.1997.0152; Borland R, 1999, TOB CONTROL, V8, P266, DOI 10.1136/tc.8.3.266; CHALOUPKA RJ, 1996, NATL BUR EC RES WORK, V5740; Chapman S, 1999, AM J PUBLIC HEALTH, V89, P1018, DOI 10.2105/AJPH.89.7.1018; CHARLTON A, 1994, HLTH ED J, V53, P191; EISER JR, 1989, BRIT J SOC PSYCHOL, V28, P193, DOI 10.1111/j.2044-8309.1989.tb00861.x; Emont SL., 1993, TOB CONTROL, V2, P13, DOI [10.1136/tc.2.1.13, DOI 10.1136/TC.2.1.13]; Farkas AJ, 1999, TOB CONTROL, V8, P261, DOI 10.1136/tc.8.3.261; FLAY BR, 1993, NICOTINE ADDICTION P, P365; Gilpin E A, 1999, Nicotine Tob Res, V1, P153, DOI 10.1080/14622299050011261; Hedeker D, 1998, MULTIVAR BEHAV RES, V33, P427, DOI 10.1207/s15327906mbr3304_1; HEDEKER D, 2000, MIXOR MIXREG PROGRAM; HOCKING B, 1991, J OCCUP ENVIRON MED, V33, P163; Hyland A, 1999, J Public Health Manag Pract, V5, P22; Jacobson PD, 1999, J HEALTH POLIT POLIC, V24, P567, DOI 10.1215/03616878-24-3-567; Mermelstein R, 1999, Nicotine Tob Res, V1 Suppl 1, pS91; *OFF SMOK HLTH, 2000, STAT TOB ACT TRACK E; PENTZ MA, 1989, JAMA-J AM MED ASSOC, V261, P3259, DOI 10.1001/jama.261.22.3259; Pentz MA, 1997, ADDICTION, V92, P1165; Pierce JP, 1996, HEALTH PSYCHOL, V15, P355, DOI 10.1037/0278-6133.15.5.355; Pierce JP., 1998, TOBACCO CONTROL CALI; Tauras JohnA, 1999, 6937 NAT BUR EC RES; Wakefield M, 1996, Tob Control, V5, P205, DOI 10.1136/tc.5.3.205; WAKEFIELD M, 2000, IMPACTEEN WORKING PA, V3; WASSERMAN J, 1991, J HEALTH ECON, V10, P43, DOI 10.1016/0167-6296(91)90016-G	26	373	381	0	20	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 5	2000	321	7257					333	337		10.1136/bmj.321.7257.333	http://dx.doi.org/10.1136/bmj.321.7257.333			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	342QH	10926588	Green Published, Bronze			2022-12-24	WOS:000088656300022
J	Palczewski, K; Kumasaka, T; Hori, T; Behnke, CA; Motoshima, H; Fox, BA; Le Trong, I; Teller, DC; Okada, T; Stenkamp, RE; Yamamoto, M; Miyano, M				Palczewski, K; Kumasaka, T; Hori, T; Behnke, CA; Motoshima, H; Fox, BA; Le Trong, I; Teller, DC; Okada, T; Stenkamp, RE; Yamamoto, M; Miyano, M			Crystal structure of rhodopsin: A G protein-coupled receptor	SCIENCE			English	Article							SCHIFF-BASE COUNTERION; BOVINE RHODOPSIN; VISUAL PIGMENTS; TRANSMEMBRANE HELICES; ANGSTROM RESOLUTION; RETINAL CHROMOPHORE; LIGHT ACTIVATION; AMINO-ACID; ROD; BACTERIORHODOPSIN	Heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors (GPCRs) respond to a variety of different external stimuli and activate G proteins. GPCRs share many structural features, including a bundle of seven transmembrane alpha helices connected by six Loops of varying Lengths. We determined the structure of rhodopsin from diffraction data extending to 2.8 angstroms resolution. The highly organized structure in the extracellular region, including a conserved disulfide bridge, forms a basis for the arrangement of the seven-helix transmembrane motif. The ground-state chromophore, Il-cis-retinal, holds the transmembrane region of the protein in the inactive conformation. Interactions of the chromophore with a cluster of key residues determine the wavelength of the maximum absorption. Changes in these interactions among rhodopsins facilitate color discrimination. Identification of a set of residues that mediate interactions between the transmembrane helices and the cytoplasmic surface, where C-protein activation occurs, also suggests a possible structural change upon photoactivation.	Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Dept Chem, Seattle, WA 98195 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; Univ Washington, Biomol Struct Ctr, Seattle, WA 98195 USA; RIKEN, Harima Inst, Struct Biophys Lab, Mikazuki, Hyogo 6795148, Japan; Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; RIKEN; Tokyo Institute of Technology	Palczewski, K (corresponding author), Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA.	palczews@u.washington.edu; stenkamp@u.washington.edu; miyano@spring8.or.jp	Kumasaka, Takashi/D-7428-2018; Miyano, Masashi/R-2785-2016; Oka, Yoshitaka/C-9670-2010; Yamamoto, Masaki/B-7844-2015; Martinez, Octavio/B-7375-2009; soler, martha maricel m gomez/L-6025-2014	Kumasaka, Takashi/0000-0001-9289-1557; Miyano, Masashi/0000-0003-2253-6175; Oka, Yoshitaka/0000-0002-3482-3051; Yamamoto, Masaki/0000-0002-1311-1768; soler, martha maricel m gomez/0000-0002-4412-8108; Fox, Brian/0000-0001-6620-3853; Behnke, Craig/0000-0001-6949-7957	NEI NIH HHS [EY09339] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY009339] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; Belrhali H, 1999, STRUCTURE, V7, P909, DOI 10.1016/S0969-2126(99)80118-X; Borhan B, 2000, SCIENCE, V288, P2209, DOI 10.1126/science.288.5474.2209; BROWN PK, 1956, J BIOL CHEM, V222, P865; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CALLENDER RH, 1976, BIOCHEMISTRY-US, V15, P1621, DOI 10.1021/bi00653a005; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Creemers AFL, 1999, BIOCHEMISTRY-US, V38, P7195, DOI 10.1021/bi9830157; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DOI T, 1990, P NATL ACAD SCI USA, V87, P4991, DOI 10.1073/pnas.87.13.4991; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; EBREY T, 1980, FEBS LETT, V116, P217, DOI 10.1016/0014-5793(80)80647-8; Ernst OP, 2000, J BIOL CHEM, V275, P1937, DOI 10.1074/jbc.275.3.1937; FARAHBAKHSH ZT, 1995, BIOCHEMISTRY-US, V34, P8812, DOI 10.1021/bi00027a033; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; FUKUDA MN, 1979, J BIOL CHEM, V254, P8201; FUNG BKK, 1980, P NATL ACAD SCI-BIOL, V77, P2500, DOI 10.1073/pnas.77.5.2500; HARGRAVE PA, 1992, FASEB J, V6, P2323, DOI 10.1096/fasebj.6.6.1544542; HARGRAVE PA, 1983, BIOPHYS STRUCT MECH, V9, P235, DOI 10.1007/BF00535659; Hecht S, 1942, J GEN PHYSIOL, V25, P819, DOI 10.1085/jgp.25.6.819; Herzyk P, 1998, J MOL BIOL, V281, P741, DOI 10.1006/jmbi.1998.1981; Iiri T, 1998, NATURE, V394, P35, DOI 10.1038/27831; Imai H, 1997, P NATL ACAD SCI USA, V94, P2322, DOI 10.1073/pnas.94.6.2322; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jung H, 1996, BIOCHEMISTRY-US, V35, P6399, DOI 10.1021/bi952575s; Kim JM, 1997, P NATL ACAD SCI USA, V94, P14273, DOI 10.1073/pnas.94.26.14273; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; KONIG B, 1989, P NATL ACAD SCI USA, V86, P6878, DOI 10.1073/pnas.86.18.6878; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; MATTHEWS RG, 1963, J GEN PHYSIOL, V47, P215, DOI 10.1085/jgp.47.2.215; Meyer CK, 2000, J BIOL CHEM, V275, P19713, DOI 10.1074/jbc.M000603200; NEITZ M, 1991, SCIENCE, V252, P971, DOI 10.1126/science.1903559; Okada T, 1998, PHOTOCHEM PHOTOBIOL, V67, P495, DOI 10.1111/j.1751-1097.1998.tb09445.x; Okada T, 2000, J STRUCT BIOL, V130, P73, DOI 10.1006/jsbi.1999.4209; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OVCHINNIKOV YA, 1982, FEBS LETT, V148, P179, DOI 10.1016/0014-5793(82)80805-3; OVCHINNIKOV YA, 1988, FEBS LETT, V230, P1, DOI 10.1016/0014-5793(88)80628-8; PALINGS I, 1987, BIOCHEMISTRY-US, V26, P2544, DOI 10.1021/bi00383a021; Pogozheva ID, 1997, BIOPHYS J, V72, P1963, DOI 10.1016/S0006-3495(97)78842-8; RAO VR, 1994, NATURE, V367, P639, DOI 10.1038/367639a0; ROBINSON PR, 1992, NEURON, V9, P719, DOI 10.1016/0896-6273(92)90034-B; Sakmar TP, 1998, PROG NUCLEIC ACID RE, V59, P1; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Shichida Y, 1998, CELL MOL LIFE SCI, V54, P1299, DOI 10.1007/s000180050256; Shieh T, 1997, J MOL BIOL, V269, P373, DOI 10.1006/jmbi.1997.1035; SMITH SO, 1987, BIOCHEMISTRY-US, V26, P1606, DOI 10.1021/bi00380a018; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THOMAS DD, 1982, J MOL BIOL, V154, P145, DOI 10.1016/0022-2836(82)90422-3; Unger VM, 1997, NATURE, V389, P203, DOI 10.1038/38316; WAKAMATSU K, 1992, BIOCHEMISTRY-US, V31, P5654, DOI 10.1021/bi00139a032; WANG ZY, 1993, BIOCHEMISTRY-US, V32, P2125, DOI 10.1021/bi00060a001; Yamamoto M, 1998, J SYNCHROTRON RADIAT, V5, P222, DOI 10.1107/S0909049597014738; YOSHIZAWA T, 1963, NATURE, V197, P1279, DOI 10.1038/1971279a0; ZHUKOVSKY EA, 1989, SCIENCE, V246, P928, DOI 10.1126/science.2573154	55	4748	4885	10	715	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2000	289	5480					739	745		10.1126/science.289.5480.739	http://dx.doi.org/10.1126/science.289.5480.739			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341FZ	10926528				2022-12-24	WOS:000088581500029
J	Daily, GC; Soderqvist, T; Aniyar, S; Arrow, K; Dasgupta, P; Ehrlich, PR; Folke, C; Jansson, A; Jansson, BO; Kautsky, N; Levin, S; Lubchenco, J; Maler, KG; Simpson, D; Starrett, D; Tilman, D; Walker, B				Daily, GC; Soderqvist, T; Aniyar, S; Arrow, K; Dasgupta, P; Ehrlich, PR; Folke, C; Jansson, A; Jansson, BO; Kautsky, N; Levin, S; Lubchenco, J; Maler, KG; Simpson, D; Starrett, D; Tilman, D; Walker, B			Ecology - The value of nature and the nature of value	SCIENCE			English	Article									Royal Swedish Acad Sci, Beijer Inst, S-10405 Stockholm, Sweden	Royal Swedish Academy of Sciences; Beijer Institute of Ecological Economics	Daily, GC (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.		Walker, Brian H/F-2386-2011; Folke, Carl/Z-1545-2019; Tilman, David/ABD-5309-2021; Levin, Simon A/J-1218-2014	Levin, Simon A/0000-0002-8216-5639; Folke, Carl/0000-0002-4050-3281; Soderqvist, Tore/0000-0001-7347-9567				[Anonymous], 1996, CLIMATE CHANGE 1995; [Anonymous], 1997, NATURES SERVICES; Berkes F., 1998, LINKING SOCIAL ECOLO, DOI DOI 10.1017/CBO9780511541957; CASTRO R, 1998, COSTA RICAN EXPERIEN; Chichilnisky G, 1998, NATURE, V391, P629, DOI 10.1038/35481; CORK S, 2000, P 3 QUEENSL ENV C 25; Costanza R, 2000, ECOSYSTEMS, V3, P4, DOI 10.1007/s100210000002; Daily Gretchen C., 1999, Conservation Ecology, V3, pUnpaginated; ECHAVARRIA M, 1999, POLICY MECHANISMS WA; Gatto M, 2000, BIOSCIENCE, V50, P347, DOI 10.1641/0006-3568(2000)050[0347:PBAEST]2.3.CO;2; HEAL G, IN PRESS NATURE MARK; HOSKING L, 2000, FOR GREEN EC C COSP; Janzen D, 1999, P NATL ACAD SCI USA, V96, P5987, DOI 10.1073/pnas.96.11.5987; Kremen C, 2000, SCIENCE, V288, P1828, DOI 10.1126/science.288.5472.1828; LOBO RG, 1999, BIODIVERSIDAD GENTES; Ludwig D, 2000, ECOSYSTEMS, V3, P31, DOI 10.1007/s100210000007; Masood E, 1998, NATURE, V395, P426, DOI 10.1038/26587; National Research Council, 2000, WAT MAN POT WAT SUPP; Naylor RL, 1998, SCIENCE, V282, P883, DOI 10.1126/science.282.5390.883; REID W, IN PRESS MANAGING HU; Scheffer M., 1998, ECOLOGY SHALLOW LAKE; SCHNEIDER S, IN PRESS PACIFIC ASI; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494	23	573	735	18	406	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2000	289	5478					395	396		10.1126/science.289.5478.395	http://dx.doi.org/10.1126/science.289.5478.395			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336ME	10939949				2022-12-24	WOS:000088305500022
J	Schultes, EA; Bartel, DP				Schultes, EA; Bartel, DP			One sequence, two ribozymes: Implications for the emergence of new ribozyme folds	SCIENCE			English	Article							RNA SECONDARY STRUCTURES; GROUP-I INTRON; NEUTRAL NETWORKS; PROTEIN SPACE; EVOLUTION; LIGATION	We describe a single RNA sequence that can assume either of two ribozyme folds and catalyze the two respective reactions. The two ribozyme fords share no evolutionary history and are completely different, with no base pairs rand probably no hydrogen bonds) in common, Minor variants of this sequence are highly active for one or the other reaction, and can be accessed from prototype ribozymes through a series of neutral mutations. Thus, in the course of evolution, new RNA folds could arise from preexisting folds, without the need to carry inactive intermediate sequences. This raises the possibility that biological RNAs having no structural or functional similarity might share a common ancestry. Furthermore, functional and structural divergence might, in some cases, precede rather than follow gene duplication.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Bartel, DP (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dbartel@wi.mit.edu	Schultes, Erik/B-6035-2012	Schultes, Erik/0000-0001-8888-635X				ARONSON HEG, 1994, PROTEIN SCI, V3, P1706, DOI 10.1002/pro.5560031009; Babajide A, 1997, FOLD DES, V2, P261, DOI 10.1016/S1359-0278(97)00037-0; Been MD, 1997, EUR J BIOCHEM, V247, P741, DOI 10.1111/j.1432-1033.1997.00741.x; Ciesiolka J, 1998, J MOL BIOL, V275, P211, DOI 10.1006/jmbi.1997.1462; Cohen FE, 1999, J MOL BIOL, V293, P313, DOI 10.1006/jmbi.1999.2990; Cordes MHJ, 1999, SCIENCE, V284, P325, DOI 10.1126/science.284.5412.325; Dalal S, 1997, FOLD DES, V2, pR71, DOI 10.1016/S1359-0278(97)00036-9; EKLAND EH, 1995, NUCLEIC ACIDS RES, V23, P3231, DOI 10.1093/nar/23.16.3231; EKLAND EH, 1995, SCIENCE, V269, P364, DOI 10.1126/science.7618102; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; Flamm C, 2000, RNA, V6, P325, DOI 10.1017/S1355838200992161; Fontana W, 1998, SCIENCE, V280, P1451, DOI 10.1126/science.280.5368.1451; Huynen MA, 1996, P NATL ACAD SCI USA, V93, P397, DOI 10.1073/pnas.93.1.397; Li YF, 1999, J AM CHEM SOC, V121, P5364, DOI 10.1021/ja990592p; LISACEK F, 1994, J MOL BIOL, V235, P1206, DOI 10.1006/jmbi.1994.1074; Minor DL, 1996, NATURE, V380, P730, DOI 10.1038/380730a0; Ohno S., 1970, EVOLUTION GENE DUPLI; Perrotta AT, 1998, J MOL BIOL, V279, P361, DOI 10.1006/jmbi.1998.1798; Reidys C, 1997, B MATH BIOL, V59, P339, DOI 10.1007/BF02462007; Rohatgi R, 1996, J AM CHEM SOC, V118, P3340, DOI 10.1021/ja9537134; Rohatgi R, 1996, J AM CHEM SOC, V118, P3332, DOI 10.1021/ja953712b; SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Tanner MA, 1996, RNA, V2, P74; Ye XM, 1999, CHEM BIOL, V6, P657, DOI 10.1016/S1074-5521(99)80117-3	25	257	268	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 21	2000	289	5478					448	452		10.1126/science.289.5478.448	http://dx.doi.org/10.1126/science.289.5478.448			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336ME	10903205				2022-12-24	WOS:000088305500047
J	Furst, DE				Furst, DE			Aggressive strategies for treating aggressive rheumatoid arthritis: has the case been proven?	LANCET			English	Editorial Material									Virginia Mason Res Ctr, Arthrit Clin Res Ctr, Seattle, WA 98101 USA	Virginia Mason Medical Center	Furst, DE (corresponding author), Virginia Mason Res Ctr, Arthrit Clin Res Ctr, 1000 Seneca St, Seattle, WA 98101 USA.							BENSEN WG, 1990, J RHEUMATOL, V17, P987; Boers M, 1997, LANCET, V350, P309, DOI 10.1016/S0140-6736(97)01300-7; Firestein GS, 1996, ARTHRITIS RHEUM, V39, P1781, DOI 10.1002/art.1780391103; FRIES JF, 1990, J RHEUMATOL, V17, P12; Hawley D J, 1992, Arthritis Care Res, V5, P130, DOI 10.1002/art.1790050304; HAWLEY DJ, 1992, ARTHRIT CARE RES, V5, P229; Mottonen T, 1988, Scand J Rheumatol Suppl, V75, P244; PINCUS T, 1984, ARTHRITIS RHEUM-US, V27, P864, DOI 10.1002/art.1780270805; Sokka T, 2000, RHEUMATOLOGY, V39, P34, DOI 10.1093/rheumatology/39.1.34; VANDEPUTTE LBA, 1995, CLIN EXP RHEUMATOL, V13, P27; VANSCHAARDENBURG D, 1993, J RHEUMATOL, V20, P45; WILSKE KR, 1989, J RHEUMATOL, V16, P565; WORDSWORTH P, 1994, ARTHRITIS RHEUM, V37, P1166	13	6	6	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 15	2000	356	9225					183	184		10.1016/S0140-6736(00)02477-6	http://dx.doi.org/10.1016/S0140-6736(00)02477-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334GQ	10963194				2022-12-24	WOS:000088179100007
J	DesMarteau, DD				DesMarteau, DD			Chemistry - Superacids - It's a lot about anions	SCIENCE			English	Editorial Material									Clemson Univ, Dept Chem, Clemson, SC 29634 USA	Clemson University	DesMarteau, DD (corresponding author), Clemson Univ, Dept Chem, Clemson, SC 29634 USA.							DESMARTEAU DD, 1995, J FLUORINE CHEM, V72, P203, DOI 10.1016/0022-1139(94)00408-8; GILLESPI.RJ, 1973, J AM CHEM SOC, V95, P5173, DOI 10.1021/ja00797a013; GILLESPIE RJ, 1988, J AM CHEM SOC, V110, P6053, DOI 10.1021/ja00226a020; Hall NF, 1927, J AM CHEM SOC, V49, P3047, DOI 10.1021/ja01411a010; KOPPEL IA, 1994, J AM CHEM SOC, V116, P3047, DOI 10.1021/ja00086a038; OLAH GA, 1973, ANGEW CHEM INT EDIT, V12, P173, DOI 10.1002/anie.197301731; OLAH GA, 1985, SUPERACIDS; Reed CA, 2000, SCIENCE, V289, P101, DOI 10.1126/science.289.5476.101; STRAUSS SH, 1993, CHEM REV, V93, P927, DOI 10.1021/cr00019a005	9	26	29	2	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 7	2000	289	5476					72	73		10.1126/science.289.5476.72	http://dx.doi.org/10.1126/science.289.5476.72			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332TW	10928933				2022-12-24	WOS:000088090400032
J	Piccirillo, JF; Duntley, S; Schotland, H				Piccirillo, JF; Duntley, S; Schotland, H			Obstructive sleep apnea	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							POSITIVE AIRWAY PRESSURE; DAYTIME SLEEPINESS; THERAPY; FRAGMENTATION; DEPRIVATION; DIAGNOSIS; OBESITY; ADULTS		Washington Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Clin Outcomes Res Off, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Div Pulm & Crit Care Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Piccirillo, JF (corresponding author), Washington Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Clin Outcomes Res Off, Campus Box 8115,660 Euclid Ave, St Louis, MO 63110 USA.							*AG HLTHCAR POL RE, 1999, 1 US DEP HLTH HUM SE; Ball EM, 1997, ARCH INTERN MED, V157, P419, DOI 10.1001/archinte.157.4.419; CHARUZI I, 1992, American Journal of Clinical Nutrition, V55, p594S, DOI 10.1093/ajcn/55.2.594s; Cohen R, 1998, ORAL SURG ORAL MED O, V85, P388, DOI 10.1016/S1079-2104(98)90062-2; Conradt R, 1998, J SLEEP RES, V7, P217, DOI 10.1046/j.1365-2869.1998.00116.x; Douketis JD, 1999, CAN MED ASSOC J, V160, P513; GUILLEMINAULT C, 1981, CLIN RES PROC, V17, P341; GUILLEMINAULT C, 1993, CHEST, V104, P781, DOI 10.1378/chest.104.3.781; Haponik EF, 1996, J GEN INTERN MED, V11, P759, DOI 10.1007/BF02598994; Hoy CJ, 1999, AM J RESP CRIT CARE, V159, P1096, DOI 10.1164/ajrccm.159.4.9808008; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jokic R, 1999, CHEST, V115, P771, DOI 10.1378/chest.115.3.771; KRIBBS NB, 1993, AM REV RESPIR DIS, V147, P887, DOI 10.1164/ajrccm/147.4.887; KRIEGER J, 1983, LANCET, V2, P1429; Li KK, 2000, OTOLARYNG HEAD NECK, V122, P410, DOI 10.1016/S0194-5998(00)70057-X; Loube DI, 1999, CHEST, V115, P863, DOI 10.1378/chest.115.3.863; Man GCW, 1996, MED CLIN N AM, V80, P803, DOI 10.1016/S0025-7125(05)70468-5; Marklund M, 1998, CHEST, V113, P707, DOI 10.1378/chest.113.3.707; Mickelson SA, 1996, LARYNGOSCOPE, V106, P10, DOI 10.1097/00005537-199601000-00003; NINOMURCIA G, 1989, WESTERN J MED, V150, P165; PACK AI, 1994, ADV INTERNAL MED, V39, P517; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Persson HE, 1996, CHEST, V109, P645, DOI 10.1378/chest.109.3.645; Powell NB, 1998, CLIN CHEST MED, V19, P77, DOI 10.1016/S0272-5231(05)70433-0; Powell NB, 1999, OTOLARYNG HEAD NECK, V120, P656, DOI 10.1053/hn.1999.v120.a96956; ROCHESTER DF, 1974, AM J MED, V57, P402, DOI 10.1016/0002-9343(74)90135-1; Ryan CF, 2000, THORAX, V55, P399, DOI 10.1136/thorax.55.5.399; Sher AE, 1996, SLEEP, V19, P156, DOI 10.1093/sleep/19.2.156; Strollo PJ, 1998, CLIN CHEST MED, V19, P55, DOI 10.1016/S0272-5231(05)70431-7; SURATT PM, 1987, CHEST, V92, P631, DOI 10.1378/chest.92.4.631; THORPY M, 1994, SLEEP, V17, P372; WETTER DW, 1994, ARCH INTERN MED, V154, P2219, DOI 10.1001/archinte.154.19.2219; Woodson BT, 2000, OTOLARYNG HEAD NECK, V122, P395, DOI 10.1016/S0194-5998(00)70055-6; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Young T, 1997, SLEEP, V20, P705, DOI 10.1093/sleep/20.9.705	35	9	9	1	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 27	2000	284	12					1492	1494		10.1001/jama.284.12.1492	http://dx.doi.org/10.1001/jama.284.12.1492			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	355HF	11000621				2022-12-24	WOS:000089379700002
J	Lanas, A; Bajador, E; Serrano, P; Fuentes, J; Carreno, S; Guardia, J; Sanz, M; Montoro, M; Sainz, R				Lanas, A; Bajador, E; Serrano, P; Fuentes, J; Carreno, S; Guardia, J; Sanz, M; Montoro, M; Sainz, R			Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PEPTIC-ULCER DISEASE; PROPHYLACTIC ASPIRIN; CYCLOOXYGENASE; PERFORATION; PREVENTION; RAT	Background: The relation between medications that release nitric oxide, such as nitroglycerin and other nitrovasodilators, and upper gastrointestinal bleeding is uncertain. In animals, these medications reduce the gastric damage induced by nonsteroidal antiinflammatory drugs. Nitric oxide, however, inhibits platelet aggregation and may contribute to bleeding from an ulcer. Methods: We performed a case-control study to determine the risk of bleeding in patients taking nitrovasodilators, low-dose aspirin, or other nonsteroidal antiinflammatory drugs. The case group was made up of 1122 consecutive patients admitted to one of four hospitals with bleeding from a peptic lesion. The 2231 control subjects were 1109 patients hospitalized for other reasons and 1122 outpatients from the same geographic area. Results: In the week before admission, 520 (46.3 percent) of the patients with bleeding had taken a nonsteroidal antiinflammatory drug other than low-dose aspirin, 120 (10.7 percent) had taken low-dose aspirin (less than or equal to 300 mg per day), 60 (5.3 percent) a nitrovasodilator, and 135 (12.0 percent) an antisecretory agent such as a histamine H-2-receptor antagonist or a proton-pump inhibitor. In multivariate models that adjusted for age, sex, and clinical risk factors, the use of a nonsteroidal antiinflammatory drug other than low-dose aspirin was independently associated with an increased risk of bleeding from a peptic ulcer (odds ratio, 7.4; 95 percent confidence interval, 4.5 to 12.0), as was the use of low-dose aspirin alone (odds ratio, 2.4; 95 percent confidence interval, 1.8 to 3.3). The use of a nitrovasodilator was associated with a decreased risk of bleeding (odds ratio, 0.6; 95 percent confidence interval, 0.4 to 0.9), as was antisecretory therapy (odds ratio, 0.6; 95 percent confidence interval, 0.4 to 0.8). In patients taking any type of nonsteroidal antiinflammatory drug, the use of a nitrovasodilator or antisecretory therapy was independently associated with a decreased risk of bleeding. Conclusions: The use of nitrovasodilator drugs is independently associated with a decreased risk of upper gastrointestinal bleeding. (N Engl J Med 2000;343:834-9.) (C) 2000, Massachusetts Medical Society.	Univ Hosp, Serv Digest Dis, Zaragoza, Spain; Hosp Miguel Servet, Serv Digest Dis, Zaragoza, Spain; Hosp San Jorge, Serv Digest Dis, Huesca, Spain; Hosp San Millan, Serv Digest Dis, Logrono, Spain	Miguel Servet University Hospital; Miguel Servet University Hospital; Hospital Universidad San Jorge	Lanas, A (corresponding author), Hosp Clin Univ, Serv Aparato Digest, Zaragoza 50009, Spain.	alanas@posta.unizar.cs	Montoro, Miguel/M-3631-2013	Montoro, Miguel/0000-0001-7676-9842				BARRACHINA MD, 1995, EUR J PHARMACOL, V281, pR3, DOI 10.1016/0014-2999(95)00399-6; Donnelly MT, 1998, GASTROENTEROLOGY, V114, pA107; ELLIOTT SN, 1995, GASTROENTEROLOGY, V109, P524, DOI 10.1016/0016-5085(95)90341-0; GRIFFIN MR, 1991, ANN INTERN MED, V114, P257, DOI 10.7326/0003-4819-114-4-257; Kelly JP, 1996, LANCET, V348, P1413, DOI 10.1016/S0140-6736(96)01254-8; Lanas A, 1997, GASTROENTEROLOGY, V112, P683, DOI 10.1053/gast.1997.v112.pm9041228; LANAS A, 1992, GASTROENTEROLOGY, V103, P862, DOI 10.1016/0016-5085(92)90018-T; Lanas A, 1998, J INT MED RES, V26, P120, DOI 10.1177/030006059802600302; Lanas AI, 1996, GUT, V39, P654, DOI 10.1136/gut.39.5.654; LOPEZBELMONTE J, 1993, BRIT J PHARMACOL, V108, P73, DOI 10.1111/j.1476-5381.1993.tb13442.x; MCCARTHY DM, 1995, SCAND J GASTROENTERO, V30, P24, DOI 10.3109/00365529509107758; MITCHELL JA, 1993, P NATL ACAD SCI USA, V90, P11693, DOI 10.1073/pnas.90.24.11693; PETROSKI D, 1993, CLIN THER, V15, P314; RODRIGUEZ LAG, 1994, LANCET, V343, P769, DOI 10.1016/S0140-6736(94)91843-0; Rodriguez LAG, 1999, EPIDEMIOLOGY, V10, P228, DOI 10.1097/00001648-199905000-00006; Salvemini D, 1996, J CLIN INVEST, V97, P2562, DOI 10.1172/JCI118704; Singh G, 1996, ARCH INTERN MED, V156, P1530, DOI 10.1001/archinte.156.14.1530; SOLL AH, 1991, ANN INTERN MED, V114, P307, DOI 10.7326/0003-4819-114-4-307; Taha AS, 1999, GASTROENTEROLOGY, V116, P254, DOI 10.1016/S0016-5085(99)70120-4; Wallace JL, 1997, GASTROENTEROLOGY, V112, P1000, DOI 10.1053/gast.1997.v112.pm9041264; Wallace JL, 1999, THROMB RES, V93, P43, DOI 10.1016/S0049-3848(98)00134-0; WALLACE JL, 1990, AM J PHYSIOL, V259, pG462, DOI 10.1152/ajpgi.1990.259.3.G462; WALLACE JL, 1994, GASTROENTEROLOGY, V107, P173, DOI 10.1016/0016-5085(94)90074-4; WEIL J, 1995, BMJ-BRIT MED J, V310, P827, DOI 10.1136/bmj.310.6983.827	24	324	336	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 21	2000	343	12					834	839		10.1056/NEJM200009213431202	http://dx.doi.org/10.1056/NEJM200009213431202			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354XB	10995862				2022-12-24	WOS:000089355600002
J	Girelli, D; Russo, C; Ferraresi, P; Olivieri, O; Pinotti, M; Friso, S; Manzato, F; Mazzucco, A; Bernardi, F; Corrocher, R				Girelli, D; Russo, C; Ferraresi, P; Olivieri, O; Pinotti, M; Friso, S; Manzato, F; Mazzucco, A; Bernardi, F; Corrocher, R			Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COAGULATION-FACTOR-VII; ISCHEMIC-HEART-DISEASE; TISSUE FACTOR; HEMOSTATIC FACTORS; BLOOD-COAGULATION; FACTOR-V; FIBRINOGEN; THROMBOSIS; REGION; ATHEROSCLEROSIS	Background: High plasma levels of coagulation factor VII have been suggested to be predictors of death due to coronary artery disease. Since polymorphisms in the factor VII gene contribute to variations in factor VII levels, such polymorphisms may be associated with the risk of myocardial infarction, which is precipitated by thrombosis. Methods: We studied a total of 444 patients, 311 of whom had severe, angiographically documented coronary atherosclerosis. Of these 311 patients, 175 had documentation of a previous myocardial infarction. As a control group, 133 patients with normal coronary arteriograms were also included. We measured the levels of activated factor VII and assessed three polymorphisms in the factor VII gene, one involving the promoter (A1 and A2 alleles), one involving the catalytic region (R353Q), and one involving intron 7. Results: Each of the polymorphisms influenced factor VII levels. Patients with the A2A2 and QQ genotypes had the lowest levels of activated factor VII (66 percent and 72 percent lower, respectively, than the levels in patients with the wild-type genotypes). The frequencies of the various genotypes in the patients free of coronary artery disease were similar to those in the entire population of patients with coronary artery disease. In the latter group, there were significantly more heterozygotes and homozygotes for the A2 and Q alleles among those who had not had a myocardial infarction than among those who had had an infarction (P=0.008 for the presence of the promoter polymorphism and P=0.01 for the presence of the R353Q polymorphism by chi-square analysis). The adjusted odds ratio for myocardial infarction among the patients with the A1A2 or RQ genotype was 0.47 (95 percent confidence interval, 0.27 to 0.81). Conclusions: Our findings suggest that certain factor VII genotypes have a role in protection against myocardial infarction. This may explain why some patients do not have myocardial infarction despite the presence of severe coronary atherosclerosis. (N Engl J Med 2000;343:774-80.) (C) 2000, Massachusetts Medical Society.	Univ Verona, Dept Clin & Expt Med, I-37100 Verona, Italy; Univ Verona, Inst Clin Chem, I-37100 Verona, Italy; Univ Verona, Inst Cardiovasc Surg, I-37100 Verona, Italy; Univ Ferrara, Dept Biochem & Mol Biol, Ferrara, Italy	University of Verona; University of Verona; University of Verona; University of Ferrara	Girelli, D (corresponding author), Univ Verona, Policlin GB Rossi, Dept Clin & Expt Med, I-37134 Verona, Italy.		bernardi, francesco/F-5443-2013; Friso, Simonetta/K-4715-2016; Girelli, Domenico/B-1183-2008; Olivieri, Oliviero/A-9126-2008	Girelli, Domenico/0000-0001-9684-1899; Olivieri, Oliviero/0000-0001-8209-9056; Pinotti, Mirko/0000-0002-4114-7055; FERRARESI, Paolo/0000-0001-6742-7832	Telethon [E.0675] Funding Source: Medline	Telethon(Fondazione Telethon)		Ardissino D, 1999, BLOOD, V94, P46; BALLEISEN L, 1985, THROMB HAEMOSTASIS, V54, P475; Bernardi F, 1996, ARTERIOSCL THROM VAS, V16, P72; Bernardi F, 1997, ARTERIOSCL THROM VAS, V17, P2548, DOI 10.1161/01.ATV.17.11.2548; deMaat MPM, 1997, ARTERIOSCL THROM VAS, V17, P1918, DOI 10.1161/01.ATV.17.10.1918; Doggen CJM, 1998, THROMB HAEMOSTASIS, V80, P281, DOI 10.1055/s-0037-1615188; Folsom AR, 1997, CIRCULATION, V96, P1102, DOI 10.1161/01.CIR.96.4.1102; FUSTER V, 1992, NEW ENGL J MED, V326, P242, DOI 10.1056/NEJM199201233260406; Ghaddar HM, 1998, CIRCULATION, V98, P2815, DOI 10.1161/01.CIR.98.25.2815; Girelli D, 1998, BLOOD, V91, P4158, DOI 10.1182/blood.V91.11.4158.411k23_4158_4163; GREEN F, 1994, BAILLIERE CLIN HAEM, V7, P675, DOI 10.1016/S0950-3536(05)80103-9; GREEN F, 1991, ARTERIOSCLER THROMB, V11, P540, DOI 10.1161/01.ATV.11.3.540; HEINRICH J, 1994, ARTERIOSCLER THROMB, V14, P54, DOI 10.1161/01.ATV.14.1.54; HEINRICH J, 1994, ARTERIOSCLER THROMB, V14, P1392; Hunault M, 1997, ARTERIOSCL THROM VAS, V17, P2825, DOI 10.1161/01.ATV.17.11.2825; Iacoviello L, 1998, NEW ENGL J MED, V338, P79, DOI 10.1056/NEJM199801083380202; Iacoviello L, 1998, LANCET, V351, P1205; LANDER ES, 1994, SCIENCE, V266, P353; Lane A, 1996, ATHEROSCLEROSIS, V119, P119, DOI 10.1016/0021-9150(95)05638-6; MARCHETTI G, 1993, HUM GENET, V90, P575; Marckmann P, 1998, EUR J CLIN NUTR, V52, P75, DOI 10.1038/sj.ejcn.1600533; Meade TW, 1998, LANCET, V351, P233; MEADE TW, 1986, LANCET, V2, P533, DOI 10.1016/S0140-6736(86)90111-X; MORRISSEY JH, 1993, BLOOD, V81, P734; Pollak ES, 1996, J BIOL CHEM, V271, P1738, DOI 10.1074/jbc.271.3.1738; RAO LVM, 1988, P NATL ACAD SCI USA, V85, P6687, DOI 10.1073/pnas.85.18.6687; Redondo M, 1999, ARTERIOSCL THROM VAS, V19, P1020, DOI 10.1161/01.ATV.19.4.1020; Ridker PM, 1999, LANCET, V353, P687, DOI 10.1016/S0140-6736(99)00067-7; Smith FB, 1997, ARTERIOSCL THROM VAS, V17, P3321, DOI 10.1161/01.ATV.17.11.3321; van't Hooft FM, 1999, BLOOD, V93, P3432, DOI 10.1182/blood.V93.10.3432.410k16_3432_3441; Wang XL, 1997, ARTERIOSCL THROM VAS, V17, P246, DOI 10.1161/01.ATV.17.2.246; WILCOX JN, 1989, P NATL ACAD SCI USA, V86, P2839, DOI 10.1073/pnas.86.8.2839	32	190	214	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 14	2000	343	11					774	780		10.1056/NEJM200009143431104	http://dx.doi.org/10.1056/NEJM200009143431104			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	352LZ	10984565	Bronze			2022-12-24	WOS:000089221300004
J	Kondo, T; Raff, M				Kondo, T; Raff, M			Oligodendrocyte precursor cells reprogrammed to become multipotential CNS stem cells	SCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; ZONE PROGENITOR CELLS; RAT OPTIC-NERVE; VENTRICULAR ZONE; NEURONAL DIFFERENTIATION; MONOCLONAL-ANTIBODY; ASTROCYTES; LINEAGE; GALACTOCEREBROSIDE; PROLIFERATION	During animal development, cells become progressively more restricted in the cell types to which they can give rise. In the central nervous system (CNS), for example, multipotential stem cells produce various kinds of specified precursors that divide a limited number of times before they terminally differentiate into either neurons OF glial cells. We show here that certain extracellular signals can induce oligodendrocyte precursor cells to revert to multipotential neural stem cells, which can self-renew and give rise to neurons and astrocytes, as well as to oligodendrocytes, Thus, these precursor cells have greater developmental potential than previously thought.	UCL, MRC, Dev Neurobiol Programme, Mol Cell Biol Lab, London WC1E 6BT, England; UCL, Dept Biol, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Kondo, T (corresponding author), UCL, MRC, Dev Neurobiol Programme, Mol Cell Biol Lab, Mortimer St, London WC1E 6BT, England.	tkondo@ucl.ac.uk	Kondo, Toru/F-9420-2012; Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763				BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BARRES BA, 1994, DEVELOPMENT, V120, P1097; BARTLETT PF, 1980, BRAIN RES, V204, P339; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; EISENBARTH GS, 1979, P NATL ACAD SCI USA, V76, P4913, DOI 10.1073/pnas.76.10.4913; FFRENCHCONSTANT C, 1986, NATURE, V319, P499, DOI 10.1038/319499a0; GARD AL, 1990, NEURON, V5, P615, DOI 10.1016/0896-6273(90)90216-3; Geiger H, 1998, CELL, V93, P1055, DOI 10.1016/S0092-8674(00)81210-6; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; HARDY R, 1991, DEVELOPMENT, V111, P1061; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; KILPATRICK TJ, 1993, NEURON, V10, P255, DOI 10.1016/0896-6273(93)90316-J; Li WW, 1998, J NEUROSCI, V18, P8853; Mabie PC, 1997, J NEUROSCI, V17, P4112; NOLL E, 1993, DEVELOPMENT, V118, P563; Palmer TD, 1999, J NEUROSCI, V19, P8487; RAFF MC, 1984, DEV BIOL, V106, P53, DOI 10.1016/0012-1606(84)90060-5; RAFF MC, 1978, NATURE, V274, P813, DOI 10.1038/274813a0; RAFF MC, 1983, NATURE, V303, P396; RANSCHT B, 1982, P NATL ACAD SCI-BIOL, V79, P2709, DOI 10.1073/pnas.79.8.2709; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Williams BP, 1997, NEURON, V18, P553, DOI 10.1016/S0896-6273(00)80297-4; WOLSWIJK G, 1989, DEVELOPMENT, V105, P387; WREN D, 1992, J CELL BIOL, V116, P167, DOI 10.1083/jcb.116.1.167; YU WP, 1994, NEURON, V12, P1353, DOI 10.1016/0896-6273(94)90450-2	28	663	716	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 8	2000	289	5485					1754	1757		10.1126/science.289.5485.1754	http://dx.doi.org/10.1126/science.289.5485.1754			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352BT	10976069				2022-12-24	WOS:000089195200047
J	Buffetaut, E; Suteethorn, V; Cuny, G; Tong, HY; Le Loeuff, J; Khansubha, S; Jongautchariyakul, S				Buffetaut, E; Suteethorn, V; Cuny, G; Tong, HY; Le Loeuff, J; Khansubha, S; Jongautchariyakul, S			The earliest known sauropod dinosaur	NATURE			English	Article							EVOLUTION; THAILAND	Sauropods were a very successful group of dinosaurs during the Jurassic and Cretaceous periods, but their earlier history is poorly known. Until now, the earliest reported sauropod bones were from the Early Jurassic(1-3), and the only tentative evidence of earlier sauropods was in the form of controversial footprints(4,5). Here we report the discovery of an incomplete sauropod skeleton from the Late Triassic period of Thailand, which provides the first osteological evidence of pre-Jurassic sauropods. This dinosaur is markedly different from prosauropods and substantiates theoretical predictions that there was a fairly long period of sauropod evolution during the Triassic.	CNRS, F-75013 Paris, France; Dept Mineral Resources, Geol Survey Div, Bangkok 10400, Thailand; Musee Dinosaures, F-11260 Esperaza, France; Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England	Centre National de la Recherche Scientifique (CNRS); Department of Mineral Resources - Thailand; University of Bristol	Buffetaut, E (corresponding author), CNRS, 16 Cour Liegat, F-75013 Paris, France.	Eric.Buffetaut@wanadoo.fr	Cuny, Gilles/A-4775-2013; Cuny, Gilles/F-8949-2017	Cuny, Gilles/0000-0001-7680-1697; Cuny, Gilles/0000-0001-7680-1697				Avanzini M, 1997, PALAIOS, V12, P538, DOI 10.2307/3515410; Barrett PM, 1999, J VERTEBR PALEONTOL, V19, P785, DOI 10.1080/02724634.1999.10011191; Bonaparte J.F., 1971, OPERA LILLOANA, V22, P1; Bonaparte JF, 1999, AMEGHINIANA, V36, P115; BUFFETAUT E, 1995, GEOL MAG, V132, P739, DOI 10.1017/S0016756800018951; Buffetaut Eric, 1998, P83; Charig A. J., 1965, Proceedings of the Linnean Society of London, V176, P197; COOPER M R, 1984, Palaeontologia Africana, V25, P203; Ellenberger F., 1958, C R SOC GEOL FRANCE, V4, P65; Ellenberger P., 1972, PALAEOVERTEBRATA, P1; Galton P.M., 1990, P320; GALTON PM, 1985, GEOBIOS-LYON, V18, P671, DOI 10.1016/S0016-6995(85)80065-6; Gauffre F-X, 1993, NEUES JB GEOLOGIE PA, V11, P648; GIERLINSKI R, 1998, GEOL Q, V42, P477; Haubold H., 1984, SAURIERFAHRTEN; He X. L., 1998, ACTA GEOLOGICA SICHU, V18, P1; JAIN SL, 1979, 4 INT GONDW S, P204; McIntosh J.S., 1990, P345; Racey A, 1996, J PETROL GEOL, V19, P5, DOI 10.1111/j.1747-5457.1996.tb00511.x; Sues H.-D., 1990, P143; Thulborn T., 1990, DINOSAUR TRACKS; Upchurch P, 1998, ZOOL J LINN SOC-LOND, V124, P43, DOI 10.1111/j.1096-3642.1998.tb00569.x; UPCHURCH P, 1995, PHILOS T R SOC B, V349, P365, DOI 10.1098/rstb.1995.0125; Wellnhofer Peter, 1994, Revue de Paleobiologie Volume Special, V7, P263; Wilson JA, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011115; YADAGIRI P, 1988, RECORDS GEOLOGICAL S, V11, P102; ZHANG FJ, 1989, ACTA MATH APPL SIN-E, V1, P1; Zhang Y, 1983, PALAEONTOLOGICA SI C, V162, P1	28	80	87	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 7	2000	407	6800					72	74		10.1038/35024060	http://dx.doi.org/10.1038/35024060			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	350WE	10993074				2022-12-24	WOS:000089124000043
J	Morrow, J				Morrow, J			Making mortal decisions at the beginning of life: The case of impaired and imperiled infants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BABY DOE		Univ Texas, Med Branch, Galveston, TX 77550 USA	University of Texas System; University of Texas Medical Branch Galveston	Morrow, J (corresponding author), Univ Texas, Med Branch, Galveston, TX 77550 USA.							Affleck G., 1991, INFANTS CRISIS PAREN; AMUNDSEN DW, 1987, EUTHANASIA NEWBORN, P10; Beauchamp TL., 1994, PRINCIPLES BIOMEDICA; Dworkin R., 1993, LIFES DOMINION; Jones G E, 1990, Pediatrician, V17, P87; KOOP CE, 1989, HASTINGS CENT REP, V19, pS2; MCMILLAN RC, 1987, EUTHANASIA NEWBORN, pR14; More ES, 1994, EMPATHIC PRACTITIONE; MOSKOP JC, 1986, HASTINGS CENT REP, V16, P8, DOI 10.2307/3563084; NOLAN K, 1990, HASTINGS CENT REP, V20, P3; REISER SJ, 1986, J HEALTH POLIT POLIC, V11, P199, DOI 10.1215/03616878-11-2-199; RHODEN NK, 1985, MILBANK FUND Q, V63, P18, DOI 10.2307/3349897; SINCLAIR JC, 1987, EUTHANASIA NEWBORN, P169; Singer P., 1993, PRACTICAL ETHICS; WEIR R, 1992, COMPELLED COMPASSION, P10	15	7	7	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2000	284	9					1146	1147		10.1001/jama.284.9.1146	http://dx.doi.org/10.1001/jama.284.9.1146			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	349GK	10974700				2022-12-24	WOS:000089037200021
J	Weiss, SC				Weiss, SC			Parental decisions and physician responsibilities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		Asch A, 1997, HASTINGS CENT REP, V27, P17; 1974, NY TIMES        0612, pA18	2	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2000	284	9					1142	1142		10.1001/jama.284.9.1142	http://dx.doi.org/10.1001/jama.284.9.1142			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	349GK	10974697				2022-12-24	WOS:000089037200018
J	Egeland, GM; Skjaerven, R; Irgens, LM				Egeland, GM; Skjaerven, R; Irgens, LM			Birth characteristics of women who develop gestational diabetes: population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MELLITUS		Univ Bergen, Dept Publ Hlth & Primary Hlth, Locus Registry Based Epidemiol, N-5021 Bergen, Norway; Univ Bergen, Dept Publ Hlth & Primary Hlth, Sect Med Stat, Bergen, Norway; Univ Bergen, Med Birth Registry Norway, N-5020 Bergen, Norway	University of Bergen; University of Bergen; University of Bergen	Egeland, GM (corresponding author), Univ Bergen, Dept Publ Hlth & Primary Hlth, Locus Registry Based Epidemiol, N-5021 Bergen, Norway.	grace.egeland@isf.uib.no						BARKER DJP, 1995, BRIT MED J, V511, P171; DEVECIANA M, 1995, NEW ENGL J MED, V333, P1237, DOI 10.1056/NEJM199511093331901; Lithell HO, 1996, BMJ-BRIT MED J, V312, P406; Melve KK, 1999, AM J EPIDEMIOL, V150, P756; Peters RK, 1996, LANCET, V347, P227, DOI 10.1016/S0140-6736(96)90405-5	5	82	84	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 2	2000	321	7260					546	547		10.1136/bmj.321.7260.546	http://dx.doi.org/10.1136/bmj.321.7260.546			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	351TK	10968815	Green Published, Bronze			2022-12-24	WOS:000089174100020
J	Watkinson, AR; Freckleton, RP; Robinson, RA; Sutherland, WJ				Watkinson, AR; Freckleton, RP; Robinson, RA; Sutherland, WJ			Predictions of biodiversity response to genetically modified herbicide-tolerant crops	SCIENCE			English	Article							ABUNDANCE; SCALE; BIRDS	We simulated the effects of the introduction of genetically modified herbicide-tolerant (GMHT) crops on weed populations and the consequences for seed-eating birds. We predict that weed populations might be reduced to Low Levels or practically eradicated, depending on the exact form of management. Consequent effects on the local use of fields by birds might be severe, because such reductions represent a major Loss of food resources. The regional impacts of GMHT crops are shown to depend on whether the adoption of GMHT crops by farmers covaries with current weed levels.	Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; British Trust Ornithol, Thetford IP24 2PU, Norfolk, England	University of East Anglia; University of East Anglia; British Trust for Ornithology	Watkinson, AR (corresponding author), Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England.		Robinson, Robert/B-8237-2009; Sutherland, William/B-1291-2013; Watkinson, Andrew R/N-1649-2013; Freckleton, Rob P/B-6455-2013	Robinson, Robert/0000-0003-0504-9906; Sutherland, William/0000-0002-6498-0437; Freckleton, Robert/0000-0002-8338-864X				Clark SJ, 1996, WEED RES, V36, P405, DOI 10.1111/j.1365-3180.1996.tb01670.x; Firbank LG, 1999, NATURE, V399, P727, DOI 10.1038/21516; Freckleton RP, 1998, J APPL ECOL, V35, P904, DOI 10.1111/j.1365-2664.1998.tb00008.x; Freckleton RP, 1998, J APPL ECOL, V35, P340, DOI 10.1046/j.1365-2664.1998.00308.x; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; MOLL S, 1997, BRIGHT CROP PROT C W, P931; READ MA, 1998, ASPECTS APPL BIOL, V52, P401; Robinson R.A., 1997, THESIS U E ANGLIA NO; Robinson RA, 1999, ECOGRAPHY, V22, P447, DOI 10.1111/j.1600-0587.1999.tb00581.x; Sutherland WJ, 1998, J APPL ECOL, V35, P418, DOI 10.1046/j.1365-2664.1998.00320.x; WEVERS JDA, 1998, ASPECTS APPL BIOL, V52, P393; Wilson JD, 1999, AGR ECOSYST ENVIRON, V75, P13, DOI 10.1016/S0167-8809(99)00064-X	12	154	173	1	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 1	2000	289	5484					1554	1557		10.1126/science.289.5484.1554	http://dx.doi.org/10.1126/science.289.5484.1554			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349XW	10968791				2022-12-24	WOS:000089071700047
J	Desai, SA; Bezrukov, SM; Zimmerberg, J				Desai, SA; Bezrukov, SM; Zimmerberg, J			A voltage-dependent channel involved in nutrient uptake by red blood cells infected with the malaria parasite	NATURE			English	Article							PLASMODIUM-FALCIPARUM; TRANSPORT; MEMBRANE; ERYTHROCYTES; PERMEATION; CULTURE	Growth of the malaria parasite in human red blood cells (RBCs) is accompanied by an increased uptake of many solutes including anions(1), sugars(2), purines(3), amino acids(4) and organic cations(5). Although the pharmacological properties and selectivity of this uptake suggest that a chloride channel is involved, the precise mechanism has not been identified. Moreover, the location of this uptake in the infected RBC is unknown because tracer studies are complicated by possible uptake through fluid-phase pinocytosis(6) or membranous ducts(7). Here we have studied the permeability of infected RBCs using the whole-cell voltage-clamp method. With this method, uninfected RBCs had ohmic whole-cell conductances of less than 100 pS, consistent with their low tracer permeabilities(8). In contrast, trophozoite-infected RBCs exhibited voltage-dependent, non-saturating currents that were 150-fold larger, predominantly carried by anions and abruptly abolished by channel blockers. Patch-clamp measurements and spectral analysis confirmed that a small (<10 pS) ion channel on the infected RBC surface, present at about 1,000 copies per cell, is responsible for these currents. Because its pharmacological properties and substrate selectivities match those seen with tracer studies, this channel accounts for the increased uptake of small solutes in infected RBCs. The surface location of this new channel and its permeability to organic solutes needed for parasite growth indicate that it may have a primary role in a sequential diffusive pathway for parasite nutrient acquisition.	NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; NICHD, Lab Phys & Struct Biol, NIH, Bethesda, MD 20892 USA; NICHD, Lab Cellular & Mol Biophys, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Desai, SA (corresponding author), NIAID, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	sdesai@niaid.nih.gov	Desai, Sanjay A/B-7110-2009	Desai, Sanjay/0000-0003-2150-2483	Intramural NIH HHS [Z01 AI000882-07] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001409, Z01HD000241, Z01HD000242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000841, Z01AI000882] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BREUER WV, 1987, J CELL PHYSIOL, V133, P55, DOI 10.1002/jcp.1041330107; Bull PC, 1998, NAT MED, V4, P358, DOI 10.1038/nm0398-358; BURNS ER, 1988, IN VITRO CELL DEV B, V24, P481, DOI 10.1007/BF02628503; CABANTCHIK ZI, 1990, BLOOD CELLS, V16, P421; Carter NS, 2000, J BIOL CHEM, V275, P10683, DOI 10.1074/jbc.275.14.10683; CRANDALL I, 1991, PARASITOLOGY, V102, P335, DOI 10.1017/S0031182000064271; DESAI SA, 1993, NATURE, V362, P643, DOI 10.1038/362643a0; DIVO AA, 1985, J PROTOZOOL, V32, P59, DOI 10.1111/j.1550-7408.1985.tb03013.x; ELFORD BC, 1995, BIOCHEM J, V308, P361, DOI 10.1042/bj3080361; GINSBURG H, 1985, MOL BIOCHEM PARASIT, V14, P313, DOI 10.1016/0166-6851(85)90059-3; GINSBURG H, 1987, J MEMBRANE BIOL, V96, P1, DOI 10.1007/BF01869329; Goldman DE, 1943, J GEN PHYSIOL, V27, P37, DOI 10.1085/jgp.27.1.37; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hibbs AR, 1997, EUR J CELL BIOL, V72, P182; HUNTER MJ, 1977, J PHYSIOL-LONDON, V268, P35, DOI 10.1113/jphysiol.1977.sp011845; KIRK K, 1993, FEBS LETT, V323, P123, DOI 10.1016/0014-5793(93)81462-9; KIRK K, 1994, J BIOL CHEM, V269, P3339; Kirk K, 1996, MOL BIOCHEM PARASIT, V82, P195, DOI 10.1016/0166-6851(96)02734-X; KIRK K, 1995, J BIOL CHEM, V270, P24270, DOI 10.1074/jbc.270.41.24270; KUTNER S, 1987, BIOCHEM PHARMACOL, V36, P123, DOI 10.1016/0006-2952(87)90389-3; Lauer SA, 1997, SCIENCE, V276, P1122, DOI 10.1126/science.276.5315.1122; POUVELLE B, 1991, NATURE, V353, P73, DOI 10.1038/353073a0; SAUVE R, 1985, J THEOR BIOL, V113, P501, DOI 10.1016/S0022-5193(85)80035-7; Staines HM, 2000, BBA-BIOMEMBRANES, V1463, P88, DOI 10.1016/S0005-2736(99)00187-X; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; UPSTON JM, 1995, BBA-BIOMEMBRANES, V1236, P249, DOI 10.1016/0005-2736(95)00055-8; WRIGHT EM, 1977, PHYSIOL REV, V57, P109, DOI 10.1152/physrev.1977.57.1.109	27	212	222	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2000	406	6799					1001	1005		10.1038/35023000	http://dx.doi.org/10.1038/35023000			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	348ZW	10984055				2022-12-24	WOS:000089020200047
J	Krummel, MF; Sjaastad, MD; Wulfing, C; Davis, MM				Krummel, MF; Sjaastad, MD; Wulfing, C; Davis, MM			Differential clustering of CD4 and CD3 zeta during T cell recognition	SCIENCE			English	Article							RECEPTOR ZETA-CHAIN; SIGNAL-TRANSDUCTION; ANTIGEN-RECEPTOR; TYROSINE KINASE; BINDING-SITE; ACTIVATION; MHC; LIGANDS; COSTIMULATION; CYTOSKELETON	Whereas T helper cells recognize peptide-major histocompatibility complex (MHC) class II complexes through their T cell receptors (TCRs), CD4 binds to an antigen-independent region of the MHC. Using green fluorescent protein-tagged chimeras and three-dimensional video microscopy, we show that CD4 and TCR-associated CD3 zeta cluster in the interface coincident with increases in intracellular calcium. Signaling-, costimulation-, and cytoskeleton-dependent processes then stabilize CD3 zeta in a single cluster at the center of the interface, while CD4 moves to the periphery. Thus, the CD4 coreceptor may serve primarily to "boost" recognition of ligand by the TCR and may not be required once activation has been initiated.	Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Howard Hughes Med Inst, Stanford, CA 94305 USA; Universal Imaging Corp, W Chester, PA 19380 USA	Stanford University; Howard Hughes Medical Institute	Davis, MM (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.			Wuelfing, Christoph/0000-0002-6156-9861; Davis, Mark/0000-0001-6868-657X				BARCLAY N, UNPUB; Boniface JJ, 1998, IMMUNITY, V9, P459, DOI 10.1016/S1074-7613(00)80629-9; Bootman MD, 1997, CELL, V91, P367, DOI 10.1016/S0092-8674(00)80420-1; CAMMAROTA G, 1992, NATURE, V356, P799, DOI 10.1038/356799a0; CAPLAN S, 1995, P NATL ACAD SCI USA, V92, P4768, DOI 10.1073/pnas.92.11.4768; Cochran JR, 2000, IMMUNITY, V12, P241, DOI 10.1016/S1074-7613(00)80177-6; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hampl J, 1997, IMMUNITY, V7, P379, DOI 10.1016/S1074-7613(00)80359-3; JANEWAY CA, 1992, ANNU REV IMMUNOL, V10, P645, DOI 10.1146/annurev.immunol.10.1.645; KAYE J, 1988, NATURE, V336, P580, DOI 10.1038/336580a0; KAYE J, 1983, J EXP MED, V158, P836, DOI 10.1084/jem.158.3.836; KONIG R, 1992, NATURE, V356, P796, DOI 10.1038/356796a0; KUPFER A, 1989, J EXP MED, V170, P1697, DOI 10.1084/jem.170.5.1697; Madrenas J, 1997, J EXP MED, V185, P219, DOI 10.1084/jem.185.2.219; MARRACK P, 1983, J EXP MED, V158, P1077, DOI 10.1084/jem.158.4.1077; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; NEGULESCU PA, 1994, P NATL ACAD SCI USA, V91, P2873, DOI 10.1073/pnas.91.7.2873; Reich Z, 1997, NATURE, V387, P617, DOI 10.1038/42500; ROZDZIAL MM, 1995, IMMUNITY, V3, P623, DOI 10.1016/1074-7613(95)90133-7; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; TURNER JM, 1990, CELL, V60, P755, DOI 10.1016/0092-8674(90)90090-2; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Wulfing C, 1998, P NATL ACAD SCI USA, V95, P6302, DOI 10.1073/pnas.95.11.6302; Wulfing C, 1998, SCIENCE, V282, P2266, DOI 10.1126/science.282.5397.2266; WULFING C, UNPUB	28	315	319	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 25	2000	289	5483					1349	1352		10.1126/science.289.5483.1349	http://dx.doi.org/10.1126/science.289.5483.1349			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347RF	10958781				2022-12-24	WOS:000088942400038
J	Hiramoto, M; Hiromi, Y; Giniger, E; Hotta, Y				Hiramoto, M; Hiromi, Y; Giniger, E; Hotta, Y			The Drosophila Netrin receptor Frazzled guides axons by controlling Netrin distribution	NATURE			English	Article							C-ELEGANS; COLORECTAL-CANCER; COMMISSURAL AXONS; GENETIC-ANALYSIS; PIONEER NEURONS; NERVOUS-SYSTEM; MOTOR AXONS; GUIDANCE; UNC-6; CNS	Netrin is a secreted protein that can act as a chemotropic axon guidance cue(1,2). Two classes of Netrin receptor, DCC3-5 and UNC-5 (refs 6-9), are required for axon guidance(3,4,6-11) and are thought to mediate Netrin signals in growth cones through their cytoplasmic domains(12,13). However, in the guidance of Drosophila photoreceptor axons, the DCC orthologue Frazzled(3) is required not in the photoreceptor neurons but instead in their targets, indicating that Frazzled also has a non-cell-autonomous function(14). Here we show that Frazzled can capture Netrin and 'present' it for recognition by other receptors. Moreover, Frazzled itself is actively localized within the axon through its cytoplasmic domain, and thereby rearranges Netrin protein into a spatial pattern completely different from the pattern of Netrin gene expression. Frazzled-dependent guidance of one pioneer neuron in the central nervous system can be accounted for solely on the basis of this ability of Frazzled to control Netrin distribution, and not by Frazzled signalling. We propose a model of patterning mechanism in which a receptor rearranges secreted ligand molecules, thereby creating positional information for other receptors.	Natl Inst Genet, Dept Dev Genet, Shizuoka 4118540, Japan; Grad Univ Adv Studies, Dept Genet, Shizuoka 4118540, Japan; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Japan Sci & Technol Corp, Kawaguchi 3320012, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Fred Hutchinson Cancer Center; Japan Science & Technology Agency (JST)	Hotta, Y (corresponding author), Natl Inst Genet, Dept Dev Genet, 1111 Yata, Shizuoka 4118540, Japan.		Giniger, Edward/C-1764-2015	Giniger, Edward/0000-0002-8340-6158				Ackerman SL, 1997, NATURE, V386, P838, DOI 10.1038/386838a0; Ashburner M., 2004, DROSOPHILA LAB MANUA, V2nd; Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; Gong QZ, 1999, DEVELOPMENT, V126, P1451; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hidalgo A, 1997, DEVELOPMENT, V124, P3253; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; JACOBS JR, 1989, J NEUROSCI, V9, P2412; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Przyborski SA, 1998, DEVELOPMENT, V125, P41; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3	30	101	102	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 24	2000	406	6798					886	889		10.1038/35022571	http://dx.doi.org/10.1038/35022571			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347AG	10972289				2022-12-24	WOS:000088903600043
J	Tanaka, Y; Guhde, G; Suter, A; Eskelinen, EL; Hartmann, D; Lullmann-Rauch, R; Janssen, PML; Blanz, J; von Figura, K; Saftig, P				Tanaka, Y; Guhde, G; Suter, A; Eskelinen, EL; Hartmann, D; Lullmann-Rauch, R; Janssen, PML; Blanz, J; von Figura, K; Saftig, P			Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice	NATURE			English	Article							LYSOSOMAL MEMBRANE-GLYCOPROTEINS; GLYCOGEN-STORAGE-DISEASE; ISOLATED RAT HEPATOCYTES; NORMAL ACID MALTASE; PROTEIN-DEGRADATION; GENE; SEQUENCE; RECEPTOR; MOUSE; CDNA	Lysosome-associated membrane protein-2 (LAMP-2) is a highly glycosylated protein and an important constituent of the lysosomal membrane(1-7). Here we show that LAMP-2 deficiency in mice increases mortality between 20 and 40 days of age. The surviving mice are fertile and have an almost normal life span. Ultrastructurally, there is extensive accumulation of autophagic vacuoles in many tissues including liver, pancreas, spleen, kidney and skeletal and heart muscle. In hepatocytes, the autophagic degradation of long-lived proteins is severely impaired. Cardiac myocytes are ultrastructurally abnormal and heart contractility is severely reduced. These findings indicate that LAMP-2 is critical for autophagy. This theory is further substantiated by the finding that human LAMP-2 deficiency(8) causing Danon's disease is associated with the accumulation of autophagic material in striated myocytes.	Univ Gottingen, Zentrum Biochem & Mol Zellbiol, Biochem Abt 2, D-37073 Gottingen, Germany; Univ Dundee, Dept Biol Sci, Dundee DD1 4HN, Scotland; Univ Helsinki, Inst Biotechnol, Helsinki 0001A, Finland; Univ Kiel, Inst Anat, D-24118 Kiel, Germany; Univ Gottingen, Abt Kardiol & Pneumol, D-37075 Gottingen, Germany	University of Gottingen; University of Dundee; University of Helsinki; University of Kiel; University of Gottingen	Saftig, P (corresponding author), Univ Gottingen, Zentrum Biochem & Mol Zellbiol, Biochem Abt 2, Heinrich Duker Weg 12, D-37073 Gottingen, Germany.	saftig@uni-bc2.gwdg.de	Eskelinen, Eeva-Liisa/AAF-3496-2019; Saftig, Paul/A-7966-2010; Janssen, Paul ML/E-3307-2011	Eskelinen, Eeva-Liisa/0000-0003-0006-7785; Janssen, Paul/0000-0002-9682-3014				ANDERSON RGW, 1989, METHOD CELL BIOL, V31, P463; ANDREWS FM, 1974, SOC INDIC RES, V1, P1, DOI 10.1007/BF00286419; ARSTILA AU, 1968, AM J PATHOL, V53, P687; Aumuller G, 1997, CELL TISSUE RES, V287, P335, DOI 10.1007/s004410050758; CHA Y, 1990, J BIOL CHEM, V265, P5008; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; DANON MJ, 1981, NEUROLOGY, V31, P51, DOI 10.1212/WNL.31.1.51; DUNN WA, 1990, J CELL BIOL, V110, P1923, DOI 10.1083/jcb.110.6.1923; FAMBROUGH DM, 1988, J CELL BIOL, V106, P61, DOI 10.1083/jcb.106.1.61; FUKUDA M, 1991, J BIOL CHEM, V266, P21327; GRANGER BL, 1990, J BIOL CHEM, V265, P12036; HENELL F, 1987, EXP MOL PATHOL, V46, P1, DOI 10.1016/0014-4800(87)90026-8; ISBRANDT D, 1994, AM J HUM GENET, V54, P454; JANSSEN PML, 1995, AM J PHYSIOL-HEART C, V269, pH676, DOI 10.1152/ajpheart.1995.269.2.H676; KONECKI DS, 1995, BIOCHEM BIOPH RES CO, V215, P757, DOI 10.1006/bbrc.1995.2528; KOSTER A, 1993, EMBO J, V12, P5219, DOI 10.1002/j.1460-2075.1993.tb06217.x; LEWIS V, 1985, J CELL BIOL, V100, P1839, DOI 10.1083/jcb.100.6.1839; Liou W, 1997, J CELL BIOL, V136, P61, DOI 10.1083/jcb.136.1.61; MEREDITH MJ, 1988, CELL BIOL TOXICOL, V4, P405, DOI 10.1007/BF00117769; Morisawa Y, 1998, J NEUROL SCI, V160, P175, DOI 10.1016/S0022-510X(98)00242-1; MUNTONI F, 1994, NEUROMUSCULAR DISORD, V4, P233, DOI 10.1016/0960-8966(94)90024-8; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; SEGLEN PO, 1984, J CELL BIOL, V99, P435, DOI 10.1083/jcb.99.2.435; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Town M, 1998, NAT GENET, V18, P319, DOI 10.1038/ng0498-319; Verheijen FW, 1999, NAT GENET, V23, P462, DOI 10.1038/70585	26	685	720	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2000	406	6798					902	906		10.1038/35022595	http://dx.doi.org/10.1038/35022595			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347AG	10972293				2022-12-24	WOS:000088903600047
J	MacLean, CH; Louie, R; Leake, B; McCaffrey, DF; Paulus, HE; Brook, RH; Shekelle, PG				MacLean, CH; Louie, R; Leake, B; McCaffrey, DF; Paulus, HE; Brook, RH; Shekelle, PG			Quality of care for patients with rheumatoid arthritis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; ASSOCIATION TASK-FORCE; PRACTICE GUIDELINES; UNITED-STATES; PHYSICIAN MASTERFILE; DEATH; SENSITIVITY; MANAGEMENT; MAMMOGRAPHY; IMPROVEMENT	Context Patients with rheumatoid arthritis are at risk for substantial morbidity because of their arthritis and premature mortality due to comorbid diseases. However, little is known about the quality of the health care that these patients receive. Objective To assess the quality of the health care that rheumatoid arthritis patients receive for their arthritis, comorbid diseases, and health care maintenance and to determine the effect of patterns of specialty care on quality. Design, Setting, and Participants Historical cohort study of 1355 adult rheumatoid arthritis patients en rolled in the fee-for-service or discounted fee-for-service plans of a nationwide US insurance company, Patients were identified and followed up through administrative data between 1991 and 1995. Main Outcome Measures Quality scores for arthritis, comorbid disease, and health care maintenance were developed from performance on explicit process measures that related to each of these domains and described the percentage of indicated health care processes performed within each domain during each person-year of the study. Results During 4598 person-years of follow-up, quality scores were 62% (95% confidence interval [CI], 61%-64%) for arthritis care, 52% (95% CI, 49%-55%) for comorbid disease care, and 42% (95% CI, 40%-43%) for health care maintenance. Across domains, care patterns including relevant specialists yielded performance scores 30% to 187% higher than those that did not (P<.001) and 45% to 67% of person-years were associated with patterns of care that did not include a relevant specialist. Presence of primary care without specialty care yielded health care maintenance scores that were 43% higher than those for patterns that included neither primary nor relevant specialty care (P<.001). Conclusions In this population, health care quality appears to be suboptimal for arthritis, comorbid disease, and health care maintenance. Patterns of care that included relevant specialists were associated with substantially higher quality across all domains. Patterns that included generalists were associated with substantially higher quality health care maintenance than patterns that included neither a generalist nor a relevant specialist. The optimal roles of primary care physicians and specialists in the care of patients with complex conditions should be reassessed.	Univ Calif Los Angeles, Div Rheumatol, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Nursing, Los Angeles, CA 90095 USA; RAND Corp, Hlth Program, Santa Monica, CA USA; Greater Los Angeles VA Hlth Care Syst, Los Angeles, CA USA; Vet Affairs Hlth Serv Res & Dev Serv, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; RAND Corporation; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	MacLean, CH (corresponding author), Univ Calif Los Angeles, Div Rheumatol, Dept Med, 1000 Vet Ave,Room 32-59, Los Angeles, CA 90095 USA.				NIAMS NIH HHS [P60-AR36834] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR036834] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		*AM COLL OBST GYN, 1993, OBST GYN PRIM PREV H; American Cancer Society, 1993, GUID CANC REL CHECK; ANDERSON LM, 1995, AM J PUBLIC HEALTH, V85, P840, DOI 10.2105/AJPH.85.6.840; [Anonymous], 2000, Diabetes Care, V23 Suppl 1, pS1; ASCH S, 1995, ACCESS CARE ELDERLY; Bendor R, 1999, ANN INTERN MED, V131, P150, DOI 10.7326/0003-4819-131-2-199907200-00015; BRAND DA, 1995, J AM COLL CARDIOL, V26, P1432, DOI 10.1016/0735-1097(95)00362-2; BRECHNER RJ, 1993, JAMA-J AM MED ASSOC, V270, P1714, DOI 10.1001/jama.270.14.1714; Brook RH, 1996, NEW ENGL J MED, V335, P966, DOI 10.1056/NEJM199609263351311; CHERKIN D, 1977, MED CARE, V15, P767; COBB S, 1953, NEW ENGL J MED, V249, P553, DOI 10.1056/NEJM195310012491402; Feldman AM, 2000, J AM COLL CARDIOL, V35, P537, DOI 10.1016/S0735-1097(99)00600-2; Fontana SA, 1997, AM J PUBLIC HEALTH, V87, P1190, DOI 10.2105/AJPH.87.7.1190; Fowles J B, 1995, Health Care Financ Rev, V16, P189; GABRIEL SE, 1991, ANN INTERN MED, V115, P787, DOI 10.7326/0003-4819-115-10-787; GABRIEL SE, 1994, ARTHRITIS RHEUM, V37, P821, DOI 10.1002/art.1780370607; Gibbons RJ, 1999, J AM COLL CARDIOL, V33, P2092, DOI 10.1016/S0735-1097(99)00150-3; GILES WH, 1993, JAMA-J AM MED ASSOC, V269, P1133, DOI 10.1001/jama.269.9.1133; Greenfield S, 1999, J GEN INTERN MED, V14, P516, DOI 10.1046/j.1525-1497.1999.05059.x; Harrold LR, 1999, J GEN INTERN MED, V14, P499, DOI 10.1046/j.1525-1497.1999.08168.x; Huber P., 1967, P 5 BERK S MATH STAT; Ives DG, 1996, PUBLIC HEALTH REP, V111, P244; KASSIRER JP, 1994, NEW ENGL J MED, V331, P1151, DOI 10.1056/NEJM199410273311709; Katz JN, 1997, ARTHRITIS RHEUM, V40, P1594, DOI 10.1002/art.1780400908; Katz P P, 1995, Arthritis Care Res, V8, P272, DOI 10.1002/art.1790080411; KATZ SJ, 1994, JAMA-J AM MED ASSOC, V272, P530, DOI 10.1001/jama.272.7.530; Klempner MS, 1999, J GEN INTERN MED, V14, P514, DOI 10.1046/j.1525-1497.1999.06069.x; Kwoh CK, 1996, ARTHRITIS RHEUM-US, V39, P713; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; LEWIS P, 1980, ANN RHEUM DIS, V39, P457, DOI 10.1136/ard.39.5.457; LUKERT BP, 1990, ANN INTERN MED, V112, P352, DOI 10.7326/0003-4819-112-5-352; MANT J, 1995, BMJ-BRIT MED J, V311, P793, DOI 10.1136/bmj.311.7008.793; McCarthy BD, 1996, AM J PREV MED, V12, P91, DOI 10.1016/S0749-3797(18)30350-7; McLaughlin TJ, 1997, J GEN INTERN MED, V12, P1, DOI 10.1046/j.1525-1497.1997.12105.x; MEEHAN TP, 1995, ANN INTERN MED, V122, P928, DOI 10.7326/0003-4819-122-12-199506150-00007; MENDELSSOHN DC, 1995, ARCH INTERN MED, V155, P2473, DOI 10.1001/archinte.155.22.2473; MITCHELL DM, 1986, ARTHRITIS RHEUM-US, V29, P706, DOI 10.1002/art.1780290602; MONSON RR, 1976, J CHRON DIS, V29, P459, DOI 10.1016/0021-9681(76)90086-2; Nash DB, 1997, ANN INTERN MED, V127, P72, DOI 10.7326/0003-4819-127-1-199707010-00012; *NAT COMM QUAL ASS, 2000, MEAS QUAL AM HLTH CA; PINCUS T, 1986, J RHEUMATOL, V13, P841; PINCUS T, 1984, ARTHRITIS RHEUM, V27, P846; RASKER JJ, 1981, ANN RHEUM DIS, V40, P115, DOI 10.1136/ard.40.2.115; Redelmeier DA, 1998, NEW ENGL J MED, V338, P1516, DOI 10.1056/NEJM199805213382106; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; ROMANO P, 1995, AHCPR PUB; Ryan TJ, 1999, CIRCULATION, V100, P1016, DOI 10.1161/01.CIR.100.9.1016; Shea JA, 1999, MED CARE, V37, P333, DOI 10.1097/00005650-199904000-00003; Simms RW, 1996, ARTHRITIS RHEUM-US, V39, P723; Soumeral SB, 1997, JAMA-J AM MED ASSOC, V277, P115, DOI 10.1001/jama.277.2.115; *US PREV SERV TASK, 1996, GUID CLIN PREV SERV, P105; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P73; VANDENBROUCKE JP, 1984, J RHEUMATOL, V11, P158; Wallberg-Jonsson S, 2000, J RHEUMATOL, V27, P71; Weiner J P, 1990, QRB Qual Rev Bull, V16, P424; WEINER JP, 1995, JAMA-J AM MED ASSOC, V273, P1503, DOI 10.1001/jama.273.19.1503; WEIR GC, 1994, DIABETES CARE, V17, P1514, DOI 10.2337/diacare.17.12.1514; WILLIAMS JF, 1995, J AM COLL CARDIOL, V26, P1376; Wisdom K, 1997, DIABETES CARE, V20, P971, DOI 10.2337/diacare.20.6.971; YELIN E, 1987, J RHEUMATOL, V14, P710	60	180	181	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 23	2000	284	8					984	992		10.1001/jama.284.8.984	http://dx.doi.org/10.1001/jama.284.8.984			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344PX	10944644				2022-12-24	WOS:000088769000025
J	Farmer, RDT; Williams, TJ; Simpson, EL; Nightingale, AL				Farmer, RDT; Williams, TJ; Simpson, EL; Nightingale, AL			Effect of 1995 pill scare on rates of venous thromboembolism among women taking combined oral contraceptives: analysis of General Practice Research Database	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK	Objective To compare the incidence of venous rhromboembolism among women taking combined oral contraceptives before and after the October 1995 pill scare. Design Analysis of General Practice Research Database. Setting United Kingdom, January 1993 to December 1998. Subjects Women aged 15-49 taking combined oral contraceptives. Main outcome measures Incidence of venous thromboembolism. Results Use of so called "third generation" combined oral contraceptives fell from 53% during January 1993 to October 1995 to 14% during November 1995 to December 1998. There was no significant change in the incidence of venous thromboembolism between the two periods after age was adjusted for (incidence ratio 1.04, 95%, confidence interval 0.78 to 1.39). Conclusions The findings are not compatible with the assertion that third generation oral contraceptives are associated with a twofold increase in risk of venous thromboembolism compared with older progestogens.	Univ Surrey, Postgrad Med Sch, Guildford GU2 7DJ, Surrey, England	University of Surrey	Farmer, RDT (corresponding author), Univ Surrey, Postgrad Med Sch, Guildford GU2 7DJ, Surrey, England.	r.farmer@surrey.ac.uk		Nightingale, Alison/0000-0001-8611-2940				Bloemenkamp KWM, 1999, ARCH INTERN MED, V159, P65, DOI 10.1001/archinte.159.1.65; Committee on the Safety of Medicines, 1995, COMB OR CONTR THROMB; Farmer RDT, 2000, BRIT J CLIN PHARMACO, V49, P580, DOI 10.1046/j.1365-2125.2000.00198.x; Farmer RDT, 1997, LANCET, V349, P83, DOI 10.1016/S0140-6736(96)07496-X; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; JICK H, 1995, LANCET, V346, P1589, DOI 10.1016/S0140-6736(95)91928-7; Lawrenson R, 2000, BRIT J CLIN PHARMACO, V49, P591, DOI 10.1046/j.1365-2125.2000.00199.x; Lawrenson RA, 1999, BRIT MED J, V319, P387, DOI 10.1136/bmj.319.7206.387; Lewis MA, 1999, HUM REPROD, V14, P1493, DOI 10.1093/humrep/14.6.1493; Lidegaard O, 1998, CONTRACEPTION, V57, P291, DOI 10.1016/S0010-7824(98)00033-X; Mayor S, 1999, BRIT MED J, V318, P1026, DOI 10.1136/bmj.318.7190.1026a; Mellemkjaer L, 1999, BRIT MED J, V319, P820, DOI 10.1136/bmj.319.7213.820; Parkin L, 2000, LANCET, V355, P2133, DOI 10.1016/S0140-6736(00)02382-5; POULTER NR, 1995, LANCET, V346, P1575; Spitzer WO, 1996, BRIT MED J, V312, P83; *STAT CORP, 1997, STAT STAT SOFTW REL; Suissa S, 1998, CONTRACEPTION, V57, P64	17	53	53	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 19	2000	321	7259					477	479		10.1136/bmj.321.7259.477	http://dx.doi.org/10.1136/bmj.321.7259.477			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	347MC	10948026	Bronze, Green Published			2022-12-24	WOS:000088932800019
J	Barber, PH; Palumbi, SR; Erdmann, MV; Moosa, MK				Barber, PH; Palumbi, SR; Erdmann, MV; Moosa, MK			Biogeography - A marine Wallace's line?	NATURE			English	Article							CORAL-REEF FISH; RECRUITMENT; POPULATION		Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; Pusat Penelitian dan Pengembangan Oseanol, Jakarta 1048, Indonesia	Harvard University; University of California System; University of California Berkeley	Barber, PH (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.							Barber PH, 2000, J CRUSTACEAN BIOL, V20, P20, DOI 10.1163/1937240X-90000004; EXCOFFIER L, 1992, GENETICS, V131, P479; Jones GP, 1999, NATURE, V402, P802, DOI 10.1038/45538; KNOWLTON N, 1986, B MAR SCI, V39, P213; LLEWELLYN G, 1999, CONSERVATION ASSESSM; LUKAS R, 1991, J GEOPHYS RES-OCEANS, V96, P7089, DOI 10.1029/91JC00062; MCMANUS JW, 1985, 5TH P INT COR REEF C, V4, P133; PALUMBI SR, 1997, CORAL REEFS S, V16, P47; PALUMBI SR, IN PRESS MARINE COMM; PORTER SC, 1989, QUATERNARY RES, V32, P245, DOI 10.1016/0033-5894(89)90092-6; Randall JE, 1998, ZOOL STUD, V37, P227; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Wyrtki K, 1961, NAGA REPORT, V2	14	298	304	1	89	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2000	406	6797					692	693		10.1038/35021135	http://dx.doi.org/10.1038/35021135			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963585				2022-12-24	WOS:000088767700032
J	Perou, CM; Sorlie, T; Eisen, MB; van de Rijn, M; Jeffrey, SS; Rees, CA; Pollack, JR; Ross, DT; Johnsen, H; Akslen, LA; Fluge, O; Pergamenschikov, A; Williams, C; Zhu, SX; Lonning, PE; Borresen-Dale, AL; Brown, PO; Botstein, D				Perou, CM; Sorlie, T; Eisen, MB; van de Rijn, M; Jeffrey, SS; Rees, CA; Pollack, JR; Ross, DT; Johnsen, H; Akslen, LA; Fluge, O; Pergamenschikov, A; Williams, C; Zhu, SX; Lonning, PE; Borresen-Dale, AL; Brown, PO; Botstein, D			Molecular portraits of human breast tumours	NATURE			English	Article							MAMMARY EPITHELIAL-CELLS; GENE-EXPRESSION; MALIGNANT BREAST; CDNA MICROARRAYS; CANCER; AMPLIFICATION; CARCINOMAS; PATTERNS; BENIGN	Human breast tumours are diverse in their natural history and in their responsiveness to treatments(1). Variation in transcriptional programs accounts for much of the biological diversity of human cells and tumours. In each cell, signal transduction and regulatory systems transduce information from the cell's identity to its environmental status, thereby controlling the level of expression of every gene in the genome. Here we have characterized variation in gene expression patterns in a set of 65 surgical specimens of human breast tumours from 42 different individuals, using complementary DNA microarrays representing 8,102 human genes. These patterns provided a distinctive molecular portrait of each tumour. Twenty of the tumours were sampled twice, before and after a 16-week course of doxorubicin chemotherapy, and two tumours were paired with a lymph node metastasis from the same patient. Gene expression patterns in two tumour samples from the same individual were almost always more similar to each other than either was to any other sample. Sets of co-expressed genes were identified for which variation in messenger RNA levels could be related to specific features of physiological variation. The tumours could be classified into subtypes distinguished by pervasive differences in their gene expression patterns.	Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Norwegian Radium Hosp, Dept Genet, N-0310 Oslo, Norway; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; Haukeland Univ Hosp, Gade Inst, Dept Pathol, N-5021 Bergen, Norway; Univ Bergen, Dept Mol Biol, N-5020 Bergen, Norway; Haukeland Univ Hosp, Dept Oncol, N-5021 Bergen, Norway; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; University of Oslo; Stanford University; Stanford University; Stanford University; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; Howard Hughes Medical Institute; Stanford University	Botstein, D (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	pbrown@cmgm.stanford.edu; botstein@genome.stanford.edu	Perou, Charles M/H-9934-2014; Akslen, Lars A/C-1202-2017; Sørlie, Therese/B-1413-2015; Akslen, Lars A./AAG-6097-2021	Perou, Charles M/0000-0001-9827-2247; Akslen, Lars A/0000-0003-2710-9543; Sørlie, Therese/0000-0002-5995-2319; Akslen, Lars A./0000-0003-2710-9543; Jeffrey, Stefanie/0000-0003-4478-2764; van de Rijn, Matt/0000-0002-1909-9739; Eisen, Michael/0000-0002-7528-738X; Lonning, Per Eystein/0000-0002-8890-6303	NATIONAL CANCER INSTITUTE [P50CA058223] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA058223] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aas T, 1996, NAT MED, V2, P811, DOI 10.1038/nm0796-811; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; BERNASCONI R, 1992, PHARM COMMUN, V2, P28; DAIRKEE SH, 1988, J NATL CANCER I, V80, P691, DOI 10.1093/jnci/80.9.691; DAIRKEE SH, 1987, LANCET, V1, P514; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; GUELSTEIN VI, 1988, INT J CANCER, V42, P147, DOI 10.1002/ijc.2910420202; GUSTERSON BA, 1982, CANCER RES, V42, P4763; HEINTZ NH, 1990, ARCH PATHOL LAB MED, V114, P160; Hoch RV, 1999, INT J CANCER, V84, P122; Malzahn K, 1998, VIRCHOWS ARCH, V433, P119, DOI 10.1007/s004280050226; NAGLE RB, 1986, J HISTOCHEM CYTOCHEM, V34, P869, DOI 10.1177/34.7.2423579; Pauletti G, 1996, ONCOGENE, V13, P63; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; RonnovJessen L, 1996, PHYSIOL REV, V76, P69, DOI 10.1152/physrev.1996.76.1.69; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Tavassoli FA, 1992, PATHOLOGY BREAST, P193; TAYLORPAPADIMITRIOU J, 1989, J CELL SCI, V94, P403; Yang GP, 1999, NUCLEIC ACIDS RES, V27, P1517, DOI 10.1093/nar/27.6.1517	23	10711	11372	47	1291	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2000	406	6797					747	752		10.1038/35021093	http://dx.doi.org/10.1038/35021093			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963602	Green Submitted			2022-12-24	WOS:000088767700049
J	Stratton, IM; Adler, AI; Neil, HAW; Matthews, DR; Manley, SE; Cull, CA; Hadden, D; Turner, RC; Holman, RR				Stratton, IM; Adler, AI; Neil, HAW; Matthews, DR; Manley, SE; Cull, CA; Hadden, D; Turner, RC; Holman, RR		UK Prospective Diabetes Study Grp	Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; RISK-FACTORS; CARDIOVASCULAR MORTALITY; SENSORY NEUROPATHY; GLYCEMIC THRESHOLD; FOLLOW-UP; MELLITUS; NIDDM; GLUCOSE; STROKE	Objective To determine the relation between exposure to glycaemia over time and the risk of macro vascular or microvascular complications in patients with type 2 diabetes. Design Prospective observational study. Setting 23 hospital based clinics in England, Scotland, and Northern ireland. Participants 4585 white, Asian Indian, and Afro-Caribbean UKPDS patients, whether randomised or not to treatment, were included in analyses of incidence; of these, 3642 were included in analyses of relative risk. Outcome measures Primary predefined aggregate clinical outcomes: any end point or deaths related to diabetes and all cause mortality. Secondary aggregate outcomes: myocardial infarction, stroke, amputation (including death from peripheral vascular disease), and microvascular disease (predominantly retinal photocoagulation). Single end points: non-fatal heart failure and cataract extraction. Risk reduction associated with a 1% reduction in updated mean HbA(1c) adjusted for possible confounders at diagnosis of diabetes. Results The incidence of clinical complications was significantly associated with glycaemia. Each 1% reduction in updated mean HbA(1c) was associated with reductions in risk of 21% for any end point related to diabetes (95% confidence interval 17% to 24%, P < 0.0001), 21% for deaths related to diabetes (15% to 27%, P < 0.0001), 14% for myocardial infarction (8% to 21%, P< 0.0001), and 37% for microvascular complications (33% to 41%, P < 0.0001). No threshold of risk was observed for any end point Conclusions Ln patients with type 2 diabetes the risk of diabetic complications was strongly associated with previous hyperglycaemia. Any reduction in HbA(1c) is likely to reduce the risk of complications, with the lowest risk being in those with HbA(1c) values in the normal range (< 6.0%).	Univ Oxford, Radcliffe Infirm, Oxford Ctr Diabet Endocrinol & Metab, Diabet Trials Unit, Oxford OX2 6HE, England; Univ Oxford, Inst Hlth Sci, Div Publ Hlth & Primary Care, Oxford OX3 7LF, England; Royal Victoria Hosp, Belfast BT12 6BA, Antrim, North Ireland; Univ Oxford, Radcliffe Infirm, Oxford Ctr Diabet Endocrinol & Metab, Diabet Res Labs, Oxford OX2 6HE, England	Radcliffe Infirmary; University of Oxford; University of Oxford; Radcliffe Infirmary; University of Oxford	Stratton, IM (corresponding author), Univ Oxford, Radcliffe Infirm, Oxford Ctr Diabet Endocrinol & Metab, Diabet Trials Unit, Oxford OX2 6HE, England.	irene.stratton@dtu.ox.ac.uk	stratton, irene/AAZ-3627-2020	stratton, irene/0000-0003-1172-7865; Manley, Susan/0000-0002-8298-4511				Adler A, 1998, DIABETES, V47, pA71; Adler AI, 1999, DIABETES CARE, V22, P1029, DOI 10.2337/diacare.22.7.1029; Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; Adler AI, 1997, DIABETES CARE, V20, P1162, DOI 10.2337/diacare.20.7.1162; Agresti A., 1990, CATEGORICAL DATA ANA, pXV; *AM DIAB ASS, 1998, DIABETES CARE S1, V21, P5; [Anonymous], 1996, DIABETES, V45, P1289; Balkau B, 1999, DIABETES CARE, V22, P696, DOI 10.2337/diacare.22.5.696; Balkau B, 1998, DIABETES CARE, V21, P360, DOI 10.2337/diacare.21.3.360; Breslow NE., 1987, STAT METHODS CANC RE, P81; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Cull CA, 1997, CLIN CHEM, V43, P1913; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; FRANKLIN GM, 1994, DIABETES CARE, V17, P1172, DOI 10.2337/diacare.17.10.1172; FULLER JH, 1983, BMJ-BRIT MED J, V287, P867, DOI 10.1136/bmj.287.6396.867; GOODKIN G, 1975, J OCCUP ENVIRON MED, V17, P716; Groeneveld Y, 1999, DIABETIC MED, V16, P2, DOI 10.1046/j.1464-5491.1999.00003.x; Hanefeld M, 1996, DIABETOLOGIA, V39, P1577, DOI 10.1007/s001250050617; HARRIS M, 1993, DIABETES CARE, V16, P1446, DOI 10.2337/diacare.16.11.1446; JARRETT RJ, 1976, LANCET, V2, P1009; KLEIN R, 1995, DIABETES CARE, V18, P258, DOI 10.2337/diacare.18.2.258; KNUIMAN MW, 1992, AM J EPIDEMIOL, V135, P638, DOI 10.1093/oxfordjournals.aje.a116343; KROLEWSKI AS, 1995, NEW ENGL J MED, V332, P1251, DOI 10.1056/NEJM199505113321902; KUUSISTO J, 1994, DIABETES, V43, P960, DOI 10.2337/diabetes.43.8.960; Lehto S, 1996, STROKE, V27, P63, DOI 10.1161/01.STR.27.1.63; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Manley SE, 2000, DIABETES, V49, pA180; MANLEY SE, 1994, DIABETIC MED, V11, P534; Orchard TJ, 1997, ARCH INTERN MED, V157, P1851, DOI 10.1001/archinte.157.16.1851; PALUMBO PJ, 1976, DIABETES, V25, P566, DOI 10.2337/diabetes.25.7.566; PANZRAM G, 1987, DIABETOLOGIA, V30, P123, DOI 10.1007/BF00274216; PETTITT DJ, 1980, LANCET, V2, P1050; Pirart J., 1978, DIABETES CARE, V1, P168, DOI 10.2337/diacare.1.3.168; *SAS I, 1990, SAS VERS 6; SASAKI A, 1983, Tohoku Journal of Experimental Medicine, V141, P639; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; STAMLER J, 1987, CARDIOLOGY, P1; Standl E, 1996, DIABETOLOGIA, V39, P1540, DOI 10.1007/s001250050612; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Turner RC, 1998, BMJ-BRIT MED J, V316, P823, DOI 10.1136/bmj.316.7134.823; TURNER RC, 1991, DIABETOLOGIA, V34, P877; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; UUSITUPA MIJ, 1993, DIABETOLOGIA, V36, P1175, DOI 10.1007/BF00401063; Wei M, 1998, DIABETES CARE, V21, P1167, DOI 10.2337/diacare.21.7.1167; WETTERHALL SF, 1992, DIABETES CARE, V15, P960, DOI 10.2337/diacare.15.8.960; Wright A, 1998, ANN INTERN MED, V128, P165, DOI 10.7326/0003-4819-128-3-199802010-00001	47	5659	6037	12	356	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2000	321	7258					405	412		10.1136/bmj.321.7258.405	http://dx.doi.org/10.1136/bmj.321.7258.405			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344QC	10938048	Green Published, Bronze			2022-12-24	WOS:000088769500019
J	Henney, JE				Henney, JE			Elevated cholesterol treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item											Henney, JE (corresponding author), HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	2	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2000	284	6					685	685		10.1001/jama.284.6.685	http://dx.doi.org/10.1001/jama.284.6.685			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341JM	10950660				2022-12-24	WOS:000088587300005
J	Gu, M; Cooper, JM; Butler, P; Walker, AP; Mistry, PK; Dooley, JS; Schapira, AHV				Gu, M; Cooper, JM; Butler, P; Walker, AP; Mistry, PK; Dooley, JS; Schapira, AHV			Oxidative-phosphorylation defects in liver of patients with Wilson's disease	LANCET			English	Article							EVANS CINNAMON RATS; LEC RAT; HEREDITARY HEPATITIS; MITOCHONDRIAL-DNA; COPPER OVERLOAD; HEPATOCYTES; PROTEIN; MODEL; EXPRESSION; DEFICIENCY	Background Wilson's disease (WD) is caused by mutations in a P-type ATPase and is associated with copper deposition in liver and brain. The WD protein is present in the trans-Golgi network and may also be imported into mitochondria. The WD protein functions as a P-type copper transporting ATPase in the Golgi but any action in mitochondria is at present unknown. Methods We studied mitochondrial function and aconitase activity in WD liver tissue and compared the results with those in a series of healthy controls and patients without WD. Findings There was evidence of severe mitochondrial dysfunction in the livers of patients with WD. Enzyme activities were decreased as follows: complex I by 62%, complex II+III by 52%, complex IV by 33%, and aconitase by 71%. These defects did not seem to be secondary to penicillamine use, cholestasis, or poor hepatocellular synthetic function, Interpretation The results show that there is a defect of energy metabolism in WD. The pattern of enzyme defects suggests that free-radical formation and oxidative damage, probably mediated via mitochondrial copper accumulation, are important in WD pathogenesis, These results provide a rationale for a study of the use of antioxidants in WD.	UCL Royal Free & Univ Coll Med Sch, Univ Dept Clin Neurosci, London NW3 2PF, England; UCL Royal Free & Univ Coll Med Sch, Dept Med, London NW3 2PF, England; Inst Neurol, London WC1, England	University of London; University College London; UCL Medical School; University of London; University College London; UCL Medical School	Schapira, AHV (corresponding author), UCL Royal Free & Univ Coll Med Sch, Univ Dept Clin Neurosci, Rowland Hill St, London NW3 2PF, England.	schapira@rfc.ucl.ac.uk	Cooper, J Mark/D-5826-2013; Walker, Ann P/C-1628-2008; Schapira, Anthony H V/A-1245-2010; Cooper, Jonathan/GLS-9195-2022	Cooper, J Mark/0000-0002-3007-3054; Schapira, Anthony H V/0000-0002-3018-3966; Cooper, Jonathan/0000-0002-2358-1050				BODNAR AG, 1993, AM J HUM GENET, V53, P663; Bradley JL, 2000, HUM MOL GENET, V9, P275, DOI 10.1093/hmg/9.2.275; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; GOLDFISCHER S, 1968, AM J PATHOL, V53, P883; Goodyer ID, 1999, HUM MOL GENET, V8, P1473, DOI 10.1093/hmg/8.8.1473; GROSS JB, 1989, J CLIN INVEST, V83, P30, DOI 10.1172/JCI113873; Halliwell B, 1989, FREE RADICALS BIOL M, VUK; Hung IH, 1997, J BIOL CHEM, V272, P21461, DOI 10.1074/jbc.272.34.21461; KENNEY S, 2000, WILSON DIS MUTATION; Klein D, 1998, EUR J CLIN INVEST, V28, P302; KOWDLEY KV, 1994, DIGEST DIS SCI, V39, P2416, DOI 10.1007/BF02087659; KRAHENBUHL S, 1994, HEPATOLOGY, V19, P471, DOI 10.1016/0270-9139(94)90027-2; LI Y, 1991, J CLIN INVEST, V87, P1858, DOI 10.1172/JCI115208; Lodi R, 1999, P NATL ACAD SCI USA, V96, P11492, DOI 10.1073/pnas.96.20.11492; Lutsenko S, 1998, P NATL ACAD SCI USA, V95, P6004, DOI 10.1073/pnas.95.11.6004; Mansouri A, 1997, GASTROENTEROLOGY, V113, P599, DOI 10.1053/gast.1997.v113.pm9247482; MCKIM JM, 1994, GASTROENTEROLOGY, V106, pA941; Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846; MURATA Y, 1995, BIOCHEM BIOPH RES CO, V209, P349, DOI 10.1006/bbrc.1995.1510; Nagano K, 1998, HEPATOLOGY, V27, P799, DOI 10.1002/hep.510270323; NETTER P, 1987, CLIN PHARMACOKINET, V13, P317, DOI 10.2165/00003088-198713050-00003; OGIHARA H, 1995, PEDIATR RES, V37, P219, DOI 10.1203/00006450-199502000-00016; OWEN CA, 1997, MAYO CLIN P, V52, P73; Ragan MT, 1987, MITOCHONDRIA PRACTIC, P79; Schaefer M, 1999, AM J PHYSIOL-GASTR L, V276, pG639, DOI 10.1152/ajpgi.1999.276.3.G639; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; SCHENKER S, 1966, GUT, V7, P409, DOI 10.1136/gut.7.4.409; SCHILSKY ML, 1994, AM J PHYSIOL, V266, pG907, DOI 10.1152/ajpgi.1994.266.5.G907; SOKOL RJ, 1993, GASTROENTEROLOGY, V105, P178, DOI 10.1016/0016-5085(93)90024-7; SOKOL RJ, 1994, GASTROENTEROLOGY, V107, P1788, DOI 10.1016/0016-5085(94)90822-2; SOKOL RJ, 1990, GASTROENTEROLOGY, V99, P1061, DOI 10.1016/0016-5085(90)90627-D; STERNLIE.I, 1968, GASTROENTEROLOGY, V55, P354; Sternlieb I, 1995, HEPATOLOGY, V22, P1782, DOI 10.1002/hep.1840220626; Tabrizi SJ, 1999, ANN NEUROL, V45, P25, DOI 10.1002/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E; TERADA K, 1995, BBA-MOL BASIS DIS, V1270, P58, DOI 10.1016/0925-4439(94)00072-X; THOMAS GR, 1995, NAT GENET, V9, P451, DOI 10.1038/ng0495-451e; Wilson RB, 1997, NAT GENET, V16, P352, DOI 10.1038/ng0897-352; WU JS, 1994, NAT GENET, V7, P541, DOI 10.1038/ng0894-541; YAMAZAKI K, 1993, LAB ANIM SCI, V43, P61	39	85	95	1	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 5	2000	356	9228					469	474		10.1016/S0140-6736(00)02556-3	http://dx.doi.org/10.1016/S0140-6736(00)02556-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342QY	10981891				2022-12-24	WOS:000088657700013
J	Watt, G; Kantipong, P; de Souza, M; Chanbancherd, P; Jongsakul, K; Ruangweerayud, R; Loomis-Price, LD; Polonis, V; Myint, KS; Birx, DL; Brown, AE; Krishna, S				Watt, G; Kantipong, P; de Souza, M; Chanbancherd, P; Jongsakul, K; Ruangweerayud, R; Loomis-Price, LD; Polonis, V; Myint, KS; Birx, DL; Brown, AE; Krishna, S			HIV-1 suppression during acute scrub-typhus infection	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NECROSIS-FACTOR-ALPHA; TYPE-1; LOAD; DIAGNOSIS; IMPACT	Background In HIV-1-infected individuals, viral load has been reported to rise transiently if an acute infection with another organism occurs. Our study was prompted by the unexpected finding that HIV-1 copy number fell during an acute infection with Orientia tsutsugamushi, the causative agent of scrub typhus. Methods Serial HIV-1 viral load determinations were made in ten Thai adults with scrub typhus, who were not receiving antiretroviral therapy, and in five HIV-1-infected patients who had other infections (four malaria, one leptospirosis), during and after acute infections. Sera from HIV-1-infected patients with scrub typhus and from mice immunised with O tsutsugamushi were examined for HIV-1-suppressive activity. Findings Median viral load 3 days after admission was significantly lower in the scrub-typhus group than in patients with other infections (193% vs 376% of day 28 values, p=0.03). In four O tsutsugamushi-infected patients HIV-1 RNA copy number fell by three-fold or more compared with day 28 values, and HIV-1 copy numbers were below the assay threshold in two patients with scrub typhus, Five of seven HIV-1 isolates from non-typhus patients with CD4 lymphocytes less than 200 cells/mu L were syncytia-inducing variants, whereas all ten isolates from O tsutsugamushi-infected individuals matched by CD4-cell count were non-syncytia inducing (p=0.03). Sera from an HIV-1-negative patient with scrub typhus bad potent HIV-1-suppressive activity in vitro, Sera from typhus-infected mice inhibited HIV-1 syncytia formation and bound by immunofluorescence to HIV-1-infected lymphocytes. Interpretation HIV-1-suppressive factors are produced during some scrub-typhus infection and should be investigated further in the search for novel strategies for the treatment and prevention of AIDS.	Armed Forces Res Inst Med Sci, USAMC, Retrovirol Dept, Bangkok 10400, Thailand; Armed Forces Res Inst Med Sci, USAMC, Dept Virol, Bangkok 10400, Thailand; Chiangrai Reg Hosp, Chiangrai, Thailand; Army Inst Pathol, Bangkok, Thailand; Maesod Hosp, Tak Prov, Thailand; Walter Reed Army Inst Res, Div Retrovirol, Rockville, MD USA; Univ London St Georges Hosp, Sch Med, Dept Infect Dis, London SW17 0RE, England	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); St Georges University London	Watt, G (corresponding author), AFRIMS, Dept Retrovirol, HIV Interact Sect, APO, AP 96546 USA.		Myint, Khin/HHS-2027-2022	Myint, Khin/0000-0002-2087-7331; Krishna, Sanjeev/0000-0003-0066-0634				ARTENSTEIN AW, 1995, J INFECT DIS, V171, P805, DOI 10.1093/infdis/171.4.805; BLOOM BR, 1998, SCIENCE, V268, P516; Brichacek B, 1996, J INFECT DIS, V174, P1191, DOI 10.1093/infdis/174.6.1191; Carpenter C, 1998, ANN INTERN MED, V128, P1057, DOI 10.7326/0003-4819-128-12_Part_2-199806151-00002; Colin JF, 1999, HEPATOLOGY, V29, P1306, DOI 10.1002/hep.510290447; *DIV AIDS, 1997, NIH PUBL; Garcia F, 1998, J ACQ IMMUN DEF SYND, V18, P398, DOI 10.1097/00042560-199808010-00019; Kantipong P, 1996, CLIN INFECT DIS, V23, P1168, DOI 10.1093/clinids/23.5.1168; Karp CL, 1999, CLIN INFECT DIS, V28, P947, DOI 10.1086/514745; McGuire W, 1996, T ROY SOC TROP MED H, V90, P10, DOI 10.1016/S0035-9203(96)90461-7; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Mole L, 1997, J INFECT DIS, V176, P766, DOI 10.1086/517297; NARA PL, 1988, NATURE, V332, P469, DOI 10.1038/332469a0; Newman GW, 1999, CLIN INFECT DIS, V28, P514, DOI 10.1086/515166; OAKS EV, 1989, INFECT IMMUN, V57, P3116, DOI 10.1128/IAI.57.10.3116-3122.1989; Ortigao-deo-Sampaio MB, 1998, AIDS, V12, pF145, DOI 10.1097/00002030-199814000-00001; RICHMAN DD, 1994, J INFECT DIS, V169, P968, DOI 10.1093/infdis/169.5.968; Sulkowski MS, 1998, J INFECT DIS, V178, P1642, DOI 10.1086/314491; Watt G, 1996, LANCET, V348, P86, DOI 10.1016/S0140-6736(96)02501-9; Watt G, 1998, J INFECT DIS, V177, P800, DOI 10.1086/517813; Winslow WE, 1997, J CLIN MICROBIOL, V35, P1938, DOI 10.1128/JCM.35.8.1938-1942.1997; Xiao LH, 1998, J INFECT DIS, V177, P437, DOI 10.1086/514212; ZollaPazner S, 1997, J INFECT DIS, V175, P764, DOI 10.1086/513969	23	59	61	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 5	2000	356	9228					475	479		10.1016/S0140-6736(00)02557-5	http://dx.doi.org/10.1016/S0140-6736(00)02557-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342QY	10981892				2022-12-24	WOS:000088657700014
J	Nohturfft, A; Yabe, D; Goldstein, JL; Brown, MS; Espenshade, PJ				Nohturfft, A; Yabe, D; Goldstein, JL; Brown, MS; Espenshade, PJ			Regulated step in cholesterol feedback localized to budding of SCAP from ER membranes	CELL			English	Article							CLEAVAGE-ACTIVATING PROTEIN; ELEMENT-BINDING PROTEINS; BOUND TRANSCRIPTION FACTOR; LOW-DENSITY LIPOPROTEIN; ENDOPLASMIC-RETICULUM; COMPETITIVE INHIBITOR; HUMAN FIBROBLASTS; CELLS; PATHWAY; TRANSPORT	SREBPs exit the ER in a complex with SCAP. Together, they move to the Golgi where SREBP is cleaved, releasing a fragment that activates genes encoding lipid biosynthetic enzymes. Sterols block ER exit, preventing cleavage, decreasing transcription, and achieving feedback control of lipid synthesis. Here, we report an in vitro system to measure incorporation of SCAP into ER vesicles. When membranes were isolated from sterol-depleted cells, SCAP entered vesicles in a reaction requiring nucleoside triphosphates and cytosol. SCAP budding was diminished in membranes from sterol-treated cells. Kinetics of induction of budding in vitro matched kinetics of ER exit in living cells expressing GFP-SCAP. These data localize the sterol-regulated step to budding of SCAP from ER and provide a system for biochemical dissection.	Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Goldstein, JL (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA.	jgolds@mednet.swmed.edu; mbrow1@mednet.swmed.edu	Yabe, Daisuke/J-6682-2014	Yabe, Daisuke/0000-0002-5334-7687; Nohturfft, Axel/0000-0001-9484-3209	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948, F32HL009993] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-09993, HL-20948] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AKUSJARVI G, 1987, MOL CELL BIOL, V7, P549, DOI 10.1128/MCB.7.1.549; BECKERS CJM, 1987, CELL, V50, P523, DOI 10.1016/0092-8674(87)90025-0; Bergmann JE, 1989, METHOD CELL BIOL, V32, P85; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; BROWN MS, 1978, J BIOL CHEM, V253, P1121; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; DeBose-Boyd RA, 1999, CELL, V99, P703, DOI 10.1016/S0092-8674(00)81668-2; Duncan EA, 1997, J BIOL CHEM, V272, P12778, DOI 10.1074/jbc.272.19.12778; Duncan EA, 1998, J BIOL CHEM, V273, P17801, DOI 10.1074/jbc.273.28.17801; Edwards PA, 1999, ANNU REV BIOCHEM, V68, P157, DOI 10.1146/annurev.biochem.68.1.157; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Espenshade PJ, 1999, J BIOL CHEM, V274, P22795, DOI 10.1074/jbc.274.32.22795; FANGER BO, 1987, ANAL BIOCHEM, V162, P11, DOI 10.1016/0003-2697(87)90004-2; GALLIONE CJ, 1985, J VIROL, V54, P374, DOI 10.1128/JVI.54.2.374-382.1985; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Hua XX, 1996, J BIOL CHEM, V271, P10379, DOI 10.1074/jbc.271.17.10379; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; KITA T, 1980, J CLIN INVEST, V66, P1094, DOI 10.1172/JCI109938; Klumperman J, 1998, J CELL SCI, V111, P3411; KRIEGER M, 1978, P NATL ACAD SCI USA, V75, P5052, DOI 10.1073/pnas.75.10.5052; Nohturfft A, 1998, P NATL ACAD SCI USA, V95, P12848, DOI 10.1073/pnas.95.22.12848; Nohturfft A, 1999, P NATL ACAD SCI USA, V96, P11235, DOI 10.1073/pnas.96.20.11235; Nohturfft A, 1998, J BIOL CHEM, V273, P17243, DOI 10.1074/jbc.273.27.17243; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Rawson RB, 1999, J BIOL CHEM, V274, P28549, DOI 10.1074/jbc.274.40.28549; REXACH MF, 1991, J CELL BIOL, V114, P219, DOI 10.1083/jcb.114.2.219; Rowe T, 1996, J CELL BIOL, V135, P895, DOI 10.1083/jcb.135.4.895; Sakai J, 1998, J BIOL CHEM, V273, P5785, DOI 10.1074/jbc.273.10.5785; Sakai J, 1997, J BIOL CHEM, V272, P20213, DOI 10.1074/jbc.272.32.20213; SATO R, 1994, J BIOL CHEM, V269, P17267; Springer S, 1999, CELL, V97, P145, DOI 10.1016/S0092-8674(00)80722-9; WANG XD, 1994, CELL, V77, P53, DOI 10.1016/0092-8674(94)90234-8; YANG JX, 1995, J BIOL CHEM, V270, P12152, DOI 10.1074/jbc.270.20.12152	37	263	271	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 4	2000	102	3					315	323		10.1016/S0092-8674(00)00037-4	http://dx.doi.org/10.1016/S0092-8674(00)00037-4			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	342BP	10975522	Bronze			2022-12-24	WOS:000088625600007
J	Sessions, A; Yanofsky, MF; Weigel, D				Sessions, A; Yanofsky, MF; Weigel, D			Cell-cell signaling and movement by the floral transcription factors LEAFY and APETALA1	SCIENCE			English	Article							HOMEOTIC GENES; FLOWER DEVELOPMENT; MERISTEM IDENTITY; ARABIDOPSIS; ANTIRRHINUM; PLASMODESMATA; TRAFFICKING; ACTIVATION; FLORICAULA; EXPRESSION	LEAFY (LFY) and APETALA1 (AP1) encode unrelated transcription factors that activate overlapping sets of homeotic genes in Arabidopsis flowers. Sector analysis and targeted expression in transgenic plants were used to study whether LFY and AP1 can participate in cell-cell signaling between and within different layers of the floral meristem. LFY signaled equally well from all Layers and had substantial Long-range action within layers. Nonautonomous action of LFY was accompanied by movement of the protein to adjacent cells, where it directly activated homeotic target genes. In contrast, AP1 had only Limited nonautonomous effects, apparently mediated by downstream genes because activation of early target genes by AP1 was cell-autonomous.	Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA	University of California System; University of California San Diego; Salk Institute	Yanofsky, MF (corresponding author), Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA.		Weigel, Detlef/GSJ-0799-2022; Weigel, Detlef/AAR-3312-2021; Weigel, Detlef/C-1418-2008	Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963				Bouhidel K, 1996, DEV BIOL, V174, P22, DOI 10.1006/dbio.1996.0048; Bradley D, 1996, NATURE, V379, P791, DOI 10.1038/379791a0; Busch MA, 1999, SCIENCE, V285, P585, DOI 10.1126/science.285.5427.585; CARPENTER R, 1995, DEVELOPMENT, V121, P19; CARPENTER R, 1990, GENE DEV, V4, P1483, DOI 10.1101/gad.4.9.1483; Ferrandiz C, 2000, DEVELOPMENT, V127, P725; HANTKE SS, 1995, DEVELOPMENT, V121, P27; Hill TA, 1998, DEVELOPMENT, V125, P1711; HUALA E, 1992, PLANT CELL, V4, P901, DOI 10.1105/tpc.4.8.901; IRISH VF, 1990, PLANT CELL, V2, P741, DOI 10.1105/tpc.2.8.741; JACKSON D, 1994, DEVELOPMENT, V120, P405; KILBY NJ, 1995, PLANT J, V8, P637, DOI 10.1046/j.1365-313X.1995.08050637.x; LUCAS WJ, 1995, SCIENCE, V270, P1980, DOI 10.1126/science.270.5244.1980; LUCAS WJ, 1995, CURR OPIN CELL BIOL, V7, P673, DOI 10.1016/0955-0674(95)80109-X; Perbal MC, 1996, DEVELOPMENT, V122, P3433; Sieburth LE, 1998, DEVELOPMENT, V125, P4303; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; WEIGEL D, 1993, SCIENCE, V261, P1723, DOI 10.1126/science.261.5129.1723; WEIGEL D, 1992, CELL, V69, P843, DOI 10.1016/0092-8674(92)90295-N; WEIGEL D, 1995, NATURE, V377, P4950	20	241	265	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 4	2000	289	5480					779	781		10.1126/science.289.5480.779	http://dx.doi.org/10.1126/science.289.5480.779			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341FZ	10926540				2022-12-24	WOS:000088581500041
J	Gershon, D				Gershon, D			Collaborations prepare to untangle the circuitry of the brain	NATURE			English	Article																			0	0	0	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2000	406	6795					545	546		10.1038/35020199	http://dx.doi.org/10.1038/35020199			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952319				2022-12-24	WOS:000088538000053
J	Gershon, D				Gershon, D			Mahoney centre set to tackle brain cancer head on	NATURE			English	Article																			0	0	0	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2000	406	6795					546	546		10.1038/35020204	http://dx.doi.org/10.1038/35020204			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952320				2022-12-24	WOS:000088538000054
J	Neumann, P; Koeniger, N; Koeniger, G; Tingek, S; Kryger, P; Moritz, RFA				Neumann, P; Koeniger, N; Koeniger, G; Tingek, S; Kryger, P; Moritz, RFA			Entomology - Home-site fidelity in migratory honeybees	NATURE			English	Article							DORSATA; POLYANDRY		Univ Halle Wittenberg, Inst Zool, D-06099 Halle, Germany; Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, South Africa; Goethe Univ Frankfurt, D-61440 Oberursel, Germany; Agr Res Stn, Tenom 89908, Sabah, Malaysia; Univ Pretoria, Dept Zool & Entomol, ZA-0001 Pretoria, South Africa	Martin Luther University Halle Wittenberg; Rhodes University; Goethe University Frankfurt; University of Pretoria	Neumann, P (corresponding author), Univ Halle Wittenberg, Inst Zool, D-06099 Halle, Germany.	p.neumann@ru.ac.za	Neumann, Peter/C-9964-2015; Kryger, Per/C-1773-2013; Moritz, Robin FA/K-6053-2012	Neumann, Peter/0000-0001-5163-5215; Kryger, Per/0000-0001-5306-3230; Moritz, Robin FA/0000-0003-0791-887X				BREED MD, 1995, ANIM BEHAV, V50, P489, DOI 10.1006/anbe.1995.0263; ESTOUP A, 1994, P ROY SOC B-BIOL SCI, V258, P1, DOI 10.1098/rspb.1994.0133; ESTOUP A, 1993, NUCLEIC ACIDS RES, V21, P1427, DOI 10.1093/nar/21.6.1427; KOENIGER N, 1980, J APICULT RES, V19, P21, DOI 10.1080/00218839.1980.11099994; LINDAUER M, 1956, Z VERGL PHYSIOL, V38, P521, DOI 10.1007/BF00341108; MORITZ RFA, 1995, BEHAV ECOL SOCIOBIOL, V37, P357, DOI 10.1007/BF00174141; Neumann P, 1999, APIDOLOGIE, V30, P505, DOI 10.1051/apido:19990605; Oldroyd BP, 1996, ANN ENTOMOL SOC AM, V89, P276, DOI 10.1093/aesa/89.2.276; Otis G.W., 1990, P378; RUTTNER F, 1988, TAXONOMY BIOGEOGRAPH; THAPA R, 1999, SOCIAL INSECTS TURN, P469; VISSCHER PK, 1985, INSECT SOC, V32, P217, DOI 10.1007/BF02224236	12	31	37	0	18	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 3	2000	406	6795					474	475		10.1038/35020193	http://dx.doi.org/10.1038/35020193			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952299				2022-12-24	WOS:000088538000033
J	Brand, U; Fletcher, JC; Hobe, M; Meyerowitz, EM; Simon, R				Brand, U; Fletcher, JC; Hobe, M; Meyerowitz, EM; Simon, R			Dependence of stem cell fate in Arabidopsis an a feedback loop regulated by CLV3 activity	SCIENCE			English	Article							SHOOT APICAL MERISTEM; RECEPTOR-LIKE KINASE; GENE ENCODES; CLAVATA1; PROTEIN; THALIANA; WUSCHEL; PLANTS	The fate of stem cells in plant meristems is governed by directional signaling systems that are regulated by negative feedback. In Arabidopsis thaliana, the CLAVATA (CLV) genes encode the essential components of a negative, stem cell-restricting pathway. We used transgenic plants overexpressing CLV3 to show that meristem cell accumulation and fate depends directly on the Level of CLV3 activity and that CLV3 signaling occurs exclusively through a CLV1/ CLV2 receptor kinase complex. We also demonstrate that the CLV pathway acts by repressing the activity of the transcription factor WUSCHEL, an element of the positive, stem cell-promoting pathway.	Univ Cologne, Inst Entwicklungsbiol, D-50923 Cologne, Germany; CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA	University of Cologne; California Institute of Technology	Simon, R (corresponding author), Univ Cologne, Inst Entwicklungsbiol, Gyrhofstr 17, D-50923 Cologne, Germany.	ruediger.simon@uni-koeln.de	Meyerowitz, Elliot M/A-7118-2009; Simon, Rudiger/T-6755-2018	Simon, Rudiger/0000-0002-1317-7716				BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; BRAND U, UNPUB; CLARK SE, 1993, DEVELOPMENT, V119, P397; CLARK SE, 1995, DEVELOPMENT, V121, P2057; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Fletcher JC, 2000, CURR OPIN PLANT BIOL, V3, P23, DOI 10.1016/S1369-5266(99)00033-3; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Jeong S, 1999, PLANT CELL, V11, P1925, DOI 10.1105/tpc.11.10.1925; Kayes JM, 1998, DEVELOPMENT, V125, P3843; Laufs P, 1998, PLANT CELL, V10, P1375, DOI 10.1105/tpc.10.8.1375; Laux T, 1996, DEVELOPMENT, V122, P87; Lee I, 1997, CURR BIOL, V7, P95, DOI 10.1016/S0960-9822(06)00053-4; LEYSER HMO, 1992, DEVELOPMENT, V116, P397; Long JA, 1998, DEVELOPMENT, V125, P3027; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Meyerowitz EM, 1997, CELL, V88, P299, DOI 10.1016/S0092-8674(00)81868-1; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Steeves T.A., 1989, PATTERNS PLANT DEV, DOI 10.1017/CBO9780511626227; Trotochaud AE, 1999, PLANT CELL, V11, P393, DOI 10.1105/tpc.11.3.393; Williams RW, 1997, P NATL ACAD SCI USA, V94, P10467, DOI 10.1073/pnas.94.19.10467; Yu LP, 2000, DEVELOPMENT, V127, P1661	21	794	853	53	509	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2000	289	5479					617	619		10.1126/science.289.5479.617	http://dx.doi.org/10.1126/science.289.5479.617			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	338XD	10915624				2022-12-24	WOS:000088447800053
J	Takahashi, T; Hori, T; Kajikawa, Y; Tsujimoto, T				Takahashi, T; Hori, T; Kajikawa, Y; Tsujimoto, T			The role of GTP-binding protein activity in fast central synaptic transmission	SCIENCE			English	Article							FROG NEUROMUSCULAR-JUNCTION; PRESYNAPTIC CALCIUM CURRENT; READILY RELEASABLE POOL; CA2+-DEPENDENT EXOCYTOSIS; REGULATED EXOCYTOSIS; TRANSMITTER RELEASE; CHROMAFFIN CELLS; CALYX SYNAPSE; DEPRESSION; VESICLES	Guanosine 5'-triphosphate (GTP)-binding proteins (G proteins) are involved in exocytosis, endocytosis, and recycling of vesicles in yeast and mammalian secretory cells. However, little is known about their contribution to fast synaptic transmission. We Loaded guanine nucleotide analogs directly into a giant nerve terminal in rat brainstem slices. Inhibition of G-protein activity had no effect on basal synaptic transmission, but augmented synaptic depression and significantly slowed recovery from depression. A nonhydrolyzable GTP analog blocked recovery of transmission from activity-dependent depression. Neither effect was accompanied by a change in presynaptic calcium currents. Thus, G proteins contribute to fast synaptic transmission by refitting synaptic vesicles depleted after massive exocytosis.	Univ Tokyo, Fac Med, Dept Neurophysiol, Tokyo 1130033, Japan	University of Tokyo	Takahashi, T (corresponding author), Univ Tokyo, Fac Med, Dept Neurophysiol, Tokyo 1130033, Japan.		Takahashi, Tomoyuki/G-5951-2015	Takahashi, Tomoyuki/0000-0002-8771-7666; Hori, Tetsuya/0000-0002-0823-3306				Ashery U, 1999, P NATL ACAD SCI USA, V96, P1094, DOI 10.1073/pnas.96.3.1094; Augustine GJ, 1999, J PHYSIOL-LONDON, V520, P33, DOI 10.1111/j.1469-7793.1999.00033.x; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; Burns ME, 1998, J GEN PHYSIOL, V111, P243, DOI 10.1085/jgp.111.2.243; Cuttle MF, 1998, J PHYSIOL-LONDON, V512, P723, DOI 10.1111/j.1469-7793.1998.723bd.x; Dittman JS, 1998, J NEUROSCI, V18, P6147; FERRONOVICK S, 1993, ANNU REV CELL BIOL, V9, P575; FORSYTHE ID, 1994, J PHYSIOL-LONDON, V479, P381, DOI 10.1113/jphysiol.1994.sp020303; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; Galas MC, 1997, J BIOL CHEM, V272, P2788, DOI 10.1074/jbc.272.5.2788; Geppert M, 1997, NATURE, V387, P810, DOI 10.1038/42954; HAROOTUNIAN AT, 1991, CELL CALCIUM, V12, P153, DOI 10.1016/0143-4160(91)90017-9; HESS SD, 1993, SCIENCE, V259, P1169, DOI 10.1126/science.8438167; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; HOLZ RW, 1994, J BIOL CHEM, V269, P10229; Hori T, 1999, J NEUROSCI, V19, P7262, DOI 10.1523/JNEUROSCI.19-17-07262.1999; Hsu SF, 1996, NEURON, V17, P501, DOI 10.1016/S0896-6273(00)80182-8; Katz B., 1969, RELEASE NEURAL TRANS; Nagao M, 1999, ONCOGENE, V18, P4425, DOI 10.1038/sj.onc.1202832; NUOFFER C, 1994, ANNU REV BIOCHEM, V63, P949, DOI 10.1146/annurev.bi.63.070194.004505; Oishi H, 1998, J BIOL CHEM, V273, P34580, DOI 10.1074/jbc.273.51.34580; Otis T, 1996, J NEUROSCI, V16, P7496; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; RUPNIK M, 1995, NEUROREPORT, V6, P853, DOI 10.1097/00001756-199504190-00007; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; Takahashi T, 1998, J NEUROSCI, V18, P3138; Takahashi T, UNPUB; vonGersdorff H, 1997, J NEUROSCI, V17, P8137; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8	33	39	39	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2000	289	5478					460	463		10.1126/science.289.5478.460	http://dx.doi.org/10.1126/science.289.5478.460			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336ME	10903208				2022-12-24	WOS:000088305500050
J	Tamura, K; Sudo, T; Senftleben, U; Dadak, AM; Johnson, R; Karin, M				Tamura, K; Sudo, T; Senftleben, U; Dadak, AM; Johnson, R; Karin, M			Requirement for p38 alpha in erythropoietin expression: A role for stress kinases in erythropoiesis	CELL			English	Article							ATF1 TRANSCRIPTION FACTOR; HEMATOPOIETIC STEM-CELLS; INDUCIBLE FACTOR 1-ALPHA; MAP KINASE; MESSENGER-RNA; C-JUN; SIGNAL-TRANSDUCTION; PROTEIN-KINASES; FISSION YEAST; SPC1 KINASE	Activity of the p38 alpha MAP kinase is stimulated by various stresses and hematopoietic growth factors. A role for p38 alpha in mouse development and physiology was investigated by targeted disruption of the p38 alpha locus. Whereas some p38 alpha(-/-) embryos die between embryonic days 11.5 and 12.5, those that develop past this stage have normal morphology but are anemic owing to failed definitive erythropoiesis, caused by diminished erythropoietin (Epo) gene expression. As p38 alpha-deficient hematopoietic stem cells reconstitute lethally irradiated hosts, p38 alpha function is not required downstream of Epo receptor. Inhibition of p38 activity also interferes with stabilization of Epo mRNA in human hepatoma cells undergoing hypoxic stress. The p38a MAP kinase plays a critical role linking developmental and stress-induced erythropoiesis through regulation of Epo expression.	Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Inst Phys & Chem Res, Biodesign Grp, Wako, Saitama 3510198, Japan	University of California System; University of California San Diego; University of California System; University of California San Diego; RIKEN	Karin, M (corresponding author), Univ Calif San Diego, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA.		Johnson, Randall/AAM-1189-2021	Johnson, Randall/0000-0002-4084-6639; Dadak, Agnes/0000-0002-0948-4764	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL035018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES006376, R37ES004151, R01ES004151] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL35018] Funding Source: Medline; NIEHS NIH HHS [ES06376, ES04151] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ADAMS RH, 2000, IN PRESS MOL CELL; Allen M, 2000, J EXP MED, V191, P859, DOI 10.1084/jem.191.5.859; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Chen CY, 1998, SCIENCE, V280, P1945, DOI 10.1126/science.280.5371.1945; Conrad PW, 1999, J BIOL CHEM, V274, P23570, DOI 10.1074/jbc.274.33.23570; Crawley JB, 1997, J BIOL CHEM, V272, P15023, DOI 10.1074/jbc.272.23.15023; Dean JLE, 1999, J BIOL CHEM, V274, P264, DOI 10.1074/jbc.274.1.264; Degols G, 1997, MOL CELL BIOL, V17, P3356, DOI 10.1128/MCB.17.6.3356; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Ebert BL, 1999, BLOOD, V94, P1864; Eferl R, 1999, J CELL BIOL, V145, P1049, DOI 10.1083/jcb.145.5.1049; Fahnenstich H, 1996, J PERINAT MED, V24, P85, DOI 10.1515/jpme.1996.24.1.85; Foltz IN, 1997, J BIOL CHEM, V272, P3296, DOI 10.1074/jbc.272.6.3296; Ghaffari S, 1999, EXP HEMATOL, V27, P978, DOI 10.1016/S0301-472X(99)00023-5; Godin I, 1999, J EXP MED, V190, P43, DOI 10.1084/jem.190.1.43; GOLDBERG MA, 1991, BLOOD, V77, P271; GREENBERG ME, 1987, CURRENT PROTOCOLS MO; GREGORY CJ, 1978, BLOOD, V51, P527; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; KANSAS GS, 1990, BLOOD, V76, P2483; Kato T, 1996, FEBS LETT, V378, P207, DOI 10.1016/0014-5793(95)01442-X; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Lee JC, 1996, J LEUKOCYTE BIOL, V59, P152, DOI 10.1002/jlb.59.2.152; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Nagata Y, 1997, BLOOD, V90, P929, DOI 10.1182/blood.V90.3.929.929_929_934; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; New LG, 1998, TRENDS CARDIOVAS MED, V8, P220, DOI 10.1016/S1050-1738(98)00012-7; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Puri PL, 2000, GENE DEV, V14, P574; Richard DE, 1999, J BIOL CHEM, V274, P32631, DOI 10.1074/jbc.274.46.32631; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Sabapathy K, 1999, MECH DEVELOP, V89, P115, DOI 10.1016/S0925-4773(99)00213-0; Sabapathy K, 1999, CURR BIOL, V9, P116, DOI 10.1016/S0960-9822(99)80065-7; Shiozaki K, 1996, GENE DEV, V10, P2276, DOI 10.1101/gad.10.18.2276; Su B, 1996, CURR OPIN IMMUNOL, V8, P402, DOI 10.1016/S0952-7915(96)80131-2; SUDO T, 2000, IN PRESS METH ENZYMO; WASKIEWICZ AJ, 1995, CURR OPIN CELL BIOL, V7, P798, DOI 10.1016/0955-0674(95)80063-8; WEISS MJ, 1994, GENE DEV, V8, P1184, DOI 10.1101/gad.8.10.1184; WHITELAW E, 1990, MOL CELL BIOL, V10, P6596, DOI 10.1128/MCB.10.12.6596; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193	51	294	308	1	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 21	2000	102	2					221	231		10.1016/S0092-8674(00)00027-1	http://dx.doi.org/10.1016/S0092-8674(00)00027-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	337NA	10943842	Bronze			2022-12-24	WOS:000088366800012
J	Ahissar, E; Sosnik, R; Haidarliu, S				Ahissar, E; Sosnik, R; Haidarliu, S			Transformation from temporal to rate coding in a somatosensory thalamocortical pathway	NATURE			English	Article							POSTERIOR MEDIAL NUCLEUS; SOMATIC SENSORY RESPONSES; BARREL CORTEX; ANTEROGRADE TRACER; ROSTRAL SECTOR; GROUP POM; THALAMUS; NEURONS; ORGANIZATION; FIELD	The anatomical connections from the whiskers to the rodent somatosensory (barrel) cortex form two parallel (lemniscal and paralemniscal) pathways(1,2). It is unclear whether the paralemniscal pathway is directly involved in tactile processing, because paralemniscal neuronal responses show poor spatial resolution, labile latencies and strong dependence on cortical feedback(3-5). Here we show that the paralemniscal system can transform temporally encoded vibrissal information into a rate code. We recorded the representations of the frequency of whisker movement along the two pathways in anaesthetized rats. In response to varying stimulus frequencies, the lemniscal neurons exhibited amplitude modulations and constant latencies. In contrast, paralemniscal neurons in both thalamus and cortex coded the input frequency as changes in latency. Because the onset latencies increased and the offset latencies remained constant, the latency increments were translated into a rate code: increasing onset latencies led to lower spike counts. A thalamocortical loop that includes cortical oscillations and thalamic gating can account for these results. Thus, variable latencies and effective cortical feedback in the paralemniscal system can serve the processing of temporal sensory cues, such as those that encode object location during whisking. In contrast, fixed time locking in the lemniscal system is crucial for reliable spatial processing.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Ahissar, E (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	Ehud.Ahissar@weizmann.ac.il						Ahissar E, 1998, NEURAL COMPUT, V10, P597, DOI 10.1162/089976698300017683; Ahissar E, 1997, P NATL ACAD SCI USA, V94, P11633, DOI 10.1073/pnas.94.21.11633; BOURASSA J, 1995, EUR J NEUROSCI, V7, P19, DOI 10.1111/j.1460-9568.1995.tb01016.x; CARR CE, 1993, ANNU REV NEUROSCI, V16, P223, DOI 10.1146/annurev.ne.16.030193.001255; CARVELL GE, 1990, J NEUROSCI, V10, P2638; CHIAIA NL, 1991, J COMP NEUROL, V314, P217, DOI 10.1002/cne.903140203; CHMIELOWSKA J, 1989, J COMP NEUROL, V285, P325, DOI 10.1002/cne.902850304; Crabtree JW, 1998, NAT NEUROSCI, V1, P389, DOI 10.1038/1603; DIAMOND ME, 1992, J COMP NEUROL, V319, P66, DOI 10.1002/cne.903190108; DIAMOND ME, 1992, J COMP NEUROL, V318, P462, DOI 10.1002/cne.903180410; DIAMOND ME, 1992, CONCEPT NEUROSCI, V3, P55; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; Friedberg MH, 1999, J NEUROPHYSIOL, V81, P2243, DOI 10.1152/jn.1999.81.5.2243; Haidarliu S, 1999, J NEUROSCI METH, V94, P27, DOI 10.1016/S0165-0270(99)00123-5; Hartings JA, 1998, J NEUROPHYSIOL, V80, P1016, DOI 10.1152/jn.1998.80.2.1016; HOOGLAND PV, 1988, CELLULAR THALAMIC ME, P152; Kleinfeld D, 1999, SOMATOSENS MOT RES, V16, P69, DOI 10.1080/08990229970528; KORALEK KA, 1988, BRAIN RES, V463, P346, DOI 10.1016/0006-8993(88)90408-8; LU SM, 1993, SOMATOSENS MOT RES, V10, P1, DOI 10.3109/08990229309028819; NICOLELIS MAL, 1995, SCIENCE, V268, P1353, DOI 10.1126/science.7761855; NICOLELIS MAL, 1994, J NEUROSCI, V14, P3511; Sherman SM, 1996, J NEUROPHYSIOL, V76, P1367, DOI 10.1152/jn.1996.76.3.1367; SILVA LR, 1991, SCIENCE, V251, P432, DOI 10.1126/science.1824881; SIMONS DJ, 1992, EXP BRAIN RES, V91, P259; SWADLOW HA, 1995, J NEUROPHYSIOL, V73, P1584, DOI 10.1152/jn.1995.73.4.1584; Welker W. I., 1964, Behaviour, V22, P223, DOI 10.1163/156853964X00030; WHITE EL, 1987, J COMP NEUROL, V262, P13, DOI 10.1002/cne.902620103; WILLIAMS MN, 1994, EUR J NEUROSCI, V6, P429, DOI 10.1111/j.1460-9568.1994.tb00286.x; WOOLSEY TA, 1997, ENCY NEUROSCIENCE, P195; ZUCKER E, 1969, BRAIN RES, V12, P138, DOI 10.1016/0006-8993(69)90061-4	30	283	286	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2000	406	6793					302	306		10.1038/35018568	http://dx.doi.org/10.1038/35018568			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917531				2022-12-24	WOS:000088251900049
J	Heath, RJ; Rock, CO				Heath, RJ; Rock, CO			Microbiology - A triclosan-resistant bacterial enzyme	NATURE			English	Article							ACYL CARRIER PROTEIN; FATTY-ACID ELONGATION; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; REDUCTASE FABI; TARGET; BIOSYNTHESIS		St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA; Univ Tennessee, Dept Biochem, Memphis, TN 38105 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Heath, RJ (corresponding author), St Jude Childrens Res Hosp, Dept Biochem, 332 N Lauderdale St, Memphis, TN 38105 USA.			Heath, Richard/0000-0002-1795-1254				Bhargava HN, 1996, AM J INFECT CONTROL, V24, P209, DOI 10.1016/S0196-6553(96)90017-6; Heath RJ, 1996, J BIOL CHEM, V271, P1833, DOI 10.1074/jbc.271.4.1833; HEATH RJ, 1995, J BIOL CHEM, V270, P26538, DOI 10.1074/jbc.270.44.26538; Heath RJ, 1998, J BIOL CHEM, V273, P30316, DOI 10.1074/jbc.273.46.30316; Heath RJ, 1999, J BIOL CHEM, V274, P11110, DOI 10.1074/jbc.274.16.11110; Hoang TT, 1999, J BACTERIOL, V181, P5489, DOI 10.1128/JB.181.17.5489-5497.1999; Levy CW, 1999, NATURE, V398, P383, DOI 10.1038/18803; McMurry LM, 1998, NATURE, V394, P531, DOI 10.1038/28970; NAGY M, 1992, P NATL ACAD SCI USA, V89, P8966, DOI 10.1073/pnas.89.19.8966; ROCK CO, 1986, BIOCHIM BIOPHYS ACTA, V1302, P1; Rozwarski DA, 1998, SCIENCE, V279, P98, DOI 10.1126/science.279.5347.98; Schweizer HP, 1998, ANTIMICROB AGENTS CH, V42, P394	12	247	275	2	41	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 13	2000	406	6792					145	146		10.1038/35018162	http://dx.doi.org/10.1038/35018162			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910344				2022-12-24	WOS:000088221100034
J	Platzer, J; Engel, J; Schrott-Fischer, A; Stephan, K; Bova, S; Chen, H; Zheng, H; Striessnig, J				Platzer, J; Engel, J; Schrott-Fischer, A; Stephan, K; Bova, S; Chen, H; Zheng, H; Striessnig, J			Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels	CELL			English	Article							STATIONARY NIGHT BLINDNESS; SENSITIVE CALCIUM CHANNELS; HEART-RATE REGULATION; HAIR-CELLS; BETA-SUBUNIT; FUNCTIONAL EXPRESSION; CREB PHOSPHORYLATION; HIPPOCAMPAL-NEURONS; KINETIC-ANALYSIS; GENE-EXPRESSION	Voltage-Elated L-type Ca2+ channels (LTCCs) containing a pore-forming alpha 1D subunit (D-LTCCs) are expressed in neurons and neuroendocrine cells. Their relative contribution to total L-type Ca2+ currents and their physiological role and significance as a drug target remain unknown. Therefore, we generated D-LTCC deficient mice (alpha 1D(-/-)) that were viable with no major disturbances of glucose metabolism. alpha 1D(-/-) mice were deaf due to the complete absence of L-type currents in cochlear inner hair cells and degeneration of outer and inner hair cells. In wild-type controls, D-LTCC-mediated currents showed low activation thresholds and slow inactivation kinetics. Electrocardiogram recordings revealed sinoatrial node dysfunction (bradycardia and arrhythmia) in alpha 1D(-/-) mice. We conclude that alpha 1D can form LTCCs with negative activation thresholds essential for normal auditory function and control of cardiac pacemaker activity.	Inst Biochem Pharmakol, A-6020 Innsbruck, Austria; Univ Tubingen, HNO Klin, Sekt Sensor Biophys, Inst Physiol 2, D-72026 Tubingen, Germany; Univ Innsbruck, Klin Hals Nasen & Ohrenheilkunde, A-6020 Innsbruck, Austria; Univ Padua, Dipartimento Farmacol, I-35131 Padua, Italy; Merck Res Labs, Dept Metab Disorders, Rahway, NJ 07065 USA	Eberhard Karls University of Tubingen; University of Innsbruck; University of Padua; Merck & Company	Striessnig, J (corresponding author), Inst Biochem Pharmakol, Peter Mayrstr 1, A-6020 Innsbruck, Austria.	joerg.striessnig@uibk.ac.at	Tuluc, Petronel/C-2527-2011; Striessnig, Joerg/S-9334-2017; Stephan, Kurt/AAK-9124-2020	Striessnig, Joerg/0000-0002-9406-7120; schrott-fischer, Annelies/0000-0002-4514-9867				ASHCROFT FM, 1989, PROG BIOPHYS MOL BIO, V54, P87, DOI 10.1016/0079-6107(89)90013-8; Bech-Hansen NT, 1998, NAT GENET, V19, P264, DOI 10.1038/947; BOHMER A, 1988, ACTA OTO-LARYNGOL, V106, P368, DOI 10.3109/00016488809122259; Boyer C, 1998, EUR J NEUROSCI, V10, P971, DOI 10.1046/j.1460-9568.1998.00107.x; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; DIFRANCESCO D, 1991, J PHYSIOL-LONDON, V434, P23, DOI 10.1113/jphysiol.1991.sp018457; Forrest D, 1996, NAT GENET, V13, P354, DOI 10.1038/ng0796-354; FUCHS PA, 1990, J PHYSIOL-LONDON, V429, P553, DOI 10.1113/jphysiol.1990.sp018272; Glowatzki E, 1997, NEUROPHARMACOLOGY, V36, P1269, DOI 10.1016/S0028-3908(97)00108-1; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Green GE, 1996, J NEUROCHEM, V67, P37; GUO JQ, 1995, J PHYSIOL-LONDON, V483, P1; HAGIWARA N, 1988, J PHYSIOL-LONDON, V395, P233, DOI 10.1113/jphysiol.1988.sp016916; Hardingham GE, 1998, CELL CALCIUM, V23, P131, DOI 10.1016/S0143-4160(98)90111-7; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; HUDSPETH AJ, 1988, J PHYSIOL-LONDON, V400, P237, DOI 10.1113/jphysiol.1988.sp017119; IRISAWA H, 1993, PHYSIOL REV, V73, P197, DOI 10.1152/physrev.1993.73.1.197; Ison JR, 1997, HEARING RES, V106, P179, DOI 10.1016/S0378-5955(96)00216-X; IWASHIMA Y, 1993, DIABETES, V42, P948, DOI 10.2337/diabetes.42.7.948; Johansson C, 1997, ACTA PHYSIOL SCAND, V160, P133, DOI 10.1046/j.1365-201X.1997.00134.x; Jumrussirikul P, 1998, J CLIN INVEST, V102, P1279, DOI 10.1172/JCI2843; Kodama I, 1997, AM J PHYSIOL-HEART C, V272, pH2793, DOI 10.1152/ajpheart.1997.272.6.H2793; Kollmar R, 1997, P NATL ACAD SCI USA, V94, P14883, DOI 10.1073/pnas.94.26.14883; LIBERMAN MC, 1984, HEARING RES, V16, P55, DOI 10.1016/0378-5955(84)90025-X; Lopez I, 1999, NEUROSCIENCE, V92, P773, DOI 10.1016/S0306-4522(99)00005-6; MartinezDunst C, 1997, J NEUROSCI, V17, P9133; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; Moser T, 2000, P NATL ACAD SCI USA, V97, P883, DOI 10.1073/pnas.97.2.883; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; Pichler M, 1997, J BIOL CHEM, V272, P13877, DOI 10.1074/jbc.272.21.13877; Rajadhyaksha A, 1999, J NEUROSCI, V19, P6348; Safayhi H, 1997, MOL ENDOCRINOL, V11, P619, DOI 10.1210/me.11.5.619; SCHROTT A, 1990, EUR ARCH OTO-RHINO-L, V247, P8; SINGEWALD N, 1993, N-S ARCH PHARMACOL, V347, P21; Striessnig J, 1999, CELL PHYSIOL BIOCHEM, V9, P242, DOI 10.1159/000016320; STRIESSNIG J, 1990, P NATL ACAD SCI USA, V87, P9108, DOI 10.1073/pnas.87.23.9108; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Takimoto K, 1997, J MOL CELL CARDIOL, V29, P3035, DOI 10.1006/jmcc.1997.0532; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; TAO X, 1998, NEURON, V20, P1297; Verheijck EE, 1999, AM J PHYSIOL-HEART C, V276, pH1064, DOI 10.1152/ajpheart.1999.276.3.H1064; Wickman K, 1998, NEURON, V20, P103, DOI 10.1016/S0896-6273(00)80438-9; WILLIAMS ME, 1992, NEURON, V8, P71, DOI 10.1016/0896-6273(92)90109-Q; YAMADA Y, 1995, GENOMICS, V27, P312, DOI 10.1006/geno.1995.1048; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9; ZIDANIC M, 1995, BIOPHYS J, V68, P1323, DOI 10.1016/S0006-3495(95)80305-X	46	631	655	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 7	2000	102	1					89	97		10.1016/S0092-8674(00)00013-1	http://dx.doi.org/10.1016/S0092-8674(00)00013-1			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	332UL	10929716	Bronze			2022-12-24	WOS:000088091700011
J	Wikoff, WR; Liljas, L; Duda, RL; Tsuruta, H; Hendrix, RW; Johnson, JE				Wikoff, WR; Liljas, L; Duda, RL; Tsuruta, H; Hendrix, RW; Johnson, JE			Topologically linked protein rings in the bacteriophage HK97 capsid	SCIENCE			English	Article							3-DIMENSIONAL STRUCTURE; CONFORMATIONAL-CHANGES; BACTERIAL-VIRUS; CROSS-LINKING; MATURATION; TRANSITIONS; DEAMIDATION; ASPARAGINYL; MOLSCRIPT; RESIDUES	The crystal structure of the double-stranded DNA bacteriophage HK97 mature empty capsid was determined at 3.6 angstrom resolution. The 660 angstrom diameter icosahedral particle contains 420 subunits with a new fold. The final capsid maturation step is an autocatalytic reaction that creates 420 isopeptide bonds between proteins. Each subunit is joined to two of its neighbors by Ligation of the side-chain Lysine 169 to asparagine 356. This generates 12 pentameric and 60 hexameric rings of covalently joined subunits that loop through each other, creating protein chainmail: topologically linked protein catenanes arranged with icosahedral symmetry. Catenanes have not been previously observed in proteins and provide a stabilization mechanism for the very thin HK97 capsid.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Uppsala Univ, Ctr Biomed, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden; Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Pittsburgh Bacteriophage Inst, Pittsburgh, PA 15260 USA; Stanford Univ, Stanford Synchrotron Radiat Lab, Stanford, CA 94309 USA	Scripps Research Institute; Uppsala University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Johnson, JE (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Duda, Robert/0000-0002-9517-2731	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047795] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI040101, AI40101] Funding Source: Medline; NIGMS NIH HHS [R01 GM047795, GM47795] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Benson SD, 1999, CELL, V98, P825, DOI 10.1016/S0092-8674(00)81516-0; Casjens S., 1988, BACTERIOPHAGES, V1, P16; CHEN JH, 1995, CELL, V80, P61, DOI 10.1016/0092-8674(95)90451-4; CONWAY JF, 1995, J MOL BIOL, V253, P86, DOI 10.1006/jmbi.1995.0538; DOKLAND T, 1993, J MOL BIOL, V233, P682, DOI 10.1006/jmbi.1993.1545; DUDA RL, 1995, J MOL BIOL, V247, P636, DOI 10.1006/jmbi.1994.0169; DUDA RL, 1995, J MOL BIOL, V247, P618, DOI 10.1016/S0022-2836(05)80143-3; Duda RL, 1998, CELL, V94, P55, DOI 10.1016/S0092-8674(00)81221-0; EARNSHAW WC, 1979, J MOL BIOL, V131, P14; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; GEIGER T, 1987, J BIOL CHEM, V262, P785; Gilakjan ZA, 1999, J BACTERIOL, V181, P7221, DOI 10.1128/JB.181.23.7221-7227.1999; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kleywegt GJ, 1994, 1 MAP FINAL MODEL, P59; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lata R, 2000, CELL, V100, P253, DOI 10.1016/S0092-8674(00)81563-9; LIDDINGTON RC, 1991, NATURE, V354, P278, DOI 10.1038/354278a0; LURA R, 1988, BIOCHEMISTRY-US, V27, P7671, DOI 10.1021/bi00420a015; MCKENNA R, 1992, NATURE, V355, P137, DOI 10.1038/355137a0; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; POPA MP, 1991, J VIROL, V65, P3227, DOI 10.1128/JVI.65.6.3227-3237.1991; Sauvage, 1999, MOL CATENANES ROTAXA; Seeman NC, 1998, ANNU REV BIOPH BIOM, V27, P225, DOI 10.1146/annurev.biophys.27.1.225; STEVEN AC, 1992, J MOL BIOL, V228, P870, DOI 10.1016/0022-2836(92)90871-G; STEVEN AC, 1983, VIROLOGY, V124, P109, DOI 10.1016/0042-6822(83)90294-5; SUNDIN O, 1980, CELL, V21, P103, DOI 10.1016/0092-8674(80)90118-X; Tao YZ, 1998, CELL, V95, P431, DOI 10.1016/S0092-8674(00)81773-0; ThumanCommike PA, 1996, J MOL BIOL, V260, P85, DOI 10.1006/jmbi.1996.0383; Trus BL, 1996, J MOL BIOL, V263, P447, DOI 10.1016/S0022-2836(96)80018-0; VALEGARD K, 1990, NATURE, V345, P36, DOI 10.1038/345036a0; WHITE JH, 1984, P NATL ACAD SCI-BIOL, V81, P3322, DOI 10.1073/pnas.81.11.3322; Wikoff WR, 1998, VIROLOGY, V243, P113, DOI 10.1006/viro.1998.9040; Wikoff WR, 1999, ACTA CRYSTALLOGR D, V55, P763, DOI 10.1107/S0907444998017661; Wikoff WR, 2000, ACTA CRYSTALLOGR D, V56, P890, DOI 10.1107/S0907444900005941; WIKOFF WR, UNPUB; WILLIAMS RC, 1974, J MOL BIOL, V88, P547, DOI 10.1016/0022-2836(74)90501-4; XIE ZH, 1995, J MOL BIOL, V253, P74, DOI 10.1006/jmbi.1995.0537; Yang F, 2000, NAT STRUCT BIOL, V7, P230; YEE VC, 1994, P NATL ACAD SCI USA, V91, P7296, DOI 10.1073/pnas.91.15.7296	42	536	546	0	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2000	289	5487					2129	2133		10.1126/science.289.5487.2129	http://dx.doi.org/10.1126/science.289.5487.2129			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11000116				2022-12-24	WOS:000089430900046
J	Ellenberg, SS; Temple, R				Ellenberg, SS; Temple, R			Placebo-controlled trials and active-control trials in the evaluation of new treatments - Part 2: Practical issues and specific cases	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MEDICATION-FREE RESEARCH; METASTATIC COLORECTAL-CANCER; ACUTE ISCHEMIC STROKE; CLINICAL RESEARCH; PERINATAL TRANSMISSION; FLUOROURACIL FAILURE; DEVELOPING-COUNTRIES; RANDOMIZED TRIAL; ETHICAL DILEMMAS	Placebo controls are commonly used in clinical trials of investigational treatments because they have important advantages. In recent years, some have criticized the use of placebo-controlled trials when effective alternative therapy exists, regardless of the expected effect of the therapy. In part 1 of this paper, ethical arguments are addressed and the interpretive problems inherent in the use of active-control equivalence trials to establish efficacy of a new treatment are clarified. However, uncertainties may complicate decisions about appropriate use of placebo controls in some situations. Part 2 discusses more fully the ethical considerations for using placebo controls in particular medical settings. The value and relevance of placebo-controlled trials of new agents in situations in which proven effective therapy is available are also explored.	US FDA, Ctr Biol Evaluat & Res, Rockville, MD 20852 USA; US FDA, Ctr Drug Evaluat & Res, Rockville, MD 20852 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Ellenberg, SS (corresponding author), US FDA, Ctr Biol Evaluat & Res, 1401 Rockville Pike, Rockville, MD 20852 USA.							Angell M, 1997, NEW ENGL J MED, V337, P847, DOI 10.1056/NEJM199709183371209; [Anonymous], 1989, NEW ENGL J MED, V321, P406; Appelbaum Paul S, 1996, IRB, V18, P1, DOI 10.2307/3563910; Baldessarini RJ, 1999, J CLIN PSYCHIAT, V60, P117; Bath P, 1998, LANCET, V352, P1238, DOI 10.1016/S0140-6736(98)00039-7; BEASLEY CM, 1991, BMJ-BRIT MED J, V303, P685, DOI 10.1136/bmj.303.6804.685; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Brody BA, 1997, CONTROL CLIN TRIALS, V18, P602, DOI 10.1016/S0197-2456(97)00006-8; Carpenter WT, 1997, ARCH GEN PSYCHIAT, V54, P401; CHRISTAKIS NA, 1991, IRB, V31, P6; Cunningham D, 1998, LANCET, V352, P1413, DOI 10.1016/S0140-6736(98)02309-5; Detre T, 1996, PSYCHOPHARMACOL BULL, V32, P15; Fins JJ, 1997, ARCH GEN PSYCHIAT, V54, P415; FISCHL MA, 1990, ANN INTERN MED, V112, P727, DOI 10.7326/0003-4819-112-10-727; Friend WC, 1996, J PSYCHIATR NEUROSCI, V21, P354; Furlan AJ, 1999, STROKE, V30, P234; Greco D, 1996, NEW ENGL J MED, V334, P341, DOI 10.1056/NEJM199602083340601; Gustafsson L, 1996, NEW ENGL J MED, V334, P349, DOI 10.1056/NEJM199602083340602; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; Halsey NA, 1997, BRIT MED J, V315, P965, DOI 10.1136/bmj.315.7114.965; Henn FA, 1997, ARCH GEN PSYCHIAT, V54, P412; Karim SSA, 1998, AM J PUBLIC HEALTH, V88, P564, DOI 10.2105/AJPH.88.4.564; Khan A, 2000, ARCH GEN PSYCHIAT, V57, P311, DOI 10.1001/archpsyc.57.4.311; LEBER PD, 1989, EPILEPSIA, V30, pS57, DOI 10.1111/j.1528-1157.1989.tb05816.x; Levine RJ, 1999, NEW ENGL J MED, V341, P531, DOI 10.1056/NEJM199908123410713; Lieberman JA, 1996, PSYCHOPHARMACOL BULL, V32, P19; Lurie P, 1997, NEW ENGL J MED, V337, P853, DOI 10.1056/NEJM199709183371212; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; *MRC, 1994, LANCET, V343, P871; National Bioethics Advisory Commission, 1998, RES INV PERS MENT DI, V1; PEREZSTABLE EJ, 1995, J GEN INTERN MED, V10, P419, DOI 10.1007/BF02599912; Perry G, 1997, NEW ENGL J MED, V336, P525; ROTHMAN KJ, 1994, NEW ENGL J MED, V331, P394, DOI 10.1056/NEJM199408113310611; Rougier P, 1998, LANCET, V352, P1407, DOI 10.1016/S0140-6736(98)03085-2; Sherman DG, 1999, STROKE, V30, P234; Stein CM, 1999, LANCET, V353, P400, DOI 10.1016/S0140-6736(98)01373-7; Temple R, 2000, ANN INTERN MED, V133, P455, DOI 10.7326/0003-4819-133-6-200009190-00014; United States Food and Drug Administration, 1999, GUID IND CLIN DEV PR; *US DEP HHS, 1993, AHCPR PUBL US DEP HH, V2; *US FDA, 1999, GUID IND FDA APPR NE; Varmus H, 1997, NEW ENGL J MED, V337, P1003, DOI 10.1056/NEJM199710023371411; VOLBERDING PA, 1990, NEW ENGL J MED, V322, P941, DOI 10.1056/NEJM199004053221401; Wilfert CM, 1999, LANCET, V353, P832, DOI 10.1016/S0140-6736(98)10414-2; 1998, P ROYAL COLL PHYS ED, V28, P367	44	246	248	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 19	2000	133	6					464	470		10.7326/0003-4819-133-6-200009190-00015	http://dx.doi.org/10.7326/0003-4819-133-6-200009190-00015			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	354KM	10975965				2022-12-24	WOS:000089329700009
J	Macfarlane, GJ; Hunt, IM; Silman, AJ				Macfarlane, GJ; Hunt, IM; Silman, AJ			Role of mechanical and psychosocial factors in the onset of forearm pain: prospective population based study	BRITISH MEDICAL JOURNAL			English	Article							REPETITIVE STRAIN INJURY; UPPER-LIMB; FIBROMYALGIA; WORKERS	Objective To deter-mine the aetiology of forearm pain. In particular to determine the relative contribution of (a) psychological factors, features of somatisation, and health anxiety and behaviour, (b) work related mechanical factors, and (c) work related psychosocial factors in the onset of forearm pain. Design 2 year prospective population based cohort study, with retrospective assessment of exposures at work. Setting Altrincham, Greater Manchester. Participants 1953 individuals aged 18-65 years. Outcome measures Forearm pain of new onset. Results At follow up, 105 (8.3%) participants reported forearm pain of new onset lasting at least one day in the past month. Among these, 67% also reported shoulder pain, 65% back pain, and 45% chronic widespread pain. Increased risks of onset were associated with high levels of psychological distress (relative risk 2.4, 95% confidence interval 1.5 to 3.8), reporting at least two other somatic symptoms (1.7, 0.95 to 3.0), and high scores on the illness behaviour subscale of the illness attitude scales. The two work related mechanical exposures associated with the highest risk of forearm pain in the future were repetitive movements of the arm (4.1, 1.7 to 10) or wrists (3.4, 1.3 to 8.7), whereas the strongest work related psychosocial risk was dissatisfaction with support from colleagues or supervisors (4.7, 2.2 to 10). Conclusions Psychological distress, aspects of illness behaviour, and other somatic symptoms are important predictors of onset of forearm pain in addition to work related psychosocial and mechanical factors. Misleading terms such as "cumulative trauma disorder" or "repetitive strain injury," implying a single uniform aetiology, should be avoided.	Univ Manchester, Sch Med, Sch Epidemiol & Hlth Sci, Unit Chron Dis Epidemiol, Manchester M13 9PT, Lancs, England; Univ Manchester, Sch Epidemiol & Hlth Sci, Arthrit Res Campaign Epidemiol Unit, Manchester M13 9PL, Lancs, England	University of Manchester; University of Manchester	Macfarlane, GJ (corresponding author), Univ Manchester, Sch Med, Sch Epidemiol & Hlth Sci, Unit Chron Dis Epidemiol, Manchester M13 9PT, Lancs, England.		Macfarlane, Gary J/I-9521-2014; Hunt, Isabelle/AAM-4281-2021	Macfarlane, Gary J/0000-0003-2322-3314; Hunt, Isabelle/0000-0003-4875-8593				BONGERS PM, 1993, SCAND J WORK ENV HEA, V19, P297, DOI 10.5271/sjweh.1470; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; Greening J, 1998, INT ARCH OCC ENV HEA, V71, P29, DOI 10.1007/s004200050246; Harrington JM, 1998, OCCUP ENVIRON MED, V55, P264, DOI 10.1136/oem.55.4.264; HELLIWELL P, 1999, CLIN RHEUMATOLOGY RE, P311; Hunt IM, 1999, RHEUMATOLOGY, V38, P275, DOI 10.1093/rheumatology/38.3.275; Macfarlane GJ, 1999, BEST PRACT RES CL RH, V13, P403, DOI 10.1053/berh.1999.0029; OTHMER E, 1985, AM J PSYCHIAT, V142, P1146; Papageorgiou AC, 1997, SPINE, V22, P1137, DOI 10.1097/00007632-199705150-00014; Pope DP, 1997, OCCUP ENVIRON MED, V54, P316, DOI 10.1136/oem.54.5.316; Pritchard MH, 1999, RHEUMATOLOGY, V38, P636, DOI 10.1093/rheumatology/38.7.636; PUNNETT L, 1985, SCAND J WORK ENV HEA, V11, P417, DOI 10.5271/sjweh.2205; RITCHIE J, 1981, ACCESS PRIMARY HLTH; Sharma SD, 1997, BRIT MED J, V314, P118, DOI 10.1136/bmj.314.7074.118; Speckens AEM, 1996, J PSYCHOSOM RES, V40, P95, DOI 10.1016/0022-3999(95)00561-7; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203	16	145	149	0	11	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	SEP 16	2000	321	7262					676	679		10.1136/bmj.321.7262.676	http://dx.doi.org/10.1136/bmj.321.7262.676			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356LE	10987773	Green Published, Bronze			2022-12-24	WOS:000089444100029
J	Bond, CT; Sprengel, R; Bissonnette, JM; Kaufmann, WA; Pribnow, D; Neelands, T; Storck, T; Baetscher, M; Jerecic, J; Maylie, J; Knaus, HG; Seeburg, PH; Adelman, JP				Bond, CT; Sprengel, R; Bissonnette, JM; Kaufmann, WA; Pribnow, D; Neelands, T; Storck, T; Baetscher, M; Jerecic, J; Maylie, J; Knaus, HG; Seeburg, PH; Adelman, JP			Respiration and parturition affected by conditional overexpression of the Ca2+-activated K+ channel subunit, SK3	SCIENCE			English	Article							ACTIVATED POTASSIUM CHANNELS; SMALL-CONDUCTANCE; MYOTONIC-DYSTROPHY; SKELETAL-MUSCLE; GENE-EXPRESSION; EPILEPSY; MUTATION; DISEASE; BRAIN; RAT	In:excitable cells, small-conductance Ca2+-activated potassium channels (SK channels) are responsible for the slow after-hyperpolarization that often follows an action potential. Three SK channel subunits have been molecularly characterized. The SK3 gene was targeted by homologous recombination for the insertion of a gene switch that permitted experimental regulation of SK3 expression while retaining normal SK3 promoter function. An absence of SK3 did not-present overt phenotypic consequences. However, SK3 overexpression induced abnormal respiratory responses to hypoxia and compromised parturition. Both conditions were corrected by silencing the gene. The results implicate SK3 channels as potential therapeutic targets for disorders such as sleep apnea Or sudden infant death syndrome and for regulating uterine contractions during labor.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; Univ Innsbruck, Inst Biochem Pharmacol, A-6020 Innsbruck, Austria; Max Planck Inst Med Res, Dept Mol Neurosci, D-69120 Heidelberg, Germany	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of Innsbruck; Max Planck Society	Adelman, JP (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA.	adelman@ohsu.edu		Kaufmann, Walter Anton/0000-0001-9735-5315				ADAMS BA, 1990, NATURE, V346, P569, DOI 10.1038/346569a0; Adelman JP, 1995, NEURON, V15, P1449, DOI 10.1016/0896-6273(95)90022-5; BEHRENS MI, 1994, MUSCLE NERVE, V17, P1264, DOI 10.1002/mus.880171104; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; BLATZ AL, 1986, NATURE, V323, P718, DOI 10.1038/323718a0; BLATZ AL, 1987, TRENDS NEUROSCI, V10, P463, DOI 10.1016/0166-2236(87)90101-9; BOND CT, UNPUB; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; Chandy KG, 1998, MOL PSYCHIATR, V3, P32, DOI 10.1038/sj.mp.4000353; CHEN EY, 1989, GENOMICS, V4, P479, DOI 10.1016/0888-7543(89)90271-1; Dufour P, 1997, EUR J OBSTET GYN R B, V72, P159, DOI 10.1016/S0301-2115(96)02690-5; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; Gozal D, 1997, AM J RESP CRIT CARE, V155, P1755, DOI 10.1164/ajrccm.155.5.9154888; Jerecic J, 1999, ANN NY ACAD SCI, V868, P27, DOI 10.1111/j.1749-6632.1999.tb11271.x; Kaufmann WA, 1998, EUR J NEUROSCI, V10, P1084, DOI 10.1046/j.1460-9568.1998.00121.x; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Mortola JP, 1996, TISSUE OXYGEN DEPRIV, P433; Nishimori K, 1996, P NATL ACAD SCI USA, V93, P11699, DOI 10.1073/pnas.93.21.11699; Pribnow D, 1999, MUSCLE NERVE, V22, P742, DOI 10.1002/(SICI)1097-4598(199906)22:6<742::AID-MUS11>3.0.CO;2-1; PRIBNOW D, 1999, CURR RES ION CHANNEL, V3, P221; Ramirez JM, 1996, CURR OPIN NEUROBIOL, V6, P817, DOI 10.1016/S0959-4388(96)80033-X; RENAUD JF, 1986, NATURE, V319, P678, DOI 10.1038/319678a0; Rudnik-Schoneborn S, 1998, AM J MED GENET, V80, P314, DOI 10.1002/(SICI)1096-8628(19981204)80:4<314::AID-AJMG3>3.0.CO;2-I; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; Stocker R, 1999, GLOBAL CHANGE BIOL, V5, P95, DOI 10.1046/j.1365-2486.1998.00198.x; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Zuberi SM, 1999, BRAIN, V122, P817, DOI 10.1093/brain/122.5.817	28	134	138	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 15	2000	289	5486					1942	1946		10.1126/science.289.5486.1942	http://dx.doi.org/10.1126/science.289.5486.1942			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354XD	10988076				2022-12-24	WOS:000089355800048
J	Kameyama, K; Kishi, Y; Yoshimura, M; Kanzawa, N; Sameshima, M; Tsuchiya, T				Kameyama, K; Kishi, Y; Yoshimura, M; Kanzawa, N; Sameshima, M; Tsuchiya, T			Tyrosine phosphorylation in plant bending - Puckering in a ticklish plant is controlled by dephosphorylation of its actin.	NATURE			English	Article									Sophia Univ, Fac Sci & Technol, Dept Chem, Chiyoda Ku, Tokyo 1028554, Japan; Tokyo Metropolitan Org Med Res, Tokyo Metropolitan Inst Med Sci, Dept Cell Biol, Bunkyo Ku, Tokyo 1710021, Japan	Sophia University; Tokyo Metropolitan Institute of Medical Science	Kameyama, K (corresponding author), Sophia Univ, Fac Sci & Technol, Dept Chem, Chiyoda Ku, 7-1 Kioicho, Tokyo 1028554, Japan.			Kanzawa, Nobuyuki/0000-0002-8703-6828				Barizza E, 1999, FEBS LETT, V447, P191, DOI 10.1016/S0014-5793(99)00272-0; BOYLE W J, 1992, Current Opinion in Oncology, V4, P156, DOI 10.1097/00001622-199202000-00021; DATTA M, 1957, NATURE, V179, P253, DOI 10.1038/179253a0; Eun SO, 1997, PLANT PHYSIOL, V115, P1491, DOI 10.1104/pp.115.4.1491; FLEURATLESSARD P, 1988, J EXP BOT, V39, P209, DOI 10.1093/jxb/39.2.209; HOWARD PK, 1993, SCIENCE, V259, P241, DOI 10.1126/science.7678470; Kishi Y, 1998, J CELL SCI, V111, P2923; SUN H, 1994, TRENDS BIOCHEM SCI, V19, P480, DOI 10.1016/0968-0004(94)90134-1; TAMIYA T, 1988, J BIOCHEM-TOKYO, V104, P5, DOI 10.1093/oxfordjournals.jbchem.a122421; TORIYAMA H, 1971, CYTOLOGIA, V36, P359, DOI 10.1508/cytologia.36.359	10	100	107	2	24	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 7	2000	407	6800					37	37		10.1038/35024149	http://dx.doi.org/10.1038/35024149			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	350WE	10993062				2022-12-24	WOS:000089124000030
J	Franklin, CE; Axelsson, M				Franklin, CE; Axelsson, M			An actively controlled heart valve	NATURE			English	Article							ALLIGATOR HEART; DYNAMICS		Univ Queensland, Dept Zool & Entomol, Brisbane, Qld 4072, Australia; Univ Gothenburg, Dept Zoophysiol, S-40530 Gothenburg, Sweden	University of Queensland; University of Gothenburg	Franklin, CE (corresponding author), Univ Queensland, Dept Zool & Entomol, Brisbane, Qld 4072, Australia.	cfranklin@zen.uq.edu.au	Franklin, Craig/G-7343-2012; Axelsson, Michael/D-1412-2009	Franklin, Craig/0000-0003-1315-3797; Axelsson, Michael/0000-0002-7839-3233				AXELSSON M, 1989, AM J PHYSIOL, V256, pR875, DOI 10.1152/ajpregu.1989.256.4.R875; Axelsson M, 1996, J EXP BIOL, V199, P359; FRANKLIN CE, 1994, J EXP BIOL, V186, P269; GREENFIELD LAZAR J., 1961, JOUR SURG RES, V1, P97, DOI 10.1016/S0022-4804(61)80003-6; GRIGG GC, 1987, J COMP PHYSIOL B, V157, P381, DOI 10.1007/BF00693365; JONES DR, 1993, J EXP BIOL, V176, P247; MALVIN GM, 1995, AM J PHYSIOL-REG I, V269, pR1133, DOI 10.1152/ajpregu.1995.269.5.R1133; SHELTON G, 1991, J EXP BIOL, V158, P539; VANMIEROP LHS, 1985, CARDIOVASCULAR SHUNT; WEBB GJW, 1979, J MORPHOL, V161, P221, DOI 10.1002/jmor.1051610209; WHITE FN, 1969, COPEIA, P567; WHITE FN, 1968, AM ZOOL, V8, P211	12	30	30	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2000	406	6798					847	848		10.1038/35022652	http://dx.doi.org/10.1038/35022652			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347AG	10972278				2022-12-24	WOS:000088903600031
J	Taylor, WR				Taylor, WR			A deeply knotted protein structure and how it might fold	NATURE			English	Article								The search for knots in protein has uncovered little that would cause Alexander the Great to reach for his sword. Excluding knots formed by post-translational crosslinking, the few proteins considered to be knotted form simple trefoil knots with one end of the chain extending through a loop by only a few residues(1,2), ten in the 'best' example(3). A knot in an open chain (as distinct from a closed circle) is not rigorously defined and many weak protein knots disappear if the structure is viewed from a different angle. Here I describe a computer algorithm to detect knots in open chains that is not sensitive to viewpoint and that can define the region of the chain giving rise to the knot. It characterizes knots in proteins by the number of residues that must be removed from each end to abolish the knot. I applied this algorithm to the protein structure database and discovered a deep, figure-of-eight knot in the plant protein acetohydroxy acid isomeroreductase(4). I propose a protein folding pathway that may explain how such a knot is formed.	Natl Inst Med Res, Div Math Biol, London NW7 1AA, England	MRC National Institute for Medical Research	Taylor, WR (corresponding author), Natl Inst Med Res, Div Math Biol, Mill Hill, London NW7 1AA, England.							Adams C.C, 1994, KNOT BOOK ELEMENTARY; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; Biou V, 1997, EMBO J, V16, P3405, DOI 10.1093/emboj/16.12.3405; HERING J, 1995, CURR OPIN STRUC BIOL, V7, P416; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; MANSFIELD ML, 1994, NAT STRUCT BIOL, V1, P213, DOI 10.1038/nsb0494-213; MANSFIELD ML, 1997, NAT STRUCT BIOL, V4, P116; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Takusagawa F, 1996, J AM CHEM SOC, V118, P8945; Taylor WR, 1997, J MOL BIOL, V269, P902, DOI 10.1006/jmbi.1997.1008; Taylor WR, 1999, PROTEIN SCI, V8, P654	11	376	380	1	39	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 24	2000	406	6798					916	919		10.1038/35022623	http://dx.doi.org/10.1038/35022623			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347AG	10972297				2022-12-24	WOS:000088903600051
J	Lennon, BW; Williams, CH; Ludwig, ML				Lennon, BW; Williams, CH; Ludwig, ML			Twists in catalysis: Alternating conformations of Escherichia coli thioredoxin reductase	SCIENCE			English	Article							GLUTATHIONE-REDUCTASE; MECHANISM; DISULFIDE; ROTATION; MOTIONS; FLAVIN	In thioredoxin reductase (TrxR) from Escherichia coli, cycles of reduction and reoxidation of the flavin adenine dinucleotide (FAD) cofactor depend on rate-limiting rearrangements of the FAD and NADPH (reduced form of nicotinamide adenine dinucleotide phosphate) domains. We describe the structure of the ftavin-reducing conformation of E. coli TrxR at a resolution of 3.0 angstroms. The orientation of the two domains permits reduction of FAD by NADPH and oxidation of the enzyme dithiol by the protein substrate, thioredoxin. The alternate conformation, described by Kuriyan and co-workers, permits internal transfer of reducing equivalents from reduced FAD to the active-site disulfide. Comparison of these structures demonstrates that switching between the two conformations involves a "ball-and-socket" motion in which the pyridine nucleotide-binding domain rotates by 67 degrees.	Univ Michigan, Div Biophys Res, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; Dept Vet Affairs Med Ctr, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ludwig, ML (corresponding author), Univ Michigan, Div Biophys Res, Ann Arbor, MI 48109 USA.	mlludwig@umich.edu			NIGMS NIH HHS [GM16429, GM18723, GM21444] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arscott LD, 1997, P NATL ACAD SCI USA, V94, P3621, DOI 10.1073/pnas.94.8.3621; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; DOESBURG HM, 1983, ACTA CRYSTALLOGR A, V39, P368, DOI 10.1107/S0108767383000811; EKLUND H, 1984, EMBO J, V3, P1443, DOI 10.1002/j.1460-2075.1984.tb01994.x; EKLUND H, 1991, PROTEINS, V11, P13, DOI 10.1002/prot.340110103; GERSTEIN M, 1993, J MOL BIOL, V234, P357, DOI 10.1006/jmbi.1993.1592; Gerstein M, 1998, NUCLEIC ACIDS RES, V26, P4280, DOI 10.1093/nar/26.18.4280; Gilberger TW, 1998, FEBS LETT, V425, P407, DOI 10.1016/S0014-5793(98)00270-1; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Herzberg O, 1996, P NATL ACAD SCI USA, V93, P2652, DOI 10.1073/pnas.93.7.2652; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lennon BW, 1997, BIOCHEMISTRY-US, V36, P9464, DOI 10.1021/bi970307j; LESK AM, 1988, NATURE, V335, P188, DOI 10.1038/335188a0; MARK DF, 1976, P NATL ACAD SCI USA, V73, P780, DOI 10.1073/pnas.73.3.780; Mulrooney SB, 1997, PROTEIN SCI, V6, P2188; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAI EF, 1983, J BIOL CHEM, V258, P1752; Schulz GE, 1991, CURR OPIN STRUC BIOL, V1, P883, DOI 10.1016/0959-440X(91)90082-5; THELANDER L, 1979, ANNU REV BIOCHEM, V48, P133, DOI 10.1146/annurev.bi.48.070179.001025; Tong L, 1997, METHOD ENZYMOL, V276, P594, DOI 10.1016/S0076-6879(97)76080-4; Veine DM, 1998, PROTEIN SCI, V7, P1441, DOI 10.1002/pro.5560070621; Veine DM, 1998, PROTEIN SCI, V7, P369; WAKSMAN G, 1994, J MOL BIOL, V236, P800, DOI 10.1006/jmbi.1994.1190; Wang PF, 1996, BIOCHEMISTRY-US, V35, P4812, DOI 10.1021/bi9526793; WILLIAMS CH, 1995, FASEB J, V9, P1267, DOI 10.1096/fasebj.9.13.7557016; WILLIAMS CH, 1992, CHEM BIOCH FLAVOENZY, V3, pCH5	28	192	197	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2000	289	5482					1190	1194		10.1126/science.289.5482.1190	http://dx.doi.org/10.1126/science.289.5482.1190			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346JE	10947986				2022-12-24	WOS:000088866600042
J	Bingley, PJ; Douek, IF; Rogers, CA; Gale, EAM				Bingley, PJ; Douek, IF; Rogers, CA; Gale, EAM		BOX Barts Oxford Study Grp	Influence of maternal age at delivery and birth order on risk of type 1 diabetes in childhood: prospective population based family study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FINNISH CHILDREN; IDDM; MELLITUS; ONSET; YOUNGER; ASTHMA	Objectives To examine the influence of parental age at delivery; and birth order on subsequent risk of childhood diabetes. Design Prospective population based family study Setting Area formerly administered by the Oxford Regional Health Authority. Participants 1375 families in which one child or more had diabetes. Of 3221 offspring, 1431 had diabetes (median age at diagnosis 10.5 years, range 0.5-28.5) and 1790 remained non-diabetic at a median age of 16.1 years. Main outcome measures Disease free survival and hazard ratios for the development of type 1 diabetes in all offspring, assessed by Cox proportional hazard regression. Results Maternal age at delivery was strongly related to risk of type 1 diabetes in the offspring, risk increased by 25% (95% confidence interval 17% to 34%) for each five year band of maternal age, so that maternal age at delivery of 45 years or more was associated with a relative risk of 3.11 (2.07 to 4.66) compared with a maternal age of less than 20 years. Paternal age was also associated with a 9% (3% to 16%) increase for each five year increase in paternal age. The relative risk of diabetes, adjusted for parental age at delivery and sex of offspring, decreased with increasing birth order; the overall effect was a 15% risk reduction (10% to 21%) per child born Conclusions A strong association was found between increasing maternal age at delivery and risk of diabetes in the child. Risk was highest in firstborn children and decreased progressively with higher birth order. The fetal environment seems to have a strong influence on risk of trpe I diabetes in the child. The increase in maternal age at delivery in the United Kingdom over the past two decades could partly account for the increase in incidence of childhood diabetes over this period.	Univ Bristol, Southmead Hosp, Div Med, Bristol BS10 5NB, Avon, England; Southmead Hosp, Res & Dev Support Unit, Southmead, England	Southmead Hospital; University of Bristol; Southmead Hospital	Gale, EAM (corresponding author), Univ Bristol, Southmead Hosp, Div Med, Bristol BS10 5NB, Avon, England.	edwin.gale@bristol.ac.uk						Bache I, 1999, DIABETES CARE, V22, P1063, DOI 10.2337/diacare.22.7.1063; BLOM L, 1989, DIABETOLOGIA, V32, P7; COLLETT D, 1994, MODELLING SURVIVAL D, P54; Dahlquist G, 1996, BRIT MED J, V313, P1174, DOI 10.1136/bmj.313.7066.1174; DAHLQUIST GG, 1995, DIABETES, V44, P408, DOI 10.2337/diabetes.44.4.408; Douek IF, 1999, LANCET, V353, P1850, DOI 10.1016/S0140-6736(99)00988-5; FLOOD TM, 1982, DIABETES CARE, V5, P571, DOI 10.2337/diacare.5.6.571; Gardner SG, 1997, BRIT MED J, V315, P713, DOI 10.1136/bmj.315.7110.713; GINSBERGFELLNER F, 1985, REV INFECT DIS, V7, pS170; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; HYOTY H, 1995, DIABETES, V44, P652, DOI 10.2337/diabetes.44.6.652; Karvonen M, 1999, DIABETES CARE, V22, P1066, DOI 10.2337/diacare.22.7.1066; KHAN N, 1994, DIABETES CARE, V17, P653, DOI 10.2337/diacare.17.7.653; Lewis S, 1996, THORAX, V51, P670, DOI 10.1136/thx.51.7.670; MAYER EJ, 1988, DIABETES, V37, P1625, DOI 10.2337/diabetes.37.12.1625; METCALFE MA, 1992, ARCH DIS CHILD, V67, P731, DOI 10.1136/adc.67.6.731; *ORG EC COOP DEV, 1996, BEYOND 2000 NEW SOC; PATTERSON CC, 1994, DIABETES CARE, V17, P376, DOI 10.2337/diacare.17.5.376; SCHWARTZ J, 1990, AM REV RESPIR DIS, V142, P555, DOI 10.1164/ajrccm/142.3.555; Svanes C, 1998, EUR RESPIR J, V12, P1366, DOI 10.1183/09031936.98.12061366; Tuomilehto J, 1999, DIABETOLOGIA, V42, P655, DOI 10.1007/s001250051212; WAGENER DK, 1983, DIABETOLOGIA, V25, P82; WRYOBEK AJ, 1996, EXP MOL MUTAGEN, V28, P254; Ziegler AG, 1999, DIABETES, V48, P460, DOI 10.2337/diabetes.48.3.460	24	100	101	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2000	321	7258					420	424		10.1136/bmj.321.7258.420	http://dx.doi.org/10.1136/bmj.321.7258.420			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344QC	10938050	Green Published, Bronze			2022-12-24	WOS:000088769500021
J	Henney, JE				Henney, JE			Surgical sealant for lung cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item											Henney, JE (corresponding author), HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	2	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2000	284	6					685	685		10.1001/jama.284.6.685	http://dx.doi.org/10.1001/jama.284.6.685			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341JM	10950660				2022-12-24	WOS:000088587300004
J	Higenbottam, T; Siddons, T; Demoncheaux, E				Higenbottam, T; Siddons, T; Demoncheaux, E			A therapeutic role for chronic inhaled nitric oxide?	LANCET			English	Editorial Material							PRIMARY PULMONARY-HYPERTENSION; OXYGEN-THERAPY; DISEASE; PROSTACYCLIN; DELIVERY; GAS		Univ Sheffield, Sch Med, CSUHT, Div Clin Sci, Sheffield S10 2RX, S Yorkshire, England	University of Sheffield	Higenbottam, T (corresponding author), Univ Sheffield, Sch Med, CSUHT, Div Clin Sci, Sheffield S10 2RX, S Yorkshire, England.							Ashutosh K, 2000, THORAX, V55, P109, DOI 10.1136/thorax.55.2.109; Barbera JA, 1996, LANCET, V347, P436, DOI 10.1016/S0140-6736(96)90011-2; Barst RJ, 1997, HEART, V77, P299, DOI 10.1136/hrt.77.4.299; BISHOP JM, 1984, B EUR PHYSIOPATH RES, V20, P495; Channick RN, 1996, CHEST, V109, P1545, DOI 10.1378/chest.109.6.1545; Clark RH, 2000, NEW ENGL J MED, V342, P469, DOI 10.1056/NEJM200002173420704; Cremona G, 1997, J APPL PHYSIOL, V82, P23, DOI 10.1152/jappl.1997.82.1.23; Cuthbertson BH, 1997, INTENS CARE MED, V23, P1212, DOI 10.1007/s001340050488; Dellinger RP, 1999, INTENS CARE MED, V25, P881, DOI 10.1007/s001340050973; Demoncheaux EAG, 1996, J PHYSIOL-LONDON, V491P, pP101; FLENLEY DC, 1981, LANCET, V1, P681; Higenbottam T, 1999, LANCET, V353, P338, DOI 10.1016/S0140-6736(98)00330-4; Katayama Y, 1998, CIRCULATION, V98, P2429, DOI 10.1161/01.CIR.98.22.2429; Katayama Y, 1997, THORAX, V52, P120, DOI 10.1136/thx.52.2.120; McLaughlin VV, 1998, NEW ENGL J MED, V338, P273, DOI 10.1056/NEJM199801293380501; OSWALDMAMMOSSER M, 1995, CHEST, V107, P1193, DOI 10.1378/chest.107.5.1193; SIDDONS T, 2000, AM REV RESP CRIT CAR, V3, pA848; Sitbon O, 1998, EUR RESPIR J, V12, P265, DOI 10.1183/09031936.98.12020265; TIMMS RM, 1985, ANN INTERN MED, V102, P29, DOI 10.7326/0003-4819-102-1-29	19	10	11	1	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 5	2000	356	9228					446	447		10.1016/S0140-6736(00)02548-4	http://dx.doi.org/10.1016/S0140-6736(00)02548-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342QY	10981884				2022-12-24	WOS:000088657700005
J	Korswagen, HC; Herman, MA; Clevers, HC				Korswagen, HC; Herman, MA; Clevers, HC			Distinct beta-catenins mediate adhesion and signalling functions in C-elegans	NATURE			English	Article							HOX GENE-EXPRESSION; CAENORHABDITIS-ELEGANS; POLARITY SIGNALS; AXIS FORMATION; CELL-ADHESION; MAP KINASE; PROTEIN; HOMOLOG; EMBRYOS; DROSOPHILA	In flies and vertebrates, Armadillo/beta-catenin forms a complex with Tcf/Lef-1 transcription factors, serving as an essential coactivator to mediate Wnt signalling. It also associates with cadherins to mediate adhesion. In Caenorhabditis elegans, three putative beta-catenin homologues have been identified: WRM-1, BAR-1 and HMP-2. WRM-1 and the Tcf homologue POP-1 mediate Wnt signalling by a mechanism that has challenged current views of the Wnt pathway(1-3). Here we show that BAR-1 is the only beta-catenin homologue that interacts directly with POP-1. BAR-1 mediates Wnt signalling by forming a BAR-1/POP-1 bipartite transcription factor that activates expression of Wnt target genes such as the Hox gene mab-5. HMP-2 is the only beta-catenin homologue that interacts with the single cadherin of C. elegans, HMR-1. We conclude that a canonical Wnt pathway exists in C. elegans. Furthermore, our analysis shows that the functions of C. elegans beta-catenins in adhesion and in signalling are performed by separate proteins.	Univ Med Ctr Utrecht, Dept Immunol, NL-3584 CX Utrecht, Netherlands; Univ Med Ctr Utrecht, Ctr Biomed Genet, NL-3584 CX Utrecht, Netherlands; Kansas State Univ, Div Biol, Program Mol Cellular & Dev Biol, Manhattan, KS 66506 USA	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Kansas State University	Korswagen, HC (corresponding author), Univ Med Ctr Utrecht, Dept Immunol, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.		Korswagen, Hendrik/I-8782-2012	Herman, Michael/0000-0001-6796-1568				Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Christofori G, 1999, TRENDS BIOCHEM SCI, V24, P73, DOI 10.1016/S0968-0004(98)01343-7; Costa M, 1998, J CELL BIOL, V141, P297, DOI 10.1083/jcb.141.1.297; Eisenmann DM, 1998, DEVELOPMENT, V125, P3667; Fagotto F, 1996, J CELL BIOL, V132, P1105, DOI 10.1083/jcb.132.6.1105; Harris J, 1996, DEVELOPMENT, V122, P3117; KENYON C, 1986, CELL, V46, P477, DOI 10.1016/0092-8674(86)90668-9; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lin RL, 1998, CELL, V92, P229, DOI 10.1016/S0092-8674(00)80917-4; LIN RL, 1995, CELL, V83, P599, DOI 10.1016/0092-8674(95)90100-0; Maloof JN, 1999, DEVELOPMENT, V126, P37; Meneghini MD, 1999, NATURE, V399, P793, DOI 10.1038/21666; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Orsulic S, 1996, J CELL BIOL, V134, P1283, DOI 10.1083/jcb.134.5.1283; Riese J, 1997, CELL, V88, P777, DOI 10.1016/S0092-8674(00)81924-8; Rocheleau CE, 1999, CELL, V97, P717, DOI 10.1016/S0092-8674(00)80784-9; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Ruvkun G, 1998, SCIENCE, V282, P2033, DOI 10.1126/science.282.5396.2033; SALSER SJ, 1992, NATURE, V355, P255, DOI 10.1038/355255a0; Sawa H, 1996, GENE DEV, V10, P2189, DOI 10.1101/gad.10.17.2189; Shin TH, 1999, MOL CELL, V4, P275, DOI 10.1016/S1097-2765(00)80375-5; Simcha I, 1998, J CELL BIOL, V141, P1433, DOI 10.1083/jcb.141.6.1433; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; Thorpe CJ, 2000, TRENDS CELL BIOL, V10, P10, DOI 10.1016/S0962-8924(99)01672-4; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X	30	171	190	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2000	406	6795					527	532		10.1038/35020099	http://dx.doi.org/10.1038/35020099			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952315				2022-12-24	WOS:000088538000049
J	Hawkey, CJ				Hawkey, CJ			Outcomes studies of drug induced ulcer complications: do we need them and how should they be done?	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PLACEBO-CONTROLLED TRIAL; RHEUMATOID-ARTHRITIS; DOUBLE-BLIND; GASTRIC-ULCER; MISOPROSTOL; CYCLOOXYGENASE-2; OSTEOARTHRITIS; PREVENTION; INHIBITOR		Univ Nottingham Hosp, Queens Med Ctr, Div Gastroenterol, Nottingham NG7 2UH, England	University of Nottingham	Hawkey, CJ (corresponding author), Univ Nottingham Hosp, Queens Med Ctr, Div Gastroenterol, Nottingham NG7 2UH, England.	cj.hawkey@nottingham.ac.uk						[Anonymous], 1986, LANCET, V2, P57; Boyce EG, 1999, FORMULARY, V34, P405; Chan FKL, 1998, GASTROENTEROLOGY, V114, pA87, DOI 10.1016/S0016-5085(98)80353-3; ELLIOTT SL, 1994, SCAND J RHEUMATOL, V23, P171, DOI 10.3109/03009749409103056; Emery P, 1999, LANCET, V354, P2106, DOI 10.1016/S0140-6736(99)02332-6; GOLDSTEIN JL, 1999, GASTROENTEROLOGY, V116, pA17; GRAHAM DY, 1988, LANCET, V2, P1277; GRAHAM DY, 1993, ANN INTERN MED, V119, P257, DOI 10.7326/0003-4819-119-4-199308150-00001; *GROUP ISIS 4, 1994, LANCET, V343, P115; Hawkey C, 1998, BRIT J RHEUMATOL, V37, P937; Hawkey C, 2000, ARTHRITIS RHEUM-US, V43, P370, DOI 10.1002/1529-0131(200002)43:2<370::AID-ANR17>3.0.CO;2-D; Hawkey CJ, 1998, NEW ENGL J MED, V338, P727, DOI 10.1056/NEJM199803123381105; HAWKEY CJ, 1990, BMJ-BRIT MED J, V300, P278, DOI 10.1136/bmj.300.6720.278; Hawkey CJ, 1997, ALIMENT PHARM THERAP, V11, P293, DOI 10.1046/j.1365-2036.1997.150326000.x; Hawkey CJ, 1999, LANCET, V353, P307, DOI 10.1016/S0140-6736(98)12154-2; KOCH M, 1995, DIGEST DIS, V13, P62, DOI 10.1159/000171527; Laine L, 1999, GASTROENTEROLOGY, V117, P776, DOI 10.1016/S0016-5085(99)70334-3; Langman MJ, 1999, JAMA-J AM MED ASSOC, V282, P1929, DOI 10.1001/jama.282.20.1929; Lanza FL, 1999, ALIMENT PHARM THERAP, V13, P761, DOI 10.1046/j.1365-2036.1999.00529.x; Luong C, 1996, NAT STRUCT BIOL, V3, P927, DOI 10.1038/nsb1196-927; Raskin JB, 1996, AM J GASTROENTEROL, V91, P223; Scott LJ, 1999, DRUGS, V58, P499, DOI 10.2165/00003495-199958030-00016; SILVERSTEIN FE, 1995, ANN INTERN MED, V123, P241, DOI 10.7326/0003-4819-123-4-199508150-00001; Simon LS, 1998, ARTHRITIS RHEUM-US, V41, P1591, DOI 10.1002/1529-0131(199809)41:9<1591::AID-ART9>3.0.CO;2-J; Tramer MR, 2000, PAIN, V85, P169, DOI 10.1016/S0304-3959(99)00267-5; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563; WIGHT NJ, 1999, GUT, V45, P30; Yeomans ND, 1998, NEW ENGL J MED, V338, P719, DOI 10.1056/NEJM199803123381104	28	13	13	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2000	321	7256					291	293		10.1136/bmj.321.7256.291	http://dx.doi.org/10.1136/bmj.321.7256.291			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341ZA	10915140	Green Published			2022-12-24	WOS:000088619800034
J	Holliman, R				Holliman, R			Commentary: Congenital toxoplasmosis-further thought for food	BRITISH MEDICAL JOURNAL			English	Editorial Material									St Georges Hosp & Med Sch, London SW17 0QT, England	St Georges University London	Holliman, R (corresponding author), St Georges Hosp & Med Sch, London SW17 0QT, England.							CHATTERTON JM, 1992, HUMAN TOXOPLASMOSIS, P174; HOLLIMAN RE, 1995, J HOSP INFECT, V30, P179, DOI 10.1016/0195-6701(95)90018-7; *MULT WORK GROUP, 1992, PREN SCREEN TOX UK	3	2	2	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 15	2000	321	7254					147	147						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	336MG	10950535				2022-12-24	WOS:000088305700020
J	Kaul, A; Koster, M; Neuhaus, H; Braun, T				Kaul, A; Koster, M; Neuhaus, H; Braun, T			Myf-5 revisited: Loss of early myotome formation does not lead to a rib phenotype in homozygous Myf-5 mutant mice	CELL			English	Article							BHLH GENE MRF4; MYOGENIN; SPECIFICATION; INACTIVATION; SOMITE; DEATH; CELLS		Univ Halle Wittenberg, Inst Physiol Chem, D-06097 Halle, Germany	Martin Luther University Halle Wittenberg	Braun, T (corresponding author), Univ Halle Wittenberg, Inst Physiol Chem, Hollystr 1, D-06097 Halle, Germany.	thomas.braun@medizin.uni-halle.de	Braun, Thomas/B-2310-2008	Braun, Thomas/0000-0002-6165-4804				BRAUN T, 1992, CELL, V71, P369, DOI 10.1016/0092-8674(92)90507-9; BRAUN T, 1995, EMBO J, V14, P1176, DOI 10.1002/j.1460-2075.1995.tb07101.x; Grass S, 1996, DEVELOPMENT, V122, P141; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Henderson DJ, 1999, DEV BIOL, V209, P143, DOI 10.1006/dbio.1999.9215; Huang RJ, 2000, DEVELOPMENT, V127, P527; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; PATAPOUTIAN A, 1995, DEVELOPMENT, V121, P3347; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Tajbakhsh S, 1996, NATURE, V384, P266, DOI 10.1038/384266a0; VENUTI JM, 1995, J CELL BIOL, V128, P563, DOI 10.1083/jcb.128.4.563; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; ZHANG W, 1995, GENE DEV, V9, P1388, DOI 10.1101/gad.9.11.1388	13	75	79	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 7	2000	102	1					17	19		10.1016/S0092-8674(00)00006-4	http://dx.doi.org/10.1016/S0092-8674(00)00006-4			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	332UL	10929709	Bronze			2022-12-24	WOS:000088091700004
J	Eisenberg, MS				Eisenberg, MS			Is it time for over-the-counter defibrillators?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AUTOMATIC EXTERNAL DEFIBRILLATOR; HOSPITAL CARDIAC-ARREST; VENTRICULAR-FIBRILLATION; SURVIVAL; CPR; RESUSCITATION; PROFESSIONALS; INSTRUCTION; COMMUNITY		Univ Washington, Med Ctr, Dept Med, Div Emergency Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Eisenberg, MS (corresponding author), Univ Washington, Med Ctr, Dept Med, Div Emergency Med, Box 356123, Seattle, WA 98195 USA.							Atkins DL, 1998, PEDIATRICS, V101, P393, DOI 10.1542/peds.101.3.393; BANDINI F, 1997, G ITAL CARDIOL, V11, P1121; Becker L, 1999, Prehosp Emerg Care, V3, P353, DOI 10.1080/10903129908958968; Becker L, 1998, CIRCULATION, V97, P2106, DOI 10.1161/01.CIR.97.21.2106; BECKER LB, 1991, ANN EMERG MED, V20, P355, DOI 10.1016/S0196-0644(05)81654-3; Braslow A, 1997, RESUSCITATION, V34, P207, DOI 10.1016/S0300-9572(97)01096-4; CHADDA KD, 1987, AM J CARDIOL, V60, P732, DOI 10.1016/0002-9149(87)90396-1; CUMMINS RO, 1991, CIRCULATION, V83, P1832, DOI 10.1161/01.CIR.83.5.1832; EISENBERG M, 1995, ANN EMERG MED, V25, P198, DOI 10.1016/S0196-0644(95)70324-1; EISENBERG MS, 1989, AM J CARDIOL, V63, P443, DOI 10.1016/0002-9149(89)90316-0; EISENBERG MS, 1990, ANN EMERG MED, V19, P179, DOI 10.1016/S0196-0644(05)81805-0; EISENBERG MS, 1979, JAMA-J AM MED ASSOC, V241, P1905, DOI 10.1001/jama.241.18.1905; Gundry JW, 1999, CIRCULATION, V100, P1703, DOI 10.1161/01.CIR.100.16.1703; Hossack KF, 1982, J CARDIAC REHABIL, V2, P402; LARSEN MP, 1993, ANN EMERG MED, V22, P1652, DOI 10.1016/S0196-0644(05)81302-2; LITWIN PE, 1987, ANN EMERG MED, V16, P787, DOI 10.1016/S0196-0644(87)80576-0; LOMBARDI G, 1994, JAMA-J AM MED ASSOC, V271, P678; Stolberg S G, 2000, N Y Times Web, pA15; Todd KH, 1998, ANN EMERG MED, V31, P364, DOI 10.1016/S0196-0644(98)70348-8; WEAVER WD, 1990, PROGR CLIN PACING 19, P47; WEINSTEIN MC, 1995, VALUING HLTH CARE CO, P77, DOI DOI 10.1017/CBO9780511625817.005; 2000, EM TODAY        0614, P1	22	21	22	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2000	284	11					1435	1438		10.1001/jama.284.11.1435	http://dx.doi.org/10.1001/jama.284.11.1435			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	352WN	10989409				2022-12-24	WOS:000089242500041
J	Mankodi, A; Logigian, E; Callahan, L; McClain, C; White, R; Henderson, D; Krym, M; Thornton, CA				Mankodi, A; Logigian, E; Callahan, L; McClain, C; White, R; Henderson, D; Krym, M; Thornton, CA			Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat	SCIENCE			English	Article							TRINUCLEOTIDE REPEAT; BINDING PROTEIN; REDUCES EXPRESSION; MOLECULAR-BASIS; ACTIN GENE; CTG REPEAT; EXPANSION; MUSCLE; RNA; TRANSCRIPTS	Myotonic dystrophy (DM), the most common form of muscular dystrophy in adult humans, results from expansion of a CTC repeat in the 3' untranslated region of the DMPK gene. The mutant DMPK messenger RNA (mRNA) contains an expanded CUG repeat and is retained in the nucleus. We have expressed an untranslated CUG repeat in an unrelated mRNA in transgenic mice. Mice that expressed expanded CUG repeats developed myotonia and myopathy, whereas mice expressing a nonexpanded repeat did not, Thus, transcripts with expanded CUG repeats are sufficient to generate a DM phenotype. This result supports a role for RNA gain of function in disease pathogenesis.	Univ Rochester, Sch Med & Dent, Dept Neurol, Rochester, NY 14642 USA; Univ Rochester, Sch Med & Dent, Dept Neurobiol & Anat, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Thornton, CA (corresponding author), Univ Rochester, Sch Med & Dent, Dept Neurol, Box 673,601 Elmwood Ave, Rochester, NY 14642 USA.			Mankodi, Ami/0000-0002-5131-7767; WHITE, ROBERT J/0000-0002-4289-1046				ARNACK JD, 1999, HUM MOL GENET, V8, P1975; Berul CI, 1999, J CLIN INVEST, V103, pR1, DOI 10.1172/JCI5346; BRENNAN KJ, 1993, J BIOL CHEM, V268, P719; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; DUBOWITZ V, 1996, MUSCLE BIOPSY PRACTI; FU YH, 1993, SCIENCE, V260, P235, DOI 10.1126/science.8469976; HARDEMAN E, COMMUNICATION; Harper P.S., 1989, MYOTONIC DYSTROPHY; HUDECKI MS, 1990, ADV EXP MED BIOL, V280, P251; Jansen G, 1996, NAT GENET, V13, P316, DOI 10.1038/ng0796-316; Klesert TR, 1997, NAT GENET, V16, P402, DOI 10.1038/ng0897-402; Klesert TR, 2000, NAT GENET, V25, P105, DOI 10.1038/75490; Koob MD, 1999, NAT GENET, V21, P379, DOI 10.1038/7710; Michalowski S, 1999, NUCLEIC ACIDS RES, V27, P3534, DOI 10.1093/nar/27.17.3534; OTTEN AD, 1995, P NATL ACAD SCI USA, V92, P5465, DOI 10.1073/pnas.92.12.5465; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; Reddy S, 1996, NAT GENET, V13, P325, DOI 10.1038/ng0796-325; REININGHAUS J, 1988, MUSCLE NERVE, V11, P433, DOI 10.1002/mus.880110504; Sarkar PS, 2000, NAT GENET, V25, P110, DOI 10.1038/75500; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; TAYLOR A, 1988, GENOMICS, V3, P323, DOI 10.1016/0888-7543(88)90123-1; THORNTON CA, 1994, ANN NEUROL, V35, P104, DOI 10.1002/ana.410350116; Thornton CA, 1997, NAT GENET, V16, P407, DOI 10.1038/ng0897-407; Tian B, 2000, RNA, V6, P79, DOI 10.1017/S1355838200991544; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; TOHGI H, 1994, MUSCLE NERVE, V17, P1037, DOI 10.1002/mus.880170911; VASSILOPOULOS D, 1980, EUR NEUROL, V19, P237, DOI 10.1159/000115152; WANG JZ, 1995, HUM MOL GENET, V4, P599, DOI 10.1093/hmg/4.4.599; WILKIE AOM, 1994, J MED GENET, V31, P89, DOI 10.1136/jmg.31.2.89	30	517	543	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 8	2000	289	5485					1769	1772		10.1126/science.289.5485.1769	http://dx.doi.org/10.1126/science.289.5485.1769			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352BT	10976074				2022-12-24	WOS:000089195200052
J	van der Laan, LJW; Lockey, C; Griffeth, BC; Frasier, FS; Wilson, CA; Onions, DE; Hering, BJ; Long, ZF; Otto, E; Torbett, BE; Salomon, DR				van der Laan, LJW; Lockey, C; Griffeth, BC; Frasier, FS; Wilson, CA; Onions, DE; Hering, BJ; Long, ZF; Otto, E; Torbett, BE; Salomon, DR			Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice	NATURE			English	Article							HUMAN-CELLS; ENGRAFTMENT; PIGS	Animal donors such as pigs could provide an alternative source of organs for transplantation. However, the promise of xenotransplantation is offset by the possible public health risk of a cross-species infection(1,2). All pigs contain several copies of porcine endogenous retroviruses (PERV)(3,4), and at least three variants of PERV can infect human cell lines in vitro in co-culture, infectivity and pseudotyping experiments(3,5-7). Thus, if xenotransplantation of pig tissues results in PERV viral replication, there is a risk of spreading and adaptation of this retrovirus to the human host. C-type retroviruses related to PERV are associated with malignancies of haematopoietic lineage cells in their natural hosts(8). Here we show that pig pancreatic islets produce PERV and can infect human cells in culture. After transplantation into NOD/SCID (non-obese diabetic, severe combined immunodeficiency) mice, we detect ongoing viral expression and several tissue compartments become infected. This is the first evidence that PERV is transcriptionally active and infectious cross-species in vivo after transplantation of pig tissues. These results show that a concern for PERV infection risk associated with pig islet xenotransplantation in immunosuppressed human patients may be justified.	Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; Genet Therapy Inc, Gaithersburg, MD 20878 USA; US FDA, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA; Univ Glasgow, Dept Vet Pathol, Glasgow G61 1QH, Lanark, Scotland; Q One Biotech Ltd, Glasgow G20 OXA, Lanark, Scotland; Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA	Scripps Research Institute; Novartis; US Food & Drug Administration (FDA); University of Glasgow; University of Minnesota System; University of Minnesota Twin Cities	Salomon, DR (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Salomon, Daniel/E-9380-2012; van der Laan, Luc/M-5495-2019	van der Laan, Luc/0000-0002-0651-5334				Akiyoshi DE, 1998, J VIROL, V72, P4503, DOI 10.1128/JVI.72.5.4503-4507.1998; BEATTIE GM, 1994, TRANSPLANT P, V26, P3299; CHAPMAN LE, 1995, NEW ENGL J MED, V333, P1498, DOI 10.1056/NEJM199511303332211; Crisa L, 1999, BLOOD, V94, P3928, DOI 10.1182/blood.V94.11.3928.423k02_3928_3940; Heneine W, 1998, LANCET, V352, P1478; HESSELTON RM, 1995, J INFECT DIS, V172, P974, DOI 10.1093/infdis/172.4.974; LAMONT C, 1991, J VIROL, V65, P4619, DOI 10.1128/JVI.65.9.4619-4628.1991; LeTissier P, 1997, NATURE, V389, P681, DOI 10.1038/39489; LEVY JA, 1973, SCIENCE, V182, P1151, DOI 10.1126/science.182.4117.1151; Liu X, 1997, TRANSPL P, V29, P768, DOI 10.1016/S0041-1345(96)00476-9; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; Miyoshi H, 1999, SCIENCE, V283, P682, DOI 10.1126/science.283.5402.682; Paradis K, 1999, SCIENCE, V285, P1236, DOI 10.1126/science.285.5431.1236; Patience C, 1998, LANCET, V352, P699, DOI 10.1016/S0140-6736(98)04369-4; Patience C, 1997, NAT MED, V3, P282, DOI 10.1038/nm0397-282; Sandrin MS, 1999, CURR OPIN IMMUNOL, V11, P527, DOI 10.1016/S0952-7915(99)00011-4; Stoye JP, 1997, NATURE, V386, P126, DOI 10.1038/386126b0; Takeuchi Y, 1998, J VIROL, V72, P9986, DOI 10.1128/JVI.72.12.9986-9991.1998; TOTH SR, 1986, VET PATHOL, V23, P462, DOI 10.1177/030098588602300417; Weiss RA, 1998, NATURE, V391, P327, DOI 10.1038/34772; Wilson CA, 2000, J VIROL, V74, P49, DOI 10.1128/JVI.74.1.49-56.2000; Wilson CA, 1998, J VIROL, V72, P3082, DOI 10.1128/JVI.72.4.3082-3087.1998	22	292	304	0	16	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 7	2000	407	6800					90	94		10.1038/35024089	http://dx.doi.org/10.1038/35024089			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	350WE	10993079				2022-12-24	WOS:000089124000048
J	Repa, JJ; Turley, SD; Lobaccaro, JMA; Medina, J; Li, L; Lustig, K; Shan, B; Heyman, RA; Dietschy, JM; Mangelsdorf, DJ				Repa, JJ; Turley, SD; Lobaccaro, JMA; Medina, J; Li, L; Lustig, K; Shan, B; Heyman, RA; Dietschy, JM; Mangelsdorf, DJ			Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers	SCIENCE			English	Article							BINDING CASSETTE TRANSPORTER-1; BILE-ACID METABOLISM; TANGIER-DISEASE; NUCLEAR RECEPTOR; MICE; GENE; IDENTIFICATION; DEFICIENCY; MUTATIONS; MEMBRANE	Several nuclear hormone receptors involved in lipid metabolism form obligate heterodimers with retinoid X receptors (RXRs) and are activated by RXR agonists such as rexinoids. Animals treated with rexinoids exhibited marked changes in cholesterol balance, including inhibition of cholesterol absorption and repressed bile acid synthesis. Studies with receptor-selective agonists revealed that oxysterol receptors (LXRs) and the bile acid receptor (FXR) are the RXR heterodimeric partners that mediate these effects by regulating expression of the reverse cholesterol transporter, ABC1, and the rate-limiting enzyme of bile acid synthesis, CYP7A1, respectively. Thus, these RXR heterodimers serve as key regulators of cholesterol homeostasis by governing reverse cholesterol transport from peripheral tissues, bile acid synthesis in Liver, and cholesterol absorption in intestine.	Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Tularik, S San Francisco, CA 94080 USA; Ligand Pharmaceut Inc, San Diego, CA 92121 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Ligand Pharmaceuticals	Mangelsdorf, DJ (corresponding author), Univ Texas, SW Med Ctr, Howard Hughes Med Inst, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.		Lobaccaro, Jean-Marc A./U-1928-2019; Lobaccaro, Jean-Marc/Q-3926-2019; Eckhardt, Erik/G-1567-2010	Lobaccaro, Jean-Marc/0000-0001-9890-2392; Repa, Joyce/0000-0001-5740-1954	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL009610] Funding Source: NIH RePORTER; NHLBI NIH HHS [R37 HL 09610] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ATTIE AD, UNPUB; Auwerx J, 1999, CELL, V97, P161; Bodzioch M, 1999, NAT GENET, V22, P347, DOI 10.1038/11914; BOEHM MF, 1995, J MED CHEM, V38, P3146, DOI 10.1021/jm00016a018; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; Carter CP, 1997, J NUTR, V127, P1344, DOI 10.1093/jn/127.7.1344; CASTILLOOLIVARE.A, 2000, J BIOL CHEM, V275, P17793; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; COSTET P, IN PRESS J BIOL CHEM; Dawson PA, 1999, CURR OPIN LIPIDOL, V10, P315, DOI 10.1097/00041433-199908000-00005; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Gottardis MM, 1996, CANCER RES, V56, P5566; Homan R, 1997, CURR PHARM DESIGN, V3, P29; IKEDA I, 1988, J LIPID RES, V29, P1583; Ishibashi S, 1996, J BIOL CHEM, V271, P18017, DOI 10.1074/jbc.271.30.18017; Laffitte BA, 2000, J BIOL CHEM, V275, P10638, DOI 10.1074/jbc.275.14.10638; Langmann T, 1999, BIOCHEM BIOPH RES CO, V257, P29, DOI 10.1006/bbrc.1999.0406; LOBACARRO JMA, UNPUB; LU TT, IN PRESS MOL CELL; LUCIANI MF, 1994, GENOMICS, V21, P150, DOI 10.1006/geno.1994.1237; Luo Y, 2000, J CLIN INVEST, V105, P513, DOI 10.1172/JCI8573; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; McNeish J, 2000, P NATL ACAD SCI USA, V97, P4245, DOI 10.1073/pnas.97.8.4245; MIETTINEN TA, 1989, AM J CLIN NUTR, V49, P629, DOI 10.1093/ajcn/49.4.629; Mukherjee R, 1998, ARTERIOSCL THROM VAS, V18, P272, DOI 10.1161/01.ATV.18.2.272; Mukherjee R, 1997, NATURE, V386, P407, DOI 10.1038/386407a0; Orso E, 2000, NAT GENET, V24, P192, DOI 10.1038/72869; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Remaley AT, 1999, P NATL ACAD SCI USA, V96, P12685, DOI 10.1073/pnas.96.22.12685; Repa JJ, 1999, CURR OPIN BIOTECH, V10, P557, DOI 10.1016/S0958-1669(99)00031-2; REPA JJ, UNPUB; Russell DW, 1999, CELL, V97, P539, DOI 10.1016/S0092-8674(00)80763-1; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Santamarina-Fojo S, 2000, P NATL ACAD SCI USA, V97, P7987, DOI 10.1073/pnas.97.14.7987; SCHMITZ G, 1990, EUR HEART J, V11, P197, DOI 10.1093/eurheartj/11.suppl_E.197; Schwarz M, 1998, J LIPID RES, V39, P1833; Schwarz M, 1997, J BIOL CHEM, V272, P23995, DOI 10.1074/jbc.272.38.23995; Seol W, 1996, SCIENCE, V272, P1336, DOI 10.1126/science.272.5266.1336; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; SYLVEN C, 1970, SCAND J GASTROENTERO, V5, P57; THURNHOFER H, 1990, BIOCHEMISTRY-US, V29, P2142, DOI 10.1021/bi00460a026; Turley SD, 1999, EUR HEART J SUPPL, V1, pS29; van Heek M, 2000, BRIT J PHARMACOL, V129, P1748, DOI 10.1038/sj.bjp.0703235; Venkateswaran A, 2000, J BIOL CHEM, V275, P14700, DOI 10.1074/jbc.275.19.14700; Wang DQH, 1999, AM J PHYSIOL-GASTR L, V276, pG751, DOI 10.1152/ajpgi.1999.276.3.G751; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2	48	1100	1152	3	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 1	2000	289	5484					1524	1529		10.1126/science.289.5484.1524	http://dx.doi.org/10.1126/science.289.5484.1524			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349XW	10968783				2022-12-24	WOS:000089071700039
J	Amrani, A; Verdaguer, J; Serra, P; Tafuro, S; Tan, RS; Santamaria, P				Amrani, A; Verdaguer, J; Serra, P; Tafuro, S; Tan, RS; Santamaria, P			Progression of autoimmune diabetes driven by avidity maturation of a T-cell population	NATURE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; IMMUNE-RESPONSE; MICE; INSULITIS; COMPLEX; LIGANDS; TCR; AFFINITIES; MOLECULES; KINETICS	For unknown reasons, autoimmune diseases such as type 1 diabetes develop after prolonged periods of inflammation of mononuclear cells in target tissues 1. Here we show that progression of pancreatic islet inflammation to overt diabetes in nonobese diabetic (NOD) mice is driven by the 'avidity maturation' of a prevailing, pancreatic beta-cell-specirc T-lymphocyte population carrying the CD8 antigen. This T-lymphocyte population recognizes two related peptides (NRP and NRP-A7)(2) in the context of H-2K(d) class I molecules of the major histocompatibility complex (MHC). As pre-diabetic NOD mice age, their islet-associated CD8(+) T lymphocytes contain increasing numbers of NRP-A7-reactive cells, and these cells bind NRP-A7/H-2K(d) tetramers with increased specificity, increased avidity and longer half-lives. Repeated treatment of pre-diabetic NOD mice with soluble NRP-A7 peptide blunts the avidity maturation of the NRP-A7-reactive CD8(+) T-cell population by selectively deleting those clonotypes expressing T-cell receptors with the highest affinity and lowest dissociation rates for peptide-MHC binding. This inhibits the local production of T cells that are cytotoxic to beta cells, and halts the progression from severe insulitis to diabetes. We conclude that avidity maturation of pathogenic T-cell populations may be the key event in the progression of benign inflammation to overt disease in autoimmunity.	Univ Calgary, Hlth Sci Ctr, Dept Microbiol & Infect Dis, Fac Med, Calgary, AB T2N 4N1, Canada; John Radcliffe Hosp, Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 9DU, England; British Columbia Childrens Hosp, Vancouver, BC V6H 3V4, Canada; Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6H 3V4, Canada	University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Oxford; BC Childrens Hospital; University of British Columbia; University of British Columbia	Santamaria, P (corresponding author), Univ Calgary, Hlth Sci Ctr, Dept Microbiol & Infect Dis, Fac Med, 3330 Hosp Dr NW, Calgary, AB T2N 4N1, Canada.		Autonell, Joan Verdaguer/A-2059-2010; Santamaria, Pere/ABF-6823-2021	Autonell, Joan Verdaguer/0000-0003-1768-9310; Tan, Rusung/0000-0002-2204-2004				ABIRU N, 1999, CAN J DIABETES CARE, V23, P59; Alam SM, 1996, NATURE, V381, P616, DOI 10.1038/381616a0; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Anderson B, 1999, P NATL ACAD SCI USA, V96, P9311, DOI 10.1073/pnas.96.16.9311; Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; DiLorenzo TP, 1998, P NATL ACAD SCI USA, V95, P12538, DOI 10.1073/pnas.95.21.12538; KATZ J, 1993, EUR J IMMUNOL, V23, P3358, DOI 10.1002/eji.1830231244; KAUFMAN DL, 1993, NATURE, V366, P69, DOI 10.1038/366069a0; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; Lyons DS, 1996, IMMUNITY, V5, P53, DOI 10.1016/S1074-7613(00)80309-X; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; NAGATA M, 1994, J IMMUNOL, V152, P2042; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Reich Z, 1997, NATURE, V387, P617, DOI 10.1038/42500; SANTAMARIA P, 1995, J IMMUNOL, V154, P2494; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; SERREZE DV, 1994, DIABETES, V43, P505, DOI 10.2337/diabetes.43.3.505; TISCH R, 1993, NATURE, V366, P72, DOI 10.1038/366072a0; Verdaguer J, 1997, J EXP MED, V186, P1663, DOI 10.1084/jem.186.10.1663; Verdaguer J, 1996, J IMMUNOL, V157, P4726; Wegmann DR, 1996, CURR OPIN IMMUNOL, V8, P860, DOI 10.1016/S0952-7915(96)80016-1; WICKER LS, 1994, DIABETES, V43, P500, DOI 10.2337/diabetes.43.3.500; Wong FS, 1999, NAT MED, V5, P1026, DOI 10.1038/12465	24	285	296	0	17	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2000	406	6797					739	742		10.1038/35021081	http://dx.doi.org/10.1038/35021081			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963600				2022-12-24	WOS:000088767700047
J	Iwasato, T; Datwani, A; Wolf, AM; Nishiyama, H; Taguchi, Y; Tonegawa, S; Knopfel, T; Erzurumlu, RS; Itohara, S				Iwasato, T; Datwani, A; Wolf, AM; Nishiyama, H; Taguchi, Y; Tonegawa, S; Knopfel, T; Erzurumlu, RS; Itohara, S			Cortex-restricted disruption of NMDAR1 impairs neuronal patterns in the barrel cortex	NATURE			English	Article							RAT SOMATOSENSORY CORTEX; CEREBRAL-CORTEX; CRITICAL PERIOD; MOUSE; PLASTICITY; MICE; ORGANIZATION; CONNECTIONS; AFFERENTS; BLOCKADE	In the rodent primary somatosensory cortex, the configuration of whiskers and sinus hairs on the snout and of receptor-dense zones on the paws is topographically represented as discrete modules of layer IV granule cells (barrels) and thalamocortical afferent terminals(1,2). The role of neural activity, particularly activity mediated by NMDARs (N-methyl-D-aspartate receptors), in patterning of the somatosensory cortex has been a subject of debate(3-6). We have generated mice in which deletion of the NMDAR1 (NR1) gene is restricted to excitatory cortical neurons, and here we show that sensory periphery-related patterns develop normally in the brainstem and thalamic somatosensory relay stations of these mice. In the somatosensory cortex, thalamocortical afferents corresponding to large whiskers form patterns and display critical period plasticity, but their patterning is not as distinct as that seen in the cortex of normal mice. Other thalamocortical patterns corresponding to sinus hairs and digits are mostly absent. The cellular aggregates known as barrels and barrel boundaries do not develop even at sites where thalamocortical afferents cluster. Our findings indicate that cortical NMDARs are essential for the aggregation of layer IV cells into barrels and for development of the full complement of thalamocortical patterns.	RIKEN, Brain Sci Inst, Lab Behav Genet, Wako, Saitama 3510198, Japan; LSUHSC, Dept Anat & Cell Biol, New Orleans, LA 70112 USA; LSUHSC, Ctr Neurosci, New Orleans, LA 70112 USA; RIKEN, Brain Sci Inst, Lab Neuronal Circuit Dynam, Wako, Saitama 3510198, Japan; Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan; MIT, RIKEN MIT Neurosci Res Ctr, Howard Hughes Med Inst, Ctr Learning & Memory, Cambridge, MA 02139 USA	RIKEN; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; RIKEN; Kyoto University; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); RIKEN	Itohara, S (corresponding author), RIKEN, Brain Sci Inst, Lab Behav Genet, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	sitohara@brain.riken.go.jp	Knöpfel, Thomas/B-1128-2008; Itohara, Shigeyoshi/I-8769-2012	Knöpfel, Thomas/0000-0002-5718-0765; Itohara, Shigeyoshi/0000-0002-2410-9989; Wolf, Alexander/0000-0002-5755-8756	NINDS NIH HHS [R01 NS039050] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039050] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Cases O, 1996, NEURON, V16, P297, DOI 10.1016/S0896-6273(00)80048-3; CHIAIA NL, 1992, DEV BRAIN RES, V66, P244, DOI 10.1016/0165-3806(92)90086-C; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; Cramer Karina S., 1995, Current Opinion in Neurobiology, V5, P106, DOI 10.1016/0959-4388(95)80094-8; ERZURUMLU RS, 1990, DEV BRAIN RES, V56, P229; Feldmeyer D, 1999, J PHYSIOL-LONDON, V521, P169, DOI 10.1111/j.1469-7793.1999.00169.x; Fox K, 1996, P NATL ACAD SCI USA, V93, P5584, DOI 10.1073/pnas.93.11.5584; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Gulisano M, 1996, EUR J NEUROSCI, V8, P1037, DOI 10.1111/j.1460-9568.1996.tb01590.x; HARRIS RM, 1981, J COMP NEUROL, V196, P357, DOI 10.1002/cne.901960302; Iwasato T, 1997, NEURON, V19, P1201, DOI 10.1016/S0896-6273(00)80412-2; JHAVERI S, 1991, P NATL ACAD SCI USA, V88, P4489, DOI 10.1073/pnas.88.10.4489; Jhaveri S, 1992, DEV CENTRAL NERVOUS, P167; KATZ LC, 1988, J NEUROSCI, V8, P3160; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; Messersmith EK, 1997, MOL CELL NEUROSCI, V9, P347, DOI 10.1006/mcne.1997.0646; Molnar Z, 2000, RES PRO CEL, V30, P293; O'Leary D D, 1994, Curr Opin Neurobiol, V4, P535, DOI 10.1016/0959-4388(94)90054-X; OTTERSEN OP, 1984, J COMP NEUROL, V229, P374, DOI 10.1002/cne.902290308; Parnavelas JG, 2000, TRENDS NEUROSCI, V23, P126, DOI 10.1016/S0166-2236(00)01553-8; Rajan I, 1998, J NEUROSCI, V18, P7836; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; SCHLAGGAR BL, 1993, NATURE, V364, P623, DOI 10.1038/364623a0; Tanifuji M, 1996, BRAIN RES, V738, P83, DOI 10.1016/0006-8993(96)00767-6; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; WONGRILEY MTT, 1980, P NATL ACAD SCI-BIOL, V77, P2333, DOI 10.1073/pnas.77.4.2333; Woolsey T.A., 1990, P461; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Yoshida M, 1997, DEVELOPMENT, V124, P101	30	403	410	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2000	406	6797					726	731		10.1038/35021059	http://dx.doi.org/10.1038/35021059			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963597	Green Accepted			2022-12-24	WOS:000088767700044
J	Ruda, MA; Ling, QD; Hohmann, AG; Peng, YB; Tachibana, T				Ruda, MA; Ling, QD; Hohmann, AG; Peng, YB; Tachibana, T			Altered nociceptive neuronal circuits after neonatal peripheral inflammation	SCIENCE			English	Article							SCIATIC-NERVE AFFERENTS; PAIN RESPONSE; DORSAL HORN; ADULT-RAT; SENSITIVITY; TERMINALS; PRETERM; SECTION	Nociceptive neuronal circuits are formed during embryonic and postnatal times when painful stimuli are normally absent or Limited. Today, medical procedures for neonates with health risks can involve tissue injury and pain for which the Long-term effects are unknown. To investigate the impact of neonatal tissue injury and pain on development of nociceptive neuronal circuitry, we used an animal model of persistent hind paw peripheral inflammation, We found that, as adults, these animals exhibited spinal neuronal circuits with increased input and segmental changes in nociceptive primary afferent axons and altered responses to sensory stimulation.	Natl Inst Dent & Craniofacial Res, Cellular Neurosci Sect, Pain & Neurosensory Mechanisms Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Ruda, MA (corresponding author), Natl Inst Dent & Craniofacial Res, Cellular Neurosci Sect, Pain & Neurosensory Mechanisms Branch, NIH, Bethesda, MD 20892 USA.			Peng, Yuan B/0000-0002-3124-859X				ABBOTT FV, 1995, PAIN, V60, P91, DOI 10.1016/0304-3959(94)00095-V; ANAND KJS, 1993, PAIN NEONATES, P1; BUCK SH, 1986, PHARMACOL REV, V38, P179; COLEMAN JR, 1990, DEV SENSORY SYSTEMS; CONSTANTINOU J, 1994, NEUROREPORT, V5, P2281, DOI 10.1097/00001756-199411000-00019; CRAIG KD, 1993, PAIN, V52, P287, DOI 10.1016/0304-3959(93)90162-I; Doubell TP, 1997, J COMP NEUROL, V380, P95, DOI 10.1002/(SICI)1096-9861(19970331)380:1<95::AID-CNE7>3.0.CO;2-O; FITZGERALD M, 1995, BRIT J ANAESTH, V75, P177, DOI 10.1093/bja/75.2.177; FITZGERALD M, 1983, NEUROSCI LETT, V43, P149, DOI 10.1016/0304-3940(83)90179-9; GRUNAU RVE, 1994, PAIN, V58, P341, DOI 10.1016/0304-3959(94)90128-7; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; LAMOTTE CC, 1991, J COMP NEUROL, V311, P546, DOI 10.1002/cne.903110409; MESULAM MM, 1978, J HISTOCHEM CYTOCHEM, V26, P106, DOI 10.1177/26.2.24068; SHORTLAND P, 1994, EUR J NEUROSCI, V6, P75, DOI 10.1111/j.1460-9568.1994.tb00249.x; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Taddio A, 1997, LANCET, V349, P599, DOI 10.1016/S0140-6736(96)10316-0	16	282	297	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 28	2000	289	5479					628	630		10.1126/science.289.5479.628	http://dx.doi.org/10.1126/science.289.5479.628			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	338XD	10915627				2022-12-24	WOS:000088447800056
J	Dixon, MJ; Smilek, D; Cudahy, C; Merikle, PM				Dixon, MJ; Smilek, D; Cudahy, C; Merikle, PM			Five plus two equals yellow	NATURE			English	Article							DIGIT		Univ Waterloo, Dept Psychol, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Dixon, MJ (corresponding author), Univ Waterloo, Dept Psychol, Waterloo, ON N2L 3G1, Canada.							Bailey M. E. S., 1997, SYNAESTHESIA CLASSIC, P182; BARONCOHEN S, 1987, PERCEPTION, V16, P761, DOI 10.1068/p160761; Cytowic RE, 1993, MAN WHO TASTED SHAPE; Frith C.D., 1997, SYNAESTHESIA CLASSIC, P123; Mills CB, 1999, COGNITIVE NEUROPSYCH, V16, P181, DOI 10.1080/026432999380951; Odgaard EC, 1999, PERCEPTION, V28, P651, DOI 10.1068/p2910	6	190	190	0	31	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					365	365		10.1038/35019148	http://dx.doi.org/10.1038/35019148			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	337WC	10935623	Bronze			2022-12-24	WOS:000088383800030
J	Van Esch, H; Groenen, P; Nesbit, MA; Schuffenhauer, S; Lichtner, P; Vanderlinden, G; Harding, B; Beetz, R; Bilous, RW; Holdaway, I; Shaw, NJ; Fryns, JP; Van de Ven, WV; Thakker, RV; Devriendt, K				Van Esch, H; Groenen, P; Nesbit, MA; Schuffenhauer, S; Lichtner, P; Vanderlinden, G; Harding, B; Beetz, R; Bilous, RW; Holdaway, I; Shaw, NJ; Fryns, JP; Van de Ven, WV; Thakker, RV; Devriendt, K			GATA3 haplo-insufficiency causes human HDR syndrome	NATURE			English	Article							TRANSCRIPTION FACTOR GATA-3; EMBRYONIC EXPRESSION; DIGEORGE-SYNDROME; GENE; MUTATIONS; 10P; HYPOPARATHYROIDISM; DEAFNESS; REGION; SYSTEM	Terminal deletions of chromosome 10p result in a DiGeorge-like phenotype that includes hypoparathyroidism, heart defects, immune deficiency, deafness and renal malformations(1). Studies in patients with 10p deletions have defined two non-overlapping regions that contribute to this complex phenotype. These are the DiGeorge critical region II (refs 1, 2), which is located on 10p13-14, and the region for the hypoparathyroidism, sensorineural deafness, renal anomaly (HDR) syndrome(3) (Mendelian Inheritance in Man number 146255)(4), which is located more telomeric (10p14-10pter)(5,6). We have performed deletion-mapping studies in two HDR patients, and here we define a critical 200-kilobase region which contains the GATA3 gene(7). This gene belongs to a family of zinc-finger transcription factors that are involved in vertebrate embryonic development(8-10). Investigation for GATA3 mutations in three other HDR probands identified one nonsense mutation and two intragenic deletions that predicted a loss of function, as confirmed by absence of DNA binding by the mutant GATA3 protein. These results show that GATA3 is essential in the embryonic development of the parathyroids, auditory system and kidneys, and indicate that other GATA family members may be involved in the aetiology of human malformations.	Univ Leuven, Ctr Human Genet, Dept Clin Genet, B-3000 Louvain, Belgium; Birmingham Childrens Hosp, Dept Endocrinol, Birmingham B46 1YH, W Midlands, England; Auckland Hosp, Dept Endocrinol, Auckland 1, New Zealand; Med Sch Newcastle Upon Tyne, Dept Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Mainz, Childrens Hosp, D-55101 Mainz, Germany; Univ Munich, Childrens Hosp, Dept Med Genet, D-80336 Munich, Germany; Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Mol Endocrinol Grp, Oxford OX3 9DU, England; Univ Leuven, Ctr Human Genet, Oncol Mol Lab, B-3000 Louvain, Belgium; Flanders Interuniv Inst Biotechnol, B-3000 Louvain, Belgium	KU Leuven; University of Birmingham; Auckland City Hospital; Newcastle University - UK; Johannes Gutenberg University of Mainz; University of Munich; University of Oxford; KU Leuven	Devriendt, K (corresponding author), Univ Leuven, Ctr Human Genet, Dept Clin Genet, Herestr 49, B-3000 Louvain, Belgium.		Van+Esch, Hilde/AAU-5688-2020	Van Esch, Hilde/0000-0002-9604-5726; Thakker, Rajesh/0000-0002-1438-3220				Beetz R, 1997, MONATSSCHR KINDERH, V145, P347, DOI 10.1007/s001120050131; BILOUS RW, 1992, NEW ENGL J MED, V327, P1069, DOI 10.1056/NEJM199210083271506; Brown SA, 1998, NAT GENET, V20, P180, DOI 10.1038/2484; Daw SCM, 1996, NAT GENET, V13, P458, DOI 10.1038/ng0896-458; Debacker C, 1999, MECH DEVELOP, V85, P183, DOI 10.1016/S0925-4773(99)00088-X; GEORGE KM, 1994, DEVELOPMENT, V120, P2673; Hendriks RW, 1999, EUR J IMMUNOL, V29, P1912, DOI 10.1002/(SICI)1521-4141(199906)29:06<1912::AID-IMMU1912>3.3.CO;2-4; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; LABASTIE MC, 1995, KIDNEY INT, V47, P1597, DOI 10.1038/ki.1995.223; LABASTIE MC, 1994, GENOMICS, V21, P1, DOI 10.1006/geno.1994.1217; Latchman D. S., 1993, TRANSCRIPTION FACTOR; Lichtner P, 2000, J MED GENET, V37, P33, DOI 10.1136/jmg.37.1.33; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; McKusick V.A., 1998, MENDELIAN INHERITANC; Momeni P, 2000, NAT GENET, V24, P71, DOI 10.1038/71717; Nanni L, 1999, HUM MOL GENET, V8, P2479, DOI 10.1093/hmg/8.13.2479; Nichols KE, 2000, NAT GENET, V24, P266, DOI 10.1038/73480; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; Rivolta MN, 1998, J NEUROCYTOL, V27, P637, DOI 10.1023/A:1006951813063; Rosenthal N, 1999, J CLIN INVEST, V104, P1483, DOI 10.1172/JCI8825; Schuffenhauer S, 1998, EUR J HUM GENET, V6, P213, DOI 10.1038/sj.ejhg.5200183; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; SIMON MC, 1995, NAT GENET, V11, P9, DOI 10.1038/ng0995-9; Soderlund C, 1997, COMPUT APPL BIOSCI, V13, P523; SULSTON J, 1989, COMPUT APPL BIOSCI, V5, P101; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Van Esch H, 1999, CLIN GENET, V55, P269, DOI 10.1034/j.1399-0004.1999.550410.x; YANG ZY, 1994, MOL CELL BIOL, V14, P2201, DOI 10.1128/MCB.14.3.2201	28	372	377	0	14	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					419	422		10.1038/35019088	http://dx.doi.org/10.1038/35019088			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935639				2022-12-24	WOS:000088383800049
J	Labarrere, CA; Nelson, DR; Cox, CJ; Pitts, D; Kirlin, P; Halbrook, H				Labarrere, CA; Nelson, DR; Cox, CJ; Pitts, D; Kirlin, P; Halbrook, H			Cardiac-specific troponin I levels and risk of coronary artery disease and graft failure following heart transplantation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; PLASMINOGEN-ACTIVATOR INHIBITOR-1; KINASE ISOENZYME-MB; ALLOGRAFT-REJECTION; PROGNOSTIC VALUE; UNSTABLE ANGINA; NONINVASIVE MARKER; T LEVELS; INJURY; PREDICT	Context Previous studies have yielded conflicting data regarding whether a relationship exists between elevated cardiac troponin levels and acute allograft rejection in patients who have received heart transplants, Objective To determine whether cardiac troponin I levels after heart transplantation were associated with a procoagulant microvasculature and long-term allograft outcome. Design Prospective cohort study with a mean (SE) follow-up of 45.1 (2.5) months. Serum troponin I levels were measured 9.9 (0.2) times per patient during the first 12 months after heart transplantation. Setting Heart transplant center in the United States. Patients A total of 110 consecutive patients who received a heart transplant between 1989 and 1997 and survived at least 1 year after transplantation. Main Outcome Measures Histological and immunohistochemical biopsy findings, development of coronary artery disease (CAD), and graft failure in patients with vs without elevated serum cardiac troponin I levels. Results All recipients had elevated troponin I levels during the first month after transplantation. Troponin I levels remained persistently elevated during the first 12 months in 56 patients (51%) and became undetectable in 54 patients (49%). Persistently elevated troponin I levels were associated with increasing fibrin deposits in microvasculature and cardiomyocytes (P<.001). Patients with persistently elevated levels of troponin I had significantly increased risk for subsequent development of CAD (odds ratio [OR], 4.3, 95% confidence interval [CI], 1.8-10.1; P<.001) and graft failure (OR, 3.4; 95% CI, 1.2-9.7; P=.02), and also developed more severe CAD (OR, 4.2; 95% CI, 1.9-9.3; P<.001) and showed more disease progression (OR, 3.7; 95% CI, 1.3-10.4; P=.009). Conclusion In this study, elevated cardiac troponin I levels, which are considered to be a noninvasive surrogate marker of a procoagulant microvasculature, identified a subgroup of patients with high risk for developing CAD and graft failure after cardiac transplantation.	Clarian Hlth, Methodist Res Inst, Indianapolis, IN 46202 USA; Clarian Hlth, Transplant Ctr, Indianapolis, IN 46202 USA; Clarian Hlth, Dept Pathol, Indianapolis, IN 46202 USA; Cleveland Clin Fdn, Dept Biostat & Epidemiol, Cleveland, OH 44195 USA	Indiana University System; Cleveland Clinic Foundation	Labarrere, CA (corresponding author), Clarian Hlth, Methodist Res Inst, 1812 N Capitol Ave, Indianapolis, IN 46202 USA.	Clabarrere@clarian.com		Nelson, David/0000-0002-3240-0725				ADAMS JE, 1994, NEW ENGL J MED, V330, P670, DOI 10.1056/NEJM199403103301003; ADAMS JE, 1993, CIRCULATION, V88, P101, DOI 10.1161/01.CIR.88.1.101; Alexis JD, 1998, J HEART LUNG TRANSPL, V17, P395; Antman EM, 1996, NEW ENGL J MED, V335, P1342, DOI 10.1056/NEJM199610313351802; Benza RL, 1998, CIRCULATION, V98, P2248, DOI 10.1161/01.CIR.98.21.2248; Billingham M E, 1990, J Heart Transplant, V9, P587; BODOR GS, 1992, CLIN CHEM, V38, P2203; Costanzo MR, 1998, J HEART LUNG TRANSPL, V17, P744; Dengler TJ, 1998, J AM COLL CARDIOL, V32, P405, DOI 10.1016/S0735-1097(98)00257-5; DONNELLY R, 1993, LANCET, V341, P410, DOI 10.1016/0140-6736(93)92996-7; Faulk WP, 1998, TRANSPLANTATION, V66, P1335, DOI 10.1097/00007890-199811270-00013; Fyfe B, 1996, CIRCULATION, V93, P1133, DOI 10.1161/01.CIR.93.6.1133; Gag SZ, 1996, J AM COLL CARDIOL, V28, P673, DOI 10.1016/0735-1097(96)00201-X; GERHARDT W, 1991, CLIN CHEM, V37, P1405; GRATTAN MT, 1989, JAMA-J AM MED ASSOC, V261, P3561, DOI 10.1001/jama.261.24.3561; Hamm CW, 1997, NEW ENGL J MED, V337, P1648, DOI 10.1056/NEJM199712043372302; Hamm CW, 1999, NEW ENGL J MED, V340, P1623, DOI 10.1056/NEJM199905273402103; HAMM CW, 1992, NEW ENGL J MED, V327, P146, DOI 10.1056/NEJM199207163270302; Heeschen C, 1999, LANCET, V354, P1757, DOI 10.1016/S0140-6736(99)10285-X; HOSSEINNIA M, 1993, LANCET, V341, P838, DOI 10.1016/0140-6736(93)90621-M; JOHNSON DE, 1989, J HEART TRANSPLANT, V8, P349; KATUS HA, 1991, CIRCULATION, V83, P902, DOI 10.1161/01.CIR.83.3.902; KATUS HA, 1991, BRIT HEART J, V65, P259; Labarrere CA, 1998, AM J MED, V105, P207, DOI 10.1016/S0002-9343(98)00246-0; Labarrere CA, 1999, CURR OPIN CARDIOL, V14, P133, DOI 10.1097/00001573-199903000-00010; LABARRERE CA, 1994, CIRCULATION, V89, P1599, DOI 10.1161/01.CIR.89.4.1599; LABARRERE CA, 1995, NEW ENGL J MED, V333, P1111, DOI 10.1056/NEJM199510263331704; Labarrere CA, 1997, JAMA-J AM MED ASSOC, V278, P1169, DOI 10.1001/jama.278.14.1169; Lindahl B, 1996, CIRCULATION, V93, P1651, DOI 10.1161/01.CIR.93.9.1651; Lipshultz SE, 1997, CIRCULATION, V96, P2641, DOI 10.1161/01.CIR.96.8.2641; Luscher MS, 1997, CIRCULATION, V96, P2578, DOI 10.1161/01.CIR.96.8.2578; MAIR J, 1993, LANCET, V341, P838, DOI 10.1016/0140-6736(93)90622-N; MILLER LW, 1995, TRANSPLANT REV, V9, P77; Ohman EM, 1996, NEW ENGL J MED, V335, P1333, DOI 10.1056/NEJM199610313351801; ONI AA, 1992, TRANSPLANTATION, V53, P1247, DOI 10.1097/00007890-199206000-00015; POBER JS, 1988, AM J PATHOL, V133, P426; RAVKILDE J, 1995, J AM COLL CARDIOL, V25, P574, DOI 10.1016/0735-1097(94)00430-X; RAVKILDE J, 1993, SCAND J CLIN LAB INV, V53, P677, DOI 10.3109/00365519309092571; TOPOL EJ, 1995, CIRCULATION, V92, P2333, DOI 10.1161/01.CIR.92.8.2333; Troponin T, 1991, LANCET, V338, P23; WALPOTH BH, 1995, TRANSPLANT P, V27, P2084; Wang CW, 1996, TRANSPLANTATION, V62, P1938, DOI 10.1097/00007890-199612270-00046; WU AHB, 1995, AM J CARDIOL, V76, P970, DOI 10.1016/S0002-9149(99)80274-4; ZIMMERMANN R, 1993, BRIT HEART J, V69, P395; Zund G, 1997, AM J PHYSIOL-CELL PH, V273, pC1571, DOI 10.1152/ajpcell.1997.273.5.C1571	45	77	80	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 26	2000	284	4					457	464		10.1001/jama.284.4.457	http://dx.doi.org/10.1001/jama.284.4.457			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335QB	10904509	Bronze			2022-12-24	WOS:000088254200032
J	Stotter, A; Bright, N; Silcocks, PB; Botha, JL				Stotter, A; Bright, N; Silcocks, PB; Botha, JL			Effect of improved data collection on breast cancer incidence and survival: reconciliation of a registry with a clinical database	BRITISH MEDICAL JOURNAL			English	Article									Glenfield Hosp NHS Trust, Leicester LE3 9QP, Leics, England; Weston Pk Hosp NHS Trust, Trent Canc Registry, Sheffield S10 2SJ, S Yorkshire, England	Weston Park Hospital	Stotter, A (corresponding author), Glenfield Hosp NHS Trust, Leicester LE3 9QP, Leics, England.							Coleman MP., 1999, CANC SURVIVAL TRENDS; COX DR, 1972, J R STAT SOC B, V34, P187; Office for National Statistics, 1998, CANC STAT REG CANC D; Quinn MJ, 1998, EUR J CANCER, V34, P2204, DOI 10.1016/S0959-8049(98)00323-2	4	18	18	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 22	2000	321	7255					214	214		10.1136/bmj.321.7255.214	http://dx.doi.org/10.1136/bmj.321.7255.214			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	338XG	10903654	Bronze, Green Published			2022-12-24	WOS:000088448100023
J	Frank, J; Agrawal, RK				Frank, J; Agrawal, RK			A ratchet-like inter-subunit reorganization of the ribosome during translocation	NATURE			English	Article							ESCHERICHIA-COLI RIBOSOME; ELONGATION-FACTOR-G; 70S RIBOSOME; CRYOELECTRON MICROSCOPY; ANGSTROM RESOLUTION; TRANSFER-RNAS; EF-TU; VISUALIZATION; MOVEMENT; PROTEIN	The ribosome is a macromolecular assembly that is responsible for protein biosynthesis following genetic instructions in all organisms. It is composed of two unequal subunits: the smaller subunit binds messenger RNA and the anticodon end of transfer RNAs, and helps to decode the mRNA; and the larger subunit interacts with the amino-acid-carrying end of tRNAs and catalyses the formation of the peptide bonds. After peptide-bond formation, elongation factor G (EF-G) binds to the ribosome, triggering the translocation of peptidyl-tRNA from its aminoacyl site to the peptidyl site, and movement of mRNA by one codon(1). Here we analyse three-dimensional cryo-electron microscopy maps of the Escherichia coli 70S ribosome in various functional states, and show that both EF-G binding and subsequent GTP hydrolysis lead to ratchet-like rotations of the small 30S subunit relative to the large 50S subunit. Furthermore, our finding indicates a two-step mechanism of translocation: first, relative rotation of the subunits and opening of the mRNA channel following binding of GTP to EF-G; and second, advance of the mRNA/(tRNA)(2) complex in the direction of the rotation of the 30S subunit, following GTP hydrolysis.	SUNY Albany, Howard Hughes Med Inst, Albany, NY 12201 USA; SUNY Albany, Wadsworth Ctr, Hlth Res Inc, Albany, NY 12201 USA; SUNY Albany, Dept Biomed Sci, Albany, NY 12201 USA	Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Health Research Inc; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Frank, J (corresponding author), SUNY Albany, Howard Hughes Med Inst, Empire State Plaza,POB 509, Albany, NY 12201 USA.							Agrawal RK, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P53; Agrawal RK, 1996, J BIOL CHEM, V271, P21285, DOI 10.1074/jbc.271.35.21285; Agrawal RK, 1999, INT J BIOCHEM CELL B, V31, P243, DOI 10.1016/S1357-2725(98)00149-6; Agrawal RK, 1996, SCIENCE, V271, P1000, DOI 10.1126/science.271.5251.1000; Agrawal RK, 1998, P NATL ACAD SCI USA, V95, P6134, DOI 10.1073/pnas.95.11.6134; Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; AGRAWAL RK, IN PRESS J CELL BIOL; BRETSCHER MS, 1968, NATURE, V218, P675, DOI 10.1038/218675a0; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Clemons WM, 1999, NATURE, V400, P833, DOI 10.1038/23631; Frank J, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P45; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; FRANK J, 1995, NATURE, V376, P441, DOI 10.1038/376441a0; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Lata KR, 1996, J MOL BIOL, V262, P43, DOI 10.1006/jmbi.1996.0497; Malhotra A, 1998, J MOL BIOL, V280, P103, DOI 10.1006/jmbi.1998.1859; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Mueller F, 1997, J MOL BIOL, V271, P566, DOI 10.1006/jmbi.1997.1212; Newcomb LF, 1999, RNA, V5, P849, DOI 10.1017/S1355838299990192; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Porse BT, 1998, J MOL BIOL, V276, P391, DOI 10.1006/jmbi.1997.1541; POWERS T, 1994, TRENDS GENET, V10, P27, DOI 10.1016/0168-9525(94)90016-7; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; SERDYUK I, 1992, BIOCHIMIE, V74, P299, DOI 10.1016/0300-9084(92)90107-P; SPIRIN AS, 1969, COLD SPRING HARB SYM, V34, P197, DOI 10.1101/SQB.1969.034.01.026; SPIRIN AS, 1987, J MOL BIOL, V194, P119, DOI 10.1016/0022-2836(87)90720-0; Stark H, 1997, CELL, V88, P19, DOI 10.1016/S0092-8674(00)81854-1; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; Wilson KS, 1998, CELL, V92, P337, DOI 10.1016/S0092-8674(00)80927-7; WOESE C, 1970, NATURE, V226, P817, DOI 10.1038/226817a0	31	648	663	0	46	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 20	2000	406	6793					318	322		10.1038/35018597	http://dx.doi.org/10.1038/35018597			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917535				2022-12-24	WOS:000088251900053
J	Lipworth, BJ				Lipworth, BJ			Therapeutic implications of non-genomic glucocorticoid activity	LANCET			English	Editorial Material							A-STIMULATED THYMOCYTES; ENERGY-METABOLISM; METHYLPREDNISOLONE; HIERARCHY		Univ Dundee, Ninewells Hosp & Med Sch, Dept Clin Pharmacol & Therapeut, Asthma & Allergy Res Grp, Dundee DD1 9SY, Scotland	University of Dundee	Lipworth, BJ (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Dept Clin Pharmacol & Therapeut, Asthma & Allergy Res Grp, Dundee DD1 9SY, Scotland.							Barnes PJ, 1998, CLIN SCI, V94, P557, DOI 10.1042/cs0940557; BUTTGEREIT F, 1993, BIOSCIENCE REP, V13, P41, DOI 10.1007/BF01138177; Buttgereit F, 1999, BIOCHEM PHARMACOL, V58, P363, DOI 10.1016/S0006-2952(99)00090-8; Buttgereit F, 1997, BIOCHEM J, V326, P329, DOI 10.1042/bj3260329; BUTTGEREIT F, 1995, BIOCHEM J, V312, P163, DOI 10.1042/bj3120163; BUTTGEREIT F, 1994, EUR J BIOCHEM, V223, P513, DOI 10.1111/j.1432-1033.1994.tb19020.x; Buttgereit F, 1998, ARTHRITIS RHEUM, V41, P761, DOI 10.1002/1529-0131(199805)41:5<761::AID-ART2>3.0.CO;2-M; MARTENS ME, 1991, BIOCHIM BIOPHYS ACTA, V1058, P152, DOI 10.1016/S0005-2728(05)80232-4; Sanden S, 2000, J RHEUMATOL, V27, P1265; SILVA CM, 1994, STEROIDS, V59, P436, DOI 10.1016/0039-128X(94)90013-2; Wehling M, 1997, ANNU REV PHYSIOL, V59, P365, DOI 10.1146/annurev.physiol.59.1.365	11	71	74	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 8	2000	356	9224					87	89		10.1016/S0140-6736(00)02463-6	http://dx.doi.org/10.1016/S0140-6736(00)02463-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331UG	10963239				2022-12-24	WOS:000088036600003
J	Feenstra, P				Feenstra, P			Strengths and weaknesses of leprosy-elimination campaigns	LANCET			English	Editorial Material									Royal Trop Inst, Dept Hlth, NL-1092 AD Amsterdam, Netherlands		Feenstra, P (corresponding author), Royal Trop Inst, Dept Hlth, NL-1092 AD Amsterdam, Netherlands.							Croft R, 1999, LEPROSY REV, V70, P428; Croft RP, 2000, LANCET, V355, P1603, DOI 10.1016/S0140-6736(00)02216-9; Dharmshaktu NS, 1999, LEPROSY REV, V70, P430; Patnaik PKB, 1999, LEPROSY REV, V70, P440; Smith WCS, 1999, LEPROSY REV, V70, P498; Sofola O, 1999, LEPROSY REV, V70, P465; van Beers SM, 1999, INT J LEPROSY, V67, P119; vanBeers SM, 1996, FEMS MICROBIOL LETT, V136, P221, DOI 10.1016/0378-1097(95)00505-6; *WHO, 1999, LEPROSY REV, V70, P404; *WHO, 1999, WHOLEP991; *WHO, 1999, LEPROSY REV, V70, P408; World Health Organization, 1998, WEEKLY EPIDEMIOLOGIC, V73, P177	12	8	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 17	2000	355	9221					2089	2090		10.1016/S0140-6736(00)02370-9	http://dx.doi.org/10.1016/S0140-6736(00)02370-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325QD	10902617				2022-12-24	WOS:000087687100003
J	Wood, E; Braitstein, P; Montaner, JSG; Schechter, MT; Tyndall, MW; O'Shaughnessy, MV; Hogg, RS				Wood, E; Braitstein, P; Montaner, JSG; Schechter, MT; Tyndall, MW; O'Shaughnessy, MV; Hogg, RS			Extent to which low-level use of antiretroviral treatment could curb the AIDS epidemic in sub-Saharan Africa	LANCET			English	Article							TO-CHILD TRANSMISSION; COST-EFFECTIVENESS; VERTICAL TRANSMISSION; RANDOMIZED TRIAL; ORAL ZIDOVUDINE; COTE-DIVOIRE; NEVIRAPINE; THERAPY; HIV; PREVENTION	Background Despite growing international pressure to provide HIV-1 treatment to less-developed countries, potential demographic and epidemiological impacts have yet to be characterised. We modelled the future impact of antiretroviral use in South Africa from 2000 to 2005. Methods We produced a population projection model that assumed zero antiretroviral use to estimate the future demographic impacts of the HIV-1 epidemic. We also constructed four antiretroviral-adjusted scenarios to estimate the potential effect of antiretroviral use. We modelled total drug cost, cost per life-year gained, and the proportion of per-person health-care expenditure required to finance antiretroviral treatment in each scenario. Findings With no antiretroviral use between 2000 and 2005, there will be about 276 000 cumulative HIV-1-positive births, 2 302 000 cumulative new AIDS cases, and the life expectancy at birth will be 46.6 years by 2005. By contrast, 110 000 HIV-1-positive births could be prevented by short-course antiretroviral prophylaxis, as well as a decline of up to 1 year of life expectancy. The direct drug costs of universal coverage for this intervention would be US$54 million-less than 0.001% of the per-person health-care expenditure. In comparison, triple-combination treatment for 25% of the HIV-1-positive population could prevent a 3.1-year decline in life expectancy and more than 430 000 incident AIDS cases. The drug costs of this intervention would, however, be more than $19 billion at present prices, and would require 12.5% of the country's per-person healthcare expenditure. Interpretation Although there are barriers to widespread HIV-1 treatment, limited use of antiretrovirals could have an immediate and substantial impact on South Africa's AIDS epidemic.	St Pauls Hosp, British Columbia Excellence HIV AIDS, Vancouver, BC V6Z 1YG, Canada; Univ British Columbia, Dept Hlth Care & Epidemiol, Vancouver, BC V6T 1W5, Canada; Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 1W5, Canada; Univ British Columbia, Dept Med, Vancouver, BC V6T 1W5, Canada	St. Paul's Hospital; University of Saskatchewan; University of British Columbia; University of British Columbia; University of British Columbia	Hogg, RS (corresponding author), BC Ctr Excellence HIV AIDS, Div Epidemiol & Publ Hlth, Vancouver, BC V6Z 1Y6, Canada.	bobhogg@hivnet.ubc.ca	Montaner, Julio/K-7621-2012; Hogg, Robert S/B-2783-2012	Hogg, Robert S/0000-0003-3463-5488; Schechter, Martin/0000-0001-6063-2155; Tyndall, Mark/0000-0003-4450-5679				Blower SM, 2000, SCIENCE, V287, P650, DOI 10.1126/science.287.5453.650; Campa AM, 1999, LANCET, V354, P1817, DOI 10.1016/S0140-6736(05)70582-1; Dabis F, 1999, LANCET, V353, P786, DOI 10.1016/S0140-6736(98)11046-2; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; Gallant JE, 2000, JAMA-J AM MED ASSOC, V283, P1329, DOI 10.1001/jama.283.10.1329; Gilson L, 1997, LANCET, V350, P1805, DOI 10.1016/S0140-6736(97)08222-6; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Hogg RS, 1998, AIDS, V12, P2203, DOI 10.1097/00002030-199816000-00016; Hogg RS, 1998, JAMA-J AM MED ASSOC, V279, P450, DOI 10.1001/jama.279.6.450; Hogg RS, 1998, AIDS, V12, P279, DOI 10.1097/00002030-199803000-00005; Hogg RS, 1996, AIDS, V10, P889, DOI 10.1097/00002030-199607000-00012; *IAS, 1999, AIDS, V13, P5; Marseille E, 1999, LANCET, V354, P803, DOI 10.1016/S0140-6736(99)80009-9; Marseille E, 1998, AIDS, V12, P939, DOI 10.1097/00002030-199808000-00017; Marseille E, 1999, LANCET, V354, P1818, DOI 10.1016/S0140-6736(05)70584-5; MCINTYRE JA, 1998, INT C AIDS, V12, P406; Mirochnick M, 1998, J INFECT DIS, V178, P368, DOI 10.1086/515641; Musoke P, 1999, AIDS, V13, P479, DOI 10.1097/00002030-199903110-00006; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; Phair JP, 1999, J INFECT DIS, V179, pS384, DOI 10.1086/513839; Pollard RB, 1998, CLIN THER, V20, P1071, DOI 10.1016/S0149-2918(98)80105-7; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; SABA J, 1999, 2 C GLOB STRAT PREV; Soderlund N, 1999, BRIT MED J, V318, P1650, DOI 10.1136/bmj.318.7199.1650; Stover J, 1998, AIDS, V12, pS29; U.S. Bureau of the Census, 1999, WP98 US BUR CENS, P9; *UN SECR, 1999, DEM IMP HIV AIDS REP; *UNAIDS WHO, 1998, GUID MOD ANT TREATM, P40; *US BUR CENS, 1999, POP DIV INT DAT; Vernazza PL, 2000, AIDS, V14, P117, DOI 10.1097/00002030-200001280-00006; Vittinghoff E, 1999, J INFECT DIS, V179, P717, DOI 10.1086/314623; Wiktor SZ, 1999, LANCET, V353, P781, DOI 10.1016/S0140-6736(98)10412-9; Wilfert CM, 1999, LANCET, V353, P832, DOI 10.1016/S0140-6736(98)10414-2; Wood E, 2000, AIDS, V14, P1229, DOI 10.1097/00002030-200006160-00021; Wood E, 2000, CAN J PUBLIC HEALTH, V91, P125, DOI 10.1007/BF03404927; *WORLD BANK, 2000, WORLD DEV IND 2000; 2000, SUNDAY TIMES S  0409	37	57	57	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 17	2000	355	9221					2095	2100		10.1016/S0140-6736(00)02375-8	http://dx.doi.org/10.1016/S0140-6736(00)02375-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325QD	10902622				2022-12-24	WOS:000087687100008
J	Bruning, JC; Gautam, D; Burks, DJ; Gillette, J; Schubert, M; Orban, PC; Klein, R; Krone, W; Muller-Wieland, D; Kahn, CR				Bruning, JC; Gautam, D; Burks, DJ; Gillette, J; Schubert, M; Orban, PC; Klein, R; Krone, W; Muller-Wieland, D; Kahn, CR			Role of brain insulin receptor in control of body weight and reproduction	SCIENCE			English	Article							GROWTH-FACTOR-I; CENTRAL-NERVOUS-SYSTEM; FOOD-INTAKE; GENE; RAT; RESISTANCE; KNOCKOUT; NEURONS; NIDDM	Insulin receptors (IRs) and insulin signaling proteins are widely distributed throughout the central nervous system (CNS). To study the physiological role of insulin signaling in the brain, we created mice with a neuron-specific disruption of the IR gene (NIRKO mice), Inactivation of the IR had no impact on brain development or neuronal survival. However, female NIRKO mice showed increased food intake, and both male and female mice developed diet-sensitive obesity with increases in body fat and plasma leptin levels, mild insulin resistance, elevated plasma insulin Levels, and hypertriglyceridemia. NIRKO mice also exhibited impaired spermatogenesis and ovarian follicle maturation because of hypothalamic dysregulation of luteinizing hormone. Thus, IR signaling in the CNS plays an important role in regulation of energy disposal, fuel metabolism, and reproduction.	Univ Cologne, Klin & Poliklin Innere Med 2, D-50931 Cologne, Germany; Univ Cologne, Ctr Mol Med, D-50931 Cologne, Germany; Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA; European Mol Biol Lab, D-69117 Heidelberg, Germany	University of Cologne; University of Cologne; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; European Molecular Biology Laboratory (EMBL)	Bruning, JC (corresponding author), Univ Cologne, Klin & Poliklin Innere Med 2, Stelzmann Str 9, D-50931 Cologne, Germany.		Klein, Ruediger/C-6147-2008; Kahn, Ronald/AAY-2435-2021; Schubert, Markus/F-5150-2010	Klein, Ruediger/0000-0002-3109-0163; Kahn, Ronald/0000-0002-7583-9228; 	NIDDK NIH HHS [DK55326-01A2, DK31036] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031036, R01DK055326, R37DK031036] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baskin DG, 1999, BRAIN RES, V848, P114, DOI 10.1016/S0006-8993(99)01974-5; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Bruning JC, 1997, CELL, V88, P561, DOI 10.1016/S0092-8674(00)81896-6; BURKS DJ, UNPUB; Dunaif A, 1997, ENDOCR REV, V18, P774, DOI 10.1210/er.18.6.774; FIGLEWICZ DP, 1995, BEHAV NEUROSCI, V109, P567, DOI 10.1037/0735-7044.109.3.567; Frolich L, 1998, J NEURAL TRANSM, V105, P423, DOI 10.1007/s007020050068; GAUTAM D, UNPUB; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; HAVRANKOVA J, 1978, NATURE, V272, P827, DOI 10.1038/272827a0; HEIDENREICH KA, 1993, ANN NY ACAD SCI, V692, P72; Jonas EA, 1997, NATURE, V385, P343, DOI 10.1038/385343a0; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; NAKAMURA F, 1989, ENDOCRINOL JAPON, V36, P349; OLSON BR, 1995, NEUROENDOCRINOLOGY, V62, P155, DOI 10.1159/000127000; Porte D, 1998, DIABETOLOGIA, V41, P863, DOI 10.1007/s001250051002; ROBINSON LJ, 1994, ENDOCRINOLOGY, V135, P2568, DOI 10.1210/en.135.6.2568; SCHWARTZ MW, 1992, ENDOCRINOLOGY, V130, P3608, DOI 10.1210/en.130.6.3608; Svenningsen AF, 1996, GLIA, V18, P68, DOI 10.1002/(SICI)1098-1136(199609)18:1<68::AID-GLIA7>3.0.CO;2-#; Takahashi M, 1996, NEUROSCI LETT, V204, P201, DOI 10.1016/0304-3940(96)12357-0; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Vento R, 1997, MOL CELL BIOCHEM, V170, P163, DOI 10.1023/A:1006813705101; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792; WERTHER GA, 1987, ENDOCRINOLOGY, V121, P1562, DOI 10.1210/endo-121-4-1562; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378; Yura S, 2000, J CLIN INVEST, V105, P749, DOI 10.1172/JCI8353	28	1582	1640	2	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2000	289	5487					2122	2125		10.1126/science.289.5487.2122	http://dx.doi.org/10.1126/science.289.5487.2122			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11000114				2022-12-24	WOS:000089430900044
J	Neish, AS; Gewirtz, AT; Zeng, H; Young, AN; Hobert, ME; Karmali, V; Rao, AS; Madara, JL				Neish, AS; Gewirtz, AT; Zeng, H; Young, AN; Hobert, ME; Karmali, V; Rao, AS; Madara, JL			Prokaryotic regulation of epithelial responses by inhibition of I kappa B-alpha ubiquitination	SCIENCE			English	Article							SALMONELLA-TYPHIMURIUM; BETA-CATENIN; PROTEASOME PATHWAY; NEUTROPHILS; ATTACHMENT; ACTIVATION; BACTERIAL; SECRETION; CELLS; TRCP	Epithelia of the vertebrate intestinal tract characteristically maintain an inflammatory hyporesponsiveness toward the lumenal prokaryotic microflora. We report the identification of enteric organisms (nonvirulent Salmonella strains) whose direct interaction with model human epithelia attenuate synthesis of inflammatory effector molecules elicited by diverse proinflammatory stimuli. This immunosuppressive effect involves inhibition of the inhibitor kappa B/nuclear factor kappa B (I kappa B/NF-kappa B) pathway by blockade of I kappa B-alpha degradation, which prevents subsequent nuclear translocation of active NF-kappa B dimer, Although phosphorylation of I kappa B-alpha occurs, subsequent polyubiquitination necessary for regulated I kappa B-alpha degradation is completely abrogated. These data suggest that prokaryotic determinants could be responsible for the unique tolerance of the gastrointestinal mucosa to proinflammatory stimuli.	Emory Univ, Sch Med, Dept Pathol & Lab Med, Epithelial Pathobiol Unit, Atlanta, GA 30322 USA	Emory University	Neish, AS (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Epithelial Pathobiol Unit, Atlanta, GA 30322 USA.	aneish@emory.edu	Neish, Andrew/B-3895-2009		NIDDK NIH HHS [DK-35932, DK09800, DK-47662] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK035932, F32DK009800, R01DK047662, R01DK035932] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Elewaut D, 1999, J IMMUNOL, V163, P1457; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Gewirtz AT, 1998, J CLIN INVEST, V101, P1860, DOI 10.1172/JCI1339; Gewirtz AT, 2000, J CLIN INVEST, V105, P79, DOI 10.1172/JCI8066; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; Hobbie S, 1997, J IMMUNOL, V159, P5550; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; MADARA JL, 1990, AM J PATHOL, V137, P1273; Maniatis T, 1999, GENE DEV, V13, P505, DOI 10.1101/gad.13.5.505; MCCORMICK BA, 1995, J CELL BIOL, V131, P1599, DOI 10.1083/jcb.131.6.1599; MCCORMICK BA, 1995, INFECT IMMUN, V63, P2302, DOI 10.1128/IAI.63.6.2302-2309.1995; MCCORMICK BA, 1993, J CELL BIOL, V123, P895, DOI 10.1083/jcb.123.4.895; Morin PJ, 1999, BIOESSAYS, V21, P1021, DOI 10.1002/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P; NELSH A, UNPUB; Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920; Roff M, 1996, J BIOL CHEM, V271, P7844, DOI 10.1074/jbc.271.13.7844; Schesser K, 1998, MOL MICROBIOL, V28, P1067, DOI 10.1046/j.1365-2958.1998.00851.x; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Thurberg BL, 1998, CURR OPIN LIPIDOL, V9, P387, DOI 10.1097/00041433-199810000-00002; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159	24	687	750	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2000	289	5484					1560	1563		10.1126/science.289.5484.1560	http://dx.doi.org/10.1126/science.289.5484.1560			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349XW	10968793				2022-12-24	WOS:000089071700049
J	Johnson, RE; Washington, MT; Haracska, L; Prakash, S; Prakash, L				Johnson, RE; Washington, MT; Haracska, L; Prakash, S; Prakash, L			Eukaryotic polymerases iota and zeta act sequentially to bypass DNA lesions	NATURE			English	Article							THYMINE-THYMINE DIMER; SACCHAROMYCES-CEREVISIAE; XERODERMA-PIGMENTOSUM; REPLICATION FIDELITY; ESCHERICHIA-COLI; YEAST; ETA; PHOTOPRODUCT; EXTENSION; KINETICS	DNA lesions can often block DNA replication, so cells possess specialized low-fidelity, and often error-prone, DNA polymerases that can bypass such lesions and promote replication of damaged DNA(1). The Saccharomyces cerevisiae RAD30 and human hRAD30A encode Pol eta, which bypasses a cis-syn thymine-thymine dimer efficiently and accurately(2-7). Here we show that a related human gene, hRAD30B(8), encodes the DNA polymerase Pol iota, which misincorporates deoxynucleotides at a high rate. To bypass damage, Pol iota specifically incorporates deoxynucleotides opposite highly distorting or non-instructional DNA lesions. This action is combined with that of DNA polymerase Pol zeta, which is essential for damage-induced mutagenesis, to complete the lesion bypass. Pol zeta is very inefficient in inserting deoxynucleotides opposite DNA lesions, but readily extends from such deoxynucleotides once they have been inserted. Thus, in a new model for mutagenic bypass of DNA lesions in eukaryotes, the two DNA polymerases act sequentially: Pol iota incorporates deoxynucleotides opposite DNA lesions, and Pol zeta functions as a mispair extender.	Univ Texas, Med Branch, Sealy Ctr Mol Sci, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Prakash, L (corresponding author), Univ Texas, Med Branch, Sealy Ctr Mol Sci, 6-104 Med Res Bldg,11th & Mech St, Galveston, TX 77555 USA.		Prakash, Satya/C-6420-2013	Washington, Todd/0000-0001-8680-2992; Prakash, Satya/0000-0001-7228-1444; Prakash, Louise/0000-0001-9143-6261				CIARROCCHI G, 1982, J MOL BIOL, V155, P177, DOI 10.1016/0022-2836(82)90445-4; Creighton S, 1995, METHOD ENZYMOL, V262, P232; GIBBS PEM, 1995, NUCLEIC ACIDS RES, V23, P1919, DOI 10.1093/nar/23.11.1919; Gibbs PEM, 1998, P NATL ACAD SCI USA, V95, P6876, DOI 10.1073/pnas.95.12.6876; GIBBS PEM, 1993, J BACTERIOL, V175, P2607, DOI 10.1128/JB.175.9.2607-2612.1993; GOODMAN MF, 1993, CRIT REV BIOCHEM MOL, V28, P83, DOI 10.3109/10409239309086792; HUANG MM, 1992, NUCLEIC ACIDS RES, V20, P4567, DOI 10.1093/nar/20.17.4567; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Johnson RE, 2000, J BIOL CHEM, V275, P7447, DOI 10.1074/jbc.275.11.7447; Johnson RE, 1999, P NATL ACAD SCI USA, V96, P12224, DOI 10.1073/pnas.96.22.12224; KIM JK, 1995, EUR J BIOCHEM, V228, P849, DOI 10.1111/j.1432-1033.1995.0849m.x; KIM WC, 1995, ORGAN SCI, V6, P44, DOI 10.1287/orsc.6.1.44; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; McDonald JP, 1999, GENOMICS, V60, P20, DOI 10.1006/geno.1999.5906; MENDELMAN LV, 1990, J BIOL CHEM, V265, P2338; Nelson JR, 1996, SCIENCE, V272, P1646, DOI 10.1126/science.272.5268.1646; THOMAS DC, 1991, BIOCHEMISTRY-US, V30, P11751, DOI 10.1021/bi00115a003; Washington MT, 2000, P NATL ACAD SCI USA, V97, P3094, DOI 10.1073/pnas.050491997; Washington MT, 1999, J BIOL CHEM, V274, P36835, DOI 10.1074/jbc.274.52.36835; WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030	21	559	569	0	15	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 31	2000	406	6799					1015	1019		10.1038/35023030	http://dx.doi.org/10.1038/35023030			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	348ZW	10984059				2022-12-24	WOS:000089020200051
J	Tatsuo, H; Ono, N; Tanaka, K; Yanagi, Y				Tatsuo, H; Ono, N; Tanaka, K; Yanagi, Y			SLAM (CDw150) is a cellular receptor for measles virus	NATURE			English	Article							DIFFERENTIAL DOWN-REGULATION; ACTIVATION MOLECULE SLAM; HUMAN B-LYMPHOCYTES; WILD-TYPE; CD46; PROTEIN; HEMAGGLUTININ; PROLIFERATION; GLYCOPROTEIN; STRAINS	Measles virus continues to be a major killer of children, claiming roughly one million lives a year(1). Measles virus infection causes profound immunosuppression, which makes measles patients susceptible to secondary infections accounting for high morbidity and mortality(2). The Edmonston strain of measles virus, and vaccine strains derived from it, use as a cellular receptor human CD46 (refs 3, 4), which is expressed on all nucleated cells; however, most clinical isolates of measles virus cannot use CD46 as a receptor(5). Here we show that human SLAM (signalling lymphocyte-activation molecule; also known as CDw150), a recently discovered membrane glycoprotein expressed on some T and B cells(6), is a cellular receptor for measles virus, including the Edmonston strain. Transfection with a human SLAM complementary DNA enables non-susceptible cell lines to bind measles virus, support measles virus replication and develop cytopathic effects. The distribution of SLAM on various cell lines is consistent with their susceptibility to clinical isolates of measles virus. The identification of SLAM as a receptor for measles virus opens the way to a better understanding of the pathogenesis of measles virus infection, especially the immunosuppression induced by measles virus.	Kyushu Univ, Fac Med, Dept Virol, Fukuoka 8128582, Japan	Kyushu University	Yanagi, Y (corresponding author), Kyushu Univ, Fac Med, Dept Virol, Fukuoka 8128582, Japan.			ONO, NOBUYUKI/0000-0003-0709-4858; Yanagi, Yusuke/0000-0001-7815-1667				Aversa G, 1997, IMMUNOL CELL BIOL, V75, P202, DOI 10.1038/icb.1997.30; Aversa G, 1997, J IMMUNOL, V158, P4036; Buckland R, 1997, VIRUS RES, V48, P1, DOI 10.1016/S0168-1702(96)01421-9; COCKS BG, 1995, NATURE, V376, P260, DOI 10.1038/376260a0; DORIG RE, 1993, CELL, V75, P295, DOI 10.1016/0092-8674(93)80071-L; Griffin D., 1996, FIELDS VIROLOGY, V3rd ed., P1267; GRIFFIN DE, 1993, J INFECT DIS, V168, P275, DOI 10.1093/infdis/168.2.275; Hsu EC, 1998, J VIROL, V72, P2905, DOI 10.1128/JVI.72.4.2905-2916.1998; HUBER M, 1991, VIROLOGY, V185, P299, DOI 10.1016/0042-6822(91)90777-9; Kobune F, 1996, LAB ANIM SCI, V46, P315; KOBUNE F, 1990, J VIROL, V64, P700, DOI 10.1128/JVI.64.2.700-705.1990; Lecouturier V, 1996, J VIROL, V70, P4200, DOI 10.1128/JVI.70.7.4200-4204.1996; LISZEWSKI MK, 1991, ANNU REV IMMUNOL, V9, P431, DOI 10.1146/annurev.iy.09.040191.002243; Manchester M, 2000, J VIROL, V74, P3967, DOI 10.1128/JVI.74.9.3967-3974.2000; McChesney MB, 1997, VIROLOGY, V233, P74, DOI 10.1006/viro.1997.8576; MCFARLIN DE, 1980, J GEN VIROL, V48, P425, DOI 10.1099/0022-1317-48-2-425; Mikhalap SV, 1999, J IMMUNOL, V162, P5719; NANICHE D, 1993, J VIROL, V67, P6025, DOI 10.1128/JVI.67.10.6025-6032.1993; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Oldstone M.B.A., 1998, VIRUSES PLAGUES HIST; Punnonen J, 1997, J EXP MED, V185, P993, DOI 10.1084/jem.185.6.993; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Schlender J, 1996, P NATL ACAD SCI USA, V93, P13194, DOI 10.1073/pnas.93.23.13194; SCHNEIDERSCHAULIES J, 1995, J VIROL, V69, P7257, DOI 10.1128/JVI.69.11.7257-7259.1995; SCHNEIDERSCHAULIES J, 1995, P NATL ACAD SCI USA, V92, P3943, DOI 10.1073/pnas.92.9.3943; SIDORENKO SP, 1993, J IMMUNOL, V151, P4614; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Tanaka K, 1998, ARCH VIROL, V143, P213, DOI 10.1007/s007050050281; Tatsuo H, 2000, J VIROL, V74, P4139, DOI 10.1128/JVI.74.9.4139-4145.2000; YANAGI Y, 1992, VIROLOGY, V187, P280, DOI 10.1016/0042-6822(92)90316-H	30	811	849	0	42	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 24	2000	406	6798					893	897		10.1038/35022579	http://dx.doi.org/10.1038/35022579			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347AG	10972291				2022-12-24	WOS:000088903600045
J	Marshall, BC; Liou, TG				Marshall, BC; Liou, TG			Elusiveness of ideal approach to Pseudomonas aeruginosa infection complicating cystic fibrosis	LANCET			English	Editorial Material									Univ Utah, Hlth Sci Ctr, Intermt Cyst Fibrosis Ctr, Salt Lake City, UT 84132 USA; Vet Adm Med Ctr, Salt Lake City, UT 84148 USA	Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Marshall, BC (corresponding author), Univ Utah, Hlth Sci Ctr, Intermt Cyst Fibrosis Ctr, Salt Lake City, UT 84132 USA.		Liou, Theodore/AAI-3667-2021	Liou, Theodore/0000-0003-0121-4847	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL003656] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Elborn JS, 2000, THORAX, V55, P355, DOI 10.1136/thorax.55.5.355; Frederiksen B, 1997, PEDIATR PULM, V23, P330, DOI 10.1002/(SICI)1099-0496(199705)23:5<330::AID-PPUL4>3.0.CO;2-O; HOIBY N, 1989, ACTA PAEDIATR SCAND, V78, P395, DOI 10.1111/j.1651-2227.1989.tb11099.x; Morgan WJ, 1999, PEDIATR PULM, V28, P231, DOI 10.1002/(SICI)1099-0496(199910)28:4<231::AID-PPUL1>3.3.CO;2-U; QUAN J, 1999, 23 EUR CYST FIBR C H, pS84; Ramsey BW, 1999, NEW ENGL J MED, V340, P23, DOI 10.1056/NEJM199901073400104; SZAFF M, 1983, ACTA PAEDIATR SCAND, V72, P651, DOI 10.1111/j.1651-2227.1983.tb09789.x; WOHL ME, 1998, PEDIATR PULM, V17, P148	8	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 19	2000	356	9230					613	614		10.1016/S0140-6736(00)02600-3	http://dx.doi.org/10.1016/S0140-6736(00)02600-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346RD	10968431				2022-12-24	WOS:000088884100006
J	Hazzard, WR				Hazzard, WR			The department of internal medicine: Hub of the academic health center response to the aging imperative	ANNALS OF INTERNAL MEDICINE			English	Article								In the 21st century, geriatrics will increasingly dominate U.S. health care as the median age of the population progressively increases. Academic departments of geriatrics have been created in nations that have already experienced this shift. As an alternative strategy that builds on traditional strengths of academic medicine in the United States, departments of internal medicine should lead a multidepartmental, pan-institutional response to the aging imperative. Recognition of gerontology and geriatric medicine as central to the missions of internal medicine in clinical care, education, and research must be increased. In the process, academic departments of internal medicine will develop a high level of geriatric expertise and will launch many programs that address this challenge. Successful development of geriatric programs will serve as a catalyst to strengthen the integration among and between generalists and subspecialists. This will entail developing optimal sites and systems of geriatric care-at different levels of care and over time-that can enhance the geriatric education of medical students, residents, fellows, and practicing physicians. The study of aging and geriatric health care will also become an integral part of departmental research, in its subspecialty divisions as well as its divisions of general internal medicine and geriatrics. This strategy is urgently recommended as both a challenge and an opportunity for all departments of internal medicine.	Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA 98108 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Hazzard, WR (corresponding author), Vet Affairs Puget Sound Hlth Care Syst, 1660 S Columbian Way, Seattle, WA 98108 USA.	william.hazzard@med.va.gov						HAZZARD WR, 1986, AGE AGEING, V15, P307, DOI 10.1093/ageing/15.5.307; HAZZARD WR, 1979, AGE AGEING, V8, P141, DOI 10.1093/ageing/8.3.141; HAZZARD WR, 1994, AM J MED, V97; HAZZARD WR, 1990, AGING NEW DIMENSIONS	4	17	18	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 15	2000	133	4					293	296		10.7326/0003-4819-133-4-200008150-00014	http://dx.doi.org/10.7326/0003-4819-133-4-200008150-00014			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346NG	10929171				2022-12-24	WOS:000088877500007
J	Yurke, B; Turberfield, AJ; Mills, AP; Simmel, FC; Neumann, JL				Yurke, B; Turberfield, AJ; Mills, AP; Simmel, FC; Neumann, JL			A DNA-fuelled molecular machine made of DNA	NATURE			English	Article							PICONEWTON FORCES; BRANCH MIGRATION; SINGLE; RIBOZYME; DESIGN	Molecular recognition between complementary strands of DNA allows construction on a nanometre length scale. For example, DNA tags may be used to organize the assembly of colloidal particles(1,2), and DNA templates can direct the growth of semiconductor nanocrystals(3) and metal wires(4). As a structural material in its own right, DNA can be used to make ordered static arrays of tiles(5), linked rings(6) and polyhedra(7). The construction of active devices is also possible-for example, a nanomechanical switch(8), whose conformation is changed by inducing a transition in the chirality of the DNA double helix. Melting of chemically modified DNA has been induced by optical absorption(9), and conformational changes caused by the binding of oligonucleotides or other small groups have been shown to change the enzymatic activity of ribozymes(10-13). Here we report the construction of a DNA machine in which the DNA is used not only as a structural material, but also as 'fuel'. The machine, made from three strands of DNA, has the form of a pair of tweezers. It may be closed and opened by addition of auxiliary strands of 'fuel' DNA; each cycle produces a duplex DNA waste product.	Bell Labs, Lucent Technol, Murray Hill, NJ 07974 USA; Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England	Alcatel-Lucent; Lucent Technologies; AT&T; University of Oxford	Yurke, B (corresponding author), Bell Labs, Lucent Technol, 600 Mt Ave, Murray Hill, NJ 07974 USA.		Simmel, Friedrich/G-3281-2010; Turberfield, Andrew J/O-2135-2017	Simmel, Friedrich/0000-0003-3829-3446; Turberfield, Andrew J/0000-0002-3876-0190				Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0; Araki M, 1998, NUCLEIC ACIDS RES, V26, P3379, DOI 10.1093/nar/26.14.3379; Asanuma H, 1999, ANGEW CHEM INT EDIT, V38, P2393, DOI 10.1002/(SICI)1521-3773(19990816)38:16<2393::AID-ANIE2393>3.0.CO;2-7; Bockelmann U, 1997, PHYS REV LETT, V79, P4489, DOI 10.1103/PhysRevLett.79.4489; Braun E, 1998, NATURE, V391, P775, DOI 10.1038/35826; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; Coffer JL, 1996, APPL PHYS LETT, V69, P3851, DOI 10.1063/1.117126; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; GREEN C, 1981, NUCLEIC ACIDS RES, V9, P1905, DOI 10.1093/nar/9.8.1905; HELLER MJ, 1985, RAPID DETECTION IDEN, P245; ISHIJIMA A, 1994, BIOCHEM BIOPH RES CO, V199, P1057, DOI 10.1006/bbrc.1994.1336; KUO SC, 1993, SCIENCE, V260, P232, DOI 10.1126/science.8469975; LEE CS, 1970, J MOL BIOL, V48, P1, DOI 10.1016/0022-2836(70)90215-9; MANNING GS, 1981, BIOPOLYMERS, V20, P1751, DOI 10.1002/bip.1981.360200815; Mao CD, 1999, NATURE, V397, P144, DOI 10.1038/16437; Mao CD, 1997, NATURE, V386, P137, DOI 10.1038/386137b0; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; PORTA H, 1995, BIO-TECHNOL, V13, P161, DOI 10.1038/nbt0295-161; RADDING CM, 1977, J MOL BIOL, V116, P825, DOI 10.1016/0022-2836(77)90273-X; RECORD MT, 1978, Q REV BIOPHYS, V11, P103, DOI 10.1017/S003358350000202X; Robertson MP, 1999, NAT BIOTECHNOL, V17, P62, DOI 10.1038/5236; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; SMITH SB, 1992, SCIENCE, V258, P1122, DOI 10.1126/science.1439819; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; Tang J, 1997, CHEM BIOL, V4, P453, DOI 10.1016/S1074-5521(97)90197-6; TURBERFIELD AJ, 1999, B AM PHYS SOC, V44, P1711; WETMUR JG, 1968, J MOL BIOL, V31, P349, DOI 10.1016/0022-2836(68)90414-2; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998	30	1661	1756	48	781	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2000	406	6796					605	608		10.1038/35020524	http://dx.doi.org/10.1038/35020524			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949296				2022-12-24	WOS:000088653800041
J	Kassen, R; Buckling, A; Bell, G; Rainey, PB				Kassen, R; Buckling, A; Bell, G; Rainey, PB			Diversity peaks at intermediate productivity in a laboratory microcosm	NATURE			English	Article							SPECIES RICHNESS; STANDING CROP; COMPETITION; ENVIRONMENT; VEGETATION; MODEL; GRADIENTS; DOMINANCE; COMMUNITY; ECOSYSTEM	The species diversity of natural communities is often strongly related to their productivity. The pattern of this relationship seems to vary: diversity is known to increase monotonically with productivity, to decrease monotonically with productivity, and to be unimodally related to productivity, with maximum diversity occurring at intermediate levels of productivity(1-3). The mechanism underlying these patterns remains obscure, although many possibilities have been suggested(3-6). Here we outline a simple mechanism-involving selection in a heterogeneous environment-to explain these patterns, and test it using laboratory cultures of the bacterium Pseudomonas fluorescens. We grew diverse cultures over a wide range of nutrient concentrations, and found a strongly unimodal relationship between diversity and productivity in heterogeneous, but not in homogeneous, environments. Our result provides experimental evidence that the unimodal relationship often observed in natural communities can be caused by selection for specialized types in a heterogeneous environment.	McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; McGill Univ, Redpath Museum, Montreal, PQ H3A 2K6, Canada; Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England	McGill University; McGill University; University of Oxford	Kassen, R (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	rkassen@biol.lan.mcgill.ca	Rainey, Paul/A-3207-2008	Rainey, Paul/0000-0003-0879-5795; Buckling, Angus/0000-0003-1170-4604				ABRAMS PA, 1995, ECOLOGY, V76, P2019, DOI 10.2307/1941677; ABRAMSKY Z, 1984, NATURE, V309, P150, DOI 10.1038/309150a0; ALMUFTI MM, 1977, J ECOL, V65, P759, DOI 10.2307/2259378; BAKELAAR RG, 1978, ECOLOGY, V59, P660, DOI 10.2307/1938767; BELL G, 1992, EVOLUTION, V46, P561, DOI 10.1111/j.1558-5646.1992.tb02060.x; BELL G, 1993, OECOLOGIA, V96, P114, DOI 10.1007/BF00318038; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; DEMPSTER ER, 1955, COLD SPRING HARB SYM, V20, P25, DOI 10.1101/SQB.1955.020.01.005; GOLDBERG DE, 1990, ECOLOGY, V71, P213, DOI 10.2307/1940261; GRIME JP, 1973, J ENVIRON MANAGE, V1, P151; HOLT RD, 1994, AM NAT, V144, P741, DOI 10.1086/285705; Leibold MA, 1996, AM NAT, V147, P784, DOI 10.1086/285879; LEVENE H, 1953, AM NAT, V87, P331, DOI 10.1086/281792; MOORE DRJ, 1989, VEGETATIO, V79, P99; ODUM E. P, 1959, FUNDAMENTALS ECOLOGY; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; ROSENSZWEIG ML, 1995, SPECIES DIVERSITY SP; Rosenzweig Michael L., 1993, P52; SCHINDLER DW, 1990, OIKOS, V57, P25, DOI 10.2307/3565733; SHIPLEY B, 1991, ECOLOGY, V72, P1658, DOI 10.2307/1940965; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; SMITH JM, 1980, GENET RES, V35, P45, DOI 10.1017/S0016672300013926; Tilman D., 1982, Monographs in Population Biology, pi; Tilman David, 1993, P13; Waide RB, 1999, ANNU REV ECOL SYST, V30, P257, DOI 10.1146/annurev.ecolsys.30.1.257; WHEELER BD, 1991, J ECOL, V79, P285, DOI 10.2307/2260713; WILSON SD, 1991, ECOLOGY, V72, P1050, DOI 10.2307/1940605; WISHEU IC, 1989, CAN J BOT, V67, P1609, DOI 10.1139/b89-203; YOUNT JL, 1956, LIMNOL OCEANOGR, V1, P286, DOI 10.4319/lo.1956.1.4.0286	29	231	276	0	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2000	406	6795					508	512		10.1038/35020060	http://dx.doi.org/10.1038/35020060			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952310				2022-12-24	WOS:000088538000044
J	Forsen, T; Eriksson, J; Tuomilehto, J; Reunanen, A; Osmond, C; Barker, D				Forsen, T; Eriksson, J; Tuomilehto, J; Reunanen, A; Osmond, C; Barker, D			The fetal and childhood growth of persons who develop type 2 diabetes	ANNALS OF INTERNAL MEDICINE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; CORONARY HEART-DISEASE; LOW-BIRTH-WEIGHT; INSULIN-RESISTANCE; FAMILY HISTORY; MELLITUS; OBESITY; MEN; PREGNANCY; WOMEN	Background: Type 2 diabetes is associated with low birthweight followed by obesity in adulthood. Persons who develop the disease may therefore have a particular pattern of growth from birth through childhood. Objective: To examine the relation of type 2 diabetes to size at birth and childhood growth. Design: Cohort study. Setting: Helsinki, Finland. Participants: Men (n = 3639) and women (n = 3447) who were born at the Helsinki University Central Hospital between 1924 and 1933, who went to school in Helsinki, and who still lived in Finland in 1971. Detailed birth and school health records were available for all 7086 participants. We identified 471 men and women who developed type 2 diabetes by using the national Social Insurance Institution's register of all persons in Finland who are receiving long-term therapy with medication. Measurements: Incidence of diabetes ascertained from a national register. The main explanatory measurements were size at birth and childhood growth in terms of height, weight, and body mass index. Results: The cumulative incidence of type 2 diabetes was 7.9% (n = 286) in men and 5.4% (n = 185) In women. The incidence increased with decreasing birthweight, birth length, ponderal index (birthweight/length(3)), and placental weight. The odds ratio for type 2 diabetes was 1.38 (95% CI, 1.15 to 1.66; P < 0.001) for each l-kg decrease in birthweight. The mean weights and heights of the children at 7 years of age who later developed type 2 diabetes were about average. Thereafter, their growth in weight and height;was accelerated until 15 years of age. The odds ratio for development of type 2 diabetes was 1.39 (CI, 1.21 to 1.61; P < 0.001) for each standard deviation Increase in weight between 7 and 15 years of age. The odds ratio became 1.83 (CI, 1.37 to 2.45; P < 0.001) in an analysis restricted to persons whose birthweights were below 3000 g. Children of both sexes whose mothers had a high body mass index in pregnancy had more rapid growth during childhood and an increased incidence of type 2 diabetes. Conclusions: These findings are consistent with the hypothesis that type 2 diabetes is programmed In utero in association with low rates of fetal growth. The increased risk for type 2 diabetes associated with small size at birth is further increased by high growth rates after 7 years of age.	Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, FIN-00300 Helsinki, Finland; Dept Hlth & Disabil, Helsinki, Finland; Univ Southampton, Southampton Gen Hosp, Southampton, Hants, England	Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Southampton	Eriksson, J (corresponding author), Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, Mannerheimintie 166, FIN-00300 Helsinki, Finland.			Osmond, Clive/0000-0002-9054-4655				BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Barker DJP, 1998, MOTHERS BABIES HLTH; Bavdekar A, 1999, DIABETES, V48, P2422, DOI 10.2337/diabetes.48.12.2422; Carlsson S, 1999, DIABETES CARE, V22, P1043, DOI 10.2337/diacare.22.7.1043; CARMELLI D, 1994, AM J HUM GENET, V55, P566; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Elbein SC, 1997, J NUTR, V127, pS1891, DOI 10.1093/jn/127.9.1891S; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; Fall CHD, 1998, DIABETIC MED, V15, P220, DOI 10.1002/(SICI)1096-9136(199803)15:3<220::AID-DIA544>3.0.CO;2-O; Flanagan DE, 2000, AM J PHYSIOL-ENDOC M, V278, pE700, DOI 10.1152/ajpendo.2000.278.4.E700; Forsen T, 1999, BRIT MED J, V319, P1403, DOI 10.1136/bmj.319.7222.1403; Forsen T, 1997, BRIT MED J, V315, P837, DOI 10.1136/bmj.315.7112.837; GUILLAUME M, 1995, INT J OBESITY, V19, pS5; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Hales CN, 1996, BIOCHEM SOC T, V24, P341, DOI 10.1042/bst0240341; KANGAS T, 1995, 58 NAT RES DEV CTR W; Lithell HO, 1996, BMJ-BRIT MED J, V312, P406; MCCRABB GJ, 1991, BRIT J NUTR, V65, P157, DOI 10.1079/BJN19910077; Mi J, 2000, ANN INTERN MED, V132, P253, DOI 10.7326/0003-4819-132-4-200002150-00002; MYKKANEN L, 1990, DIABETES CARE, V13, P1099, DOI 10.2337/diacare.13.11.1099; PHILLIPS DIW, 1994, DIABETOLOGIA, V37, P150, DOI 10.1007/s001250050086; PHIPPS K, 1993, DIABETOLOGIA, V36, P225, DOI 10.1007/BF00399954; Poulsen P, 1997, DIABETOLOGIA, V40, P439, DOI 10.1007/s001250050698; Rich-Edwards JW, 1999, ANN INTERN MED, V130, P278, DOI 10.7326/0003-4819-130-4_Part_1-199902160-00005; ROYSTON P, 1991, STAT MED, V10, P675, DOI 10.1002/sim.4780100502; SNOECK A, 1990, BIOL NEONATE, V57, P107, DOI 10.1159/000243170; TANNER JM, 1989, FOETUS MAN PHYSICAL; TUOMILEHTO J, 1991, INT J EPIDEMIOL, V20, P1010, DOI 10.1093/ije/20.4.1010; Vanhala M, 1998, BRIT MED J, V317, P319, DOI 10.1136/bmj.317.7154.319; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; *WHO STUD GROUP DI, 1985, WHO TECHN REP SER, V727	33	493	509	0	31	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	2000	133	3					176	182		10.7326/0003-4819-133-3-200008010-00008	http://dx.doi.org/10.7326/0003-4819-133-3-200008010-00008			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	338XW	10906831				2022-12-24	WOS:000088449400002
J	Ramrakha, S; Caspi, A; Dickson, N; Moffitt, TF; Paul, C				Ramrakha, S; Caspi, A; Dickson, N; Moffitt, TF; Paul, C			Psychiatric disorders and risky sexual behaviour in young adulthood: cross sectional study in birth cohort	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NATIONAL-COMORBIDITY-SURVEY; ADOLESCENT GIRLS; MENTAL-HEALTH; SUBSTANCE USE; PREVALENCE; LIFETIME; DEPRESSION; VALIDITY	Objective To determine if risky sexual intercourse, sexually transmitted diseases, and sexual intercourse at an early age are associated with psychiatric disorder. Design Cross sectional study of a birth cohort at age 21 years with assessments presented by computer (for sexual behaviour) and by trained interviewers (for psychiatric disorder). Setting New Zealand in 1993-4. Participants 992 study members (487 women) from the Dunedin multidisciplinary health and development study. Complete data were available on both measures for 930 study members. Main outcome measures Psychiatric disorders (anxiety, depression eating disorder; substance dependence, antisocial disorder, mania, schizophrenia spectrum) and measures of sexual behaviour. Results Young people diagnosed with substance dependence, schizophrenia spectrum, and antisocial disorders were more likely to engage in risky sexual intercourse, contract sexually transmitted diseases, and have sexual intercourse at an early age (before 16 years). Unexpectedly, so were young people with depressive disorders. Young people with mania were more likely to report risky sexual intercourse and have sexually transmitted diseases. The likelihood of risky behaviour was increased by psychiatric comorbidity. Conclusions There is a clear association between risky sexual behaviour and common psychiatric disorders. Although the temporal relation is uncertain, the results indicate the need to coordinate sexual medicine with mental health services in the treatment of young people.	Univ Otago, Sch Med, Dept Prevent & Social Med, Dunedin Multidisciplinary Hlth & Dev Res Unit, Dunedin, New Zealand; Univ Otago, Sch Med, Dept Prevent & Social Med, Dunedin, New Zealand; Inst Psychiat, Social Genet & Dev Psychiat Res Ctr, London SE5 8AF, England	University of Otago; University of Otago; University of London; King's College London	Ramrakha, S (corresponding author), Univ Otago, Sch Med, Dept Prevent & Social Med, Dunedin Multidisciplinary Hlth & Dev Res Unit, POB 913, Dunedin, New Zealand.	sramrakha@gandalf.otago.ac.nz	caspi, avshalom/D-5294-2011; caspi, avshalom/AAJ-5874-2020; Moffitt, Terrie E/D-5295-2011	caspi, avshalom/0000-0003-0082-4600; caspi, avshalom/0000-0003-0082-4600; Moffitt, Terrie E/0000-0002-8589-6760	NIMH NIH HHS [MH-4507, MH-49414, MH-56344, R01 MH049414] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH056344, R29MH049414, R01MH049414] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ADCOCK AG, 1991, ADOLESCENCE, V26, P817; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; [Anonymous], 1996, GLOBAL BURDEN DIS CO; BAKER DG, 1991, AM J PSYCHIAT, V148, P528; Bardone AM, 1996, DEV PSYCHOPATHOL, V8, P811, DOI 10.1017/S0954579400007446; Centers for Disease Control and Prevention (CDC), 1993, MMWR Morb Mortal Wkly Rep, V42, P589; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P749; COOPER ML, 1994, HEALTH PSYCHOL, V13, P251, DOI 10.1037/0278-6133.13.3.251; Dickson N, 1998, BRIT MED J, V316, P29, DOI 10.1136/bmj.316.7124.29; Dickson N, 1996, NEW ZEAL MED J, V109, P308; ELLEY WB, 1972, NEW ZEAL J EDUC STUD, V7, P153; Hankin BL, 1998, J ABNORM PSYCHOL, V107, P128, DOI 10.1037/0021-843X.107.1.128; *I MED COMM PREV M, 1994, REDUCING MENTAL DISO; JOHNSON AM, 1994, SEXUAL ATTITUDES LIF; Kendler KS, 1996, ARCH GEN PSYCHIAT, V53, P1022; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; LOWRY R, 1994, AM J PUBLIC HEALTH, V84, P1116, DOI 10.2105/AJPH.84.7.1116; Newman DL, 1996, J CONSULT CLIN PSYCH, V64, P552, DOI 10.1037/0022-006X.64.3.552; Newman DL, 1998, J ABNORM PSYCHOL, V107, P305, DOI 10.1037/0021-843X.107.2.305; Paul C, 2000, J ADOLESCENT HEALTH, V27, P136, DOI 10.1016/S1054-139X(99)00095-6; ROBINS LN, 1981, ARCH GEN PSYCHIAT, V38, P381; Silva P., 1996, CHILD ADULT DUNEDIN; USTUN TB, 1995, ILLNESS GEN HLTH CAR; WHO (World Health Organization), 1998, WORLD HLTH REP 1998	24	194	195	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2000	321	7256					263	266		10.1136/bmj.321.7256.263	http://dx.doi.org/10.1136/bmj.321.7256.263			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	341ZA	10915126	Green Published, Bronze			2022-12-24	WOS:000088619800020
J	Dahn, RD; Fallon, JF				Dahn, RD; Fallon, JF			Interdigital regulation of digit identity and homeotic transformation by modulated BMP signaling	SCIENCE			English	Article							CHICK LIMB; MESODERM INDUCTION; SONIC HEDGEHOG; CELL-DEATH; PROTEIN; HETERODIMERS	The developmental mechanisms specifying digital identity have attracted 30 years of intense interest, but still remain poorly understood, Here, through experiments on chick foot development, we show digital identity is not a fixed property of digital primordia. Rather, digital identity is specified by the interdigital mesoderm, demonstrating a patterning function for this tissue before its regression. More posterior interdigits specify more posterior digital identities, and each primordium will develop in accordance with the most posterior cues received. Furthermore, inhibition of interdigital bone morphogenetic protein (BMP) signaling can transform digit identity, suggesting a role for BMPs in this process.	Univ Wisconsin, Dept Anat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Fallon, JF (corresponding author), Univ Wisconsin, Dept Anat, 1300 Univ Ave, Madison, WI 53706 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032551, T32HD007477] Funding Source: NIH RePORTER; NICHD NIH HHS [HD32551, T32HD07477] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AONO A, 1995, BIOCHEM BIOPH RES CO, V210, P670, DOI 10.1006/bbrc.1995.1712; Bateson W., 1894, MAT STUDY VARIATION, DOI 10.5962/bhl.title.88017; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; Drossopoulou G, 2000, DEVELOPMENT, V127, P1337; Ganan Y, 1996, DEVELOPMENT, V122, P2349; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Johnson RL, 1997, CELL, V90, P979, DOI 10.1016/S0092-8674(00)80364-5; Laufer E, 1997, SCIENCE, V278, P305, DOI 10.1126/science.278.5336.305; Macias D, 1997, DEVELOPMENT, V124, P1109; Marigo V, 1996, DEVELOPMENT, V122, P1225; Nishimatsu S, 1998, MECH DEVELOP, V74, P75, DOI 10.1016/S0925-4773(98)00070-7; Pearse RV, 1998, J EXP ZOOL, V282, P677, DOI 10.1002/(SICI)1097-010X(19981215)282:6<677::AID-JEZ4>3.0.CO;2-F; Saunders J.W., 1967, MAJOR PROBLEMS DEV B, P289; Storm EE, 1996, DEVELOPMENT, V122, P3969; Suzuki A, 1997, BIOCHEM BIOPH RES CO, V232, P153, DOI 10.1006/bbrc.1997.6219; Tucker AS, 1998, SCIENCE, V282, P1136, DOI 10.1126/science.282.5391.1136; Yang Y, 1997, DEVELOPMENT, V124, P4393; Zakany J, 1999, CELL TISSUE RES, V296, P19, DOI 10.1007/s004410051262; Zhang ZY, 2000, DEV BIOL, V220, P154, DOI 10.1006/dbio.2000.9637; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6; Zou HY, 1996, SCIENCE, V272, P738, DOI 10.1126/science.272.5262.738	21	206	212	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2000	289	5478					438	441		10.1126/science.289.5478.438	http://dx.doi.org/10.1126/science.289.5478.438			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336ME	10903202				2022-12-24	WOS:000088305500044
J	Imperiale, TF; Wagner, DR; Lin, CY; Larkin, GN; Rogge, JD; Ransohoff, DF				Imperiale, TF; Wagner, DR; Lin, CY; Larkin, GN; Rogge, JD; Ransohoff, DF			Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COLONIC NEOPLASMS; FLEXIBLE SIGMOIDOSCOPY; RECTOSIGMOID ADENOMAS; AVERAGE-RISK; COLONOSCOPY; CANCER; POLYPS; LESIONS; HISTORY; AGE	Background and Methods: The clinical significance of a distal colorectal polyp is uncertain. We determined the risk of advanced proximal neoplasia, defined as a polyp with villous features, a polyp with high-grade dysplasia, or cancer, among persons with distal hyperplastic or neoplastic polyps as compared with the risk among persons with no distal polyps. We analyzed data from 1994 consecutive asymptomatic adults (age, 50 years or older) who underwent colonoscopic screening for the first time between September 1995 and December 1998 as part of a program sponsored by an employer. The location and histologic features of all polyps were recorded. Colonoscopy to the level of the cecum was completed in 97.0 percent of the patients. Results: Sixty-one patients (3.1 percent) had advanced lesions in the distal colon, including 5 with cancer, and 50 (2.5 percent) had advanced proximal lesions, including 7 with cancer. Twenty-three patients with advanced proximal neoplasms (46 percent) had no distal polyps. The prevalence of advanced proximal neoplasia among patients with no distal polyps was 1.5 percent (23 cases among 1564 persons; 95 percent confidence interval, 0.9 to 2.1 percent). Among patients with distal hyperplastic polyps, those with distal tubular adenomas, and those with advanced distal polyps, the prevalence of advanced proximal neoplasia was 4.0 percent (8 cases among 201 patients), 7.1 percent (12 cases among 168 patients), and 11.5 percent (7 cases among 61 patients), respectively. The relative risk of advanced proximal neoplasia, adjusted for age and sex, was 2.6 for patients with distal hyperplastic polyps, 4.0 for those with distal tubular adenomas, and 6.7 for those with advanced distal polyps, as compared with patients who had no distal polyps. Older age and male sex were associated with an increased risk of advanced proximal neoplasia (relative risk, 1.3 for every five years of age and 3.3 for male sex). Conclusions: Asymptomatic persons 50 years of age or older who have polyps in the distal colon are more likely to have advanced proximal neoplasia than are persons without distal polyps. However, if colonoscopic screening is performed only in persons with distal polyps, about half the cases of advanced proximal neoplasia will not be detected. (N Engl J Med 2000;343:169-74.) (C)2000, Massachusetts Medical Society.	Indiana Univ, Med Ctr, Div Gastroenterol, Dept Med, Indianapolis, IN 46202 USA; Indianapolis Gastroenterol Res Fdn, Indianapolis, IN USA; Richard L Roudebush Vet Affairs Med Ctr, Dept Med, Indianapolis, IN 46202 USA; Eli Lilly & Co, Indianapolis, IN 46285 USA	Indiana University System; Indiana University-Purdue University Indianapolis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Eli Lilly	Imperiale, TF (corresponding author), Indiana Univ, Med Ctr, Div Gastroenterol, Dept Med, 975 W Walnut St,IB-424, Indianapolis, IN 46202 USA.			Imperiale, Thomas/0000-0001-7586-1073	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK002756] Funding Source: NIH RePORTER; NIDDK NIH HHS [K24 DK02756-02] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ATKIN WS, 1992, NEW ENGL J MED, V326, P658, DOI 10.1056/NEJM199203053261002; BOND JH, 1994, ANN INTERN MED, V120, P347, DOI 10.7326/0003-4819-120-4-199402150-00032; BRADY PG, 1993, GASTROINTEST ENDOSC, V39, P481, DOI 10.1016/S0016-5107(93)70155-8; Collett JA, 1999, J GASTROEN HEPATOL, V14, P67, DOI 10.1046/j.1440-1746.1999.01804.x; Davidoff F, 1999, ANN INTERN MED, V130, P1019, DOI 10.7326/0003-4819-130-12-199906150-00022; DUKES CE, 1958, BRIT J CANCER, V12, P309, DOI 10.1038/bjc.1958.37; FOUTCH PG, 1991, AM J GASTROENTEROL, V86, P1482; Hosmer D.W., 2004, APPL LOGISTIC REGRES, VSecond; JOHNSON DA, 1990, AM J GASTROENTEROL, V85, P969; KONISHI F, 1982, J CLIN PATHOL, V35, P830, DOI 10.1136/jcp.35.8.830; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; Lemmel GT, 1996, GASTROINTEST ENDOSC, V44, P109, DOI 10.1016/S0016-5107(96)70125-6; Levin TR, 1999, JAMA-J AM MED ASSOC, V281, P1611, DOI 10.1001/jama.281.17.1611; Nusko G, 1996, EUR J GASTROEN HEPAT, V8, P351, DOI 10.1097/00042737-199604000-00012; OPELKA FG, 1992, DIS COLON RECTUM, V35, P178, DOI 10.1007/BF02050675; Otori K, 1997, GUT, V40, P660, DOI 10.1136/gut.40.5.660; Papatheodoridis GV, 1996, AM J GASTROENTEROL, V91, P1809; Read TE, 1997, NEW ENGL J MED, V336, P8, DOI 10.1056/NEJM199701023360102; Rex DK, 1999, GASTROINTEST ENDOSC, V49, P727, DOI 10.1016/S0016-5107(99)70290-7; REX DK, 1993, AM J GASTROENTEROL, V88, P825; Rothman K., 1998, MODERN EPIDEMIOLOGY; Schoen RE, 1997, GASTROINTEST ENDOSC, V46, P492, DOI 10.1016/S0016-5107(97)70002-6; Schoen RE, 1998, GASTROENTEROLOGY, V115, P533, DOI 10.1016/S0016-5085(98)70132-5; STRYKER SJ, 1987, GASTROENTEROLOGY, V93, P1009, DOI 10.1016/0016-5085(87)90563-4; TRIPP MR, 1987, CANCER, V60, P1599, DOI 10.1002/1097-0142(19871001)60:7<1599::AID-CNCR2820600730>3.0.CO;2-I; Wallace MB, 1998, ANN INTERN MED, V129, P273, DOI 10.7326/0003-4819-129-4-199808150-00002; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; Winawer SJ, 1998, GASTROENTEROLOGY, V114, P625; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P1060; ZARCHY TM, 1994, GASTROENTEROLOGY, V106, P1501, DOI 10.1016/0016-5085(94)90403-0	30	783	800	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 20	2000	343	3					169	174		10.1056/NEJM200007203430302	http://dx.doi.org/10.1056/NEJM200007203430302			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335HY	10900275	Bronze			2022-12-24	WOS:000088239100002
J	Hochhauser, D				Hochhauser, D			Relevance of mitochondrial DNA in cancer	LANCET			English	Editorial Material							MUTATIONS; DAMAGE		Royal Free & UCL Sch Med, Dept Oncol, London NW3 2QG, England	University of London; University College London	Hochhauser, D (corresponding author), Royal Free & UCL Sch Med, Dept Oncol, London NW3 2QG, England.			Hochhauser, Daniel/0000-0001-5522-9281				Ahrendt S A, 1999, Surg Oncol Clin N Am, V8, P641; ELLIS CN, 1987, BIOCHEM J, V245, P309, DOI 10.1042/bj2450309; Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; LEDOUX SP, 1992, CARCINOGENESIS, V13, P1967, DOI 10.1093/carcin/13.11.1967; Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774; ModicaNapolitano JS, 1996, CANCER RES, V56, P544; Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; Singh KK, 1999, ONCOGENE, V18, P6641, DOI 10.1038/sj.onc.1203056; Yeh JJ, 2000, ONCOGENE, V19, P2060, DOI 10.1038/sj.onc.1203537	11	35	42	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 15	2000	356	9225					181	182		10.1016/S0140-6736(00)02475-2	http://dx.doi.org/10.1016/S0140-6736(00)02475-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334GQ	10963192				2022-12-24	WOS:000088179100005
J	Allison, JJ; Kiefe, CI; Weissman, NW; Person, SD; Rousculp, M; Canto, JG; Bae, S; Williams, OD; Farmer, R; Centor, RM				Allison, JJ; Kiefe, CI; Weissman, NW; Person, SD; Rousculp, M; Canto, JG; Bae, S; Williams, OD; Farmer, R; Centor, RM			Relationship of hospital teaching status with quality of care and mortality for Medicare patients with acute MI	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; COOPERATIVE CARDIOVASCULAR PROJECT; SEVERITY-ADJUSTED MORTALITY; HEALTH-CARE; NONTEACHING HOSPITALS; RAPID CHANGES; DRUG-THERAPY; CENTERS; SYSTEM; COSTS	Context Issues of cost and quality are gaining importance in the delivery of medical care, and whether quality of care is better in teaching vs nonteaching hospitals is an essential question in this current national debate. Objective To examine the association of hospital teaching status with quality of care and mortality for fee-for-service Medicare patients with acute myocardial infarction (AMI). Design, setting, and Patients Analysis of Cooperative Cardiovascular Project data for 114411 Medicare patients from 4361 hospitals (22 354 patients from 439 major teaching hospitals, 22 493 patients from 455 minor teaching hospitals, and 69 564 patients from 3467 nonteaching hospitals) who had AMI between February 1994 and July 1995. Main Outcome Measures Administration of reperfusion therapy on admission, aspirin during hospitalization, and beta-blockers and angiotensin-converting enzyme inhibitors at discharge for patients meeting strict inclusion criteria; mortality at 30, 60, and 90 days and 2 years after admission. Results Among major teaching, minor teaching, and nonteaching hospitals, respectively, administration rates for aspirin were 91.2%, 86.4%, and 81.4% (P<.001); for angiotensin-converting enzyme inhibitors, 63.7%, 60.0%, and 58.0% (P<.001); for P-blockers, 48.8%, 40.3%, and 36.4% (P<.001); and for reperfusion therapy, 55.5%, 58.9%, and 55.2% (P = .29). Differences in unadjusted 30-day, 60-day, 90-day, and 2-year mortality among hospitals were significant at P<.001 for all time periods, with a gradient of increasing mortality from major teaching to minor teaching to nonteaching hospitals. Mortality differences were attenuated by adjustment for patient characteristics and were almost eliminated by additional adjustment for receipt of therapy. Conclusions In this study of elderly patients with AMI, admission to a teaching hospital was associated with better quality of care based on 3 of 4 quality indicators and lower mortality.	Univ Alabama Birmingham, Ctr Outcomes & Effectiveness Res & Educ, Div Gen Internal Med,Dept Med, Dept Hlth Serv Adm,Sch Related Hlth Profess, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Ctr Outcomes & Effectiveness Res & Educ, Sch Related Hlth Profess,Div Prevent Med, Dept Med,Dept Hlth Serv Adm, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Ctr Outcomes & Effectiveness Res & Educ, Sch Related Hlth Profess,Div Cardiovasc Med, Dept Med,Dept Hlth Serv Adm, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Pittman Gen Clin Res Ctr, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Lister Hill Ctr Hlth Policy, Birmingham, AL 35294 USA; Vet Affairs Med Ctr, Birmingham, AL USA; Alabama Qual Assurance Fdn, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Allison, JJ (corresponding author), Univ Alabama Birmingham, Ctr Outcomes & Effectiveness Res & Educ, Div Gen Internal Med,Dept Med, Dept Hlth Serv Adm,Sch Related Hlth Profess, 1530 3rd Ave S,MEB 621, Birmingham, AL 35294 USA.	jallison@uab.edu		Allison, Jeroan/0000-0003-4472-2112; bae, sejong/0000-0001-9982-3223	AHRQ HHS [HS08843, HS09446] Funding Source: Medline; NCRR NIH HHS [RR00032] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS008843, U18HS009446] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		ALHAIDER AS, 1991, HEALTH SERV RES, V26, P303; Allison J J, 2000, Jt Comm J Qual Improv, V26, P115; Ayanian JZ, 1998, HEALTH AFFAIR, V17, P194, DOI 10.1377/hlthaff.17.6.194; BALLARD DJ, 1994, HEALTH SERV RES, V28, P771; Bernard AM, 1996, ACAD MED, V71, P262, DOI 10.1097/00001888-199603000-00019; CENTOR RM, 1991, MED DECIS MAKING, V11, P102, DOI 10.1177/0272989X9101100205; Chen J, 1999, NEW ENGL J MED, V340, P286, DOI 10.1056/NEJM199901283400407; Chen J, 1999, HEALTH AFFAIR, V18, P53, DOI 10.1377/hlthaff.18.4.53; CLOUGH JD, 1993, CLEV CLIN J MED, V60, P449, DOI 10.3949/ccjm.60.6.449; Collins R, 1997, NEW ENGL J MED, V336, P847, DOI 10.1056/NEJM199703203361207; COS JL, 1994, J GEN INTERN MED, V9, P674, DOI 10.1007/BF02599007; Covinsky KE, 1997, J GEN INTERN MED, V12, P203, DOI 10.1007/s11606-006-5041-5; Donabedian A., 1980, EXPLORATIONS QUALITY; Eddy DM, 1998, HEALTH AFFAIR, V17, P7, DOI 10.1377/hlthaff.17.4.7; ELLERBECK EF, 1995, JAMA-J AM MED ASSOC, V273, P1509, DOI 10.1001/jama.273.19.1509; EPSTEIN AM, 1995, JAMA-J AM MED ASSOC, V273, P1203, DOI 10.1001/jama.273.15.1203; Espehaug B, 1999, ACTA ORTHOP SCAND, V70, P12, DOI 10.3109/17453679909000949; Fogelman AM, 1996, ACAD MED, V71, P1168, DOI 10.1097/00001888-199611000-00015; Gordon HS, 1996, MED CARE, V34, P295, DOI 10.1097/00005650-199604000-00002; Greer J, 1992, Health Care Financ Rev Annu Suppl, P199; Hamilton L. C., 1992, REGRESSION GRAPHICS; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; *HEALTHC INF, 1996, AM HOSP ASS GUID HLT; Hennekens CH, 1996, NEW ENGL J MED, V335, P1660, DOI 10.1056/NEJM199611283352207; Iezzoni LI, 1996, AM J PUBLIC HEALTH, V86, P1379, DOI 10.2105/AJPH.86.10.1379; IEZZONI LI, 1990, JAMA-J AM MED ASSOC, V264, P1426, DOI 10.1001/jama.264.11.1426; IGLEHART JK, 1994, NEW ENGL J MED, V331, P1391, DOI 10.1056/NEJM199411173312025; IGLEHART JK, 1995, NEW ENGL J MED, V332, P407, DOI 10.1056/NEJM199502093320624; JENCKS SF, 1992, JAMA-J AM MED ASSOC, V268, P900, DOI 10.1001/jama.268.7.900; JOLLIS JG, 1993, ANN INTERN MED, V119, P844, DOI 10.7326/0003-4819-119-8-199310150-00011; KAHN KL, 1994, JAMA-J AM MED ASSOC, V271, P1169, DOI 10.1001/jama.271.15.1169; KASSIRER JP, 1994, NEW ENGL J MED, V331, P1370, DOI 10.1056/NEJM199411173312010; Kassirer JP, 1999, NEW ENGL J MED, V340, P309, DOI 10.1056/NEJM199901283400410; KEELER EB, 1992, JAMA-J AM MED ASSOC, V268, P1709, DOI 10.1001/jama.268.13.1709; Kolb D. A., 1991, ORG BEHAV EXPERIENTI; KRALEWSKI JE, 1995, ACAD MED, V70, P867, DOI 10.1097/00001888-199510000-00008; Krumholz HM, 1999, CIRCULATION, V99, P2986, DOI 10.1161/01.CIR.99.23.2986; KUHN EM, 1991, MED CARE, V29, P1028, DOI 10.1097/00005650-199110000-00008; LAMBERTHUBER DA, 1994, CLIN PERFORMANCE QUA, V2, P219; Lauderdale DS, 1996, AM J PUBLIC HEALTH, V86, P712, DOI 10.2105/AJPH.86.5.712; Magnusen K. O., 1977, ORG DESIGN DEV BEHAV; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; McArthur JH, 1997, JAMA-J AM MED ASSOC, V277, P985, DOI 10.1001/jama.277.12.985; Mechanic R, 1998, JAMA-J AM MED ASSOC, V280, P1015, DOI 10.1001/jama.280.11.1015; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Newhouse J P, 1989, Health Care Financ Rev, V11, P33; Pan CX, 1999, J AM GERIATR SOC, V47, P730, DOI 10.1111/j.1532-5415.1999.tb01599.x; QUAM L, 1993, MED CARE, V31, P498, DOI 10.1097/00005650-199306000-00003; Rosborough TK, 1998, BRIT MED J, V316, P1107, DOI 10.1136/bmj.316.7138.1107; Rosenthal GE, 1997, JAMA-J AM MED ASSOC, V278, P485, DOI 10.1001/jama.278.6.485; Rosner B., 2011, FUNDAMENTALS BIOSTAT, P352; Ryan TJ, 1996, CIRCULATION, V94, P2341, DOI 10.1161/01.CIR.94.9.2341; Schlesinger M, 1997, HEALTH SERV RES, V32, P561; Scholer SJ, 1996, ARCH PEDIAT ADOL MED, V150, P1154, DOI 10.1001/archpedi.1996.02170360044006; Shortell, 1996, REMAKING HLTH CARE A; SHORTELL SM, 1995, HEALTH SERV RES, V30, P377; Taylor DH, 1999, NEW ENGL J MED, V340, P293, DOI 10.1056/NEJM199901283400408; UDVARHELYI IS, 1990, AM J PUBLIC HEALTH, V80, P1095, DOI 10.2105/AJPH.80.9.1095; *US DEP HHS, 1997, INT CLASS DIS CLIN M; Wells RD, 1998, ACAD MED, V73, P192, DOI 10.1097/00001888-199802000-00019; Wyatt SM, 1997, ACAD MED, V72, P922; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; ZIMMERMAN JE, 1993, CRIT CARE MED, V21, P1432, DOI 10.1097/00003246-199310000-00009	63	246	247	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 13	2000	284	10					1256	1262		10.1001/jama.284.10.1256	http://dx.doi.org/10.1001/jama.284.10.1256			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	350WL	10979112	Bronze, Green Published			2022-12-24	WOS:000089124600032
J	Wise, RP; Salive, ME; Braun, MM; Mootrey, GT; Seward, JF; Rider, LG; Krause, PR				Wise, RP; Salive, ME; Braun, MM; Mootrey, GT; Seward, JF; Rider, LG; Krause, PR			Postlicensure safety surveillance for varicella vaccine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REPORTING-SYSTEM VAERS; POLYMERASE CHAIN-REACTION; PERIPHERAL FACIAL PALSY; ZOSTER VIRUS; HEALTHY-CHILDREN; FOLLOW-UP; THROMBOCYTOPENIA; IMMUNIZATION; CHICKENPOX; EFFICACY	Context Since its licensure in 1995, the extensive use of varicella vaccine and close surveillance of the associated anecdotal reports of suspected adverse effects provide the opportunity to detect potential risks not observed before licensure because of the relatively small sample size and other limitations of clinical trials. Objectives To detect potential hazards, including rare events, associated with varicella vaccine, and to assess case reports for clinical and epidemiological implications. Design and Setting Postlicensure case-series study of suspected vaccine adverse events reported to the US Vaccine Adverse Event Reporting System (VAERS) from March 17, 1995, through July 25, 1998. Main Outcome Measures Numbers of reported adverse events, proportions, and reporting rates (reports per 100 000 doses distributed). Results VAERS received 6574 case reports of adverse events in recipients of varicella vaccine, a rate of 67.5 reports per 100 000 doses sold. Approximately 4% of reports described serious adverse events, including 14 deaths. The most frequently reported adverse events were rashes, possible vaccine failures, and injection site reactions. Misinterpretation of varicella serology after vaccination appeared to account for 17% of reports of possible vaccine failures. Among 251 patients with herpes tester, 14 had the vaccine strain of varicella tester virus (VZV), while 12 had the wild-type virus. None of 30 anaphylaxis cases was fatal, An immunodeficient patient with pneumonia had the vaccine strain of VZV in a lung biopsy, Pregnant women occasionally received varicella vaccine through confusion with varicella tester immunoglobulin. Although the role of varicella vaccine remained unproven in most serious adverse event reports, there were a few positive rechallenge reports and consistency of many cases with syndromes recognized as complications of natural varicella. Conclusion Most of the reported adverse events associated with varicella vaccine are minor, and serious risks appear to be rare. We could not confirm a vaccine etiology for most of the reported serious events; several will require further study to clarify whether varicella vaccine plays a role. Education is needed to ensure appropriate use of varicella serologic assays and to eliminate confusion between varicella vaccine and varicella zoster immunoglobulin.	US FDA, Ctr Biol Evaluat & Res, Off Biostat & Epidemiol, Div Epidemiol, Rockville, MD 20857 USA; US FDA, Off Therapeut Res & Review & DNA Viruses, Div Monoclonal Antibodies, Labs Mol & Dev Immunol, Rockville, MD 20857 USA; US FDA, Off Vaccines Res & Review, Rockville, MD 20857 USA; Ctr Dis Control & Prevent, Branch Vaccine Safety & Dev, Div Epidemiol & Surveillance, Natl Immunizat Program, Atlanta, GA USA; Ctr Dis Control & Prevent, Branch Child Vaccine Preventable Dis, Div Epidemiol & Surveillance, Natl Immunizat Program, Atlanta, GA USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Wise, RP (corresponding author), 1401 rockville Pike,FDA CBER HFM-225, Rockville, MD 20852 USA.		Rider, Lisa G/C-7083-2018	Rider, Lisa G/0000-0002-6912-2458; Krause, Philip/0000-0002-1045-7536				[Anonymous], 1998, MMWR MORB MORTAL WKL, V47, P365; ARBETER AM, 1984, AM J DIS CHILD, V138, P434, DOI 10.1001/archpedi.1984.02140430012004; Arvin AM, 1996, ANNU REV MICROBIOL, V50, P59, DOI 10.1146/annurev.micro.50.1.59; ASANO Y, 1976, LANCET, V1, P965; BERNSTEIN HH, 1993, PEDIATRICS, V92, P833; Black S, 1999, PEDIATR INFECT DIS J, V18, P1041, DOI 10.1097/00006454-199912000-00003; Braun MM, 1997, J PEDIATR-US, V131, P529, DOI 10.1016/S0022-3476(97)70056-8; CHEN RT, 1994, VACCINE, V12, P542, DOI 10.1016/0264-410X(94)90315-8; Chen RT, 1997, PEDIATRICS, V99, P765, DOI 10.1542/peds.99.6.765; CHEN RT, 2000, PHARMACOEPIDEMIOLOGY; COPLAN P, 1998, PHARMACOEPIDEMIOL S2, V7, pS90; *DEP HLTH HUM SERV, 1997, 94 DEP HLTH HUM SERV; ELLENBERG SE, 1997, PUBLIC HLTH REP, V112, P9; ENDERS G, 1994, LANCET, V343, P1548, DOI 10.1016/S0140-6736(94)92943-2; FAICH GA, 1986, NEW ENGL J MED, V314, P1589, DOI 10.1056/NEJM198606123142427; FEUSNER JH, 1979, AM J HEMATOL, V7, P255, DOI 10.1002/ajh.2830070308; *FOOD DRUG ADM, 1995, COSTART COD SYMB THE; Furuta Y, 1997, J MED VIROL, V52, P316, DOI 10.1002/(SICI)1096-9071(199707)52:3&lt;316::AID-JMV13&gt;3.0.CO;2-G; Gilden DH, 2000, NEW ENGL J MED, V342, P635, DOI 10.1056/NEJM200003023420906; HENG MCY, 1985, BRIT J DERMATOL, V112, P235, DOI 10.1111/j.1365-2133.1985.tb00089.x; Hosseinipour MC, 1998, SOUTHERN MED J, V91, P1070, DOI 10.1097/00007611-199811000-00018; Intussusception among recipients of rotavirus vaccine-United States, 1999, MMWR MORB MORTAL WKL, V48, P577; Izurieta HS, 1997, JAMA-J AM MED ASSOC, V278, P1495, DOI 10.1001/jama.278.18.1495; JOHNSON CE, 1988, PEDIATRICS, V81, P512; KAHANE S, 1981, CLIN EXP IMMUNOL, V44, P49; KELSO JM, 1993, J ALLERGY CLIN IMMUN, V91, P867, DOI 10.1016/0091-6749(93)90344-F; KleinschmidtDeMasters BK, 1996, HUM PATHOL, V27, P927, DOI 10.1016/S0046-8177(96)90220-8; Kohl S, 1999, PEDIATR INFECT DIS J, V18, P1112, DOI 10.1097/00006454-199912000-00023; KRAUSE PR, 1995, J PEDIATR-US, V127, P518, DOI 10.1016/S0022-3476(95)70106-0; KUTER BJ, 1991, VACCINE, V9, P643, DOI 10.1016/0264-410X(91)90189-D; LARUSSA P, 1992, J VIROL, V66, P1016, DOI 10.1128/JVI.66.2.1016-1020.1992; Lasky T, 1998, NEW ENGL J MED, V339, P1797, DOI 10.1056/NEJM199812173392501; LAWRENCE R, 1988, NEW ENGL J MED, V318, P543, DOI 10.1056/NEJM198803033180904; Lee MS, 1998, OPHTHALMOLOGY, V105, P467, DOI 10.1016/S0161-6420(98)93029-9; Mayer JLR, 1996, PEDIATR RES, V40, P615, DOI 10.1203/00006450-199610000-00017; *MED EC CO, 1999, PHYSICIANS DESK REFE, P1908; *MERCK RES LAB, 1999, PREGN REG VAR 3 ANN; MILLER DH, 1986, J NEUROL, V233, P182, DOI 10.1007/BF00314431; MORGAN M, 1995, J INFECTION, V30, P29, DOI 10.1016/S0163-4453(95)92769-7; PETER G, 1999, MMWR-MORBID MORTAL W, V48, P1; ROBILLARD RB, 1986, OTOLARYNG HEAD NECK, V95, P292, DOI 10.1177/01945998860953P105; SAKAGUCHI M, 1995, J ALLERGY CLIN IMMUN, V96, P563, DOI 10.1016/S0091-6749(95)70304-7; Sakaguchi M, 1997, J ALLERGY CLIN IMMUN, V99, P263, DOI 10.1016/S0091-6749(97)70108-8; Salzman MB, 1997, J PEDIATR-US, V131, P151, DOI 10.1016/S0022-3476(97)70140-9; Sebire G, 1999, ANN NEUROL, V45, P679, DOI 10.1002/1531-8249(199905)45:5<679::AID-ANA22>3.0.CO;2-E; SHAPIRO E, 1998, 36 ANN M INF DIS SOC; Singleton JA, 1999, VACCINE, V17, P2908, DOI 10.1016/S0264-410X(99)00132-2; STEIDMAN DS, 1996, BRIT MED J, V313, P701; STROM BL, 1994, PHARMACOEPIDEMIOLOGY, P431; TABONY L, 1998, 36 ANN M INF DIS SOC; TAUB JW, 1995, AM J HEMATOL, V48, P104, DOI 10.1002/ajh.2830480207; TOVI F, 1980, ISRAEL J MED SCI, V16, P576; Varicella-related deaths among adults-United States 1997, 1997, MMWR MORB MORTAL WKL, V46, P409; WATSON BM, 1993, PEDIATRICS, V91, P17; WEBER RE, 1984, MOL PHYSIOL, V6, P1; WEIBEL RE, 1984, NEW ENGL J MED, V310, P1409, DOI 10.1056/NEJM198405313102201; WEIBEL RE, 1985, JAMA-J AM MED ASSOC, V254, P2435, DOI 10.1001/jama.254.17.2435; WINIARSKI J, 1990, ARCH DIS CHILD, V65, P137, DOI 10.1136/adc.65.1.137; Wise RP, 1997, JAMA-J AM MED ASSOC, V278, P1176, DOI 10.1001/jama.278.14.1176; WISE RP, 1996, PRINCIPLES DRUG DEV; Wright JF, 1996, BRIT J HAEMATOL, V95, P145, DOI 10.1046/j.1365-2141.1996.d01-1872.x; 1999, MMWR MORB MORTAL WKL, V48, P55; 1999, MMWR MORB MORTAL WKL, V48, P829; 1996, MMWR MORB MORTAL WKL, V45, P1017; 1996, MMWR MORB MORTAL WKL, V45, P12; 1996, MMWR MORB MORTAL WKL, V45, P239; 1997, MMWR MORB MORTAL WKL, V46, P657; 1999, MMWR MORB MORTAL WKL, V48, P1; 1996, MMWR MORB MORTAL WKL, V45, P18	69	146	150	1	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 13	2000	284	10					1271	1279		10.1001/jama.284.10.1271	http://dx.doi.org/10.1001/jama.284.10.1271			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	350WL	10979114	Bronze			2022-12-24	WOS:000089124600034
J	Holy, TE; Dulac, C; Meister, M				Holy, TE; Dulac, C; Meister, M			Responses of vomeronasal neurons to natural stimuli	SCIENCE			English	Article							PUTATIVE PHEROMONE RECEPTORS; MULTIGENE FAMILY; SENSORY NEURONS; TRANSDUCTION; CELLS; ADAPTATION; MAMMALS; ORGAN; ACTIVATION; PATHWAY	The vomeronasal organ (VNO) of mammals plays an essential role in the detection of pheromones, We obtained simultaneous recordings of action potentials from Large subsets of VNO neurons. These cells responded to components of urine by increasing their firing rate. This chemosensory activation required phospholipase C function. Unlike most other sensory neurons, VNO neurons did not adapt under prolonged stimulus exposure, The full time course of the VNO spiking response is captured by a simple quantitative model of ligand binding. Many individual VNO neurons were strongly selective for either male or female mouse urine, with the effective concentrations differing as much as a thousandfold. These results establish a framework for understanding sensory coding in the vomeronasal system.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; Harvard University; Howard Hughes Medical Institute	Holy, TE (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.			Dulac, Catherine/0000-0001-5024-5418; Meister, Markus/0000-0003-2136-6506				Belluscio L, 1999, CELL, V97, P209, DOI 10.1016/S0092-8674(00)80731-X; Berghard A, 1996, J NEUROSCI, V16, P909; BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756; Doving KB, 1998, J EXP BIOL, V201, P2913; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Falke JJ, 1997, ANNU REV CELL DEV BI, V13, P457, DOI 10.1146/annurev.cellbio.13.1.457; FIRESTEIN S, 1989, SCIENCE, V244, P79, DOI 10.1126/science.2704991; HALPERN M, 1987, ANNU REV NEUROSCI, V10, P325, DOI 10.1146/annurev.ne.10.030187.001545; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Inamura I, 1999, J PHYSIOL-LONDON, V517, P731, DOI 10.1111/j.1469-7793.1999.0731s.x; Inamura K, 1997, NEUROSCI LETT, V233, P129, DOI 10.1016/S0304-3940(97)00655-1; Liman ER, 1999, P NATL ACAD SCI USA, V96, P5791, DOI 10.1073/pnas.96.10.5791; Liman ER, 1996, J NEUROSCI, V16, P4625; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; McClintic J., 1978, PHYSL HUMAN BODY; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; MEREDITH M, 1994, PHYSIOL BEHAV, V56, P345, DOI 10.1016/0031-9384(94)90205-4; Moss RL, 1998, CHEM SENSES, V23, P483, DOI 10.1093/chemse/23.4.483; Moss RL, 1997, J NEUROPHYSIOL, V77, P2856, DOI 10.1152/jn.1997.77.5.2856; Reisert J, 1999, J PHYSIOL-LONDON, V519, P801, DOI 10.1111/j.1469-7793.1999.0801n.x; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Scott K, 1998, CURR OPIN NEUROBIOL, V8, P383, DOI 10.1016/S0959-4388(98)80065-2; Torre V, 1995, J NEUROSCI, V15, P7757; WYSOCKI CJ, 1991, J STEROID BIOCHEM, V39, P661, DOI 10.1016/0960-0760(91)90265-7	25	204	209	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 1	2000	289	5484					1569	1572		10.1126/science.289.5484.1569	http://dx.doi.org/10.1126/science.289.5484.1569			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349XW	10968796				2022-12-24	WOS:000089071700052
J	Steidler, L; Hans, W; Schotte, L; Neirynck, S; Obermeier, F; Falk, W; Fiers, W; Remaut, E				Steidler, L; Hans, W; Schotte, L; Neirynck, S; Obermeier, F; Falk, W; Fiers, W; Remaut, E			Treatment of murine colitis by Lactococcus lactis secreting interleukin-10	SCIENCE			English	Article							MONOCLONAL-ANTIBODY CA2; CROHNS-DISEASE; PREVENTS COLITIS; MICE; INFLAMMATION; ENTEROCOLITIS; RESPONSES; INDUCTION; CYTOKINE; INTEGRIN	The cytokine interleukin-10 (IL-10) has shown promise in clinical trials for treatment of inflammatory bower disease (IBD), Using two mouse models, we show that the therapeutic dose of IL-10 can be reduced by Localized delivery of a bacterium genetically engineered to secrete the cytokine, Intragastric administration of IL-10-secreting Lactococcus lactis caused a 50% reduction in colitis in mice treated with dextran sulfate sodium and prevented the onset of colitis in IL-10(-/-) mice. This approach may Lead to better methods for cost-effective and Long-term management of IBD in humans.	Univ Ghent, Dept Mol Biol, B-9000 Ghent, Belgium; Flanders Interuniv Inst Biotechnol, B-9000 Ghent, Belgium; Univ Regensburg, Dept Internal Med 1, D-93042 Regensburg, Germany	Ghent University; University of Regensburg	Steidler, L (corresponding author), Univ Ghent, Dept Mol Biol, KL Ledeganckstr 35, B-9000 Ghent, Belgium.	lothar.steidler@dmb.rug.ac.be						Berg DJ, 1996, J CLIN INVEST, V98, P1010, DOI 10.1172/JCI118861; Boirivant M, 1998, J EXP MED, V188, P1929, DOI 10.1084/jem.188.10.1929; COLLINS JK, 1999, GASTROENTEROLOGY, V116, pG2981; Corthier G, 1998, APPL ENVIRON MICROB, V64, P2721; D'Haens G, 1999, GASTROENTEROLOGY, V116, P1029, DOI 10.1016/S0016-5085(99)70005-3; Ehrhardt RO, 1997, J IMMUNOL, V158, P566; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Kojouharoff G, 1997, CLIN EXP IMMUNOL, V107, P353, DOI 10.1111/j.1365-2249.1997.291-ce1184.x; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; MacDonald TT, 2000, SCAND J IMMUNOL, V51, P2; Madsen KL, 1999, GASTROENTEROLOGY, V116, P1107, DOI 10.1016/S0016-5085(99)70013-2; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Pender SLF, 1998, GASTROENTEROLOGY, V115, P573, DOI 10.1016/S0016-5085(98)70136-2; Picarella D, 1997, J IMMUNOL, V158, P2099; PODOLSKY DK, 1993, J CLIN INVEST, V92, P372, DOI 10.1172/JCI116575; Rath HC, 1996, J CLIN INVEST, V98, P945, DOI 10.1172/JCI118878; Rennick DM, 1997, J LEUKOCYTE BIOL, V61, P389, DOI 10.1002/jlb.61.4.389; Sartor RB, 1997, AM J GASTROENTEROL, V92, pS5; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Steidler L, 1998, INFECT IMMUN, V66, P3183, DOI 10.1128/IAI.66.7.3183-3189.1998; STEIDLER L, 1995, APPL ENVIRON MICROB, V61, P1627, DOI 10.1128/AEM.61.4.1627-1629.1995; STEIDLER L, 1996, NATO ASI SERIES H, V98, P63; Stordeur P, 1998, Int Rev Immunol, V16, P501, DOI 10.3109/08830189809043006; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; THOMPSONSNIPES LA, 1991, J EXP MED, V173, P507, DOI 10.1084/jem.173.2.507; vanDeventer SJH, 1997, GASTROENTEROLOGY, V113, P383, DOI 10.1053/gast.1997.v113.pm9247454; VANDULLEMEN HM, 1995, GASTROENTEROLOGY, V109, P129, DOI 10.1016/0016-5085(95)90277-5; WYSOCKA M, 1995, EUR J IMMUNOL, V25, P672, DOI 10.1002/eji.1830250307	29	1064	1181	13	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2000	289	5483					1352	1355		10.1126/science.289.5483.1352	http://dx.doi.org/10.1126/science.289.5483.1352			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347RF	10958782				2022-12-24	WOS:000088942400039
J	Schneggenburger, R; Neher, E				Schneggenburger, R; Neher, E			Intracellular calcium dependence of transmitter release rates at a fast central synapse	NATURE			English	Article							BOVINE CHROMAFFIN CELLS; NEUROTRANSMITTER RELEASE; FLASH-PHOTOLYSIS; CA2+ BINDING; TIME-COURSE; CAGED CA2+; CHELATORS; CNS; DESENSITIZATION; RECEPTORS	Calcium-triggered fusion of synaptic vesicles and neurotransmitter release are fundamental signalling steps in the central nervous system. It is generally assumed that fast transmitter release is triggered by elevations in intracellular calcium concentration ([Ca2+](i)) to at least 100 mu M near the sites of vesicle fusion(1-5). For synapses in the central nervous system, however, there are no experimental estimates of this local [Ca2+](i) signal. Here we show, by using calcium ion uncaging in the large synaptic terminals of the calyx of Held, that step-like elevations to only 10 mu M [Ca2+](i) induce fast transmitter release, which depletes around 80% of a pool of available vesicles in less than 3 ms. Kinetic analysis of transmitter release rates after [Ca2+](i) steps revealed the rate constants for calcium binding and vesicle fusion. These show that transient (around 0.5 ms) local elevations of [Ca2+](i) to peak values as low as 25 mu M can account for transmitter release during single presynaptic action potentials. The calcium sensors for vesicle fusion are far from saturation at normal release probability. This non-saturation, and the high intracellular calcium cooperativity in triggering vesicle fusion, make fast synaptic transmission very sensitive to modulation by changes in local [Ca2+](i).	Max Planck Inst Biophys Chem, Abt Membranbiophys, D-37077 Gottingen, Germany	Max Planck Society	Schneggenburger, R (corresponding author), Max Planck Inst Biophys Chem, Abt Membranbiophys, Fassberg 11, D-37077 Gottingen, Germany.	rschneg@gwdg.de	Neher, Erwin/A-2109-2013					ADLER EM, 1991, J NEUROSCI, V11, P1496; BARNESDAVIES M, 1995, J PHYSIOL-LONDON, V488, P387, DOI 10.1113/jphysiol.1995.sp020974; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Borst JGG, 1995, J PHYSIOL-LONDON, V489, P825, DOI 10.1113/jphysiol.1995.sp021095; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; FORSYTHE ID, 1994, J PHYSIOL-LONDON, V479, P381, DOI 10.1113/jphysiol.1994.sp020303; Goda Y, 1997, CURR OPIN CELL BIOL, V9, P513, DOI 10.1016/S0955-0674(97)80027-0; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; Helmchen F, 1997, BIOPHYS J, V72, P1458, DOI 10.1016/S0006-3495(97)78792-7; Lagnado L, 1996, NEURON, V17, P957, DOI 10.1016/S0896-6273(00)80226-3; LANDO L, 1994, J NEUROPHYSIOL, V72, P825, DOI 10.1152/jn.1994.72.2.825; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; Naraghi M, 1998, BIOPHYS J, V75, P1635, DOI 10.1016/S0006-3495(98)77606-4; Ohana O, 1998, J PHYSIOL-LONDON, V513, P135, DOI 10.1111/j.1469-7793.1998.135by.x; ROBERTS WM, 1994, J NEUROSCI, V14, P3246; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; THOMAS P, 1993, EMBO J, V12, P303, DOI 10.1002/j.1460-2075.1993.tb05657.x; Traynelis SF, 1998, J NEUROSCI METH, V86, P25, DOI 10.1016/S0165-0270(98)00140-X; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; VANDERKLOOT W, 1988, J PHYSIOL-LONDON, V402, P595, DOI 10.1113/jphysiol.1988.sp017224; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6; Xu T, 1997, BIOPHYS J, V73, P532, DOI 10.1016/S0006-3495(97)78091-3; Xu-Friedman MA, 1999, BIOPHYS J, V76, P2029, DOI 10.1016/S0006-3495(99)77360-1; YAMADA KA, 1993, J NEUROSCI, V13, P3904; YAMADA WM, 1992, BIOPHYS J, V61, P671, DOI 10.1016/S0006-3495(92)81872-6; ZUCKER RS, 1992, CELL CALCIUM, V13, P29, DOI 10.1016/0143-4160(92)90027-P; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	31	541	547	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2000	406	6798					889	893		10.1038/35022702	http://dx.doi.org/10.1038/35022702			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347AG	10972290				2022-12-24	WOS:000088903600044
J	Weinstock, MA				Weinstock, MA			Early detection of melanoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CUTANEOUS MALIGNANT-MELANOMA; SKIN-CANCER PREVENTION; FAMILY PHYSICIANS; SCREENING-PROGRAM; SELF-EXAMINATION; EARLY DIAGNOSIS; FOLLOW-UP; DERMATOLOGISTS; DELAY; CARE		VA Med Ctr 111D, Dermatoepidemiol Unit, Providence, RI 02908 USA; Rhode Isl Hosp, Dept Dermatol, Providence, RI USA; Brown Univ, Providence, RI 02912 USA	Lifespan Health Rhode Island; Rhode Island Hospital; Brown University	Weinstock, MA (corresponding author), VA Med Ctr 111D, Dermatoepidemiol Unit, 830 Chalkstone Ave, Providence, RI 02908 USA.	maw@brown.edu						ACKERMAN AB, 1985, J DERMATOL SURG ONC, V11, P771, DOI 10.1016/S0190-9622(85)80242-5; *AM MED ASS, IN PRESS PHYS CHAR D; Berwick M, 1996, J NATL CANCER I, V88, P17, DOI 10.1093/jnci/88.1.17; BINDER M, 1995, ARCH DERMATOL, V131, P286, DOI 10.1001/archderm.131.3.286; Blum A, 1999, BRIT J DERMATOL, V141, P783, DOI 10.1046/j.1365-2133.1999.03196.x; Burton RC, 1998, J MED SCREEN, V5, P156, DOI 10.1136/jms.5.3.156; CASSILETH BR, 1988, J AM ACAD DERMATOL, V18, P591, DOI 10.1016/S0190-9622(88)70081-X; CASSILETH BR, 1986, J AM ACAD DERMATOL, V14, P555, DOI 10.1016/S0190-9622(86)70068-6; *CONS DEV PAN, 1992, NIH CONSENSUS STATE, V10, P1; CRISTOFOLINI M, 1993, CANCER, V71, P370, DOI 10.1002/1097-0142(19930115)71:2&lt;370::AID-CNCR2820710217&gt;3.0.CO;2-M; Elwood JM, 1988, PIGMENT CELL RES, V9, P118; Engelberg D, 1999, J AM ACAD DERMATOL, V41, P37, DOI 10.1016/S0190-9622(99)70403-2; Federman DG, 1997, ARCH DERMATOL, V133, P1423, DOI 10.1001/archderm.133.11.1423; Freedberg KA, 1999, J AM ACAD DERMATOL, V41, P738, DOI 10.1016/S0190-9622(99)70010-1; Gerbert B, 1998, J GEN INTERN MED, V13, P91, DOI 10.1046/j.1525-1497.1998.00024.x; Gerbert B, 1996, ARCH DERMATOL, V132, P1030, DOI 10.1001/archderm.132.9.1030; Girgis A, 1996, CANCER DETECT PREV, V20, P316; Girgis A, 1996, J Med Screen, V3, P47; Girgis A, 1995, MED EDUC, V29, P364, DOI 10.1111/j.1365-2923.1995.tb00027.x; Hill L, 1998, CA-CANCER J CLIN, V48, P232, DOI 10.3322/canjclin.48.4.232; Jonna BP, 1998, PREV MED, V27, P611, DOI 10.1006/pmed.1998.0334; Kelly JW, 1997, MED J AUSTRALIA, V167, P191, DOI 10.5694/j.1326-5377.1997.tb138843.x; KOH HK, 1990, CANCER, V65, P375, DOI 10.1002/1097-0142(19900115)65:2<375::AID-CNCR2820650233>3.0.CO;2-Z; KOH HK, 1992, J AM ACAD DERMATOL, V26, P914, DOI 10.1016/0190-9622(92)70132-Y; Koh HK, 1996, J AM ACAD DERMATOL, V34, P971, DOI 10.1016/S0190-9622(96)90274-1; KRIGE JEJ, 1991, CANCER, V68, P2064, DOI 10.1002/1097-0142(19911101)68:9<2064::AID-CNCR2820680937>3.0.CO;2-3; Laidlaw JM, 1996, MED EDUC, V30, P226, DOI 10.1111/j.1365-2923.1996.tb00747.x; Lindelof Bernt, 1994, Journal of Dermatology (Tokyo), V21, P461; LNADIS SH, 2000, CA-CANCER J CLIN, V50, P1; MacKenzie-Wood A R, 1998, Australas J Dermatol, V39, P31, DOI 10.1111/j.1440-0960.1998.tb01238.x; MACKIE RM, 1992, BRIT MED J, V304, P1012, DOI 10.1136/bmj.304.6833.1012; MASRI GD, 1990, J AM ACAD DERMATOL, V22, P1042, DOI 10.1016/0190-9622(90)70149-C; Mikkilineni R., 2000, Journal of Investigative Dermatology, V114, P888; Mikkilineni R., 2000, Journal of Investigative Dermatology, V114, P775; Miller DR, 1996, J AM ACAD DERMATOL, V34, P962, DOI 10.1016/S0190-9622(96)90273-X; Morton CA, 1998, BRIT J DERMATOL, V138, P283; *NCI, 1999, SEER CANC INC PUBL U; NELSON C, 1998, VITAL HLTH STAT, V13, P1; Polster AM, 1998, ARCH DERMATOL, V134, P1095, DOI 10.1001/archderm.134.9.1095; Richard MA, 1999, ARCH DERMATOL, V135, P269, DOI 10.1001/archderm.135.3.269; Schuchter L, 1996, ANN INTERN MED, V125, P369, DOI 10.7326/0003-4819-125-5-199609010-00003; Smith ES, 1998, DERMATOL SURG, V24, P981, DOI 10.1111/j.1524-4725.1998.tb04291.x; Stephenson A, 1997, J AM ACAD DERMATOL, V37, P953, DOI 10.1016/S0190-9622(97)70071-9; TUCKER MA, 1993, J INVEST DERMATOL, V100, pS350, DOI 10.1111/1523-1747.ep12470264; *US PREV SERV TASK, 1996, GUID CLIN PREV SERV, P141; VASEN HFA, 1989, EUR J CANCER CLIN ON, V25, P337, DOI 10.1016/0277-5379(89)90027-8; Weinstock MA, 1999, AM J PREV MED, V17, P169, DOI 10.1016/S0749-3797(99)00077-X; Weinstock MA, 1999, J INVEST DERMATOL, V112, P664; Weinstock MA, 1996, J AM ACAD DERMATOL, V34, P1063, DOI 10.1016/S0190-9622(96)90287-X; WENDER RC, 1995, CANCER, V75, P691, DOI 10.1002/1097-0142(19950115)75:2+<691::AID-CNCR2820751412>3.0.CO;2-G	50	78	80	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2000	284	7					886	889		10.1001/jama.284.7.886	http://dx.doi.org/10.1001/jama.284.7.886			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342PM	10938181				2022-12-24	WOS:000088654400034
J	Peto, R; Darby, S; Deo, H; Silcocks, P; Whitley, E; Doll, R				Peto, R; Darby, S; Deo, H; Silcocks, P; Whitley, E; Doll, R			Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies	BRITISH MEDICAL JOURNAL			English	Article							MALE BRITISH DOCTORS; MORTALITY; TOBACCO	Objective and design To relate UK national trends since 1950 in smoking, in smoking cessation, and in lung cancer to the contrasting results from two large case-control studies centred around 1950 and 1990. Setting United Kingdom. Participants Hospital patients under 75 years of age with and without lung cancer in 1950 and 1990, plus, in 1990, a matched sample of the local population: 1465 case-control pairs in the 1950 study, and 982 cases plus 3185 controls in the 1990 study. Main outcome measures Smoking prevalence and lung cancer Results For men in ear-iv middle age in the United Kingdom the prevalence of smoking halved between 1950 and 1990 but the death rate from lung cancer at ages 35-54 fell even more rapidly, indicating some reduction in the risk among continuing smokers. Ln contrast women and older men who were still current smokers in 1990 were more likely than those in 1950 to have been persistent cigarette smokers throughout adult life and so had higher lung cancer rates than current smokers in 1950. The cumulative risk of death from lung cancer by age 75 tin the absence of other causes of death) rose from 6% at 1950 rates to 16% at 1990 rates in male cigarette smokers, and from 1% to 10% in female cigarette smokers. Among both men and women in 1990, however, the farmer smokers had only a fraction of the lung cancer rate of continuing smokers, and this fraction fell steeply with time since stopping. By 1990 cessation had almost halved the number of lung cancers that would have been expected if the former smokers had continued. For men who stopped at ages 60, 50, 40, and 30 the cumulative risks of lung cancer by age 75 were 10%, 6%, 3%, and 2%. Conclusions People who stop smoking, even well into middle age, avoid most of their subsequent risk of lung cancer, and stopping before middle age avoids more than 90% of the risk attributable to tobacco. Mortality in the near future and throughout the first half of the 21st century could be substantially reduced by current smokers giving up the habit. In contrast, the extent to which young people henceforth become persistent smokers will affect mortality rates chiefly in the middle or second half of the 21st century.	Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England; Radcliffe Infirm, Epidemiol Studies Unit, Oxford OX2 6HE, England; Radcliffe Infirm, Canc Epidemiol Unit, Oxford OX2 6HE, England; Queens Med Ctr, Trent Inst Hlth Serv Res, Nottingham NG7 2UH, England; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	Radcliffe Infirmary; University of Oxford; Radcliffe Infirmary; University of Oxford; Radcliffe Infirmary; University of Oxford; University of Nottingham; University of Bristol	Darby, S (corresponding author), Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England.							Darby S, 1998, BRIT J CANCER, V78, P394, DOI 10.1038/bjc.1998.506; DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; DOLL R, 1952, BMJ-BRIT MED J, V2, P1271, DOI 10.1136/bmj.2.4797.1271; Doll R, 1998, Stat Methods Med Res, V7, P87, DOI 10.1191/096228098668199908; DOLL R, 1976, BRIT MED J, V2, P1525, DOI 10.1136/bmj.2.6051.1525; DOLL R, 1950, BRIT MED J, V2, P739, DOI 10.1136/bmj.2.4682.739; DOLL R, 1980, BRIT MED J, V280, P967, DOI 10.1136/bmj.280.6219.967; DOLL R, 1997, HLTH ADULT BRITAIN 1, V1, P128; LEVIN ML, 1950, JAMA-J AM MED ASSOC, V143, P336, DOI 10.1001/jama.1950.02910390008002; MILLS CA, 1950, CANCER RES, V10, P539; NICOLAIDESBOUMA.A, 1993, INT SMOKING STAT; *OFF NAT STAT, 2000, RES 1998 GEN HOUS SU; *OFF NAT STAT, 1997, MORT STAT GEN 1993 1; Peto R, 1999, NAT MED, V5, P15, DOI 10.1038/4691; Peto R, 1986, IARC Sci Publ, P211; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; PETO R, 2000, GLOBAL HLTH 21 CENTU; PETO R, 1994, MORTALITY TOBACCO DE; SCHREK R, 1950, CANCER RES, V10, P49; *STAT CORP, 1997, STAT STAT SOFTW REL; THUN MJ, 1995, AM J PUBLIC HEALTH, V85, P1223, DOI 10.2105/AJPH.85.9.1223; Wald N, 1988, UK SMOKING STAT; *WHO, MORT STAT UK 1950 19; WYNDER EL, 1950, JAMA-J AM MED ASSOC, V143, P329, DOI 10.1001/jama.1950.02910390001001	25	922	956	1	125	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 5	2000	321	7257					323	329		10.1136/bmj.321.7257.323	http://dx.doi.org/10.1136/bmj.321.7257.323			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342QH	10926586	Bronze, Green Published			2022-12-24	WOS:000088656300020
J	Zheng, LL; Sekerkova, G; Vranich, K; Tilney, LG; Mugnaini, E; Bartles, JR				Zheng, LL; Sekerkova, G; Vranich, K; Tilney, LG; Mugnaini, E; Bartles, JR			The deaf jerker mouse has a mutation in the gene encoding the espin actin-bundling proteins of hair cell stereocilia and lacks espins	CELL			English	Article							INNER-EAR; UNCONVENTIONAL MYOSIN; INSITU HYBRIDIZATION; LOCALIZATION; TRANSDUCTION; IDENTIFICATION; COCHLEA; MUTANT; CHICK; MICE	The espins are actin-bundling proteins of brush border microvilli and Sertoli cell-spermatid junctions. We have determined that espins are also present in hair cell stereocilia and have uncovered a connection between the espin gene and jerker, a recessive mutation that causes hair cell degeneration, deafness, and vestibular dysfunction. The espin gene maps to the same region of mouse chromosome 4 as jerker. The tissues of jerker mice do not accumulate espin proteins but contain normal levels of espin mRNAs. The espin gene of jerker mice has a frameshift mutation that affects the espin C-terminal actin-bundling module. These data suggest that jerker mice are, in effect, espin null and that the jerker phenotype results from a mutation in the espin gene.	Northwestern Univ, Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, Inst Neurosci, Chicago, IL 60611 USA; Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	Northwestern University; Northwestern University; University of Pennsylvania	Bartles, JR (corresponding author), Northwestern Univ, Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA.	j-bartles@northwestern.edu		Bartles, James/0000-0002-7056-3875	NICHD NIH HHS [HD01210, HD35280, K02 HD001210-04] Funding Source: Medline; NIDCD NIH HHS [DC04314, R01 DC004314-01, R01 DC004314] Funding Source: Medline; NIGMS NIH HHS [R37 GM052857, R37 GM052857-23] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K02HD001210, R01HD035280] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM052857] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004314] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ANNIKO M, 1989, ARCH OTO-RHINO-LARYN, V246, P43, DOI 10.1007/BF00454133; AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; Bartles JR, 2000, CURR OPIN CELL BIOL, V12, P72, DOI 10.1016/S0955-0674(99)00059-9; Bartles JR, 1996, J CELL SCI, V109, P1229; Bartles JR, 1998, J CELL BIOL, V143, P107, DOI 10.1083/jcb.143.1.107; Chen B, 1999, MOL BIOL CELL, V10, P4327, DOI 10.1091/mbc.10.12.4327; Denk W, 1995, NEURON, V15, P1311, DOI 10.1016/0896-6273(95)90010-1; DEOL MS, 1954, J GENET, V52, P562, DOI 10.1007/BF02985081; Eatock RA, 1998, OTOLARYNG HEAD NECK, V119, P172, DOI 10.1016/S0194-5998(98)70052-X; EHRET G, 1977, J ACOUST SOC AM, V62, P143, DOI 10.1121/1.381496; FLOCK A, 1982, HEARING RES, V7, P75, DOI 10.1016/0378-5955(82)90082-X; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; Gruneberg H, 1941, P NATL ACAD SCI USA, V27, P562, DOI 10.1073/pnas.27.12.562; HENG HHQ, 1993, CHROMOSOMA, V102, P325, DOI 10.1007/BF00661275; HENG HHQ, 1992, P NATL ACAD SCI USA, V89, P9509, DOI 10.1073/pnas.89.20.9509; KALTENBACH JA, 1994, J COMP NEUROL, V350, P187, DOI 10.1002/cne.903500204; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LIM DJ, 1986, HEARING RES, V22, P117, DOI 10.1016/0378-5955(86)90089-4; LIM DJ, 1985, ACTA OTO-LARYNGOL, P1; Lumpkin EA, 1998, J NEUROSCI, V18, P6300; MATSUDAIRA P, 1991, TRENDS BIOCHEM SCI, V16, P87, DOI 10.1016/0968-0004(91)90039-X; OHMORI H, 1988, J PHYSIOL-LONDON, V399, P115; PICKLES JO, 1992, TRENDS NEUROSCI, V15, P254, DOI 10.1016/0166-2236(92)90066-H; Probst FJ, 1999, HEARING RES, V130, P1, DOI 10.1016/S0378-5955(98)00231-7; Probst FJ, 1998, SCIENCE, V280, P1444, DOI 10.1126/science.280.5368.1444; Puius YA, 1998, CURR OPIN CELL BIOL, V10, P23, DOI 10.1016/S0955-0674(98)80083-5; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/0968-0004(96)10031-1; ROBERTS WM, 1988, ANNU REV CELL BIOL, V4, P63, DOI 10.1146/annurev.cellbio.4.1.63; SJOSTROM B, 1992, ACTA OTO-LARYNGOL, P141; SJOSTROM B, 1990, EUR ARCH OTO-RHINO-L, V247, P51; SJOSTROM B, 1990, ACTA OTO-LARYNGOL, V109, P353, DOI 10.3109/00016489009125155; SJOSTROM B, 1992, ORL J OTO-RHINO-LARY, V54, P220; SOBIN A, 1983, ACTA OTO-LARYNGOL, V96, P407, DOI 10.3109/00016488309132726; Steel KP, 1995, ANNU REV GENET, V29, P675; Steel KP, 1997, ANN OTO RHINOL LARYN, V106, P59; STEEL KP, 1983, BEHAV NEUROSCI, V97, P381, DOI 10.1037/0735-7044.97.3.381; TILNEY LG, 1992, ANNU REV CELL BIOL, V8, P257, DOI 10.1146/annurev.cb.08.110192.001353; Tilney LG, 1998, J CELL BIOL, V143, P121, DOI 10.1083/jcb.143.1.121; TILNEY MS, 1989, J CELL BIOL, V109, P1711, DOI 10.1083/jcb.109.4.1711; Truett GE, 1996, MAMM GENOME, V7, P356, DOI 10.1007/s003359900103	40	208	215	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 4	2000	102	3					377	385		10.1016/S0092-8674(00)00042-8	http://dx.doi.org/10.1016/S0092-8674(00)00042-8			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	342BP	10975527	Green Accepted, Bronze			2022-12-24	WOS:000088625600012
J	Xie, W; Barwick, JL; Downes, M; Blumberg, B; Simon, CM; Nelson, MC; Neuschwander-Tetri, BA; Bruntk, EM; Guzelian, PS; Evans, RM				Xie, W; Barwick, JL; Downes, M; Blumberg, B; Simon, CM; Nelson, MC; Neuschwander-Tetri, BA; Bruntk, EM; Guzelian, PS; Evans, RM			Humanized xenobiotic response in mice expressing nuclear receptor SXR	NATURE			English	Article							SMALL-BOWEL ENTEROCYTES; TRANSCRIPTIONAL ACTIVATION; SIGNALING PATHWAY; TRANSGENIC MICE; ADULT-RAT; INDUCTION; CYTOCHROME-P-450; CYP3A4; LIVER; IDENTIFICATION	The cytochrome CYP3A gene products, expressed in mammalian liver, are essential for the metabolism of lipophilic substrates, including endogenous steroid hormones and prescription drugs(1,2). CYP3A enzymes are extremely versatile and are inducible by many of their natural and xenobiotic substrates. Consequently, they form the molecular basis for many clinical drug-drug interactions(3). The induction of CYP3A enzymes is species-specific(4,5), and we have postulated that it involves one or more cellular factors, or receptor-like xeno-sensors(6). Here we identify one such factor unequivocally as the nuclear receptor pregnenolone X receptor (PXR)(7,8) and its human homologue, steroid and xenobiotic receptor (SXR)(8-10). We show that targeted disruption of the mouse PXR gene abolishes induction of CYP3A by prototypic inducers such as dexamethasone or pregnenolone-16 alpha-carbonitrile. In transgenic mice, an activated form of SXR causes constitutive upregulation of CYP3A gene expression and enhanced protection against toxic xenobiotic compounds. Furthermore, we show that the species origin of the receptor, rather than the promoter structure of CYP3A genes, dictates the species-specific pattern of CYP3A inducibility. Thus, we can generate 'humanized' transgenic mice that are responsive to human-specific inducers such as the antibiotic rifampicin. We conclude that SXR/PXR genes encode the primary species-specific xeno-sensors that mediate the adaptive hepatic response, and may represent the critical biochemical mechanism of human xenoprotection.	Salk Inst Biol Studies, Howard Hughes Med Inst, Gene Express Lab, La Jolla, CA 92037 USA; Univ Colorado, Hlth Sci Ctr, Denver, CO 80262 USA; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; St Louis Univ, Sch Med, Dept Pathol, Kansas City, MO 64108 USA; St Louis Univ, Sch Med, Div Gastroenterol & Hepatol, Kansas City, MO 64108 USA	Howard Hughes Medical Institute; Salk Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of California System; University of California Irvine; Saint Louis University; Saint Louis University	Evans, RM (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Evans, Ronald/AAF-4001-2019; Xie, Wen/M-1768-2016	Evans, Ronald/0000-0002-9986-5965; 				Barwick JL, 1996, MOL PHARMACOL, V50, P10; Bertilsson G, 1998, P NATL ACAD SCI USA, V95, P12208, DOI 10.1073/pnas.95.21.12208; Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195; Blumberg B, 1998, GENE DEV, V12, P3149, DOI 10.1101/gad.12.20.3149; BOCHERDING SM, 1992, ARCH INTERN MED, V152, P711; BURGER HJ, 1992, P NATL ACAD SCI USA, V89, P2145, DOI 10.1073/pnas.89.6.2145; DENISON MS, 1995, J BIOL CHEM, V270, P18175, DOI 10.1074/jbc.270.31.18175; GONZALEZ FJ, 1992, TRENDS PHARMACOL SCI, V13, P346, DOI 10.1016/0165-6147(92)90107-H; GONZALEZ FJ, 1990, PHARMACOL THERAPEUT, V45, P11; HASHIMOTO H, 1993, EUR J BIOCHEM, V218, P585, DOI 10.1111/j.1432-1033.1993.tb18412.x; HEBERT MF, 1992, CLIN PHARMACOL THER, V52, P453, DOI 10.1038/clpt.1992.171; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; JELINEK DF, 1990, J BIOL CHEM, V265, P8190; Jones SA, 2000, MOL ENDOCRINOL, V14, P27, DOI 10.1210/me.14.1.27; KIMURA S, 1984, NUCLEIC ACIDS RES, V12, P2917, DOI 10.1093/nar/12.6.2917; Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9; KOLARS JC, 1992, J CLIN INVEST, V90, P1871, DOI 10.1172/JCI116064; KOLARS JC, 1994, GASTROENTEROLOGY, V106, P433, DOI 10.1016/0016-5085(94)90602-5; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; MAUREL P, 1996, CYTOCHROMES P450 MET, P241; Nelson DR, 1999, ARCH BIOCHEM BIOPHYS, V369, P1, DOI 10.1006/abbi.1999.1352; PINKERT CA, 1987, GENE DEV, V1, P268, DOI 10.1101/gad.1.3.268; Savas U, 1999, MOL PHARMACOL, V56, P851, DOI 10.1124/mol.56.5.851; SCHUETZ EG, 1984, J BIOL CHEM, V259, P2007; Schuetz EG, 1996, P NATL ACAD SCI USA, V93, P4001, DOI 10.1073/pnas.93.9.4001; SELYE H, 1971, J PHARM SCI, V60, P1, DOI 10.1002/jps.2600600102; Waxman DJ, 1999, ARCH BIOCHEM BIOPHYS, V369, P11, DOI 10.1006/abbi.1999.1351; WRIGHTON SA, 1985, MOL PHARMACOL, V28, P312; Xie W, 1999, ONCOGENE, V18, P3593, DOI 10.1038/sj.onc.1202673; YANAGIMOTO T, 1992, BIOCHIM BIOPHYS ACTA, V1130, P329, DOI 10.1016/0167-4781(92)90447-8	30	561	593	6	22	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					435	439		10.1038/35019116	http://dx.doi.org/10.1038/35019116			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935643				2022-12-24	WOS:000088383800053
J	Simpson, AJG; Reinach, FC; Arruda, P; Abreu, FA; Acencio, M; Alvarenga, R; Alves, LMC; Araya, JE; Baia, GS; Baptista, CS; Barros, MH; Bonaccorsi, ED; Bordin, S; Bove, JM; Briones, MRS; Bueno, MRP; Camargo, AA; Camargo, LEA; Carraro, DM; Carrer, H; Colauto, NB; Colombo, C; Costa, FF; Costa, MCR; Costa-Neto, CM; Coutinho, LL; Cristofani, M; Dias-Neto, E; Docena, C; El-Dorry, H; Facincani, AP; Ferreira, AJS; Ferreira, VCA; Ferro, JA; Fraga, JS; Franca, SC; Franco, MC; Frohme, M; Furlan, LR; Garnier, M; Goldman, GH; Goldman, MHS; Gomes, SL; Gruber, A; Ho, PL; Hoheisel, JD; Junqueira, ML; Kemper, EL; Kitajima, JP; Krieger, JE; Kuramae, EE; Laigret, F; Lambais, MR; Leite, LCC; Lemos, EGM; Lemos, MVF; Lopes, SA; Lopes, CR; Machado, JA; Machado, MA; Madeira, AMBN; Madeira, HMF; Marino, CL; Marques, MV; Martins, EAL; Martins, EMF; Matsukuma, AY; Menck, CFM; Miracca, EC; Miyaki, CY; Monteiro-Vitorello, CB; Moon, DH; Nagai, MA; Nascimento, ALTO; Netto, LES; Nhani, A; Nobrega, FG; Nunes, LR; Oliveira, MA; de Oliveira, MC; de Oliveira, RC; Palmieri, DA; Paris, A; Peixoto, BR; Pereira, GAG; Pereira, HA; Pesquero, JB; Quaggio, RB; Roberto, PG; Rodrigues, V; Rosa, AJD; de Rosa, VE; de Sa, RG; Santelli, RV; Sawasaki, HE; da Silva, ACR; da Silva, AM; da Silva, FR; Silva, WA; da Silveira, JF; Silvestri, MLZ; Siqueira, WJ; de Souza, AA; de Souza, AP; Terenzi, MF; Truffi, D; Tsai, SM; Tsuhako, MH; Vallada, H; Van Sluys, MA; Verjovski-Almeida, S; Vettore, AL; Zago, MA; Zatz, M; Meidanis, J; Setubal, JC				Simpson, AJG; Reinach, FC; Arruda, P; Abreu, FA; Acencio, M; Alvarenga, R; Alves, LMC; Araya, JE; Baia, GS; Baptista, CS; Barros, MH; Bonaccorsi, ED; Bordin, S; Bove, JM; Briones, MRS; Bueno, MRP; Camargo, AA; Camargo, LEA; Carraro, DM; Carrer, H; Colauto, NB; Colombo, C; Costa, FF; Costa, MCR; Costa-Neto, CM; Coutinho, LL; Cristofani, M; Dias-Neto, E; Docena, C; El-Dorry, H; Facincani, AP; Ferreira, AJS; Ferreira, VCA; Ferro, JA; Fraga, JS; Franca, SC; Franco, MC; Frohme, M; Furlan, LR; Garnier, M; Goldman, GH; Goldman, MHS; Gomes, SL; Gruber, A; Ho, PL; Hoheisel, JD; Junqueira, ML; Kemper, EL; Kitajima, JP; Krieger, JE; Kuramae, EE; Laigret, F; Lambais, MR; Leite, LCC; Lemos, EGM; Lemos, MVF; Lopes, SA; Lopes, CR; Machado, JA; Machado, MA; Madeira, AMBN; Madeira, HMF; Marino, CL; Marques, MV; Martins, EAL; Martins, EMF; Matsukuma, AY; Menck, CFM; Miracca, EC; Miyaki, CY; Monteiro-Vitorello, CB; Moon, DH; Nagai, MA; Nascimento, ALTO; Netto, LES; Nhani, A; Nobrega, FG; Nunes, LR; Oliveira, MA; de Oliveira, MC; de Oliveira, RC; Palmieri, DA; Paris, A; Peixoto, BR; Pereira, GAG; Pereira, HA; Pesquero, JB; Quaggio, RB; Roberto, PG; Rodrigues, V; Rosa, AJD; de Rosa, VE; de Sa, RG; Santelli, RV; Sawasaki, HE; da Silva, ACR; da Silva, AM; da Silva, FR; Silva, WA; da Silveira, JF; Silvestri, MLZ; Siqueira, WJ; de Souza, AA; de Souza, AP; Terenzi, MF; Truffi, D; Tsai, SM; Tsuhako, MH; Vallada, H; Van Sluys, MA; Verjovski-Almeida, S; Vettore, AL; Zago, MA; Zatz, M; Meidanis, J; Setubal, JC		Xylella fastidiosa Consortium Org	The genome sequence of the plant pathogen Xylella fastidiosa	NATURE			English	Article							CITRUS VARIEGATED CHLOROSIS; VIRULENCE FACTORS; SWEET ORANGE; HAEMOPHILUS-INFLUENZAE; DICHELOBACTER-NODOSUS; LIMITED BACTERIUM; ESCHERICHIA-COLI; RTX TOXINS; IDENTIFICATION; SECRETION	Xylella fastidiosa is a fastidious, xylem-limited bacterium that causes a range of economically important plant diseases. Here we report the complete genome sequence of X. fastidiosa clone 9a5c, which causes citrus variegated chlorosis-a serious disease of orange trees. The genome comprises a 52.7% GC-rich 2,679,305-base-pair (bp) circular chromosome and two plasmids of 51,158 bp and 1,285 bp. We can assign putative functions to 47% of the 2,904 predicted coding regions. Efficient metabolic functions are predicted, with sugars as the principal energy and carbon source, supporting existence in the nutrient-poor xylem sap. The mechanisms associated with pathogenicity and virulence involve toxins, antibiotics and ion sequestration systems, as well as bacterium-bacterium and bacterium-host interactions mediated by a range of proteins. Orthologues of some of these proteins have only been identified in animal and human pathogens; their presence in X. fastidiosa indicates that the molecular basis for bacterial pathogenicity is both conserved and independent of host. At least 83 genes are bacteriophage-derived and include virulence-associated genes from other bacteria, providing direct evidence of phage-mediated horizontal gene transfer.	Univ Estadual Campinas, Inst Computacao, BR-13083970 Campinas, SP, Brazil; Inst Ludwig Pesquisa Canc, BR-01509010 Sao Paulo, Brazil; Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508900 Sao Paulo, Brazil; Univ Estadual Campinas, Ctr Biol Mol & Engn Genet, BR-13083970 Campinas, SP, Brazil; Univ Sao Paulo, Fac Med Vet & Zootecnia, Dept Patol, Mol Biol Lab, BR-05508000 Sao Paulo, Brazil; Univ Sao Paulo, Fac Med, Dept Radiol, Disciplina Oncol, BR-01296903 Sao Paulo, Brazil; Univ Estadual Paulista, Fac Ciencias Agr & Vet Jaboticabal, Dept Tecnol, BR-14884900 Jaboticabal, SP, Brazil; Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, BR-04023062 Sao Paulo, Brazil; Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, BR-05508900 Sao Paulo, Brazil; Univ Estadual Campinas, Fac Ciencias Med, Hemoctr, BR-13083970 Campinas, SP, Brazil; INRA, F-33883 Vilenave Dornon, France; Univ Bordeaux 2, Biol Cellulaire & Mol Lab, F-33883 Vilenave Dornon, France; Univ Sao Paulo, Inst Biociencias, Dept Biol, BR-05508900 Sao Paulo, Brazil; Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, BR-13418900 Piracicaba, SP, Brazil; Univ Estadual Paulista, Inst Biociencias, Dept Genet, BR-18618000 Botucatu, SP, Brazil; Inst Agron Campinas, Ctr Genet Biol Mol & Fitoquim, BR-13001970 Campinas, SP, Brazil; Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Clin Med, BR-14049900 Ribeirao Preto, SP, Brazil; Univ Fed Sao Paulo, Escola Paulista Med, Dept Biofis, BR-04023062 Sao Paulo, Brazil; Inst Agron Campinas, Ctr Citricultura Sylvio Moreira, BR-13490970 Cordeiropolis, SP, Brazil; Inst Biol, Lab Bioquim Fitopatol, BR-04014002 Sao Paulo, Brazil; Inst Biol, Lab Imunol, BR-04014002 Sao Paulo, Brazil; Univ Ribeirao Preto, Dept Biotecnol Plantas Med, BR-14096380 Ribeirao Preto, SP, Brazil; Univ Sao Paulo, Ctr Energia Nucl Agr, BR-13400970 Piracicaba, SP, Brazil; Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany; Univ Estadual Paulista, Fac Med Vet & Zootecnia, Dept Melhoramento & Nutr, BR-18600000 Botucatu, SP, Brazil; Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Dept Ciencias Farmaceut, BR-14040903 Ribeirao Preto, SP, Brazil; Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Pret, Dept Biol, BR-14040901 Ribeirao Preto, SP, Brazil; Inst Butantan, Ctr Biotecnol, BR-05503900 Sao Paulo, Brazil; Univ Sao Paulo, Fac Med, Inst Coracao, Lab Genet & Cardiol Mol LIM 13, BR-05403000 Sao Paulo, Brazil; Univ Estadual Paulista, Fac Ciencias Agron, Dept Prod Vegetal, BR-18603970 Botucatu, SP, Brazil; Univ Estadual Paulista, Fac Ciencias Agr & Vet Jaboticabal, Dept Biol Aplicada Agropecuaria, BR-14884900 Jaboticabal, SP, Brazil; Hosp Canc AC Camargo, BR-01509010 Sao Paulo, Brazil; Univ Mogi das Cruzes, Nucleo Integrado Biotecnol, BR-08780911 Mogi Das Cruzes, SP, Brazil; Univ Estadual Campinas, Inst Biol, Dept Genet & Evolucao, BR-13083970 Campinas, SP, Brazil; Univ Sao Paulo, Inst Biociencias, Dept Bot, BR-05508900 Sao Paulo, Brazil; Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Parasitol Microbiol & Imunol, BR-14049900 Ribeirao Preto, SP, Brazil; Univ Sao Paulo, Fac Med, Inst Psiquiatria, Dept Psiquiatria, BR-05403010 Sao Paulo, Brazil; Univ Vale Paraiba, Sao Jose dos Campos, Brazil	Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Estadual de Campinas; INRAE; UDICE-French Research Universities; Universite de Bordeaux; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual Paulista; Instituto Agronomico de Campinas (IAC); Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Instituto Agronomico de Campinas (IAC); Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Ribeirao Preto; Universidade de Sao Paulo; Helmholtz Association; German Cancer Research Center (DKFZ); Universidade Estadual Paulista; Universidade de Sao Paulo; Universidade de Sao Paulo; Instituto Butantan; Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade Estadual Paulista; A.C.Camargo Cancer Center; Universidade de Mogi das Cruzes; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade do Vale do Paraiba	Setubal, JC (corresponding author), Univ Estadual Campinas, Inst Computacao, Caixa Postal 6176, BR-13083970 Campinas, SP, Brazil.	setubal@ic.unicamp.br	Lopes, Silvio/X-6733-2019; Camargo, Anamaria A/E-9388-2012; Van Sluys, Marie-Anne/A-8483-2012; carraro, dirce/C-9179-2009; de Oliveira, Mariana Cabral/G-2512-2012; Meidanis, Joao/P-8140-2015; Acencio, Marcio Luis/ABH-1930-2020; Acencio, Marcio L/D-9264-2012; Martins, Elizabeth AL/B-7135-2015; Pereira, Gonçalo A. G./B-7944-2012; Lopes, Silvio/L-8100-2016; de Souza, Alessandra Alves/GLR-7357-2022; da Silva, Felipe Rodrigues/A-5627-2008; Madeira, AMBN/E-7971-2012; Briones, Marcelo RS/C-5760-2013; Monteiro-Vitorello, Claudia B/F-2436-2012; Verjovski-Almeida, Sergio/E-4082-2012; Silva Jr, Wilson Araújo/E-9487-2011; Vallada, Homero/D-1333-2014; Madeira, Humberto/C-2212-2008; Gruber, Arthur/B-4711-2011; De Souza, Alessandra/C-3458-2012; Lopes Gomes, Suely/HGC-5280-2022; Menck, Carlos FM/G-6321-2011; Camargo, Luis Eduardo Aranha/Y-9954-2019; Dias-Neto, Emmanuel/AAA-6701-2019; LEMOS, ELIANA GM/A-3604-2008; Miyaki, Cristina Y/J-2431-2015; Cristofani-Yaly, Mariângela/D-2288-2012; Marques, Marilis V/C-3085-2013; Setubal, Joao Carlos/C-7305-2012; Carrer, Helaine/C-3159-2012; Netto, Luis/A-3783-2008; Palmieri, Darío/C-3613-2012; Krieger, Jose E/C-3117-2011; Zatz, Mayana/M-5338-2015; Lambais, Marcio R/C-1319-2012; de Oliveira, Marcos A/K-5746-2015; Goldman, Gustavo Henrique/F-1848-2013; Vettore, Andre L/J-5168-2012; Barros, Mario/Q-6358-2019; Camargo, Luis Eduardo A/C-2735-2012; da Silveira, Jose Franco/F-5390-2012; Marino, celso/AAH-2836-2020; Colauto, Nelson/AAG-5416-2019; Nunes, Luiz R/M-4804-2013; alves, lucia maria carareto/AAH-6555-2020; Gomes, Suely Lopes/D-8938-2012; Nhani, Antonio/P-2317-2017; Dias-Neto, Emmanuel/A-5869-2008; Coutinho, Luiz/P-5233-2019; Siqueira, Walter/ABE-4069-2021; Nagai, Maria A/C-6162-2012; da Silva, Aline Maria/C-3649-2012; Simpson, Amelia/HGB-1823-2022; Costa de Oliveira, Regina/A-4571-2017; Alves, Lucia/D-2270-2012; Machado, Marcos/G-3582-2012; Pesquero, Joao/C-1470-2012; Ferro, Jesus Aparecido A/C-8251-2013; Kuramae, Eiko Eurya/F-4738-2012; de Macedo Lemos, Eliana Gertrudes/AAA-4225-2020; Costa, Fernando F/D-1566-2012; Nascimento, Ana L. T. O./E-8488-2012; Barros, Mario H/B-8118-2012; DE SOUZA, ANETE PEREIRA/B-8663-2012; Dias-Neto, Emmanuel/AAE-9147-2020; Papais-Alvarenga, Regina M/A-9385-2012; ZAGO, MARCO A/E-9442-2017; Pereira, Alexandre/HHN-1038-2022; Ferreira, Ari J S/C-2266-2015; Goldman, Maria Helena S./D-1424-2012; Arruda, Paulo/H-1440-2011; Ho, Paulo/P-8267-2015; Leite, Luciana/D-1353-2012; Coutinho, Luiz L/C-8455-2012; Bordin, Silvana/G-3147-2012; Tsai, Siu Mui/C-2793-2012; Franca, Suzelei/E-4069-2013; Costa-Neto, Claudio/K-7291-2015; Rosa, Artur/H-7093-2013	Camargo, Anamaria A/0000-0002-6076-9597; Van Sluys, Marie-Anne/0000-0002-6506-2734; carraro, dirce/0000-0001-5667-1418; de Oliveira, Mariana Cabral/0000-0001-8495-2962; Acencio, Marcio Luis/0000-0002-8278-240X; Acencio, Marcio L/0000-0002-8278-240X; Martins, Elizabeth AL/0000-0002-2333-9379; Lopes, Silvio/0000-0002-7417-3057; de Souza, Alessandra Alves/0000-0003-4589-8355; da Silva, Felipe Rodrigues/0000-0002-3527-6870; Madeira, AMBN/0000-0002-3917-1849; Monteiro-Vitorello, Claudia B/0000-0002-1238-9354; Verjovski-Almeida, Sergio/0000-0002-6356-2401; Silva Jr, Wilson Araújo/0000-0001-9364-2886; Vallada, Homero/0000-0001-5123-8295; Madeira, Humberto/0000-0002-0567-8246; Gruber, Arthur/0000-0001-8093-2278; Menck, Carlos FM/0000-0003-1941-0694; Camargo, Luis Eduardo Aranha/0000-0002-5650-5695; LEMOS, ELIANA GM/0000-0002-1119-7748; Miyaki, Cristina Y/0000-0002-9708-9202; Cristofani-Yaly, Mariângela/0000-0003-0283-989X; Setubal, Joao Carlos/0000-0001-9174-2816; Carrer, Helaine/0000-0002-9329-1841; Netto, Luis/0000-0002-4250-9177; Palmieri, Darío/0000-0003-0841-6257; Krieger, Jose E/0000-0001-5464-1792; Zatz, Mayana/0000-0003-3970-8025; Lambais, Marcio R/0000-0002-7218-3665; de Oliveira, Marcos A/0000-0002-1192-7296; Goldman, Gustavo Henrique/0000-0002-2986-350X; Vettore, Andre L/0000-0001-8526-5478; Barros, Mario/0000-0003-2977-9815; Camargo, Luis Eduardo A/0000-0002-5650-5695; Colauto, Nelson/0000-0003-4390-8302; Nunes, Luiz R/0000-0001-9619-269X; Gomes, Suely Lopes/0000-0002-3367-9676; Nhani, Antonio/0000-0002-3096-4009; Dias-Neto, Emmanuel/0000-0001-5670-8559; Coutinho, Luiz/0000-0002-7266-8881; Nagai, Maria A/0000-0002-0728-4937; da Silva, Aline Maria/0000-0001-9249-4922; Costa de Oliveira, Regina/0000-0002-2446-5510; Alves, Lucia/0000-0002-9328-2726; Machado, Marcos/0000-0001-9780-3990; Pesquero, Joao/0000-0002-4507-632X; Ferro, Jesus Aparecido A/0000-0002-3966-1303; Kuramae, Eiko Eurya/0000-0001-6701-8668; de Macedo Lemos, Eliana Gertrudes/0000-0002-1119-7748; Costa, Fernando F/0000-0002-4632-572X; Nascimento, Ana L. T. O./0000-0003-4851-0870; DE SOUZA, ANETE PEREIRA/0000-0003-3831-9829; Ferreira, Ari J S/0000-0002-7526-5543; Goldman, Maria Helena S./0000-0002-6786-9320; Ho, Paulo/0000-0003-3652-241X; Leite, Luciana/0000-0003-0156-1312; Coutinho, Luiz L/0000-0002-7266-8881; Bordin, Silvana/0000-0002-0192-8869; Tsai, Siu Mui/0000-0002-3733-6312; Franca, Suzelei/0000-0003-4864-430X; colombo, carlos/0000-0003-3269-6068; Costa-Neto, Claudio/0000-0002-7256-6412; ROBERTO, PATRICIA/0000-0001-8932-4666; Briones, Marcelo/0000-0001-8045-2477; Marques, Marilis/0000-0003-1542-8221; Rosa, Artur/0000-0002-7015-9207; Marino, Celso/0000-0003-4524-954X				Alfano JR, 1997, J BACTERIOL, V179, P5655, DOI 10.1128/jb.179.18.5655-5662.1997; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Billington SJ, 1996, FEMS MICROBIOL LETT, V145, P147, DOI 10.1111/j.1574-6968.1996.tb08570.x; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bridges BA, 1999, CURR BIOL, V9, pR475, DOI 10.1016/S0960-9822(99)80299-1; BRLANSKY RH, 1983, PHYTOPATHOLOGY, V73, P530, DOI 10.1094/Phyto-73-530; Brodbeck BV, 1999, ARCH INSECT BIOCHEM, V42, P37, DOI 10.1002/(SICI)1520-6327(199909)42:1&lt;37::AID-ARCH5&gt;3.0.CO;2-9; CHAGAS CM, 1992, J PHYTOPATHOL, V134, P306, DOI 10.1111/j.1439-0434.1992.tb01238.x; CHANG CJ, 1993, CURR MICROBIOL, V27, P137, DOI 10.1007/BF01576010; Cope LD, 1999, J BACTERIOL, V181, P4026, DOI 10.1128/JB.181.13.4026-4034.1999; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Felsenstein J, 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FERAT JL, 1993, NATURE, V364, P358, DOI 10.1038/364358a0; Fernandez LA, 2000, FEMS MICROBIOL REV, V24, P21, DOI 10.1111/j.1574-6976.2000.tb00531.x; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Francino MP, 1997, TRENDS GENET, V13, P240, DOI 10.1016/S0168-9525(97)01118-9; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; HAVARSTEIN LS, 1994, MICROBIOL-SGM, V140, P2383, DOI 10.1099/13500872-140-9-2383; Henderson IR, 1998, TRENDS MICROBIOL, V6, P370, DOI 10.1016/S0966-842X(98)01318-3; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; HOBEISEL JD, 1993, CELL, V73, P109; KATZ ME, 1992, INFECT IMMUN, V60, P4586, DOI 10.1128/IAI.60.11.4586-4592.1992; KNOOP V, 1994, J MOL BIOL, V242, P389, DOI 10.1006/jmbi.1994.1589; Lally ET, 1999, TRENDS MICROBIOL, V7, P356, DOI 10.1016/S0966-842X(99)01530-9; Li WB, 1999, CURR MICROBIOL, V39, P106, DOI 10.1007/s002849900428; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Merlin C, 1999, PLASMID, V41, P40, DOI 10.1006/plas.1998.1375; Mhlanga-Mutangadura T, 1998, J BACTERIOL, V180, P4693, DOI 10.1128/JB.180.17.4693-4703.1998; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; Oresnik IJ, 1999, APPL ENVIRON MICROB, V65, P2833; Paulsen IT, 1998, J MOL BIOL, V277, P573, DOI 10.1006/jmbi.1998.1609; Preston GM, 1998, CURR OPIN MICROBIOL, V1, P589, DOI 10.1016/S1369-5274(98)80094-5; Purcell AH, 1996, ANNU REV PHYTOPATHOL, V34, P131, DOI 10.1146/annurev.phyto.34.1.131; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; RAJU BC, 1986, PLANT DIS, V70, P182, DOI 10.1094/PD-70-182; RILEY M, 1993, MICROBIOL REV, V57, P862, DOI 10.1128/MMBR.57.4.862-952.1993; Roberto Sergio R., 1996, Fitopatologia Brasileira, V21, P517; ROSSETTI V, 1990, CR ACAD SCI III-VIE, V310, P345; Simpson AJG, 1998, NAT BIOTECHNOL, V16, P795, DOI 10.1038/nbt0998-795; Soto GE, 1999, J BACTERIOL, V181, P1059, DOI 10.1128/JB.181.4.1059-1071.1999; StGeme JW, 1996, AM J RESP CRIT CARE, V154, pS192, DOI 10.1164/ajrccm/154.4_Pt_2.S192; TANG JL, 1991, MOL GEN GENET, V226, P409, DOI 10.1007/BF00260653; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; YE FC, 1994, CURR MICROBIOL, V29, P23, DOI 10.1007/BF01570187; YE FC, 1992, NUCLEIC ACIDS RES, V20, P1559, DOI 10.1093/nar/20.7.1559; Young GM, 1999, P NATL ACAD SCI USA, V96, P6456, DOI 10.1073/pnas.96.11.6456	50	667	1220	16	243	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 13	2000	406	6792					151	157		10.1038/35018003	http://dx.doi.org/10.1038/35018003			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910347	Bronze			2022-12-24	WOS:000088221100037
J	Henney, JE				Henney, JE			New system for monitoring intrapartum fetal oxygen saturation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 5	2000	284	1					33	33		10.1001/jama.284.1.33	http://dx.doi.org/10.1001/jama.284.1.33			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	328GX	10905906				2022-12-24	WOS:000087843000004
J	Rogers, AE; Addington-Hall, JM; Abery, AJ; McCoy, ASM; Bulpitt, C; Coats, AJS; Gibbs, JSR				Rogers, AE; Addington-Hall, JM; Abery, AJ; McCoy, ASM; Bulpitt, C; Coats, AJS; Gibbs, JSR			Knowledge and communication difficulties for patients with chronic heart failure: qualitative study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EDUCATION; DISEASE	Objectives To explore patients' understanding of chronic heart failure; to investigate their need for information and issues concerning communication. Design Qualitative analysis of in-depth interviews by a constant comparative approach. Participants 27 patients identified by cardiology and care of the elderly physicians as having symptomatic heart failure (New York Heart Association functional class of II, III, or IV) and who had been admitted to hospital with heart failure in the past 20 months. Results Participants were aged 38-94 (mean 69 years); 20 had a New York Heart Association classification of III or IV. All had at least one concurrent illness. Participants sought information from the research interviewer about their heart failure, their prognosis, and likely manner of death. They also described several factors that could inhibit successful communication with their doctors. These included difficulties in getting to hospital appointments, confusion, short term memory loss, and the belief that doctors did not want to provide patients with too much knowledge. Conclusions Good communication requires the ability both to listen and to impart relevant information. Effective and better ways of communicating with patients with chronic heart failure need to be tested. Disease specific barriers to effective communication, such as short term memory loss, confusion, and fatigue should be addressed. Strategies to help patients ask questions, including those related to prognosis, should be developed.	Guys Kings & St Thomass Med Sch, Dept Palliat Care & Policy, London SE5 6PJ, England; St Christophers Hospice, London SE5 6PJ, England; Charing Cross Hosp, Natl Heart & Lung Inst, Imperial Coll Sch Med, Dept Cardiol, London W6 8RF, England; Hammersmith Hosp, Imperial Coll Sch Med, London W12 0NN, England; Royal Brompton Hosp, London SW3 6NP, England	University of London; King's College London; Imperial College London; Imperial College London; Royal Brompton Hospital	Rogers, AE (corresponding author), Guys Kings & St Thomass Med Sch, Dept Palliat Care & Policy, New Med Sch Bldg, London SE5 6PJ, England.	Angela.rogers@kcl.ac.uk	Coats, Andrew J Stewart/E-4451-2012	Coats, Andrew J Stewart/0000-0002-2771-4260				[Anonymous], 1997, J R Coll Physicians Lond, V31, P258; BONNEUX L, 1994, AM J PUBLIC HEALTH, V84, P20, DOI 10.2105/AJPH.84.1.20; DAVISON C, 1991, SOCIOL HEALTH ILL, V13, P1, DOI 10.1111/1467-9566.ep11340301; DRACUP K, 1994, JAMA-J AM MED ASSOC, V272, P1442, DOI 10.1001/jama.272.18.1442; FREEDLAND KE, 1991, J GERIATR PSYCHIAT, V24, P59; Green J, 1999, BRIT MED J, V319, P421; Koenig HG, 1998, GEN HOSP PSYCHIAT, V20, P29, DOI 10.1016/S0163-8343(98)80001-7; Lynn J, 1997, New Horiz, V5, P56; Mair FS, 1996, BRIT J GEN PRACT, V46, P77; McCarthy M, 1997, J ROY SOC MED, V90, P128, DOI 10.1177/014107689709000304; Meredith C, 1996, BMJ-BRIT MED J, V313, P724; Morse JM, 1999, QUAL HEALTH RES, V9, P5, DOI 10.1177/104973299129121622; PONIKOWSKI P, 1997, AM J CARDIOL, V80, P90; STEWART AL, 1989, JAMA-J AM MED ASSOC, V262, P907, DOI 10.1001/jama.262.7.907; Swan JW, 1997, J AM COLL CARDIOL, V30, P527, DOI 10.1016/S0735-1097(97)00185-X; Wehby D, 1999, HEART LUNG, V28, P31, DOI 10.1016/S0147-9563(99)70041-5	16	163	172	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 9	2000	321	7261					605	607		10.1136/bmj.321.7261.605	http://dx.doi.org/10.1136/bmj.321.7261.605			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	352WW	10977838	Bronze, Green Published			2022-12-24	WOS:000089243200021
J	Schnohr, P; Parner, J; Lange, P				Schnohr, P; Parner, J; Lange, P			Mortality in joggers: population based study of 4658 men	BRITISH MEDICAL JOURNAL			English	Article							DISEASE; HEALTH		Bispebjerg Univ Hosp, Copenhagen City Heart Study, DK-2400 Copenhagen NV, Denmark; Univ Copenhagen, Dept Biostat, DK-2200 Copenhagen, Denmark; Hvidovre Univ Hosp, Dept Resp Dis, DK-2650 Hvidovre, Denmark	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; University of Copenhagen	Schnohr, P (corresponding author), Bispebjerg Univ Hosp, Copenhagen City Heart Study, Bispebjerg Bakke 24, DK-2400 Copenhagen NV, Denmark.							Andersen P. K., 2012, STAT MODELS BASED CO; Appleyard M., 1989, SCAND J SOC MED, V41, P1; FENTEM P, 1994, BRIT MED J, V308, P1291, DOI 10.1136/bmj.308.6939.1291; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402	4	32	32	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	SEP 9	2000	321	7261					602	603		10.1136/bmj.321.7261.602	http://dx.doi.org/10.1136/bmj.321.7261.602			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	352WW	10977835	Green Published, Bronze			2022-12-24	WOS:000089243200019
J	Showman, AP; Dowling, TE				Showman, AP; Dowling, TE			Nonlinear simulations of Jupiter's 5-micron hot spots	SCIENCE			English	Article							GALILEO PROBE; CLOUD STRUCTURE; ATMOSPHERIC COMPOSITION; WATER-VAPOR; ABUNDANCE; WAVES; SHOEMAKER-LEVY-9; DOWNDRAFTS; ORIGIN	Large-scale nonlinear simulations of Jupiter's 5-micron hot spots produce Long-lived coherent structures that cause subsidence in local regions, explaining the Low cloudiness and the dryness measured by the Galileo probe inside a hot spot. Like observed hot spots, the simulated coherent structures are equatorially confined, have periodic spacing, propagate west relative to the flow, are generally confined to one hemisphere, and have an anticyclonic gyre on their equatorward side, The southern edge of the simulated hot spots develops vertical shear of up to 70 meters per second in the eastward wind, which can explain the results of the Galileo probe Doppler wind experiment.	NASA, Ames Res Ctr, Natl Res Council, Moffett Field, CA 94035 USA; Univ Louisville, Comparat Planetol Lab, Louisville, KY 40292 USA	National Academies of Sciences, Engineering & Medicine; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Louisville	Showman, AP (corresponding author), NASA, Ames Res Ctr, Natl Res Council, Mail Stop 245-3, Moffett Field, CA 94035 USA.		Dowling, Timothy E/J-4537-2013	Dowling, Timothy E/0000-0002-7400-2274				ALLISON M, 1990, ICARUS, V83, P282, DOI 10.1016/0019-1035(90)90069-L; Atkinson DH, 1998, J GEOPHYS RES-PLANET, V103, P22911, DOI 10.1029/98JE00060; Atreya SK, 1999, PLANET SPACE SCI, V47, P1243, DOI 10.1016/S0032-0633(99)00047-1; ATREYA SK, 1997, 3 GALILEOS MAN SPACE; Baker RD, 1998, ICARUS, V136, P340, DOI 10.1006/icar.1998.6016; Beebe R.F., 1989, NASA SPEC PUBL, V494, P245; Beebe RF, 1996, SCIENCE, V272, P841, DOI 10.1126/science.272.5263.841; BJORAKER GL, 1986, ASTROPHYS J, V311, P1058, DOI 10.1086/164842; BOYD JP, 1991, ENRICO FERMI, V109, P51; CARLSON BE, 1994, J GEOPHYS RES-PLANET, V99, P14623, DOI 10.1029/94JE01222; CARLSON BE, 1992, ASTROPHYS J, V388, P648, DOI 10.1086/171182; Dowling TE, 1998, ICARUS, V132, P221, DOI 10.1006/icar.1998.5917; DOWLING TE, 1995, ICARUS, V117, P439, DOI 10.1006/icar.1995.1169; FLASAR FM, 1986, J ATMOS SCI, V43, P2683, DOI 10.1175/1520-0469(1986)043<2683:MWAAPO>2.0.CO;2; Folkner WM, 1998, J GEOPHYS RES-PLANET, V103, P22847, DOI 10.1029/98JE01635; Friedson A.J., 1999, B AM ASTRON SOC, V31, P1155; Guillot T, 1999, SCIENCE, V286, P72, DOI 10.1126/science.286.5437.72; INGERSOLL AP, 1995, NATURE, V374, P706, DOI 10.1038/374706a0; Irwin PGJ, 1998, J GEOPHYS RES-PLANET, V103, P23001, DOI 10.1029/98JE00948; LIMAYE SS, 1986, ICARUS, V65, P335, DOI 10.1016/0019-1035(86)90142-9; MAHAFFY PR, 1999, B AM ASTRON SOC, V31, P1154; Niemann HB, 1998, J GEOPHYS RES-PLANET, V103, P22831, DOI 10.1029/98JE01050; Ortiz JL, 1998, J GEOPHYS RES-PLANET, V103, P23051, DOI 10.1029/98JE00696; Orton GS, 1998, J GEOPHYS RES-PLANET, V103, P22791, DOI 10.1029/98JE02380; Owen T, 1999, NATURE, V402, P269, DOI 10.1038/46232; OWEN TC, 1996, EOS S, V77, pS171; POLLACK JB, 1989, ORIGIN EVOLUTION PLA, P564; Roos-Serote M, 1998, J GEOPHYS RES-PLANET, V103, P23023, DOI 10.1029/98JE01049; Showman AP, 1998, ICARUS, V132, P205, DOI 10.1006/icar.1998.5898; Vasavada AR, 1998, ICARUS, V135, P265, DOI 10.1006/icar.1998.5984	30	97	98	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 8	2000	289	5485					1737	1740						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352BT	10976064				2022-12-24	WOS:000089195200042
J	Tumbula, DL; Becker, HD; Chang, W; Soll, D				Tumbula, DL; Becker, HD; Chang, W; Soll, D			Domain-specific recruitment of amide amino acids for protein synthesis	NATURE			English	Article							TRANSFER-RNA-SYNTHETASE; ESCHERICHIA-COLI; EVOLUTION; GENE; BIOSYNTHESIS; BACTERIA; AMIDOTRANSFERASE; TRANSLATION; RECOGNITION; ENZYME	The formation of aminoacyl-transfer RNA is a crucial step in ensuring the accuracy of protein synthesis. Despite the central importance of this process in all living organisms, it remains unknown how archaea and some bacteria synthesize Asn-tRNA and Gln-tRNA. These amide aminoacyl-tRNAs can be formed by the direct acylation of tRNA, catalysed by asparaginyl-tRNA synthetase and glutaminyl-tRNA synthetase, respectively. A separate, indirect pathway involves the formation of mis-acylated Asp-tRNA(Asn) or Glu-tRNA(Gln), and the subsequent amidation of these amino acids while they are bound to tRNA, which is catalysed by amidotransferases(1,2). Here we show that all archaea possess an archaea-specific heterodimeric amidotransferase (encoded by gatD and gatE) for Gln-tRNA formation. However, Asn-tRNA synthesis in archaea is divergent: some archaea use asparaginyl-tRNA synthetase, whereas others use a heterotrimeric amidotransferase (encoded by the gatA, gatB and gatC genes). Because bacteria primarily use transamidation(3), and the eukaryal cytoplasm uses glutaminyl-tRNA synthetase, it appears that the three domains use different mechanisms for Gln-tRNA synthesis; as such, this is the only known step in protein synthesis where all three domains have diverged. Closer inspection of the two amidotransferases reveals that each of them recruited a metabolic enzyme to aid its function; this provides direct evidence for a relationship between amino-acid metabolism and protein biosynthesis.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA	Yale University; Yale University	Soll, D (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.			Hansen, Debra T./0000-0003-4395-8297; Becker, Hubert/0000-0002-4102-7520				BAYLEY ST, 1967, CAN J BIOCHEM, V46, P937; Becker HD, 1998, P NATL ACAD SCI USA, V95, P12832, DOI 10.1073/pnas.95.22.12832; Brown JR, 1999, J MOL EVOL, V49, P485, DOI 10.1007/PL00006571; Curnow AW, 1996, NATURE, V382, P589, DOI 10.1038/382589b0; Curnow AW, 1998, P NATL ACAD SCI USA, V95, P12838, DOI 10.1073/pnas.95.22.12838; Curnow AW, 1997, P NATL ACAD SCI USA, V94, P11819, DOI 10.1073/pnas.94.22.11819; Di Giulio M, 2000, TRENDS GENET, V16, P17, DOI 10.1016/S0168-9525(99)01893-4; Fournand D, 1998, APPL ENVIRON MICROB, V64, P2844; Gagnon Y, 1996, J BIOL CHEM, V271, P14856, DOI 10.1074/jbc.271.25.14856; GUPTA R, 1984, J BIOL CHEM, V259, P9461; Handy J, 1999, J MOL EVOL, V49, P709, DOI 10.1007/PL00006592; HAYASE Y, 1992, EMBO J, V11, P4159, DOI 10.1002/j.1460-2075.1992.tb05509.x; Ibba M, 1997, P NATL ACAD SCI USA, V94, P14383, DOI 10.1073/pnas.94.26.14383; Ibba M, 1996, P NATL ACAD SCI USA, V93, P6953, DOI 10.1073/pnas.93.14.6953; Ibba M, 1997, SCIENCE, V278, P1119, DOI 10.1126/science.278.5340.1119; Kim R, 1998, BIOTECHNOL LETT, V20, P207, DOI 10.1023/A:1005305330517; Kim SI, 1997, J BACTERIOL, V179, P5625, DOI 10.1128/jb.179.17.5625-5627.1997; LUDMERER SW, 1987, J BIOL CHEM, V262, P10801; Nabholz CE, 1997, P NATL ACAD SCI USA, V94, P7903, DOI 10.1073/pnas.94.15.7903; SCHON A, 1988, NATURE, V331, P187, DOI 10.1038/331187a0; Siatecka M, 1998, EUR J BIOCHEM, V256, P80, DOI 10.1046/j.1432-1327.1998.2560080.x; Sissler M, 1999, P NATL ACAD SCI USA, V96, P8985, DOI 10.1073/pnas.96.16.8985; Soll D., 1974, ENZYMES, V10, P489; SPRING KJ, 1986, J BACTERIOL, V166, P135, DOI 10.1128/jb.166.1.135-142.1986; Stathopoulos C, 2000, SCIENCE, V287, P479, DOI 10.1126/science.287.5452.479; Weiner AM, 1999, CURR BIOL, V9, pR842, DOI 10.1016/S0960-9822(00)80041-X; WILCOX M, 1968, P NATL ACAD SCI USA, V61, P229, DOI 10.1073/pnas.61.1.229; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; Wolf YI, 1999, GENOME RES, V9, P689; WONG JTF, 1975, P NATL ACAD SCI USA, V72, P1909, DOI 10.1073/pnas.72.5.1909	30	133	139	0	9	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 7	2000	407	6800					106	110		10.1038/35024120	http://dx.doi.org/10.1038/35024120			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	350WE	10993083				2022-12-24	WOS:000089124000052
J	Kivelson, MG; Khurana, KK; Russell, CT; Volwerk, M; Walker, RJ; Zimmer, C				Kivelson, MG; Khurana, KK; Russell, CT; Volwerk, M; Walker, RJ; Zimmer, C			Galileo magnetometer measurements: A stronger case for a subsurface ocean at Europa	SCIENCE			English	Article							JOVIAN MAGNETOSPHERE; PLASMA ENVIRONMENT; CALLISTO; FIELDS; IO	On 3 January 2000, the Galileo spacecraft passed close to Europa when it was located far south of Jupiter's magnetic equator in a region where the radial component of the magnetospheric magnetic field points inward toward Jupiter, This pass with a previously unexamined orientation of the external forcing field distinguished between an induced and a permanent magnetic dipole moment model of Europa's internal field. The Galileo magnetometer measured changes in the magnetic field predicted if a current-carrying outer shell, such as a planet-scale liquid ocean, is present beneath the icy surface. The evidence that Europa's field varies temporally strengthens the argument that a liquid ocean exists beneath the present-day surface.	Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Kivelson, MG (corresponding author), Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA.		Kivelson, Margaret G/I-9019-2012; Russell, Christopher T/E-7745-2012	Kivelson, Margaret G/0000-0003-3859-8581; Russell, Christopher T/0000-0003-1639-8298; Khurana, Krishan/0000-0002-2856-1171				COLBURN DS, 1985, ICARUS, V63, P39, DOI 10.1016/0019-1035(85)90019-3; Greeley R, 1998, ICARUS, V135, P25, DOI 10.1006/icar.1998.5977; Greenberg R, 1999, ICARUS, V141, P263, DOI 10.1006/icar.1999.6187; Hall DT, 1998, ASTROPHYS J, V499, P475, DOI 10.1086/305604; Hoppa GV, 1999, SCIENCE, V285, P1899, DOI 10.1126/science.285.5435.1899; Khurana KK, 1998, NATURE, V395, P777, DOI 10.1038/27394; Kivelson MG, 1997, SCIENCE, V276, P1239, DOI 10.1126/science.276.5316.1239; Kivelson MG, 1999, J GEOPHYS RES-SPACE, V104, P4609, DOI 10.1029/1998JA900095; Kliore AJ, 1997, SCIENCE, V277, P355, DOI 10.1126/science.277.5324.355; MONTGOMERY RB, 1963, AM I PHYSICS HDB, P125; NEUBAUER FM, 1980, J GEOPHYS RES-SPACE, V85, P1171, DOI 10.1029/JA085iA03p01171; Neubauer FM, 1999, J GEOPHYS RES-SPACE, V104, P28671, DOI 10.1029/1999JA900217; Neubauer FM, 1998, J GEOPHYS RES-PLANET, V103, P19843, DOI 10.1029/97JE03370; Pappalardo RT, 1999, SCI AM, V281, P54, DOI 10.1038/scientificamerican1099-54; PARKINSON WD, 1983, INTRO GEOMAGNETISM, P313; Saur J, 1998, J GEOPHYS RES-PLANET, V103, P19947, DOI 10.1029/97JE03556; SOUTHWOOD DJ, 1980, J GEOPHYS RES-SPACE, V85, P5959, DOI 10.1029/JA085iA11p05959; ZIMMER C, IN PRESS ICARUS	18	389	403	4	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 25	2000	289	5483					1340	1343		10.1126/science.289.5483.1340	http://dx.doi.org/10.1126/science.289.5483.1340			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347RF	10958778				2022-12-24	WOS:000088942400035
J	Blasius, B; Stone, L				Blasius, B; Stone, L			Ecology - Nonlinearity and the Moran effect	NATURE			English	Article							DYNAMICS; SHEEP		Tel Aviv Univ, Dept Zool, Porter Super Ctr Ecol & Environm Studies, IL-69978 Tel Aviv, Israel	Tel Aviv University	Blasius, B (corresponding author), Tel Aviv Univ, Dept Zool, Porter Super Ctr Ecol & Environm Studies, Ramat Aviv, IL-69978 Tel Aviv, Israel.		Blasius, Bernd/AAH-1897-2019; Blasius, Bernd/GLU-4137-2022	Blasius, Bernd/0000-0002-6558-1462; Stone, Lewi/0000-0002-6465-579X				Blasius B, 1999, NATURE, V399, P354, DOI 10.1038/20676; Grenfell BT, 1998, NATURE, V394, P674, DOI 10.1038/29291; Hudson PJ, 1999, TRENDS ECOL EVOL, V14, P1, DOI 10.1016/S0169-5347(98)01498-0; MORAN PAP, 1953, AUST J ZOOL, V1, P291, DOI 10.1071/ZO9530291; Stenseth NC, 1998, NATURE, V394, P620, DOI 10.1038/29177	5	38	39	0	8	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 24	2000	406	6798					846	847		10.1038/35022646	http://dx.doi.org/10.1038/35022646			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347AG	10972277				2022-12-24	WOS:000088903600029
J	Yusuf, HR; Daniels, D; Smith, P; Coronado, V; Rodewald, L				Yusuf, HR; Daniels, D; Smith, P; Coronado, V; Rodewald, L			Association between administration of hepatitis B vaccine at birth and completion of the hepatitis B and 4 : 3 : 1 : 3 vaccine series	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK-FACTORS; DELAYED IMMUNIZATION; VIRUS-INFECTION; CHILDREN; COVERAGE; INFANTS	Context The association between infant age at initiation of hepatitis B vaccination and completion of the 3-dose hepatitis B vaccination series is unclear. Objective To assess the association between administration of the first dose of hepatitis B vaccine within 7 days of birth and completion of the hepatitis B vaccine series and the 4:3:1:3 vaccine series (4 doses of diphtheria-tetanus-pertussis vaccine, 3 doses of polio vaccine, 1 dose of measles-containing vaccine, and 3 doses of Haemophilus influenzae type b vaccine). Design, Setting, and Participants Analysis of data from the 1998 National Immunization Survey, a random-digit-dialing telephone survey (n=34480 completed interviews) of parents of children aged 19 to 35 months from 50 states and 28 selected urban areas in the United States that included a provider record check mail survey. Main Outcome Measures Percentage of infants who received at least 3 doses of hepatitis B vaccine and percentage who received the 4:3:1:3 vaccine series, by age at receipt of the first dose of hepatitis B vaccine. Results Overall, 86.9% of children 19 to 35 months of age in 1998 received 3 or more doses of hepatitis B vaccine, and 79.9% completed the 4:3:1:3 vaccine series. Multivariate analysis indicated that, compared with children who received the first hepatitis B vaccine dose within 7 days of birth, odds ratios (ORs) for not completing the 3-dose hepatitis B vaccine series among children who received the first dose at 8 to 41 days, 42 to 91 days, 92 to 182 days, 183 to 273 days, and 274 or more days of age were 2.4 (95% confidence interval [CI], 2.0-3.0), 7.8 (95% CI, 6.5-9.3), 9.6 (95% ci, 7.0-13.3), 18.3 (95% CI, 12.0-28.0), and 46.6 (95% CI, 33.7-64.5), respectively; ORs for not completing the 4:3:1:3 vaccine series among these same groups were 1.0 (95% CI, 0.8-1.1), 1.0 (95% CI, 0.8-1.1), 1.7 (95% CI, 1.3-2.3), 3.8 (95% CI, 2.6-5.6), and 4.0 (95% CI, 2.9-5.5), respectively. Conclusion Administration of the first dose of hepatitis 3 vaccine at birth is associated with increased likelihood of completion of the hepatitis 8 vaccination series.	Ctr Dis Control & Prevent, Immunizat Serv Div, Natl Immunizat Program, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Data Management Div, Natl Immunizat Program, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Yusuf, HR (corresponding author), Ctr Dis Control & Prevent, Immunizat Serv Div, Natl Immunizat Program, 1600 Clifton Rd,Mailstop E52, Atlanta, GA 30333 USA.			Rodewald, Lance/0000-0003-2593-542X				*AM AC FAM PHYS, 1993, REC HEP B PREEXP VAC; [Anonymous], 1994, MMWR Recomm Rep, V43, P1; BATES AS, 1994, JAMA-J AM MED ASSOC, V272, P1105, DOI 10.1001/jama.272.14.1105; BOBO JK, 1993, PEDIATRICS, V91, P308; Centers for Disease Control and Prevention, 1991, MMWR MORB MORTAL WKL, V40; Freed GL, 1996, J FAM PRACTICE, V42, P587; FREED GL, 1994, PEDIATRICS, V93, P747; GUYER B, 1994, PEDIATRICS, V94, P53; HALL CB, 1992, PEDIATRICS, V89, P795; HYAMS KC, 1995, CLIN INFECT DIS, V20, P992, DOI 10.1093/clinids/20.4.992; Lauderdale DS, 1999, JAMA-J AM MED ASSOC, V282, P1725, DOI 10.1001/jama.282.18.1725; Madlon-Kay D J, 1994, Arch Fam Med, V3, P610, DOI 10.1001/archfami.3.7.610; MAHONEY FJ, 1993, AM FAM PHYSICIAN, V47, P865; MAHONEY FJ, 1996, PRINCIPLES PRACTICE, P1194; MARGOLIS HS, 1991, SEMIN LIVER DIS, V11, P84, DOI 10.1055/s-2008-1040427; MILLER LA, 1994, PEDIATRICS, V94, P213; Ross A, 1998, PEDIATRICS, V101, P970, DOI 10.1542/peds.101.6.970; Shah BV, 1997, SUDAAN USERS MANUAL; SMITH PJ, IN PRESS VITAL HLTH, V2; USA National Vaccine Advisory Committee, 1999, JAMA, Journal of the American Medical Association, V282, P363, DOI 10.1001/jama.282.4.363; WOOD D, 1995, PEDIATRICS, V96, P295; Woodruff BA, 1996, PEDIATRICS, V97, P798; Zell ER, 2000, PUBLIC HEALTH REP, V115, P65, DOI 10.1093/phr/115.1.65	23	57	59	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 23	2000	284	8					978	983		10.1001/jama.284.8.978	http://dx.doi.org/10.1001/jama.284.8.978			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344PX	10944643	Bronze			2022-12-24	WOS:000088769000024
J	Onishi, A; Iwamoto, M; Akita, T; Mikawa, S; Takeda, K; Awata, T; Hanada, H; Perry, ACF				Onishi, A; Iwamoto, M; Akita, T; Mikawa, S; Takeda, K; Awata, T; Hanada, H; Perry, ACF			Pig cloning by microinjection of fetal fibroblast nuclei	SCIENCE			English	Article							CLONED TRANSGENIC CALVES; SEX IDENTIFICATION; PORCINE EMBRYOS; SHEEP; CELLS; ADULT; TRANSPLANTATION; GOATS; MICE	Pig cloning will have a marked impact on the optimization of meat production and xenotransplantation. To clone pigs from differentiated cells, we microinjected the nuclei of porcine (Sus scrofa) fetal fibroblasts into enucleated oocytes, and development was induced by electroactivation. The transfer of 110 cloned embryos to four surrogate mothers produced an apparently normal female piglet. The clonal provenance of the piglet was indicated by her coat color and confirmed by DNA microsatellite analysis.	Natl Inst Anim Ind, Dept Anim Breeding & Genet, Tsukuba Norin Danchi, Ibaraki 3050901, Japan; Prima Meatpackers, Basic Res Div, Tsuchiura, Ibaraki 3000841, Japan; Rockefeller Univ, Dev Biol Lab, New York, NY 10021 USA	National Agriculture & Food Research Organization - Japan; Rockefeller University	Onishi, A (corresponding author), Natl Inst Anim Ind, Dept Anim Breeding & Genet, Tsukuba Norin Danchi, Ibaraki 3050901, Japan.	onishi@niai.affrc.go.jp		Perry, Tony/0000-0003-3136-5355				AASEN E, 1990, BIO-TECHNOL, V8, P1279, DOI 10.1038/nbt1290-1279; Baguisi A, 1999, NAT BIOTECHNOL, V17, P456, DOI 10.1038/8632; Campbell K H, 1996, Rev Reprod, V1, P40, DOI 10.1530/ror.0.0010040; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256; Dobrinsky JR, 1996, BIOL REPROD, V55, P1069, DOI 10.1095/biolreprod55.5.1069; Funahashi H, 1997, THERIOGENOLOGY, V47, P679, DOI 10.1016/S0093-691X(97)00026-5; Hill JR, 1999, THERIOGENOLOGY, V51, P1451, DOI 10.1016/S0093-691X(99)00089-8; Kato Y, 1998, SCIENCE, V282, P2095, DOI 10.1126/science.282.5396.2095; Machaty Z, 1998, BIOL REPROD, V59, P451, DOI 10.1095/biolreprod59.2.451; Martin MJ, 2000, BIOL REPROD, V63, P109, DOI 10.1095/biolreprod63.1.109; McCreath KJ, 2000, NATURE, V405, P1066, DOI 10.1038/35016604; ONISHI A, UNPUB; PETTERS RM, 1993, J REPROD FERTIL, P61; Platt JL, 1998, NATURE, V392, P11; POMP D, 1995, J ANIM SCI, V73, P1408; PRATHER RS, 1989, BIOL REPROD, V41, P123, DOI 10.1095/biolreprod41.1.123; Rohrer GA, 1996, GENOME RES, V6, P371, DOI 10.1101/gr.6.5.371; Schnieke AE, 1997, SCIENCE, V278, P2130, DOI 10.1126/science.278.5346.2130; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 1999, NAT GENET, V22, P127, DOI 10.1038/9632; WAKAYAMA T, COMMUNICATION; Wells DN, 1999, BIOL REPROD, V60, P996, DOI 10.1095/biolreprod60.4.996; WILLADSEN SM, 1986, NATURE, V320, P63, DOI 10.1038/320063a0; YOUNGS CR, 1993, J ANIM SCI, V71, P1561, DOI 10.2527/1993.7161561x	25	650	787	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 18	2000	289	5482					1188	1190		10.1126/science.289.5482.1188	http://dx.doi.org/10.1126/science.289.5482.1188			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346JE	10947985				2022-12-24	WOS:000088866600041
J	Artandi, SE; Chang, S; Lee, SL; Alson, S; Gottlieb, GJ; Chin, L; DePinho, RA				Artandi, SE; Chang, S; Lee, SL; Alson, S; Gottlieb, GJ; Chin, L; DePinho, RA			Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice	NATURE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; CARCINOMA IN-SITU; MOUSE TELOMERASE; V(D)J RECOMBINATION; P53-DEFICIENT MICE; HUMAN FIBROBLASTS; EXPRESSION; CELLS; BREAST; METASTASES	Aged humans sustain a high rate of epithelial cancers such as carcinomas of the breast and colon, whereas mice carrying common tumour suppressor gene mutations typically develop soft tissue sarcomas and lymphomas. Among the many factors that may contribute to this species variance are differences in telomere length and regulation. Telomeres comprise the nucleoprotein complexes that cap the ends of eukaryotic chromosomes and are maintained by the reverse transcriptase, telomerase(1). In human cells, insufficient levels of telomerase lead to telomere attrition with cell division in culture(2) and possibly with ageing and tumorigenesis in vivo(3-5). In contrast, critical reduction in telomere length is not observed in the mouse owing to promiscuous telomerase expression and long telomeres(6-10). Here we provide evidence that telomere attrition in ageing telomerase-deficient p53 mutant mice promotes the development of epithelial cancers by a process of fusion-bridge breakage that leads to the formation of complex non-reciprocal translocations-a classical cytogenetic feature of human carcinomas. Our data suggest a model in which telomere dysfunction brought about by continual epithelial renewal during life generates the massive ploidy changes associated with the development of epithelial cancers.	Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; CPI Ameripath Lab, Beachwood, OH 44122 USA; Ackerman Acad Dermatopathol, New York, NY 10016 USA; Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	DePinho, RA (corresponding author), Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA.			DePinho, Ronald/0000-0002-5625-577X	NIA NIH HHS [K08 AG001019] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K08AG001019] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Al-Mulla F, 1999, GENE CHROMOSOME CANC, V24, P306, DOI 10.1002/(SICI)1098-2264(199904)24:4<306::AID-GCC3>3.0.CO;2-5; ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; ATKIN NB, 1986, CANCER GENET CYTOGEN, V21, P275, DOI 10.1016/0165-4608(86)90009-9; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Broccoli D, 1996, MOL CELL BIOL, V16, P3765; Buerger H, 1999, J PATHOL, V187, P396, DOI 10.1002/(SICI)1096-9896(199903)187:4<396::AID-PATH286>3.0.CO;2-L; CHADENEAU C, 1995, CANCER RES, V55, P2533; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Greenberg RA, 1998, ONCOGENE, V16, P1723, DOI 10.1038/sj.onc.1201933; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HARVEY M, 1993, NAT GENET, V5, P225, DOI 10.1038/ng1193-225; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; HEIM S, 1995, CANC CYTOGENETICS, P369; Hilgenfeld E, 1999, CURR TOP MICROBIOL, V246, P169; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; Kirk KE, 1997, SCIENCE, V275, P1478, DOI 10.1126/science.275.5305.1478; Kolquist KA, 1998, NAT GENET, V19, P182, DOI 10.1038/554; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Liao MJ, 1998, MOL CELL BIOL, V18, P3495, DOI 10.1128/MCB.18.6.3495; Liyanage M, 1996, NAT GENET, V14, P312, DOI 10.1038/ng1196-312; Martin-Rivera L, 1998, P NATL ACAD SCI USA, V95, P10471, DOI 10.1073/pnas.95.18.10471; McClintock B, 1941, GENETICS, V26, P234; Nacht M, 1998, CELL GROWTH DIFFER, V9, P131; Nishizaki T, 1997, GENE CHROMOSOME CANC, V19, P267, DOI 10.1002/(SICI)1098-2264(199708)19:4<267::AID-GCC9>3.0.CO;2-V; PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Sedivy JM, 1998, P NATL ACAD SCI USA, V95, P9078, DOI 10.1073/pnas.95.16.9078; Shpitz B, 1999, BREAST CANCER RES TR, V58, P65, DOI 10.1023/A:1006394209922; TSUKAMOTO AS, 1988, CELL, V55, P619, DOI 10.1016/0092-8674(88)90220-6; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0	32	883	916	0	55	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2000	406	6796					641	645		10.1038/35020592	http://dx.doi.org/10.1038/35020592			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949306				2022-12-24	WOS:000088653800051
J	Gravenor, MB; Cox, DR; Hoinville, LJ; Hoek, A; McLean, AR				Gravenor, MB; Cox, DR; Hoinville, LJ; Hoek, A; McLean, AR			Encephalopathies - Scrapie in Britain during the BSE years	NATURE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; VARIANT CJD; SHEEP; AGENT		Inst Anim Hlth, Compton RG20 7NN, Berks, England; Univ Oxford, Dept Stat, Oxford OX1 3TG, England; Vet Labs Agcy, Dept Epidemiol, Addelestone KT15 3NB, Surrey, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Oxford	Gravenor, MB (corresponding author), Inst Anim Hlth, Compton RG20 7NN, Berks, England.							Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Butler D, 1998, NATURE, V395, P6, DOI 10.1038/25573; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; FOSTER JD, 1993, VET REC, V133, P339, DOI 10.1136/vr.133.14.339; GOLDMANN W, 1994, J GEN VIROL, V75, P989, DOI 10.1099/0022-1317-75-5-989; GRAVENOR MB, UNPUB P R SOC LOND B; Hill AF, 1998, NEUROSCI LETT, V255, P159, DOI 10.1016/S0304-3940(98)00736-8; Hoinville L, 1999, VET REC, V145, P405, DOI 10.1136/vr.145.14.405; KIRKWOOD JK, 1994, VET REC, V135, P296, DOI 10.1136/vr.135.13.296; McLean AR, 1999, P ROY SOC B-BIOL SCI, V266, P2531, DOI 10.1098/rspb.1999.0956	10	20	22	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2000	406	6796					584	585		10.1038/35020692	http://dx.doi.org/10.1038/35020692			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949289				2022-12-24	WOS:000088653800034
J	Swaddle, JP; Biewener, AA				Swaddle, JP; Biewener, AA			Physiology - Exercise and reduced muscle mass in starlings	NATURE			English	Article							BODY-MASS; PECTORALIS-MUSCLE; FLIGHT-MUSCLE; ADAPTATIONS; HYPERTROPHY		Univ Bristol, Sch Biol Sci, Ctr Behav Biol, Bristol BS8 1UG, Avon, England; Harvard Univ, MCZ, Concord Field Stn, Bedford, MA 01730 USA	University of Bristol; Harvard University	Swaddle, JP (corresponding author), Univ Bristol, Sch Biol Sci, Ctr Behav Biol, Bristol BS8 1UG, Avon, England.		Biewener, Andrew/O-2989-2016	Biewener, Andrew/0000-0003-3303-8737				AUSTIN JE, 1987, AUK, V104, P694, DOI 10.1093/auk/104.4.694; BIEWENER AA, 1992, J EXP BIOL, V164, P1; Brown RE, 1998, CAN J ZOOL, V76, P26, DOI 10.1139/cjz-76-1-26; DRIEDZIC WR, 1993, CAN J ZOOL, V71, P1602, DOI 10.1139/z93-226; GAUNT AS, 1990, AUK, V107, P649, DOI 10.2307/4087994; Helms C. W., 1960, BIRDBANDING, V31, P1, DOI [DOI 10.2307/4510793, 10.2307/4510793]; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; MARSH RL, 1984, PHYSIOL ZOOL, V57, P105, DOI 10.1086/physzool.57.1.30155973; OCONNOR TP, 1995, J COMP PHYSIOL B, V165, P298, DOI 10.1007/BF00367313; ROSSER BWC, 1986, CAN J ZOOL, V64, P1174, DOI 10.1139/z86-176; Swaddle JP, 1997, CAN J ZOOL, V75, P1135, DOI 10.1139/z97-136; WITTER MS, 1993, PHILOS T R SOC B, V340, P73, DOI 10.1098/rstb.1993.0050	12	29	31	0	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2000	406	6796					585	586		10.1038/35020695	http://dx.doi.org/10.1038/35020695			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949290				2022-12-24	WOS:000088653800035
J	Wood, NS; Marlow, N; Costeloe, K; Gibson, AT; Wilkinson, AR				Wood, NS; Marlow, N; Costeloe, K; Gibson, AT; Wilkinson, AR		EPICure Study Grp	Neurologic and developmental disability after extremely preterm birth	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GESTATIONAL-AGE INFANT; WEIGHT CHILDREN; OUTCOMES; NETHERLANDS; DISORDERS; PREMATURE; DEFICIT; LIFE; BORN	Background Small studies show that many children born as extremely preterm infants have logic and developmental disabilities. We evaluated all children who were born at 25 or fewer completed weeks of gestation in the United Kingdom and Ireland from March through December 1995 at the time when they reached a median age of 30 months. Methods Each child underwent a formal ment by an independent examiner. Development was evaluated with use of the Bayley Scales of Infant Development, and neurologic function was assessed by a standardized examination. Disability and severe were defined by predetermined criteria. Results At a median age of 30 months, corrected for gestational age, 283 (92 percent) of the 308 surviving children were formally assessed. The mean (+/- SD) scores on the Bayley Mental and Psychomotor Developmental Indexes, referenced to a population mean of 100, were 84 +/- 12 and 87 +/- 13, respectively. Fifty-three children (19 percent) had severely delayed development (with scores more than 3 SD below the mean), and a further 32 children (11 percent) had scores from 2 SD to 3 SD below the mean. eight children (10 percent) had severe neuromotor disability, 7 (2 percent) were blind or perceived light only, and 8 (3 percent) had hearing loss that was uncorrectable or required hearing aids. Overall, 138 children had disability (49 percent; 95 percent confidence 43 to 55 percent), including 64 who met the criteria for severe disability (23 percent; 95 percent confidence interval, 18 to 28 percent). When data from 17 assessments by local pediatricians were included, 155 of the 314 infants discharged (49 percent) had no disability. Conclusions Severe disability is common among children born as extremely preterm infants and remains a major challenge in this group of children. (N Engl J Med 2000; 343:378-84.) (C) 2000, Massachusetts Medical Society.	Univ Nottingham, Sch Human Dev, Nottingham NG7 2RD, England; Univ London, Univ London Queen Mary & Westfield Coll, St Bartholomews & Royal London Sch Med & Dent, London E1 4NS, England; Univ Sheffield, Jessop Hosp Women, Sheffield S3 7RE, S Yorkshire, England; Univ Oxford, Dept Paediat, Oxford, England	University of Nottingham; University of London; Queen Mary University London; University of Sheffield; University of Oxford	Marlow, N (corresponding author), Queens Med Ctr, Acad Div Child Hlth, Level E East Block, Nottingham NG7 2UH, England.		Marlow, Neil/D-2918-2009	Marlow, Neil/0000-0001-5890-2953				AMIELTISON C, 1989, ARCH DIS CHILD-FETAL, V64, P496, DOI 10.1136/adc.64.4_Spec_No.496; ARNOLD CC, 1991, AM J EPIDEMIOL, V134, P604, DOI 10.1093/oxfordjournals.aje.a116133; Botting N, 1998, DEV MED CHILD NEUROL, V40, P652; Botting N, 1997, J CHILD PSYCHOL PSYC, V38, P931, DOI 10.1111/j.1469-7610.1997.tb01612.x; COSTELOE K, IN PRESS PEDIATRICS; Doyle LW, 1997, J PAEDIATR CHILD H, V33, P161; ELLIMAN AM, 1991, ACTA PAEDIATR SCAND, V80, P316, DOI 10.1111/j.1651-2227.1991.tb11855.x; EVANS P, 1989, DEV MED CHILD NEUROL, V31, P119; GRIFFITHS R, 1957, ABILITIES YOUNG CHIL; Hack M, 1999, EARLY HUM DEV, V53, P193, DOI 10.1016/S0378-3782(98)00052-8; HACK M, 1994, NEW ENGL J MED, V331, P753, DOI 10.1056/NEJM199409223311201; *INF HLTH DEV PROG, 1997, HELP LOW BIRTH WEIGH; JOHNSON A, 1993, BRIT MED J, V306, P1715, DOI 10.1136/bmj.306.6894.1715; McCarton CM, 1996, PEDIATRICS, V98, P1167; MILLIGAN JE, 1984, AM J OBSTET GYNECOL, V148, P499, DOI 10.1016/0002-9378(84)90734-8; *NAT PER EP UN, 1995, REP 2 WORK GROUPS DI; NELSON KB, 1982, PEDIATRICS, V69, P529; PENA IC, 1988, J PEDIATR-US, V113, P1066, DOI 10.1016/S0022-3476(88)80584-5; PHAROAH POD, 1994, ARCH DIS CHILD, V70, P271, DOI 10.1136/adc.70.4.271; POWLS A, 1995, ARCH DIS CHILD, V72, pF62; Robinson M, 1998, ARCH DIS CHILD-FETAL, V79, pF4; Ross G, 1997, J DEV BEHAV PEDIATR, V18, P109, DOI 10.1097/00004703-199704000-00007; SANLEY FJ, 1987, 2 NAT HLTH MED RES C; Tin W, 1997, BMJ-BRIT MED J, V314, P107, DOI 10.1136/bmj.314.7074.107; VANZEBENVANDERAA TM, 1989, LANCET, V1, P253; VERLOOVEVANHORICK SP, 1986, LANCET, V1, P55; WIGGLESWORTH JS, 1978, EARLY HUM DEV, V2, P179, DOI 10.1016/0378-3782(78)90010-5; Yi S.H., 1993, MANUAL BAYLEY SCALES	28	929	956	1	56	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 10	2000	343	6					378	384		10.1056/NEJM200008103430601	http://dx.doi.org/10.1056/NEJM200008103430601			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342DT	10933736				2022-12-24	WOS:000088630500001
J	Imbach, P; Kuhne, T				Imbach, P; Kuhne, T			Sequelae of treatment of ITP with anti-D (Rh-o) immunoglobulin	LANCET			English	Editorial Material							IMMUNE THROMBOCYTOPENIC PURPURA		Childrens Univ Hosp UKBB, Dept Pediat Oncol Hematol, CH-4005 Basel, Switzerland		Imbach, P (corresponding author), Childrens Univ Hosp UKBB, Dept Pediat Oncol Hematol, CH-4005 Basel, Switzerland.		Kuehne, Thomas/I-6143-2019	Kuehne, Thomas/0000-0002-7387-7028				BLANCHETTE V, 1994, LANCET, V344, P703, DOI 10.1016/S0140-6736(94)92205-5; Gaines AR, 2000, BLOOD, V95, P2523, DOI 10.1182/blood.V95.8.2523.008k13_2523_2529; Imbach Paul A., 1997, Current Opinion in Pediatrics, V9, P35, DOI 10.1097/00008480-199702000-00009; SALAMA A, 1986, AM J HEMATOL, V22, P241, DOI 10.1002/ajh.2830220304; Tarantino MD, 1999, J PEDIATR-US, V134, P21, DOI 10.1016/S0022-3476(99)70367-7	5	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 5	2000	356	9228					447	448		10.1016/S0140-6736(00)02549-6	http://dx.doi.org/10.1016/S0140-6736(00)02549-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342QY	10981885				2022-12-24	WOS:000088657700006
J	Fitzpatrick, JM				Fitzpatrick, JM			Will laser replace TURP for the treatment of benign prostatic hyperplasia?	LANCET			English	Editorial Material							TRANSURETHRAL RESECTION; PROSTATECTOMY; ABLATION; MORTALITY		Mater Misericordiae Hosp, Dublin 7, Ireland; Univ Coll Dublin, Dublin 7, Ireland	Mater Misericordiae University Hospital; University College Dublin; University College Dublin	Fitzpatrick, JM (corresponding author), Mater Misericordiae Hosp, Dublin 7, Ireland.							ANSON K, 1995, UROLOGY, V46, P305, DOI 10.1016/S0090-4295(99)80211-8; COWLES RS, 1995, UROLOGY, V46, P155, DOI 10.1016/S0090-4295(99)80185-X; Gilling PJ, 1999, J UROLOGY, V162, P1640, DOI 10.1016/S0022-5347(05)68186-4; Keoghane SR, 2000, BJU INT, V85, P74, DOI 10.1046/j.1464-410x.2000.00407.x; McAllister WJ, 2000, BJU INT, V85, P437, DOI 10.1046/j.1464-410x.2000.00439.x; MEBUST WK, 1989, J UROLOGY, V141, P243, DOI 10.1016/S0022-5347(17)40731-2; NARAYAN P, 1995, J UROLOGY, V154, P2083, DOI 10.1016/S0022-5347(01)66701-6; Neal DE, 1997, BRIT J UROL, V79, P69; ROOS NP, 1989, NEW ENGL J MED, V320, P1120, DOI 10.1056/NEJM198904273201705; SEAGROATT V, 1995, LANCET, V346, P1521, DOI 10.1016/S0140-6736(95)92052-8	10	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 29	2000	356	9227					357	358		10.1016/S0140-6736(00)02524-1	http://dx.doi.org/10.1016/S0140-6736(00)02524-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	339NZ	10972365				2022-12-24	WOS:000088486000005
J	Kaneko, S; Hikida, T; Watanabe, D; Ichinose, H; Nagatsu, T; Kreitman, RJ; Pastan, I; Nakanishi, S				Kaneko, S; Hikida, T; Watanabe, D; Ichinose, H; Nagatsu, T; Kreitman, RJ; Pastan, I; Nakanishi, S			Synaptic integration mediated by striatal cholinergic interneurons in basal ganglia function	SCIENCE			English	Article							DOPAMINE-RECEPTORS; STRIATOPALLIDAL NEURONS; GENE-EXPRESSION; MESSENGER-RNAS; MICE LACKING; RAT-BRAIN; D1; DISORDERS; LOCALIZATION; AMPHETAMINE	The physiological role of striatal cholinergic interneurons was investigated with immunotoxin-mediated cell targeting (IMCT). Unilateral cholinergic cell ablation caused an acute abnormal turning behavior. These mice showed gradual recovery but displayed abnormal turning by both excess stimulation and inhibition of dopamine actions. In the acute phase, basal ganglia function was shifted to a hyperactive state by stimulation and suppression of striatonigral and striatopallidal neurons, respectively. D1 and D2 dopamine receptors were then down-regulated, relieving dopamine-predomimant synaptic perturbation but leaving a defect in controlling dopamine responses. The acetylcholine-dopamine interaction is concertedly and adaptively regulated for basal ganglia synaptic integration.	Kyoto Univ, Fac Med, Dept Biol Sci, Kyoto 6068501, Japan; Fujita Hlth Univ, Sch Med, Inst Comprehens Med Sci, Toyoake, Aichi 4701192, Japan; NCI, Mol Biol Lab, Div Basic Sci, NIH, Bethesda, MD 20892 USA	Kyoto University; Fujita Health University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Nakanishi, S (corresponding author), Kyoto Univ, Fac Med, Dept Biol Sci, Kyoto 6068501, Japan.	snakanis@phy.med.kyoto-u.ac.jp	pastan, ira/P-9319-2019; Hikida, Takatoshi/J-5561-2017; Ichinose, Hiroshi/D-8986-2015	pastan, ira/0000-0002-9223-0270; Hikida, Takatoshi/0000-0002-8653-311X; Ichinose, Hiroshi/0000-0001-6008-6860				Aizman O, 2000, NAT NEUROSCI, V3, P226, DOI 10.1038/72929; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; BERGER K, 1991, BRAIN RES BULL, V26, P301, DOI 10.1016/0361-9230(91)90242-C; BERNARD V, 1993, EUR J NEUROSCI, V5, P1218, DOI 10.1111/j.1460-9568.1993.tb00976.x; Chesselet MF, 1996, TRENDS NEUROSCI, V19, P417; DI CG, 1994, TRENDS NEUROSCI, V17, P228; FAHN S, 1990, PROG BRAIN RES, V84, P389; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Graybiel AM, 1995, CURR OPIN NEUROBIOL, V5, P733, DOI 10.1016/0959-4388(95)80100-6; HALLETT M, 1993, CAN J NEUROL SCI, V20, P177, DOI 10.1017/S0317167100047909; HOUK JC, 1995, CEREB CORTEX, V5, P95, DOI 10.1093/cercor/5.2.95; KANEKO S, UNPUB; KAWASHIMA K, 1980, J PHARMACOL METHOD, V3, P115, DOI 10.1016/0160-5402(80)90022-4; KOBAYASHI K, 1995, P NATL ACAD SCI USA, V92, P1132, DOI 10.1073/pnas.92.4.1132; LEMOINE C, 1995, J COMP NEUROL, V355, P418, DOI 10.1002/cne.903550308; LEVEY AI, 1993, P NATL ACAD SCI USA, V90, P8861, DOI 10.1073/pnas.90.19.8861; NISENBAUM LK, 1994, NEUROSCIENCE, V63, P435, DOI 10.1016/0306-4522(94)90541-X; OHISHI H, 1993, NEUROSCIENCE, V53, P1009, DOI 10.1016/0306-4522(93)90485-X; PHELPS PE, 1985, J COMP NEUROL, V238, P286, DOI 10.1002/cne.902380305; PYCOCK CJ, 1980, NEUROSCIENCE, V5, P461, DOI 10.1016/0306-4522(80)90048-2; Robbins TW, 1996, CURR OPIN NEUROBIOL, V6, P228, DOI 10.1016/S0959-4388(96)80077-8; ROBERTSON GS, 1992, NEUROSCIENCE, V49, P285, DOI 10.1016/0306-4522(92)90096-K; SCHULTZ W, 1995, MODELS INFORMATION P, pCH2; Steiner H, 1998, EXP BRAIN RES, V123, P60, DOI 10.1007/s002210050545; SURMEIER DJ, 1993, TRENDS NEUROSCI, V16, P299, DOI 10.1016/0166-2236(93)90103-S; Wang JQ, 1997, BRAIN RES, V748, P62, DOI 10.1016/S0006-8993(96)01244-9; WARNHOFF M, 1984, J CHROMATOGR, V307, P271, DOI 10.1016/S0378-4347(00)84099-2; Watanabe D, 1998, CELL, V95, P17, DOI 10.1016/S0092-8674(00)81779-1; Wichmann T, 1996, CURR OPIN NEUROBIOL, V6, P751, DOI 10.1016/S0959-4388(96)80024-9; WILSON CJ, 1998, SYNAPTIC ORG BRAIN, pCH9; XU M, 1994, CELL, V79, P945, DOI 10.1016/0092-8674(94)90026-4	35	145	152	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2000	289	5479					633	637		10.1126/science.289.5479.633	http://dx.doi.org/10.1126/science.289.5479.633			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	338XD	10915629	Green Submitted			2022-12-24	WOS:000088447800058
J	Bochar, DA; Wang, L; Beniya, H; Kinev, A; Xue, YT; Lane, WS; Wang, WD; Kashanchi, F; Shiekhattar, R				Bochar, DA; Wang, L; Beniya, H; Kinev, A; Xue, YT; Lane, WS; Wang, WD; Kashanchi, F; Shiekhattar, R			BRCA1 is associated with a human SWI/SNF-related complex: Linking chromatin remodeling to breast cancer	CELL			English	Article							POLYMERASE-II HOLOENZYME; TRANSCRIPTIONAL ACTIVATION; MEIOTIC CELLS; DNA-DAMAGE; EXPRESSION; PROTEIN; REPAIR; DOMAIN; GROWTH; BINDS	Germline mutations in the tumor suppressor gene, BRCA1, predispose individuals to breast and ovarian cancers. Using a combination of affinity- and conventional chromatographic techniques, we have isolated a predominant form of a multiprotein BRCA1-containing complex from human cells displaying chromatin-remodeling activity. Mass spectrometric sequencing of components of this complex indicated that BRCA1 is associated with a SWI/SNF-related complex. We show that BRCA1 can directly interact with the BRG1 subunit of the SWI/SNF complex. Moreover, p53-mediated stimulation of transcription by BRCA1 was completely abrogated by either a dominant-negative mutant of BRG1 or the cancer-causing deletion in exon 11 of BRCA1. These findings reveal a direct function for BRCA1 in transcriptional control through modulation of chromatin structure.	Wistar Inst, Philadelphia, PA 19104 USA; Harvard Univ, Harvard Microchem Facil, Cambridge, MA 02138 USA; NIA, Genet Lab, NIH, Gerontol Res Ctr, Baltimore, MD 21224 USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07103 USA	The Wistar Institute; Harvard University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Rutgers State University New Brunswick; Rutgers State University Medical Center	Shiekhattar, R (corresponding author), Wistar Inst, 3601 Spruce St, Philadelphia, PA 19104 USA.		Kinev, Alexander V/K-3970-2013; Bochar, Daniel A/A-9224-2009; Wang, Weidong/AAV-2446-2021	Wang, Weidong/0000-0002-0658-7928				Anderson SE, 1998, NAT GENET, V19, P254, DOI 10.1038/930; Bochar DA, 1999, J BIOL CHEM, V274, P13162, DOI 10.1074/jbc.274.19.13162; Bochar DA, 2000, P NATL ACAD SCI USA, V97, P1038, DOI 10.1073/pnas.97.3.1038; Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Chittum HS, 1998, BIOCHEMISTRY-US, V37, P10866, DOI 10.1021/bi981042r; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Gowen LC, 1998, SCIENCE, V281, P1009, DOI 10.1126/science.281.5379.1009; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Harkin DP, 1999, CELL, V97, P575, DOI 10.1016/S0092-8674(00)80769-2; Harlow E, 1988, ANTIBODIES LAB MANUA; Hu YF, 1999, GENE DEV, V13, P637, DOI 10.1101/gad.13.6.637; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; KASHANCHI F, 1992, NUCLEIC ACIDS RES, V20, P4673, DOI 10.1093/nar/20.17.4673; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; MacLachlan TK, 2000, J BIOL CHEM, V275, P2777, DOI 10.1074/jbc.275.4.2777; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; MONTEIRO AN, 1996, P NATL ACAD SCI USA, V26, P13595; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Muralidhar S, 1996, J VIROL, V70, P8691, DOI 10.1128/JVI.70.12.8691-8700.1996; Ouchi T, 1998, P NATL ACAD SCI USA, V95, P2302, DOI 10.1073/pnas.95.5.2302; OwenHughes T, 1996, SCIENCE, V273, P513, DOI 10.1126/science.273.5274.513; Pao GM, 2000, P NATL ACAD SCI USA, V97, P1020, DOI 10.1073/pnas.97.3.1020; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1999, MOL CELL, V4, P1093, DOI 10.1016/S1097-2765(00)80238-5; Scully R, 1997, P NATL ACAD SCI USA, V94, P5605, DOI 10.1073/pnas.94.11.5605; Sif S, 1998, GENE DEV, V12, P2842, DOI 10.1101/gad.12.18.2842; Somasundaram K, 1997, NATURE, V389, P187, DOI 10.1038/38291; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; WOLFFE AP, 1999, SCI MED, V6, P28; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747	36	425	441	2	23	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 21	2000	102	2					257	265		10.1016/S0092-8674(00)00030-1	http://dx.doi.org/10.1016/S0092-8674(00)00030-1			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	337NA	10943845	Bronze			2022-12-24	WOS:000088366800015
J	Boudvillain, M; de Lencastre, A; Pyle, AM				Boudvillain, M; de Lencastre, A; Pyle, AM			A tertiary interaction that links active-site domains to the 5 ' splice site of a group II intron	NATURE			English	Article							U6 SNRNA; RNA HELIX; RIBOZYME; NUCLEOTIDES; MECHANISM; SELECTION; CONTACTS; PACKING; BINDING; CORE	Group II introns are self-splicing RNAs that are commonly found in the genes of plants, fungi, yeast and bacteria(1,2). Little is known about the tertiary structure of group II introns, which are among the largest natural ribozymes. The most conserved region of the intron is domain 5 (D5), which, together with domain 1 (D1), is required for all reactions catalysed by the intron(3). Despite the importance of D5, its spatial relationship and tertiary contacts to other active-site constituents have remained obscure. Furthermore, D5 has never been placed directly at a site of catalysis by the intron. Here we show that a set of tertiary interactions (lambda-lambda') links catalytically essential regions of D5 and D1, creating the framework for an active-site and anchoring it at the 5' splice site. Highly conserved elements similar to components of the lambda-lambda' interaction are found in the eukaryotic spliceosome.	Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute	Pyle, AM (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	amp11@columbia.edu		Boudvillain, Marc/0000-0002-6398-9122; de Lencastre, Alexandre/0000-0002-3951-8515				Abramovitz DL, 1996, SCIENCE, V271, P1410, DOI 10.1126/science.271.5254.1410; Boudvillain M, 1998, EMBO J, V17, P7091, DOI 10.1093/emboj/17.23.7091; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; CHANFREAU G, 1994, SCIENCE, V266, P1383, DOI 10.1126/science.7973729; CHIN K, 1995, RNA, V1, P391; COSTA M, 1995, EMBO J, V14, P1276, DOI 10.1002/j.1460-2075.1995.tb07111.x; Costa M, 1999, EMBO J, V18, P1025, DOI 10.1093/emboj/18.4.1025; JACQUIER A, 1990, J MOL BIOL, V213, P437, DOI 10.1016/S0022-2836(05)80206-2; JARRELL KA, 1988, MOL CELL BIOL, V8, P2361, DOI 10.1128/MCB.8.6.2361; KANDELSLEWIS S, 1993, SCIENCE, V262, P2035, DOI 10.1126/science.8266100; Konforti BB, 1998, MOL CELL, V1, P433, DOI 10.1016/S1097-2765(00)80043-X; LESSER CF, 1993, SCIENCE, V262, P1982, DOI 10.1126/science.8266093; MADHANI HD, 1992, CELL, V71, P803, DOI 10.1016/0092-8674(92)90556-R; MICHEL F, 1989, GENE, V82, P5, DOI 10.1016/0378-1119(89)90026-7; MICHEL F, 1995, ANNU REV BIOCHEM, V64, P435, DOI 10.1146/annurev.bi.64.070195.002251; Moore M., 1993, RNA WORLD, P303; Ortoleva-Donnelly L, 1998, BIOCHEMISTRY-US, V37, P12933, DOI 10.1021/bi980723j; Ortoleva-Donnelly L, 1998, RNA, V4, P498, DOI 10.1017/S1355838298980086; PEEBLES CL, 1995, P NATL ACAD SCI USA, V92, P4422, DOI 10.1073/pnas.92.10.4422; PLEY HW, 1994, NATURE, V372, P111, DOI 10.1038/372111a0; PYLE AM, 1994, BIOCHEMISTRY-US, V33, P2716, DOI 10.1021/bi00175a047; PYLE AM, 1996, NUCL ACIDS MOL BIOL, V10, P75; Qin PZ, 1998, CURR OPIN STRUC BIOL, V8, P301, DOI 10.1016/S0959-440X(98)80062-6; Strobel SA, 1998, NAT STRUCT BIOL, V5, P60, DOI 10.1038/nsb0198-60; Strobel SA, 1997, P NATL ACAD SCI USA, V94, P2903, DOI 10.1073/pnas.94.7.2903; Szewczak AA, 1998, NAT STRUCT BIOL, V5, P1037, DOI 10.1038/4146; YU YT, 1995, RNA, V1, P46	27	74	75	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2000	406	6793					315	318		10.1038/35018589	http://dx.doi.org/10.1038/35018589			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917534				2022-12-24	WOS:000088251900052
J	Eberhard, WG				Eberhard, WG			Spider manipulation by a wasp larva	NATURE			English	Article							NEPHILA-CLAVIPES ARANEAE; TETRAGNATHIDAE; PHYLOGENY		Univ Costa Rica, Smithsonian Trop Res Inst, San Jose, Costa Rica; Univ Costa Rica, Escuela Biol, San Jose, Costa Rica	Smithsonian Institution; Smithsonian Tropical Research Institute; Universidad Costa Rica; Universidad Costa Rica	Eberhard, WG (corresponding author), Univ Costa Rica, Smithsonian Trop Res Inst, Ciudad Univ, San Jose, Costa Rica.							Barnard C.J., 1990, PARASITISM HOST BEHA; CODDINGTON JA, 1968, SPIDERS WEBS BEHAV E, P319; EBERHARD WG, 1990, J ARACHNOL, V18, P205; EBERHARD WG, 1982, EVOLUTION, V36, P1067, DOI 10.1111/j.1558-5646.1982.tb05475.x; EBERHARD WG, IN PRESS J HYMEN RES; FINCKE OM, 1990, J ARACHNOL, V18, P321; Godfray HCJ, 1994, PARASITOIDS BEHAV EV, DOI [10.1515/9780691207025, DOI 10.1515/9780691207025]; Griswold CE, 1998, ZOOL J LINN SOC-LOND, V123, P1; Holmes J. C., 1972, , Behavioural aspects of parasite transmission., P123; JENNI L, 1980, NATURE, V283, P383, DOI 10.1038/283383a0; TILQUIN A, 1942, TOILE GEOMETRIQUE AR; TOFT CA, 1991, PARASITE HOST ASS; WENZEL JW, 1992, ANNU REV ECOL SYST, V23, P361, DOI 10.1146/annurev.es.23.110192.002045; WICKLER WZ, 1976, TIERPSYCHOLOGIE, V42, P200; Witt P. N., 1968, SPIDERS WEB	15	114	126	2	67	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 20	2000	406	6793					255	256		10.1038/35018636	http://dx.doi.org/10.1038/35018636			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917517				2022-12-24	WOS:000088251900035
J	Hoebe, CJPA; Kool, JL				Hoebe, CJPA; Kool, JL			Control of legionella in drinking-water systems	LANCET			English	Editorial Material							NOSOCOMIAL LEGIONNAIRES-DISEASE; PNEUMOPHILA; CHLORINE; RISK; SURVEILLANCE; EFFICACY; COPPER; OZONE		Municipal Hlth Serv, Dept Infect Dis, NL-6400 AD Heerlen, Netherlands; Natl Inst Publ Hlth & Environm, Dept Infect Dis Epidemiol, NL-3720 BA Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment	Hoebe, CJPA (corresponding author), Municipal Hlth Serv, Dept Infect Dis, POB 155, NL-6400 AD Heerlen, Netherlands.			Kool, Jacob/0000-0002-9605-2918; Hoebe, Christian/0000-0003-1815-0974				BLACK I, 2000, GUARDIAN        0510; Chen X, 1996, ENVIRON SCI TECHNOL, V30, P2078, DOI 10.1021/es9509184; EDELSTEIN PH, 1982, APPL ENVIRON MICROB, V44, P1330, DOI 10.1128/AEM.44.6.1330-1333.1982; Fiore AE, 1999, INFECT CONT HOSP EP, V20, P412, DOI 10.1086/501642; Hoebe C J, 1999, Ned Tijdschr Geneeskd, V143, P1041; Hoebe CJP, 1998, EUR J CLIN MICROBIOL, V17, P740, DOI 10.1007/s100960050173; Kool JL, 1999, INFECT CONT HOSP EP, V20, P798, DOI 10.1086/501587; Kool JL, 1999, LANCET, V353, P272, DOI 10.1016/S0140-6736(98)06394-6; LANDEEN LK, 1989, APPL ENVIRON MICROB, V55, P3045, DOI 10.1128/AEM.55.12.3045-3050.1989; MARSTON BJ, 1994, ARCH INTERN MED, V154, P2417, DOI 10.1001/archinte.154.21.2417; MURACA P, 1987, APPL ENVIRON MICROB, V53, P447, DOI 10.1128/AEM.53.2.447-453.1987; PICALUAS L, 2000, 4 DEC INT C NOS HEAL, P263; Rohr U, 1999, CLIN INFECT DIS, V29, P1507, DOI 10.1086/313512; Stout JE, 1998, INFECT CONT HOSP EP, V19, P911; *WHO COMM DIS SURV, LEG DIS AUSTR UPD	15	26	27	1	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 17	2000	355	9221					2093	2094		10.1016/S0140-6736(00)02374-6	http://dx.doi.org/10.1016/S0140-6736(00)02374-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325QD	10902621				2022-12-24	WOS:000087687100007
J	Vernino, S; Low, PA; Fealey, RD; Stewart, JD; Farrugia, G; Lennon, VA				Vernino, S; Low, PA; Fealey, RD; Stewart, JD; Farrugia, G; Lennon, VA			Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MYASTHENIA-GRAVIS; TACHYCARDIA SYNDROME; NERVOUS-SYSTEM; ANTIBODIES; THYMOMA; PSEUDOOBSTRUCTION; DYSAUTONOMIA; RECOVERY; DISEASE	Background: Idiopathic autonomic neuropathy is a severe, subacute disorder with a presumed autoimmune basis. It is indistinguishable from the subacute autonomic neuropathy that may accompany lung cancer or other tumors. Autoantibodies specific for nicotinic acetylcholine receptors in the autonomic ganglia are potentially pathogenic and may serve as serologic markers of various forms of autoimmune autonomic neuropathy. Methods: We tested serum from 157 patients with a variety of types of dysautonomia. Immunoprecipitation assays with iodine-125-labeled epibatidine and solubilized human neuroblastoma acetylcholine receptors were used to detect autoantibodies that bound to or blocked ganglionic receptors. Results: Ganglionic-receptor-binding antibodies were found in 19 of 46 patients with idiopathic or paraneoplastic autonomic neuropathy (41 percent), in 6 of 67 patients with postural tachycardia syndrome, idiopathic gastrointestinal dysmotility, or diabetic autonomic neuropathy (9 percent), and in none of 44 patients with other autonomic disorders. High levels of the binding antibodies correlated with more severe autonomic dysfunction (including the presence of tonic pupils). Levels of these antibodies decreased in patients who had clinical improvement. All seven patients with ganglionic-receptor-blocking antibodies had ganglionic-receptor-binding antibodies and had idiopathic or paraneoplastic autonomic neuropathy. Conclusions: Seropositivity for antibodies that bind to or block ganglionic acetylcholine receptors identifies patients with various forms of autoimmune autonomic neuropathy and distinguishes these disorders from other types of dysautonomia. The positive correlation between high levels of ganglionic-receptor antibodies and the severity of autonomic dysfunction suggests that the antibodies have a pathogenic role in these types of neuropathy. (N Engl J Med 2000;343:847-55.) (C) 2000, Massachusetts Medical Society.	Mayo Clin & Mayo Fdn, Dept Neurol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Immunol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Lab Med & Pathol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; McGill Univ, Montreal Neurol Hosp & Inst, Dept Neurol & Neurosurg, Montreal, PQ, Canada	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; McGill University	Vernino, S (corresponding author), Mayo Clin & Mayo Fdn, Dept Neurol, 200 1st St SW, Rochester, MN 55905 USA.	verns@mayo.edu	Vernino, Steven/AAD-5181-2020	Vernino, Steven/0000-0001-7799-8495				Anderson NE, 1996, NEUROLOGY, V47, P985, DOI 10.1212/WNL.47.4.985; BESINGER UA, 1983, NEUROLOGY, V33, P1316, DOI 10.1212/WNL.33.10.1316; Bohnen Nicolaas I., 1997, Neurology, V48, pA131; Bradbury S, 1925, AM HEART J, V1, P73, DOI 10.1016/S0002-8703(25)90007-5; CAMILLERI M, 1990, DIGEST DIS SCI, V35, P609, DOI 10.1007/BF01540409; DRACHMAN DB, 1994, NEW ENGL J MED, V330, P1797, DOI 10.1056/NEJM199406233302507; FEALEY RD, 1989, MAYO CLIN PROC, V64, P617, DOI 10.1016/S0025-6196(12)65338-5; GERZANICH V, 1995, MOL PHARMACOL, V48, P774; GRIESMANN GE, 1997, MANUAL CLIN LAB IMMU, P983; Hart IK, 1997, ANN NEUROL, V41, P238, DOI 10.1002/ana.410410215; HOWARD FM, 1987, ANN NY ACAD SCI, V505, P526, DOI 10.1111/j.1749-6632.1987.tb51321.x; KHURANA RK, 1997, CLIN AUTONOMIC DISOR, P545; LENNON VA, 1995, NEW ENGL J MED, V332, P1467, DOI 10.1056/NEJM199506013322203; LENNON VA, 1991, GASTROENTEROLOGY, V100, P137, DOI 10.1016/0016-5085(91)90593-A; LENNON VA, 1996, TXB AUTOANTIBODIES, P139; Lennon Vanda A., 1997, Neurology, V48, pS23; Low PA, 1997, MUSCLE NERVE, V20, P1561, DOI 10.1002/(SICI)1097-4598(199712)20:12<1561::AID-MUS11>3.0.CO;2-3; LOW PA, 1993, J CLIN NEUROPHYSIOL, V10, P14, DOI 10.1097/00004691-199301000-00003; LOW PA, 1993, MAYO CLIN PROC, V68, P748, DOI 10.1016/S0025-6196(12)60631-4; LOW PA, 1997, CLIN AUTONOMIC DISOR, P463; Lucchinetti CF, 1998, NEUROLOGY, V50, P652, DOI 10.1212/WNL.50.3.652; RUST G, 1994, EUR J NEUROSCI, V6, P478, DOI 10.1111/j.1460-9568.1994.tb00290.x; Sandroni P, 1999, MAYO CLIN PROC, V74, P1106, DOI 10.4065/74.11.1106; SCHONDORF R, 1993, NEUROLOGY, V43, P132, DOI 10.1212/WNL.43.1_Part_1.132; SHY GM, 1960, ARCH NEUROL-CHICAGO, V2, P511, DOI 10.1001/archneur.1960.03840110025004; SKOK VI, 1987, J AUTONOM NERV SYST, V21, P91, DOI 10.1016/0165-1838(87)90012-9; Smit AAJ, 1997, MAYO CLIN PROC, V72, P333, DOI 10.4065/72.4.333; SUAREZ GA, 1994, NEUROLOGY, V44, P1675, DOI 10.1212/WNL.44.9.1675; TABBAA MA, 1986, ARCH NEUROL-CHICAGO, V43, P955, DOI 10.1001/archneur.1986.00520090079023; Venkataraman S, 1998, NEUROLOGY, V51, P1764, DOI 10.1212/WNL.51.6.1764; Vernino S, 1998, NEUROLOGY, V50, P1806, DOI 10.1212/WNL.50.6.1806; Vernino S, 2000, ANN NEUROL, V47, P297, DOI 10.1002/1531-8249(200003)47:3<297::AID-ANA4>3.3.CO;2-W; Vernino S, 1999, NEUROLOGY, V53, P1233, DOI 10.1212/WNL.53.6.1233; Xu W, 1999, P NATL ACAD SCI USA, V96, P5746, DOI 10.1073/pnas.96.10.5746; YOUNG RR, 1975, BRAIN, V98, P613, DOI 10.1093/brain/98.4.613; Yu ZY, 1999, NEW ENGL J MED, V340, P227, DOI 10.1056/NEJM199901213400311	36	445	453	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 21	2000	343	12					847	855		10.1056/NEJM200009213431204	http://dx.doi.org/10.1056/NEJM200009213431204			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354XB	10995864				2022-12-24	WOS:000089355600004
J	Nishime, EO; Cole, CR; Blackstone, EH; Pashkow, FJ; Lauer, MS				Nishime, EO; Cole, CR; Blackstone, EH; Pashkow, FJ; Lauer, MS			Heart rate recovery and treadmill exercise score as predictors of mortality in patients referred for exercise ECG	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY-ARTERY DISEASE; MEDICALLY TREATED PATIENTS; CHRONOTROPIC INCOMPETENCE; PROGNOSTIC INFORMATION; MYOCARDIAL-INFARCTION; VITAL STATUS; DEATH; ASSOCIATION; SURVIVAL	Context Both attenuated heart rate recovery following exercise and the Duke tread mill exercise score have been demonstrated to be independent predictors of mortality, belt their prognostic value relative to each other has not been studied. Objective To assess the associations among abnormal heart rate recovery, treadmill exercise score, and death in patients referred specifically for exercise electrocardiography. Design and Setting Prospective cohort study conducted in an academic medical center between September 1990 and December 1997, with a median follow-up of 5.2 years. Patients A total of 9454 consecutive patients (mean [SD] age, 53 [11] years; 78% male) who underwent symptom-limited exercise electrocardiographic testing. Exclusion criteria included age younger than 30 years, history of heart failure or valvular disease, pacemaker implantation, and uninterpretable electrocardiograms. Main Outcome Measures All-cause mortality, as predicted by abnormal heart rate recovery, defined as failure of heart rate to decrease by more than 12/min during the first minute after peak exercise, and by treadmill exercise score, defined as (exercise time) - (5 x maximum ST-segment deviation) - (4 x treadmill angina index). Results Three hundred twelve deaths occurred in the cohort. Abnormal heart rate recovery and intermediate- or high-risk treadmill exercise score were present in 20% (n =1852) and 21% (n =1996) of patients. respectively. in univariate analyses, death was predicted by both abnormal heart rate recovery (8% vs 2% in patients with normal heart rate recovery; hazard ratio [HR], 4.16; 95% confidence interval [CI], 3.33-5.19; chi(2)=158; P<.001) and intermediate- or high-risk treadmill exercise score (8% vs 2% in patients with low-risk scores; HR, 4.28; 95% CI, 3.43-5.35; chi(2)=164; P<.001). After adjusting for age, sex, standard cardiovascular risk factors, medication use, and other potential confounders, abnormal heart rate recovery remained predictive of death (among the 8549 patients not taking p-blockers, adjusted HR, 2.13; 95% CI, 1.63-2.78; P<.001), as did intermediate- or high-risk treadmill exercise score (adjusted HR, 1.49, 95% CI, 2.15-1.92; P=.002). There was no interaction between these 2 predictors. Conclusions in this cohort of patients referred specifically for exercise electrocardiography, both abnormal heart rate recovery and treadmill exercise score were independent predictors of mortality. Heart rate recovery appears to provide additional prognostic information to the established treadmill exercise score and should be considered for routine incorporation into exercise test interpretation.	Cleveland Clin Fdn, Dept Cardiol, Clin Res & Exercise Lab, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Cardiothorac Surg, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Biostat & Epidemiol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Lauer, MS (corresponding author), Cleveland Clin Fdn, Dept Cardiol, Clin Res & Exercise Lab, Desk F25, Cleveland, OH 44195 USA.		Lauer, Michael S/L-9656-2013	Lauer, Michael S/0000-0002-9217-8177				ARAI Y, 1989, AM J PHYSIOL, V256, pH132, DOI 10.1152/ajpheart.1989.256.1.H132; BOYLE CA, 1990, AM J EPIDEMIOL, V131, P160, DOI 10.1093/oxfordjournals.aje.a115470; BRUNELLI C, 1989, EUR HEART J, V10, P292, DOI 10.1093/oxfordjournals.eurheartj.a059486; Chen SC, 1999, ADV POLYM TECH, V18, P1, DOI 10.1002/(SICI)1098-2329(199921)18:1<1::AID-ADV1>3.0.CO;2-0; Cole CR, 2000, ANN INTERN MED, V132, P552, DOI 10.7326/0003-4819-132-7-200004040-00007; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; COX DR, 1972, J R STAT SOC B, V34, P187; CURB JD, 1985, AM J EPIDEMIOL, V121, P754, DOI 10.1093/aje/121.5.754; FLETCHER GF, 1995, CIRCULATION, V91, P580, DOI 10.1161/01.CIR.91.2.580; GIFFORD RW, 1993, ARCH INTERN MED, V153, P154; GOHLKE H, 1983, CIRCULATION, V68, P979, DOI 10.1161/01.CIR.68.5.979; HAMMERMEISTER KE, 1979, CIRCULATION, V59, P421, DOI 10.1161/01.CIR.59.3.421; HUBBARD BL, 1992, ARCH INTERN MED, V152, P309, DOI 10.1001/archinte.152.2.309; IMAI K, 1994, J AM COLL CARDIOL, V24, P1529, DOI 10.1016/0735-1097(94)90150-3; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kwok JMF, 1999, JAMA-J AM MED ASSOC, V282, P1047, DOI 10.1001/jama.282.11.1047; LADENHEIM ML, 1987, AM J CARDIOL, V59, P270, DOI 10.1016/0002-9149(87)90798-3; Lauer MS, 1997, CIRCULATION, V96, P897; Lauer MS, 1999, J AM COLL CARDIOL, V34, P618, DOI 10.1016/S0735-1097(99)00250-8; Lauer MS, 1996, CIRCULATION, V93, P1520, DOI 10.1161/01.CIR.93.8.1520; Lauer MS, 1999, JAMA-J AM MED ASSOC, V281, P524, DOI 10.1001/jama.281.6.524; Lauer MS, 1998, LANCET, V351, P615, DOI 10.1016/S0140-6736(97)07062-1; Lauer MS, 1998, J AM COLL CARDIOL, V32, P1280, DOI 10.1016/S0735-1097(98)00377-5; LUWAERT RJ, 1988, EUR HEART J, V9, P418, DOI 10.1093/oxfordjournals.eurheartj.a062519; MARK DB, 1987, ANN INTERN MED, V106, P793, DOI 10.7326/0003-4819-106-6-793; MARK DB, 1991, NEW ENGL J MED, V325, P849, DOI 10.1056/NEJM199109193251204; MORROW K, 1993, ANN INTERN MED, V118, P689, DOI 10.7326/0003-4819-118-9-199305010-00005; Newman TB, 1997, J AM MED INFORM ASSN, V4, P233, DOI 10.1136/jamia.1997.0040233; Pilote L, 1998, AM J CARDIOL, V81, P219, DOI 10.1016/S0002-9149(97)00871-0; Snader CE, 1997, J AM COLL CARDIOL, V30, P641, DOI 10.1016/S0735-1097(97)00217-9; WEINER DA, 1984, J AM COLL CARDIOL, V3, P772, DOI 10.1016/S0735-1097(84)80254-5; Wilkoff Bruce L., 1992, Cardiology Clinics, V10, P705; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	33	492	523	0	25	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2000	284	11					1392	1398		10.1001/jama.284.11.1392	http://dx.doi.org/10.1001/jama.284.11.1392			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	352WN	10989401	Bronze			2022-12-24	WOS:000089242500033
J	DiRita, VJ				DiRita, VJ			Genomics - Genomics happens	SCIENCE			English	Editorial Material							VIBRIO-CHOLERAE GENOME; PATHOGENICITY ISLAND; GENE-CLUSTER; EL-TOR; IDENTIFICATION; EPIDEMIC; BACTERIA; STRAINS; PILUS; TOXIN		Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Unit Lab Anim Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	DiRita, VJ (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.							Akerley BJ, 1998, P NATL ACAD SCI USA, V95, P8927, DOI 10.1073/pnas.95.15.8927; BIK EM, 1995, EMBO J, V14, P209, DOI 10.1002/j.1460-2075.1995.tb06993.x; Champion GA, 1997, MOL MICROBIOL, V23, P323, DOI 10.1046/j.1365-2958.1997.2191585.x; Fullner KJ, 1999, INFECT IMMUN, V67, P1393, DOI 10.1128/IAI.67.3.1393-1404.1999; FULLNER KJ, 2000, GEN M AM SOC MICR LO; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Karaolis DKR, 1999, NATURE, V399, P375, DOI 10.1038/20715; Karaolis DKR, 1998, P NATL ACAD SCI USA, V95, P3134, DOI 10.1073/pnas.95.6.3134; Lee SH, 1999, CELL, V99, P625, DOI 10.1016/S0092-8674(00)81551-2; Lin W, 1999, P NATL ACAD SCI USA, V96, P1071, DOI 10.1073/pnas.96.3.1071; Lobitz B, 2000, P NATL ACAD SCI USA, V97, P1438, DOI 10.1073/pnas.97.4.1438; Marsh JW, 1998, MOL MICROBIOL, V29, P1481, DOI 10.1046/j.1365-2958.1998.01031.x; Mazel D, 1998, SCIENCE, V280, P605, DOI 10.1126/science.280.5363.605; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; ROSZAK DB, 1987, MICROBIOL REV, V51, P365, DOI 10.1128/MMBR.51.3.365-379.1987; Stock JB, 1996, ESCHERICHIA COLI SAL, P1103; Trucksis M, 1998, P NATL ACAD SCI USA, V95, P14464, DOI 10.1073/pnas.95.24.14464; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Watnick PI, 1999, J BACTERIOL, V181, P3606, DOI 10.1128/JB.181.11.3606-3609.1999	19	5	5	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 1	2000	289	5484					1488	1489		10.1126/science.289.5484.1488	http://dx.doi.org/10.1126/science.289.5484.1488			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349XW	10991736				2022-12-24	WOS:000089071700031
J	Diagne, N; Rogier, C; Sokhna, CS; Tall, A; Fontenille, D; Roussilhon, C; Spiegel, A; Trape, JF				Diagne, N; Rogier, C; Sokhna, CS; Tall, A; Fontenille, D; Roussilhon, C; Spiegel, A; Trape, JF			Increased susceptibility to malaria during the early postpartum period	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLASMODIUM-FALCIPARUM; CHONDROITIN SULFATE; CLINICAL MALARIA; HOLOENDEMIC AREA; IMMUNE-RESPONSE; PREGNANT-WOMEN; INFECTION; PLACENTA; ANTIGENS; ADHESION	Background Pregnancy is associated with increased susceptibility to malaria. It is generally agreed that this increased risk ends with delivery, but the possible persistence of increased susceptibility during the puerperium has not been investigated. Methods From June 1 1990, to December 31, 1998, we monitored exposure to malaria, parasitemia, and morbidity among the residents of a village in gal in which the rate of transmission of malaria was In this population we analyzed 71 pregnancies in 38 women from the year before conception through one year after delivery. Results Among the 38 women, there were 58 episodes of clinical Plasmodium falciparum malaria during 61, 081 person-days of observation. The incidence of malaria was 20.2 episodes per 1000 person-months during the year preceding conception and 12.0 episodes per 1000 person-months during the period from 91 to 365 days after delivery. The incidence of episodes of malaria increased significantly during the second and third trimesters of pregnancy and reached a maximum of 75.1 episodes per 1000 person-months during the first 60 days after delivery. The adjusted relative risk of an episode of malaria was 4.1 (95 percent confidence interval, 1.8 to 9.5) during the first 60 days post partum, as compared with the year ceding pregnancy. The duration of fever during the episodes of malaria was longer and the prevalence and density of asymptomatic malarial parasitemia were significantly higher during pregnancy and the early postpartum period than during the other periods. Conclusions Among women who live in areas with high rates of transmission of malaria, the susceptibility to malaria is highest during the second and third trimesters of pregnancy and the early postpartum period. (N Engl J Med 2000; 343: 598-603.) (C) 2000, Massachusetts Medical Society.	Inst Rech Dev, Lab Paludol, F-34032 Montpellier, France; Inst Rech Dev, Lab Paludol, Dakar, Senegal; Inst Rech Dev, Lab Zool Med, Dakar, Senegal; Serv Sante Armees, Inst Trop Med, Marseille, France; Inst Pasteur, Serv Epidemiol, Dakar, Senegal; Inst Pasteur, Dept Immunol, Dakar, Senegal	Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar	Trape, JF (corresponding author), Inst Rech Dev, Lab Paludol, BP 5045, F-34032 Montpellier, France.		FONTENILLE, didier/G-4091-2013; ROGIER, Christophe/C-2550-2008	FONTENILLE, didier/0000-0002-0544-3885				BRABIN B, 1991, APPL FIELD RES MALAR, V1; BRABIN BJ, 1983, B WORLD HEALTH ORGAN, V61, P1005; BRAY RS, 1979, T ROY SOC TROP MED H, V73, P427, DOI 10.1016/0035-9203(79)90170-6; Diagne N, 1997, T ROY SOC TROP MED H, V91, P166, DOI 10.1016/S0035-9203(97)90209-1; Fievet N, 1997, CLIN EXP IMMUNOL, V107, P462, DOI 10.1046/j.1365-2249.1997.d01-966.x; Fontenille D, 1997, AM J TROP MED HYG, V56, P247, DOI 10.4269/ajtmh.1997.56.247; Fried M, 1998, J MOL MED-JMM, V76, P162, DOI 10.1007/s001090050205; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Gysin J, 1997, MOL BIOCHEM PARASIT, V88, P267, DOI 10.1016/S0166-6851(97)00082-0; HART CA, 1988, BAILLIERE CLIN IMMUN, V2, P735; KORTMANN HFC, 1972, THESIS U AMSTERDAM; MCGREGOR IA, 1983, T ROY SOC TROP MED H, V77, P232, DOI 10.1016/0035-9203(83)90081-0; MCGREGOR IA, 1984, AM J TROP MED HYG, V33, P517, DOI 10.4269/ajtmh.1984.33.517; MENENDEZ C, 1994, T ROY SOC TROP MED H, V88, P590, DOI 10.1016/0035-9203(94)90176-7; MENENDEZ C, 1995, PARASITOL TODAY, V11, P178, DOI 10.1016/0169-4758(95)80151-0; Miller LH, 1998, NAT MED, V4, P1244, DOI 10.1038/3223; *MIN C MAL, 1992, WKLY EPIDEMIOL REC, V47, P349; MOUNT DL, 1989, B WORLD HEALTH ORGAN, V67, P295; Nahmias AJ, 1997, CLIN PERINATOL, V24, P497, DOI 10.1016/S0095-5108(18)30178-7; NGUYENDINH P, 1988, LANCET, V2, P751; RASHEED FN, 1993, AM J TROP MED HYG, V48, P154, DOI 10.4269/ajtmh.1993.48.154; Reid TMS, 1998, LANCET, V351, P1670, DOI 10.1016/S0140-6736(98)22023-X; RILEY EM, 1989, AM J TROP MED HYG, V40, P141, DOI 10.4269/ajtmh.1989.40.141; Rogier C, 1999, AM J TROP MED HYG, V60, P410, DOI 10.4269/ajtmh.1999.60.410; Rogier C, 1996, AM J TROP MED HYG, V54, P613, DOI 10.4269/ajtmh.1996.54.613; Smith NC, 1996, PARASITOL TODAY, V12, P4, DOI 10.1016/0169-4758(96)80637-5; TRAPE JF, 1994, AM J TROP MED HYG, V51, P123, DOI 10.4269/ajtmh.1994.51.123; VLEUGELS MPH, 1987, BRIT J OBSTET GYNAEC, V94, P758, DOI 10.1111/j.1471-0528.1987.tb03722.x; VLEUGELS MPH, 1989, T ROY SOC TROP MED H, V83, P173, DOI 10.1016/0035-9203(89)90632-9; WEINBERG ED, 1984, REV INFECT DIS, V6, P814; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	31	91	93	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 31	2000	343	9					598	603		10.1056/NEJM200008313430901	http://dx.doi.org/10.1056/NEJM200008313430901			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	348RE	10965006				2022-12-24	WOS:000088999600001
J	Cropley, IM; Lockwood, DNJ; Mack, D; Pasvol, G; Davidson, RN				Cropley, IM; Lockwood, DNJ; Mack, D; Pasvol, G; Davidson, RN			Rapid diagnosis of falciparum malaria by using the ParaSight F test in travellers returning to the United Kingdom: prospective study	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Northwick Pk Hosp & Clin Res Ctr, Lister Unit, Harrow HA1 3UJ, Middx, England; Northwick Pk Hosp & Clin Res Ctr, Dept Haematol, Harrow HA1 3UJ, Middx, England	Imperial College London; Imperial College London	Lockwood, DNJ (corresponding author), Hosp Trop Dis, London WC1E 6AU, England.	diana.lockwood@ishtm.ac.uk						BEADLE C, 1994, LANCET, V343, P564, DOI 10.1016/S0140-6736(94)91520-2; Genton Blaise, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P35; Pieroni P, 1998, T ROY SOC TROP MED H, V92, P166, DOI 10.1016/S0035-9203(98)90730-1; SHIFF CJ, 1993, T ROY SOC TROP MED H, V87, P646, DOI 10.1016/0035-9203(93)90273-S; Van den Ende J, 1998, T ROY SOC TROP MED H, V92, P285, DOI 10.1016/S0035-9203(98)91013-6	5	12	13	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 19	2000	321	7259					484	485		10.1136/bmj.321.7259.484	http://dx.doi.org/10.1136/bmj.321.7259.484			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	347MC	10948029	Bronze, Green Published			2022-12-24	WOS:000088932800022
J	Belaaouaj, AA; Kim, KS; Shapiro, SD				Belaaouaj, AA; Kim, KS; Shapiro, SD			Degradation of outer membrane protein A in Escherichia coli killing by neutrophil elastase	SCIENCE			English	Article							IMMUNOGOLD TECHNIQUE; CATHEPSIN-G; CLONING; MICE	In determining the mechanism of neutrophil elastase (NE)-mediated killing of Escherichia coli, we found that NE degraded outer membrane protein A (OmpA), Localized on the surface of Cram-negative bacteria. NE killed wild-type, but not OmpA-deficient, E, coli. Also, whereas NE-deficient mice had impaired survival in response to E, coli sepsis, as compared to wild-type mice, the presence or absence of NE had no influence on survival in response to sepsis that had been induced with OmpA-deficient E. coli. These findings define a mechanism of nonoxidative bacterial killing by NE and point to OmpA as a bacterial target in host defense.	Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; Childrens Hosp, Div Infect Dis, Los Angeles, CA 90027 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Children's Hospital Los Angeles	Belaaouaj, AA (corresponding author), Washington Univ, Sch Med, Div Pulm & Crit Care Med, 660 S Euclid Ave,Campus Box 8052, St Louis, MO 63110 USA.		Bentaher, Abderrazzaq/M-4424-2017; A, Bentaher/F-6531-2018	A, Bentaher/0000-0001-6001-5456				BEESLEY JE, 1984, J GEN MICROBIOL, V130, P1481; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Betsuyaku T, 1999, AM J RESP CELL MOL, V20, P1303, DOI 10.1165/ajrcmb.20.6.3558; Blondin J., 1978, NEUTRAL PROTEASES HU, P39; KLOSE M, 1988, J BIOL CHEM, V263, P13291; MacIvor DM, 1999, BLOOD, V94, P4282, DOI 10.1182/blood.V94.12.4282.424k45_4282_4293; NIKAIDO H, 1983, J BACTERIOL, V153, P241, DOI 10.1128/JB.153.1.241-252.1983; Prasadarao NV, 1996, INFECT IMMUN, V64, P146, DOI 10.1128/IAI.64.1.146-153.1996; REST RF, 1981, INFECT IMMUN, V34, P62, DOI 10.1128/IAI.34.1.62-68.1981; Shafer WM, 1996, INFECT IMMUN, V64, P4842, DOI 10.1128/IAI.64.11.4842-4845.1996; SHAPIRO SD, 1993, J BIOL CHEM, V268, P23824; SLOT JW, 1988, METHOD MICROBIOL, V20, P211, DOI 10.1016/S0580-9517(08)70053-9; ZIMMER M, 1992, P NATL ACAD SCI USA, V89, P8215, DOI 10.1073/pnas.89.17.8215; Zitnik RJ, 1997, BIOCHEM BIOPH RES CO, V232, P687, DOI 10.1006/bbrc.1997.6358	14	273	282	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 18	2000	289	5482					1185	1187		10.1126/science.289.5482.1185	http://dx.doi.org/10.1126/science.289.5482.1185			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346JE	10947984				2022-12-24	WOS:000088866600040
J	Ikura, T; Ogryzko, VV; Grigoriev, M; Groisman, R; Wang, J; Horikoshi, M; Scully, R; Qin, J; Nakatani, Y				Ikura, T; Ogryzko, VV; Grigoriev, M; Groisman, R; Wang, J; Horikoshi, M; Scully, R; Qin, J; Nakatani, Y			Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis	CELL			English	Article							GCN5-RELATED N-ACETYLTRANSFERASE; STRAND BREAK REPAIR; RUVB-LIKE PROTEIN; COENZYME-A; CRYSTAL-STRUCTURE; SUPERFAMILY; CHROMATIN; SWI/SNF; COACTIVATOR; COMPONENTS	It is well known that histone acetylases are important chromatin modifiers and that they play a central role in chromatin transcription. Here, we present evidence for novel roles of histone acetylases. The TIP60 histone acetylase purifies as a multimeric protein complex. Besides histone acetylase activity on chromatin, the TIP60 complex possesses ATPase, DNA helicase, and structural DNA binding activities. Ectopic expression of mutated TIP60 lacking histone acetylase activity results in cells with defective double-strand DNA break repair. Importantly, the resulting cells lose their apoptotic competence, suggesting a defect in the cells' ability to signal the existence of DNA damage to the apoptotic machinery. These results indicate that the histone acetylase TIP60-containing complex plays a role in DNA repair and apoptosis.	Dana Farber Canc Inst, Boston, MA 02115 USA; NIDDKD, NIH, Bethesda, MD 20892 USA; NICHHD, NIH, Bethesda, MD 20892 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Baylor Coll Med, Dept Biochem, Houston, TX 77030 USA; Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA; Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan; Japan Sci & Technol Corp, Exploratory Res Adv Technol, Horikoshi Gene Selector Project, Tsukuba, Ibaraki 3002635, Japan	Harvard University; Dana-Farber Cancer Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Harvard University; Harvard Medical School; Baylor College of Medicine; Baylor College of Medicine; University of Tokyo; Japan Science & Technology Agency (JST)	Nakatani, Y (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.		Scully, Ralph/F-5008-2013; Ogryzko, Vasily/M-6665-2015	Ogryzko, Vasily/0000-0002-8548-1389; Grigoriev, Michel/0000-0002-0252-2254; Groisman, Regina/0000-0003-3990-7622; Groisman, Sonia/0000-0003-1153-3841	NATIONAL CANCER INSTITUTE [K01CA079576] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allard S, 1999, EMBO J, V18, P5108, DOI 10.1093/emboj/18.18.5108; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Cairns BR, 1998, MOL CELL, V2, P639, DOI 10.1016/S1097-2765(00)80162-8; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Clements A, 1999, EMBO J, V18, P3521, DOI 10.1093/emboj/18.13.3521; D'Atri S, 1998, MOL PHARMACOL, V54, P334, DOI 10.1124/mol.54.2.334; Dutnall RN, 1998, CELL, V94, P427, DOI 10.1016/S0092-8674(00)81584-6; Galarneau L, 2000, MOL CELL, V5, P927, DOI 10.1016/S1097-2765(00)80258-0; Grant PA, 1998, CELL, V94, P45, DOI 10.1016/S0092-8674(00)81220-9; Hoffmann A, 1996, NATURE, V380, P356, DOI 10.1038/380356a0; Kamine J, 1996, VIROLOGY, V216, P357, DOI 10.1006/viro.1996.0071; Kanemaki M, 1999, J BIOL CHEM, V274, P22437, DOI 10.1074/jbc.274.32.22437; Karran P, 2000, CURR OPIN GENET DEV, V10, P144, DOI 10.1016/S0959-437X(00)00069-1; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Lin YX, 1999, NATURE, V400, P86, DOI 10.1038/21922; Makino Y, 1999, J BIOL CHEM, V274, P15329, DOI 10.1074/jbc.274.22.15329; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; Mizzen CA, 1996, CELL, V87, P1261, DOI 10.1016/S0092-8674(00)81821-8; Nakatani Y, 1996, J BIOL CHEM, V271, P6575, DOI 10.1074/jbc.271.12.6575; Nelms BE, 1998, SCIENCE, V280, P590, DOI 10.1126/science.280.5363.590; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; PANYUTIN IG, 1994, P NATL ACAD SCI USA, V91, P2021, DOI 10.1073/pnas.91.6.2021; Peterson CL, 1998, J BIOL CHEM, V273, P23641, DOI 10.1074/jbc.273.37.23641; Petrini JHJ, 2000, CURR OPIN CELL BIOL, V12, P293, DOI 10.1016/S0955-0674(00)00091-0; Qiu XB, 1998, J BIOL CHEM, V273, P27786, DOI 10.1074/jbc.273.43.27786; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; Schiltz RL, 2000, BBA-REV CANCER, V1470, pM37, DOI 10.1016/S0304-419X(99)00037-2; Scully R, 1999, MOL CELL, V4, P1093, DOI 10.1016/S1097-2765(00)80238-5; SHEN X, IN PRESS NATURE; SIMON RH, 1979, NUCLEIC ACIDS RES, V6, P689, DOI 10.1093/nar/6.2.689; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Vassilev A, 1998, MOL CELL, V2, P869, DOI 10.1016/S1097-2765(00)80301-9; West SC, 1997, ANNU REV GENET, V31, P213, DOI 10.1146/annurev.genet.31.1.213; Wolf E, 1998, CELL, V94, P439, DOI 10.1016/S0092-8674(00)81585-8; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; WU X, 2000, IN PRESS NATURE; Xie XL, 1996, NATURE, V380, P316, DOI 10.1038/380316a0; Yamamoto T, 1997, J BIOL CHEM, V272, P30595, DOI 10.1074/jbc.272.49.30595; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	47	839	869	3	47	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 18	2000	102	4					463	473		10.1016/S0092-8674(00)00051-9	http://dx.doi.org/10.1016/S0092-8674(00)00051-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	347BX	10966108	Bronze			2022-12-24	WOS:000088908000008
J	Neutze, R; Wouts, R; van der Spoel, D; Weckert, E; Hajdu, J				Neutze, R; Wouts, R; van der Spoel, D; Weckert, E; Hajdu, J			Potential for biomolecular imaging with femtosecond X-ray pulses	NATURE			English	Article							ELECTRON; RESOLUTION; CRYSTALLOGRAPHY; DIFFRACTION; MICROSCOPY; SPECIMENS; PROTEIN; VIRUS; LASER	Sample damage by X-rays and other radiation limits the resolution of structural studies on non-repetitive and non-reproducible structures such as individual biomolecules or cells(1). Cooling can slow sample deterioration, but cannot eliminate damage-induced sample movement during the time needed for conventional measurements(1,2). Analyses of the dynamics of damage formation(3-5) suggest that the conventional damage barrier (about 200 X-ray photons per Angstrom(2) with X-rays of 12 keV energy or 1 Angstrom wavelength 2) may be extended at very high dose rates and very short exposure times. Here we have used computer simulations to investigate the structural information that can be recovered from the scattering of intense femtosecond X-ray pulses by single protein molecules and small assemblies. Estimations of radiation damage as a function of photon energy, pulse length, integrated pulse intensity and sample size show that experiments using very high X-ray dose rates and ultrashort exposures may provide useful structural information before radiation damage destroys the sample. We predict that such ultrashort, high-intensity X-ray pulses from free-electron lasers(6,7) that are currently under development, in combination with container-free sample handling methods based on spraying techniques, will provide a new approach to structural determinations with X-rays.	Uppsala Univ, Ctr Biomed, Dept Biochem, S-75123 Uppsala, Sweden; Univ Karlsruhe, Inst Kristallog, D-76128 Karlsruhe, Germany	Uppsala University; Helmholtz Association; Karlsruhe Institute of Technology	Hajdu, J (corresponding author), Uppsala Univ, Ctr Biomed, Dept Biochem, Box 576, S-75123 Uppsala, Sweden.	janos@xray.bmc.uu.se	van der Spoel, David/AAD-9820-2019; Neutze, Richard/A-7573-2010; van der Spoel, David/A-5471-2008	van der Spoel, David/0000-0002-7659-8526; Neutze, Richard/0000-0003-0986-6153; van der Spoel, David/0000-0002-7659-8526				BEENDSEN HJC, 1981, INTERMOLECULAR FORCE, P331; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; Ditmire T, 1998, PHYS REV A, V57, pR4094, DOI 10.1103/PhysRevA.57.R4094; Doniach S, 1996, J SYNCHROTRON RADIAT, V3, P260, DOI 10.1107/S0909049596009739; Dyson N., 1973, XRAYS ATOMIC NUCL PH; Faigel G, 1999, REP PROG PHYS, V62, P355, DOI 10.1088/0034-4885/62/3/002; HAJDU J, 1990, ALFRED BENZON SYMP S, V28, P375; HARRISON SC, 1978, NATURE, V276, P368, DOI 10.1038/276368a0; HENDERSON R, 1995, Q REV BIOPHYS, V28, P171, DOI 10.1017/S003358350000305X; HENDERSON R, 1990, P ROY SOC B-BIOL SCI, V241, P6, DOI 10.1098/rspb.1990.0057; Hubbell J. H., 1975, Journal of Physical and Chemical Reference Data, V4, P471, DOI 10.1063/1.555523; KRAUSE MO, 1979, J PHYS CHEM REF DATA, V8, P329, DOI 10.1063/1.555595; Lin F., 1996, DISCRETE CONTINUOUS, V2, P1, DOI [10.3934/dcds.1996.2.1, DOI 10.3934/DCDS.1996.2.1, DOI 10.3934/dcds.1996.2.1]; Miao JW, 1999, NATURE, V400, P342, DOI 10.1038/22498; Mueller F, 2000, J MOL BIOL, V298, P35, DOI 10.1006/jmbi.2000.3635; Reiss HR, 1997, LASER PHYS, V7, P543; Rischel C, 1997, NATURE, V390, P490, DOI 10.1038/37317; Rostom AA, 2000, P NATL ACAD SCI USA, V97, P5185, DOI 10.1073/pnas.97.10.5185; Siuzdak G, 1996, CHEM BIOL, V3, P45, DOI 10.1016/S1074-5521(96)90083-6; SOLEM JC, 1986, J OPT SOC AM B, V3, P1551, DOI 10.1364/JOSAB.3.001551; Stowell MHB, 1998, CURR OPIN STRUC BIOL, V8, P595, DOI 10.1016/S0959-440X(98)80150-4; SZOKE A, 1993, ACTA CRYSTALLOGR A, V49, P853, DOI 10.1107/S0108767393004076; Tito MA, 2000, J AM CHEM SOC, V122, P3550, DOI 10.1021/ja993740k; Van Gunsteren WF, 1987, GROMOS 87 MANUAL; van Heel M, 1997, SCANNING MICROSC, V11, P195; Veigele Wm. J., 1973, Atomic Data, V5, P51, DOI 10.1016/S0092-640X(73)80015-4; WEAVER LH, 1987, J MOL BIOL, V193, P189, DOI 10.1016/0022-2836(87)90636-X; Wiik BH, 1997, NUCL INSTRUM METH A, V398, P1, DOI 10.1016/S0168-9002(97)00978-9; Winick H, 1995, J ELECTRON SPECTROSC, V75, P1, DOI 10.1016/0368-2048(95)02385-2	30	1453	1477	9	322	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2000	406	6797					752	757		10.1038/35021099	http://dx.doi.org/10.1038/35021099			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963603				2022-12-24	WOS:000088767700050
J	Rigotti, NA; Lee, JE; Wechsler, H				Rigotti, NA; Lee, JE; Wechsler, H			US college students' use of tobacco products - Results of a national survey	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BINGE-DRINKING; CIGAR SMOKING; PREVALENCE	Context Adults aged 18 to 24 years, many of whom are in college, represent the youngest legal targets for tobacco industry marketing. Cigarette smoking has been described among college students, but little is known about noncigarette tobacco use by college students or cigar use by adults of any age. Objectives To assess the prevalence of all forms of tobacco use (cigarettes, cigars, pipes, and smokeless tobacco) among US college students and to identify student- and college-level factors associated with use of each product. Design The Harvard College Alcohol Survey, a self-administered survey conducted in 1999. Setting One hundred nineteen nationally representative US 4-year colleges. Subjects A total of 14138 randomly selected students (60% response rate). Main Outcome Measures Self-report of current (in the past 30 days), past-year, and lifetime use of cigarettes, cigars, pipes, smokeless tobacco, and all tobacco products. Results Nearly half (45.7%) of respondents had used a tobacco product in the past year and one third (32.9%) currently used tobacco. Cigarettes accounted for most of the tobacco use (28.5% current prevalence), but cigar use was also substantial (37.1% lifetime prevalence, 23.0% past-year prevalence, and 8.5% current prevalence) and combinations of the 2 were common. Total tobacco use was higher in men than in women (37.9% vs 29.7%; P<.001), despite nearly identical current cigarette smoking rates between the sexes (28.5% for women vs 28.4% for men), because of greater use of cigars (current prevalence, 15.7% vs 3.9%; P<.001) and smokeless tobacco (current prevalence, 8.7% vs 0.4%; P<.001) by men. Tobacco use was significantly higher among white students (P<.001), users of other substances (alcohol and marijuana) (P<.001), and students whose priorities were social rather than educational or athletic (P<.05). Among students who had used both cigars and cigarettes, only 8.9% smoked cigars at an earlier age than they had smoked cigarettes. Conclusion Our study indicates that tobacco use is common among college students and is not limited to cigarettes. College appears to be a time when many students are trying a range of tobacco products and are in danger of developing lifelong nicotine dependence. National efforts to monitor and reduce tobacco use of all types should expand to focus on college students and other young adults.	Massachusetts Gen Hosp, Dept Med, Div Gen Med, Tobacco Res & Treatment Ctr, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Hlth & Social Behav, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Rigotti, NA (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Gen Med, Tobacco Res & Treatment Ctr, 50 Staniford St,9th Floor, Boston, MA 02114 USA.	nrigotti@partners.org						CARABALLO RS, 1998, ANN M SOC RES NIC TO; Centers for Disease Control and Prevention, 1997, MMWR-MORBID MORTAL W, V46, pSS; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P986; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P229; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P433; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P248; Emmons KM, 1998, AM J PUBLIC HEALTH, V88, P104, DOI 10.2105/AJPH.88.1.104; FRIER ME, 1991, TEENS TELL TRUTH VAL; Gilpin EA, 1999, AM J PREV MED, V16, P195, DOI 10.1016/S0749-3797(98)00092-0; Hatsukami D K, 1999, Nicotine Tob Res, V1, P21, DOI 10.1080/14622299050011131; Healton C, 2000, MMWR Morb Mortal Wkly Rep, V49, P49; Hyland A, 1998, AM J PUBLIC HEALTH, V88, P1086, DOI 10.2105/AJPH.88.7.1086; Jamner MS, 1999, PREV MED, V29, P187, DOI 10.1006/pmed.1999.0521; *NAT CTR ED STAT, 1996, NCES PUBL US DEP ED; U.S. Bureau of the Census, 1997, STAT ABSTR US 1997; *US BUR CENS, 1997, CURR POP REP P20443; *US DEP AGR, 1999, TOB SIT OUTL REP; *US DEP ED, 1997, DIG ED STAT; *US DEP HHS, 1998, NIH PUBL US DEP HHS; US Department of Health and Human Services, 1986, HLTH CONS INV SMOK R; WECHSLER H, 1992, JAMA-J AM MED ASSOC, V267, P2929; WECHSLER H, 1994, JAMA-J AM MED ASSOC, V272, P1672, DOI 10.1001/jama.272.21.1672; Wechsler H, 1998, JAMA-J AM MED ASSOC, V280, P1673, DOI 10.1001/jama.280.19.1673; WECHSLER H, 1995, AM J PUBLIC HEALTH, V85, P921, DOI 10.2105/AJPH.85.7.921; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734; [No title captured]; 1999, MMWR MORB MORTAL WKL, V48, P993	27	403	408	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2000	284	6					699	705		10.1001/jama.284.6.699	http://dx.doi.org/10.1001/jama.284.6.699			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	341JM	10927777	Bronze			2022-12-24	WOS:000088587300027
J	Whyatt, D; Lindeboom, F; Karis, A; Ferreira, R; Milot, E; Hendriks, R; de Bruijn, M; Langeveld, A; Gribnau, J; Grosveld, F; Philipsen, S				Whyatt, D; Lindeboom, F; Karis, A; Ferreira, R; Milot, E; Hendriks, R; de Bruijn, M; Langeveld, A; Gribnau, J; Grosveld, F; Philipsen, S			An intrinsic but cell-nonautonomous defect in GATA-1-overexpressing mouse erythroid cells	NATURE			English	Article							TRANSCRIPTION FACTOR GATA-1; X-CHROMOSOME INACTIVATION; CHIMERIC MICE; RETINOBLASTOMA GENE; IN-VIVO; DIFFERENTIATION; PRECURSORS; MUTATION; ERYTHROPOIESIS; STABILIZATION	GATA-1 is a tissue-specific transcription factor that is essential for the production of red blood cells(1,2). Here we show that overexpression of GATA-1 in erythroid cells inhibits their differentiation, leading to a lethal anaemia. Using chromosome-X-inactivation of a GATA-1 transgene and chimaeric animals, we show that this defect is intrinsic to erythroid cells, but nevertheless cell nonautonomous. Usually, cell nonautonomy is thought to reflect aberrant gene function in cells other than those that exhibit the phenotype(3). On the basis of our data, we propose an alternative mechanism in which a signal originating from wild-type erythroid cells restores normal differentiation to cells overexpressing GATA-1 in vivo. The existence of such a signalling mechanism indicates that previous interpretations of cell-nonautonomous defects may be erroneous in some cases and may in fact assign gene function to incorrect cell types.	Erasmus Univ, Dept Cell Biol & Genet, Ctr Med Genet, NL-3000 DR Rotterdam, Netherlands; Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands	Erasmus University Rotterdam; Netherlands Cancer Institute	Grosveld, F (corresponding author), Erasmus Univ, Dept Cell Biol & Genet, Ctr Med Genet, POB 1738, NL-3000 DR Rotterdam, Netherlands.		Ferreira, Rita/GZL-4970-2022; Whyatt, David J/H-6088-2014	Whyatt, David J/0000-0002-6905-1979; Ferreira, Rita/0000-0001-7440-2246				ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Apfeld J, 1998, CELL, V95, P199, DOI 10.1016/S0092-8674(00)81751-1; BERNARD J, 1991, BLOOD CELLS, V17, P5; Bessis M, 1983, HEMATOLOGY, P257; Briegel K, 1996, DEVELOPMENT, V122, P3839; CORMACK D, 1976, EXP HEMATOL, V4, P319; De Maria R, 1999, NATURE, V401, P489, DOI 10.1038/46809; Dubart A, 1996, BLOOD, V87, P3711, DOI 10.1182/blood.V87.9.3711.bloodjournal8793711; Elefanty AG, 1996, EMBO J, V15, P319, DOI 10.1002/j.1460-2075.1996.tb00362.x; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Hendriks RW, 1996, EMBO J, V15, P4862, DOI 10.1002/j.1460-2075.1996.tb00867.x; Hu NP, 1997, CANCER RES, V57, P4123; Kuroda MI, 1997, CELL, V91, P9, DOI 10.1016/S0092-8674(01)80003-9; MAANDAG ECR, 1994, EMBO J, V13, P4260, DOI 10.1002/j.1460-2075.1994.tb06746.x; MULDER MP, 1995, HUM GENET, V96, P133, DOI 10.1007/BF00207368; NAGAMINE CM, 1989, SCIENCE, V243, P80, DOI 10.1126/science.2563174; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; Panning B, 1997, CELL, V90, P907, DOI 10.1016/S0092-8674(00)80355-4; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Rossant J, 1998, TRENDS GENET, V14, P358, DOI 10.1016/S0168-9525(98)01552-2; SAWADA K, 1989, J CLIN INVEST, V83, P1701, DOI 10.1172/JCI114070; Sheardown SA, 1997, CELL, V91, P99, DOI 10.1016/S0092-8674(01)80012-X; Takahashi S, 1998, BLOOD, V92, P434, DOI 10.1182/blood.V92.2.434.414k24_434_442; Tsai FY, 1998, DEV BIOL, V196, P218, DOI 10.1006/dbio.1997.8842; WEISS MJ, 1994, GENE DEV, V8, P1184, DOI 10.1101/gad.8.10.1184; WEISS MJ, 1995, P NATL ACAD SCI USA, V92, P9623, DOI 10.1073/pnas.92.21.9623; Whyatt David J., 1997, Genes and Function, V1, P11; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0; WILLIAMS BO, 1994, EMBO J, V13, P4251, DOI 10.1002/j.1460-2075.1994.tb06745.x; WONG PMC, 1986, P NATL ACAD SCI USA, V83, P3851, DOI 10.1073/pnas.83.11.3851	30	91	93	1	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2000	406	6795					519	524		10.1038/35020086	http://dx.doi.org/10.1038/35020086			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952313				2022-12-24	WOS:000088538000047
J	Doyle, LW				Doyle, LW			Effects of perinatal necropsy on counselling	LANCET			English	Editorial Material							AUTOPSY; CARE		Royal Womens Hosp, Dept Obstet & Gynaecol, Carlton, Vic 3053, Australia		Doyle, LW (corresponding author), Royal Womens Hosp, Dept Obstet & Gynaecol, Carlton, Vic 3053, Australia.			Doyle, Lex/0000-0002-7667-7312				Barr P, 1999, J PAEDIATR CHILD H, V35, P185, DOI 10.1046/j.1440-1754.1999.t01-1-00338.x; *CONS COUNC OBST P, 1998, ANN REP YEAR 1997 IN; Faye-Petersen OM, 1999, OBSTET GYNECOL, V94, P915, DOI 10.1016/S0029-7844(99)00468-8; FORREST CG, 1982, BRIT MED J, V285, P1475; HARPER MB, 1994, J REPROD MED, V39, P80; Iwarsson E, 1998, MOL HUM REPROD, V4, P871, DOI 10.1093/molehr/4.9.871; LAKE MF, 1987, AM J OBSTET GYNECOL, V157, P1203, DOI 10.1016/S0002-9378(87)80295-8; LILFORD RJ, 1994, BRIT J OBSTET GYNAEC, V101, P291, DOI 10.1111/j.1471-0528.1994.tb13612.x; RUSHTON DI, 1994, BRIT J HOSP MED, V52, P450	9	9	9	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 17	2000	355	9221					2093	2093		10.1016/S0140-6736(00)02373-4	http://dx.doi.org/10.1016/S0140-6736(00)02373-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325QD	10902620				2022-12-24	WOS:000087687100006
J	Michael, WM; Ott, R; Fanning, E; Newport, J				Michael, WM; Ott, R; Fanning, E; Newport, J			Activation of the DNA replication checkpoint through RNA synthesis by primase	SCIENCE			English	Article							POLYMERASE-ALPHA; PROTEIN-KINASE; FISSION YEAST; S-PHASE; INITIATION; INHIBITOR; MITOSIS; DAMAGE; CDK	When DNA replication is inhibited during the synthesis (S) phase of the cell cycle, a signaling pathway (checkpoint) is activated that serves to prevent mitosis from initiating before completion of replication. This replication checkpoint acts by down-regulating the activity of the mitotic inducer cdc2-cyclin B. Here, we report the relation between chromatin structure and induction of the replication checkpoint. Chromatin was competent to initiate a checkpoint response only after the DNA was unwound and DNA polymerase or had been Loaded. Checkpoint induction did not require new DNA synthesis on the unwound template strand but did require RNA primer synthesis by primase. These findings Identify the RNA portion of the primer as an important component of the signal that activates the replication checkpoint.	Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Vanderbilt Univ, Dept Mol Biol, Nashville, TN 37235 USA	University of California System; University of California San Diego; Harvard University; Vanderbilt University	Michael, WM (corresponding author), Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA.	matt@mcb.harvard.edu	McDermott, Michael Francis/GZM-5330-2022		NIGMS NIH HHS [R01GM33523-16] Funding Source: Medline; PHS HHS [52948] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033523] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bhaumik D, 1998, MOL BIOL CELL, V9, P2107, DOI 10.1091/mbc.9.8.2107; BULLOCK PA, 1991, MOL CELL BIOL, V11, P2350, DOI 10.1128/MCB.11.5.2350; DURSO G, 1995, J CELL SCI, V108, P3109; Dutta A, 1997, ANNU REV CELL DEV BI, V13, P293, DOI 10.1146/annurev.cellbio.13.1.293; GROSSE F, 1985, J BIOL CHEM, V260, P1881; Kirk BW, 1999, BIOCHEMISTRY-US, V38, P7727, DOI 10.1021/bi990247c; KORNBERG A, 1992, DNA REPLICATION, P466; Kumagai A, 1998, J CELL BIOL, V142, P1559, DOI 10.1083/jcb.142.6.1559; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; MICHAEL WM, UNPUB; Mimura S, 1998, EMBO J, V17, P5699, DOI 10.1093/emboj/17.19.5699; MURRAY GB, 1995, PSYCHOSOMATICS, V36, P581, DOI 10.1016/S0033-3182(95)71616-4; Rhind N, 1998, CURR OPIN CELL BIOL, V10, P749, DOI 10.1016/S0955-0674(98)80118-X; Russell P, 1998, TRENDS BIOCHEM SCI, V23, P399, DOI 10.1016/S0968-0004(98)01291-2; Schneider A, 1998, J BIOL CHEM, V273, P21608, DOI 10.1074/jbc.273.34.21608; SHEAFF R, 1991, BIOCHEMISTRY-US, V30, P8590, DOI 10.1021/bi00099a014; TANAKA S, 1982, J BIOL CHEM, V257, P8386; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Walter J, 1999, PRACT APPROACH SER, V199, P201; Walworth NC, 1996, SCIENCE, V271, P353, DOI 10.1126/science.271.5247.353; Wang TSF, 1995, METHOD ENZYMOL, V262, P77; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Yuzhakov A, 1999, EMBO J, V18, P6189, DOI 10.1093/emboj/18.21.6189	24	162	166	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 22	2000	289	5487					2133	2137		10.1126/science.289.5487.2133	http://dx.doi.org/10.1126/science.289.5487.2133			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11000117				2022-12-24	WOS:000089430900047
J	Mouillet-Richard, S; Ermonval, M; Chebassier, C; Laplanche, JL; Lehmann, S; Launay, JM; Kellermann, O				Mouillet-Richard, S; Ermonval, M; Chebassier, C; Laplanche, JL; Lehmann, S; Launay, JM; Kellermann, O			Signal transduction through prion protein	SCIENCE			English	Article							EXPRESSION; MOLECULES; KINASES; CELLS	The cellular prion protein PrPc is a glycosylphosphaltidylinositol-anchored cell-surface protein whose biological function is unclear: We used the murine 1C11 neuronal differentiation model to search for PrPc-dependent signal transduction through antibody-mediated cross-linking. A caveolin-1-dependent coupling of PrPc to the tyrosine kinase Fyn was observed. Clathrin might also contribute to this coupling. The ability of the 1C11 cell line to trigger PrPc-dependent Fyn activation was restricted to its fully differentiated serotonergic or noradrenergic progenies. Moreover, the signaling activity of PrPc occurred mainly at neurites. Thus, PrPc may be a signal transduction protein.	Inst Pasteur, CNRS, F-75724 Paris 15, France; Hop Lariboisiere, Serv Biochim, CR Claude Bernard, F-75009 Paris, France; IGH, CNRS, UPR 1142, F-34396 Montpellier 5, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Mouillet-Richard, S (corresponding author), Inst Pasteur, CNRS, F-75724 Paris 15, France.		Lehmann, Sylvain/P-1301-2017; LAPLANCHE, Jean-Louis/S-8707-2016; Mouillet, Sophie/E-4960-2017	Lehmann, Sylvain/0000-0001-6117-562X; Mouillet, Sophie/0000-0002-8950-1949; Ermonval, Myriam/0000-0002-9685-9826; Lafay-Chebassier, Claire/0000-0001-8970-5514; LAPLANCHE, Jean-Louis/0000-0003-2836-2903				Brockes JP, 1999, CURR OPIN NEUROBIOL, V9, P571, DOI 10.1016/S0959-4388(99)00016-1; Gainer AL, 1996, TRANSPLANTATION, V61, P1567, DOI 10.1097/00007890-199606150-00003; Herms J, 1999, J NEUROSCI, V19, P8866, DOI 10.1523/JNEUROSCI.19-20-08866.1999; KLEIN TM, 1987, NATURE, V327, P70, DOI 10.1038/327070a0; Kramer EM, 1999, J BIOL CHEM, V274, P29042, DOI 10.1074/jbc.274.41.29042; KRETZSCHMAR HA, 1986, AM J PATHOL, V122, P1; Mouillet-Richard S, 1999, MICROBES INFECT, V1, P969, DOI 10.1016/S1286-4579(99)80514-0; Mouillet-Richard S, 2000, J BIOL CHEM, V275, P9186, DOI 10.1074/jbc.275.13.9186; Nishida N., UNPUB; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Raeber AJ, 1998, BRAIN PATHOL, V8, P715, DOI 10.1111/j.1750-3639.1998.tb00197.x; Rieger R, 1997, NAT MED, V3, P1383, DOI 10.1038/nm1297-1383; SCHERER PE, 1995, J BIOL CHEM, V270, P16395, DOI 10.1074/jbc.270.27.16395; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; SOBUE K, 1989, NEURON, V3, P311, DOI 10.1016/0896-6273(89)90255-9; STEFANOVA I, 1991, SCIENCE, V254, P1016, DOI 10.1126/science.1719635; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513	17	658	673	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 15	2000	289	5486					1925	1928		10.1126/science.289.5486.1925	http://dx.doi.org/10.1126/science.289.5486.1925			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354XD	10988071				2022-12-24	WOS:000089355800043
J	Denef, N; Neubuser, D; Perez, L; Cohen, SM				Denef, N; Neubuser, D; Perez, L; Cohen, SM			Hedgehog induces opposite changes in turnover and subcellular localization of patched and smoothened	CELL			English	Article							DROSOPHILA CUBITUS INTERRUPTUS; TARGET GENE-EXPRESSION; PROXIMAL-DISTAL AXIS; RECEPTOR COMPLEX; TRANSCRIPTIONAL ACTIVATOR; SIGNAL-TRANSDUCTION; PROTEIN-KINASE; SONIC HEDGEHOG; IMAGINAL DISKS; WINGLESS	Secreted signaling proteins of the Hedgehog family organize spatial pattern during animal development. Two integral membrane proteins have been identified with distinct roles in Hedgehog signaling. Patched functions in Hedgehog binding, and Smoothened functions in transducing the signal. Current models view Patched and Smoothened as a preformed receptor complex that is activated by Hedgehog binding. Here we present evidence that Patched destabilizes Smoothened in the absence of Hedgehog. Hedgehog binding causes removal of Patched from the cell surface. In contrast, Hedgehog causes phosphorylation, stabilization, and accumulation of Smoothened at the cell surface. Comparable effects can be produced by removing Patched from cells by RNA-mediated interference. These findings raise the possibility that Patched acts indirectly to regulate Smoothened activity.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Cohen, SM (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.		Cohen, Stephen M/G-9930-2011; Perez, Lidia/F-7695-2016	Cohen, Stephen M/0000-0003-2858-9163; Perez, Lidia/0000-0002-8821-1202				Alcedo J, 1997, BIOL CHEM, V378, P583; Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Alexandre C, 1996, GENE DEV, V10, P2003, DOI 10.1101/gad.10.16.2003; Alves G, 1998, MECH DEVELOP, V78, P17, DOI 10.1016/S0925-4773(98)00130-0; Aza-Blanc P, 1999, TRENDS GENET, V15, P458, DOI 10.1016/S0168-9525(99)01869-7; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Brook WJ, 1996, SCIENCE, V273, P1373, DOI 10.1126/science.273.5280.1373; Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; Calleja M, 1996, SCIENCE, V274, P252, DOI 10.1126/science.274.5285.252; CAPDEVILA J, 1994, EMBO J, V13, P71, DOI 10.1002/j.1460-2075.1994.tb06236.x; Chen CH, 1999, CELL, V98, P305, DOI 10.1016/S0092-8674(00)81960-1; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Chen Y, 1998, DEVELOPMENT, V125, P4943; DIAZBENJUMEA FJ, 1994, NATURE, V372, P175, DOI 10.1038/372175a0; Dominguez M, 1996, SCIENCE, V272, P1621, DOI 10.1126/science.272.5268.1621; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hepker J, 1997, DEVELOPMENT, V124, P549; Incardona JP, 2000, CURR OPIN CELL BIOL, V12, P193, DOI 10.1016/S0955-0674(99)00076-9; INGHAM PW, 1995, CURR OPIN GENET DEV, V5, P492, DOI 10.1016/0959-437X(95)90054-K; INGHAM PW, 1991, NATURE, V353, P184, DOI 10.1038/353184a0; Jiang J, 1996, CELL, V86, P401, DOI 10.1016/S0092-8674(00)80113-0; KORNEZOS A, 1992, MOL GEN GENET, V235, P397, DOI 10.1007/BF00279386; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Lecuit T, 1997, NATURE, V388, P139, DOI 10.1038/40563; LEE JJ, 1992, CELL, V71, P33, DOI 10.1016/0092-8674(92)90264-D; LI W, 1995, CELL, V80, P553, DOI 10.1016/0092-8674(95)90509-X; MA CY, 1993, CELL, V75, P927, DOI 10.1016/0092-8674(93)90536-Y; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9; Monnier V, 1998, CURR BIOL, V8, P583, DOI 10.1016/S0960-9822(98)70227-1; MOTZNY CK, 1995, MECH DEVELOP, V52, P137, DOI 10.1016/0925-4773(95)00397-J; Mullor JL, 1997, DEVELOPMENT, V124, P1227; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Neufeld EB, 1999, J BIOL CHEM, V274, P9627, DOI 10.1074/jbc.274.14.9627; Ohlmeyer JT, 1998, NATURE, V396, P749, DOI 10.1038/25533; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; Pignoni F, 1997, DEVELOPMENT, V124, P271; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rorth P, 1998, DEVELOPMENT, V125, P1049; SCHWARTZ C, 1995, DEVELOPMENT, V121, P1625; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Strigini M, 1997, DEVELOPMENT, V124, P4697; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; TABATA T, 1992, GENE DEV, V6, P2635, DOI 10.1101/gad.6.12b.2635; Therond PP, 1999, DEVELOPMENT, V126, P4039; Therond PP, 1996, P NATL ACAD SCI USA, V93, P4224, DOI 10.1073/pnas.93.9.4224; vandenHeuvel M, 1996, NATURE, V382, P547, DOI 10.1038/382547a0; VANLEEUWEN F, 1994, NATURE, V368, P342, DOI 10.1038/368342a0; Wang QT, 1999, DEVELOPMENT, V126, P5097; ZECCA M, 1995, DEVELOPMENT, V121, P2265	52	420	436	1	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 18	2000	102	4					521	531		10.1016/S0092-8674(00)00056-8	http://dx.doi.org/10.1016/S0092-8674(00)00056-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	347BX	10966113	Bronze			2022-12-24	WOS:000088908000013
J	Kohno, M; Koizumi, Y				Kohno, M; Koizumi, Y			Tokaimura accident - Neutron dose estimates from 5-yen coins	NATURE			English	Article									Kyoto Univ, Dept Nucl Engn, Sakyo Ku, Kyoto 6068501, Japan; Univ Tokyo, Isotope Ctr, Bunkyo Ku, Tokyo 1130032, Japan	Kyoto University; University of Tokyo	Kohno, M (corresponding author), Kyoto Univ, Dept Nucl Engn, Sakyo Ku, Kyoto 6068501, Japan.							IMANAKA T, 1999, GIJUTSU TO NIGEN, V28, P56; Komura K, 2000, J ENVIRON RADIOACTIV, V50, P1; *SCI TECHN AG JAP, 1999, DOS EST ENV NEIGHB J	3	1	1	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2000	406	6797					693	693		10.1038/35021138	http://dx.doi.org/10.1038/35021138			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963586				2022-12-24	WOS:000088767700033
J	Bollmann, JH; Sakmann, B; Gerard, J; Borst, G				Bollmann, JH; Sakmann, B; Gerard, J; Borst, G			Calcium sensitivity of glutamate release in a calyx-type terminal	SCIENCE			English	Article							BOVINE CHROMAFFIN CELLS; TRANSMITTER RELEASE; DM-NITROPHEN; NERVE-TERMINALS; DEPENDENT EXOCYTOSIS; FLASH-PHOTOLYSIS; TIME-COURSE; SYNAPSE; CA2+; DEPRESSION	Synaptic efficacy critically depends on the presynaptic intracellular calcium concentration ([Ca2+](i)). We measured the calcium sensitivity of glutamate release in a rat auditory brainstem synapse by Laser photolysis of caged calcium. A rise in [Ca2+](i) to 1 micromolar readily evoked release. An increase to >30 micromolar depleted the releasable vesicle pool in <0.5 millisecond. A comparison with action potential-evoked release suggested that a brief increase of [Ca2+](i) to similar to 10 micromolar would be sufficient to reproduce the physiological release pattern. Thus, the calcium sensitivity of release at this synapse is high, and the distinction between phasic and delayed release is Less pronounced than previously thought.	Max Planck Inst Med Res, Dept Cell Physiol, D-69120 Heidelberg, Germany; Univ Amsterdam, Swammerdam Inst Life Sci, NL-1098 SM Amsterdam, Netherlands	Max Planck Society; University of Amsterdam	Bollmann, JH (corresponding author), Max Planck Inst Med Res, Dept Cell Physiol, Jahnstr 29, D-69120 Heidelberg, Germany.	jbollman@mpimf-heidelberg.mpg.de						AUGUSTINE GJ, 1991, ANN NY ACAD SCI, V635, P365, DOI 10.1111/j.1749-6632.1991.tb36505.x; Borst JGG, 1995, J PHYSIOL-LONDON, V489, P825, DOI 10.1113/jphysiol.1995.sp021095; Borst JGG, 1998, J PHYSIOL-LONDON, V506, P143, DOI 10.1111/j.1469-7793.1998.143bx.x; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Burgoyne RD, 1998, CELL CALCIUM, V24, P367, DOI 10.1016/S0143-4160(98)90060-4; Chen CF, 1999, J NEUROSCI, V19, P6257; CHOW RH, 1994, P NATL ACAD SCI USA, V91, P12765, DOI 10.1073/pnas.91.26.12765; Cummings DD, 1996, J NEUROSCI, V16, P5312; DELANEY KR, 1990, J PHYSIOL-LONDON, V426, P473, DOI 10.1113/jphysiol.1990.sp018150; DiGregorio DA, 1999, J NEUROSCI, V19, P7846; EllisDavies GCR, 1996, BIOPHYS J, V70, P1006, DOI 10.1016/S0006-3495(96)79644-3; Escobar AL, 1997, PFLUG ARCH EUR J PHY, V434, P615, DOI 10.1007/s004240050444; Hazard AL, 1998, PROTEIN SCI, V7, P2451, DOI 10.1002/pro.5560071123; Heidelberger R, 1998, J GEN PHYSIOL, V111, P225, DOI 10.1085/jgp.111.2.225; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; Helmchen F, 1997, BIOPHYS J, V72, P1458, DOI 10.1016/S0006-3495(97)78792-7; Hsu SF, 1996, NEURON, V17, P501, DOI 10.1016/S0896-6273(00)80182-8; KAPLAN JH, 1988, P NATL ACAD SCI USA, V85, P6571, DOI 10.1073/pnas.85.17.6571; Kasai H, 1999, TRENDS NEUROSCI, V22, P88, DOI 10.1016/S0166-2236(98)01293-4; Naraghi M, 1997, CELL CALCIUM, V22, P255, DOI 10.1016/S0143-4160(97)90064-6; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Ohana O, 1998, J PHYSIOL-LONDON, V513, P135, DOI 10.1111/j.1469-7793.1998.135by.x; Proks P, 1996, J PHYSIOL-LONDON, V496, P255, DOI 10.1113/jphysiol.1996.sp021682; Ravin R, 1999, J NEUROPHYSIOL, V81, P634, DOI 10.1152/jn.1999.81.2.634; ROBITAILLE R, 1993, NEURON, V11, P645, DOI 10.1016/0896-6273(93)90076-4; ROSENBOOM H, 1994, P NATL ACAD SCI USA, V91, P5267, DOI 10.1073/pnas.91.12.5267; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Sudhof TC, 1996, NEURON, V17, P379, DOI 10.1016/S0896-6273(00)80171-3; Tandon A, 1998, NEURON, V21, P147, DOI 10.1016/S0896-6273(00)80522-X; THOMAS P, 1993, NEURON, V11, P93, DOI 10.1016/0896-6273(93)90274-U; Traynelis SF, 1998, J NEUROSCI METH, V86, P25, DOI 10.1016/S0165-0270(98)00140-X; vonGersdorff H, 1997, J NEUROSCI, V17, P8137; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8; YAMADA WM, 1992, BIOPHYS J, V61, P671, DOI 10.1016/S0006-3495(92)81872-6; ZUCKER RS, 1993, CELL CALCIUM, V14, P87, DOI 10.1016/0143-4160(93)90079-L; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	38	371	375	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2000	289	5481					953	957		10.1126/science.289.5481.953	http://dx.doi.org/10.1126/science.289.5481.953			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343KH	10937999				2022-12-24	WOS:000088701200033
J	Sandak, R; Fiez, JA				Sandak, R; Fiez, JA			Stuttering: a view from neuroimaging	LANCET			English	Editorial Material							POSITRON EMISSION TOMOGRAPHY		Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sandak, R (corresponding author), Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA.							ANDREWS G, 1983, J SPEECH HEAR DISORD, V48, P226, DOI 10.1044/jshd.4803.226; Braun AR, 1997, BRAIN, V120, P761, DOI 10.1093/brain/120.5.761; Fox PT, 1996, NATURE, V382, P158, DOI 10.1038/382158a0; Geschwind N, 1984, CEREBRAL DOMINANCE B; Ingham RJ, 1996, J SPEECH HEAR RES, V39, P1208, DOI 10.1044/jshr.3906.1208; Lawrence M, 1998, AM FAM PHYSICIAN, V57, P2175; Packman A, 2000, DISABIL REHABIL, V22, P65, DOI 10.1080/096382800297132; Peters HFM, 2000, FOLIA PHONIATR LOGO, V52, P103, DOI 10.1159/000021518; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Salmelin R, 2000, BRAIN, V123, P1184, DOI 10.1093/brain/123.6.1184; WU JC, 1995, NEUROREPORT, V6, P501, DOI 10.1097/00001756-199502000-00024; Zanini S, 1999, PERCEPT MOTOR SKILL, V89, P1095, DOI 10.2466/PMS.89.7.1095-1109; ZEBROWSKI PM, 1995, J COMMUN DISORD, V28, P75, DOI 10.1016/0021-9924(95)00002-U	13	12	14	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 5	2000	356	9228					445	446		10.1016/S0140-6736(00)02547-2	http://dx.doi.org/10.1016/S0140-6736(00)02547-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	342QY	10981883				2022-12-24	WOS:000088657700004
J	Collins, S; Myatt, M				Collins, S; Myatt, M			Short-term prognosis in severe adult and adolescent malnutrition during famine - Use of a simple prognostic model based on counting clinical signs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context In the setting of famine, infection is likely to cause mortality among severely malnourished persons. Although clinical signs are likely to be useful prognostic indicators in this setting, use of a clinical assessment model has not been studied. Objective To examine the use of clinical signs in the prediction of short-term mortality in severely malnourished adults and adolescents during famine. Design Retrospective cohort study. Setting Concern Worldwide Adult Therapeutic Feeding Center in Baidoa, Somalia. Patients Data from the clinical records of 383 adult and adolescent inpatients admitted to the center between November 1992 through March 1993 who were aged 15 years or older and had a body mass index (BMI) of 13.5 kg/m(2) or less or any signs of edematous malnutrition. Main Outcome Measures Association of mortality with presence dr absence of 8 clinical signs (edema, hydration, ascites, dysentery, diarrhea, anemia, chest infection, and ability to stand) and BMI at admission, and sensitivity and specificity of models including a count of clinical signs and BMI in the prediction of mortality at the center. Results Ninety-one patients (23.8%) died, with a median time to death of 8 days from admission. Of the 8 clinical signs, severe edema (unadjusted odds ratio [OR], 2.45; 95% confidence interval [CI], 1.41-4.27), apparent dehydration (unadjusted OR, 2.73; 95% CI, 1.60-4.66), and inability to stand (unadjusted OR, 2.96; 95% CI, 1.40-6.26) were independently associated with mortality. The most useful clinical model was that based on the presence of any 1 of these 3 signs, with a sensitivity of 77% and a specificity of 59%. Ability of admission BMI to predict mortality was less than random. Conclusions Models based on clinical signs predicted death better than BMI, Simple counts of clinical signs performed as well as more complex models based on the addition of ORs. Counting relevant clinical signs is an easy and effective prognostic tool in severe adult and adolescent malnutrition during famine; however, it is not sensitive enough for use as a screening tool.	Concern Worldwide, Dublin, Ireland; UCL, Ctr Int Child Hlth, Inst Child Hlth, London, England; UCL, Int Ctr Eye Hlth, Inst Ophthalmol, London, England; Valid Int Ltd, Llanidloes, Wales	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University College London	Collins, S (corresponding author), Oleuffynon, Old Hall, Powys SY18 6PJ, Wales.	steve@validinternational.org						[Anonymous], 1989, ACC SCN STATE OF THE; BAKER JP, 1982, NEW ENGL J MED, V306, P969, DOI 10.1056/NEJM198204223061606; BEATTIE J, 1948, BRIT J NUTR, V2, P47, DOI 10.1079/BJN19480008; BUCHANANSMITH MS, 1999, EVALUATION DANISH HU; Collins S, 1998, AM J CLIN NUTR, V68, P193, DOI 10.1093/ajcn/68.1.193; Collins S, 1996, JAMA-J AM MED ASSOC, V276, P391, DOI 10.1001/jama.276.5.391; COLLINS S, 1995, NAT MED, V1, P810, DOI 10.1038/nm0895-810; Dallal GE, 1988, AM STAT, V42, P272; de Waal A., 1989, FAMINE KILLS DARFUR; DEAN AG, 1990, EPI INFO VERSION 6 W; HABICHT JP, 1980, AM J CLIN NUTR, V33, P531, DOI 10.1093/ajcn/33.3.531; Korcok M, 1981, JAMA, V246, P1878, DOI 10.1001/jama.246.17.1878; LEITER LA, 1982, JAMA-J AM MED ASSOC, V248, P2306, DOI 10.1001/jama.248.18.2306; MCLAREN DS, 1969, AM J CLIN NUTR, V22, P863; MCLAREN DS, 1967, LANCET, V1, P533; *MICR CORP, 1994, MICR EXC COMP PROGR; WATERLOW JC, 1972, BRIT MED J, V3, P566, DOI 10.1136/bmj.3.5826.566; WATERLOW JC, 1993, PROTEIN ENERGY MALNU; 1999, MINIMUM STANDARDS NU, pCH3	19	21	21	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 2	2000	284	5					621	626		10.1001/jama.284.5.621	http://dx.doi.org/10.1001/jama.284.5.621			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	337WG	10918712				2022-12-24	WOS:000088385400035
J	Nakanishi, N; Nakamura, K; Matsuo, Y; Suzuki, K; Tatara, K				Nakanishi, N; Nakamura, K; Matsuo, Y; Suzuki, K; Tatara, K			Cigarette smoking and risk for impaired fasting glucose and type 2 diabetes in middle-aged Japanese men	ANNALS OF INTERNAL MEDICINE			English	Article							INSULIN-RESISTANCE SYNDROME; OSAKA HEALTH SURVEY; BLOOD-PRESSURE; DIETARY FIBER; MELLITUS; WOMEN; EPIDEMIOLOGY; TOLERANCE; OBESITY; SMOKERS	Background: The contribution of cigarette smoking to development of impaired fasting glucose and type 2 diabetes remains unclear. Objective: To investigate the association of cigarette smoking with development of impaired fasting glucose and type 2 diabetes. Design: Prospective cohort study. Setting: Work site in Osaka, Japan. Participants: 1266 Japanese male office workers 35 to 59 years of age who did not have impaired fasting glucose or type 2 diabetes and were not taking medication for hypertension at study entry. Measurements: Fasting plasma glucose levels were measured at annual health examinations from May 1994 through May 1999. Impaired fasting glucose was defined as a fasting glucose level of at least 6.1 mmol/L (110 mg/dL) but less than 7.0 mmol/L (126 mg/dL). Type 2 diabetes was defined as a fasting glucose level of 7.0 mmol/L or more or current receipt of hypoglycemic medication. Results: 87 and 54 men developed impaired fasting glucose and type 2 diabetes during 5817 and 5937 person-years follow-up, respectively After controlling for potential predictors of diabetes, the relative risk for impaired fasting glucose compared with never-smokers was 1.62 (95% CI, 0.85 to 3.10) for ever-smokers, 1.14 (CI, 0.58 to 2.25) for persons who smoked 1 to 20 cigarettes/d, 1.33 (CI, 0.63 to 2.80) for those who smoked 21 to 30 cigarettes/d, and 2.56 (CI, 1.32 to 4.95) for those who smoked 31 or more cigarettes/d (P for trend for current smokers only = 0.013). The respective multivariate-adjusted relative risks for type 2 diabetes compared with never-smokers were 1.08 (CI, 0.34 to 3.42), 1.88 (CI, 0.71 to 5.00) 3.02 (CI, 1.15 to 7.94), and 4.09 (CI, 1.62 to 10.29) (P for trend for current smokers only < 0.001). The number of pack-years of exposure was also positively related to development of impaired fasting glucose and type 2 diabetes (P for trend = 0.039 and 0.002, respectively). The relative risk for impaired fasting glucose and type 2 diabetes in current smokers versus never-smokers was stronger among men with a body mass index less than 24.2 kg/m(2) than among men with a body mass index of 24.2 kg/m(2) or more, although the absolute risk was greater in more obese men. Conclusion: The number of cigarettes smoked daily and the number of pack-years of exposure seem to be associated with development of impaired fasting glucose and type 2 diabetes in middle-aged Japanese men.	Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Suita, Osaka 5650871, Japan; Takenaka Corp, Osaka, Japan; Japan Labor & Welf Assoc, Tokyo, Japan	Osaka University; Takenaka Corporation	Nakanishi, N (corresponding author), Osaka Univ, Grad Sch Med, Dept Social & Environm Med, F2,2-2 Yamadaoka, Suita, Osaka 5650871, Japan.							Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; ANDERSON JW, 1987, J AM DIET ASSOC, V87, P1189; ATTVALL S, 1993, J INTERN MED, V233, P327, DOI 10.1111/j.1365-2796.1993.tb00680.x; BARRETTCONNOR E, 1989, EPIDEMIOL REV, V11, P172, DOI 10.1093/oxfordjournals.epirev.a036035; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; COX DR, 1972, J R STAT SOC B, V34, P187; CRYER PE, 1976, NEW ENGL J MED, V295, P573, DOI 10.1056/NEJM197609092951101; ELIASSON B, 1994, ARTERIOSCLER THROMB, V14, P1946, DOI 10.1161/01.ATV.14.12.1946; ELIASSON M, 1995, ATHEROSCLEROSIS, V113, P41, DOI 10.1016/0021-9150(94)05425-I; FACCHINI FS, 1992, LANCET, V339, P1128, DOI 10.1016/0140-6736(92)90730-Q; FESKENS EJM, 1989, AM J EPIDEMIOL, V130, P1101, DOI 10.1093/oxfordjournals.aje.a115437; Frati AC, 1996, DIABETES CARE, V19, P112, DOI 10.2337/diacare.19.2.112; Gavin JR, 1997, DIABETES CARE, V20, P1183; Hayashi T, 1999, DIABETES CARE, V22, P1683, DOI 10.2337/diacare.22.10.1683; HELMRICH SP, 1991, NEW ENGL J MED, V325, P147, DOI 10.1056/NEJM199107183250302; *HLTH WELF STAT AS, 1999, KOSEI NO SHIHYO, V46, P98; HUMPHREY LL, 1989, ANN INTERN MED, V111, P788, DOI 10.7326/0003-4819-111-10-788; Kawakami N, 1997, AM J EPIDEMIOL, V145, P103; MANSON JE, 1991, ARCH INTERN MED, V151, P1141, DOI 10.1001/archinte.151.6.1141; MAYER EJ, 1993, DIABETES CARE, V16, P1459, DOI 10.2337/diacare.16.11.1459; MILLER JCB, 1994, AM J CLIN NUTR, V59, p747S, DOI 10.1093/ajcn/59.3.747S; MORRIS RD, 1989, AM J EPIDEMIOL, V130, P112, DOI 10.1093/oxfordjournals.aje.a115302; NATHAN DM, 1986, DIABETES, V35, P797, DOI 10.2337/diabetes.35.7.797; NILSSON PM, 1995, METABOLISM, V44, P557, DOI 10.1016/0026-0495(95)90110-8; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; PERRY IJ, 1995, BRIT MED J, V310, P560, DOI 10.1136/bmj.310.6979.560; RIMM EB, 1995, BRIT MED J, V310, P555, DOI 10.1136/bmj.310.6979.555; Ronnemaa T, 1996, DIABETES CARE, V19, P1229, DOI 10.2337/diacare.19.11.1229; Salmeron J, 1997, JAMA-J AM MED ASSOC, V277, P472, DOI 10.1001/jama.277.6.472; SANDBERG H, 1973, J PHARMACOL EXP THER, V184, P787; STOLK RP, 1993, EUR J EPIDEMIOL, V9, P134, DOI 10.1007/BF00158782; Uchimoto S, 1999, DIABETIC MED, V16, P951, DOI 10.1046/j.1464-5491.1999.00173.x; WILSON PWF, 1986, AM J MED, V80, P3, DOI 10.1016/0002-9343(86)90532-2	33	107	118	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	2000	133	3					183	191		10.7326/0003-4819-133-3-200008010-00009	http://dx.doi.org/10.7326/0003-4819-133-3-200008010-00009			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	338XW	10906832				2022-12-24	WOS:000088449400003
J	Bruckner, K; Perez, L; Clausen, H; Cohen, S				Bruckner, K; Perez, L; Clausen, H; Cohen, S			Glycosyltransferase activity of fringe modulates notch-delta interactions	NATURE			English	Article							DORSAL-VENTRAL BOUNDARY; WING IMAGINAL DISC; O-LINKED FUCOSE; SIGNALING MOLECULE; GOLGI-APPARATUS; LUNATIC FRINGE; DROSOPHILA; FAMILY; ACTIVATION; SERRATE	Ligands that are capable of activating Notch family receptors are broadly expressed in animal development, but their activity is tightly regulated to allow formation of tissue boundaries(1). Members of the fringe gene family have been implicated in limiting Notch activation during boundary formation(2-8), but the mechanism of Fringe function has not been determined. Here we present evidence that Fringe acts in the Golgi as a glycosyltransferase enzyme that modifies the epidermal growth factor (EGF) modules of Notch and alters the ability of Notch to bind its ligand Delta. Fringe catalyses the addition of N-acetylglucosamine to fucose, which is consistent with a role in the elongation of O-linked fucose O-glycosylation that is associated with EGF repeats. We suggest that cell-type-specific modification of glycosylation may provide a general mechanism to regulate ligand-receptor interactions in vivo.	European Mol Biol Lab, D-69117 Heidelberg, Germany; Univ Copenhagen, Sch Dent, DK-2200 Copenhagen N, Denmark	European Molecular Biology Laboratory (EMBL); University of Copenhagen	Cohen, S (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.		clausen, henrik/AAD-8016-2021; Cohen, Stephen M/G-9930-2011; Perez, Lidia/F-7695-2016	Cohen, Stephen M/0000-0003-2858-9163; Perez, Lidia/0000-0002-8821-1202; Clausen, Henrik/0000-0002-0915-5055				Amado M, 1999, BBA-GEN SUBJECTS, V1473, P35, DOI 10.1016/S0304-4165(99)00168-3; Amado M, 1998, J BIOL CHEM, V273, P12770, DOI 10.1074/jbc.273.21.12770; BERGEMANN AD, 1995, MOL CELL BIOL, V15, P4921; Blaumueller CM, 1997, CELL, V90, P281, DOI 10.1016/S0092-8674(00)80336-0; Breton C, 1999, CURR OPIN STRUC BIOL, V9, P563, DOI 10.1016/S0959-440X(99)00006-8; Bruckner K, 1999, NEURON, V22, P511, DOI 10.1016/S0896-6273(00)80706-0; deCelis JF, 1996, DEVELOPMENT, V122, P359; DiazBenjumea FJ, 1995, DEVELOPMENT, V121, P4215; Doherty D, 1996, GENE DEV, V10, P421, DOI 10.1101/gad.10.4.421; Evrard YA, 1998, NATURE, V394, P377, DOI 10.1038/28632; Fleming RJ, 1997, DEVELOPMENT, V124, P2973; Gastinel LN, 1999, EMBO J, V18, P3546, DOI 10.1093/emboj/18.13.3546; Goode S, 1997, COLD SPRING HARB SYM, V62, P177; HARRIS RJ, 1993, GLYCOBIOLOGY, V3, P219, DOI 10.1093/glycob/3.3.219; Irvine KD, 1999, CURR OPIN GENET DEV, V9, P434, DOI 10.1016/S0959-437X(99)80066-5; IRVINE KD, 1994, CELL, V79, P595, DOI 10.1016/0092-8674(94)90545-2; Johnston SH, 1997, DEVELOPMENT, V124, P2245; KIM J, 1995, CELL, V82, P795, DOI 10.1016/0092-8674(95)90476-X; Laufer E, 1997, NATURE, V386, P366, DOI 10.1038/386366a0; Logeat F, 1998, P NATL ACAD SCI USA, V95, P8108, DOI 10.1073/pnas.95.14.8108; Moloney DJ, 1999, GLYCOBIOLOGY, V9, P679, DOI 10.1093/glycob/9.7.679; NILSSON T, 1994, CURR OPIN CELL BIOL, V6, P517, DOI 10.1016/0955-0674(94)90070-1; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; RodriguezEsteban C, 1997, NATURE, V386, P360, DOI 10.1038/386360a0; Rottger S, 1998, J CELL SCI, V111, P45; RULIFSON EJ, 1995, DEVELOPMENT, V121, P2813; Stanley H, 1997, P NATL ACAD SCI USA, V94, P14467, DOI 10.1073/pnas.94.26.14467; Wu JY, 1996, SCIENCE, V273, P355, DOI 10.1126/science.273.5273.355; Yuan YP, 1997, CELL, V88, P9, DOI 10.1016/S0092-8674(00)81852-8; Zhang NA, 1998, NATURE, V394, P374, DOI 10.1038/28625	30	574	596	0	27	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					411	415		10.1038/35019075	http://dx.doi.org/10.1038/35019075			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935637				2022-12-24	WOS:000088383800047
J	Phillips, DM				Phillips, DM			JCAHO pain management standards are unveiled	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	387	396	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 26	2000	284	4					428	429		10.1001/jama.284.4.428	http://dx.doi.org/10.1001/jama.284.4.428			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335QB	10904487				2022-12-24	WOS:000088254200005
J	Thomas, DL; Astemborski, J; Rai, RM; Anania, FA; Schaeffer, M; Galai, N; Nolt, K; Nelson, KE; Strathdee, SA; Johnson, L; Laeyendecker, O; Boitnott, J; Wilson, LE; Vlahov, D				Thomas, DL; Astemborski, J; Rai, RM; Anania, FA; Schaeffer, M; Galai, N; Nolt, K; Nelson, KE; Strathdee, SA; Johnson, L; Laeyendecker, O; Boitnott, J; Wilson, LE; Vlahov, D			The natural history of hepatitis C virus infection - Host, viral, and environmental factors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INJECTION-DRUG USERS; NON-B-HEPATITIS; TERM FOLLOW-UP; POLYMERASE-CHAIN-REACTION; CHRONIC ACTIVE HEPATITIS; LONG-TERM; NON-A; POSTTRANSFUSION HEPATITIS; HEPATOCELLULAR-CARCINOMA; RNA LEVELS	Context Hepatitis C virus (HCV) infection may resolve (viral clearance), persist without complications, or cause end-stage liver disease (ESLD), The frequency and determinants of these outcomes are poorly understood. Objective To assess the incidence and determinants of viral clearance and ESLD among persons who acquired HCV infection from injection drug use. Design and Setting Community-based prospective cohort study with enrollment in 1988-1989 and a median follow-up of 8.8 years. Subjects A total of 1667 persons aged 17 years or older with a history of injection drug use and an HCV antibody-positive test result during follow-up. Main outcome Measures Viral clearance was assessed in a subset of 919 patients and defined as failure to detect HCV RNA in at least 2 consecutive samples collected 5 or more months apart. End-stage liver disease was assessed at semiannual visits and by review of medical records and death certificates and defined by the presence of ascites, esophageal varices, or hepatic encephalopathy, or when ESLD was stated as a cause of death. Results Viral clearance was observed in 90 persons who were compared with 722 with persistent viremia, while the viremia of 107 was not resolved. Viral clearance occurred more often in nonblacks (adjusted odds ratio [OR], 5.15; 95% confidence interval [CI], 2.60-10.17) and those not infected with human immunodeficiency virus (HIV) (adjusted OR, 2.19; 95% CI, 1.26-3.47). Forty cases of ESLD were observed throughout follow-up (incidence, 3.1 per 1000 person-years). In a multivariate model, risk of ESLD was higher for persons aged 38 years or older at enrollment (adjusted relative incidence, 3.67; 95% CI, 1.96-6.88) and who reported ingestion of more than 260 g of alcohol per week (adjusted relative incidence, 3.60; 95% CI, 1.73-7.52). Of 210 patients without ESLD randomly selected for biopsy, only 2 had cirrhosis. Conclusions Our results indicate that although HCV infection can be self-limited or associated with ESLD, the majority of adults have persistent viremia without clinically demonstrable liver disease. Further research is needed to explain the less frequent clearance of HCV infection among black persons and to improve utilization of treatment for those infected in the context of injection drug use.	Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Epidemiol, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Thomas, DL (corresponding author), 1147 Ross Bldg,720 Rutland Ave, Baltimore, MD 21205 USA.		Strathdee, Steffanie A/B-9042-2009; Laeyendecker, Oliver B/B-9331-2009; Galai, Noya/HII-8086-2022	Laeyendecker, Oliver/0000-0002-6429-4760	NCRR NIH HHS [M01 RR00052] Funding Source: Medline; NIDA NIH HHS [DA04334, DA12568] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA004334, R01DA012568, R01DA004334] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ALTER MJ, 1992, NEW ENGL J MED, V327, P1899, DOI 10.1056/NEJM199212313272702; Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; BARRERA JM, 1995, HEPATOLOGY, V21, P639, DOI 10.1016/0270-9139(95)90511-1; Corrao G, 1998, HEPATOLOGY, V27, P914, DOI 10.1002/hep.510270404; Darby SC, 1997, LANCET, V350, P1425, DOI 10.1016/S0140-6736(97)05413-5; De Moliner L, 1998, GUT, V42, P856, DOI 10.1136/gut.42.6.856; DIBISCEGLIE AM, 1991, HEPATOLOGY, V14, P969, DOI 10.1016/0270-9139(91)90113-A; EYSTER ME, 1993, J ACQ IMMUN DEF SYND, V6, P602; FARCI P, 1991, NEW ENGL J MED, V325, P98, DOI 10.1056/NEJM199107113250205; Garfein RS, 1996, AM J PUBLIC HEALTH, V86, P655, DOI 10.2105/AJPH.86.5.655; GRETCH D, 1994, J INFECT DIS, V169, P1219, DOI 10.1093/infdis/169.6.1219; Haydon GH, 1998, GUT, V42, P570, DOI 10.1136/gut.42.4.570; HOOFNAGLE JH, 1981, ANN INTERN MED, V94, P744, DOI 10.7326/0003-4819-94-6-744; HOPF U, 1990, J HEPATOL, V10, P69, DOI 10.1016/0168-8278(90)90075-3; Inglesby TV, 1999, HEPATOLOGY, V29, P590, DOI 10.1002/hep.510290219; Kasahara A, 1998, HEPATOLOGY, V27, P1394, DOI 10.1002/hep.510270529; Kenny-Walsh E, 1999, NEW ENGL J MED, V340, P1228, DOI 10.1056/NEJM199904223401602; KIYOSAWA K, 1990, HEPATOLOGY, V12, P671, DOI 10.1002/hep.1840120409; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; KORETZ RL, 1993, ANN INTERN MED, V119, P110, DOI 10.7326/0003-4819-119-2-199307150-00003; LAU JYN, 1993, LANCET, V341, P1501, DOI 10.1016/0140-6736(93)90635-T; LEVINE OS, 1995, AM J EPIDEMIOL, V142, P331, DOI 10.1093/oxfordjournals.aje.a117639; MATTSON L, 1993, LIVER, V13, P274; Mazzella G, 1996, J HEPATOL, V24, P141, DOI 10.1016/S0168-8278(96)80022-5; MCOMISH F, 1994, J CLIN MICROBIOL, V32, P884, DOI 10.1128/JCM.32.4.884-892.1994; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Negro F, 1999, HEPATOLOGY, V29, P536, DOI 10.1002/hep.510290223; NISHIGUCHI S, 1995, LANCET, V346, P1051, DOI 10.1016/S0140-6736(95)91739-X; OHKAWA K, 1995, J MED VIROL, V46, P258, DOI 10.1002/jmv.1890460316; Ostapowicz G, 1998, HEPATOLOGY, V27, P1730, DOI 10.1002/hep.510270637; Pessione F, 1998, HEPATOLOGY, V27, P1717, DOI 10.1002/hep.510270635; SEEFF LB, 1992, NEW ENGL J MED, V327, P1906, DOI 10.1056/NEJM199212313272703; Seeff LB, 2000, ANN INTERN MED, V132, P105, DOI 10.7326/0003-4819-132-2-200001180-00003; SHEEN IS, 1992, J INFECT DIS, V165, P831, DOI 10.1093/infdis/165.5.831; Thomas DL, 2000, J INFECT DIS, V181, P844, DOI 10.1086/315314; THOMAS DL, 1995, MEDICINE, V74, P212, DOI 10.1097/00005792-199507000-00005; TONG MJ, 1995, NEW ENGL J MED, V332, P1463, DOI 10.1056/NEJM199506013322202; TREMOLADA F, 1992, J HEPATOL, V16, P273, DOI 10.1016/S0168-8278(05)80657-9; Villano SA, 1999, HEPATOLOGY, V29, P908, DOI 10.1002/hep.510290311; Villano SA, 1997, J CLIN MICROBIOL, V35, P3274, DOI 10.1128/JCM.35.12.3274-3277.1997; Vlahov D, 1998, JAMA-J AM MED ASSOC, V279, P35, DOI 10.1001/jama.279.1.35; VLAHOV D, 1991, J DRUG ISSUES, V21, P759, DOI 10.1177/002204269102100406; Vogt M, 1999, NEW ENGL J MED, V341, P866, DOI 10.1056/NEJM199909163411202; *WHO, 1997, WKLY EPIDEMIOL REC, V72, P341	44	838	867	0	40	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 26	2000	284	4					450	456		10.1001/jama.284.4.450	http://dx.doi.org/10.1001/jama.284.4.450			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335QB	10904508	Bronze			2022-12-24	WOS:000088254200031
J	Kania, A; Johnson, RL; Jessell, TM				Kania, A; Johnson, RL; Jessell, TM			Coordinate roles for LIM homeobox genes in directing the dorsoventral trajectory of motor axons in the vertebrate limb	CELL			English	Article							SUBTYPE IDENTITY; CHICK HINDLIMB; SPINAL-CORD; NEURON; EXPRESSION; INNERVATION; OUTGROWTH; REQUIREMENT; PATHWAY; CELLS	Motor neurons extend axons along specific trajectories, but the molecules that control their pathfinding remain poorly defined. We show that two LIM homeodomain transcription factors, Lim1 and Lmx1b, control the initial trajectory of motor axons in the developing mammalian limb. The expression of Lim1 by a lateral set of lateral motor column (LMC) neurons ensures that their axons select a dorsal trajectory in the limb. In a complementary manner, the expression of Lmx1b by dorsal limb mesenchymal cells controls the dorsal and ventral axonal trajectories of medial and lateral LMC neurons. In the absence of these two proteins, motor axons appear to select dorsal and ventral trajectories at random. Thus, LIM homeodomain proteins act within motor neurons and cells that guide motor axons to establish the fidelity of a binary choice in axonal trajectory.	Columbia Univ, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, New York, NY 10032 USA; Univ Texas, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Columbia University; Howard Hughes Medical Institute; University of Texas System; UTMD Anderson Cancer Center	Jessell, TM (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, 630 W 168th St, New York, NY 10032 USA.			Kania, Artur/0000-0002-5209-2520				Araujo M, 1998, DEVELOPMENT, V125, P4195; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Caton A, 2000, DEVELOPMENT, V127, P1751; Chen H, 1998, NAT GENET, V19, P51, DOI 10.1038/ng0598-51; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; Crossley PH, 1996, CELL, V84, P127, DOI 10.1016/S0092-8674(00)80999-X; Dou CL, 1997, NEURON, V18, P539, DOI 10.1016/S0896-6273(00)80296-2; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; Ensini M, 1998, DEVELOPMENT, V125, P969; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Feng GP, 2000, NEURON, V25, P295, DOI 10.1016/S0896-6273(00)80895-8; FERGUSON BA, 1983, J NEUROSCI, V3, P1760; FernandezTeran M, 1997, DEV BIOL, V189, P246, DOI 10.1006/dbio.1997.8680; HAMBURGER V, 1977, NEUROSCI RES PROG B, V15, P1; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P391, DOI 10.1113/jphysiol.1978.sp012546; LANDMESSER L, 1994, PROG BRAIN RES, V103, P67; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MORTENSEN RM, 1992, MOL CELL BIOL, V12, P2391, DOI 10.1128/MCB.12.5.2391; Nohno T, 1997, BIOCHEM BIOPH RES CO, V238, P506, DOI 10.1006/bbrc.1997.7320; Ohuchi H, 1997, DEVELOPMENT, V124, P2235; PARR BA, 1995, NATURE, V374, P350, DOI 10.1038/374350a0; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; RIDDLE RD, 1995, CELL, V83, P631, DOI 10.1016/0092-8674(95)90103-5; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Shawlot W, 1999, DEVELOPMENT, V126, P4925; SHAWLOT W, 1995, NATURE, V374, P425, DOI 10.1038/374425a0; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; STEPHENS TD, 1993, PROG CLIN BIOL RES, V383, P317; SUMMERBELL D, 1981, J EMBRYOL EXP MORPH, V61, P233; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; Thor S, 1997, NEURON, V18, P397, DOI 10.1016/S0896-6273(00)81241-6; TOSNEY KW, 1985, DEV BIOL, V109, P193, DOI 10.1016/0012-1606(85)90360-4; TOSNEY KW, 1985, J NEUROSCI, V5, P2345; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; VOGEL A, 1995, NATURE, V378, P716, DOI 10.1038/378716a0; Wang HU, 1997, NEURON, V18, P383, DOI 10.1016/S0896-6273(00)81240-4; WHITELAW V, 1983, J NEUROSCI, V3, P1226; Wilkinson DG, 2000, INT REV CYTOL, V196, P177; Zhao D, 1996, EUR J BIOCHEM, V240, P15, DOI 10.1111/j.1432-1033.1996.0015h.x	46	232	233	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 21	2000	102	2					161	173		10.1016/S0092-8674(00)00022-2	http://dx.doi.org/10.1016/S0092-8674(00)00022-2			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	337NA	10943837	Bronze			2022-12-24	WOS:000088366800007
J	Pearson, M; Carbone, R; Sebastiani, C; Cioce, M; Fagioli, M; Saito, S; Higashimoto, Y; Appella, E; Minucci, S; Pandolfi, PP; Pelicci, PG				Pearson, M; Carbone, R; Sebastiani, C; Cioce, M; Fagioli, M; Saito, S; Higashimoto, Y; Appella, E; Minucci, S; Pandolfi, PP; Pelicci, PG			PML regulates p53 acetylation and premature senescence induced by oncogenic Ras	NATURE			English	Article							CREB BINDING-PROTEIN; WILD-TYPE P53; PROMYELOCYTIC LEUKEMIA; GENE AMPLIFICATION; DNA-DAMAGE; IN-VITRO; CELLS; MODULATION; GROWTH; TRANSFORMATION	The tumour suppressor p53 induces cellular senescence in response to oncogenic signals(1). p53 activity is modulated by protein stability and post-translational modification, including phosphorylation and acetylation(2). The mechanism of p53 activation by oncogenes remains largely unknown. Here we report that the tumour suppressor PML regulates the p53 response to oncogenic signals. We found that oncogenic pas upregulates PML expression, and overexpression of PML induces senescence in a p53-dependent manner. p53 is acetylated at lysine 382 upon Ras expression, an event that is essential for its biological function. pas induces re-localization of p53 and the CBP acetyltransferase within the PML nuclear bodies and induces the formation of a trimeric p53-PML-CBP complex. Lastly, Ras-induced p53 acetylation, p53-CBP complex stabilization and senescence are lost in PML-/- fibroblasts. Our data establish a link between PML and p53 and indicate that integrity of the PML bodies is required for p53 acetylation and senescence upon oncogene expression.	European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy; Univ Perugia, Ist Med Interna & Sci Oncol, I-06100 Perugia, Italy; NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA; Cornell Univ, Mem Sloan Kettering Canc Ctr, Dept Human Genet, New York, NY 10021 USA; Cornell Univ, Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	IRCCS European Institute of Oncology (IEO); University of Perugia; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Cornell University; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center	Pelicci, PG (corresponding author), European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy.	pgpelicci@ieo.it	Pelicci, Pier Giuseppe/AAL-6572-2020; Cioce, Mario/R-9734-2017; Sebastiani, Carla/AAB-9817-2022; Minucci, Saverio/J-9669-2012	Cioce, Mario/0000-0001-8129-6664; Sebastiani, Carla/0000-0003-3927-3279; Higashimoto, Yuichiro/0000-0003-1382-8598	NATIONAL CANCER INSTITUTE [Z01BC005599, ZIABC005599] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alcorta DA, 1996, P NATL ACAD SCI USA, V93, P13742, DOI 10.1073/pnas.93.24.13742; BORROW J, 1990, SCIENCE, V249, P1577, DOI 10.1126/science.2218500; DETHE H, 1990, NATURE, V347, P558, DOI 10.1038/347558a0; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Doucas V, 1999, P NATL ACAD SCI USA, V96, P2627, DOI 10.1073/pnas.96.6.2627; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fagioli M, 1998, ONCOGENE, V16, P2905, DOI 10.1038/sj.onc.1201811; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Grignani F, 1998, NATURE, V391, P815, DOI 10.1038/35901; Grignani F, 1998, CANCER RES, V58, P14; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; HARVEY M, 1993, ONCOGENE, V8, P2457; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; LaMorte VJ, 1998, P NATL ACAD SCI USA, V95, P4991, DOI 10.1073/pnas.95.9.4991; Le XF, 1996, J BIOL CHEM, V271, P130, DOI 10.1074/jbc.271.1.130; Lill NL, 1997, NATURE, V387, P823, DOI 10.1038/42981; LIU JH, 1995, J EXP MED, V181, P1965, DOI 10.1084/jem.181.6.1965; Liu L, 1999, MOL CELL BIOL, V19, P1202; LIVINGSTONE LR, 1992, CELL, V70, P923, DOI 10.1016/0092-8674(92)90243-6; METZ T, 1995, CELL, V82, P29, DOI 10.1016/0092-8674(95)90049-7; Quignon F, 1998, NAT GENET, V20, P259, DOI 10.1038/3068; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Sherr CJ, 1998, GENE DEV, V12, P2984, DOI 10.1101/gad.12.19.2984; Wang ZG, 1998, SCIENCE, V279, P1547; YIN YX, 1992, CELL, V70, P937, DOI 10.1016/0092-8674(92)90244-7; Zhong S, 2000, BLOOD, V95, P2748, DOI 10.1182/blood.V95.9.2748.009k31a_2748_2752; Zong S, 1999, ONCOGENE, V18, P7941, DOI 10.1038/sj.onc.1203367	30	668	694	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2000	406	6792					207	210		10.1038/35018127	http://dx.doi.org/10.1038/35018127			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910364				2022-12-24	WOS:000088221100054
J	Shigenobu, S; Watanabe, H; Hattori, M; Sakaki, Y; Ishikawa, H				Shigenobu, S; Watanabe, H; Hattori, M; Sakaki, Y; Ishikawa, H			Genome sequence of the endocellular bacterial symbiont of aphids Buchnera sp APS	NATURE			English	Article							PROTEIN-SECRETION SYSTEM; ENDOSYMBIOTIC BACTERIA; ACYRTHOSIPHON-PISUM; GENES	Almost all aphid species (Homoptera, Insecta) have 60-80 huge cells called bacteriocytes, within which are round-shaped bacteria that are designated Buchnera(1). These bacteria are maternally transmitted to eggs and embryos through host generations, and the mutualism between the host and the bacteria is so obligate that neither can reproduce independently(2). Buchnera is a close relative of Escherichia coli(3), but it contains more than 100 genomic copies per cell(4), and its genome size is only a seventh of that of E. coli(5). Here we report the complete genome sequence of Buchnera sp. strain APS, which is composed of one 640,681-base-pair chromosome and two small plasmids. There are genes for the biosyntheses of amino acids essential for the hosts in the genome, but those for non-essential amino acids are missing, indicating complementarity and syntrophy between the host and the symbiont. In addition, Buchnera lacks genes for the biosynthesis of cell-surface components, including lipopolysaccharides and phospholipids, regulator genes and genes involved in defence of the cell. These results indicate that Buchnera is completely symbiotic and viable only in its limited niche, the bacteriocyte.	RIKEN, Genome Sci Ctr, Sagamihara, Kanagawa 2288555, Japan; Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Inst Med Sci, Ctr Human Genome, Minato Ku, Tokyo 1088639, Japan	RIKEN; University of Tokyo; University of Tokyo	Sakaki, Y (corresponding author), RIKEN, Genome Sci Ctr, Kitasato 1-15-1, Sagamihara, Kanagawa 2288555, Japan.	sakai@ims.u-tokyo.ac.jp; iskw@biol.s.u-tokyo.ac.jp	Shigenobu, Shuji/B-6239-2011; Hattori, Masahira/C-6958-2016; Hattori, Masahira/AAD-3785-2019	Shigenobu, Shuji/0000-0003-4640-2323; Hattori, Masahira/0000-0001-9467-0344; 				BAUMANN P, 2000, PROKARYOTES; Buchner P, 1965, ENDOSYMBIOSIS ANIMAL; Charles H, 1999, J MOL EVOL, V48, P142, DOI 10.1007/PL00006452; DOUGLAS AE, 1988, INSECT BIOCHEM, V18, P599, DOI 10.1016/0020-1790(88)90012-1; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Eisen JA, 1999, MUTAT RES-DNA REPAIR, V435, P171, DOI 10.1016/S0921-8777(99)00050-6; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Hattori M, 1997, NUCLEIC ACIDS RES, V25, P1802, DOI 10.1093/nar/25.9.1802; HOUK EJ, 1980, ANNU REV ENTOMOL, V25, P161, DOI 10.1146/annurev.en.25.010180.001113; Komaki K, 1999, J MOL EVOL, V48, P717, DOI 10.1007/PL00006516; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Marais A, 1996, J BACTERIOL, V178, P7003, DOI 10.1128/jb.178.23.7003-7009.1996; MITTLER TE, 1971, J NUTR, V101, P1023, DOI 10.1093/jn/101.8.1023; MORAN NA, 1993, P ROY SOC B-BIOL SCI, V253, P167, DOI 10.1098/rspb.1993.0098; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; MUNSON MA, 1991, INT J SYST BACTERIOL, V41, P566, DOI 10.1099/00207713-41-4-566; Nakabachi A, 1999, J INSECT PHYSIOL, V45, P1, DOI 10.1016/S0022-1910(98)00104-8; Nogueira T, 2000, CURR OPIN MICROBIOL, V3, P154, DOI 10.1016/S1369-5274(00)00068-0; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; RILEY M, 1993, MICROBIOL REV, V57, P862, DOI 10.1128/MMBR.57.4.862-952.1993; SASAKI T, 1995, J INSECT PHYSIOL, V41, P41, DOI 10.1016/0022-1910(94)00080-Z; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Tomii K, 1998, GENOME RES, V8, P1048, DOI 10.1101/gr.8.10.1048; vanHam RCHJ, 1997, J BACTERIOL, V179, P4768, DOI 10.1128/jb.179.15.4768-4777.1997; Watanabe H, 1997, J MOL EVOL, V44, pS57, DOI 10.1007/PL00000052; WHITEHEAD LF, 1993, J GEN MICROBIOL, V139, P821, DOI 10.1099/00221287-139-4-821; Yada T, 1996, DNA Res, V3, P355, DOI 10.1093/dnares/3.6.355; Young GM, 1999, P NATL ACAD SCI USA, V96, P6456, DOI 10.1073/pnas.96.11.6456; [No title captured]	30	972	1586	4	169	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 7	2000	407	6800					81	86		10.1038/35024074	http://dx.doi.org/10.1038/35024074			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	350WE	10993077	Bronze			2022-12-24	WOS:000089124000046
J	Yin, HW; Pruyne, D; Huffaker, TC; Bretscher, A				Yin, HW; Pruyne, D; Huffaker, TC; Bretscher, A			Myosin V orientates the mitotic spindle in yeast	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; MICROTUBULE ORIENTATION; ASTRAL MICROTUBULES; POLARIZED DELIVERY; BUDDING YEAST; ACTIN; LOCALIZATION; KINESIN; PROTEIN; GROWTH	Coordination of spindle orientation with the axis of cell division is an essential process in all eukaryotes. In addition to ensuring accurate chromosomal segregation, proper spindle orientation also establishes differential cell fates and proper morphogenesis(1). In both animal and yeast cells, this process is dependent on cytoplasmic microtubules interacting with the cortical actin-based cytoskeleton(2-5), although the motive force was unknown. Here we show that yeast Myo2, a myosin V that translocates along polarized actin cables into the bud(6), orientates the spindle early in the cell cycle by binding and polarizing the microtubule-associated protein Kar9 (refs 7-9). The tail domain of Myo2 that binds Kar9 also interacts with secretory vesicles(12) and vacuolar elements(13), making it a pivotal component of yeast cell polarization.	Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Huffaker, TC (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Biotechnol Bldg, Ithaca, NY 14853 USA.			Huffaker, Tim/0000-0003-0916-0441	NIGMS NIH HHS [R01 GM040479] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040479] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS AEM, 1984, J CELL BIOL, V98, P934, DOI 10.1083/jcb.98.3.934; Beningo KA, 2000, MOL BIOL CELL, V11, P691, DOI 10.1091/mbc.11.2.691; Catlett NL, 1998, P NATL ACAD SCI USA, V95, P14799, DOI 10.1073/pnas.95.25.14799; Chen XYP, 1998, J CELL BIOL, V141, P1169, DOI 10.1083/jcb.141.5.1169; Cottingham FR, 1997, J CELL BIOL, V138, P1041, DOI 10.1083/jcb.138.5.1041; DeZwaan TM, 1997, J CELL BIOL, V138, P1023, DOI 10.1083/jcb.138.5.1023; Goode BL, 2000, CURR OPIN CELL BIOL, V12, P63, DOI 10.1016/S0955-0674(99)00058-7; Heil-Chapdelaine RA, 1999, J CELL BIOL, V144, P809, DOI 10.1083/jcb.144.5.809; Korinek WS, 2000, SCIENCE, V287, P2257, DOI 10.1126/science.287.5461.2257; KURIHARA LJ, 1994, J CELL BIOL, V126, P911, DOI 10.1083/jcb.126.4.911; Lee L, 2000, SCIENCE, V287, P2260, DOI 10.1126/science.287.5461.2260; Lee L, 1999, J CELL BIOL, V144, P947, DOI 10.1083/jcb.144.5.947; LILLIE SH, 1992, NATURE, V356, P358, DOI 10.1038/356358a0; LILLIE SH, 1994, J CELL BIOL, V125, P825, DOI 10.1083/jcb.125.4.825; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; Mermall V, 1998, SCIENCE, V279, P527, DOI 10.1126/science.279.5350.527; Miller RK, 1998, J CELL BIOL, V140, P377, DOI 10.1083/jcb.140.2.377; Miller RK, 1999, J CELL BIOL, V144, P963, DOI 10.1083/jcb.144.5.963; PALMER RE, 1992, J CELL BIOL, V119, P583, DOI 10.1083/jcb.119.3.583; Pruyne D, 2000, J CELL SCI, V113, P365; Pruyne DW, 1998, J CELL BIOL, V143, P1931, DOI 10.1083/jcb.143.7.1931; Rose LS, 1998, ANNU REV GENET, V32, P521, DOI 10.1146/annurev.genet.32.1.521; Schott D, 1999, J CELL BIOL, V147, P791, DOI 10.1083/jcb.147.4.791; Schwartz K, 1997, MOL BIOL CELL, V8, P2677, DOI 10.1091/mbc.8.12.2677; Stearns T, 1997, J CELL BIOL, V138, P957, DOI 10.1083/jcb.138.5.957; SULLIVAN DS, 1992, J CELL BIOL, V119, P379, DOI 10.1083/jcb.119.2.379; Takizawa PA, 1997, NATURE, V389, P90, DOI 10.1038/38015; Theesfeld CL, 1999, J CELL BIOL, V146, P1019, DOI 10.1083/jcb.146.5.1019; Tirnauer JS, 1999, J CELL BIOL, V145, P993, DOI 10.1083/jcb.145.5.993; WalchSolimena C, 1997, J CELL BIOL, V137, P1495, DOI 10.1083/jcb.137.7.1495	30	251	255	0	12	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 31	2000	406	6799					1013	1015		10.1038/35023024	http://dx.doi.org/10.1038/35023024			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	348ZW	10984058				2022-12-24	WOS:000089020200050
J	Hu, FB; Stampfer, MJ; Manson, JE; Grodstein, F; Colditz, GA; Speizer, FE; Willett, WC				Hu, FB; Stampfer, MJ; Manson, JE; Grodstein, F; Colditz, GA; Speizer, FE; Willett, WC			Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; RISK-FACTORS; ADIPOSE-TISSUE; SURVIVAL RATES; GLYCEMIC LOAD; FATTY-ACIDS; MORTALITY; PREVENTION; POPULATION; FIBER	Background: Previous studies have found concurrent declines in blood pressure, serum cholesterol levels, and the incidence of and mortality from coronary disease. However, the effects of changes in diet and lifestyle on trends in coronary disease are largely unknown. Methods: We followed 85,941 women who were 34 to 59 years old and had no previously diagnosed cardiovascular disease or cancer from 1980 to 1994 in the Nurses' Health Study. Diet and lifestyle variables were assessed at base line and updated during follow-up. Results: After adjustment for the effect of age, the incidence of coronary disease declined by 31 percent from the two-year period 1980-1982 to the two-year period 1992-1994. From 1980 to 1992, the proportion of participants currently smoking declined by 41 percent, the proportion of postmenopausal women using hormone therapy increased by 175 percent, and the prevalence of overweight, defined as a body-mass index (the weight in kilograms divided by the square of the height in meters) of 25 or more, increased by 38 percent. During the study period, diet improved substantially. Statistically, changes in these variables - when considered simultaneously - explained a 21 percent decline in the incidence of coronary disease, representing 68 percent of the overall decline from 1980-1982 to 1992-1994. Taken individually, the reduction in smoking explained a 13 percent decline in the incidence of coronary disease; improvement in diet explained a 16 percent decline; and increase in postmenopausal hormone use explained a 9 percent decline. On the other hand, the increase in body-mass index explained an 8 percent increase in the incidence of coronary disease. Conclusions: Reduction in smoking, improvement in diet, and an increase in postmenopausal hormone use accounted for much of the decline in the incidence of coronary disease in this group of women. An increasing prevalence of obesity, however, appears to have slowed the decline in the incidence of coronary disease. (N Engl J Med 2000;343:530-7.) (C)2000, Massachusetts Medical Society.	Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Hu, FB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	frank.hu@channing.harvard.edu	Colditz, Graham/A-3963-2009; Hu, Frank/C-1919-2013	Colditz, Graham/0000-0002-7307-0291; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594, R01HL060712] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL34594, HL60712, HL24074] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		CARACCIOLO EA, 1995, CIRCULATION, V91, P2325, DOI 10.1161/01.CIR.91.9.2325; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; FISHER L, 1984, NEW ENGL J MED, V310, P750; Garland M, 1998, AM J CLIN NUTR, V67, P25, DOI 10.1093/ajcn/67.1.25; GOLDBERG RJ, 1986, JAMA-J AM MED ASSOC, V255, P2774, DOI 10.1001/jama.255.20.2774; GOLDBERG RJ, 1993, CIRCULATION, V87, P1947, DOI 10.1161/01.CIR.87.6.1947; GRODSTEIN F, 1996, REPROD ENDOCRINOLOGY, V2, P1852; Hu FB, 1999, AM J CLIN NUTR, V70, P1001; Hu FB, 1997, NEW ENGL J MED, V337, P1491, DOI 10.1056/NEJM199711203372102; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Hunink MGM, 1997, JAMA-J AM MED ASSOC, V277, P535, DOI 10.1001/jama.277.7.535; HUNTER DJ, 1992, AM J EPIDEMIOL, V135, P418, DOI 10.1093/oxfordjournals.aje.a116302; KUCZMARSKI RJ, 1994, JAMA-J AM MED ASSOC, V272, P205, DOI 10.1001/jama.272.3.205; Liu SM, 2000, AM J CLIN NUTR, V71, P1455; LONDON SJ, 1991, AM J CLIN NUTR, V54, P340, DOI 10.1093/ajcn/54.2.340; Ludwig DS, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.3.e26; Manson JE, 1999, NEW ENGL J MED, V341, P650, DOI 10.1056/NEJM199908263410904; McGovern PG, 1996, NEW ENGL J MED, V334, P884, DOI 10.1056/NEJM199604043341403; Mosterd A, 1999, NEW ENGL J MED, V340, P1221, DOI 10.1056/NEJM199904223401601; *NAT CTR HLTH STAT, 1997, DHHS PUBL PHS, P183; *NUTR MON TID, 1990, AGR HDB USDA, V813; PELL S, 1985, NEW ENGL J MED, V312, P1005, DOI 10.1056/NEJM198504183121601; Pietinen P, 1996, PREV MED, V25, P243, DOI 10.1006/pmed.1996.0053; PISUNYER FX, 1993, ANN INTERN MED, V119, P655, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00006; RICHEDWARDS JW, 1995, NEW ENGL J MED, V332, P1758, DOI 10.1056/NEJM199506293322607; Rimm EB, 1998, JAMA-J AM MED ASSOC, V279, P359, DOI 10.1001/jama.279.5.359; Rosamond WD, 1998, NEW ENGL J MED, V339, P861, DOI 10.1056/NEJM199809243391301; Rose GA, 1982, WHO MONOGRAPH SERIES, V56; Salmeron J, 1997, JAMA-J AM MED ASSOC, V277, P472, DOI 10.1001/jama.277.6.472; Salmeron J, 1997, DIABETES CARE, V20, P545, DOI 10.2337/diacare.20.4.545; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; SYTKOWSKI PA, 1990, NEW ENGL J MED, V322, P1635, DOI 10.1056/NEJM199006073222304; *US BUR CENS, 1994, STAT ABSTR US 1994; WILLETT W, 1983, AM J EPIDEMIOL, V117, P651, DOI 10.1093/oxfordjournals.aje.a113598; WILLETT WC, 1987, NEW ENGL J MED, V317, P1303, DOI 10.1056/NEJM198711193172102; WILLETT WC, 1993, LANCET, V341, P581, DOI 10.1016/0140-6736(93)90350-P; Willett WC, 1998, OXFORD SCHOLARSHIP O; Wolk A, 1999, JAMA-J AM MED ASSOC, V281, P1998, DOI 10.1001/jama.281.21.1998	39	289	296	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 24	2000	343	8					530	537		10.1056/NEJM200008243430802	http://dx.doi.org/10.1056/NEJM200008243430802			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346QM	10954760				2022-12-24	WOS:000088882600002
J	Armstrong, D				Armstrong, D			Long-term safety and efficacy of omeprazole in gastro-oesophageal reflux disease	LANCET			English	Editorial Material							EXPERIENCE; THERAPY; TRIAL; RISK; ACID		McMaster Univ, Med Ctr, Div Gastroenterol, Hamilton, ON L8N 3Z5, Canada	McMaster University	Armstrong, D (corresponding author), McMaster Univ, Med Ctr, Div Gastroenterol, Hamilton, ON L8N 3Z5, Canada.							Choudhry U, 1998, AM J CLIN PATHOL, V110, P615, DOI 10.1093/ajcp/110.5.615; Freston JW, 1999, DRUG SAFETY, V20, P195, DOI 10.2165/00002018-199920020-00008; HAVU N, 1986, DIGESTION, V35, P42, DOI 10.1159/000199381; JOELSON S, 1992, DIGESTION, V51, P93, DOI 10.1159/000200922; Klinkenberg-Knol EC, 2000, GASTROENTEROLOGY, V118, P661, DOI 10.1016/S0016-5085(00)70135-1; Kuipers EJ, 2000, GASTROENTEROLOGY, V118, P795, DOI 10.1016/S0016-5085(00)70149-1; KUIPERS EJ, 1996, N ENGL J MED, V334; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Laine L, 2000, ALIMENT PHARM THER, V14, P651; Lind T, 1999, ALIMENT PHARM THERAP, V13, P907; Lundell L, 1998, GASTROENTEROLOGY, V114, pA207, DOI 10.1016/S0016-5085(98)80841-X; Lundell L, 1999, GASTROENTEROLOGY, V117, P319, DOI 10.1053/gast.1999.0029900319; Rodriguez LAG, 1997, EPIDEMIOLOGY, V8, P571; Stolte M, 2000, PATHOL RES PRACT, V196, P9; Viani F, 2000, EUR J GASTROEN HEPAT, V12, P165, DOI 10.1097/00042737-200012020-00006	15	10	10	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 19	2000	356	9230					610	612		10.1016/S0140-6736(00)02598-8	http://dx.doi.org/10.1016/S0140-6736(00)02598-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346RD	10968429				2022-12-24	WOS:000088884100004
J	Antonio, C; Ferby, I; Wilhelm, H; Jones, M; Karsenti, E; Nebreda, AR; Vernos, I				Antonio, C; Ferby, I; Wilhelm, H; Jones, M; Karsenti, E; Nebreda, AR; Vernos, I			Xkid, a chromokinesin required for chromosome alignment on the metaphase plate	CELL			English	Article							KINESIN-LIKE PROTEIN; XENOPUS EGG EXTRACTS; NEWT LUNG-CELLS; MITOTIC SPINDLE; CENP-E; DNA-BINDING; DIRECTIONAL INSTABILITY; DIFFERENTIAL DISPLAY; MICROTUBULE FLUX; DROSOPHILA	Metaphase chromosome alignment is a key step of animal cell mitosis. The molecular mechanism leading to this equatorial positioning is still not fully understood. Forces exerted at kinetochores and on chromosome arms drive chromosome movements that culminate in their alignment on the metaphase plate. In this paper, we show that Xkid, a kinesin-like protein localized on chromosome arms, plays an essential role in metaphase chromosome alignment and in its maintenance. We propose that Xkid is responsible for the polar ejection forces acting on chromosome arms. Our results show that these forces are essential to ensure that kinetochores and chromosome arms align on a narrow equatorial plate during metaphase, a prerequisite for proper chromosome segregation.	European Mol Biol Lab, Cell Biol & Biophys Program, D-69117 Heidelberg, Germany; European Mol Biol Lab, Dev Biol Program, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL)	Vernos, I (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Program, D-69117 Heidelberg, Germany.		Vernos, Isabelle/C-1687-2015; Nebreda, Angel Rodriguez/R-9594-2019; Ferby, Ingvar/B-7895-2008	Vernos, Isabelle/0000-0003-1469-9214; Ferby, Ingvar/0000-0002-3435-1728				AFSHAR K, 1995, CELL, V81, P129, DOI 10.1016/0092-8674(95)90377-1; CASSIMERIS L, 1994, J CELL SCI, V107, P285; Cooke CA, 1997, CHROMOSOMA, V106, P446, DOI 10.1007/s004120050266; Desai A, 1998, J CELL BIOL, V141, P703, DOI 10.1083/jcb.141.3.703; Desai A, 1999, METHOD CELL BIOL, V61, P385; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Ferby I, 1999, GENE DEV, V13, P2177, DOI 10.1101/gad.13.16.2177; Funabiki H, 2000, CELL, V102, P411, DOI 10.1016/S0092-8674(00)00047-7; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gorbsky GJ, 1998, J CELL BIOL, V141, P1193, DOI 10.1083/jcb.141.5.1193; HAYDEN JH, 1990, J CELL BIOL, V111, P1039, DOI 10.1083/jcb.111.3.1039; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Inoue S., 1981, Journal of Cell Biology, V91, P131; KOBEL HR, 1986, TRENDS GENET, V2, P310, DOI 10.1016/0168-9525(86)90286-6; Le Bot N, 1998, J CELL BIOL, V143, P1559, DOI 10.1083/jcb.143.6.1559; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; LINSKENS MHK, 1995, NUCLEIC ACIDS RES, V23, P3244, DOI 10.1093/nar/23.16.3244; LOMBILLO VA, 1995, J CELL BIOL, V128, P107, DOI 10.1083/jcb.128.1.107; Makkerh JPS, 1996, CURR BIOL, V6, P1025, DOI 10.1016/S0960-9822(02)00648-6; MILLER L, 1977, IN VITRO CELL DEV B, V13, P557; MINSHULL J, 1994, CELL, V79, P475, DOI 10.1016/0092-8674(94)90256-9; Molina I, 1997, J CELL BIOL, V139, P1361, DOI 10.1083/jcb.139.6.1361; MURPHY TD, 1995, CELL, V81, P139, DOI 10.1016/0092-8674(95)90378-X; MURRAY AW, 1991, XENOPUS LAEVIS PRACT, P581; Ohkura H, 1997, J CELL SCI, V110, P945; RAFFERTY KA, 1969, CYTOGENETICS, V8, P427; RATTNER JB, 1989, J CELL BIOL, V108, P1209, DOI 10.1083/jcb.108.4.1209; RIEDER CL, 1982, INT REV CYTOL, V79, P1, DOI 10.1016/S0074-7696(08)61672-1; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; RIEDER CL, 1994, J CELL BIOL, V124, P223, DOI 10.1083/jcb.124.3.223; RIEDER CL, 1986, J CELL BIOL, V103, P581, DOI 10.1083/jcb.103.2.581; Ruden DM, 1997, DEV BIOL, V191, P284, DOI 10.1006/dbio.1997.8726; SAWIN KE, 1991, J CELL BIOL, V112, P941, DOI 10.1083/jcb.112.5.941; SAWIN KE, 1991, J CELL BIOL, V112, P925, DOI 10.1083/jcb.112.5.925; Schaar BT, 1997, J CELL BIOL, V139, P1373, DOI 10.1083/jcb.139.6.1373; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; SKIBBENS RV, 1993, J CELL BIOL, V122, P859, DOI 10.1083/jcb.122.4.859; THEURKAUF WE, 1992, J CELL BIOL, V116, P1167, DOI 10.1083/jcb.116.5.1167; Tokai N, 1996, EMBO J, V15, P457, DOI 10.1002/j.1460-2075.1996.tb00378.x; VERNOS I, 1995, CELL, V81, P117, DOI 10.1016/0092-8674(95)90376-3; Walczak CE, 1998, CURR BIOL, V8, P903, DOI 10.1016/S0960-9822(07)00370-3; WANG SZ, 1995, J CELL BIOL, V128, P761, DOI 10.1083/jcb.128.5.761; Wilhelm H, 1997, METHOD ENZYMOL, V283, P12; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; Yao XB, 1997, J CELL BIOL, V139, P435, DOI 10.1083/jcb.139.2.435; ZHANG P, 1990, CELL, V62, P1053, DOI 10.1016/0092-8674(90)90383-P	46	186	190	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 18	2000	102	4					425	435		10.1016/S0092-8674(00)00048-9	http://dx.doi.org/10.1016/S0092-8674(00)00048-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	347BX	10966105	Bronze			2022-12-24	WOS:000088908000005
J	Pei, ZM; Murata, Y; Benning, G; Thomine, S; Klusener, B; Allen, GJ; Grill, E; Schroeder, JI				Pei, ZM; Murata, Y; Benning, G; Thomine, S; Klusener, B; Allen, GJ; Grill, E; Schroeder, JI			Calcium channels activated by hydrogen peroxide mediate abscisic acid signalling in guard cells	NATURE			English	Article							INDUCED STOMATAL CLOSURE; CYTOSOLIC-FREE CALCIUM; CYTOPLASMIC CALCIUM; PLASMA-MEMBRANE; COMMELINA-COMMUNIS; ANION CHANNELS; CA-2+; TRANSDUCTION; ELICITORS; INCREASES	Drought is a major threat to agricultural production. Plants synthesize the hormone abscisic acid (ABA) in response to drought, triggering a signalling cascade in guard cells that results in stomatal closure, thus reducing water loss(1). ABA triggers an increase in cytosolic calcium in guard cells ([Ca2+](cyt))(2-6) that has been proposed to include Ca2+ influx across the plasma membrane(3,5,7-9). However, direct recordings of Ca2+ currents have been limited(3) and the upstream activation mechanisms of plasma membrane Ca2+ channels remain unknown. Here we report activation of Ca2+-permeable channels in the plasma membrane of Arabidopsis guard cells by hydrogen peroxide. The H2O2-activated Ca2+ channels mediate both influx of Ca2+ in protoplasts and increases in [Ca2+](cyt) in intact guard cells. ABA induces the production of H2O2 in guard cells. If H2O2 production is blocked, ABA-induced closure of stomata is inhibited. Moreover, activation of Ca2+ channels by H2O2 and ABA- and H2O2-induced stomatal closing are disrupted in the recessive ABA-insensitive mutant gca2. These data indicate that ABA-induced H2O2 production and the H2O2-activated Ca2+ channels are important mechanisms for ABA-induced stomatal closing.	Univ Calif San Diego, Div Biol Cell & Dev Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Mol Genet, La Jolla, CA 92093 USA; Tech Univ Munich, Lehrstuhl Bot, D-85350 Freising, Germany	University of California System; University of California San Diego; University of California System; University of California San Diego; Technical University of Munich	Schroeder, JI (corresponding author), Univ Calif San Diego, Div Biol Cell & Dev Biol, La Jolla, CA 92093 USA.		Murata, Yoshiyuki/B-2098-2011; Thomine, Sébastien/V-9029-2019; Barickman, Thomas/I-6993-2012					Allen GJ, 1999, PLANT CELL, V11, P1785, DOI 10.1105/tpc.11.9.1785; Allen GJ, 1999, PLANT J, V19, P735, DOI 10.1046/j.1365-313x.1999.00574.x; Alvarez ME, 1998, CELL, V92, P773, DOI 10.1016/S0092-8674(00)81405-1; DESILVA DLR, 1985, NEW PHYTOL, V101, P555, DOI 10.1111/j.1469-8137.1985.tb02861.x; Frachisse JM, 1999, PLANT PHYSIOL, V121, P253, DOI 10.1104/pp.121.1.253; Gelli A, 1997, PLANT PHYSIOL, V113, P269, DOI 10.1104/pp.113.1.269; GILROY S, 1991, PLANT CELL, V3, P333, DOI 10.1105/tpc.3.4.333; Grabov A, 1998, P NATL ACAD SCI USA, V95, P4778, DOI 10.1073/pnas.95.8.4778; Hamilton DWA, 2000, P NATL ACAD SCI USA, V97, P4967, DOI 10.1073/pnas.080068897; HEDRICH R, 1990, EMBO J, V9, P3889, DOI 10.1002/j.1460-2075.1990.tb07608.x; Himmelbach A, 1998, PHILOS T R SOC B, V353, P1439, DOI 10.1098/rstb.1998.0299; Jacob T, 1999, P NATL ACAD SCI USA, V96, P12192, DOI 10.1073/pnas.96.21.12192; Kiegle E, 2000, PLANT J, V21, P225, DOI 10.1046/j.1365-313x.2000.00659.x; KNIGHT MR, 1991, NATURE, V352, P524, DOI 10.1038/352524a0; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Leckie CP, 1998, P NATL ACAD SCI USA, V95, P15837, DOI 10.1073/pnas.95.26.15837; Lee S, 1999, PLANT PHYSIOL, V121, P147, DOI 10.1104/pp.121.1.147; MacRobbie EAC, 1998, PHILOS T ROY SOC B, V353, P1475, DOI 10.1098/rstb.1998.0303; MARSHALL J, 1994, PLANT J, V5, P683, DOI 10.1111/j.1365-313X.1994.00683.x; McAinsh MR, 1996, PLANT PHYSIOL, V111, P1031, DOI 10.1104/pp.111.4.1031; MCAINSH MR, 1990, NATURE, V343, P186, DOI 10.1038/343186a0; MCAINSH MR, 1991, P ROY SOC B-BIOL SCI, V243, P195, DOI 10.1098/rspb.1991.0031; Orozco-Cardenas M, 1999, P NATL ACAD SCI USA, V96, P6553, DOI 10.1073/pnas.96.11.6553; Pei ZM, 1997, PLANT CELL, V9, P409, DOI 10.1105/tpc.9.3.409; PINEROS M, 1995, PLANTA, V195, P478, DOI 10.1007/BF00195704; PRICE AH, 1994, PLANT CELL, V6, P1301, DOI 10.1105/tpc.6.9.1301; Sanders D, 1999, PLANT CELL, V11, P691, DOI 10.1105/tpc.11.4.691; SCHROEDER JI, 1990, P NATL ACAD SCI USA, V87, P9305, DOI 10.1073/pnas.87.23.9305; SCHWARTZ A, 1985, PLANT PHYSIOL, V79, P1003, DOI 10.1104/pp.79.4.1003; Staxen I, 1999, P NATL ACAD SCI USA, V96, P1779, DOI 10.1073/pnas.96.4.1779; Zimmermann S, 1997, P NATL ACAD SCI USA, V94, P2751, DOI 10.1073/pnas.94.6.2751	31	1518	1736	33	434	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2000	406	6797					731	734		10.1038/35021067	http://dx.doi.org/10.1038/35021067			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963598				2022-12-24	WOS:000088767700045
J	Nissen, P; Hansen, J; Ban, N; Moore, PB; Steitz, TA				Nissen, P; Hansen, J; Ban, N; Moore, PB; Steitz, TA			The structural basis of ribosome activity in peptide bond synthesis	SCIENCE			English	Article							TRANSFER-RNA; COLI RIBOSOME; A-SITE; PROTEIN; SUBUNIT; TRANSLATION; RECOGNITION; MICROSCOPY; LOCATION; RIBOZYME	Using the atomic structures of the large ribosomal subunit from Haloarcula marismortui and its complexes with two substrate analogs, we establish that the ribosome is a ribozyme and address the catalytic properties of its all-RNA active site. Both substrate analogs are contacted exclusively by conserved ribosomal RNA (rRNA) residues from domain V of 23S rRNA; there are no protein side-chain atoms closer than about 18 angstroms to the peptide bond being synthesized. The mechanism of peptide band synthesis appears to resemble the reverse of the acylation step in serine proteases, with the base of A2486 (A2451 in Escherichia coti) playing the same general base role as histidine-57 in chymotrypsin. The unusual pK(a) (where K-a is the acid dissociation constant) required for A2486 to perform this function may derive in part from its hydrogen bonding to G2482 (G2447 in E. coli), which also interacts with a buried phosphate that could stabilize unusual tautomers of these two bases. The polypeptide exit tunnel is largely formed by RNA but has significant contributions from proteins L4, L22, and L39e, and its exit is encircled by proteins L19, L22, L23, L24, L29, and L31e.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Chem, New Haven, CT 06520 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute	Nissen, P (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.		Steitz, Thomas A./C-6559-2009; Nissen, Poul/D-5774-2014	Nissen, Poul/0000-0003-0948-6628	NIGMS NIH HHS [GM22778, GM54216] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BARTA A, 1984, P NATL ACAD SCI-BIOL, V81, P3607, DOI 10.1073/pnas.81.12.3607; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; BENNETT WS, 1978, P NATL ACAD SCI USA, V75, P4848, DOI 10.1073/pnas.75.10.4848; BERNABEU C, 1982, P NATL ACAD SCI-BIOL, V79, P3111, DOI 10.1073/pnas.79.10.3111; BLOBEL G, 1970, J CELL BIOL, V45, P130, DOI 10.1083/jcb.45.1.130; BLOW DM, 1969, NATURE, V221, P337, DOI 10.1038/221337a0; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; COOPERMAN BS, 1980, RIBOSOMES STRUCTURE, P531; CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6; DOBBERSTEIN B, COMMUNICATION; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; FRANCESCHI FJ, 1990, J BIOL CHEM, V265, P16676; Frank J, 1995, BIOCHEM CELL BIOL, V73, P757, DOI 10.1139/o95-084; FRANK J, 1995, NATURE, V376, P441, DOI 10.1038/376441a0; Garrett R. A., 1996, RIBOSOMAL RNA STRUCT, P327; Green R, 1998, SCIENCE, V280, P286, DOI 10.1126/science.280.5361.286; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; GUTELL RR, UNPUB; Khaitovich P, 1999, P NATL ACAD SCI USA, V96, P85, DOI 10.1073/pnas.96.1.85; Khaitovich P, 1999, RNA, V5, P605, DOI 10.1017/S1355838299990295; Kim DF, 1999, MOL CELL, V4, P859, DOI 10.1016/S1097-2765(00)80395-0; KOSHLAND DE, 1963, COLD SPRING HARB SYM, V28, P473, DOI 10.1101/SQB.1963.028.01.063; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; MADEN BEH, 1968, J MOL BIOL, V35, P333, DOI 10.1016/S0022-2836(68)80028-2; MILLIGAN RA, 1986, NATURE, V319, P693, DOI 10.1038/319693a0; MOAZED D, 1991, P NATL ACAD SCI USA, V88, P3725, DOI 10.1073/pnas.88.9.3725; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; MOAZED D, 1989, CELL, V57, P585, DOI 10.1016/0092-8674(89)90128-1; MONRO RE, 1967, J MOL BIOL, V26, P147, DOI 10.1016/0022-2836(67)90271-9; MONRO RE, 1969, NATURE, V222, P356, DOI 10.1038/222356a0; MOORE PB, 1996, RIBOSOMAL RNA STRUCT, P199; Muth GW, 2000, SCIENCE, V289, P947, DOI 10.1126/science.289.5481.947; Nakano S, 2000, SCIENCE, V287, P1493, DOI 10.1126/science.287.5457.1493; Nissen P, 1996, BIOCHIMIE, V78, P921, DOI 10.1016/S0300-9084(97)86714-4; Nitta I, 1998, RNA, V4, P257; Nitta I, 1998, SCIENCE, V281, P666, DOI 10.1126/science.281.5377.666; NOLLER HF, 1984, ANNU REV BIOCHEM, V53, P119, DOI 10.1146/annurev.bi.53.070184.001003; NOLLER HF, 1992, SCIENCE, V256, P1416, DOI 10.1126/science.1604315; NOLLER HF, 1991, ANNU REV BIOCHEM, V60, P191, DOI 10.1146/annurev.biochem.60.1.191; OFENGAND J, 1980, RIBOSOMES STRUCTURE, P497; Perrotta AT, 1999, SCIENCE, V286, P123, DOI 10.1126/science.286.5437.123; PICKING WD, 1992, BIOCHEMISTRY-US, V31, P2368, DOI 10.1021/bi00123a023; Prinz A, 2000, EMBO J, V19, P1900, DOI 10.1093/emboj/19.8.1900; RYABOVA LA, 1988, FEBS LETT, V226, P255, DOI 10.1016/0014-5793(88)81434-0; RYCHLIK I, 1966, BIOCHIM BIOPHYS ACTA, V114, P425, DOI 10.1016/0005-2787(66)90327-3; Saenger W., 1984, PRINCIPLES NUCL ACID; SAMAHA RR, 1995, NATURE, V377, P309, DOI 10.1038/377309a0; Stark H, 1997, CELL, V88, P19, DOI 10.1016/S0092-8674(00)81854-1; STARK H, 1995, STRUCTURE, V3, P815, DOI 10.1016/S0969-2126(01)00216-7; STEITZ TA, 1982, ANNU REV BIOPHYS BIO, V11, P419, DOI 10.1146/annurev.bb.11.060182.002223; TRAUT RR, 1964, J MOL BIOL, V10, P63, DOI 10.1016/S0022-2836(64)80028-0; VESTER B, 1988, EMBO J, V7, P3577, DOI 10.1002/j.1460-2075.1988.tb03235.x; WELCH M, 1995, BIOCHEMISTRY-US, V34, P385, DOI 10.1021/bi00002a001; Welch M, 1997, BIOCHEMISTRY-US, V36, P6614, DOI 10.1021/bi963135j; WITTMANNLIEBOLD B, 1990, RIBOSOME, P598; Xu ZH, 1998, J STRUCT BIOL, V124, P129, DOI 10.1006/jsbi.1998.4060; YONATH A, 1987, SCIENCE, V236, P813, DOI 10.1126/science.3576200; ZHAUG B, 1998, CHEM BIOL, V5, P539	62	1630	1719	7	274	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 11	2000	289	5481					920	930		10.1126/science.289.5481.920	http://dx.doi.org/10.1126/science.289.5481.920			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343KH	10937990				2022-12-24	WOS:000088701200024
J	Garrett, WS; Chen, LM; Kroschewski, R; Ebersold, M; Turley, S; Trombetta, S; Galan, JE; Mellman, I				Garrett, WS; Chen, LM; Kroschewski, R; Ebersold, M; Turley, S; Trombetta, S; Galan, JE; Mellman, I			Developmental control of endocytosis in dendritic cells by Cdc42	CELL			English	Article							GTP-BINDING PROTEIN; SALMONELLA-TYPHIMURIUM; RHO-GTPASES; NUCLEAR RESPONSES; SECRETION SYSTEM; EPITHELIAL-CELLS; HOST-CELLS; MEMBRANE; COMPLEX; ANTIGEN	Dendritic cells (DCs) developmentally regulate antigen uptake by controlling their endocytic capacity. Immature DCs actively internalize antigen. However, mature DCs are poorly endocytic, functioning instead to present antigens to T cells. We have found that endocytic downregulation reflects a decrease in endocytic activity controlled by Rho family GTPases, especially Cdc42. Blocking Cdc42 function by Toxin B treatment or injection of dominant-negative inhibitors of Cdc42 abrogates endocytosis in immature DCs. In mature DCs, injection of constitutively active Cdc42 or microbial delivery of a Cdc42 nucleotide exchange factor reactivates endocytosis. DCs regulate endogenous levels of Cdc42-GTP with activated Cdc42 detectable only in immature cells. We conclude that DCs developmentally regulate endocytosis at least in part by controlling levels of activated Cdc42.	Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Ludwig Inst Canc Res, New Haven, CT 06520 USA; Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06520 USA	Yale University; Yale University; Ludwig Institute for Cancer Research; Yale University; Yale University	Mellman, I (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, 333 Cedar St, New Haven, CT 06520 USA.	ira.mellman@yale.edu	Mellman, Ira/ABG-5896-2020	Garrett, Wendy/0000-0002-5092-0150; Kroschewski, Ruth/0000-0002-6032-2568	NATIONAL CANCER INSTITUTE [P01CA046128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034098, R01AI034098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029765] Funding Source: NIH RePORTER; NCI NIH HHS [CA-46128] Funding Source: Medline; NIAID NIH HHS [AI-34098] Funding Source: Medline; NIGMS NIH HHS [GM-29765] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; Aktories K, 1997, J CLIN INVEST, V99, P827, DOI 10.1172/JCI119245; Austyn JM, 1996, J EXP MED, V183, P1287, DOI 10.1084/jem.183.4.1287; Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; Chen LM, 1996, SCIENCE, V274, P2115, DOI 10.1126/science.274.5295.2115; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; DIDSBURY J, 1989, J BIOL CHEM, V264, P16378; Driessen C, 1999, J CELL BIOL, V147, P775, DOI 10.1083/jcb.147.4.775; Erickson JW, 1996, J BIOL CHEM, V271, P26850, DOI 10.1074/jbc.271.43.26850; Galan JE, 1999, CURR OPIN MICROBIOL, V2, P46, DOI 10.1016/S1369-5274(99)80008-3; GALAN JE, 1992, J BACTERIOL, V174, P4338; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Inaba K, 2000, J EXP MED, V191, P927, DOI 10.1084/jem.191.6.927; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Inaba K, 1998, J EXP MED, V188, P2163, DOI 10.1084/jem.188.11.2163; INABA K, 1993, J EXP MED, V178, P479, DOI 10.1084/jem.178.2.479; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; Kroschewski R, 1999, NAT CELL BIOL, V1, P8, DOI 10.1038/8977; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Li GP, 1997, J BIOL CHEM, V272, P10337; Ma L, 1998, P NATL ACAD SCI USA, V95, P15362, DOI 10.1073/pnas.95.26.15362; Massol P, 1998, EMBO J, V17, P6219, DOI 10.1093/emboj/17.21.6219; Mellman I, 1998, TRENDS CELL BIOL, V8, P231, DOI 10.1016/S0962-8924(98)01276-8; Merrifield CJ, 1999, NAT CELL BIOL, V1, P72, DOI 10.1038/9048; Mott HR, 1999, NATURE, V399, P384, DOI 10.1038/20732; Norbury CC, 1997, EUR J IMMUNOL, V27, P280, DOI 10.1002/eji.1830270141; Pierre P, 1998, CELL, V93, P1135, DOI 10.1016/S0092-8674(00)81458-0; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; PYPAERT M, 1992, METHOD ENZYMOL, V219, P212; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Rudolph MG, 1999, J BIOL CHEM, V274, P30501, DOI 10.1074/jbc.274.43.30501; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Stam J C, 1999, Prog Mol Subcell Biol, V22, P51; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; Taylor SJ, 1996, CURR BIOL, V6, P1621, DOI 10.1016/S0960-9822(02)70785-9; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; Van Nhieu GT, 1999, CURR OPIN MICROBIOL, V2, P51; Watarai M, 1997, J EXP MED, V185, P281, DOI 10.1084/jem.185.2.281; West MA, 1999, EUR J IMMUNOL, V29, P3450, DOI 10.1002/(SICI)1521-4141(199911)29:11<3450::AID-IMMU3450>3.0.CO;2-A; Whitehead IP, 1997, BIOCHIM BIOPHYS ACTA, V1332, P1	47	344	349	3	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 4	2000	102	3					325	334		10.1016/S0092-8674(00)00038-6	http://dx.doi.org/10.1016/S0092-8674(00)00038-6			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	342BP	10975523	Bronze			2022-12-24	WOS:000088625600008
J	Zoo, YM; Stoeckli, E; Chen, H; Tessier-Lavigne, M				Zoo, YM; Stoeckli, E; Chen, H; Tessier-Lavigne, M			Squeezing axons out of the gray matter: A role for slit and semaphorin proteins from midline and ventral spinal cord	CELL			English	Article							OLFACTORY-BULB AXONS; GROWTH CONE GUIDANCE; COMMISSURAL NEURONS; FLOOR-PLATE; INTERMEDIATE TARGET; NERVOUS-SYSTEM; CNS MIDLINE; ROOF PLATE; FAMILY; CHEMOATTRACTANT	Commissural axons cross the nervous system midline and then turn to grow alongside it, neither recrossing nor projecting back into ventral regions. In Drosophila, the midline repellent Slit prevents recrossing: axons cross once because they are initially unresponsive to Slit, becoming responsive only upon crossing. We show that commissural axons in mammals similarly acquire responsiveness to a midline repellent activity upon crossing. Remarkably, they also become responsive to a repellent activity from ventral spinal cord, helping explain why they never reenter that region. Several Slit and Semaphorin proteins, expressed in midline and/or ventral tissues, mimic these repellent activities, and midline guidance defects are observed in mice lacking neuropilin-2, a Semaphorin receptor. Thus, Slit and Semaphorin repellents from midline and nonmidline tissues may help prevent crossing axons from reentering gray matter, squeezing them into surrounding fiber tracts.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Basel, Dept Integrat Biol, CH-4051 Basel, Switzerland	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Basel	Tessier-Lavigne, M (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA.	marctl@itsa.ucsf.edu		Stoeckli, Esther/0000-0002-8485-0648	NINDS NIH HHS [F32 NS010273] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS010273] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTMAN J, 1984, ADV ANAT EMBRYOL CEL, V85, P1; Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; BOVOLENTA P, 1990, DEVELOPMENT, V109, P435; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Cajal SR., 1893, CELLULE, V9, P119; Chen H, 1998, NEURON, V21, P1283, DOI 10.1016/S0896-6273(00)80648-0; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; Chen H, 2000, NEURON, V25, P43, DOI 10.1016/S0896-6273(00)80870-3; Christensen CRL, 1998, CANCER RES, V58, P1238; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; de Castro F, 1999, J NEUROSCI, V19, P4428; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; FROHMAN MA, 1990, DEVELOPMENT, V110, P589; Giger RJ, 2000, NEURON, V25, P29, DOI 10.1016/S0896-6273(00)80869-7; Goodman CS, 1999, CELL, V97, P551, DOI 10.1016/S0092-8674(00)80766-7; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Imondi R, 2000, DEVELOPMENT, V127, P1397; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; LUO YL, 1995, NEURON, V14, P1131, DOI 10.1016/0896-6273(95)90261-9; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; PLACZEK M, 1990, DEVELOPMENT, V110, P19; Puschel AW, 1996, MOL CELL NEUROSCI, V7, P419, DOI 10.1006/mcne.1996.0030; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; Richards LJ, 1997, J NEUROSCI, V17, P2445; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shepherd IT, 1997, DEVELOPMENT, V124, P1377; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; SILOSSANTIAGO I, 1992, J COMP NEUROL, V325, P514, DOI 10.1002/cne.903250405; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; STOECKLI ET, 1995, NEURON, V14, P1165, DOI 10.1016/0896-6273(95)90264-3; Stoeckli ET, 1997, NEURON, V18, P209, DOI 10.1016/S0896-6273(00)80262-7; Takahashi T, 1998, NAT NEUROSCI, V1, P487, DOI 10.1038/2203; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; Wang H, 1999, NATURE, V401, P765, DOI 10.1038/44521; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7	46	289	293	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 4	2000	102	3					363	375		10.1016/S0092-8674(00)00041-6	http://dx.doi.org/10.1016/S0092-8674(00)00041-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	342BP	10975526	Bronze, Green Accepted			2022-12-24	WOS:000088625600011
J	Jenkins, PJ; Sohaib, SA; Akker, S; Phillips, RR; Spillane, K; Wass, JAH; Monson, JP; Grossman, AB; Besser, GM; Reznek, RH				Jenkins, PJ; Sohaib, SA; Akker, S; Phillips, RR; Spillane, K; Wass, JAH; Monson, JP; Grossman, AB; Besser, GM; Reznek, RH			The pathology of median neuropathy in acromegaly	ANNALS OF INTERNAL MEDICINE			English	Article							CARPAL-TUNNEL SYNDROME	Background: Median neuropathy is commonly associated with acromegaly, although its pathology is uncertain. Objective: To study the pathology of median neuropathy in acromegaly by using magnetic resonance imaging (MRI). Design: Case series. Setting: Outpatient clinic and MRI unit. Patients: Nine patients with acromegaly, four of whom had clinical symptoms of neuropathy. Measurements: At presentation and 6 months after treatment, median nerve size, its signal intensity, and the volume of the carpal tunnel contents were measured. Results: At presentation, patients with symptoms of neuropathy had increased nerve size and signal intensity compared with asymptomatic patients, but the two groups did not differ in volume of carpal tunnel contents. These measures improved with treatment of acromegaly in symptomatic patients; asymptomatic patients experienced no change or worsening. Conclusion: The predominant pathology of median neuropathy in acromegaly seems to be increased edema of the median nerve within the carpal tunnel rather than extrinsic compression from increased volume of the carpal tunnel contents.	St Bartholomews Hosp, Dept Endocrinol, London EC1A 7BE, England	University of London; Queen Mary University London	Jenkins, PJ (corresponding author), St Bartholomews Hosp, Dept Endocrinol, W Smithfield, London EC1A 7BE, England.							BAUM H, 1986, ACTA NEUROCHIR, V83, P54, DOI 10.1007/BF01420508; DALINKA MK, 1991, HAND CLIN, V7, P87; DINN JJ, 1970, J CLIN ENDOCR METAB, V31, P140, DOI 10.1210/jcem-31-2-140; Gondring W H, 1966, J Okla State Med Assoc, V59, P274; GOODWILL C J, 1965, Ann Phys Med, V8, P12; HEALY C, 1990, J HAND SURG-BRIT EUR, V15B, P243, DOI 10.1016/0266-7681(90)90131-M; JAMAL GA, 1987, J NEUROL NEUROSUR PS, V50, P886, DOI 10.1136/jnnp.50.7.886; JOHNSTON AW, 1960, BRIT MED J, V1, P1616, DOI 10.1136/bmj.1.5186.1616; Kameyama Shigeki, 1993, Neurologia Medico-Chirurgica, V33, P547, DOI 10.2176/nmc.33.547; LUBOSHITZKY R, 1980, JAMA-J AM MED ASSOC, V244, P1825, DOI 10.1001/jama.244.16.1825; Ma DM, 1983, NERVE CONDUCTION HDB, P362; MELVIN J L, 1968, Archives of Physical Medicine and Rehabilitation, V49, P502; MESGARZADEH M, 1989, RADIOLOGY, V171, P749, DOI 10.1148/radiology.171.3.2541464; MESGARZADEH M, 1989, RADIOLOGY, V171, P743, DOI 10.1148/radiology.171.3.2717746; ODUFFY JD, 1973, ANN INTERN MED, V78, P379, DOI 10.7326/0003-4819-78-3-379; Radack DM, 1997, AM J ROENTGENOL, V169, P1649, DOI 10.2214/ajr.169.6.9393185; ROSENBAUM RB, 1993, CARPAL TUNNEL SYNDRO, P127; SCHILLER F, 1954, NEUROLOGY, V4, P271, DOI 10.1212/WNL.4.4.271; TRAINER PJ, 1995, BARTS ENDOCRINE PROT, P41; Verma A K, 1994, J Indian Med Assoc, V92, P225	20	41	44	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	2000	133	3					197	201		10.7326/0003-4819-133-3-200008010-00011	http://dx.doi.org/10.7326/0003-4819-133-3-200008010-00011			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	338XW	10906834				2022-12-24	WOS:000088449400005
J	Sibilia, M; Fleischmann, A; Behrens, A; Stingl, L; Carroll, J; Watt, FM; Schlessinger, J; Wagner, EF				Sibilia, M; Fleischmann, A; Behrens, A; Stingl, L; Carroll, J; Watt, FM; Schlessinger, J; Wagner, EF			The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development	CELL			English	Article							GROWTH-FACTOR RECEPTOR; KINASE-C-DELTA; BCL-X-L; HAIR FOLLICLE; MICE LACKING; TGF-ALPHA; TYROSINE PHOSPHORYLATION; TARGETED DISRUPTION; SQUAMOUS PAPILLOMAS; HUMAN KERATINOCYTES	The EGF receptor (EGFR) is required for skin development and is implicated in epithelial tumor formation. Transgenic mice expressing a dominant form of Son of Sevenless (SOS-F) in basal keratinocytes develop skin papillomas with 100% penetrance. However, tumor formation is inhibited in a hypomorphic (wa2) and null EGFR background. Similarly, EGFR-deficient fibroblasts are resistant to transformation by SOS-F and rasV12, however, tumorigenicity is restored by expression of the anti-apoptotic bcl-2 gene. The K5-SOS-F papillomas and primary keratinocytes from wa2 mice display increased apoptosis, reduced Akt phosphorylation and grafting experiments imply a cell-autonomous requirement for EGFR in keratinocytes. Therefore, EGFR functions as a survival factor in oncogenic transformation and provides a valuable target for therapeutic intervention in a broader range of tumors than anticipated.	Res Inst Mol Pathol, A-1030 Vienna, Austria; Imperial Canc Res Fund, London WC2A 3PX, England; NYU Med Ctr, Dept Pharmacol, New York, NY 10016 USA	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Cancer Research UK; New York University	Sibilia, M (corresponding author), Univ Vienna, Sch Med, VIRCC, Dept Dermatol,DIAID, Brunnerstr 59, A-1235 Vienna, Austria.		Watt, Fiona/AHB-0226-2022	Watt, Fiona/0000-0001-9151-5154; Sibilia, Maria/0000-0001-6129-5613; Behrens, Axel/0000-0002-1557-1143; Wagner, Erwin F/0000-0001-7872-0196				ARONHEIM A, 1994, CELL, V78, P949, DOI 10.1016/0092-8674(94)90271-2; BAILLEUL B, 1990, CELL, V62, P697, DOI 10.1016/0092-8674(90)90115-U; BARBACID M, 1990, EUR J CLIN INVEST, V20, P225, DOI 10.1111/j.1365-2362.1990.tb01848.x; Bergmann A, 1998, CELL, V95, P331, DOI 10.1016/S0092-8674(00)81765-1; Brown K, 1998, CURR BIOL, V8, P516, DOI 10.1016/S0960-9822(98)70203-9; BROWN K, 1986, CELL, V46, P447, DOI 10.1016/0092-8674(86)90665-3; CARROLL JM, 1995, CELL, V83, P957, DOI 10.1016/0092-8674(95)90211-2; DENNING MF, 1993, J BIOL CHEM, V268, P26079; Denning MF, 1996, J BIOL CHEM, V271, P5325, DOI 10.1074/jbc.271.10.5325; DERYNCK R, 1992, ADV CANCER RES, V58, P27, DOI 10.1016/S0065-230X(08)60289-4; Dlugosz AA, 1997, CANCER RES, V57, P3180; DLUGOSZ AA, 1994, CANCER RES, V54, P6413; DOMINEY AM, 1993, CELL GROWTH DIFFER, V4, P1071; Downward J, 1998, CURR OPIN GENET DEV, V8, P49, DOI 10.1016/S0959-437X(98)80061-0; EARP HS, 1995, BREAST CANCER RES TR, V35, P115, DOI 10.1007/BF00694752; FOWLER KJ, 1995, P NATL ACAD SCI USA, V92, P1465, DOI 10.1073/pnas.92.5.1465; FUCHS E, 1992, J INVEST DERMATOL, V99, P671, DOI 10.1111/1523-1747.ep12613737; FUCHS E, 1990, J CELL BIOL, V111, P2807, DOI 10.1083/jcb.111.6.2807; Gandarillas A, 1999, EXP DERMATOL, V8, P71, DOI 10.1111/j.1600-0625.1999.tb00350.x; Gangarosa LM, 1997, J BIOL CHEM, V272, P18926, DOI 10.1074/jbc.272.30.18926; Hansen LA, 1997, AM J PATHOL, V150, P1959; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; KING LE, 1990, J INVEST DERMATOL, V94, P164; Kurada P, 1998, CELL, V95, P319, DOI 10.1016/S0092-8674(00)81764-X; LEMMON MA, 1994, TRENDS BIOCHEM SCI, V19, P459, DOI 10.1016/0968-0004(94)90130-9; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; LUETTEKE NC, 1993, CELL, V73, P263, DOI 10.1016/0092-8674(93)90228-I; LUETTEKE NC, 1994, GENE DEV, V8, P399, DOI 10.1101/gad.8.4.399; MANN GB, 1993, CELL, V73, P249, DOI 10.1016/0092-8674(93)90227-H; MCCARTHY SA, 1995, GENE DEV, V9, P1953, DOI 10.1101/gad.9.16.1953; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; MURILLAS R, 1995, EMBO J, V14, P5216, DOI 10.1002/j.1460-2075.1995.tb00206.x; Nagane M, 1998, P NATL ACAD SCI USA, V95, P5724, DOI 10.1073/pnas.95.10.5724; PRIGENT S A, 1992, Progress in Growth Factor Research, V4, P1, DOI 10.1016/0955-2235(92)90002-Y; RAMIREZ A, 1994, DIFFERENTIATION, V58, P53, DOI 10.1007/s002580050065; REDEMANN N, 1992, MOL CELL BIOL, V12, P491, DOI 10.1128/MCB.12.2.491; REICHMANN E, 1994, SEMIN CANCER BIOL, V5, P157; Rodeck U, 1997, P NATL ACAD SCI USA, V94, P5067, DOI 10.1073/pnas.94.10.5067; Rodeck U, 1997, J CELL SCI, V110, P113; ROOP DR, 1986, NATURE, V323, P822, DOI 10.1038/323822a0; SCHLESSINGER J, 1994, CURR OPIN GENET DEV, V4, P25, DOI 10.1016/0959-437X(94)90087-6; Sibilia M, 1998, EMBO J, V17, P719, DOI 10.1093/emboj/17.3.719; SIBILIA M, 1995, SCIENCE, V269, P234, DOI 10.1126/science.7618085; Stoll SW, 1998, ONCOGENE, V16, P1493, DOI 10.1038/sj.onc.1201657; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; TODARO GJ, 1965, J CELL COMPAR PHYSL, V66, P325, DOI 10.1002/jcp.1030660310; VARDY DA, 1995, J CELL PHYSIOL, V163, P257, DOI 10.1002/jcp.1041630206; VASSAR R, 1991, GENE DEV, V5, P714, DOI 10.1101/gad.5.5.714; WANG W, 1995, NAT GENET, V10, P294, DOI 10.1038/ng0795-294; Weiss FU, 1997, CURR OPIN GENET DEV, V7, P80, DOI 10.1016/S0959-437X(97)80113-X	51	252	259	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 21	2000	102	2					211	220		10.1016/S0092-8674(00)00026-X	http://dx.doi.org/10.1016/S0092-8674(00)00026-X			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	337NA	10943841	Bronze			2022-12-24	WOS:000088366800011
J	Hughes, TR; Marton, MJ; Jones, AR; Roberts, CJ; Stoughton, R; Armour, CD; Bennett, HA; Coffey, E; Dai, HY; He, YDD; Kidd, MJ; King, AM; Meyer, MR; Slade, D; Lum, PY; Stepaniants, SB; Shoemaker, DD; Gachotte, D; Chakraburtty, K; Simon, J; Bard, M; Friend, SH				Hughes, TR; Marton, MJ; Jones, AR; Roberts, CJ; Stoughton, R; Armour, CD; Bennett, HA; Coffey, E; Dai, HY; He, YDD; Kidd, MJ; King, AM; Meyer, MR; Slade, D; Lum, PY; Stepaniants, SB; Shoemaker, DD; Gachotte, D; Chakraburtty, K; Simon, J; Bard, M; Friend, SH			Functional discovery via a compendium of expression profiles	CELL			English	Article							STEROL C-8-C-7 ISOMERASE; VACUOLAR H+-ATPASE; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; COPPER DETOXIFICATION; CALCOFLUOR WHITE; HIGH-AFFINITY; YEAST GENOME; BINDING-SITE; CELL-CYCLE	Ascertaining the impact of uncharacterized perturbations on the cell is a fundamental problem in biology. Here, we describe how a single assay can be used to monitor hundreds of different cellular functions simultaneously. We constructed a reference database or "compendium" of expression profiles corresponding to 300 diverse mutations and chemical treatments in S. cerevisiae, and we show that the cellular pathways affected can be determined by pattern matching, even among very subtle profiles. The utility of this approach is validated by examining profiles caused by deletions of uncharacterized genes: we identify and experimentally confirm that eight uncharacterized open reading frames encode proteins required for sterol metabolism, cell wall function, mitochondrial respiration, or protein synthesis. We also show that the compendium can be used to characterize pharmacological perturbations by identifying a novel target of the commonly used drug dyclonine.	Rosetta Inpharmat Inc, Kirkland, WA 98034 USA; Indiana Univ Purdue Univ, Dept Biol, Indianapolis, IN 46202 USA; Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Medical College of Wisconsin; Fred Hutchinson Cancer Center	Friend, SH (corresponding author), Rosetta Inpharmat Inc, 12040 115th Ave NE, Kirkland, WA 98034 USA.				NATIONAL CANCER INSTITUTE [R01CA078746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI038598] Funding Source: NIH RePORTER; NCI NIH HHS [CA78746] Funding Source: Medline; NIAID NIH HHS [AI38598] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALBERTS AW, 1980, P NATL ACAD SCI-BIOL, V77, P3957, DOI 10.1073/pnas.77.7.3957; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; BARD M, 1972, Journal of Bacteriology, V111, P649; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; EIDE DJ, 1993, MOL GEN GENET, V241, P447, DOI 10.1007/BF00284699; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gray NS, 1998, SCIENCE, V281, P533, DOI 10.1126/science.281.5376.533; Hanner M, 1996, P NATL ACAD SCI USA, V93, P8072, DOI 10.1073/pnas.93.15.8072; Hartigan J. A., 1975, CLUSTERING ALGORITHM; Heller RA, 1997, P NATL ACAD SCI USA, V94, P2150, DOI 10.1073/pnas.94.6.2150; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; HUGHES TR, 2000, IN PRESS NAT GENET; JUNGMANN J, 1993, EMBO J, V12, P5051, DOI 10.1002/j.1460-2075.1993.tb06198.x; Kekuda R, 1996, BIOCHEM BIOPH RES CO, V229, P553, DOI 10.1006/bbrc.1996.1842; KELEHER CA, 1992, CELL, V68, P709, DOI 10.1016/0092-8674(92)90146-4; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; LIPKE PN, 1976, J BACTERIOL, V127, P610, DOI 10.1128/JB.127.1.610-618.1976; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Lussier M, 1997, GENETICS, V147, P435; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Marton MJ, 1998, NAT MED, V4, P1293, DOI 10.1038/3282; Mewes HW, 1997, NUCLEIC ACIDS RES, V25, P28, DOI 10.1093/nar/25.1.28; Moebius FF, 1996, BIOCHEMISTRY-US, V35, P16871, DOI 10.1021/bi961996m; Moebius FF, 1997, BRIT J PHARMACOL, V121, P1, DOI 10.1038/sj.bjp.0701079; MOLZAHN SW, 1972, J GEN MICROBIOL, V72, P339, DOI 10.1099/00221287-72-2-339; Nakajima H, 1998, EXP CELL RES, V241, P126, DOI 10.1006/excr.1998.4027; NELSON H, 1995, P NATL ACAD SCI USA, V92, P497, DOI 10.1073/pnas.92.2.497; Nguyen VH, 1998, EUR J PHARMACOL, V361, P157, DOI 10.1016/S0014-2999(98)00706-7; OHYA Y, 1991, J BIOL CHEM, V266, P13971; Ovalle R, 1998, YEAST, V14, P1159, DOI 10.1002/(SICI)1097-0061(19980930)14:13<1159::AID-YEA317>3.0.CO;2-3; PARKS LW, 1995, LIPIDS, V30, P227, DOI 10.1007/BF02537825; Pennisi E, 1998, SCIENCE, V282, P1972, DOI 10.1126/science.282.5396.1972; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; RAGUZZI F, 1988, FEBS LETT, V231, P253, DOI 10.1016/0014-5793(88)80742-7; RAM AFJ, 1994, YEAST, V10, P1019, DOI 10.1002/yea.320100804; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; RONCERO C, 1988, J BACTERIOL, V170, P1950, DOI 10.1128/jb.170.4.1950-1954.1988; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shoemaker DD, 1996, NAT GENET, V14, P450, DOI 10.1038/ng1296-450; Smith V, 1996, SCIENCE, V274, P2069, DOI 10.1126/science.274.5295.2069; Somerville C, 1999, SCIENCE, V285, P380, DOI 10.1126/science.285.5426.380; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Spradling AC, 1999, GENETICS, V153, P135; Szczypka MS, 1997, YEAST, V13, P1423, DOI 10.1002/(SICI)1097-0061(199712)13:15<1423::AID-YEA190>3.3.CO;2-3; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; Veitia RA, 1999, CYTOGENET CELL GENET, V85, P217, DOI 10.1159/000015296; Velculescu VE, 1997, CELL, V88, P243, DOI 10.1016/S0092-8674(00)81845-0; Wilke RA, 1999, J PHYSIOL-LONDON, V517, P391, DOI 10.1111/j.1469-7793.1999.00391.x; WILLIAMS FE, 1991, MOL CELL BIOL, V11, P3307, DOI 10.1128/MCB.11.6.3307; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wittes J, 1999, J NATL CANCER I, V91, P400, DOI 10.1093/jnci/91.5.400; ZHOU Z, 1992, GENETICS, V131, P851	59	1918	2009	0	90	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 7	2000	102	1					109	126		10.1016/S0092-8674(00)00015-5	http://dx.doi.org/10.1016/S0092-8674(00)00015-5			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	332UL	10929718	Bronze			2022-12-24	WOS:000088091700013
J	Abbott, RJ; Smith, LC; Milne, RI; Crawford, RMM; Wolff, K; Balfour, J				Abbott, RJ; Smith, LC; Milne, RI; Crawford, RMM; Wolff, K; Balfour, J			Molecular analysis of plant migration and refugia in the Arctic	SCIENCE			English	Article							SAXIFRAGA-OPPOSITIFOLIA; PHYLOGEOGRAPHY; DIVERSITY; EVOLUTION	The arctic flora is thought to have originated during the Late Tertiary, approximately 3 million years ago. Plant migration routes during colonization of the Arctic are currently unknown, and uncertainty remains over where arctic plants survived Pleistocene glaciations. A phylogenetic analysis of chloroplast DNA variation in the purple saxifrage (Saxifraga oppositifolia) indicates that this plant first occurred in the Arctic in western Beringia before it migrated east and west to achieve a circumpolar distribution. The geographical distribution of chloroplast DNA variation in the species supports the hypothesis that, during Pleistocene glaciations, some plant refugia were Located in the Arctic as well as at more southern Latitudes.	Univ St Andrews, Sch Biol, Div Environm & Evolutionary Biol, St Andrews KY16 9TH, Fife, Scotland; Newcastle Univ, Dept Agr & Environm Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of St Andrews; Newcastle University - UK	Abbott, RJ (corresponding author), Univ St Andrews, Sch Biol, Div Environm & Evolutionary Biol, Harold Mitchell Bldg, St Andrews KY16 9TH, Fife, Scotland.	rja@st-and.ac.uk	Wolff, Kirsten/E-7961-2012	Wolff, Kirsten/0000-0002-6050-8493				ABBOTT RJ, 1995, MOL ECOL, V4, P199, DOI 10.1111/j.1365-294X.1995.tb00209.x; [Anonymous], 1937, OUTLINE HIST ARCTIC; [Anonymous], 1967, BERING LAND BRIDGE; BENNIKE O, 1990, ARCTIC, V43, P331; Birks HH, 1994, DISS BOT, V234, P129; Comes HP, 1998, TRENDS PLANT SCI, V3, P432, DOI 10.1016/S1360-1385(98)01327-2; CWYNAR LC, 1982, ECOL MONOGR, V52, P1, DOI 10.2307/2937342; FRENZEL B, 1968, SCIENCE, V161, P637, DOI 10.1126/science.161.3842.637; Gabrielsen TM, 1997, MOL ECOL, V6, P831; GORNALL RJ, UNPUB; HEDBERG KO, 1992, BOT J LINN SOC, V109, P377, DOI 10.1111/j.1095-8339.1992.tb00280.x; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; HULTEN E, 1973, BOT NOTISER, V126, P459; Hulten E., 1986, ATLAS N EUROPEAN VAS, V1-3; MATTHEWS JV, 1990, ARCTIC, V43, P324; McIver EE, 1999, ANN MO BOT GARD, V86, P523, DOI 10.2307/2666184; Milne RI, 1999, AM J BOT, V86, P1776, DOI 10.2307/2656674; MURRAY D. F., 1981, EVOLUTION TODAY, P11; MURRAY DF, 1995, ECOL STU AN, V113, P21; PONS O, 1995, THEOR APPL GENET, V90, P462, DOI 10.1007/BF00221991; RITCHIE J C, 1992, Acta Botanica Fennica, V144, P81; SOLTIS DE, 1990, J HERED, V81, P168; STENSTROM M, 1992, ARCTIC ALPINE RES, V24, P337, DOI 10.2307/1551289; Svendsen JI, 1999, BOREAS, V28, P234, DOI 10.1111/j.1502-3885.1999.tb00217.x; SWOFFORD D.L., 2003, PAUP PHYLOGENETIC AN; Tremblay NO, 1999, MOL ECOL, V8, P1187, DOI 10.1046/j.1365-294x.1999.00680.x; Webb DA., 1989, SAXIFRAGES EUROPE NO; Willis KJ, 2000, SCIENCE, V287, P1406, DOI 10.1126/science.287.5457.1406	28	328	347	2	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2000	289	5483					1343	1346		10.1126/science.289.5483.1343	http://dx.doi.org/10.1126/science.289.5483.1343			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347RF	10958779				2022-12-24	WOS:000088942400036
J	Berger, A				Berger, A			Science commentary: Th1 and Th2 responses: what are they?	BRITISH MEDICAL JOURNAL			English	Editorial Material																		Gereda JE, 2000, LANCET, V355, P1680, DOI 10.1016/S0140-6736(00)02239-X; Jones CA, 2000, ALLERGY, V55, P2, DOI 10.1034/j.1398-9995.2000.00109.x	2	280	299	2	22	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	AUG 12	2000	321	7258					424	424		10.1136/bmj.321.7258.424	http://dx.doi.org/10.1136/bmj.321.7258.424			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344QC	10938051	Green Published, Bronze			2022-12-24	WOS:000088769500022
J	Khakh, BS; Zhou, XP; Sydes, J; Galligan, JJ; Lester, HA				Khakh, BS; Zhou, XP; Sydes, J; Galligan, JJ; Lester, HA			State-dependent cross-inhibition between transmitter-gated cation channels	NATURE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; PARASYMPATHETIC CARDIAC GANGLIA; GUINEA-PIG; ION CHANNELS; SYMPATHETIC NEURONS; EVOKED CURRENTS; MICE LACKING; ATP; DYSFUNCTION; ADENOSINE	Transmitter-gated cation channels are detectors of excitatory chemical signals at synapses in the nervous system(1). Here we show that structurally distinct alpha 3 beta 4 nicotinic and P2X(2) channels influence each other when co-activated. The activation of one channel type affects distinct kinetic and conductance states of the other, and co-activation results in non-additive responses owing to inhibition of both channel types. State-dependent inhibition of nicotinic channels is revealed most clearly with mutant P2X(2) channels, and inhibition is decreased at lower densities of channel expression. In synaptically coupled myenteric neurons, nicotinic fast excitatory postsynaptic currents are occluded during activation of endogenously co-expressed P2X channels. Our data provide a molecular basis and a synaptic context for cross-inhibition between transmitter-gated channels.	CALTECH, Div Biol, Pasadena, CA 91125 USA; Michigan State Univ, Dept Pharmacol & Toxicol, E Lansing, MI 48824 USA; Michigan State Univ, Program Neurosci, E Lansing, MI 48824 USA	California Institute of Technology; Michigan State University; Michigan State University	Khakh, BS (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.							Barajas-Lopez C, 1998, J PHYSIOL-LONDON, V513, P671, DOI 10.1111/j.1469-7793.1998.671ba.x; Boue-Grabot E, 2000, J BIOL CHEM, V275, P10190, DOI 10.1074/jbc.275.14.10190; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; Bueno L, 1999, Can J Gastroenterol, V13 Suppl A, p42A; Collo G, 1996, J NEUROSCI, V16, P2495; Duke TAJ, 1999, P NATL ACAD SCI USA, V96, P10104, DOI 10.1073/pnas.96.18.10104; Evans RJ, 1996, J PHYSIOL-LONDON, V497, P413, DOI 10.1113/jphysiol.1996.sp021777; FIEBER LA, 1991, J PHYSIOL-LONDON, V434, P239, DOI 10.1113/jphysiol.1991.sp018467; FIEBER LA, 1991, J PHYSIOL-LONDON, V434, P215, DOI 10.1113/jphysiol.1991.sp018466; Figl A, 1996, J GEN PHYSIOL, V107, P369, DOI 10.1085/jgp.107.3.369; Green T, 1998, NEURON, V20, P427, DOI 10.1016/S0896-6273(00)80986-1; HONORE E, 1992, EMBO J, V11, P2465, DOI 10.1002/j.1460-2075.1992.tb05311.x; Khakh BS, 1999, NAT NEUROSCI, V2, P322, DOI 10.1038/7233; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; Liu F, 2000, NATURE, V403, P274, DOI 10.1038/35002014; Lutz PL, 1997, BRAIN RES, V769, P281, DOI 10.1016/S0006-8993(97)00719-1; Miyazawa A, 1999, J MOL BIOL, V288, P765, DOI 10.1006/jmbi.1999.2721; NAKAZAWA K, 1994, J NEUROSCI, V14, P740; North RA, 1996, CURR OPIN CELL BIOL, V8, P474, DOI 10.1016/S0955-0674(96)80023-8; Rogers M, 1997, J NEUROPHYSIOL, V77, P1407, DOI 10.1152/jn.1997.77.3.1407; Searl TJ, 1998, J PHYSIOL-LONDON, V510, P783, DOI 10.1111/j.1469-7793.1998.783bj.x; TALEB O, 1994, EMBO J, V13, P1318, DOI 10.1002/j.1460-2075.1994.tb06384.x; Virginio C, 1999, NAT NEUROSCI, V2, P315, DOI 10.1038/7225; Xu W, 1999, P NATL ACAD SCI USA, V96, P5746, DOI 10.1073/pnas.96.10.5746; Xu W, 1999, J NEUROSCI, V19, P9298; Zhou XP, 1996, J PHYSIOL-LONDON, V496, P719, DOI 10.1113/jphysiol.1996.sp021722; Zhou XP, 1998, J PHYSIOL-LONDON, V513, P685, DOI 10.1111/j.1469-7793.1998.685ba.x	27	148	155	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					405	410		10.1038/35019066	http://dx.doi.org/10.1038/35019066			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935636				2022-12-24	WOS:000088383800046
J	Wald, NJ; Law, MR; Morris, JK; Zhou, X; Wong, Y; Ward, ME				Wald, NJ; Law, MR; Morris, JK; Zhou, X; Wong, Y; Ward, ME			Chlamydia pneumoniae infection and mortality from ischaemic heart disease: large prospective studs	BRITISH MEDICAL JOURNAL			English	Article							HELICOBACTER-PYLORI; MYOCARDIAL-INFARCTION; RISK FACTOR; ASSOCIATION; CYTOMEGALOVIRUS	Objective To determine whether there is an independent association between infection with Chlamydia pneumoniae and ischaemic heart disease. Design Prospective study using a nested case-control design, Setting Medical centre in London run by BUPA, a private medical organisation. Participants 21 520 professional men aged 35-64 who attended for a medical examination in London between 1975 and 1982. Main outcome measure Death from ischaemic heart disease. Results The distributions of concentrations of IgG and IgA antibodies to C pneumoniae were similar in the 647 men who subsequently died of ischaemic heart disease and in 1294 age matched controls who did not There was no material association with heart disease irrespective of the cut-off point chosen to define seropositivity, At a cut-off point that defines 15% of controls as positive, for example, the odds ratios were 1.26 (95% confidence interval 0.95 to 1.68) for IgG and 1.09 (0.82 to 1.43) for IgA. Conclusions No material association was found between infection with C pneumoniae and ischaemic heart disease. The size and prospective design of the study and the socioeconomic homogeneity of the cohort minimise both random and systematic error.	St Bartholomews & Royal London Sch Med & Dent, Wolfson Inst Prevent Med, BUPA Epidemiol Res Grp, London EC1M 6BQ, England; Southampton Gen Hosp, Mol Microbiol Grp, Southampton SO16 6YD, Hants, England	University of London; Queen Mary University London; University of Southampton	Wald, NJ (corresponding author), St Bartholomews & Royal London Sch Med & Dent, Wolfson Inst Prevent Med, BUPA Epidemiol Res Grp, London EC1M 6BQ, England.		Wald, Nicholas/AAY-2814-2021; Wald, Nicholas/AAY-8924-2021	Morris, Joan/0000-0002-7164-612X				Danesh J, 1999, HEART, V81, P245, DOI 10.1136/hrt.81.3.245; Danesh J, 1997, LANCET, V350, P430, DOI 10.1016/S0140-6736(97)03079-1; Haider Agha W., 1999, Journal of the American College of Cardiology, V33, p314A; Jackson LA, 1999, EMERG INFECT DIS, V5, P281, DOI 10.3201/eid0502.990216; Miettinen H, 1996, EUR HEART J, V17, P682; Ossewaarde JM, 1998, EPIDEMIOL INFECT, V120, P93, DOI 10.1017/S0950268897008303; PATEL P, 1995, BRIT MED J, V311, P711, DOI 10.1136/bmj.311.7007.711; Ridker PM, 1999, CIRCULATION, V99, P1161, DOI 10.1161/01.CIR.99.9.1161; SAIKKU P, 1992, ANN INTERN MED, V116, P273, DOI 10.7326/0003-4819-116-4-273; Strachan DP, 1999, BMJ-BRIT MED J, V318, P1035, DOI 10.1136/bmj.318.7190.1035; von Hertzen L, 1999, BRIT MED J, V319, P1575, DOI 10.1136/bmj.319.7224.1575; Wald NJ, 1997, BMJ-BRIT MED J, V315, P1199, DOI 10.1136/bmj.315.7117.1199; Wong YK, 1999, J CLIN PATHOL, V52, P99, DOI 10.1136/jcp.52.2.99	13	69	73	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 22	2000	321	7255					204	207		10.1136/bmj.321.7255.204	http://dx.doi.org/10.1136/bmj.321.7255.204			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	338XG	10903649	Green Published, Bronze			2022-12-24	WOS:000088448100020
J	Agarwal, S; Roeder, GS				Agarwal, S; Roeder, GS			Zip3 provides a link between recombination enzymes and synaptonemal complex proteins	CELL			English	Article							HOMOLOGOUS CHROMOSOME SYNAPSIS; SACCHAROMYCES-CEREVISIAE; MEIOTIC RECOMBINATION; BUDDING YEAST; MUTS HOMOLOG; MEIOSIS; PHOSPHORYLATION; INTERACT; EXCHANGE; NODULES	In budding yeast, absence of the meiosis-specific Zip3 protein (also known as Cst9) causes synaptonemal complex formation to be delayed and incomplete. The Zip3 protein colocalizes with Zip2 at discrete foci on meiotic chromosomes, corresponding to the sites where synapsis initiates. Observations suggest that Zip3 promotes synapsis by recruiting the Zip2 protein to chromosomes and/or stabilizing the association of Zip2 with chromosomes. Zip3 interacts with a number of gene products involved in meiotic recombination, including proteins that act at both early (Mre11, Rad51, and Rad57) and late (Msh4 and Msh5) steps in the exchange process. We speculate that Zip3 is a component of recombination nodules and serves to link the initiation of synapsis to meiotic recombination.	Yale Univ, Howard Hughes Med Inst, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University; Howard Hughes Medical Institute; Yale University	Roeder, GS (corresponding author), Yale Univ, Howard Hughes Med Inst, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028904] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM28904] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson LK, 1997, P NATL ACAD SCI USA, V94, P6868, DOI 10.1073/pnas.94.13.6868; Bailis JM, 2000, CELL, V101, P211, DOI 10.1016/S0092-8674(00)80831-4; Bailis JM, 1998, GENE DEV, V12, P3551, DOI 10.1101/gad.12.22.3551; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Chua PR, 1998, CELL, V93, P349, DOI 10.1016/S0092-8674(00)81164-2; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Dong HJ, 2000, J CELL BIOL, V148, P417, DOI 10.1083/jcb.148.3.417; GAME JC, 1989, GENETICS, V123, P695; Gasior SL, 1998, GENE DEV, V12, P2208, DOI 10.1101/gad.12.14.2208; GOLDWAY M, 1993, GENETICS, V133, P159; Haber JE, 1998, CELL, V95, P583, DOI 10.1016/S0092-8674(00)81626-8; HAWLEY RS, 1980, GENETICS, V94, P625; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; KELLOGG DR, 1995, J CELL BIOL, V130, P661, DOI 10.1083/jcb.130.3.661; MALONE RE, 1983, MOL GEN GENET, V189, P405, DOI 10.1007/BF00325902; McKim KS, 1998, SCIENCE, V279, P876, DOI 10.1126/science.279.5352.876; MITCHELL AP, 1994, MICROBIOL REV, V58, P56, DOI 10.1128/MMBR.58.1.56-70.1994; Nelms BE, 1998, SCIENCE, V280, P590, DOI 10.1126/science.280.5363.590; Ouspenski II, 1999, NUCLEIC ACIDS RES, V27, P3001, DOI 10.1093/nar/27.15.3001; PAQUES F, 1999, MOL BIO REV, V63, P319; Pochart P, 1997, J BIOL CHEM, V272, P30345, DOI 10.1074/jbc.272.48.30345; ROCKMILL B, 1990, GENETICS, V126, P563; Rockmill B, 1998, GENE DEV, V12, P2574, DOI 10.1101/gad.12.16.2574; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Ross-Macdonald P, 1999, NATURE, V402, P413, DOI 10.1038/46558; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; Schmekel K, 1998, CHROMOSOME RES, V6, P155, DOI 10.1023/A:1009295115033; Seedorf M, 1999, MOL CELL BIOL, V19, P1547; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; SYM M, 1995, J CELL BIOL, V128, P455, DOI 10.1083/jcb.128.4.455; SYM M, 1994, CELL, V79, P283, DOI 10.1016/0092-8674(94)90197-X; TYERS M, 1992, EMBO J, V11, P1773, DOI 10.1002/j.1460-2075.1992.tb05229.x; Usui T, 1998, CELL, V95, P705, DOI 10.1016/S0092-8674(00)81640-2; XU LZ, 1995, MOL CELL BIOL, V15, P6572; Yoshida K, 1998, MOL CELL, V1, P707, DOI 10.1016/S1097-2765(00)80070-2; Zeng XM, 1999, J CELL BIOL, V146, P415, DOI 10.1083/jcb.146.2.415; ZETKA M, 1995, TRENDS GENET, V11, P27, DOI 10.1016/S0168-9525(00)88983-0	39	206	212	0	18	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 21	2000	102	2					245	255		10.1016/S0092-8674(00)00029-5	http://dx.doi.org/10.1016/S0092-8674(00)00029-5			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	337NA	10943844	Bronze			2022-12-24	WOS:000088366800014
J	Ruiz-Gomez, M; Coutts, N; Price, A; Taylor, MV; Bate, M				Ruiz-Gomez, M; Coutts, N; Price, A; Taylor, MV; Bate, M			Drosophila dumbfounded: A myoblast attractant essential for fusion	CELL			English	Article							MAMMALIAN SKELETAL-MUSCLES; SECONDARY MYOTUBES; GENE-EXPRESSION; HOMEOBOX GENE; CELL FATES; EMBRYOGENESIS; PROTEIN; WINGLESS; EMBRYOS; FIBER	Aggregation and fusion of myoblasts to form myotubes is essential for myogenesis in many organisms. In Drosophila the formation of syncytial myotubes is seeded by founder myoblasts. Founders fuse with clusters of fusion-competent myoblasts. Here we identify the gene dumbfounded (duf) and show that it is required for myoblast aggregation and fusion. duf encodes a member of the immunoglobulin superfamily of proteins that is an attractant for fusion-competent myoblasts. It is expressed by founder cells and serves to attract clusters of myoblasts from which myotubes form by fusion.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Ruiz-Gomez, M (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain.		Ruiz-Gómez, Mar/K-9266-2014; Taylor, Michael/A-8204-2010; Price, Alivia/AAX-4614-2021	Ruiz-Gómez, Mar/0000-0002-9024-1400; Taylor, Michael/0000-0003-1351-939X; Price, Alivia/0000-0002-0890-4667				ALTSCHUL SF, 1990, P NATL ACAD SCI USA, V87, P5509, DOI 10.1073/pnas.87.14.5509; Bate Michael, 1993, P1013; Baylies MK, 1996, SCIENCE, V272, P1481, DOI 10.1126/science.272.5267.1481; Baylies MK, 1998, CELL, V93, P921, DOI 10.1016/S0092-8674(00)81198-8; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brook WJ, 1996, SCIENCE, V273, P1373, DOI 10.1126/science.273.5280.1373; BROWN NH, 1988, J MOL BIOL, V203, P425, DOI 10.1016/0022-2836(88)90010-1; Calleja M, 1996, SCIENCE, V274, P252, DOI 10.1126/science.274.5285.252; CARMENA A, 1995, GENE DEV, V9, P2373, DOI 10.1101/gad.9.19.2373; CAVENER DR, 1991, NUCLEIC ACIDS RES, V19, P3185, DOI 10.1093/nar/19.12.3185; CHIBA A, 1993, J NEUROSCI, V13, P714; COHEN B, 1991, MECH DEVELOP, V33, P229, DOI 10.1016/0925-4773(91)90030-A; Doberstein SK, 1997, J CELL BIOL, V136, P1249, DOI 10.1083/jcb.136.6.1249; DOHRMANN C, 1990, GENE DEV, V4, P2098, DOI 10.1101/gad.4.12a.2098; DUXSON MJ, 1989, DEVELOPMENT, V107, P243; DUXSON MJ, 1989, DEVELOPMENT, V107, P743; Frasch M, 1999, CURR OPIN GENET DEV, V9, P522, DOI 10.1016/S0959-437X(99)00014-3; Gelbart WM, 1999, NUCLEIC ACIDS RES, V27, P85, DOI 10.1093/nar/27.1.85; Glise B, 1997, GENE DEV, V11, P1738, DOI 10.1101/gad.11.13.1738; GONZALEZ F, 1991, MECH DEVELOP, V35, P43, DOI 10.1016/0925-4773(91)90040-D; HARRIS AJ, 1981, PHILOS T ROY SOC B, V293, P257, DOI 10.1098/rstb.1981.0076; HARRIS AJ, 1989, DEVELOPMENT, V107, P771; HO RK, 1983, NATURE, V301, P66, DOI 10.1038/301066a0; Hughes SM, 1999, CURR OPIN NEUROBIOL, V9, P54, DOI 10.1016/S0959-4388(99)80007-5; JELLIES J, 1990, TRENDS NEUROSCI, V13, P126, DOI 10.1016/0166-2236(90)90003-S; Kardon G, 1998, DEVELOPMENT, V125, P4019; Keller CA, 1998, DEV BIOL, V202, P157, DOI 10.1006/dbio.1998.9009; KIEHART DP, 1986, J CELL BIOL, V103, P1517, DOI 10.1083/jcb.103.4.1517; Knirr S, 1999, DEVELOPMENT, V126, P4525; Kosman D, 1998, DEV GENES EVOL, V208, P290, DOI 10.1007/s004270050184; LAWRENCE PA, 1982, NATURE, V295, P55, DOI 10.1038/295055a0; Maeland Anne D., 1996, Molecular Biology of the Cell, V7, p39A; MLODZIK M, 1990, CELL, V60, P211, DOI 10.1016/0092-8674(90)90737-Y; Nose A, 1998, DEVELOPMENT, V125, P215; NOSE A, 1992, CELL, V70, P553, DOI 10.1016/0092-8674(92)90426-D; Paululat A, 1999, MECH DEVELOP, V83, P17, DOI 10.1016/S0925-4773(99)00029-5; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; RAMOS RGP, 1989, GENETICS, V123, P337; RAMOS RGP, 1993, GENE DEV, V7, P2533, DOI 10.1101/gad.7.12b.2533; Rizki T.M., 1978, P397; RuizGomez M, 1997, DEVELOPMENT, V124, P3407; RUSHTON E, 1995, DEVELOPMENT, V121, P1979; Simpson P, 1997, CURR OPIN GENET DEV, V7, P537, DOI 10.1016/S0959-437X(97)80083-4; Taylor MV, 2000, DEV BIOL, V220, P37, DOI 10.1006/dbio.2000.9608; VANDENHEUVEL M, 1989, CELL, V59, P739, DOI 10.1016/0092-8674(89)90020-2; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5	46	248	251	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 21	2000	102	2					189	198		10.1016/S0092-8674(00)00024-6	http://dx.doi.org/10.1016/S0092-8674(00)00024-6			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	337NA	10943839	Bronze			2022-12-24	WOS:000088366800009
J	Alison, MR; Poulsom, R; Jeffery, R; Dhillon, AP; Quaglia, A; Jacob, J; Novelli, M; Prentice, G; Williamson, J; Wright, NA				Alison, MR; Poulsom, R; Jeffery, R; Dhillon, AP; Quaglia, A; Jacob, J; Novelli, M; Prentice, G; Williamson, J; Wright, NA			Cell differentiation - Hepatocytes from nonhepatic adult stem cells	NATURE			English	Article							PRIMARY BILIARY-CIRRHOSIS; Y-CHROMOSOME; LIVER; TRANSPLANTATION; MICROCHIMERISM		Imperial Coll Sch Med, Dept Histopathol, London W12 0NN, England; Imperial Canc Res Fund, Histopathol Unit, London WC2A 3PX, England; UCL Royal Free & Univ Coll Sch Med, Dept Histopathol, London NW3 2PF, England; UCL Royal Free & Univ Coll Sch Med, Dept Haematol, London NW3 2PF, England; UCL, Dept Histopathol, London WC1E 6JJ, England; Imperial Canc Res Fund, Human Cytogenet Lab, London WC2A 3PX, England	Imperial College London; Cancer Research UK; University of London; University College London; University of London; University College London; University of London; University College London; Cancer Research UK	Alison, MR (corresponding author), Imperial Coll Sch Med, Dept Histopathol, Hammersmith Campus, London W12 0NN, England.	m.alison@ic.ac.uk	Dhillon, Amar P/C-5619-2009; Alison, Malcolm/H-6961-2019; Wright, Nicholas/HHY-7227-2022	Wright, Nicholas/0000-0002-5525-3457				Alison M, 1998, CURR OPIN CELL BIOL, V10, P710, DOI 10.1016/S0955-0674(98)80111-7; Laconi E, 1998, AM J PATHOL, V153, P319, DOI 10.1016/S0002-9440(10)65574-5; Novelli MR, 1996, SCIENCE, V272, P1187, DOI 10.1126/science.272.5265.1187; Oren R, 1999, HEPATOLOGY, V30, P903, DOI 10.1002/hep.510300418; Overturf K, 1997, AM J PATHOL, V151, P1273; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Rubbia-Brandt L, 1999, HEPATOLOGY, V30, P821, DOI 10.1002/hep.510300322; Tanaka A, 1999, HEPATOLOGY, V30, P833, DOI 10.1002/hep.510300410; Theise ND, 2000, HEPATOLOGY, V31, P235, DOI 10.1002/hep.510310135; VANEYKEN P, 1993, LIVER, V13, P113; WOLFE J, 1985, J MOL BIOL, V182, P477, DOI 10.1016/0022-2836(85)90234-7	11	837	936	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 20	2000	406	6793					257	257		10.1038/35018642	http://dx.doi.org/10.1038/35018642			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917519	Bronze			2022-12-24	WOS:000088251900037
J	Ansel, KM; Ngo, VN; Hyman, PL; Luther, SA; Forster, R; Sedgwick, JD; Browning, JL; Lipp, M; Cyster, JG				Ansel, KM; Ngo, VN; Hyman, PL; Luther, SA; Forster, R; Sedgwick, JD; Browning, JL; Lipp, M; Cyster, JG			A chemokine-driven positive feedback loop organizes lymphoid follicles	NATURE			English	Article							TUMOR-NECROSIS-FACTOR; FOLLICULAR DENDRITIC CELLS; B-CELL; LYMPHOTOXIN-ALPHA; IMMUNE-RESPONSES; T-CELL; LYMPHOCYTES; EXPRESSION; BETA; RECEPTOR	Lymphoid follicles are B-cell-rich compartments of lymphoid organs that function as sites of B-cell antigen encounter and differentiation. CXC chemokine receptor-5 (CXCR5) is required for B-cell migration to splenic follicles(1), but the requirements for homing to B-cell areas in lymph nodes remain to be defined. Here we show that lymph nodes contain two types of B-cell-rich compartment: follicles containing follicular dendritic cells, and areas lacking such cells. Using gene-targeted mice, we establish that B-lymphocyte chemoattractant (BLC/BCA1)(2,3) and its receptor, CXCR5, are needed for B-cell homing to follicles in lymph nodes as well as in spleen. We also rnd that BLC is required for the development of most lymph nodes and Peyer's patches. In addition to mediating chemoattraction, BLC induces B cells to upregulate membrane lymphotoxin alpha 1 beta 2, a cytokine that promotes follicular dendritic cell development and BLC expression(4,5), establishing a positive feedback loop that is likely to be important in follicle development and homeostasis. In germinal centres the feedback loop is overridden, with B-cell lymphotoxin a1b2 expression being induced by a mechanism independent of BLC.	Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; DNAX Res Inst Mol & Cellular Biol Inc, Palo Alto, CA 94304 USA; Biogen Inc, Cambridge, MA 02142 USA	University of California System; University of California San Francisco; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; Biogen	Cyster, JG (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.		Luther, Sanjiv/AAP-6525-2020; Förster, Reinhold/D-6770-2011; Luther, Sanjiv A/B-4380-2016; Lipp, Martin/G-2235-2010; , Sanjiv/B-4380-2016	Luther, Sanjiv/0000-0002-8758-957X; Luther, Sanjiv A/0000-0002-8758-957X; Forster, Reinhold/0000-0001-6190-7923; , Sanjiv/0000-0002-0614-561X; Browning, Jeffrey/0000-0001-9168-5233; Ngo, Vu/0000-0002-9501-6990				ANDEL KM, 1999, J EXP MED, V190, P1123; Browning JL, 1997, J IMMUNOL, V159, P3288; BROWNING JL, 1993, CELL, V72, P847, DOI 10.1016/0092-8674(93)90574-A; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; Endres R, 1999, J EXP MED, V189, P159, DOI 10.1084/jem.189.1.159; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Fu YX, 1998, J EXP MED, V187, P1009, DOI 10.1084/jem.187.7.1009; Golovkina TV, 1999, SCIENCE, V286, P1965, DOI 10.1126/science.286.5446.1965; Gonzalez M, 1998, J EXP MED, V187, P997, DOI 10.1084/jem.187.7.997; Gunn MD, 1998, NATURE, V391, P799, DOI 10.1038/35876; GUTMAN GA, 1973, TRANSPLANTATION, V16, P621, DOI 10.1097/00007890-197312000-00014; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Korner H, 1997, EUR J IMMUNOL, V27, P2600, DOI 10.1002/eji.1830271020; Legler DF, 1998, J EXP MED, V187, P655, DOI 10.1084/jem.187.4.655; Luther SA, 2000, IMMUNITY, V12, P471, DOI 10.1016/S1074-7613(00)80199-5; Mackay F, 1998, NATURE, V395, P26, DOI 10.1038/25630; MASON DY, 1992, INT IMMUNOL, V4, P163, DOI 10.1093/intimm/4.2.163; Matsumoto M, 1996, SCIENCE, V271, P1289, DOI 10.1126/science.271.5253.1289; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; MILLER JJ, 1968, NATURE, V217, P1059, DOI 10.1038/2171059a0; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; POKHOLOK DK, 1995, P NATL ACAD SCI USA, V92, P674, DOI 10.1073/pnas.92.3.674; Tew JG, 1997, IMMUNOL REV, V156, P39, DOI 10.1111/j.1600-065X.1997.tb00957.x; TILNEY NL, 1971, J ANAT, V109, P369; VAJDY M, 1995, J EXP MED, V181, P41, DOI 10.1084/jem.181.1.41; Voigt I, 2000, EUR J IMMUNOL, V30, P560, DOI 10.1002/1521-4141(200002)30:2<560::AID-IMMU560>3.0.CO;2-T; WORM M, 1994, INT IMMUNOL, V6, P1883, DOI 10.1093/intimm/6.12.1883; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yoshida H, 1999, INT IMMUNOL, V11, P643, DOI 10.1093/intimm/11.5.643	30	948	987	1	44	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 20	2000	406	6793					309	314		10.1038/35018581	http://dx.doi.org/10.1038/35018581			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917533				2022-12-24	WOS:000088251900051
J	Le Souef, PN; Goldblatt, J; Lynch, NR				Le Souef, PN; Goldblatt, J; Lynch, NR			Evolutionary adaptation of inflammatory immune responses in human beings	LANCET			English	Article							EPSILON-RI-BETA; BETA(2)-ADRENORECEPTOR GENE; ETHNIC-DIFFERENCES; ASTHMA; PREVALENCE; CHILDREN; POLYMORPHISMS; ASSOCIATION; RATES; RACE	Modern man's ancestors lived in an environment where Infectious, tropical diseases would have been endemic. We postulate that this relatively hostile environment would have caused genetic selection for Increased proinflammatory immune responses. On migrating to temperate regions, pronounced proinflammatory responses would have been less important and selected against due to increased mortality from overly vigorous responses to harmless environmental agents. This hypothesis is supported by the observation that proinflammatory alleles In several genes involved in Inflammation are more prevalent in populations with long-term tropical ancestry than those with long-term residence in temperate regions. In addition, when the former populations relocate from a tropical to a temperate region, they have a higher incidence of allergic inflammatory diseases than the latter populations. These observations suggest that there may be general patterns of recent evolutionary adaptation of the human immune system to particular regions and that these adaptations can produce differences in disease susceptibility.	Univ Western Australia, Princess Margaret Hosp Children, Dept Paediat, Perth, WA 6001, Australia; Cent Univ Venezuela, Inst Biomed, Caracas, Venezuela	University of Western Australia; University of Central Venezuela	Le Souef, PN (corresponding author), Univ Western Australia, Princess Margaret Hosp Children, Dept Paediat, GPO Box D184, Perth, WA 6001, Australia.		Le Souef, Peter N/H-5256-2014; Lynch, Natalie/GSI-7336-2022	Le Souef, Peter/0000-0003-0930-1654				Beasley R, 1998, LANCET, V351, P1225, DOI 10.1016/S0140-6736(97)07302-9; Burchard EG, 1999, AM J RESP CRIT CARE, V160, P919, DOI 10.1164/ajrccm.160.3.9812024; Burchard EG, 1999, AM J RESP CRIT CARE, V159, pA645; Diamond J, 1998, GUNS GERMS STEEL; DIECHMANN K, 1997, BIOCHEM BIOPH RES CO, V231, P696; DOWSE GK, 1985, J ALLERGY CLIN IMMUN, V75, P75, DOI 10.1016/0091-6749(85)90016-8; Eber E., 1998, European Respiratory Journal, V12, p443S; GILLAM SJ, 1989, BRIT MED J, V299, P953, DOI 10.1136/bmj.299.6705.953; Gilthorpe MS, 1998, RESP MED, V92, P642, DOI 10.1016/S0954-6111(98)90511-X; GOLD DR, 1993, AM REV RESPIR DIS, V148, P10, DOI 10.1164/ajrccm/148.1.10; Green SL, 1998, AM J RESP CRIT CARE, V158, P1487, DOI 10.1164/ajrccm.158.5.9707099; HAYDEN CM, IN PRESS EUR RESP J; Hill MR, 1996, HUM MOL GENET, V5, P959, DOI 10.1093/hmg/5.7.959; Laing IA, 1998, J MED GENET, V35, P463, DOI 10.1136/jmg.35.6.463; Laing IA, 2000, AM J RESP CRIT CARE, V161, P124, DOI 10.1164/ajrccm.161.1.9904073; Leakey MG, 1998, NATURE, V393, P62, DOI 10.1038/29972; Leakey R., 1993, ORIGINS RECONSIDERED; Litonjua AA, 1999, PEDIATR PULM, V28, P394, DOI 10.1002/(SICI)1099-0496(199912)28:6<394::AID-PPUL2>3.0.CO;2-6; Lynch NR, 1999, THORAX, V54, P659, DOI 10.1136/thx.54.8.659; Lynch NR, 1998, J ALLERGY CLIN IMMUN, V101, P217, DOI 10.1016/S0091-6749(98)70386-0; Miller JE, 2000, AM J PUBLIC HEALTH, V90, P428, DOI 10.2105/AJPH.90.3.428; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; MYERS P, 1992, RESP MED, V86, P297, DOI 10.1016/S0954-6111(06)80027-2; Nelson DA, 1997, ANN ALLERG ASTHMA IM, V78, P21, DOI 10.1016/S1081-1206(10)63365-0; Nickel R, 1999, J ALLERGY CLIN IMMUN, V103, pS174; Nickel R, 1999, J ALLERGY CLIN IMMUN, V104, P723, DOI 10.1016/S0091-6749(99)70281-2; PILLARI A, 1999, AM J RESP CRIT CARE, V159, pA645; Ramsay CE, 1999, CLIN EXP ALLERGY, V29, P1195; Ramsay CE, 1999, HUM GENET, V104, P269, DOI 10.1007/s004390050947; REISHAUS E, 1993, AM J RESPIR CELL MOL, V8, P334; ROSSENWASSER LJ, 1995, CLIN EXP ALLERGY S2, V25, P74; Sarpong SB, 1996, J ALLERGY CLIN IMMUN, V97, P1393, DOI 10.1016/S0091-6749(96)70209-9; STRINGER CB, 1997, AFRICAN EXODUS ORIGI; Stromberg BE, 1997, VET PARASITOL, V72, P247, DOI 10.1016/S0304-4017(97)00100-3; Von Behren J, 1999, J ASTHMA, V36, P575, DOI 10.3109/02770909909087294	35	76	80	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 15	2000	356	9225					242	244						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334GQ	10963213				2022-12-24	WOS:000088179100038
J	Harvey, JA; Corley, LS; Strand, MR				Harvey, JA; Corley, LS; Strand, MR			Competition induces adaptive shifts in caste ratios of a polyembryonic wasp	NATURE			English	Article							COPIDOSOMA-FLORIDANUM HYMENOPTERA; PSEUDOPLUSIA-INCLUDENS; MICROPLITIS-DEMOLITOR; HARVESTER ANTS; FORMICIDAE; ENCYRTIDAE; ALLOCATION; EVOLUTION; DYNAMICS; COLONIES	An important transition in insect life-history evolution was the shift from a solitary existence to living in groups comprising specialized castes. Caste-forming species produce some individuals that reproduce and others with worker functions that have few or no offspring(1). Morphologically specialized castes are well known in eusocial species like ants and termites(1), but castes have also evolved in less-studied groups like thrips, aphids and polyembryonic wasps(2-5). Because selection acts at both the individual and the colony level, ratios of investment in different castes are predicted to vary with environmental factors like competition and resources(6-8). However, experimental evidence for adaptive shifts in caste ratios is limited(9) owing to the experimental difficulty of manipulating factors thought to influence caste ratios(10-13), and because some species produce behaviourally flexible castes that switch tasks in response to colony needs(14,15). Unlike other caste-forming species, the broods of polyembryonic wasps develop clonally, so that increased production of one caste probably results in decreased production of the other(16). Here we show that the polyembryonic wasp Copidosoma floridanum alters caste ratios in response to interspecific competition. Our results reveal a distinct trade-off by C. floridanum between reproduction and defence, and show experimentally that caste ratios shift in an adaptive manner.	Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Strand, MR (corresponding author), Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA.	mrstrand@facstaff.wisc.edu	Harvey, Jeffrey A/B-7439-2008	Harvey, Jeffrey A/0000-0002-4227-7935; Lavine, Laura/0000-0002-0262-359X				BAEHRECKE EH, 1993, DEV BIOL, V158, P275, DOI 10.1006/dbio.1993.1188; BESHERS SN, 1994, ECOLOGY, V75, P763, DOI 10.2307/1941733; BROWNING HW, 1984, ENVIRON ENTOMOL, V13, P551, DOI 10.1093/ee/13.2.551; CRESPI BJ, 1992, NATURE, V359, P724, DOI 10.1038/359724a0; CRUZ YP, 1981, NATURE, V294, P446, DOI 10.1038/294446a0; Godfray HCJ, 1994, PARASITOIDS BEHAV EV, DOI [10.1515/9780691207025, DOI 10.1515/9780691207025]; GORDON DM, 1989, ANIM BEHAV, V38, P194, DOI 10.1016/S0003-3472(89)80082-X; GORDON DM, 1987, ANIM BEHAV, V35, P833, DOI 10.1016/S0003-3472(87)80119-7; Grbic M, 1997, J INSECT PHYSIOL, V43, P553, DOI 10.1016/S0022-1910(97)00004-8; GRBIC M, 1992, NATURE, V360, P254, DOI 10.1038/360254a0; Grbic M, 1998, DEV GENES EVOL, V208, P69, DOI 10.1007/s004270050156; HASEGAWA E, 1993, BEHAV ECOL SOCIOBIOL, V33, P73; Hasegawa E, 1997, AM NAT, V149, P706, DOI 10.1086/286016; HERBERS JM, 1980, EVOLUTION, V34, P575, DOI 10.1111/j.1558-5646.1980.tb04845.x; JOHNSTON AB, 1985, ANN ENTOMOL SOC AM, V78, P8, DOI 10.1093/aesa/78.1.8; ODE PJ, 1995, J ANIM ECOL, V64, P213, DOI 10.2307/5756; Oster G.F., 1978, Monographs in Population Biology, pi; Passera L, 1996, NATURE, V379, P630, DOI 10.1038/379630a0; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Stern DL, 1996, BIOL REV, V71, P27, DOI 10.1111/j.1469-185X.1996.tb00741.x; STRAND MR, 1995, ANNU REV ENTOMOL, V40, P31, DOI 10.1146/annurev.en.40.010195.000335; Strand MR, 1997, J VIROL, V71, P2146, DOI 10.1128/JVI.71.3.2146-2156.1997; STRAND MR, 1990, ENTOMOL EXP APPL, V55, P275, DOI 10.1111/j.1570-7458.1990.tb01372.x; Strand MR, 1997, CURR TOP DEV BIOL, V35, P121, DOI 10.1016/S0070-2153(08)60258-6; STRAND MR, 1989, J INSECT BEHAV, V2, P355, DOI 10.1007/BF01068061; Webb BA, 1998, VIRUSES, P105; WHEELER DE, 1991, AM NAT, V138, P1218, DOI 10.1086/285279; WILSON EO, 1984, BEHAV ECOL SOCIOBIOL, V16, P89, DOI 10.1007/BF00293108	28	81	84	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2000	406	6792					183	186		10.1038/35018074	http://dx.doi.org/10.1038/35018074			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910357				2022-12-24	WOS:000088221100047
J	Katona, C; Livingston, G				Katona, C; Livingston, G			Impact of screening old people with physical illness for depression?	LANCET			English	Editorial Material							COMMUNITY; ISLINGTON; SCALE; LIFE		UCL Royal Free & Univ Coll Med Sch, Dept Psychiat & Behav Sci, London W1N 8AA, England	University of London; University College London; UCL Medical School	Katona, C (corresponding author), UCL Royal Free & Univ Coll Med Sch, Dept Psychiat & Behav Sci, London W1N 8AA, England.			Katona, Cornelius/0000-0001-7451-0167; Livingston, Gill/0000-0001-6741-5516				ADSHEAD F, 1992, BRIT MED J, V305, P397, DOI 10.1136/bmj.305.6850.397; Beekman ATF, 1999, BRIT J PSYCHIAT, V174, P307, DOI 10.1192/bjp.174.4.307; Hoyl MT, 1999, J AM GERIATR SOC, V47, P873, DOI 10.1111/j.1532-5415.1999.tb03848.x; ILIFFE S, 1991, BRIT J GEN PRACT, V41, P13; KATONA C, 1997, COMORBID DEPRESSION; Katona CLE, 1997, AGING MENT HEALTH, V1, P57, DOI 10.1080/13607869757380; KODER DA, 1996, INT J GERIATR PSYCH, V11, P57; Livingston G, 1997, BRIT J PSYCHIAT, V171, P56, DOI 10.1192/bjp.171.1.56; Livingston G, 1997, J AFFECT DISORDERS, V46, P255, DOI 10.1016/S0165-0327(97)00155-9; Mittmann N, 1997, J AFFECT DISORDERS, V46, P191, DOI 10.1016/S0165-0327(97)00107-9; MULLANE MR, 1994, INVEST NEW DRUG, V12, P267, DOI 10.1007/BF00873971; Schein RL, 1997, INT J GERIATR PSYCH, V12, P436; WELLS KB, 1989, JAMA-J AM MED ASSOC, V262, P914, DOI 10.1001/jama.262.7.914; WILLIAMS EI, 1993, OCCASIONAL PAPER ROY, V59, P1	14	25	26	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 8	2000	356	9224					91	92		10.1016/S0140-6736(00)02466-1	http://dx.doi.org/10.1016/S0140-6736(00)02466-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	331UG	10963242				2022-12-24	WOS:000088036600006
J	Bayliss, R; Littlewood, T; Stewart, M				Bayliss, R; Littlewood, T; Stewart, M			Structural basis for the interaction between FxFG nucleoporin repeats and importin-beta in nuclear trafficking	CELL			English	Article							TRANSPORT FACTOR-2 NTF2; PORE COMPLEX PROTEINS; BINDING-SITES; GDP-RAN; DOMAIN; PATHWAYS; EXPORT; IDENTIFICATION; NUP153; P62	We describe the crystal structure of a complex between importin-beta residues 1-442 (Ib442) and five FxFG nucleoporin repeats from Nsp1p. Nucleoporin FxFG cores bind on the convex face of Ib442 to a primary site between the A helices of HEAT repeats 5 and 6, and to a secondary site between HEAT repeats 6 and 7. Mutations at importin-beta IIe178 in the primary FxFG binding site reduce both binding and nuclear protein import, providing direct evidence for the functional significance of the importin-beta-FxFG interaction. The FxFG binding sites on importin-beta do not overlap with the RanGTP binding site. Instead, RanGTP may release importin-beta from FxFG nucleoporins by generating a conformational change that alters the structure of the FxFG binding site.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Stewart, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	ms@mrc-lmb.cam.ac.uk		Bayliss, Richard/0000-0003-0604-2773				Adam SA, 1999, CURR OPIN CELL BIOL, V11, P402, DOI 10.1016/S0955-0674(99)80056-8; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bayliss R, 1999, J MOL BIOL, V293, P579, DOI 10.1006/jmbi.1999.3166; Bonifaci N, 1997, P NATL ACAD SCI USA, V94, P5055, DOI 10.1073/pnas.94.10.5055; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUSS F, 1995, J CELL BIOL, V128, P251, DOI 10.1083/jcb.128.3.251; Chi NC, 1997, MOL BIOL CELL, V8, P945, DOI 10.1091/mbc.8.6.945; Chook YM, 1999, NATURE, V399, P230, DOI 10.1038/20375; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Clarkson WD, 1997, J MOL BIOL, V272, P716, DOI 10.1006/jmbi.1997.1255; Clarkson WD, 1996, J MOL BIOL, V263, P517, DOI 10.1006/jmbi.1996.0594; Damelin M, 2000, MOL CELL, V5, P133, DOI 10.1016/S1097-2765(00)80409-8; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; FELDHERR CM, 1984, J CELL BIOL, V99, P2216, DOI 10.1083/jcb.99.6.2216; FINLAY DR, 1990, CELL, V60, P17, DOI 10.1016/0092-8674(90)90712-N; Gorlich D, 1998, EMBO J, V17, P2721, DOI 10.1093/emboj/17.10.2721; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; GROTE M, 1995, J CELL SCI, V108, P2963; Hu TH, 1996, J CELL BIOL, V134, P589, DOI 10.1083/jcb.134.3.589; Iovine MK, 1995, J CELL BIOL, V131, P1699, DOI 10.1083/jcb.131.6.1699; Iovine MK, 1997, J CELL BIOL, V137, P797, DOI 10.1083/jcb.137.4.797; Kehlenbach RH, 1999, J CELL BIOL, V145, P645, DOI 10.1083/jcb.145.4.645; Kose S, 1999, J BIOL CHEM, V274, P3946, DOI 10.1074/jbc.274.7.3946; Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Melchior F, 1998, TRENDS CELL BIOL, V8, P175, DOI 10.1016/S0962-8924(98)01252-5; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; Nakielny S, 1999, EMBO J, V18, P1982, DOI 10.1093/emboj/18.7.1982; NEHRBASS U, 1990, CELL, V61, P979, DOI 10.1016/0092-8674(90)90063-K; PASCHAL BM, 1995, J CELL BIOL, V129, P925, DOI 10.1083/jcb.129.4.925; Pemberton LF, 1998, CURR OPIN CELL BIOL, V10, P392, DOI 10.1016/S0955-0674(98)80016-1; Percipalle P, 1997, J MOL BIOL, V266, P722, DOI 10.1006/jmbi.1996.0801; Powers MA, 1997, J CELL BIOL, V136, P241, DOI 10.1083/jcb.136.2.241; RADU A, 1995, CELL, V81, P215, DOI 10.1016/0092-8674(95)90331-3; RADU A, 1995, P NATL ACAD SCI USA, V92, P1769, DOI 10.1073/pnas.92.5.1769; REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7; Rout Michael P., 1994, Trends in Cell Biology, V4, P357, DOI 10.1016/0962-8924(94)90085-X; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Seedorf M, 1999, MOL CELL BIOL, V19, P1547; Shah S, 1998, J CELL BIOL, V141, P31, DOI 10.1083/jcb.141.1.31; Shah S, 1998, CURR BIOL, V8, P1376, DOI 10.1016/S0960-9822(98)00018-9; Stewart M, 1999, NAT STRUCT BIOL, V6, P301, DOI 10.1038/7529; Stoffler D, 1999, CURR OPIN CELL BIOL, V11, P391, DOI 10.1016/S0955-0674(99)80055-6; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Talcott B, 1999, TRENDS CELL BIOL, V9, P312, DOI 10.1016/S0962-8924(99)01608-6; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Yaseen NR, 1999, J BIOL CHEM, V274, P26493, DOI 10.1074/jbc.274.37.26493; Yokoya F, 1999, MOL BIOL CELL, V10, P1119, DOI 10.1091/mbc.10.4.1119	53	375	385	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 7	2000	102	1					99	108		10.1016/S0092-8674(00)00014-3	http://dx.doi.org/10.1016/S0092-8674(00)00014-3			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	332UL	10929717	Bronze			2022-12-24	WOS:000088091700012
J	Du, CY; Fang, M; Li, YC; Li, L; Wang, XD				Du, CY; Fang, M; Li, YC; Li, L; Wang, XD			Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition	CELL			English	Article							PROGRAMMED CELL-DEATH; APOPTOSIS PROTEINS; DROSOPHILA; BCL-2; GENE; RELEASE; COMPLEX; FAMILY; GRIM; PROCASPASE-9	We report here the identification of a novel protein, Smac, which promotes caspase activation in the cytochrome c/Apaf-1/caspase-9 pathway. Smac promotes caspase-9 activation by binding to inhibitor of apoptosis proteins, IAPs, and removing their inhibitory activity. Smac is normally a mitochondrial protein but is released into the cytosol when cells undergo apoptosis. Mitochondrial import and cleavage of its signal peptide are required for Smac to gain its apoptotic activity. Overexpression of Smac increases cells' sensitivity to apoptotic stimuli. Smac is the second mitochondrial protein, along with cytochrome c, that promotes apoptosis by activating caspases.	Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75235 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Wang, XD (corresponding author), Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75235 USA.			Wang, Xiaodong/0000-0001-9885-356X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057158] Funding Source: NIH RePORTER; NIGMS NIH HHS [GMRO1-57158] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; CROOK NE, 1993, J VIROL, V67, P2168, DOI 10.1128/JVI.67.4.2168-2174.1993; Deshmukh M, 1998, NEURON, V21, P695, DOI 10.1016/S0896-6273(00)80587-5; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Haining WN, 1999, P NATL ACAD SCI USA, V96, P4936, DOI 10.1073/pnas.96.9.4936; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Li F, 1997, J BIOL CHEM, V272, P30299, DOI 10.1074/jbc.272.48.30299; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; MacFarlane M, 1997, J CELL BIOL, V137, P469, DOI 10.1083/jcb.137.2.469; McCarthy JV, 1998, J BIOL CHEM, V273, P24009, DOI 10.1074/jbc.273.37.24009; Purring C, 1999, J AM CHEM SOC, V121, P7435, DOI 10.1021/ja991235h; Reed JC, 1997, CELL, V91, P559, DOI 10.1016/S0092-8674(00)80442-0; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; UREN AG, 1996, P NATL ACAD SCI USA, V93, P4947; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vucic D, 1998, MOL CELL BIOL, V18, P3300, DOI 10.1128/MCB.18.6.3300; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; YUAN JY, 1992, DEVELOPMENT, V116, P309; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	33	2678	2897	16	166	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 7	2000	102	1					33	42		10.1016/S0092-8674(00)00008-8	http://dx.doi.org/10.1016/S0092-8674(00)00008-8			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	332UL	10929711	Bronze			2022-12-24	WOS:000088091700006
J	Money, NP				Money, NP			Genetics - Fungal get-together	NATURE			English	Editorial Material									Miami Univ, Dept Bot, Oxford, OH 45056 USA	Miami University	Money, NP (corresponding author), Miami Univ, Dept Bot, Oxford, OH 45056 USA.							Peabody RB, 2000, FUNGAL GENET BIOL, V29, P72, DOI 10.1006/fgbi.2000.1187; SMITH ML, 1992, NATURE, V356, P428, DOI 10.1038/356428a0	2	4	4	0	1	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 15	2000	405	6788					751	751		10.1038/35015659	http://dx.doi.org/10.1038/35015659			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	324KJ	10896567	Bronze			2022-12-24	WOS:000087620600032
J	MacBeath, G; Schreiber, SL				MacBeath, G; Schreiber, SL			Printing proteins as microarrays for high-throughput function determination	SCIENCE			English	Article							RECEPTOR; CLONING; KINASE; ACTIVATION; DOMAIN; GENES	Systematic efforts are currently under way to construct defined sets of cloned genes for high-throughput expression and purification of recombinant proteins. To facilitate subsequent studies of protein function, we have developed miniaturized assays that accommodate extremely Low sample volumes and enable the rapid, simultaneous processing of thousands of proteins. A high-precision robot designed to manufacture complementary DNA microarrays was used to spot proteins onto chemically derivatized glass slides at extremely high spatial densities. The proteins attached covalently to the slide surface yet retained their ability to interact specifically with other proteins, or with small molecules, in solution. Three applications for protein microarrays were demonstrated: screening for protein-protein interactions, identifying the substrates of protein kinases, and identifying the protein targets of small molecules.	Harvard Univ, Ctr Genome Res, Cambridge, MA 02138 USA; Harvard Univ, Dept Chem & Biol Chem, Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; Harvard University; Howard Hughes Medical Institute	MacBeath, G (corresponding author), Harvard Univ, Ctr Genome Res, 16 Divin Ave, Cambridge, MA 02138 USA.							Arenkov P, 2000, ANAL BIOCHEM, V278, P123, DOI 10.1006/abio.1999.4363; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BJORCK L, 1984, J IMMUNOL, V133, P969; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHAIET L, 1964, ARCH BIOCHEM BIOPHYS, V106, P1, DOI 10.1016/0003-9861(64)90150-X; DEPAOLIROACH AA, 1984, J BIOL CHEM, V259, P2144; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; HOLT DA, 1993, J AM CHEM SOC, V115, P9925, DOI 10.1021/ja00075a008; KEMP BE, 1977, J BIOL CHEM, V252, P4888; Licitra EJ, 1996, P NATL ACAD SCI USA, V93, P12817, DOI 10.1073/pnas.93.23.12817; MacBeath G, 1999, J AM CHEM SOC, V121, P7967, DOI 10.1021/ja991083q; Madin K, 2000, P NATL ACAD SCI USA, V97, P559, DOI 10.1073/pnas.97.2.559; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; Sche PP, 1999, CHEM BIOL, V6, P707, DOI 10.1016/S1074-5521(00)80018-6; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Sparks AB, 1996, NAT BIOTECHNOL, V14, P741, DOI 10.1038/nbt0696-741; Tanaka H, 1999, MOL PHARMACOL, V55, P356, DOI 10.1124/mol.55.2.356; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; YOUNG RA, 1983, SCIENCE, V222, P778, DOI 10.1126/science.6356359	21	2293	2745	12	467	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 8	2000	289	5485					1760	1763						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352BT	10976071				2022-12-24	WOS:000089195200049
J	Nowak, MA; Page, KM; Sigmund, K				Nowak, MA; Page, KM; Sigmund, K			Fairness versus reason in the Ultimatum Game	SCIENCE			English	Article							EVOLUTION; COOPERATION; RECIPROCITY; BEHAVIOR	In the Ultimatum Came, two players are offered a chance to win a certain sum of money. ALL they must do is divide it. The proposer suggests how to split the sum. The responder can accept or reject the deal. If the deal is rejected, neither player gets anything. The rational solution, suggested by game theory, is for the proposer to offer the smallest possible share and for the responder to accept it. If humans play the game, however, the most frequent outcome is a fair share. In this paper, we develop an evolutionary approach to the Ultimatum Came. We show that fairness will evolve if the proposer can obtain some information on what deals the responder has accepted in the past. Hence, the evolution of fairness, similarly to the evolution of cooperation, is Linked to reputation.	Inst Adv Study, Einstein Dr, Princeton, NJ 08540 USA; Univ Vienna, Inst Math, A-1090 Vienna, Austria; Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria	Institute for Advanced Study - USA; University of Vienna; International Institute for Applied Systems Analysis (IIASA)	Nowak, MA (corresponding author), Inst Adv Study, Einstein Dr, Princeton, NJ 08540 USA.	nowak@ias.edu	Nowak, Martin A/A-6977-2008					BANERJEE A, 1995, LEARNING RATIONALITY; Bethwaite J, 1996, J ECON PSYCHOL, V17, P259, DOI 10.1016/0167-4870(96)00006-2; BINMORE K, 1985, AM ECON REV, V75, P1178; Binmore K., 1992, FUN GAMES TEXT GAME; Bolton GE, 2000, AM ECON REV, V90, P166, DOI 10.1257/aer.90.1.166; BOLTON GE, 1995, GAME ECON BEHAV, V10, P95, DOI 10.1006/game.1995.1026; Ellingsen T, 1997, Q J ECON, V112, P581, DOI 10.1162/003355397555299; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; FEHR E, 1999, HOMO RECIPROCANS HUM; Frank R. H., 1988, PASSIONS REASON; GALE J, 1995, GAME ECON BEHAV, V8, P56, DOI 10.1016/S0899-8256(05)80017-X; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; GUTH W, 1990, J ECON PSYCHOL, V11, P417, DOI 10.1016/0167-4870(90)90021-Z; Hofbauer J, 1998, VIEN CIR INST YEARBK, V5, P245; Hofbauer J., 1998, EVOLUTIONARY GAMES P; Huck S, 1999, GAME ECON BEHAV, V28, P13, DOI 10.1006/game.1998.0691; KAHNEMAN D, 1986, J BUS, V59, pS285, DOI 10.1086/296367; KANDORI M, 1993, ECONOMETRICA, V61, P29, DOI 10.2307/2951777; KIRCHSTEIGER G, 1994, J ECON BEHAV ORGAN, V25, P373, DOI 10.1016/0167-2681(94)90106-6; Lotem A, 1999, NATURE, V400, P226, DOI 10.1038/22247; Maynard Smith J., 1982, pi; Nowak MA, 1998, J THEOR BIOL, V194, P561, DOI 10.1006/jtbi.1998.0775; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Roth A.E., 1995, HDB EXPT EC; ROTH AE, 1991, AM ECON REV, V81, P1068; RUBINSTEIN A, 1982, ECONOMETRICA, V50, P97, DOI 10.2307/1912531; Schelling T. C., 1960, STRATEGY CONFLICT; THALER RH, 1988, J ECON PERSPECT, V2, P195, DOI 10.1257/jep.2.4.195; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850; YOUNG HP, 1993, J ECON THEORY, V59, P145, DOI 10.1006/jeth.1993.1009; YOUNG HP, 1993, ECONOMETRICA, V61, P57, DOI 10.2307/2951778; Zahavi A, 1996, HANDICAP PRINCIPLE	32	480	489	7	129	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2000	289	5485					1773	1775		10.1126/science.289.5485.1773	http://dx.doi.org/10.1126/science.289.5485.1773			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	352BT	10976075	Green Submitted			2022-12-24	WOS:000089195200053
J	Xiong, J; Fischer, WM; Inoue, K; Nakahara, M; Bauer, CE				Xiong, J; Fischer, WM; Inoue, K; Nakahara, M; Bauer, CE			Molecular evidence for the early evolution of photosynthesis	SCIENCE			English	Article							REACTION CENTERS; MG-CHELATASE; CHL-D; PROTEINS; SUBUNIT; PROKARYOTES; TOBACCO; ORIGIN; TREE; RNA	The origin and evolution of photosynthesis have Long remained enigmatic due to a Lack of sequence information of photosynthesis genes across the entire photosynthetic domain. To probe early evolutionary history of photosynthesis, we obtained new sequence information of a number of photosynthesis genes from the green sulfur bacterium Chlorobium tepidum and the green nonsulfur bacterium Chloroflexus aurantiacus. A total of 31 open reading frames that encode enzymes involved in bacteriochlorophyll/porphyrin biosynthesis, carotenoid biosynthesis, and photosynthetic electron transfer were identified in about 100 kilobase pairs of genomic sequence. Phylogenetic analyses of multiple magnesium-tetrapyrrole biosynthesis genes using a combination of distance, maximum parsimony, and maximum likelihood methods indicate that heliobacteria are closest to the Last common ancestor of all oxygenic photosynthetic Lineages and that green sulfur bacteria and green nonsulfur bacteria are each other's closest relatives. Parsimony and distance analyses further identify purple bacteria as the earliest emerging photosynthetic Lineage. These results challenge previous conclusions based on 16S ribosomal RNA and Hsp60/Hsp70 analyses that green nonsulfur bacteria or heliobacteria are the earliest phototrophs. The overall consensus of our phylogenetic analysis, that bacteriochlorophyll biosynthesis evolved before chlorophyll biosynthesis, also argues against the long-held Granick hypothesis.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; Kanagawa Univ, Dept Biol Sci, Kanagawa 2591293, Japan	Indiana University System; Indiana University Bloomington; Kanagawa University	Bauer, CE (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	cbauer@bio.indiana.edu	Fischer, Will/AAD-2807-2019	Fischer, Will/0000-0003-4579-4062	NIGMS NIH HHS [R01 GM040941, R01 GM053940, GM53940] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053940] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alberti M, 1995, ANOXYGENIC PHOTOSYNT, P1083; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BEER-ROMERO P, 1988, FEMS Microbiology Letters, V49, P451, DOI 10.1016/0378-1097(88)90341-2; BLANKENSHIP RE, 1994, ANTON LEEUW INT J G, V65, P311, DOI 10.1007/BF00872216; BLANKENSHIP RE, 1992, PHOTOSYNTH RES, V33, P91, DOI 10.1007/BF00039173; BURKE DH, 1993, P NATL ACAD SCI USA, V90, P7134, DOI 10.1073/pnas.90.15.7134; Chaw SM, 2000, P NATL ACAD SCI USA, V97, P4086, DOI 10.1073/pnas.97.8.4086; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Felsenstein J, 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fujita Y, 2000, J BIOL CHEM, V275, P23583, DOI 10.1074/jbc.M002904200; Goodwin PJ, 1998, BIOCHEMISTRY-US, V37, P10420, DOI 10.1021/bi980435n; Grafe S, 1999, P NATL ACAD SCI USA, V96, P1941, DOI 10.1073/pnas.96.5.1941; GRAY MW, 1992, INT REV CYTOL, V141, P233, DOI 10.1016/S0074-7696(08)62068-9; GRNAICK S, 1965, EVOLVING GENES PROTE, P67; Gupta RS, 1999, MOL MICROBIOL, V32, P893, DOI 10.1046/j.1365-2958.1999.01417.x; Moreira D, 2000, NATURE, V405, P69, DOI 10.1038/35011054; NEEFS JM, 1993, NUCLEIC ACIDS RES, V21, P3025, DOI 10.1093/nar/21.13.3025; NITSCHKE W, 1997, PHOTOSYNTHESIS COMPR, P285; OCHMAN H, 1988, GENETICS, V120, P621; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; OLSEN GJ, 1994, J BACTERIOL, V176, P1, DOI 10.1128/JB.176.1.1-6.1994; OLSON JM, 1987, INT REV CYTOL, V108, P209, DOI 10.1016/S0074-7696(08)61439-4; Papenbrock J, 1997, PLANT J, V12, P981, DOI 10.1046/j.1365-313X.1997.12050981.x; POSPIECH A, 1995, TRENDS GENET, V11, P217, DOI 10.1016/S0168-9525(00)89052-6; Qiu YL, 1999, NATURE, V402, P404, DOI 10.1038/46536; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schubert WD, 1998, J MOL BIOL, V280, P297, DOI 10.1006/jmbi.1998.1824; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; TRUMPOWER BL, 1990, MICROBIOL REV, V54, P101, DOI 10.1128/MMBR.54.2.101-129.1990; Van de Peer Y, 1997, J MOL EVOL, V45, P619, DOI 10.1007/PL00006266; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Xiong J, 1998, P NATL ACAD SCI USA, V95, P14851, DOI 10.1073/pnas.95.25.14851; XIONG J, UNPUB; YOUNG DA, 1989, MOL GEN GENET, V218, P1, DOI 10.1007/BF00330558	35	351	401	5	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2000	289	5485					1724	1730		10.1126/science.289.5485.1724	http://dx.doi.org/10.1126/science.289.5485.1724			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352BT	10976061				2022-12-24	WOS:000089195200039
J	Merz, AJ; So, M; Sheetz, MP				Merz, AJ; So, M; Sheetz, MP			Pilus retraction powers bacterial twitching motility	NATURE			English	Article							NEISSERIA-GONORRHOEAE; EPITHELIAL-CELLS; IV PILI; ESCHERICHIA-COLI; PROTEIN; GENE; TRANSFORMATION; RESOLUTION; BIOGENESIS; VIRULENCE	Twitching and social gliding motility allow many Gram negative bacteria to crawl along surfaces, and are implicated in a wide range of biological functions(1). Type IV pili (Tfp) are required for twitching and social gliding, but the mechanism by which these filaments promote motility has remained enigmatic(1-4). Here we use laser tweezers(5) to show that Tfp forcefully retract. Neisseria gonorrhoeae cells that produce Tfp actively crawl on a glass surface and form adherent microcolonies. When laser tweezers are used to place and hold cells near a microcolony, retractile forces pull the cells toward the microcolony. In quantitative experiments, the Tfp of immobilized bacteria bind to latex beads and retract, pulling beads from the tweezers at forces that can exceed 80 pN. Episodes of retraction terminate with release or breakage of the Tfp tether. Both motility and retraction mediated by Tfp occur at about 1 mu m s(-1) and require protein synthesis and function of the PilT protein. Our experiments establish that Tfp filaments retract, generate substantial force and directly mediate cell movement.	Oregon Hlth Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA; Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27705 USA	Oregon Health & Science University; Duke University	Sheetz, MP (corresponding author), Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA.		So, Magdalene/ABB-8918-2020	So, Magdalene/0000-0001-8301-0674				Bieber D, 1998, SCIENCE, V280, P2114, DOI 10.1126/science.280.5372.2114; BRADLEY DE, 1972, BIOCHEM BIOPH RES CO, V47, P142, DOI 10.1016/S0006-291X(72)80021-4; BRADLEY DE, 1980, CAN J MICROBIOL, V26, P146, DOI 10.1139/m80-022; BROSSAY L, 1994, INFECT IMMUN, V62, P2302, DOI 10.1128/IAI.62.6.2302-2308.1994; Comolli JC, 1999, INFECT IMMUN, V67, P3625, DOI 10.1128/IAI.67.7.3625-3630.1999; Coppin CM, 1996, P NATL ACAD SCI USA, V93, P1913, DOI 10.1073/pnas.93.5.1913; Dubnau D, 1999, ANNU REV MICROBIOL, V53, P217, DOI 10.1146/annurev.micro.53.1.217; DUPUY B, 1991, J BACTERIOL, V173, P7589, DOI 10.1128/jb.173.23.7589-7598.1991; EVANS E, 1991, BIOPHYS J, V59, P838, DOI 10.1016/S0006-3495(91)82296-2; Felsenfeld DP, 1999, NAT CELL BIOL, V1, P200, DOI 10.1038/12021; Forest KT, 1997, GENE, V192, P165, DOI 10.1016/S0378-1119(97)00008-5; GINOCCHIO CC, 1994, CELL, V76, P717, DOI 10.1016/0092-8674(94)90510-X; HENRICHSEN J, 1983, ANNU REV MICROBIOL, V37, P81, DOI 10.1146/annurev.mi.37.100183.000501; Karaolis DKR, 1999, NATURE, V399, P375, DOI 10.1038/20715; Krause S, 2000, P NATL ACAD SCI USA, V97, P3067, DOI 10.1073/pnas.050578697; Mahadevan L, 2000, SCIENCE, V288, P95, DOI 10.1126/science.288.5463.95; Merz AJ, 1999, MOL MICROBIOL, V32, P1316, DOI 10.1046/j.1365-2958.1999.01459.x; NOVOTNY CP, 1974, J BACTERIOL, V117, P1306, DOI 10.1128/JB.117.3.1306-1311.1974; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; PARGE HE, 1995, NATURE, V378, P32, DOI 10.1038/378032a0; Pujol C, 1999, P NATL ACAD SCI USA, V96, P4017, DOI 10.1073/pnas.96.7.4017; SEIFERT HS, 1988, NATURE, V336, P392, DOI 10.1038/336392a0; Shao JY, 1998, P NATL ACAD SCI USA, V95, P6797, DOI 10.1073/pnas.95.12.6797; SHEETZ MP, 1997, LASER TWEEZERS CELL; SWANSON J, 1978, INFECT IMMUN, V19, P320, DOI 10.1128/IAI.19.1.320-331.1978; Wall D, 1999, MOL MICROBIOL, V32, P1, DOI 10.1046/j.1365-2958.1999.01339.x; WHITCHURCH CB, 1991, GENE, V101, P33, DOI 10.1016/0378-1119(91)90221-V; Wolfgang M, 1998, P NATL ACAD SCI USA, V95, P14973, DOI 10.1073/pnas.95.25.14973; Wolfgang M, 1998, MOL MICROBIOL, V29, P321, DOI 10.1046/j.1365-2958.1998.00935.x; Yoshida T, 1999, J BACTERIOL, V181, P2038, DOI 10.1128/JB.181.7.2038-2043.1999	30	595	606	1	72	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 7	2000	407	6800					98	102		10.1038/35024105	http://dx.doi.org/10.1038/35024105			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	350WE	10993081				2022-12-24	WOS:000089124000050
J	May, MJ; D'Acquisto, F; Madge, LA; Glockner, J; Pober, JS; Ghosh, S				May, MJ; D'Acquisto, F; Madge, LA; Glockner, J; Pober, JS; Ghosh, S			Selective inhibition of NF-kappa B activation by a peptide that blocks the interaction of NEMO with the I kappa B kinase complex	SCIENCE			English	Article							IKK-BETA SUBUNIT; GAMMA; MICE; IDENTIFICATION; APOPTOSIS; COMPONENT; PROTEINS; SKIN	Activation of the transcription factor nuclear factor (NF)-kappa B by proinflammatory stimuli Leads to increased expression of genes involved in inflammation. Activation of NF-kappa B requires the activity of an inhibitor of kappa B (I kappa B)-kinase (IKK) complex containing two kinases (IKK alpha and IKK beta) and the regulatory protein NEMO (NF-kappa B essential modifier). An amino-terminal alpha-helical region of NEMO associated with a carboxyl-terminal segment of IKK alpha and IKK beta that we term the NEMO-binding domain (NBD), A cell-permeable NBD peptide blocked association of NEMO with the IKK complex and inhibited cytokine-induced NF-kappa B activation and NF-kappa B-dependent gene expression. The peptide also ameliorated inflammatory responses in two experimental mouse models of acute inflammation. The NBD provides a target for the development of drugs that would block proinflammatory activation of the IKK complex without inhibiting basal NF-kappa B activity.	Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06510 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Intdepartmental Program Vasc Biol & Transplantat, New Haven, CT 06536 USA	Howard Hughes Medical Institute; Yale University; Howard Hughes Medical Institute; Yale University; Yale University	Ghosh, S (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06510 USA.	sankar.ghosh@yale.edu	D'Acquisto, Fulvio/E-7204-2018	D'Acquisto, Fulvio/0000-0002-4513-1608; May, Michael/0000-0002-2485-3716	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033443, R01AI033443] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 33443] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ajuebor MN, 1998, IMMUNOLOGY, V95, P625; BEVILACQUA MP, 1987, P NATL ACAD SCI USA, V84, P9238, DOI 10.1073/pnas.84.24.9238; CHANG J, 1987, EUR J PHARMACOL, V142, P197, DOI 10.1016/0014-2999(87)90108-7; Chu ZL, 1999, J BIOL CHEM, V274, P15297, DOI 10.1074/jbc.274.22.15297; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; GETTING SJ, BR J PHARM, V120, P1075; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hall H, 1996, CURR BIOL, V6, P580, DOI 10.1016/S0960-9822(02)00544-4; Harhaj EW, 1999, J BIOL CHEM, V274, P22911, DOI 10.1074/jbc.274.33.22911; Hildt E, 1999, J EXP MED, V189, P1707, DOI 10.1084/jem.189.11.1707; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Jin DY, 1999, J BIOL CHEM, V274, P17402, DOI 10.1074/jbc.274.25.17402; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Madge LA, 1999, J BIOL CHEM, V274, P13643, DOI 10.1074/jbc.274.19.13643; May M. M., UNPUB; May MJ, 1997, SEMIN CANCER BIOL, V8, P63, DOI 10.1006/scbi.1997.0057; Mercurio F, 1999, MOL CELL BIOL, V19, P1526; POBER JS, 1986, J IMMUNOL, V136, P1680; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Rudolph D, 2000, GENE DEV, V14, P854; Shimada T, 1999, INT IMMUNOL, V11, P1357, DOI 10.1093/intimm/11.8.1357; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Ye JJ, 2000, J BIOL CHEM, V275, P9882, DOI 10.1074/jbc.275.13.9882; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6	32	588	644	2	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2000	289	5484					1550	1554		10.1126/science.289.5484.1550	http://dx.doi.org/10.1126/science.289.5484.1550			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349XW	10968790				2022-12-24	WOS:000089071700046
J	Taipale, J; Chen, JK; Cooper, MK; Wang, BL; Mann, RK; Milenkovic, L; Scott, MP; Beachy, PA				Taipale, J; Chen, JK; Cooper, MK; Wang, BL; Mann, RK; Milenkovic, L; Scott, MP; Beachy, PA			Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine	NATURE			English	Article							BASAL-CELL CARCINOMAS; SONIC HEDGEHOG; HUMAN HOMOLOG; CUBITUS-INTERRUPTUS; PROTEIN; MICE; GENE; MEDULLOBLASTOMAS; REPRESSOR	Basal cell carcinoma, medulloblastoma, rhabdomyosarcoma and other human tumours are associated with mutations that activate the proto-oncogene Smoothened (SMO) or that inactivate the tumour suppressor Patched (PTCH). Smoothened and Patched mediate the cellular response to the Hedgehog (Hh) secreted protein signal, and oncogenic mutations affecting these proteins cause excess activity of the Hh response pathway(1,2). Here we show that the plant-derived teratogen cyclopamine, which inhibits the Hh response(3,4), is a potential 'mechanism-based' therapeutic agent for treatment of these tumours. We show that cyclopamine or synthetic derivatives with improved potency block activation of the Hh response pathway and abnormal cell growth associated with both types of oncogenic mutation. Our results also indicate that cyclopamine may act by influencing the balance between active and inactive forms of Smoothened.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurol, Baltimore, MD 21205 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University	Beachy, PA (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.		Chen, James/G-9972-2011	Chen, James/0000-0002-9220-8436	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; Beachy PA, 1997, COLD SPRING HARB SYM, V62, P191; BOND RA, 1995, NATURE, V374, P272, DOI 10.1038/374272a0; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; Chen CH, 1999, CELL, V98, P305, DOI 10.1016/S0092-8674(00)81960-1; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Fuse N, 1999, P NATL ACAD SCI USA, V96, P10992, DOI 10.1073/pnas.96.20.10992; Gailani MR, 1996, NAT GENET, V14, P78, DOI 10.1038/ng0996-78; Gibbs JB, 2000, SCIENCE, V287, P1969, DOI 10.1126/science.287.5460.1969; Goodrich LV, 1998, NEURON, V21, P1243, DOI 10.1016/S0896-6273(00)80645-5; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hahn H, 1999, J MOL MED-JMM, V77, P459, DOI 10.1007/s001099900018; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Ingham PW, 1998, EMBO J, V17, P3505, DOI 10.1093/emboj/17.13.3505; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; KEELER RF, 1968, TERATOLOGY, V1, P5, DOI 10.1002/tera.1420010103; Lange Y, 1999, J LIPID RES, V40, P2264; Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; Pepinsky RB, 1998, J BIOL CHEM, V273, P14037, DOI 10.1074/jbc.273.22.14037; Pietsch T, 1997, CANCER RES, V57, P2085; Raffel C, 1997, CANCER RES, V57, P842; Reifenberger J, 1998, CANCER RES, V58, P1798; Sasaki H, 1997, DEVELOPMENT, V124, P1313; SHIN SI, 1975, P NATL ACAD SCI USA, V72, P4435, DOI 10.1073/pnas.72.11.4435; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201	29	1058	1128	1	79	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 31	2000	406	6799					1005	1009		10.1038/35023008	http://dx.doi.org/10.1038/35023008			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	348ZW	10984056				2022-12-24	WOS:000089020200048
J	Ball, TM; Castro-Rodriguez, JA; Griffith, KA; Holberg, CJ; Martinez, FD; Wright, AL				Ball, TM; Castro-Rodriguez, JA; Griffith, KA; Holberg, CJ; Martinez, FD; Wright, AL			Siblings, day-care attendance, and the risk of asthma and wheezing during childhood	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	39th Annual Meeting of the Ambulatory-Pediatric-Association	MAY 01-04, 1999	SAN FRANCISCO, CA	Ambulatory Pediat Assoc			RESPIRATORY-TRACT ILLNESS; HAY-FEVER; 1ST YEAR; CHILDREN; ALLERGEN; ATOPY; LIFE; SENSITIZATION; RESPONSES; DISEASE	Background: Young children with older siblings and those who attend day care are at increased risk for infections, which in turn may protect against the development of allergic diseases, including asthma. However, the results of studies examining the relation between exposure to other children and the subsequent development of asthma have been conflicting. Methods: In a study involving 1035 children followed since birth as part of the Tucson Children's Respiratory Study, we determined the incidence of asthma (defined as at least one episode of asthma diagnosed by a physician when the child was 6 to 13 years old) and the prevalence of frequent wheezing (more than three wheezing episodes during the preceding year) in relation to the number of siblings at home and in relation to attendance at day care during infancy. Results: The presence of one or more older siblings at home protected against the development of asthma (adjusted relative risk for each additional older sibling, 0.8; 95 percent confidence interval, 0.7 to 1.0; P = 0.04), as did attendance at day care during the first six months of life (adjusted relative risk, 0.4; 95 percent confidence interval, 0.2 to 1.0; P = 0.04). Children with more exposure to other children at home or at day care were more likely to have frequent wheezing at the age of 2 years than children with little or no exposure (adjusted relative risk, 1.4; 95 percent confidence interval, 1.1 to 1.8; P = 0.01) but were less likely to have frequent wheezing from the age of 6 (adjusted relative risk, 0.8; 95 percent confidence interval, 0.6 to 1.0; P = 0.03) through the age of 13 (adjusted relative risk, 0.3; 95 percent confidence interval, 0.2 to 0.5; P<0.001). Conclusions: Exposure of young children to older children at home or to other children at day care protects against the development of asthma and frequent wheezing later in childhood. (N Engl J Med 2000;343:538-43.) (C)2000, Massachusetts Medical Society.	Univ Arizona, Coll Med, Resp Sci Ctr, Tucson, AZ 85724 USA; Univ Arizona, Coll Med, Dept Pediat, Tucson, AZ 85724 USA	University of Arizona; University of Arizona	Wright, AL (corresponding author), Univ Arizona, Coll Med, Resp Sci Ctr, 1501 N Campbell Ave,POB 245073, Tucson, AZ 85724 USA.	awright@resp-sci.arizona.edu	Castro-Rodriguez, Jose A./ABA-2760-2021; Castro-Rodriguez, Jose A./ABA-6591-2021	Castro-Rodriguez, Jose A./0000-0002-0708-4281	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056177, P50HL014136] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 03154, HL 14136, HL 56177] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ADAMS PF, 1995, VITAL HLTH STAT 10, V193; BACKMAN A, 1984, ALLERGY, V39, P309, DOI 10.1111/j.1398-9995.1984.tb00867.x; Halonen M, 1997, AM J RESP CRIT CARE, V155, P1356, DOI 10.1164/ajrccm.155.4.9105079; HOLBERG CJ, 1993, PEDIATRICS, V91, P885; KJELLMAN NIM, 1976, CLIN ALLERGY, V6, P51, DOI 10.1111/j.1365-2222.1976.tb01411.x; Kramer U, 1999, LANCET, V353, P450, DOI 10.1016/S0140-6736(98)06329-6; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; Lombardi E, 1997, AM J RESP CRIT CARE, V156, P1863, DOI 10.1164/ajrccm.156.6.9612066; Mannino D M, 1998, MMWR CDC Surveill Summ, V47, P1; Marbury MC, 1997, AM J RESP CRIT CARE, V155, P156, DOI 10.1164/ajrccm.155.1.9001305; Martinez FD, 1999, J ALLERGY CLIN IMMUN, V103, P355, DOI 10.1016/S0091-6749(99)70456-2; Matricardi PM, 1997, BRIT MED J, V314, P999, DOI 10.1136/bmj.314.7086.999; Nafstad P, 1999, PEDIATRICS, V103, P753, DOI 10.1542/peds.103.4.753; OSTERHOLM MT, 1994, PEDIATRICS, V94, P987; Ponsonby AL, 1998, ARCH DIS CHILD, V79, P328, DOI 10.1136/adc.79.4.328; Prescott SL, 1999, LANCET, V353, P196, DOI 10.1016/S0140-6736(98)05104-6; Rona RJ, 1997, J ALLERGY CLIN IMMUN, V99, P454, DOI 10.1016/S0091-6749(97)70070-8; Shaheen SO, 1996, LANCET, V347, P1792, DOI 10.1016/S0140-6736(96)91617-7; Shirakawa T, 1997, SCIENCE, V275, P77, DOI 10.1126/science.275.5296.77; SILVERMAN M, 1993, THORAX, V48, P1200, DOI 10.1136/thx.48.12.1200; SPORIK R, 1990, NEW ENGL J MED, V323, P502, DOI 10.1056/NEJM199008233230802; Stein RT, 1997, THORAX, V52, P946, DOI 10.1136/thx.52.11.946; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Strachan DP, 1997, J ALLERGY CLIN IMMUN, V99, P6, DOI 10.1016/S0091-6749(97)81038-X; Strachan DP, 1996, ARCH DIS CHILD, V74, P422, DOI 10.1136/adc.74.5.422; TAUSSIG LM, 1989, AM J EPIDEMIOL, V129, P1219, DOI 10.1093/oxfordjournals.aje.a115242; TAUSSIG LM, 1995, AM J RESP CRIT CARE, V151, pS32, DOI 10.1164/ajrccm/151.2_Pt_2.S32; *US BUR CENS, 1998, CURR POP REP P20, V515; *US BUR CENS, 1976, CURR POP REP P20, V291, P4; VONMUTIUS E, 1994, BRIT MED J, V308, P692, DOI 10.1136/bmj.308.6930.692; WEST J, 1995, DHEW PUBL NCES; WISSOW LS, 1988, AM J PUBLIC HEALTH, V78, P777, DOI 10.2105/AJPH.78.7.777; WRIGHT AL, 1989, BRIT MED J, V299, P946, DOI 10.1136/bmj.299.6705.946; WRIGHT AL, 1989, AM J EPIDEMIOL, V129, P1232, DOI 10.1093/oxfordjournals.aje.a115243; YUNGINGER JW, 1992, AM REV RESPIR DIS, V146, P888, DOI 10.1164/ajrccm/146.4.888	35	656	680	0	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 24	2000	343	8					538	543		10.1056/NEJM200008243430803	http://dx.doi.org/10.1056/NEJM200008243430803			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	346QM	10954761				2022-12-24	WOS:000088882600003
J	Rochon, PA; Tu, JV; Anderson, GM; Gurwitz, JH; Clark, JP; Lau, P; Szalai, JP; Sykora, K; Naylor, CD				Rochon, PA; Tu, JV; Anderson, GM; Gurwitz, JH; Clark, JP; Lau, P; Szalai, JP; Sykora, K; Naylor, CD			Rate of heart failure and 1-year survival for older people receiving low-dose beta-blocker therapy after myocardial infarction	LANCET			English	Article							CLINICAL-TRIALS; ELDERLY PATIENTS; DRUG-THERAPY; HIGH-RISK; MORTALITY; MORBIDITY; OUTCOMES; PROJECT	Background Many older people do not receive beta-blocker therapy after myocardial infarction or receive doses lower than those tested in trials, perhaps because physicians fear that beta-blockers may precipitate heart failure. We examined the relation between use of beta-blockers, the dose used, and hospital admission for heart failure and 1-year survival in a cohort of all older patients surviving myocardial infarction in Ontario, Canada. Methods We collected data on a cohort of 13 623 patients aged 66 years or older who were discharged from hospital after a myocardial infarction and who did not receive beta-blocker therapy or received low, standard, or high doses. We used Cox's proportional-hazards models to study the association of dose with admission for heart failure and survival with adjustment for factors including age, sex, and comorbidity. Findings Among 8232 patients with no previous history of heart failure, dispensing of beta-blocker therapy was associated with a 43% reduction in subsequent admission for heart failure (adjusted risk ratio 0.57 [95% CI 0.48-0.69]) compared with patients not dispensed this therapy. Among the 4681 patients prescribed beta-blockers, the risk of admission was greater in the high-dose than in the low-dose group (1.53 [1.01-2.31]). Among all 13 623 patients in the cohort, 2326 (17.1%) died by 1 year. Compared with those not dispensed beta-blocker therapy, the adjusted risk ratio for mortality was lower for all three doses (low 0.40 [0.34-0.47], standard 0.36 [0.31-0.42], high 0.43 [0.33-0.56]), Interpretation Compared with high-dose beta-blocker therapy, low-dose treatment is associated with a lower rate of hospital admission for heart failure and has a similar 1-year survival benefit. Our findings support the need for a randomised controlled trial comparing doses of beta-blocker therapy in elderly patients.	Baycrest Ctr Geriatr Care, Kunin Lunenfeld Appl Res Unit, Toronto, ON M6A 2E1, Canada; Sunnybrooke & Womens Coll Hlth Sci Ctr, Dept Med, Toronto, ON, Canada; Sunnybrooke & Womens Coll Hlth Sci Ctr, Dept Publ Hlth Sci, Toronto, ON, Canada; Sunnybrooke & Womens Coll Hlth Sci Ctr, Dept Hlth Adm, Toronto, ON, Canada; Univ Toronto, Fac Med, Deans Off, Toronto, ON, Canada; Inst Clin Evaluat Sci, Toronto, ON, Canada; Fallon Healthcare Syst, Meyers Primary Care Inst, Worcester, MA USA; Univ Massachusetts, Sch Med, Worcester, MA 01605 USA	University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Massachusetts System; University of Massachusetts Worcester	Rochon, PA (corresponding author), Baycrest Ctr Geriatr Care, Kunin Lunenfeld Appl Res Unit, 3560 Bathurst St, Toronto, ON M6A 2E1, Canada.		Rochon, Paula A/J-2918-2016	Rochon, Paula A/0000-0002-5973-4151; Clark, Jocalyn/0000-0002-8014-3989				Agresti A., 1990, CATEGORICAL DATA ANA, pXV; Barron HV, 1998, ARCH INTERN MED, V158, P449, DOI 10.1001/archinte.158.5.449; BOISSEL JP, 1990, AM J CARDIOL, V66, P251, DOI 10.1016/0002-9149(90)90831-K; *CAN PHARM ASS, 1998, COMP PHARM SPEC; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Commission on Professional and Hospital Activities, 1992, INT CLASS DIS; Cox JL, 1997, CAN J CARDIOL, V13, P351; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; FALLEN EL, 1995, CAN J CARDIOL, V11, P477; FRIEDMAN LM, 1982, JAMA-J AM MED ASSOC, V247, P1707; Gottlieb SS, 1998, NEW ENGL J MED, V339, P489, DOI 10.1056/NEJM199808203390801; GURWITZ JH, 1992, JAMA-J AM MED ASSOC, V268, P1417, DOI 10.1001/jama.1992.03490110055029; Hjalmarson A, 2000, JAMA-J AM MED ASSOC, V283, P1295, DOI 10.1001/jama.283.10.1295; Hjalmarson A, 1999, LANCET, V353, P2001; HJALMARSON A, 1983, CIRCULATION, V67, P26; *JOINT FORM COMM 1, 1997, BRIT NAT FORM; Krumholz HM, 1998, JAMA-J AM MED ASSOC, V280, P623, DOI 10.1001/jama.280.7.623; Lechat P, 1999, LANCET, V353, P9; Lechat P, 1998, CIRCULATION, V98, P1184, DOI 10.1161/01.CIR.98.12.1184; MCCLELLAN M, 1994, JAMA-J AM MED ASSOC, V272, P859, DOI 10.1001/jama.272.11.859; *MED EC CO INC, 1997, PHYS DESK REF; PASHOS CL, 1993, JAMA-J AM MED ASSOC, V270, P1832, DOI 10.1001/jama.270.15.1832; PEDERSEN TR, 1981, NEW ENGL J MED, V304, P801; ROCHON PA, 1993, ARCH INTERN MED, V153, P243, DOI 10.1001/archinte.153.2.243; Rochon PA, 1999, J AM GERIATR SOC, V47, P954, DOI 10.1111/j.1532-5415.1999.tb01290.x; Rochon PA, 1998, CAN MED ASSOC J, V159, P321; Rochon PA, 1999, CAN MED ASSOC J, V161, P1403; SCHOCKEN DD, 1992, J AM COLL CARDIOL, V20, P301, DOI 10.1016/0735-1097(92)90094-4; Sharpe N, 1999, LANCET, V353, P1988, DOI 10.1016/S0140-6736(99)90183-6; TU JV, 1999, CARDIOVASCULAR HLTH, P25; Tu LV, 1999, CAN MED ASSOC J, V161, P1257; WEN SW, 1995, JAMA-J AM MED ASSOC, V274, P1687, DOI 10.1001/jama.274.21.1687; WILCOX RG, 1980, BRIT MED J, V280, P885, DOI 10.1136/bmj.280.6218.885	33	57	59	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 19	2000	356	9230					639	644		10.1016/S0140-6736(00)02606-4	http://dx.doi.org/10.1016/S0140-6736(00)02606-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346RD	10968437				2022-12-24	WOS:000088884100012
J	Kramer, MS; Demissie, K; Yang, H; Platt, RW; Sauve, R; Liston, R				Kramer, MS; Demissie, K; Yang, H; Platt, RW; Sauve, R; Liston, R		Fetal Infant Hlth Study Grp Canadi	The contribution of mild and moderate preterm birth to infant mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEONATAL MORBIDITY; WEIGHT INFANTS; OUTCOMES; CHILDREN; DELIVERY; COHORT; DEATH; RISK; BORN; CARE	Context The World Health Organization defines preterm birth as birth at less than 37 completed gestational weeks, but most studies have focused on very preterm infants (birth at <32 weeks) because of their high risk of mortality and serious morbidity. However, infants born at 32 through 36 weeks are more common and their public health impact has not been well studied. Objective To assess the quantitative contribution of mild (birth at 34-36 gestational weeks) and moderate (birth at 32-33 gestational weeks) preterm birth to infant mortality. Design, Setting, and Participants Population-based cohort study using linked singleton live birth-infant death cohort files for US birth cohorts for 1985 and 1995 and Canadian birth cohorts (excluding Ontario) for 1985-1987 and 1992-1994. Main Outcome Measures Relative risks (RRs) and etiologic fractions (EFs) for overall and cause-specific early neonatal (age 0-6 days), late neonatal (age 7-27 days), postneonatal (age 28-364 days), and total infant death among mild and moderate preterm births vs term births (at greater than or equal to 37 gestational weeks). Results Relative risks for infant death from ail causes among singletons born at 32 through 33 gestational weeks were 6.6 (95% confidence interval [CI], 6.1-7.0) in the United States in 1995 and 15.2 (95% CI, 13.2-17.5) in Canada in 1992-1994; among singletons born at 34 through 36 gestational weeks, the RRs were 2.9 (95% CI, 2.8-3.0) and 4.5 (95% CI, 4.0-5.0), respectively. Corresponding EFs were 3.2% and 4.8%, respectively, at 32 through 33 gestational weeks and 6.3% and 8.0%, respectively, at 34 through 36 gestational weeks; the sum of the EFs for births at 32 through 33 and 34 through 36 gestational weeks exceeded those for births at 28 through 31 gestational weeks. Substantial RRs were observed overall for the neonatal (eg, for early neonatal deaths, 14.6 and 33.0 for US and Canadian infants, respectively, born at 32-33 gestational weeks; EFs, 3.6% and and 6.2% for US and Canadian infants, respectively) and postneonatal (RRs, 2.1-3.8 and 3.0-7.0 for US and Canadian infants, respectively, born at 32-36 gestational weeks; EFs, 2.7%-5.8% and 3.0%-7.0% for the same groups, respectively) periods and for death due to asphyxia, infection, sudden infant death syndrome, and external causes. Except for a reduction in the RR and EF for neonatal mortality due to infection, the patterns have changed little since 1985 in either country. Conclusions Mild- and moderate-preterm birth infants are at high RR for death during infancy and are responsible for an important fraction of infant deaths.	McGill Univ, Fac Med, Dept Pediat, Montreal, PQ, Canada; McGill Univ, Fac Med, Dept Epidemiol & Biostat, Montreal, PQ, Canada; Hlth Canada, Vur Reprod & Child Hlth, Lab Ctr Dis Control, Ottawa, ON, Canada; Univ Med & Dent New Jersey, Dept Environm & Community Med, Piscataway, NJ 08854 USA; Univ Calgary, Fac Med, Dept Pediat, Calgary, AB, Canada; Univ Calgary, Fac Med, Dept Community Med, Calgary, AB, Canada; Univ British Columbia, Dept Obstet & Gynecol, Vancouver, BC V5Z 1M9, Canada	McGill University; McGill University; Health Canada; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Calgary; University of Calgary; University of British Columbia	Kramer, MS (corresponding author), 1020 Pine Ave W, Montreal, PQ H3A 1A2, Canada.	mkrame@po-box.mcgill.ca		Platt, Robert/0000-0002-5981-8443				[Anonymous], 1985, PREV LOW BIRTHW; COLE S, 1989, ACTA OBSTET GYN SCAN, V68, P113, DOI 10.3109/00016348909009897; DOLLFUS C, 1990, PEDIATRICS, V86, P176; Doyle LW, 1999, MED J AUSTRALIA, V170, P528, DOI 10.5694/j.1326-5377.1999.tb127877.x; Goldenberg RL, 1998, NEW ENGL J MED, V339, P313, DOI 10.1056/NEJM199807303390506; Gould JB, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.3.e37; HACK M, 1994, NEW ENGL J MED, V331, P753, DOI 10.1056/NEJM199409223311201; Kalter HD, 1998, AM J PUBLIC HEALTH, V88, P816, DOI 10.2105/AJPH.88.5.816; Kimberlin DF, 1999, AM J OBSTET GYNECOL, V180, P683, DOI 10.1016/S0002-9378(99)70273-5; LEE K, 1995, AM J EPIDEMIOL, V141, P1188, DOI 10.1093/oxfordjournals.aje.a117392; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; MIETTINE.OS, 1974, AM J EPIDEMIOL, V99, P325, DOI 10.1093/oxfordjournals.aje.a121617; MORRISON JC, 1990, OBSTET GYNECOL, V76, pS5; O'Shea TM, 1998, PEDIATRICS, V101, P642, DOI 10.1542/peds.101.4.642; Platt RW, 1999, AM J EPIDEMIOL, V149, pS50; Richardson DK, 1998, PEDIATRICS, V102, P893, DOI 10.1542/peds.102.4.893; ROBERTSON PA, 1992, AM J OBSTET GYNECOL, V166, P1629, DOI 10.1016/0002-9378(92)91551-K; RUSH RW, 1976, BRIT MED J, V2, P965, DOI 10.1136/bmj.2.6042.965; Saigal S, 1996, JAMA-J AM MED ASSOC, V276, P453, DOI 10.1001/jama.276.6.453; Schendel DE, 1997, AM J EPIDEMIOL, V146, P740; Sutton L, 1999, PAEDIATR PERINAT EP, V13, P288; *WHO, 1970, WHO TECHN REP SER, V457; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	23	480	500	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2000	284	7					843	849		10.1001/jama.284.7.843	http://dx.doi.org/10.1001/jama.284.7.843			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342PM	10938173	Bronze			2022-12-24	WOS:000088654400026
J	Ghani, AC; Ferguson, NM; Donnelly, CA; Anderson, RM				Ghani, AC; Ferguson, NM; Donnelly, CA; Anderson, RM			Predicted vCJD mortality in Great Britain - Modelling the latest data puts a ceiling on the likely number of vCJD cases.	NATURE			English	Article									Univ Oxford, Wellcome Trust Ctr Epidemiol Infect Dis, Oxford OX1 3FY, England	University of Oxford	Ghani, AC (corresponding author), Univ Oxford, Wellcome Trust Ctr Epidemiol Infect Dis, Oxford OX1 3FY, England.		Ferguson, Neil/B-8578-2008; Ghani, Azra/B-8560-2009	Ferguson, Neil/0000-0002-1154-8093; Ghani, Azra/0000-0002-0007-4910; Anderson, Roy/0000-0002-9528-3175; Donnelly, Christl/0000-0002-0195-2463				Anderson RM, 1996, NATURE, V382, P779, DOI 10.1038/382779a0; *EUR UN SCI STEER, 1999, OP SCI STEER COMM HU; Ferguson NM, 1997, PHILOS T R SOC B, V352, P803, DOI 10.1098/rstb.1997.0063; Ghani AC, 2000, P ROY SOC B-BIOL SCI, V267, P23, DOI 10.1098/rspb.2000.0961; Ghani AC, 1998, P ROY SOC B-BIOL SCI, V265, P2443, DOI 10.1098/rspb.1998.0596; Ironside JW, 2000, LANCET, V355, P1693, DOI 10.1016/S0140-6736(00)02243-1	6	157	161	0	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2000	406	6796					583	584		10.1038/35020688	http://dx.doi.org/10.1038/35020688			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949288				2022-12-24	WOS:000088653800033
J	Kaiser, P; Flick, K; Wittenberg, C; Reed, SI				Kaiser, P; Flick, K; Wittenberg, C; Reed, SI			Regulation of transcription by ubiquitination without proteolysis: Cdc34/SCFMet30-mediated inactivation of the transcription factor Met4	CELL			English	Article							CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; YEAST KINETOCHORE; PROTEIN; PROTEASOME; COMPLEXES; KINASE; LIGASE; CDC34; DEGRADATION	Polyubiquitination of proteins by Cdc34/SCF complexes targets them for degradation by the 26S proteasome. The essential F-box protein Met30 is the substrate recognition subunit of the ubiquitin ligase SCFMet30. The critical target of SCFMet30 is the transcription factor Met4, as deletion of MET4 suppresses the lethality of met30 mutants. Surprisingly, Met4 is a relatively stable protein and its abundance is not influenced by Met30. However, transcriptional repression of Met4 target genes correlates with Cdc34 /SCFMet30-dependent ubiquitination of Met4. Functionally, ubiquitinated Met4 associates with target promoters but fails to form functional transcription complexes. Our data reveal a novel proteolysis-independent function for Cdc34/SCF and indicate that ubiquitination of transcription factors can be utilized to directly regulate their activities.	Scripps Res Inst, La Jolla, CA USA	Scripps Research Institute	Reed, SI (corresponding author), Scripps Res Inst, MB7, La Jolla, CA USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043487, R37GM038328, R01GM038328, P01GM046006] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM38328, GM43487, GM46006] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; CAI MJ, 1990, CELL, V61, P437, DOI 10.1016/0092-8674(90)90525-J; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Guthrie C., 1991, GUIDE YEAST GENETICS, V194; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; Kaiser P, 1998, GENE DEV, V12, P2587, DOI 10.1101/gad.12.16.2587; Kaiser P, 1999, GENE DEV, V13, P1190, DOI 10.1101/gad.13.9.1190; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Kaplan KB, 1997, CELL, V91, P491, DOI 10.1016/S0092-8674(00)80435-3; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; Patton EE, 1998, GENE DEV, V12, P692, DOI 10.1101/gad.12.5.692; PATTON EE, 1988, YEAST GEN MOL BIOL M; REED SI, 1985, P NATL ACAD SCI USA, V82, P4055, DOI 10.1073/pnas.82.12.4055; Rouillon A, 2000, EMBO J, V19, P282, DOI 10.1093/emboj/19.2.282; Russell SJ, 1999, MOL CELL, V3, P687, DOI 10.1016/S1097-2765(01)80001-0; Seol JH, 1999, GENE DEV, V13, P1614, DOI 10.1101/gad.13.12.1614; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; STUART D, 1994, MOL CELL BIOL, V14, P4788, DOI 10.1128/MCB.14.7.4788; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; THOMPSON AH, 1995, CAN J PSYCHIAT, V40, P15, DOI 10.1177/070674379504000106; Verma R, 1997, METHOD ENZYMOL, V283, P366; YOON HJ, 1995, MOL CELL BIOL, V15, P4835	27	232	237	0	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 4	2000	102	3					303	314		10.1016/S0092-8674(00)00036-2	http://dx.doi.org/10.1016/S0092-8674(00)00036-2			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	342BP	10975521	Bronze			2022-12-24	WOS:000088625600006
J	Strayer, C; Oyama, T; Schultz, TF; Raman, R; Somers, DE; Mas, P; Panda, S; Kreps, JA; Kay, SA				Strayer, C; Oyama, T; Schultz, TF; Raman, R; Somers, DE; Mas, P; Panda, S; Kreps, JA; Kay, SA			Cloning of the Arabidopsis clock cone TOC1, an autoregulatory response regulator homolog	SCIENCE			English	Article							CIRCADIAN CLOCK; GENE; PERIOD; PROTEIN; TRANSCRIPTION; PHYTOCHROMES; EXPRESSION; DROSOPHILA; TIMELESS; THALIANA	The toc1 mutation causes shortened circadian rhythms in Light-grown Arabidopsis plants. Here, we report the same toc1 effect in the absence of tight input to the clock. We also show that TOC1 controls photoperiodic flowering response through clock function. The TOC1 gene was isolated and found to encode a nuclear protein containing an atypical response regulator receiver domain and two motifs that suggest a role in transcriptional regulation: a basic motif conserved within the CONSTANS family of transcription factors and an acidic domain. TOC1 is itself circadianly regulated and participates in a feedback Loop to control its own expression.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA	Scripps Research Institute; University of Virginia	Kay, SA (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.		Kay, Steve A/F-6025-2011; Somers, David E/A-9209-2010; Panda, Satchidananda/J-6891-2012; Mas, Paloma/B-8215-2016	Kay, Steve A/0000-0002-0402-2878; Mas, Paloma/0000-0002-3780-8041; Schultz, Thomas/0000-0001-9694-9920	NIGMS NIH HHS [GM 56006] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; CRESS WD, 1991, SCIENCE, V251, P87, DOI 10.1126/science.1846049; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; *GENB, AL162973 GENB; *GENB, AC005310 GENB; *GENB, AB019231 GENB; *GENB, AB0256415 GENB; Imamura A, 1999, PLANT CELL PHYSIOL, V40, P733, DOI 10.1093/oxfordjournals.pcp.a029600; Iwasaki H, 2000, CELL, V101, P223, DOI 10.1016/S0092-8674(00)80832-6; Kaneko M, 1997, J NEUROSCI, V17, P6745; Kreps JA, 1997, PLANT CELL, V9, P297, DOI 10.1105/tpc.9.3.297; Kurup S, 2000, PLANT J, V21, P143, DOI 10.1046/j.1365-313x.2000.00663.x; Makino S, 2000, PLANT CELL PHYSIOL, V41, P791, DOI 10.1093/pcp/41.6.791; Matera AG, 1999, TRENDS CELL BIOL, V9, P302, DOI 10.1016/S0962-8924(99)01606-2; MILLAR AJ, 1995, SCIENCE, V267, P1163, DOI 10.1126/science.7855596; MILLAR AJ, 1995, SCIENCE, V267, P1161, DOI 10.1126/science.7855595; Pellequer JL, 1998, P NATL ACAD SCI USA, V95, P5884, DOI 10.1073/pnas.95.11.5884; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Putterill J., 1997, PLANT PHYSIOL, V114, P396; Robert LS, 1998, PLANT MOL BIOL, V37, P763, DOI 10.1023/A:1006064514311; ROBSON F, COMMUNICATION; Somers DE, 2000, CELL, V101, P319, DOI 10.1016/S0092-8674(00)80841-7; Somers DE, 1998, DEVELOPMENT, V125, P485; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; STOCK JB, 1990, NATURE, V344, P395, DOI 10.1038/344395a0; STRAYER C, UNPUB; Urao T, 2000, TRENDS PLANT SCI, V5, P67, DOI 10.1016/S1360-1385(99)01542-3; Yeh KC, 1998, P NATL ACAD SCI USA, V95, P13976, DOI 10.1073/pnas.95.23.13976	29	623	673	7	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 4	2000	289	5480					768	771		10.1126/science.289.5480.768	http://dx.doi.org/10.1126/science.289.5480.768			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341FZ	10926537				2022-12-24	WOS:000088581500038
J	Humphrey, JH; Rice, AL				Humphrey, JH; Rice, AL			Vitamin A supplementation of young infants	LANCET			English	Editorial Material							A SUPPLEMENTATION; MOTHERS; AGE; IMMUNIZATION; FONTANELLE; MORBIDITY; MORTALITY; TOLERANCE; VACCINES; DELIVERY		Johns Hopkins Univ, Sch Hyg & Publ Hlth, Ctr Human Nutr, Baltimore, MD 21205 USA	Johns Hopkins University	Humphrey, JH (corresponding author), ZVITAMBO Project, 21 Van Praagh Ave, Harare, Zimbabwe.	humphrey@zvitambo.icon.co.zw						AGOESTINA T, 1994, B WORLD HEALTH ORGAN, V72, P859; BAQUI AH, 1995, ACTA PAEDIATR, V84, P863, DOI 10.1111/j.1651-2227.1995.tb13781.x; Beaton G, 1993, ACC SCN STATE ART SE; BECKER NH, 1963, AM J PATHOL, V43, P1017; CHAPPELL JE, 1985, EARLY HUM DEV, V11, P157, DOI 10.1016/0378-3782(85)90103-3; DEFRANCISCO A, 1993, LANCET, V342, P526, DOI 10.1016/0140-6736(93)91648-6; *ESGPAN COMM, 1977, ACTA PAEDIATR SC   S, V262, P8; [FAO WHO Expert Consultation], 1988, FAO FOOD NUTR SER; FOMON AJ, 1993, NUTR NORMAL INFANTS, P409; HILL A, 1981, PEDIATRICS, V68, P623; Humphrey JH, 1996, J PEDIATR-US, V128, P489, DOI 10.1016/S0022-3476(96)70359-1; Humphrey JH, 1998, AM J CLIN NUTR, V68, P109, DOI 10.1093/ajcn/68.1.109; Iliff PJ, 1999, NUTR RES, V19, P1437, DOI 10.1016/S0271-5317(99)00101-3; MADDUX GW, 1974, J NUTR, V104, P478, DOI 10.1093/jn/104.4.478; Martines J, 1998, LANCET, V352, P1257, DOI 10.1016/S0140-6736(98)02487-8; OLSON JA, 1979, ARCH LATINOAM NUTR, V29, P521; OLSON JA, 1984, AM J CLIN NUTR, V39, P903, DOI 10.1093/ajcn/39.6.903; RAHMAN MM, 1995, EUR J CLIN NUTR, V49, P439; Rice AL, 1999, J NUTR, V129, P356, DOI 10.1093/jn/129.2.356; Roy SK, 1997, EUR J CLIN NUTR, V51, P302, DOI 10.1038/sj.ejcn.1600398; SHAPIRO K, 1985, J NEUROSURG, V63, P69, DOI 10.3171/jns.1985.63.1.0069; STABELL C, 1995, EUR J CLIN NUTR, V49, P73; STOLTZFUS RJ, 1993, J NUTR, V123, P666, DOI 10.1093/jn/123.4.666; Thanangkul O., 1974, JOINT WHO USAID M CO; vanDillen J, 1996, LANCET, V347, P1705, DOI 10.1016/S0140-6736(96)91541-X; Wallingford JC, 1986, VITAMIN A DEFICIENCY, P101; WEST KP, 1995, AM J CLIN NUTR, V62, P143, DOI 10.1093/ajcn/62.1.143; WEST KP, 1992, B WORLD HEALTH ORGAN, V70, P733; WEST KP, 1986, VITAMIN A DEFICIENCY, P325	29	34	37	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 29	2000	356	9227					422	424		10.1016/S0140-6736(00)02541-1	http://dx.doi.org/10.1016/S0140-6736(00)02541-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	339NZ	10972388				2022-12-24	WOS:000088486000038
J	Heinrich, SU; Mothes, W; Brunner, J; Rapoport, TA				Heinrich, SU; Mothes, W; Brunner, J; Rapoport, TA			The Sec61p complex mediates the integration of a membrane protein by allowing lipid partitioning of the transmembrane domain	CELL			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; SIGNAL SEQUENCE RECOGNITION; POSITIVELY CHARGED RESIDUES; CONDUCTING CHANNEL; ANCHOR PROTEINS; TRANSLOCATION; INSERTION; TOPOLOGY; ORIENTATION; BIOGENESIS	We have investigated how the transmembrane (TM) domain of a membrane protein is cotranslationally integrated into the endoplasmic reticulum. We demonstrate that the Sec61p channel allows the TM domain to bypass the barrier posed by the polar head groups of the lipid bilayer and come into contact with the hydrophobic interior of the membrane. Together with the TRAM protein, Sec61p provides a site in the membrane, at the interface of channel and lipid, through which a TM domain can dynamically equilibrate between the lipid and aqueous phases, depending on the hydrophobicity of the TM domain and the length of the polypeptide segment tethering it to the ribosome. Our results suggest a unifying, lipid-partitioning model which can explain the general behavior of hydrophobic topogenic sequences.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; ETH Zurich, Biochem Lab, CH-8092 Zurich, Switzerland	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Swiss Federal Institutes of Technology Domain; ETH Zurich	Rapoport, TA (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA.				NIGMS NIH HHS [GM52586] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052586] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Borel AC, 1996, CELL, V85, P379, DOI 10.1016/S0092-8674(00)81116-2; BRUNNER J, 1980, J BIOL CHEM, V255, P3313; Denzer AJ, 1995, EMBO J, V14, P6311, DOI 10.1002/j.1460-2075.1995.tb00321.x; Do H, 1996, CELL, V85, P369, DOI 10.1016/S0092-8674(00)81115-0; GORLICH D, 1992, NATURE, V357, P47, DOI 10.1038/357047a0; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; Hegde RS, 1997, CELL, V91, P575, DOI 10.1016/S0092-8674(00)80445-6; HIGH S, 1993, J CELL BIOL, V121, P743, DOI 10.1083/jcb.121.4.743; JUNGNICKEL B, 1995, CELL, V82, P261, DOI 10.1016/0092-8674(95)90313-5; Kopito RR, 1997, CELL, V88, P427, DOI 10.1016/S0092-8674(00)81881-4; MARTOGLIO B, 1995, CELL, V81, P207, DOI 10.1016/0092-8674(95)90330-5; Matlack KES, 1998, CELL, V92, P381, DOI 10.1016/S0092-8674(00)80930-7; Mothes W, 1998, J CELL BIOL, V142, P355, DOI 10.1083/jcb.142.2.355; Mothes W, 1997, CELL, V89, P523, DOI 10.1016/S0092-8674(00)80234-2; PARKS GD, 1991, CELL, V64, P777, DOI 10.1016/0092-8674(91)90507-U; Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9; RAPOPORT TA, 1985, FEBS LETT, V187, P1, DOI 10.1016/0014-5793(85)81202-3; SAKAGUCHI M, 1987, EMBO J, V6, P2425, DOI 10.1002/j.1460-2075.1987.tb02521.x; SIMON SM, 1991, CELL, V65, P371, DOI 10.1016/0092-8674(91)90455-8; SINGER SJ, 1987, P NATL ACAD SCI USA, V84, P1960, DOI 10.1073/pnas.84.7.1960; Voigt S, 1996, J CELL BIOL, V134, P25, DOI 10.1083/jcb.134.1.25; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511	25	209	213	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 21	2000	102	2					233	244		10.1016/S0092-8674(00)00028-3	http://dx.doi.org/10.1016/S0092-8674(00)00028-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	337NA	10943843	Bronze			2022-12-24	WOS:000088366800013
J	Bounameaux, H				Bounameaux, H			Factor V Leiden paradox: risk of deep-vein thrombosis but not of pulmonary embolism	LANCET			English	Editorial Material							ACTIVATED PROTEIN-C; MUTATION; POPULATION; RESISTANCE		Univ Hosp Geneva, Div Angiol & Haemostasis, CH-1211 Geneva 14, Switzerland	University of Geneva	Bounameaux, H (corresponding author), Univ Hosp Geneva, Div Angiol & Haemostasis, CH-1211 Geneva 14, Switzerland.							Baglin TP, 1997, THROMB HAEMOSTASIS, V77, P1219; Bajzar L, 1996, J BIOL CHEM, V271, P22949, DOI 10.1074/jbc.271.38.22949; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; Bjorgell O, 2000, THROMB HAEMOSTASIS, V83, P648; Dahlback B, 2000, LANCET, V355, P1627, DOI 10.1016/S0140-6736(00)02225-X; DAHLBACK B, 1993, P NATL ACAD SCI USA, V90, P1004, DOI 10.1073/pnas.90.3.1004; DEMOERLOOSE P, IN PRESS BR J HAEMAT; Desmarais S, 1996, LANCET, V347, P1374, DOI 10.1016/S0140-6736(96)91013-2; Ehrenforth S., 2000, Haemostasis, V30, P36; Manten B, 1996, THROMB HAEMOSTASIS, V76, P510; Marinelli I, 1997, THROMB HAEMOSTASIS, V77, P440; MEYER G, IN PRESS AM J MED; Turkstra F, 1999, THROMB HAEMOSTASIS, V81, P345; vantVeer C, 1997, J BIOL CHEM, V272, P20721, DOI 10.1074/jbc.272.33.20721	14	93	95	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 15	2000	356	9225					182	183		10.1016/S0140-6736(00)02476-4	http://dx.doi.org/10.1016/S0140-6736(00)02476-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334GQ	10963193				2022-12-24	WOS:000088179100006
J	Kupperman, E; An, SZ; Osborne, N; Waldron, S; Stainier, DYR				Kupperman, E; An, SZ; Osborne, N; Waldron, S; Stainier, DYR			A sphingosine-1-phosphate receptor regulates cell migration during vertebrate heart development	NATURE			English	Article							PROTEIN-COUPLED RECEPTORS; SPHINGOSINE 1-PHOSPHATE; CARDIOVASCULAR-SYSTEM; ENDODERM FORMATION; ZEBRAFISH; DROSOPHILA; EXPRESSION; CLONING; GENES; ACID	Coordinated cell migration is essential in many fundamental biological processes including embryonic development, organogenesis, wound healing and the immune response. During organogenesis, groups of cells are directed to specific locations within the embryo. Here we show that the zebrafish miles apart (mil) mutation(1,2) specifically affects the migration of the heart precursors to the midline. We found that mutant cells transplanted into a wild-type embryo migrate normally and that wild-type cells in a mutant embryo fail to migrate, suggesting that mil may be involved in generating an environment permissive for migration. We isolated mil by positional cloning and show that it encodes a member of the lysosphingolipid G-protein-coupled receptor family. We also show that sphingosine-1-phosphate is a ligand for Mil, and that it activates several downstream signalling events that are not activated by the mutant alleles. These data reveal a new role for lysosphingolipids in regulating cell migration during vertebrate development and provide the first molecular clues into the fusion of the bilateral heart primordia during organogenesis of the heart.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Dev Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Genet Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Human Genet, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Stainier, DYR (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.			Stainier, Didier/0000-0002-0382-0026				Alexander J, 1999, DEV BIOL, V215, P343, DOI 10.1006/dbio.1999.9441; ALEXANDER J, 1999, MUTATIONS AFFECTING; An SZ, 2000, J BIOL CHEM, V275, P288, DOI 10.1074/jbc.275.1.288; An SZ, 1997, FEBS LETT, V417, P279, DOI 10.1016/S0014-5793(97)01301-X; An SZ, 1999, MOL PHARMACOL, V55, P787; Chan FY, 1997, BLOOD, V89, P688, DOI 10.1182/blood.V89.2.688; Chen JN, 1996, DEVELOPMENT, V123, P293; Forbes A, 1999, CURR OPIN GENET DEV, V9, P473, DOI 10.1016/S0959-437X(99)80072-0; Goetzl EJ, 1998, FASEB J, V12, P1589, DOI 10.1096/fasebj.12.15.1589; Hla T, 1999, BIOCHEM PHARMACOL, V58, P201; Kikuchi Y, 2000, GENE DEV, V14, P1279; Knapik EW, 1998, NAT GENET, V18, P338, DOI 10.1038/ng0498-338; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; MACLENNAN AJ, 1994, MOL CELL NEUROSCI, V5, P201, DOI 10.1006/mcne.1994.1024; Martin CC, 1999, DEV BIOL, V206, P189, DOI 10.1006/dbio.1998.9105; Moolenaar WH, 1999, EXP CELL RES, V253, P230, DOI 10.1006/excr.1999.4702; OKAZAKI H, 1993, BIOCHEM BIOPH RES CO, V190, P1104, DOI 10.1006/bbrc.1993.1163; Reiter JF, 1999, GENE DEV, V13, P2983, DOI 10.1101/gad.13.22.2983; Roberts R, 1998, J BIOL CHEM, V273, P22059, DOI 10.1074/jbc.273.34.22059; Scheer A, 2000, MOL PHARMACOL, V57, P219; Schier AF, 1997, DEVELOPMENT, V124, P327; Spiegel S, 1999, J LEUKOCYTE BIOL, V65, P341, DOI 10.1002/jlb.65.3.341; Stainier DYR, 1996, DEVELOPMENT, V123, P285; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; STRAHLE U, 1993, GENE DEV, V7, P1436, DOI 10.1101/gad.7.7b.1436; Yelon D, 2000, DEVELOPMENT, V127, P2573; Yelon D, 1999, DEV BIOL, V214, P23, DOI 10.1006/dbio.1999.9406; Zhang N, 1997, NATURE, V385, P64, DOI 10.1038/385064a0	28	316	320	0	20	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 13	2000	406	6792					192	195		10.1038/35018092	http://dx.doi.org/10.1038/35018092			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910360				2022-12-24	WOS:000088221100050
J	Deng, J; Newton, NM; Hall-Craggs, MA; Shirley, RA; Linney, AD; Lees, WR; Rodeck, CH; McGrouther, DA				Deng, J; Newton, NM; Hall-Craggs, MA; Shirley, RA; Linney, AD; Lees, WR; Rodeck, CH; McGrouther, DA			Novel technique for three-dimensional visualisation and quantification of deformable, moving soft-tissue body parts	LANCET			English	Article							ECHOCARDIOGRAPHY; SURGERY; MRI	Background Three-dimensional (3D) imaging of delicate, moving soft-tissue body parts is very difficult. Our understanding of the muscles that control lip movements is based largely on histological and cadaveric studies, which provide scant information about dynamic morphology. Our aim was to develop an innovative scanning technique for the imaging and reconstruction of dynamic orofacial morphology by use of 3D and four-dimensional (4D, ie, 3D plus time) ultrasonography. Methods Four volunteers (including one patient) underwent ultrasonography with 3D/4D imaging systems. To avoid deformation of the delicate orofacial structures, a water bath with an acoustic window was devised. The orofacial part was immersed in the bath throughout scanning, and a timer was used to synchronise lip movements with the 4D scan. Findings 4D views showed the functional differences in superficial and deep muscle groups of the lips, and clearly showed the changes occurring with movement of the lips and mouth. In the patient, a pathological layer and its extension corresponding to surface malformation were clearly identified. Interpretation We have developed a prototype device that has made possible 3D and 40 examination of orofacial anatomy and function. With further refinement of the device and improvement in 4D acquisition timing, this technique may offer a new way of dynamically imaging and quantifying many soft-tissue parts in 3D without deforming structure or disturbing function.	UCL, Dept Med Phys, London WC1E 6JA, England; UCL, Dept Obstet & Gynaecol, London WC1E 6JA, England; UCL, Dept Plast & Reconstruct Surg, London WC1E 6JA, England; UCL, Dept Med Imaging, London WC1E 6JA, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	Deng, J (corresponding author), UCL, Dept Med Phys, 1st Floor Shropshire House,11-20 Capper St, London WC1E 6JA, England.	jdeng@medphys.ucl.ac.uk; n.newton@ucl.ac.uk	Deng, J/S-9428-2019	Hall-Craggs, Margaret/0000-0001-8734-4065; Deng, Jing/0000-0002-1736-1801				Bell Charles, 1984, ESSAYS ANATOMY EXPRE; Cacou C, 1997, PLAST RECONSTR SURG, V99, P982, DOI 10.1097/00006534-199704000-00008; Chen Q, 1999, EUR J RADIOL, V29, P90, DOI 10.1016/S0720-048X(98)00172-7; Chikui T, 1997, ORAL SURG ORAL MED O, V84, P88, DOI 10.1016/S1079-2104(97)90302-4; Clark MPA, 1998, PLAST RECONSTR SURG, V101, P1945, DOI 10.1097/00006534-199806000-00027; Deng J, 1996, ULTRASOUND MED BIOL, V22, P979, DOI 10.1016/S0301-5629(96)00119-6; DENT J, 2000, IN PRESS ULTRASOUND; HELL B, 1993, INT J ORAL MAX SURG, V22, P173, DOI 10.1016/S0901-5027(05)80247-4; HOWRY DH, 1952, J LAB CLIN MED, V40, P579; LATHAM RA, 1976, J ANAT, V121, P151; LEE S T, 1988, Annals Academy of Medicine Singapore, V17, P328; Light ED, 1998, ULTRASONIC IMAGING, V20, P1; Lightoller GHS, 1925, J ANAT, V60, P1; McAlister RW, 1998, EUR J ORTHODONT, V20, P713, DOI 10.1093/ejo/20.6.713; McGrouther DA, 1997, BRIT MED J, V314, P991, DOI 10.1136/bmj.314.7086.991; MERZ E, 1995, ULTRASOUND OBST GYN, V5, P222, DOI 10.1046/j.1469-0705.1995.05040222.x; NEWTON NM, 1999, P BRIT ASS PLAST SUR, P78; Rasheed S A, 1996, J Clin Pediatr Dent, V20, P305; SALMON S, 1995, GRAYS ANATOMY ANATOM, P798; SCHWARTZ SL, 1994, AM J CARDIOL, V73, P501, DOI 10.1016/0002-9149(94)90682-3; VINKKAPUHAKKA H, 1989, J ANAT, V166, P121; Welzel J, 1997, J AM ACAD DERMATOL, V37, P958, DOI 10.1016/S0190-9622(97)70072-0	22	25	27	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 8	2000	356	9224					127	131		10.1016/S0140-6736(00)02449-1	http://dx.doi.org/10.1016/S0140-6736(00)02449-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331UG	10963249				2022-12-24	WOS:000088036600013
J	Soll, R				Soll, R			Patient-triggered ventilation of the newborn	LANCET			English	Editorial Material									Univ Vermont, Coll Med, Dept Pediat, Burlington, VT 05405 USA	University of Vermont	Soll, R (corresponding author), Univ Vermont, Coll Med, Dept Pediat, Burlington, VT 05405 USA.							Baumer JH, 2000, ARCH DIS CHILD-FETAL, V82, pF5, DOI 10.1136/fn.82.1.F5; Beresford MW, 2000, ARCH DIS CHILD-FETAL, V82, pF14, DOI 10.1136/fn.82.1.F14; GREENOUGH A, 1991, J PERINAT MED, V19, P471, DOI 10.1515/jpme.1991.19.6.471; GREENOUGH A, 1985, BRIT MED J, V290, P597, DOI 10.1136/bmj.290.6468.597; GREENOUGH A, 1992, ARCH DIS CHILD-FETAL, V67, P69, DOI 10.1136/adc.67.1_Spec_No.69; GREENOUGH A, 1999, COCHRANE LIB; LIPSCOMB AP, 1981, LANCET, V1, P414; NORTHWAY WH, 1967, NEW ENGL J MED, V276, P357, DOI 10.1056/NEJM196702162760701	8	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 8	2000	356	9224					90	91		10.1016/S0140-6736(00)02465-X	http://dx.doi.org/10.1016/S0140-6736(00)02465-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331UG	10963241				2022-12-24	WOS:000088036600005
J	Brown, A; Yates, PA; Burrola, P; Ortuno, D; Vaidya, A; Jessell, TM; Pfaff, SL; O'Leary, DDM; Lemke, G				Brown, A; Yates, PA; Burrola, P; Ortuno, D; Vaidya, A; Jessell, TM; Pfaff, SL; O'Leary, DDM; Lemke, G			Topographic mapping from the retina to the midbrain is controlled by relative but not absolute levels of EphA receptor signaling	CELL			English	Article							GANGLION-CELL AXONS; MAMMALIAN RETINOCOLLICULAR PROJECTION; FLUORESCENT LATEX MICROSPHERES; CHICK VISUAL-SYSTEM; NEURAL DEVELOPMENT; TYROSINE KINASES; MOUSE RETINA; IN-VITRO; GUIDANCE; EXPRESSION	Topographic maps are a fundamental feature of sensory representations in nervous systems. The formation of one such map, defined by the connection of ganglion cells in the retina to their targets in the superior colliculus of the midbrain, is thought to depend upon an interaction between complementary gradients of retinal EphA receptors and collicular ephrin-a ligands. We have tested this hypothesis by using gene targeting to elevate EphA receptor expression in a subset of mouse ganglion cells, thereby producing two intermingled ganglion cell populations that express distinct EphA receptor gradients. We find that these two populations form separate maps in the colliculus, which can be predicted as a function of the net EphA receptor level that a given ganglion cell expresses relative to its neighbors.	Univ Western Ontario, John P Robarts Res Inst, London, ON N6A 5K8, Canada; Univ Western Ontario, Dept Physiol, London, ON N6A 5K8, Canada; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Western University (University of Western Ontario); Western University (University of Western Ontario); University of California System; University of California San Diego; Columbia University; Howard Hughes Medical Institute	Lemke, G (corresponding author), Univ Western Ontario, John P Robarts Res Inst, London, ON N6A 5K8, Canada.		Brown, Arthur/K-8328-2013	Brown, Arthur/0000-0002-8725-3195				BAIER H, 1992, SCIENCE, V255, P472, DOI 10.1126/science.1734526; BASTMEYER M, 1995, J CELL BIOL, V130, P969, DOI 10.1083/jcb.130.4.969; CHEN G, 1994, BIOL CONTROL, V4, P157, DOI 10.1006/bcon.1994.1025; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Connor RJ, 1998, DEV BIOL, V193, P21, DOI 10.1006/dbio.1997.8786; COX EC, 1990, NEURON, V4, P31, DOI 10.1016/0896-6273(90)90441-H; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Flanagan JG, 1997, CELL, V90, P403; FRASER SE, 1980, ANNU REV NEUROSCI, V3, P319, DOI 10.1146/annurev.ne.03.030180.001535; Frisen J, 1998, NEURON, V20, P235, DOI 10.1016/S0896-6273(00)80452-3; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; Gao PP, 1998, P NATL ACAD SCI USA, V95, P5329, DOI 10.1073/pnas.95.9.5329; Gao PP, 1996, P NATL ACAD SCI USA, V93, P11161, DOI 10.1073/pnas.93.20.11161; GAZE RM, 1972, NATURE, V237, P375, DOI 10.1038/237375a0; Goodhill GJ, 1999, TRENDS NEUROSCI, V22, P529, DOI 10.1016/S0166-2236(99)01469-1; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kaas JH, 1997, BRAIN RES BULL, V44, P107, DOI 10.1016/S0361-9230(97)00094-4; KATZ LC, 1990, NEUROSCIENCE, V34, P511, DOI 10.1016/0306-4522(90)90159-2; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KATZ LC, 1984, NATURE, V310, P498, DOI 10.1038/310498a0; Mackarehtschian K, 1999, CEREB CORTEX, V9, P601, DOI 10.1093/cercor/9.6.601; Marcus RC, 1996, DEV BIOL, V180, P786, DOI 10.1006/dbio.1996.0347; McLaughlin T, 1999, NEURON, V22, P636, DOI 10.1016/S0896-6273(00)80718-7; Miskevich F, 1998, MOL CELL NEUROSCI, V12, P240, DOI 10.1006/mcne.1998.0718; Monschau B, 1997, EMBO J, V16, P1258, DOI 10.1093/emboj/16.6.1258; Nakamoto M, 1996, CELL, V86, P755, DOI 10.1016/S0092-8674(00)80150-6; O'Leary DDM, 1999, CELL, V96, P255, DOI 10.1016/S0092-8674(00)80565-6; O'Leary DDM, 1999, CURR OPIN NEUROBIOL, V9, P65, DOI 10.1016/S0959-4388(99)80008-7; Orioli D, 1997, TRENDS GENET, V13, P354, DOI 10.1016/S0168-9525(97)01220-1; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SIMON DK, 1992, J NEUROSCI, V12, P1212; SIMON DK, 1992, P NATL ACAD SCI USA, V89, P10593, DOI 10.1073/pnas.89.22.10593; SIMON DK, 1994, DEV BIOL, V162, P384, DOI 10.1006/dbio.1994.1095; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; STAHL B, 1990, NEURON, V5, P735, DOI 10.1016/0896-6273(90)90227-7; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; YEN LS, 1995, J NEUROSCI, V15, P4712; Zhang JH, 1996, J NEUROSCI, V16, P7182; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	44	263	265	0	18	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 7	2000	102	1					77	88		10.1016/S0092-8674(00)00012-X	http://dx.doi.org/10.1016/S0092-8674(00)00012-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	332UL	10929715	Bronze			2022-12-24	WOS:000088091700010
J	Gereda, JE; Leung, DYM; Thatayatikom, A; Streib, JE; Price, MR; Klinnert, MD; Liu, AH				Gereda, JE; Leung, DYM; Thatayatikom, A; Streib, JE; Price, MR; Klinnert, MD; Liu, AH			Relation between house-dust endotoxin exposure, type 1 T cell development, and allergen sensitisation in infants at high risk of asthma	LANCET			English	Article							INTERFERON-GAMMA PRODUCTION; BLOOD MONONUCLEAR-CELLS; PERIPHERAL-BLOOD; CHILDREN; ATOPY; PREVALENCE; SENSITIZATION; ASSOCIATION; RESPONSES; INTERLEUKIN-4	Background Bacterial endotoxin is known to induce interferon gamma and interleukin 12 production, and therefore has the potential to decrease allergen sensitisation. To find out the role of early chronic endotoxin exposure in the development of allergen sensitisation and asthma, we compared concentrations of endotoxin in house dust with allergen sensitisation in infants at high risk for developing asthma. Methods 61 infants 9-24 months old with at. least three physician-documented episodes of wheezing were studied. Concentrations of house-dust endotoxin and allergens were measured in the infants' homes. Allergen sensitisation was measured by skin-prick testing with a panel of common inhalant and food allergens. In a subset of these infants, proportions of T lymphocytes producing interferon gamma, and interleukins 4, 5, and 13 were calculated by cell-surface and intracellular cytokine staining, with flow cytometry. Findings House-dust endotoxin concentrations ranged from 104 to 10 000 endotoxin units (EU) per mt (geometric mean 912 EU/mL). Concentrations did not vary significantly over a 6-month interval. Ten infants (16%) were sensitised to at least one allergen. The homes of allergen-sensitised infants contained significantly lower concentrations of house-dust endotoxin than those of non-sensitised infants (mean 468 vs 1035 EU/mL, respectively; p=0.01). Increased house-dust endotoxin concentrations correlated with increased proportions of interferon-gamma-producing CD4 T cells (p=0.01). Such concentrations did not correlate with proportions of cells that produced interleukins 4, 5, or 13. Interpretation This study may provide the first direct in-vivo evidence that indoor endotoxin exposure early in life may protect against allergen sensitisation by enhancing type 1 immunity.	Natl Jewish Med & REs Ctr, Dept Behav Sci, Denver, CO 80206 USA; Natl Jewish Med & REs Ctr, Dept Pediat, Div Pediat Allergy & Immunol, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Denver, CO USA	National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Liu, AH (corresponding author), Natl Jewish Med & REs Ctr, Dept Pediat, Div Pediat Allergy & Immunol, Denver, CO 80206 USA.	liua@njc.org	Thatayatikom, Akaluck/AAK-7166-2021		NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000051] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R18AI041137] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR00051] Funding Source: Medline; NHLBI NIH HHS [HL-36577] Funding Source: Medline; NIAID NIH HHS [R18AI41137] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Baldini M, 1999, AM J RESP CELL MOL, V20, P976, DOI 10.1165/ajrcmb.20.5.3494; Braun-Fahrlander C, 1999, CLIN EXP ALLERGY, V29, P28, DOI 10.1046/j.1365-2222.1999.00479.x; DANDREA A, 1992, J EXP MED, V176, P1387, DOI 10.1084/jem.176.5.1387; DONHAM K, 1989, BRIT J IND MED, V46, P31; Hamilton RG, 1997, METHODS, V13, P53, DOI 10.1006/meth.1997.0495; Hoekstra MO, 1997, CLIN EXP ALLERGY, V27, P1254; Kramer U, 1999, LANCET, V353, P450, DOI 10.1016/S0140-6736(98)06329-6; LE JM, 1986, J IMMUNOL, V136, P4525; MARTINEZ FD, 1995, J ALLERGY CLIN IMMUN, V96, P652, DOI 10.1016/S0091-6749(95)70264-4; Martinez FD, 1999, J ALLERGY CLIN IMMUN, V103, P355, DOI 10.1016/S0091-6749(99)70456-2; Martinez FD, 1999, LANCET, V354, pS12, DOI 10.1016/S0140-6736(99)90437-3; Matricardi PM, 1998, J ALLERGY CLIN IMMUN, V101, P439, DOI 10.1016/S0091-6749(98)70350-1; Matricardi PM, 1997, BRIT MED J, V314, P999, DOI 10.1136/bmj.314.7086.999; Michel O, 1996, AM J RESP CRIT CARE, V154, P1641, DOI 10.1164/ajrccm.154.6.8970348; Milton DK, 1997, AM IND HYG ASSOC J, V58, P861; Munir AKM, 1997, J ALLERGY CLIN IMMUN, V100, P177, DOI 10.1016/S0091-6749(97)70221-5; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; PLATTMILLS TAE, 1995, RELEVANCE INDOOR ALL, P111; PLATTSMILLS TAE, 1992, J ALLERGY CLIN IMMUN, V89, P1046, DOI 10.1016/0091-6749(92)90228-T; Prescott SL, 1999, LANCET, V353, P196, DOI 10.1016/S0140-6736(98)05104-6; Rizzo MC, 1997, PEDIAT ALLERG IMM-UK, V8, P121; RYLANDER R, 1985, AM REV RESPIR DIS, V131, P209; Sarpong SB, 1996, J ALLERGY CLIN IMMUN, V97, P1393, DOI 10.1016/S0091-6749(96)70209-9; SCHWARTZ J, 1990, AM REV RESPIR DIS, V142, P555, DOI 10.1164/ajrccm/142.3.555; Shaheen SO, 1996, LANCET, V347, P1792, DOI 10.1016/S0140-6736(96)91617-7; Shirakawa T, 1997, SCIENCE, V275, P77, DOI 10.1126/science.275.5296.77; Svanes C, 1999, J ALLERGY CLIN IMMUN, V103, P415, DOI 10.1016/S0091-6749(99)70465-3; TANG MLK, 1995, CLIN EXP ALLERGY, V25, P515, DOI 10.1111/j.1365-2222.1995.tb01088.x; VANASPEREN PP, 1984, J ALLERGY CLIN IMMUN, V73, P381, DOI 10.1016/0091-6749(84)90412-3; VANNIEKERK CH, 1979, CLIN ALLERGY, V9, P319; VONMUTIUS E, 1994, AM J RESP CRIT CARE, V149, P358, DOI 10.1164/ajrccm.149.2.8306030; Wahn U, 1997, J ALLERGY CLIN IMMUN, V99, P763, DOI 10.1016/S0091-6749(97)80009-7; WAITE DA, 1980, CLIN ALLERGY, V10, P71, DOI 10.1111/j.1365-2222.1980.tb02082.x; WEISS KB, 1992, CHEST, V101, pS362, DOI 10.1378/chest.101.6_Supplement.362S; WOODFOLK JA, 1992, ANN ALLERGY, V69, P273	35	511	530	0	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 13	2000	355	9216					1680	1683		10.1016/S0140-6736(00)02239-X	http://dx.doi.org/10.1016/S0140-6736(00)02239-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	313CY	10905243				2022-12-24	WOS:000086983800010
J	Grosberg, RK; Hart, MW				Grosberg, RK; Hart, MW			Mate selection and the evolution of highly polymorphic self/nonself recognition genes	SCIENCE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; ASCIDIAN BOTRYLLUS-SCHLOSSERI; HYDRACTINIA-SYMBIOLONGICARPUS; CLONAL INVERTEBRATES; MATING PREFERENCES; NO EVIDENCE; ALLORECOGNITION; SYSTEM; GERM; HLA	Multicellular organisms use the products of highly polymorphic genes to distinguish self from conspecific nonself cells or tissues. These allorecognition polymorphisms may regulate somatic interactions between hosts and pathogens or between competitors (to avoid various forms of parasitism), as well as reproductive interactions between mates or between gametes (to avoid inbreeding). In both cases, rare alleles may be advantageous, but it remains unclear which mechanism maintains the genetic polymorphism for specificity in self/nonself recognition. Contrary to earlier reports, we show that mate selection cannot be a strong force maintaining allorecognition polymorphism in two colonial marine invertebrates. Instead, the regulation of intraspecific competitive interactions appears to promote the evolution of polymorphisms in these species.	Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA; Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA; Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada	University of California System; University of California Davis; University of California System; University of California Davis; Dalhousie University	Grosberg, RK (corresponding author), Univ Calif Davis, Sect Evolut & Ecol, 1 Shields Dr, Davis, CA 95616 USA.	rkgrosberg@ucdavis.edu						Apanius V, 1997, CRIT REV IMMUNOL, V17, P179, DOI 10.1615/CritRevImmunol.v17.i2.40; BROWN JL, 1994, AM NAT, V143, P435, DOI 10.1086/285612; BURNET FM, 1971, NATURE, V232, P230, DOI 10.1038/232230a0; BUSS LW, 1984, BIOL BULL, V167, P139, DOI 10.2307/1541343; BUSS LW, 1985, DEV COMP IMMUNOL, V9, P191, DOI 10.1016/0145-305X(85)90110-7; BUSS LW, 1990, TRENDS ECOL EVOL, V5, P352, DOI 10.1016/0169-5347(90)90093-S; Buss LW, 1987, EVOLUTION INDIVIDUAL, DOI 10.1515/9781400858712; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Cohen CS, 1998, EVOLUTION, V52, P746, DOI 10.1111/j.1558-5646.1998.tb03699.x; Edwards SV, 1998, TRENDS ECOL EVOL, V13, P305, DOI 10.1016/S0169-5347(98)01416-5; GRAFEN A, 1990, ANIM BEHAV, V39, P42, DOI 10.1016/S0003-3472(05)80724-9; Grosberg RK, 1996, EVOLUTION, V50, P2221, DOI 10.1111/j.1558-5646.1996.tb03612.x; GROSBERG RK, 1988, Q REV BIOL, V63, P377, DOI 10.1086/416026; GROSBERG RK, 1991, EVOLUTION, V45, P130, DOI 10.1111/j.1558-5646.1991.tb05272.x; GROSBERG RK, 1987, INVERTEBRATE HISTORE, P157; Hedrick PW, 1997, AM J HUM GENET, V61, P505, DOI 10.1086/515519; Keller L, 1998, NATURE, V394, P573, DOI 10.1038/29064; MATTON DP, 1994, P NATL ACAD SCI USA, V91, P1992, DOI 10.1073/pnas.91.6.1992; Mokady O, 1996, GENETICS, V143, P823; Ober C, 1997, AM J HUM GENET, V61, P497, DOI 10.1086/515511; Oka H., 1957, Proceedings of the Japan Academy, V33, P657; Oka H., 1970, PROFILES JAPANESE SC, P195; Palumbi SR, 1998, ENDLESS FORMS, P271; Paterson S, 1997, P ROY SOC B-BIOL SCI, V264, P1813, DOI 10.1098/rspb.1997.0250; Penn D, 1998, P ROY SOC B-BIOL SCI, V265, P1299, DOI 10.1098/rspb.1998.0433; Penn DJ, 1999, AM NAT, V153, P145, DOI 10.1086/303166; RINKEVICH B, 1995, P ROY SOC B-BIOL SCI, V259, P319, DOI 10.1098/rspb.1995.0047; SABBADIN A, 1979, J EXP ZOOL, V207, P289, DOI 10.1002/jez.1402070212; SABBADIN A, 1989, Acta Embryologiae et Morphologiae Experimentalis New Series, V10, P205; SCOFIELD VL, 1982, NATURE, V295, P499, DOI 10.1038/295499a0; Smith J. M., 1995, MAJOR TRANSITIONS EV; Stoner DS, 1999, P NATL ACAD SCI USA, V96, P9148, DOI 10.1073/pnas.96.16.9148; Stoner DS, 1996, P NATL ACAD SCI USA, V93, P15254, DOI 10.1073/pnas.93.26.15254; Vacquier VD, 1998, SCIENCE, V281, P1995, DOI 10.1126/science.281.5385.1995; Velicer GJ, 2000, NATURE, V404, P598, DOI 10.1038/35007066; WEDEKIND C, 1995, P ROY SOC B-BIOL SCI, V260, P245, DOI 10.1098/rspb.1995.0087	36	100	101	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 22	2000	289	5487					2111	2114		10.1126/science.289.5487.2111	http://dx.doi.org/10.1126/science.289.5487.2111			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11000110				2022-12-24	WOS:000089430900040
J	Malkowski, MG; Ginell, SL; Smith, WL; Garavito, RM				Malkowski, MG; Ginell, SL; Smith, WL; Garavito, RM			The productive conformation of arachidonic acid bound to prostaglandin synthase	SCIENCE			English	Article							CYCLOOXYGENASE ACTIVE-SITE; ENDOPEROXIDE-H SYNTHASE-1; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; HUMAN COLON-CANCER; CRYSTAL-STRUCTURE; H-2 SYNTHASE; ASPIRIN; INHIBITION; BINDING; COX-2	Prostaglandin H synthase-1 and -2 (PGHS-1 and -2) catalyze the committed step in prostaglandin synthesis and are targets for nonsteroidal anti-inflammatory drugs (NSAIDs) Like aspirin. We have determined the structure of PGHS-1 at 3 angstrom resolution with arachidonic acid (AA) bound in a chemically productive conformation. The fatty acid adopts an extended L-shaped conformation that positions the 13proS hydrogen of AA for abstraction by tyrosine-385, the Likely radical donor. A space also exists for oxygen addition on the antarafacial surface of the carbon in the 11-position (C-11). While this conformation allows endoperoxide formation between C-11 and C-9, it also implies that a subsequent conformational rearrangement must occur to allow formation of the C-8/C-12 bond and to position C-15 for attack by a second molecule of oxygen.	Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; Argonne Natl Lab, Struct Biol Ctr, Argonne, IL 60439 USA	Michigan State University; United States Department of Energy (DOE); Argonne National Laboratory	Garavito, RM (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	garavito@magaera.bch.msu.edu	Malkowski, Michael G/G-4939-2011	Malkowski, Michael G/0000-0003-1025-0014; Malkowski, Michael/0000-0002-1203-7463	NHLBI NIH HHS [F32 HL10170-01, R01 HL56773] Funding Source: Medline; NIGMS NIH HHS [P01 GM57323] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056773, F32HL010170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM057323] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bhattacharyya DK, 1996, J BIOL CHEM, V271, P2179, DOI 10.1074/jbc.271.4.2179; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeWitt DL, 1999, MOL PHARMACOL, V55, P625; DEWITT DL, 1990, J BIOL CHEM, V265, P5192; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Garavito RM, 1996, J BIOENERG BIOMEMBR, V28, P13, DOI 10.1007/BF02150674; Gierse JK, 1996, J BIOL CHEM, V271, P15810, DOI 10.1074/jbc.271.26.15810; HSI LC, 1995, BIOCHEM BIOPH RES CO, V207, P652, DOI 10.1006/bbrc.1995.1237; Hwang D, 1998, J NATL CANCER I, V90, P455, DOI 10.1093/jnci/90.6.455; KARGMAN SL, 1995, CANCER RES, V55, P2556; Kiefer JR, 2000, NATURE, V405, P97, DOI 10.1038/35011103; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; Kutchera W, 1996, P NATL ACAD SCI USA, V93, P4816, DOI 10.1073/pnas.93.10.4816; LANEUVILLE O, 1995, J BIOL CHEM, V270, P19330, DOI 10.1074/jbc.270.33.19330; LANEUVILLE O, 1994, J PHARMACOL EXP THER, V271, P927; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LECOMTE M, 1994, J BIOL CHEM, V269, P13207; Levy GN, 1997, FASEB J, V11, P234, DOI 10.1096/fasebj.11.4.9068612; Loll PJ, 1996, BIOCHEMISTRY-US, V35, P7330, DOI 10.1021/bi952776w; LOLL PJ, 1995, NAT STRUCT BIOL, V2, P637, DOI 10.1038/nsb0895-637; Luong C, 1996, NAT STRUCT BIOL, V3, P927, DOI 10.1038/nsb1196-927; Malkowski MG, 2000, ARCH BIOCHEM BIOPHYS, V380, P39, DOI 10.1006/abbi.2000.1906; Marnett LJ, 1998, CURR OPIN CHEM BIOL, V2, P482, DOI 10.1016/S1367-5931(98)80124-5; Marnett LJ, 1999, J BIOL CHEM, V274, P22903, DOI 10.1074/jbc.274.33.22903; McGeer PL, 1999, J LEUKOCYTE BIOL, V65, P409, DOI 10.1002/jlb.65.4.409; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PATRIGNANI P, 1994, J PHARMACOL EXP THER, V271, P1705; PATRONO C, 1994, NEW ENGL J MED, V330, P1287; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Rieke CJ, 1999, J BIOL CHEM, V274, P17109, DOI 10.1074/jbc.274.24.17109; Riendeau D, 1997, BRIT J PHARMACOL, V121, P105, DOI 10.1038/sj.bjp.0701076; Rowlinson SW, 1999, J BIOL CHEM, V274, P23305, DOI 10.1074/jbc.274.33.23305; Sheng HM, 1997, J CLIN INVEST, V99, P2254, DOI 10.1172/JCI119400; SHIMOKAWA T, 1992, J BIOL CHEM, V267, P12387; SMITH P, 1995, INT J ENVIRON HEAL R, V5, P5; SMITH WL, 1992, BIOCHEMISTRY-US, V31, P3, DOI 10.1021/bi00116a001; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; SMITH WW, UNPUB; Thuresson ED, 2000, J BIOL CHEM, V275, P8501, DOI 10.1074/jbc.275.12.8501; Zhang Y, 1997, J PHARMACOL EXP THER, V283, P1069	40	243	246	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 15	2000	289	5486					1933	1937		10.1126/science.289.5486.1933	http://dx.doi.org/10.1126/science.289.5486.1933			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354XD	10988074				2022-12-24	WOS:000089355800046
J	Hutchings, JA				Hutchings, JA			Collapse and recovery of marine fishes	NATURE			English	Article							COD; EXTINCTION	Over-exploitation and subsequent collapse of marine fishes has focused attention on the ability of affected populations to recover to former abundance levels(1-3) and on the degree to which their persistence is threatened by extinction(4,5). Although potential for recovery has been assessed indirectly(1), actual changes in population size following long-term declines have not been examined empirically. Here I show that there is very little evidence for rapid recovery from prolonged declines, in contrast to the perception that marine fishes are highly resilient to large population reductions(6,7). With the possible exception of herring and related species that mature early in life and are fished with highly selective equipment, my analysis of 90 stocks reveals that many gadids (for example, cod, haddock) and other non-clupeids (for example, flatfishes) have experienced little, if any, recovery as much as 15 years after 45-99% reductions in reproductive biomass. Although the effects of overfishing on single species may generally be reversible(1), the actual time required for recovery appears to be considerable. To exempt marine fishes from existing criteria used to assign extinction risk(6,7) would be inconsistent with precautionary approaches to fisheries management and the conservation of marine biodiversity.	Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada	Dalhousie University	Hutchings, JA (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada.	jhutch@mscs.dal.ca	Hutchings, Jeffrey/ABA-1098-2020	Hutchings, Jeffrey/0000-0003-1572-5429				Alverson DL, 1994, FISH TECHNOL, DOI DOI 10.3168/JDS.S0022-0302(94)77044-2; Campbell RR, 1996, CAN FIELD NAT, V110, P454; Carlton JT, 1999, ANNU REV ECOL SYST, V30, P515, DOI 10.1146/annurev.ecolsys.30.1.515; Casey JM, 1998, SCIENCE, V281, P690, DOI 10.1126/science.281.5377.690; Cook RM, 1997, NATURE, V385, P521, DOI 10.1038/385521a0; FROESE R, 1999, FISHBASE 99; HILBORN R, 1992; Hudson E, 1996, MARINE FISH IUCN RED; Hutchings J. A., 1995, N ATLANTIC FISHERIES, P38; HUTCHINGS JA, 1994, CAN J FISH AQUAT SCI, V51, P2126, DOI 10.1139/f94-214; *INT UN CONS NAT, 1996, IUCN RED LIST THREAT; *IUCN SPEC SURV CO, 1999, IUCN RED LIST CAT; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; Liermann M, 1997, CAN J FISH AQUAT SCI, V54, P1976, DOI 10.1139/cjfas-54-9-1976; Musick JA, 1999, FISHERIES, V24, P6, DOI 10.1577/1548-8446(1999)024<0006:CTDERI>2.0.CO;2; Myers RA, 1996, MAR ECOL PROG SER, V138, P293, DOI 10.3354/meps138293; MYERS RA, 1995, SCIENCE, V269, P1106, DOI 10.1126/science.269.5227.1106; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Roff Derek A., 1992; Saether BE, 1998, OIKOS, V83, P403, DOI 10.2307/3546856; Shank CC, 1999, CAN FIELD NAT, V113, P318; Sinclair Alan F., 1997, P71; Smith T. D., 1994, SCALING FISHERIES SC	24	611	639	4	491	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2000	406	6798					882	+		10.1038/35022565	http://dx.doi.org/10.1038/35022565			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347AG	10972288				2022-12-24	WOS:000088903600042
J	Rea, S; Eisenhaber, F; O'Carroll, N; Strahl, BD; Sun, ZW; Schmid, M; Opravil, S; Mechtler, K; Ponting, CP; Allis, CD; Jenuwein, T				Rea, S; Eisenhaber, F; O'Carroll, N; Strahl, BD; Sun, ZW; Schmid, M; Opravil, S; Mechtler, K; Ponting, CP; Allis, CD; Jenuwein, T			Regulation of chromatin structure by site-specific histone H3 methyltransferases	NATURE			English	Article							POSITION-EFFECT VARIEGATION; HETEROCHROMATIN-ASSOCIATED PROTEIN; GROUP GENE ENHANCER; FISSION YEAST; DROSOPHILA HETEROCHROMATIN; CHROMOSOME CONDENSATION; MAMMALIAN HOMOLOGS; DOMAIN; CENTROMERE; MUTATIONS	The organization of chromatin into higher-order structures influences chromosome function and epigenetic gene regulation. Higher-order chromatin has been proposed to be nucleated by the covalent modification of histone tails and the subsequent establishment of chromosomal subdomains by non-histone modifier factors. Here we show that human SUV39H1 and murine Suv39h1-mammalian homologues of Drosophila Su(var)3-9 and of Schizosaccharomyces pombe cir4-encode histone H3-specific methyltransferases that selectively methylate lysine 9 of the amino terminus of histone H3 in vitro. We mapped the catalytic motif to the evolutionarily conserved SET domain, which requires adjacent cysteine-rich regions to confer histone methyltransferase activity. Methylation of lysine 9 interferes with phosphorylation of serine 10, but is also influenced by preexisting modifications in the amino terminus of H3. In vivo, deregulated SUV39H1 or disrupted Suv39h activity modulate H3 serine 10 phosphorylation in native chromatin and induce aberrant mitotic divisions. Our data reveal a functional interdependence of site-specific H3 tail modifications and suggest a dynamic mechanism for the regulation of higher-order chromatin.	Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria; Univ Virginia, Hlth Sci Ctr, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; Univ Oxford, Dept Human Anat & Genet, MRC, Funct Genet Unit, Oxford OX1 3QX, England	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Virginia; University of Oxford	Jenuwein, T (corresponding author), Vienna Bioctr, Res Inst Mol Pathol, Dr Bohrgasse 7, A-1030 Vienna, Austria.	jenuwein@nt.imp.univie.ac.at	Mechtler, Karl/AAF-2717-2019; Strahl, Brian/C-7601-2012; Ponting, Chris/AAV-2621-2021; Schmid, Manfred/E-6725-2012	Mechtler, Karl/0000-0002-3392-9946; Strahl, Brian/0000-0002-4947-6259; Schmid, Manfred/0000-0003-0516-3055; O'Carroll, Donal/0000-0002-8626-2217; Ponting, Chris/0000-0003-0202-7816; Rea, Stephen/0000-0001-5797-5157				Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; AASLAND R, 1995, NUCLEIC ACIDS RES, V23, P3168; ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAKSA K, 1993, GENETICS, V135, P117; Ball LJ, 1997, EMBO J, V16, P2473, DOI 10.1093/emboj/16.9.2473; Birney E, 1996, NUCLEIC ACIDS RES, V24, P2730, DOI 10.1093/nar/24.14.2730; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Cleard F, 1997, EMBO J, V16, P5280, DOI 10.1093/emboj/16.17.5280; Cui XM, 1998, NAT GENET, V18, P331, DOI 10.1038/ng0498-331; DeRubertis F, 1996, NATURE, V384, P589; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; EISSENBERG JC, 1992, GENETICS, V131, P345; Ekwall K, 1996, J CELL SCI, V109, P2637; Firestein R, 2000, MOL CELL BIOL, V20, P4900, DOI 10.1128/MCB.20.13.4900-4909.2000; Frishman D, 1997, PROTEINS, V27, P329, DOI 10.1002/(SICI)1097-0134(199703)27:3<329::AID-PROT1>3.0.CO;2-8; Grewal SIS, 1998, GENETICS, V150, P563; Grunstein M, 1998, CELL, V93, P325, DOI 10.1016/S0092-8674(00)81160-5; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; HENIKOFF S, 1996, EPIGENETIC MECH GENE, P319; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Ivanova AV, 1998, NAT GENET, V19, P192, DOI 10.1038/566; Jenuwein T, 1998, CELL MOL LIFE SCI, V54, P80, DOI 10.1007/s000180050127; JONES RS, 1993, MOL CELL BIOL, V13, P6357, DOI 10.1128/MCB.13.10.6357; Karpen GH, 1997, TRENDS GENET, V13, P489, DOI 10.1016/S0168-9525(97)01298-5; KLEIN RR, 1995, PLANT MOL BIOL, V27, P249, DOI 10.1007/BF00020181; KOONIN EV, 1995, NUCLEIC ACIDS RES, V23, P4229, DOI 10.1093/nar/23.21.4229; Laible G, 1997, EMBO J, V16, P3219, DOI 10.1093/emboj/16.11.3219; Larsson J, 1996, GENETICS, V143, P887; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; Melcher M, 2000, MOL CELL BIOL, V20, P3728, DOI 10.1128/MCB.20.10.3728-3741.2000; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; PEHRSON JR, 1992, SCIENCE, V257, P1398; PLATERO JS, 1995, EMBO J, V14, P3977, DOI 10.1002/j.1460-2075.1995.tb00069.x; REUTER G, 1992, BIOESSAYS, V14, P605, DOI 10.1002/bies.950140907; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Schotta G, 2000, MOL GEN GENET, V262, P916, DOI 10.1007/PL00008659; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; STASSEN MJ, 1995, MECH DEVELOP, V52, P209, DOI 10.1016/0925-4773(95)00402-M; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; SULLIVAN KF, 1994, J CELL BIOL, V127, P581, DOI 10.1083/jcb.127.3.581; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; TSCHIERSCH B, 1994, EMBO J, V13, P3822, DOI 10.1002/j.1460-2075.1994.tb06693.x; Turner BM, 1998, CELL MOL LIFE SCI, V54, P21, DOI 10.1007/s000180050122; Wallrath L, 1998, CURR OPIN GENET DEV, V8, P147, DOI 10.1016/S0959-437X(98)80135-4; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Zheng Q, 1998, PROTEIN EXPRES PURIF, V14, P104, DOI 10.1006/prep.1998.0936	49	2054	2134	6	244	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2000	406	6796					593	599		10.1038/35020506	http://dx.doi.org/10.1038/35020506			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949293				2022-12-24	WOS:000088653800038
J	Wang, ZH; Castano, IB; De Las Penas, A; Adams, C; Christman, MF				Wang, ZH; Castano, IB; De Las Penas, A; Adams, C; Christman, MF			Pol kappa: A DNA polymerase required for sister chromatid cohesion	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; CHROMOSOME CONDENSATION; TOPOISOMERASE-I; BUDDING YEAST; REPLICATION; PROTEIN; IDENTIFICATION; COMPLEXES; SITES; BETA	Establishment of cohesion between sister chromatids is coupled to replication fork passage through an unknown mechanism. Here we report that TRF4, an evolutionarily conserved gene necessary for chromosome segregation, encodes a DNA polymerase with beta-polymerase-like properties. A double mutant in the redundant homologs, TRF4 and TRF5, is unable to complete S phase, whereas a trf4 single mutant completes a presumably defective S phase that results in a failure of cohesion between the replicated sister chromatids. This suggests that TRFs are a key Link in the coordination between DNA replication and sister chromatid cohesion. Trf4 and Trf5 represent the fourth class of essential nuclear DNA polymerases (designated DNA polymerase kappa) in Saccharomyces cerevisiae and probably in all eukaryotes.	Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA	University of Virginia	Christman, MF (corresponding author), Univ Virginia, Dept Microbiol, Box 441,Jordan Hall,1300 Jefferson Pk Ave, Charlottesville, VA 22908 USA.		De Las Penas, Alejandro/M-7719-2013	De Las Penas, Alejandro/0000-0002-2933-2856; Castano, Irene/0000-0002-5968-2101				Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1609, DOI 10.1093/nar/27.7.1609; Blat Y, 1999, CELL, V98, P249, DOI 10.1016/S0092-8674(00)81019-3; Castano IB, 1996, NUCLEIC ACIDS RES, V24, P2404, DOI 10.1093/nar/24.12.2404; Castano IB, 1996, GENE DEV, V10, P2564, DOI 10.1101/gad.10.20.2564; Cha RS, 2000, GENE DEV, V14, P493; DEPAMHILIS ML, 1996, DNA REPLICATION EUKA; GUACCI V, 1994, J CELL BIOL, V125, P517, DOI 10.1083/jcb.125.3.517; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Kornberg A., 1992, DNA REPLICATION; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Nasmyth K, 2000, SCIENCE, V288, P1379, DOI 10.1126/science.288.5470.1379; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; RUSCITTI T, 1992, J BIOL CHEM, V267, P16806; SADOFF BU, 1995, GENETICS, V141, P465; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; Tanaka K, 2000, MOL CELL BIOL, V20, P3459, DOI 10.1128/MCB.20.10.3459-3469.2000; Toth A, 1999, GENE DEV, V13, P320, DOI 10.1101/gad.13.3.320; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; Walowsky C, 1999, J BIOL CHEM, V274, P7302, DOI 10.1074/jbc.274.11.7302; Wang SW, 2000, MOL CELL BIOL, V20, P3234, DOI 10.1128/MCB.20.9.3234-3244.2000; WANG Z, UNPUB; Wilson SH, 1998, MUTAT RES-DNA REPAIR, V407, P203, DOI 10.1016/S0921-8777(98)00002-0	25	163	167	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 4	2000	289	5480					774	779		10.1126/science.289.5480.774	http://dx.doi.org/10.1126/science.289.5480.774			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341FZ	10926539				2022-12-24	WOS:000088581500040
J	Salama, P; Spiegel, P; Van Dyke, M; Phelps, L; Wilkinson, C				Salama, P; Spiegel, P; Van Dyke, M; Phelps, L; Wilkinson, C			Mental health and nutritional status among the adult Serbian minority in Kosovo	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REFUGEE; QUESTIONNAIRE; POPULATIONS; PENSIONERS; MORTALITY	Context Since the beginning of the North Atlantic Treaty Organization intervention in Kosovo in June 1999, few objective data have been available on relevant health indicators for the Serbian ethnic minority in Kosovo. Objective To determine the prevalence of undernutrition among Serbian adults aged 60 years or older and psychiatric morbidity among the adult Serbian population in Kosovo. Design, Setting, and Participants A systematic random sample survey of 212 households was conducted between September 27 and October 2, 1999, in Pristina, the capital city, and in 10 towns in the rural municipality of Gnjilane in Kosovo. Of the 212 households surveyed, 204 adults aged 15 years or older completed the General Health Questionnaire-28 (GHQ-28) and anthropometric measurements were taken for 98 adults aged 60 years or older and for a comparison group of 51 adults aged 18 to 59 years. Main Outcome Measures Body mass index of less than 18.5 kg/m(2) in older adults; nonspecific psychiatric morbidity among adults; and self-reported use of health care services, access to food rations, and primary sources of prewar and postwar income. Results Undernutrition was found in 11.2% (95% confidence interval [CI], 5.7%-19.2%) of Serbian adults aged 60 years or older compared with 2.0% (95% CI, 0.1% 11.8%) of Serbian adults aged 18 to 59 years. The mean (SE) total score for the GHQ-28 was 13.0 (0.52). In a comparison of the GHQ-28 scores of the Serbian adults with the Kosovar Albanian adults (data from a recent survey), the mean (SE) score adjusted for age and sex was 12.8 (0.52) vs 11.1 (0.58); P=.03, respectively. The GHQ-28 scores were also higher for the Serbians in the subcategories of social dysfunction (2.8 [0.17] vs 2.2 [0.13], P=.008) and severe depression (1.9 [0.15] vs 0.9 [0.09]; P<.001), respectively. Serbian women and persons living alone or in small family units were more prone to psychiatric morbidity. Of the 141 respondents reporting the need for health care services, 83 (57.6%) reported not obtaining such services; 204 of 212 (96.2%) households were on a food distribution list. The majority of prewar income came from government jobs compared with farming and humanitarian aid for postwar income. Conclusions The undernutrition of older Serbian adults in Kosovo should be monitored. The high prevalence of symptoms of social dysfunction and severe depression suggest the need for implementation of mental health programs in the Serbian community.	Ctr Dis Control & Prevent, Epidem Intelligence Serv, Epidemiol Program Off, Natl Ctr Environm Hlth, Atlanta, GA 30341 USA; Ctr Dis Control & Prevent, Int Emergency & Refugee Hlth Branch, Natl Ctr Environm Hlth, Atlanta, GA 30341 USA; Int Rescue Comm, Pristina, Kosovo, Yugoslavia; Action Against Hunger, Pristina, Kosovo, Yugoslavia	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Salama, P (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv, Epidemiol Program Off, Natl Ctr Environm Hlth, 4770 Buford Hwy NE,Mailstop F-48, Atlanta, GA 30341 USA.		Spiegel, Paul/AAL-3238-2021	Spiegel, Paul/0000-0002-6158-6661				*ACT AG HUNG, 1999, ANTHR NUTR INF FEED; BASSEY EJ, 1986, ANN HUM BIOL, V13, P499, DOI 10.1080/03014468600008661; BRANCA F, 1996, HLTH NUTR SURVEY INT; Cardozo BL, 2000, JAMA-J AM MED ASSOC, V284, P569, DOI 10.1001/jama.284.5.569; Coyne JC, 2000, JAMA-J AM MED ASSOC, V283, P55, DOI 10.1001/jama.283.1.55; Furukawa TA, 1999, LANCET, V353, P561, DOI 10.1016/S0140-6736(98)05470-1; GOLDBERG D, 1986, BRIT MED J, V293, P1188, DOI 10.1136/bmj.293.6556.1188; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; Karcic AA, 2000, JAMA-J AM MED ASSOC, V283, P55; KOZARICKOVACIC D, 1995, AM J ORTHOPSYCHIAT, V65, P428, DOI 10.1037/h0079656; KWOK T, 1991, J AM GERIATR SOC, V39, P492, DOI 10.1111/j.1532-5415.1991.tb02495.x; LAWRENCE M, 2000, JOINT WFP UNHCR FOOD; MCNABB SJN, 1994, AM J PREV MED, V10, P65, DOI 10.1016/S0749-3797(18)30620-2; Mollica RF, 1997, J AM ACAD CHILD PSY, V36, P1098, DOI 10.1097/00004583-199708000-00017; Mollica RF, 1999, JAMA-J AM MED ASSOC, V282, P433, DOI 10.1001/jama.282.5.433; *PHYS HUM RIGHTS, 1999, WAR CRIM KOS POP BAS; Popkin BM, 1996, AM J PUBLIC HEALTH, V86, P355, DOI 10.2105/AJPH.86.3.355; Rush D, 1996, AM J PUBLIC HEALTH, V86, P361, DOI 10.2105/AJPH.86.3.361; Shetty P. S., 1994, BODY MASS INDEX MEAS; Spiegel PB, 2000, LANCET, V355, P2204, DOI 10.1016/S0140-6736(00)02404-1; TOOLE MJ, 1988, J TROP PEDIATRICS, V34, P218, DOI 10.1093/tropej/34.5.218; Toole MJ, 1997, ANNU REV PUBL HEALTH, V18, P283, DOI 10.1146/annurev.publhealth.18.1.283; TOOLE MJ, 1990, JAMA-J AM MED ASSOC, V263, P3296, DOI 10.1001/jama.263.24.3296; *UN HIGH COMM REF, 2000, 4 ASS SIT ETHN MIN K; *UN HIGH COMM REF, 1999, 2 ASS SIT ETHN MIN K, P1; *UN HIGH COMM REF, 1999, KOS CRIS UPD; *US STAT DEP, 1999, POSTSCR ALB RETR MIS, P1; WATSON F, 1995, DISASTERS, V19, P216, DOI 10.1111/j.1467-7717.1995.tb00341.x; *WHO, 1995, WHO TECHN REP SER, P439	30	24	24	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 2	2000	284	5					578	584		10.1001/jama.284.5.578	http://dx.doi.org/10.1001/jama.284.5.578			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	337WG	10918703	Bronze			2022-12-24	WOS:000088385400026
J	Lagergren, J; Bergstrom, R; Adami, HO; Nyren, O				Lagergren, J; Bergstrom, R; Adami, HO; Nyren, O			Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma	ANNALS OF INTERNAL MEDICINE			English	Article							GASTROESOPHAGEAL REFLUX; UNITED-STATES; ISOSORBIDE DINITRATE; INCREASING INCIDENCE; GASTRIC-CARCINOMA; RISING INCIDENCE; THEOPHYLLINE; PRESSURE; ACHALASIA; ASTHMA	Background: The incidence of esophageal adenocarcinoma is increasing rapidly. Gastroesophageal reflux is a strong risk factor for this disease. The increase in incidence of esophageal adenocarcinoma coincided with the introduction of medications that promote reflux by relaxing the lower esophageal sphincter (LES), such as nitroglycerin, anticholinergics, beta-adrenergic agonists, aminophyllines, and benzodiazepines. Objective: To test the possible association between use of LES-relaxing medications and risk for adenocarcinoma of the esophagus and gastric cardia. Design: A nationwide population-based case-control study with in-person interviews. Setting: Sweden, 1995 through 1997. Patients: 189 patients with newly diagnosed esophageal adenocarcinoma, 262 with adenocarcinoma of the gastric cardia, and 167 with esophageal squamous-cell carcinoma were compared with 820 population-based controls. Measurements: Estimated incidence rate ratios, calculated by using multivariate logistic regression from case-control data with adjustment for potential confounding. Results: Past use of LES-relaxing drugs was positively associated with risk for esophageal adenocarcinoma. Among daily, long-term users (>5 years) of LES-relaxing drugs, the estimated incidence rate ratio was 3.8 (95% CI, 2.2 to 6.4) compared with persons who had never used these drugs. Drugs of all classes contributed to the increased risk, but the association was particularly strong for anticholinergics. Short-term use of other types of LES-relaxing drugs did not seem to be strongly associated with risk. The association almost disappeared after adjustment for reflux symptoms, indicating that promotion of reflux is the link between use of LES-relaxing drugs and esophageal adenocarcinoma. If 15 490 men in any age group take LES-relaxing drugs daily far 5 years, 1 additional case of adenocarcinoma would be expected (number needed to treat for harm); in men older than 60 years of age, the number needed to treat for harm is 5570. Assuming a causal relation, about 10% of the esophageal adenocarcinomas occurring in the population may be attributable to intake of LES-relaxing drugs. Cardia adenocarcinoma and esophageal squamous-cell carcinoma were not associated with use of LES-relaxing drugs. Conclusions: The widespread use of LES-relaxing drugs may have contributed to the increasing incidence of esophageal adenocarcinoma.	Karolinska Inst, Dept Med Epidemiol, SE-17177 Stockholm, Sweden; Danderyd Hosp, Stockholm, Sweden; Uppsala Univ, Uppsala, Sweden; Harvard Univ, Harvard Ctr Canc Prevent, Boston, MA 02115 USA	Karolinska Institutet; Danderyds Hospital; Uppsala University; Harvard University	Lagergren, J (corresponding author), Karolinska Inst, Dept Med Epidemiol, Box 281, SE-17177 Stockholm, Sweden.	jesper.lagergren@mep.ki.se		Lagergren, Jesper/0000-0002-5143-5448	NCI NIH HHS [R01 CA57947-03] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA057947] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AGGESTRUP S, 1991, DIGEST DIS, V9, P360, DOI 10.1159/000171324; Armstrong RW, 1996, INT J EPIDEMIOL, V25, P941, DOI 10.1093/ije/25.5.941; Ayres JG, 1996, EUR RESPIR J, V9, P1073, DOI 10.1183/09031936.96.09051073; BERQUIST WE, 1981, J ALLERGY CLIN IMMUN, V67, P407, DOI 10.1016/0091-6749(81)90087-7; BLOT WJ, 1991, JAMA-J AM MED ASSOC, V265, P1287, DOI 10.1001/jama.265.10.1287; CASTELL DO, 1975, ANN INTERN MED, V83, P390, DOI 10.7326/0003-4819-83-3-390; Davies HTO, 1998, BRIT MED J, V316, P989, DOI 10.1136/bmj.316.7136.989; Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2; DIMARINO AJ, 1982, DIGEST DIS SCI, V27, P1063, DOI 10.1007/BF01391441; ElSerag HB, 1997, GASTROENTEROLOGY, V113, P755, DOI 10.1016/S0016-5085(97)70168-9; GELFOND M, 1982, GASTROENTEROLOGY, V83, P963; GOYAL RK, 1973, J CLIN INVEST, V52, P337, DOI 10.1172/JCI107189; Hansen S, 1997, INT J CANCER, V71, P340, DOI 10.1002/(SICI)1097-0215(19970502)71:3<340::AID-IJC5>3.0.CO;2-Y; HANSSON LE, 1993, INT J CANCER, V54, P402, DOI 10.1002/ijc.2910540309; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; NELSON LM, 1990, EPIDEMIOL REV, V12, P71, DOI 10.1093/oxfordjournals.epirev.a036063; PERA M, 1993, GASTROENTEROLOGY, V104, P510, DOI 10.1016/0016-5085(93)90420-H; Powell J, 1992, Eur J Cancer Prev, V1, P265, DOI 10.1097/00008469-199204000-00008; ROTHMAN KJ, 1998, MODERN EPIDEMIOLOGY, P54; Rothman KJ, 1998, MODERN EPIDEMIOLOGY, P150; ROTHMAN KJ, 1998, MODERN EPIDEMIOLOGY, P127; RUSHNAK MJ, 1980, AM J GASTROENTEROL, V73, P127; RUZKOWSKI CJ, 1992, ARCH INTERN MED, V152, P783, DOI 10.1001/archinte.152.4.783; Salas M, 1999, AM J EPIDEMIOL, V149, P981; Sontag SJ, 1997, AM J MED, V103, p84S, DOI 10.1016/S0002-9343(97)00330-6; SPECHLER SJ, 1986, NEW ENGL J MED, V315, P362, DOI 10.1056/NEJM198608073150605; Stacher G, 1997, ALIMENT PHARM THERAP, V11, P967, DOI 10.1046/j.1365-2036.1997.00241.x; STEIN MR, 1980, ANN ALLERGY, V45, P238; Vaughan TL, 1998, CANCER EPIDEM BIOMAR, V7, P749; WANG HH, 1994, CANCER CAUSE CONTROL, V5, P573, DOI 10.1007/BF01831386; WEST SL, 1994, PHARMACOEPIDEM DR S, P549; WONG RKH, 1987, J CLIN GASTROENTEROL, V9, P386, DOI 10.1097/00004836-198708000-00006; ZFASS AM, 1970, AM J DIG DIS, V15, P303, DOI 10.1007/BF02239282	33	133	134	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 1	2000	133	3					165	175		10.7326/0003-4819-133-3-200008010-00007	http://dx.doi.org/10.7326/0003-4819-133-3-200008010-00007			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	338XW	10906830				2022-12-24	WOS:000088449400001
J	Korzheva, N; Mustaev, A; Kozlov, M; Malhotra, A; Nikiforov, V; Goldfarb, A; Darst, SA				Korzheva, N; Mustaev, A; Kozlov, M; Malhotra, A; Nikiforov, V; Goldfarb, A; Darst, SA			A structural model of transcription elongation	SCIENCE			English	Article							COLI RNA-POLYMERASE; ESCHERICHIA-COLI; BETA-SUBUNIT; FUNCTIONAL TOPOGRAPHY; ANGSTROM RESOLUTION; PROMOTER COMPLEXES; CRYSTAL-STRUCTURE; DNA-REPLICATION; ACTIVE-CENTER; NASCENT RNA	The path of the nucleic acids through a transcription elongation complex was tracked by mapping cross-links between bacterial RNA polymerase (RNAP) and transcript RNA or template DNA onto the x-ray crystal structure. In the resulting model, the downstream duplex DNA is nestled in a trough formed by the beta' subunit and enclosed an top by the beta subunit. In the RNAP channel, the RNA/DNA hybrid extends from the enzyme active site, along a region of the beta subunit harboring rifampicin resistance mutations, to the beta' subunit "rudder. The single-stranded RNA is then extruded through another channel formed by the beta-subunit flap domain. The model provides insight into the functional properties of the transcription complex.	Rockefeller Univ, New York, NY 10021 USA; Publ Hlth Res Inst City New York Inc, New York, NY 10016 USA; Univ Miami, Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA; Russian Acad Sci, Inst Mol Genet, Moscow 123182, Russia	Rockefeller University; University of Miami; Russian Academy of Sciences	Darst, SA (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	darst@rockvax.rockefeller.edu	Kozlov, Maxim/GLN-3047-2022; Malhotra, Arun/A-3916-2008; Malhotra, Arun/Z-5140-2019	Kozlov, Maxim/0000-0002-5994-9099; Malhotra, Arun/0000-0001-6656-7841; Malhotra, Arun/0000-0001-6656-7841	NIGMS NIH HHS [GM30717, GM49242, GM53759] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053759, R01GM030717, R01GM049242] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams PD, 1997, P NATL ACAD SCI USA, V94, P5018, DOI 10.1073/pnas.94.10.5018; ARCHAMBAULT J, 1993, MICROBIOL REV, V57, P703, DOI 10.1128/MMBR.57.3.703-724.1993; Bartlett MS, 1998, J MOL BIOL, V279, P331, DOI 10.1006/jmbi.1998.1779; BORUKHOV S, 1991, J BIOL CHEM, V266, P23921; BORUKHOV S, 1991, J BIOL CHEM, V266, P23932; CHAMBERLIN MJ, 1993, HARVEY LECT, V88, P1; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; CHENG SWC, 1991, SCIENCE, V254, P1205, DOI 10.1126/science.1835546; Darst SA, 1998, COLD SPRING HARB SYM, V63, P269, DOI 10.1101/sqb.1998.63.269; DARST SA, UNPUB; DAUBE SS, 1992, SCIENCE, V258, P1320, DOI 10.1126/science.1280856; DORVAL BC, 1991, J MOL BIOL, V221, P837, DOI 10.1016/0022-2836(91)80179-X; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; EPSHTEIN V, UNPUB; Gelles J, 1998, CELL, V93, P13, DOI 10.1016/S0092-8674(00)81140-X; GRACHEV MA, 1989, EUR J BIOCHEM, V180, P577, DOI 10.1111/j.1432-1033.1989.tb14684.x; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Horton NC, 1996, J MOL BIOL, V264, P521, DOI 10.1006/jmbi.1996.0658; JIN DJ, 1988, J MOL BIOL, V202, P45, DOI 10.1016/0022-2836(88)90517-7; JOKERST RS, 1989, MOL GEN GENET, V215, P266, DOI 10.1007/BF00339727; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KEANA JFW, 1990, J ORG CHEM, V55, P3640, DOI 10.1021/jo00298a048; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; KIRKEGAARD K, 1983, P NATL ACAD SCI-BIOL, V80, P2544, DOI 10.1073/pnas.80.9.2544; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Komissarova N, 1998, P NATL ACAD SCI USA, V95, P14699, DOI 10.1073/pnas.95.25.14699; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Korzheva N, 1998, COLD SPRING HARB SYM, V63, P337, DOI 10.1101/sqb.1998.63.337; LYNN SP, 1988, J BIOL CHEM, V263, P472; Markovtsov V, 1996, P NATL ACAD SCI USA, V93, P3221, DOI 10.1073/pnas.93.8.3221; MCCLURE WR, 1978, J BIOL CHEM, V253, P8949; MECSAS J, 1991, J MOL BIOL, V220, P585, DOI 10.1016/0022-2836(91)90102-C; MONFORTE JA, 1990, BIOCHEMISTRY-US, V29, P7882, DOI 10.1021/bi00486a015; Mooney RA, 1998, J BACTERIOL, V180, P3265, DOI 10.1128/JB.180.13.3265-3275.1998; Mustaev A, 1997, P NATL ACAD SCI USA, V94, P6641, DOI 10.1073/pnas.94.13.6641; Nudler E, 1998, SCIENCE, V281, P424, DOI 10.1126/science.281.5375.424; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Nudler E, 1996, SCIENCE, V273, P211, DOI 10.1126/science.273.5272.211; Polyakov A, 1998, J MOL BIOL, V281, P465, DOI 10.1006/jmbi.1998.1958; Reeder TC, 1996, CELL, V87, P767, DOI 10.1016/S0092-8674(00)81395-1; REES WA, 1993, SCIENCE, V260, P1646, DOI 10.1126/science.8503010; RICHARDSON JP, 1975, J MOL BIOL, V98, P565, DOI 10.1016/S0022-2836(75)80087-8; SEVERINOV K, 1994, J BIOL CHEM, V269, P14254; SEVERINOV K, 1995, P NATL ACAD SCI USA, V92, P4591, DOI 10.1073/pnas.92.10.4591; SEVERINOV K, 1994, MOL GEN GENET, V244, P120, DOI 10.1007/BF00283512; Severinov K, 1996, J BIOL CHEM, V271, P27969, DOI 10.1074/jbc.271.44.27969; SIEBENLIST U, 1980, CELL, V20, P269, DOI 10.1016/0092-8674(80)90613-3; SWEETSER D, 1987, P NATL ACAD SCI USA, V84, P1192, DOI 10.1073/pnas.84.5.1192; Uptain SM, 1997, ANNU REV BIOCHEM, V66, P117, DOI 10.1146/annurev.biochem.66.1.117; Wang DG, 1997, J BIOL CHEM, V272, P5989, DOI 10.1074/jbc.272.9.5989; WILSON KS, 1995, P NATL ACAD SCI USA, V92, P8793, DOI 10.1073/pnas.92.19.8793; YAGER TD, 1987, ESCHERICHIA COLI SAL, P1241; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611; ZAYCHIKOV E, 1995, P NATL ACAD SCI USA, V92, P1739, DOI 10.1073/pnas.92.5.1739; Zaychikov E, 1996, SCIENCE, V273, P107, DOI 10.1126/science.273.5271.107; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	56	328	340	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2000	289	5479					619	625		10.1126/science.289.5479.619	http://dx.doi.org/10.1126/science.289.5479.619			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	338XD	10915625				2022-12-24	WOS:000088447800054
J	Duncan, J; Seitz, RJ; Kolodny, J; Bor, D; Herzog, H; Ahmed, A; Newell, FN; Emslie, H				Duncan, J; Seitz, RJ; Kolodny, J; Bor, D; Herzog, H; Ahmed, A; Newell, FN; Emslie, H			A neural basis for general intelligence	SCIENCE			English	Article							FRONTAL-LOBE; PET; ACTIVATION; ATTENTION; BEHAVIOR; HUMANS; MODELS; FMRI	Universal positive correlations between different cognitive tests motivate the concept of "general intelligence" or Spearman's g. Here the neural basis for g is investigated by means of positron emission tomography. Spatial, verbal, and perceptuo-motor tasks with high-g involvement are compared with matched Low-g control tasks. In contrast to the common view that g reflects a broad sample of major cognitive functions, high-g tasks do not show diffuse recruitment of multiple brain regions. Instead they are associated with selective recruitment of lateral frontal cortex in one or both hemispheres. Despite very different task content in the three high-g-low-g contrasts, Lateral frontal recruitment is markedly similar in each case, Many previous experiments have shown these same frontal regions to be recruited by a broad range of different cognitive demands. The results suggest that "general intelligence" derives from a specific frontal system important in the control of diverse forms of behavior.	MRC, Cognit & Brain Sci Unit, Cambridge CB2 2EF, England; Univ Dusseldorf, Dept Neurol, D-40225 Dusseldorf, Germany; Forschungszentrum Julich, Res Ctr, Inst Med, D-52407 Julich, Germany	Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich	Duncan, J (corresponding author), MRC, Cognit & Brain Sci Unit, 15 Chaucer Rd, Cambridge CB2 2EF, England.	john.duncan@mrc-cbu.cam.ac.uk	Newell, Fiona/AIE-2422-2022	Newell, Fiona/0000-0002-7363-2346; Duncan, John/0000-0002-9695-2764; Bor, Daniel/0000-0002-0741-8157				[Anonymous], 1998, G FACTOR; BRETT M, 1999, NEUROIMAGE, V9, pS56; Cattell RB, 1973, MEASURING INTELLIGEN; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; DUNCAN J, 1995, NEUROPSYCHOLOGIA, V33, P261, DOI 10.1016/0028-3932(94)00124-8; DUNCAN J, 1990, ERGONOMICS, V33, P1265, DOI 10.1080/00140139008925331; Duncan J, 1996, COGNITIVE PSYCHOL, V30, P257, DOI 10.1006/cogp.1996.0008; DUNCAN J, IN PRESS TRENDS NEUR; Ekstrom R.B., 1976, ETS KIT FACTOR REFER; Engle Randall W., 1999, MODELS WORKING MEMOR, P102; Esposito G, 1999, BRAIN, V122, P963, DOI 10.1093/brain/122.5.963; Heim AW., 1970, AH4 GROUP TEST GEN I; HERZOG H, 1994, EUR J NUCL MED, V21, P138; Herzog H, 1996, J CEREBR BLOOD F MET, V16, P645, DOI 10.1097/00004647-199607000-00015; HUMPHREYS LG, 1981, INTELLIGENCE LEARNIN, P87, DOI DOI 10.1007/978-1-4684-1083-9_7; Mackintosh Nicholas J., 2011, IQ HUMAN INTELLIGENC; MARSHALEK B, 1983, INTELLIGENCE, V7, P107, DOI 10.1016/0160-2896(83)90023-5; Petrides M, 1994, HDB NEUROPSYCHOLOGY, V9, P59; Prabhakaran V, 1997, COGNITIVE PSYCHOL, V33, P43, DOI 10.1006/cogp.1997.0659; Raven JC, 1988, MANUAL RAVENS PROGR; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; Thomson GH, 1916, BRIT J PSYCHOL, V8, P271, DOI 10.1111/j.2044-8295.1916.tb00133.x; THURSTONE LL, 1940, VECTORS MIND; Wojciulik E, 1999, NEURON, V23, P747, DOI 10.1016/S0896-6273(01)80033-7; Worsley KJ, 1997, NEUROIMAGE, V6, P305, DOI 10.1006/nimg.1997.0294; WOTHKE W, 1991, AFHRLTR9067	28	672	690	1	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2000	289	5478					457	460		10.1126/science.289.5478.457	http://dx.doi.org/10.1126/science.289.5478.457			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	336ME	10903207	Green Published			2022-12-24	WOS:000088305500049
J	Diebel, CE; Proksch, R; Green, CR; Neilson, P; Walker, MM				Diebel, CE; Proksch, R; Green, CR; Neilson, P; Walker, MM			Magnetite defines a vertebrate magnetoreceptor	NATURE			English	Article							FORCE MICROSCOPY; BIOGENIC MAGNETITE; ONCORHYNCHUS-NERKA; SOCKEYE SALMON; HOMING PIGEONS; SENSITIVITY; ANIMALS	The key behavioural, physiological and anatomical components of a magnetite-based magnetic sense have been demonstrated in rainbow trout (Oncorhynchus mykiss)(1). Candidate receptor cells located within a discrete sub-layer of the olfactory lamellae contained iron-rich crystals that were similar in size and shape to magnetite crystals extracted from salmon(1,2). Here we show that these crystals, which mapped to individual receptors using confocal and atomic force microscopy, are magnetic, as they are uniquely associated with dipoles detected by magnetic force microscopy. Analysis of their magnetic properties identifies the crystals as single-domain magnetite. In addition, three-dimensional reconstruction of the candidate receptors using confocal and atomic force microscopy imaging confirm that several magnetic crystals are arranged in a chain of about 1 mm within the receptor, and that the receptor is a multi-lobed single cell. These results are consistent with a magnetite-based detection mechanism(2,3), as 1-mu m chains of single-domain magnetite crystals are highly suitable for the behavioural and physiological responses to magnetic intensity previously reported in the trout.	Univ Auckland, Sch Biol Sci, Expt Biol Res Grp, Auckland, New Zealand; Digital Instruments, Magnet Lab, Goleta, CA 93117 USA; Univ Auckland, Sch Med, Dept Anat Radiol, Auckland, New Zealand	University of Auckland; University of Auckland	Diebel, CE (corresponding author), Auckland Museum, Private Bag 92018, Auckland, New Zealand.		Green, Colin R/B-5663-2012	Green, Colin R/0000-0003-3459-6298; Walker, Michael/0000-0001-9631-9128				BABCOCK K, 1995, MATER RES SOC SYMP P, V355, P311; DIAZRICCI JC, 1992, J GEOPHYS RES, V97, P17039; Dunin-Borkowski RE, 1998, SCIENCE, V282, P1868, DOI 10.1126/science.282.5395.1868; GOULD JL, 1984, ANNU REV PHYSIOL, V46, P585, DOI 10.1146/annurev.ph.46.030184.003101; GOULD JL, 1978, SCIENCE, V201, P1026, DOI 10.1126/science.201.4360.1026; Kirschvink J. L., 1983, BIOMAGNETISM, P501; KIRSCHVINK JL, 1981, BIOSYSTEMS, V13, P181, DOI 10.1016/0303-2647(81)90060-5; KIRSCHVINK JL, 1985, MAGNETITE BIOMINERAL, P243; Liou SH, 1998, J MAGN MAGN MATER, V190, P130, DOI 10.1016/S0304-8853(98)00284-4; LOHMANN KJ, 1984, J EXP BIOL, V113, P29; MANN S, 1988, J EXP BIOL, V140, P35; PROKSCH R, 1995, J APPL PHYS, V78, P3303, DOI 10.1063/1.360022; PROKSCH RB, 1995, APPL PHYS LETT, V66, P2582, DOI 10.1063/1.113508; SEMM P, 1990, BRAIN RES BULL, V25, P735, DOI 10.1016/0361-9230(90)90051-Z; Walker MM, 1999, J THEOR BIOL, V197, P271, DOI 10.1006/jtbi.1998.0875; WALKER MM, 1988, J EXP BIOL, V140, P51; WALKER MM, 1984, J COMP PHYSIOL, V155, P673, DOI 10.1007/BF00610853; WALKER MM, 1989, J EXP BIOL, V145, P489; Walker MM, 1997, NATURE, V390, P371, DOI 10.1038/37057; Walker MM, 1998, J THEOR BIOL, V192, P341, DOI 10.1006/jtbi.1998.0653; Wiltschko R., 1995, TIEROSYCHOL; Wittborn J, 1999, NANOSTRUCT MATER, V12, P1149, DOI 10.1016/S0965-9773(99)00316-5; YORKE ED, 1981, J THEOR BIOL, V89, P533, DOI 10.1016/0022-5193(81)90367-2; YORKE ED, 1979, J THEOR BIOL, V77, P101, DOI 10.1016/0022-5193(79)90140-1	24	177	191	3	61	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 20	2000	406	6793					299	302		10.1038/35018561	http://dx.doi.org/10.1038/35018561			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917530				2022-12-24	WOS:000088251900048
J	Graether, SP; Kuiper, MJ; Gagne, SM; Walker, VK; Jia, ZC; Sykes, BD; Davies, PL				Graether, SP; Kuiper, MJ; Gagne, SM; Walker, VK; Jia, ZC; Sykes, BD; Davies, PL			beta-helix structure and ice-binding properties of a hyperactive antifreeze protein from an insect	NATURE			English	Article							WINTER FLOUNDER; HYSTERESIS; ADSORPTION; MECHANISM; PROGRAM	Insect antifreeze proteins (AFP) are considerably more active at inhibiting ice crystal growth than AFP from fish or plants. Several insect AFPs, also known as thermal hysteresis proteins, have been cloned(1-3) and expressed(1,2). Their maximum activity is 3-4 times that of fish AFPs(1) and they are 10-100 times more effective at micromolar concentrations. Here we report the solution structure of spruce budworm (Choristoneura fumiferana) AFP and characterize its ice-binding properties. The 9-kDa AFP is a beta-helix with a triangular cross-section and rectangular sides that form stacked parallel beta-sheets; a fold which is distinct from the three known fish AFP structures. The ice-binding side contains 9 of the 14 surface-accessible threonines organized in a regular array of TXT motifs that match the ice lattice on both prism and basal planes. In support of this model, ice crystal morphology and ice-etching experiments are consistent with AFP binding to both of these planes and thus may explain the greater activity of the spruce budworm antifreeze.	Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada	Queens University - Canada; Queens University - Canada; University of Alberta	Davies, PL (corresponding author), Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada.	daviesp@post.queensu.ca	Graether, Steffen P./AAR-8849-2021; Graether, Steffen P./AFU-0892-2022	Graether, Steffen P./0000-0002-2356-3936; Graether, Steffen P./0000-0002-2356-3936				Beaman TW, 1998, BIOCHEMISTRY-US, V37, P6689, DOI 10.1021/bi980106v; BRUNGER AT, 1992, X PLOR MANUAL VERSIO; Chao HM, 1997, BIOCHEMISTRY-US, V36, P14652, DOI 10.1021/bi970817d; CHOU KC, 1992, J MOL BIOL, V223, P509, DOI 10.1016/0022-2836(92)90666-8; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deng GJ, 1997, FEBS LETT, V402, P17, DOI 10.1016/S0014-5793(96)01466-4; Duman JG, 1998, J COMP PHYSIOL B, V168, P225, DOI 10.1007/s003600050140; Gauthier SY, 1998, EUR J BIOCHEM, V258, P445, DOI 10.1046/j.1432-1327.1998.2580445.x; Graether SP, 1999, J BIOL CHEM, V274, P11842, DOI 10.1074/jbc.274.17.11842; Graham LA, 1997, NATURE, V388, P727, DOI 10.1038/41908; Haymet ADJ, 1998, FEBS LETT, V430, P301, DOI 10.1016/S0014-5793(98)00652-8; Jia ZC, 1996, NATURE, V384, P285, DOI 10.1038/384285a0; Kisker C, 1996, EMBO J, V15, P2323, DOI 10.1002/j.1460-2075.1996.tb00588.x; KNIGHT CA, 1993, BIOPHYS J, V64, P252, DOI 10.1016/S0006-3495(93)81361-4; KNIGHT CA, 1991, BIOPHYS J, V59, P409, DOI 10.1016/S0006-3495(91)82234-2; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUSZEWSKI J, 1995, J MAGN RESON SER B, V106, P92, DOI 10.1006/jmrb.1995.1017; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liou YC, 2000, NATURE, V406, P322, DOI 10.1038/35018604; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; SICHERI F, 1995, NATURE, V375, P427, DOI 10.1038/375427a0; Sonnichsen FD, 1996, STRUCTURE, V4, P1325, DOI 10.1016/S0969-2126(96)00140-2; *TRIP SOFTW, 1998, SYBYL MOL MOD PACK V; Tyshenko MG, 1997, NAT BIOTECHNOL, V15, P887, DOI 10.1038/nbt0997-887; WEN DY, 1992, BIOPHYS J, V63, P1659, DOI 10.1016/S0006-3495(92)81750-2; Zhang W, 1998, J BIOL CHEM, V273, P34806, DOI 10.1074/jbc.273.52.34806; [No title captured]	27	363	416	8	175	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2000	406	6793					325	328		10.1038/35018610	http://dx.doi.org/10.1038/35018610			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917537				2022-12-24	WOS:000088251900055
J	Hofstra, L; Liem, IH; Dumont, EA; Boersma, HH; van Heerde, WL; Doevendans, PA; DeMuinck, E; Wellens, HJJ; Kemerink, GJ; Reutelingsperger, CPM; Heidendal, GA				Hofstra, L; Liem, IH; Dumont, EA; Boersma, HH; van Heerde, WL; Doevendans, PA; DeMuinck, E; Wellens, HJJ; Kemerink, GJ; Reutelingsperger, CPM; Heidendal, GA			Visualisation of cell death in vivo in patients with acute myocardial infarction	LANCET			English	Article							APOPTOSIS	Background In-vivo visualisation and quantification of the extent and time-frame of cell death after acute myocardial infarction would be of great interest. We studied in-vivo cell death in the hearts of patients with an acute myocardial infarction using imaging with technetium-99m-labelled annexin-V-a protein that binds to cells undergoing annexin-V-a apoptosis. Methods Seven patients with an acute myocardial infarction and one control were studied. All patients were treated by percutaneous transluminal coronary angioplasty (six primary and one rescue), resulting in thrombolysis in myocardial infarction (TIMI) III flow of the infarct-related artery. 2 h after reperfusion, 1 mg annexin-V labelled with 584 MBq Tc-99m was injected intravenously. Early (mean 3.4 h) and late (mean 20.5 h) single-photon-emission computed tomo graphic (SPECT) images of the heart were obtained. Routine myocardial resting-perfusion imaging was also done to verify infarct localisation. Findings In six of the seven patients, increased uptake of Tc-99m-labelled annexin-V was seen in the infarct area of the heart on early and late SPECT images. No increased uptake was seen in the heart outside the infarct area. All patients with increased Tc99m-labelled annexin-V uptake in the infarct area showed a matching perfusion defect, in a control individual, no increased uptake in the heart was seen. Interpretation Increased uptake of Tc-99m-labelled annexin-V is present in the infarct area of patients with an acute myocardial infarction, suggesting that programmed cell death occurs in that area. The annexin-V imaging protocol might allow us to study the dynamics of reperfusion-induced cell death in the area at risk and may help to assess interventions that inhibit cell death in patients with an acute myocardial infarction.	Univ Hosp Maastricht, Dept Cardiol, Maastricht, Netherlands; Univ Hosp Maastricht, Dept Nucl Med, Maastricht, Netherlands; Univ Hosp Maastricht, Dept Biochem, Maastricht, Netherlands; Univ Hosp Maastricht, Dept Clin Pharm, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC)	Reutelingsperger, CPM (corresponding author), Univ Limburg, Cardiovasc Res Inst Maastricht, Dept Biochem, POB 616, NL-6200 MD Maastricht, Netherlands.		Boersma, Hendrikus/AAF-8139-2020; van Heerde, Waander/L-4357-2015	Boersma, Hendrikus/0000-0003-1892-9830; van Heerde, Waander/0000-0001-7101-8775				Barinaga M, 1998, SCIENCE, V281, P1302, DOI 10.1126/science.281.5381.1302; Blankenberg FG, 1998, P NATL ACAD SCI USA, V95, P6349, DOI 10.1073/pnas.95.11.6349; DUMONT E, 1999, LANCET S3, V353, pS27; FADOK VA, 1992, J IMMUNOL, V149, P4029; Fliss H, 1996, CIRC RES, V79, P949, DOI 10.1161/01.RES.79.5.949; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; GOTTLIEB RA, 1994, J CLIN INVEST, V94, P1621, DOI 10.1172/JCI117504; Kajstura J, 1996, LAB INVEST, V74, P86; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KOOPMAN G, 1994, BLOOD, V84, P5; Martin SJ, 1996, J BIOL CHEM, V271, P28753, DOI 10.1074/jbc.271.46.28753; Ohno M, 1998, CIRCULATION, V98, P1422, DOI 10.1161/01.CIR.98.14.1422; Saraste A, 1997, CIRCULATION, V95, P320; Schwaiger M, 1999, LANCET, V354, P661, DOI 10.1016/S0140-6736(99)06057-2; van Heerde WL, 2000, CARDIOVASC RES, V45, P549, DOI 10.1016/S0008-6363(99)00396-X; vandenEijnde SM, 1997, CYTOMETRY, V29, P313, DOI 10.1002/(SICI)1097-0320(19971201)29:4<313::AID-CYTO8>3.0.CO;2-A; Veinot JP, 1997, HUM PATHOL, V28, P485, DOI 10.1016/S0046-8177(97)90039-3; VERMES I, 1995, J IMMUNOL METHODS, V184, P144; YEH ET, 1997, CIRCULATION, V97, P782	19	336	351	0	12	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 15	2000	356	9225					209	212		10.1016/S0140-6736(00)02482-X	http://dx.doi.org/10.1016/S0140-6736(00)02482-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334GQ	10963199				2022-12-24	WOS:000088179100012
J	Okamoto, H; Yonemori, F; Wakitani, K; Minowa, T; Maeda, K; Shinkai, H				Okamoto, H; Yonemori, F; Wakitani, K; Minowa, T; Maeda, K; Shinkai, H			A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits	NATURE			English	Article							HIGH-DENSITY-LIPOPROTEINS; LIPID-TRANSFER PROTEIN; CORONARY HEART-DISEASE; PLASMA; HDL; DEFICIENCY; TRANSPORT; MUTATION; GENE	Cholesteryl ester transfer protein (CETP) is a plasma protein that mediates the exchange of cholesteryl ester in high-density lipoprotein (HDL) for triglyceride in very low density lipoprotein (VLDL)(1,2). This process decreases the level of antiatherogenic HDL cholesterol and increases pro-atherogenic VLDL and low density lipoprotein (LDL) cholesterol, so CETP is potentially atherogenic(3-9). On the other hand, CETP could also be anti-atherogenic(10-14), because it participates in reverse cholesterol transport (transfer of cholesterol from peripheral cells through the plasma to the liver)(15). Because the role of CETP in atherosclerosis remains unclear, we have attempted to develop a potent and specific CETP inhibitor. Here we describe CETP inhibitors that form a disulphide bond with CETP, and present one such inhibitor (JTT-705) that increases HDL cholesterol, decreases non-HDL cholesterol and inhibits the progression of atherosclerosis in rabbits. Our findings indicate that CETP may be atherogenic in vivo and that JTT-705 may be a potential antiatherogenic drug.	JT Inc, Cent Pharmaceut Res Inst, Biol Pharmacol Res Labs, Osaka 5691125, Japan; JT Inc, Cent Pharmaceut Res Inst, Chem Res Labs, Osaka 5691125, Japan; JT Inc, Cent Pharmaceut Res Inst, Pharmaceut Frontier Res Labs, Kanazawa Ku, Kanagawa 2360004, Japan		Okamoto, H (corresponding author), JT Inc, Cent Pharmaceut Res Inst, Biol Pharmacol Res Labs, 1-1 Murasaki Cho, Osaka 5691125, Japan.							BHATNAGAR D, 1993, ATHEROSCLEROSIS, V98, P25, DOI 10.1016/0021-9150(93)90220-O; BROWN ML, 1989, NATURE, V342, P448, DOI 10.1038/342448a0; Bruce C, 1998, ANNU REV NUTR, V18, P297, DOI 10.1146/annurev.nutr.18.1.297; Chiba H, 1997, J LIPID RES, V38, P1204; Connolly DT, 1996, BIOCHEM BIOPH RES CO, V223, P42, DOI 10.1006/bbrc.1996.0843; Fielding CJ, 1996, J CLIN INVEST, V97, P2687, DOI 10.1172/JCI118719; FIELDING CJ, 1995, J LIPID RES, V36, P211; Foger B, 1999, J BIOL CHEM, V274, P36912, DOI 10.1074/jbc.274.52.36912; FOGER B, 1995, J MOL MED, V73, P369; FRANK D, 1996, ARTERIOSCL THROM VAS, V16, P1454; GERDES LU, 1992, CLIN CHIM ACTA, V205, P1, DOI 10.1016/0009-8981(92)90348-T; HAYEK T, 1995, J CLIN INVEST, V96, P2071, DOI 10.1172/JCI118255; Herrera VLM, 1999, NAT MED, V5, P1383, DOI 10.1038/70956; INAZU A, 1990, NEW ENGL J MED, V323, P1234, DOI 10.1056/NEJM199011013231803; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAGROST L, 1994, BBA-LIPID LIPID MET, V1215, P209, DOI 10.1016/0005-2760(94)90047-7; MACKNESS MI, 1995, ATHEROSCLEROSIS, V115, P243, DOI 10.1016/0021-9150(94)05524-M; MAROTTI KR, 1993, NATURE, V364, P73, DOI 10.1038/364073a0; MORTON RE, 1983, J BIOL CHEM, V258, P1751; Oram JF, 1996, J LIPID RES, V37, P2473; QUINET E, 1991, J CLIN INVEST, V87, P1559, DOI 10.1172/JCI115169; Suc I, 1997, ARTERIOSCL THROM VAS, V17, P2158, DOI 10.1161/01.ATV.17.10.2158; Sugano M, 1998, J BIOL CHEM, V273, P5033, DOI 10.1074/jbc.273.9.5033; TALL AR, 1993, J LIPID RES, V34, P1255; Tollefson J H, 1986, Methods Enzymol, V129, P797; WHITLOCK ME, 1989, J CLIN INVEST, V84, P129, DOI 10.1172/JCI114132; WILSON PWF, 1988, ARTERIOSCLEROSIS, V8, P737, DOI 10.1161/01.ATV.8.6.737; Zhong SB, 1996, J CLIN INVEST, V97, P2917, DOI 10.1172/JCI118751	28	443	470	0	14	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 13	2000	406	6792					203	207		10.1038/35018119	http://dx.doi.org/10.1038/35018119			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910363				2022-12-24	WOS:000088221100053
J	Kennedy, RL				Kennedy, RL			Commentary: Time for improved diagnosis and management of patients presenting with acute chest pain	BRITISH MEDICAL JOURNAL			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; ADMISSION; EMERGENCY		Sunderland Royal Hosp, Dept Med, Sunderland SR4 7TP, England	Sunderland Royal Hospital	Kennedy, RL (corresponding author), Sunderland Royal Hosp, Dept Med, Sunderland SR4 7TP, England.							BAKKER AJ, 1993, LANCET, V342, P1220, DOI 10.1016/0140-6736(93)92192-V; FINEBERG HV, 1984, NEW ENGL J MED, V310, P1301, DOI 10.1056/NEJM198405173102006; GIBLER WB, 1995, ANN EMERG MED, V25, P1, DOI 10.1016/S0196-0644(95)70347-0; Hamm CW, 1999, NEW ENGL J MED, V340, P1623, DOI 10.1056/NEJM199905273402103; Heeschen C, 1999, LANCET, V354, P1757, DOI 10.1016/S0140-6736(99)10285-X; Kennedy RL, 1997, COMPUT METH PROG BIO, V52, P93, DOI 10.1016/S0169-2607(96)01782-8; KENNEDY RL, 1995, BR HEART J S3, V73, pA107	7	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUN 24	2000	320	7251					1704	1705						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	329UJ	10917697				2022-12-24	WOS:000087926400023
J	Thorvaldsen, JL; Bartolomei, MS				Thorvaldsen, JL; Bartolomei, MS			Molecular biology - Mothers setting boundaries	SCIENCE			English	Editorial Material							MOUSE H19 GENE; CONTROL ELEMENT; PROTEIN CTCF; DOMAIN; IGF2; EXPRESSION; UPSTREAM; DELETION; ASSAY		Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania	Thorvaldsen, JL (corresponding author), Univ Penn, Sch Med, Howard Hughes Med Inst, Philadelphia, PA 19104 USA.							Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Burcin M, 1997, MOL CELL BIOL, V17, P1281, DOI 10.1128/MCB.17.3.1281; FILLPPOVA GN, 1996, MOL CELL BIOL, V16, P2802; Frevel MAE, 1999, TRENDS GENET, V15, P216, DOI 10.1016/S0168-9525(99)01752-7; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Hark AT, 1998, HUM MOL GENET, V7, P1979, DOI 10.1093/hmg/7.12.1979; Kanduri C, 2000, CURR BIOL, V10, P449, DOI 10.1016/S0960-9822(00)00442-5; Kellum R, 1998, CURR BIOL, V8, pR521, DOI 10.1016/S0960-9822(07)00337-5; KELLUM R, 1991, CELL, V64, P941, DOI 10.1016/0092-8674(91)90318-S; KELLUM R, 1992, MOL CELL BIOL, V12, P2424, DOI 10.1128/MCB.12.5.2424; Khosla S, 1999, MOL CELL BIOL, V19, P2556; LEIGHTON PA, 1995, GENE DEV, V9, P2079, DOI 10.1101/gad.9.17.2079; Stadnick MP, 1999, DEV GENES EVOL, V209, P239, DOI 10.1007/s004270050248; Thorvaldsen JL, 1998, GENE DEV, V12, P3693, DOI 10.1101/gad.12.23.3693; Tremblay KD, 1997, MOL CELL BIOL, V17, P4322, DOI 10.1128/MCB.17.8.4322; Vostrov AA, 1997, J BIOL CHEM, V272, P33353, DOI 10.1074/jbc.272.52.33353; Webber AL, 1998, NATURE, V391, P711, DOI 10.1038/35655	18	19	19	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 23	2000	288	5474					2145	2146		10.1126/science.288.5474.2145	http://dx.doi.org/10.1126/science.288.5474.2145			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FH	10896590				2022-12-24	WOS:000087782900028
J	Weijer, C; Shapiro, SH; Glass, KC; Enkin, MW				Weijer, C; Shapiro, SH; Glass, KC; Enkin, MW			For and against - Clinical equipoise and not the uncertainty principle is the moral underpinning of the randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								The ethical basis for entering patients in randomised controlled trials is under debate, Some doctors espouse the uncertainty principle whereby randomisation to treatment is acceptable when an individual doctor is genuinely unsure which treatment is best for a patient. Others believe that clinical equipoise, reflecting collective professional uncertainty over treatment, is the soundest ethical criterion. Here doctors from two Canadian centres discuss their positions.	Dalhousie Univ, Dept Bioeth, Halifax, NS B3H 4H7, Canada; McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ H3A 1A2, Canada; McGill Univ, Dept Human Genet, Biomed Eth Unit, Montreal, PQ H3A 1A2, Canada; McGill Univ, Dept Pediat, Biomed Eth Unit, Montreal, PQ H3A 1A2, Canada	Dalhousie University; McGill University; McGill University; McGill University	Weijer, C (corresponding author), Dalhousie Univ, Dept Bioeth, Halifax, NS B3H 4H7, Canada.	charles.weijer@dal.ca		Weijer, Charles/0000-0002-5510-1074				COLLINS R, 1992, INTRO NEW TREATMENTS; FREEDMAN B, 1987, NEW ENGL J MED, V317, P141, DOI 10.1056/NEJM198707163170304; Fuks A, 1998, J CLIN EPIDEMIOL, V51, P69, DOI 10.1016/S0895-4356(97)00240-0; HELLMAN S, 1991, NEW ENGL J MED, V324, P1585, DOI 10.1056/NEJM199105303242208; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; Peto R, 1998, BMJ-BRIT MED J, V317, P1170, DOI 10.1136/bmj.317.7167.1170; SCHWARTZ D, 1967, J CHRON DIS, V20, P637, DOI 10.1016/0021-9681(67)90041-0; TAYLOR KM, 1984, NEW ENGL J MED, V310, P1363, DOI 10.1056/NEJM198405243102106; Weijer C, 1999, SCHIZOPHR RES, V35, P211, DOI 10.1016/S0920-9964(98)00127-3; Weijer C, 1999, J CLIN ETHIC, V10, P100; YUSUF S, 1984, STAT MED, V3, P409, DOI 10.1002/sim.4780030421	11	115	117	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2000	321	7263					756	758		10.1136/bmj.321.7263.756	http://dx.doi.org/10.1136/bmj.321.7263.756			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FE	10999914	Green Published			2022-12-24	WOS:000089546600034
J	Brendza, RP; Serbus, LR; Duffy, JB; Saxton, WM				Brendza, RP; Serbus, LR; Duffy, JB; Saxton, WM			A function for kinesin I in the posterior transport of oskar mRNA and Staufen protein	SCIENCE			English	Article							DROSOPHILA OOGENESIS; ANTERIOR-POSTERIOR; MESSENGER-RNA; EGF RECEPTOR; LOCALIZATION; OOCYTES; ORB; POLARIZATION; MICROTUBULES; COMPONENT	The asymmetric localization of messenger RNA (mRNA) and protein determinants plays an important role in the establishment of complex body plans. In Drosophila oocytes, the anterior localization of bicoid mRNA and the posterior Localization of oskar mRNA are key events in establishing the anterior-posterior axis. Although the mechanisms that drive bicoid and oskar Localization have been elusive, oocyte microtubules are known to be essential. Here we report that the plus end-directed microtubule motor kinesin 1 is required for the posterior Localization of oskar mRNA and an associated protein, Staufen, but not for the anterior-posterior localization of other asymmetric factors. Thus, a complex containing oskar mRNA and Staufen may be transported along microtubules to the posterior pole by kinesin I.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Saxton, WM (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046295] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM046295, R01 GM046295-09, R01GM46295] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brendza RP, 2000, MOL BIOL CELL, V11, P1329, DOI 10.1091/mbc.11.4.1329; BRENDZA RP, 1999, THESIS INDIANA U; Chang JS, 1999, DEV BIOL, V215, P91, DOI 10.1006/dbio.1999.9444; CHOU TB, 1993, DEVELOPMENT, V119, P1359; CHRISTERSON LB, 1994, GENE DEV, V8, P614, DOI 10.1101/gad.8.5.614; CLARK I, 1994, CURR BIOL, V4, P289, DOI 10.1016/S0960-9822(00)00068-3; Clark IE, 1997, DEVELOPMENT, V124, P461; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; Ghiglione C, 1999, CELL, V96, P847, DOI 10.1016/S0092-8674(00)80594-2; Goldstein LSB, 2000, J CELL BIOL, V150, pF63, DOI 10.1083/jcb.150.2.F63; GONZALEZREYES A, 1995, NATURE, V375, P654, DOI 10.1038/375654a0; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; KOCH EA, 1983, CELL TISSUE RES, V228, P21; LANTZ V, 1994, GENE DEV, V8, P598, DOI 10.1101/gad.8.5.598; Lasko P, 1999, FASEB J, V13, P421, DOI 10.1096/fasebj.13.3.421; Li KJ, 1996, CELL, V85, P585, DOI 10.1016/S0092-8674(00)81258-1; Martin MAE, 1999, CELL MOL LIFE SCI, V56, P200, DOI 10.1007/s000180050422; Micklem DR, 2000, EMBO J, V19, P1366, DOI 10.1093/emboj/19.6.1366; POKRYWKA NJ, 1995, DEV BIOL, V167, P363, DOI 10.1006/dbio.1995.1030; POKRYWKA NJ, 1991, DEVELOPMENT, V113, P55; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; SAXTON WM, 1991, CELL, V64, P1093, DOI 10.1016/0092-8674(91)90264-Y; Schnorrer F, 2000, NAT CELL BIOL, V2, P185, DOI 10.1038/35008601; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; THEURKAUF WE, 1992, DEVELOPMENT, V115, P923; van Eeden F, 1999, CURR OPIN GENET DEV, V9, P396, DOI 10.1016/S0959-437X(99)80060-4	26	283	291	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2000	289	5487					2120	2122		10.1126/science.289.5487.2120	http://dx.doi.org/10.1126/science.289.5487.2120			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11000113	Green Accepted			2022-12-24	WOS:000089430900043
J	Zenisek, D; Steyer, JA; Almers, W				Zenisek, D; Steyer, JA; Almers, W			Transport, capture and exocytosis of single synaptic vesicles at active zones	NATURE			English	Article							RETINAL BIPOLAR CELLS; FROG NEUROMUSCULAR-JUNCTION; LIVE CHROMAFFIN CELLS; TRANSMITTER RELEASE; SECRETORY GRANULES; CALCIUM CURRENT; HAIR-CELLS; ENDOCYTOSIS; TERMINALS; MEMBRANE	To sustain high rates of transmitter release, synaptic terminals must rapidly re-supply vesicles to release sites and prime them for exocytosis. Here we describe imaging of single synaptic vesicles near the plasma membrane of live ribbon synaptic terminals. Vesicles were captured at small, discrete active zones near the terminal surface. An electric stimulus caused them to undergo rapid exocytosis, seen as the release of a fluorescent lipid from the vesicles into the plasma membrane. Next, vesicles held in reserve about 20 nm from the plasma membrane advanced to exocytic sites, and became release-ready 250 ms later. Apparently a specific structure holds vesicles at an active zone to bring v-SNAREs and t-SNAREs, the proteins that mediate vesicle fusion, within striking distance of each other, and then allows the triggered movement of such vesicles to the plasma membrane.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Oregon Health & Science University; University of California System; University of California Berkeley	Almers, W (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	almersw@ohsu.edu	Zenisek, David/C-6555-2011					Axelrod D, 1992, TOPICS FLUORESCENCE, P289; Betz WJ, 1996, CURR OPIN NEUROBIOL, V6, P365, DOI 10.1016/S0959-4388(96)80121-8; BETZ WJ, 1993, J PHYSIOL-LONDON, V460, P287, DOI 10.1113/jphysiol.1993.sp019472; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; GRAY EG, 1971, BRAIN RES, V35, P1, DOI 10.1016/0006-8993(71)90591-9; Han WP, 1999, P NATL ACAD SCI USA, V96, P14577, DOI 10.1073/pnas.96.25.14577; HEIDELBERGER R, 1992, J PHYSIOL-LONDON, V447, P235, DOI 10.1113/jphysiol.1992.sp019000; ISSA NP, 1994, P NATL ACAD SCI USA, V91, P7578, DOI 10.1073/pnas.91.16.7578; KOBAYASHI K, 1995, J PHYSIOL-LONDON, V483, P79, DOI 10.1113/jphysiol.1995.sp020569; Lagnado L, 1996, NEURON, V17, P957, DOI 10.1016/S0896-6273(00)80226-3; Lang T, 2000, BIOPHYS J, V78, P2863, DOI 10.1016/S0006-3495(00)76828-7; Lenzi D, 1999, J NEUROSCI, V19, P119, DOI 10.1523/JNEUROSCI.19-01-00119.1999; LILEY AW, 1953, J NEUROPHYSIOL, V16, P509, DOI 10.1152/jn.1953.16.5.509; Lowe M, 1998, TRENDS CELL BIOL, V8, P40, DOI 10.1016/S0962-8924(97)01189-6; Mennerick S, 1996, NEURON, V17, P1241, DOI 10.1016/S0896-6273(00)80254-8; Murthy VN, 1998, NATURE, V392, P497, DOI 10.1038/33152; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Neves G, 1999, J PHYSIOL-LONDON, V515, P181, DOI 10.1111/j.1469-7793.1999.181ad.x; Oheim M, 1998, EUR BIOPHYS J BIOPHY, V27, P83, DOI 10.1007/s002490050114; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; RAVIOLA E, 1975, J CELL BIOL, V65, P192, DOI 10.1083/jcb.65.1.192; Rouze NC, 1998, J NEUROSCI, V18, P8614; Ryan TA, 1997, NATURE, V388, P478, DOI 10.1038/41335; Sakaba T, 1997, NEUROSCI RES, V27, P357, DOI 10.1016/S0168-0102(97)01168-1; Schmidt A, 1997, J CELL BIOL, V137, P445, DOI 10.1083/jcb.137.2.445; Schmoranzer J, 2000, J CELL BIOL, V149, P23, DOI 10.1083/jcb.149.1.23; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Smith CB, 1996, NATURE, V380, P531, DOI 10.1038/380531a0; Steyer JA, 1999, BIOPHYS J, V76, P2262, DOI 10.1016/S0006-3495(99)77382-0; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; STOUT AL, 1989, APPL OPTICS, V28, P5237, DOI 10.1364/AO.28.005237; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Toomre D, 2000, J CELL BIOL, V149, P33, DOI 10.1083/jcb.149.1.33; von Gersdorff H, 1998, NEURON, V21, P1177, DOI 10.1016/S0896-6273(00)80634-0; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	40	349	358	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2000	406	6798					849	854		10.1038/35022500	http://dx.doi.org/10.1038/35022500			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347AG	10972279				2022-12-24	WOS:000088903600033
J	Bloom, BR				Bloom, BR			On the particularity of pathogens	NATURE			English	Article								In the elemental struggle between pathogenic microbes and the immune system of the host, each strives for a unique advantage and thus each exploits its own unique particularities in pathogenesis and protection. And each presumably selects for the diversity that generally characterizes the wide range of successful host-pathogen interactions.	Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Bloom, BR (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.								0	14	14	0	2	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2000	406	6797					760	761		10.1038/35021204	http://dx.doi.org/10.1038/35021204			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963604				2022-12-24	WOS:000088767700051
J	Coopman, PJP; Do, MTH; Barth, M; Bowden, ET; Hayes, AJ; Basyuk, E; Blancato, JK; Vezza, PR; McLeskey, SW; Mangeat, PH; Mueller, SC				Coopman, PJP; Do, MTH; Barth, M; Bowden, ET; Hayes, AJ; Basyuk, E; Blancato, JK; Vezza, PR; McLeskey, SW; Mangeat, PH; Mueller, SC			The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells	NATURE			English	Article							ANTIGEN RECEPTOR; PROTEIN; PHAGOCYTOSIS; EXPRESSION; HYBRIDIZATION; TRANSCRIPTS; METASTASIS; INTERACTS; P72(SYK); CLONING	Syk is a protein tyrosine kinase that is widely expressed in haematopoietic cells. It is involved in coupling activated immunoreceptors to downstream signalling events that mediate diverse cellular responses including proliferation, differentiation and phagocytosis(1-4). Syk expression has been reported in cell lines of epithelial origin(5), but its function in these cells remains unknown. Here we show that Syk is commonly expressed in normal human breast tissue, benign breast lesions and low-tumorigenic breast cancer cell lines. Syk messenger RNA and protein, however, are low or undetectable in invasive breast carcinoma tissue and cell lines. Transfection of wild-type Syk into a Syk-negative breast cancer cell line markedly inhibited its tumour growth and metastasis formation in athymic mice. Conversely, overexpression of a kinase-deficient Syk in a Syk-positive breast cancer cell line significantly increased its tumour incidence and growth. Suppression of tumour growth by the reintroduction of Syk appeared to be the result of aberrant mitosis and cytokinesis. We propose that Syk is a potent modulator of epithelial cell growth and a potential tumour suppressor in human breast carcinomas.	Georgetown Univ, Sch Med, Dept Cell Biol, Washington, DC 20007 USA; Georgetown Univ, Sch Med, Dept Oncol, Washington, DC 20007 USA; Georgetown Univ, Sch Med, Dept Pathol, Washington, DC 20007 USA; Georgetown Univ, Sch Med, Dept Pharmacol, Washington, DC 20007 USA; Georgetown Univ, Sch Med, Sch Nursing, Washington, DC 20007 USA; Georgetown Univ, Sch Med, Inst Mol & Human Genet, Washington, DC 20007 USA; Georgetown Univ, Sch Med, Vincent T Lombardi Canc Res Ctr, Washington, DC 20007 USA; CNRS, UPR 9023, F-34095 Montpellier, France; CNRS, UMR 5539, F-34095 Montpellier, France	Georgetown University; Georgetown University; Georgetown University; Georgetown University; Georgetown University; Georgetown University; Georgetown University; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS)	Mueller, SC (corresponding author), Georgetown Univ, Sch Med, Dept Cell Biol, Washington, DC 20007 USA.		Coopman, Peter/G-7416-2019; H, Michael Tri/A-5917-2009	Coopman, Peter/0000-0003-3720-523X; H, Michael Tri/0000-0001-6418-0977; Basyuk, Eugenia/0000-0001-9768-4557				BRUNNER N, 1992, EUR J CANCER, V28A, P1989, DOI 10.1016/0959-8049(92)90245-W; Cheng AM, 1997, CURR OPIN IMMUNOL, V9, P528, DOI 10.1016/S0952-7915(97)80106-9; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Chu DH, 1998, IMMUNOL REV, V165, P167, DOI 10.1111/j.1600-065X.1998.tb01238.x; Coopman PJ, 1998, CLIN CANCER RES, V4, P507; Coopman PJ, 1996, MOL BIOL CELL, V7, P1789, DOI 10.1091/mbc.7.11.1789; Deckert M, 1996, IMMUNITY, V5, P591, DOI 10.1016/S1074-7613(00)80273-3; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; FANG WJ, 1992, J BIOL CHEM, V267, P25889; FARGNOLI J, 1995, J BIOL CHEM, V270, P26533, DOI 10.1074/jbc.270.44.26533; FLUCK M, 1995, BIOCHEM BIOPH RES CO, V213, P273, DOI 10.1006/bbrc.1995.2126; INDIK ZK, 1995, BLOOD, V85, P1175, DOI 10.1182/blood.V85.5.1175.bloodjournal8551175; KUREBAYASHI J, 1993, CANCER RES, V53, P2178; Kurosaki T, 1997, CURR OPIN IMMUNOL, V9, P309, DOI 10.1016/S0952-7915(97)80075-1; Law CL, 1996, MOL CELL BIOL, V16, P1305; LAW CL, 1994, J BIOL CHEM, V269, P12310; Lingle WL, 1999, AM J PATHOL, V155, P1941, DOI 10.1016/S0002-9440(10)65513-7; Minobe K, 1998, JPN J CANCER RES, V89, P916, DOI 10.1111/j.1349-7006.1998.tb00649.x; Miranti CK, 1998, CURR BIOL, V8, P1289, DOI 10.1016/S0960-9822(07)00559-3; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; NAGAI K, 1994, J BIOCHEM-TOKYO, V116, P1176, DOI 10.1093/oxfordjournals.jbchem.a124646; Peters JD, 1996, J BIOL CHEM, V271, P4755; PINKEL D, 1986, COLD SPRING HARB SYM, V51, P151, DOI 10.1101/SQB.1986.051.01.018; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; THOMPSON EW, 1992, J CELL PHYSIOL, V150, P534, DOI 10.1002/jcp.1041500314; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; WILLIAMS RJ, 1984, ADV PLANT PATHOL, V2, P1; YAGI S, 1994, BIOCHEM BIOPH RES CO, V200, P28, DOI 10.1006/bbrc.1994.1409	29	264	326	0	14	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2000	406	6797					742	747		10.1038/35021086	http://dx.doi.org/10.1038/35021086			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963601				2022-12-24	WOS:000088767700048
J	Laabi, Y; Strasser, A				Laabi, Y; Strasser, A			Immunology - Lymphocyte survival - Ignorance is BLys	SCIENCE			English	Editorial Material							TUMOR-NECROSIS-FACTOR; FACTOR FAMILY; RECEPTOR SUPERFAMILY; CELL GROWTH; B-CELLS; DEATH; BCL-2; MICE; ACTIVATION; APOPTOSIS		Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia	Walter & Eliza Hall Institute	Laabi, Y (corresponding author), Walter & Eliza Hall Inst Med Res, PO Royal Melbourne Hosp, Melbourne, Vic 3050, Australia.	laabi@wehi.edu.au; strasser@wehi.edu.au	Strasser, Andreas/C-7581-2013	Strasser, Andreas/0000-0002-5020-4891				ANDERSON PN, 1969, NATURE, V222, P994, DOI 10.1038/222994a0; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Baker SJ, 1998, ONCOGENE, V17, P3261, DOI 10.1038/sj.onc.1202568; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Grell M, 1999, EMBO J, V18, P3034, DOI 10.1093/emboj/18.11.3034; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Grumont RJ, 1998, J EXP MED, V187, P663, DOI 10.1084/jem.187.5.663; Hahne M, 1998, J EXP MED, V188, P1185, DOI 10.1084/jem.188.6.1185; Hatzoglou A, 2000, J IMMUNOL, V165, P1322, DOI 10.4049/jimmunol.165.3.1322; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; LAABI Y, 1992, EMBO J, V11, P3897, DOI 10.1002/j.1460-2075.1992.tb05482.x; LAABI Y, 1994, NUCLEIC ACIDS RES, V22, P1147, DOI 10.1093/nar/22.7.1147; Levens JM, 2000, CELL DEATH DIFFER, V7, P59, DOI 10.1038/sj.cdd.4400636; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; MacLennan ICM, 1998, CURR OPIN IMMUNOL, V10, P220, DOI 10.1016/S0952-7915(98)80252-5; Marsters SA, 2000, CURR BIOL, V10, P785, DOI 10.1016/S0960-9822(00)00566-2; McLaughlin Peter, 1999, Current Opinion in Oncology, V11, P333, DOI 10.1097/00001622-199909000-00003; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Mukhopadhyay A, 1999, J BIOL CHEM, V274, P15978, DOI 10.1074/jbc.274.23.15978; Newton K, 2000, EMBO J, V19, P931, DOI 10.1093/emboj/19.5.931; Newton K, 1998, EMBO J, V17, P706, DOI 10.1093/emboj/17.3.706; RATHMELL JC, 1995, NATURE, V376, P181, DOI 10.1038/376181a0; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Shu HB, 2000, P NATL ACAD SCI USA, V97, P9156, DOI 10.1073/pnas.160213497; Shu HB, 1999, J LEUKOCYTE BIOL, V65, P680, DOI 10.1002/jlb.65.5.680; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; Strasser A, 1995, EMBO J, V14, P6136, DOI 10.1002/j.1460-2075.1995.tb00304.x; Thompson JS, 2000, J EXP MED, V192, P129, DOI 10.1084/jem.192.1.129; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; vonBulow GU, 1997, SCIENCE, V278, P138, DOI 10.1126/science.278.5335.138; Wang J, 2000, EUR J IMMUNOL, V30, P155, DOI 10.1002/1521-4141(200001)30:1<155::AID-IMMU155>3.3.CO;2-O; Xia XZ, 2000, J EXP MED, V192, P137, DOI 10.1084/jem.192.1.137; Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441; Yan MH, 2000, NAT IMMUNOL, V1, P37, DOI 10.1038/76889; Yoshida T, 2000, INT IMMUNOL, V12, P517, DOI 10.1093/intimm/12.4.517; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681	38	43	58	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2000	289	5481					883	884		10.1126/science.289.5481.883	http://dx.doi.org/10.1126/science.289.5481.883			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343KH	10960320				2022-12-24	WOS:000088701200021
J	Rensberger, JM; Watabe, M				Rensberger, JM; Watabe, M			Fine structure of bone in dinosaurs, birds and mammals	NATURE			English	Article							COMPACT-BONE; COLLAGEN	After observation of detailed structural evidence for the origin of birds from dinosaurs(1), and in light of evidence that dinosaur bone tissue resembles the histology in mammals(2), the histology of bone has become one of the focal points in discussions of the physiology of dinosaurs and Mesozoic birds(3-10). Most of this microstructural information has focused on features related to the vascular organization and the amount of remodelled bone around vascular canals. However, the finer structures have received less attention, although differences in such structures have been observed among modern vertebrates(10,11). Here we present evidence that canaliculi-the submicrometre-sized channels that interconnect bone cells and vascular canals-and the collagen fibre bundles in bone are differently organized among certain dinosaur lineages. Ornithomimid dinosaurs(12) are more like birds than mammals in these features. In canalicular structure, and to some extent in fibre bundle arrangement, ornithischian dinosaurs are more like mammals. These differences in both canalicular and lamellar structure are probably linked to differences in the process and rate(13) of bone formation.	Univ Washington, Burke Museum Nat Hist & Culture, Seattle, WA 98195 USA; Univ Washington, Dept Geol Sci, Seattle, WA 98195 USA; Hayashibara Museum Nat Sci, Okayama 7000907, Japan	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rensberger, JM (corresponding author), Univ Washington, Burke Museum Nat Hist & Culture, Seattle, WA 98195 USA.							Amprino R., 1947, ARCH BIOL SCI, V58, P315; AMPRINO RODOLFO, 1947, COMMENTATIONES PONTIFICIA ACAD SCI, V11, P329; [Anonymous], 1980, COLD LOOK WARM BLOOD; BAKKER RT, 1972, NATURE, V238, P81, DOI 10.1038/238081a0; Boyde A., 1972, BIOCH PHYSL BONE, V1, P259; Castanet J, 1996, CR ACAD SCI III-VIE, V319, P301; CHINSAMY A, 1990, Palaeontologia Africana, V27, P77; Crawford GNC, 1940, J ANAT, V74, P284; Currey J. D., 1962, Palaeontology, V5, P238; Currey JD., 1984, MECH ADAPTATIONS BON; CURTIS TA, 1985, ANAT RECORD, V212, P336, DOI 10.1002/ar.1092120403; DERICQLES A, 1975, ANN PALEONTOL, V61, P51; Enlow D. H., 1957, Texas Journal of Science, V9, P186; GAUTHIER JA, 1986, MEM CALIF ACAD SCI, V8, P1; GEBHARDT W, 1906, ARCH ENTW MECH ORG, V20, P187; GIRAUDGUILLE MM, 1988, CALCIFIED TISSUE INT, V42, P167, DOI 10.1007/BF02556330; HOLTZ TR, 1994, J PALEONTOL, V68, P1100, DOI 10.1017/S0022336000026706; MARTIN RB, 1989, STRUCTURE FUNCTION A; MCMAHON JM, 1995, ANAT RECORD, V242, P147, DOI 10.1002/ar.1092420203; OSTROM JH, 1973, NATURE, V242, P136, DOI 10.1038/242136a0; PAWLICKI R, 1966, NATURE, V211, P655, DOI 10.1038/211655a0; PAWLICKI R, 1984, FOLIA HISTOCHEM CYTO, V22, P91; Raspanti M, 1996, ACTA ANAT, V155, P249; REID REH, 1985, J PALEONTOL, V59, P140; REID REH, 1984, S ZOOLOGICAL SOC LON, V52, P629; Ricqles A., 1991, BONE BONE MATRIX BON, V3, P1, DOI DOI 10.1111/J.0021-8782.2004.00275.X; Rimblot-Baly Frederique, 1995, Annales de Paleontologie, V81, P49; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Varricchio David J., 1993, Journal of Vertebrate Paleontology, V13, P99; Xu X, 1999, NATURE, V399, P350, DOI 10.1038/20670	30	36	57	0	21	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2000	406	6796					619	622		10.1038/35020550	http://dx.doi.org/10.1038/35020550			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949300				2022-12-24	WOS:000088653800045
J	Jarvis, MJ; Goddard, E; Higgins, V; Feyerabend, C; Bryant, A; Cook, DG				Jarvis, MJ; Goddard, E; Higgins, V; Feyerabend, C; Bryant, A; Cook, DG			Children's exposure to passive smoking in England since the 1980s: cotinine evidence from population surveys	BRITISH MEDICAL JOURNAL			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; DETERMINANTS; HOME	Objective To determine whether children's exposure to passive smoking has changed since the late 1980s. Design Cross sectional surveys of nationally representative samples of secondary; school children carried out between 1988 and 1998 by Office for National Statistics. Setting England. Subjects Secondary school children aged 11-15. Main outcome measures Salivary cotinine concentrations in non-smoking children. Results Cotinine concentrations in all non-smoking children almost halved between 1988 and 1998, from a geometric mean of 0.96 (95% confidence interval 0.83 to 1.11) ng/ml in 1988 to 0.52 (0.43 to 0.62) ng/ml in 1998, This reduction was largely due to reductions in exposure in children from non-smoking households and to decreases in the percentage of parents who smoked. Children living with mothers or fathers who smoked experienced little reduction in exposure. Conclusions Exposure to passive smoking among children in England has approximately halved since the late 1980s. This reduction is partly explained by the fall in the percentage of both mothers and fathers who smoke and is also likely to reflect reductions of smoking in public places. However, there is only limited evidence that children from smoking households have experienced a reduction in exposure through parents' avoidance of smoking in their presence.	UCL, Dept Epidemiol & Publ Hlth, Imperial Canc Res Fund, Hlth Behav Unit, London WC1E 6BT, England; Off Natl Stat, London SW1V 2QQ, England; New Cross Hosp, Med Toxicol Unit, London SE14 5ER, England; Univ London St Georges Hosp, Sch Med, Dept Publ Hlth Sci, London SW17 0RE, England	Cancer Research UK; University of London; University College London; New Cross Hospital; St Georges University London	Jarvis, MJ (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Imperial Canc Res Fund, Hlth Behav Unit, Mortimer St, London WC1E 6BT, England.	martin.jarvis@ucl.ac.uk	Jarvis, Martin J/B-1034-2008	Jarvis, Martin J/0000-0001-9238-8038; Cook, Derek/0000-0002-9723-5759				BOLLING K, 1994, SMOKING SECONDARY SC; Borland R, 1999, TOB CONTROL, V8, P266, DOI 10.1136/tc.8.3.266; Cook DG, 1999, THORAX, V54, P357, DOI 10.1136/thx.54.4.357; DIAMOND A, 1995, SMOKING SECONDARY SC; ERIKSEN W, 1995, SCAND J PRIM HEALTH, V13, P275, DOI 10.3109/02813439508996775; FEYERABEND C, 1990, J PHARM PHARMACOL, V42, P450, DOI 10.1111/j.2042-7158.1990.tb06592.x; GODDARD E, 1989, SMOKING SECONDARY SC; Goddard E., 1999, SMOKING DRINKING DRU, V1; JAAKKOLA N, 1994, SCAND J SOC MED, V22, P107, DOI 10.1177/140349489402200205; Jarvis L., 1997, SMOKING SECONDARY SC; JARVIS MJ, 1992, AM J PUBLIC HEALTH, V82, P1225, DOI 10.2105/AJPH.82.9.1225; JARVIS MJ, 1991, INT J EPIDEMIOL, V20, P26; LADER D, 1991, SMOKING SECONDARY SC; MCNEILL AD, 1987, BRIT J ADDICT, V82, P1355; THOMAS M, 1993, SMOKING SECONDARY SC; Thomas M, 1998, LIVING BRITAIN RESUL; *US CDCP, 1997, MMWR-MORBID MORTAL W, V46, P1038	17	106	110	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 5	2000	321	7257					343	345		10.1136/bmj.321.7257.343	http://dx.doi.org/10.1136/bmj.321.7257.343			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342QH	10926591	Green Published, Bronze			2022-12-24	WOS:000088656300024
J	Nolo, R; Abbott, LA; Bellen, HJ				Nolo, R; Abbott, LA; Bellen, HJ			Senseless, a Zn finger transcription factor, is necessary and sufficient for sensory organ development in Drosophila	CELL			English	Article							PERIPHERAL NERVOUS-SYSTEM; ACHAETE-SCUTE COMPLEX; DEPENDENT KINASE INHIBITOR; HAIRY-WING MUTATIONS; PRONEURAL GENE; CELL FATE; NEURONAL PRECURSORS; ADULT DROSOPHILA; NEUROGENIC GENES; CUT LOCUS	The senseless (sens) gene is required for proper development of most cell types of the embryonic and adult peripheral nervous system (PNS) of Drosophila. Sens is a nuclear protein with four Zn fingers that is expressed and required in the sensory organ precursors (SOP) for proper proneural gene expression. Ectopic expression of Sens in many ectodermal cells causes induction of PNS external sensory organ formation and is able to recreate an ectopic proneural field. Hence, sens is both necessary and sufficient for PNS development. Our data indicate that proneural genes activate sens expression. Sens is then in turn required to further activate and maintain proneural gene expression. This feedback mechanism is essential for selective enhancement and maintenance of proneural gene expression in the SOPs.	Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Program Dev Biol, Houston, TX 77030 USA; Univ Colorado, Mol Cellular Dev Biol Dept, Boulder, CO 80309 USA	Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; University of Colorado System; University of Colorado Boulder	Bellen, HJ (corresponding author), Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA.			Bellen, Hugo/0000-0001-5992-5989				ABBOTT LA, 1986, DEV BIOL, V115, P233, DOI 10.1016/0012-1606(86)90243-5; ABBOTT LA, 1990, ROUX ARCH DEV BIOL, V198, P448, DOI 10.1007/BF00399055; ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; ARTAVANISTSAKONAS S, 1991, TRENDS GENET, V7, P403, DOI 10.1016/0168-9525(91)90264-Q; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; BALCELLS L, 1988, EMBO J, V7, P3899, DOI 10.1002/j.1460-2075.1988.tb03276.x; BELLEN HJ, 1992, GENE DEV, V6, P2125, DOI 10.1101/gad.6.11.2125; BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288; Ben-Arie N, 2000, DEVELOPMENT, V127, P1039; BLAIR SS, 1992, DEV BIOL, V152, P263, DOI 10.1016/0012-1606(92)90134-3; BODMER R, 1987, CELL, V51, P293, DOI 10.1016/0092-8674(87)90156-5; BRAND M, 1993, DEVELOPMENT, V119, P1; BREWSTER R, 1995, DEVELOPMENT, V121, P2923; Calleja M, 1996, SCIENCE, V274, P252, DOI 10.1126/science.274.5285.252; CAMPUZANO S, 1986, CELL, V44, P303, DOI 10.1016/0092-8674(86)90764-6; CAUDY M, 1988, CELL, V55, P1061, DOI 10.1016/0092-8674(88)90250-4; Chanut F, 1997, DEVELOPMENT, V124, P559; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; Chen R, 1997, CELL, V91, P893, DOI 10.1016/S0092-8674(00)80481-X; CUBAS P, 1992, EMBO J, V11, P3385, DOI 10.1002/j.1460-2075.1992.tb05417.x; CUBAS P, 1991, GENE DEV, V5, P996, DOI 10.1101/gad.5.6.996; Culi J, 1998, GENE DEV, V12, P2036, DOI 10.1101/gad.12.13.2036; deNooij JC, 1996, CELL, V87, P1237, DOI 10.1016/S0092-8674(00)81819-X; Dietrich U, 1984, J Neurogenet, V1, P315, DOI 10.3109/01677068409107094; DOMINGUEZ M, 1993, EMBO J, V12, P2049, DOI 10.1002/j.1460-2075.1993.tb05854.x; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; GHYSEN A, 1989, DEVELOPMENT, V105, P35; GILKS CB, 1993, MOL CELL BIOL, V13, P1759, DOI 10.1128/MCB.13.3.1759; GONZALEZ F, 1989, EMBO J, V8, P3553, DOI 10.1002/j.1460-2075.1989.tb08527.x; Goulding SE, 2000, NEURON, V25, P69, DOI 10.1016/S0896-6273(00)80872-7; Grimes HL, 1996, MOL CELL BIOL, V16, P6263; Hansen GM, 2000, GENOME RES, V10, P237, DOI 10.1101/gr.10.2.237; Hassan B, 1997, DEV GENET, V21, P117, DOI 10.1002/(SICI)1520-6408(1997)21:2<117::AID-DVG1>3.0.CO;2-A; HINZ U, 1994, CELL, V76, P77, DOI 10.1016/0092-8674(94)90174-0; HUANG F, 1991, DEVELOPMENT, V111, P1087; Huang ML, 2000, NEURON, V25, P57, DOI 10.1016/S0896-6273(00)80871-5; IP YT, 1994, DEVELOPMENT, V120, P199; JACK J, 1991, DEVELOPMENT, V113, P735; Jan Yuh Nung, 1993, P1207; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; JARMAN AP, 1994, NATURE, V369, P398, DOI 10.1038/369398a0; JENNINGS B, 1994, DEVELOPMENT, V120, P3537; JENNINGS B, 1995, DEVELOPMENT, V121, P3745; Jia YW, 1997, DEVELOPMENT, V124, P2063; Jia YW, 1996, GENETICS, V142, P141; KANIA A, 1993, NEURON, V11, P673, DOI 10.1016/0896-6273(93)90078-6; KRAMATSCHEK B, 1994, DEVELOPMENT, V120, P815; Lane ME, 1996, CELL, V87, P1225, DOI 10.1016/S0092-8674(00)81818-8; LECOURTOIS M, 1995, GENE DEV, V9, P2598, DOI 10.1101/gad.9.21.2598; Li JY, 1999, NAT GENET, V23, P348, DOI 10.1038/15531; Ligoxygakis P, 1999, DEVELOPMENT, V126, P2205; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Modolell J, 1997, PERSPECT DEV NEUROBI, V4, P285; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Murphy EP, 1996, GENE EXPRESSION, V5, P169; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Nakao K, 1996, NEURON, V16, P275, DOI 10.1016/S0896-6273(00)80046-X; OELLERS N, 1994, MOL GEN GENET, V244, P465, DOI 10.1007/BF00583897; Salzberg A, 1997, GENETICS, V147, P1723; SALZBERG A, 1994, NEURON, V13, P269, DOI 10.1016/0896-6273(94)90346-8; Schmidt T, 1998, EMBO J, V17, P5349, DOI 10.1093/emboj/17.18.5349; Schweisguth F, 1996, DEV GENET, V18, P28, DOI 10.1002/(SICI)1520-6408(1996)18:1&lt;28::AID-DVG4&gt;3.0.CO;2-3; SINGSON A, 1994, GENE DEV, V8, P2058, DOI 10.1101/gad.8.17.2058; SKEATH JB, 1991, GENE DEV, V5, P984, DOI 10.1101/gad.5.6.984; Spradling AC, 1999, GENETICS, V153, P135; TATA F, 1993, DEVELOPMENT, P139; VAESSIN H, 1994, DEVELOPMENT, V120, P935; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; VANDOREN M, 1992, GENE DEV, V6, P2592, DOI 10.1101/gad.6.12b.2592; VINCENT JP, 1994, DEV BIOL, V164, P328, DOI 10.1006/dbio.1994.1203; XU T, 1993, DEVELOPMENT, V117, P1223; zurLage P, 1997, CURR BIOL, V7, P166, DOI 10.1016/S0960-9822(97)70087-3; ZweidlerMcKay PA, 1996, MOL CELL BIOL, V16, P4024	74	402	406	0	22	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 4	2000	102	3					349	362		10.1016/S0092-8674(00)00040-4	http://dx.doi.org/10.1016/S0092-8674(00)00040-4			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	342BP	10975525	Bronze			2022-12-24	WOS:000088625600010
J	Sparrer, HE; Santoso, A; Szoka, FC; Weissman, JS				Sparrer, HE; Santoso, A; Szoka, FC; Weissman, JS			Evidence for the prion hypothesis: Induction of the yeast [PSI+] factor by in vitro-converted Sup35 protein	SCIENCE			English	Article							DE-NOVO APPEARANCE; SACCHAROMYCES-CEREVISIAE; DISEASE; PROPAGATION; GENE; DETERMINANT; TERMINATION; HSP104; PSI(+)	Starting with purified, bacterially produced protein, we have created a [PSI+]-inducing agent based on an altered (prion) conformation of the yeast Sup35 protein. After converting Sup35p to its prion conformation in vitro, we introduced it into the cytoplasm of living yeast using a liposome transformation protocol. Introduction of substoichiometric quantities of converted Sup35p greatly increased the rate of appearance of the well-characterized epigenetic factor [PSI+], which results from self-propagating aggregates of cellular Sup35p. Thus, as predicted by the prion hypothesis, proteins can act as infectious agents by causing self-propagating conformational changes.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Weissman, JS (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.		FRECHET, Jean M/P-1497-2016	Weissman, Jonathan/0000-0003-2445-670X				Bates GP, 1998, BIOCHEM SOC T, V26, P471, DOI 10.1042/bst0260471; BESSEN RA, 1995, NATURE, V375, P698, DOI 10.1038/375698a0; BOLTON DC, 1991, J GEN VIROL, V72, P2905, DOI 10.1099/0022-1317-72-12-2905; Chernoff YO, 2000, MOL MICROBIOL, V35, P865, DOI 10.1046/j.1365-2958.2000.01761.x; Chernoff YO, 1999, MOL CELL BIOL, V19, P8103; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; CHERNOFF YO, 1993, CURR GENET, V24, P268, DOI 10.1007/BF00351802; COX BS, 1988, YEAST, V4, P159, DOI 10.1002/yea.320040302; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Derkatch IL, 1998, P NATL ACAD SCI USA, V95, P2400, DOI 10.1073/pnas.95.5.2400; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 2000, EMBO J, V19, P1942, DOI 10.1093/emboj/19.9.1942; DIDICHENKO SA, 1991, EUR J BIOCHEM, V198, P705, DOI 10.1111/j.1432-1033.1991.tb16070.x; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Jackson GS, 1999, SCIENCE, V283, P1935, DOI 10.1126/science.283.5409.1935; Kaneko K, 2000, J MOL BIOL, V295, P997, DOI 10.1006/jmbi.1999.3386; King CY, 1997, P NATL ACAD SCI USA, V94, P6618, DOI 10.1073/pnas.94.13.6618; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Kushnirov VV, 2000, EMBO J, V19, P324, DOI 10.1093/emboj/19.3.324; Lansbury PT, 1999, P NATL ACAD SCI USA, V96, P3342, DOI 10.1073/pnas.96.7.3342; Li LM, 2000, SCIENCE, V287, P661, DOI 10.1126/science.287.5453.661; MICHELITSCH MD, UNPUB; Newnam GP, 1999, MOL CELL BIOL, V19, P1325; Olanow CW, 1999, ANNU REV NEUROSCI, V22, P123, DOI 10.1002/mds.23732; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Paushkin SV, 1996, EMBO J, V15, P3127, DOI 10.1002/j.1460-2075.1996.tb00675.x; Price DL, 1998, ANNU REV GENET, V32, P461, DOI 10.1146/annurev.genet.32.1.461; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Serio TR, 1999, ANNU REV CELL DEV BI, V15, P661, DOI 10.1146/annurev.cellbio.15.1.661; SPARRER HE, UNPUB; STANSFIELD I, 1992, MOL MICROBIOL, V6, P3469, DOI 10.1111/j.1365-2958.1992.tb01782.x; STANSFIELD I, 1995, EMBO J, V14, P4365, DOI 10.1002/j.1460-2075.1995.tb00111.x; SZOKA F, 1981, P NATL ACAD SCI-BIOL, V78, P1685, DOI 10.1073/pnas.78.3.1685; TERAVANESYAN MD, 1993, MOL MICROBIOL, V7, P683, DOI 10.1111/j.1365-2958.1993.tb01159.x; TUITE MF, 1981, GENETICS, V98, P691; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170	38	131	138	2	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 28	2000	289	5479					595	599		10.1126/science.289.5479.595	http://dx.doi.org/10.1126/science.289.5479.595			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	338XD	10915616				2022-12-24	WOS:000088447800045
J	Caruana, L; Petrie, MC; Davie, AP; McMurray, JJV				Caruana, L; Petrie, MC; Davie, AP; McMurray, JJV			Do patients with suspected heart failure and preserved left ventricular systolic function suffer from "diastolic heart failure" or from misdiagnosis? A prospective descriptive study	BRITISH MEDICAL JOURNAL			English	Article							PREVALENCE; DYSFUNCTION; POPULATION; CARE	Objectives To characterise the clinical features of patients with suspected heart failure but preserved left ventricular systolic function to determine if they have other potential causes for their symptoms rather than being diagnosed with "diastolic heart failure." Design Prospective descriptive study. Setting Outpatient based direct access echocardiography service. Participants 159 consecutive patients with suspected heart failure referred by general practitioners. Main outcome measures Symptoms (including shortness of breath, ankle oedema, and paroxysmal nocturnal dyspnoea) and history of coronary heart disease and chronic pulmonary disease. Transthoracic echocardiography, body mass index, pulmonary function tests, and electrocardiography. Results 109 of 159 participants had suspected heart failure in the absence of left ventricular systolic dysfunction, valvular heart disease, or atrial fibrillation. Of these 109, 40 were either obese or very obese, 54 had a reduction in forced expiratory volume in 1 second to less than or equal to 70%, and 97 had a peak expiratory flow rate less than or equal to 70% of normal. Thirty one patients had a history of angina, 12 had had a myocardial infarction, and seven had undergone a coronary artery bypass graft. Only seven patients lacked a recognised explanation for their symptoms. Conclusions For most patients with a diagnosis of heart failure but preserved left ventricular systolic function there is an alternative explanation for their symptoms-for example, obesity, lung disease, and myocardial ischaemia-and the diagnosis of diastolic heart failure is rarely needed These alternative diagnoses should be rigorously sought and managed accordingly.	Univ Glasgow, Western Infirm, Dept Cardiol, Glasgow G11 6NT, Lanark, Scotland	University of Glasgow	McMurray, JJV (corresponding author), Univ Glasgow, Western Infirm, Dept Cardiol, Glasgow G11 6NT, Lanark, Scotland.		mcmurray, John/B-2467-2013	mcmurray, John/0000-0002-6317-3975				ANDERSSON B, 1995, CHEST, V107, P680, DOI 10.1378/chest.107.3.680; CAMPEAU L, 1976, CIRCULATION, V54, P522, DOI 10.1161/circ.54.3.947585; Caruana L, 1999, EUR HEART J, V20, P393; CHOY AMJ, 1994, BRIT HEART J, V72, P16; Cowie MR, 1997, LANCET, V350, P1349, DOI 10.1016/S0140-6736(97)06031-5; Davie AP, 1997, EUR HEART J, V18, P981; Diller PM, 1999, ARCH FAM MED, V8, P414, DOI 10.1001/archfami.8.5.414; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; MIYITAKE K, 1984, AM J CARDIOL, V53, P586; Mosterd A, 1999, EUR HEART J, V20, P447, DOI 10.1053/euhj.1998.1239; REMES J, 1991, EUR HEART J, V12, P315, DOI 10.1093/oxfordjournals.eurheartj.a059896; SCHILLER NB, 1979, CIRCULATION, V60, P547, DOI 10.1161/01.CIR.60.3.547; Senni M, 1998, CIRCULATION, V98, P2282, DOI 10.1161/01.CIR.98.21.2282; Vasan RS, 1999, J AM COLL CARDIOL, V33, P1948, DOI 10.1016/S0735-1097(99)00118-7; VASAN RS, 1995, J AM COLL CARDIOL, V26, P1565, DOI 10.1016/0735-1097(95)00381-9; Williams DG, 1997, TRANSPORT Q, V51, P9	16	236	249	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 22	2000	321	7255					215	218		10.1136/bmj.321.7255.215	http://dx.doi.org/10.1136/bmj.321.7255.215			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	338XG	10903655	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000088448100024
J	Jin, YG; Wang, Y; Wang, W; Shang, QH; Cao, CQ; Erwin, DH				Jin, YG; Wang, Y; Wang, W; Shang, QH; Cao, CQ; Erwin, DH			Pattern of marine mass extinction near the Permian-Triassic boundary in South China	SCIENCE			English	Article							TETHYS; RANGE	The Meishan section across the Permian-Triassic boundary in South China is the most thoroughly investigated in the world. A statistical analysis of the occurrences of 162 genera and 333 species confirms a sudden extinction event at 251.4 million years ago, coincident with a dramatic depletion of delta(13)C(carbonate) and an increase in microspherules.	Acad Sinica, Nanjing Inst Geol & Palaeontol, Nanjing 210008, Peoples R China; Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20560 USA	Chinese Academy of Sciences; Smithsonian Institution; Smithsonian National Museum of Natural History	Jin, YG (corresponding author), Acad Sinica, Nanjing Inst Geol & Palaeontol, Nanjing 210008, Peoples R China.		Wang, Wen/AAP-9873-2020; Erwin, Douglas H/A-9668-2009; Wang, Wei/B-5617-2019	Erwin, Douglas/0000-0003-2518-5614				Asaro F., 1982, GEOL SOC AM SPEC PAP, V190, P517; BAUD A, 1989, GEOL RUNDSCH, V78, P649, DOI 10.1007/BF01776196; Bowring SA, 1998, SCIENCE, V280, P1039, DOI 10.1126/science.280.5366.1039; CAMPBELL IH, 1992, SCIENCE, V258, P1760, DOI 10.1126/science.258.5089.1760; Cao C. Q., 1998, PALAEOWORLD, V9, P147; CAO CQ, 1999, THESIS NANJING I GEO; DHONDT S, COMMUNICATION; ERWIN DH, 1993, GRAT PALEOZOIC CRISI; Gao Zhengang, 1987, GEOLOGICAL REV, V33, P203; HAO WC, 1994, J GEOSCI OSAKA CITY, V39, P19; He J.W., 1987, J STRATIGR, V11, P194; Marshall CR, 1996, SCIENCE, V274, P1360, DOI 10.1126/science.274.5291.1360; MARSHALL CR, 1994, PALEOBIOLOGY, V20, P459, DOI 10.1017/S0094837300012938; MELDAHL KH, 1990, GEOLOGY, V18, P890, DOI 10.1130/0091-7613(1990)018<0890:SSAATS>2.3.CO;2; OUYANG S, 1990, REV PALAEOBOT PALYNO, V66, P65, DOI DOI 10.1016/0034-6667(90)90029-I; RENNE PR, 1995, SCIENCE, V269, P1413, DOI 10.1126/science.269.5229.1413; RETALLACK GJ, 1995, SCIENCE, V267, P77, DOI 10.1126/science.267.5194.77; SHENG J-Z, 1984, Journal of the Faculty of Science Hokkaido University Series IV Geology and Mineralogy, V21, P133; Signor P.W., 1982, GEOL SOC AM SPEC PAP, V190, P291, DOI DOI 10.1130/SPE190-P291; SPRINGER MS, 1990, PALEOBIOLOGY, V16, P512, DOI 10.1017/S0094837300010228; TONG J., 1993, PERMO TRIASSIC EVENT, P90; Visscher H, 1996, P NATL ACAD SCI USA, V93, P2155, DOI 10.1073/pnas.93.5.2155; WIGNALL PB, 1993, PALAEOGEOGR PALAEOCL, V102, P215, DOI 10.1016/0031-0182(93)90068-T; YAN Z, 1989, PALAEOWORLD, V1, P113; YIN HF, 1992, PERMOTRIASSIC EVENTS; Zhang K., 1996, PALAEOZOIC MESOZOIC; ZHAO JK, 1981, B NANJING I GEOL PAL, V1, P95	27	534	662	9	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2000	289	5478					432	436		10.1126/science.289.5478.432	http://dx.doi.org/10.1126/science.289.5478.432			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336ME	10903200				2022-12-24	WOS:000088305500042
J	Liou, YC; Tocilj, A; Davies, PL; Jia, ZC				Liou, YC; Tocilj, A; Davies, PL; Jia, ZC			Mimicry of ice structure by surface hydroxyls and water of a beta-helix antifreeze protein	NATURE			English	Article							BEETLE DENDROIDES CANADENSIS; CRYSTAL-STRUCTURE; BINDING; COMPLEX; LARVAE; ATOM	Insect antifreeze proteins (AFP) are much more effective than fish AFPs at depressing solution freezing points by ice-growth inhibition(1,2). AFP from the beetle Tenebrio molitor is a small protein (8.4 kDa) composed of tandem 12-residue repeats(3) (TCTxSxxCxxAx). Here we report its 1.4-Angstrom resolution crystal structure, showing that this repetitive sequence translates into an exceptionally regular beta-helix. Not only are the 12-amino-acid loops almost identical in the backbone, but also the conserved side chains are positioned in essentially identical orientations, making this AFP perhaps the most regular protein structure yet observed. The protein has almost no hydrophobic core but is stabilized by numerous disulphide and hydrogen bonds. On the conserved side of the protein, threonine-cysteine-threonine motifs are arrayed to form a flat beta-sheet, the putative ice-binding surface. The threonine side chains have exactly the same rotameric conformation and the spacing between OH groups is a near-perfect match to the ice lattice. Together with tightly bound co-planar external water, three ranks of oxygen atoms form a two-dimensional array, mimicking an ice section.	Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Davies, PL (corresponding author), Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada.	daviesp@post.queensu.ca						Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHEN LQ, 1991, P NATL ACAD SCI USA, V88, P4240, DOI 10.1073/pnas.88.10.4240; Davies PL, 1997, CURR OPIN STRUC BIOL, V7, P828, DOI 10.1016/S0959-440X(97)80154-6; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Duman JG, 1998, J COMP PHYSIOL B, V168, P225, DOI 10.1007/s003600050140; Graether SP, 2000, NATURE, V406, P325, DOI 10.1038/35018610; Graham LA, 1997, NATURE, V388, P727, DOI 10.1038/41908; Jenkins J, 1998, J STRUCT BIOL, V122, P236, DOI 10.1006/jsbi.1998.3985; Jia ZC, 1996, NATURE, V384, P285, DOI 10.1038/384285a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KNIGHT CA, 1993, BIOPHYS J, V64, P252, DOI 10.1016/S0006-3495(93)81361-4; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li N, 1998, BIOCHEMISTRY-US, V37, P6343, DOI 10.1021/bi972853i; Lieu YC, 2000, PROTEIN EXPRES PURIF, V19, P148, DOI 10.1006/prep.2000.1219; Liou YC, 1999, BIOCHEMISTRY-US, V38, P11415, DOI 10.1021/bi990613s; Liou YC, 2000, ACTA CRYSTALLOGR D, V56, P354, DOI 10.1107/S0907444999016844; Mayans O, 1997, STRUCTURE, V5, P677, DOI 10.1016/S0969-2126(97)00222-0; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Petersen TN, 1997, STRUCTURE, V5, P533, DOI 10.1016/S0969-2126(97)00209-8; RAETZ CRH, 1995, SCIENCE, V270, P997, DOI 10.1126/science.270.5238.997; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; SICHERI F, 1995, NATURE, V375, P427, DOI 10.1038/375427a0; STEINBACHER S, 1994, SCIENCE, V265, P383, DOI 10.1126/science.8023158; Tyshenko MG, 1997, NAT BIOTECHNOL, V15, P887, DOI 10.1038/nbt0997-887; YODER MD, 1993, SCIENCE, V260, P1503, DOI 10.1126/science.8502994	26	371	407	7	164	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2000	406	6793					322	324		10.1038/35018604	http://dx.doi.org/10.1038/35018604			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917536				2022-12-24	WOS:000088251900054
J	Gunsilius, E; Duba, HC; Petzer, AL; Kahler, CM; Grunewald, K; Stockhammer, G; Gabl, C; Dirnhofer, S; Clausen, J; Gastl, G				Gunsilius, E; Duba, HC; Petzer, AL; Kahler, CM; Grunewald, K; Stockhammer, G; Gabl, C; Dirnhofer, S; Clausen, J; Gastl, G			Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells	LANCET			English	Article							CHRONIC MYELOID-LEUKEMIA; IN-SITU HYBRIDIZATION; BLOOD; ANGIOGENESIS; FLUORESCENCE; VASCULOGENESIS; COMMON; TUMORS; FISH; CML	Background Vascular endothelial cells lost from the blood-vessel endothelium through necrosis or apoptosis must be replaced. We investigated in a leukaemia model whether bone-marrow-derived endothelial cells contribute to this maintenance angiogenesis. Methods We studied six patients with chronic myelogenous leukaemia (CML) carrying the BCR/ABL fusion gene in their bone-marrow-derived cells. We screened endothelial cells generated in vitro from bone-marrow-derived progenitor cells and vascular endothelium in myocardial tissue for the BCR/ABL fusion gene by in-situ hybridisation. For detection of donor-type endothelial cells after transplantation of haemopoietic stem cells, recipient tissue was stained with monoclonal antibodies against donor-type HLA antigens, Findings We identified the BCR/ABL fusion gene in variable proportions (0-56%) of endothelial cells generated in vitro. Endothelial cells expressing the fusion gene were found in the vascular endothelium of a patient. In a recipient of an allogeneic stem-cell transplant, normal donor-type endothelial cells were detected in the Vascular endothelium. Interpretation These findings suggest that CML is not solely a haematological disease but originates from a bone-marrow-derived haemangioblastic precursor cell that can give rise to both blood cells and endothelial cells. Moreover, normal bone-marrow-derived endothelial cells can contribute to the maintenance of the blood vascular endothelium. The integration of bone-marrow-derived endothelial cells into the vascular endothelium provides a rationale for developing vascular targeting strategies in vasculopathies, inflammatory diseases, and cancer.	Univ Innsbruck, Div Haematol & Oncol, A-6020 Innsbruck, Austria; Univ Innsbruck, Inst Med Biol & Human Genet, A-6020 Innsbruck, Austria; Univ Innsbruck, Div Gen Internal Med, A-6020 Innsbruck, Austria; Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria; Univ Innsbruck, Dept Pathol, A-6020 Innsbruck, Austria	University of Innsbruck; University of Innsbruck; University of Innsbruck; University of Innsbruck; University of Innsbruck	Gunsilius, E (corresponding author), Univ Innsbruck Hosp, Div Haematol & Oncol, Anichstr 35, A-6020 Innsbruck, Austria.	eberhard.gunsilius@uibk.ac.at	Gunsilius, Eberhard/AAI-9333-2021	Gunsilius, Eberhard/0000-0003-1327-2921				Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Choi K, 1998, DEVELOPMENT, V125, P725; Dobler M, 1999, INT J ONCOL, V14, P571; Duba HC, 1999, INT J ONCOL, V14, P145; Eibl B, 1997, GENE CHROMOSOME CANC, V20, P215, DOI 10.1002/(SICI)1098-2264(199711)20:3<215::AID-GCC1>3.0.CO;2-5; FIALKOW PJ, 1977, AM J MED, V63, P125, DOI 10.1016/0002-9343(77)90124-3; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; His W, 1900, ABHANDL KS GES WISS, V22, P171; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; HSU SM, 1981, AM J CLIN PATHOL, V75, P816, DOI 10.1093/ajcp/75.6.816; LANSDORP PM, 1993, J EXP MED, V178, P787, DOI 10.1084/jem.178.3.787; Muhlmann J, 1998, GENE CHROMOSOME CANC, V21, P90, DOI 10.1002/(SICI)1098-2264(199802)21:2<90::AID-GCC3>3.0.CO;2-2; NOWELL PC, 1960, SCIENCE, V132, P1497; Petzer AL, 1996, BLOOD, V88, P2162, DOI 10.1182/blood.V88.6.2162.bloodjournal8862162; RISAU W, 1988, DEVELOPMENT, V102, P471; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shi Q, 1998, BLOOD, V92, P362, DOI 10.1182/blood.V92.2.362.414k38_362_367	20	254	273	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 13	2000	355	9216					1688	1691		10.1016/S0140-6736(00)02241-8	http://dx.doi.org/10.1016/S0140-6736(00)02241-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	313CY	10905245				2022-12-24	WOS:000086983800012
J	Yu, G; Nishimura, M; Arawaka, S; Levitan, D; Zhang, LL; Tandon, A; Song, YQ; Rogaeva, E; Chen, FS; Kawaral, T; Supala, A; Levesque, L; Yu, H; Yang, DS; Holmes, E; Millman, P; Liang, Y; Zhang, DM; Xu, DH; Sato, C; Rogaev, E; Smith, M; Janus, C; Zhang, YN; Aebersold, R; Farrer, L; Sorbi, S; Bruni, A; Fraser, P; St George-Hyslop, P				Yu, G; Nishimura, M; Arawaka, S; Levitan, D; Zhang, LL; Tandon, A; Song, YQ; Rogaeva, E; Chen, FS; Kawaral, T; Supala, A; Levesque, L; Yu, H; Yang, DS; Holmes, E; Millman, P; Liang, Y; Zhang, DM; Xu, DH; Sato, C; Rogaev, E; Smith, M; Janus, C; Zhang, YN; Aebersold, R; Farrer, L; Sorbi, S; Bruni, A; Fraser, P; St George-Hyslop, P			Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and beta APP processing	NATURE			English	Article							AMYLOID PRECURSOR PROTEIN; FAMILIAL ALZHEIMERS-DISEASE; GAMMA-SECRETASE; MISSENSE MUTATIONS; NOTCH; COMPLEX; CATENIN; COMPONENT; CLEAVAGE; RELEASE	Nicastrin, a transmembrane glycoprotein, forms high molecular weight complexes with presenilin 1 and presenilin 2. Suppression of nicastrin expression in Caenorhabditis elegans embryos induces a subset of notch/glp-1 phenotypes similar to those induced by simultaneous null mutations in both presenilin homologues of C. elegans(sel-12 and hop-1). Nicastrin also binds carboxy-terminal derivatives of beta-amyloid precursor protein (beta APP), and modulates the production of the amyloid beta-peptide (A beta) from these derivatives. Missense mutations in a conserved hydrophilic domain of nicastrin increase A beta(42) and A beta(40) peptide secretion. Deletions in this domain inhibit A beta production. Nicastrin and presenilins are therefore likely to be functional components of a multimeric complex necessary for the intramembranous proteolysis of proteins such as Notch/GLP-1 and beta APP.	Univ Toronto, Toronto Western Hosp, Univ Hlth Network, Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada; Univ Toronto, Dept Med Neurol, Toronto, ON M5S 3H2, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5S 3H2, Canada; Schering Plough Corp, Res Inst, Dept CNS & Cardiovasc Res, Kenilworth, NJ 07033 USA; Univ Washington, Seattle, WA 98195 USA; Boston Univ, Sch Med, Genet Program, Boston, MA 02118 USA; Univ Florence, Dept Neurol, I-50134 Florence, Italy; Ctr Reg Neurogenet, USL 6, I-88046 Lamezia Terme, Italy	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Merck & Company; Schering Plough Corporation; University of Washington; University of Washington Seattle; Boston University; University of Florence	St George-Hyslop, P (corresponding author), Univ Toronto, Toronto Western Hosp, Univ Hlth Network, Ctr Res Neurodegenerat Dis, Neurosci Bldg,6 Queens Pk Crescent W, Toronto, ON M5S 3H2, Canada.		Farrer, Lindsay/AAS-1035-2020; Rogaev, Evgeny/AAN-7662-2020; Song, You-qiang/C-4401-2009; Song, You-Qiang/E-5207-2011; Bruni, Amalia/K-5038-2016	St George-Hyslop, Peter/0000-0003-0796-7209; Arawaka, Shigeki/0000-0002-1505-3012; Farrer, Lindsay/0000-0001-5533-4225; Song, You-Qiang/0000-0001-9407-2256; Xu, Dazhong/0000-0001-9264-3342; Yu, Wai Haung/0000-0001-7186-6731; Bruni, Amalia/0000-0003-3471-3343				Capell A, 1998, J BIOL CHEM, V273, P3205, DOI 10.1074/jbc.273.6.3205; CHEN F, IN PRESS J BIOL CHEM; Citron M, 1998, NEUROBIOL DIS, V5, P107, DOI 10.1006/nbdi.1998.0183; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; DeStrooper B, 1997, J BIOL CHEM, V272, P3590, DOI 10.1074/jbc.272.6.3590; FELDMAN RG, 1963, NEUROLOGY, V13, P811, DOI 10.1212/WNL.13.10.811; Figeys D, 1996, NAT BIOTECHNOL, V14, P1579, DOI 10.1038/nbt1196-1579; FONCIN JF, 1985, REV NEUROL, V141, P194; Goutte C, 2000, DEVELOPMENT, V127, P2481; Hay JC, 1997, CELL, V89, P149, DOI 10.1016/S0092-8674(00)80191-9; Howell D. C., 2013, STAT METHODS PSYCHOL; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; Kehoe P, 1999, HUM MOL GENET, V8, P237, DOI 10.1093/hmg/8.2.237; Levesque G, 1999, J NEUROCHEM, V72, P999, DOI 10.1046/j.1471-4159.1999.0720999.x; Li XJ, 1997, P NATL ACAD SCI USA, V94, P12204, DOI 10.1073/pnas.94.22.12204; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Nishimura M, 1999, NAT MED, V5, P164, DOI 10.1038/5526; Niwa M, 1999, CELL, V99, P691, DOI 10.1016/S0092-8674(00)81667-0; PREISS JR, 1987, CELL, V51, P601; Ray WJ, 1999, P NATL ACAD SCI USA, V96, P3263, DOI 10.1073/pnas.96.6.3263; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; SELKOE DJ, 1994, ANNU REV NEUROSCI, V17, P489, DOI 10.1146/annurev.neuro.17.1.489; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Song WH, 1999, P NATL ACAD SCI USA, V96, P6959, DOI 10.1073/pnas.96.12.6959; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Thinakaran G, 1997, J BIOL CHEM, V272, P28415, DOI 10.1074/jbc.272.45.28415; Thinakaran G, 1998, NEUROBIOL DIS, V4, P438, DOI 10.1006/nbdi.1998.0171; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Westlund B, 1999, P NATL ACAD SCI USA, V96, P2497, DOI 10.1073/pnas.96.5.2497; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xia WM, 1997, P NATL ACAD SCI USA, V94, P8208, DOI 10.1073/pnas.94.15.8208; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; Yu G, 1998, J BIOL CHEM, V273, P16470, DOI 10.1074/jbc.273.26.16470; YU G, IN PRESS J BIOL CHEM; Zhang LL, 1999, J BIOL CHEM, V274, P8966, DOI 10.1074/jbc.274.13.8966; Zhou JH, 1997, NEUROREPORT, V8, P2085, DOI 10.1097/00001756-199705260-00054; Zubenko GS, 1998, GENOMICS, V50, P121, DOI 10.1006/geno.1998.5306	44	795	840	0	46	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 7	2000	407	6800					48	54		10.1038/35024009	http://dx.doi.org/10.1038/35024009			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	350WE	10993067				2022-12-24	WOS:000089124000036
J	Beutler, E; Felitti, V; Gelbart, T; Ho, N				Beutler, E; Felitti, V; Gelbart, T; Ho, N			The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic	ANNALS OF INTERNAL MEDICINE			English	Article							INCREASED TRANSFERRIN SATURATION; VOLUNTARY BLOOD-DONORS; HEREDITARY HEMOCHROMATOSIS; S65C VARIANT; GENE; POPULATION; MUTATIONS; HOMOZYGOTES; HEMOGLOBIN; RECEPTOR	Background: The gene that causes most cases of hereditary hemochromatosis is designated HFE. Three mutations exist at this locus at a relatively high gene frequency. Objective: To determine the gene frequency of the three HFE mutations and to relate genotypes to various clinical and laboratory variables. Design: Observational study. Setting: Health appraisal clinic. Patients: 10 198 adults who registered for health appraisal and consented to DNA examination for hemochromatosis. Consenting patients were slightly older and had attained a slightly higher educational level than nonconsenting patients. Measurements: Extensive medical history and laboratory tests, including complete blood count, transferrin saturation, and other chemistries; serum ferritin levels; and HFE genotype. Results: In white participants, the gene frequencies were 0.063 for the C282Y mutation, 0.152 for the H63D mutation, and 0.016 for the S65C mutation. Gene frequencies were lower in other ethnic groups. In participants with HFE mutations, the average serum transferrin saturation and ferritin levels were slightly increased, as were mean hemoglobin levels and mean corpuscular volume. A transferrin saturation of 50% had a sensitivity of only 0.52 (95% CI, 0.345 to 0.686) and a specificity of 0.908 (CI, 0.902 to 0.914) for detection of homozygosity. A ferritin level of 200 mu g/L in women and 250 mu g/L in men had a sensitivity of 0.70 (CI, 0.540 to 0.854) and a specificity of 0.803 (CI, 0.796 to 0.811). The prevalence of iron deficiency anemia was lower in women who carried HFE mutations. Conclusions: Screening for transferrin saturation and ferritin levels does not detect all homozygotes for the major hemochromatosis mutation. Heterozygotes for HFE mutations had a lower prevalence of iron deficiency anemia.	Scripps Res Inst, La Jolla, CA 92037 USA; Kaiser Permanente, San Diego, CA USA	Scripps Research Institute; Kaiser Permanente	Beutler, E (corresponding author), Scripps Res Inst, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	beutler@scripps.edu		Gelbart, Terri/0000-0002-7863-1262	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00833] Funding Source: Medline; NIDDK NIH HHS [DK53505-02] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arya N, 1999, BLOOD CELL MOL DIS, V25, P354, DOI 10.1006/bcmd.1999.0264; Barton JC, 2000, J LAB CLIN MED, V135, P96, DOI 10.1016/S0022-2143(00)70026-6; Beutler E, 1997, AM J HUM GENET, V61, P762; Beutler E, 1999, BLOOD CELL MOL DIS, V25, P358, DOI 10.1006/bcmd.1999.0265; BEUTLER E, 1957, NEW ENGL J MED, V256, P692, DOI 10.1056/NEJM195704112561506; BEUTLER E, IN PRESS GENETIC TES; BEUTLER E, 2000, BLOOD CELLS MOL DIS; Beutler Ernest, 1996, Blood Cells Molecules and Diseases, V22, P187, DOI 10.1006/bcmd.1996.0027; Burke W, 1999, MOL MED TODAY, V5, P428, DOI 10.1016/S1357-4310(99)01578-6; Datz C, 1998, CLIN CHEM, V44, P2429; EDWARDS CQ, 1980, ANN INTERN MED, V93, P519, DOI 10.7326/0003-4819-93-4-519; EDWARDS CQ, 1994, ADV EXP MED BIOL, V356, P303; Edwards CQ, 1998, SEMIN HEMATOL, V35, P72; Fairbanks VF, 1998, GUT, V43, P441, DOI 10.1136/gut.43.3.441; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Jazwinska EC, 1996, NAT GENET, V14, P249, DOI 10.1038/ng1196-249; Jezequel P, 1998, HUM GENET, V102, P332, DOI 10.1007/s004390050701; Jouanolle AM, 1996, NAT GENET, V14, P251, DOI 10.1038/ng1196-251; Lebron JA, 1998, CELL, V93, P111, DOI 10.1016/S0092-8674(00)81151-4; Lebron JA, 1999, J MOL BIOL, V289, P1109, DOI 10.1006/jmbi.1999.2842; McDonnell SM, 1999, AM J MED, V107, P30, DOI 10.1016/S0002-9343(99)00163-1; McLaren CE, 1998, GASTROENTEROLOGY, V114, P543, DOI 10.1016/S0016-5085(98)70538-4; Mura C, 1999, BLOOD, V93, P2502, DOI 10.1182/blood.V93.8.2502.408k27_2502_2505; Olynyk JK, 1999, NEW ENGL J MED, V341, P718, DOI 10.1056/NEJM199909023411002; PERRY GS, 1992, J NUTR, V122, P1417, DOI 10.1093/jn/122.7.1417; Rochette J, 1999, AM J HUM GENET, V64, P1056, DOI 10.1086/302318; Rossi E, 2000, CLIN CHEM, V46, P162; Ryan E, 1998, BLOOD CELL MOL DIS, V24, P428, DOI 10.1006/bcmd.1998.0211; Somerville MJ, 1999, AM J HUM GENET, V65, P924, DOI 10.1086/302550; Spriggs EL, 1999, AM J HUM GENET, V65, pA492; Willis G, 2000, GUT, V46, P401, DOI 10.1136/gut.46.3.401; Willis G, 1999, LANCET, V354, P221, DOI 10.1016/S0140-6736(99)02195-9; Worwood M, 1998, CLIN LAB HAEMATOL, V20, P65, DOI 10.1046/j.1365-2257.1998.00028.x	33	221	223	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 5	2000	133	5					329	337		10.7326/0003-4819-133-5-200009050-00008	http://dx.doi.org/10.7326/0003-4819-133-5-200009050-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	350QD	10979877				2022-12-24	WOS:000089111900002
J	Schmid, PE; Tokeshi, M; Schmid-Araya, JM				Schmid, PE; Tokeshi, M; Schmid-Araya, JM			Relation between population density and body size in stream communities	SCIENCE			English	Article							GRAVEL STREAM; ABUNDANCE; CHIRONOMIDAE; ASSEMBLAGES; REGRESSION; SEDIMENTS; DYNAMICS; DIPTERA	The existence of a general relation between population density and body size in animal assemblages has been debated because of known biases and ambiguities in the published data and data handling. Using new comprehensive data sets from two geographically separated stream communities that encompass 448 and 260 invertebrate taxa with a wide range of body sizes, we show that an inverse proportionality between density and body size is a consistent feature in these communities. The scaling across taxa is not statistically different between the two systems, indicating a convergent pattern of communities, Variation in the regression slope among different taxonomic groups indicates that these communities are not governed universally by a single ecological or energetic rule.	Queen Mary Univ London, Sch Biol Sci, London E1 4NS, England; Kyushu Univ, Amakusa Marine Biol Lab, Kumamoto, Japan	University of London; Queen Mary University London; Kyushu University	Schmid, PE (corresponding author), Queen Mary Univ London, Sch Biol Sci, Mile End Rd, London E1 4NS, England.	p.e.schmid@qmw.ac.uk		Schmid, Peter E./0000-0002-2510-3941				BABU GJ, 1992, COMMUN STAT SIMULAT, V21, P533, DOI 10.1080/03610919208813034; BLACKBURN TM, 1993, J ANIM ECOL, V62, P694, DOI 10.2307/5389; BLACKBURN TM, 1994, PHILOS T ROY SOC B, V343, P33, DOI 10.1098/rstb.1994.0005; Blackburn TM, 1999, OIKOS, V85, P570, DOI 10.2307/3546707; BRETSCHKO G, 1992, Regulated Rivers Research and Management, V7, P17, DOI 10.1002/rrr.3450070104; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; DUNCAN A, 1989, HYDROBIOLOGIA, V186, P11, DOI 10.1007/BF00048891; GASTON KJ, 1988, AM NAT, V132, P662, DOI 10.1086/284881; GRIFFITHS D, 1992, J ANIM ECOL, V61, P307, DOI 10.2307/5323; Griffiths D, 1998, J ANIM ECOL, V67, P795, DOI 10.1046/j.1365-2656.1998.00244.x; ISOBE T, 1990, ASTROPHYS J, V364, P104, DOI 10.1086/169390; Kleiber M., 1962, FIRE LIFE; LABARBERA M, 1989, ANNU REV ECOL SYST, V20, P97, DOI 10.1146/annurev.es.20.110189.000525; LAWTON JH, 1989, OIKOS, V55, P429, DOI 10.2307/3565606; LEICHTFRIED M, 1991, MITT OSTERR GEOL GES, V83, P229; MARQUET PA, 1990, SCIENCE, V250, P1125, DOI 10.1126/science.250.4984.1125; MARQUET PA, 1995, J ANIM ECOL, V64, P325, DOI 10.2307/5894; MORSE DR, 1985, NATURE, V314, P731, DOI 10.1038/314731a0; NEE S, 1991, NATURE, V351, P212; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; SCHMID PE, 1993, FRESHWATER BIOL, V30, P239, DOI 10.1111/j.1365-2427.1993.tb00806.x; Schmid PE, 1997, FRESHWATER BIOL, V38, P67, DOI 10.1046/j.1365-2427.1997.00197.x; Schmid PE, 2000, ADV ECOL RES, V30, P339; SCHMID PE, 1999, JAHRESBER BIOL STATI, V16, P51; SCHMIDARAYA JM, 1994, LIMNOL OCEANOGR, V39, P1813, DOI 10.4319/lo.1994.39.8.1813; SCHMIDARAYA JM, 1995, JBER BIOL STN LUNZ, V15, P11; SCHONBORN W, 1977, OECOLOGIA, V27, P171, DOI 10.1007/BF00345821; TOKESHI M, 1999, SPECIES COEXISTENCE, P318	28	102	107	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 1	2000	289	5484					1557	1560		10.1126/science.289.5484.1557	http://dx.doi.org/10.1126/science.289.5484.1557			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349XW	10968792				2022-12-24	WOS:000089071700048
J	Stover, CK; Pham, XQ; Erwin, AL; Mizoguchi, SD; Warrener, P; Hickey, MJ; Brinkman, FSL; Hufnagle, WO; Kowalik, DJ; Lagrou, M; Garber, RL; Goltry, L; Tolentino, E; Westbrock-Wadman, S; Yuan, Y; Brody, LL; Coulter, SN; Folger, KR; Kas, A; Larbig, K; Lim, R; Smith, K; Spencer, D; Wong, GKS; Wu, Z; Paulsen, IT; Reizer, J; Saier, MH; Hancock, REW; Lory, S; Olson, MV				Stover, CK; Pham, XQ; Erwin, AL; Mizoguchi, SD; Warrener, P; Hickey, MJ; Brinkman, FSL; Hufnagle, WO; Kowalik, DJ; Lagrou, M; Garber, RL; Goltry, L; Tolentino, E; Westbrock-Wadman, S; Yuan, Y; Brody, LL; Coulter, SN; Folger, KR; Kas, A; Larbig, K; Lim, R; Smith, K; Spencer, D; Wong, GKS; Wu, Z; Paulsen, IT; Reizer, J; Saier, MH; Hancock, REW; Lory, S; Olson, MV			Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen	NATURE			English	Article							BACTERIUM MYXOCOCCUS-XANTHUS; MYCOBACTERIUM-TUBERCULOSIS; TWITCHING MOTILITY; ESCHERICHIA-COLI; CYSTIC-FIBROSIS; CHEMOTAXIS; INFECTIONS; SECRETION; PROTEINS; GENES	Pseudomonas aeruginosa is a ubiquitous environmental bacterium that is one of the top three causes of opportunistic human infections. A major factor in its prominence as a pathogen is its intrinsic resistance to antibiotics and disinfectants. Here we report the complete sequence of P. aeruginosa strain PAO1. At 6.3 million base pairs, this is the largest bacterial genome sequenced, and the sequence provides insights into the basis of the versatility and intrinsic drug resistance of P. aeruginosa. Consistent with its larger genome size and environmental adaptability, P. aeruginosa contains the highest proportion of regulatory genes observed for a bacterial genome and a large number of genes involved in the catabolism, transport and efflux of organic compounds as well as four potential chemotaxis systems. We propose that the size and complexity of the P. aeruginosa genome reflect an evolutionary adaptation permitting it to thrive in diverse environments and resist the effects of a variety of antimicrobial substances.	Univ Washington, Genome Ctr, Dept Med & Genet, Seattle, WA 98195 USA; Pathogenesis Corp, Seattle, WA 98119 USA; Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; Hannover Med Sch, Klin Forschergrp, D-30623 Hannover, Germany; Inst Genom Res, Rockville, MD 20850 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of British Columbia; Hannover Medical School; J. Craig Venter Institute; University of California System; University of California San Diego; University of Washington; University of Washington Seattle	Olson, MV (corresponding author), Univ Washington, Genome Ctr, Dept Med & Genet, Box 352145, Seattle, WA 98195 USA.	mvo@u.washington.edu	Brinkman, Fiona/N-3195-2013; WONG, Gane Ka-Shu/G-5784-2013; Hancock, Robert E. W./E-1145-2013; Paulsen, Ian T/K-3832-2012	Brinkman, Fiona/0000-0002-0584-4099; WONG, Gane Ka-Shu/0000-0001-6108-5560; Hancock, Robert E. W./0000-0001-5989-8503; Paulsen, Ian T/0000-0001-9015-9418; Stover, Charles/0000-0002-7406-1696				Ahearn DG, 1999, METHOD ENZYMOL, V310, P551; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Armitage JP, 1997, MICROBIOL-UK, V143, P3671, DOI 10.1099/00221287-143-12-3671; Ball CA, 2000, NUCLEIC ACIDS RES, V28, P77, DOI 10.1093/nar/28.1.77; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bleves S, 1999, J BACTERIOL, V181, P4012, DOI 10.1128/JB.181.13.4012-4019.1999; BODEY GP, 1983, REV INFECT DIS, V5, P279; Brown MH, 1999, MOL MICROBIOL, V31, P394, DOI 10.1046/j.1365-2958.1999.01162.x; China B, 1999, VET RES, V30, P181; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; DARZINS A, 1994, MOL MICROBIOL, V11, P137, DOI 10.1111/j.1365-2958.1994.tb00296.x; DOMENIGHINI M, 1990, MOL MICROBIOL, V4, P787, DOI 10.1111/j.1365-2958.1990.tb00649.x; Ewing B, 2000, NAT GENET, V25, P232, DOI 10.1038/76115; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hancock REW, 1998, NAT BIOTECHNOL, V16, P216, DOI 10.1038/nbt0398-216; Hancock REW, 1998, CLIN INFECT DIS, V27, pS93, DOI 10.1086/514909; Hardalo C, 1997, CRIT REV MICROBIOL, V23, P47, DOI 10.3109/10408419709115130; HOLLOWAY BW, 1955, J GEN MICROBIOL, V13, P572, DOI 10.1099/00221287-13-3-572; Kaneko T, 1996, DNA Res, V3, P109; KATO J, 1994, J BACTERIOL, V176, P5874, DOI 10.1128/JB.176.18.5874-5877.1994; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; MAHAN MJ, 1991, GENETICS, V129, P1021; MCBRIDE MJ, 1989, P NATL ACAD SCI USA, V86, P424, DOI 10.1073/pnas.86.2.424; MOULTON RC, 1979, J BACTERIOL, V137, P274, DOI 10.1128/JB.137.1.274-280.1979; NELSON JW, 1990, INFECT IMMUN, V58, P1489, DOI 10.1128/IAI.58.6.1489-1495.1990; Nikaido H, 1998, CLIN INFECT DIS, V27, pS32, DOI 10.1086/514920; NOEL GJ, 1994, J INFECT DIS, V169, P425, DOI 10.1093/infdis/169.2.425; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; OHGA T, 1993, FEMS MICROBIOL LETT, V113, P63; Paulsen IT, 1998, J MOL BIOL, V277, P573, DOI 10.1006/jmbi.1998.1609; Schmidt KD, 1996, J BACTERIOL, V178, P85, DOI 10.1128/jb.178.1.85-93.1996; Schmidt KD, 1998, ELECTROPHORESIS, V19, P509, DOI 10.1002/elps.1150190410; Stock JB, 1996, ESCHERICHIA COLI SAL, P1103; Temple LM, 1998, BIOTECH HAN, V10, P35; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Westbrock-Wadman S, 1999, ANTIMICROB AGENTS CH, V43, P2975, DOI 10.1128/AAC.43.12.2975; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; Yahr TL, 1998, P NATL ACAD SCI USA, V95, P13899, DOI 10.1073/pnas.95.23.13899	44	3186	4822	19	631	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2000	406	6799					959	964		10.1038/35023079	http://dx.doi.org/10.1038/35023079			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	348ZW	10984043	Bronze			2022-12-24	WOS:000089020200035
J	Sasaki, T; Irie-Sasaki, J; Horie, Y; Bachmaier, K; Fata, JE; Li, M; Suzuki, A; Bouchard, D; Ho, A; Redston, M; Gallinger, S; Khokha, R; Mak, TW; Hawkins, PT; Stephens, L; Scherer, SW; Tsao, M; Penninger, JM				Sasaki, T; Irie-Sasaki, J; Horie, Y; Bachmaier, K; Fata, JE; Li, M; Suzuki, A; Bouchard, D; Ho, A; Redston, M; Gallinger, S; Khokha, R; Mak, TW; Hawkins, PT; Stephens, L; Scherer, SW; Tsao, M; Penninger, JM			Colorectal carcinomas in mice lacking the catalytic subunit of PI(3)K gamma	NATURE			English	Article							PHOSPHOINOSITIDE 3-KINASE; TUMOR SUPPRESSION; COLON-CARCINOMA; CANCER; PTEN; PATHWAY; KINASE; PI3K; GENE; APC	Phosphoinositide-3-OH kinases (PI(3)Ks) constitute a family of evolutionarily conserved lipid kinases that regulate a vast array of fundamental cellular responses, including proliferation, transformation, differentiation and protection from apoptosis(1,2). PI(3)K-mediated activation of the cell survival kinase PKB/Akt, and negative regulation of PI(3)K signalling by the tumour suppressor PTEN (refs 3, 4) are key regulatory events in tumorigenesis(5-7). Thus, a model has arisen that PI(3)K gamma promote development of cancers. Here we report that genetic inactivation of the p110 gamma catalytic subunit of PI(3)K gamma (ref. 8) leads to development of invasive colorectal adenocarcinomas in mice. In humans, p110 gamma protein expression is lost in primary colorectal adenocarcinomas from patients and in colon cancer cell lines. Overexpression of wild-type or kinase-dead p110 gamma in human colon cancer cells with mutations of the tumour suppressors APC and p53, or the oncogenes beta-catenin and Ki-ras, suppressed tumorigenesis. Thus, loss of p110 gamma in mice leads to spontaneous, malignant epithelial tumours in the colorectum and p110 gamma can block the growth of human colon cancer cells.	Ontario Canc Inst, Amegen Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2C1, Canada; Univ Toronto, Ontario Canc Inst, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; Univ Toronto, Ontario Canc Inst, Dept Lab Med & Pathobiol, Toronto, ON M5G 2M9, Canada; Hosp Sick Children, Dept Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; Samuel Lunenfeld Res Inst, Ctr Canc Genet, Toronto, ON M5G 1X5, Canada; Babraham Inst, Cambridge CB2 4AT, England; Univ Toronto, Dept Lab Med, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Pathol, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Toronto; University of Toronto	Penninger, JM (corresponding author), Ontario Canc Inst, Amegen Inst, 620 Univ Ave, Toronto, ON M5G 2C1, Canada.	Jpenning@amgen.com	Scherer, Stephen W./B-3785-2013; Penninger, Josef M/I-6860-2013; Gallinger, Steven/E-4575-2013; Bachmaier, Kurt/B-6331-2014; Suzuki, Akira/GYD-6697-2022; Bachmaier, Kurt/AHC-5491-2022; Tsao, Ming Sound/AFQ-7332-2022; Tsao, Ming-Sound/M-3503-2017	Scherer, Stephen W./0000-0002-8326-1999; Penninger, Josef M/0000-0002-8194-3777; Bachmaier, Kurt/0000-0002-0299-2707; Suzuki, Akira/0000-0002-5950-8808; Bachmaier, Kurt/0000-0002-0299-2707; Tsao, Ming Sound/0000-0002-9160-5405; stephens, len/0000-0002-2771-3487; Sasaki, Takehiko/0000-0003-1837-3748; Hawkins, Phillip/0000-0002-6979-0464				Bernstein HG, 1998, CELL MOL BIOL, V44, P973; BOUTRON MC, 1991, EUROPEAN JOURNAL OF CANCER PREVENTION, VOL 1, SUPPLEMENT 2, OCTOBER 1991, P13, DOI 10.1097/00008469-199110002-00003; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Fata JE, 1999, DEV BIOL, V211, P238, DOI 10.1006/dbio.1999.9313; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; GRODEN J, 1995, CANCER RES, V55, P1531; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; MACPHEE M, 1995, CELL, V81, P957, DOI 10.1016/0092-8674(95)90015-2; Maehama T, 1999, TRENDS CELL BIOL, V9, P125, DOI 10.1016/S0962-8924(99)01519-6; RUDOLPH U, 1995, NAT GENET, V10, P143, DOI 10.1038/ng0695-143; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Shayesteh L, 1999, NAT GENET, V21, P99, DOI 10.1038/5042; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; White RL, 1998, CELL, V92, P591, DOI 10.1016/S0092-8674(00)81124-1; Zhou SB, 1999, NEW ENGL J MED, V341, P1144, DOI 10.1056/NEJM199910073411510	24	91	100	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2000	406	6798					897	902		10.1038/35022585	http://dx.doi.org/10.1038/35022585			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347AG	10972292				2022-12-24	WOS:000088903600046
J	Moran, GJ; Talan, DA; Mower, W; Newdow, M; Ong, S; Nakase, JY; Pinner, RW; Childs, JE				Moran, GJ; Talan, DA; Mower, W; Newdow, M; Ong, S; Nakase, JY; Pinner, RW; Childs, JE		Emergency ID Net Study Grp	Appropriateness of rabies postexposure prophylaxis treatment for animal exposures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; EPIDEMIOLOGY	Context Rabies postexposure prophylaxis (RPEP) treatments and associated costs have increased in the United States. The extent to which RPEP use is consistent with guidelines is not well understood. Objective To characterize animal contacts and determine the frequency and factors associated with inappropriate RPEP use. Design, Setting, and Patients Prospective case series study of patients presenting with an animal exposure-related complaint from July 1996 to September 1998 at 11 university-affiliated, urban emergency departments (the Emergency ID Net). Main Outcome Measures Exposure type, circumstances, and RPEP use (appropriateness defined by local public health departments). Results Of 2030 exposures, 1635 (81%) were to dogs; 268 (13%) to cats; 88 (4%) to rodents/rabbits; 70 (0.5%) to raccoons; 5 (0.2%) to bats; and 24 (1.2%) to other animals. Among those exposed, 136 (6.7%) received RPEP after dog (95), cat (21), raccoon (8), bat (4), or other animal (8) exposures. Use of RPEP varied by site (range, 0%-27.7% of exposures), with most frequent use reported at sites in the eastern United States, Management was considered appropriate in 1857 exposures (91.5%), Use of RPEP was considered inappropriate in 54 cases (40% of those in which it was given), owing to factors including animal availability for observation and exposure in a low-endemicity area. Rabies postexposure prophylaxis was considered inappropriately withheld from 119 cases (6.3% of those not receiving RPEP), often because a domestic animal was unavailable for observation or testing. Conclusion These results suggest that use of RPEP is often inappropriate. Greater compliance with current guidelines would increase RPEP use. Physician education, improved coordination with public health officials, and clarification of RPEP guidelines could optimize use of this expensive resource.	Olive View UCLA Med Ctr, Dept Emergency Med, Sylmar, CA 91342 USA; Univ Calif Los Angeles, Sch Med, Los Angeles, CA USA; Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Atlanta, GA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Centers for Disease Control & Prevention - USA	Moran, GJ (corresponding author), Olive View UCLA Med Ctr, Dept Emergency Med, 14445 Olive View Dr,N Annex, Sylmar, CA 91342 USA.	gmoran@ucla.edu	Childs, James E/B-4002-2012	Chiang, William/0000-0003-3562-8896	PHS HHS [U50/CCU912342] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		[Anonymous], 1999, MMWR Recomm Rep, V48, P1; [Anonymous], 1991, MMWR Recomm Rep, V40, P1; Auslander M, 1997, EMERG INFECT DIS, V3, P199, DOI 10.3201/eid0302.970216; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V45, P1117; CIESLAK PR, 1998, INT C EM INF DIS MAR; Harrigan Richard A., 1996, Journal of Emergency Medicine, V14, P287, DOI 10.1016/0736-4679(96)00023-6; HELMICK CG, 1983, JAMA-J AM MED ASSOC, V250, P1990, DOI 10.1001/jama.250.15.1990; Krebs J W, 1998, J Public Health Manag Pract, V4, P56; Krebs JW, 1998, J AM VET MED ASSOC, V213, P1713; Meltzer MI, 1998, PHARMACOECONOMICS, V14, P365, DOI 10.2165/00019053-199814040-00004; Noah DL, 1998, ANN INTERN MED, V128, P922, DOI 10.7326/0003-4819-128-11-199806010-00012; Talan DA, 1998, ANN EMERG MED, V32, P703, DOI 10.1016/S0196-0644(98)70071-X; U.S. Department of Health and Human Services, 1991, DHHS PUBL; Weiss HB, 1998, JAMA-J AM MED ASSOC, V279, P51, DOI 10.1001/jama.279.1.51; 1998, JAMA, V30, P1525	15	81	82	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 23	2000	284	8					1001	1007		10.1001/jama.284.8.1001	http://dx.doi.org/10.1001/jama.284.8.1001			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344PX	10944646	Bronze			2022-12-24	WOS:000088769000027
J	Palladino, MJ; Keegan, LP; O'Connell, MA; Reenan, RA				Palladino, MJ; Keegan, LP; O'Connell, MA; Reenan, RA			A-to-I pre-mRNA editing in Drosophila is primarily involved in adult nervous system function and integrity	CELL			English	Article							DOUBLE-STRANDED-RNA; GLUTAMATE-RECEPTOR CHANNELS; SUBUNIT GLUR-B; MESSENGER-RNAS; ADENOSINE-DEAMINASE; ION FLOW; GENE; INOSINE; HYPERMUTATION; PURIFICATION	Specific A-to-I RNA editing, like that seen in mammals, has been reported for several Drosophila ion channel genes. Drosophila possesses a candidate editing enzyme, dADAR. Here, we describe dADAR deletion mutants that lack ADAR activity in extracts. Correspondingly, all known Drosophila site-specific RNA editing (25 sites in three ion channel transcripts) is abolished. Adults lacking dADAR are morphologically wild-type but exhibit extreme behavioral deficits including temperature-sensitive paralysis, locomotor uncoordination, and tremors which increase in severity with age. Neurodegeneration accompanies the increase in phenotypic severity. Surprisingly, dADAR mutants are not short-lived. Thus, A-to-I editing of pre-mRNAs in Drosophila acts predominantly through nervous system targets to affect adult nervous system function, integrity, and behavior.	Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, Farmington, CT 06030 USA; Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of Connecticut; University of Edinburgh	Reenan, RA (corresponding author), Univ Connecticut, Ctr Hlth, Dept Genet & Dev Biol, 263 Farmington Ave, Farmington, CT 06030 USA.	rreenan@neuron.uchc.edu	Keegan, Liam P/F-1106-2017; OConnell, Mary Anne/G-4740-2015; Keegan, Liam P./AAL-3753-2021; O'Connell, Mary Anne/U-7693-2019	Keegan, Liam P/0000-0001-7915-5790; OConnell, Mary Anne/0000-0003-3844-6174; Keegan, Liam P./0000-0001-7915-5790; O'Connell, Mary Anne/0000-0003-3844-6174				AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; Auxilien S, 1996, J MOL BIOL, V262, P437, DOI 10.1006/jmbi.1996.0527; BALLINGER DG, 1989, P NATL ACAD SCI USA, V86, P9402, DOI 10.1073/pnas.86.23.9402; BASILIO C, 1962, P NATL ACAD SCI USA, V48, P613, DOI 10.1073/pnas.48.4.613; BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; Bass BL, 1997, TRENDS BIOCHEM SCI, V22, P157, DOI 10.1016/S0968-0004(97)01035-9; BASS BL, 1989, CELL, V56, P331, DOI 10.1016/0092-8674(89)90234-1; BENNE R, 1986, CELL, V46, P819, DOI 10.1016/0092-8674(86)90063-2; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; Burns CM, 1997, NATURE, V387, P303, DOI 10.1038/387303a0; CASEY JL, 1995, J VIROL, V69, P7593, DOI 10.1128/JVI.69.12.7593-7600.1995; Chan L, 1997, BBA-LIPID LIPID MET, V1345, P11, DOI 10.1016/S0005-2760(96)00156-7; Cleland TA, 1996, MOL NEUROBIOL, V13, P97, DOI 10.1007/BF02740637; Cully DF, 1996, J BIOL CHEM, V271, P20187, DOI 10.1074/jbc.271.33.20187; DELGADO R, 1989, FEBS LETT, V243, P337, DOI 10.1016/0014-5793(89)80157-7; Feldmeyer D, 1999, NAT NEUROSCI, V2, P57, DOI 10.1038/4561; Feyereisen R, 1995, TOXICOL LETT, V82-3, P83, DOI 10.1016/0378-4274(95)03470-6; Gerber A, 1998, EMBO J, V17, P4780, DOI 10.1093/emboj/17.16.4780; Gerber AP, 1999, SCIENCE, V286, P1146, DOI 10.1126/science.286.5442.1146; Hanrahan CJ, 2000, GENETICS, V155, P1149; Herb A, 1996, P NATL ACAD SCI USA, V93, P1875, DOI 10.1073/pnas.93.5.1875; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; Hough RF, 1999, NUCLEIC ACIDS RES, V27, P3424, DOI 10.1093/nar/27.17.3424; Keegan LP, 2000, MOL CELL BIOL, V20, P825, DOI 10.1128/MCB.20.3.825-833.2000; Keller W, 1999, FEBS LETT, V452, P71, DOI 10.1016/S0014-5793(99)00590-6; KOHLER M, 1993, NEURON, V10, P491, DOI 10.1016/0896-6273(93)90336-P; Kumar M, 1997, P NATL ACAD SCI USA, V94, P3542, DOI 10.1073/pnas.94.8.3542; LILLY M, 1994, GENETICS, V136, P1087; Littleton JT, 1999, INT REV NEUROBIOL, V43, P139, DOI 10.1016/S0074-7742(08)60544-9; LOUGHNEY K, 1989, CELL, V58, P1143, DOI 10.1016/0092-8674(89)90512-6; Maas S, 1997, CURR OPIN CELL BIOL, V9, P343, DOI 10.1016/S0955-0674(97)80006-3; Morse DP, 1999, P NATL ACAD SCI USA, V96, P6048, DOI 10.1073/pnas.96.11.6048; Niswender CM, 1999, J BIOL CHEM, V274, P9472, DOI 10.1074/jbc.274.14.9472; OConnell MA, 1997, CURR BIOL, V7, pR437, DOI 10.1016/S0960-9822(06)00212-0; OCONNELL MA, 1994, P NATL ACAD SCI USA, V91, P10596, DOI 10.1073/pnas.91.22.10596; Palladino MJ, 2000, RNA, V6, P1004, DOI 10.1017/S1355838200000248; Patton DE, 1997, NEURON, V19, P711, DOI 10.1016/S0896-6273(00)80383-9; Paul MS, 1998, EMBO J, V17, P1120, DOI 10.1093/emboj/17.4.1120; Peixoto AA, 1997, GENETICS, V145, P1003; Peixoto AA, 1998, GENETICS, V148, P827; Pittendrigh B, 1997, MOL GEN GENET, V256, P602, DOI 10.1007/s004380050608; RAJENDRA S, 1995, TRENDS NEUROSCI, V18, P80; Reenan RA, 2000, NEURON, V25, P139, DOI 10.1016/S0896-6273(00)80878-8; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992; RUETER SM, 1998, MODIFICATION EDITING; Seeburg PH, 2000, NEURON, V25, P261, DOI 10.1016/S0896-6273(00)80891-0; Seeburg PH, 1998, BRAIN RES REV, V26, P217, DOI 10.1016/S0165-0173(97)00062-3; Semenov EP, 1999, J NEUROCHEM, V72, P66, DOI 10.1046/j.1471-4159.1999.0720066.x; SIMPSON L, 1999, RNA WORLD; Smith L A, 1998, J Neurogenet, V12, P227; Smith LA, 1998, GENETICS, V149, P1407; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; STERN M, 1990, GENETICS, V124, P133; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; WAGNER RW, 1990, MOL CELL BIOL, V10, P5586, DOI 10.1128/MCB.10.10.5586; Wu C F, 1992, Ion Channels, V3, P261	56	296	318	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 18	2000	102	4					437	449		10.1016/S0092-8674(00)00049-0	http://dx.doi.org/10.1016/S0092-8674(00)00049-0			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	347BX	10966106	Bronze, Green Published			2022-12-24	WOS:000088908000006
J	Adler, AI; Stratton, IM; Neil, HAW; Yudkin, JS; Matthews, DR; Cull, CA; Wright, AD; Turner, RC; Holman, RR				Adler, AI; Stratton, IM; Neil, HAW; Yudkin, JS; Matthews, DR; Cull, CA; Wright, AD; Turner, RC; Holman, RR		UK Prospective Diabetes Study Grp	Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; MIDDLE-AGED PATIENTS; RISK-FACTORS; CARDIOVASCULAR MORTALITY; FOLLOW-UP; MYOCARDIAL-INFARCTION; STROKE; MEN; HYPERTENSION; MELLITUS	Objective To determine the relation between systolic blood pressure over time and the risk of macrovascular or microvascular complications in patients dth type 2 diabetes. Design Prospective observational study. Setting 23 hospital based clinics in England, Scotland and Northern Ireland Participants 4801 white, Asian Indian, and Afro-Caribbean UKPDS patients, whether randomised or not to treatment, were included in analyses of incidence; of these, 3642 were included in analyses of relative risk, Outcome measures Primary predefined aggregate clinical outcomes: any complications or deaths related to diabetes and all cause mortality. Secondary aggregate outcomes: myocardial infarction, stroke, lower extremity amputation (including death from peripheral vascular disease), and microvascular disease (predominantly retinal photocoagulation). Single end points: non-fatal heart failure and cataract extraction Risk reduction associated with a 10 mm Hg decrease in updated mean systolic blood pressure adjusted for specific confounders Results The incidence of clinical complications was significantly associated with systolic blood pressure, except for cataract extraction. Each 10 mm Hg decrease in updated mean systolic blood pressure was associated with reductions in risk of 12% for any complication related to diabetes (95%, confidence interval 10% to 14%, P < 0.0001), 15% for deaths related to diabetes (12% to 18%, P< 0.0001), 11% for myocardial infarction (7% to 14%, P< 0.0001), and 13% for microvascular complications (10% to 16%, P< 0.0001). No threshold of risk was observed for any end point. Conclusions In patients with type 2 diabetes the risk of diabetic complications was strongly associated with raised blood pressure. Any reduction in blood pressure is likely to reduce the risk of complications, with the lowest risk being in those with systolic blood pressure less than 120 mm Hg.	Univ Oxford, Radcliffe Infirm, Oxford Ctr Diabet Endocrinol & Metab, Diabet Trial Unit, Oxford OX2 6HE, England; Univ Oxford, Inst Hlth Sci, Div Publ Hlth & Primary Care, Oxford OX3 7LF, England; UCL, Sch Med, Whittington Hosp, London N19 3UA, England; Selly Oak Hosp, Birmingham B29 6JD, W Midlands, England; Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Diabet Res Labs, Oxford OX2 6HE, England	Radcliffe Infirmary; University of Oxford; University of Oxford; University of London; University College London; UCL Medical School; University of Oxford	Adler, AI (corresponding author), Univ Oxford, Radcliffe Infirm, Oxford Ctr Diabet Endocrinol & Metab, Diabet Trial Unit, Oxford OX2 6HE, England.	amanda.adler@dtu.ox.ac.uk	Yudkin, John S/C-1988-2008; stratton, irene/AAZ-3627-2020	stratton, irene/0000-0003-1172-7865				[Anonymous], 1994, Diabet Med, V11, P773; [Anonymous], 1995, Diabetes, V44, P1249; [Anonymous], 1997, ARCH INTERN MED, V157, P2413; BARRETTCONNOR E, 1988, AM J EPIDEMIOL, V128, P116, DOI 10.1093/oxfordjournals.aje.a114934; BARRETTCONNOR EL, 1991, JAMA-J AM MED ASSOC, V265, P627, DOI 10.1001/jama.265.5.627; Birke JA, 1998, DIABETES CARE, V21, P23, DOI 10.2337/diacare.21.1.23; Borghi C, 1998, J CARDIOVASC PHARM, V32, pS24, DOI 10.1097/00005344-199800004-00005; Bruno G, 1999, DIABETOLOGIA, V42, P297, DOI 10.1007/s001250051154; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; COWIE CC, 1995, DIABETES AM; Curb JD, 1996, JAMA-J AM MED ASSOC, V276, P1886, DOI 10.1001/jama.276.23.1886; Cutler JA, 1996, J HYPERTENS        S, V14, P3; Doughty RN, 1997, EUR HEART J, V18, P560; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; Eriksson J, 1999, DIABETOLOGIA, V42, P793, DOI 10.1007/s001250051229; Ferrari R, 1998, EUR HEART J, V19, pJ30; Freemantle N, 1999, BMJ-BRIT MED J, V318, P1730, DOI 10.1136/bmj.318.7200.1730; Gerstein HC, 2000, LANCET, V355, P253; GOODKIN G, 1975, J OCCUP ENVIRON MED, V17, P716; Hanefeld M, 1996, DIABETOLOGIA, V39, P1577, DOI 10.1007/s001250050617; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; KANNEL WB, 1979, JAMA-J AM MED ASSOC, V241, P2035, DOI 10.1001/jama.241.19.2035; KEIL JE, 1993, NEW ENGL J MED, V329, P73, DOI 10.1056/NEJM199307083290201; KLEIN R, 1995, DIABETES CARE, V18, P258, DOI 10.2337/diacare.18.2.258; KUUSISTO J, 1994, DIABETES, V43, P960, DOI 10.2337/diabetes.43.8.960; Lehto S, 1997, DIABETES, V46, P1354, DOI 10.2337/diabetes.46.8.1354; Lehto S, 1996, STROKE, V27, P63, DOI 10.1161/01.STR.27.1.63; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; MANLEY SE, 1994, DIABETIC MED, V11, P534; MANSON JE, 1991, ARCH INTERN MED, V151, P1141, DOI 10.1001/archinte.151.6.1141; Meltzer S, 1998, CAN MED ASSOC J, V159, pS1; Palumbo P J, 1978, Adv Neurol, V19, P593; Psaty BM, 1997, JAMA-J AM MED ASSOC, V277, P739, DOI 10.1001/jama.277.9.739; Rodby RA, 1996, DIABETES CARE, V19, P1051, DOI 10.2337/diacare.19.10.1051; ROSE G, 1981, BMJ-BRIT MED J, V282, P1847, DOI 10.1136/bmj.282.6279.1847; ROSENGREN A, 1989, BRIT MED J, V299, P1127, DOI 10.1136/bmj.299.6708.1127; *SAS I, 1990, SAS VERS 6; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Standl E, 1996, DIABETOLOGIA, V39, P1540, DOI 10.1007/s001250050612; Stearne MR, 1998, BMJ-BRIT MED J, V317, P720; Stearne MR, 1998, BRIT MED J, V317, P713; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Svetkey LP, 1999, ARCH INTERN MED, V159, P285, DOI 10.1001/archinte.159.3.285; Taggart DP, 1998, HEART, V80, P1; TATE RB, 1995, AM J EPIDEMIOL, V142, P946, DOI 10.1093/oxfordjournals.aje.a117742; Tuomilehto J, 1999, NEW ENGL J MED, V340, P677, DOI 10.1056/NEJM199903043400902; TURNER RC, 1993, J HYPERTENS, V11, P309; TURNER RC, 1991, DIABETOLOGIA, V34, P877; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; UUSITUPA MIJ, 1993, DIABETOLOGIA, V36, P1175, DOI 10.1007/BF00401063; van den Hoogen PCW, 2000, NEW ENGL J MED, V342, P1, DOI 10.1056/NEJM200001063420101; VATTEN LJ, 1995, EPIDEMIOLOGY, V6, P70, DOI 10.1097/00001648-199501000-00014; Wei M, 1998, DIABETES CARE, V21, P1167, DOI 10.2337/diacare.21.7.1167; Yusuf S, 2000, NEW ENGL J MED, V342, P145	56	1417	1493	1	50	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2000	321	7258					412	419		10.1136/bmj.321.7258.412	http://dx.doi.org/10.1136/bmj.321.7258.412			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344QC	10938049	Green Published, Bronze			2022-12-24	WOS:000088769500020
J	Muth, GW; Ortoleva-Donnelly, L; Strobel, SA				Muth, GW; Ortoleva-Donnelly, L; Strobel, SA			A single adenosine with a neutral pK(a) in the ribosomal peptidyl transferase center	SCIENCE			English	Article							TRANSFER-RNA; SERINE PROTEASES; ESCHERICHIA-COLI; A-SITES; P-SITES; CHLORAMPHENICOL; ERYTHROMYCIN; RESISTANCE; CATALYSIS; RIBOZYME	Biochemical and crystallographic evidence suggests that 23S ribosomal RNA (rRNA) is the catalyst of peptide bond formation. To explore the mechanism of this reaction, we screened for nucleotides in Escherichia coli 23S rRNA that may have a perturbed pK(a) (where K-a is the acid constant) based on the pH dependence of dimethylsulfate modification. A single universally conserved A (number 2451) within the central loop of domain V has a near neutral pK(a) of 7.6 +/- 0.2, which is about the same as that reported for the peptidyl transferase reaction. In vivo mutational analysis of this nucleotide indicates that it has an essential role in ribosomal function. These results are consistent with a mechanism wherein the nucleotide base of A2451 serves as a general acid base during peptide bond formation.	Yale Univ, Dept Chem, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Strobel, SA (corresponding author), Yale Univ, Dept Chem, Dept Mol Biophys & Biochem, 260 Whitney Ave, New Haven, CT 06520 USA.	strobel@csb.yale.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054839] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM54839] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; CONNELL GJ, 1994, SCIENCE, V264, P1137, DOI 10.1126/science.7513905; DOUTHWAITE S, 1989, J MOL BIOL, V209, P655, DOI 10.1016/0022-2836(89)93000-3; Fasman G. D., 1975, HDB BIOCH MOL BIOL, V1; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; Fersht A., 1985, ENZYME STRUCTURE MEC; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; GUTELL RR, 1994, MICROBIOL REV, V58, P10, DOI 10.1128/MMBR.58.1.10-26.1994; KEARSEY SE, 1981, NATURE, V290, P607, DOI 10.1038/290607a0; KRAUT J, 1977, ANNU REV BIOCHEM, V46, P331, DOI 10.1146/annurev.bi.46.070177.001555; LAWLEY PD, 1963, BIOCHEM J, V89, P127, DOI 10.1042/bj0890127; MADEN BEH, 1968, EUR J BIOCHEM, V6, P309, DOI 10.1111/j.1432-1033.1968.tb00450.x; MADEN BEH, 1968, J MOL BIOL, V35, P333, DOI 10.1016/S0022-2836(68)80028-2; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; Minakawa N, 1999, J ORG CHEM, V64, P7158, DOI 10.1021/jo990638x; MOAZED D, 1991, P NATL ACAD SCI USA, V88, P3725, DOI 10.1073/pnas.88.9.3725; MOAZED D, 1989, CELL, V57, P585, DOI 10.1016/0092-8674(89)90128-1; MOAZED D, 1987, BIOCHIMIE, V69, P879, DOI 10.1016/0300-9084(87)90215-X; Nakano S, 2000, SCIENCE, V287, P1493, DOI 10.1126/science.287.5457.1493; Narlikar GJ, 1997, ANNU REV BIOCHEM, V66, P19, DOI 10.1146/annurev.biochem.66.1.19; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Perrotta AT, 1999, SCIENCE, V286, P123, DOI 10.1126/science.286.5437.123; PESTKA S, 1972, P NATL ACAD SCI USA, V69, P624, DOI 10.1073/pnas.69.3.624; RHEINBERGER HJ, 1988, METHOD ENZYMOL, V164, P658; Saenger W., 1984, PRINCIPLES NUCL ACID; SAITO T, 1979, J CHEM SOC CHEM COMM, P135, DOI 10.1039/c39790000135; STEINER G, 1988, EMBO J, V7, P3949, DOI 10.1002/j.1460-2075.1988.tb03281.x; STEITZ TA, 1982, ANNU REV BIOPHYS BIO, V11, P419, DOI 10.1146/annurev.bb.11.060182.002223; STERN S, 1988, METHOD ENZYMOL, V164, P481; VANNUFFEL P, 1994, NUCLEIC ACIDS RES, V22, P4449, DOI 10.1093/nar/22.21.4449	30	238	244	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2000	289	5481					947	950		10.1126/science.289.5481.947	http://dx.doi.org/10.1126/science.289.5481.947			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343KH	10937997				2022-12-24	WOS:000088701200031
J	Jarvis, ED; Ribeiro, S; da Silva, ML; Ventura, D; Vielliard, J; Mello, CV				Jarvis, ED; Ribeiro, S; da Silva, ML; Ventura, D; Vielliard, J; Mello, CV			Behaviourally driven gene expression reveals song nuclei in hummingbird brain	NATURE			English	Article							SYSTEM; FOREBRAIN; PATHWAYS; CANARY; BIRDS	Hummingbirds have developed a wealth of intriguing features, such as backwards flight, ultraviolet vision, extremely high metabolic rates, nocturnal hibernation, high brain-to-body size ratio and a remarkable species-specific diversity of vocalizations(1-4). Like humans, they have also developed the rare trait of vocal learning, this being the ability to acquire vocalizations through imitation rather than instinct(5,6). Here we show, using behaviourally driven gene expression in freely ranging tropical animals, that the forebrain of hummingbirds contains seven discrete structures that are active during singing, providing the first anatomical and functional demonstration of vocal nuclei in hummingbirds. These structures are strikingly similar to seven forebrain regions that are involved in vocal learning and production in songbirds and parrots(7-13)-the only other avian orders known to be vocal learners(5). This similarity is surprising, as songbirds, parrots and hummingbirds are thought to have evolved vocal learning and associated brain structures independently(5,14), and it indicates that strong constraints may influence the evolution of forebrain vocal nuclei.	Rockefeller Univ, Lab Anim Behav, New York, NY 10021 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Univ Sao Paulo, PG Neurociencias & Comportamento, BR-09500900 Sao Paulo, Brazil; Univ Estadual Campinas, Dept Zool, BR-13083970 Campinas, SP, Brazil; Univ Sao Paulo, Dept Psicol Expt, BR-09500900 Sao Paulo, Brazil	Rockefeller University; Duke University; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo	Jarvis, ED (corresponding author), Rockefeller Univ, Lab Anim Behav, 1230 York Ave, New York, NY 10021 USA.	jarvis@neuro.duke.edu; mello@rockvax.rockefeller.edu	Jarvis, Erich D/A-2319-2008; Ventura, Dora F/B-9071-2012; Ribeiro, Sidarta/C-5794-2016	Jarvis, Erich D/0000-0001-8931-5049; Ventura, Dora F/0000-0002-7616-4031; Mello, Claudio/0000-0002-9826-8421; Ribeiro, Sidarta/0000-0001-9325-9545	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R29DC002853] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BAPTISTA LF, 1990, ETHOLOGY, V84, P15; Brenowitz EA, 1997, J NEUROBIOL, V33, P517, DOI 10.1002/(SICI)1097-4695(19971105)33:5<517::AID-NEU3>3.0.CO;2-7; Chaudhuri A, 1997, NEUROREPORT, V8, pR5; Durand SE, 1997, J COMP NEUROL, V377, P179, DOI 10.1002/(SICI)1096-9861(19970113)377:2<179::AID-CNE3>3.0.CO;2-0; Ellis DH, 1998, BEHAV PROCESS, V43, P125, DOI 10.1016/S0376-6357(98)00008-4; ESSER KH, 1994, NEUROREPORT, V5, P1718, DOI 10.1097/00001756-199409080-00007; FEDUCCIA A, 1995, SCIENCE, V267, P637, DOI 10.1126/science.267.5198.637; GUINEE LN, 1988, ETHOLOGY, V79, P295; Hessler NA, 1999, J NEUROSCI, V19, P10461; Jarvis ED, 1997, NEUROREPORT, V8, P2073, DOI 10.1097/00001756-199705260-00052; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Jarvis ED, 2000, J COMP NEUROL, V419, P1, DOI 10.1002/(SICI)1096-9861(20000327)419:1<1::AID-CNE1>3.0.CO;2-M; KROODSMA DE, 1991, ANIM BEHAV, V42, P477, DOI 10.1016/S0003-3472(05)80047-8; LIDSKY TI, 1985, BRAIN RES REV, V9, P133, DOI 10.1016/0165-0173(85)90010-4; MELLO CV, 1994, J NEUROSCI, V14, P6652; Miller Edward H., 1996, P241; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; NOTTEBOHM F, 1972, AM NAT, V106, P116, DOI 10.1086/282756; NOTTEBOHM F, 1982, J COMP NEUROL, V207, P344, DOI 10.1002/cne.902070406; Payne R.B., 1986, Current Ornithology, V3, P87; REHKAMPER G, 1991, BRAIN BEHAV EVOLUT, V37, P85, DOI 10.1159/000114349; Ruschi A, 1982, HUMMINGBIRDS STATE E; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Schuchmann K.-L., 1999, HDB BIRDS WORLD, P468; Sibley CG., 1990, PHYLOGENY CLASSIFICA; VENTURA DF, 1994, INVEST OPHTH VIS SCI, V35, P2168; Wild JM, 1997, J COMP NEUROL, V377, P392, DOI 10.1002/(SICI)1096-9861(19970120)377:3<392::AID-CNE7>3.0.CO;2-Y; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871; [No title captured]; [No title captured]	30	174	181	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2000	406	6796					628	632		10.1038/35020570	http://dx.doi.org/10.1038/35020570			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949303	Green Accepted, Green Published			2022-12-24	WOS:000088653800048
J	Nance, WE; Liu, XZ; Pandya, A				Nance, WE; Liu, XZ; Pandya, A			Relation between choice of partner and high frequency of cannexin-26 deafness	LANCET			English	Article							MUTATIONS	Recessive mutations at the connexin-26 gene locus are now recognised as the cause of nearly half of all cases of genetic deafness in many populations. We suggest that this high frequency is only seen In populations with a long tradition of intermarriage among deaf people. Available data are consistent with the hypothesis that such marriages might well have contributed to the high frequency of connexin-ae deafness in the USA, and could represent a novel mechanism for maintaining specific genotypes at unexpectedly high frequencies.	Virginia Commonwealth Univ, Dept Human Genet, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Dept Otolaryngol, Richmond, VA 23298 USA; Virginia Commonwealth Univ, Dept Pediat, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Nance, WE (corresponding author), Virginia Commonwealth Univ, Dept Human Genet, POB 980033, Richmond, VA 23298 USA.	nance@hsc.vcu.edu			NIDCD NIH HHS [DC-02530, DC-04293, DC-04530] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002530, R03DC004530, R01DC004293] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BELL AG, 1883, NAT ACAD SCI MEM, V2, P177; Denoyelle F, 1999, LANCET, V353, P1298, DOI 10.1016/S0140-6736(98)11071-1; Estivill X, 1998, LANCET, V351, P394, DOI 10.1016/S0140-6736(97)11124-2; Fay E.A., 1898, MARRIAGES DEAF AM; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Fuse Y, 1999, NEUROREPORT, V10, P1853, DOI 10.1097/00001756-199906230-00010; GREEN GE, 1999, JAMA-J AM MED ASSOC, V281, P193; KEISELL DP, 1997, NATURE, V387, P80; LIU XZ, 1988, CHINESE MED GENET, V5, P193; Reardon W, 1998, LANCET, V351, P383, DOI 10.1016/S0140-6736(05)78347-1; ROSE SP, 1975, THESIS INDIANA U BLO; Rose SP, 1977, CHILDHOOD DEAFNESS, P19	12	48	57	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 5	2000	356	9228					500	501		10.1016/S0140-6736(00)02565-4	http://dx.doi.org/10.1016/S0140-6736(00)02565-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342QY	10981905				2022-12-24	WOS:000088657700036
J	Arimura, G; Ozawa, R; Shimoda, T; Nishioka, T; Boland, W; Takabayashi, J				Arimura, G; Ozawa, R; Shimoda, T; Nishioka, T; Boland, W; Takabayashi, J			Herbivory-induced volatiles elicit defence genes in lima bean leaves	NATURE			English	Article							PREDATOR-PREY INTERACTIONS; ACQUIRED-RESISTANCE; PHASEOLUS-VULGARIS; JASMONIC ACID; SPIDER-MITES; PLANT; IDENTIFICATION; LIPOXYGENASE; ACCUMULATION; ARABIDOPSIS	In response to herbivore damage, several plant species emit volatiles that attract natural predators of the attacking herbivores(1-5). Using spider mites (Tetranychus urticae) and predatory mites (Phytoseiulus persimilis)(1-4), it has been shown that not only the attacked plant but also neighbouring plants are affected, becoming more attractive to predatory mites(3,6) and less susceptible to spider mites(6). The mechanism involved in such interactions, however, remains elusive. Here we show that uninfested lima bean leaves activate five separate defence genes when exposed to volatiles from conspecific leaves infested with T. urticae, but not when exposed to volatiles from artificially wounded leaves. The expression pattern of these genes is similar to that produced by exposure to jasmonic acid. At least three terpenoids in the volatiles are responsible for this gene activation; they are released in response to herbivory but not artificial wounding. Expression of these genes requires calcium influx and protein phosphorylation/dephosphorylation.	Kyoto Univ, Grad Sch Agr, Lab Ecol Informat, Kyoto 6068502, Japan; Biooriented Technol Res Advancement Inst, Tokyo 1050001, Japan; Kyoto Univ, Grad Sch Agr, Lab Insect Physiol, Kyoto 6068502, Japan; Max Planck Inst Chem Ecol, D-07745 Jena, Germany	Kyoto University; National Agriculture & Food Research Organization - Japan; Kyoto University; Max Planck Society	Takabayashi, J (corresponding author), Kyoto Univ, Grad Sch Agr, Lab Ecol Informat, Kyoto 6068502, Japan.	junji@kais.kyoto-u.ac.jp	Takabayashi, Junji/G-2212-2010; Boland, Wilhelm/K-7762-2012	Takabayashi, Junji/0000-0002-3575-9952; Boland, Wilhelm/0000-0001-6784-2534				Bate NJ, 1998, PLANT J, V16, P561, DOI 10.1046/j.1365-313x.1998.00324.x; BELL E, 1995, P NATL ACAD SCI USA, V92, P8675, DOI 10.1073/pnas.92.19.8675; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREDERODE FT, 1991, PLANT MOL BIOL, V17, P1117, DOI 10.1007/BF00028729; BROGLIE KE, 1986, P NATL ACAD SCI USA, V83, P6820, DOI 10.1073/pnas.83.18.6820; BRUIN J, 1992, EXPERIENTIA, V48, P525, DOI 10.1007/BF01928181; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; DICKE M, 1990, J CHEM ECOL, V16, P3091, DOI 10.1007/BF00979614; DICKE M, 1990, J CHEM ECOL, V16, P381, DOI 10.1007/BF01021772; Dicke M, 1999, J CHEM ECOL, V25, P1907, DOI 10.1023/A:1020942102181; EDINGTON BV, 1991, PLANT MOL BIOL, V16, P81, DOI 10.1007/BF00017919; EDWARDS K, 1985, P NATL ACAD SCI USA, V82, P6731, DOI 10.1073/pnas.82.20.6731; FARMER EE, 1990, P NATL ACAD SCI USA, V87, P7713, DOI 10.1073/pnas.87.19.7713; HILDEBRAND DF, 1986, J ECON ENTOMOL, V79, P1459, DOI 10.1093/jee/79.6.1459; Kahl J, 2000, PLANTA, V210, P336, DOI 10.1007/PL00008142; Li CP, 1996, GENE, V171, P193, DOI 10.1016/0378-1119(95)00880-2; MacKinney G, 1941, J BIOL CHEM, V140, P315; MARGISPINHEIRO M, 1991, PLANT MOL BIOL, V17, P243, DOI 10.1007/BF00039499; McConn M, 1997, P NATL ACAD SCI USA, V94, P5473, DOI 10.1073/pnas.94.10.5473; MEIER BM, 1993, MOL PLANT MICROBE IN, V6, P453, DOI 10.1094/MPMI-6-453; Ozawa R, 2000, PLANT CELL PHYSIOL, V41, P391, DOI 10.1093/pcp/41.4.391; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; Shulaev V, 1997, NATURE, V385, P718, DOI 10.1038/385718a0; Takabayashi J, 1996, TRENDS PLANT SCI, V1, P109, DOI 10.1016/S1360-1385(96)90004-7	25	504	575	10	206	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2000	406	6795					512	515		10.1038/35020072	http://dx.doi.org/10.1038/35020072			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952311				2022-12-24	WOS:000088538000045
J	Clark, EA; Golub, TR; Lander, ES; Hynes, RO				Clark, EA; Golub, TR; Lander, ES; Hynes, RO			Genomic analysis of metastasis reveals an essential role for RhoC	NATURE			English	Article							MELANOMA-CELLS; CANCER; PROGRESSION; EXPRESSION; PROTEIN; GROWTH; GENES; OVEREXPRESSION; TUMORIGENICITY; FIBRONECTIN	The most damaging change during cancer progression is the switch from a locally growing tumour to a metastatic killer. This switch is believed to involve numerous alterations that allow tumour cells to complete the complex series of events needed for metastasis(1). Relatively few genes have been implicated in these events(2-5.) Here we use an in vivo selection scheme to select highly metastatic melanoma cells. By analysing these cells on DNA arrays, we define a pattern of gene expression that correlates with progression to a metastatic phenotype. In particular, we show enhanced expression of several genes involved in extracellular matrix assembly and of a second set of genes that regulate, either directly or indirectly, the actin-based cytoskeleton. One of these, the small GTPase RhoC, enhances metastasis when overexpressed, whereas a dominant-negative Rho inhibits metastasis. Analysis of the phenotype of cells expressing dominant-negative Rho or RhoC indicates that RhoC is important in tumour cell invasion. The genomic approach allows us to identify families of genes involved in a process, not just single genes, and can indicate which molecular and cellular events might be important in complex biological processes such as metastasis.	MIT, Ctr Canc Res, Howard Hughes Med Inst, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Whitehead Inst MIT Ctr Genome Res, Cambridge, MA 02142 USA; Dana Farber Canc Inst, Boston, MA 02115 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Dana-Farber Cancer Institute	Hynes, RO (corresponding author), MIT, Ctr Canc Res, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.							ALBELDA SM, 1990, CANCER RES, V50, P6757; Bao LR, 1996, NAT MED, V2, P1322, DOI 10.1038/nm1296-1322; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; CHEN L, 1990, ONCOGENE, V5, P1391; Clark EA, 1998, J CELL BIOL, V142, P573, DOI 10.1083/jcb.142.2.573; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; Fidler IJ, 1996, J NATL CANCER I, V88, P1700, DOI 10.1093/jnci/88.23.1700; FIDLER IJ, 1973, NATURE-NEW BIOL, V242, P148, DOI 10.1038/newbio242148a0; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; HALL AK, 1991, INT J CANCER, V48, P672, DOI 10.1002/ijc.2910480507; HUMPHRIES MJ, 1986, SCIENCE, V233, P467, DOI 10.1126/science.3726541; Jeffers M, 1996, MOL CELL BIOL, V16, P1115; KOZLOWSKI JM, 1984, J NATL CANCER I, V72, P913; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Liu XD, 1997, P NATL ACAD SCI USA, V94, P10669, DOI 10.1073/pnas.94.20.10669; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; QUILLIAM LA, 1995, BIOESSAYS, V17, P395, DOI 10.1002/bies.950170507; Roberts DD, 1996, FASEB J, V10, P1183, DOI 10.1096/fasebj.10.10.8751720; Ruoslahti E, 1999, ADV CANCER RES, V76, P1, DOI 10.1016/S0065-230X(08)60772-1; SCHONHERR E, 1995, J BIOL CHEM, V270, P2776, DOI 10.1074/jbc.270.6.2776; Suwa H, 1998, BRIT J CANCER, V77, P147, DOI 10.1038/bjc.1998.23; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; Van Noorden CJF, 1998, AM SCI, V86, P130; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; WELCH DR, 1994, ONCOGENE, V9, P255; WETERMAN MAJ, 1993, INT J CANCER, V53, P278, DOI 10.1002/ijc.2910530218; Yebra M, 1996, J BIOL CHEM, V271, P29393, DOI 10.1074/jbc.271.46.29393; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268	29	1218	1321	0	74	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2000	406	6795					532	535		10.1038/35020106	http://dx.doi.org/10.1038/35020106			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952316				2022-12-24	WOS:000088538000050
J	Heidelberg, JF; Eisen, JA; Nelson, WC; Clayton, RA; Gwinn, ML; Dodson, RJ; Haft, DH; Hickey, EK; Peterson, JD; Umayam, L; Gill, SR; Nelson, KE; Read, TD; Tettelin, H; Richardson, D; Ermolaeva, MD; Vamathevan, J; Bass, S; Qin, HY; Dragoi, I; Sellers, P; McDonald, L; Utterback, T; Fleishmann, RD; Nierman, WC; White, O; Salzberg, SL; Smith, HO; Colwell, RR; Mekalanos, JJ; Venter, JC; Fraser, CM				Heidelberg, JF; Eisen, JA; Nelson, WC; Clayton, RA; Gwinn, ML; Dodson, RJ; Haft, DH; Hickey, EK; Peterson, JD; Umayam, L; Gill, SR; Nelson, KE; Read, TD; Tettelin, H; Richardson, D; Ermolaeva, MD; Vamathevan, J; Bass, S; Qin, HY; Dragoi, I; Sellers, P; McDonald, L; Utterback, T; Fleishmann, RD; Nierman, WC; White, O; Salzberg, SL; Smith, HO; Colwell, RR; Mekalanos, JJ; Venter, JC; Fraser, CM			DNA sequence of both chromosomes of the cholera pathogen Vibrio cholerae	NATURE			English	Article							MANNOSE-SENSITIVE HEMAGGLUTININ; O1 EL-TOR; NUCLEOTIDE-SEQUENCE; GENE-CLUSTER; BIOFILM FORMATION; TOXIN; PILUS; IDENTIFICATION; VIRULENCE; BACTERIA	Here we determine the complete genomic sequence of the Gram negative, gamma-Proteobacterium Vibrio cholerae El Tor N16961 to be 4,033,460 base pairs (bp). The genome consists of two circular chromosomes of 2,961,146 bp and 1,072,314 bp that together encode 3,885 open reading frames. The vast majority of recognizable genes for essential cell functions (such as DNA replication, transcription, translation and cell-wall biosynthesis) and pathogenicity (for example, toxins, surface antigens and adhesins) are located on the large chromosome. In contrast, the small chromosome contains a larger fraction (59%) of hypothetical genes compared with the large chromosome (42%), and also contains many more genes that appear to have origins other than the g-Proteobacteria. The small chromosome also carries a gene capture system (the integron island) and host 'addiction' genes that are typically found on plasmids; thus, the small chromosome may have originally been a megaplasmid that was captured by an ancestral Vibrio species. The V. cholerae genomic sequence provides a starting point for understanding how a free-living, environmental organism emerged to become a significant human bacterial pathogen.	Inst Genom Res, Rockville, MD 20850 USA; Univ Maryland, Ctr Marine Biotechnol, Inst Biotechnol, Baltimore, MD 21202 USA; Univ Maryland, Dept Cell & Mol Biol, College Pk, MD 20742 USA; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	J. Craig Venter Institute; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland College Park; Harvard University; Harvard Medical School	Fraser, CM (corresponding author), Inst Genom Res, 9712 Med Ctr Dr, Rockville, MD 20850 USA.	gvc@tigr.org	Eisen, Jonathan A./H-2706-2019; Nelson, William C/E-9263-2016; Read, Timothy/E-6240-2011; Salzberg, Steven/Q-6514-2019; Salzberg, Steven L/F-6162-2011	Eisen, Jonathan A./0000-0002-0159-2197; Nelson, William C/0000-0002-1873-3929; Salzberg, Steven/0000-0002-8859-7432; Salzberg, Steven L/0000-0002-8859-7432; Heidelberg, John/0000-0003-0673-3224; Read, Timothy/0000-0001-8966-9680; Fraser, Claire/0000-0003-1462-2428; Vamathevan, Jessica/0000-0003-2016-9754				ALM RA, 1988, MOL MICROBIOL, V2, P481; Attridge SR, 1996, INFECT IMMUN, V64, P3369, DOI 10.1128/IAI.64.8.3369-3373.1996; BASSLER BL, 1991, J BIOL CHEM, V266, P24276; Bassler BL, 1997, J BACTERIOL, V179, P4043, DOI 10.1128/jb.179.12.4043-4045.1997; Bateman A, 1999, NUCLEIC ACIDS RES, V27, P260, DOI 10.1093/nar/27.1.260; BIK EM, 1995, EMBO J, V14, P209, DOI 10.1002/j.1460-2075.1995.tb06993.x; BROWN RC, 1995, MOL MICROBIOL, V16, P425, DOI 10.1111/j.1365-2958.1995.tb02408.x; Colwell Rita R., 1992, P107; COLWELL RR, 1994, ANN NY ACAD SCI, V740, P44, DOI 10.1111/j.1749-6632.1994.tb19852.x; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; Davis BM, 1999, J BACTERIOL, V181, P6779, DOI 10.1128/JB.181.21.6779-6787.1999; Eisen JA, 1999, MUTAT RES-DNA REPAIR, V435, P171, DOI 10.1016/S0921-8777(99)00050-6; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Fullner KJ, 1999, INFECT IMMUN, V67, P1393, DOI 10.1128/IAI.67.3.1393-1404.1999; HALL RM, 1991, MOL MICROBIOL, V5, P1941, DOI 10.1111/j.1365-2958.1991.tb00817.x; Hochhut B, 1999, MOL MICROBIOL, V32, P99, DOI 10.1046/j.1365-2958.1999.01330.x; HUQ A, 1983, APPL ENVIRON MICROB, V45, P275, DOI 10.1128/AEM.45.1.275-283.1983; JONSON G, 1991, MICROB PATHOGENESIS, V11, P433, DOI 10.1016/0882-4010(91)90039-D; JONSON G, 1994, MOL MICROBIOL, V13, P109, DOI 10.1111/j.1365-2958.1994.tb00406.x; Karaolis DKR, 1999, NATURE, V399, P375, DOI 10.1038/20715; Karaolis DKR, 1998, P NATL ACAD SCI USA, V95, P3134, DOI 10.1073/pnas.95.6.3134; Kovach ME, 1996, MICROBIOL-SGM, V142, P2165, DOI 10.1099/13500872-142-8-2165; Lee SH, 1999, CELL, V99, P625, DOI 10.1016/S0092-8674(00)81551-2; Lin W, 1999, P NATL ACAD SCI USA, V96, P1071, DOI 10.1073/pnas.96.3.1071; Lobitz B, 2000, P NATL ACAD SCI USA, V97, P1438, DOI 10.1073/pnas.97.4.1438; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Manning PA, 1997, GENE, V192, P63, DOI 10.1016/S0378-1119(97)00036-X; Marsh JW, 1998, MOL MICROBIOL, V29, P1481, DOI 10.1046/j.1365-2958.1998.01031.x; Mazel D, 1998, SCIENCE, V280, P605, DOI 10.1126/science.280.5363.605; Mekalanos JJ, 1997, FEMS IMMUNOL MED MIC, V18, P241, DOI 10.1016/S0928-8244(97)00054-0; MEKALANOS JJ, 1983, CELL, V35, P253, DOI 10.1016/0092-8674(83)90228-3; OBRIEN AD, 1984, LANCET, V1, P77; OGAWA A, 1990, INFECT IMMUN, V58, P3325, DOI 10.1128/IAI.58.10.3325-3329.1990; ROSZAK DB, 1987, MICROBIOL REV, V51, P365, DOI 10.1128/MMBR.51.3.365-379.1987; Rowe-Magnus DA, 1999, RES MICROBIOL, V150, P641, DOI 10.1016/S0923-2508(99)00127-8; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Tacket CO, 1998, INFECT IMMUN, V66, P692, DOI 10.1128/IAI.66.2.692-695.1998; Thelin KH, 1996, INFECT IMMUN, V64, P2853, DOI 10.1128/IAI.64.7.2853-2856.1996; Trucksis M, 1998, P NATL ACAD SCI USA, V95, P14464, DOI 10.1073/pnas.95.24.14464; Wachmuth Kaye, 1994, P357; WALDOR MK, 1994, P NATL ACAD SCI USA, V91, P11388, DOI 10.1073/pnas.91.24.11388; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Watnick PI, 1999, MOL MICROBIOL, V34, P586, DOI 10.1046/j.1365-2958.1999.01624.x; Watnick PI, 1999, J BACTERIOL, V181, P3606, DOI 10.1128/JB.181.11.3606-3609.1999; WILLIAMS SG, 1993, MOL MICROBIOL, V9, P751, DOI 10.1111/j.1365-2958.1993.tb01735.x; Wu ZY, 1996, MICROB PATHOGENESIS, V21, P111, DOI 10.1006/mpat.1996.0047; Yamaichi Y, 1999, MOL MICROBIOL, V31, P1513, DOI 10.1046/j.1365-2958.1999.01296.x; Yildiz FH, 1999, P NATL ACAD SCI USA, V96, P4028, DOI 10.1073/pnas.96.7.4028; Yildiz FH, 1998, J BACTERIOL, V180, P773, DOI 10.1128/JB.180.4.773-784.1998	50	1383	2470	6	177	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2000	406	6795					477	483		10.1038/35020000	http://dx.doi.org/10.1038/35020000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952301	hybrid, Green Published			2022-12-24	WOS:000088538000035
J	Suissa, S; Ernst, P; Benayoun, S; Baltzan, M; Cai, B				Suissa, S; Ernst, P; Benayoun, S; Baltzan, M; Cai, B			Low-dose inhaled corticosteroids and the prevention of death from asthma.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEW-ZEALAND; PRESCRIBED FENOTEROL; BETA-AGONISTS; MORTALITY; RISK; GLUCOCORTICOIDS	Background: Although inhaled corticosteroids are effective for the treatment of asthma, it is uncertain whether their use can prevent death from asthma. Methods: We used the Saskatchewan Health data bases to form a population-based cohort of all subjects from 5 through 44 years of age who were using antiasthma drugs during the period from 1975 through 1991. We followed subjects until the end of 1997, their 55th birthday, death, emigration, or termination of health insurance coverage, whichever came first. We conducted a nested case-control study in which subjects who died of asthma were matched with controls within the cohort according to the length of follow-up at the time of death of the case patient (the index date), the date of study entry, and the severity of asthma. We calculated rate ratios after adjustment for the subject's age and sex; the number of prescriptions of theophylline, nebulized and oral (beta)-adrenergic agonists, and oral corticosteroids in the year before the index date; the number of canisters of inhaled (beta)-adrenergic agonists used in the year before the index date; and the number of hospitalizations for asthma in the two years before the index date. Results: The cohort consisted of 30,569 subjects. Of the 562 deaths, 77 were classified as due to asthma. We matched the 66 subjects who died of asthma for whom there were complete data with 2681 controls. Fifty-three percent of the case patients and 46 percent of the control patients had used inhaled corticosteroids in the previous year, most commonly low-dose beclomethasone. The mean number of canisters was 1.18 for the patients who died and 1.57 for the controls. On the basis of a continuous dose-response analysis, we calculated that the rate of death from asthma decreased by 21 percent with each additional canister of inhaled corticosteroids used in the previous year (adjusted rate ratio, 0.79; 95 percent confidence interval, 0.65 to 0.97). The rate of death from asthma during the first three months after discontinuation of inhaled corticosteroids was higher than the rate among patients who continued to use the drugs. Conclusions: The regular use of low-dose inhaled corticosteroids is associated with a decreased risk of death from asthma. (N Engl J Med 2000;343:332-6.) (C) 2000, Massachusetts Medical Society.	McGill Univ, Ctr Hlth, Royal Victoria Hosp, Div Clin Epidemiol, Montreal, PQ H3A 1A1, Canada; McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada; McGill Univ, Dept Med, Montreal, PQ, Canada; McGill Univ, Ctr Hlth, Div Resp Med, Montreal, PQ, Canada	McGill University; Royal Victoria Hospital; McGill University; McGill University; McGill University	Suissa, S (corresponding author), McGill Univ, Ctr Hlth, Royal Victoria Hosp, Div Clin Epidemiol, 687 Pine Ave W,Ross 4-29, Montreal, PQ H3A 1A1, Canada.							ARRIGHI HM, 1995, ANN ALLERG ASTHMA IM, V74, P321; Barnes PJ, 1998, J ALLERGY CLIN IMMUN, V101, pS427, DOI 10.1016/S0091-6749(98)70154-X; Blais L, 1998, THORAX, V53, P1025, DOI 10.1136/thx.53.12.1025; Blais L, 1998, AM J RESP CRIT CARE, V158, P126, DOI 10.1164/ajrccm.158.1.9707107; CRANE J, 1989, LANCET, V1, P917; Cumming RG, 1997, NEW ENGL J MED, V337, P8, DOI 10.1056/NEJM199707033370102; DEVOY MAB, 1995, CHEST, V108, P1768, DOI 10.1378/chest.108.6.1768-a; Donahue JG, 1997, JAMA-J AM MED ASSOC, V277, P887, DOI 10.1001/jama.277.11.887; ERNST P, 1992, EUR RESPIR J, V5, P773; ERNST P, 1992, JAMA-J AM MED ASSOC, V268, P3462, DOI 10.1001/jama.268.24.3462; Garbe E, 1997, JAMA-J AM MED ASSOC, V277, P722, DOI 10.1001/jama.277.9.722; Garbe E, 1998, JAMA-J AM MED ASSOC, V280, P539, DOI 10.1001/jama.280.6.539; GARBE S, 1998, JAMA-J AM MED ASSOC, V280, P1830; GARRETT J, 1995, THORAX, V50, P303, DOI 10.1136/thx.50.3.303; GRAINGER J, 1991, THORAX, V46, P105, DOI 10.1136/thx.46.2.105; Lipworth BJ, 1999, ARCH INTERN MED, V159, P941, DOI 10.1001/archinte.159.9.941; PEARCE N, 1990, THORAX, V45, P170, DOI 10.1136/thx.45.3.170; REA HH, 1986, THORAX, V41, P833, DOI 10.1136/thx.41.11.833; Sears MR, 1997, LANCET, V350, P1; Simons FER, 1998, J ALLERGY CLIN IMMUN, V102, pS77, DOI 10.1016/S0091-6749(98)70035-1; SPITZER WO, 1992, NEW ENGL J MED, V326, P501, DOI 10.1056/NEJM199202203260801; Strand LM, 1994, PHARMACOEPIDEM DR S, P217; Suissa S, 1997, J CLIN EPIDEMIOL, V50, P1079, DOI 10.1016/S0895-4356(97)00158-3; SUISSA S, 1994, AM J RESP CRIT CARE, V149, P604, DOI 10.1164/ajrccm.149.3.8118625	24	767	798	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 3	2000	343	5					332	336		10.1056/NEJM200008033430504	http://dx.doi.org/10.1056/NEJM200008033430504			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	340GR	10922423				2022-12-24	WOS:000088525200004
J	Hochstrasser, M				Hochstrasser, M			Biochemistry - All in the ubiquitin family	SCIENCE			English	Editorial Material							MODIFIERS		Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Hochstrasser, M (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave, New Haven, CT 06520 USA.			Hochstrasser, Mark/0000-0002-1131-5484				Bhaskar V, 2000, J BIOL CHEM, V275, P4033, DOI 10.1074/jbc.275.6.4033; Buschmann T, 2000, CELL, V101, P753, DOI 10.1016/S0092-8674(00)80887-9; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Epps JL, 1998, CURR BIOL, V8, P1277, DOI 10.1016/S0960-9822(07)00538-6; Furukawa K, 2000, J BIOL CHEM, V275, P7462, DOI 10.1074/jbc.275.11.7462; Hochstrasser M, 1998, GENE DEV, V12, P901, DOI 10.1101/gad.12.7.901; Kamura T, 1999, GENE DEV, V13, P2928, DOI 10.1101/gad.13.22.2928; Klionsky DT, 1999, ANNU REV CELL DEV BI, V15, P1, DOI 10.1146/annurev.cellbio.15.1.1; Kretz-Remy C, 1999, BIOCHEM CELL BIOL, V77, P299, DOI 10.1139/bcb-77-4-299; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Vierstra RD, 1999, PLANT MOL BIOL, V41, P435, DOI 10.1023/A:1006323317890	13	95	100	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 28	2000	289	5479					563	564		10.1126/science.289.5479.563	http://dx.doi.org/10.1126/science.289.5479.563			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	338XD	10939967				2022-12-24	WOS:000088447800033
J	Sondermann, P; Huber, R; Oosthuizen, V; Jacob, U				Sondermann, P; Huber, R; Oosthuizen, V; Jacob, U			The 3.2-angstrom crystal structure of the human IgG1 Fc fragment-Fc gamma RIII complex	NATURE			English	Article							CYANOGEN-BROMIDE FRAGMENTS; BINDING-SITE; EPSILON-RI; EFFECTOR FUNCTIONS; RECEPTOR IIB; AMINO-ACID; HUMAN IGE; IMMUNOGLOBULIN; ANTIBODIES; REGION	The immune response depends on the binding of opsonized antigens to cellular Fc receptors and the subsequent initiation of various cellular effector functions of the immune system. Here we describe the crystal structures of a soluble Fc gamma receptor (sFc gamma RIII, CD16), an Fc fragment from human IgG1 (hFc1) and their complex. In the 1:1 complex the receptor binds to the two halves of the Fc fragment in contact with residues of the C gamma 2 domains and the hinge region. Upon complex formation the angle between the two sFcgRIII domains increases significantly and the Fc fragment opens asymmetrically. The high degree of amino acid conservation between sFC gamma RIII and other Fc receptors, and similarly between hFc1 and related immunoglobulins, suggest similar structures and modes of association. Thus the described structure is a model for immune complex recognition and helps to explain the vastly differing affinities of other Fc gamma R-IgG complexes and the Fc epsilon RI alpha-IgE complex.	Max Planck Inst Biochem, Abt Strukturforsch, D-82152 Martinsried, Germany; Univ Port Elizabeth, Dept Biochem & Microbiol, ZA-6000 Port Elizabeth, South Africa	Max Planck Society; Nelson Mandela University	Sondermann, P (corresponding author), Max Planck Inst Biochem, Abt Strukturforsch, Klopferspitz 18A, D-82152 Martinsried, Germany.	sonderma@biochem.mpg.de						BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; CHAPPEL MS, 1991, P NATL ACAD SCI USA, V88, P9036, DOI 10.1073/pnas.88.20.9036; Clynes R, 1998, SCIENCE, V279, P1052, DOI 10.1126/science.279.5353.1052; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Cook JPD, 1997, BIOCHEMISTRY-US, V36, P15579, DOI 10.1021/bi9713005; Curnow RT, 1997, CANCER IMMUNOL IMMUN, V45, P210, DOI 10.1007/s002620050435; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; DIAMOND B, 1985, J IMMUNOL, V134, P1080; DUNCAN AR, 1988, NATURE, V332, P563, DOI 10.1038/332563a0; Edberg JC, 1997, J IMMUNOL, V159, P3849; Galon J, 1997, Int Rev Immunol, V16, P87, DOI 10.3109/08830189709045704; Garman SC, 1998, CELL, V95, P951, DOI 10.1016/S0092-8674(00)81719-5; GERGELY J, 1990, FASEB J, V4, P3275, DOI 10.1096/fasebj.4.15.2253843; Gessner JE, 1998, ANN HEMATOL, V76, P231, DOI 10.1007/s002770050396; GHIRLANDO R, 1995, BIOCHEMISTRY-US, V34, P13320, DOI 10.1021/bi00041a007; GREENWOOD J, 1993, EUR J IMMUNOL, V23, P1098, DOI 10.1002/eji.1830230518; Henry AJ, 1997, BIOCHEMISTRY-US, V36, P15568, DOI 10.1021/bi971299+; HUBER R, 1976, NATURE, V264, P415, DOI 10.1038/264415a0; HULETT MD, 1995, J BIOL CHEM, V270, P21188, DOI 10.1074/jbc.270.36.21188; Hulett MD, 1999, J BIOL CHEM, V274, P13345, DOI 10.1074/jbc.274.19.13345; Hulett MD, 1998, MOL IMMUNOL, V35, P989, DOI 10.1016/S0161-5890(98)00069-8; Isakov N, 1997, IMMUNOL RES, V16, P85, DOI 10.1007/BF02786325; ISHIZAKA T, 1978, J IMMUNOL, V120, P800; Jefferis R, 1998, IMMUNOL REV, V163, P59, DOI 10.1111/j.1600-065X.1998.tb01188.x; Kato K, 2000, J MOL BIOL, V295, P213, DOI 10.1006/jmbi.1999.3351; Keown MB, 1998, BIOCHEMISTRY-US, V37, P8863, DOI 10.1021/bi972354h; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LUND J, 1992, MOL IMMUNOL, V29, P53, DOI 10.1016/0161-5890(92)90156-R; Maxwell KF, 1999, NAT STRUCT BIOL, V6, P437; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; METZGER H, 1992, J IMMUNOL, V149, P1477; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Reddy MP, 2000, J IMMUNOL, V164, P1925, DOI 10.4049/jimmunol.164.4.1925; RUTISHAUSER U, 1970, BIOCHEMISTRY-US, V9, P3171, DOI 10.1021/bi00818a009; SARMAY G, 1992, MOL IMMUNOL, V29, P633, DOI 10.1016/0161-5890(92)90200-H; SAUERERIKSSON AE, 1995, STRUCTURE, V3, P265, DOI 10.1016/S0969-2126(01)00157-5; Sondermann P, 1999, BIOL CHEM, V380, P717, DOI 10.1515/BC.1999.090; Sondermann P, 1999, BIOCHEMISTRY-US, V38, P8469, DOI 10.1021/bi982889q; Sondermann P, 1999, EMBO J, V18, P1095, DOI 10.1093/emboj/18.5.1095; SUTTON BJ, 1993, NATURE, V366, P421, DOI 10.1038/366421a0; Tamm A, 1997, Int Rev Immunol, V16, P57, DOI 10.3109/08830189709045703; TAX WJM, 1983, NATURE, V304, P445, DOI 10.1038/304445a0; WARMERDAM PAM, 1991, J IMMUNOL, V147, P1338; Woodle ES, 1999, TRANSPLANTATION, V68, P608, DOI 10.1097/00007890-199909150-00003; WOOF JM, 1986, MOL IMMUNOL, V23, P319, DOI 10.1016/0161-5890(86)90059-3	48	578	742	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2000	406	6793					267	273		10.1038/35018508	http://dx.doi.org/10.1038/35018508			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917521				2022-12-24	WOS:000088251900039
J	Halloran, PF				Halloran, PF			Sirolimus and ciclosporin for renal transplantation	LANCET			English	Editorial Material							RAPAMYCIN AY-22,989; ANTIFUNGAL		Univ Alberta, Div Nephrol & Immunol, Edmonton, AB T6G 2S2, Canada	University of Alberta	Halloran, PF (corresponding author), Univ Alberta, Div Nephrol & Immunol, Edmonton, AB T6G 2S2, Canada.		Halloran, Philip F/J-1390-2012	Halloran, Philip F/0000-0003-1371-1947				BOREL JF, 1976, AGENTS ACTIONS, V6, P468, DOI 10.1007/BF01973261; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; GREGORY CR, 1993, TRANSPLANTATION, V55, P1409, DOI 10.1097/00007890-199306000-00037; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Li YS, 1999, NAT MED, V5, P1298, DOI 10.1038/15256; McAlister VC, 2000, LANCET, V355, P376, DOI 10.1016/S0140-6736(99)03882-9; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; Peterson RT, 1999, P NATL ACAD SCI USA, V96, P4438, DOI 10.1073/pnas.96.8.4438; Raught B, 2000, EMBO J, V19, P434, DOI 10.1093/emboj/19.3.434; SEHGAL SN, 1975, J ANTIBIOT, V28, P727, DOI 10.7164/antibiotics.28.727; SHAPIRO AMJ, IN PRESS N ENGL J ME; VEZINA C, 1975, J ANTIBIOT, V28, P721, DOI 10.7164/antibiotics.28.721	12	43	43	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 15	2000	356	9225					179	180		10.1016/S0140-6736(00)02473-9	http://dx.doi.org/10.1016/S0140-6736(00)02473-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334GQ	10963190				2022-12-24	WOS:000088179100003
J	David, P; Bjorksten, T; Fowler, K; Pomiankowski, A				David, P; Bjorksten, T; Fowler, K; Pomiankowski, A			Condition-dependent signalling of genetic variation in stalk-eyes flies	NATURE			English	Article							SECONDARY SEXUAL CHARACTER; EVOLUTION; SELECTION; TRAITS; PREFERENCES; ORNAMENTS	Handicap models of sexual selection predict that male sexual ornaments have strong condition-dependent expression and this allows females to evaluate male genetic quality(1-5). A number of previous experiments have demonstrated heightened condition-dependence of sexual ornaments in response to environmental stress(6-9). Here we show that genetic variation underlies the response to environmental stress (variable food quality) of a sexual ornament (male eye span) in the stalk-eyed fly Cyrtodiopsis dalmanni. Some male genotypes develop large eye span under all conditions, whereas other genotypes progressively reduce eye span as conditions deteriorate. Several non-sexual traits (female eye span, male and female wing length) also show genetic variation in condition-dependent expression, but their genetic response is entirely explained by scaling with body size. In contrast, the male sexual ornament still reveals genetic variation in the response to environmental stress after accounting for differences in body size. These results strongly support the hypothesis that female mate choice yields genetic benefits for offspring.	UCL, Dept Biol, Galton Lab, London NW1 2HE, England; CNRS, CEFE, F-34293 Montpellier 05, France; Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA	University of London; University College London; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Colorado State University	Pomiankowski, A (corresponding author), UCL, Dept Biol, Galton Lab, 4 Stephenson Way, London NW1 2HE, England.	ucbhpom@ucl.ac.uk	Pomiankowski, Andrew/X-3888-2019	Pomiankowski, Andrew/0000-0002-5171-8755				ANDERSSON M, 1986, EVOLUTION, V40, P804, DOI 10.1111/j.1558-5646.1986.tb00540.x; BURKHARDT D, 1988, J COMP PHYSIOL A, V162, P649, DOI 10.1007/BF01342640; Falconer D. S., 1996, INTRO QUANTITATIVE G; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; Griffith SC, 1999, NATURE, V400, P358, DOI 10.1038/22536; GUSTAFSSON L, 1995, NATURE, V375, P311, DOI 10.1038/375311a0; HILL GE, 1992, AUK, V109, P1; Hunt J, 1997, BEHAV ECOL SOCIOBIOL, V41, P109, DOI 10.1007/s002650050370; IWASA Y, 1994, EVOLUTION, V48, P853, DOI 10.1111/j.1558-5646.1994.tb01367.x; Lynch M., 1998, AM J HUM GENET; POMIANKOWSKI A, 1987, PROC R SOC SER B-BIO, V231, P123, DOI 10.1098/rspb.1987.0038; Qvarnstrom A, 1999, EVOLUTION, V53, P1564, DOI 10.1111/j.1558-5646.1999.tb05419.x; Roff D.A., 1997, EVOLUTIONARY QUANTIT; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Wilkinson GS, 1999, P ROY SOC B-BIOL SCI, V266, P1685, DOI 10.1098/rspb.1999.0832; WILKINSON GS, 1994, P ROY SOC B-BIOL SCI, V255, P1, DOI 10.1098/rspb.1994.0001; [No title captured]	17	243	244	0	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2000	406	6792					186	188		10.1038/35018079	http://dx.doi.org/10.1038/35018079			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910358				2022-12-24	WOS:000088221100048
J	Zhang, PC; Shao, GF; Zhao, G; Le Master, DC; Parker, GR; Dunning, JB; Li, QL				Zhang, PC; Shao, GF; Zhao, G; Le Master, DC; Parker, GR; Dunning, JB; Li, QL			Ecology - China's forest policy for the 21st century	SCIENCE			English	Article									Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA; State Forestry Adm, Ctr Nat Forest Conservat & Management, Beijing 100714, Peoples R China; S Carolina Dept Hlth & Environm Control, Columbia, SC 29201 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Shao, GF (corresponding author), Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA.	gshao@fnr.purdue.edu	Shao, Guofan/F-1276-2010					LI W, 1993, CHINAS BIODIVERSITY, P168; LIU J, 1996, MACRO INVENTORY CHIN, P353; LIU S, 1963, CHINESE FORESTRY, V10, P8; MINISTRY OF FORESTRY, 1997, CHIN FOR YB; QU G, 1999, ENV PROTECTION KNOWL, P354; Richardson SD, 1990, FOREST FORESTRY CHIN; Shao G, 1998, NAT AREA J, V18, P358; SHAW N, 1914, CHINESE FOREST TREES; WANG T, 1991, HDB ABT AGENT BIOL T, P330; ZHANG P, 1999, INTRO NATURAL FOREST, P388; Zhang PeiChang, 1999, Scientia Silvae Sinicae, V35, P124	11	402	462	19	176	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 23	2000	288	5474					2135	2136		10.1126/science.288.5474.2135	http://dx.doi.org/10.1126/science.288.5474.2135			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FH	10896587				2022-12-24	WOS:000087782900021
J	Hingson, RW; Heeren, T; Jamanka, A; Howland, J				Hingson, RW; Heeren, T; Jamanka, A; Howland, J			Age of drinking onset and unintentional injury involvement after drinking	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALCOHOL-USE; ACCIDENTAL FALLS; RISK; INTERVENTIONS; BEHAVIORS; ADULTS; DEATH	Context In 1997, unintentional injury was the leading cause of death for persons aged 1 to 34 years. Approximately one third of deaths due to unintentional injury in the United States are estimated to be alcohol related. Onset of drinking at an early age has been found to be associated with alcohol dependence, but whether early-onset drinking increases risk for unintentional injury while drinking is unknown. Objective To explore whether persons who started drinking at an early age are more likely to have experienced unintentional injuries while under the influence of alcohol. Design and Setting The National Longitudinal Alcohol Epidemiology Survey, a cross-sectional survey conducted in 1992 of a representative sample of the US population. Participants A total of 42 862 randomly selected adults (response rate, 90%; mean age, 44 years). Main Outcome Measures Unintentional injury involvement while under the influence of alcohol by age of drinking onset (categorized as <14 years, each age from 14-20 years, or greater than or equal to 21 years). Results Relative to respondents who began drinking at age 21 years or older, those who started before age 14 years as well as those who started at each intervening age up to 21 years were significantly more likely to have been injured while under the influence of alcohol, even after controlling for history of alcohol dependence, heavy drinking frequency during the period that they drank most, family history of alcoholism, and other characteristics associated with earlier onset of drinking. After adjusting for these variables, odds ratios for having been injured while under the influence of alcohol were as follows: for younger than 14 years, 2.98 (95% confidence interval [CI], 2.29-3.89); age 14 years, 2.96 (95% CI, 2.26-3.88); age 15 years, 3.14 (95% CI, 2.48-3.97); age 16 years, 2.38 (95% CI, 1.90-2.98); age 17 years, 2.12 (95% CI, 1.66-2.71); age 18 years, 1.33 (95% CI, 1.08-1.64); age 19 years, 1.42 (95% CI, 1.07-1.89); and age 20 years, 1.39 (95% CI, 1.01-1.91). Conclusion Drinking onset at ages younger than 21 years is associated with;having experienced alcohol-related injuries.	Boston Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Data Coordinating Ctr, Boston, MA 02118 USA	Boston University; Boston University; Boston University	Hingson, RW (corresponding author), Boston Univ, Sch Publ Hlth, Dept Social & Behav Sci, 715 Albany St,T 2W, Boston, MA 02118 USA.	rhingson@bu.edu		Howland, Jonathan/0000-0001-8079-1188; Heeren, Timothy/0000-0001-5643-3559				*CDC NAT CTR HLTH, 1999, OFF STAT PROGR DAT; CLAPPER RL, 1995, INT J ADDICT, V30, P507, DOI 10.3109/10826089509048741; Dinh-Zarr T, 1999, ALCOHOL ALCOHOLISM, V34, P609, DOI 10.1093/alcalc/34.4.609; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; *GEN ACC OFF, 1987, DRINK AG LAWS EV SYN; Gentilello LM, 1999, ANN SURG, V230, P473, DOI 10.1097/00000658-199910000-00003; Grant BF, 1998, ALCOHOL HEALTH RES W, V22, P144; GRANT BF, 1995, DRUG ALCOHOL DEPEN, V39, P37, DOI 10.1016/0376-8716(95)01134-K; HINGSON R, 1993, ADDICTION, V88, P877, DOI 10.1111/j.1360-0443.1993.tb02105.x; HINGSON R, 1987, J STUD ALCOHOL, V48, P212, DOI 10.15288/jsa.1987.48.212; Hingson R., 1990, J TRAFFIC MED, V3, P123; HONKANEN R, 1983, J STUD ALCOHOL, V44, P231, DOI 10.15288/jsa.1983.44.231; HOWLAND J, 1988, ACCIDENT ANAL PREV, V20, P19, DOI 10.1016/0001-4575(88)90011-5; JONES NE, 1992, AM J PUBLIC HEALTH, V82, P112, DOI 10.2105/AJPH.82.1.112; MASSEY JT, 1985, VITAL HLTH STAT REPO, V2; *NAT HIGHW TRAFF S, 1996, US DEP TRANSP PUBL; *NAT HIGHW TRAFF S, 1998, TRAFF SAF FACTS 1997; *NAT HIGHW TRAFF S, 1998, TRAFF SAF FACTS ALC; O'Malley PM, 1999, AM J PUBLIC HEALTH, V89, P678, DOI 10.2105/AJPH.89.5.678; OMALLEY PM, 1991, J STUD ALCOHOL, V52, P478, DOI 10.15288/jsa.1991.52.478; Prescott CA, 1999, ALCOHOL CLIN EXP RES, V23, P101, DOI 10.1097/00000374-199901000-00014; Robins L. N., 1993, MENTAL DISORDER CRIM, P173; Schuckit MA, 1999, JAMA-J AM MED ASSOC, V281, P1875, DOI 10.1001/jama.281.20.1875; Shah BV, 1996, SUDAAN USERS MANUAL; Smith GS, 1999, ANN EMERG MED, V33, P659, DOI 10.1016/S0196-0644(99)70195-2; Zador PL, 2000, J STUD ALCOHOL, V61, P387, DOI 10.15288/jsa.2000.61.387; ZADOR PL, 1991, J STUD ALCOHOL, V52, P302, DOI 10.15288/jsa.1991.52.302	27	219	219	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 27	2000	284	12					1527	1533		10.1001/jama.284.12.1527	http://dx.doi.org/10.1001/jama.284.12.1527			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	355HF	11000646	Green Submitted, Bronze			2022-12-24	WOS:000089379700028
J	Lin, SJ; Defossez, PA; Guarente, L				Lin, SJ; Defossez, PA; Guarente, L			Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae	SCIENCE			English	Article							GENE-EXPRESSION; YEAST; PATHWAY; RAS; MECHANISMS; COMPLEX; MUTANTS; STRESS	Calorie restriction extends Life-span in a wide variety of organisms. Although it has been suggested that calorie restriction may work by reducing the levels of reactive oxygen species produced during respiration. the mechanism by which this regimen slows aging is uncertain. Here, we mimicked calorie restriction in yeast by physiological or genetic means and showed a substantial extension in Life-span. This extension was not observed in strains mutant for SIR2 (which encodes the silencing protein Sir2p) or NPT1 (a gene in a pathway in the synthesis of NAD, the oxidized form of nicotinamide adenine dinucleotide), These findings suggest that the increased longevity induced by calorie restriction requires the activation of Sir2p by NAD.	MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Guarente, L (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.			Defossez, Pierre-Antoine/0000-0002-6463-9263	NIA NIH HHS [5-F32-AG05857-02] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [F32AG005857] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BROACH JR, 1991, TRENDS GENET, V7, P28, DOI 10.1016/0168-9525(91)90018-L; Colombo S, 1998, EMBO J, V17, P3326, DOI 10.1093/emboj/17.12.3326; Defossez PA, 1999, MOL CELL, V3, P447, DOI 10.1016/S1097-2765(00)80472-4; Grubmeyer CT, 1999, METHOD ENZYMOL, V308, P28; Grunstein M, 1998, CELL, V93, P325, DOI 10.1016/S0092-8674(00)81160-5; Guarente L, 1999, NAT GENET, V23, P281, DOI 10.1038/15458; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lin S.-T., UNPUB; MULLER I, 1980, MECH AGEING DEV, V12, P47, DOI 10.1016/0047-6374(80)90028-7; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Rajavel M, 1998, BIOCHEMISTRY-US, V37, P4181, DOI 10.1021/bi9720134; Roth GS, 1999, J AM GERIATR SOC, V47, P896, DOI 10.1111/j.1532-5415.1999.tb03851.x; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Smith A, 1998, EMBO J, V17, P3556, DOI 10.1093/emboj/17.13.3556; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Thevelein JM, 1999, MOL MICROBIOL, V33, P904, DOI 10.1046/j.1365-2958.1999.01538.x; WALSH RB, 1983, J BACTERIOL, V154, P1002, DOI 10.1128/JB.154.2.1002-1004.1983; Xue Y, 1998, EMBO J, V17, P1996, DOI 10.1093/emboj/17.7.1996; YU BP, 1994, MODULATION AGING PRO	24	1383	1443	4	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2000	289	5487					2126	2128		10.1126/science.289.5487.2126	http://dx.doi.org/10.1126/science.289.5487.2126			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11000115				2022-12-24	WOS:000089430900045
J	Turner, GC; Varshavsky, A				Turner, GC; Varshavsky, A			Detecting and measuring cotranslational protein degradation in vivo	SCIENCE			English	Article							N-END RULE; SACCHAROMYCES-CEREVISIAE; IN-VITRO; UBIQUITIN; PROTEASOME	Nascent polypeptides emerging from the ribosome and not yet folded may at Least transiently present degradation signals similar to those recognized by the ubiquitin system in misfolded proteins. The ubiquitin sandwich technique was used to detect and measure cotranslational protein degradation in living cells. More than 50 percent of nascent protein molecules bearing an amino-terminal degradation signal can be degraded cotranslationally, never reaching their mature size before their destruction by processive proteolysis. Thus, the folding of nascent proteins, including abnormal ones, may be in kinetic competition with pathways that target these proteins for degradation cotranslationally.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Varshavsky, A (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.			Turner, Glenn/0000-0002-5341-2784				BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; DEGROOT RJ, 1991, P NATL ACAD SCI USA, V88, P8967, DOI 10.1073/pnas.88.20.8967; Frydman J, 1996, SCIENCE, V272, P1497, DOI 10.1126/science.272.5267.1497; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; JOHNSSON N, 1994, EMBO J, V13, P2686, DOI 10.1002/j.1460-2075.1994.tb06559.x; Levy F, 1996, P NATL ACAD SCI USA, V93, P4907, DOI 10.1073/pnas.93.10.4907; Liao W, 1998, J BIOL CHEM, V273, P27225, DOI 10.1074/jbc.273.42.27225; Lin L, 1998, CELL, V92, P819, DOI 10.1016/S0092-8674(00)81409-9; LOUVION JF, 1993, GENE, V131, P129, DOI 10.1016/0378-1119(93)90681-R; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Sato S, 1998, J BIOL CHEM, V273, P7189, DOI 10.1074/jbc.273.13.7189; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Spirin A, 1986, RIBOSOME STRUCTURE P; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5	19	201	205	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2000	289	5487					2117	2120		10.1126/science.289.5487.2117	http://dx.doi.org/10.1126/science.289.5487.2117			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11000112				2022-12-24	WOS:000089430900042
J	Jouven, X; Zureik, M; Desnos, M; Courbon, D; Ducimetiere, P				Jouven, X; Zureik, M; Desnos, M; Courbon, D; Ducimetiere, P			Long-term outcome in asymptomatic men with exercise-induced premature ventricular depolarizations	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-ARTERY DISEASE; MITRAL-VALVE PROLAPSE; PROGNOSTIC-SIGNIFICANCE; HEART-DISEASE; FOLLOW-UP; HYPERTROPHIC CARDIOMYOPATHY; TREADMILL EXERCISE; HEALTHY-MEN; ARRHYTHMIAS; PREVALENCE	Background: Exercise testing is widely used in the diagnosis of coronary artery disease, but the long-term outcome for asymptomatic persons with exercise-induced premature ventricular depolarizations remains unclear. We used data from the Paris Prospective Study I to assess the long-term outcome of such persons. Methods: A total of 6101 asymptomatic French men (42 to 53 years of age) who were free of clinically detectable cardiovascular disease underwent a standardized graded exercise test between 1967 and 1972. Subjects were prospectively classified as having or not having frequent premature ventricular depolarizations (a run of two or more consecutive premature ventricular depolarizations or premature ventricular depolarizations constituting more than 10 percent of all ventricular depolarizations during any of the 30-second electrocardiographic recordings). Results: During exercise, 138 subjects had frequent premature ventricular depolarizations. After 23 years of follow-up, these subjects had a higher risk of death from cardiovascular causes than the men without frequent premature ventricular depolarizations during exercise (relative risk, 2.67; 95 percent confidence interval, 1.76 to 4.07). In a multivariate model, with adjustment for standard coronary risk factors and the presence or absence of premature ventricular depolarizations before exercise and during recovery from exercise, both exercise-induced ischemia and the occurrence of frequent premature ventricular depolarizations during exercise remained independently associated with an increased risk of death from cardiovascular causes, with similar relative risks (2.63 [95 percent confidence interval, 1.93 to 3.59] and 2.53 [95 percent confidence interval, 1.65 to 3.88], respectively). Conclusions: The occurrence of frequent premature ventricular depolarizations during exercise in asymptomatic middle-aged men is associated with a long-term increase in the risk of death from cardiovascular causes. (N Engl J Med 2000;343:826-33.) (C) 2000, Massachusetts Medical Society.	Univ Paris 05, Serv Cardiol, Hop Europeen Georges Pompidou, Fac Necker Enfants Malad, F-75015 Paris, France; Hop Paul Brousse, INSERM, U258, Villejuif, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Jouven, X (corresponding author), Univ Paris 05, Serv Cardiol, Hop Europeen Georges Pompidou, Fac Necker Enfants Malad, 20 Rue Le Blanc, F-75015 Paris, France.	xavier.jouven@bcc.ap-hop-paris.fr	Zureik, Mahmoud/F-7855-2018	Zureik, Mahmoud/0000-0002-8393-4217				BRUCE RA, 1980, AM J CARDIOL, V46, P371, DOI 10.1016/0002-9149(80)90003-X; CALIFF RM, 1983, J AM COLL CARDIOL, V2, P1060, DOI 10.1016/S0735-1097(83)80330-1; DIMSDALE JE, 1984, JAMA-J AM MED ASSOC, V251, P630, DOI 10.1001/jama.251.5.630; DRORY Y, 1990, AM J CARDIOL, V66, P1092, DOI 10.1016/0002-9149(90)90510-8; DUCIMETIERE P, 1980, LANCET, V1, P1346; FARIS JV, 1976, AM J CARDIOL, V37, P617, DOI 10.1016/0002-9149(76)90404-5; FILIPOVSKY J, 1992, HYPERTENSION, V20, P333, DOI 10.1161/01.HYP.20.3.333; FLEG JL, 1984, AM J CARDIOL, V54, P762, DOI 10.1016/S0002-9149(84)80204-0; Fontaine G, 1998, CIRCULATION, V97, P1532, DOI 10.1161/01.CIR.97.16.1532; Freed LA, 1999, NEW ENGL J MED, V341, P1, DOI 10.1056/NEJM199907013410101; Froelicher V F Jr, 1974, Am J Cardiol, V34, P770, DOI 10.1016/0002-9149(74)90694-8; GIAGNONI E, 1983, NEW ENGL J MED, V309, P1085, DOI 10.1056/NEJM198311033091803; GIANROSSI R, 1989, CIRCULATION, V80, P87, DOI 10.1161/01.CIR.80.1.87; GORDON DJ, 1986, CIRCULATION, V74, P252, DOI 10.1161/01.CIR.74.2.252; JANSSEN MJA, 1995, EUR HEART J, V16, P674, DOI 10.1093/oxfordjournals.eurheartj.a060972; Kuck KH, 1997, PACE, V20, P2706, DOI 10.1111/j.1540-8159.1997.tb06120.x; La Vecchia L, 1998, CLIN CARDIOL, V21, P731; MARCUS FI, 1982, CIRCULATION, V65, P384, DOI 10.1161/01.CIR.65.2.384; Maron BJ, 1997, LANCET, V350, P1330; MCHENRY PL, 1984, CIRCULATION, V70, P547, DOI 10.1161/01.CIR.70.4.547; Michaelides AP, 1999, NEW ENGL J MED, V340, P340, DOI 10.1056/NEJM199902043400502; MORROW K, 1993, ANN INTERN MED, V118, P689, DOI 10.7326/0003-4819-118-9-199305010-00005; NAIR CK, 1983, J AM COLL CARDIOL, V1, P1201, DOI 10.1016/S0735-1097(83)80130-2; Pogwizd SM, 1998, CIRCULATION, V98, P2404, DOI 10.1161/01.CIR.98.22.2404; Rywik TM, 1998, CIRCULATION, V97, P2117, DOI 10.1161/01.CIR.97.21.2117; SAMI M, 1984, AM J CARDIOL, V54, P1182, DOI 10.1016/S0002-9149(84)80064-8; Shaw LJ, 1998, CIRCULATION, V98, P1622, DOI 10.1161/01.CIR.98.16.1622; SPIRITO P, 1989, NEW ENGL J MED, V320, P749, DOI 10.1056/NEJM198903233201201; TOFF WD, 1988, EUR HEART J SUPPL, V9, pG119; UDALL JA, 1977, CIRCULATION, V56, P985, DOI 10.1161/01.CIR.56.6.985; VEDIN JA, 1972, AM J CARDIOL, V29, P25, DOI 10.1016/0002-9149(72)90120-8; WEINER DA, 1984, J AM COLL CARDIOL, V3, P772, DOI 10.1016/S0735-1097(84)80254-5; *WHO, 1967, INT CLASS DIS MAN IN, V1, P3	33	162	172	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 21	2000	343	12					826	833		10.1056/NEJM200009213431201	http://dx.doi.org/10.1056/NEJM200009213431201			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354XB	10995861				2022-12-24	WOS:000089355600001
J	Kolesnikova, OA; Entelis, NS; Mireau, H; Fox, TD; Martin, RP; Tarassov, IA				Kolesnikova, OA; Entelis, NS; Mireau, H; Fox, TD; Martin, RP; Tarassov, IA			Suppression of mutations in mitochondrial DNA by tRNAs imported from the cytoplasm	SCIENCE			English	Article							TRANSFER-RNA; SACCHAROMYCES-CEREVISIAE; YEAST MITOCHONDRIA; TRYPANOSOMA-BRUCEI; PROTEIN; TRNA(LYS); AMINOACYLATION; IDENTITY; INVIVO; LEADER	Mitochondrial import of a cytoplasmic transfer RNA (tRNA) in yeast requires the preprotein import machinery and cytosolic factors. We investigated whether the tRNA import pathway can be used to correct respirator,, deficiencies due to mutations in the mitochondrial DNA and whether this system can be transferred into human cells. We show that cytoplasmic tRNAs with altered aminoacylation identity can be specifically targeted to the mitochondria and participate in mitochondrial translation. We also show that human mitochondria, which do not normally import tRNAs, are able to internalize yeast tRNA derivatives in vitro and that this import requires an essential yeast import factor.	Moscow MV Lomonosov State Univ, Dept Mol Biol, Moscow 119899, Russia; Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Lomonosov Moscow State University; Cornell University	Tarassov, IA (corresponding author), Mecan Mol Div Cellulaire & Dev, CNRS, FRE 2168, 21 Rue Rene Descartes, F-57084 Strasbourg, France.	I.Tarassov@ibmc.u-strasbg.fr		Fox, Thomas/0000-0001-7629-3661; Mireau, Hakim/0000-0002-2299-5139	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029362] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM29362] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adhya S, 1997, J BIOL CHEM, V272, P21396, DOI 10.1074/jbc.272.34.21396; Aphasizhev R, 1997, RNA, V3, P489; BEATTIE DS, 1987, MITOCHONDRIA PRACTIC, P283; Dietrich A, 1996, PLANT J, V10, P913, DOI 10.1046/j.1365-313X.1996.10050913.x; DOERSEN CJ, 1985, J BIOL CHEM, V260, P5942; Entelis NS, 1996, FEBS LETT, V384, P38, DOI 10.1016/0014-5793(96)00259-1; Entelis NS, 1998, P NATL ACAD SCI USA, V95, P2838, DOI 10.1073/pnas.95.6.2838; GAINES G, 1984, MOL CELL BIOL, V4, P1605, DOI 10.1128/MCB.4.8.1605; HOU YM, 1988, NATURE, V333, P140, DOI 10.1038/333140a0; Kazakova HA, 1999, FEBS LETT, V442, P193, DOI 10.1016/S0014-5793(98)01653-6; LI K, 1994, J CELL BIOL, V124, P871, DOI 10.1083/jcb.124.6.871; Magalhaes PJ, 1998, MOL BIOL CELL, V9, P2375, DOI 10.1091/mbc.9.9.2375; MARTIN RP, 1979, BIOCHEMISTRY-US, V18, P4600, DOI 10.1021/bi00588a021; MCKEE EE, 1984, J BIOL CHEM, V259, P9320; Mireau H, 2000, J BIOL CHEM, V275, P13291, DOI 10.1074/jbc.275.18.13291; MULERO JJ, 1993, MOL BIOL CELL, V4, P1327, DOI 10.1091/mbc.4.12.1327; Nabholz CE, 1999, MOL BIOL CELL, V10, P2547, DOI 10.1091/mbc.10.8.2547; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Schneider Andre, 1994, Trends in Cell Biology, V4, P282, DOI 10.1016/0962-8924(94)90218-6; TARASSOV I, 1995, EMBO J, V14, P3461, DOI 10.1002/j.1460-2075.1995.tb07352.x; TARASSOV I, 1995, J MOL BIOL, V245, P315, DOI 10.1006/jmbi.1994.0026; TARASSOV IA, 1999, MITOCHONDRIAL DIS MO, P303; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; WIESENBERGER G, 1995, MOL CELL BIOL, V15, P3291; Yermovsky-Kammerer AE, 1999, MOL CELL BIOL, V19, P6253	26	119	127	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 15	2000	289	5486					1931	1933		10.1126/science.289.5486.1931	http://dx.doi.org/10.1126/science.289.5486.1931			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354XD	10988073				2022-12-24	WOS:000089355800045
J	Redecker, D; Kodner, R; Graham, LE				Redecker, D; Kodner, R; Graham, LE			Glomalean fungi from the Ordovician	SCIENCE			English	Article							ARBUSCULAR MYCORRHIZAE; GEOSIPHON-PYRIFORME; LAND PLANTS; CYANOBACTERIA; ORIGIN	Fossilized fungal hyphae and spores from the Ordovician of Wisconsin (with an age of about 460 million years) strongly resemble modern arbuscular mycorrhizal fungi (Glomales, Zygomycetes), These fossils indicate that Glomales-like fungi were present at a time when the Land flora most likely only consisted of plants; on,the bryophytic Level. Thus, these fungi may have played a crucial role in facilitating the colonization of Land by plants, and the fossils support molecular estimates of fungal phylogeny that place the origin of the major groups of terrestrial fungi (Ascomycota, Basidiomycota, and Glomales) around 600 million years ago.	Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; Univ Wisconsin, Dept Bot, Madison, WI 53706 USA	University of California System; University of California Berkeley; University of Wisconsin System; University of Wisconsin Madison	Redecker, D (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, 111 Koshland Hall, Berkeley, CA 94720 USA.	redecker@nature.berkeley.edu						Alexopoulos C. J., 1996; Berbee ML, 2001, MYCOTA, V7, P229; DENNIS RL, 1970, MYCOLOGIA, V62, P578, DOI 10.2307/3757529; Gehrig H, 1996, J MOL EVOL, V43, P71, DOI 10.1007/BF02352301; GRAY J, 1982, GEOLOGY, V10, P197, DOI 10.1130/0091-7613(1982)10<197:CLPMFL>2.0.CO;2; HIBBETT DS, 1995, NATURE, V377, P487, DOI 10.1038/377487a0; HUFF WD, 1992, GEOLOGY, V20, P875, DOI 10.1130/0091-7613(1992)020<0875:GOVAFI>2.3.CO;2; ILLMAN WI, 1984, MYCOLOGIA, V76, P545, DOI 10.2307/3793338; MORTON JB, 1988, MYCOTAXON, V32, P267; OSBORN JM, 1995, AM J BOT, V82, P1074, DOI 10.2307/2446238; Phipps CJ, 1996, MYCOLOGIA, V88, P707, DOI 10.2307/3760964; PIROZYNSKI KA, 1975, BIOSYSTEMS, V6, P153, DOI 10.1016/0303-2647(75)90023-4; Ragan MA, 1996, P NATL ACAD SCI USA, V93, P11907, DOI 10.1073/pnas.93.21.11907; Redecker D, 2000, MOL PHYLOGENET EVOL, V14, P276, DOI 10.1006/mpev.1999.0713; REMY W, 1994, P NATL ACAD SCI USA, V91, P11841, DOI 10.1073/pnas.91.25.11841; Schussler A, 2000, MYCORRHIZA, V10, P15, DOI 10.1007/s005720050282; SCHUSSLER A, 1994, BOT ACTA, V107, P36, DOI 10.1111/j.1438-8677.1994.tb00406.x; SHERWOODPIKE MA, 1985, LETHAIA, V18, P1, DOI 10.1111/j.1502-3931.1985.tb00680.x; SIMON L, 1993, NATURE, V363, P67, DOI 10.1038/363067a0; SLOAN RE, 1987, MINNESOTA GEOLOGICAL, V35, P7; Smith S.E., 2010, MYCORRHIZAL SYMBIOSI; STAHL M, 1949, PLANTA, V37, P103, DOI 10.1007/BF01929705; Swofford D.L., 1999, PAUP PHYLOGENETIC AN; Taylor T.N., 1996, PALYNOLOGY PRINCIPLE, P427; TAYLOR TN, 1994, NATURE, V367, P601, DOI 10.1038/367601a0; Taylor TN, 1999, NATURE, V399, P648, DOI 10.1038/21349	26	661	725	4	235	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 15	2000	289	5486					1920	1921		10.1126/science.289.5486.1920	http://dx.doi.org/10.1126/science.289.5486.1920			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354XD	10988069				2022-12-24	WOS:000089355800041
J	Guyatt, GH; Haynes, RB; Jaeschke, RZ; Cook, DJ; Green, L; Naylor, CD; Wilson, MC; Richardson, WS				Guyatt, GH; Haynes, RB; Jaeschke, RZ; Cook, DJ; Green, L; Naylor, CD; Wilson, MC; Richardson, WS		Evidence-Based Med Working Grp	Users' Guides to The Medical Literature - XXV. Evidence-based medicine: Principles for applying the Users' Guides to patient care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL-PRACTICE GUIDELINES; RANDOMIZED CONTROLLED TRIAL; NARRATIVE BASED MEDICINE; HELP ME; DECISION-ANALYSIS; HEART-FAILURE; ARTICLE; WILL; THERAPY; RECOMMENDATIONS	This series provides clinicians with strategies and tools to interpret and integrate evidence from published research in their care of patients. The 2 key principles for applying all the articles in this series to patient care relate to the value-laden nature of clinical decisions and to the hierarchy of evidence postulated by evidence-based medicine. Clinicians need to be able to distinguish high from low quality in primary studies, systematic reviews, practice guidelines, and other integrative research focused on management recommendations. An evidence-based practitioner must also understand the patient's circumstances or predicament; identify knowledge gaps and frame questions to fill those gaps; conduct an efficient literature search; critically appraise the research evidence; and apply that evidence to patient care. However, treatment judgments often reflect clinician or societal values concerning whether intervention benefits are worth the cost. Many unanswered questions concerning how to elicit preferences and how to incorporate them in clinical encounters constitute an enormously challenging frontier for evidence-based medicine. Time limitation remains the biggest obstacle to evidence-based practice but clinicians should seek evidence from as high in the appropriate hierarchy of evidence as possible, and every clinical decision should be geared toward the particular circumstances of the patient.	McMaster Univ, Fac Hlth Sci, Dept Clin Epidemiol & Biostat, Hamilton, ON L8N 3Z5, Canada; McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada; Univ Toronto, Fac Med, Dept Med, Toronto, ON, Canada; Univ Toronto, Fac Med, Off Dean, Toronto, ON, Canada; Univ Michigan, Dept Family Med, Ann Arbor, MI 48109 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Med, Winston Salem, NC USA; Univ Texas, Hlth Sci Ctr, S Texas Vet Hlth Care Syst & Med, Dept Ambulatory Care, San Antonio, TX USA; Univ Texas, Hlth Sci Ctr, S Texas Vet Hlth Care Syst & Med, Dept Res, San Antonio, TX USA	McMaster University; McMaster University; University of Toronto; University of Toronto; University of Michigan System; University of Michigan; Wake Forest University; Wake Forest Baptist Medical Center; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Guyatt, GH (corresponding author), McMaster Univ, Fac Hlth Sci, Dept Clin Epidemiol & Biostat, Room 2C12,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.			Haynes, Robert Brian/0000-0002-1453-3196				Califf RM, 1997, AM HEART J, V134, P44, DOI 10.1016/S0002-8703(97)70105-4; Dans AL, 1998, JAMA-J AM MED ASSOC, V279, P545, DOI 10.1001/jama.279.7.545; Drummond MF, 1997, JAMA-J AM MED ASSOC, V277, P1552, DOI 10.1001/jama.277.19.1552; FEENY D, 1995, PHARMACOECONOMICS, V7, P490, DOI 10.2165/00019053-199507060-00004; Greenhalgh T, 1999, BRIT MED J, V318, P48; Greenhalgh T, 1999, BMJ-BRIT MED J, V318, P323, DOI 10.1136/bmj.318.7179.323; GUYAT GH, 1993, JAMA-J AM MED ASSOC, V270, P2096, DOI 10.1001/jama.270.17.2096; GUYATT G, 1992, JAMA-J AM MED ASSOC, V268, P2420, DOI 10.1001/jama.1992.03490170092032; GUYATT G, 1986, NEW ENGL J MED, V314, P889, DOI 10.1056/NEJM198604033141406; Guyatt GH, 2000, J CLIN EPIDEMIOL, V53, P167, DOI 10.1016/S0895-4356(99)00160-2; Guyatt GH, 1999, JAMA-J AM MED ASSOC, V281, P1836, DOI 10.1001/jama.281.19.1836; GUYATT GH, 1990, ANN INTERN MED, V112, P293, DOI 10.7326/0003-4819-112-4-293; GUYATT GH, 1995, JAMA-J AM MED ASSOC, V274, P1800, DOI 10.1001/jama.274.22.1800; GUYATT GH, 1994, JAMA-J AM MED ASSOC, V271, P59, DOI 10.1001/jama.271.1.59; GUYATT GH, 1993, JAMA-J AM MED ASSOC, V270, P2598, DOI 10.1001/jama.270.21.2598; GUYATT GH, 2000, BRIT MED J, V320, P945; Hampton JR, 1997, LANCET, V349, P971, DOI 10.1016/S0140-6736(96)10488-8; Haynes R B, 1996, ACP J Club, V125, pA14; Haynes R B, 1997, ACP J Club, V126, pA14; HAYWARD RSA, 1995, JAMA-J AM MED ASSOC, V274, P570, DOI 10.1001/jama.274.7.570; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Hunt DL, 2000, JAMA-J AM MED ASSOC, V283, P1875, DOI 10.1001/jama.283.14.1875; Hunt DL, 1998, JAMA-J AM MED ASSOC, V280, P1339, DOI 10.1001/jama.280.15.1339; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Kunz R, 1998, BRIT MED J, V317, P1185, DOI 10.1136/bmj.317.7167.1185; LARSON EB, 1993, JAMA-J AM MED ASSOC, V270, P2708, DOI 10.1001/jama.270.22.2708; Lechat P, 1999, LANCET, V353, P9; LEVINE M, 1994, JAMA-J AM MED ASSOC, V271, P1615, DOI 10.1001/jama.271.20.1615; Mahon J, 1996, BRIT MED J, V312, P1069; McAlister FA, 2000, JAMA-J AM MED ASSOC, V283, P2829, DOI 10.1001/jama.283.21.2829; Nisbett R., 1980, HUMAN INFERENCE; O'Connor AM, 1999, BRIT MED J, V319, P731, DOI 10.1136/bmj.319.7212.731; OBrien BJ, 1997, JAMA-J AM MED ASSOC, V277, P1802; OXMAN AD, 1994, JAMA-J AM MED ASSOC, V272, P1367, DOI 10.1001/jama.272.17.1367; Rapola JM, 1997, LANCET, V349, P1715, DOI 10.1016/S0140-6736(97)01234-8; RICHARDSON WS, 1995, JAMA-J AM MED ASSOC, V273, P1610, DOI 10.1001/jama.273.20.1610; RICHARDSON WS, 1995, JAMA-J AM MED ASSOC, V273, P1292, DOI 10.1001/jama.273.16.1292; SACKETT DL, 1992, JAMA-J AM MED ASSOC, V267, P2638, DOI 10.1001/jama.267.19.2638; Shaneyfelt TM, 1999, JAMA-J AM MED ASSOC, V281, P1900, DOI 10.1001/jama.281.20.1900; SUTHERLAND HJ, 1989, J ROY SOC MED, V82, P260, DOI 10.1177/014107688908200506; Takala J, 1999, NEW ENGL J MED, V341, P785, DOI 10.1056/NEJM199909093411102; WILSON MC, 1995, JAMA-J AM MED ASSOC, V274, P1630, DOI 10.1001/jama.274.20.1630	42	488	507	0	31	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 13	2000	284	10					1290	1296		10.1001/jama.284.10.1290	http://dx.doi.org/10.1001/jama.284.10.1290			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	350WL	10979117				2022-12-24	WOS:000089124600037
J	Akoulitchev, S; Chuikov, S; Reinberg, D				Akoulitchev, S; Chuikov, S; Reinberg, D			TFIIH is negatively regulated by cdk8-containing mediator complexes	NATURE			English	Article							RNA-POLYMERASE-II; TRANSCRIPTIONAL ACTIVATION; KINASE-ACTIVITY; PHOSPHORYLATION; CDK7; CTD; SRB; E1A; CAK	The mammalian cyclin-dependent kinase 8 (cdk8)(1) gene has been linked with a subset of acute lymphoblastic leukaemias(2), and its corresponding protein has been functionally implicated in regulation of transcription(3,4). Mammalian cdk8 and cyclin C, and their respective yeast homologues, Srb10 and Srb11, are components of the RNA polymerase II holoenzyme complex(5,6) where they function as a protein kinase that phosphorylates the carboxyterminal domain (CTD) of the largest subunit of RNA polymerase II (ref. 7). The yeast SRB10 and SRB11 genes have been implicated in the negative regulation of transcription(8). The cdk8/cyclin C protein complex is also found in a number of mammalian Mediator-like protein complexes(3,5,9-12), which repress activated transcription independently of the CTD in vitro(9,10). Here we show that cdk8/cyclin C can regulate transcription by targeting the cdk7/cyclin H subunits of the general transcription initiation factor IIH (TFIIH). cdk8 phosphorylates mammalian cyclin H in the vicinity of its functionally unique amino-terminal and carboxy-terminal alpha-helical domains(13). This phosphorylation represses both the ability of TFIIH to activate transcription and its CTD kinase activity. In addition, mimicking cdk8 phosphorylation of cyclin H in vivo has a dominant-negative effect on cell growth. Our results link the Mediator complex and the basal transcription machinery by a regulatory pathway involving two cyclin-dependent kinases. This pathway appears to be unique to higher organisms.	Robert Wood Johnson Med Sch, Howard Hughes Med Inst, Dept Biochem, Div Nucl Acids Enzymol, Piscataway, NJ 08854 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University Medical Center	Reinberg, D (corresponding author), Robert Wood Johnson Med Sch, Howard Hughes Med Inst, Dept Biochem, Div Nucl Acids Enzymol, Piscataway, NJ 08854 USA.	reinbedf@umdnj.edu		Reinberg, Danny/0000-0003-4288-2016				Akoulitchev S, 1998, GENE DEV, V12, P3541, DOI 10.1101/gad.12.22.3541; Andersen G, 1997, EMBO J, V16, P958, DOI 10.1093/emboj/16.5.958; Boyer TG, 1999, NATURE, V399, P276, DOI 10.1038/20466; Carlson M, 1997, ANNU REV CELL DEV BI, V13, P1, DOI 10.1146/annurev.cellbio.13.1.1; DESAI D, 1995, MOL CELL BIOL, V15, P345, DOI 10.1128/MCB.15.1.345; GE H, 1994, P NATL ACAD SCI USA, V91, P12691, DOI 10.1073/pnas.91.26.12691; Gold MO, 1996, NUCLEIC ACIDS RES, V24, P3771, DOI 10.1093/nar/24.19.3771; Gould K.L., 1994, PROTEIN KINASES, P149; Gu W, 1999, MOL CELL, V3, P97, DOI 10.1016/S1097-2765(00)80178-1; Hampsey M, 1999, CURR OPIN GENET DEV, V9, P132, DOI 10.1016/S0959-437X(99)80020-3; Harper JW, 1998, GENE DEV, V12, P285, DOI 10.1101/gad.12.3.285; HAUER CA, 1989, NUCLEIC ACIDS RES, V17, P1989, DOI 10.1093/nar/17.5.1989; Hengartner CJ, 1998, MOL CELL, V2, P43, DOI 10.1016/S1097-2765(00)80112-4; Kazmi MA, 1996, BIOTECHNIQUES, V21, P304; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Kong M, 2000, EMBO J, V19, P1378, DOI 10.1093/emboj/19.6.1378; LeRoy G, 1998, J BIOL CHEM, V273, P7134, DOI 10.1074/jbc.273.12.7134; Li HM, 1996, GENOMICS, V32, P253, DOI 10.1006/geno.1996.0112; LIAO SM, 1995, NATURE, V374, P193, DOI 10.1038/374193a0; Long JJ, 1998, MOL CELL BIOL, V18, P1467, DOI 10.1128/MCB.18.3.1467; Maldonado E, 1996, NATURE, V381, P86, DOI 10.1038/381086a0; Naar AM, 1999, NATURE, V398, P828, DOI 10.1038/19789; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; PARVIN JD, 1993, CELL, V73, P533, DOI 10.1016/0092-8674(93)90140-L; Rachez C, 1999, NATURE, V398, P824, DOI 10.1038/19783; Rickert P, 1996, ONCOGENE, V12, P2631; Ryu SJ, 1999, NATURE, V397, P446, DOI 10.1038/17141; Sun XQ, 1998, MOL CELL, V2, P213, DOI 10.1016/S1097-2765(00)80131-8; TASSAN JP, 1995, P NATL ACAD SCI USA, V92, P8871, DOI 10.1073/pnas.92.19.8871	29	290	309	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 7	2000	407	6800					102	106		10.1038/35024111	http://dx.doi.org/10.1038/35024111			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	350WE	10993082				2022-12-24	WOS:000089124000051
J	Kyrle, PA; Minar, E; Hirschl, M; Bialonczyk, C; Stain, M; Schneider, B; Weltermann, A; Speiser, W; Lechner, K; Eichinger, S				Kyrle, PA; Minar, E; Hirschl, M; Bialonczyk, C; Stain, M; Schneider, B; Weltermann, A; Speiser, W; Lechner, K; Eichinger, S			High plasma levels of factor VIII and the risk of recurrent venous thromboembolism.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ORAL ANTICOAGULANT-THERAPY; FACTOR-V-LEIDEN; PROTHROMBIN GENE; FIRST EPISODE; PROTEIN-C; THROMBOSIS; THROMBOPHILIA; FIBRINOGEN; PREVALENCE; MUTATION	Background: A high plasma level of factor VIII is a risk factor for venous thromboembolism. We evaluated the risk of a recurrence of thrombosis after an initial episode of spontaneous venous thromboembolism among patients with high plasma levels of factor VIII. Methods: We studied 360 patients for an average follow-up period of 30 months after a first episode of venous thromboembolism and discontinuation of oral anticoagulants. Patients who had recurrent or secondary venous thromboembolism, a congenital deficiency of an anticoagulant, the lupus anticoagulant, hyperhomocysteinemia, cancer, or a requirement for long-term treatment with antithrombotic drugs or who were pregnant were excluded. The end point was objectively documented, symptomatic recurrent venous thromboembolism. Results: Recurrent venous thromboembolism developed in 38 of the 360 patients (10.6 percent). Patients with recurrence had higher mean (+/-SD) plasma levels of factor VIII than those without recurrence (182+/-66 vs. 157+/-54 IU per deciliter, P=0.009). The relative risk of recurrent venous thrombosis was 1.08 (95 percent confidence interval, 1.04 to 1.12; P<0.001) for each increase of 10 IU per deciliter in the plasma level of factor VIII. Among patients with a factor VIII level above the 90th percentile of the values in the study population, the likelihood of recurrence at two years was 37 percent, as compared with a 5 percent likelihood among patients with lower levels (P<0.001). Among patients with plasma factor VIII levels above the 90th percentile, as compared with those with lower levels, the overall relative risk of recurrence was 6.7 (95 percent confidence interval, 3.0 to 14.8) after adjustment for age, sex, the presence or absence of factor V Leiden or the G20210A prothrombin mutation, and the duration of oral anticoagulation. Conclusions: Patients with a high plasma level of factor VIII have an increased risk of recurrent venous thromboembolism. (N Engl J Med 2000;343:457-62.) (C)2000, Massachusetts Medical Society.	Univ Hosp Vienna, Dept Internal Med 1, Div Hematol & Hemostasis, Vienna, Austria; Univ Hosp Vienna, Dept Internal Med 2, Div Angiol, Vienna, Austria; Univ Hosp Vienna, Dept Med Stat, Vienna, Austria; Univ Hosp Vienna, Clin Inst Med & Chem Lab Diagnost, Vienna, Austria; Hanuschkrankenhaus, Vienna, Austria; Wilhelminenspital Stadt Wien, Vienna, Austria	University Hospital Vienna; University Hospital Vienna; University Hospital Vienna; University Hospital Vienna; WGKK - Hanusch Hospital; Wilhelminenspital	Kyrle, PA (corresponding author), Allgemeines Krankenhaus Wien, Innere Med Klin 1, Abt Hamatol & Hamostaseol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	paul.kyrle@akh-wien.ac.at						BALLEISEN L, 1985, THROMB HAEMOSTASIS, V54, P475; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; BRANDT JT, 1995, THROMB HAEMOSTASIS, V74, P1185; De Stefano V, 1999, NEW ENGL J MED, V341, P801, DOI 10.1056/NEJM199909093411104; Douketis JD, 1998, JAMA-J AM MED ASSOC, V279, P458, DOI 10.1001/jama.279.6.458; Eichinger S, 1997, THROMB HAEMOSTASIS, V77, P624; Eichinger S, 1999, THROMB HAEMOSTASIS, V81, P14; Eichinger S, 1998, THROMB HAEMOSTASIS, V80, P566; Kalbfleisch JD, 1980, STAT ANAL FAILURE TI; Kamphuisen PW, 1999, THROMB HAEMOSTASIS, V81, P680, DOI 10.1055/s-0037-1614553; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kearon C, 1999, NEW ENGL J MED, V341, P298; Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201; KHAMASHTA MA, 1995, NEW ENGL J MED, V332, P993, DOI 10.1056/NEJM199504133321504; KOSTER T, 1995, LANCET, V345, P152, DOI 10.1016/S0140-6736(95)90166-3; Kraaijenhagen RA, 2000, THROMB HAEMOSTASIS, V83, P5; Levine MN, 1998, CHEST, V114, p511S, DOI 10.1378/chest.114.5_Supplement.511S; Lindmarker P, 1999, THROMB HAEMOSTASIS, V81, P684; O'Donnell J, 2000, THROMB HAEMOSTASIS, V83, P10; ODonnell J, 1997, THROMB HAEMOSTASIS, V77, P825; PABINGER I, 1992, BLOOD COAGUL FIBRIN, V3, P547, DOI 10.1097/00001721-199210000-00005; Palareti G, 1996, LANCET, V348, P423, DOI 10.1016/S0140-6736(96)01109-9; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; Schulman S, 1997, NEW ENGL J MED, V336, P393, DOI 10.1056/NEJM199702063360601; SCHULMAN S, 1995, NEW ENGL J MED, V332, P1661, DOI 10.1056/NEJM199506223322501; vandenBelt AGM, 1997, ARCH INTERN MED, V157, P2227, DOI 10.1001/archinte.157.19.2227; vanderMeer FJM, 1996, THROMB HAEMOSTASIS, V76, P12; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753	29	555	567	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 17	2000	343	7					457	462		10.1056/NEJM200008173430702	http://dx.doi.org/10.1056/NEJM200008173430702			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344FC	10950667				2022-12-24	WOS:000088747700002
J	Sinha, AA				Sinha, AA			How do we measure up?	LANCET			English	Editorial Material									Cornell Univ, Weill Med Coll, Dept Dermatol, New York, NY 10021 USA	Cornell University	Sinha, AA (corresponding author), Cornell Univ, Weill Med Coll, Dept Dermatol, New York, NY 10021 USA.							CAZENAVE PLA, 1852, ANN MALAD PEAU SYPH, V4, P113; Parodi A, 2000, BRIT J DERMATOL, V142, P457, DOI 10.1046/j.1365-2133.2000.03356.x; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101	3	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 5	2000	356	9228					448	448		10.1016/S0140-6736(00)02550-2	http://dx.doi.org/10.1016/S0140-6736(00)02550-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342QY	10981886				2022-12-24	WOS:000088657700007
J	Banfield, JF; Welch, SA; Zhang, HZ; Ebert, TT; Penn, RL				Banfield, JF; Welch, SA; Zhang, HZ; Ebert, TT; Penn, RL			Aggregation-based crystal growth and microstructure development in natural iron oxyhydroxide biomineralization products	SCIENCE			English	Article							PHASE-STABILITY; NANOCRYSTALLINE TITANIA; ORIENTED ATTACHMENT; FERRIHYDRITE; HYDROLYSIS; FEROXYHITE; MECHANISM; HEMATITE; INSIGHTS; MODEL	Crystals are generally considered to grow by attachment of ions to inorganic surfaces or organic templates. High-resolution transmission electron microscopy of biomineralization products of iron-oxidizing bacteria revealed an alternative coarsening mechanism in which adjacent 2- to 3-nanometer particles aggregate and rotate so their structures adopt parallel orientations in three dimensions. Crystal growth is accomplished by eliminating water molecules at interfaces and forming iron-oxygen bonds. Self-assembly occurs at multiple sites, Leading to a coarser, polycrystalline material. Point defects (from surface-adsorbed impurities), dislocations, and slabs of structurally distinct material are created as a consequence of this growth mechanism and can dramatically impact subsequent reactivity.	Univ Wisconsin, Dept Geol & Geophys, Madison, WI 53706 USA; Divers Scuba, Madison, WI 53705 USA; Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA	University of Wisconsin System; University of Wisconsin Madison; Johns Hopkins University	Banfield, JF (corresponding author), Univ Wisconsin, Dept Geol & Geophys, 1215 W Dayton St, Madison, WI 53706 USA.			Welch, Susan/0000-0002-2890-0065; Banfield, Jill/0000-0001-8203-8771				BAILEY JK, 1993, J COLLOID INTERF SCI, V157, P1, DOI 10.1006/jcis.1993.1150; DRITS VA, 1993, CLAY MINER, V28, P185, DOI 10.1180/claymin.1993.028.2.02; DRITS VA, 1993, CLAY MINER, V28, P209, DOI 10.1180/claymin.1993.028.2.03; Emerson D, 1997, APPL ENVIRON MICROB, V63, P4784, DOI 10.1128/AEM.63.12.4784-4792.1997; Gribb AA, 1997, AM MINERAL, V82, P717, DOI 10.2138/am-1997-7-809; LANGMUIR D, 1971, AM J SCI, V271, P147, DOI 10.2475/ajs.271.2.147; MANCEAU A, 1993, CLAY MINER, V28, P165, DOI 10.1180/claymin.1993.028.2.01; McHale JM, 1997, SCIENCE, V277, P788, DOI 10.1126/science.277.5327.788; Onuma K, 1998, CHEM MATER, V10, P3346, DOI 10.1021/cm980062c; Penn RL, 1999, AM MINERAL, V84, P871, DOI 10.2138/am-1999-5-621; Penn RL, 1998, SCIENCE, V281, P969, DOI 10.1126/science.281.5379.969; Penn RL, 1999, GEOCHIM COSMOCHIM AC, V63, P1549, DOI 10.1016/S0016-7037(99)00037-X; Penn RL, 1998, AM MINERAL, V83, P1077; Privman V, 1999, J COLLOID INTERF SCI, V213, P36, DOI 10.1006/jcis.1999.6106; Pykhteev OY, 1999, RUSS J APPL CHEM+, V72, P9; Schwertmann U, 1999, J COLLOID INTERF SCI, V209, P215, DOI 10.1006/jcis.1998.5899; Zhang HZ, 1998, J MATER CHEM, V8, P2073, DOI 10.1039/a802619j; Zhu HL, 1996, PHIL MAG LETT, V73, P27, DOI 10.1080/095008396181073	18	1515	1566	20	894	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 4	2000	289	5480					751	754		10.1126/science.289.5480.751	http://dx.doi.org/10.1126/science.289.5480.751			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341FZ	10926531				2022-12-24	WOS:000088581500032
J	Schmitz, O; Katayama, M; Williams, SB; Kondo, T; Golden, SS				Schmitz, O; Katayama, M; Williams, SB; Kondo, T; Golden, SS			CikA, a bacteriophytochrome that resets the cyanobacterial circadian clock	SCIENCE			English	Article							GENE-EXPRESSION; PHYTOCHROME; SYSTEM; TRANSCRIPTION; ARABIDOPSIS; PROKARYOTES; SEQUENCES	The circadian oscillator of the cyanobacterium Synechococcus elongatus, Like those in eukaryotes, is entrained by environmental cues. Inactivation of the gene cikA (circadian input kinase) shortens the circadian period of gene expression rhythms in S. elongatus by approximately 2 hours, changes the phasing of a subset of rhythms, and nearly abolishes resetting of phase by a pulse of darkness. The CikA protein sequence reveals that it is a divergent bacterio-phytochrome with characteristic histidine protein kinase motifs and a cryptic response regulator motif. CikA is Likely a key component of a pathway that provides environmental input to the circadian oscillator in S. elongatus.	Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA; Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Texas A&M University System; Texas A&M University College Station; Nagoya University	Golden, SS (corresponding author), Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037040] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM37040] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersson CR, 2000, METHOD ENZYMOL, V305, P527; CLACK T, 1994, PLANT MOL BIOL, V25, P413, DOI 10.1007/BF00043870; Crosthwaite SK, 1997, SCIENCE, V276, P763, DOI 10.1126/science.276.5313.763; Davis SJ, 1999, SCIENCE, V286, P2517, DOI 10.1126/science.286.5449.2517; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; *GENB, AF258464 GENB; *GENB, X53695; Golden S. S., 1994, MOL BIOL CYANOBACTER, P693; GOLDEN SS, 1989, J BACTERIOL, V171, P4707, DOI 10.1128/jb.171.9.4707-4713.1989; Golden SS, 1998, CURR OPIN MICROBIOL, V1, P669, DOI 10.1016/S1369-5274(98)80113-6; HERSHEY HP, 1985, NUCLEIC ACIDS RES, V13, P8543, DOI 10.1093/nar/13.23.8543; Hughes O, 1999, PLANT PHYSIOL, V121, P1059; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Iwasaki H, 2000, CELL, V101, P223, DOI 10.1016/S0092-8674(00)80832-6; Katayama M, 1999, J BACTERIOL, V181, P3516, DOI 10.1128/JB.181.11.3516-3524.1999; Kehoe DM, 1996, SCIENCE, V273, P1409, DOI 10.1126/science.273.5280.1409; KONDO T, 1993, P NATL ACAD SCI USA, V90, P5672, DOI 10.1073/pnas.90.12.5672; KONDO T, 1994, SCIENCE, V266, P1233, DOI 10.1126/science.7973706; LI LM, 1992, J BIOL CHEM, V267, P19204; LIU Y, 1995, GENE DEV, V9, P1469, DOI 10.1101/gad.9.12.1469; OUYANG Y, 1998, THESIS VANDERBILT U; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; RIPPKA M, 1992, CATALOGUE STRAINS; ROIPPKA R, 1983, ANN MICROBIOL PARIS, V134, P21; SCHMITZ O, UNPUB; Smith RF, 1996, GENOME RES, V6, P454, DOI 10.1101/gr.6.5.454; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Stock J.B., 1995, 2 COMPONENT SIGNAL T, P25; Tsinoremas NF, 1996, EMBO J, V15, P2488, DOI 10.1002/j.1460-2075.1996.tb00606.x; VOLZ K, 1995, 2 COMPONENT SIGNAL T, P25; WILMOTTE AMR, 1984, J GEN MICROBIOL, V130, P2737; Wu S., UNPUB; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505	33	200	220	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 4	2000	289	5480					765	768		10.1126/science.289.5480.765	http://dx.doi.org/10.1126/science.289.5480.765			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341FZ	10926536				2022-12-24	WOS:000088581500037
J	Shin, JS; Gao, ZM; Abraham, SN				Shin, JS; Gao, ZM; Abraham, SN			Involvement of cellular caveolae in bacterial entry into mast cells	SCIENCE			English	Article							FACTOR-ALPHA RESPONSE; MEMBRANE; SEQUESTRATION; PURIFICATION; MICRODOMAINS; TRANSPORT; MOLECULES; PROTEINS; COMPLEX	Caveolae are subcellular structures implicated in the import and transcytosis of macromolecules and in transmembrane signaling. To date, evidence for the existence of caveolae in hematopoietic cells has been ambiguous. Caveolae were detected in the microvilli and intracellular vesicles of cultured mouse bone marrow-derived mast cells (BMMCs). CD48, a receptor for FimH-expressing (type 1 fimbriated) Escherichia coli, was specifically Localized to plasmalemmal caveolae in BMMCs, The involvement of caveolae in bacterial entry into BMMCs was indicated because caveolae-disrupting and -usurping agents specifically blocked E, coli entry, and markers of caveolae were actively recruited to sites of bacterial entry. The formation of bacteria-encapsulating caveolar chambers in BMMCs represents a distinct mechanism of microbial entry into phagocytes.	Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Microbiol, Durham, NC 27710 USA	Duke University; Duke University	Shin, JS (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.	abrah006@mc.duke.edu			NCI NIH HHS [CA 14236] Funding Source: Medline; NIAID NIH HHS [AI 35678] Funding Source: Medline; NIDDK NIH HHS [DK 50814] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA014236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI035678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050814, R37DK050814] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABRAHAM SN, 1988, NATURE, V336, P682, DOI 10.1038/336682a0; ANDERSON RGW, 1992, SCIENCE, V255, P410, DOI 10.1126/science.1310359; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Arock M, 1998, INFECT IMMUN, V66, P6030, DOI 10.1128/IAI.66.12.6030-6034.1998; Baorto DM, 1997, NATURE, V389, P636, DOI 10.1038/39376; CHANG WJ, 1994, J CELL BIOL, V126, P127, DOI 10.1083/jcb.126.1.127; CONRAD PA, 1995, J CELL BIOL, V131, P1421, DOI 10.1083/jcb.131.6.1421; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; FIELD KA, 1995, P NATL ACAD SCI USA, V92, P9201, DOI 10.1073/pnas.92.20.9201; FRA AM, 1994, J BIOL CHEM, V269, P30745; GAO Z, UNPUB; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; Malaviya R, 1999, P NATL ACAD SCI USA, V96, P8110, DOI 10.1073/pnas.96.14.8110; MAYOR S, 1994, SCIENCE, V264, P1948, DOI 10.1126/science.7516582; MICHAEL PL, 1995, MOL MEMBR BIOL, V12, P121; MONTESANO R, 1982, NATURE, V296, P651, DOI 10.1038/296651a0; Parton RG, 1996, CURR OPIN CELL BIOL, V8, P542, DOI 10.1016/S0955-0674(96)80033-0; SARGIACOMO M, 1993, J CELL BIOL, V122, P789, DOI 10.1083/jcb.122.4.789; Schlegel A, 1998, CELL SIGNAL, V10, P457, DOI 10.1016/S0898-6568(98)00007-2; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P89, DOI 10.1016/S0962-8924(00)88956-4; TAKASHI O, 1998, J BIOL CHEM, V273, P5419; YAMADA E, 1955, J BIOPHYS BIOCHEM CY, V1, P445, DOI 10.1083/jcb.1.5.445; Yancey PG, 1996, J BIOL CHEM, V271, P16026, DOI 10.1074/jbc.271.27.16026	26	265	275	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2000	289	5480					785	788		10.1126/science.289.5480.785	http://dx.doi.org/10.1126/science.289.5480.785			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341FZ	10926542				2022-12-24	WOS:000088581500043
J	Buggy, D				Buggy, D			Can anaesthetic management influence surgical-wound healing?	LANCET			English	Editorial Material							COLORECTAL-CANCER; OXYGEN-TENSION; INFECTION; RISK		Univ Leicester, Dept Anaesthesia, Leicester LE5 4PW, Leics, England; Leicester Gen Hosp, Leicester NHS Trust, Univ Hosp, Leicester LE5 4PW, Leics, England	University of Leicester; University Hospitals of Leicester NHS Trust; Leicester General Hospital	Buggy, D (corresponding author), Univ Leicester, Dept Anaesthesia, Leicester LE5 4PW, Leics, England.			Buggy, Donal/0000-0003-3922-4397				Akca O, 1999, LANCET, V354, P41, DOI 10.1016/S0140-6736(99)00874-0; Akca O, 1999, ANESTHESIOLOGY, V91, P991, DOI 10.1097/00000542-199910000-00019; Allen DB, 1997, ARCH SURG-CHICAGO, V132, P991; Ballantyne JC, 1998, ANESTH ANALG, V86, P598, DOI 10.1097/00000539-199803000-00032; BREMMELGAARD A, 1989, J HOSP INFECT, V13, P1, DOI 10.1016/0195-6701(89)90090-X; Buggy DJ, 2000, BRIT J ANAESTH, V84, P615, DOI 10.1093/bja/84.5.615; BUSCH ORC, 1993, NEW ENGL J MED, V328, P1372, DOI 10.1056/NEJM199305133281902; Carli F, 1997, ANESTHESIOLOGY, V86, P1033, DOI 10.1097/00000542-199705000-00005; Gannong WF, 1999, REV MED PHYSL; Greif R, 1999, ANESTHESIOLOGY, V91, P1246, DOI 10.1097/00000542-199911000-00014; Greif R, 2000, NEW ENGL J MED, V342, P161, DOI 10.1056/NEJM200001203420303; HEISS MM, 1993, LANCET, V342, P1328, DOI 10.1016/0140-6736(93)92247-Q; Hopf HW, 1997, ARCH SURG-CHICAGO, V132, P997; JONSSON K, 1991, ANN SURG, V214, P605, DOI 10.1097/00000658-199111000-00011; Kurz A, 1996, NEW ENGL J MED, V334, P1209, DOI 10.1056/NEJM199605093341901; McBride WT, 1996, ANAESTHESIA, V51, P465, DOI 10.1111/j.1365-2044.1996.tb07793.x; PROCKOP DJ, 1979, NEW ENGL J MED, V301, P13, DOI 10.1056/NEJM197907053010104; VANOSS CJ, 1980, J RETICULOENDOTH SOC, V27, P561	18	48	50	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 29	2000	356	9227					355	357		10.1016/S0140-6736(00)02523-X	http://dx.doi.org/10.1016/S0140-6736(00)02523-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	339NZ	10972364				2022-12-24	WOS:000088486000004
J	Heller, G; Misselwitz, B; Schmidt, S				Heller, G; Misselwitz, B; Schmidt, S			Early neonatal mortality asphyxia related deaths, and timing of low risk births in Hesse, Germany, 1990-8: observational study	BRITISH MEDICAL JOURNAL			English	Article							INTRAPARTUM		Univ Marburg, Sch Med, Med Ctr Methodol & Hlth Res, Inst Med Sociol & Social Med, D-35033 Marburg, Germany; Univ Marburg, Ctr Gynaecol & Obstet, Dept Obstet, D-35032 Marburg, Germany; Inst Qual Assurance Hesse, D-65760 Eschborn, Germany	Philipps University Marburg; Philipps University Marburg	Heller, G (corresponding author), Univ Marburg, Sch Med, Med Ctr Methodol & Hlth Res, Inst Med Sociol & Social Med, D-35033 Marburg, Germany.							Chalmers JWT, 1998, BRIT MED J, V317, P539; HOFACKER G, 1999, STAAT WIRTSCHAFT HES, V11, P326; KUNZEL W, 1994, EUR J OBSTET GYN R B, V54, P13, DOI 10.1016/0028-2243(94)90075-2; Stewart JH, 1998, BRIT MED J, V316, P657, DOI 10.1136/bmj.316.7132.657	4	60	63	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 29	2000	321	7256					274	275		10.1136/bmj.321.7256.274	http://dx.doi.org/10.1136/bmj.321.7256.274			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341ZA	10915130	Bronze, Green Published			2022-12-24	WOS:000088619800026
J	Kunnas, TA; Laippala, P; Penttila, A; Lehtimaki, T; Karhunen, PK				Kunnas, TA; Laippala, P; Penttila, A; Lehtimaki, T; Karhunen, PK			Association of polymorphism of human a oestrogen receptor gene with coronary artery disease in men: a necropsy study	BRITISH MEDICAL JOURNAL			English	Article									Univ Tampere, Tampere Univ Hosp, Sch Med, Dept Forens Med, FIN-33014 Tampere, Finland; Univ Tampere, Sch Publ Hlth, FIN-33014 Tampere, Finland; Univ Helsinki, Dept Forens Med, FIN-00014 Helsinki, Finland; Univ Tampere, Dept Clin Chem, Lab Atherosclerosis Genet, FIN-33014 Tampere, Finland	Tampere University; Tampere University Hospital; Tampere University; University of Helsinki; Tampere University	Kunnas, TA (corresponding author), Univ Tampere, Tampere Univ Hosp, Sch Med, Dept Forens Med, FIN-33014 Tampere, Finland.		Lehtimäki, Terho/AAD-1094-2022	Lehtimäki, Terho/0000-0002-2555-4427; Kunnas, Tarja/0000-0002-9647-642X				Kunnas TA, 1999, HUM HERED, V49, P142, DOI 10.1159/000022862; LOSORDO DW, 1994, CIRCULATION, V89, P1501, DOI 10.1161/01.CIR.89.4.1501; Matsubara Y, 1997, ARTERIOSCL THROM VAS, V17, P3006, DOI 10.1161/01.ATV.17.11.3006; Mikkelsson J, 1999, ARTERIOSCL THROM VAS, V19, P2573, DOI 10.1161/01.ATV.19.10.2573; SANO M, 1995, BIOCHEM BIOPH RES CO, V217, P378, DOI 10.1006/bbrc.1995.2787	5	71	74	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	JUL 29	2000	321	7256					273	274		10.1136/bmj.321.7256.273	http://dx.doi.org/10.1136/bmj.321.7256.273			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341ZA	10915129	Bronze, Green Published			2022-12-24	WOS:000088619800025
J	Stevenson, IR; Bryant, DM				Stevenson, IR; Bryant, DM			Avian phenology - Climate change and constraints on breeding	NATURE			English	Article							EGG-LAYING TRENDS; GREAT TITS; TEMPERATURE		Univ Stirling, Inst Biol Sci, Stirling FK9 4LA, Scotland	University of Stirling	Stevenson, IR (corresponding author), Univ Stirling, Inst Biol Sci, Stirling FK9 4LA, Scotland.							Both C, 1999, P ROY SOC B-BIOL SCI, V266, P465, DOI 10.1098/rspb.1999.0660; Cramp S., 1977, HDB BIRDS EUROPE MID; Crick HQP, 1999, NATURE, V399, P423, DOI 10.1038/20839; DRENT RH, 1980, ARDEA, V68, P225; Forchhammer MC, 1998, NATURE, V391, P29, DOI 10.1038/34070; HASHIM RB, 1996, THESIS U STIRLING; McCleery RH, 1998, NATURE, V391, P30, DOI 10.1038/34073; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.2307/2334389; Perrins CM, 1996, IBIS, V138, P2, DOI 10.1111/j.1474-919X.1996.tb04308.x; Reiss M.J., 1989, ALLOMETRY GROWTH REP; Speakman J.R., 1997, DOUBLY LABELLED WATE; Tinbergen JM, 2000, J ANIM ECOL, V69, P323, DOI 10.1046/j.1365-2656.2000.00395.x; VANNOORDWIJK AJ, 1995, J ANIM ECOL, V64, P451, DOI 10.2307/5648; Visser ME, 1998, P ROY SOC B-BIOL SCI, V265, P1867, DOI 10.1098/rspb.1998.0514	14	180	183	1	87	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					366	367		10.1038/35019151	http://dx.doi.org/10.1038/35019151			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935624				2022-12-24	WOS:000088383800031
J	Massad, LS				Massad, LS			Missed connections	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		GREGG J, 1994, SOC SCI MED, V39, P519, DOI 10.1016/0277-9536(94)90094-9; Jennings K M, 1997, Oncol Nurs Forum, V24, P827; KLEINMAN A, 1978, ANN INTERN MED, V88, P251, DOI 10.7326/0003-4819-88-2-251; LACEY L, 1993, CANCER, V72, P1078, DOI 10.1002/1097-0142(19930801)72:3+<1078::AID-CNCR2820721323>3.0.CO;2-7	4	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 26	2000	284	4					409	410		10.1001/jama.284.4.409	http://dx.doi.org/10.1001/jama.284.4.409			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335QB	10904482				2022-12-24	WOS:000088254200001
J	Sidebottom, C; Buckley, S; Pudney, P; Twigg, S; Jarman, C; Holt, C; Telford, J; McArthur, A; Worrall, D; Hubbard, R; Lillford, P				Sidebottom, C; Buckley, S; Pudney, P; Twigg, S; Jarman, C; Holt, C; Telford, J; McArthur, A; Worrall, D; Hubbard, R; Lillford, P			Phytochemistry - Heat-stable antifreeze protein from grass	NATURE			English	Article							ICE; RECRYSTALLIZATION; MECHANISM		Unilever Res, Colworth House, Sharnbrook MK44 1LQ, Beds, England; Univ York, Dept Biol, Plant Lab, York YO1 5YW, N Yorkshire, England	Unilever; University of York - UK	Sidebottom, C (corresponding author), Unilever Res, Colworth House, Sharnbrook MK44 1LQ, Beds, England.	Chris.Sidebottom@unilever.com	pudney, paul/R-6733-2019	Worrall, Dawn/0000-0002-9062-7987				ARRONDO JLR, 1988, BIOCHIM BIOPHYS ACTA, V952, P261, DOI 10.1016/0167-4838(88)90125-2; Duman John G., 1993, Advances in Low-Temperature Biology, V2, P131; FEENEY RE, 1993, FOOD TECHNOL-CHICAGO, V47, P82; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Graham LA, 1997, NATURE, V388, P727, DOI 10.1038/41908; GUY CL, 1990, ANNU REV PLANT PHYS, V41, P187, DOI 10.1146/annurev.pp.41.060190.001155; Hall DG, 1999, LANGMUIR, V15, P1905, DOI 10.1021/la980657m; KNIGHT CA, 1984, NATURE, V308, P295, DOI 10.1038/308295a0; KNIGHT CA, 1991, BIOPHYS J, V59, P409, DOI 10.1016/S0006-3495(91)82234-2; Li N, 1998, J EXP BIOL, V201, P2243; Li N, 1998, ARCH BIOCHEM BIOPHYS, V360, P25, DOI 10.1006/abbi.1998.0930; Thomashow M. F., 1990, Advances in Genetics, V28, P99; Worrall D, 1998, SCIENCE, V282, P115, DOI 10.1126/science.282.5386.115	13	207	243	2	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2000	406	6793					256	256		10.1038/35018639	http://dx.doi.org/10.1038/35018639			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917518				2022-12-24	WOS:000088251900036
J	von Dassow, G; Meir, E; Munro, EM; Odell, GM				von Dassow, G; Meir, E; Munro, EM; Odell, GM			The segment polarity network is a robust developmental module	NATURE			English	Article							CUBITUS-INTERRUPTUS PROTEIN; FUSHI-TARAZU; EMBRYONIC EXPRESSION; GENE-EXPRESSION; DROSOPHILA; PATTERN; CONSERVATION; EVOLUTION; TARGET; CELLS	All insects possess homologous segments, but segment specification differs radically among insect orders. In Drosophila, maternal morphogens control the patterned activation of gap genes, which encode transcriptional regulators that shape the patterned expression of pair-rule genes. This patterning cascade takes place before cellularization. Pair-rule gene products subsequently 'imprint' segment polarity genes with reiterated patterns, thus defining the primordial segments. This mechanism must be greatly modified in insect groups in which many segments emerge only after cellularization(1). In beetles,and parasitic wasps, for instance, pair-rule homologues are expressed in patterns consistent with roles during segmentation, but these patterns emerge within cellular fields(2-4). In contrast, although in locusts pair-rule homologues may not control segmentation(5,6), some segment polarity genes and their interactions are conserved(3,7-10). Perhaps segmentation is modular, with each module autonomously expressing a characteristic intrinsic behaviour in response to transient stimuli. If so, evolution could rearrange inputs to modules without changing their intrinsic behaviours. Here we suggest, using computer simulations, that the Drosophila segment polarity genes constitute such a module, and that this module is resistant to variations in the kinetic constants that govern its behaviour.	Univ Washington, Dept Zool, Box 351800, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	von Dassow, G (corresponding author), Univ Washington, Dept Zool, Box 351800, Seattle, WA 98195 USA.	dassow@u.washington.edu		Meir, Eli/0000-0002-1874-1750				AKAM M, 1987, DEVELOPMENT, V101, P1; Alexandre C, 1996, GENE DEV, V10, P2003, DOI 10.1101/gad.10.16.2003; ARIAS AM, 1988, DEVELOPMENT, V103, P157; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; BROWN SJ, 1994, DEV GENET, V15, P7, DOI 10.1002/dvg.1020150103; BROWN SJ, 1994, P NATL ACAD SCI USA, V91, P12922, DOI 10.1073/pnas.91.26.12922; Brown SJ, 1997, MECH DEVELOP, V61, P165, DOI 10.1016/S0925-4773(96)00642-9; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; DAWES R, 1994, DEVELOPMENT, V120, P1561; DINARDO S, 1994, CURR OPIN GENET DEV, V4, P529, DOI 10.1016/0959-437X(94)90068-E; DINARDO S, 1988, NATURE, V332, P604, DOI 10.1038/332604a0; Dominguez M, 1996, SCIENCE, V272, P1621, DOI 10.1126/science.272.5268.1621; Grbic M, 1996, DEVELOPMENT, V122, P795; HEEMSKERK J, 1991, NATURE, V352, P404, DOI 10.1038/352404a0; HOOPER JE, 1994, NATURE, V372, P461, DOI 10.1038/372461a0; INGHAM PW, 1988, NATURE, V331, P73, DOI 10.1038/331073a0; Kauffman S. A., 1993, ORIGINS ORDER SELF O; Morton-Firth CJ, 1999, J MOL BIOL, V286, P1059, DOI 10.1006/jmbi.1999.2535; NAGY LM, 1994, NATURE, V367, P460, DOI 10.1038/367460a0; Oppenheimer DI, 1999, CURR BIOL, V9, P1288, DOI 10.1016/S0960-9822(00)80050-0; PATEL NH, 1994, DEVELOPMENT, P201; PATEL NH, 1989, DEVELOPMENT, V107, P201; PATEL NH, 1992, NATURE, V357, P339, DOI 10.1038/357339a0; Sanchez L, 1997, J THEOR BIOL, V189, P377, DOI 10.1006/jtbi.1997.0523; SCHWARTZ C, 1995, DEVELOPMENT, V121, P1625; Slack JMW, 1983, EGG EMBRYO DETERMINA; TABATA T, 1992, GENE DEV, V6, P2635, DOI 10.1101/gad.6.12b.2635; VINCENT JP, 1994, CELL, V77, P909, DOI 10.1016/0092-8674(94)90139-2; VonOhlen T, 1997, P NATL ACAD SCI USA, V94, P2404, DOI 10.1073/pnas.94.6.2404	30	821	854	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2000	406	6792					188	192		10.1038/35018085	http://dx.doi.org/10.1038/35018085			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910359				2022-12-24	WOS:000088221100049
J	Parmanum, J; Field, D; Rennie, J; Steer, P				Parmanum, J; Field, D; Rennie, J; Steer, P		Brit Assoc Perinatal Med	National census of availability of neonatal intensive care	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COTS	Objective To determine whether availability of neonatal intensive care cots is a problem in any or all parts of the United Kingdom. Design Three month census fi-om 1 April to 30 June 1999 comprising simple data sheets on transfers out of tertiary units. Setting The 37 largest high risk perinatal centres in the United Kingdom. Participants One obstetric specialist and one neonatal specialist in each centre. Main outcome measures Suboptimal care resulting directly from pressure on service-that is, transfers out of tertiary units (either in utero or after delivery) because the unit was "full" and not because the hospital was incapable of providing the care needed. Results All units provided data. The number of intensive care cots in each unit was between five and 16. During the three months 309 transfers occurred (equivalent to 1236 per year), of which 264 were in utero and 45 postnatal. Sixty five in utero transfers involved multiple births, hence the census related to 382 babies (1528 per year). There was considerable regional variation. The reason for transfer in most cases was "lack of neonatal beds". Conclusions Currently most major perinatal centres in the United Kingdom are regularly unable to meet in-house demand; this has implications for the service as a whole. The NHS has set no standards to help health authorities and primary care groups develop services relating to this specialty; such a step may well be an appropriate lever for change.	Univ Leicester, Dept Child Hlth, Leicester LE2 7LX, Leics, England; Kings Coll Hosp London, London SE5 9RS, England; Imperial Coll Sch Med, London W2 1PG, England	University of Leicester; King's College Hospital NHS Foundation Trust; King's College Hospital; Imperial College London	Field, D (corresponding author), Univ Leicester, Dept Child Hlth, Robert Kilpatrick Clin Sci Bldg, Leicester LE2 7LX, Leics, England.	dfield@lri.org.uk						BURTON P, 1995, J EPIDEMIOL PUBLIC H, V48, P617; *CLIN STAND ADV GR, 1993, ACC AV NEON INT CAR; *DEP EP PUBL HLTH, 1999, TRENT NEON SURV 1998; Field D, 1999, ARCH DIS CHILD-FETAL, V80, pF111, DOI 10.1136/fn.80.2.F111; FIELD DJ, 1989, BRIT MED J, V299, P1305, DOI 10.1136/bmj.299.6711.1305; MCINTOSH N, 1989, BRIT MED J, V298, P169; MCLOUGHLIN A, 1993, ARCH DIS CHILD-FETAL, V68, P597, DOI 10.1136/adc.68.5_Spec_No.597; Milligan DWA, 1997, ARCH DIS CHILD-FETAL, V76, pF197, DOI 10.1136/fn.76.3.F197; MORRIS D, 1993, ARCH DIS CHILD-FETAL, V68, P544; National Association of Health Authorities, 1993, REINV HLTH CAR NEW M; *ROYAL COLL PHYS, 1988, MED CAR NEWB ENGL WA; SIMPSON H, 1981, ARCH DIS CHILD, V56, P90, DOI 10.1136/adc.56.2.90; 1999, TIMES           0803	13	39	40	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 23	2000	321	7263					727	729		10.1136/bmj.321.7263.727	http://dx.doi.org/10.1136/bmj.321.7263.727			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FE	10999901	Green Published, Bronze			2022-12-24	WOS:000089546600018
J	Hujoel, PP; Drangsholt, M; Spiekerman, C; DeRouen, TA				Hujoel, PP; Drangsholt, M; Spiekerman, C; DeRouen, TA			Periodontal disease and coronary heart disease risk	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; DENTAL DISEASE; CARDIOVASCULAR-DISEASE; INFECTION; HEALTH; ATHEROSCLEROSIS; INFORMATION; MORTALITY; PATHOGENS; INVASION	Context Research has suggested a relationship between periodontal disease and coronary heart disease (CHD), but data on the association between these 2 common conditions are inconclusive due to the possibility of confounding. Objective To evaluate the risk of CHD in persons with periodontitis, gingivitis, or no periodontal disease. Design Prospective cohort study. Setting The First National Health and Nutrition Examination Survey Epidemiologic Follow-up Study, conducted in 1982-1984, 1986, 1987, and 1992. Participants A total of 8032 dentate adults aged 25 to 74 years with no reported history of cardiovascular disease, including 1859 individuals with periodontitis, 2421 with gingivitis, and 3752 with healthy periodontal tissues. Main Outcome Measure First occurrence of death from CHD or hospitalization due to CHD, or revascularization procedures, obtained from death certificates and medical records, by baseline periodontal status. Results During follow-up, 1265 individuals had at least 1 CHD event, including CHD fatality (n=468) or at least 1 hospitalization with a diagnosis of CHD (n=1022), including coronary revascularization procedures (n=155). After adjustment for known cardiovascular risk factors, gingivitis was not associated with CHD (hazard ratio, 1.05; 95% confidence interval. 0.88-1.26), while periodontitis was associated with a nonsignificant increased risk for CHD event (hazard ratio, 1.14; 95% confidence interval, 0.96-1.36). Conclusion This study did not find convincing evidence of a causal association be tween periodontal disease and CHD risk.	Univ Washington, Sch Dent, Dept Dent Publ Hlth Sci, Seattle, WA 98195 USA; Univ Washington, Sch Publ Hlth, Dept Epidemiol, Seattle, WA 98195 USA; Univ Washington, Sch Dent, Dept Oral Med, Seattle, WA 98195 USA; Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA; Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Hujoel, PP (corresponding author), Univ Washington, Sch Dent, Dept Dent Publ Hlth Sci, Box 357475, Seattle, WA 98195 USA.			Hujoel, Philippe/0000-0002-4040-104X	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R29DE012190, P30DE009743] Funding Source: NIH RePORTER; NIDCR NIH HHS [P30-DE09743, R29-DE12190] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Albandar JM, 1999, J PERIODONTOL, V70, P30, DOI 10.1902/jop.1999.70.1.30; Beck J, 1996, J PERIODONTOL, V67, P1123, DOI 10.1902/jop.1996.67.10s.1123; Beck J D, 1998, Ann Periodontol, V3, P127, DOI 10.1902/annals.1998.3.1.127; Breslow RA, 1999, ANN EPIDEMIOL, V9, P254, DOI 10.1016/S1047-2797(98)00071-4; Christen WG, 1998, CIRCULATION, V97, P821; Danesh J, 1999, AM HEART J, V138, pS434, DOI 10.1016/S0002-8703(99)70270-X; Danesh J, 1997, LANCET, V350, P430, DOI 10.1016/S0140-6736(97)03079-1; Deshpande RG, 1998, INFECT IMMUN, V66, P5337, DOI 10.1128/IAI.66.11.5337-5343.1998; DESTEFANO F, 1993, BRIT MED J, V306, P688, DOI 10.1136/bmj.306.6879.688; Dorn BR, 1999, INFECT IMMUN, V67, P5792, DOI 10.1128/IAI.67.11.5792-5798.1999; Graubard BL, 1999, JNCI-J NATL CANCER I, V91, P1005, DOI 10.1093/jnci/91.12.1005; Herzberg M C, 1998, Ann Periodontol, V3, P151, DOI 10.1902/annals.1998.3.1.151; Herzberg MC, 1996, J PERIODONTOL, V67, P1138, DOI 10.1902/jop.1996.67.10s.1138; Joshipura K J, 1998, Ann Periodontol, V3, P175, DOI 10.1902/annals.1998.3.1.175; Joshipura KJ, 1996, J DENT RES, V75, P1631, DOI 10.1177/00220345960750090301; KISH L, 1974, J ROY STAT SOC B MET, V36, P1; KORN EL, 1991, AM J PUBLIC HEALTH, V81, P1166, DOI 10.2105/AJPH.81.9.1166; KRONMAL RA, 1993, J ROY STAT SOC A STA, V156, P379, DOI 10.2307/2983064; KWEIDER M, 1993, SCOT MED J, V38, P73, DOI 10.1177/003693309303800304; MACHLIN SR, 1989, STAT MED, V8, P997, DOI 10.1002/sim.4780080810; MACLURE M, 1990, INT J EPIDEMIOL, V19, P782, DOI 10.1093/ije/19.4.782; MATTILA KJ, 1993, EUR HEART J, V14, P51; MATTILA KJ, 1989, BRIT MED J, V298, P779, DOI 10.1136/bmj.298.6676.779; Mattila KJ, 1998, CLIN INFECT DIS, V26, P719, DOI 10.1086/514570; MCLAUGHLIN JK, 1987, AM J EPIDEMIOL, V126, P144, DOI 10.1093/oxfordjournals.aje.a114647; Meyer DH, 1998, CURR OPIN MICROBIOL, V1, P88, DOI 10.1016/S1369-5274(98)80147-1; Morrison HI, 1999, J CARDIOVASC RISK, V6, P7; Newman HN, 1998, INT DENT J, V48, P173, DOI 10.1111/j.1875-595X.1998.tb00474.x; RUSSELL A. L., 1956, JOUR DENTAL RES, V35, P350, DOI 10.1177/00220345560350030401; Shah BV, 1997, SUDAAN USERS MANUAL; Slavkin HC, 1999, J AM DENT ASSOC, V130, P109, DOI 10.14219/jada.archive.1999.0038; Slots J, 1998, J DENT RES, V77, P1764, DOI 10.1177/00220345980770100101; VALTONEN VV, 1991, ANN MED, V23, P539, DOI 10.3109/07853899109150515; WU T, 1999, CIRCULATION, V99, P8	34	293	301	0	22	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2000	284	11					1406	1410		10.1001/jama.284.11.1406	http://dx.doi.org/10.1001/jama.284.11.1406			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	352WN	10989403	Bronze			2022-12-24	WOS:000089242500035
J	Reynolds, T				Reynolds, T			The ethics of placebo-controlled trials	ANNALS OF INTERNAL MEDICINE			English	News Item																			0	10	11	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 19	2000	133	6					491	492		10.7326/0003-4819-133-6-200009190-00103	http://dx.doi.org/10.7326/0003-4819-133-6-200009190-00103			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354KM	10975985				2022-12-24	WOS:000089329700024
J	Blanks, RG; Moss, SM; McGahan, CE; Quinn, MJ; Babb, PJ				Blanks, RG; Moss, SM; McGahan, CE; Quinn, MJ; Babb, PJ			Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality	BRITISH MEDICAL JOURNAL			English	Article							LONG-TERM SURVIVAL; RATES; AGE	Objective To assess the impact of the NHS breast screening programme on mortality from breast cancer in women aged 55-69 years over the period 1990-8. Design Age cohort model with data for 1971-89 used to predict mortality for 1990-8 with assumption of no major effect from screening or improvements in treatment until after 1989. Effect of screening and other factors on mortality estimated by comparing three year moving averages of observed mortality with those predicted (by five year age groups from 50-54 to 75-79), the effect of screening being restricted to certain age groups. Setting England and Wales. Subjects Women aged 40 to 79 years. Results Compared with predicted mortality in the absence of screening or other effects the total reduction in mortality from breast cancer in 1998 in women aged 55-69 was estimated as 21.3%. Direct effect of screening was estimated as 6.4% (range of estimates from 5.4-11.8%). Effect of all other factors (improved treatment with tamoxifen and chemotherapy, and earlier presentation outside the screening programme) was estimated as 14.9% (range 12.2-14.9%). Conclusions By 1998 both screening and other factors, including improvements in treatment, had resulted in substantial reductions in mortality from breast cancer. Many deaths in the 1990s will be of women diagnosed in the 1980s and early 1990s, before invitation to screening. Further major effects from screening and treatment are expected, which together with cohort effects should result in further substantial reductions in mortality from breast cancer, particularly for women aged 55-69, over die next 10 years.	Inst Canc Res, Canc Screening Evaluat Unit, Epidemiol Sect, Sutton SM2 5NG, Surrey, England; Off Natl Stat, Demog & Hlth Div, London SW1V 2QQ, England	University of London; Institute of Cancer Research - UK	Moss, SM (corresponding author), Inst Canc Res, Canc Screening Evaluat Unit, Epidemiol Sect, Sutton SM2 5NG, Surrey, England.							ABE O, 1992, LANCET, V339, P71; CHOUILLET AM, 1994, BRIT MED J, V308, P168, DOI 10.1136/bmj.308.6922.168; CLAYTON D, 1987, STAT MED, V6, P449, DOI 10.1002/sim.4780060405; COLEMAN MP, 1999, STUDIES MED POULATIO, V61; COLEMAN MP, 1993, SCI PUBLICATIONS, V121; DAY NE, 1989, BRIT J CANCER, V59, P954, DOI 10.1038/bjc.1989.203; Department of Health, 1992, HLTH NAT STRAT HLTH; Department of Health and Welsh Office, 1995, POL FRAM COMM CANC S; DUFFY SW, 1996, LANCET, V346, P852; Forrest APM, 1986, BREAST CANC SCREENIN; LANGLANDS AO, 1979, BRIT MED J, V2, P1247, DOI 10.1136/bmj.2.6200.1247; Moss S, 1998, J EPIDEMIOL COMMUN H, V52, P111, DOI 10.1136/jech.52.2.111; *NHS BREAST SCREEN, 1999, NHS BSP 1999; Peto R, 1996, J NATL CANCER I, V88, P1791, DOI 10.1093/jnci/88.24.1791; QUINN M, 1995, BRIT MED J, V311, P1391, DOI 10.1136/bmj.311.7017.1391; Stockton D, 1997, BRIT MED J, V314, P472, DOI 10.1136/bmj.314.7079.472; TABAR L, 1985, LANCET, V1, P829, DOI 10.1016/S0140-6736(85)92204-4; van den Akker-van Marle E, 1999, J MED SCREEN, V6, P30, DOI 10.1136/jms.6.1.30; Young KC, 1997, BRIT J RADIOL, V70, P482, DOI 10.1259/bjr.70.833.9227229; Zahl PH, 1997, STAT MED, V16, P1435, DOI 10.1002/(SICI)1097-0258(19970715)16:13<1435::AID-SIM570>3.0.CO;2-8	20	257	261	0	16	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	SEP 16	2000	321	7262					665	669		10.1136/bmj.321.7262.665	http://dx.doi.org/10.1136/bmj.321.7262.665			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356LE	10987769	Green Published, Bronze			2022-12-24	WOS:000089444100021
J	Janik, VM				Janik, VM			Whistle matching in wild bottlenose dolphins (Tursiops truncatus)	SCIENCE			English	Article							SIGNATURE WHISTLES; NOSED DOLPHINS; PATTERNS; MIMICRY	Dolphin communication is suspected to be complex, on the basis of their call repertoires, cognitive abilities, and ability to modify signals through vocal Learning. Because of the difficulties involved in observing and recording individual cetaceans, very Little is known about how they use their calls. This report shows that wild, unrestrained bottlenose dolphins use their Learned whistles in matching interactions, in which an individual responds to a whistle of a conspecific by emitting the same whistle type. Vocal matching occurred over distances of up to 580 meters and is indicative of animals addressing each other individually.	Univ Aberdeen, Lighthouse Field Stn, Cromarty IV11 8YJ, Rossshire, Scotland; Univ St Andrews, Sch Biol, St Andrews KY16 9TS, Fife, Scotland	University of Aberdeen; University of St Andrews	Janik, VM (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.							CALDWELL M C, 1969, Mammalia, V33, P505, DOI 10.1515/mamm.1969.33.3.505; Caldwell M.C., 1990, P199; Catchpole C.K., 1995, BIRD SONG BIOL THEME; Dabelsteen T, 1997, ANIM BEHAV, V53, P249, DOI 10.1006/anbe.1996.0369; Dabelsteen T, 1996, J AVIAN BIOL, V27, P189, DOI 10.2307/3677221; HERMAN LM, 1993, COMPAR COGN, P403; Janik VM, 1997, ADV STUD BEHAV, V26, P59, DOI 10.1016/S0065-3454(08)60377-0; Janik VM, 1996, MAR MAMMAL SCI, V12, P597, DOI 10.1111/j.1748-7692.1996.tb00073.x; JANIK VM, 1994, BEHAV ECOL SOCIOBIOL, V35, P243, DOI 10.1007/s002650050094; Janik VM, 1999, ANIM BEHAV, V57, P133, DOI 10.1006/anbe.1998.0923; Janik VM, 1998, ANIM BEHAV, V56, P829, DOI 10.1006/anbe.1998.0881; Janik VM, 2000, MAR MAMMAL SCI, V16, P437, DOI 10.1111/j.1748-7692.2000.tb00935.x; LANG TG, 1966, SCIENCE, V151, P588, DOI 10.1126/science.151.3710.588; Manly BFJ., 2017, RANDOMIZATION MONTE, DOI 10.1201/9781315273075; RICHARDS DG, 1984, J COMP PSYCHOL, V98, P10, DOI 10.1037/0735-7036.98.1.10; SAYIGH LS, 1990, BEHAV ECOL SOCIOBIOL, V26, P247; TERRACE HS, 1985, AM PSYCHOL, V40, P1011, DOI 10.1037/0003-066X.40.9.1011; TODT D, 1981, Z TIERPSYCHOL, V57, P73; TYACK P, 1986, BEHAV ECOL SOCIOBIOL, V18, P251, DOI 10.1007/BF00300001; Tyack Peter L., 1997, Bioacoustics, V8, P21; WILKINS WK, 1995, BEHAV BRAIN SCI, V18, P161, DOI 10.1017/S0140525X00037924; Wilson B, 1997, J APPL ECOL, V34, P1365, DOI 10.2307/2405254	22	249	260	3	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 25	2000	289	5483					1355	+		10.1126/science.289.5483.1355	http://dx.doi.org/10.1126/science.289.5483.1355			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347RF	10958783				2022-12-24	WOS:000088942400040
J	McKinney, JD; zu Bentrup, KH; Munoz-Elias, EJ; Miczak, A; Chen, B; Chan, WT; Swenson, D; Sacchettini, JC; Jacobs, WR; Russell, DG				McKinney, JD; zu Bentrup, KH; Munoz-Elias, EJ; Miczak, A; Chen, B; Chan, WT; Swenson, D; Sacchettini, JC; Jacobs, WR; Russell, DG			Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase	NATURE			English	Article							ALLELIC EXCHANGE; EXPRESSION; MATURATION; SMEGMATIS; SURVIVAL; MUTANTS; AVIUM; CELLS	Mycobacterium tuberculosis claims more human lives each year than any other bacterial pathogen. Infection is maintained in spite of acquired immunity and resists eradication by antimicrobials(1,2). Despite an urgent need for new therapies targeting persistent bacteria, our knowledge of bacterial metabolism throughout the course of infection remains rudimentary. Here we report that persistence of M. tuberculosis in mice is facilitated by isocitrate lyase (ICL), an enzyme essential for the metabolism of fatty acids(3,4). Disruption of the icl gene attenuated bacterial persistence and virulence in immune-competent mice without affecting bacterial growth during the acute phase of infection. A link between the requirement for ICL and the immune status of the host was established by the restored virulence of Delta icl bacteria in interferon-gamma knockout mice. This link was apparent at the level of the infected macrophage: Activation of infected macrophages increased expression of ICL, and the Delta icl mutant was markedly attenuated for survival in activated but not resting macrophages. These data suggest that the metabolism of M. tuberculosis in vivo is profoundly influenced by the host response to infection, an observation with important implications for the treatment of chronic tuberculosis.	Yeshiva Univ Albert Einstein Coll Med, Howard Hughes Med Inst, Bronx, NY 10461 USA; Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; Rockefeller Univ, New York, NY 10021 USA; Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Howard Hughes Medical Institute; Yeshiva University; Albert Einstein College of Medicine; Washington University (WUSTL); Rockefeller University; Texas A&M University System; Texas A&M University College Station	Russell, DG (corresponding author), Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA.	dgr8@cornell.edu	Russell, David G/D-4533-2009; Russell, David G/N-5280-2019	Russell, David G/0000-0002-9748-750X; Russell, David G/0000-0002-9748-750X; Jacobs, William/0000-0003-3321-3080				Bentrup KHZ, 1999, J BACTERIOL, V181, P7161; Clark D. P., 1996, ESCHERICHIA COLI SAL, P343; Clemens DL, 1996, J EXP MED, V184, P1349, DOI 10.1084/jem.184.4.1349; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Cronan JE, 1996, ESCHERICHIA COLI SAL, V1, P206; Farewell A, 1996, J BACTERIOL, V178, P6443, DOI 10.1128/jb.178.22.6443-6450.1996; GIRLING DJ, 1989, BIOL MYCOBACTERIA, V3, P285; Graham JE, 1999, P NATL ACAD SCI USA, V96, P11554, DOI 10.1073/pnas.96.20.11554; HART PD, 1975, NATURE, V256, P47, DOI 10.1038/256047a0; JAMES PE, 1995, J CELL PHYSIOL, V163, P241, DOI 10.1002/jcp.1041630204; McKinney JD, 1998, BIOMED RES REP, P51; MITCHISON DA, 1980, J ROY COLL PHYS LOND, V14, P91; MURTHY PS, 1973, AM REV RESPIR DIS, V108, P689; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Pavelka MS, 1999, J BACTERIOL, V181, P4780, DOI 10.1128/JB.181.16.4780-4789.1999; Pelicic V, 1997, P NATL ACAD SCI USA, V94, P10955, DOI 10.1073/pnas.94.20.10955; REES RJ, 1961, BRIT J EXP PATHOL, V42, P83; RUSSOMARIE F, 1993, P NATL ACAD SCI USA, V90, P8194, DOI 10.1073/pnas.90.17.8194; Schaible UE, 1998, J IMMUNOL, V160, P1290; Sega W., 1984, MYCOBACTERIA SOURCEB, P547; SHARMA V, IN PRESS NATURE STRU; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Spector MP, 1999, MICROBIOL-SGM, V145, P15, DOI 10.1099/13500872-145-1-15; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Sturgill-Koszycki S, 1997, ELECTROPHORESIS, V18, P2558, DOI 10.1002/elps.1150181411; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; SturgillKoszycki S, 1996, EMBO J, V15, P6960, DOI 10.1002/j.1460-2075.1996.tb01088.x; Via LE, 1998, J CELL SCI, V111, P897; WALLACE JG, 1961, AM REV RESPIR DIS, V83, P866; WAYNE LG, 1982, INFECT IMMUN, V37, P1042, DOI 10.1128/IAI.37.3.1042-1049.1982; Wheeler Paul R., 1994, P353	31	1045	1116	3	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2000	406	6797					735	738		10.1038/35021074	http://dx.doi.org/10.1038/35021074			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963599				2022-12-24	WOS:000088767700046
J	Kaukonen, J; Juselius, JK; Tiranti, V; Kyttala, A; Zeviani, M; Comi, GP; Keranen, S; Peltonen, L; Suomalainen, A				Kaukonen, J; Juselius, JK; Tiranti, V; Kyttala, A; Zeviani, M; Comi, GP; Keranen, S; Peltonen, L; Suomalainen, A			Role of adenine nucleotide translocator 1 in mtDNA maintenance	SCIENCE			English	Article							PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MITOCHONDRIAL-DNA DELETIONS; MULTIPLE DELETIONS; GENETIC FEATURES; ADP/ATP CARRIER; MUSCLE; YEAST; EXPRESSION; MUTATIONS; DISORDER	Autosomal dominant progressive external ophthalmoplegia is a rare human disease that shows a Mendelian inheritance pattern, but is characterized by Large-scale mitochondrial DNA (mtDNA) deletions. We have identified two heterozygous missense mutations in the nuclear gene encoding the heart/skeletal muscle isoform of the adenine nucleotide translocator (ANT1) in five families and one sporadic patient. The familiar mutation substitutes a proline for a highly conserved alanine at position 114 in the ANT1 protein. The analogous mutation in yeast caused a respiratory defect. These results indicate that ANT has a role in mtDNA maintenance and that a mitochondrial disease can be caused by a dominant mechanism.	Natl Publ Hlth Inst, Dept Human Mol Genet, SF-00300 Helsinki, Finland; VTT Biotechnol, Espoo, Finland; Natl Neurol Inst C Besta, Dept Neurol Res, Div Biochem & Genet, Milan, Italy; Univ Milan, Osped Maggiore Policlin, Ist Ricovero & Cura Carattere Sci, Ist Clin Neurol,Ctr Dino Ferrari, Milan, Italy; Univ Calif Los Angeles, Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA	Finland National Institute for Health & Welfare; VTT Technical Research Center Finland; IRCCS Istituto Neurologico Besta; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Suomalainen, A (corresponding author), Natl Publ Hlth Inst, Dept Human Mol Genet, Mannerheimintie 166, SF-00300 Helsinki, Finland.		Tiranti, Valeria/J-8233-2016; Zeviani, Massimo/AAU-2632-2021; Comi, Giacomo P/K-5702-2016; Tiranti, Valeria/AFN-5783-2022; Zeviani, Massimo/K-2891-2014	Tiranti, Valeria/0000-0002-3584-7338; Zeviani, Massimo/0000-0002-9067-5508; Comi, Giacomo P/0000-0002-1383-5248; Tiranti, Valeria/0000-0002-3584-7338; Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195	Telethon [1180] Funding Source: Medline	Telethon(Fondazione Telethon)		BAKKER HD, 1993, J INHERIT METAB DIS, V16, P548, DOI 10.1007/BF00711678; Bauer MKA, 1999, J CELL BIOL, V147, P1493, DOI 10.1083/jcb.147.7.1493; BODENSTEINLANG J, 1989, FEBS LETT, V258, P22, DOI 10.1016/0014-5793(89)81606-0; Bohlega S, 1996, NEUROLOGY, V46, P1329, DOI 10.1212/WNL.46.5.1329; Brustovetsky N, 1996, BIOCHEMISTRY-US, V35, P8483, DOI 10.1021/bi960833v; Carrozzo R, 1999, J NEUROL SCI, V170, P24, DOI 10.1016/S0022-510X(99)00193-8; Doerner A, 1997, FEBS LETT, V414, P258, DOI 10.1016/S0014-5793(97)01000-4; DRGON T, 1992, FEBS LETT, V304, P277, DOI 10.1016/0014-5793(92)80637-V; Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820; Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226; HIRANO M, 1994, NEUROLOGY, V44, P721, DOI 10.1212/WNL.44.4.721; JUSELILUS J, UNPUB; Kaukonen J, 1999, AM J HUM GENET, V65, P256, DOI 10.1086/302445; Kaukonen JA, 1996, AM J HUM GENET, V58, P763; Klingenberg M, 1976, ENZYMES BIOLOGICAL M, V3, P383; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; Melberg A, 1996, MUSCLE NERVE, V19, P751; MORAES CT, 1991, AM J HUM GENET, V48, P492; Muller V, 1996, BIOCHEMISTRY-US, V35, P16132, DOI 10.1021/bi960667r; NELSON DR, 1993, J MOL BIOL, V230, P1159, DOI 10.1006/jmbi.1993.1233; Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; SERVIDEI S, 1991, NEUROLOGY, V41, P1053, DOI 10.1212/WNL.41.7.1053; STEPIEN G, 1992, J BIOL CHEM, V267, P14592; Suomalainen A, 1997, ANN MED, V29, P235, DOI 10.3109/07853899708999341; Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244; SUOMALAINEN A, 1995, NAT GENET, V9, P146, DOI 10.1038/ng0295-146; SUOMALAINEN A, UNPUB; SYVANEN AC, 1994, CLIN CHIM ACTA, V226, P225, DOI 10.1016/0009-8981(94)90217-8; TIRANTI V, UNPUB; Toikkanen J, 1996, YEAST, V12, P425, DOI 10.1002/(SICI)1097-0061(199604)12:5<425::AID-YEA924>3.3.CO;2-2; VIOLA AM, 1995, CURR GENET, V27, P229, DOI 10.1007/BF00326153; WALKER JE, 1993, J BIOENERG BIOMEMBR, V25, P435, DOI 10.1007/BF01108401; Yan LJ, 1998, P NATL ACAD SCI USA, V95, P12896, DOI 10.1073/pnas.95.22.12896; YOUNG P, 1994, BIOCHEM BIOPH RES CO, V203, P46, DOI 10.1006/bbrc.1994.2146; ZEVIANI M, 1988, NEUROLOGY, V38, P1339; ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0	37	465	476	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 4	2000	289	5480					782	785		10.1126/science.289.5480.782	http://dx.doi.org/10.1126/science.289.5480.782			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341FZ	10926541				2022-12-24	WOS:000088581500042
J	Shen, XT; Mizuguchi, G; Hamiche, A; Wu, C				Shen, XT; Mizuguchi, G; Hamiche, A; Wu, C			A chromatin remodelling complex involved in transcription and DNA processing	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; NUCLEOSOME; BINDING; PROTEIN; SWI/SNF; RUVB; RECOMBINATION; HELICASE; SUBUNIT; FAMILY	The packaging of the eukaryotic genome in chromatin presents barriers that restrict the access of enzymes that process DNA(1,2). To overcome these barriers, cells possess a number of multi-protein, ATP-dependent chromatin remodelling complexes, each containing an ATPase subunit from the SNF2/SWI2 superfamily(3,4). Chromatin remodelling complexes function by increasing nucleosome mobility and are clearly implicated in transcription(5-7). Here we have analysed SNF2/SWI2- and ISWI-related proteins to identify remodelling complexes that potentially assist other DNA transactions. We purified a complex from Saccharomyces cerevisiae that contains the Ino80 ATPase(8). The INO80 complex contains about 12 polypeptides including two proteins related to the bacterial RuvB DNA helicase(9-11), which catalyses branch migration of Holliday junctions. The purified complex remodels chromatin, facilitates transcription in vitro and displays 3' to 5' DNA helicase activity. Mutants of ino80 show hypersensitivity to agents that cause DNA damage, in addition to defects in transcription(8). These results indicate that chromatin remodelling driven by the Ino80 ATPase may be connected to transcription as well as DNA damage repair.	NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA; Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Kyoto University	Wu, C (corresponding author), NCI, Mol Cell Biol Lab, NIH, Bethesda, MD 20892 USA.			Shen, Xuetong/0000-0002-4267-5298				Armstrong JA, 1998, CURR OPIN GENET DEV, V8, P165, DOI 10.1016/S0959-437X(98)80137-8; Cairns BR, 1998, MOL CELL, V2, P639, DOI 10.1016/S1097-2765(00)80162-8; Cairns BR, 1996, CELL, V87, P1249, DOI 10.1016/S0092-8674(00)81820-6; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; Ebbert R, 1999, MOL MICROBIOL, V32, P741, DOI 10.1046/j.1365-2958.1999.01390.x; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Galarneau L, 2000, MOL CELL, V5, P927, DOI 10.1016/S1097-2765(00)80258-0; Gdula DA, 1998, GENE DEV, V12, P3206, DOI 10.1101/gad.12.20.3206; Haber JE, 1999, TRENDS BIOCHEM SCI, V24, P271, DOI 10.1016/S0968-0004(99)01413-9; HANSEN SK, 1995, CELL, V82, P565, DOI 10.1016/0092-8674(95)90029-2; Huang MX, 1997, MOL CELL BIOL, V17, P6105, DOI 10.1128/MCB.17.10.6105; IKURA T, UNPUT NATURE; Kadonaga JT, 1998, CELL, V92, P307, DOI 10.1016/S0092-8674(00)80924-1; Kanemaki M, 1997, BIOCHEM BIOPH RES CO, V235, P64, DOI 10.1006/bbrc.1997.6729; Kanemaki M, 1999, J BIOL CHEM, V274, P22437, DOI 10.1074/jbc.274.32.22437; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Luger K, 1998, CURR OPIN STRUC BIOL, V8, P33, DOI 10.1016/S0959-440X(98)80007-9; Mizuguchi G, 1997, MOL CELL, V1, P141, DOI 10.1016/S1097-2765(00)80015-5; Park JS, 1997, J BIOL CHEM, V272, P18910, DOI 10.1074/jbc.272.30.18910; Peterson CL, 1996, CURR OPIN GENET DEV, V6, P171, DOI 10.1016/S0959-437X(96)80047-5; Qiu XB, 1998, J BIOL CHEM, V273, P27786, DOI 10.1074/jbc.273.43.27786; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; TSUKIYAMA T, 1995, CELL, V83, P1011, DOI 10.1016/0092-8674(95)90216-3; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; TSUKIYAMA T, 1995, CELL, V83, P1021, DOI 10.1016/0092-8674(95)90217-1; WEINERT TA, 1990, MOL CELL BIOL, V10, P6554, DOI 10.1128/MCB.10.12.6554; West SC, 1997, ANNU REV GENET, V31, P213, DOI 10.1146/annurev.genet.31.1.213; Wood MA, 2000, MOL CELL, V5, P321, DOI 10.1016/S1097-2765(00)80427-X; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	30	621	640	1	53	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2000	406	6795					541	544		10.1038/35020123	http://dx.doi.org/10.1038/35020123			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952318				2022-12-24	WOS:000088538000052
J	Tanabe, T; Kuwabara, T; Warashina, M; Tani, K; Taira, K; Asano, S				Tanabe, T; Kuwabara, T; Warashina, M; Tani, K; Taira, K; Asano, S			Oncogene inactivation in a mouse model - Tissue invasion by leukaemic cells is stalled by loading them with a designer ribozyme.	NATURE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; PHILADELPHIA-CHROMOSOME; MARROW TRANSPLANTATION; BONE-MARROW; CLEAVAGE; GENE		Univ Tokyo, Inst Med Sci, Dept Hematol Oncol, Minato Ku, Tokyo 1088539, Japan; Natl Inst Adv Interdisciplinary Res, Tsukuba Sci City, Ibaraki 3058562, Japan; Univ Tsukuba, Inst Appl Biochem, Tsukuba Sci City, Ibaraki 3058572, Japan; Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Tokyo 1138656, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba; University of Tokyo	Tanabe, T (corresponding author), Univ Tokyo, Inst Med Sci, Dept Hematol Oncol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088539, Japan.							Amontov SV, 1996, J AM CHEM SOC, V118, P1624, DOI 10.1021/ja9517734; BARTRAM CR, 1983, NATURE, V306, P277, DOI 10.1038/306277a0; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; DEISSEROTH AB, 1994, BLOOD, V83, P3068, DOI 10.1182/blood.V83.10.3068.3068; GISHIZKY ML, 1992, SCIENCE, V256, P836, DOI 10.1126/science.1375394; KONOPKA JB, 1984, CELL, V37, P1035, DOI 10.1016/0092-8674(84)90438-0; Kuwabara T, 1999, P NATL ACAD SCI USA, V96, P1886, DOI 10.1073/pnas.96.5.1886; Kuwabara T, 1998, NAT BIOTECHNOL, V16, P961, DOI 10.1038/nbt1098-961; Kuwabara T, 1998, MOL CELL, V2, P617, DOI 10.1016/S1097-2765(00)80160-4; MCGLAVE P, 1993, BLOOD, V81, P543; Onishi M, 1996, EXP HEMATOL, V24, P324; SNYDER DS, 1990, HEMATOL ONCOL CLIN N, V4, P535, DOI 10.1016/S0889-8588(18)30477-5; Tanabe T, 2000, BIOMACROMOLECULES, V1, P108, DOI 10.1021/bm990009x	13	67	74	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2000	406	6795					473	474		10.1038/35020190	http://dx.doi.org/10.1038/35020190			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952298				2022-12-24	WOS:000088538000032
J	Klausner, JD; Wolf, W; Fischer-Ponce, L; Zolt, I; Katz, MH				Klausner, JD; Wolf, W; Fischer-Ponce, L; Zolt, I; Katz, MH			Tracing a syphilis outbreak through cyberspace	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ELIMINATION	Context A recent outbreak of syphilis among users of an Internet chat room challenged traditional methods of partner notification and community education because locating information on sexual partners was limited to screen names and privacy concerns precluded identifying sexual partners through the Internet service provider. Objectives To determine the association of Internet use and acquisition of syphilis and to describe innovative methods of partner notification in cyberspace. Design, Setting, and Patients Outbreak investigation conducted at the San Francisco (Calif) Department of Public Health (SFDPH) in June-August 1999 of 7 cases of early syphilis among gay men linked to an online chat room; case-control study of 6 gay men with syphilis reported to SFDPH in July-August 1999 (cases) and 32 gay men without syphilis who presented to a city clinic in April-July 1999 (controls), Main Outcome Measures Association of syphilis infection with Internet use, Internet use among cases vs controls, and partner notification methods and partner evaluation indexes. Results During the outbreak, cases were significantly more likely than controls to have met their sexual partners through use of the Internet (67% vs 19%; odds ratio, 8.7; P=.03). We notified and confirmed testing for 42% of named partners; the mean number of sexual partners medically evaluated per index case was 5.9, Conclusions In this study, meeting sexual partners through the Internet was associated with acquisition of syphilis among gay men. Public health efforts must continually adapt disease control procedures to new venues, carefully weighing the rights to privacy vs the need to protect public health.	San Francisco Dept Publ Hlth, STD Serv, San Francisco, CA 94103 USA; Univ Calif San Francisco, Dept Med, Div AIDS & Oncol, San Francisco, CA USA; Ctr Dis Control & Prevent, Natl Ctr HIV STD & TB Prevent, Atlanta, GA USA	San Francisco Department of Public Health; University of California System; University of California San Francisco; Centers for Disease Control & Prevention - USA	Klausner, JD (corresponding author), San Francisco Dept Publ Hlth, STD Serv, 1360 Mission St,Suite 401, San Francisco, CA 94103 USA.	jeff_klausner@dph.sf.ca.us						Cates W, 1996, SEX TRANSM DIS, V23, P68, DOI 10.1097/00007435-199601000-00013; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P45; *DEP PUBL HLTH, 1999, FACT SHEET; DOUGHERTY WJ, 1962, J MED SOC NEW JERSEY, V59, P564; Ekstrand ML, 1999, AIDS, V13, P1525, DOI 10.1097/00002030-199908200-00013; LELCHUK I, 1999, SAN FRANCISCO E 0826, pA1; MOORE MB, 1963, PUBLIC HEALTH REP, V78, P966, DOI 10.2307/4591989; NIEVES E, 1999, NY TIMES        0825, pA1; Richards E. P., 1999, SEXUALLY TRANSMITTED, P1441; ROTHENBERG RB, 1984, SEXUALLY TRANSMITTED, P970; *SAN FRANC DEP PUB, 2000, SAN FRANC MONTHL STD; *SAN FRANC DEP PUB, 1999, SAN FRANC SEX TRANSM; St Louis ME, 1998, SCIENCE, V281, P353, DOI 10.1126/science.281.5375.353; Williams LA, 1999, AM J PUBLIC HEALTH, V89, P1093, DOI 10.2105/AJPH.89.7.1093	14	228	231	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 26	2000	284	4					447	+		10.1001/jama.284.4.447	http://dx.doi.org/10.1001/jama.284.4.447			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335QB	10904507				2022-12-24	WOS:000088254200030
J	Vosshall, LB; Wong, AM; Axel, R				Vosshall, LB; Wong, AM; Axel, R			An olfactory sensory map in the fly brain	CELL			English	Article							ODORANT RECEPTOR EXPRESSION; MITRAL TUFTED CELLS; ANTENNAL LOBE; DROSOPHILA-MELANOGASTER; NEURONAL-ACTIVITY; GENE-EXPRESSION; BULB; ORGANIZATION; RESPONSES; PROTEIN	We have isolated the "complete" repertoire of genes encoding the odorant receptors in Drosophila and employ these genes to provide a molecular description of the organization of the peripheral olfactory system. The repertoire of Drosophila odorant receptors is encoded by 57 genes. Individual sensory neurons are likely to express only a single receptor gene. Neurons expressing a given gene project axons to one or two spatially invariant glomeruli in the antennal robe. The insect brain therefore retains a two-dimensional map of receptor activation such that the quality of an odor may be encoded by different spatial patterns of activity in the antennal lobe.	Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Axel, R (corresponding author), Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	ra27@columbia.edu		Vosshall, Leslie/0000-0002-6060-8099; Axel, Richard/0000-0002-3141-4076	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH050733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS029832] Funding Source: NIH RePORTER; NIMH NIH HHS [5P50 MH50733-06] Funding Source: Medline; NINDS NIH HHS [NS29832-08] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BENARIE N, 1994, HUM MOL GENET, V3, P229, DOI 10.1093/hmg/3.2.229; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Carlson JR, 1996, TRENDS GENET, V12, P175, DOI 10.1016/0168-9525(96)10015-9; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Clyne PJ, 1999, NEURON, V22, P339, DOI 10.1016/S0896-6273(00)81094-6; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Cobb M, 1999, BIOL REV, V74, P425, DOI 10.1017/S0006323199005393; COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Elliott G, 1997, CELL, V88, P223, DOI 10.1016/S0092-8674(00)81843-7; Estes PS, 2000, J NEUROGENET, V13, P233, DOI 10.3109/01677060009084496; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Galizia CG, 1999, NAT NEUROSCI, V2, P473, DOI 10.1038/8144; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Goulding SE, 2000, NEURON, V25, P69, DOI 10.1016/S0896-6273(00)80872-7; HANSSON BS, 1992, SCIENCE, V256, P1313, DOI 10.1126/science.1598574; HAY BA, 1994, DEVELOPMENT, V120, P2121; HIGA I, 1993, GENETICA, V88, P129, DOI 10.1007/BF02424469; HILDEBRAND JG, 1995, P NATL ACAD SCI USA, V92, P67, DOI 10.1073/pnas.92.1.67; HOLLDOBLER B, 1995, P NATL ACAD SCI USA, V92, P19, DOI 10.1073/pnas.92.1.19; Holldobler B., 1990, pi; IMAMURA K, 1992, J NEUROPHYSIOL, V68, P1986, DOI 10.1152/jn.1992.68.6.1986; ISINGRINI M, 1985, P NATL ACAD SCI USA, V82, P8545, DOI 10.1073/pnas.82.24.8545; Ito K, 1998, LEARN MEMORY, V5, P52; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; KATOH K, 1993, J NEUROPHYSIOL, V70, P2161, DOI 10.1152/jn.1993.70.5.2161; KAUER JS, 1987, BRAIN RES, V418, P255, DOI 10.1016/0006-8993(87)90093-X; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Laissue PP, 1999, J COMP NEUROL, V405, P543; LANCET D, 1982, P NATL ACAD SCI-BIOL, V79, P670, DOI 10.1073/pnas.79.2.670; Leibovici M, 1996, DEV BIOL, V175, P118, DOI 10.1006/dbio.1996.0100; LEVY NS, 1991, J STEROID BIOCHEM, V39, P633, DOI 10.1016/0960-0760(91)90262-4; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; MARTIN KA, 1995, NEURON, V14, P229, DOI 10.1016/0896-6273(95)90281-3; Menzel R, 1996, ANNU REV NEUROSCI, V19, P379, DOI 10.1146/annurev.ne.19.030196.002115; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MORI K, 1992, J NEUROPHYSIOL, V67, P786, DOI 10.1152/jn.1992.67.3.786; Nef S, 1996, MECH DEVELOP, V55, P65, DOI 10.1016/0925-4773(95)00491-2; NGAI J, 1993, CELL, V72, P657, DOI 10.1016/0092-8674(93)90396-8; Qasba P, 1998, J NEUROSCI, V18, P227; RAY K, 1995, DEV BIOL, V167, P426, DOI 10.1006/dbio.1995.1039; Reddy GV, 1997, DEVELOPMENT, V124, P703; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Robertson HM, 1998, GENOME RES, V8, P449, DOI 10.1101/gr.8.5.449; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; RODRIGUES V, 1984, BRAIN RES, V324, P374, DOI 10.1016/0006-8993(84)90053-2; RODRIGUES V, 1988, BRAIN RES, V453, P299, DOI 10.1016/0006-8993(88)90170-9; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Sachse S, 1999, EUR J NEUROSCI, V11, P3970, DOI 10.1046/j.1460-9568.1999.00826.x; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; SIDDIQI O, 1987, TRENDS GENET, V3, P137, DOI 10.1016/0168-9525(87)90204-6; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; STOCKER RF, 1983, CELL TISSUE RES, V232, P237, DOI 10.1007/BF00213783; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Warr CG, 2000, CELL, V102, P145; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354	72	763	837	7	101	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 21	2000	102	2					147	159		10.1016/S0092-8674(00)00021-0	http://dx.doi.org/10.1016/S0092-8674(00)00021-0			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	337NA	10943836	Bronze			2022-12-24	WOS:000088366800006
J	Norman, C				Norman, C			HIV and Africa's future	SCIENCE			English	Editorial Material																			0	3	3	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 23	2000	288	5474					2149	2149		10.1126/science.288.5474.2149	http://dx.doi.org/10.1126/science.288.5474.2149			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	327FH	10896591				2022-12-24	WOS:000087782900030
J	Guthrie, B; Wyke, S				Guthrie, B; Wyke, S			Controversy in primary care - Does continuity in general practice really matter?	BRITISH MEDICAL JOURNAL			English	Article							PATIENT SATISFACTION; RANDOMIZED TRIAL; PRACTITIONERS; CONSULTATIONS	Continuity is an official core value of general practice in the United Kingdom,(1) but there are at least two potentially conflicting definitions of it Both definitions are powerfully expressed in a recent report from the BMA, entitled Shaping Tomorrow.(2) For general practitioners, continuity of care has traditionally meant that a patient visits the same doctor(3 4) What matters is personal continuity, in which an ongoing doctor-patient relationship ensures that care takes account of the patient's personal and social context By contrast, recent statements from the NHS Executive emphasise the importance of consistency and coordination of care.(5) From this perspective, continuity can be enhanced by appropriate organisation, guidelines, and electronic medical records, irrespective of which doctor is seen.	Univ Edinburgh, Dept Community Hlth Sci, Div Gen Practice, Edinburgh EH8 9DX, Midlothian, Scotland; Royal Coll Gen Practitioners, Scottish Sch Primary Care, Edinburgh EH2 1JX, Midlothian, Scotland	University of Edinburgh	Guthrie, B (corresponding author), Univ Edinburgh, Dept Community Hlth Sci, Div Gen Practice, Edinburgh EH8 9DX, Midlothian, Scotland.		Guthrie, Bruce/HHM-9696-2022	Guthrie, Bruce/0000-0003-4191-4880				BAKER R, 1995, BRIT J GEN PRACT, V45, P654; Baker R, 1996, BRIT J GEN PRACT, V46, P601; BECKER MH, 1974, AM J PUBLIC HEALTH, V64, P1062, DOI 10.2105/AJPH.64.11.1062; *BMA GEN PRACT COM, 2000, PRIM CAR TRUSTS IMPL; *BMA GEN PRACT COM, 2000, SHAP TOM ISS FAC GEN; ETTLINGER PRA, 1981, BRIT MED J, V282, P1192, DOI 10.1136/bmj.282.6271.1192; Flint C, 1989, Midwifery, V5, P11, DOI 10.1016/S0266-6138(89)80059-2; FREEMAN G, 1985, J ROY COLL GEN PRACT, V35, P423; Freeman G, 1997, BRIT MED J, V314, P1870, DOI 10.1136/bmj.314.7098.1870; FREEMAN GK, 1994, BRIT J GEN PRACT, V44, P395; GORDIS L, 1971, PEDIATRICS, V48, P766; HJORTDAHL P, 1992, BRIT MED J, V304, P1287, DOI 10.1136/bmj.304.6837.1287; Howie JGR, 1999, BMJ-BRIT MED J, V319, P738, DOI 10.1136/bmj.319.7212.738; NAZARETH I, 1993, BRIT MED J, V306, P1103, DOI 10.1136/bmj.306.6885.1103; *NHS EX, 2000, PRIM COMM CAR; ROWLEY MJ, 1995, MED J AUSTRALIA, V163, P289, DOI 10.5694/j.1326-5377.1995.tb124592.x; Royal College of General Practitioners, 1972, FUT GEN PRACT; WASSON JH, 1984, JAMA-J AM MED ASSOC, V252, P2413	18	44	47	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	SEP 23	2000	321	7263					734	735		10.1136/bmj.321.7263.734	http://dx.doi.org/10.1136/bmj.321.7263.734			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FE	10999906	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000089546600025
J	Ross, EA; Szabo, NJ; Tebbett, IR				Ross, EA; Szabo, NJ; Tebbett, IR			Lead content of calcium supplements	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; DIETARY LEAD; EXPOSURE	Context Substantial quantities of lead have been reported in some over-the-counter calcium supplement preparations, including not only bonemeal and dolomite, but also over-the-counter natural and refined calcium carbonate formulations. Examination of this issue is warranted given recent increases in physician recommendations for calcium supplements for prevention and treatment of osteoporosis. Objectives To determine the lead content of calcium supplements and to quantify the lead exposure from popular brands of calcium in dosages used for childhood recommended daily allowance, osteoporosis, and phosphate binding in dialysis patients. Design and Setting Analysis of lead content in 21 formulations of nonprescription calcium carbonate (including 7 natural [ie, oyster shell] and 14 refined), 1 brand of prescription-only calcium acetate, and 1 noncalcium synthetic phosphate binder conducted in March 2000, Main Outcome Measures Lead content, assayed using electrothermal atomic absorption, expressed as micrograms of lead per 800 mg/d of elemental calcium, per 1500 mg/d of calcium, and for a range of dosages for patients with renal failure. Six mu g/d of lead was considered the absolute dietary limit, with no more than 1 mu g/d being the goal for supplements. Results Four of 7 natural products had measurable lead content, amounting to approximately 1 mu g/d for 800 mg/d of calcium, between 1 and 2 mu g/d for 1500 mg/d of calcium, and up to 10 mu g/d for renal dosages, Four of the 14 refined products had similar lead content, including up to 3 mu g/d of lead in osteoporosis calcium dosages and up to 20 mu g/d in high renal dosages, No lead was detected in the calcium acetate or polymer products. Lead was present even in some brand name products from major pharmaceutical companies not of natural oyster shell derivation. Conclusions Despite increasingly stringent limits of lead exposure, many calcium supplement formulations contain lead and thereby may pose an easily avoidable public health concern.	Univ Florida, Div Nephrol Hypertens & Transplantat, Coll Med, Gainesville, FL 32610 USA; Univ Florida, Coll Vet Med, Dept Physiol Sci, Analyt Toxicol Core Lab, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Ross, EA (corresponding author), Univ Florida, Div Nephrol Hypertens & Transplantat, Coll Med, Box 100224, Gainesville, FL 32610 USA.	Rossea@medicine.ufl.edu						Adachi JD, 1998, CALCIFIED TISSUE INT, V63, P429, DOI 10.1007/s002239900552; Bolger PM, 1996, FOOD ADDIT CONTAM A, V13, P53, DOI 10.1080/02652039609374380; BOULOS BM, 1988, AM J HYPERTENS, V1, pS137, DOI 10.1093/ajh/1.3.137S; BOURGOIN BP, 1993, AM J PUBLIC HEALTH, V83, P1155, DOI 10.2105/AJPH.83.8.1155; CARR C J, 1987, American Pharmacy, V27, P49; CARRINGTON CD, 1992, REGUL TOXICOL PHARM, V16, P265, DOI 10.1016/0273-2300(92)90006-U; Carrington CD, 1996, FOOD ADDIT CONTAM, V13, P61, DOI 10.1080/02652039609374381; D'Haese PC, 1999, CLIN CHEM, V45, P1548; Ervin R.B., 1999, VITAL HLTH STAT, V11, P1; NAVARRO JA, 1992, CLIN CHIM ACTA, V211, P133, DOI 10.1016/0009-8981(92)90189-W; ROBERTS HJ, 1983, SOUTHERN MED J, V76, P556, DOI 10.1097/00007611-198305000-00005; Sargent JD, 1999, AM J CLIN NUTR, V69, P1224; SLESINSKI MJ, 1995, J AM DIET ASSOC, V95, P921, DOI 10.1016/S0002-8223(95)00255-3; SLITONEN PH, 1994, J ASSOC OFF ANA CHEM, V77, P1299; SUITOR CW, 1990, J AM DIET ASSOC, V90, P268; *US DEP HHS AG TOX, 1999, TOX PROF LEAD; *US EPA OFF HLTH E, 1999, INT RISK INF SYST; *US FDA, 1990, HFF156 US FDA US PHS; *US FDA, 1981, LEAD BON; *US PHARM CONV INC, 2000, US PHARM NAT FORM, P277; VANDEVYVER FL, 1988, KIDNEY INT, V33, P601, DOI 10.1038/ki.1988.39; WHITING SJ, 1994, NUTR REV, V52, P95, DOI 10.1111/j.1753-4887.1994.tb01396.x; 1999, CONSUMER REPORTS, V64, P9	23	44	47	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 20	2000	284	11					1425	1429		10.1001/jama.284.11.1425	http://dx.doi.org/10.1001/jama.284.11.1425			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	352WN	10989406				2022-12-24	WOS:000089242500038
J	Bourara, K; Litvak, S; Araya, A				Bourara, K; Litvak, S; Araya, A			Generation of G-to-A and C-to-U changes in HIV-1 transcripts by RNA editing	SCIENCE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE-TRANSCRIPTASE; SEQUENCE; PROTEIN; TRANSLATION; MECHANISM; ADENOSINE; CLONING; SITE	RNA editing involves posttranscriptional alterations of messenger RNA (mRNA) sequences modifying the information content encoded by the genetic message. Here, it is shown that, in chronically infected H9 cells, human immunodeficiency virus-type 1 (HIV-1) mRNAs undergo guanine-to-adenine (G-to-A) and cytosine-to-uracil (C-to-U) changes. C-to-A modification in the untranslated region of exon 1 was present only in spliced HIV-1 mRNAs. The creation of stop codons in HIV-1 mRNAs may function to control the translation of viral proteins, such as viral protein R, that are involved in the regulation of HIV-1 expression and the survival of chronically infected cells.	Univ Bordeaux 2, Lab Replicat & Express Genomes Eucaryotes & Retro, CNRS, UMR 5097, F-33076 Bordeaux, France; IFR 66 Pathol Infect, F-33076 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Araya, A (corresponding author), Univ Bordeaux 2, Lab Replicat & Express Genomes Eucaryotes & Retro, CNRS, UMR 5097, 146 Rue Leo Saignat, F-33076 Bordeaux, France.							ARAYA A, 1994, PHYSIOL PLANTARUM, V91, P543, DOI 10.1111/j.1399-3054.1994.tb02986.x; BLANC V, 1995, FEBS LETT, V373, P56, DOI 10.1016/0014-5793(95)00991-H; Cantor C. R., 1980, BIOPHYSICAL CHEM 1; CASEY JL, 1995, J VIROL, V69, P7593, DOI 10.1128/JVI.69.12.7593-7600.1995; CATTANEO R, 1989, CELL, V56, P759, DOI 10.1016/0092-8674(89)90679-X; Coffin J.M., 1997, RETROVIRUSES; Damier L, 1997, BIOCHEM BIOPH RES CO, V237, P182, DOI 10.1006/bbrc.1997.7091; DelGatto F, 1996, NUCLEIC ACIDS RES, V24, P2017, DOI 10.1093/nar/24.11.2017; JACQUES JP, 1994, EMBO J, V13, P5496, DOI 10.1002/j.1460-2075.1994.tb06884.x; Kim T, 1996, J VIROL, V70, P7594, DOI 10.1128/JVI.70.11.7594-7602.1996; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Li Y, 1997, J VIROL, V71, P6315, DOI 10.1128/JVI.71.9.6315-6322.1997; LITVAK S, 1996, RETROVIRAL REVERSE T; LORD RC, 1968, DEV APPL SPECTROSC, V6, P179; MARTINEZ MA, 1995, NUCLEIC ACIDS RES, V23, P2573, DOI 10.1093/nar/23.14.2573; Popov S, 1998, EMBO J, V17, P909, DOI 10.1093/emboj/17.4.909; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; ROGEL ME, 1995, J VIROL, V69, P882, DOI 10.1128/JVI.69.2.882-888.1995; SAMBROOK T, 1989, MOL CLONING LAB MANU, P2; SCHWARTZ S, 1990, J VIROL, V64, P2519, DOI 10.1128/JVI.64.6.2519-2529.1990; SCHWARTZ S, 1992, MOL CELL BIOL, V12, P207, DOI 10.1128/MCB.12.1.207; SHARMEEN L, 1991, P NATL ACAD SCI USA, V88, P8096, DOI 10.1073/pnas.88.18.8096; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; TRONO D, 1995, CELL, V82, P189, DOI 10.1016/0092-8674(95)90306-2; Ventura M, 1999, ARCH VIROL, V144, P513, DOI 10.1007/s007050050522; WAINHOBSON S, 1985, CELL, V40, P9, DOI 10.1016/0092-8674(85)90303-4; ZHENG HQ, 1992, J VIROL, V66, P4693, DOI 10.1128/JVI.66.8.4693-4697.1992	27	41	43	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 1	2000	289	5484					1564	1566		10.1126/science.289.5484.1564	http://dx.doi.org/10.1126/science.289.5484.1564			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349XW	10968794				2022-12-24	WOS:000089071700050
J	Lang, D; Thoma, R; Henn-Sax, M; Sterner, R; Wilmanns, M				Lang, D; Thoma, R; Henn-Sax, M; Sterner, R; Wilmanns, M			Structural evidence for evolution of the beta/alpha barrel scaffold by gene duplication and fusion	SCIENCE			English	Article							HISTIDINE BIOSYNTHESIS; SEQUENCE-ANALYSIS; PROTEIN FUNCTION; IDENTIFICATION; CONSERVATION; REFINEMENT; PATHWAY; PROGRAM; ENZYMES; MAPS	The atomic structures of two proteins in the histidine biosynthesis pathway consist of beta/alpha barrels with a twofold repeat pattern. It is Likely that these proteins evolved by twofold gene duplication and gene fusion from a common half-barrel ancestor. These ancestral domains are not visible as independent domains in the extant proteins but can be inferred from a combination of sequence and structural analysis. The detection of subdomain structures may be useful in efforts to search genome sequences for functionally and structurally related proteins.	DESY, EMBL, Hamburg Outstn, D-22603 Hamburg, Germany; Univ Basel, Biozentrum, Biophys Chem Abt, CH-4056 Basel, Switzerland; Univ Gottingen, Inst Mikrobiol & Genet, D-37077 Gottingen, Germany; Univ Cologne, Inst Biochem, D-50674 Cologne, Germany	European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Basel; University of Gottingen; University of Cologne	Wilmanns, M (corresponding author), DESY, EMBL, Hamburg Outstn, Notkestr 85, D-22603 Hamburg, Germany.		Thomä, Reiner S./I-3719-2013	Wilmanns, Matthias/0000-0002-4643-5435; Sterner, Reinhard/0000-0001-8177-8460				Alifano P, 1996, MICROBIOL REV, V60, P44, DOI 10.1128/MMBR.60.1.44-69.1996; Altamirano MM, 2000, NATURE, V403, P617, DOI 10.1038/35001001; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; BORK P, 1995, PROTEIN SCI, V4, P268; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cohen GH, 1997, J APPL CRYSTALLOGR, V30, P1160, DOI 10.1107/S0021889897006729; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; DOOLITTLE RF, 1995, ANNU REV BIOCHEM, V64, P287, DOI 10.1146/annurev.bi.64.070195.001443; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; FANI R, 1994, J MOL EVOL, V38, P489, DOI 10.1007/BF00178849; Gerlt JA, 1998, CURR OPIN CHEM BIOL, V2, P607, DOI 10.1016/S1367-5931(98)80091-4; Gerlt JA, 2000, NAT STRUCT BIOL, V7, P171, DOI 10.1038/73249; Hasson MS, 1998, P NATL ACAD SCI USA, V95, P10396, DOI 10.1073/pnas.95.18.10396; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; HOMMEL U, 1995, BIOCHEMISTRY-US, V34, P5429, DOI 10.1021/bi00016a014; HOROWITZ NH, 1945, P NATL ACAD SCI USA, V31, P153, DOI 10.1073/pnas.31.6.153; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jurgens C, 2000, P NATL ACAD SCI USA, V97, P9925, DOI 10.1073/pnas.160255397; KLEM TJ, 1993, BIOCHEMISTRY-US, V32, P5177, DOI 10.1021/bi00070a029; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LAFORTELLE E, 1997, CRYSTALLOGRAPHIC COM, P100; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Mendelsohn AR, 1999, SCIENCE, V284, P1948, DOI 10.1126/science.284.5422.1948; Morgenstern B, 1999, MOL BIOL EVOL, V16, P1654, DOI 10.1093/oxfordjournals.molbev.a026079; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nagano N, 1999, PROTEIN SCI, V8, P2072, DOI 10.1110/ps.8.10.2072; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petsko GA, 2000, NATURE, V403, P606, DOI 10.1038/35001176; REARDON D, 1995, FASEB J, V9, P497, DOI 10.1096/fasebj.9.7.7737457; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Thoma R, 1998, EXTREMOPHILES, V2, P379, DOI 10.1007/s007920050082; Thoma R, 1999, FEBS LETT, V454, P1, DOI 10.1016/S0014-5793(99)00757-7; WILMANNS M, 1993, P NATL ACAD SCI USA, V90, P1379, DOI 10.1073/pnas.90.4.1379; WILMANNS M, 1991, BIOCHEMISTRY-US, V30, P9161, DOI 10.1021/bi00102a006; YANOFSKY C, 1999, ENCY MOL BIOL, V4, P2676	38	254	260	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 1	2000	289	5484					1546	1550		10.1126/science.289.5484.1546	http://dx.doi.org/10.1126/science.289.5484.1546			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349XW	10968789				2022-12-24	WOS:000089071700045
J	Rosenhek, R; Binder, T; Porenta, G; Lang, I; Christ, G; Schemper, M; Maurer, G; Baumgartner, H				Rosenhek, R; Binder, T; Porenta, G; Lang, I; Christ, G; Schemper, M; Maurer, G; Baumgartner, H			Predictors of outcome in severe, asymptomatic aortic stenosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEART-VALVE REPLACEMENT; NATURAL-HISTORY; DISEASE; ADULTS; SURVIVAL; PATIENT	Background Whether to perform valve ment in patients with asymptomatic but severe aortic stenosis is controversial. Therefore, we studied the natural history of this condition to identify predictors of outcome. Methods During 1994, we identified 128 consecutive patients with asymptomatic, severe aortic (59 women and 69 men; mean [+/- SD] age, 60 +/- 18 years; aortic-jet velocity, 5.0 +/- 0.6 m per second). The patients were prospectively followed until 1998. Results Follow-up information was available for 126 patients (98 percent) for a mean of 22 +/- 18 months. Event-free survival, with the end point defined as death (8 patients) or valve replacement necessitated by the development of symptoms ( 59 patients), was 67 +/- 5 percent at one year, 56 +/- 5 percent at two years, and 33 +/- 5 percent at four years. Five of the six deaths from cardiac disease were preceded by symptoms. According to multivariate analysis, only the extent of aortic-valve calcification was an independent tor of outcome, whereas age, sex, and the presence or absence of coronary artery disease, hypertension, diabetes, and hypercholesterolemia were not. survival for patients with no or mild valvular calcification was 92 +/- 5 percent at one year, 84 +/- 8 percent at two years, and 75 +/- 9 percent at four years, as compared with 60 +/- 6 percent, 47 +/- 6 percent, and 20 +/- 5 respectively, for those with moderate or severe calcification. The rate of progression of stenosis, as reflected by the aortic-jet velocity, was significantly higher in patients who had cardiac events (0.45 +/- 0.38 m per second per year) than those who did not have cardiac events (0.14 +/- 0.18 m per second year, P<0.001), and the rate of progression of stenosis provided useful prognostic information. Of the patients with moderately or severely calcified aortic valves whose aortic-jet velocity increased by 0.3 m per second or more within one year, 79 percent surgery or died within two years of the observed increase. Conclusions In asymptomatic patients with aortic stenosis, it appears to be relatively safe to delay surgery until symptoms develop. However, outcomes vary widely. The presence of moderate or severe valvular calcification, together with a raid increase in aortic-jet velocity, identifies patients with a ver poor prognosis. These patients should be considered for early valve replacement rather than have surgery delayed until symptoms develop. (N Engl J Med 2000; 343:611-7.) (C) 2000, Massachusetts Medical Society.	Univ Vienna, Vienna Gen Hosp, Dept Cardiol, A-1090 Vienna, Austria; Univ Vienna, Ludwig Boltzmann Inst Cardiovasc Res, A-1090 Vienna, Austria; Univ Vienna, Dept Med Comp Sci, A-1090 Vienna, Austria	University of Vienna; Ludwig Boltzmann Institute; University of Vienna; University of Vienna	Baumgartner, H (corresponding author), Univ Vienna, Vienna Gen Hosp, Dept Cardiol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.		Winter, Max P/E-8456-2011	Maurer, Gerald/0000-0002-9043-7657; Lang, Irene/0000-0003-0485-2692				AKINS CW, 1991, ANN THORAC SURG, V52, P161, DOI 10.1016/0003-4975(91)91453-3; BLOOMFIELD P, 1991, NEW ENGL J MED, V324, P573, DOI 10.1056/NEJM199102283240901; Bonow RO, 1998, J AM COLL CARDIOL, V32, P1486, DOI 10.1016/S0735-1097(98)00454-9; Carabello BA, 1997, CIRCULATION, V95, P2241, DOI 10.1161/01.CIR.95.9.2241; CHIZNER MA, 1980, AM HEART J, V99, P419, DOI 10.1016/0002-8703(80)90375-0; Connolly HM, 1997, CIRCULATION, V95, P2395, DOI 10.1161/01.CIR.95.10.2395; ENGELSTEIN ED, 1998, HURSTS HEART ARTERIE, V1, P1081; FAGGIANO P, 1992, AM J CARDIOL, V70, P229, DOI 10.1016/0002-9149(92)91280-H; FRANK S, 1973, BRIT HEART J, V35, P41; HAMMERMEISTER KE, 1993, NEW ENGL J MED, V328, P1289, DOI 10.1056/NEJM199305063281801; HORSTKOTTE D, 1988, EUR HEART J, V9, P57, DOI 10.1093/eurheartj/9.suppl_E.57; Iivanainen AM, 1996, AM J CARDIOL, V78, P97, DOI 10.1016/S0002-9149(96)00235-4; KELLY TA, 1988, AM J CARDIOL, V61, P123, DOI 10.1016/0002-9149(88)91317-3; KOUCHOUKOS NT, 1994, NEW ENGL J MED, V330, P1, DOI 10.1056/NEJM199401063300101; LINDBLOM D, 1990, J AM COLL CARDIOL, V15, P566, DOI 10.1016/0735-1097(90)90627-2; Lund O, 1996, THORAC CARDIOV SURG, V44, P289, DOI 10.1055/s-2007-1012039; LUND O, 1990, CIRCULATION, V82, P124, DOI 10.1161/01.CIR.82.1.124; LUND O, 1989, SCAND J THORAC CARD, V23, P263, DOI 10.3109/14017438909106006; MURPHY ES, 1981, CIRCULATION, V64, P184; OBRIEN MF, 1995, ANN THORAC SURG, V60, pS65, DOI 10.1016/0003-4975(95)00223-8; OTTO CM, 1997, CIRCULATION, V95, P222; PELLIKKA PA, 1990, J AM COLL CARDIOL, V15, P1012, DOI 10.1016/0735-1097(90)90234-G; RAPAPORT E, 1975, AM J CARDIOL, V35, P221, DOI 10.1016/0002-9149(75)90005-3; Ross J Jr, 1968, Circulation, V38, P61; SCHWARZ F, 1982, CIRCULATION, V66, P1105, DOI 10.1161/01.CIR.66.5.1105; SMITH N, 1978, CIRCULATION, V58, P255, DOI 10.1161/01.CIR.58.2.255; SPRIGINGS DC, 1995, BRIT HEART J, V74, P481; *STS NAT DAT, 2000, STS US CARD SURG DAT; TURINA J, 1987, EUR HEART J, V8, P471, DOI 10.1093/oxfordjournals.eurheartj.a062307; Vongpatanasin W, 1996, NEW ENGL J MED, V335, P407, DOI 10.1056/NEJM199608083350607; WOOD P, 1958, AM J CARDIOL, V1, P553, DOI 10.1016/0002-9149(58)90138-3; YACOUB M, 1995, J THORAC CARDIOV SUR, V110, P186, DOI 10.1016/S0022-5223(05)80025-X	32	938	967	0	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 31	2000	343	9					611	617		10.1056/NEJM200008313430903	http://dx.doi.org/10.1056/NEJM200008313430903			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	348RE	10965007	Bronze			2022-12-24	WOS:000088999600003
J	Bard, J; Zhelkovsky, AM; Helmling, S; Earnest, TN; Moore, CL; Bohm, A				Bard, J; Zhelkovsky, AM; Helmling, S; Earnest, TN; Moore, CL; Bohm, A			Structure of yeast poly(A) polymerase alone and in complex with 3 '-dATP	SCIENCE			English	Article							DNA-POLYMERASE; CRYSTAL-STRUCTURES; MESSENGER-RNA; BINDING; MECHANISM; DOMAIN; BETA; NUCLEOTIDYLTRANSFERASE; EUKARYOTES; FRAGMENT	Polyadenylate [poly(A)] polymerase (PAP) catalyzes the addition of a polyadenosine tail to almost all eukaryotic messenger RNAs (mRNAs). The crystal structure of the PAP from Saccharomyces cerevisiae (Pap1) has been solved to 2.6 angstroms, both alone and in complex with 3'-deoxyadenosine triphosphate (3'-dATP). Like other nucleic acid polymerases, Pap1 is composed of three domains that encircle the active site. The arrangement of these domains, however, is quite different from that seen in polymerases that use a template to select and position their incoming nucleotides. The first two domains are functionally analogous to polymerase palm and fingers domains. The third domain is attached to the fingers domain and is' known to interact with the single-stranded RNA primer. In the nucleotide complex, two molecules of 3'-dATP are bound to Pap1, One occupies the position of the incoming base, prior to its addition to the mRNA chain. The other is believed to occupy the position of the 3' end of the mRNA primer.	Boston Biomed Res Inst, Watertown, MA 02472 USA; Tufts Univ, Sch Med, Dept Mol Microbiol, Boston, MA 02111 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Phys Sci, Macromol Crystallog Facil Adv Light Source, Berkeley, CA 94720 USA; Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA	Boston Biomedical Research Institute; Tufts University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Tufts University	Bohm, A (corresponding author), Boston Biomed Res Inst, 64 Grove St, Watertown, MA 02472 USA.				NIGMS NIH HHS [R01 GM57218-01A2] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057218] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agalarov SC, 2000, SCIENCE, V288, P107, DOI 10.1126/science.288.5463.107; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; BEESE LS, 1993, BIOCHEMISTRY-US, V32, P14095, DOI 10.1021/bi00214a004; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; Bricogne G, 1997, METHOD ENZYMOL, V276, P361, DOI 10.1016/S0076-6879(97)76069-5; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carpousis AJ, 1999, TRENDS GENET, V15, P24, DOI 10.1016/S0168-9525(98)01627-8; Coburn GA, 1999, PROG NUCLEIC ACID RE, V62, P55; Conte MR, 2000, EMBO J, V19, P3132, DOI 10.1093/emboj/19.12.3132; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Doublie S, 1998, CURR OPIN STRUC BIOL, V8, P704, DOI 10.1016/S0959-440X(98)80089-4; Doublie S, 1999, STRUCTURE, V7, pR31, DOI 10.1016/S0969-2126(99)80017-3; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P345, DOI 10.1016/S0968-0004(00)89071-4; Huang YQ, 1996, MOL CELL BIOL, V16, P1534; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Martin G, 1996, EMBO J, V15, P2593, DOI 10.1002/j.1460-2075.1996.tb00617.x; MARTIN G, IN PRESS EMBO J; Ohnacker M, 1996, NUCLEIC ACIDS RES, V24, P2585, DOI 10.1093/nar/24.13.2585; OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0; PEDERSEN LC, 1995, BIOCHEMISTRY-US, V34, P13305, DOI 10.1021/bi00041a005; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999; Zhelkovsky A, 1998, MOL CELL BIOL, V18, P5942, DOI 10.1128/MCB.18.10.5942; ZHELKOVSKY AM, 1995, J BIOL CHEM, V270, P26715, DOI 10.1074/jbc.270.44.26715; ZHELKOVSKY AM, UNPUB; [No title captured]	32	94	96	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 25	2000	289	5483					1346	1349		10.1126/science.289.5483.1346	http://dx.doi.org/10.1126/science.289.5483.1346			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347RF	10958780				2022-12-24	WOS:000088942400037
J	Werlen, G; Hausmann, B; Palmer, E				Werlen, G; Hausmann, B; Palmer, E			A motif in the alpha beta T-cell receptor controls positive selection by modulating ERK activity	NATURE			English	Article							MAP KINASE ACTIVATION; NEGATIVE SELECTION; DIFFERENTIATION; LYMPHOCYTES; THYMOCYTES; APOPTOSIS; PATHWAYS; SIGNAL; MICE; JNK2	Positive selection allows thymocytes that recognize an individual's own major histocompatibility complex (self-MHC) molecules to survive and differentiate, whereas negative selection removes overtly self-reactive thymocytes(1). Although both forms of thymic selection are mediated by the alpha beta T-cell receptor (TCR) and require self-MHC recognition, an important question is whether they are controlled by distinct signalling cascades(2). We have shown that mutation of an essential motif within the TCR alpha-chain-connecting peptide domain (alpha-CPM) profoundly affects positive but not negative selection(3). Using transgenic mice expressing a mutant alpha-CPM TCR we examined the contribution of several mitogen-activated protein kinase (MAPK) cascades to thymic selection. Here we show that in thymocytes expressing a mutant alpha-CPM receptor, a positively selecting peptide failed to activate the extracellular signal-regulated kinase (ERK), although other MAPK cascades were induced normally. The defect in ERK activation was associated with impaired recruitment of the activated tyrosine kinases Lck and ZAP-70, phosphorylated forms of the TCR component CD3 zeta and the adaptor protein LAT to detergent-insoluble glycolipid-enriched microdomains (DIGs). Therefore, an intact DIG-associated signalosome is essential for sustained ERK activation, which leads to positive selection.	Basel Inst Immunol, CH-4005 Basel, Switzerland		Werlen, G (corresponding author), Basel Inst Immunol, Grenzacherstr 487, CH-4005 Basel, Switzerland.							AlberolaIla J, 1996, J EXP MED, V184, P9, DOI 10.1084/jem.184.1.9; ALBEROLAILA J, 1995, NATURE, V373, P620, DOI 10.1038/373620a0; ALEXANDER J, 1989, IMMUNOGENETICS, V29, P380, DOI 10.1007/BF00375866; Backstrom BT, 1998, SCIENCE, V281, P835, DOI 10.1126/science.281.5378.835; Backstrom BT, 1996, IMMUNITY, V5, P437, DOI 10.1016/S1074-7613(00)80500-2; Dave VP, 1997, EMBO J, V16, P1360, DOI 10.1093/emboj/16.6.1360; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; HOGQUIST KA, 1995, IMMUNITY, V3, P79, DOI 10.1016/1074-7613(95)90160-4; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Jacinto E, 1998, IMMUNITY, V8, P31, DOI 10.1016/S1074-7613(00)80456-2; Mariathasan S, 1999, SEMIN IMMUNOL, V11, P263, DOI 10.1006/smim.1999.0182; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; OShea CC, 1996, EUR J IMMUNOL, V26, P2350, DOI 10.1002/eji.1830261012; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Sabapathy K, 1999, CURR BIOL, V9, P116, DOI 10.1016/S0960-9822(99)80065-7; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Stotz SH, 1999, J EXP MED, V189, P253, DOI 10.1084/jem.189.2.253; Sugawara T, 1998, IMMUNITY, V9, P565, DOI 10.1016/S1074-7613(00)80639-1; SWAN KA, 1995, EMBO J, V14, P276, DOI 10.1002/j.1460-2075.1995.tb07001.x; SWAT W, 1991, NATURE, V351, P150, DOI 10.1038/351150a0; VONBOEHMER H, 1989, IMMUNOL TODAY, V10, P57, DOI 10.1016/0167-5699(89)90307-1; Werlen G, 1998, EMBO J, V17, P3101, DOI 10.1093/emboj/17.11.3101; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	30	161	164	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					422	426		10.1038/35019094	http://dx.doi.org/10.1038/35019094			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935640				2022-12-24	WOS:000088383800050
J	Henney, JE				Henney, JE			New first-line therapy for colorectal cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 5	2000	284	1					33	33		10.1001/jama.284.1.33	http://dx.doi.org/10.1001/jama.284.1.33			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	328GX	10905906				2022-12-24	WOS:000087843000003
J	Haber, D				Haber, D			BRCA1: an emerging role in the cellular response to DNA damage	LANCET			English	Editorial Material							MEIOTIC CELLS; BREAST-CANCER; PHOSPHORYLATION; MUTATIONS; REPAIR; GENES; CYCLE; ATM		Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University	Haber, D (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA.							Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Chehab NH, 2000, GENE DEV, V14, P278; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Hakem R, 1996, CELL, V85, P1009, DOI 10.1016/S0092-8674(00)81302-1; Harkin DP, 1999, CELL, V97, P575, DOI 10.1016/S0092-8674(00)80769-2; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Lee JS, 2000, NATURE, V404, P201, DOI 10.1038/35004614; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Phillips KA, 1999, J CLIN ONCOL, V17, P3653, DOI 10.1200/JCO.1999.17.11.3653; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Somasundaram K, 1997, NATURE, V389, P187, DOI 10.1038/38291; Venkitaraman AR, 1999, SCIENCE, V286, P1100, DOI 10.1126/science.286.5442.1100; Xu XL, 1999, NAT GENET, V22, P37, DOI 10.1038/8743	17	6	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 17	2000	355	9221					2090	2091		10.1016/S0140-6736(00)02371-0	http://dx.doi.org/10.1016/S0140-6736(00)02371-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325QD	10902618				2022-12-24	WOS:000087687100004
J	Liu, SM; Manson, JE; Stampfer, MJ; Rexrode, KM; Hu, FB; Rimm, EB; Willett, WC				Liu, SM; Manson, JE; Stampfer, MJ; Rexrode, KM; Hu, FB; Rimm, EB; Willett, WC			Whole grain consumption and risk of ischemic stroke in women - A prospective study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORONARY HEART-DISEASE; FOOD-FREQUENCY QUESTIONNAIRE; DIETARY PATTERNS; POPULATION; FRUIT; MEN; REPRODUCIBILITY; POTASSIUM; MORTALITY; VALIDITY	Context Although increased intake of grain products has been recommended to prevent cardiovascular disease (CVD), prospective data examining the relation of whole grain intake to risk of ischemic stroke are sparse, especially among women. Objective To examine the hypothesis that higher whole grain intake reduces the risk of ischemic stroke in women. Design, Setting, and Participants A prospective cohort of 75521 US women aged 38 to 63 years without previous diagnosis of diabetes mellitus, coronary heart disease, stroke, or other CVDs in 1984, who completed detailed food frequency questionnaires (FFQs) in 1984, 1986, 1990, and 1994, and were followed up for 12 years as part of the Nurses' Health Study. Main Outcome Measure Incidence of ischemic stroke, confirmed by medical records, by quintile of whole grain intake according to FFQ responses. Results During 861 900 person-years of follow-up, 352 confirmed incident cases of ischemic stroke occurred. We observed an inverse association between whole grain intake and ischemic stroke risk. The age-adjusted relative risks (RRs) from the lowest to highest quintiles of whole grain intake were 1.00 (referent), 0.68 (95% confidence interval [CII, 0.49-0.94), 0.69 (95% CI, 0.51-0.95), 0.49 (95% CI, 0.35-0.69), and 0.57 (95% CI, 0.42-0.78; P=.003 for trend). Adjustment for smoking modestly attenuated this association (RR comparing extreme quintiles, 0.64; 95% CI, 0.47-0.89). This inverse association remained essentially unchanged with further adjustment for known CVD risk factors, including saturated fat and transfatty acid intake (multivariate-adjusted RR comparing extreme quintiles, 0.69; 95% Cf, 0.50-0.98). The inverse relation between whole grain intake and risk of ischemic stroke was also consistently observed among subgroups of women who never smoked, did not drink alcohol, did not exercise regularly, or who did not use postmenopausal hormones. No significant association was observed between total grain intake and risk of ischemic stroke. Conclusions tn this cohort, higher intake of whole grain foods was associated with a lower risk of ischemic stroke among women, independent of known CVD risk factors. These prospective data support the notion that higher intake of whole grains may reduce the risk of ischemic stroke.	Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston, MA 02215 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Liu, SM (corresponding author), Brigham & Womens Hosp, Dept Med, Div Prevent Med, 900 Commonwealth Ave E, Boston, MA 02215 USA.		Liu, Simin/I-3689-2014; Liu, Simin/GSN-4159-2022; Rexrode, Kathryn M/I-1177-2018	Liu, Simin/0000-0003-2098-3844; Rexrode, Kathryn/0000-0003-3387-8429	NATIONAL CANCER INSTITUTE [R37CA040356, R01CA040356] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594] Funding Source: NIH RePORTER; NCI NIH HHS [CA40356] Funding Source: Medline; NHLBI NIH HHS [HL34594, HL24704] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALBERTSON AM, 1995, J AM DIET ASSOC, V95, P703, DOI 10.1016/S0002-8223(95)00194-8; *AM HEART ASS, 2000, 200 HEART STROK STAT; ANDERSON GH, 1994, CRIT REV FOOD SCI, V34, P435, DOI 10.1080/10408399409527673; Ascherio A, 1998, CIRCULATION, V98, P1198, DOI 10.1161/01.CIR.98.12.1198; BRONNER LL, 1995, NEW ENGL J MED, V333, P1392, DOI 10.1056/NEJM199511233332106; CUPPLES LA, 1988, STAT MED, V7, P205, DOI 10.1002/sim.4780070122; GRUNDY SM, 1990, J LIPID RES, V31, P1149; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 1999, AM J CLIN NUTR, V69, P243; Jacobs DR, 1998, AM J CLIN NUTR, V68, P248, DOI 10.1093/ajcn/68.2.248; Joshipura KJ, 1999, JAMA-J AM MED ASSOC, V282, P1233, DOI 10.1001/jama.282.13.1233; KHAW KT, 1987, NEW ENGL J MED, V316, P235, DOI 10.1056/NEJM198701293160502; Knekt P, 1996, BRIT MED J, V312, P478, DOI 10.1136/bmj.312.7029.478; LIU S, IN PRESS AM J CLIN N; Liu SM, 1999, AM J CLIN NUTR, V70, P412; *MMWR, 1999, MMWR-MORBID MORTAL W, V48, P649; Ness AR, 1999, J CARDIOVASC RISK, V6, P229; Rimm EB, 1998, JAMA-J AM MED ASSOC, V279, P359, DOI 10.1001/jama.279.5.359; Rimm EB, 1996, JAMA-J AM MED ASSOC, V275, P447, DOI 10.1001/jama.275.6.447; RIMM EB, 1993, NEW ENGL J MED, V328, P1450, DOI 10.1056/NEJM199305203282004; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Selhub J, 1996, J NUTR, V126, pS1258, DOI 10.1093/jn/126.suppl_4.1258S; Slavin J, 1997, NUTR CANCER, V27, P14, DOI 10.1080/01635589709514495; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Taylor TN, 1996, STROKE, V27, P1459, DOI 10.1161/01.STR.27.9.1459; *USDA, 2000, NUTR YOUR HLTH DIET; Weinfeld, 1981, STROKE S1, V12, pI13; Willett W., 2012, NUTR EPIDEMIOLOGY; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; WILLETT WC, 1998, MODERN EPIDEMIOLOGY, P623; WOLK AM, IN PRESS BMJ	31	216	226	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 27	2000	284	12					1534	1540		10.1001/jama.284.12.1534	http://dx.doi.org/10.1001/jama.284.12.1534			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	355HF	11000647				2022-12-24	WOS:000089379700029
J	Gaeta, G; De Michele, M; Cuomo, S; Guarini, P; Foglia, MC; Bond, MG; Trevisan, M				Gaeta, G; De Michele, M; Cuomo, S; Guarini, P; Foglia, MC; Bond, MG; Trevisan, M			Arterial abnormalities in the offspring of patients with premature myocardial infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; INTIMA-MEDIA THICKNESS; OXIDE SYNTHASE GENE; RISK-FACTORS; PARENTAL HISTORY; FAMILY HISTORY; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; NITRIC-OXIDE; DEPENDENT DILATATION	Background: The offspring of patients with premature coronary disease may be at increased risk for atherosclerosis. We undertook a study to determine whether changes in brachial-artery reactivity and the thickness of the carotid intima and media, two markers of early atherosclerosis, are present in adolescents and young adults with a parental history of premature myocardial infarction. Methods: We enrolled 40 healthy young people whose parents had had premature myocardial infarction (48 percent male; mean [+/-SD] age, 19.0+/-5.2 years) and 40 control subjects who were matched with the first group according to age and sex. All the subjects underwent high-resolution B-mode ultrasound examinations for the measurement of the brachial-artery vasodilatory response after arterial occlusion (i.e., reactive hyperemia) and the intima-media thickness of the distal common carotid arteries. Results: As compared with the control subjects, the offspring of patients with premature myocardial infarction had lower flow-mediated reactivity of the brachial arteries (5.7+/-5.0 percent, vs. 10.2+/-6.6 percent in the control subjects; P=0.001) and greater mean intima-media thickness of the common carotid artery (0.49+/-0.08 mm, vs. 0.44+/-0.07 mm in the control subjects; P=0.004). In the subjects with a parental history of premature myocardial infarction, an inverse association was found between brachial-artery reactivity and carotid intima-media thickness (r=-0.46, P=0.003). In a conditional logistic-regression analysis, both brachial-artery reactivity and carotid intima-media thickness were significantly and independently correlated with a parental history of premature myocardial infarction. Conclusions: Structural and functional changes are present at an early age in the arteries of persons with a parental history of premature myocardial infarction. (N Engl J Med 2000;343:840-6.) (C) 2000, Massachusetts Medical Society.	Wake Forest Univ, Bowman Gray Sch Med, Div Vasc Ultrasound Res, Winston Salem, NC 27157 USA; A Cardarelli Hosp, Div Cardiol, Naples, Italy; A Cardarelli Hosp, Clin Anal Lab, Naples, Italy; Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy; S Maria di Lorcto Hosp, Div Cardiol, Naples, Italy; SUNY Buffalo, Dept Social & Prevent Med, Buffalo, NY 14260 USA	Wake Forest University; Wake Forest Baptist Medical Center; Antonio Cardarelli Hospital; Antonio Cardarelli Hospital; University of Naples Federico II; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Bond, MG (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Div Vasc Ultrasound Res, Med Ctr Blvd, Winston Salem, NC 27157 USA.		Tanaka, Gohichi/A-1684-2010	Crisanti, Andrea/0000-0002-2406-4426; trevisan, maurizio/0000-0001-5479-0050				BAO WH, 1995, CIRCULATION, V91, P365, DOI 10.1161/01.CIR.91.2.365; BARRETTCONNOR E, 1984, CIRCULATION, V69, P1065, DOI 10.1161/01.CIR.69.6.1065; Bots ML, 1997, CIRCULATION, V96, P1432, DOI 10.1161/01.CIR.96.5.1432; CELERMAJER DS, 1992, LANCET, V340, P1111, DOI 10.1016/0140-6736(92)93147-F; CELERMAJER DS, 1994, J AM COLL CARDIOL, V24, P1468, DOI 10.1016/0735-1097(94)90141-4; Clarkson P, 1997, CIRCULATION, V96, P3378; COOKE JP, 1994, ARTERIOSCLER THROMB, V14, P653, DOI 10.1161/01.ATV.14.5.653; De Bacquer D, 1999, J AM COLL CARDIOL, V33, P1491, DOI 10.1016/S0735-1097(99)00067-4; Enderle MD, 1998, HEART, V80, P349, DOI 10.1136/hrt.80.4.349; FREEDMAN DS, 1986, NEW ENGL J MED, V315, P721, DOI 10.1056/NEJM198609183151202; Friedlander Y, 1998, CIRCULATION, V97, P155, DOI 10.1161/01.CIR.97.2.155; Ghiadoni L, 1998, HYPERTENSION, V32, P25, DOI 10.1161/01.HYP.32.1.25; Greenlund KJ, 1999, CIRCULATION, V99, P2144, DOI 10.1161/01.CIR.99.16.2144; HEISS G, 1991, AM J EPIDEMIOL, V134, P250, DOI 10.1093/oxfordjournals.aje.a116078; JOANNIDES R, 1995, CIRCULATION, V91, P1314, DOI 10.1161/01.CIR.91.5.1314; Jousilahti P, 1996, J CLIN EPIDEMIOL, V49, P497, DOI 10.1016/0895-4356(95)00581-1; KAPRIO J, 1993, CIRCULATION, V87, P1960, DOI 10.1161/01.CIR.87.6.1960; Nakayama M, 1999, CIRCULATION, V99, P2864, DOI 10.1161/01.CIR.99.22.2864; *NAT CHOL ED PROGR, 1992, PEDIATRICS, V89, P525; Neunteufl T, 1997, ATHEROSCLEROSIS, V129, P111, DOI 10.1016/S0021-9150(96)06018-2; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; PHILLIPS RL, 1974, AM J EPIDEMIOL, V100, P87, DOI 10.1093/oxfordjournals.aje.a112021; PIGNOLI P, 1986, CIRCULATION, V74, P1399, DOI 10.1161/01.CIR.74.6.1399; RILEY WA, 1986, ARTERIOSCLEROSIS, V6, P378, DOI 10.1161/01.ATV.6.4.378; Rose GA, 1982, WHO MONOGRAPH SERIES, V56; SLACK J., 1966, J MED GENET, V3, P239, DOI 10.1136/jmg.3.4.239; SRINIVASAN SR, 1991, CIRCULATION, V84, P160, DOI 10.1161/01.CIR.84.1.160; Wang XL, 1996, NAT MED, V2, P41, DOI 10.1038/nm0196-41; Wood D, 1998, EUR HEART J, V19, P1434; Yataco AR, 1999, AM J CARDIOL, V83, P754, DOI 10.1016/S0002-9149(98)00984-9; Zannad F, 1998, HUM GENET, V103, P183, DOI 10.1007/s004390050804; Zureik M, 1999, ARTERIOSCL THROM VAS, V19, P366, DOI 10.1161/01.ATV.19.2.366	32	135	142	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 21	2000	343	12					840	846		10.1056/NEJM200009213431203	http://dx.doi.org/10.1056/NEJM200009213431203			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354XB	10995863	Bronze			2022-12-24	WOS:000089355600003
J	Temple, R; Ellenberg, SS				Temple, R; Ellenberg, SS			Placebo-controlled trials and active-control trials in the evaluation of new treatments - Part 1: Ethical and scientific issues	ANNALS OF INTERNAL MEDICINE			English	Article							CLINICAL-TRIALS; EQUIVALENCE; ORTHODOXY; MYTHS	In recent years, several authors have argued that placebo-controlled trials are invariably unethical when known effective therapy is available for the condition being studied, regardless of the condition or the consequences of deferring treatment. Some have also disputed the Value of placebo-controlled trials in such a setting, asserting that the comparison of new treatment with old treatment is sufficient to establish efficacy and is all that should be of interest. This article considers the ethical concerns about use of placebo controls and describes the limited ability of active-control equivalence (also known as noninferiority) trials to establish efficacy of new therapies in many medical contexts. The authors conclude that placebo-controlled trials are not uniformly unethical when known effective therapies are available; rather. their acceptability is determined by whether the patient will be harmed by deferral of therapy. If patients are not harmed, such trials can ethically be carried out. Furthermore, active-control trials, although valuable, informative, and appropriate in many circumstances, often cannot provide reliable evidence of the effectiveness of a new therapy.	US FDA, Ctr Drug Evaluat & Res, Rockville, MD 20857 USA; US FDA, Ctr Biol Evaluat & Res, Rockville, MD 20857 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Temple, R (corresponding author), US FDA, Ctr Drug Evaluat & Res, 5600 Fishers Lane,HFD-101-WOC II-6014, Rockville, MD 20857 USA.							AGOSTINI A, 1995, LANCET, V310, P170; *AM MED ASS COUNC, 1996, 2A1996 AM MED ASS CO; AMERY W, 1975, J CLIN PHARMACOL, V15, P674, DOI 10.1002/j.1552-4604.1975.tb05919.x; Angell M, 1997, NEW ENGL J MED, V337, P847, DOI 10.1056/NEJM199709183371209; ASPINALL RL, 1995, BRIT MED J, V311, P844, DOI 10.1136/bmj.311.7009.844; BLACKWELDER WC, 1982, CONTROL CLIN TRIALS, V3, P345, DOI 10.1016/0197-2456(82)90024-1; *COUNC INT ORG MED, 1993, INT ETH GUID BIOM RE; DOLLERY CT, 1979, EUR J CLIN PHARMACOL, V15, P219, DOI 10.1007/BF00618508; Ellenberg SS, 2000, ANN INTERN MED, V133, P464, DOI 10.7326/0003-4819-133-6-200009190-00015; FLEMING TR, 1990, J ACQ IMMUN DEF SYND, V3, pS82; FLEMING TR, 1987, CANCER TREAT REP, V71, P1061; Freedman B, 1996, J LAW MED ETHICS, V24, P243, DOI 10.1111/j.1748-720X.1996.tb01859.x; Freedman B, 1996, J LAW MED ETHICS, V24, P252, DOI 10.1111/j.1748-720X.1996.tb01860.x; FRESTON JW, 1986, AM J GASTROENTEROL, V81, P307; GROF P, 1993, WHO EXPERT SERIES BI, V2, P28; HENRY D, 1995, BMJ-BRIT MED J, V310, P1279, DOI 10.1136/bmj.310.6990.1279; *INT C HARM, 1999, FED REGISTER, V64, P51767; Jones E, 1996, BMJ-BRIT MED J, V313, P36, DOI 10.1136/bmj.313.7048.36; LASAGNA L, 1979, EUR J CLIN PHARMACOL, V15, P373, DOI 10.1007/BF00561733; Laska Eugene M., 1994, P29; LEBER PD, 1989, EPILEPSIA, V30, pS57, DOI 10.1111/j.1528-1157.1989.tb05816.x; Levine RJ, 1986, ETHICS REGULATION CL, V2nd; MAKUCH R, 1989, J CLIN EPIDEMIOL, V42, P503, DOI 10.1016/0895-4356(89)90146-7; MAX MB, 1994, CLIN PHARMACOL THER, V56, P237, DOI 10.1038/clpt.1994.130; MODELL W, 1958, JAMA-J AM MED ASSOC, V167, P2190, DOI 10.1001/jama.1958.72990350005006; PLEDGER G, 1990, STAT ISSUES DRUG RES, P226; PRIEN RF, 1988, PSYCHOPHARMACOL BULL, V24, P4; ROTHMAN KJ, 1994, NEW ENGL J MED, V331, P394, DOI 10.1056/NEJM199408113310611; SACHAR DB, 1984, AM J GASTROENTEROL, V79, P913; SMITH JL, 1989, AM J GASTROENTEROL, V84, P469; SRAMEK JJ, 1995, NEW ENGL J MED, V332, P62; Temple R, 1982, DRUG INF J, V10-17, DOI DOI 10.1177/009286158201600102; TEMPLE R, 1983, P AM STAT ASS, P1; TEMPLE RJ, 1994, COMMUN STAT THEORY, V23, P499, DOI 10.1080/03610929408831269; Temple Robert, 1996, Account Res, V4, P267, DOI 10.1080/08989629608573887; Tramer MR, 1998, BMJ-BRIT MED J, V317, P875, DOI 10.1136/bmj.317.7162.875; US Department of Health and Human Services. Food and Drug Administration, 1988, GUID FORM CONT CLIN; *WORLD MED ASS, 1985, SUMM HIST WORLD MED; *WORLD MED ASS DEC, 1997, JAMA-J AM MED ASSOC, V277, P925, DOI DOI 10.1001/JAMA.1997.03540350075038; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7	40	584	598	1	28	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 19	2000	133	6					455	463		10.7326/0003-4819-133-6-200009190-00014	http://dx.doi.org/10.7326/0003-4819-133-6-200009190-00014			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354KM	10975964				2022-12-24	WOS:000089329700008
J	AbdAlla, S; Lother, H; Quitterer, U				AbdAlla, S; Lother, H; Quitterer, U			AT(1)-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration	NATURE			English	Article							BRADYKININ B2 RECEPTOR; B-2 RECEPTOR; INTERNALIZATION; OVEREXPRESSION; DIMERIZATION; MECHANISMS; TERMINUS; BINDING; SYSTEM	The vasopressor angiotensin II regulates vascular contractility and blood pressure through binding to type 1 angiotensin II receptors (AT(1); refs 1, 2). Bradykinin, a vasodepressor, is a functional antagonist of angiotensin II (ref. 3). The two hormone systems are interconnected by the angiotensin-converting enzyme, which releases angiotensin II from its precursor and inactivates the vasodepressor bradykinin(4). Here we show that the AT(1) receptor and the bradykinin (B-2) receptor also communicate directly with each other. They form stable heterodimers, causing increased activation of G alpha(q) and G alpha(i) proteins, the two major signalling proteins triggered by AT(1). Furthermore, the endocytotic pathway of both receptors changed with heterodimerization. This is the first example of signal enhancement triggered by heterodimerization of two different vasoactive hormone receptors.	Inst Pharmakol, D-97078 Wurzburg, Germany; Heinrich Pette Inst, D-20251 Hamburg, Germany; Genet Engn & Biotechnol Res Inst, Alexandria, Egypt	University of Wurzburg; Heinrich Pette Institute	Quitterer, U (corresponding author), Inst Pharmakol, Versbacher Str 9, D-97078 Wurzburg, Germany.	toph029@rzbox.uni-wuerzburg.de						AbdAlla S, 1999, J BIOL CHEM, V274, P26079, DOI 10.1074/jbc.274.37.26079; AbdAlla S, 1996, J BIOL CHEM, V271, P27382, DOI 10.1074/jbc.271.44.27382; BASCANDS JL, 1994, AM J PHYSIOL-RENAL, V267, pF871, DOI 10.1152/ajprenal.1994.267.5.F871; BORKOWSKI JA, 1995, J BIOL CHEM, V270, P13706, DOI 10.1074/jbc.270.23.13706; DIXON BS, 1994, AM J PHYSIOL, V266, pC1406, DOI 10.1152/ajpcell.1994.266.5.C1406; DUDLEY DT, 1990, MOL PHARMACOL, V38, P370; Hebert TE, 1996, J BIOL CHEM, V271, P16384, DOI 10.1074/jbc.271.27.16384; Hein L, 1997, P NATL ACAD SCI USA, V94, P6391, DOI 10.1073/pnas.94.12.6391; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Liu F, 2000, NATURE, V403, P274, DOI 10.1038/35002014; MACEWAN DJ, 1995, MOL PHARMACOL, V48, P316; Masaki H, 1998, J CLIN INVEST, V101, P527, DOI 10.1172/JCI1885; Mastro R, 1999, ANAL BIOCHEM, V273, P313, DOI 10.1006/abio.1999.4224; NARDONE J, 1994, P NATL ACAD SCI USA, V91, P4417, DOI 10.1073/pnas.91.10.4417; PARRATT JR, 1994, TRENDS PHARMACOL SCI, V15, P19, DOI 10.1016/0165-6147(94)90129-5; PEACH MJ, 1977, PHYSIOL REV, V57, P313, DOI 10.1152/physrev.1977.57.2.313; Prado GN, 1997, J BIOL CHEM, V272, P14638, DOI 10.1074/jbc.272.23.14638; Quitterer U, 1999, J BIOL CHEM, V274, P14773, DOI 10.1074/jbc.274.21.14773; Quitterer U, 1999, P NATL ACAD SCI USA, V96, P10626, DOI 10.1073/pnas.96.19.10626; RANSNAS LA, 1989, P NATL ACAD SCI USA, V86, P7900, DOI 10.1073/pnas.86.20.7900; Romano C, 1996, J BIOL CHEM, V271, P28612, DOI 10.1074/jbc.271.45.28612; SOUBRIER F, 1988, P NATL ACAD SCI USA, V85, P9386, DOI 10.1073/pnas.85.24.9386; Tsuchida S, 1999, KIDNEY INT, V56, P509, DOI 10.1046/j.1523-1755.1999.00574.x; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302; Zhuo JL, 1998, KIDNEY INT, V54, pS22, DOI 10.1046/j.1523-1755.1998.06705.x	28	388	407	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 7	2000	407	6800					94	98		10.1038/35024095	http://dx.doi.org/10.1038/35024095			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	350WE	10993080				2022-12-24	WOS:000089124000049
J	Rosin-Arbesfeld, R; Townsley, F; Bienz, M				Rosin-Arbesfeld, R; Townsley, F; Bienz, M			The APC tumour suppressor has a nuclear export function	NATURE			English	Article							POLYPOSIS-COLI PROTEIN; BETA-CATENIN; ADENOMATOUS POLYPOSIS; SOMATIC MUTATION; SIGNAL; CRM1; GENE; ASSOCIATION; ACTIVATION; GSK3-BETA	The adenomatous polpyposis coli (APC) protein is mutated in most colorectal tumours(1). Nearly all APC mutations are truncations, and many of these terminate in the mutation cluster region located halfway through the protein(2-4). In cancer cells expressing mutant APC, beta-catenin is stabilized(5,6) and translocates into the nucleus to act as a transcriptional co-activator of T-cell factor(7). During normal development, APC also promotes the destabilization of beta-catenin and Drosophila Armadillo(8-11). It does so by binding to the Axin complex which earmarks beta-catenin/Armadillo for degradation by the proteasome pathway(12). APC has a regulatory role in this process(13,14), which is poorly understood. Here we show that APC contains highly conserved nuclear export signals 3' adjacent to the mutation cluster region that enable it to exit from the nucleus. This ability is lost in APC mutant cancer cells, and we provide evidence that beta-catenin accumulates in the nucleus as a result. Thus, the ability of APC to exit from the nucleus appears to be critical for its tumour suppressor function.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Bienz, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.							Ahmed Y, 1998, CELL, V93, P1171, DOI 10.1016/S0092-8674(00)81461-0; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Bienz M, 1999, CURR OPIN GENET DEV, V9, P595, DOI 10.1016/S0959-437X(99)00016-7; Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X; Farr GH, 2000, J CELL BIOL, V148, P691, DOI 10.1083/jcb.148.4.691; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; Hamada F, 1999, GENES CELLS, V4, P465, DOI 10.1046/j.1365-2443.1999.00272.x; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Lal G, 2000, SEMIN SURG ONCOL, V18, P314; Lamlum H, 1999, NAT MED, V5, P1071, DOI 10.1038/12511; Lantz VA, 1999, MECH DEVELOP, V85, P111, DOI 10.1016/S0925-4773(99)00096-9; McCartney BM, 1999, J CELL BIOL, V146, P1303, DOI 10.1083/jcb.146.6.1303; MIYAKI M, 1994, CANCER RES, V54, P3011; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; MUNEMITSU S, 1995, P NATL ACAD SCI USA, V92, P3046, DOI 10.1073/pnas.92.7.3046; NAGASE H, 1993, HUM MUTAT, V2, P425, DOI 10.1002/humu.1380020602; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Neufeld KL, 1997, P NATL ACAD SCI USA, V94, P3034, DOI 10.1073/pnas.94.7.3034; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; Rubinfeld B, 1997, CANCER RES, V57, P4624; Shih IM, 2000, CANCER RES, V60, P1671; Smits R, 1999, GENE DEV, V13, P1309, DOI 10.1101/gad.13.10.1309; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; Yokoya F, 1999, MOL BIOL CELL, V10, P1119, DOI 10.1091/mbc.10.4.1119; Yu X, 1999, NAT CELL BIOL, V1, P144, DOI 10.1038/11064	30	283	289	0	7	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 31	2000	406	6799					1009	1012		10.1038/35023016	http://dx.doi.org/10.1038/35023016			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	348ZW	10984057				2022-12-24	WOS:000089020200049
J	Johansson, J; Balsalobre, C; Wang, SY; Urbonaviciene, J; Jin, DJ; Sonden, B; Uhlin, BE				Johansson, J; Balsalobre, C; Wang, SY; Urbonaviciene, J; Jin, DJ; Sonden, B; Uhlin, BE			Nucleoid proteins stimulate stringently controlled bacterial promoters: A link between the cAMP-CRP and the (p)ppGpp regulons in Escherichia coli	CELL			English	Article							HISTONE-LIKE PROTEINS; GUANOSINE 5'-DIPHOSPHATE 3'-DIPHOSPHATE; H-NS; STATIONARY PHASE; GENE-EXPRESSION; PPGPP SYNTHESIS; RNA-POLYMERASE; DNA TOPOLOGY; INVITRO; COMPLEXES	We report that the H-NS nucleoid protein plays a positive role in the expression of stringently regulated genes in Escherichia coli. Bacteria lacking both H-NS and the paralog StpA show reduced growth rate. Colonies displaying an increased growth rate were isolated, and mapping of a suppressor mutation revealed a base pair substitution in the spoT gene. The spoT(A404E) mutant showed low ppGpp synthesizing ability. The crp gene, which encodes the global regulator CRP, was subject to negative stringent regulation. The stable RNA/protein ratio in an hns, stpA strain was decreased, whereas it was restored in the suppressor strain. Our findings provide evidence of a direct link between the cAMP-CRP modulon and the stringent response.	Umea Univ, Dept Microbiol, S-90187 Umea, Sweden; NCI, NIH, Mol Biol Lab, Bethesda, MD 20892 USA	Umea University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Uhlin, BE (corresponding author), Umea Univ, Dept Microbiol, S-90187 Umea, Sweden.	bernt.eric.uhlin@micro.umu.se	Uhlin, Bernt Eric/AAO-6292-2021; Balsalobre, Carlos/E-4213-2016	Uhlin, Bernt Eric/0000-0002-2991-8072; Balsalobre, Carlos/0000-0002-4147-219X; Johansson, Jorgen/0000-0002-0904-497X				AIBA H, 1982, NUCLEIC ACIDS RES, V10, P1345, DOI 10.1093/nar/10.4.1345; ARNQVIST A, 1992, MOL MICROBIOL, V6, P2443; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; CASHEL M, 1969, J BIOL CHEM, V244, P3133; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; DRLICA K, 1987, MICROBIOL REV, V51, P301, DOI 10.1128/MMBR.51.3.301-319.1987; FALCONI M, 1993, MOL MICROBIOL, V10, P273, DOI 10.1111/j.1365-2958.1993.tb01953.x; Figueroa-Bossi N, 1998, EMBO J, V17, P2359, DOI 10.1093/emboj/17.8.2359; Gentry DR, 1996, MOL MICROBIOL, V19, P1373, DOI 10.1111/j.1365-2958.1996.tb02480.x; Gonzalez-Gil G, 1998, EMBO J, V17, P2877, DOI 10.1093/emboj/17.10.2877; GORANSSON M, 1989, MOL MICROBIOL, V3, P1557, DOI 10.1111/j.1365-2958.1989.tb00141.x; GORANSSON M, 1990, NATURE, V344, P682, DOI 10.1038/344682a0; GUYER MS, 1980, COLD SPRING HARB SYM, V45, P135, DOI 10.1101/SQB.1981.045.01.022; HAGER DA, 1990, BIOCHEMISTRY-US, V29, P7890, DOI 10.1021/bi00486a016; HEINEMEYER EA, 1978, P NATL ACAD SCI USA, V75, P4180, DOI 10.1073/pnas.75.9.4180; Johansson J, 1998, J BACTERIOL, V180, P6117; Keener J, 1996, ESCHERICHIA COLI SAL, V2, P1417; KLECKNER N, 1991, METHOD ENZYMOL, V204, P139; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Kvint K, 2000, MOL MICROBIOL, V35, P435, DOI 10.1046/j.1365-2958.2000.01714.x; LAGOSKY PA, 1980, J BACTERIOL, V144, P499, DOI 10.1128/JB.144.2.499-508.1980; LAZZARINI RA, 1971, J BIOL CHEM, V246, P4381; LINN T, 1992, J BIOL CHEM, V267, P1449; METZGER S, 1989, J BIOL CHEM, V264, P21146; Murray KD, 1996, J MOL BIOL, V259, P41; NEIDHARDT FC, 1977, J BACTERIOL, V129, P378, DOI 10.1128/JB.129.1.378-387.1977; NINNEMANN O, 1992, EMBO J, V11, P1075, DOI 10.1002/j.1460-2075.1992.tb05146.x; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; OHLSEN KL, 1992, J BIOL CHEM, V267, P19813; OHLSEN KL, 1992, MOL MICROBIOL, V6, P2243, DOI 10.1111/j.1365-2958.1992.tb01400.x; OWENHUGHES TA, 1992, CELL, V71, P255, DOI 10.1016/0092-8674(92)90354-F; Pettijohn D.E., 1996, ESCHERICHIA COLI SAL, P158; Raghavan A, 1998, BIOPHYS CHEM, V75, P7, DOI 10.1016/S0301-4622(98)00185-9; ROSS W, 1990, EMBO J, V9, P3733, DOI 10.1002/j.1460-2075.1990.tb07586.x; ROSS W, 1989, J BACTERIOL, V171, P4009, DOI 10.1128/jb.171.7.4009-4018.1989; SCHMID MB, 1990, CELL, V63, P451, DOI 10.1016/0092-8674(90)90438-K; SCHNEIDER WC, 1945, J BIOL CHEM, V161, P293; Sonden B, 1996, EMBO J, V15, P4970, DOI 10.1002/j.1460-2075.1996.tb00877.x; SPASSKY A, 1984, NUCLEIC ACIDS RES, V12, P5321, DOI 10.1093/nar/12.13.5321; Tao H, 1999, J BACTERIOL, V181, P6425, DOI 10.1128/JB.181.20.6425-6440.1999; TUPPER AE, 1994, EMBO J, V13, P258, DOI 10.1002/j.1460-2075.1994.tb06256.x; VANBOGELEN RA, 1992, ELECTROPHORESIS, V13, P1014, DOI 10.1002/elps.11501301203; VONGABAIN A, 1983, P NATL ACAD SCI-BIOL, V80, P653; Williams RM, 1997, FEMS MICROBIOL LETT, V156, P175, DOI 10.1016/S0378-1097(97)00397-2; XIAO H, 1991, J BIOL CHEM, V266, P5980; YAMASHINO T, 1995, EMBO J, V14, P594, DOI 10.1002/j.1460-2075.1995.tb07035.x; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; ZHANG AX, 1992, NUCLEIC ACIDS RES, V20, P6735, DOI 10.1093/nar/20.24.6735; Zhang AX, 1996, EMBO J, V15, P1340, DOI 10.1002/j.1460-2075.1996.tb00476.x; Zhou YN, 1998, P NATL ACAD SCI USA, V95, P2908, DOI 10.1073/pnas.95.6.2908	53	75	76	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 18	2000	102	4					475	485		10.1016/S0092-8674(00)00052-0	http://dx.doi.org/10.1016/S0092-8674(00)00052-0			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	347BX	10966109	Bronze			2022-12-24	WOS:000088908000009
J	Pearson, PN; Palmer, MR				Pearson, PN; Palmer, MR			Atmospheric carbon dioxide concentrations over the past 60 million years	NATURE			English	Article							BORON ISOTOPIC COMPOSITION; EQUATORIAL PACIFIC; OCEAN PH; EOCENE; CO2; FORAMINIFERA; CLIMATE; PHOTOSYNTHESIS; DISSOCIATION; TEMPERATURES	Knowledge of the evolution of atmospheric carbon dioxide concentrations throughout the Earth's history is important for a reconstruction of the links between climate and radiative forcing of the Earth's surface temperatures. Although atmospheric carbon dioxide concentrations in the early Cenozoic era (about 60 Myr ago) are widely believed to have been higher than at present, there is disagreement regarding the exact carbon dioxide levels, the timing of the decline and the mechanisms that are most important for the control of CO2 concentrations over geological timescales. Here we use the boron-isotope ratios of ancient planktonic foraminifer shells to estimate the pH of surface-layer sea water throughout the past 60 million years, which can be used to reconstruct atmospheric CO2 concentrations. We estimate CO2 concentrations of more than 2,000 p.p.m. for the late Palaeocene and earliest Eocene periods (from about 60 to 52 Myr ago), and rnd an erratic decline between 55 and 40 Myr ago that may have been caused by reduced CO2 outgassing from ocean ridges, volcanoes and metamorphic belts and increased carbon burial. Since the early Miocene (about 24 Myr ago), atmospheric CO2 concentrations appear to have remained below 500 p.p.m. and were more stable than before, although transient intervals of CO2 reduction may have occurred during periods of rapid cooling approximately 15 and 3 Myr ago.	Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England; Univ London Imperial Coll Sci Technol & Med, TH Huxley Sch, London SW7 2BP, England	University of Bristol; Imperial College London	Pearson, PN (corresponding author), Univ Bristol, Dept Earth Sci, Queens Rd, Bristol BS8 1RJ, Avon, England.	Paul.Pearson@Bristol.ac.uk	Pearson, Paul N/B-2276-2009; Palmer, Martin R/I-6765-2012	Pearson, Paul N/0000-0003-4628-9818; Palmer, Martin R/0000-0003-1660-3714				Arrhenius S., 1896, LOND EDINB DUBLIN PH, V41, P237, DOI [10.1080/14786449608620846, DOI 10.1080/14786449608620846]; Beck RA, 1998, LATE PALEOCENE-EARLY EOCENE CLIMATIC AND BIOTIC EVENTS IN THE MARINE AND TERRESTRIAL RECORDS, P103; BERGER WH, 1986, GEOL RUNDSCH, V75, P249, DOI 10.1007/BF01770192; Berggren WA, 1995, GEOCHRONOLOGY TIME S, V54, P129, DOI DOI 10.2110/PEC.95.04.0129; BERNER RA, 1983, AM J SCI, V283, P641, DOI 10.2475/ajs.283.7.641; BRADY PV, 1991, J GEOPHYS RES-SOL EA, V96, P18101, DOI 10.1029/91JB01898; BRALOWER TJ, 1995, PALEOCEANOGRAPHY, V10, P841, DOI 10.1029/95PA01143; Broecker WS, 1998, GLOBAL BIOGEOCHEM CY, V12, P403, DOI 10.1029/98GB01927; Chamberlin T.C., 1899, J GEOL, V7, P545, DOI [10.1086/, 10.1086/608449, DOI 10.1086/608449]; Coxall HK, 2000, GEOLOGY, V28, P87, DOI 10.1130/0091-7613(2000)028<0087:HDAAEL>2.3.CO;2; CROWLEY TJ, 2000, WARM CLIMATES EARTH, P425; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Frakes L. A, 1992, CLIMATE MODES PHANER; Hemming NG, 1998, GLOBAL BIOGEOCHEM CY, V12, P581, DOI 10.1029/98GB02337; HEMMING NG, 1992, GEOCHIM COSMOCHIM AC, V56, P537, DOI 10.1016/0016-7037(92)90151-8; HEMMING NG, 1995, GEOCHIM COSMOCHIM AC, V59, P371, DOI 10.1016/0016-7037(95)00288-B; ISRAELSON C, 1995, P ODP SCI RES, V144, P737; JORGENSEN BB, 1985, LIMNOL OCEANOGR, V30, P1253, DOI 10.4319/lo.1985.30.6.1253; KAKIHANA H, 1977, B CHEM SOC JPN, V50, P158, DOI 10.1246/bcsj.50.158; Kerrick DM, 1998, CHEM GEOL, V145, P213, DOI 10.1016/S0009-2541(97)00144-7; KIEHL JT, 1987, J GEOPHYS RES-ATMOS, V92, P2991, DOI 10.1029/JD092iD03p02991; MCGOWRAN B, 1989, GEOLOGY, V17, P857, DOI 10.1130/0091-7613(1989)017<0857:SBITEO>2.3.CO;2; Miller KG, 1987, PALEOCEANOGRAPHY, V2, P1, DOI 10.1029/PA002i001p00001; MILLERO FJ, 1995, GEOCHIM COSMOCHIM AC, V59, P661, DOI 10.1016/0016-7037(94)00354-O; Opdyke Bradley N., 1995, Proceedings of the Ocean Drilling Program Scientific Results, V144, P993; OWEN RM, 1985, SCIENCE, V227, P166, DOI 10.1126/science.11536555; Pagani M, 1999, PALEOCEANOGRAPHY, V14, P273, DOI 10.1029/1999PA900006; Palmer MR, 1998, SCIENCE, V282, P1468, DOI 10.1126/science.282.5393.1468; Paytan A, 1998, SCIENCE, V282, P1459, DOI 10.1126/science.282.5393.1459; Pearson Paul N., 1995, Proceedings of the Ocean Drilling Program Scientific Results, V144, P401; Pearson Paul N., 1995, Proceedings of the Ocean Drilling Program Scientific Results, V144, P21, DOI 10.2973/odp.proc.sr.144.013.1995; Pearson PN, 1999, SCIENCE, V284, P1824, DOI 10.1126/science.284.5421.1824; RAYMO ME, 1992, NATURE, V359, P117, DOI 10.1038/359117a0; Rink S, 1998, MAR BIOL, V131, P583, DOI 10.1007/s002270050350; RITCHIE JD, 1996, GEOLOGICAL SOC SPECI, V101, P63; Sanyal A, 1997, GLOBAL BIOGEOCHEM CY, V11, P125, DOI 10.1029/97GB00223; Sanyal A, 1996, PALEOCEANOGRAPHY, V11, P513, DOI 10.1029/96PA01858; SANYAL A, 1995, NATURE, V373, P234, DOI 10.1038/373234a0; Scotese C.R., 1994, PANGEA PALEOCLIMATE, V288, P57, DOI DOI 10.1130/SPE288-P57; SHACKLETON NJ, 1986, PALAEOGEOGR PALAEOCL, V57, P91, DOI 10.1016/0031-0182(86)90008-8; SLOAN LC, 1992, NATURE, V357, P320, DOI 10.1038/357320a0; SPIVACK AJ, 1993, NATURE, V363, P149, DOI 10.1038/363149a0; Taylor S.R, 1985, CONTINENTAL CRUST IT; Thomas Ellen, 2000, P132; VANANDEL TH, 1975, EARTH PLANET SC LETT, V26, P187, DOI 10.1016/0012-821X(75)90086-2; Wanninkhof R, 1999, MAR CHEM, V65, P291, DOI 10.1016/S0304-4203(99)00021-3; Wing S., 2000, WARM CLIMATES EARTH, V7, P197; Wright JD, 1992, PALEOCEANOGRAPHY, V7, P357, DOI 10.1029/92PA00760; ZACHOS JC, 1993, J GEOL, V101, P191, DOI 10.1086/648216; ZACHOS JC, 1994, PALEOCEANOGRAPHY, V9, P353, DOI 10.1029/93PA03266	50	1028	1111	9	608	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 17	2000	406	6797					695	699		10.1038/35021000	http://dx.doi.org/10.1038/35021000			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963587				2022-12-24	WOS:000088767700034
J	Guo, HT; Karberg, M; Long, M; Jones, JP; Sullenger, B; Lambowitz, AM				Guo, HT; Karberg, M; Long, M; Jones, JP; Sullenger, B; Lambowitz, AM			Group II introns designed to insert into therapeutically relevant DNA target sites in human cells	SCIENCE			English	Article							PRIMED REVERSE TRANSCRIPTION; T7 RNA-POLYMERASE; HIV-1 INFECTION; CLONED GENES; MOBILITY; TERMINATION; CORECEPTOR; EXPRESSION	Mobile group II intron RNAs insert directly into DNA target sites and are then reverse-transcribed into genomic DNA by the associated intron-encoded protein. Target site recognition involves modifiable base-pairing interactions between the intron RNA and a >14-nucleotide region of the DNA target site, as well as fixed interactions between the protein and flanking regions. Here, we developed a highly efficient Escherichia coli genetic assay to determine detailed target site recognition rules for the Lactococcus lactis group II intron LL.LtrB and to select introns that insert into desired target sites. Using human immunodeficiency virus-type 1 (HIV-1) proviral DNA and the human CCR5 gene as examples, we show that group II introns can be retargeted to insert efficiently into virtually any target DNA and that the retargeted introns retain activity in human cells. This work provides the practical basis for potential applications of targeted group II introns in genetic engineering, functional genomics, and gene therapy.	Univ Texas, Sch Biol Sci, Inst Mol & Cellular Biol, Austin, TX 78712 USA; Univ Texas, Sch Biol Sci, Dept Chem & Biochem, Austin, TX 78712 USA; Univ Texas, Sch Biol Sci, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; Duke Univ, Med Ctr, Dept Surg, Ctr Genet & Cellular Therapies, Durham, NC 27710 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Duke University	Lambowitz, AM (corresponding author), Univ Texas, Sch Biol Sci, Inst Mol & Cellular Biol, Austin, TX 78712 USA.				NIAID NIH HHS [AI40981] Funding Source: Medline; NIGMS NIH HHS [GM37949] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI040981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037949] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bieniasz PD, 1997, EMBO J, V16, P2599, DOI 10.1093/emboj/16.10.2599; Cousineau B, 1998, CELL, V94, P451, DOI 10.1016/S0092-8674(00)81586-X; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; DEMINOFF SJ, 1995, GENETICS, V141, P1263; Eskes R, 1997, CELL, V88, P865, DOI 10.1016/S0092-8674(00)81932-7; Guo HT, 1997, EMBO J, V16, P6835, DOI 10.1093/emboj/16.22.6835; Hartvig L, 1996, EMBO J, V15, P4767, DOI 10.1002/j.1460-2075.1996.tb00854.x; KARBERG M, UNPUB; Lambowitz AM., 1999, GROUP GROUP 2 RIBOZY, P451; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Matsuura M, 1997, GENE DEV, V11, P2910, DOI 10.1101/gad.11.21.2910; MICHEL F, 1995, ANNU REV BIOCHEM, V64, P435, DOI 10.1146/annurev.bi.64.070195.002251; Mills DA, 1997, J BACTERIOL, V179, P6107, DOI 10.1128/jb.179.19.6107-6111.1997; Mohr G, 2000, GENE DEV, V14, P559; MOHR G, UNPUB; OROSZ A, 1991, EUR J BIOCHEM, V201, P653, DOI 10.1111/j.1432-1033.1991.tb16326.x; PEDEN K, 1991, VIROLOGY, V185, P661, DOI 10.1016/0042-6822(91)90537-L; Saldanha R, 1999, BIOCHEMISTRY-US, V38, P9069, DOI 10.1021/bi982799l; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Wank H, 1999, MOL CELL, V4, P239, DOI 10.1016/S1097-2765(00)80371-8; Yang J, 1998, J MOL BIOL, V282, P505, DOI 10.1006/jmbi.1998.2029; Yang J, 1996, NATURE, V381, P332, DOI 10.1038/381332a0; ZIMMERLY S, 1995, CELL, V83, P529, DOI 10.1016/0092-8674(95)90092-6; ZIMMERLY S, 1995, CELL, V82, P545, DOI 10.1016/0092-8674(95)90027-6	25	151	178	2	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2000	289	5478					452	457		10.1126/science.289.5478.452	http://dx.doi.org/10.1126/science.289.5478.452			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336ME	10903206				2022-12-24	WOS:000088305500048
J	Nuth, JA; Hill, HGM; Kletetschka, G				Nuth, JA; Hill, HGM; Kletetschka, G			Determining the ages of comets from the fraction of crystalline dust	NATURE			English	Article							SOLAR NEBULA; SILICATE GRAINS; BETA-PICTORIS; DISK	The timescale for the accretion of bodies in the disk surrounding a young star depends upon a number of assumptions, but there are few observational constraints. In our own Solar System, measurements of meteoritic components can provide information about the inner regions of the nebula, but not the outer parts. Observations of the evolution of more massive protostellar systems (Herbig A(e)/B-e stars) imply that significant changes occur in the physical properties of their dust with time(1). The simplest explanation is that thermal annealing of the original, amorphous grains in the hot inner nebula slowly increases the fractional abundance of crystalline material over time. Crystalline dust is then transported outward, where it is incorporated into comets that serve as a longterm reservoir for dust disks, such as that surrounding Beta Pictoris. Here we show that when applied to our own Solar System, this process can explain observed variations in both the volatile and dusty components of comets, while also providing a natural indicator of a comet's mean formation age. Studies of comets with different dust contents can therefore be used to investigate the timescales of the early Solar System.	NASA, Goddard Space Flight Ctr, Astrochem Branch, Greenbelt, MD 20771 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Nuth, JA (corresponding author), NASA, Goddard Space Flight Ctr, Astrochem Branch, Code 691, Greenbelt, MD 20771 USA.	uljan@lepvax.gsfc.nasa.gov	Nuth, Joseph/E-7085-2012; Kletetschka, Gunther/C-9996-2011; Kletetschka, Gunther/AAA-2008-2021	Kletetschka, Gunther/0000-0002-0645-9037; Kletetschka, Gunther/0000-0002-0645-9037				AHearn MF, 1995, ICARUS, V118, P223, DOI 10.1006/icar.1995.1190; Brown G. N.  Jr., 1980, Advances in Cryogenic Engineering. Vol.25. Proceedings of the 1979 Cryogenic Engineering Conference, P662; CAMPINS H, 1989, ASTROPHYS J, V341, P1059, DOI 10.1086/167563; DRAINE BT, 1984, ASTROPHYS J, V285, P89, DOI 10.1086/162480; FEGLEY B, 1993, NATO ADV SCI INST SE, V416, P75; Gerakines PA, 1999, ASTROPHYS J, V522, P357, DOI 10.1086/307611; Grady C. A., 2000, PROTOSTARS PLANETS, P613; Hallenbeck SL, 2000, ASTROPHYS J, V535, P247, DOI 10.1086/308810; HALLENBECK SL, ICARUS; HANNER MS, 1994, ASTROPHYS J, V425, P274, DOI 10.1086/173984; Hanner MS, 1999, SPACE SCI REV, V90, P99, DOI 10.1023/A:1005285711945; KNACKE RF, 1993, ASTROPHYS J, V418, P440, DOI 10.1086/173405; LIDE DR, 1994, CRC HDB CHEM PHYSICS, P66; Mumma M. J., 1993, PROTOSTARS PLANETS, P1177; Prinn R.G.P., 1989, ORIGIN EVOLUTION PLA, P78; PRINN RG, 1990, ASTROPHYS J, V348, P725, DOI 10.1086/168281; RYAN EV, 1991, ASTRON J, V101, P694, DOI 10.1086/115716; SMITH BA, 1984, SCIENCE, V226, P1421, DOI 10.1126/science.226.4681.1421; STEVENSON DJ, 1990, ASTROPHYS J, V348, P730, DOI 10.1086/168282; Weidenschilling SJ, 1997, ICARUS, V127, P290, DOI 10.1006/icar.1997.5712; Woolum DS, 1999, METEORIT PLANET SCI, V34, P897, DOI 10.1111/j.1945-5100.1999.tb01408.x	21	69	69	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2000	406	6793					275	276		10.1038/35018516	http://dx.doi.org/10.1038/35018516			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917522				2022-12-24	WOS:000088251900040
J	Saito, I; Folsom, AR; Brancati, FL; Duncan, BB; Chambless, LE; McGovern, PG				Saito, I; Folsom, AR; Brancati, FL; Duncan, BB; Chambless, LE; McGovern, PG			Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: The Atherosclerosis Risk in Communities (ARIC) Study	ANNALS OF INTERNAL MEDICINE			English	Article							HIGH-DENSITY-LIPOPROTEIN; IMPROVED LIPOLYTIC EFFICIENCY; FACTOR INTERVENTION TRIAL; VON-WILLEBRAND-FACTOR; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; ENZYMATIC DETERMINATION; ALBUMIN EXCRETION; GLYCEMIC CONTROL; PLASMA-LEVELS	Background: Major risk factors explain much of the excess risk for coronary heart disease produced by diabetes, but nontraditional factors may also relate to incident coronary heart disease. Objective: To examine the association of traditional and nontraditional risk factors with incidence of coronary heart disease in adults with diabetes. Design: Prospective cohort study, Setting: The Atherosclerosis Risk in Communities (ARIC) Study. Participants: 1676 middle-aged persons who had diabetes but no history of prevalent coronary heart disease. Measurements: Multiple risk factors were recorded at baseline. Follow-up was from 1987 through 1995, Results: 186 participants developed incident coronary heart disease events during follow-up. As expected, the incidence of coronary heart disease in participants with diabetes was associated positively with traditional risk factors (hypertension, smoking, total cholesterol level, and low high-density lipoprotein [HDL] cholesterol level). After adjustment for sex, age, ethnicity, and ARIC field center, incident coronary heart disease was also significantly associated with waist-to-hip ratio; levels of HDL3 cholesterol, apo-lipoproteins A-1 and B, albumin, fibrinogen, and von Willebrand factor; factor VIII activity; and leukocyte count. However, after adjustment for traditional risk factors for coronary heart disease, only levels of albumin, fibrinogen, and von Willebrand factor; factor VIII activity; and leukocyte count remained independently associated with coronary heart disease (P < 0.03). The relative risks associated with the highest compared with lowest groupings of albumin, fibrinogen, factor VIII, and von Willebrand factor values and leukocyte count were 0.64 (95% CI, 0.44 to 0.92), 1.75 (CI, 1.12 to 2.73), 1.58 (CI, 1.02 to 2.42), 1.71 (Cl, 1.11 to 2.63), and 1.90 (Cl, 1.16 to 3.13), respectively. Adjustment for diabetes treatment status attenuated these associations somewhat Conclusions: Levels of albumin, fibrinogen, and von Willebrand factor; factor VIII activity; and leukocyte count were predictors of coronary heart disease among persons with diabetes. These associations may reflect 1) the underlying inflammatory reaction or microvascular injury related to atherosclerosis and a tendency toward thrombosis or 2) common antecedents for both diabetes and coronary heart disease.	Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55454 USA; Oita Med Univ, Oita, Japan; Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA; Univ Fed Rio Grande do Sul, Sch Med, Porto Alegre, RS, Brazil; Univ N Carolina, Chapel Hill, NC USA	University of Minnesota System; University of Minnesota Twin Cities; Oita University; Johns Hopkins University; Johns Hopkins Medicine; Universidade Federal do Rio Grande do Sul; University of North Carolina; University of North Carolina Chapel Hill	Folsom, AR (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Suite 300,1300 S 2nd St, Minneapolis, MN 55454 USA.	folsom@epi.umn.edu	Duncan, Bruce B/L-4140-2016	Duncan, Bruce B/0000-0002-7491-2630	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055018, N01HC055016, N01HC055015] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-55018, N01-HC-55015, N01-HC-55016] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABRAIRA C, 1995, DIABETES CARE, V18, P1113, DOI 10.2337/diacare.18.8.1113; [Anonymous], 1999, Diabetologia, V42, P647; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Borch-Johnsen K, 1999, LANCET, V354, P617; Bruno G, 1996, ANN INTERN MED, V125, P653, DOI 10.7326/0003-4819-125-8-199610150-00005; CERIELLO A, 1994, THROMB HAEMOSTASIS, V71, P593; CLAUSS A., 1957, ACTA HAEMATOL, V17, P237; CONLAN MG, 1993, THROMB HAEMOSTASIS, V70, P380; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; DEFEO P, 1993, DIABETES, V42, P995, DOI 10.2337/diabetes.42.7.995; Destefano Frank, 1993, Ethnicity and Disease, V3, P145; DOUMAS BT, 1971, CLIN CHIM ACTA, V31, P87, DOI 10.1016/0009-8981(71)90365-2; Duncan BB, 1999, DIABETES CARE, V22, P767, DOI 10.2337/diacare.22.5.767; ECKFELDT JH, 1994, ARCH PATHOL LAB MED, V118, P496; FACCHINI F, 1992, J INTERN MED, V232, P267, DOI 10.1111/j.1365-2796.1992.tb00582.x; Folsom AR, 1997, CIRCULATION, V96, P1102, DOI 10.1161/01.CIR.96.4.1102; Folsom AR, 1997, DIABETES CARE, V20, P935, DOI 10.2337/diacare.20.6.935; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GAUBATZ JW, 1990, J LIPID RES, V31, P603; Gavin JR, 1997, DIABETES CARE, V20, P1183; GETZ GS, 1993, ARTERIOSCLER THROMB, V13, P459, DOI 10.1161/01.ATV.13.3.459; GINDLER EM, 1971, CLIN CHEM, V17, P662; Grundy SM, 1999, CIRCULATION, V100, P1134, DOI 10.1161/01.CIR.100.10.1134; Gu K, 1999, JAMA-J AM MED ASSOC, V281, P1291, DOI 10.1001/jama.281.14.1291; Haffner SM, 1997, AM J MED, V103, P152, DOI 10.1016/S0002-9343(97)00027-2; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; Jackson R, 1996, J CLIN EPIDEMIOL, V49, P1441, DOI 10.1016/0895-4356(95)00047-X; JARRETT RJ, 1988, DIABETOLOGIA, V31, P737, DOI 10.1007/BF00274775; JuhanVague I, 1996, ANN MED, V28, P371, DOI 10.3109/07853899608999095; KANNEL WB, 1979, CIRCULATION, V59, P8, DOI 10.1161/01.CIR.59.1.8; KANNEL WB, 1990, AM HEART J, V120, P672, DOI 10.1016/0002-8703(90)90026-T; Kessler L, 1998, DIABETES METAB, V24, P327; LAAKSO M, 1993, CIRCULATION, V88, P1421, DOI 10.1161/01.CIR.88.4.1421; Lehto S, 1997, DIABETES, V46, P1354, DOI 10.2337/diabetes.46.8.1354; Liao FZ, 1998, AM HEART J, V136, P480, DOI 10.1016/S0002-8703(98)70224-8; MACIEJKO JJ, 1982, CLIN CHEM, V28, P199; Mattock MB, 1998, DIABETES, V47, P1786, DOI 10.2337/diabetes.47.11.1786; Missov RM, 1996, DIABETES CARE, V19, P157, DOI 10.2337/diacare.19.2.157; MOGENSEN CE, 1984, NEW ENGL J MED, V310, P356, DOI 10.1056/NEJM198402093100605; NAGELE U, 1984, J CLIN CHEM CLIN BIO, V22, P165; NISKANEN LK, 1995, DIABETES CARE, V18, P1557, DOI 10.2337/diacare.18.12.1557; PATSCH W, 1989, CLIN CHEM, V35, P265; Pickup JC, 1998, DIABETOLOGIA, V41, P1241, DOI 10.1007/s001250051058; Prineas R., 1982, MINNESOTA CODE MANUA; RAUTAHARJU PM, 1981, CIRCULATION, V64, P249, DOI 10.1161/01.CIR.64.2.249; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Rosamond WD, 1998, NEW ENGL J MED, V339, P861, DOI 10.1056/NEJM199809243391301; Schmidt MI, 1999, LANCET, V353, P1649, DOI 10.1016/S0140-6736(99)01046-6; SCHONFELD G, 1974, J CLIN INVEST, V54, P236, DOI 10.1172/JCI107758; SCHONFELD G, 1974, J CLIN INVEST, V53, P1458, DOI 10.1172/JCI107694; Schreiner PJ, 1996, ARTERIOSCL THROM VAS, V16, P471, DOI 10.1161/01.ATV.16.3.471; SIEDEL J, 1983, CLIN CHEM, V29, P1075; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Standl E, 1996, DIABETOLOGIA, V39, P1540, DOI 10.1007/s001250050612; STEHOUWER CDA, 1992, LANCET, V340, P319, DOI 10.1016/0140-6736(92)91401-S; STERN MP, 1995, DIABETES, V44, P369, DOI 10.2337/diabetes.44.4.369; TUMER R, 1997, LANCET, V350, P1288; Turner RC, 1998, BMJ-BRIT MED J, V316, P823, DOI 10.1136/bmj.316.7134.823; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; UK Prospective Diabet Study Grp, 1998, DIABETES CARE, V21, P1271; UUSITUPA MIJ, 1990, CIRCULATION, V82, P27, DOI 10.1161/01.CIR.82.1.27; Vaccaro O, 1998, INT J EPIDEMIOL, V27, P636, DOI 10.1093/ije/27.4.636; Vilbergsson S, 1998, J INTERN MED, V244, P309, DOI 10.1046/j.1365-2796.1998.00368.x; WARNICK GR, 1982, CLIN CHEM, V28, P1574; White AD, 1996, J CLIN EPIDEMIOL, V49, P223, DOI 10.1016/0895-4356(95)00041-0; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Yudkin JS, 1996, DIABETOLOGIA, V39, P1407, DOI 10.1007/s001250050592	67	179	189	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 18	2000	133	2					81	91		10.7326/0003-4819-133-2-200007180-00007	http://dx.doi.org/10.7326/0003-4819-133-2-200007180-00007			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	335RL	10896647				2022-12-24	WOS:000088258500001
J	Finestone, HM				Finestone, HM			Safe feeding methods in stroke patients	LANCET			English	Editorial Material							MALNUTRITION		London Hlth Sci Ctr, Dept Phys Med & Rehabil, London, ON N6A 5A5, Canada	London Health Sciences Centre	Finestone, HM (corresponding author), London Hlth Sci Ctr, Dept Phys Med & Rehabil, Univ Campus, London, ON N6A 5A5, Canada.							APTAKER RL, 1994, ARCH PHYS MED REHAB, V75, P80; AXELSSON K, 1989, J AM DIET ASSOC, V89, P1092; Buelow J M, 1990, Rehabil Nurs, V15, P260; Davalos A, 1996, STROKE, V27, P1028, DOI 10.1161/01.STR.27.6.1028; FINEGOLD SM, 1991, REV INFECT DIS, V13, pS737; FINESTONE HM, 1995, ARCH PHYS MED REHAB, V76, P310, DOI 10.1016/S0003-9993(95)80655-5; FINESTONE HM, 1996, ARCH PHYS MED REHAB, V77, P430; GORDON C, 1987, BRIT MED J, V295, P411, DOI 10.1136/bmj.295.6595.411; HICKS ME, 1990, AM J ROENTGENOL, V154, P725, DOI 10.2214/ajr.154.4.2107665; LAZARUS BA, 1990, ARCH PHYS MED REHAB, V71, P46; Nakajoh K, 2000, J INTERN MED, V247, P39, DOI 10.1046/j.1365-2796.2000.00565.x; Smithard DG, 1998, AGE AGEING, V27, P99, DOI 10.1093/ageing/27.2.99; WEINBERG AD, 1995, JAMA-J AM MED ASSOC, V274, P1552, DOI 10.1001/jama.274.19.1552	13	20	21	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAY 13	2000	355	9216					1662	1663		10.1016/S0140-6736(00)02234-0	http://dx.doi.org/10.1016/S0140-6736(00)02234-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	313CY	10905238				2022-12-24	WOS:000086983800005
J	Schindler, T; Bornmann, W; Pellicena, P; Miller, WT; Clarkson, B; Kuriyan, J				Schindler, T; Bornmann, W; Pellicena, P; Miller, WT; Clarkson, B; Kuriyan, J			Structural mechanism for STI-571 inhibition of Abelson tyrosine kinase	SCIENCE			English	Article							CRYSTAL-STRUCTURE; C-ABL; INSULIN-RECEPTOR; COMPLEX; DOMAIN; SPECIFICITY; GROWTH	The inadvertent activation of the Abelson tyrosine kinase (Abl) causes chronic myelogenous Leukemia (CML), A small-molecule inhibitor of Abl (STI-571) is effective in the treatment of CML. We report the crystal structure of the catalytic domain of Abl, complexed to a variant of STI-571. Critic:al to the binding of STI-571 is the adoption by the kinase of an inactive conformation, in which a centrally Located "activation Loop" is not phosphorylated. The conformation of this Loop is distinct from that in active protein kinases, as well as in the inactive form of the closely related Src kinases, These results suggest that compounds that exploit the distinctive inactivation mechanisms of individual protein kinases can achieve both high affinity and high specificity.	Rockefeller Univ, Labs Mol Biophys, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; SUNY Stony Brook, Sch Med, Dept Physiol & Biophys, Stony Brook, NY 11794 USA	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Memorial Sloan Kettering Cancer Center; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Kuriyan, J (corresponding author), Rockefeller Univ, Labs Mol Biophys, 1230 York Ave, New York, NY 10021 USA.				NIGMS NIH HHS [GM29362] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029362] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barila D, 1998, NAT GENET, V18, P280, DOI 10.1038/ng0398-280; BARKER SC, 1995, BIOCHEMISTRY-US, V34, P14843, DOI 10.1021/bi00045a027; BRASHER B, UNPUB; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buchdunger E., 1998, Proceedings of the American Association for Cancer Research Annual Meeting, V39, P559; BUCHDUNGER E, 1998, 89 ANN M AM ASS CANC; DOREY K, UNPUB; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Druker BJ, 1999, BLOOD, V94, p368A; DRUKER BJ, 1999, 41 ANN M AM SOC HEM; FRANZ WM, 1989, EMBO J, V8, P137, DOI 10.1002/j.1460-2075.1989.tb03358.x; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Hubbard SR, 1998, J BIOL CHEM, V273, P11987, DOI 10.1074/jbc.273.20.11987; JACKSON P, 1989, EMBO J, V8, P449, DOI 10.1002/j.1460-2075.1989.tb03397.x; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lionberger JM, 2000, J BIOL CHEM, V275, P18581, DOI 10.1074/jbc.C000126200; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang ZL, 1998, STRUCTURE, V6, P1117, DOI 10.1016/S0969-2126(98)00113-0; Wilson KP, 1997, CHEM BIOL, V4, P423, DOI 10.1016/S1074-5521(97)90194-0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; Zimmermann J, 1997, BIOORG MED CHEM LETT, V7, P187, DOI 10.1016/S0960-894X(96)00601-4	31	1491	1628	2	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 15	2000	289	5486					1938	1942		10.1126/science.289.5486.1938	http://dx.doi.org/10.1126/science.289.5486.1938			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354XD	10988075				2022-12-24	WOS:000089355800047
J	Pimenta, J; Catchpole, M; Gray, M; Hopwood, J; Randall, S				Pimenta, J; Catchpole, M; Gray, M; Hopwood, J; Randall, S			Evidence based health policy report - Screening for genital chlamydial infection	BRITISH MEDICAL JOURNAL			English	Article							TRACHOMATIS		Publ Hlth Lab Serv, London NW9 5EQ, England; Inst Hlth Sci, Natl Screening Comm, Oxford OX3 7LF, England; St Catherines Hosp, Evidence Based Practice Ctr, Birkenhead L42 0LQ, Merseyside, England; St Marys Hosp, Ella Gordon Unit, Portsmouth PO3 6AD, Hants, England	Public Health England; University of Oxford; University of Liverpool	Pimenta, J (corresponding author), Publ Hlth Lab Serv, London NW9 5EQ, England.							ADDISS DG, 1993, SEX TRANSM DIS, V20, P28, DOI 10.1097/00007435-199301000-00006; Boag F, 1998, BMJ-BRIT MED J, V316, P1474, DOI 10.1136/bmj.316.7143.1474; Chief Medical Officers Expert Advisory Group, 1998, MAIN REP CMOS EXP AD; *DEP HLTH, 1999, 1 EV GOV STRAT SEX H; *DEP HLTH, 1999, SEX HLTH STRAT PROF; Duncan B, 1999, BRIT MED J, V318, P931, DOI 10.1136/bmj.318.7188.931; HERRMANN BF, 1991, SEX TRANSM DIS, V18, P233, DOI 10.1097/00007435-199110000-00007; JOHNSON AM, 1994, SEXUAL ATTITUDES LIF; LAMAGNI T, 1999, COMMUN DIS REP S, V8, pS1; Macleod J, 1999, BRIT MED J, V319, P188, DOI 10.1136/bmj.319.7203.188b; *NAT OP POLLS SOC, 1999, JN430458 NOP SOC POL; *NAT SCREEN COMM, 1998, 1 HLTH DEP UK NAT SC; Nicoll A, 1999, BRIT MED J, V318, P1321, DOI 10.1136/bmj.318.7194.1321; RENTON A, 1994, NEED ASSESSMENT HLTH; Scholes D, 1996, NEW ENGL J MED, V334, P1362, DOI 10.1056/NEJM199605233342103; TURNER H, 1998, MAIN REPORT CMOS EXP, pCH11; van den Hoek J A, 1999, Ned Tijdschr Geneeskd, V143, P668; YORKE JA, 1978, SEX TRANSM DIS, V5, P51, DOI 10.1097/00007435-197804000-00003	18	30	31	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	SEP 9	2000	321	7261					629	631		10.1136/bmj.321.7261.629	http://dx.doi.org/10.1136/bmj.321.7261.629			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	352WW	10977848	Green Published			2022-12-24	WOS:000089243200032
J	Foca, M; Jakob, K; Whittier, S; Della Latta, P; Factor, S; Rubenstein, D; Saiman, L				Foca, M; Jakob, K; Whittier, S; Della Latta, P; Factor, S; Rubenstein, D; Saiman, L			Endemic Pseudomonas aeruginosa infection in a neonatal intensive care unit	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NOSOCOMIAL INFECTIONS; EPIDEMIOLOGY; RESERVOIRS; PERSONNEL; INFANTS; HANDS	Background Nosocomial infections due to Pseudomonas aeruginosa have been well described, but the environmental reservoir of the organism varies. We conducted an epidemiologic and molecular investigation of endemic P. aeruginosa infection among infants in a neonatal intensive care unit that was associated with carriage of the organisms on the hands of health care workers. Methods In August 1998, colonization or infection with P. aeruginosa was identified in six infants. Surveillance cultures for P. aeruginosa were obtained from the other 27 infants in the unit, and possible environmental reservoirs were also assessed. The hands of health care workers were inspected and cultured, and risk factors for P. aeruginosa colonization were evaluated. Isolates were analyzed for clonality by pulsed-field gel electrophoresis. Results Surveillance cultures showed that three additional infants were colonized with P. aeruginosa. Cultures of environmental specimens were negative, but cultures of the hands of 10 of 165 health care workers (6 percent) were positive for P. aeruginosa. Increasing age (P=0.05) and a history of the use of artificial fingernails or nail wraps (P=0.03) were both risk factors for colonization of the hands. From January 1997 to August 1998, 49 infants were infected or colonized with P. aeruginosa. Pulsed-field gel electrophoresis demonstrated that 17 of these infants and 1 health care worker who had onychomycosis had the same clone. Infants who were exposed to this health care worker in August 1998 were at greater risk of having this clone than infants who were not exposed to this health care worker (odds ratio, 41.2; 95 percent confidence interval, 1.8 to 940.0; P=0.006). Conclusions An increased rate of infection and colonization with P. aeruginosa among infants in neonatal intensive care units should be investigated by assessing potential reservoirs, including environmental sources as well as patients and health care workers. (N Engl J Med 2000; 343: 695-700.) (C) 2000, Massachusetts Medical Society.	New York Presbyterian Hosp, Dept Pediat, Div Infect Dis, New York, NY 10021 USA; New York Presbyterian Hosp, Dept Pediat, Div Neonatol, New York, NY USA; New York Presbyterian Hosp, Dept Hosp Epidemiol, New York, NY USA; New York Presbyterian Hosp, Dept Pathol, New York, NY USA; Columbia Presbyterian Med Ctr, New York, NY 10032 USA	NewYork-Presbyterian Hospital; NewYork-Presbyterian Hospital; NewYork-Presbyterian Hospital; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital	Foca, M (corresponding author), New York Presbyterian Hosp, Dept Pediat, Div Infect Dis, New York, NY 10021 USA.		Factor, Stephanie H/C-7182-2009	Factor, Stephanie H/0000-0003-0125-8639				ADAMS BG, 1982, J HYG-CAMBRIDGE, V89, P33, DOI 10.1017/S0022172400070510; ADAMS BG, 1992, J HYG LOND, V89, P23; ASAY LD, 1960, NEW ENGL J MED, V262, P1062, DOI 10.1056/NEJM196005262622104; BROWN DG, 1977, J PEDIATR-US, V90, P453, DOI 10.1016/S0022-3476(77)80715-4; Cordero L, 1999, INFECT CONT HOSP EP, V20, P242, DOI 10.1086/501619; FIERER J, 1967, NEW ENGL J MED, V276, P991, DOI 10.1056/NEJM196705042761801; Gaynes RP, 1996, PEDIATRICS, V98, P357; GRUNDMANN H, 1993, J INFECT DIS, V168, P943, DOI 10.1093/infdis/168.4.943; GUPTA AK, 1993, J TROP PEDIATRICS, V39, P32, DOI 10.1093/tropej/39.1.32; Jarvis WR, 1996, INFECT CONT HOSP EP, V17, P47; JELLARD CH, 1967, J HYG-CAMB, V65, P219, DOI 10.1017/S0022172400045708; Knights H T, 1968, N Z Med J, V67, P617; KNITTLE MA, 1975, J PEDIATR-US, V86, P433, DOI 10.1016/S0022-3476(75)80980-2; Larson EL, 1998, AM J INFECT CONTROL, V26, P513, DOI 10.1016/S0196-6553(98)70025-2; LEIGH L, 1995, PEDIATR INFECT DIS J, V14, P367, DOI 10.1097/00006454-199505000-00006; Moolenaar RL, 2000, INFECT CONT HOSP EP, V21, P80, DOI 10.1086/501739; POTTINGER J, 1989, AM J INFECT CONTROL, V17, P340, DOI 10.1016/0196-6553(89)90003-5; Shah SS, 1998, PEDIATR INFECT DIS J, V17, P97, DOI 10.1097/00006454-199802000-00004; Speijer H, 1999, J CLIN MICROBIOL, V37, P3654, DOI 10.1128/JCM.37.11.3654-3661.1999; Talon D, 1996, J HOSP INFECT, V32, P135, DOI 10.1016/S0195-6701(96)90055-9; USOWICZ AG, 1988, EARLY HUM DEV, V16, P27, DOI 10.1016/0378-3782(88)90084-9; WIDMER AF, 1993, CLIN INFECT DIS, V16, P372, DOI 10.1093/clind/16.3.372	22	139	148	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 7	2000	343	10					695	700		10.1056/NEJM200009073431004	http://dx.doi.org/10.1056/NEJM200009073431004			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	350KU	10974133				2022-12-24	WOS:000089100500004
J	Cody, GD; Boctor, NZ; Filley, TR; Hazen, RM; Scott, JH; Sharma, A; Yoder, HS				Cody, GD; Boctor, NZ; Filley, TR; Hazen, RM; Scott, JH; Sharma, A; Yoder, HS			Primordial carbonylated iron-sulfur compounds and the synthesis of pyruvate	SCIENCE			English	Article							BIOCHEMISTRY	Experiments exploring the potential catalytic role of iron sulfide at 250 degrees C and elevated pressures (50, 100, and 200 megapascals) revealed a facile, pressure-enhanced synthesis of organometallic phases formed through the reaction of alkyl thiols and carbon monoxide with iron sulfide. A suite of organometallic compounds were characterized with ultraviolet-visible and Raman spectroscopy. The natural synthesis of such compounds is anticipated in present-day and ancient environments wherever reduced hydrothermal fluids pass through iron sulfide-containing crust. Here, pyruvic acid was synthesized in the presence of such organometallic phases. These compounds could have provided the prebiotic Earth with critical biochemical functionality.	Carnegie Inst Washington, Geophys Lab, Washington, DC 20015 USA	Carnegie Institution for Science	Cody, GD (corresponding author), Carnegie Inst Washington, Geophys Lab, 5251 Broad Branch Rd NW, Washington, DC 20015 USA.		Filley, Timothy R/A-9862-2009	Filley, Timothy/0000-0001-7250-5065				Abel E. W., 1967, ORGANOMET CHEM REV, V2, P443; Adams MWW, 1998, SCIENCE, V282, P1842, DOI 10.1126/science.282.5395.1842; Barns SM, 1996, P NATL ACAD SCI USA, V93, P9188, DOI 10.1073/pnas.93.17.9188; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Blau K, 1993, HDB DERIVATIVES CHRO, V1, DOI [10.1016/s0022-328x(00)83288-x, DOI 10.1016/S0022-328X(00)83288-X]; Cammack Richard, 1996, P43; Haggerty J.A., 1992, PROC OCEAN DRILL SCI, V125, P387, DOI [10.2973/odp.proc.sr.125.125.1992, DOI 10.2973/ODP.PROC.SR.125.125.1992]; Heinen W, 1996, ORIGINS LIFE EVOL B, V26, P131, DOI 10.1007/BF01809852; HEKINIAN R, 1973, NATURE, V245, P371, DOI 10.1038/245371a0; Henrici Olive G., 1984, CHEM CATALYTIC HYDRO; Huber C, 1997, SCIENCE, V276, P245, DOI 10.1126/science.276.5310.245; KING RB, 1965, INORG CHEM, V4, P1663, DOI 10.1021/ic50033a031; KULLERUD G, 1971, RES TECHNIQUES HIGH, P289; MAYERLE JJ, 1975, J AM CHEM SOC, V97, P1032, DOI 10.1021/ja00838a015; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; PALMER DA, 1993, EOS, V74, P327; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; QIU D, 1994, SCIENCE, V264, P817, DOI 10.1126/science.8171334; Spiro T. G., 1982, IRON SULFUR PROTEINS; WACHTERSHAUSER G, 1992, PROG BIOPHYS MOL BIO, V58, P85, DOI 10.1016/0079-6107(92)90022-X; YODER HS, 1950, T AM GEOPHYS UNION, V31, P821	21	322	334	5	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 25	2000	289	5483					1337	1340		10.1126/science.289.5483.1337	http://dx.doi.org/10.1126/science.289.5483.1337			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347RF	10958777				2022-12-24	WOS:000088942400034
J	Mao, L; Begum, D; Chuang, HW; Budiman, MA; Szymkowiak, EJ; Irish, EE; Wing, RA				Mao, L; Begum, D; Chuang, HW; Budiman, MA; Szymkowiak, EJ; Irish, EE; Wing, RA			JOINTLESS is a MADS-box gene controlling tomato flower abscission zone development	NATURE			English	Article							MAP-BASED CLONING; TRANSCRIPTION FACTORS; MODEL SYSTEM; CROP PLANTS; ANTIRRHINUM; ARABIDOPSIS; HOMOLOGY	Abscission is a universal and dynamic process in plants whereby organs such as leaves, flowers and fruit are shed, both during normal development, and in response to tissue damage and stress(1). Shedding occurs by separation of cells in anatomically distinct regions of the plant, called abscission zones (AZs). During abscission, the plant hormone ethylene stimulates cells to produce enzymes that degrade the middle lamella between cells in the AZ. The physiology and regulation of abscission at fully developed AZs is well known(2,3), but the molecular biology underlying their development is not. Here we report the first isolation of a gene directly involved in the development of a functional plant AZ. Tomato plants with the jointless mutation(4) fail to develop AZs on their pedicels and so abscission of flowers or fruit does not occur normally. We identify JOINTLESS as a new MADS-box gene in a distinct phylogenetic clade separate from those functioning in floral organs. We propose that a deletion in JOINTLESS accounts for the failure of activation of pedicel AZ development in jointless tomato plants.	Clemson Univ, Genome Inst, Clemson, SC 29634 USA; Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA	Clemson University; University of Iowa	Wing, RA (corresponding author), Clemson Univ, Genome Inst, 100 Jordan Hall, Clemson, SC 29634 USA.		Wing, Rod A/Z-2885-2019; Irish, Erin/C-7331-2016	Wing, Rod A/0000-0001-6633-6226; Irish, Erin/0000-0003-4244-7938				Addicott F.T, 1982, ABSCISSION; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANTHONY RG, 1995, PLANT PHYSIOL, V108, P441, DOI 10.1104/pp.108.1.441; Bernatzky R., 1986, PLANT MOL BIOL REP, V4, P37, DOI [10.1007/BF02672487, DOI 10.1007/BF02672487]; Bleecker AB, 1997, PLANT CELL, V9, P1169, DOI 10.1105/tpc.9.7.1169; Budiman MA, 2000, GENOME RES, V10, P129; BUTLER L, 1936, J HERED, V37, P25; Carmona MJ, 1998, PLANTA, V207, P181, DOI 10.1007/s004250050471; GUO Q, 1998, DEVELOPMENT, V125, P509; Jinn TL, 2000, GENE DEV, V14, P108; Kang HG, 1997, MOL CELLS, V7, P559; Liljegren SJ, 2000, NATURE, V404, P766, DOI 10.1038/35008089; MCCORMICK S, 1986, PLANT CELL REP, V5, P81, DOI 10.1007/BF00269239; Petersen M, 1996, PLANT MOL BIOL, V31, P517, DOI 10.1007/BF00042225; PNUELI L, 1994, PLANT CELL, V6, P163, DOI 10.1105/tpc.6.2.163; Pnueli L, 1998, DEVELOPMENT, V125, P1979; PNUELI L, 1991, PLANT J, V1, P255, DOI 10.1111/j.1365-313X.1991.00255.x; RICK CM, 1988, ANNU REV GENET, V22, P281, DOI 10.1146/annurev.ge.22.120188.001433; RICK CM, 1955, AM SOC HORT SCI, V66, P354; Riechmann JL, 1997, BIOL CHEM, V378, P1079; ROBERTS JA, 1984, PLANTA, V160, P159, DOI 10.1007/BF00392864; SOMMER H, 1990, EMBO J, V9, P605, DOI 10.1002/j.1460-2075.1990.tb08152.x; Szymkowiak EJ, 1999, PLANT CELL, V11, P159, DOI 10.1105/tpc.11.2.159; WING RA, 1994, MOL GEN GENET, V242, P681, DOI 10.1007/BF00283423; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0; ZHANG HB, 1994, MOL GEN GENET, V244, P613, DOI 10.1007/BF00282751	26	231	264	6	78	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 24	2000	406	6798					910	913		10.1038/35022611	http://dx.doi.org/10.1038/35022611			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347AG	10972295				2022-12-24	WOS:000088903600049
J	Klein, I; Ojamaa, K				Klein, I; Ojamaa, K			Thyroid (neuro)myopathy	LANCET			English	Editorial Material									NYU, N Shore Univ Hosp, Sch Med, Div Endocrinol, Manhasset, NY 11030 USA	New York University; Northwell Health; North Shore University Hospital	Klein, I (corresponding author), NYU, N Shore Univ Hosp, Sch Med, Div Endocrinol, Manhasset, NY 11030 USA.							Caiozzo VJ, 1998, J APPL PHYSIOL, V85, P2237, DOI 10.1152/jappl.1998.85.6.2237; Duyff RF, 2000, J NEUROL NEUROSUR PS, V68, P750, DOI 10.1136/jnnp.68.6.750; KLEIN I, 1994, ANN INTERN MED, V121, P281, DOI 10.7326/0003-4819-121-4-199408150-00010; KLEIN I, IN PRESS N ENGL J ME; Koss KL, 1996, CIRC RES, V79, P1059, DOI 10.1161/01.RES.79.6.1059; MARTIN WH, 1993, ANN THORAC SURG, V56, pS24, DOI 10.1016/0003-4975(93)90551-R; Olson B R, 1991, Thyroid, V1, P137, DOI 10.1089/thy.1991.1.137	7	33	33	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 19	2000	356	9230					614	614						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346RD	10968432				2022-12-24	WOS:000088884100007
J	Syngal, S; Schrag, D; Falchuk, M; Tung, N; Farraye, FA; Chung, D; Wright, M; Whetsell, A; Miller, G; Garber, JE				Syngal, S; Schrag, D; Falchuk, M; Tung, N; Farraye, FA; Chung, D; Wright, M; Whetsell, A; Miller, G; Garber, JE			Phenotypic characteristics associated with the APC gene I1307K mutation in Ashkenazi Jewish patients with colorectal polyps	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OVARIAN-CANCER RISK; FAMILY HISTORY; 11307K ALLELE; BREAST-CANCER; JEWS; POLYMORPHISM; COMMUNITY; VARIANT	Context The I1307K mutation of the APC gene is found in approximately 6% of the Ashkenazi Jewish population and is associated with elevated risk of colorectal cancer. The incidence of the mutation in patients with colorectal adenomas is unknown. Objectives To determine the carrier rate of the I1307K mutation in Ashkenazi Jewish patients with a history of colorectal polyps but without colorectal cancer and to compare phenotypic characteristics and family history of carriers vs noncarriers. Design, Setting, and Patients A total of 231 patients who had at least 1 large bowel polyp diagnosed between January 1, 1992, and January 31, 1999, at 1 of 5 centers in Boston. Mass, were included, of whom 183 were Ashkenazi Jewish. DNA was isolated from cheek swab samples. Main Outcome Measures Presence of the I1307K variant in the APC gene. Results The I1307K variant was identified in 22 (14%) of 161 Ashkenazi Jewish patients with a history of adenomatous polyps and in 1 (5%) of 20 Ashkenazi Jewish patients with hyperplastic polyps. The phenotypic features of adenomas, family history of polyps, colorectal cancer, and other cancers were indistinguishable between I1307K carriers and noncarriers, Conclusions The frequency of the APC I1307K mutation is elevated in Ashkenazi Jewish patients with adenomatous polyps, but not hyperplastic polyps. The I1307K mutation represents a novel paradigm for cancer-predisposing genes, as it is associated with moderately increased risk of neoplasia without other associated distinguishing phenotypic features.	Dana Farber Canc Inst, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA; Genzyme Corp, Boston, MA USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Beth Israel Deaconess Med Ctr,Gastrointestinal Un, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Sanofi-Aventis; Genzyme Corporation; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Massachusetts General Hospital	Syngal, S (corresponding author), Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	Sapna_Syngal@dfci.harvard.edu		Farraye, Francis/0000-0001-6371-2441				Abrahamson J, 1998, CANCER RES, V58, P2919; CANNONALBRIGHT LA, 1988, NEW ENGL J MED, V319, P533, DOI 10.1056/NEJM198809013190902; Frayling IM, 1998, P NATL ACAD SCI USA, V95, P10722, DOI 10.1073/pnas.95.18.10722; FUCHS CS, 1994, NEW ENGL J MED, V331, P1669, DOI 10.1056/NEJM199412223312501; Gryfe R, 1999, AM J HUM GENET, V64, P378, DOI 10.1086/302262; Gryfe R, 1998, CANCER RES, V58, P4040; Laken SJ, 1997, NAT GENET, V17, P79, DOI 10.1038/ng0997-79; Levin M, 1999, GENET TEST, V3, P207, DOI 10.1089/gte.1999.3.207; Lothe RA, 1998, CANCER RES, V58, P2923; Maresco DL, 1999, AM J HUM GENET, V64, P1228, DOI 10.1086/302345; Petrukhin L, 1997, CANCER RES, V57, P5480; Prior TW, 1999, GASTROENTEROLOGY, V116, P58, DOI 10.1016/S0016-5085(99)70229-5; Redston M, 1998, NAT GENET, V20, P13, DOI 10.1038/1666; Rozen P, 1999, GASTROENTEROLOGY, V116, P54, DOI 10.1016/S0016-5085(99)70228-3; Shields PG, 2000, J CLIN ONCOL, V18, P2309, DOI 10.1200/JCO.2000.18.11.2309; SHUBER AP, 1993, HUM MOL GENET, V2, P153, DOI 10.1093/hmg/2.2.153; Woodage T, 1998, NAT GENET, V20, P62, DOI 10.1038/1722	17	25	25	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2000	284	7					857	860		10.1001/jama.284.7.857	http://dx.doi.org/10.1001/jama.284.7.857			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342PM	10938175				2022-12-24	WOS:000088654400028
J	Bohossian, HB; Skaletsky, H; Page, DC				Bohossian, HB; Skaletsky, H; Page, DC			Unexpectedly similar rates of nucleotide substitution found in male and female hominids	NATURE			English	Article							MALE-DRIVEN EVOLUTION; MUTATION-RATE; DNA-SEQUENCES; X-CHROMOSOME; INTRON SEQUENCES; RECOMBINATION; TRANSPOSITION; REGIONS	In 1947, it was suggested that, in humans, the mutation rate is dramatically higher in the male germ line than in the female germ line(1). This hypothesis has been supported by the observation that, among primates, Y-linked genes evolved more rapidly than homologous X-linked genes(2-6). Based on these evolutionary studies, the ratio (alpha(m)) of male to female mutation rates in primates was estimated to be about 5. However, selection could have skewed sequence evolution in introns and exons(7-10). In addition, some of the X-Y gene pairs studied lie within chromosomal regions with substantially divergent nucleotide sequences(7,11,12). Here we directly compare human X and Y sequences within a large region with no known genes. Here the two chromosomes are 99% identical, and X-Y divergence began only three or four million years ago, during hominid evolution(13-15). In apes, homologous sequences exist only on the X chromosome. We sequenced and compared 38.6 kb of this region from human X, human Y, chimpanzee X and gorilla X chromosomes. We calculated alpha(m) to be 1.7 (95% confidence interval 1.15-2.87), significantly lower than previous estimates in primates. We infer that, in humans and their immediate ancestors, male and female mutation rates were far more similar than previously supposed.	MIT, Howard Hughes Med Inst, Whitehead Inst, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Page, DC (corresponding author), MIT, Howard Hughes Med Inst, Whitehead Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.							Agresti A., 1990, CATEGORICAL DATA ANA, pXV; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bishop YM., 2007, DISCRETE MULTIVARIAT; BULMER M, 1986, MOL BIOL EVOL, V3, P322; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chang BHJ, 1996, ZOOL STUD, V35, P36; CHARLESWORTH B, 1994, GENET RES, V63, P213, DOI 10.1017/S0016672300032365; Crow JF, 1997, P NATL ACAD SCI USA, V94, P8380, DOI 10.1073/pnas.94.16.8380; Ellegren H, 1997, NAT GENET, V17, P182, DOI 10.1038/ng1097-182; HALDANE JBS, 1947, ANN EUGENIC, V13, P262; Huang W, 1997, J MOL EVOL, V44, P463, DOI 10.1007/PL00006166; Kaessmann H, 1999, SCIENCE, V286, P1159, DOI 10.1126/science.286.5442.1159; Kaessmann H, 1999, NAT GENET, V22, P78, DOI 10.1038/8785; Li W-H, 1997, MOL EVOLUTION; LI WH, 1989, MOL BIOL EVOL, V6, P424; McVean GT, 1997, NATURE, V386, P388, DOI 10.1038/386388a0; MIYATA T, 1987, COLD SPRING HARB SYM, V52, P863, DOI 10.1101/SQB.1987.052.01.094; Mumm S, 1997, GENOME RES, V7, P307, DOI 10.1101/gr.7.4.307; PAGE DC, 1984, NATURE, V311, P119, DOI 10.1038/311119a0; Rozen S, 1999, BIOINFORMATICS METHO; Schwartz A, 1998, HUM MOL GENET, V7, P1, DOI 10.1093/hmg/7.1.1; SHIMMIN LC, 1994, J MOL EVOL, V39, P569, DOI 10.1007/BF00160402; SHIMMIN LC, 1993, J MOL EVOL, V37, P160, DOI 10.1007/BF02407351; SHIMMIN LC, 1993, NATURE, V362, P745, DOI 10.1038/362745a0; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; TAJIMA F, 1984, MOL BIOL EVOL, V1, P269; UBERBACHER EC, 1991, P NATL ACAD SCI USA, V88, P11261, DOI 10.1073/pnas.88.24.11261; Vogel F., 1997, HUMAN GENETICS; Wilkin DJ, 1998, AM J HUM GENET, V63, P711, DOI 10.1086/302000; WOLFE KH, 1989, NATURE, V337, P283, DOI 10.1038/337283a0	30	71	74	0	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2000	406	6796					622	625		10.1038/35020557	http://dx.doi.org/10.1038/35020557			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949301				2022-12-24	WOS:000088653800046
J	Bolli, GB; Owens, DR				Bolli, GB; Owens, DR			Insulin glargine	LANCET			English	Editorial Material							DIABETES-MELLITUS; NPH INSULIN; I-RECEPTOR; ANALOG		Univ Perugia, Dept Internal Med, I-06126 Perugia, Italy; Cardiff Univ, Diabet Res Unit, Cardiff CF4 4XN, S Glam, Wales	University of Perugia; Cardiff University	Bolli, GB (corresponding author), Univ Perugia, Dept Internal Med, I-06126 Perugia, Italy.							Berti L, 1998, HORM METAB RES, V30, P123, DOI 10.1055/s-2007-978849; Bolli GB, 1999, DIABETOLOGIA, V42, P1151, DOI 10.1007/s001250051286; Bolli GB, 1999, J PEDIATR ENDOCR MET, V12, P737; Heinemann L, 2000, DIABETES CARE, V23, P644, DOI 10.2337/diacare.23.5.644; Jehle PM, 1999, LANCET, V354, P1604, DOI 10.1016/S0140-6736(98)12459-5; Kurtzhals P, 2000, DIABETES, V49, P999, DOI 10.2337/diabetes.49.6.999; Lepore M, 1999, DIABETES, V48, pA97; OWENS DR, 1999, DIABETES CURRENT PER; PICKUP JC, 1978, BRIT MED J, V1, P204, DOI 10.1136/bmj.1.6107.204; Pieber T, 1998, DIABETES, V47, pA62; Ratner RE, 2000, DIABETES CARE, V23, P639, DOI 10.2337/diacare.23.5.639; Slieker LJ, 1997, DIABETOLOGIA, V40, pS54, DOI 10.1007/s001250051402; Smith LEH, 1999, NAT MED, V5, P1390, DOI 10.1038/70963; Yki-Jarvinen H, 2000, DIABETES, V49, pA130	14	145	149	2	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 5	2000	356	9228					443	445		10.1016/S0140-6736(00)02546-0	http://dx.doi.org/10.1016/S0140-6736(00)02546-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342QY	10981882				2022-12-24	WOS:000088657700003
J	O'Donoghue, GM; Nikolopoulos, TP; Archbold, SM				O'Donoghue, GM; Nikolopoulos, TP; Archbold, SM			Determinants of speech perception in children after cochlear implantation	LANCET			English	Article							SKILLS	Background Cochlear implants provide access to the speech signal in those profoundly deaf children who derive no material benefit from acoustic hearing aids. Speech perception after implantation can vary widely-we have analysed the contribution of several factors. Methods We examined 40 children with mean age at implantation of 52 months who were either born deaf or became deaf before 3 years. All patients received the same multichannel implant system and were followed up for 5 years. We used connected discourse tracking (CDT) as the measure of speech perception. The effect of five potential predictors (age at implantation, number of inserted electrodes, origin of deafness, mode of communication, and socioeconomic group) on speech perception was analysed. Findings The mean number of words per minute perceived increased from 0 before implantation to 44.8 (SD 24.3) 5 years after implantation. Repeated-measures ANOVA showed that children significantly progressed over time (p=0.001). Age at implantation was a significant covariate (p=0.01) and mode of communication was a significant between-individuals factor (p=0.04). Interpretation Young age at intervention and oral communication mode are the most important known determinants of later speech perception in young children after cochlear implantation. Early identification of candidate children necessitates implementation of universal neonatal screening programmes for hearing impairment.	Univ Nottingham Hosp, Dept Otolaryngol, Nottingham Paediat Cochlear Implant Program, Nottingham NG7 2UH, England	University of Nottingham	O'Donoghue, GM (corresponding author), Univ Nottingham Hosp, Dept Otolaryngol, Nottingham Paediat Cochlear Implant Program, Nottingham NG7 2UH, England.							DEFILIPPO CL, 1978, J ACOUST SOC AM, V63, P1186, DOI 10.1121/1.381827; *GOV STAT SERV, 1991, STAND OCC CLASS, V3, P38; LANE H, 1995, AM J OTOL, V16, P393; Miyamoto R. T., 1995, Annals of Otology Rhinology and Laryngology, V104, P334; Mondain M, 1997, ARCH OTOLARYNGOL, V123, P181; Nikolopoulos TP, 1998, HOSP MED, V59, P46; O'Donoghue G M, 1998, Acta Otorhinolaryngol Belg, V52, P111; O'Donoghue GM, 1998, AM J OTOL, V19, P762; Plant G, 1998, EAR HEARING, V19, P394, DOI 10.1097/00003446-199810000-00006; SHEA JJ, 1994, AM J OTOL, V15, P66; SUMMERFIELD AQ, 1997, AM J OTOL, V18, P166; TYEMURRAY N, 1988, J SPEECH HEAR DISORD, V53, P226, DOI 10.1044/jshd.5303.226; TYEMURRAY N, 1995, J ACOUST SOC AM, V98, P2454, DOI 10.1121/1.413278; TYLER RS, 1993, COCHLEAR IMPLANTS AU, P191; Waltzman SB, 1997, AM J OTOL, V18, P342	15	150	152	0	12	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 5	2000	356	9228					466	468		10.1016/S0140-6736(00)02555-1	http://dx.doi.org/10.1016/S0140-6736(00)02555-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342QY	10981890				2022-12-24	WOS:000088657700012
J	Lei, M; Lu, WG; Meng, WY; Parrini, MC; Eck, MJ; Mayer, BJ; Harrison, SC				Lei, M; Lu, WG; Meng, WY; Parrini, MC; Eck, MJ; Mayer, BJ; Harrison, SC			Structure of PAK1 in an autoinhibited conformation reveals a multistage activation switch	CELL			English	Article							P21-ACTIVATED PROTEIN-KINASE; ALDRICH-SYNDROME PROTEIN; HEAVY-CHAIN KINASE; ADAPTER PROTEIN; MEMBRANE LOCALIZATION; CRYSTAL-STRUCTURE; TYROSINE KINASE; ALPHA-PAK; MYOSIN-I; CDC42	The p21-activated kinases (PAKs), stimulated by binding with GTP-liganded forms of Cdc42 or Pac, modulate cytoskeletal actin assembly and activate MAP-kinase pathways. The 2.3 Angstrom resolution crystal structure of a complex between the N-terminal autoregulatory fragment and the C-terminal kinase domain of PAK1 shows that GTPase binding will trigger a series of conformational changes, beginning with disruption of a PAK1 dimer and ending with rearrangement of the kinase active site into a catalytically competent state. An inhibitory switch (IS) domain, which overlaps the GTPase binding region of PAK1, positions a polypeptide segment across the kinase cleft. GTPase binding will refold part of the IS domain and unfold the rest. A related switch has been seen in the Wiskott-Aldrich syndrome protein (WASP).	Childrens Hosp, Mol Med Lab, Boston, MA 02115 USA; Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute	Harrison, SC (corresponding author), Childrens Hosp, Mol Med Lab, 320 Longwood Ave, Boston, MA 02115 USA.	harrison@xtal2000.harvard.edu	Parrini, Maria Carla/J-5390-2016	Parrini, Maria Carla/0000-0002-7082-9792	NCI NIH HHS [1R01 CA2258-01] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; Abo A, 1998, EMBO J, V17, P6527, DOI 10.1093/emboj/17.22.6527; Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; BAGRODIA S, 1995, J BIOL CHEM, V270, P27995; Bokoch GM, 1996, J BIOL CHEM, V271, P25746, DOI 10.1074/jbc.271.42.25746; Brown JL, 1996, CURR BIOL, V6, P598, DOI 10.1016/S0960-9822(02)00546-8; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brzeska H, 1997, P NATL ACAD SCI USA, V94, P1092, DOI 10.1073/pnas.94.4.1092; Brzeska H, 1999, P NATL ACAD SCI USA, V96, P394, DOI 10.1073/pnas.96.2.394; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Buss F, 1998, J CELL BIOL, V143, P1535, DOI 10.1083/jcb.143.6.1535; Cullen BR, 1996, CURR BIOL, V6, P1557, DOI 10.1016/S0960-9822(02)70770-7; Daniels RH, 1999, TRENDS BIOCHEM SCI, V24, P350, DOI 10.1016/S0968-0004(99)01442-5; Daniels RH, 1999, J BIOL CHEM, V274, P6047, DOI 10.1074/jbc.274.10.6047; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; Fackler OT, 2000, MOL CELL BIOL, V20, P2619, DOI 10.1128/MCB.20.7.2619-2627.2000; Frost JA, 1996, MOL CELL BIOL, V16, P3707, DOI 10.1128/mcb.16.7.3707; Frost JA, 1998, J BIOL CHEM, V273, P28191, DOI 10.1074/jbc.273.43.28191; Galisteo ML, 1996, J BIOL CHEM, V271, P20997, DOI 10.1074/jbc.271.35.20997; Gatti A, 1999, J BIOL CHEM, V274, P8022, DOI 10.1074/jbc.274.12.8022; Gizachew D, 2000, BIOCHEMISTRY-US, V39, P3963, DOI 10.1021/bi992646d; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; JONES TA, 1989, CRYSTALLOGRAPHIC COM; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Kleywegt G. J., 1994, P CCP4 STUD WEEK 1 M, P59; Knaus UG, 1998, INT J BIOCHEM CELL B, V30, P857, DOI 10.1016/S1357-2725(98)00059-4; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Leeuw T, 1998, NATURE, V391, P191, DOI 10.1038/34448; Lim L, 1996, EUR J BIOCHEM, V242, P171, DOI 10.1111/j.1432-1033.1996.0171r.x; Lu WG, 1999, ONCOGENE, V18, P797, DOI 10.1038/sj.onc.1202361; Lu WG, 1997, CURR BIOL, V7, P85, DOI 10.1016/S0960-9822(06)00052-2; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Morreale A, 2000, NAT STRUCT BIOL, V7, P384; Otwinowski Z., 1993, DATA COLLECTION PROC, P56; Renkema GH, 1999, CURR BIOL, V9, P1407, DOI 10.1016/S0960-9822(00)80086-X; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rudolph MG, 1998, J BIOL CHEM, V273, P18067, DOI 10.1074/jbc.273.29.18067; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; Sells MA, 1997, TRENDS CELL BIOL, V7, P162, DOI 10.1016/S0962-8924(97)01003-9; Sells MA, 1999, J CELL BIOL, V145, P837, DOI 10.1083/jcb.145.4.837; SMEAL T, 1989, GENE DEV, V3, P2091, DOI 10.1101/gad.3.12b.2091; Thompson G, 1998, BIOCHEMISTRY-US, V37, P7885, DOI 10.1021/bi980140+; Tu H, 1999, MOL CELL BIOL, V19, P602; Wardenburg JB, 1998, IMMUNITY, V9, P607, DOI 10.1016/S1074-7613(00)80658-5; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yablonski D, 1998, EMBO J, V17, P5647, DOI 10.1093/emboj/17.19.5647; Yang WN, 1997, J BIOL CHEM, V272, P24819, DOI 10.1074/jbc.272.40.24819; Zenke FT, 1999, J BIOL CHEM, V274, P32565, DOI 10.1074/jbc.274.46.32565; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934; Zhao ZS, 1998, MOL CELL BIOL, V18, P2153, DOI 10.1128/MCB.18.4.2153	57	415	423	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 4	2000	102	3					387	397		10.1016/S0092-8674(00)00043-X	http://dx.doi.org/10.1016/S0092-8674(00)00043-X			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	342BP	10975528	Bronze			2022-12-24	WOS:000088625600013
J	Allan, BB; Moyer, BD; Balch, WE				Allan, BB; Moyer, BD; Balch, WE			Rab1 recruitment of p115 into a cis-SNARE complex: Programming budding COPII vesicles for fusion	SCIENCE			English	Article							NUCLEOTIDE DISSOCIATION INHIBITOR; ENDOCYTIC MEMBRANE-FUSION; ENDOPLASMIC-RETICULUM; GOLGI TRANSPORT; VESICULAR TRANSPORT; T-SNARE; PROTEIN-TRANSPORT; CARRIER VESICLES; REQUIRES USO1P; IN-VITRO	The guanosine triphosphatase Rab1 regulates the transport of newly synthesized proteins from the endoplasmic reticulum to the Golgi apparatus through interaction with effector molecules, but the molecular mechanisms by which this occurs are unknown. Here, the tethering factor p115 was shown to be a Rab1 effector that binds directly to activated Rab1. Rab1 recruited p115 to coat protein complex II (COPII) vesicles during budding from the endoplasmic reticulum, where it interacted with a select set of COPII vesicle-associated SNAREs (soluble N-ethylmateimide-sensitive factor attachment protein receptors) to form a cis-SNARE complex that promotes targeting to the Golgi apparatus. We propose that Rab1-regulated assembly of functional effector-SNARE complexes defines a conserved molecular mechanism to coordinate recognition between subcellular compartments.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Balch, WE (corresponding author), Scripps Res Inst, Dept Cell Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.				NATIONAL CANCER INSTITUTE [P01CA058689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042336, R01GM033301] Funding Source: NIH RePORTER; NCI NIH HHS [CA58689] Funding Source: Medline; NIGMS NIH HHS [GM42336, GM 33301] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLAN BW, UNPUB; Alvarez C, 1999, J CELL BIOL, V147, P1205, DOI 10.1083/jcb.147.6.1205; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Barlowe C, 1997, J CELL BIOL, V139, P1097, DOI 10.1083/jcb.139.5.1097; BECKERS CJM, 1987, CELL, V50, P523, DOI 10.1016/0092-8674(87)90025-0; Burd CG, 1997, MOL BIOL CELL, V8, P1089, DOI 10.1091/mbc.8.6.1089; Cao XC, 2000, J CELL BIOL, V149, P55, DOI 10.1083/jcb.149.1.55; Cao XC, 1998, EMBO J, V17, P2156, DOI 10.1093/emboj/17.8.2156; Carr CM, 1999, J CELL BIOL, V146, P333, DOI 10.1083/jcb.146.2.333; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Dascher C, 1996, J BIOL CHEM, V271, P15866, DOI 10.1074/jbc.271.27.15866; DASCHER C, 1991, MOL CELL BIOL, V11, P872, DOI 10.1128/MCB.11.2.872; DAVIDSON HW, 1993, J BIOL CHEM, V268, P4216; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; Grote E, 1999, MOL BIOL CELL, V10, P4149, DOI 10.1091/mbc.10.12.4149; HARDWICK KG, 1992, J CELL BIOL, V119, P513, DOI 10.1083/jcb.119.3.513; Hui N, 1997, MOL BIOL CELL, V8, P1777, DOI 10.1091/mbc.8.9.1777; Kito M, 1996, BIOCHEM BIOPH RES CO, V220, P653, DOI 10.1006/bbrc.1996.0459; KREIS TE, 1986, EMBO J, V5, P931, DOI 10.1002/j.1460-2075.1986.tb04306.x; KUGE O, 1994, J CELL BIOL, V125, P51, DOI 10.1083/jcb.125.1.51; LIAN JP, 1994, NATURE, V372, P698, DOI 10.1038/372698a0; Lowe M, 1998, BBA-MOL CELL RES, V1404, P53, DOI 10.1016/S0167-4889(98)00046-9; Lupashin VV, 1997, SCIENCE, V276, P1255, DOI 10.1126/science.276.5316.1255; Martinez O, 1998, BBA-MOL CELL RES, V1404, P101, DOI 10.1016/S0167-4889(98)00050-0; Mayer A, 1997, J CELL BIOL, V136, P307, DOI 10.1083/jcb.136.2.307; McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2; Nelson DS, 1998, J CELL BIOL, V143, P319, DOI 10.1083/jcb.143.2.319; NEWMAN AP, 1992, EMBO J, V11, P3609, DOI 10.1002/j.1460-2075.1992.tb05445.x; NUOFFER C, 1994, J CELL BIOL, V125, P225, DOI 10.1083/jcb.125.2.225; PETER F, 1994, J CELL BIOL, V126, P1393, DOI 10.1083/jcb.126.6.1393; Peterson MR, 1999, CURR BIOL, V9, P159, DOI 10.1016/S0960-9822(99)80071-2; PIND SN, 1994, J CELL BIOL, V125, P239, DOI 10.1083/jcb.125.2.239; PLUTNER H, 1991, J CELL BIOL, V115, P31, DOI 10.1083/jcb.115.1.31; PLUTNER H, 1992, J CELL BIOL, V119, P1097, DOI 10.1083/jcb.119.5.1097; Price A, 2000, J CELL BIOL, V148, P1231, DOI 10.1083/jcb.148.6.1231; REXACH MF, 1994, J CELL BIOL, V126, P1133, DOI 10.1083/jcb.126.5.1133; Rowe T, 1996, J CELL BIOL, V135, P895, DOI 10.1083/jcb.135.4.895; Rowe T, 1998, SCIENCE, V279, P696, DOI 10.1126/science.279.5351.696; Rybin V, 1996, NATURE, V383, P266, DOI 10.1038/383266a0; Sapperstein SK, 1996, J CELL BIOL, V132, P755, DOI 10.1083/jcb.132.5.755; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; Schimmoller F, 1998, J BIOL CHEM, V273, P22161, DOI 10.1074/jbc.273.35.22161; Shorter J, 1999, J CELL BIOL, V146, P57, DOI 10.1083/jcb.146.1.57; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; SOGAARD M, 1994, CELL, V78, P937, DOI 10.1016/0092-8674(94)90270-4; Sonnichsen B, 1998, J CELL BIOL, V140, P1013, DOI 10.1083/jcb.140.5.1013; Spang A, 1998, J CELL BIOL, V143, P589, DOI 10.1083/jcb.143.3.589; Stahl B, 1996, EMBO J, V15, P1799, DOI 10.1002/j.1460-2075.1996.tb00529.x; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; Tall GG, 1999, MOL BIOL CELL, V10, P1873, DOI 10.1091/mbc.10.6.1873; Tisdale EJ, 1996, J BIOL CHEM, V271, P29372, DOI 10.1074/jbc.271.46.29372; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; Turner MD, 1997, J BIOL CHEM, V272, P13479, DOI 10.1074/jbc.272.21.13479; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Ungermann C, 1998, J CELL BIOL, V140, P61, DOI 10.1083/jcb.140.1.61; Vitale G, 1998, EMBO J, V17, P1941, DOI 10.1093/emboj/17.7.1941; VONMOLLARD GF, 1994, TRENDS BIOCHEM SCI, V19, P164, DOI 10.1016/0968-0004(94)90278-X; Walter DM, 1998, J BIOL CHEM, V273, P29565, DOI 10.1074/jbc.273.45.29565; WATERS MG, 1992, J CELL BIOL, V118, P1015, DOI 10.1083/jcb.118.5.1015; Wu SK, 1998, J BIOL CHEM, V273, P26931, DOI 10.1074/jbc.273.41.26931	60	365	374	3	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2000	289	5478					444	448		10.1126/science.289.5478.444	http://dx.doi.org/10.1126/science.289.5478.444			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336ME	10903204				2022-12-24	WOS:000088305500046
J	Clarke, G; Collins, RA; Leavitt, BR; Andrews, DF; Hayden, MR; Lumsden, CJ; McInnes, RR				Clarke, G; Collins, RA; Leavitt, BR; Andrews, DF; Hayden, MR; Lumsden, CJ; McInnes, RR			A one-hit model of cell death in inherited neuronal degenerations	NATURE			English	Article							RETINITIS-PIGMENTOSA; RETINAL DEGENERATION; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; MUTANT MOUSE; LIGHT; NEURODEGENERATION; NUCLEAR; ROD; RAT	In genetic disorders associated with premature neuronal death, symptoms may not appear for years or decades. This delay in clinical onset is often assumed to reflect the occurrence of age-dependent cumulative damage(1-6). For example, it has been suggested that oxidative stress disrupts metabolism in neurological degenerative disorders by the cumulative damage of essential macromolecules(1,4,7). A prediction of the cumulative damage hypothesis is that the probability of cell death will increase over time. Here we show in contrast that the kinetics of neuronal death in 12 models of photoreceptor degeneration, hippocampal neurons undergoing excitotoxic cell deaths, a mouse model of cerebellar degeneration(9) and Parkinson's(10) and Huntington's diseases are all exponential and better explained by mathematical models in which the risk of cell death remains constant or decreases exponentially with age. These kinetics argue against the cumulative damage hypothesis; instead, the time of death of any neuron is random. Our findings are most simply accommodated by a 'one-hit' biochemical model in which mutation imposes a mutant steady state on the neuron and a single event randomly initiates cell death. This model appears to be common to many forms of neurodegeneration and has implications for therapeutic strategies.	Hosp Sick Children, Res Inst, Program Dev Biol, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Res Inst, Genet Program, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Pediat, Toronto, ON M5S 1A8, Canada; Univ Toronto, Inst Med Sci, Dept Med, Toronto, ON M5S 1A8, Canada; Univ British Columbia, Dept Med Genet, Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada; Univ Toronto, Dept Stat, Toronto, ON M5S 3G3, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University of British Columbia; University of Toronto	McInnes, RR (corresponding author), Hosp Sick Children, Res Inst, Program Dev Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.		Hayden, Michael R/D-8581-2011; Leavitt, Blair R/G-1934-2012	Hayden, Michael R/0000-0001-5159-1419; leavitt, Blair/0000-0002-4532-766X				Alves-Rodrigues A, 1998, TRENDS NEUROSCI, V21, P516, DOI 10.1016/S0166-2236(98)01276-4; BERSON EL, 1985, AM J OPHTHALMOL, V99, P240, DOI 10.1016/0002-9394(85)90351-4; Birch DG, 1999, OPHTHALMOLOGY, V106, P258, DOI 10.1016/S0161-6420(99)90064-7; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Cassarino DS, 1999, BRAIN RES REV, V29, P1, DOI 10.1016/S0165-0173(98)00046-0; Clarke G, 2000, NAT GENET, V25, P67, DOI 10.1038/75621; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Cummings JL, 1998, NEUROLOGY, V51, pS2, DOI 10.1212/WNL.51.1_Suppl_1.S2; DUBINSKY JM, 1995, NEUROPHARMACOLOGY, V34, P701, DOI 10.1016/0028-3908(95)00041-4; Dunnett SB, 1999, NATURE, V399, pA32, DOI 10.1038/399a032; ERICKSON PA, 1983, INVEST OPHTH VIS SCI, V24, P927; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; HAWKINS RK, 1985, EXP EYE RES, V41, P701, DOI 10.1016/0014-4835(85)90179-4; Kremer B, 1999, NEUROLOGY, V53, P1000, DOI 10.1212/WNL.53.5.1000; LAVAIL MM, 1993, J COMP NEUROL, V333, P168, DOI 10.1002/cne.903330204; LAVAIL MM, 1982, J COMP NEUROL, V212, P217, DOI 10.1002/cne.902120302; Li ZY, 1995, DEGENERATIVE DISEASES OF THE RETINA, P1; MASSOF RW, 1990, CLIN VISION SCI, V5, P1; Parshall C. J., 1991, Progress in Veterinary & Comparative Ophthalmology, V1, P187; Ratkowsky D., 1983, NONLINEAR REGRESSION; SANYAL S, 1981, EXP EYE RES, V33, P213, DOI 10.1016/S0014-4835(81)80070-X; SAUER H, 1994, NEUROSCIENCE, V59, P401, DOI 10.1016/0306-4522(94)90605-X; SCHMIDT SY, 1985, INVEST OPHTH VIS SCI, V26, P679; Seigel G M, 1997, Mol Vis, V3, P14; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Travis GH, 1998, AM J HUM GENET, V62, P503, DOI 10.1086/301772; Triarhou LC, 1998, BRAIN RES BULL, V47, P219, DOI 10.1016/S0361-9230(98)00076-8; WEN R, 1995, J NEUROSCI, V15, P7377	28	242	250	1	17	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 13	2000	406	6792					195	199		10.1038/35018098	http://dx.doi.org/10.1038/35018098			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910361				2022-12-24	WOS:000088221100051
J	Schwartlander, B; Garnett, G; Walker, N; Anderson, R				Schwartlander, B; Garnett, G; Walker, N; Anderson, R			AIDS special report - AIDS in a new millennium	SCIENCE			English	Editorial Material							TRANSMISSION; RESISTANT		UNAIDS, CH-1211 Geneva 27, Switzerland; Univ Oxford, Wellcome Trust Ctr Epidemiol Infect Dis, Oxford OX1 3PS, England	UNAIDS; University of Oxford	Schwartlander, B (corresponding author), UNAIDS, 20 Ave Appia, CH-1211 Geneva 27, Switzerland.		Garnett, Geoffrey P/A-9312-2008					Anderson R.M., 1999, SEX TRANSM DIS, V3rd, P25; ANDERSON RM, 1988, NATURE, V332, P228, DOI 10.1038/332228a0; AsiimweOkiror G, 1997, AIDS, V11, P1757, DOI 10.1097/00002030-199714000-00013; *CDCP, 1998, MMWR-MORBID MORTAL W, V47, P151; Dodds JP, 2000, BRIT MED J, V320, P1510, DOI 10.1136/bmj.320.7248.1510; GOTTLIEB MS, 1981, NEW ENGL J MED, V305, P1425, DOI 10.1056/NEJM198112103052401; Hecht FM, 1998, NEW ENGL J MED, V339, P307, DOI 10.1056/NEJM199807303390504; KITSIRIPORNCHAI S, 1998, 12 WORLD AIDS C GEN; *MIN HLTH STD AIDS, 1999, HIV AIDS SURV REP; Page-Shafer KA, 1999, JAMA-J AM MED ASSOC, V281, P696; Piot P, 2000, SCIENCE, V288, P2176, DOI 10.1126/science.288.5474.2176; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; UNAIDS, 2000, REP GLOB HIV AIDS EP; *UNAIDS BEST PRACT, 2000, EV 100 PERCENT CONDO; *US CENS BUR, 2000, WORLD POP PROF 2000; Wodak A, 1995, B NEW YORK ACAD MED, V72, P339; *WPRO WHO, 1999, STI AIDS SIT PEOPL R; Yerly S, 1999, LANCET, V354, P729, DOI 10.1016/S0140-6736(98)12262-6; 1999, REPORT AIDS PREVENTI	19	26	26	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 7	2000	289	5476					64	67		10.1126/science.289.5476.64	http://dx.doi.org/10.1126/science.289.5476.64			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	332TW	10928930				2022-12-24	WOS:000088090400028
J	Sullivan, RM; Landers, M; Yeaman, B; Wilson, DA				Sullivan, RM; Landers, M; Yeaman, B; Wilson, DA			Neurophysiology - Good memories of bad events in infancy	NATURE			English	Article									Univ Oklahoma, Dept Zool, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Sullivan, RM (corresponding author), Univ Oklahoma, Dept Zool, Norman, OK 73019 USA.			Wilson, Donald/0000-0001-8918-2151; Sullivan, Regina Marie/0000-0002-2406-8857	NICHD NIH HHS [R01 HD033402] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD033402] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Amaral DG, 1992, AMYGDALA NEUROBIOLOG, P465; Bowlby J, 1969, ATTACHMENT, V1; CAMP LL, 1989, DEV PSYCHOBIOL, V22, P25; CHAMBERS KC, 1990, ANNU REV NEUROSCI, V13, P373, DOI 10.1146/annurev.ne.13.030190.002105; DAVIS M, 1992, P255; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; HAROUTUNIAN V, 1979, SCIENCE, V205, P927, DOI 10.1126/science.472715; Hunt PS, 1997, LEARN MOTIV, P53; KUCHARSKI D, 1984, DEV PSYCHOBIOL, V17, P465, DOI 10.1002/dev.420170505; WILSON DA, 1994, BEHAV NEURAL BIOL, V61, P1, DOI 10.1016/S0163-1047(05)80039-1	10	239	239	0	18	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 7	2000	407	6800					38	39		10.1038/35024156	http://dx.doi.org/10.1038/35024156			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	350WE	10993064	Green Accepted			2022-12-24	WOS:000089124000032
J	Nishino, I; Fu, J; Tanji, K; Yamada, T; Shimojo, S; Koori, T; Mora, M; Riggs, JE; Oh, SJ; Koga, Y; Sue, CM; Yamamoto, A; Murakami, N; Shanske, S; Byrne, E; Bonilla, E; Nonaka, I; DiMauro, S; Hirano, M				Nishino, I; Fu, J; Tanji, K; Yamada, T; Shimojo, S; Koori, T; Mora, M; Riggs, JE; Oh, SJ; Koga, Y; Sue, CM; Yamamoto, A; Murakami, N; Shanske, S; Byrne, E; Bonilla, E; Nonaka, I; DiMauro, S; Hirano, M			Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease)	NATURE			English	Article							LYSOSOMAL GLYCOGEN-STORAGE; NORMAL ACID MALTASE; CELL-SURFACE EXPRESSION; MEMBRANE ATTACK COMPLEX; MENTAL-RETARDATION; GENE; GLYCOPROTEINS; FORM	"Lysosomal glycogen storage disease with normal acid maltase'', which was originally described by Danon et al.(1), is characterized clinically by cardiomyopathy, myopathy and variable mental retardation. The pathological hallmark of the disease is intracytoplasmic vacuoles containing autophagic material and glycogen in skeletal and cardiac muscle cells. Sarcolemmal proteins and basal lamina are associated with the vacuolar membranes(2,3). Here we report ten unrelated patients, including one of the patients from the original case report(1), who have primary deficiencies of LAMP-2, a principal lysosomal membrane protein. From these results and the finding that LAMP-2-deficient mice manifest a similar vacuolar cardioskeletal myopathy, we conclude that primary LAMP-2 deficiency is the cause of Danon disease(4). To our knowledge this is the first example of human cardiopathymyopathy that is caused by mutations in a lysosomal structural protein rather than an enzymatic protein.	Columbia Univ, Dept Neurol, New York, NY 10032 USA; Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Ultrastruct Res, Tokyo 1878502, Japan; Kyushu Univ, Dept Neurol, Higashi Ku, Fukuoka 8128582, Japan; St Marianna Univ, Sch Med, Dept Internal Med, Miyamae Ku, Kawasaki, Kanagawa 2168512, Japan; Yokohama Rosai Hosp, Dept Pediat, Kouhoku Ku, Kanagawa 2220036, Japan; Natl Neurol Inst C Besta, Dept Neuromuscular Dis, I-20133 Milan, Italy; W Virginia Univ, Dept Neurol, Morgantown, WV 26506 USA; Univ Alabama, Dept Neurol, Birmingham, AL 35294 USA; Kurume Univ, Dept Pediat & Child Hlth, Fukuoka 8300011, Japan; St Vincents Hosp, Dept Clin Neurosci, Fitzroy, Vic 3065, Australia	Columbia University; Columbia University; National Center for Neurology & Psychiatry - Japan; Kyushu University; Saint Marianna University; Yokohama Rosai Hospital; IRCCS Istituto Neurologico Besta; West Virginia University; University of Alabama System; University of Alabama Birmingham; Kurume University; St Vincent's Hospital Melbourne	Nishino, I (corresponding author), Columbia Univ, Dept Neurol, 630 W 168th St,P&S 4-443, New York, NY 10032 USA.		Nishino, Ichizo/G-2676-2010; Fu, Jin/A-3510-2012; Mora, Marina/J-2883-2018	Nishino, Ichizo/0000-0001-9452-112X; Hirano, Michio/0000-0002-7070-7402; Koga, Yasutoshi/0000-0002-6664-1295; Mora, Marina/0000-0002-5765-2320				Auranen M, 2000, ANN NEUROL, V47, P666, DOI 10.1002/1531-8249(200005)47:5<666::AID-ANA19>3.3.CO;2-E; BYRNE E, 1986, BRAIN, V109, P523, DOI 10.1093/brain/109.3.523; Cuervo AM, 1998, J MOL MED-JMM, V76, P6, DOI 10.1007/s109-1998-8099-y; DANON MJ, 1981, NEUROLOGY, V31, P51, DOI 10.1212/WNL.31.1.51; DWORZAK F, 1994, NEUROMUSCULAR DISORD, V4, P243, DOI 10.1016/0960-8966(94)90025-6; Fukuda M, 1994, Subcell Biochem, V22, P199; Gahl WASJ, 1995, METABOLIC MOL BASIS, V7th, P3763; Itoh Masahiro, 1993, No To Hattatsu, V25, P459; KANNAN K, 1995, EUR J HAEMATOL, V55, P145; Katsumi Y, 1996, J NEUROL SCI, V140, P46, DOI 10.1016/0022-510X(96)00077-9; Katsumi Y, 1994, Rinsho Shinkeigaku, V34, P827; KONECKI DS, 1995, BIOCHEM BIOPH RES CO, V215, P757, DOI 10.1006/bbrc.1995.2528; Lewin B, 1997, GENES; Louboutin JP, 1997, ANN NEUROL, V41, P117, DOI 10.1002/ana.410410121; Louboutin JP, 1996, MUSCLE NERVE, V19, P1144, DOI 10.1002/(SICI)1097-4598(199609)19:9<1144::AID-MUS10>3.0.CO;2-V; Matsumoto S, 1999, Rinsho Shinkeigaku, V39, P717; MATTEI MG, 1990, J BIOL CHEM, V265, P7548; Morisawa Y, 1998, J NEUROL SCI, V160, P175, DOI 10.1016/S0022-510X(98)00242-1; MUNTONI F, 1994, NEUROMUSCULAR DISORD, V4, P233, DOI 10.1016/0960-8966(94)90024-8; MURAKAMI N, 1995, NEUROMUSCULAR DISORD, V5, P149, DOI 10.1016/0960-8966(94)00046-C; RIGGS JE, 1983, NEUROLOGY, V33, P873, DOI 10.1212/WNL.33.7.873; SAITOH O, 1992, J BIOL CHEM, V267, P5700; Sutton KA, 1997, GENOMICS, V45, P447, DOI 10.1006/geno.1997.4946; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Town M, 1998, NAT GENET, V18, P319, DOI 10.1038/ng0498-319; Verheijen FW, 1999, NAT GENET, V23, P462, DOI 10.1038/70585; Verloes A, 1997, AM J MED GENET, V72, P135, DOI 10.1002/(SICI)1096-8628(19971017)72:2<135::AID-AJMG3>3.0.CO;2-U; VILLANOVA M, 1995, ANN NEUROL, V37, P637, DOI 10.1002/ana.410370514; Villard L, 2000, EUR J HUM GENET, V8, P125, DOI 10.1038/sj.ejhg.5200432	29	593	629	2	31	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 24	2000	406	6798					906	910		10.1038/35022604	http://dx.doi.org/10.1038/35022604			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347AG	10972294				2022-12-24	WOS:000088903600048
J	Li, H; Kolluri, SK; Gu, J; Dawson, MI; Cao, XH; Hobbs, PD; Lin, BZ; Chen, GQ; Lu, LS; Lin, F; Xie, ZH; Fontana, JA; Reed, JC; Zhang, XK				Li, H; Kolluri, SK; Gu, J; Dawson, MI; Cao, XH; Hobbs, PD; Lin, BZ; Chen, GQ; Lu, LS; Lin, F; Xie, ZH; Fontana, JA; Reed, JC; Zhang, XK			Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3	SCIENCE			English	Article							RETINOID-X-RECEPTOR; THYROID-HORMONE; GROWTH-FACTORS; CELL-DEATH; GENE NUR77; NGFI-B; SUPERFAMILY; BCL-2; HETERODIMERIZATION; REQUIREMENT	TR3, an immediate-early response gene and an orphan member of the steroid-thyroid hormone-retinoid receptor superfamily of transcription factors, regulates apoptosis through an unknown mechanism. In response to apoptotic stimuli, TR3 translocates from the nucleus to mitochondria to induce cytochrome c release and apoptosis. Mitochondrial targeting of TR3, but not its DNA binding and transactivation, is essential for its proapoptotic effect. Our results reveal a mechanism by which a nuclear transcription factor translocates to mitochondria to initiate apoptosis.	Burnham Inst, La Jolla, CA 92037 USA; Mol Med Res Inst, Mt View, CA 94043 USA; SRI Int, Retinoid Program, Menlo Park, CA 94025 USA; Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48201 USA; John D Dingel VA Med Ctr, Detroit, MI 48201 USA	Sanford Burnham Prebys Medical Discovery Institute; SRI International; Barbara Ann Karmanos Cancer Institute; Wayne State University	Zhang, XK (corresponding author), Burnham Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Fontana, Joseph/0000-0003-3829-3358				BERNARD BA, 1992, BIOCHEM BIOPH RES CO, V186, P977, DOI 10.1016/0006-291X(92)90842-9; BISSONNETTE RP, 1992, NATURE, V359, P552, DOI 10.1038/359552a0; BODDYWETZEL E, 1997, EMBO J, V16, P1695; CHANG C, 1988, BIOCHEM BIOPH RES CO, V155, P971, DOI 10.1016/S0006-291X(88)80591-6; Cheng LEC, 1997, EMBO J, V16, P1865, DOI 10.1093/emboj/16.8.1865; FANIDI A, 1992, NATURE, V359, P554, DOI 10.1038/359554a0; FORMAN BM, 1995, CELL, V81, P541, DOI 10.1016/0092-8674(95)90075-6; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; HAZEL TG, 1988, P NATL ACAD SCI USA, V85, P8444, DOI 10.1073/pnas.85.22.8444; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; KASTNER P, 1995, CELL, V83, P859, DOI 10.1016/0092-8674(95)90202-3; Kolluri SK, 1999, GENE DEV, V13, P1742, DOI 10.1101/gad.13.13.1742; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Labelle Y, 1999, ONCOGENE, V18, P3303, DOI 10.1038/sj.onc.1202675; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; LI HN, UNPUB; Li Y, 1998, MOL CELL BIOL, V18, P4719, DOI 10.1128/MCB.18.8.4719; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; NAKAI A, 1990, MOL ENDOCRINOL, V4, P1438, DOI 10.1210/mend-4-10-1438; PERLMANN T, 1995, GENE DEV, V9, P769, DOI 10.1101/gad.9.7.769; Phillips A, 1997, MOL CELL BIOL, V17, P5946, DOI 10.1128/MCB.17.10.5946; Reed JC, 1997, CELL, V91, P559, DOI 10.1016/S0092-8674(00)80442-0; RYSECK RP, 1989, EMBO J, V8, P3327, DOI 10.1002/j.1460-2075.1989.tb08494.x; SOLTYS BJ, 1992, BIOCHEM CELL BIOL, V70, P1174, DOI 10.1139/o92-163; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.biochem.63.1.451; Uemura H, 1998, ENDOCRINOLOGY, V139, P2329, DOI 10.1210/en.139.5.2329; Weih F, 1996, P NATL ACAD SCI USA, V93, P5533, DOI 10.1073/pnas.93.11.5533; WORONICZ JD, 1994, NATURE, V367, P277, DOI 10.1038/367277a0; Wu Q, 1997, EMBO J, V16, P1656, DOI 10.1093/emboj/16.7.1656; Wu Q, 1997, MOL CELL BIOL, V17, P6598, DOI 10.1128/MCB.17.11.6598; Yoneda Y, 1997, J BIOCHEM, V121, P811; YOON JK, 1993, J BIOL CHEM, V268, P9148; YOUNG CYF, 1994, ONCOL RES, V6, P203; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248; ZHANG XK, 1993, TRENDS ENDOCRIN MET, V4, P156, DOI 10.1016/1043-2760(93)90105-N; ZHANG XK, 1992, NATURE, V355, P441, DOI 10.1038/355441a0; Zhu WJ, 1996, EMBO J, V15, P4130, DOI 10.1002/j.1460-2075.1996.tb00788.x	39	559	604	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 18	2000	289	5482					1159	1164		10.1126/science.289.5482.1159	http://dx.doi.org/10.1126/science.289.5482.1159			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346JE	10947977				2022-12-24	WOS:000088866600033
J	Seder, RA; Hill, AVS				Seder, RA; Hill, AVS			Vaccines against intracellular infections requiring cellular immunity	NATURE			English	Article							MEMORY T-CELLS; IMMUNODEFICIENCY VIRUS-INFECTION; ACTIVE ANTIRETROVIRAL THERAPY; IN-VIVO; PROTECTIVE IMMUNITY; INTERFERON-GAMMA; DNA VACCINATION; CPG MOTIFS; ANTIGEN; LYMPHOCYTES	Vaccines against a variety of infectious diseases represent one of the great triumphs of medicine. The immune correlates of protection induced by most current vaccines seem to be mediated by long-lived humoral immune responses. By contrast, there are no currently available vaccines that are uniformly effective for diseases such as HIV, malaria and tuberculosis, in which the cellular immune response might be crucial in mediating protection. Here we examine the mechanisms by which long-lived cellular immune responses are generated and maintained in vivo. We then discuss current approaches for vaccination against diseases in which cellular immune responses are important for protection.	NIAID, Clin Immunol Sect, Clin Invest Lab, NIH, Bethesda, MD 20892 USA; Univ Oxford, John Radcliffe Hosp, Nuffield Dept Med, Inst Mol Med,Mol Immunol Grp, Oxford OX3 9DU, England	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Oxford	Seder, RA (corresponding author), NIAID, Clin Immunol Sect, Clin Invest Lab, NIH, Bethesda, MD 20892 USA.	rseder@niaid.nih.gov	HILL, Adrian V>S>/C-1306-2008					Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Bachmann MF, 1997, P NATL ACAD SCI USA, V94, P640, DOI 10.1073/pnas.94.2.640; Calarota S, 1998, LANCET, V351, P1320, DOI 10.1016/S0140-6736(97)09440-3; Cho HJ, 2000, NAT BIOTECHNOL, V18, P509, DOI 10.1038/75365; Cowdery J, 1996, J IMMUNOL, V156, P4570; Doolan DL, 1996, J EXP MED, V183, P1739, DOI 10.1084/jem.183.4.1739; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Flynn KJ, 1998, IMMUNITY, V8, P683, DOI 10.1016/S1074-7613(00)80573-7; Garcia S, 1999, IMMUNITY, V11, P163, DOI 10.1016/S1074-7613(00)80091-6; GRAY D, 1991, J EXP MED, V174, P969, DOI 10.1084/jem.174.5.969; Guebre-Xabier M, 1999, EUR J IMMUNOL, V29, P3978, DOI 10.1002/(SICI)1521-4141(199912)29:12&lt;3978::AID-IMMU3978&gt;3.0.CO;2-0; Gurunathan S, 1998, NAT MED, V4, P1409, DOI 10.1038/4000; Hanke T, 1999, J VIROL, V73, P7524, DOI 10.1128/JVI.73.9.7524-7532.1999; HOU S, 1994, NATURE, V369, P652, DOI 10.1038/369652a0; Kalams SA, 1999, J VIROL, V73, P6721, DOI 10.1128/JVI.73.8.6721-6728.1999; Kent SJ, 1998, J VIROL, V72, P10180, DOI 10.1128/JVI.72.12.10180-10188.1998; Klinman DM, 1996, P NATL ACAD SCI USA, V93, P2879, DOI 10.1073/pnas.93.7.2879; Krieg AM, 1998, P NATL ACAD SCI USA, V95, P12631, DOI 10.1073/pnas.95.21.12631; Kundig TM, 1996, P NATL ACAD SCI USA, V93, P9716, DOI 10.1073/pnas.93.18.9716; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; Le TP, 2000, VACCINE, V18, P1893, DOI 10.1016/S0264-410X(99)00407-7; Lifson JD, 1997, J VIROL, V71, P9508, DOI 10.1128/JVI.71.12.9508-9514.1997; Matano T, 1998, J VIROL, V72, P164, DOI 10.1128/JVI.72.1.164-169.1998; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; MULLBACHER A, 1994, J EXP MED, V179, P317, DOI 10.1084/jem.179.1.317; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Ochsenbein AF, 1999, P NATL ACAD SCI USA, V96, P9293, DOI 10.1073/pnas.96.16.9293; OEHEN S, 1992, J EXP MED, V176, P1273, DOI 10.1084/jem.176.5.1273; Ogg GS, 1998, SCIENCE, V279, P2103, DOI 10.1126/science.279.5359.2103; Opferman JT, 1999, SCIENCE, V283, P1745, DOI 10.1126/science.283.5408.1745; Ortiz GM, 1999, J CLIN INVEST, V104, pR13, DOI 10.1172/JCI7371; RAZVI ES, 1995, ADV VIRUS RES, V45, P1, DOI 10.1016/S0065-3527(08)60057-3; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sato Y, 1996, SCIENCE, V273, P352, DOI 10.1126/science.273.5273.352; SCHELLER LF, 1995, P NATL ACAD SCI USA, V92, P4066, DOI 10.1073/pnas.92.9.4066; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Schneider J, 1998, NAT MED, V4, P397, DOI 10.1038/nm0498-397; Schneider J, 1999, IMMUNOL REV, V170, P29, DOI 10.1111/j.1600-065X.1999.tb01326.x; Schubach A, 1998, J INFECT DIS, V178, P911, DOI 10.1086/515355; Seder RA, 1999, NEW ENGL J MED, V341, P277, DOI 10.1056/NEJM199907223410410; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302; Wang RB, 1998, SCIENCE, V282, P476, DOI 10.1126/science.282.5388.476; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353	47	296	320	0	15	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 17	2000	406	6797					793	798		10.1038/35021239	http://dx.doi.org/10.1038/35021239			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963610	Bronze			2022-12-24	WOS:000088767700057
J	Prockter, LM; Pappalardo, RT				Prockter, LM; Pappalardo, RT			Folds on Europa: Implications for crustal cycling and accommodation of extension	SCIENCE			English	Article							TIDAL STRESSES; MODELS; SEPARATION; FEATURES; PATTERNS; FRACTURE; FAULT; BAND	Regional-scale undulations with associated small-scale secondary structures are inferred to be folds on Jupiter's moon Europa. Formation is consistent with stresses from tidal deformation, potentially triggering compressional instability of a region of Locally high thermal gradient. Folds may compensate for extension elsewhere on Europa and then relax away over time.	Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; Brown Univ, Dept Geol Sci, Providence, RI 02912 USA	Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Brown University	Prockter, LM (corresponding author), Johns Hopkins Univ, Appl Phys Lab, MS 7-366,11100 Johns Hopkins Rd, Laurel, MD 20723 USA.	louise.prockter@jhuapl.edu; robert_pappalardo@brown.edu	Pappalardo, Robert/AAP-8953-2021	Pappalardo, Robert/0000-0003-2571-4627				BIOT MA, 1961, GEOL SOC AM BULL, V72, P1595, DOI 10.1130/0016-7606(1961)72[1595:TOFOSV]2.0.CO;2; BIOT MA, 1960, J FRANKLIN I, V270, P190, DOI DOI 10.1016/0016-0032(60)90589-5); BIOT MA, 1959, J FRANKLIN I, V267, P211; FIGUEREDO P, IN PRESS J GEOPHYS R; Goldsby DL, 1997, SCRIPTA MATER, V37, P1399, DOI 10.1016/S1359-6462(97)00246-7; Greenberg R, 1998, ICARUS, V135, P64, DOI 10.1006/icar.1998.5986; HEAD J, 1998, LUNAR PLANET SCI C, V29; HELFENSTEIN P, 1985, ICARUS, V61, P175, DOI 10.1016/0019-1035(85)90099-5; HERRICK DL, 1990, ICARUS, V85, P191, DOI 10.1016/0019-1035(90)90110-U; HILLIER J, 1991, J GEOPHYS RES-PLANET, V96, P15665, DOI 10.1029/91JE01401; Hoppa G, 1999, ICARUS, V141, P287, DOI 10.1006/icar.1999.6185; Hoppa GV, 1999, SCIENCE, V285, P1899, DOI 10.1126/science.285.5435.1899; Leith AC, 1996, ICARUS, V120, P387, DOI 10.1006/icar.1996.0058; MCEWEN AS, 1986, NATURE, V321, P49, DOI 10.1038/321049a0; Mellor M, 1980, PHYSICS MECHANICS IC, P217; MUELLER S, 1988, ICARUS, V76, P437, DOI 10.1016/0019-1035(88)90014-0; PAPPALARDO R, 1999, LUNAR PLANET SCI C, V30; Pappalardo RT, 1996, ICARUS, V123, P557, DOI 10.1006/icar.1996.0178; Pappalardo RT, 1999, J GEOPHYS RES-PLANET, V104, P24015, DOI 10.1029/1998JE000628; PAPPALARDO RT, 1995, J GEOPHYS RES-PLANET, V100, P18985, DOI 10.1029/94JE02638; Prockter LM, 2000, J GEOPHYS RES-PLANET, V105, P9483, DOI 10.1029/1999JE001226; PROCKTER LM, 1999, LUNAR PLANET SCI C, V30; SCHENK PM, 1989, ICARUS, V79, P75, DOI 10.1016/0019-1035(89)90109-7; Schenk PM, 1998, ASTROPHYS SPACE SC L, V227, P551, DOI 10.1007/978-94-011-5252-5_23; SOLOMON SC, 1984, J GEOPHYS RES, V89, P6885, DOI 10.1029/JB089iB08p06885; Squyres S. W., 1986, SATELLITES, P293; Sullivan R, 1998, NATURE, V391, P371, DOI 10.1038/34874; SULLIVAN R, 1997, LUNAR PLANET SCI C, V27, P1343; THOMAS PJ, 1986, J GEOPHYS RES, V91, P453; Tufts BR, 1999, ICARUS, V141, P53, DOI 10.1006/icar.1999.6168	30	62	63	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 11	2000	289	5481					941	943		10.1126/science.289.5481.941	http://dx.doi.org/10.1126/science.289.5481.941			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343KH	10937995				2022-12-24	WOS:000088701200029
J	Kuo, RK; Baxter, GT; Thompson, SH; Stricker, SA; Patton, C; Bonaventura, J; Epel, D				Kuo, RK; Baxter, GT; Thompson, SH; Stricker, SA; Patton, C; Bonaventura, J; Epel, D			NO is necessary and sufficient for egg activation at fertilization	NATURE			English	Article							NITRIC-OXIDE SYNTHASE; SEA-URCHIN EGGS; ACROSOME REACTION; SPERM; CALCIUM; RELEASE; PATHWAY; FAMILY; ASSAY	The early steps that lead to the rise in calcium and egg activation at fertilization are unknown but of great interest-particularly with the advent of in vitro fertilization techniques for treating male infertility and whole-animal cloning by nuclear transfer. This calcium rise is required for egg activation and the subsequent events of development in eggs of all species(1,2). Injection of intact sperm or sperm extracts can activate eggs, suggesting that sperm-derived factors may be involved. Here we show that nitric oxide synthase is present at high concentration and active in sperm after activation by the acrosome reaction. An increase in nitrosation within eggs is evident seconds after insemination and precedes the calcium pulse of fertilization. Microinjection of nitric oxide donors or recombinant nitric oxide synthase recapitulates events of egg activation, whereas prior injection of oxyhaemoglobin, a physiological nitric oxide scavenger, prevents egg activation after fertilization. We conclude that nitric oxide synthase and nitric-oxide-related bioactivity satisfy the primary criteria of an egg activator: they are present in an appropriate place, active at an appropriate time, and are necessary and sufficient for successful fertilization.	Stanford Univ, Dept Biol Sci, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; Stanford Univ, Program Neurosci, Sch Med, Stanford, CA 94305 USA; Cornell Univ, Knight Lab, Ithaca, NY 14853 USA; Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Duke Marine Biomed Ctr, Nicholas Sch Environm, Pivers Isl, NC 28516 USA	Stanford University; Stanford University; Cornell University; University of New Mexico; Duke University; Duke University	Epel, D (corresponding author), Stanford Univ, Dept Biol Sci, Hopkins Marine Stn, Pacific Grove, CA 93950 USA.	depel@stanford.edu						Akhand AK, 1999, J BIOL CHEM, V274, P25821, DOI 10.1074/jbc.274.36.25821; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; Ciapa B, 1996, BIOCHEM BIOPH RES CO, V223, P633, DOI 10.1006/bbrc.1996.0946; CROSSLEY I, 1991, CELL REGUL, V2, P121, DOI 10.1091/mbc.2.2.121; EPEL D, 1997, HDB PHYSIOL 14, P859; Fehsel K, 1996, METHOD ENZYMOL, V269, P426; Giraldez RR, 1998, ANAL BIOCHEM, V261, P29, DOI 10.1006/abio.1998.2721; Giusti AF, 1999, DEV BIOL, V208, P189, DOI 10.1006/dbio.1998.9187; Gross SS, 1999, P NATL ACAD SCI USA, V96, P9967, DOI 10.1073/pnas.96.18.9967; GUERRERO A, 1989, J BIOL CHEM, V264, P19593; HOPE BT, 1991, P NATL ACAD SCI USA, V88, P2811, DOI 10.1073/pnas.88.7.2811; KAO JPY, 1994, PRACTICAL ASPECTS ME; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; KURODA R, IN PRESS ZYGOTE; Lee SJ, 1996, DEV BIOL, V180, P324, DOI 10.1006/dbio.1996.0304; Miller BS, 1999, DEV BIOL, V216, P394, DOI 10.1006/dbio.1999.9513; MISKO TP, 1993, ANAL BIOCHEM, V214, P11, DOI 10.1006/abio.1993.1449; NADAI CD, 1998, DEV GROWTH DIFFER, V40, P669; PODELL SB, 1984, J CELL BIOL, V99, P1598, DOI 10.1083/jcb.99.5.1598; REGULSKI M, 1995, P NATL ACAD SCI USA, V92, P9072, DOI 10.1073/pnas.92.20.9072; Rongish BJ, 1999, DEV BIOL, V215, P147, DOI 10.1006/dbio.1999.9472; Schulz JR, 1997, DEV BIOL, V191, P80, DOI 10.1006/dbio.1997.8712; SEXTON DJ, 1994, PHOTOCHEM PHOTOBIOL, V59, P463, DOI 10.1111/j.1751-1097.1994.tb05065.x; Stamler, 1996, METHODS NITRIC OXIDE, P249; Stricker SA, 1999, DEV BIOL, V211, P157, DOI 10.1006/dbio.1999.9340; TURNER E, 1987, BIOCHEMISTRY-US, V26, P4028, DOI 10.1021/bi00387a043; Willmott N, 1996, J BIOL CHEM, V271, P3699; Xu L, 1998, SCIENCE, V279, P234, DOI 10.1126/science.279.5348.234	28	145	154	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2000	406	6796					633	636		10.1038/35020577	http://dx.doi.org/10.1038/35020577			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949304				2022-12-24	WOS:000088653800049
J	Henney, JE				Henney, JE			Guidance for adverse reactions labeling	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item											Henney, JE (corresponding author), HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	2	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2000	284	6					685	685		10.1001/jama.284.6.685	http://dx.doi.org/10.1001/jama.284.6.685			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341JM	10950660				2022-12-24	WOS:000088587300006
J	Chirac, P; von Schoen-Angerer, T; Kasper, T; Ford, N				Chirac, P; von Schoen-Angerer, T; Kasper, T; Ford, N			AIDS: patent rights versus patient's rights	LANCET			English	Editorial Material									Med Sans Frontieres, F-75554 Paris 11, France	Doctors Without Borders	Chirac, P (corresponding author), Med Sans Frontieres, 8 rue St Sabin, F-75554 Paris 11, France.			von Schoen-Angerer, Tido/0000-0003-3601-7480				Ainsworth M, 2000, LANCET, V356, P55, DOI 10.1016/S0140-6736(00)02440-5; Kaitin KI, 2000, DRUG INF J, V34, P1; MITSUYA H, 1989, NY TIMES        0928; Palella FJ, 1999, NEW ENGL J MED, V279, P853; Zwi K, 2000, BRIT MED J, V320, P1551, DOI 10.1136/bmj.320.7249.1551	5	12	13	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 5	2000	356	9228					502	502		10.1016/S0140-6736(00)02566-6	http://dx.doi.org/10.1016/S0140-6736(00)02566-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342QY	10981906				2022-12-24	WOS:000088657700037
J	Paar, J; Oldroyd, BP; Kastberger, G				Paar, J; Oldroyd, BP; Kastberger, G			Entomology - Giant honeybees return to their nest sites	NATURE			English	Article									Univ Sydney, Sch Biol Sci A12, Sydney, NSW 2006, Australia; Graz Univ, Inst Zool, A-8010 Graz, Austria	University of Sydney; University of Graz	Paar, J (corresponding author), Univ Sydney, Sch Biol Sci A12, Sydney, NSW 2006, Australia.	boldroyd@bio.usyd.edu.au	Oldroyd, Benjamin/A-4800-2008	Oldroyd, Benjamin/0000-0001-6831-3677				ESTOUP A, 1994, P ROY SOC B-BIOL SCI, V258, P1, DOI 10.1098/rspb.1994.0133; KOENIGER N, 1980, J APICULT RES, V19, P21, DOI 10.1080/00218839.1980.11099994; Oldroyd BP, 1999, P ROY SOC B-BIOL SCI, V266, P1335, DOI 10.1098/rspb.1999.0784; Oldroyd BP, 2000, INSECT SOC, V47, P94, DOI 10.1007/s000400050015; WEIR BS, 1994, ANNU REV GENET, V28, P597	5	36	40	0	13	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 3	2000	406	6795					475	475		10.1038/35020196	http://dx.doi.org/10.1038/35020196			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952300				2022-12-24	WOS:000088538000034
J	Saint-Ruf, C; Panigada, M; Azogui, O; Debey, P; von Boehmer, H; Grassi, F				Saint-Ruf, C; Panigada, M; Azogui, O; Debey, P; von Boehmer, H; Grassi, F			Different initiation of pre-TCR and gamma delta TCR signalling	NATURE			English	Article							T-CELL-RECEPTOR; PROTEIN-TYROSINE KINASE; ALPHA-BETA; LINEAGE COMMITMENT; ANTIGEN RECEPTOR; LIPID RAFTS; SH2 DOMAINS; ACTIVATION; EXPRESSION; MEMBRANES	Lineage choice is of great interest in developmental biology. In the immune system, the alpha beta and gamma delta lineages of T lymphocytes diverge during the course of the beta-, gamma- and delta-chain rearrangement of T-cell receptor (TCR) genes that takes place within the same precursor cell and which results in the formation of the gamma delta TCR or pre-TCR proteins(1-3). The pre-TCR consists of the TCR beta chain covalently linked to the pre-TCR alpha protein, which is present in immature but not in mature T cells which instead express the TCR alpha chain(4,5). Animals deficient in pre-TCR alpha have few alpha beta lineage cells but an increased number of gamma delta T cells. These gamma delta T cells exhibit more extensive TCR beta rearrangement than gamma delta T cells from wild-type mice(6,7). These observations are consistent with the idea that different signals emanating from the gamma delta TCR and pre-TCR instruct lineage commitment(8). Here we show, by using confocal microscopy and biochemistry to analyse the initiation of signalling, that the pre-TCR but not the gamma delta TCR colocalizes with the p56(lck) Src kinase into glycolipid-enriched membrane domains (rafts) apparently without any need for ligation. This results in the phosphorylation of CD3 epsilon and Zap-70 signal transducing molecules. The results indicate clear differences between pre-TCR and gamma delta TCR signalling.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Fac Med Necker, INSERM, U373, Inst Necker, F-75730 Paris 15, France; Inst Biol Physicochim, Museum Natl Hist Nat, INRA, Unite 806, F-75005 Paris, France; Univ Milan, Dipartimento Biol & Genet Sci Med, I-20133 Milan, Italy	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; INRAE; Museum National d'Histoire Naturelle (MNHN); University of Milan	von Boehmer, H (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St,Smith 736, Boston, MA 02115 USA.			GRASSI, FABIO/0000-0003-3348-1712				Aifantis L, 1998, IMMUNITY, V9, P649, DOI 10.1016/S1074-7613(00)80662-7; Amirand C, 1998, J CELL SCI, V111, P3551; ANDERSON SJ, 1995, IMMUNOL TODAY, V16, P99, DOI 10.1016/0167-5699(95)80096-4; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; delPorto P, 1995, P NATL ACAD SCI USA, V92, P12105, DOI 10.1073/pnas.92.26.12105; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; GODFREY DI, 1993, J IMMUNOL, V150, P4244; GROETTRUP M, 1993, CELL, V75, P283, DOI 10.1016/0092-8674(93)80070-U; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Huby RDJ, 1997, J CELL BIOL, V137, P1639, DOI 10.1083/jcb.137.7.1639; Irving BA, 1998, SCIENCE, V280, P905, DOI 10.1126/science.280.5365.905; Janes PW, 1999, J CELL BIOL, V147, P447, DOI 10.1083/jcb.147.2.447; Lanzavecchia A, 1999, CELL, V96, P1, DOI 10.1016/S0092-8674(00)80952-6; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; RODEWALD HR, 1993, J EXP MED, V177, P1079, DOI 10.1084/jem.177.4.1079; RODGERS W, 1994, MOL CELL BIOL, V14, P5384, DOI 10.1128/MCB.14.8.5384; SAINTRUF C, 1994, SCIENCE, V266, P1208, DOI 10.1126/science.7973703; Sheets ED, 1999, J CELL BIOL, V145, P877, DOI 10.1083/jcb.145.4.877; SHENOYSCARIA AM, 1994, J CELL BIOL, V126, P353, DOI 10.1083/jcb.126.2.353; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; VANOERS NSC, 1995, J EXP MED, V182, P1585, DOI 10.1084/jem.182.5.1585; von Boehmer H, 1998, IMMUNOL REV, V165, P111; vonBoehmer H, 1997, ANNU REV IMMUNOL, V15, P433, DOI 10.1146/annurev.immunol.15.1.433; WANGE RL, 1993, J BIOL CHEM, V268, P19797; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8	29	138	139	0	6	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2000	406	6795					524	527		10.1038/35020093	http://dx.doi.org/10.1038/35020093			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952314	Green Published			2022-12-24	WOS:000088538000048
J	Moloney, DJ; Panin, VM; Johnston, SH; Chen, JH; Shao, L; Wilson, R; Wang, Y; Stanley, P; Irvine, KD; Haltiwanger, RS; Vogt, TF				Moloney, DJ; Panin, VM; Johnston, SH; Chen, JH; Shao, L; Wilson, R; Wang, Y; Stanley, P; Irvine, KD; Haltiwanger, RS; Vogt, TF			Fringe is a glycosyltransferase that modifies Notch	NATURE			English	Article							HAMSTER OVARY CELLS; O-LINKED FUCOSE; DROSOPHILA WING DEVELOPMENT; RESISTANT CHO CELLS; GDP-FUCOSE; GLYCOSYLATION PATHWAY; SIGNALING PATHWAY; MOLECULAR-CLONING; SERRATE; DORSAL	Notch receptors function in highly conserved intercellular signalling pathways that direct cell-fate decisions, proliferation and apoptosis in metazoans. Fringe proteins can positively and negatively modulate the ability of Notch ligands to activate the Notch receptor. Here we establish the biochemical mechanism of Fringe action. Drosophila and mammalian Fringe proteins possess a fucose-specific beta 1,3 N-acetylglucosaminyltransferase activity that initiates elongation of O-linked fucose residues attached to epidermal growth factor-like sequence repeats of Notch. We obtained biological evidence that Fringe-dependent elongation of O-linked fucose on Notch modulates Notch signalling by using co-culture assays in mammalian cells and by expression of an enzymatically inactive Fringe mutant in Drosophila. The post-translational modification of Notch by Fringe represents a striking example of modulation of a signalling event by differential receptor glycosylation and identifies a mechanism that is likely to be relevant to other signalling pathways.	SUNY Stony Brook, Dept Biochem & Cell Biol, Inst Cell & Dev Biol, Stony Brook, NY 11794 USA; Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; Genentech Inc, Dept Metab & Pharmacokinet, S San Francisco, CA 94080 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Princeton University; Yeshiva University; Albert Einstein College of Medicine; Roche Holding; Genentech	Haltiwanger, RS (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Inst Cell & Dev Biol, Stony Brook, NY 11794 USA.		Panin, Vlad/G-1583-2016	Panin, Vlad/0000-0001-9126-1481; Stanley, Pamela/0000-0001-5704-3747				Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Beyer T A, 1981, Adv Enzymol Relat Areas Mol Biol, V52, P23; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; CHENG HJ, 1995, CELL, V82, P371, DOI 10.1016/0092-8674(95)90426-3; Cohen B, 1997, NAT GENET, V16, P283, DOI 10.1038/ng0797-283; de Celis JF, 2000, DEVELOPMENT, V127, P1291; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; DECELIS JF, 1994, MECH DEVELOP, V46, P109, DOI 10.1016/0925-4773(94)90080-9; Fleming RJ, 1997, DEVELOPMENT, V124, P2973; HARRIS RJ, 1993, GLYCOBIOLOGY, V3, P219, DOI 10.1093/glycob/3.3.219; HICKS C, IN PRESS NATURE CELL; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; Irvine KD, 1999, CURR OPIN GENET DEV, V9, P434, DOI 10.1016/S0959-437X(99)80066-5; IRVINE KD, 1994, CELL, V79, P595, DOI 10.1016/0092-8674(94)90545-2; Irvine KD, 1997, CURR OPIN CELL BIOL, V9, P867, DOI 10.1016/S0955-0674(97)80090-7; Johnston SH, 1997, DEVELOPMENT, V124, P2245; Joutel A, 1998, SEMIN CELL DEV BIOL, V9, P619, DOI 10.1006/scdb.1998.0261; Ju BG, 2000, NATURE, V405, P191, DOI 10.1038/35012090; Kao YH, 1999, BIOCHEMISTRY-US, V38, P7097, DOI 10.1021/bi990234z; KELLEY MR, 1987, CELL, V51, P539, DOI 10.1016/0092-8674(87)90123-1; KIM J, 1995, CELL, V82, P795, DOI 10.1016/0092-8674(95)90476-X; Klein T, 1998, DEVELOPMENT, V125, P2951; Klueg KM, 1999, J CELL SCI, V112, P3289; Kornfeld S, 1998, J CLIN INVEST, V101, P1293, DOI 10.1172/JCI3140; Kotenko SV, 2000, P NATL ACAD SCI USA, V97, P1695, DOI 10.1073/pnas.97.4.1695; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Lu FM, 1996, P NATL ACAD SCI USA, V93, P5663, DOI 10.1073/pnas.93.11.5663; Lubke T, 1999, J BIOL CHEM, V274, P25986, DOI 10.1074/jbc.274.37.25986; MACARTHUR CA, 1995, CELL GROWTH DIFFER, V6, P817; Moloney DJ, 1999, GLYCOBIOLOGY, V9, P679, DOI 10.1093/glycob/9.7.679; Moloney DJ, 1997, J BIOL CHEM, V272, P19046, DOI 10.1074/jbc.272.30.19046; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Ohyama C, 1998, J BIOL CHEM, V273, P14582, DOI 10.1074/jbc.273.23.14582; Panin VM, 1998, SEMIN CELL DEV BIOL, V9, P609, DOI 10.1006/scdb.1998.0263; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; REBAY I, 1993, CELL, V74, P319, DOI 10.1016/0092-8674(93)90423-N; RIPKA J, 1986, ARCH BIOCHEM BIOPHYS, V249, P533, DOI 10.1016/0003-9861(86)90031-7; RIPKA J, 1986, SOMAT CELL MOLEC GEN, V12, P51, DOI 10.1007/BF01560727; ROBERTSON MA, 1978, CELL, V13, P515, DOI 10.1016/0092-8674(78)90325-2; STANLEY P, 1975, P NATL ACAD SCI USA, V72, P3323, DOI 10.1073/pnas.72.9.3323; Sullivan FX, 1998, J BIOL CHEM, V273, P8193, DOI 10.1074/jbc.273.14.8193; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Yuan YP, 1997, CELL, V88, P9, DOI 10.1016/S0092-8674(00)81852-8; Zhang YN, 1999, GLYCOBIOLOGY, V9, P815, DOI 10.1093/glycob/9.8.815	49	698	718	1	42	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					369	375		10.1038/35019000	http://dx.doi.org/10.1038/35019000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935626				2022-12-24	WOS:000088383800036
J	Bork, K; Barnstedt, SE; Koch, P; Traupe, H				Bork, K; Barnstedt, SE; Koch, P; Traupe, H			Hereditary angioedema with normal C1-inhibitor activity in women	LANCET			English	Article							C1 INHIBITOR; DEFICIENCY; EDEMA; AUTOANTIBODY; MANAGEMENT; ENALAPRIL; URTICARIA	Background Hereditary angioedema (HAE) is a well defined autosomal dominant disease (Mendelian Inheritance in Man #106100) that results from an inherited deficiency of C1 (the activated first component of complement) inhibitor function. We report an unusual variant of HAE with normal biochemical C1-inhibitor function, occurring only in women. Methods We screened 574 patients with recurrent angioedema of the skin for presence of HAE. 283 patients were selected, in whom angioedema was associated with abdominal pain attacks or recurrent life-threatening episodes of upper-airway obstruction, or both, rather than with urticaria. We measured C1-inhibitor concentration and functional activity as well as complement C4 concentration and took pedigrees to characterise patients. Findings 94 HAE cases with C1-inhibitor deficiency, positive family history, or both were identified. Biochemical testing showed that 84 patients from 49 families had a functional C1-inhibitor deficiency. 11 of these patients had no affected family members (probably representing de-novo mutations), Ten women with HAE, from ten families, had normal C1-inhibitor protein concentrations and function, and normal C4 concentration. A more detailed study of these families identified another 26 affected members, who were also ail women. Of those women, 14 could be studied and also had normal C1-inhibitor concentration and function. The disease was seen in successive generations, and in offspring of affected mothers, the sex ratio (M/F) was shifted to 1/1.5. Interpretation HAE with normal C1-inhibitor concentration and function represents a unique genetic disease arising only in women. The formal genetics of this entity are suggestive of an X-linked dominant mode of inheritance. For this disorder we propose the term hereditary angioedema type 3 (HAE III).	Univ Mainz, Hautklin, Dept Dermatol, D-55131 Mainz, Germany; Univ Munster, Dept Dermatol, D-4400 Munster, Germany	Johannes Gutenberg University of Mainz; University of Munster	Bork, K (corresponding author), Univ Mainz, Hautklin, Dept Dermatol, Langenbeckstr 1, D-55131 Mainz, Germany.		Bork, Konrad/AAE-4985-2022	Bork, Konrad/0000-0002-6084-4577				AGOSTONI A, 1992, MEDICINE, V71, P206, DOI 10.1097/00005792-199207000-00003; ALSENZ J, 1987, NEW ENGL J MED, V316, P1360, DOI 10.1056/NEJM198705283162202; Bissler JJ, 1997, P ASSOC AM PHYSICIAN, V109, P164; BOCKERS M, 1989, DEUT MED WOCHENSCHR, V112, P507; Bork K, 2000, MAYO CLIN PROC, V75, P349, DOI 10.4065/75.4.349; Bork K, 1997, DEUT MED WOCHENSCHR, V122, P1347, DOI 10.1055/s-2008-1047770; BORRADORI L, 1990, DERMATOLOGICA, V181, P78, DOI 10.1159/000247874; CHAMPION RH, 1969, BRIT J DERMATOL, V81, P588, DOI 10.1111/j.1365-2133.1969.tb16041.x; Cicardi M, 1999, AM J MED, V106, P650, DOI 10.1016/S0002-9343(99)00123-0; Cicardi M, 1996, NEW ENGL J MED, V334, P1666, DOI 10.1056/NEJM199606203342510; DONALDSON VH, 1963, AM J MED, V35, P37, DOI 10.1016/0002-9343(63)90162-1; Eckes B, 1999, EUR J INTERN MED S1, V10, P187; FRANK MM, 1976, ANN INTERN MED, V84, P580, DOI 10.7326/0003-4819-84-5-580; GIANNOCCARO PJ, 1989, CAN J CARDIOL, V5, P335; GREAVES M, 1991, J AM ACAD DERMATOL, V25, P155, DOI 10.1016/0190-9622(91)70183-3; JACKSON J, 1986, NATURE, V323, P722, DOI 10.1038/323722a0; JASON DR, 1992, J FORENSIC SCI, V37, P1418; LANDERMAN NS, 1962, J ALLERGY, V33, P330, DOI 10.1016/0021-8707(62)90032-1; Nielsen Erik Waage, 1995, Tidsskrift for den Norske Laegeforening, V115, P43; Nussberger J, 1998, LANCET, V351, P1693, DOI 10.1016/S0140-6736(97)09137-X; OIKE Y, 1993, INTERNAL MED, V32, P308, DOI 10.2169/internalmedicine.32.308; Osler W, 1888, AM J MED SCI, V95, P362; SHEFFER AL, 1989, ALLERGY PROC, V10, P237, DOI 10.2500/108854189778960126; SOTER NA, 1991, J AM ACAD DERMATOL, V25, P146, DOI 10.1016/0190-9622(91)70180-A; Tosi M, 1998, IMMUNOBIOLOGY, V199, P358, DOI 10.1016/S0171-2985(98)80040-5; ULMER JL, 1992, ANN PHARMACOTHER, V26, P1245, DOI 10.1177/106002809202601012; Yip J, 1992, Australas J Dermatol, V33, P35, DOI 10.1111/j.1440-0960.1992.tb00050.x	27	389	402	1	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 15	2000	356	9225					213	217		10.1016/S0140-6736(00)02483-1	http://dx.doi.org/10.1016/S0140-6736(00)02483-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	334GQ	10963200				2022-12-24	WOS:000088179100013
J	Gunther, T; Chen, ZF; Kim, JS; Priemel, M; Rueger, JM; Amling, M; Moseley, JM; Martin, TJ; Anderson, DJ; Karsenty, G				Gunther, T; Chen, ZF; Kim, JS; Priemel, M; Rueger, JM; Amling, M; Moseley, JM; Martin, TJ; Anderson, DJ; Karsenty, G			Genetic ablation of parathyroid glands reveals another source of parathyroid hormone	NATURE			English	Article							MESSENGER-RIBONUCLEIC-ACID; BLOMSTRAND CHONDRODYSPLASIA; CELLS; DROSOPHILA; EXPRESSION; RECEPTOR; HYPERCALCEMIA; CALCIUM; PROTEIN; SWITCH	The parathyroid glands are the only known source of circulating parathyroid hormone (PTH), which initiates an endocrine cascade that regulates serum calcium concentration(1). Glial cells missing2 (Gcm2), a mouse homologue of Drosophila Gcm, is the only transcription factor whose expression is restricted to the parathyroid glands(2-5). Here we show that Gcm2-deficient mice lack parathyroid glands and exhibit a biological hypoparathyroidism, identifying Gcm2 as a master regulatory gene of parathyroid gland development. Unlike PTH receptor-deficient mice, however, Gcm2-deficient mice are viable and fertile, and have only a mildly abnormal bone phenotype. Despite their lack of parathyroid glands, Gcm2-deficient mice have PTH serum levels identical to those of wild-type mice, as do parathyroidectomized wild-type animals. Expression and ablation studies identified the thymus, where Gcm1, another Gcm homologue, is expressed, as the additional, downregulatable source of PTH. Thus, Gcm2 deletion uncovers an auxiliary mechanism for the regulation of calcium homeostasis in the absence of parathyroid glands. We propose that this backup mechanism may be a general feature of endocrine regulation.	Baylor Coll Med, Program Dev Biol, Dept Mol & Human Genet, Houston, TX 77030 USA; Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ Hamburg, Dept Trauma Surg, D-20246 Hamburg, Germany; St Vincents Inst Med Res, Melbourne, Vic 3065, Australia	Baylor College of Medicine; Washington University (WUSTL); California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; University of Hamburg; St. Vincent's Institute of Medical Research	Karsenty, G (corresponding author), Baylor Coll Med, Program Dev Biol, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.			Gunther, Thomas/0000-0003-3903-9490				Akiyama Y, 1996, P NATL ACAD SCI USA, V93, P14912, DOI 10.1073/pnas.93.25.14912; AMIEL C, 1976, J CLIN INVEST, V57, P256, DOI 10.1172/JCI108276; BRONNER F, 1964, MINERAL METABOLISM D, P342; CHISAKA O, 1991, NATURE, V350, P473, DOI 10.1038/350473a0; COWIE AT, 1945, NATURE, V156, P19; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Dusso AS, 1998, AM J KIDNEY DIS, V32, pS13, DOI 10.1053/ajkd.1998.v32.pm9808140; Emanuel RL, 1996, MOL ENDOCRINOL, V10, P555, DOI 10.1210/me.10.5.555; FRASER RA, 1990, ENDOCRINOLOGY, V127, P2517, DOI 10.1210/endo-127-5-2517; GRILL V, 1991, J CLIN ENDOCR METAB, V73, P1309, DOI 10.1210/jcem-73-6-1309; Hammett FS, 1927, J BIOL CHEM, V72, P505; HOSOYA T, 1995, CELL, V82, P1025, DOI 10.1016/0092-8674(95)90281-3; Jaffe R. B., 1991, REPROD ENDOCRINOLOGY, P389; Jobert AS, 1998, J CLIN INVEST, V102, P34, DOI 10.1172/JCI2918; JONES BW, 1995, CELL, V82, P1013, DOI 10.1016/0092-8674(95)90280-5; KALU DN, 1970, LANCET, V1, P1363; Kim JS, 1998, P NATL ACAD SCI USA, V95, P12364, DOI 10.1073/pnas.95.21.12364; KOVACS CS, 1998, 80 M END SOC, P91; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Li YC, 1997, P NATL ACAD SCI USA, V94, P9831, DOI 10.1073/pnas.94.18.9831; Loshkajian A, 1997, AM J MED GENET, V71, P283, DOI 10.1002/(SICI)1096-8628(19970822)71:3<283::AID-AJMG7>3.0.CO;2-V; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; NAVEHMANY T, 1989, ENDOCRINOLOGY, V125, P275, DOI 10.1210/endo-125-1-275; NEUBUSER A, 1995, DEV BIOL, V170, P701, DOI 10.1006/dbio.1995.1248; Potts J. T., 1998, METABOLIC BONE DIS C, P52; Selye H, 1932, ENDOCRINOLOGY, V16, P547, DOI 10.1210/endo-16-5-547; SILVER J, 1985, P NATL ACAD SCI USA, V82, P4270, DOI 10.1073/pnas.82.12.4270; SUVA LJ, 1987, SCIENCE, V237, P893, DOI 10.1126/science.3616618	28	269	285	0	4	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 13	2000	406	6792					199	203		10.1038/35018111	http://dx.doi.org/10.1038/35018111			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910362				2022-12-24	WOS:000088221100052
J	Li, S; Ting, NSY; Zheng, L; Chen, PL; Ziv, Y; Shiloh, Y; Lee, EYHP; Lee, WH				Li, S; Ting, NSY; Zheng, L; Chen, PL; Ziv, Y; Shiloh, Y; Lee, EYHP; Lee, WH			Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response	NATURE			English	Article							PROTEIN-KINASE; BREAST-CANCER; CELL-CYCLE; ATM; PHOSPHORYLATION; P53; EXPRESSION; BINDING; PATHWAY; GADD45	BRCA1 encodes a familial breast cancer suppressor that has a critical role in cellular responses to DNA damage(1,2). Mouse cells deficient for Brca1 show genetic instability, defective G2-M checkpoint control and reduced homologous recombination(3,4). BRCA1 also directly interacts with proteins of the DNA repair machinery(5) and regulates expression of both the p21 and GADD45 genes(6-8). However, it remains unclear how DNA damage signals are transmitted to modulate the repair function of BRCA1. Here we show that the BRCA1-associated protein CtIP(9-12) becomes hyperphosphorylated and dissociated from BRCA1 upon ionizing radiation. This phosphorylation event requires the protein kinase (ATM) that is mutated in the disease ataxia telangiectasia(13). ATM phosphorylates CtIP at serine residues 664 and 745, and mutation of these sites to alanine abrogates the dissociation of BRCA1 from CtIP, resulting in persistent repression of BRCA1-dependent induction of GADD45 upon ionizing radiation. We conclude that ATM, by phosphorylating CtIP upon ionizing radiation, may modulate BRCA1-mediated regulation of the DNA damage-response GADD45 gene, thus providing a potential link between ATM deficiency and breast cancer.	Univ Texas, Hlth Sci Ctr, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA; Tel Aviv Univ, Sackler Sch Med, Dept Human Genet & Mol Med, IL-69978 Tel Aviv, Israel	University of Texas System; University of Texas Health San Antonio; Tel Aviv University; Sackler Faculty of Medicine	Lee, WH (corresponding author), Univ Texas, Hlth Sci Ctr, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA.	leew@uthscsa.edu	LI, SHANG/HII-4989-2022	LI, SHANG/0000-0002-6226-3362				Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; CHENG CY, 1985, INT J ANDROL, V8, P1, DOI 10.1111/j.1365-2605.1985.tb00812.x; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Harkin DP, 1999, CELL, V97, P575, DOI 10.1016/S0092-8674(00)80769-2; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Khosravi R, 1999, P NATL ACAD SCI USA, V96, P14973, DOI 10.1073/pnas.96.26.14973; Lavin M, 1998, BRIT MED J, V317, P486; LEESMILLER SP, 1995, SCIENCE, V267, P1183, DOI 10.1126/science.7855602; Li S, 1998, J BIOL CHEM, V273, P6183, DOI 10.1074/jbc.273.11.6183; Li S, 1999, J BIOL CHEM, V274, P11334, DOI 10.1074/jbc.274.16.11334; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Ouchi T, 1998, P NATL ACAD SCI USA, V95, P2302, DOI 10.1073/pnas.95.5.2302; Schaeper U, 1998, J BIOL CHEM, V273, P8549, DOI 10.1074/jbc.273.15.8549; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; Somasundaram K, 1997, NATURE, V389, P187, DOI 10.1038/38291; Swift M, 1999, BRIT MED J, V318, P400, DOI 10.1136/bmj.318.7180.400; Welcsh PL, 2000, TRENDS GENET, V16, P69, DOI 10.1016/S0168-9525(99)01930-7; Wong AKC, 1998, ONCOGENE, V17, P2279, DOI 10.1038/sj.onc.1202150; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747; Ziv Y, 1997, ONCOGENE, V15, P159, DOI 10.1038/sj.onc.1201319	25	257	268	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2000	406	6792					210	215		10.1038/35018134	http://dx.doi.org/10.1038/35018134			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910365				2022-12-24	WOS:000088221100055
J	Kane, B				Kane, B			HIV vaccines: Inch by inch	ANNALS OF INTERNAL MEDICINE			English	News Item																			0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 19	2000	133	6					489	490		10.7326/0003-4819-133-6-200009190-00102	http://dx.doi.org/10.7326/0003-4819-133-6-200009190-00102			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354KM	10975984				2022-12-24	WOS:000089329700023
J	Deakin, CD; Low, JL				Deakin, CD; Low, JL			Accuracy of the advanced trauma life support guidelines for predicting systolic blood pressure using carotid, femoral and radial pulses: observational study	BRITISH MEDICAL JOURNAL			English	Article									Southampton Gen Hosp NHS Trust, Shackleton Dept Anaesthet, Southampton SO16 6YD, Hants, England; Southampton Gen Hosp NHS Trust, Hlth Care Res Unit, Southampton SO16 6YD, Hants, England		Deakin, CD (corresponding author), Southampton Gen Hosp NHS Trust, Shackleton Dept Anaesthet, Southampton SO16 6YD, Hants, England.							Collicott, 1985, ADV TRAUMA LIFE SUPP; POULTON TJ, 1988, ANN EMERG MED, V17, P107, DOI 10.1016/S0196-0644(88)80538-9	2	85	88	1	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	SEP 16	2000	321	7262					673	674		10.1136/bmj.321.7262.673	http://dx.doi.org/10.1136/bmj.321.7262.673			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356LE	10987771	Bronze, Green Published			2022-12-24	WOS:000089444100024
J	Domeier, ME; Morse, DP; Knight, SW; Portereiko, M; Bass, BL; Mango, SE				Domeier, ME; Morse, DP; Knight, SW; Portereiko, M; Bass, BL; Mango, SE			A link between RNA interference and nonsense-mediated decay in Caenorhabditis elegans	SCIENCE			English	Article							DOUBLE-STRANDED-RNA; C-ELEGANS; GENETIC INTERFERENCE; PROTEIN; SURVEILLANCE; IDENTITY; HOMOLOG; PHA-4	Double-stranded RNA (dsRNA) inhibits expression of homologous genes by a process' involving messenger RNA degradation. To gain insight into the mechanism of degradation, we examined how RNA interference is affected by mutations in the smg genes, which are required for nonsense-mediated decay. For three of six smg genes tested, mutations resulted in animals that were initially silenced by dsRNA but then recovered; wild-type animals remained silenced. The Levels of target messenger RNAs were restored during recovery, and RNA editing and degradation of the dsRNA were identical to those of the wild type. We suggest that persistence of RNA interference relies on a subset of smg genes.	Univ Utah, Huntsman Canc Inst Ctr Children, Salt Lake City, UT 84112 USA; Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84132 USA; Univ Utah, Dept Biochem, Salt Lake City, UT 84132 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Mango, SE (corresponding author), Univ Utah, Huntsman Canc Inst Ctr Children, Salt Lake City, UT 84112 USA.			Mango, Susan/0000-0002-2146-3237	NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NCI NIH HHS [5P30CA42014] Funding Source: Medline; PHS HHS [42014] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ANDERSON PW, COMMUNICATION; Bass BL, 2000, CELL, V101, P235, DOI 10.1016/S0092-8674(02)71133-1; Bloom L, 1997, P NATL ACAD SCI USA, V94, P3414, DOI 10.1073/pnas.94.7.3414; BRENNER S, 1974, GENETICS, V77, P71; Cali BM, 1999, GENETICS, V151, P605; Cali BM, 1998, MOL GEN GENET, V260, P176, DOI 10.1007/s004380050883; CZAPLINSKI K, 1995, RNA, V1, P610; Draper BW, 1996, CELL, V87, P205, DOI 10.1016/S0092-8674(00)81339-2; Fire A, 1999, TRENDS GENET, V15, P358, DOI 10.1016/S0168-9525(99)01818-1; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Gu T, 1998, MOL CELL BIOL, V18, P4556, DOI 10.1128/MCB.18.8.4556; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; HODGKIN J, 1989, GENETICS, V123, P301; Horner MA, 1998, GENE DEV, V12, P1947, DOI 10.1101/gad.12.13.1947; KALTENBACH L, UNPUB; Ketting RF, 2000, NATURE, V404, P296, DOI 10.1038/35005113; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Korf I, 1998, DEVELOPMENT, V125, P2469; LEEDS P, 1992, MOL CELL BIOL, V12, P2165, DOI 10.1128/MCB.12.5.2165; MANGO SE, 1994, DEVELOPMENT, V120, P3019; Montgomery MK, 1998, P NATL ACAD SCI USA, V95, P15502, DOI 10.1073/pnas.95.26.15502; Morrison M, 1997, P NATL ACAD SCI USA, V94, P9782, DOI 10.1073/pnas.94.18.9782; Morrison TB, 1998, BIOTECHNIQUES, V24, P954; Page MF, 1999, MOL CELL BIOL, V19, P5943; PULAK R, 1993, GENE DEV, V7, P1885, DOI 10.1101/gad.7.10.1885; PULAK RA, 1988, MOL CELL BIOL, V8, P3748, DOI 10.1128/MCB.8.9.3748; Schiebel W, 1998, PLANT CELL, V10, P2087, DOI 10.1105/tpc.10.12.2087; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	32	122	154	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 15	2000	289	5486					1928	1930		10.1126/science.289.5486.1928	http://dx.doi.org/10.1126/science.289.5486.1928			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354XD	10988072				2022-12-24	WOS:000089355800044
J	Galuske, RAW; Schlote, W; Bratzke, H; Singer, W				Galuske, RAW; Schlote, W; Bratzke, H; Singer, W			Interhemispheric asymmetries of the modular structure in human temporal cortex	SCIENCE			English	Article							CAT VISUAL-CORTEX; INTRINSIC CONNECTIONS; HUMAN-BRAIN; SPEECH; ORGANIZATION; SPECIFICITY; ANATOMY; REGION; AREAS	Language-relevant processing of auditory signals is Lateralized and involve the posterior part of Brodmann area 22. We found that the functional Lateralization in this area was accompanied by interhemispheric differences in the organization of the intrinsic: microcircuitry. Neuronal tract tracing revealed a modular network of long-range intrinsic connections Linking regularly spaced clusters of neurons. Although the cluster diameter was similar in both hemispheres, their spacing was about 20 percent Larger in the Left hemisphere. Assuming similar relations between functional and anatomical architecture as in visual cortex, the present data suggest that more functionally distinct columnar systems are included per surface unit in the Left than in the right area 22.	Max Planck Inst Brain Res, Dept Neurophysiol, D-60528 Frankfurt, Germany; Goethe Univ Frankfurt, Sch Med, Edinger Inst, Neurol Inst, D-60528 Frankfurt, Germany; Goethe Univ Frankfurt, Sch Med, Inst Forens Med, D-60596 Frankfurt, Germany	Max Planck Society; Goethe University Frankfurt; Goethe University Frankfurt	Galuske, RAW (corresponding author), Max Planck Inst Brain Res, Dept Neurophysiol, Deutschordenstr 46, D-60528 Frankfurt, Germany.	galuske@mpih-frankfurt.mpg.de	Singer, Wolf/D-6874-2012					AMIR Y, 1993, J COMP NEUROL, V334, P19, DOI 10.1002/cne.903340103; Baynes K, 1990, J Cogn Neurosci, V2, P159, DOI 10.1162/jocn.1990.2.3.159; Belin P, 1998, J NEUROSCI, V18, P6388; Belin P, 1998, J COGNITIVE NEUROSCI, V10, P536, DOI 10.1162/089892998562834; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; Brodmann, 1909, VERGLEICHENDE LOKALI; BURKHALTER A, 1993, J NEUROSCI, V13, P1916, DOI 10.1523/jneurosci.13-05-01916.1993; Demonet J. F., 1993, Human Brain Mapping, V1, P39, DOI 10.1002/hbm.460010105; Fiez JA, 1996, CEREB CORTEX, V6, P1, DOI 10.1093/cercor/6.1.1; GALABURDA AM, 1978, ARCH NEUROL-CHICAGO, V35, P812, DOI 10.1001/archneur.1978.00500360036007; Galuske RAW, 1996, CEREB CORTEX, V6, P417, DOI 10.1093/cercor/6.3.417; GESCHWIND N, 1968, SCIENCE, V161, P186, DOI 10.1126/science.161.3837.186; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GILBERT CD, 1983, J NEUROSCI, V3, P1116; HOWARD D, 1992, BRAIN, V115, P1769, DOI 10.1093/brain/115.6.1769; Hutsler JJ, 1996, CEREB CORTEX, V6, P260, DOI 10.1093/cercor/6.2.260; KISVARDAY ZF, 1992, NEUROSCIENCE, V46, P275, DOI 10.1016/0306-4522(92)90050-C; LOFTUS WC, 1993, CEREB CORTEX, V3, P348; LUND JS, 1993, CEREB CORTEX, V3, P148, DOI 10.1093/cercor/3.2.148; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; RAICHLE ME, 1994, ANNU REV PSYCHOL, V45, P333, DOI 10.1146/annurev.psych.45.1.333; ROCKLAND KS, 1982, SCIENCE, V215, P1532, DOI 10.1126/science.7063863; Schmidt KE, 1997, J NEUROSCI, V17, P5480; SCHWARTZ J, 1980, SCIENCE, V207, P1380, DOI 10.1126/science.7355297; SELDON HL, 1981, BRAIN RES, V229, P277, DOI 10.1016/0006-8993(81)90994-X; SMITH A, 1975, NEUROLOGY, V25, P813, DOI 10.1212/WNL.25.9.813; TSO DY, 1986, J NEUROSCI, V6, P1160; von Economo C, 1925, CYTOARCHITEKTONIK HI; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994	29	189	193	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 15	2000	289	5486					1946	1949		10.1126/science.289.5486.1946	http://dx.doi.org/10.1126/science.289.5486.1946			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354XD	10988077				2022-12-24	WOS:000089355800049
J	Rogers, DJ; Randolph, SE				Rogers, DJ; Randolph, SE			The global spread of malaria in a future, warmer world	SCIENCE			English	Article							CLIMATE-CHANGE; SENSITIVITY; DISEASES; DENGUE; IMPACT; RISK	The frequent warnings that global climate change will allow falciparum malaria to spread into northern Latitudes, including Europe and Large parts of the United States, are based on biological transmission models driven principally by temperature. These models were assessed for their value in predicting present, and therefore future, malaria distribution. In an alternative statistical approach, the recorded present-day global distribution of falciparum malaria was used to establish the current multivariate climatic constraints. These results were applied to future climate scenarios to predict future distributions, which showed remarkably few changes, even under the most extreme scenarios.	Univ Oxford, Dept Zool, Trypanosomiasis & Land Use Africa Res Grp, Oxford OX1 3PS, England; Univ Oxford, Dept Zool, Oxford Tick Res Grp, Oxford OX1 3PS, England	University of Oxford; University of Oxford	Rogers, DJ (corresponding author), Univ Oxford, Dept Zool, Trypanosomiasis & Land Use Africa Res Grp, S Parks Rd, Oxford OX1 3PS, England.	david.rogers@zoology.ox.ac.uk	Randolph, Sarah/AAR-9346-2021					ANDERSON R M, 1991; Garrett-Jones C., 1964, Bulletin of the World Health Organization, V30, P241; HAINES A, 1999, CLIMATE CHANGE HUMAN; HULME M, 1998, CLIMATE CHANGE SCENA; Johns TC, 1997, CLIM DYNAM, V13, P103, DOI 10.1007/s003820050155; Lindsay SW, 1998, B WORLD HEALTH ORGAN, V76, P33; MA ZK, 1995, PHOTOGRAMM ENG REM S, V61, P435; Martens P, 1999, GLOBAL ENVIRON CHANG, V9, pS89, DOI 10.1016/S0959-3780(99)00020-5; Martens P, 1998, HLTH CLIMATE CHANGE; MARTENS WJM, 1995, ENVIRON HEALTH PERSP, V103, P458, DOI 10.2307/3432584; Martens WJM, 1997, CLIMATIC CHANGE, V35, P145, DOI 10.1023/A:1005365413932; MARTENS WJM, 1995, GLOBAL ENVIRON CHANG, V5, P195, DOI 10.1016/0959-3780(95)00051-O; MARTENS WJM, 1994, 461502003 DUTCH NAT; MARTIN PH, 1995, AMBIO, V24, P200; Matsuoka Y, 1994, J GLOBAL ENV ENG, V1, P1; McMichael AJ, 1998, BRIT MED BULL, V54, P475; New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2; Patz JA, 1998, ENVIRON HEALTH PERSP, V106, P147, DOI 10.1289/ehp.98106147; Patz JA, 1999, CURR OPIN MICROBIOL, V2, P445, DOI 10.1016/S1369-5274(99)80078-2; REEVES WC, 1994, J MED ENTOMOL, V31, P323, DOI 10.1093/jmedent/31.3.323; Rogers DJ, 1996, ANN TROP MED PARASIT, V90, P225, DOI 10.1080/00034983.1996.11813049; Schwartlander B, 1997, LANCET, V350, P141, DOI 10.1016/S0140-6736(05)61844-2; Snow RW, 1999, PARASITOL TODAY, V15, P99, DOI 10.1016/S0169-4758(99)01395-2; SNOW RW, 1999, WORLD HLTH REPORT 19; Taubes G, 1997, SCIENCE, V278, P1004, DOI 10.1126/science.278.5340.1004; *WHO, 1989, 89967 WHOVBC; *WHO, 1997, WKLY EPIDEMIOL REC, V72, P285	27	384	402	0	155	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 8	2000	289	5485					1763	1766		10.1126/science.289.5485.1763	http://dx.doi.org/10.1126/science.289.5485.1763			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352BT	10976072				2022-12-24	WOS:000089195200050
J	Clark, RT				Clark, RT			Baby Jose	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Univ Texas, SW Med Ctr, Dallas, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Clark, RT (corresponding author), Univ Texas, SW Med Ctr, 5323 Harry Hines Blvd, Dallas, TX 75235 USA.							Fost N, 1999, JAMA-J AM MED ASSOC, V281, P2041, DOI 10.1001/jama.281.21.2041; Kuhse H, 1986, J Med Humanit Bioeth, V7, P79, DOI 10.1007/BF01117900	2	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2000	284	9					1144	1145		10.1001/jama.284.9.1144	http://dx.doi.org/10.1001/jama.284.9.1144			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	349GK	10974699				2022-12-24	WOS:000089037200020
J	Endow, SA; Higuchi, H				Endow, SA; Higuchi, H			A mutant of the motor protein kinesin that moves in both directions on microtubules	NATURE			English	Article							IN-VITRO MOTILITY; CRYSTAL-STRUCTURE; NCD; MOLECULES; BINDING	Molecular motors move directionally to either the plus or the minus end of microtubules or actin filaments. Kinesin moves towards microtubule plus ends, whereas the kinesin-related Ncd motor moves to the minus ends. The 'neck'-the region between the stalk and motor domain-is required for Ncd to move to microtubule minus ends(1,2), but the mechanism underlying directional motor movement is not understood. Here we show that a single amino-acid change in the Ncd neck causes the motor to reverse directions and move with wild-type velocities towards the plus or minus end; thus, the neck is functional but directionality is defective. Mutation of a motor-core residue that touches the neck residue in crystal structures(2,3) also results in movement in both directions, indicating that directed movement to the minus end requires interactions of the neck and motor core. Low-density laser-trap assays show that a conformational change or working stroke of the Ncd motor is directional and biased towards the minus end, whereas that of the neck mutant occurs in either direction. We conclude that the directional bias of the working stroke is dependent on neck/motor core interactions. Absence of these interactions removes directional constraints and permits movement in either direction.	Duke Univ, Med Ctr, Dept Microbiol, Durham, NC 27710 USA; Tohoku Univ, Dept Met, Sendai, Miyagi 9808579, Japan; Tohoku Univ, Interdisciplinary Res Ctr, Sendai, Miyagi 9808579, Japan	Duke University; Tohoku University; Tohoku University	Endow, SA (corresponding author), Duke Univ, Med Ctr, Dept Microbiol, Durham, NC 27710 USA.	endow@duke.edu		Endow, Sharyn A./0000-0002-0907-8889	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046225] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM046225] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHANDRA R, 1993, J BIOL CHEM, V268, P9005; CHANDRA R, 1993, METHOD CELL BIOL, V39, P115, DOI 10.1016/S0091-679X(08)60165-X; Crevel IMTC, 1996, J MOL BIOL, V257, P66, DOI 10.1006/jmbi.1996.0147; Endow SA, 1998, SCIENCE, V281, P1200, DOI 10.1126/science.281.5380.1200; Endow SA, 1999, NAT CELL BIOL, V1, pE163, DOI 10.1038/14113; ENDOW SA, 1999, GUIDEBOOK CYTOSKELET, P403; HATSUMI M, 1992, J CELL SCI, V103, P1013; Houdusse A, 1999, CELL, V97, P459, DOI 10.1016/S0092-8674(00)80756-4; HOYT MA, 1993, GENETICS, V135, P35; Iwatani S, 1999, BIOCHEMISTRY-US, V38, P10318, DOI 10.1021/bi9904095; Kozielski F, 1999, STRUCTURE, V7, P1407, DOI 10.1016/S0969-2126(00)80030-1; Kozielski F, 1997, CELL, V91, P985, DOI 10.1016/S0092-8674(00)80489-4; Sablin EP, 1998, NATURE, V395, P813, DOI 10.1038/27463; Song H, 1997, P NATL ACAD SCI USA, V94, P322, DOI 10.1073/pnas.94.1.322; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; WALKER RA, 1990, NATURE, V347, P780, DOI 10.1038/347780a0; WAY M, 1990, EMBO J, V9, P4103, DOI 10.1002/j.1460-2075.1990.tb07632.x; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835	18	146	148	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 24	2000	406	6798					913	916		10.1038/35022617	http://dx.doi.org/10.1038/35022617			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347AG	10972296				2022-12-24	WOS:000088903600050
J	Eu, JP; Sun, JH; Xu, L; Stamler, JS; Meissner, G				Eu, JP; Sun, JH; Xu, L; Stamler, JS; Meissner, G			The skeletal muscle calcium release channel: Coupled O-2 sensor and NO signaling functions	CELL			English	Article							CARDIAC SARCOPLASMIC-RETICULUM; NITRIC-OXIDE; RYANODINE RECEPTOR; CA2+ RELEASE; CAROTID-BODY; TRANSCRIPTION FACTOR; S-NITROSOHEMOGLOBIN; NITROSATIVE STRESS; HYDROGEN-PEROXIDE; OXYGEN	Ion channels have been studied extensively in ambient O-2 tension (pO(2)), whereas tissue pO(2) is much lower. The skeletal muscle calcium release channel/ryanodine receptor (RyR1) is one prominent example. Here we report that pO(2) dynamically controls the redox state of 6-8 out of 50 thiols in each RyR1 subunit and thereby tunes the response to NO. At physiological pO(2), nanomolar NO activates the channel by S-nitrosylating a single cysteine residue. Among sarcoplasmic reticulum proteins, S-nitrosylation is specific to RyR1 and its effect on the channel is calmodulin dependent. Neither activation nor S-nitrosylation of the channel occurs at ambient pO(2). The demonstration that channel cysteine residues subserve coupled O-2 sensor and NO regulatory functions and that these operate through the prototypic allosteric effector calmodulin may have general implications for the regulation of redox-related systems.	Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Med,Div Pulm Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Med,Div Cardiovasc Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Howard Hughes Medical Institute; Duke University; Howard Hughes Medical Institute; Duke University	Meissner, G (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.		Sun, Junhui/C-3499-2011	Stamler, Jonathan/0000-0002-6866-1572	NHLBI NIH HHS [HL52529, HL04053] Funding Source: Medline; NIEHS NIH HHS [ES-09206] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009206] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ABRAMSON JJ, 1989, J BIOENERG BIOMEMBR, V21, P283, DOI 10.1007/BF00812073; Aghdasi B, 1997, J BIOL CHEM, V272, P25462, DOI 10.1074/jbc.272.41.25462; Archer SL, 1999, P NATL ACAD SCI USA, V96, P7944, DOI 10.1073/pnas.96.14.7944; Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; Bader M, 1999, CELL, V98, P217, DOI 10.1016/S0092-8674(00)81016-8; BALON TW, 1994, J APPL PHYSIOL, V77, P2519, DOI 10.1152/jappl.1994.77.6.2519; BOLOTINA VM, 1994, NATURE, V368, P850, DOI 10.1038/368850a0; Drummond HA, 1998, NEURON, V21, P1435, DOI 10.1016/S0896-6273(00)80661-3; Eu JP, 2000, BIOCHEMISTRY-US, V39, P1040, DOI 10.1021/bi992046e; FAVERO TG, 1995, J BIOL CHEM, V270, P25557, DOI 10.1074/jbc.270.43.25557; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; GARG UC, 1988, BIOTECHNIQUES, V6, P294; Gbadegesin M, 1999, AM J PHYSIOL-CELL PH, V277, pC673, DOI 10.1152/ajpcell.1999.277.4.C673; GOLDBERG MA, 1988, SCIENCE, V242, P1412, DOI 10.1126/science.2849206; GORCZYNSKI RJ, 1978, AM J PHYSIOL, V235, pH505, DOI 10.1152/ajpheart.1978.235.5.H505; Hausladen A, 1996, CELL, V86, P719, DOI 10.1016/S0092-8674(00)80147-6; HONIG CR, 1993, AM J PHYSIOL, V265, pH868, DOI 10.1152/ajpheart.1993.265.3.H868; Huang LE, 1999, J BIOL CHEM, V274, P9038, DOI 10.1074/jbc.274.13.9038; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; JAYARAMAN T, 1992, J BIOL CHEM, V267, P9474; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; Kawakami M, 1998, MOL PHARMACOL, V53, P497, DOI 10.1124/mol.53.3.497; Kim WK, 1999, NEURON, V24, P461, DOI 10.1016/S0896-6273(00)80859-4; KIRCHGESSER M, 1990, J CLIN CHEM CLIN BIO, V28, P407; KOBZIK L, 1994, NATURE, V372, P546, DOI 10.1038/372546a0; Kourie JI, 1997, AM J PHYSIOL-CELL PH, V272, pC324, DOI 10.1152/ajpcell.1997.272.1.C324; LAI FA, 1988, NATURE, V331, P315, DOI 10.1038/331315a0; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Li Z, 1998, NEURON, V20, P1039, DOI 10.1016/S0896-6273(00)80484-5; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Liu XP, 1998, P NATL ACAD SCI USA, V95, P2175, DOI 10.1073/pnas.95.5.2175; LOPEZBARNEO J, 1988, SCIENCE, V241, P580, DOI 10.1126/science.2456613; Malinski T, 1996, METHOD ENZYMOL, V268, P58; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413; Meszaros LG, 1996, FEBS LETT, V380, P49, DOI 10.1016/0014-5793(96)00003-8; Perez-Mato I, 1999, J BIOL CHEM, V274, P17075, DOI 10.1074/jbc.274.24.17075; Poderoso JJ, 1998, AM J PHYSIOL-CELL PH, V274, pC112, DOI 10.1152/ajpcell.1998.274.1.C112; Prabhakar NR, 1999, RESP PHYSIOL, V115, P161, DOI 10.1016/S0034-5687(99)00019-5; RUPPERSBERG JP, 1991, NATURE, V352, P711, DOI 10.1038/352711a0; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; Semenza GL, 1999, CELL, V98, P281, DOI 10.1016/S0092-8674(00)81957-1; Stamler JS, 1998, NAT STRUCT BIOL, V5, P247, DOI 10.1038/nsb0498-247; Stamler JS, 1997, SCIENCE, V276, P2034, DOI 10.1126/science.276.5321.2034; Stamler JS, 1997, NEURON, V18, P691, DOI 10.1016/S0896-6273(00)80310-4; STAMLER JS, 1994, CELL, V78, P931, DOI 10.1016/0092-8674(94)90269-0; Stone JR, 1996, BIOCHEMISTRY-US, V35, P1093, DOI 10.1021/bi9519718; Stoyanovsky D, 1997, CELL CALCIUM, V21, P19, DOI 10.1016/S0143-4160(97)90093-2; Summers BA, 1999, J NEUROPHYSIOL, V81, P1449, DOI 10.1152/jn.1999.81.4.1449; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; TRIPATHY A, 1995, BIOPHYS J, V69, P106, DOI 10.1016/S0006-3495(95)79880-0; Viner RI, 1999, BIOCHEM J, V340, P657, DOI 10.1042/0264-6021:3400657; WINK DA, 1994, CHEM RES TOXICOL, V7, P519, DOI 10.1021/tx00040a007; Xu KY, 1999, P NATL ACAD SCI USA, V96, P657, DOI 10.1073/pnas.96.2.657; Xu L, 1998, SCIENCE, V279, P234, DOI 10.1126/science.279.5348.234; YOUNGSON C, 1993, NATURE, V365, P153, DOI 10.1038/365153a0; ZAIDI NF, 1989, J BIOL CHEM, V264, P21725; Zhang JZ, 1999, AM J PHYSIOL-CELL PH, V276, pC46; Zhao Y, 1999, P NATL ACAD SCI USA, V96, P14753, DOI 10.1073/pnas.96.26.14753	60	343	356	0	21	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 18	2000	102	4					499	509		10.1016/S0092-8674(00)00054-4	http://dx.doi.org/10.1016/S0092-8674(00)00054-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	347BX	10966111	Bronze			2022-12-24	WOS:000088908000011
J	Funabiki, H; Murray, AW				Funabiki, H; Murray, AW			The Xenopus chromokinesin Xkid is essential for metaphase chromosome alignment and must be degraded to allow anaphase chromosome movement	CELL			English	Article							KINESIN-LIKE PROTEIN; SISTER-CHROMATID COHESION; MATURATION-PROMOTING FACTOR; NEWT LUNG-CELLS; B-TYPE CYCLINS; MITOTIC SPINDLE; EGG EXTRACTS; CENP-E; MICROTUBULE FLUX; BUDDING YEAST	At anaphase, the linkage between sister chromatids is dissolved and the separated sisters move toward opposite poles of the spindle. We developed a method to purify metaphase and anaphase chromosomes from frog egg extracts and identified proteins that leave chromosomes at anaphase using a new form of expression screening. This approach identified Xkid, a Xenopus homolog of human Kid (kinesin-like DNA binding protein) as a protein that is degraded in anaphase by ubiquitin-mediated proteolysis. Immunodepleting Xkid from egg extracts prevented normal chromosome alignment on the metaphase spindle. Adding a mild excess of wild-type or nondegradable Xkid to egg extracts prevented the separated chromosomes from moving toward the poles. We propose that Xkid provides the metaphase force that pushes chromosome arms toward the equator of the spindle and that its destruction is needed for anaphase chromosome movement.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Funabiki, H (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.			Funabiki, Hironori/0000-0003-4831-4087				AFSHAR K, 1995, CELL, V81, P129, DOI 10.1016/0092-8674(95)90377-1; Antonio C, 2000, CELL, V102, P425, DOI 10.1016/S0092-8674(00)00048-9; BERNAT RL, 1990, J CELL BIOL, V111, P1519, DOI 10.1083/jcb.111.4.1519; Biggins S, 1998, CURR OPIN CELL BIOL, V10, P769, DOI 10.1016/S0955-0674(98)80120-8; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Desai A, 1998, J CELL BIOL, V141, P703, DOI 10.1083/jcb.141.3.703; Desai A, 1997, P NATL ACAD SCI USA, V94, P12378, DOI 10.1073/pnas.94.23.12378; Desai A, 1999, METHOD CELL BIOL, V61, P385; EARNSHAW WC, 1991, J CELL SCI, V98, P443; Furuya K, 1998, GENE DEV, V12, P3408, DOI 10.1101/gad.12.21.3408; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Harlow E, 1988, ANTIBODIES LAB MANUA; Heald R, 1999, CURR OPIN STRUC BIOL, V9, P268, DOI 10.1016/S0959-440X(99)80037-2; HIRANO T, 1993, J CELL BIOL, V120, P601, DOI 10.1083/jcb.120.3.601; HIRANO T, 1994, CELL, V79, P449, DOI 10.1016/0092-8674(94)90254-2; HOLLOWAY SL, 1993, CELL, V73, P1393, DOI 10.1016/0092-8674(93)90364-V; Juang YL, 1997, SCIENCE, V275, P1311, DOI 10.1126/science.275.5304.1311; KELLOGG DR, 1995, J CELL BIOL, V130, P661, DOI 10.1083/jcb.130.3.661; Khodjakov A, 1996, J CELL BIOL, V135, P315, DOI 10.1083/jcb.135.2.315; Khodjakov A, 1996, J CELL BIOL, V132, P1093, DOI 10.1083/jcb.132.6.1093; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Klotzbucher A, 1996, EMBO J, V15, P3053, DOI 10.1002/j.1460-2075.1996.tb00668.x; KURIYAMA R, 1995, J CELL BIOL, V129, P1049, DOI 10.1083/jcb.129.4.1049; LOMBILLO VA, 1995, J CELL BIOL, V128, P107, DOI 10.1083/jcb.128.1.107; Losada A, 1998, GENE DEV, V12, P1986, DOI 10.1101/gad.12.13.1986; Lustig KD, 1997, METHOD ENZYMOL, V283, P83; MASUI Y, 1971, J EXP ZOOL, V177, P129, DOI 10.1002/jez.1401770202; MINSHULL J, 1994, CELL, V79, P475, DOI 10.1016/0092-8674(94)90256-9; MITCHISON TJ, 1992, J CELL BIOL, V119, P569, DOI 10.1083/jcb.119.3.569; MITCHISON TJ, 1989, J CELL BIOL, V109, P637, DOI 10.1083/jcb.109.2.637; Molina I, 1997, J CELL BIOL, V139, P1361, DOI 10.1083/jcb.139.6.1361; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Murray A, 1993, CELL CYCLE INTRO; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; MURRAY AW, 1994, CURR BIOL, V4, P38, DOI 10.1016/S0960-9822(00)00007-5; MURRAY AW, 1991, METHOD CELL BIOL, V36, P573; PFARR CM, 1990, NATURE, V345, P263, DOI 10.1038/345263a0; RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81; RIEDER CL, 1992, J CELL SCI, V102, P387; RIEDER CL, 1994, J CELL BIOL, V124, P223, DOI 10.1083/jcb.124.3.223; RIEDER CL, 1986, J CELL BIOL, V103, P581, DOI 10.1083/jcb.103.2.581; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Ruden DM, 1997, DEV BIOL, V191, P284, DOI 10.1006/dbio.1997.8726; Salmon E. D., 1989, CELL MOVEMENT, P431; SAWIN KE, 1991, J CELL BIOL, V112, P941, DOI 10.1083/jcb.112.5.941; SAWIN KE, 1991, J CELL BIOL, V112, P925, DOI 10.1083/jcb.112.5.925; Schaar BT, 1997, J CELL BIOL, V139, P1373, DOI 10.1083/jcb.139.6.1373; SHAMU CE, 1992, J CELL BIOL, V117, P921, DOI 10.1083/jcb.117.5.921; SIMERLY C, 1990, J CELL BIOL, V111, P1491, DOI 10.1083/jcb.111.4.1491; SKIBBENS RV, 1995, J CELL SCI, V108, P2537; SKIBBENS RV, 1993, J CELL BIOL, V122, P859, DOI 10.1083/jcb.122.4.859; STEUER ER, 1990, NATURE, V345, P266, DOI 10.1038/345266a0; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; SURANA U, 1993, EMBO J, V12, P1969, DOI 10.1002/j.1460-2075.1993.tb05846.x; Takizawa CG, 1999, P NATL ACAD SCI USA, V96, P7938, DOI 10.1073/pnas.96.14.7938; THEURKAUF WE, 1992, J CELL BIOL, V116, P1167, DOI 10.1083/jcb.116.5.1167; Tokai N, 1996, EMBO J, V15, P457, DOI 10.1002/j.1460-2075.1996.tb00378.x; TUGENDREICH S, 1995, CELL, V81, P261, DOI 10.1016/0092-8674(95)90336-4; VERNOS I, 1995, TRENDS CELL BIOL, V5, P297, DOI 10.1016/S0962-8924(00)89045-5; VERNOS I, 1995, CELL, V81, P117, DOI 10.1016/0092-8674(95)90376-3; Walczak CE, 1997, J CELL BIOL, V136, P859, DOI 10.1083/jcb.136.4.859; Walczak CE, 1998, CURR BIOL, V8, P903, DOI 10.1016/S0960-9822(07)00370-3; WANG SZ, 1995, J CELL BIOL, V128, P761, DOI 10.1083/jcb.128.5.761; Waters JC, 1996, J CELL SCI, V109, P2823; Wood KW, 1997, CELL, V91, P357, DOI 10.1016/S0092-8674(00)80419-5; Yamamoto A, 1996, J CELL BIOL, V133, P99, DOI 10.1083/jcb.133.1.99; YEN TJ, 1991, EMBO J, V10, P1245, DOI 10.1002/j.1460-2075.1991.tb08066.x; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; ZHANG P, 1990, CELL, V62, P1053, DOI 10.1016/0092-8674(90)90383-P; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	72	247	253	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 18	2000	102	4					411	424		10.1016/S0092-8674(00)00047-7	http://dx.doi.org/10.1016/S0092-8674(00)00047-7			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	347BX	10966104	Bronze			2022-12-24	WOS:000088908000004
J	Edman, RL; Klaus, SN				Edman, RL; Klaus, SN			Is routine screening for melanoma a benign practice?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CUTANEOUS MALIGNANT-MELANOMA; HISTOPATHOLOGIC DIAGNOSIS; EXPERT PATHOLOGISTS; MELANOCYTIC NEVI; DYSPLASTIC NEVI; SKIN-CANCER; RISK; SURVEILLANCE; DISCORDANCE; LESIONS		Dartmouth Hitchcock Med Ctr, Dept Med Dermatol, Lebanon, NH 03766 USA	Dartmouth College	Edman, RL (corresponding author), 6 Asher St, IL-32297 Haifa, Israel.							Ackerman AB, 1996, HUM PATHOL, V27, P1115, DOI 10.1016/S0046-8177(96)90301-9; ALBERT VA, 1990, J AM ACAD DERMATOL, V23, P308, DOI 10.1016/0190-9622(90)70214-3; AUSTOKER J, 1994, BRIT MED J, V308, P1682, DOI 10.1136/bmj.308.6945.1682; Brandt TP, 1996, MED CLIN N AM, V80, P99, DOI 10.1016/S0025-7125(05)70429-6; *CAN TASK FORC PER, 1994, CAN GUID CLIN PREV H, P850; Corona R, 1996, J CLIN ONCOL, V14, P1218, DOI 10.1200/JCO.1996.14.4.1218; EDMAN RL, IN PRESS AM FAM PHYS; Farmer ER, 1996, HUM PATHOL, V27, P528, DOI 10.1016/S0046-8177(96)90157-4; HALL WH, 1992, JAMA-J AM MED ASSOC, V268, P1314, DOI 10.1001/jama.1992.03490100112037; KANG SW, 1994, ARCH DERMATOL, V130, P999, DOI 10.1001/archderm.130.8.999; KOH HK, 1991, J AM ACAD DERMATOL, V24, P271, DOI 10.1016/0190-9622(91)70041-Y; MACKIE RM, 1993, LANCET, V341, P1618, DOI 10.1016/0140-6736(93)90758-9; MACKIE RM, 1992, BRIT MED J, V304, P1012, DOI 10.1136/bmj.304.6833.1012; Meyer LJ, 1996, J AM ACAD DERMATOL, V34, P618, DOI 10.1016/S0190-9622(96)80061-2; Piepkorn M, 1997, ARCH DERMATOL, V133, P1393, DOI 10.1001/archderm.133.11.1393; RIGEL DS, 1989, CANCER, V63, P386, DOI 10.1002/1097-0142(19890115)63:2<386::AID-CNCR2820630231>3.0.CO;2-6; SCHNEIDER JS, 1994, ARCH DERMATOL, V130, P1002, DOI 10.1001/archderm.130.8.1002; SLADE J, 1995, J AM ACAD DERMATOL, V32, P479, DOI 10.1016/0190-9622(95)90073-X; SOX HC, 1993, JAMA-J AM MED ASSOC, V269, P2678, DOI 10.1001/jama.269.20.2678; Swerlick RA, 1996, ARCH DERMATOL, V132, P881, DOI 10.1001/archderm.132.8.881; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; VANDERESCH EP, 1991, INT J CANCER, V47, P483, DOI 10.1002/ijc.2910470402; Weinstock MA, 1997, ARCH DERMATOL, V133, P953, DOI 10.1001/archderm.133.8.953	23	13	13	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2000	284	7					883	886		10.1001/jama.284.7.883	http://dx.doi.org/10.1001/jama.284.7.883			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342PM	10938180				2022-12-24	WOS:000088654400033
J	Yellon, DM; Baxter, GF				Yellon, DM; Baxter, GF			Sodium-hydrogen exchange in myocardial reperfusion injury	LANCET			English	Editorial Material							NA+-H+ EXCHANGE; CARIPORIDE; INHIBITOR; HOE-642		UCL Hosp, Dept Acad & Clin Cardiol, Hatter Inst, London WC1E 6DB, England	University College London Hospitals NHS Foundation Trust; University of London; University College London	Yellon, DM (corresponding author), UCL Hosp, Dept Acad & Clin Cardiol, Hatter Inst, London WC1E 6DB, England.		Yellon, Derek M/ABD-5110-2021	Yellon, Derek/0000-0001-7791-9320; Baxter, Gary/0000-0002-7887-6841				Ambrosio G, 1999, AM HEART J, V138, pS69, DOI 10.1016/S0002-8703(99)70323-6; Avkiran M, 1999, AM J CARDIOL, V83, p10G; Aye NN, 1999, BRIT J PHARMACOL, V127, P1048, DOI 10.1038/sj.bjp.0702566; Baines CP, 1999, J CARDIOVASC ELECTR, V10, P741, DOI 10.1111/j.1540-8167.1999.tb00251.x; FARB A, 1993, J AM COLL CARDIOL, V21, P1245, DOI 10.1016/0735-1097(93)90253-W; Ferguson JJ, 1999, CIRCULATION, V100, P570, DOI 10.1161/01.CIR.100.6.570; Gumina RJ, 1999, CIRCULATION, V100, P2519, DOI 10.1161/01.CIR.100.25.2519; Karmazyn M, 1999, CIRC RES, V85, P777, DOI 10.1161/01.RES.85.9.777; Linz W, 1998, CLIN EXP HYPERTENS, V20, P733, DOI 10.3109/10641969809052116; Matsumura K, 1998, CIRCULATION, V97, P795, DOI 10.1161/01.CIR.97.8.795; Miura T, 1997, J AM COLL CARDIOL, V29, P693, DOI 10.1016/S0735-1097(96)00522-0; Rupprecht HJ, 2000, CIRCULATION, V101, P2902, DOI 10.1161/01.CIR.101.25.2902; SIMOONS ML, 1999, LANCET S2, V353, P1; Stromer H, 2000, CIRCULATION, V101, P2749, DOI 10.1161/01.CIR.101.23.2749; VandenHoek TL, 1996, AM J PHYSIOL-HEART C, V270, pH1334, DOI 10.1152/ajpheart.1996.270.4.H1334; Yellon DM, 2000, HEART, V83, P381, DOI 10.1136/heart.83.4.381	16	20	21	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 12	2000	356	9229					522	523		10.1016/S0140-6736(00)02570-8	http://dx.doi.org/10.1016/S0140-6736(00)02570-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	345MY	10950222				2022-12-24	WOS:000088820800002
J	Norwitz, ER; Hoyte, LPJ; Jenkins, KJ; van der Velde, ME; Ratiu, P; Rodriguez-Thompson, D; Wilkins-Haug, L; Tempany, CMC; Fishman, SJ				Norwitz, ER; Hoyte, LPJ; Jenkins, KJ; van der Velde, ME; Ratiu, P; Rodriguez-Thompson, D; Wilkins-Haug, L; Tempany, CMC; Fishman, SJ			Separation of conjoined twins with the twin reversed-arterial-perfusion sequence after prenatal planning with three-dimensional modeling	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACARDIAC-ACEPHALUS TWIN; SELECTIVE DELIVERY; UMBILICAL-CORD; DIAGNOSIS; LIGATION; HYSTEROTOMY; PREGNANCIES; MR		Childrens Hosp, Dept Surg, Boston, MA 02115 USA; Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Fishman, SJ (corresponding author), Childrens Hosp, Dept Surg, 300 Longwood Ave, Boston, MA 02115 USA.		Rodriguez, Diana/AAX-1532-2020; Rodriguez, Diana/R-5528-2019					BENIRSCHKE K, 1981, PRINCIPLES PRACTICE, P1165; CHIU CT, 1994, J CARDIOVASC SURG, V35, P459; EDMONDS LD, 1982, TERATOLOGY, V25, P301, DOI 10.1002/tera.1420250306; FAGAN CJ, 1977, AM J ROENTGENOL, V129, P921, DOI 10.2214/ajr.129.5.921; FOLEY MR, 1995, AM J OBSTET GYNECOL, V172, P212, DOI 10.1016/0002-9378(95)90117-5; FRIES MH, 1992, OBSTET GYNECOL, V79, P601; GERING D, 1999, INTEGRATED VISUALIZA; GILLIM DL, 1953, OBSTET GYNECOL, V2, P647; GINSBERG NA, 1992, AM J OBSTET GYNECOL, V167, P33, DOI 10.1016/S0002-9378(11)91620-2; GORE RM, 1982, JAMA-J AM MED ASSOC, V247, P3351, DOI 10.1001/jama.247.24.3351; GRAIVIER L, 1980, TEX MED, V76, P60; HEMPEL S, 1907, MORPHOLOGIE MISBILDU; Hubbard AM, 1999, RADIOLOGY, V212, P43, DOI 10.1148/radiology.212.1.r99jl3143; Klein DJ, 1998, J PEDIATR SURG, V33, P354, DOI 10.1016/S0022-3468(98)90461-4; MCCURDY CM, 1993, OBSTET GYNECOL, V82, P708; MOORE TR, 1990, AM J OBSTET GYNECOL, V163, P907, DOI 10.1016/0002-9378(90)91094-S; NOONAN JA, 1987, AM J DIS CHILD, V132, P17; PATEL R, 1977, BRIT HEART J, V39, P1254; PORRECO RP, 1991, LANCET, V337, P326, DOI 10.1016/0140-6736(91)90946-M; Quinn TM, 1998, J PEDIATR SURG, V33, P553, DOI 10.1016/S0022-3468(98)90315-3; QUINTERO RA, 1994, NEW ENGL J MED, V330, P469, DOI 10.1056/NEJM199402173300705; ROBIE GF, 1989, NEW ENGL J MED, V320, P512, DOI 10.1056/NEJM198902233200808; Rodeck C, 1998, NEW ENGL J MED, V339, P1293, DOI 10.1056/NEJM199810293391805; Romero R, 1987, PRENATAL DIAGNOSIS C, P405; SEPULVEDA W, 1995, OBSTET GYNECOL, V86, P680, DOI 10.1016/0029-7844(95)00171-M; VANALLEN MI, 1983, SEMIN PERINATOL, V7, P285; WEINREB JC, 1986, RADIOLOGY, V159, P717, DOI 10.1148/radiology.159.3.3517956	27	30	38	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 10	2000	343	6					399	402		10.1056/NEJM200008103430604	http://dx.doi.org/10.1056/NEJM200008103430604			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342DT	10933739				2022-12-24	WOS:000088630500004
J	Royant, A; Edman, K; Ursby, T; Pebay-Peyroula, E; Landau, EM; Neutze, R				Royant, A; Edman, K; Ursby, T; Pebay-Peyroula, E; Landau, EM; Neutze, R			Helix deformation is coupled to vectorial proton transport in the photocycle of bacteriorhodopsin	NATURE			English	Article							LIPIDIC CUBIC PHASES; TO-M TRANSITION; ANGSTROM RESOLUTION; CONFORMATIONAL-CHANGES; STRUCTURAL-CHANGES; MEMBRANE-PROTEINS; SCHIFF-BASE; RELEASE; INTERMEDIATE; CRYSTALS	A wide variety of mechanisms are used to generate a protonmotive potential across cell membranes, a function lying at the heart of bioenergetics. Bacteriorhodopsin, the simplest known proton pump(1), provides a paradigm for understanding this process. Here we report, at 2.1 Angstrom resolution, the structural changes in bacteriorhodopsin immediately preceding the primary proton transfer event in its photocycle. The early structural rearrangements(2) propagate from the protein's core towards the extracellular surface, disrupting the network of hydrogen-bonded water molecules that stabilizes helix C in the ground state. Concomitantly, a bend of this helix enables the negatively charged(3) primary proton acceptor, Asp 85, to approach closer to the positively charged primary proton donor, the Schiff base. The primary proton transfer event would then neutralize these two groups, cancelling their electrostatic attraction and facilitating a relaxation of helix C to a less strained geometry. Reprotonation of the Schiff base by Asp 85 would thereby be impeded, ensuring vectorial proton transport. Structural rearrangements also occur near the protein's surface, aiding proton release to the extracellular medium.	Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; Univ Grenoble 1, Inst Biol Struct, CEA, CNRS,UMR 5075, F-38027 Grenoble 1, France; Uppsala Univ, Biomed Ctr, Dept Biochem, S-75123 Uppsala, Sweden; European Synchrotron Radiat Facil, F-38043 Grenoble, France	University of Basel; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Uppsala University; European Synchrotron Radiation Facility (ESRF)	Landau, EM (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.		Neutze, Richard/A-7573-2010; Royant, Antoine/G-3684-2012	Neutze, Richard/0000-0003-0986-6153; Royant, Antoine/0000-0002-1919-8649				Althaus T, 1998, BIOCHEMISTRY-US, V37, P2807, DOI 10.1021/bi9714969; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Balashov SP, 1996, BIOPHYS J, V70, P473, DOI 10.1016/S0006-3495(96)79591-7; Balashov SP, 1997, BIOCHEMISTRY-US, V36, P8671, DOI 10.1021/bi970744y; Belrhali H, 1999, STRUCTURE, V7, P909, DOI 10.1016/S0969-2126(99)80118-X; Bourgeois D, 1999, ACTA CRYSTALLOGR D, V55, P1733, DOI 10.1107/S0907444999008355; BRAIMAN MS, 1988, BIOCHEMISTRY-US, V27, P8516, DOI 10.1021/bi00423a002; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chandra N, 1999, ACTA CRYSTALLOGR D, V55, P1750, DOI 10.1107/S0907444999009968; Edman K, 1999, NATURE, V401, P822, DOI 10.1038/44623; Esnouf R. M., 1997, J MOL GRAPHICS, V15, P133; GAT Y, 1993, J AM CHEM SOC, V115, P3772, DOI 10.1021/ja00062a052; Genick UK, 1998, NATURE, V392, P206, DOI 10.1038/32462; HADFIELD A, 1993, J APPL CRYSTALLOGR, V26, P839, DOI 10.1107/S0021889893005552; HEBERLE J, 1993, EMBO J, V12, P3721, DOI 10.1002/j.1460-2075.1993.tb06049.x; Hendrickson FM, 1998, BIOPHYS J, V75, P1446, DOI 10.1016/S0006-3495(98)74063-9; Hu JGG, 1997, BIOCHEMISTRY-US, V36, P9316, DOI 10.1021/bi970416y; KHORANA HG, 1993, P NATL ACAD SCI USA, V90, P1166, DOI 10.1073/pnas.90.4.1166; Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532; Luecke H, 1999, SCIENCE, V286, P255, DOI 10.1126/science.286.5438.255; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; MAEDA A, 1994, BIOCHEMISTRY-US, V33, P1713, DOI 10.1021/bi00173a013; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Nollert P, 1998, BIOCHEM SOC T, V26, P709, DOI 10.1042/bst0260709; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; OTWINOWSKI Z, 1993, DATA COLLECTION PROC, P55; SCHLICHTING I, 1994, NATURE, V371, P808, DOI 10.1038/371808a0; Subramaniam S, 1999, J MOL BIOL, V287, P145, DOI 10.1006/jmbi.1999.2589; SUBRAMANIAM S, 1993, EMBO J, V12, P1; TAKEI H, 1994, J BIOL CHEM, V269, P7387	30	221	228	1	24	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2000	406	6796					645	648		10.1038/35020599	http://dx.doi.org/10.1038/35020599			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949307				2022-12-24	WOS:000088653800052
J	De Souza, CPC; Osmani, AH; Wu, LP; Spotts, JL; Osmani, SA				De Souza, CPC; Osmani, AH; Wu, LP; Spotts, JL; Osmani, SA			Mitotic histone H3 phosphorylation by the NIMA kinase in Aspergillus nidulans	CELL			English	Article							PEPTIDYL-PROLYL ISOMERASE; CELL-CYCLE REGULATORS; CHROMOSOME CONDENSATION; PROTEIN-KINASE; CHROMATIN CONDENSATION; 13S CONDENSIN; FISSION YEAST; SUBSTRATE-SPECIFICITY; OKADAIC ACID; MURINE NEK3	Phosphorylation of histone H3 serine 10 correlates with chromosome condensation and is required for normal chromosome segregation in Tetrahymena. This phosphorylation is dependent upon activation of the NIMA kinase in Aspergillus nidulans. NIMA expression also induces Ser-10 phosphorylation inappropriately in S phase-arrested cells and in the absence of NIMXcdc2 activity. At mitosis, NIMA becomes enriched on chromatin and subsequently localizes to the mitotic spindle and spindle pole bodies. The chromatin-like localization of NIMA early in mitosis is tightly correlated with histone H3 phosphorylation. Finally, NIMA can phosphorylate histone H3 Ser-10 in vitro, suggesting that NIMA is a mitotic histone H3 kinase, perhaps helping to explain how NIMA promotes chromatin condensation in A. nidulans and when expressed in other eukaryotes.	Geisinger Med Clin, Weis Ctr Res, Henry Hood Res Program, Danville, PA 17822 USA	Geisinger Medical Center	Osmani, SA (corresponding author), Geisinger Med Clin, Weis Ctr Res, Henry Hood Res Program, 100 N Acad Ave, Danville, PA 17822 USA.	sosmani@geisinger.edu	Osmani, Stephen A./AAS-3904-2021		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042564] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 42564] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ajiro K, 1996, J BIOL CHEM, V271, P13197, DOI 10.1074/jbc.271.22.13197; Chadee DN, 1999, J BIOL CHEM, V274, P24914, DOI 10.1074/jbc.274.35.24914; Charles JF, 1998, CURR BIOL, V8, P497, DOI 10.1016/S0960-9822(98)70201-5; Chen A, 1999, GENE, V234, P127, DOI 10.1016/S0378-1119(99)00165-1; Crenshaw DG, 1998, EMBO J, V17, P1315, DOI 10.1093/emboj/17.5.1315; DASSO M, 1994, P NATL ACAD SCI USA, V91, P12477, DOI 10.1073/pnas.91.26.12477; de la Barre AE, 2000, EMBO J, V19, P379, DOI 10.1093/emboj/19.3.379; Descombes P, 1998, EMBO J, V17, P1328, DOI 10.1093/emboj/17.5.1328; Fry AM, 1998, EMBO J, V17, P470, DOI 10.1093/emboj/17.2.470; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; GUO XW, 1995, EMBO J, V14, P976, DOI 10.1002/j.1460-2075.1995.tb07078.x; GURLEY LR, 1978, EUR J BIOCHEM, V84, P1, DOI 10.1111/j.1432-1033.1978.tb12135.x; Hayashi K, 1999, BIOCHEM BIOPH RES CO, V264, P449, DOI 10.1006/bbrc.1999.1536; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; HIRANO T, 1994, CELL, V79, P449, DOI 10.1016/0092-8674(94)90254-2; Hirano T, 1999, GENE DEV, V13, P11, DOI 10.1101/gad.13.1.11; Kimura K, 1999, CELL, V98, P239, DOI 10.1016/S0092-8674(00)81018-1; Kimura K, 1997, CELL, V90, P625, DOI 10.1016/S0092-8674(00)80524-3; Kimura K, 1998, SCIENCE, V282, P487, DOI 10.1126/science.282.5388.487; KORNBERG RD, 1977, ANNU REV BIOCHEM, V46, P931, DOI 10.1146/annurev.bi.46.070177.004435; Krien MJE, 1998, J CELL SCI, V111, P967; Kurasawa Y, 1999, ONCOGENE, V18, P5131, DOI 10.1038/sj.onc.1203133; LETWIN K, 1992, EMBO J, V11, P3521, DOI 10.1002/j.1460-2075.1992.tb05435.x; Lu KP, 1996, NATURE, V380, P544; LU KP, 1995, CELL, V81, P413, DOI 10.1016/0092-8674(95)90394-1; LU KP, 1994, EMBO J, V13, P2103, DOI 10.1002/j.1460-2075.1994.tb06486.x; LU KP, 1993, J BIOL CHEM, V268, P8769; LU KP, 1994, J BIOL CHEM, V269, P6603; MAHADEVAN LC, 1991, CELL, V65, P775, DOI 10.1016/0092-8674(91)90385-C; MIRABITO PM, 1993, J CELL BIOL, V120, P959, DOI 10.1083/jcb.120.4.959; Murray AW, 1998, SCIENCE, V282, P425, DOI 10.1126/science.282.5388.425; OAKLEY BR, 1993, CELL CYCLE PRACTICAL, P127; OCONNELL MJ, 1994, EMBO J, V13, P4926, DOI 10.1002/j.1460-2075.1994.tb06820.x; OCONNELL MJ, 1992, EMBO J, V11, P2139, DOI 10.1002/j.1460-2075.1992.tb05273.x; OHSUMI K, 1993, SCIENCE, V262, P2033, DOI 10.1126/science.8266099; OSMANI AH, 1991, CELL, V67, P283, DOI 10.1016/0092-8674(91)90180-7; OSMANI AH, 1994, J CELL SCI, V107, P1519; OSMANI AH, 1991, EMBO J, V10, P2669, DOI 10.1002/j.1460-2075.1991.tb07810.x; OSMANI SA, 1988, CELL, V53, P237, DOI 10.1016/0092-8674(88)90385-6; OSMANI SA, 1987, J CELL BIOL, V104, P1495, DOI 10.1083/jcb.104.6.1495; Osmani SA, 1996, BIOCHEM J, V317, P633, DOI 10.1042/bj3170633; PAULSON JR, 1982, J BIOL CHEM, V257, P6064; PU RT, 1995, J BIOL CHEM, V270, P18110, DOI 10.1074/jbc.270.30.18110; PU RT, 1995, EMBO J, V14, P995, DOI 10.1002/j.1460-2075.1995.tb07080.x; Rhee K, 1997, DEVELOPMENT, V124, P2167; Roth SY, 1996, CELL, V87, P5, DOI 10.1016/S0092-8674(00)81316-1; SAKA Y, 1994, EMBO J, V13, P4938, DOI 10.1002/j.1460-2075.1994.tb06821.x; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Sauve DM, 1999, J CELL BIOL, V145, P225, DOI 10.1083/jcb.145.2.225; SCHULTZ SJ, 1993, CELL GROWTH DIFFER, V4, P821; SCHULTZ SJ, 1994, CELL GROWTH DIFFER, V5, P625; Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Spencer VA, 1999, GENE, V240, P1, DOI 10.1016/S0378-1119(99)00405-9; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Sutani T, 1999, GENE DEV, V13, P2271, DOI 10.1101/gad.13.17.2271; Tanaka K, 1999, J BIOL CHEM, V274, P13491, DOI 10.1074/jbc.274.19.13491; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; TUGENDREICH S, 1995, CELL, V81, P261, DOI 10.1016/0092-8674(95)90336-4; Uto K, 1999, DEV BIOL, V208, P456, DOI 10.1006/dbio.1999.9231; Van Hooser A, 1998, J CELL SCI, V111, P3497; Wang SL, 1998, BIOCHEM J, V334, P197, DOI 10.1042/bj3340197; Wei Y, 1998, P NATL ACAD SCI USA, V95, P7480, DOI 10.1073/pnas.95.13.7480; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Wu L, 1998, J CELL BIOL, V141, P1575, DOI 10.1083/jcb.141.7.1575; YE XS, 1995, EMBO J, V14, P986, DOI 10.1002/j.1460-2075.1995.tb07079.x	66	125	129	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 4	2000	102	3					293	302		10.1016/S0092-8674(00)00035-0	http://dx.doi.org/10.1016/S0092-8674(00)00035-0			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	342BP	10975520	Bronze			2022-12-24	WOS:000088625600005
J	Wu, JF; Sunda, W; Boyle, EA; Karl, DM				Wu, JF; Sunda, W; Boyle, EA; Karl, DM			Phosphate depletion in the western North Atlantic Ocean	SCIENCE			English	Article							PACIFIC-OCEAN; NITROGEN-FIXATION; FERTILIZATION EXPERIMENT; DISSOLVED PHOSPHORUS; NUTRIENT; IRON; DENITRIFICATION; PHYTOPLANKTON; TRICHODESMIUM; RATIOS	Surface waters of the subtropical Sargasso Sea contain dissolved inorganic phosphate (DIP) concentrations of 0.2 to 1.0 nanomolar, which are sufficiently Low to result in phosphorus control of primary production. The DIP concentrations in this area (which receives high inputs of iron-rich dust from arid regions of North Africa) are one to two orders of magnitude lower than surface Levels in the North Pacific (where eolian iron inputs are much Lower and water column denitrification is much more substantial). These data indicate a severe relative phosphorus depletion in the Atlantic. We hypothesize that nitrogen versus phosphorus Limitation of primary production in the present-day ocean may be closely linked to iron supply through control of dinitrogen (N-2) fixation, an iron-intensive metabolic process. Although the oceanic phosphorus inventory may set the upper Limit for the total amount of organic matter produced in the ocean over geological time scales, at any instant in geological time, oceanic primary production may fall below this Limit because of a persistent insufficient iron supply. By controlling N-2 fixation, iron may control not only nitrogen versus phosphorus Limitation but also carbon fixation and export stoichiometry and hence biological sequestration of atmospheric carbon dioxide.	MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; NOAA, Beaufort Lab, Beaufort, NC 28516 USA; Univ Hawaii, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA	Massachusetts Institute of Technology (MIT); National Oceanic Atmospheric Admin (NOAA) - USA; University of Hawaii System	Wu, JF (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.		Karl, David/AFP-3837-2022; Wu, Jingfeng/B-1301-2012	Wu, Jingfeng/0000-0003-0156-1507; Karl, David/0000-0002-6660-6721				Abell J, 2000, J MAR RES, V58, P203, DOI 10.1357/002224000321511142; ALTABET MA, 1995, NATURE, V373, P506, DOI 10.1038/373506a0; ARMSTRONG FA, 1967, DEEP-SEA RES, V14, P381, DOI 10.1016/0011-7471(67)90082-4; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; BARBER RT, 1992, ENVIR SCI R, V43, P89; Behrenfeld MJ, 1999, SCIENCE, V283, P840, DOI 10.1126/science.283.5403.840; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; Broecker WS, 1982, TRACERS SEA; BRULAND K, COMMUNICATION; Bruland K. W., 1983, Trace Metals in Sea Water. Proceedings of the NATO Advanced Research Institute, P395; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; CARPENTER EJ, 1991, SCIENCE, V254, P1356, DOI 10.1126/science.254.5036.1356; CLINE JD, 1972, LIMNOL OCEANOGR, V17, P885, DOI 10.4319/lo.1972.17.6.0885; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; CODISPOTI LA, 1976, LIMNOL OCEANOGR, V21, P379, DOI 10.4319/lo.1976.21.3.0379; CODISPOTI LA, 1995, NATURE, V376, P724, DOI 10.1038/376724a0; CODISPOTI LA, 1985, MAR CHEM, V16, P277, DOI 10.1016/0304-4203(85)90051-9; CODISPOTI LA, 1989, LIFE SCI R, V44, P377; DITULLIO GR, 1993, LIMNOL OCEANOGR, V38, P495, DOI 10.4319/lo.1993.38.3.0495; Duce RA, 1991, GLOBAL BIOGEOCHEM CY, V5, P193, DOI 10.1029/91GB01778; DUCE RA, 1991, LIMNOL OCEANOGR, V36, P1715, DOI 10.4319/lo.1991.36.8.1715; EPPLEY RW, 1979, NATURE, V282, P677, DOI 10.1038/282677a0; Evans JC, 1997, LIMNOL OCEANOGR, V42, P461, DOI 10.4319/lo.1997.42.3.0461; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; FANNING KA, 1992, J GEOPHYS RES-OCEANS, V97, P5693, DOI 10.1029/92JC00007; GALLOWAY JN, 1995, GLOBAL BIOGEOCHEM CY, V9, P235, DOI 10.1029/95GB00158; GANESHRAM RS, 1995, NATURE, V376, P755, DOI 10.1038/376755a0; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; JACKSON GA, 1985, DEEP-SEA RES, V32, P223, DOI 10.1016/0198-0149(85)90030-5; JOHNSON DL, 1971, ENVIRON SCI TECHNOL, V5, P411, DOI 10.1021/es60052a005; Jones DR, 1996, DEEP-SEA RES PT I, V43, P1567, DOI 10.1016/S0967-0637(96)00079-9; KARI DM, 1992, MARINE PELAGIC CYANO, P219; Karl D, 1997, NATURE, V388, P533, DOI 10.1038/41474; KARL DM, 1992, LIMNOL OCEANOGR, V37, P105, DOI 10.4319/lo.1992.37.1.0105; Karl DM, 1997, MAR CHEM, V56, P77, DOI 10.1016/S0304-4203(96)00081-3; LIBES SM, 1999, INTRO MARINE BIOGEOC, V400, P525; Lipschultz F, 1996, BIOGEOCHEMISTRY, V35, P261, DOI 10.1007/BF02179830; LONGHURST AR, 1991, LIMNOL OCEANOGR, V36, P1507, DOI 10.4319/lo.1991.36.8.1507; MCELROY MB, 1983, NATURE, V302, P328, DOI 10.1038/302328a0; Michaels AF, 1996, BIOGEOCHEMISTRY, V35, P181, DOI 10.1007/BF02179827; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Prospero JM, 1996, BIOGEOCHEMISTRY, V35, P27, DOI 10.1007/BF02179824; RAVEN JA, 1988, NEW PHYTOL, V109, P279, DOI 10.1111/j.1469-8137.1988.tb04196.x; Redfield A. C, 1963, SEA, P26, DOI DOI 10.1016/J.ORGGEOCHEM.2014.06.002; RHEE GY, 1973, J PHYCOL, V9, P495, DOI 10.1111/j.1529-8817.1973.tb04126.x; RUETER JG, 1992, NATO ADV SCI I C-MAT, V362, P289; RUETER JG, 1988, J PHYCOL, V24, P249; SCHINDLER DW, 1976, SCIENCE, V193, P251; SMITH SV, 1984, LIMNOL OCEANOGR, V29, P1149, DOI 10.4319/lo.1984.29.6.1149; SMITH SV, 1986, LIMNOL OCEANOGR, V31, P161, DOI 10.4319/lo.1986.31.1.0161; STOCKNER JG, 1988, LIMNOL OCEANOGR, V33, P1348, DOI 10.4319/lo.1988.33.6.1348; STRICKLAND J. D. H., 1972, PRACTICAL HDB SEAWAT; SUNDA WG, 1992, LIMNOL OCEANOGR, V37, P25, DOI 10.4319/lo.1992.37.1.0025; THOMAS WH, 1969, J FISH RES BOARD CAN, V26, P1133, DOI 10.1139/f69-104; THOMAS WILLIAM H., 1966, DEEP SEA RES OCEANOGR ABSTR, V13, P1109, DOI 10.1016/0011-7471(66)90702-9; Thomson-Bulldis A, 1998, LIMNOL OCEANOGR, V43, P1565, DOI 10.4319/lo.1998.43.7.1565; Toggweiler JR, 1999, NATURE, V400, P511, DOI 10.1038/22892; Tyrrell T, 1999, NATURE, V400, P525, DOI 10.1038/22941; Villareal T.A., 1989, BIOL OCEANOGR, V6, P327, DOI [10.1080/01965581.1988.10749535, DOI 10.1080/01965581.1988.10749535]; WURTSBAUGH WA, 1983, CAN J FISH AQUAT SCI, V40, P1419, DOI 10.1139/f83-164	62	588	615	7	195	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 4	2000	289	5480					759	762		10.1126/science.289.5480.759	http://dx.doi.org/10.1126/science.289.5480.759			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341FZ	10926534				2022-12-24	WOS:000088581500035
J	Clapham, JC; Arch, JRS; Chapman, H; Haynes, A; Lister, C; Moore, GBT; Piercy, V; Carter, SA; Lehner, I; Smith, SA; Beeley, LJ; Godden, RJ; Herrity, N; Skehel, M; Changani, KK; Hockings, PD; Reid, DG; Squires, SM; Hatcher, J; Trail, B; Latcham, J; Rastan, S; Harper, AJ; Cadenas, S; Buckingham, JA; Brand, MD; Abuin, A				Clapham, JC; Arch, JRS; Chapman, H; Haynes, A; Lister, C; Moore, GBT; Piercy, V; Carter, SA; Lehner, I; Smith, SA; Beeley, LJ; Godden, RJ; Herrity, N; Skehel, M; Changani, KK; Hockings, PD; Reid, DG; Squires, SM; Hatcher, J; Trail, B; Latcham, J; Rastan, S; Harper, AJ; Cadenas, S; Buckingham, JA; Brand, MD; Abuin, A			Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean	NATURE			English	Article							SELECTIVE BETA(3)-ADRENOCEPTOR AGONIST; BROWN ADIPOSE-TISSUE; INSULIN ACTION; FAT OXIDATION; THERMOGENESIS; OBESITY; GENE; PALATABILITY; CL-316,243; PRODUCT	Uncoupling protein-3 (UCP-3) is a recently identified member of the mitochondrial transporter superfamily(1,2) that is expressed predominantly in skeletal muscle(1,2). However, its close relative UCP-1 is expressed exclusively in brown adipose tissue, a tissue whose main function is fat combustion and thermogenesis. Studies on the expression of UCP-3 in animals and humans in different physiological situations support a role for UCP-3 in energy balance and lipid metabolism(3,4). However, direct evidence for these roles is lacking. Here we describe the creation of transgenic mice that overexpress human UCP-3 in skeletal muscle. These mice are hyperphagic but weigh less than their wild-type littermates. Magnetic resonance imaging shows a striking reduction in adipose tissue mass. The mice also exhibit lower fasting plasma glucose and insulin levels and an increased glucose clearance rate. This provides evidence that skeletal muscle UCP-3 has the potential to influence metabolic rate and glucose homeostasis in the whole animal.	Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; MRC, Dunn Human Nutr Unit, Cambridge CB2 2XY, England; Dept Safety Assessment, Welwyn Garden City AL6 9AR, Herts, England; Lab Anim Sci, Welwyn Garden City AL6 9AR, Herts, England; SmithKline Beecham Pharmaceut, Dept Vasc Biol, Harlow CM19 5AW, Essex, England; SmithKline Beecham Pharmaceut, Dept Bioinformat, Harlow CM19 5AW, Essex, England; SmithKline Beecham Pharmaceut, Dept Mol Biol, Harlow CM19 5AW, Essex, England; SmithKline Beecham Pharmaceut, Dept Gene Express Sci, Harlow CM19 5AW, Essex, England; SmithKline Beecham Pharmaceut, Dept Bioanalyt Sci, Harlow CM19 5AW, Essex, England; SmithKline Beecham Pharmaceut, Dept Neurobehav Res, Harlow CM19 5AW, Essex, England; SmithKline Beecham Pharmaceut, Dept Comparat Genet, Harlow CM19 5AW, Essex, England	University of Cambridge; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Clapham, JC (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.		Clapham, John/AAK-4715-2020; Cadenas, Susana/D-1523-2016; Hockings, Paul/C-1629-2010; Hockings, Paul D/AAM-7950-2020; Brand, Martin D/A-9423-2012	Hockings, Paul/0000-0002-7154-9047; Hockings, Paul D/0000-0002-7154-9047; Brand, Martin D/0000-0003-4418-6153; Cadenas, Susana/0000-0003-0726-0369				ARCH JRS, 1984, INT J OBESITY, V8, P1; Argyropoulos G, 1998, J CLIN INVEST, V102, P1345, DOI 10.1172/JCI4115; BELLISLE F, 1985, AM J PHYSIOL, V249, pE639, DOI 10.1152/ajpendo.1985.249.6.E639; Boss O, 1997, FEBS LETT, V408, P39, DOI 10.1016/S0014-5793(97)00384-0; BRENNAN KJ, 1993, J BIOL CHEM, V268, P719; Cadenas S, 1999, FEBS LETT, V462, P257, DOI 10.1016/S0014-5793(99)01540-9; Chung WK, 1999, INT J OBESITY, V23, pS49, DOI 10.1038/sj.ijo.0800945; DIAMOND P, 1985, AM J PHYSIOL, V248, pE75, DOI 10.1152/ajpendo.1985.248.1.E75; Ernster L., 1967, METHOD ENZYMOL, V10, P86; Gordon CJ, 1993, TEMPERATURE REGULATI, DOI 10.1017/CBO9780511565595; GRUNNING P, 1987, MOL CELL BIOL, V7, P4100; Hogan B, 1994, MANIPULATING MOUSE E; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; JONES BJ, 1968, J PHARM PHARMACOL, V20, P302, DOI 10.1111/j.2042-7158.1968.tb09743.x; LARGIS EE, 1994, DRUG DEVELOP RES, V32, P69, DOI 10.1002/ddr.430320203; LEBLANC J, 1985, AM J PHYSIOL, V248, pE333, DOI 10.1152/ajpendo.1985.248.3.E333; Liu XL, 1998, AM J PHYSIOL-REG I, V274, pR1212, DOI 10.1152/ajpregu.1998.274.5.R1212; LIVAK KJ, 1995, PCR METH APPL, V4, P357; Otabe S, 2000, DIABETOLOGIA, V43, P245, DOI 10.1007/s001250050037; Rogers DC, 1999, BEHAV BRAIN RES, V105, P207, DOI 10.1016/S0166-4328(99)00072-8; Samec S, 1999, DIABETES, V48, P436, DOI 10.2337/diabetes.48.2.436; Samec S, 1998, FASEB J, V12, P715, DOI 10.1096/fasebj.12.9.715; Stock MJ, 1999, INT J OBESITY, V23, P1105, DOI 10.1038/sj.ijo.0801108; VidalPuig A, 1997, BIOCHEM BIOPH RES CO, V235, P79, DOI 10.1006/bbrc.1997.6740; Weyer C, 1998, DIABETES, V47, P1555, DOI 10.2337/diabetes.47.10.1555; Widdowson PS, 1997, DIABETES, V46, P1782, DOI 10.2337/diabetes.46.11.1782; YOUNG PW, 1995, DIABETES, V44, P1087, DOI 10.2337/diabetes.44.9.1087	27	498	518	1	30	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					415	418		10.1038/35019082	http://dx.doi.org/10.1038/35019082			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935638				2022-12-24	WOS:000088383800048
J	Ferrandiz, C; Liljegren, SJ; Yanofsky, MF				Ferrandiz, C; Liljegren, SJ; Yanofsky, MF			Negative regulation of the SHATTERPROOF genes by FRUITFULL during Arabidopsis fruit development	SCIENCE			English	Article							MADS-BOX GENE; TRANSCRIPTION	The terminal step of fruit development in Arabidopsis involves valve separation from the replum, allowing seed dispersal. This process requires the activities of the SHATTERPROOF MADS-box genes, which promote dehiscence zone differentiation at the valve/replum boundary. Here we show that the FRUITFULL MADS-box gene, which is necessary for fruit valve differentiation, is a negative regulator of SHATTERPROOF expression and that constitutive expression of FRUITFULL is sufficient to prevent formation of the dehiscence zone. Our studies suggest that ectopic expression of FRUITFULL may directly allow the control of pod shatter in oilseed crops such as canola.	Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Yanofsky, MF (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.		Ferrandiz, Cristina/E-6280-2015	Ferrandiz, Cristina/0000-0002-2460-1068				BENFEY PN, 1990, SCIENCE, V250, P959, DOI 10.1126/science.250.4983.959; Ferrandiz C, 2000, DEVELOPMENT, V127, P725; Flanagan CA, 1996, PLANT J, V10, P343, DOI 10.1046/j.1365-313X.1996.10020343.x; Gu Q, 1998, DEVELOPMENT, V125, P1509; Liljegren SJ, 2000, NATURE, V404, P766, DOI 10.1038/35008089; MANDEL MA, 1995, PLANT CELL, V7, P1763, DOI 10.1105/tpc.7.11.1763; SAVIDGE B, 1995, PLANT CELL, V7, P721, DOI 10.1105/tpc.7.6.721; Spence J, 1996, J MICROSC-OXFORD, V181, P195, DOI 10.1046/j.1365-2818.1996.111391.x; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797	9	335	383	6	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 21	2000	289	5478					436	438		10.1126/science.289.5478.436	http://dx.doi.org/10.1126/science.289.5478.436			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	336ME	10903201				2022-12-24	WOS:000088305500043
J	Grainger, D				Grainger, D			A votre sante?	LANCET			English	Editorial Material							MORTALITY; DISEASE		Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England	Addenbrooke's Hospital; University of Cambridge	Grainger, D (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England.							Iijima K, 2000, CIRCULATION, V101, P805, DOI 10.1161/01.CIR.101.7.805; Law M, 1999, BRIT MED J, V318, P1471, DOI 10.1136/bmj.318.7196.1471; Mackenbach JP, 1999, BRIT MED J, V318, P1478; MCMICHAEL J, 1979, LANCET, V1, P1186; Stein JH, 1999, CIRCULATION, V100, P1050, DOI 10.1161/01.CIR.100.10.1050; STLEGER AS, 1979, LANCET, V1, P1017, DOI 10.1016/S0140-6736(79)92765-X; Weissberg PL, 1996, LANCET, V347, P305, DOI 10.1016/S0140-6736(96)90472-9; *WHO, 1986, WORLD HLTH STAT ANN	8	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 8	2000	356	9224					92	92		10.1016/S0140-6736(00)02467-3	http://dx.doi.org/10.1016/S0140-6736(00)02467-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331UG	10963243				2022-12-24	WOS:000088036600007
J	Versluis, M; Schmitz, B; von der Heydt, A; Lohse, D				Versluis, M; Schmitz, B; von der Heydt, A; Lohse, D			How snapping shrimp snap: Through cavitating bubbles	SCIENCE			English	Article							ALPHEUS-HETEROCHAELIS; DYNAMICS; ACOUSTICS	The snapping shrimp (Alpheus heterochaelis) produces a loud snapping sound by an extremely rapid closure of its snapper claw. One of the effects of the snapping is to stun or kill prey animals. During the rapid snapper claw closure, a high-velocity water jet is emitted from the claw with a speed exceeding cavitation conditions. Hydrophone measurements in conjunction with time-controlled high-speed imaging of the claw closure demonstrate that the sound is emitted at the cavitation bubble collapse and not on claw closure. A model for the bubble dynamics based on a Rayleigh-Plesset-type equation quantitatively accounts for the time dependence of the bubble radius and for the emitted sound.	Univ Twente, Dept Appl Phys, NL-7500 AE Enschede, Netherlands; Univ Twente, JM Burgers Res Ctr Fluid Dynam, NL-7500 AE Enschede, Netherlands; Tech Univ Munich, Dept Zool, D-85747 Garching, Germany; Univ Marburg, Dept Phys, D-35032 Marburg, Germany	University of Twente; University of Twente; Technical University of Munich; Philipps University Marburg	Lohse, D (corresponding author), Univ Twente, Dept Appl Phys, POB 217, NL-7500 AE Enschede, Netherlands.		Lohse, Detlef/B-4915-2013; von der Heydt, Anna S/B-9250-2008; Versluis, Michel/F-3541-2011	Lohse, Detlef/0000-0003-4138-2255; von der Heydt, Anna S/0000-0002-5557-3282; Versluis, Michel/0000-0002-2296-1860				Au WWL, 1998, J ACOUST SOC AM, V103, P41, DOI 10.1121/1.423234; Blake JR, 1998, APPL SCI RES, V58, P77, DOI 10.1023/A:1000711113941; Brennen C.E., 1995, CAVITATION BUBBLE DY; Brooks WK, 1891, MEM NAT AKAD SCI WAS, V5, P319; CATO DH, 1992, MRLTR9123 DEF SCI TE; CECCIO SL, 1991, J FLUID MECH, V233, P633, DOI 10.1017/S0022112091000630; Epifanio CL, 1999, J ACOUST SOC AM, V106, P3211, DOI 10.1121/1.428175; EVEREST FA, 1948, J ACOUST SOC AM, V20, P137, DOI 10.1121/1.1906355; Hao Y, 1999, PHYS FLUIDS, V11, P2008, DOI 10.1063/1.870064; Herberholz J, 1998, BIOL BULL, V195, P156, DOI 10.2307/1542823; Herberholz J, 1999, J COMP PHYSIOL A, V185, P41, DOI 10.1007/s003590050364; Hilgenfeldt S, 1998, EUR PHYS J B, V4, P247, DOI 10.1007/s100510050375; Hilgenfeldt S, 1996, PHYS FLUIDS, V8, P2808, DOI 10.1063/1.869131; JOHNSON MW, 1947, BIOL BULL, V93, P122, DOI 10.2307/1538284; Landau L. D., 1987, FLUID MECH; MacGinitie G.E., 1949, NATURAL HIST MARINE, P276; PLESSET MS, 1977, ANNU REV FLUID MECH, V9, P145, DOI 10.1146/annurev.fl.09.010177.001045; PROSPERETTI A, 1977, Q APPL MATH, V34, P339, DOI 10.1090/qam/99652; PROSPERETTI A, 1986, J FLUID MECH, V168, P457, DOI 10.1017/S0022112086000460; RITZMANN RE, 1974, J COMP PHYSIOL, V95, P217, DOI 10.1007/BF00625445; SCHEIN H, 1975, Marine Behaviour and Physiology, V3, P83; SCHMITZ B, IN PRESS CRUSTACEAN; SCHMITZ B, 1998, NEW NEUROETHOLOGY MO, V2, P241; Schultz S., 1998, ZOOL-ANAL COMPLEX SY, V101, P85; Storey BD, 2000, P ROY SOC A-MATH PHY, V456, P1685, DOI 10.1098/rspa.2000.0582; TOGEL R, IN PRESS PHYS REV LE; Urick RJ., 1983, PRINCIPLES UNDERWATE, V3; VERSLUIS M, UNPUB; VOLZ P., 1938, ZEITSCHR MORPH U OKOL TIERE, V34, P272, DOI 10.1007/BF00408760	29	289	300	11	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 22	2000	289	5487					2114	2117		10.1126/science.289.5487.2114	http://dx.doi.org/10.1126/science.289.5487.2114			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	356EG	11000111				2022-12-24	WOS:000089430900041
J	Fairgrieve, SD; Jackson, M; Jonas, P; Walshaw, D; White, K; Montgomery, TL; Burn, J; Lynch, SA				Fairgrieve, SD; Jackson, M; Jonas, P; Walshaw, D; White, K; Montgomery, TL; Burn, J; Lynch, SA			Population based, prospective study of the care of women with epilepsy in pregnancy	BRITISH MEDICAL JOURNAL			English	Article									Royal Victoria Infirm, Dept Human Genet, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England; Royal Victoria Infirm, Dept Neurol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; Univ Newcastle Upon Tyne, Dept Stat, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Fairgrieve, SD (corresponding author), Royal Victoria Infirm, Dept Human Genet, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England.			Burn, John/0000-0002-9823-2322; Lynch, Sally Ann/0000-0003-3540-1333	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		O'Donoghue, 1997, ADULTS POORLY CONTRO; *REG MAT SURV OFF, 1991, NO REG CONG ABN SURV; *REG MAT SURV OFF, 1995, NO PER MORT SURV ANN; Ridsdale L, 1997, BRIT MED J, V314, P120, DOI 10.1136/bmj.314.7074.120; Wiebe S, 2000, BMJ-BRIT MED J, V320, P3, DOI 10.1136/bmj.320.7226.3	5	116	116	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	SEP 16	2000	321	7262					674	675		10.1136/bmj.321.7262.674	http://dx.doi.org/10.1136/bmj.321.7262.674			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356LE	10987772	Bronze, Green Published			2022-12-24	WOS:000089444100025
J	Polejaeva, IA; Chen, SH; Vaught, TD; Page, RL; Mullins, J; Ball, S; Dai, YF; Boone, J; Walker, S; Ayares, DL; Colman, A; Campbell, KHS				Polejaeva, IA; Chen, SH; Vaught, TD; Page, RL; Mullins, J; Ball, S; Dai, YF; Boone, J; Walker, S; Ayares, DL; Colman, A; Campbell, KHS			Cloned pigs produced by nuclear transfer from adult somatic cells	NATURE			English	Article							EMBRYOS; OOCYTES; FETAL; MICE; TRANSPLANTATION; LINE	Since the first report of live mammals produced by nuclear transfer from a cultured differentiated cell population in 1995 (ref. 1), successful development has been obtained in sheep(2,3), cattle(4), mice(5) and goats(6) using a variety of somatic cell types as nuclear donors. The methodology used for embryo reconstruction in each of these species is essentially similar: diploid donor nuclei have been transplanted into enucleated MII oocytes that are activated on, or after transfer. In sheep(2) and goat(6) preactivated oocytes have also proved successful as cytoplast recipients. The reconstructed embryos are then cultured and selected embryos transferred to surrogate recipients for development to term. In pigs, nuclear transfer has been significantly less successful; a single piglet was reported after transfer of a blastomere nucleus from a four-cell embryo to an enucleated oocyte(7); however, no live offspring were obtained in studies using somatic cells such as diploid or mitotic fetal fibroblasts as nuclear donors(8,9). The development of embryos reconstructed by nuclear transfer is dependent upon a range of factors. Here we investigate some of these factors and report the successful production of cloned piglets from a cultured adult somatic cell population using a new nuclear transfer procedure.	PPL Therapeut Inc, Blacksburg, VA 24060 USA; PPL Therapeut Inc, Roslin EH25 9PP, Midlothian, Scotland		Polejaeva, IA (corresponding author), PPL Therapeut Inc, 1700 Kraft Dr, Blacksburg, VA 24060 USA.	ipolejaeva@ppl-therapeutics.com	Polejaeva, Irina/G-4881-2012	Polejaeva, Irina/0000-0002-0858-5889				Baguisi A, 1999, NAT BIOTECHNOL, V17, P456, DOI 10.1038/8632; Campbell K H, 1996, Rev Reprod, V1, P40, DOI 10.1530/ror.0.0010040; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; CANSECO RS, 1994, TRANSGENIC RES, V3, P20, DOI 10.1007/BF01976023; CHRISTENSON RK, 1971, J ANIM SCI, V32, P282; Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256; Colman A, 1999, Cloning, V1, P185; Kwon OY, 1996, P NATL ACAD SCI USA, V93, P13010, DOI 10.1073/pnas.93.23.13010; McCreath KJ, 2000, NATURE, V405, P1066, DOI 10.1038/35016604; MCGRATH J, 1983, J EXP ZOOL, V228, P355, DOI 10.1002/jez.1402280218; MCGRATH J, 1983, SCIENCE, V220, P1300, DOI 10.1126/science.6857250; Ouhibi N, 1996, REPROD NUTR DEV, V36, P661; PETTERS RM, 1993, J REPROD FERTIL, P61; Platt JL, 1996, CURR OPIN IMMUNOL, V8, P721, DOI 10.1016/S0952-7915(96)80091-4; POLGE C, 1966, J REPROD FERTIL, V12, P395, DOI 10.1530/jrf.0.0120395; PRATHER RS, 1991, MOL REPROD DEV, V28, P405, DOI 10.1002/mrd.1080280413; PRATHER RS, 1989, BIOL REPROD, V41, P414, DOI 10.1095/biolreprod41.3.414; Tao T, 1999, ANIM REPROD SCI, V56, P133, DOI 10.1016/S0378-4320(99)00037-8; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wells DN, 1997, BIOL REPROD, V57, P385, DOI 10.1095/biolreprod57.2.385; Wells DN, 1999, BIOL REPROD, V60, P996, DOI 10.1095/biolreprod60.4.996; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0	22	905	1127	2	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 7	2000	407	6800					86	90		10.1038/35024082	http://dx.doi.org/10.1038/35024082			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	350WE	10993078				2022-12-24	WOS:000089124000047
J	Roditi, HA; Fisher, NS; Sanudo-Wilhelmy, SA				Roditi, HA; Fisher, NS; Sanudo-Wilhelmy, SA			Uptake of dissolved organic carbon and trace elements by zebra mussels	NATURE			English	Article							WATER HUDSON RIVER; DREISSENA-POLYMORPHA; AMINO-ACIDS; FOOD; BIOACCUMULATION; INVASION; COLLOIDS; RELEASE; METALS; MATTER	Zebra mussels (Dreissena polymorpha) are widespread and abundant in major freshwater ecosystems in North America, even though the phytoplankton food resources in some of these systems seem to be too low to sustain them(1,2). Because phytoplankton biomass is greatly depleted in ecosystems with large D. polymorpha populations(3,4) and bacteria do not seem to be an important food source for this species(5), exploitation of alternative carbon sources may explain the unexpected success of D. polymorpha in such environments. Here we examine the possibility that absorption of dissolved organic carbon (DOC) from water(6-9) could provide a nutritional supplement to zebra mussels. We find that mussels absorb C-14-labelled DOC produced by cultured diatoms with an efficiency of 0.23%; this indicates that DOC in natural waters could contribute up to 50% of the carbon demand of zebra mussels. We also find that zebra mussels absorb some dissolved metals that have been complexed by the DOM; although absorption of dissolved selenium was unaffected by DOC, absorption of dissolved cadmium, silver and mercury by the mussels increased 32-, 8.7- and 3.6-fold, respectively, in the presence of high-molecular-weight DOC.	SUNY Stony Brook, Marine Sci Res Ctr, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Fisher, NS (corresponding author), SUNY Stony Brook, Marine Sci Res Ctr, Stony Brook, NY 11794 USA.	nfisher@notes.cc.sunysb.edu						ARMSTRONG FA, 1966, NATURE, V211, P481, DOI 10.1038/211481a0; Campbell P.G.C., 1995, METAL SPECIATION BIO, P45; Caraco NF, 1997, ECOLOGY, V78, P588, DOI 10.1890/0012-9658(1997)078[0588:ZMIIAL]2.0.CO;2; Carvalho RA, 1999, LIMNOL OCEANOGR, V44, P403, DOI 10.4319/lo.1999.44.2.0403; Ciborowski JJH, 1997, J N AM BENTHOL SOC, V16, P771, DOI 10.2307/1468170; CUTTER GA, 1992, MAR CHEM, V40, P65, DOI 10.1016/0304-4203(92)90048-F; DECHO AW, 1990, OCEANOGR MAR BIOL, V28, P73; Fahnenstiel GL, 1995, J GREAT LAKES RES, V21, P435, DOI 10.1016/S0380-1330(95)71057-7; FERGUSON JC, 1982, BIOL BULL, V162, P1, DOI 10.2307/1540965; Findlay S, 1998, MICROBIAL ECOL, V36, P131, DOI 10.1007/s002489900100; Findlay S, 1996, ESTUARIES, V19, P866, DOI 10.2307/1352303; Fisher NS, 1996, ENVIRON SCI TECHNOL, V30, P3232, DOI 10.1021/es960009u; HEDGES JI, 1994, LIMNOL OCEANOGR, V39, P743, DOI 10.4319/lo.1994.39.4.0743; HOWARTH RW, 1992, BIOGEOCHEMISTRY, V16, P83; KEPKAY PE, 1994, MAR ECOL PROG SER, V109, P293, DOI 10.3354/meps109293; KOUCH J, 1996, ENVIRON INT, V22, P585; KRYGER J, 1988, OECOLOGIA, V77, P34, DOI 10.1007/BF00380921; LEE BG, 1992, LIMNOL OCEANOGR, V37, P1345; Madon SP, 1998, CAN J FISH AQUAT SCI, V55, P401, DOI 10.1139/cjfas-55-2-401; Nichols S. Jerrine, 1993, P733; Roditi HA, 1999, LIMNOL OCEANOGR, V44, P1730, DOI 10.4319/lo.1999.44.7.1730; Santschi P.H., 1999, BIOGEOCHEMISTRY GULF, P347; SANUDOWILHELMY SA, 1996, EOS, V77, pF200; STEPHENS GC, 1964, BIOL BULL, V126, P150, DOI 10.2307/1539425; Strayer DL, 1996, CAN J FISH AQUAT SCI, V53, P1143, DOI 10.1139/cjfas-53-5-1143; WALZ N, 1978, Archiv fuer Hydrobiologie Supplement, V55, P121; Wang WX, 1996, MAR ECOL PROG SER, V140, P91, DOI 10.3354/meps140091; Wotton RS, 1996, J N AM BENTHOL SOC, V15, P127, DOI 10.2307/1467438; WRIGHT SH, 1989, ANNU REV PHYSIOL, V51, P585, DOI 10.1146/annurev.ph.51.030189.003101; WRIGHT SH, 1984, J COMP PHYSIOL, V154, P249, DOI 10.1007/BF02464404	30	126	131	3	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 7	2000	407	6800					78	80		10.1038/35024069	http://dx.doi.org/10.1038/35024069			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	350WE	10993076				2022-12-24	WOS:000089124000045
J	Kroll, TG; Sarraf, P; Pecciarini, L; Chen, CJ; Mueller, E; Spiegelman, BM; Fletcher, JA				Kroll, TG; Sarraf, P; Pecciarini, L; Chen, CJ; Mueller, E; Spiegelman, BM; Fletcher, JA			PAX8-PPAR gamma 1 fusion in oncogene human thyroid carcinoma	SCIENCE			English	Article							ACTIVATED RECEPTOR-GAMMA; ACUTE PROMYELOCYTIC LEUKEMIA; HUMAN BREAST-CANCER; PPAR-GAMMA; TRANSACTIVATION PROPERTIES; ALVEOLAR RHABDOMYOSARCOMA; TERMINAL DIFFERENTIATION; TRANSCRIPTION FACTORS; COLON-CANCER; IN-VITRO	Chromosomal translocations that encode fusion oncoproteins have been observed consistently in leukemias/lymphomas and sarcomas but not in carcinomas, the most common human cancers. Here, we report that t(2;3)(q13;p25), a translocation identified in a subset of human thyroid follicular carcinomas, results in fusion of the DNA binding domains of the thyroid transcription factor PAX8 to domains A to F of the peroxisome proliferator-activated receptor (PPAR) gamma 1. PAX8-PPAR gamma 1 mRNA and protein were detected in 5 of 8 thyroid follicular carcinomas but not in 20 follicular adenomas, 10 papillary carcinomas, or 10 multinodular hyperplasias. PAX8-PPAR gamma 1 inhibited thiazolidinedione-induced transactivation by PPAR gamma 1 in a dominant negative manner. The experiments demonstrate an oncogenic role for PPAR gamma and suggest that PAX8-PPAR gamma 1 may be useful in the diagnosis and treatment of thyroid carcinoma.	Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; Childrens Hosp, Dept Pediat Oncol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	Kroll, TG (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.		Pecciarini, Lorenza/GQI-3544-2022		NCI NIH HHS [CA75425] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K08CA075425] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALCALAY M, 1991, P NATL ACAD SCI USA, V88, P1977, DOI 10.1073/pnas.88.5.1977; Barr FG, 1998, NAT GENET, V19, P121, DOI 10.1038/475; Barr FG, 1999, CANCER RES, V59, p1711S; BONDESON L, 1989, CANCER, V64, P680, DOI 10.1002/1097-0142(19890801)64:3<680::AID-CNCR2820640319>3.0.CO;2-I; Brun RP, 1996, GENE DEV, V10, P974, DOI 10.1101/gad.10.8.974; DE H, 1990, NATURE, V347, P558; Demetri GD, 1999, P NATL ACAD SCI USA, V96, P3951, DOI 10.1073/pnas.96.7.3951; Elstner E, 1998, P NATL ACAD SCI USA, V95, P8806, DOI 10.1073/pnas.95.15.8806; Enver T, 1998, CELL, V94, P9, DOI 10.1016/S0092-8674(00)81215-5; FUSCO A, 1987, NATURE, V328, P170, DOI 10.1038/328170a0; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; GEMMILL RM, 1995, NATURE, V377, P299; GODDARD AD, 1991, SCIENCE, V254, P1371, DOI 10.1126/science.1720570; GRANT CS, 1989, SURGERY, V106, P980; Greene M. E., 1995, Gene Expression, V4, P281; HAMBERGER B, 1982, AM J MED, V73, P381, DOI 10.1016/0002-9343(82)90731-8; HEDINGER C, 1998, HISTOLOGIC TYPING TH, P2; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; JENKINS RB, 1990, CANCER-AM CANCER SOC, V66, P1213, DOI 10.1002/1097-0142(19900915)66:6<1213::AID-CNCR2820660622>3.0.CO;2-9; KOZMIK Z, 1993, MOL CELL BIOL, V13, P6024, DOI 10.1128/MCB.13.10.6024; KROLL TG, 1994, J BIOL CHEM, V269, P9270; Kubota T, 1998, CANCER RES, V58, P3344; Mansouri A, 1998, NAT GENET, V19, P87, DOI 10.1038/ng0598-87; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; Mueller E, 1998, MOL CELL, V1, P465, DOI 10.1016/S1097-2765(00)80047-7; Nothwang HG, 1998, GENOMICS, V47, P276, DOI 10.1006/geno.1997.5102; Nothwang HG, 1997, GENOMICS, V41, P370, DOI 10.1006/geno.1997.4654; NOWELL PC, 1960, SCIENCE, V132, P1497; PANDOLFI PP, 1991, ONCOGENE, V6, P1285; POLEEV A, 1992, DEVELOPMENT, V116, P611; Poleev A, 1997, EUR J BIOCHEM, V247, P860, DOI 10.1111/j.1432-1033.1997.00860.x; Rabbitts TH, 1998, NEW ENGL J MED, V338, P192, DOI 10.1056/NEJM199801153380311; Rabbitts TH, 1999, CANCER RES, V59, p1794S; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; ROQUE L, 1993, CANCER GENET CYTOGEN, V67, P1, DOI 10.1016/0165-4608(93)90036-L; ROQUE L, 1993, GENE CHROMOSOME CANC, V8, P199, DOI 10.1002/gcc.2870080311; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Rowley JD, 1998, ANNU REV GENET, V32, P495, DOI 10.1146/annurev.genet.32.1.495; Sarraf P, 1998, NAT MED, V4, P1046, DOI 10.1038/2030; Sarraf P, 1999, MOL CELL, V3, P799, DOI 10.1016/S1097-2765(01)80012-5; SHAPIRO DN, 1993, CANCER RES, V53, P5108; Sinnett D, 1998, BIOTECHNIQUES, V24, P752, DOI 10.2144/98245bm12; SOZZI G, 1992, CANCER GENET CYTOGEN, V64, P38, DOI 10.1016/0165-4608(92)90320-8; SPURR N, 1996, CYTOGENET CELL GENET, V7, P255; TEYSSIER JR, 1990, CANCER GENET CYTOGEN, V50, P249, DOI 10.1016/0165-4608(90)90184-C; Tontonoz P, 1997, P NATL ACAD SCI USA, V94, P237, DOI 10.1073/pnas.94.1.237; XIAO S, 1995, AM J PATHOL, V147, P896; [No title captured]	49	638	677	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 25	2000	289	5483					1357	1360		10.1126/science.289.5483.1357	http://dx.doi.org/10.1126/science.289.5483.1357			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347RF	10958784				2022-12-24	WOS:000088942400041
J	De La Rocha, CL; DePaolo, DJ				De La Rocha, CL; DePaolo, DJ			Isotopic evidence for variations in the marine calcium cycle over the cenozoic	SCIENCE			English	Article							ATMOSPHERIC CARBON-DIOXIDE; CHEMICAL-COMPOSITION; MIOCENE; OCEAN; SEAWATER; FRACTIONATION; CONSTRAINTS; CALIFORNIA; WATERS; RECORD	Significant variations in the isotopic composition of marine calcium have occurred over the Last 80 million years. These variations reflect deviations in the balance between inputs of calcium to the ocean from weathering and outputs due to carbonate sedimentation, processes that are important in controlling the concentration of carbon dioxide in the atmosphere and, hence, global climate. The calcium isotopic ratio of paleo-seawater is an indicator of past changes in atmospheric carbon dioxide when coupled with determinations of paleo-pH.	Univ Calif Berkeley, Dept Geol & Geophys, Berkeley Ctr Isotope Geochem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Earth Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	De La Rocha, CL (corresponding author), Univ Cambridge, Dept Earth Sci, Downing St, Cambridge CB2 3EQ, England.							Berner R.A., 2012, GLOBAL ENV WATER AIR, Vsecond; BERNER RA, 1983, AM J SCI, V283, P641, DOI 10.2475/ajs.283.7.641; Broecker WS, 1982, TRACERS SEA; Chen CH, 1996, EARTH PLANET SC LETT, V143, P125, DOI 10.1016/0012-821X(96)00122-7; COPELAND P, 1987, EARTH PLANET SC LETT, V86, P240, DOI 10.1016/0012-821X(87)90224-X; DEPAOLO DJ, 1991, GEOL SOC AM BULL, V103, P112, DOI 10.1130/0016-7606(1991)103<0112:HRSISA>2.3.CO;2; Drever JI, 1982, GEOCHEMISTRY NATURAL; Elderfield H, 1996, ANNU REV EARTH PL SC, V24, P191, DOI 10.1146/annurev.earth.24.1.191; ERSKIAN MG, 1987, J FORAMIN RES, V17, P240, DOI 10.2113/gsjfr.17.3.240; GIESKES JM, 1981, GEOCHIM COSMOCHIM AC, V45, P1687, DOI 10.1016/0016-7037(81)90004-1; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI DOI 10.1007/978-1-4615-8714-9_3; GUILLOT S, 1994, GEOLOGY, V22, P559, DOI 10.1130/0091-7613(1994)022<0559:NCOTAO>2.3.CO;2; HARRISON TM, 1992, SCIENCE, V255, P1663, DOI 10.1126/science.255.5052.1663; HODELL DA, 1994, PALEOCEANOGRAPHY, V9, P405, DOI 10.1029/94PA00292; KEMPE S, 1985, CHEM GEOL, V53, P95, DOI 10.1016/0009-2541(85)90023-3; LASAGA AC, 1985, CARBON CYCLE ATMOSPH, P397; Lipps JH., 1986, SCI NEW GUINEA, V11, P126; MARSHALL BD, 1982, GEOCHIM COSMOCHIM AC, V46, P2537, DOI 10.1016/0016-7037(82)90376-3; MEYBECK M, 1979, REV GEOL DYN GEOGR, V21, P215; Miller KG, 1987, PALEOCEANOGRAPHY, V2, P1, DOI 10.1029/PA002i001p00001; MILLIMAN JD, 1993, GLOBAL BIOGEOCHEM CY, V7, P927, DOI 10.1029/93GB02524; Opdyke BN, 1988, PALEOCEANOGRAPHY, V3, P685, DOI 10.1029/PA003i006p00685; OSLICK JS, 1994, PALEOCEANOGRAPHY, V9, P427, DOI 10.1029/94PA00249; Pagani M, 1999, SCIENCE, V285, P876, DOI 10.1126/science.285.5429.876; Pearson PN, 1999, SCIENCE, V284, P1824, DOI 10.1126/science.284.5421.1824; RAYMO ME, 1988, GEOLOGY, V16, P649, DOI 10.1130/0091-7613(1988)016<0649:IOLCMB>2.3.CO;2; RICHTER FM, 1992, EARTH PLANET SC LETT, V109, P11, DOI 10.1016/0012-821X(92)90070-C; RUSSELL WA, 1978, GEOCHIM COSMOCHIM AC, V42, P1075, DOI 10.1016/0016-7037(78)90105-9; Skulan J, 1997, GEOCHIM COSMOCHIM AC, V61, P2505, DOI 10.1016/S0016-7037(97)00047-1; Skulan J, 1999, P NATL ACAD SCI USA, V96, P13709, DOI 10.1073/pnas.96.24.13709; SONG Y, 1994, PALEOBIOLOGY, V20, P14, DOI 10.1017/S0094837300011106; SORKHABI RB, 1993, GSA TODAY, V3, P85; Spencer R.J., 1990, FLUID MINERAL INTERA, V2, P409; SPIVACK AJ, 1993, NATURE, V363, P149, DOI 10.1038/363149a0; STANLEY SM, 1998, PALAEOGEOGR PALAEOCL, V107, P243; UREY C, 1952, PLANETS THEIR ORIGIN; WILKINSON BH, 1989, AM J SCI, V289, P1158, DOI 10.2475/ajs.289.10.1158; WILKINSON BH, 1986, J GEOL, V94, P321, DOI 10.1086/629032; Zhu P, 1998, GEOCHIM COSMOCHIM AC, V62, P1691, DOI 10.1016/S0016-7037(98)00110-0	39	190	193	3	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 18	2000	289	5482					1176	1178		10.1126/science.289.5482.1176	http://dx.doi.org/10.1126/science.289.5482.1176			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346JE	10947981				2022-12-24	WOS:000088866600037
J	Karlinsey, JE; Lonner, J; Brown, KL; Hughes, KT				Karlinsey, JE; Lonner, J; Brown, KL; Hughes, KT			Translation/secretion coupling by type III secretion systems	CELL			English	Article							ANTI-SIGMA FACTOR; FLAGELLUM-SPECIFIC SIGMA; MESSENGER-RNA SIGNAL; SALMONELLA-TYPHIMURIUM; YERSINIA-ENTEROCOLITICA; TRANSCRIPTIONAL CONTROL; NEGATIVE REGULATOR; TERMINAL REGIONS; MASTER OPERON; FLGM	Type III secretion systems mediate export of virulence proteins and flagellar assembly subunits in Gram-negative bacteria. Chaperones specific to each class of secreted protein are believed to prevent degradation of the secreted substrates. We show that an additional role of chaperones may be to regulate translation of secreted proteins. We show that the chaperone FlgN is required for translation of the flgM gene transcribed from one mRNA transcript (a flagellar class 3 transcript), but not from another (a flagellar class 2 transcript). FlgM translated from the class 3 transcript is primarily secreted whereas FlgM translated from the class 2 transcript is primarily retained in the cytoplasm. These results suggest FlgM and other type III secretion substrates possess both mRNA and amino acid secretion signals, and supports a new role for type III chaperones in translation/secretion coupling.	Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Hughes, KT (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	hughes@u.washington.edu		Karlinsey, Joyce E/0000-0002-3585-8301	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056141, R01GM043149] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM56141, GM43149] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIZAWA SI, 1990, J MOL BIOL, V211, P673, DOI 10.1016/0022-2836(90)90064-S; Anderson DM, 1999, MOL MICROBIOL, V31, P1139, DOI 10.1046/j.1365-2958.1999.01254.x; Anderson DM, 1997, SCIENCE, V278, P1140, DOI 10.1126/science.278.5340.1140; Bennett JCQ, 2000, TRENDS MICROBIOL, V8, P202, DOI 10.1016/S0966-842X(00)01751-0; Bonas U, 1994, Curr Top Microbiol Immunol, V192, P79; CHADSEY MS, 1998, EMBO J, V17, P3123; Cheng LW, 2000, TRENDS MICROBIOL, V8, P214, DOI 10.1016/S0966-842X(99)01665-0; Cheng LW, 1997, MOL MICROBIOL, V24, P757, DOI 10.1046/j.1365-2958.1997.3831750.x; Chilcott GS, 1998, MOL MICROBIOL, V30, P1029, DOI 10.1046/j.1365-2958.1998.01131.x; Collmer A, 1994, Curr Top Microbiol Immunol, V192, P43; Daughdrill GW, 1997, NAT STRUCT BIOL, V4, P285, DOI 10.1038/nsb0497-285; ELLIS RJ, 1991, ANNU REV BIOCHEM, V60, P321, DOI 10.1146/annurev.bi.60.070191.001541; Fraser GM, 1999, MOL MICROBIOL, V32, P569, DOI 10.1046/j.1365-2958.1999.01372.x; FRITHZLINDSTEN E, 1995, MOL MICROBIOL, V16, P635, DOI 10.1111/j.1365-2958.1995.tb02426.x; Fu YX, 1998, J BACTERIOL, V180, P3393, DOI 10.1128/JB.180.13.3393-3399.1998; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; GILLEN KL, 1993, J BACTERIOL, V175, P7006, DOI 10.1128/jb.175.21.7006-7015.1993; GILLEN KL, 1991, J BACTERIOL, V173, P2301, DOI 10.1128/JB.173.7.2301-2310.1991; GILLEN KL, 1991, J BACTERIOL, V173, P6453, DOI 10.1128/jb.173.20.6453-6459.1991; GROISMAN EA, 1991, METHOD ENZYMOL, V204, P180; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; HUGHES KT, 1993, SCIENCE, V262, P1277, DOI 10.1126/science.8235660; HUGHES KT, 1985, GENETICS, V109, P263; Hughes KT, 1998, ANNU REV MICROBIOL, V52, P231, DOI 10.1146/annurev.micro.52.1.231; KALMAN S, 1990, J BACTERIOL, V172, P5575, DOI 10.1128/jb.172.10.5575-5585.1990; Karlinsey JE, 1998, J BACTERIOL, V180, P5384, DOI 10.1128/JB.180.20.5384-5397.1998; KARLINSEY JE, 2000, IN PRESS MOL MICROBI; Kjemtrup S, 2000, CURR OPIN MICROBIOL, V3, P73, DOI 10.1016/S1369-5274(99)00054-5; KOMEDA Y, 1986, J BACTERIOL, V168, P1315, DOI 10.1128/jb.168.3.1315-1318.1986; KUTSUKAKE K, 1990, J BACTERIOL, V172, P741, DOI 10.1128/jb.172.2.741-747.1990; KUTSUKAKE K, 1994, MOL GEN GENET, V243, P605, DOI 10.1007/BF00279569; KUTSUKAKE K, 1994, GENE, V143, P49; KUTSUKAKE K, 1994, EMBO J, V13, P4568, DOI 10.1002/j.1460-2075.1994.tb06778.x; Kutsukake K, 1997, MOL GEN GENET, V254, P440, DOI 10.1007/s004380050437; LIU XY, 1994, J BACTERIOL, V176, P7345, DOI 10.1128/JB.176.23.7345-7351.1994; Macnab R., 1996, ESCHERICHIA COLI SAL, V2nd ed, P119; Macnab RM, 1999, J BACTERIOL, V181, P7149, DOI 10.1128/JB.181.23.7149-7153.1999; Maloy S.R., 1990, EXPT TECHNIQUES BACT; MENARD R, 1994, CELL, V79, P515, DOI 10.1016/0092-8674(94)90260-7; Neyt C, 1999, MOL MICROBIOL, V31, P143, DOI 10.1046/j.1365-2958.1999.01154.x; OHNISHI K, 1992, MOL MICROBIOL, V6, P3149, DOI 10.1111/j.1365-2958.1992.tb01771.x; Sauer FG, 2000, SEMIN CELL DEV BIOL, V11, P27, DOI 10.1006/scdb.1999.0348; SCHMITT CK, 1994, J BACTERIOL, V176, P368, DOI 10.1128/JB.176.2.368-377.1994; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; Tucker SC, 2000, J BACTERIOL, V182, P2262, DOI 10.1128/JB.182.8.2262-2268.2000; VONDERVISZT F, 1991, J MOL BIOL, V221, P1461, DOI 10.1016/0022-2836(91)90946-4; VONDERVISZT F, 1992, J MOL BIOL, V226, P575, DOI 10.1016/0022-2836(92)90616-R; VONDERVISZT F, 1989, J MOL BIOL, V209, P127, DOI 10.1016/0022-2836(89)90176-9; Yanagihara S, 1999, GENES GENET SYST, V74, P105, DOI 10.1266/ggs.74.105	49	107	110	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 18	2000	102	4					487	497		10.1016/S0092-8674(00)00053-2	http://dx.doi.org/10.1016/S0092-8674(00)00053-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	347BX	10966110	Bronze			2022-12-24	WOS:000088908000010
J	Kazazian, HH				Kazazian, HH			Genetics - L1 retrotransposons shape the mammalian genome	SCIENCE			English	Editorial Material							ELEMENTS; INACTIVATION; TELOMERASE; SEQUENCE		Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA	University of Pennsylvania	Kazazian, HH (corresponding author), Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA.							Bailey JA, 2000, P NATL ACAD SCI USA, V97, P6634, DOI 10.1073/pnas.97.12.6634; Boeke JD, 1997, NAT GENET, V16, P6, DOI 10.1038/ng0597-6; DeBerardinis RJ, 1998, NAT GENET, V20, P288, DOI 10.1038/3104; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Eickbush TH, 1997, SCIENCE, V277, P911, DOI 10.1126/science.277.5328.911; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; FITCH DHA, 1991, P NATL ACAD SCI USA, V88, P7396, DOI 10.1073/pnas.88.16.7396; Goodier JL, 2000, HUM MOL GENET, V9, P653, DOI 10.1093/hmg/9.4.653; Jurka J, 1997, P NATL ACAD SCI USA, V94, P1872, DOI 10.1073/pnas.94.5.1872; Kazazian HH, 1998, NAT GENET, V19, P19, DOI 10.1038/ng0598-19; Lyon MF, 1998, CYTOGENET CELL GENET, V80, P133, DOI 10.1159/000014969; Malik HS, 1999, MOL BIOL EVOL, V16, P793, DOI 10.1093/oxfordjournals.molbev.a026164; Marahrens Y, 1999, GENE DEV, V13, P2624, DOI 10.1101/gad.13.20.2624; MOL CD, 1995, NATURE, V374, P381, DOI 10.1038/374381a0; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Pickeral OK, 2000, GENOME RES, V10, P411, DOI 10.1101/gr.10.4.411; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; *U PENN DEP GEN, RETR INS HUM GEN	19	128	129	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 18	2000	289	5482					1152	1153		10.1126/science.289.5482.1152	http://dx.doi.org/10.1126/science.289.5482.1152			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346JE	10970230				2022-12-24	WOS:000088866600027
J	Bellocchio, EE; Reimer, RJ; Fremeau, RT; Edwards, RH				Bellocchio, EE; Reimer, RJ; Fremeau, RT; Edwards, RH			Uptake of glutamate into synaptic vesicles by an inorganic phosphate transporter	SCIENCE			English	Article							GAMMA-AMINOBUTYRIC ACID; SIALIC-ACID; FUNCTIONAL RECONSTITUTION; NEUROTRANSMITTER TRANSPORTERS; CAENORHABDITIS-ELEGANS; ENERGY-DEPENDENCE; XENOPUS OOCYTES; RAT-BRAIN; EXPRESSION; COTRANSPORTER	Previous work has identified two families of proteins that transport classical neurotransmitters into synaptic vesicles, but the protein responsible for vesicular transport of the principal excitatory transmitter glutamate has remained unknown. We demonstrate that a protein that is unrelated to any known neurotransmitter transporters and that was previously suggested to mediate the Na+-dependent uptake of inorganic phosphate across the plasma membrane transports glutamate into synaptic vesicles. In addition, we show that this vesicular glutamate transporter, VGLUT1, exhibits a conductance for chloride that is blocked by glutamate.	Univ Calif San Francisco, Grad Program Neurosci, Dept Neurol, Sch Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Grad Program Neurosci, Dept Neurol, Sch Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Grad Program Cell Biol, Sch Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Grad Program Biomed Sci, Sch Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Edwards, RH (corresponding author), Univ Calif San Francisco, Grad Program Neurosci, Dept Neurol, Sch Med, 513 Parnassus Ave, San Francisco, CA 94143 USA.	edwards@itsa.usf.edu						Aihara Y, 2000, J NEUROCHEM, V74, P2622, DOI 10.1046/j.1471-4159.2000.0742622.x; AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; ANDERSON GC, 1982, RES NURS HEALTH, V5, P21, DOI 10.1002/nur.4770050105; AVERY L, 1993, GENETICS, V133, P897; Barger AJ, 1998, J NEUROSCI, V18, P2871; Bellocchio EE, 1998, J NEUROSCI, V18, P8648; Broer S, 1998, J MEMBRANE BIOL, V164, P71, DOI 10.1007/s002329900394; Busch AE, 1996, P NATL ACAD SCI USA, V93, P5347, DOI 10.1073/pnas.93.11.5347; CARLSON MD, 1989, J BIOL CHEM, V264, P7369; Chaudhry FA, 1999, CELL, V99, P769, DOI 10.1016/S0092-8674(00)81674-8; CURTHOYS NP, 1995, ANNU REV NUTR, V15, P133, DOI 10.1146/annurev.nu.15.070195.001025; Forgac M, 2000, J EXP BIOL, V203, P71; Glinn M, 1998, J NEUROCHEM, V70, P1850; GLINN M, 1995, J NEUROCHEM, V65, P2358; HAMBERGER AC, 1979, BRAIN RES, V168, P513, DOI 10.1016/0006-8993(79)90306-8; HARTINGER J, 1993, J BIOL CHEM, V268, P23122; HELL JW, 1990, J BIOL CHEM, V265, P2111; KANNER BI, 1993, FEBS LETT, V325, P95, DOI 10.1016/0014-5793(93)81421-U; KISH PE, 1989, P NATL ACAD SCI USA, V86, P3877, DOI 10.1073/pnas.86.10.3877; KNOTH J, 1981, BIOCHEMISTRY-US, V20, P6625, DOI 10.1021/bi00526a016; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; Liu YJ, 1997, ANNU REV NEUROSCI, V20, P125; MANCINI GMS, 1992, P NATL ACAD SCI USA, V89, P6609, DOI 10.1073/pnas.89.14.6609; MANCINI GMS, 1989, J BIOL CHEM, V264, P15247; MAYCOX PR, 1988, J BIOL CHEM, V263, P15423; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; MIYAMOTO KI, 1995, BIOCHEM J, V305, P81, DOI 10.1042/bj3050081; MORIYAMA Y, 1995, J BIOL CHEM, V270, P22314, DOI 10.1074/jbc.270.38.22314; NAITO S, 1983, J BIOL CHEM, V258, P696; NI BH, 1995, J NEUROSCI, V15, P5789; NI BH, 1994, P NATL ACAD SCI USA, V91, P5607, DOI 10.1073/pnas.91.12.5607; Reimer RJ, 2000, P NATL ACAD SCI USA, V97, P7715, DOI 10.1073/pnas.140152797; RENLUND M, 1986, SCIENCE, V232, P759, DOI 10.1126/science.3961501; ROSETH S, 1995, J NEUROCHEM, V65, P96; SCHULDINER S, 1995, PHYSIOL REV, V75, P369, DOI 10.1152/physrev.1995.75.2.369; Sugawara M, 2000, J BIOL CHEM, V275, P16473, DOI 10.1074/jbc.C000205200; TABB JS, 1992, J BIOL CHEM, V267, P15412; TIETZE F, 1989, J BIOL CHEM, V264, P15316; Varoqui H, 2000, J BIOL CHEM, V275, P4049, DOI 10.1074/jbc.275.6.4049; Verheijen FW, 1999, NAT GENET, V23, P462, DOI 10.1038/70585; WARD HK, 1983, J NEUROCHEM, V40, P855, DOI 10.1111/j.1471-4159.1983.tb08058.x; WERNER A, 1991, P NATL ACAD SCI USA, V88, P9608, DOI 10.1073/pnas.88.21.9608; Wolosker H, 1996, J BIOL CHEM, V271, P11726, DOI 10.1074/jbc.271.20.11726	43	611	637	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 11	2000	289	5481					957	960		10.1126/science.289.5481.957	http://dx.doi.org/10.1126/science.289.5481.957			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343KH	10938000				2022-12-24	WOS:000088701200034
J	Lam, TH; Ho, LM; Hedley, AJ; Adab, P; Fielding, R; McGhee, SM; Aharonson-Daniel, L				Lam, TH; Ho, LM; Hedley, AJ; Adab, P; Fielding, R; McGhee, SM; Aharonson-Daniel, L			Environmental tobacco smoke exposure among police officers in Hong Kong	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESPIRATORY SYMPTOMS; PASSIVE SMOKING; NONSMOKING WOMEN; LUNG-FUNCTION; ADULTS	Context Few epidemiological studies have examined the relationship between chronic respiratory symptoms and exposure to environmental tobacco smoke (ETS) at work in adults, and none have shown clear dose-response relationships. Objective To examine the respiratory effects of ETS exposure at home and at work among never-smoking adults. Design, Setting, and Participants Cross-sectional, self-administered questionnaire survey conducted in December 1995 and January 1996 among 4468 male and 728 female police officers in Hong Kong who were never-smokers. Main Outcome Measures Respiratory symptoms and physician consultation in the previous 14 days for such symptoms by presence and amount of ETS exposure at work. Results Eighty percent of both men and women reported ETS exposure at work, Significant odds ratios (ORs) for respiratory symptoms were found among men with ETS exposure at work (for any respiratory symptoms, difference in absolute rate, 20.4%; OR, 2.33; 95% confidence interval [CI], 1.97-2.75; attributable risk, 57%) and physician consultation (difference in absolute rate, 4.5%; OR, 1.30; 95% CI, 1.05-1.61; attributable risk, 23%). Trends were similar among women for any respiratory symptoms (difference in absolute rate, 15.4%; OR, 1.63; 95% CI, 1.04-2.56; attributable risk, 39%) and for physician consultation (difference In absolute rates, 2.8%; OR, 1.45; 95% CI, 0.87-2.41; attributable risk, 31%), Positive dose-response relationships with number of coworkers smoking nearby and amount of ETS exposure in the work place were found. Conclusions This study provides further evidence of the serious health hazards associated with ETS exposure at work, The findings support a ban on smoking in the workplace to protect all workers in both developed and developing countries.	Univ Hong Kong, Dept Community Med, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Behav Sci Unit, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Lam, TH (corresponding author), Univ Hong Kong, Dept Community Med, Patrick Manson Bldg S Wing,7 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China.		Hedley, Anthony/C-4305-2009; Fielding, Richard/C-4268-2009; Adab, Peymane/ABC-9651-2021; McGhee, Sarah/C-4367-2009; Aharonson-Daniel, Limor/F-1998-2012; Hedley, Anthony J/A-9113-2013; McGhee, Sarah M/A-6460-2013; Lam, Tai Hing/C-4317-2009	Adab, Peymane/0000-0001-9087-3945; Aharonson-Daniel, Limor/0000-0003-4585-6892; McGhee, Sarah M/0000-0003-1025-5915; ho, lm/0000-0002-2709-927X; Lam, Tai Hing/0000-0002-2033-9971				*CENS STAT DEP, 1991, 7 CENS STAT DEP; *CENS STAT DEP, 1996, 15 CENS STAT DEP; CUMMINGS KM, 1990, ARCH ENVIRON HEALTH, V45, P74, DOI 10.1080/00039896.1990.9935929; Davis RM, 1998, JAMA-J AM MED ASSOC, V280, P1947, DOI 10.1001/jama.280.22.1947; *DEP HLTH, 2000, REP SCI COMM TOB HLT; EISNER MD, 1998, JAMA-J AM MED ASSOC, V280, P1947; FLOREY CD, 1982, WHO EUROPEAN SERIES, V12; HO SY, 1998, AS PAC 5 C TOB HLTH; HOLE DJ, 1989, BRIT MED J, V299, P423, DOI 10.1136/bmj.299.6696.423; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; Jaakkola MS, 1996, J CLIN EPIDEMIOL, V49, P581, DOI 10.1016/0895-4356(96)00004-2; KAUFFMANN F, 1989, INT J EPIDEMIOL, V18, P334, DOI 10.1093/ije/18.2.334; LEUENBERGER P, 1994, AM J RESP CRIT CARE, V150, P1222, DOI 10.1164/ajrccm.150.5.7952544; *NCI, 2000, US DEP HHS PHS SMOK, V10; NG TP, 1993, J EPIDEMIOL COMMUN H, V47, P454, DOI 10.1136/jech.47.6.454; *OCC SAF HLTH ADM, 1999, OCC SAF HLTH ADM US, V59; *OFF TOB RED PROGR, 2000, RESTR WORKPL SMOK; [Office of Research and Development Office of Health Environmental Assessment United States Environmental Protection Agency], 1992, RESP HLTH EFF PASS S; PATRICK DL, 1994, AM J PUBLIC HEALTH, V84, P1086, DOI 10.2105/AJPH.84.7.1086; POPE CA, 1993, ENVIRON HEALTH PERSP, V101, P314, DOI 10.2307/3431441; RIBOLI E, 1990, CANCER CAUSE CONTROL, V1, P243, DOI 10.1007/BF00117476; SCHWARTZ J, 1990, AM REV RESPIR DIS, V141, P62, DOI 10.1164/ajrccm/141.1.62; *STATA CORP, 1996, STATA STAT SOFTW COM; TREDANIEL J, 1994, EUR RESPIR J, V7, P173, DOI 10.1183/09031936.94.07010173; WHITE JR, 1991, CHEST, V100, P39, DOI 10.1378/chest.100.1.39; YANG GH, 1998, SMOKING HLTH CHINA 1, P44	26	31	31	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2000	284	6					756	763		10.1001/jama.284.6.756	http://dx.doi.org/10.1001/jama.284.6.756			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341JM	10927788				2022-12-24	WOS:000088587300038
J	Zhou, JQ; Monson, EK; Teng, SC; Schulz, VP; Zakian, VA				Zhou, JQ; Monson, EK; Teng, SC; Schulz, VP; Zakian, VA			Pif1p helicase, a catalytic inhibitor of telomerase in yeast	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; DNA HELICASE; S-PHASE; ELONGATION	Mutations in the yeast Saccharomyces cerevisiae PIF1 gene, which encodes a 5'-to-3/ DNA helicase, cause telomere Lengthening and a Large increase in the formation rate of new telomeres. Here, we show that Pif1p acts by inhibiting telomerase rather than telomere-telomere recombination, and this inhibition requires the helicase activity of Pif1p, Overexpression of enzymatically active Pif1p causes telomere shortening. Thus, Pif1p is a catalytic inhibitor of telomerase-mediated telomere Lengthening, Because Pif1p is associated with telomeric DNA in vivo, its effects on telomeres are Likely direct. Pif1p-like helicases are found in diverse organisms, including humans. We propose that Pif1p-mediated inhibition of telomerase promotes genetic stability by suppressing telomerase-mediated healing of double-strand breaks.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Zakian, VA (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.			Schulz, Vincent/0000-0001-6333-4284; TENG, SHU-CHUN/0000-0002-6492-2560	NIGMS NIH HHS [GM26938] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026938, R01GM026938] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Chakraverty RK, 1999, BIOESSAYS, V21, P286; CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; HARTWELL LH, 1985, GENETICS, V110, P381; Ivessa AS, 2000, CELL, V100, P479, DOI 10.1016/S0092-8674(00)80683-2; KRAMER KM, 1993, GENE DEV, V7, P2345, DOI 10.1101/gad.7.12a.2345; LAHAYE A, 1991, EMBO J, V10, P997, DOI 10.1002/j.1460-2075.1991.tb08034.x; LIN JJ, 1995, CELL, V81, P1127, DOI 10.1016/S0092-8674(05)80017-0; Martin AD, 2000, MOL CELL BIOL, V20, P786, DOI 10.1128/MCB.20.3.786-796.2000; Nugent CI, 1998, GENE DEV, V12, P1073, DOI 10.1101/gad.12.8.1073; RUNGE KW, 1989, MOL CELL BIOL, V9, P1488, DOI 10.1128/MCB.9.4.1488; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; Shiratori A, 1999, YEAST, V15, P219, DOI 10.1002/(SICI)1097-0061(199902)15:3<219::AID-YEA349>3.0.CO;2-3; SIKORSKI RS, 1989, GENETICS, V122, P19; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Teng SC, 1999, MOL CELL BIOL, V19, P8083; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WELLINGER RJ, 1993, MOL CELL BIOL, V13, P4057, DOI 10.1128/MCB.13.7.4057; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V; ZAHLER AM, 1991, NATURE, V350, P718, DOI 10.1038/350718a0; Zhou J.-S., UNPUB	24	191	198	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 4	2000	289	5480					771	774		10.1126/science.289.5480.771	http://dx.doi.org/10.1126/science.289.5480.771			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	341FZ	10926538				2022-12-24	WOS:000088581500039
J	Bittner, M; Meitzer, P; Chen, Y; Jiang, Y; Seftor, E; Hendrix, M; Radmacher, M; Simon, R; Yakhini, Z; Ben-Dor, A; Sampas, N; Dougherty, E; Wang, E; Marincola, F; Gooden, C; Lueders, J; Glatfelter, A; Pollock, P; Carpten, J; Gillanders, E; Leja, D; Dietrich, K; Beaudry, C; Berens, M; Alberts, D; Sondak, V; Hayward, N; Trent, J				Bittner, M; Meitzer, P; Chen, Y; Jiang, Y; Seftor, E; Hendrix, M; Radmacher, M; Simon, R; Yakhini, Z; Ben-Dor, A; Sampas, N; Dougherty, E; Wang, E; Marincola, F; Gooden, C; Lueders, J; Glatfelter, A; Pollock, P; Carpten, J; Gillanders, E; Leja, D; Dietrich, K; Beaudry, C; Berens, M; Alberts, D; Sondak, V; Hayward, N; Trent, J			Molecular classification of cutaneous malignant melanoma by gene expression profiling	NATURE			English	Article							EXTRACELLULAR-MATRIX; CDNA MICROARRAYS; CELL-ADHESION; IN-VITRO; MIGRATION; PATTERNS; MOTILITY; INTEGRIN; CANCER; ASSAY	The most common human cancers are malignant neoplasms of the skin(1,2). Incidence of cutaneous melanoma is rising especially steeply, with minimal progress in non-surgical treatment of advanced disease(3,4). Despite significant effort to identify independent predictors of melanoma outcome, no accepted histopathological, molecular or immunohistochemical marker defines subsets of this neoplasm(2,3). Accordingly, though melanoma is thought to present with different 'taxonomic' forms, these are considered part of a continuous spectrum rather than discrete entities(2). Here we report the discovery of a subset of melanomas identified by mathematical analysis of gene expression in a series of samples. Remarkably, many genes underlying the classification of this subset are differentially regulated in invasive melanomas that form primitive tubular networks in vitro, a feature of some highly aggressive metastatic melanomas(5). Global transcript analysis can identify unrecognized subtypes of cutaneous melanoma and predict experimentally verifiable phenotypic characteristics that may be of importance to disease progression.	Natl Human Genome Res Inst, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; Univ Iowa, Ctr Canc, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; NCI, DCTDC, NIH, Bethesda, MD 20852 USA; Agilent Labs, Chem & Biol Syst Dept, Palo Alto, CA 94304 USA; Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98105 USA; Texas A&M Univ, Dept Elect Engn, College Stn, TX 77843 USA; NCI, Surg Branch, NIH, Bethesda, MD 20850 USA; Queensland Inst Med Res, Herston, Qld 4029, Australia; Barrow Neurol Inst, Neurooncol Lab, Phoenix, AZ 85013 USA; Univ Arizona, Arizona Canc Ctr, Tucson, AZ 85724 USA; Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Iowa; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Agilent Technologies; University of Washington; University of Washington Seattle; Texas A&M University System; Texas A&M University College Station; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); QIMR Berghofer Medical Research Institute; Barrow Neurological Institute; Arizona Center Cancer Care; University of Arizona; University of Michigan System; University of Michigan	Bittner, M (corresponding author), Natl Human Genome Res Inst, Canc Genet Branch, NIH, Bethesda, MD 20892 USA.	mbittner@nhgri.nih.gov; jtrent@nih.gov	hayward, nicholas k/C-1367-2015; hayward, nick/AAV-8802-2020	hayward, nicholas k/0000-0003-4760-1033; Pollock, Pamela/0000-0001-8420-1026; Yakhini, Zohar/0000-0002-0420-5412				Adams JC, 1997, MOL BIOL CELL, V8, P2345, DOI 10.1091/mbc.8.11.2345; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Ben-Dor A, 1999, J COMPUT BIOL, V6, P281, DOI 10.1089/106652799318274; BERENS ME, 1994, CLIN EXP METASTAS, V12, P405, DOI 10.1007/BF01755884; Bittner M, 1999, NAT GENET, V22, P213, DOI 10.1038/10265; Byers HR, 1998, HEMATOL ONCOL CLIN N, V12, P717, DOI 10.1016/S0889-8588(05)70020-4; DeRisi J, 1996, NAT GENET, V14, P457; Duggan DJ, 1999, NAT GENET, V21, P10, DOI 10.1038/4434; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; EVERITT BS, 1992, APPL MULTIVARIATE AN; Giese A, 1996, J CELL SCI, V109, P2161; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hall HI, 1999, J AM ACAD DERMATOL, V40, P35, DOI 10.1016/S0190-9622(99)70562-1; Helige C, 1997, INVAS METAST, V17, P26; HENDRIX MJC, 1987, CANCER LETT, V38, P137, DOI 10.1016/0304-3835(87)90209-6; Hendrix MJC, 1996, CANCER METAST REV, V15, P507, DOI 10.1007/BF00054016; HIEKEN TJ, 1995, SURGERY, V118, P669, DOI 10.1016/S0039-6060(05)80034-0; Janji B, 1999, INT J CANCER, V83, P255, DOI 10.1002/(SICI)1097-0215(19991008)83:2<255::AID-IJC18>3.3.CO;2-O; Khan J, 1998, CANCER RES, V58, P5009; Khan J, 1999, BIOCHIM BIOPHYS ACTA, V1423, P17; Maniotis AJ, 1999, AM J PATHOL, V155, P739, DOI 10.1016/S0002-9440(10)65173-5; Maung K, 1999, ONCOGENE, V18, P6824, DOI 10.1038/sj.onc.1203094; McMasters KM, 1999, ANN SURG ONCOL, V6, P467, DOI 10.1007/s10434-999-0467-8; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; SCOTT G, 1995, EXP CELL RES, V219, P197, DOI 10.1006/excr.1995.1219; Silletti S, 1998, INT J CANCER, V76, P120, DOI 10.1002/(SICI)1097-0215(19980330)76:1<120::AID-IJC19>3.3.CO;2-G; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Van Belle PA, 1999, HUM PATHOL, V30, P562, DOI 10.1016/S0046-8177(99)90202-2; Weyers W, 1999, CANCER-AM CANCER SOC, V86, P288, DOI 10.1002/(SICI)1097-0142(19990715)86:2<288::AID-CNCR13>3.0.CO;2-S; Woods A, 2000, ARCH BIOCHEM BIOPHYS, V374, P66, DOI 10.1006/abbi.1999.1607	30	1540	1664	1	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2000	406	6795					536	540		10.1038/35020115	http://dx.doi.org/10.1038/35020115			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952317	Green Published			2022-12-24	WOS:000088538000051
J	Yau, ST; Vekilov, PG				Yau, ST; Vekilov, PG			Quasi-planar nucleus structure in apoferritin crystallization	NATURE			English	Article							ATOMIC-FORCE-MICROSCOPY; MACROMOLECULAR SYSTEMS; CRYSTAL NUCLEATION; LIGHT-SCATTERING; HUMAN-H; PROTEIN; GROWTH; WORK; SIZE	First-order phase transitions of matter, such as condensation and crystallization, proceed through the formation and subsequent growth of 'critical nuclei' of the new phase. The thermodynamics and kinetics of the formation of these critical nuclei depend on their structure, which is often assumed to be a compact, three-dimensional arrangement of the constituent molecules or atoms(5,6). Recent molecular dynamics simulations have predicted compact nucleus structures for matter made up of building blocks with a spherical interaction field(7,8), whereas strongly anisotropic, dipolar molecules may form nuclei consisting of single chains of molecules(9). Here we show, using direct atomic force microscopy observations, that the near-critical-size clusters formed during the crystallization of apoferritin, a quasi-spherical protein, and which are representative of the critical nucleus of this system, consist of planar arrays of one or two monomolecular layers that contain 5-10 rods of up to 7 molecules each. We rnd that these clusters contain between 20 and 50 molecules each, and that the arrangement of the constituent molecules is identical to that found in apoferritin crystals. We anticipate that similarly unexpected critical nucleus structures may be quite common, particularly with anisotropic molecules, suggesting that advanced nucleation theories should treat the critical nucleus structure as a variable.	Univ Alabama, Ctr Micrograv & Mat Res, Huntsville, AL 35899 USA; Univ Alabama, Dept Chem, Huntsville, AL 35899 USA	University of Alabama System; University of Alabama Huntsville; University of Alabama System; University of Alabama Huntsville	Vekilov, PG (corresponding author), Univ Alabama, Ctr Micrograv & Mat Res, Huntsville, AL 35899 USA.							Atkins P., 1998, PHYS CHEM, P834; Chernov A.A., 1984, MODERN CRYSTALLOGRAP; Galkin O, 2000, J AM CHEM SOC, V122, P156, DOI 10.1021/ja9930869; Galkin O, 1999, J PHYS CHEM B, V103, P10965, DOI 10.1021/jp992786x; Galkin O, 2000, P NATL ACAD SCI USA, V97, P6277, DOI 10.1073/pnas.110000497; Georgalis Y, 1997, ACTA CRYSTALLOGR D, V53, P691, DOI 10.1107/S0907444997006847; Gibbs J. W., 1961, COLLECTED WORKS JW G; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Hempstead PD, 1997, J MOL BIOL, V268, P424, DOI 10.1006/jmbi.1997.0970; Hill T.L., 1963, THERMODYNAMICS SMALL; KAISCHEW R, 1937, Z PHYS CHEM B LPZ, V35, P427; KASHCHIEV D, 1982, J CHEM PHYS, V76, P5098, DOI 10.1063/1.442808; Kuznetsov YG, 1998, PHYS REV B, V58, P6097, DOI 10.1103/PhysRevB.58.6097; LAWSON DM, 1991, NATURE, V349, P541, DOI 10.1038/349541a0; LIN H, 1995, J CRYST GROWTH, V151, P153, DOI 10.1016/0022-0248(95)00016-X; MALKIN A, 1994, ACTA CRYSTALLOGR D, V50, P385, DOI 10.1107/S0907444993013319; Malkin AJ, 1996, PROTEINS, V24, P247, DOI 10.1002/(SICI)1097-0134(199602)24:2<247::AID-PROT11>3.3.CO;2-C; Malkin AJ, 1996, J STRUCT BIOL, V117, P124, DOI 10.1006/jsbi.1996.0077; MALKIN AJ, 1995, PHYS REV LETT, V75, P2778, DOI 10.1103/PhysRevLett.75.2778; MILCHEV A, 1991, CONTEMP PHYS, V32, P321, DOI 10.1080/00107519108223705; MUTAFTSCHIEV B, 1993, HDB CRYSTAL GROWTH, P189; OXTOBY DW, 1994, J CHEM PHYS, V100, P7665, DOI 10.1063/1.466859; Oxtoby DW, 1998, ACCOUNTS CHEM RES, V31, P91, DOI 10.1021/ar9702278; Petsev DN, 2000, BIOPHYS J, V78, P2060, DOI 10.1016/S0006-3495(00)76753-1; Petsev DN, 2000, PHYS REV LETT, V84, P1339, DOI 10.1103/PhysRevLett.84.1339; Stranski IN, 1934, Z PHYS CHEM B-CHEM E, V26, P100; Talanquer V, 1998, J CHEM PHYS, V109, P223, DOI 10.1063/1.476554; ten Wolde PR, 1998, PHYS REV LETT, V81, P3695, DOI 10.1103/PhysRevLett.81.3695; tenWolde PR, 1997, SCIENCE, V277, P1975, DOI 10.1126/science.277.5334.1975; THOMAS BR, 1997, J CRYST GROWTH, V187, P499; UZNETSOV YG, 1999, J CRYST GROWTH, V196, P489; Vekilov PG, 1996, ACTA CRYSTALLOGR D, V52, P785, DOI 10.1107/S0907444996003265; Volmer M, 1939, KINETIK PHASENBILDUN; Yau ST, 2000, PHYS REV LETT, V85, P353, DOI 10.1103/PhysRevLett.85.353	34	215	219	3	69	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 3	2000	406	6795					494	497		10.1038/35020035	http://dx.doi.org/10.1038/35020035			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952306				2022-12-24	WOS:000088538000040
J	Wittenburg, N; Eimer, S; Lakowski, B; Rohrig, S; Rudolph, C; Baumeister, R				Wittenburg, N; Eimer, S; Lakowski, B; Rohrig, S; Rudolph, C; Baumeister, R			Presenilin is required for proper morphology and function of neurons in C-elegans	NATURE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; LIM HOMEOBOX GENE; ALZHEIMERS-DISEASE; SENSORY NEURONS; NERVOUS-SYSTEM; NOTCH; EXPRESSION; PATHWAY; LOCALIZATION; THERMOTAXIS	Mutations in the human presenilin genes cause the most frequent and aggressive forms of familial Alzheimer's disease (FAD)(1). Here we show that in addition to its role in cell fate decisions in nonneuronal tissues(2-4), presenilin activity is required in terminally differentiated neurons in vivo. Mutations in the Caenorhabditis elegans presenilin genes sel-12 and hop-1 result in a defect in the temperature memory of the animals. This defect is caused by the loss of presenilin function in two cholinergic interneurons that display neurite morphology defects in presenilin mutants. The morphology and function of the affected neurons in sel-12 mutant animals can be restored by expressing sel-12 only in these cells. The wild-type human presenilin PS1, but not the FAD mutant PS1 A246E, can also rescue these morphological defects. As lin-12 mutant animals display similar morphological and functional defects to presenilin mutants, we suggest that presenilins mediate their activity in postmitotic neurons by facilitating Notch signalling. These data indicate cell-autonomous and evolutionarily conserved control of neural morphology and function by presenilins.	Univ Munich, Genzentrum, D-81377 Munich, Germany; EleGene Gmbh, D-82152 Martinsried, Germany	University of Munich	Baumeister, R (corresponding author), Univ Munich, Genzentrum, Feodor Lynen Str 25, D-81377 Munich, Germany.	bmeister@lmb.uni-muenchen.de						Baumeister R, 1997, Genes Funct, V1, P149; Berezovska O, 1999, MOL BRAIN RES, V69, P273, DOI 10.1016/S0169-328X(99)00119-9; Berezovska O, 1999, NEUROSCIENCE, V93, P433, DOI 10.1016/S0306-4522(99)00157-8; BRENNER S, 1974, GENETICS, V77, P71; Cook DG, 1996, P NATL ACAD SCI USA, V93, P9223, DOI 10.1073/pnas.93.17.9223; Franklin JL, 1999, CURR BIOL, V9, P1448, DOI 10.1016/S0960-9822(00)80114-1; GINIGER E, 1993, DEVELOPMENT, V117, P431; Haass C, 1999, SCIENCE, V286, P916, DOI 10.1126/science.286.5441.916; HEDGECOCK EM, 1985, DEV BIOL, V111, P158, DOI 10.1016/0012-1606(85)90443-9; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Hobert O, 1997, NEURON, V19, P345, DOI 10.1016/S0896-6273(00)80944-7; Hobert O, 1998, J NEUROSCI, V18, P2084; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; Kovacs DM, 1996, NAT MED, V2, P224, DOI 10.1038/nm0296-224; Lee MK, 1996, J NEUROSCI, V16, P7513, DOI 10.1523/jneurosci.16-23-07513.1996; Lee RYN, 1997, EMBO J, V16, P6066, DOI 10.1093/emboj/16.20.6066; Levitan D, 1996, P NATL ACAD SCI USA, V93, P14940, DOI 10.1073/pnas.93.25.14940; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; MADURO M, 1995, GENETICS, V141, P977; Mayford M, 1999, TRENDS GENET, V15, P463, DOI 10.1016/S0168-9525(99)01846-6; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Peckol EL, 1999, DEVELOPMENT, V126, P1891; Pedersen WA, 1997, J BIOL CHEM, V272, P22397, DOI 10.1074/jbc.272.36.22397; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Westlund B, 1999, P NATL ACAD SCI USA, V96, P2497, DOI 10.1073/pnas.96.5.2497; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384	30	79	89	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2000	406	6793					306	309		10.1038/35018575	http://dx.doi.org/10.1038/35018575			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917532				2022-12-24	WOS:000088251900050
J	Engler, HS; Spencer, KC; Gilbert, LE				Engler, HS; Spencer, KC; Gilbert, LE			Insect metabolism - Preventing cyanide release from leaves	NATURE			English	Article							LEPIDOPTERA; GLUCOSIDES; PLANTS		Univ Texas, Sch Biol Sci, Sect Integrat Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Engler, HS (corresponding author), Univ Texas, Sch Biol Sci, Sect Integrat Biol, Austin, TX 78712 USA.							ADSERSEN A, 1993, PHYTOCHEMISTRY, V33, P365, DOI 10.1016/0031-9422(93)85519-W; CHAMBERLAIN P, 1981, CYANIDE BIOL, P184; CONN EE, 1981, CYANIDE BIOL, P335; GILBERT LE, 1982, SCI AM, V247, P110, DOI 10.1038/scientificamerican0882-110; JAROSZEWSKI JW, 1987, TETRAHEDRON, V43, P2349, DOI 10.1016/S0040-4020(01)86821-6; Jones DA, 1998, PHYTOCHEMISTRY, V47, P155, DOI 10.1016/S0031-9422(97)00425-1; NAHRSTEDT A, 1983, COMP BIOCHEM PHYS B, V75, P65, DOI 10.1016/0305-0491(83)90041-X; RAUBENHEIMER D, 1989, J CHEM ECOL, V15, P2177, DOI 10.1007/BF01014108; Seigler D., 1993, METHODS PLANT BIOCH, VVolume 8, P51; Spencer K.C., 1988, P167	10	81	83	0	37	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 13	2000	406	6792					144	145		10.1038/35018159	http://dx.doi.org/10.1038/35018159			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910343				2022-12-24	WOS:000088221100033
J	Martling, AL; Holm, T; Rutqvist, LE; Moran, BJ; Heald, RJ; Cedermark, B				Martling, AL; Holm, T; Rutqvist, LE; Moran, BJ; Heald, RJ; Cedermark, B		Stockholm Colorectal Canc Study Gr; Basingstoke Bowel Canc Res Project	Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm	LANCET			English	Article							PROSPECTIVE RANDOMIZED TRIAL; TOTAL MESORECTAL EXCISION; PREOPERATIVE RADIOTHERAPY; ANTERIOR RESECTION; LOCAL RECURRENCE; CARCINOMA; EXPERIENCE; SURGERY	Background The Stockholm I and II randomised trials demonstrated the value of preoperative radiotherapy in preventing local recurrence in rectal cancer. This study investigated the potential for further improvement by introduction of the concept of total mesorectal excision (TME) to surgeons in Stockholm, Sweden. Methods Workshops started in 1994 and included 11 television-based demonstrations and two histopathology sessions. The study population consisted of all patients who underwent abdominal operations for rectal cancer in Stockholm County during 1995-96 (TME project; n=447). Outcomes at 2 years were compared with those from the Stockholm I (n=790) and 11 (n=542) trials as historical controls. Findings For patients with curative abdominal resections, there were no differences between the Stockholm 1 (n=686), Stockholm II (n=481), and TME project (n=381) groups in 30-day mortality (30 [4%], six [1%], and 12 [3%]), anastomotic leakage (27 [10%], 18 [9%], and 23 [9%]), or all complications (204 [30%], 169 [35%], and 134 [35%]). This similarity was achieved despite a decrease in the proportion of abdominoperineal procedures from 55-60% to 27%. Local recurrence occurred in significantly fewer of the TME group than of the Stockholm I and II groups (21 [6%] vs 103 [15%] and 66 [14%], p<0.001) as did cancer-related death (35 [9%] vs 104 [15%] and 77 [16%], p<0.002). Interpretation A surgical teaching initiative had a major effect on cancer outcomes. The proportion of abdominoperineal procedures and the local recurrence rate decreased by more than 50% and there is already evidence of a decline in rectal-cancer mortality.	Karolinska Hosp, Dept Surg, SE-17176 Stockholm, Sweden; N Hampshire Hosp NHS Trust, Colorectal Res Unit, Basingstoke, Hants, England	Karolinska Institutet; Karolinska University Hospital	Holm, T (corresponding author), Karolinska Hosp, Dept Surg, SE-17176 Stockholm, Sweden.			Martling, Anna/0000-0001-5998-4735				[Anonymous], 1990, Cancer, V66, P49; [Anonymous], 1987, AM J CLIN ONCOL-CANC, V10, P369; BOULISWASSIF S, 1984, CANCER-AM CANCER SOC, V53, P1811, DOI 10.1002/1097-0142(19840501)53:9<1811::AID-CNCR2820530902>3.0.CO;2-H; Cedermark B, 1996, ANN SURG ONCOL, V3, P423; CEDERMARK B, 1995, CANCER-AM CANCER SOC, V75, P2269, DOI 10.1002/1097-0142(19950501)75:9<2269::AID-CNCR2820750913>3.0.CO;2-I; Dahlberg M, 1999, ANN SURG, V229, P493, DOI 10.1097/00000658-199904000-00007; DIXON AR, 1991, BRIT J SURG, V78, P308, DOI 10.1002/bjs.1800780314; HEALD RJ, 1986, LANCET, V1, P1479; Heald RJ, 1998, ARCH SURG-CHICAGO, V133, P894, DOI 10.1001/archsurg.133.8.894; HOLM T, 1995, BRIT J SURG, V82, P1213, DOI 10.1002/bjs.1800820920; Kapiteijn E, 1999, EUR J SURG, V165, P410, DOI 10.1080/110241599750006613; KARANJIA ND, 1991, BRIT J SURG, V78, P196, DOI 10.1002/bjs.1800780221; KARANJIA ND, 1992, BRIT J SURG, V79, P114, DOI 10.1002/bjs.1800790206; MACFARLANE JK, 1993, LANCET, V341, P457, DOI 10.1016/0140-6736(93)90207-W; Pahlman L, 1996, EUR J SURG, V162, P397; PAHLMAN L, 1990, ANN SURG, V211, P187, DOI 10.1097/00000658-199002000-00011; Pahlman L, 1997, NEW ENGL J MED, V336, P980; PAHLMAN L, 1984, ACTA CHIR SCAND, V150, P331; PHILLIPS RKS, 1984, BRIT J SURG, V71, P17, DOI 10.1002/bjs.1800710105; QUIRKE P, 1986, LANCET, V2, P996, DOI 10.1016/s0140-6736(86)92612-7; Quirke P, 1992, SURG ONCOL CLIN N AM, V3, P1	21	596	624	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 8	2000	356	9224					93	96		10.1016/S0140-6736(00)02469-7	http://dx.doi.org/10.1016/S0140-6736(00)02469-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	331UG	10963244				2022-12-24	WOS:000088036600008
J	Harris, DJ; Douglas, PS				Harris, DJ; Douglas, PS			Enrollment of women in cardiovascular clinical trials funded by the national heart, lung, and blood institute.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DISEASE; HEALTH; CARE	Background: With the recognition that certain aspects of cardiovascular disease are specific to sex, the U.S. government has sought to ensure that federally funded clinical research yields adequate high-quality information about heart disease in women. Methods: We tabulated the numbers of men and women in cardiovascular clinical trials funded by the National Heart, Lung, and Blood Institute (NHLBI) between 1965 and 1998, recording both total numbers and the numbers for each type of cardiovascular disease. We analyzed the data according to the sex-specific prevalence of disease and assessed changes in enrollment over time. We performed a similar analysis after excluding all single-sex trials. Results: A total of 398,801 subjects (215,796 women and 183,005 men) were enrolled in NHLBI-funded studies of cardiovascular disease. The overall enrollment rate for women (54 percent) exceeded the prevalence of cardiovascular disease in women in the general population (49 percent) and increased over time (P=0.002). With single-sex trials excluded, the enrollment rate for women was 38 percent, which did not change significantly over time. In studies of coronary artery disease and hypertension the rates of enrollment of women were similar to or exceeded the prevalence of these disorders in women. The enrollment rate increased significantly over time in studies of coronary artery disease (P<0.001) but not in studies of hypertension or arrhythmia. Women were underenrolled in studies of heart failure, and the rate of enrollment did not change significantly over time. When single-sex trials were excluded from the analysis of enrollment rates according to the prevalence of disease, the results were similar. There was no change in enrollment rates over time for any category of disease. Conclusions: Federal efforts to increase the representation of women in clinical trials have been moderately successful primarily because of the institution of a small number of large, single-sex trials involving coronary artery disease. There has been no change in the sex composition of cohorts in the majority of studies of cardiovascular disease. (N Engl J Med 2000;343:475-80.) (C)2000, Massachusetts Medical Society.	Univ Wisconsin, Sch Med, Sect Cardiovasc Med, Madison, WI 53792 USA; Yale Coll, New Haven, CT USA	University of Wisconsin System; University of Wisconsin Madison; Yale University	Douglas, PS (corresponding author), Univ Wisconsin, Sch Med, Sect Cardiovasc Med, 600 Highland Ave, Madison, WI 53792 USA.			Douglas, Pamela/0000-0001-9876-4049				ANGELL M, 1993, NEW ENGL J MED, V329, P271, DOI 10.1056/NEJM199307223290409; DOUGLAS PS, 1986, CIRCULATION, V74, P917, DOI 10.1161/01.CIR.74.5.917; Helmuth L, 2000, SCIENCE, V288, P1562, DOI 10.1126/science.288.5471.1562; MASON JO, 1992, JAMA-J AM MED ASSOC, V267, P482; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; Mosca L, 1997, CIRCULATION, V96, P2468; National Institutes of Health, 1994, FED REGISTER, V59, P11146; *NIH, 1987, NIH GUID GRANTS CONT, V16; *NIH, 1990, NIH GUID GRANTS CONT, V19; Roger VL, 1999, MAYO CLIN PROC, V74, P651, DOI 10.4065/74.7.651; *TASK FORC WOM HLT, 1985, DHHS PUBL PHS; Taylor Carol, 1994, J Womens Health, V3, P143, DOI 10.1089/jwh.1994.3.143	12	194	197	2	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 17	2000	343	7					475	480		10.1056/NEJM200008173430706	http://dx.doi.org/10.1056/NEJM200008173430706			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344FC	10944565				2022-12-24	WOS:000088747700006
J	Samuelson, JC; Chen, MY; Jiang, FL; Moller, I; Wiedmann, M; Kuhn, A; Phillips, GJ; Dalbey, RE				Samuelson, JC; Chen, MY; Jiang, FL; Moller, I; Wiedmann, M; Kuhn, A; Phillips, GJ; Dalbey, RE			YidC mediates membrane protein insertion in bacteria	NATURE			English	Article							SIGNAL RECOGNITION PARTICLE; ESCHERICHIA-COLI; ENDOPLASMIC-RETICULUM; TARGETING PATHWAY; NUCLEAR GENE; MITOCHONDRIA; TRANSLOCATION; EXPORT; BIOGENESIS; MACHINERY	The basic machinery for the translocation of proteins into or across membranes is remarkably conserved from Escherichia coli to humans. In eukaryotes, proteins are inserted into the endoplasmic reticulum using the signal recognition particle (SRP) and the SRP receptor, as well as the integral membrane Sec61 trimeric complex (composed of alpha, beta and gamma subunits)(1). In bacteria, most proteins are inserted by a related pathway that includes the SRP homologue Ffh(2-5), the SRP receptor FtsY(6,7), and the SecYEG trimeric complex(8), where Y and E are related to the Sec61 alpha and gamma subunits, respectively. Proteins in bacteria that exhibit no dependence on the Sec translocase were previously thought to insert into the membrane directly without the aid of a protein machinery(9,10). Here we show that membrane insertion of two Sec-independent proteins requires YidC. YidC is essential for E. coli viability and homologues are present in mitochondria and chloroplasts. Depletion of YidC also interferes with insertion of Sec-dependent membrane proteins, but it has only a minor effect on the export of secretory proteins. These results provide evidence for an additional component of the translocation machinery that is specialized for the integration of membrane proteins.	Ohio State Univ, Dept Chem, Columbus, OH 43210 USA; Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA; Univ Hohenheim, Inst Microbiol & Mol Biol, D-70599 Stuttgart, Germany; Iowa State Univ, Dept Microbiol, Ames, IA 50011 USA	University System of Ohio; Ohio State University; Memorial Sloan Kettering Cancer Center; University Hohenheim; Iowa State University	Dalbey, RE (corresponding author), Ohio State Univ, Dept Chem, 120 W 18th Ave, Columbus, OH 43210 USA.	dalbey@chemistry.ohio-state.edu						BERNSTEIN HD, 1993, P NATL ACAD SCI USA, V90, P5229, DOI 10.1073/pnas.90.11.5229; BONNEFOY N, 1994, J MOL BIOL, V239, P201, DOI 10.1006/jmbi.1994.1363; Brunner J, 1996, TRENDS CELL BIOL, V6, P154, DOI 10.1016/0962-8924(96)40001-0; Cload ST, 1996, CHEM BIOL, V3, P1033, DOI 10.1016/S1074-5521(96)90169-6; Cristobal S, 1999, J BIOL CHEM, V274, P20068, DOI 10.1074/jbc.274.29.20068; de Gier JWL, 1998, P NATL ACAD SCI USA, V95, P14646, DOI 10.1073/pnas.95.25.14646; deGier JWL, 1996, FEBS LETT, V399, P307, DOI 10.1016/S0014-5793(96)01354-3; Do H, 1996, CELL, V85, P369, DOI 10.1016/S0092-8674(00)81115-0; GELLER BL, 1985, J BIOL CHEM, V260, P3281; GILMORE R, 1991, METHOD CELL BIOL, V34, P223; Glick BS, 1996, PROTEIN SCI, V5, P2651, DOI 10.1002/pro.5560051229; GOLD LM, 1971, METHOD ENZYMOL, V20, P537; GORLICH D, 1992, NATURE, V357, P47, DOI 10.1038/357047a0; Graf R, 1998, CELL BIOLOGY - A LABOARATORY HANDBOOK, 2ND EDITION, VOL 4, P495; HAMILTON CM, 1989, J BACTERIOL, V171, P4617, DOI 10.1128/jb.171.9.4617-4622.1989; Hell K, 1998, P NATL ACAD SCI USA, V95, P2250, DOI 10.1073/pnas.95.5.2250; Hell K, 1997, FEBS LETT, V418, P367, DOI 10.1016/S0014-5793(97)01412-9; LUIRINK J, 1994, EMBO J, V13, P2289, DOI 10.1002/j.1460-2075.1994.tb06511.x; MARTOGLIO B, 1995, CELL, V81, P207, DOI 10.1016/0092-8674(95)90330-5; Moore M, 2000, J BIOL CHEM, V275, P1529, DOI 10.1074/jbc.275.3.1529; PHILLIPS GJ, 1992, NATURE, V359, P744, DOI 10.1038/359744a0; Platt R, 2000, PLASMID, V43, P12, DOI 10.1006/plas.1999.1433; Rapoport TA, 1996, ANNU REV BIOCHEM, V65, P271; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Seluanov A, 1997, J BIOL CHEM, V272, P2053; Stuart RA, 1996, TRENDS BIOCHEM SCI, V21, P261, DOI 10.1016/S0968-0004(96)10035-9; Sundberg E, 1997, PLANT CELL, V9, P717, DOI 10.1105/tpc.9.5.717; Ulbrandt ND, 1997, CELL, V88, P187, DOI 10.1016/S0092-8674(00)81839-5; WHITLEY P, 1994, EMBO J, V13, P4653, DOI 10.1002/j.1460-2075.1994.tb06788.x; Wickner W, 1996, J BIOL CHEM, V271, P29514, DOI 10.1074/jbc.271.47.29514	30	415	422	9	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 10	2000	406	6796					637	641		10.1038/35020586	http://dx.doi.org/10.1038/35020586			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949305				2022-12-24	WOS:000088653800050
J	Subramaniam, S; Henderson, R				Subramaniam, S; Henderson, R			Molecular mechanism of vectorial proton translocation by bacteriorhodopsin	NATURE			English	Article							X-RAY-DIFFRACTION; STRUCTURAL-CHANGES; CRYSTAL-STRUCTURE; PHOTOCYCLE; CHROMOPHORE; INTERMEDIATE; RESOLUTION; MODEL; NMR	Bacteriorhodopsin, a membrane protein with a relative molecular mass of 27,000, is a light driven pump which transports protons across the cell membrane of the halophilic organism Halobacterium salinarum. The chromophore retinal is covalently attached to the protein via a protonated Schiff base. Upon illumination, retinal is isomerized. The Schiff base then releases a proton to the extracellular medium, and is subsequently reprotonated from the cytoplasm. An atomic model for bacteriorhodopsin was first determined by Henderson et al(1), and has been confirmed and extended by work in a number of laboratories in the last few years(2). Here we present an atomic model for structural changes involved in the vectorial, light-driven transport of protons by bacteriorhodopsin. A 'switch' mechanism ensures the vectorial nature of pumping. First, retinal unbends, triggered by loss of the Schiff base proton, and second, a protein conformational change occurs. This conformational change, which we have determined by electron crystallography at atomic (3.2 Angstrom in-plane and 3.6 Angstrom vertical) resolution, is largely localized to helices F and G, and provides an 'opening' of the protein to protons on the cytoplasmic side of the membrane.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; NCI, Biochem Lab, Bethesda, MD 20892 USA	MRC Laboratory Molecular Biology; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Subramaniam, S (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.							Altenbach C, 1996, BIOCHEMISTRY-US, V35, P12470, DOI 10.1021/bi960849l; Brown LS, 1997, P NATL ACAD SCI USA, V94, P5040, DOI 10.1073/pnas.94.10.5040; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DENCHER NA, 1989, P NATL ACAD SCI USA, V86, P7876, DOI 10.1073/pnas.86.20.7876; Elia GR, 1996, CAN J CHEM, V74, P591, DOI 10.1139/v96-063; Essen LO, 1998, P NATL ACAD SCI USA, V95, P11673, DOI 10.1073/pnas.95.20.11673; Faruqi AR, 1999, ULTRAMICROSCOPY, V75, P235, DOI 10.1016/S0304-3991(98)00056-4; FODOR SPA, 1988, BIOCHEMISTRY-US, V27, P7097, DOI 10.1021/bi00418a064; Griffiths JM, 2000, BIOCHEMISTRY-US, V39, P362, DOI 10.1021/bi991106d; Grigorieff N, 1996, J MOL BIOL, V259, P393, DOI 10.1006/jmbi.1996.0328; HAMANAKA T, 1972, ACTA CRYSTALL B-STRU, VB 28, P214, DOI 10.1107/S0567740872002092; HENDERSON R, 1990, J MOL BIOL, V213, P899, DOI 10.1016/S0022-2836(05)80271-2; Hoff WD, 1997, ANNU REV BIOPH BIOM, V26, P223, DOI 10.1146/annurev.biophys.26.1.223; Kamikubo H, 1997, BIOCHEMISTRY-US, V36, P12282, DOI 10.1021/bi9712302; KOCH MHJ, 1991, EMBO J, V10, P521, DOI 10.1002/j.1460-2075.1991.tb07978.x; Luecke H, 1999, SCIENCE, V286, P255, DOI 10.1126/science.286.5438.255; Moltke S, 1999, BIOCHEMISTRY-US, V38, P11762, DOI 10.1021/bi990593u; Oka T, 1999, BIOPHYS J, V76, P1018, DOI 10.1016/S0006-3495(99)77266-8; SANTARSIERO BD, 1990, J AM CHEM SOC, V112, P9416, DOI 10.1021/ja00181a067; Sass HJ, 2000, NATURE, V406, P649, DOI 10.1038/35020607; SCHOBERT B, 1982, J BIOL CHEM, V257, P306; SIMMONS CJ, 1981, ACTA CRYSTALLOGR B, V37, P2197, DOI 10.1107/S0567740881008388; SIMMONS CJ, 1986, ACTA CRYSTALLOGR C, V42, P711, DOI 10.1107/S0108270186094829; STAM CH, 1972, ACTA CRYSTALL B-STRU, VB 28, P2936, DOI 10.1107/S0567740872007253; Subramaniam S, 1999, CURR OPIN STRUC BIOL, V9, P462, DOI 10.1016/S0959-440X(99)80065-7; Subramaniam S, 1999, J MOL BIOL, V287, P145, DOI 10.1006/jmbi.1999.2589; SUBRAMANIAM S, 1993, EMBO J, V12, P1; Vonck J, 2000, EMBO J, V19, P2152, DOI 10.1093/emboj/19.10.2152	28	386	396	0	77	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2000	406	6796					653	657		10.1038/35020614	http://dx.doi.org/10.1038/35020614			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949309				2022-12-24	WOS:000088653800054
J	Nicol, S; Pauly, T; Bindoff, NL; Wright, S; Thiele, D; Hosie, GW; Strutton, PG; Woehler, E				Nicol, S; Pauly, T; Bindoff, NL; Wright, S; Thiele, D; Hosie, GW; Strutton, PG; Woehler, E			Ocean circulation off east Antarctica affects ecosystem structure and sea-ice extent	NATURE			English	Article							CIRCUMPOLAR CURRENT; SOUTHERN-OCEAN; KRILL; PHOTOSYNTHESIS; PACIFIC	Sea ice and oceanic boundaries have a dominant effect in structuring Antarctic marine ecosystems. Satellite imagery and historical data have identified the southern boundary of the Antarctic Circumpolar Current(1) as a site of enhanced biological productivity(2). Meso-scale surveys off the Antarctic peninsula have related the abundances of Antarctic krill (Euphausia superba) and salps (Salpa thompsoni) to inter-annual variations in sea-ice extent(3). Here we have examined the ecosystem structure and oceanography spanning 3,500 km of the east Antarctic coastline, linking the scales of local surveys and global observations. Between 80 degrees and 150 degrees E there is a threefold variation in the extent of annual sea-ice cover, enabling us to examine the regional effects of sea ice and ocean circulation on biological productivity. Phytoplankton, primary productivity, Antarctic krill, whales and seabirds were concentrated where winter sea-ice extent is maximal, whereas salps were located where the sea-ice extent is minimal. We found enhanced biological activity south of the southern boundary of the Antarctic Circumpolar Current rather than in association with it(2). We propose that along this coastline ocean circulation determines both the sea-ice conditions and the level of biological productivity at all trophic levels.	Australian Antarctic Div, Dept Environm & Heritage, Kingston, Tas 7050, Australia; Univ Tasmania, Antarctic Cooperat Res Ctr, Hobart, Tas 7001, Australia; Sch Ecol & Environm, Warrnambool, Vic 3280, Australia; Flinders Univ S Australia, Sch Biol, Adelaide, SA 5001, Australia	Australian Antarctic Division; University of Tasmania; Flinders University South Australia	Nicol, S (corresponding author), Australian Antarctic Div, Dept Environm & Heritage, Channel Highway, Kingston, Tas 7050, Australia.	stephe_nik@antdiv.gov.au	Strutton, Peter G/C-4466-2011; Bindoff, Nathaniel L/C-8050-2011	Strutton, Peter G/0000-0002-2395-9471; Bindoff, Nathaniel L/0000-0001-5662-9519; Woehler, Eric/0000-0002-1125-0748				BISHOP JKB, 1991, J GEOPHYS RES-OCEANS, V96, P16839, DOI 10.1029/91JC01754; COMISO JC, 1993, J GEOPHYS RES-OCEANS, V98, P2419, DOI 10.1029/92JC02505; delaMare WK, 1997, NATURE, V389, P57, DOI 10.1038/37956; GREENE CH, 1991, NATURE, V349, P110, DOI 10.1038/349110a0; Heil P, 1999, J GEOPHYS RES-OCEANS, V104, P15789, DOI 10.1029/1999JC900076; HOSIE GW, 1994, SOUTHERN OCEAN ECOLOGY: THE BIOMASS PERSPECTIVE, P93; JACKA TJ, 1997, ANTARCTIC CRC AUSTR; Jeffrey S., 1997, PHYTOPLANKTON PIGMEN, P597; JOLLY GM, 1990, CAN J FISH AQUAT SCI, V47, P1282, DOI 10.1139/f90-147; Kawaguchi S., 1998, CCAMLR Science, V5, P205; Le Fevre J, 1998, J MARINE SYST, V17, P325, DOI 10.1016/S0924-7963(98)00047-5; LEWIS MR, 1983, MAR ECOL PROG SER, V13, P99, DOI 10.3354/meps013099; Loeb V, 1997, NATURE, V387, P897, DOI 10.1038/43174; MACKEY DJ, 1995, DEEP-SEA RES PT II, V42, P499, DOI 10.1016/0967-0645(95)00038-R; Mackintosh N, 1973, DISCOVERY REP, V36, P1; MIZROCH SA, 1985, CCAMLR SELECTED SCI, P113; Nicol S, 1999, AQUAT LIVING RESOUR, V12, P105, DOI 10.1016/S0990-7440(99)80020-5; NICOL S, IN PRESS DEEP SEA RE, V47; NISHIKAWA J, 1995, POLAR BIOL, V15, P31; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Perissinotto R, 1998, J MARINE SYST, V17, P361, DOI 10.1016/S0924-7963(98)00049-9; PLATT T, 1980, J MAR RES, V38, P687; Priddle J., 1988, P169; Quetin Langdon B., 1996, Antarctic Research Series, V70, P357; Tchernia P., 1984, POLAR REC, V22, P263, DOI [DOI 10.1017/, 10.1017/S0032247400005386, DOI 10.1017/S0032247400005386]; THIELE D, IN PRESS DEEP SEA RE, V47; Tynan CT, 1998, NATURE, V392, P708, DOI 10.1038/33675; VEIT RR, 1993, J ANIM ECOL, V62, P551, DOI 10.2307/5204; Weber L.H., 1985, P284; White WB, 1996, NATURE, V380, P699, DOI 10.1038/380699a0; 1984, MAR ORNITHOL, V20, P51	31	237	252	2	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 3	2000	406	6795					504	507		10.1038/35020053	http://dx.doi.org/10.1038/35020053			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	340ML	10952309				2022-12-24	WOS:000088538000043
J	Bardin, AJ; Visintin, R; Amon, A				Bardin, AJ; Visintin, R; Amon, A			A mechanism for coupling exit from mitosis to partitioning of the nucleus	CELL			English	Article							SPINDLE POLE BODY; SISTER-CHROMATID SEPARATION; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; CELL-CYCLE; GAMMA-TUBULIN; MITOTIC EXIT; MICROTUBULE ORGANIZATION; ANAPHASE TRANSITION; CHECKPOINT PATHWAY	Exit from mitosis must not occur prior to partitioning of chromosomes between daughter cells. We find that the GTP binding protein Tem1, a regulator of mitotic exit, is present on the spindle pole body that migrates into the bud during S phase and mitosis. Tem1's exchange factor, Lte1, localizes to the bud. Thus, Tem1 and Lte1 are present in the same cellular compartment (the bud) only after the nucleus enters the bud during nuclear division. We also find that the presence of Tem1 and Ltel in the bud is required for mitotic exit. Our results suggest that the spatial segregation of Tem1 and Ltel ensures that exit from mitosis only occurs after the genetic material is partitioned between mother and daughter cell.	MIT, Ctr Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Amon, A (corresponding author), MIT, Ctr Canc Res, E17 40 Ames St, Cambridge, MA 02139 USA.		Bardin, Amy/AFW-5158-2022; Visintin, Rosella/J-9690-2012	Amon, Angelika/0000-0001-9837-0314; Visintin, Rosella/0000-0001-6758-9946; Bardin, Allison J./0000-0002-0200-4465	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM056800, R01GM056800] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 56800] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams IR, 1999, J CELL BIOL, V145, P809, DOI 10.1083/jcb.145.4.809; Alexandru G, 1999, EMBO J, V18, P2707, DOI 10.1093/emboj/18.10.2707; AMON A, 1993, CELL, V74, P993, DOI 10.1016/0092-8674(93)90722-3; Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629; Cerutti L, 1999, J CELL SCI, V112, P2313; Ciosk R, 1998, CELL, V93, P1067, DOI 10.1016/S0092-8674(00)81211-8; Cohen-Fix O, 1999, GENE DEV, V13, P1950, DOI 10.1101/gad.13.15.1950; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Fesquet D, 1999, EMBO J, V18, P2424, DOI 10.1093/emboj/18.9.2424; Fraschini R, 1999, J CELL BIOL, V145, P979, DOI 10.1083/jcb.145.5.979; Geissler S, 1996, EMBO J, V15, P3899, DOI 10.1002/j.1460-2075.1996.tb00764.x; GOVINDAN B, 1995, J CELL BIOL, V128, P1055, DOI 10.1083/jcb.128.6.1055; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Jansen RP, 1996, CELL, V84, P687, DOI 10.1016/S0092-8674(00)81047-8; Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0; Jaspersen SL, 1998, MOL BIOL CELL, V9, P2803, DOI 10.1091/mbc.9.10.2803; JOHNSTON GC, 1991, J CELL BIOL, V113, P539, DOI 10.1083/jcb.113.3.539; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Knop M, 1997, EMBO J, V16, P1550, DOI 10.1093/emboj/16.7.1550; Li R, 1999, P NATL ACAD SCI USA, V96, P4989, DOI 10.1073/pnas.96.9.4989; MCGREW JT, 1992, MOL BIOL CELL, V3, P1443, DOI 10.1091/mbc.3.12.1443; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Morgan DO, 1999, NAT CELL BIOL, V1, pE47, DOI 10.1038/10039; Muhua L, 1998, NATURE, V393, P487, DOI 10.1038/31014; ROUT MP, 1990, J CELL BIOL, V111, P1913, DOI 10.1083/jcb.111.5.1913; SAUNDERS WS, 1995, J CELL BIOL, V128, P617, DOI 10.1083/jcb.128.4.617; Schmidt S, 1997, GENE DEV, V11, P1519, DOI 10.1101/gad.11.12.1519; SCHNEIDER BL, 1995, YEAST, V11, P1265, DOI 10.1002/yea.320111306; Shaw SL, 1997, J CELL BIOL, V139, P985, DOI 10.1083/jcb.139.4.985; SHIRAYAMA M, 1994, MOL CELL BIOL, V14, P7476, DOI 10.1128/MCB.14.11.7476; SHIRAYAMA M, 1994, YEAST, V10, P451, DOI 10.1002/yea.320100404; Shirayama M, 1999, NATURE, V402, P203, DOI 10.1038/46080; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Sobel SG, 1995, J CELL BIOL, V131, P1775, DOI 10.1083/jcb.131.6.1775; Straight AF, 1999, CELL, V97, P245, DOI 10.1016/S0092-8674(00)80734-5; SURANA U, 1993, EMBO J, V12, P1969, DOI 10.1002/j.1460-2075.1993.tb05846.x; Theesfeld CL, 1999, J CELL BIOL, V146, P1019, DOI 10.1083/jcb.146.5.1019; Tinker-Kulberg RL, 1999, GENE DEV, V13, P1936, DOI 10.1101/gad.13.15.1936; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Visintin R, 1999, NATURE, V398, P818, DOI 10.1038/19775; Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; YEH E, 1995, J CELL BIOL, V130, P687, DOI 10.1083/jcb.130.3.687	44	267	270	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 7	2000	102	1					21	31		10.1016/S0092-8674(00)00007-6	http://dx.doi.org/10.1016/S0092-8674(00)00007-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	332UL	10929710	Bronze			2022-12-24	WOS:000088091700005
J	Spence, J; Gali, RR; Dittmar, G; Sherman, F; Karin, M; Finley, D				Spence, J; Gali, RR; Dittmar, G; Sherman, F; Karin, M; Finley, D			Cell cycle-regulated modification of the ribosome by a variant multiubiquitin chain	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSLATION INITIATION; POLYUBIQUITIN CHAINS; CONJUGATING ENZYMES; DOWN-REGULATION; MESSENGER-RNA; DNA-REPAIR; PROTEIN; UBIQUITIN; YEAST	Ubiquitin is ligated to L28, a component of the large ribosomal subunit, to form the most abundant ubiquitin-protein conjugate in S. cerevisiae. The human ortholog of L28 is also ubiquitinated, indicating that this modification is highly conserved in evolution. During S phase of the yeast cell cycle, L28 is strongly ubiquitinated, while reduced levels of L28 ubiquitination are observed in G(1) cells. L28 ubiquitination is inhibited by a Lys63 to Arg substitution in ubiquitin, indicating that L28 is modified by a variant, Lys63-linked multiubiquitin chain. The K63R mutant of ubiquitin displays defects in ribosomal function in vivo and in vitro, including a dramatic sensitivity to translational inhibitors. L28, like other ribosomal proteins, is metabolically stable. Therefore, these data suggest a regulatory role for multiubiquitin chains that is reversible and does not function to target the acceptor protein for degradation.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Univ Rochester, Sch Med, Dept Biochem & Biophys, Rochester, NY 14642 USA; Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA	Harvard University; Harvard Medical School; University of Rochester; University of California System; University of California San Diego	Finley, D (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.		Dittmar, Gunnar/B-6383-2016; Dittmar, Gunnar/C-6333-2019	Dittmar, Gunnar/0000-0003-3647-8623; Dittmar, Gunnar/0000-0003-3647-8623	NIGMS NIH HHS [GM12702, GM43601] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043601, R37GM043601] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARNASON T, 1994, MOL CELL BIOL, V14, P7876, DOI 10.1128/MCB.14.12.7876; Baboshina OV, 1996, J BIOL CHEM, V271, P2823, DOI 10.1074/jbc.271.5.2823; Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; BEERS EP, 1993, J BIOL CHEM, V268, P21645; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; CIECHANOVER A, 1984, CELL, V37, P57, DOI 10.1016/0092-8674(84)90300-3; Dubiel W, 1999, CURR BIOL, V9, pR554, DOI 10.1016/S0960-9822(99)80353-4; FINLEY D, 1989, NATURE, V338, P394, DOI 10.1038/338394a0; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; Fisk HA, 1999, J CELL BIOL, V145, P1199, DOI 10.1083/jcb.145.6.1199; FRIED HM, 1981, P NATL ACAD SCI-BIOL, V78, P238, DOI 10.1073/pnas.78.1.238; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; GORENSTEIN C, 1977, MOL GEN GENET, V157, P327, DOI 10.1007/BF00268670; GORENSTEIN C, 1976, P NATL ACAD SCI USA, V73, P1547, DOI 10.1073/pnas.73.5.1547; HAAS AL, 1985, J BIOL CHEM, V260, P2464; HARLOW E, 1988, ANTIBODIES; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 1997, FASEB J, V11, P1215, DOI 10.1096/fasebj.11.14.9409540; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; HUTTER KJ, 1979, J GEN MICROBIOL, V113, P369, DOI 10.1099/00221287-113-2-369; JIMENEZ A, 1975, BIOCHIM BIOPHYS ACTA, V383, P427, DOI 10.1016/0005-2787(75)90312-3; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; KAUFER NF, 1983, NUCLEIC ACIDS RES, V11, P3123; King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Mager WH, 1997, NUCLEIC ACIDS RES, V25, P4872, DOI 10.1093/nar/25.24.4872; MAICAS E, 1988, MOL CELL BIOL, V8, P169, DOI 10.1128/MCB.8.1.169; Mastrandrea LD, 1999, J BIOL CHEM, V274, P27299, DOI 10.1074/jbc.274.38.27299; MASUREKAR M, 1981, J MOL BIOL, V147, P381, DOI 10.1016/0022-2836(81)90490-3; Mondesert G, 1996, J CELL BIOL, V132, P137, DOI 10.1083/jcb.132.1.137; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; PETERS JM, 1998, UBIQUITIN BIOL CELL; Pickart CM, 1997, FASEB J, V11, P1055, DOI 10.1096/fasebj.11.13.9367341; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; RODRIGUEZFONSECA C, 1995, J MOL BIOL, V247, P224, DOI 10.1006/jmbi.1994.0135; Sagliocco F A, 1996, Methods Mol Biol, V53, P297; Sancho E, 1998, MOL CELL BIOL, V18, P576, DOI 10.1128/MCB.18.1.576; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Springael JY, 1999, J CELL SCI, V112, P1375; SWEENEY R, 1991, GENETICS, V127, P327; TARUN SZ, 1995, GENE DEV, V9, P2997, DOI 10.1101/gad.9.23.2997; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Wang PJ, 1997, MOL CELL BIOL, V17, P6114, DOI 10.1128/MCB.17.10.6114; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; WARNER JR, 1985, MOL CELL BIOL, V5, P1512, DOI 10.1128/MCB.5.6.1512; WINTERMEYER W, 1990, RIBOSOME, P348; XIANG RH, 1989, J BIOL CHEM, V264, P10542; Xiao W, 1998, NUCLEIC ACIDS RES, V26, P3908, DOI 10.1093/nar/26.17.3908	52	297	315	0	18	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 7	2000	102	1					67	76		10.1016/S0092-8674(00)00011-8	http://dx.doi.org/10.1016/S0092-8674(00)00011-8			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	332UL	10929714	Bronze			2022-12-24	WOS:000088091700009
J	McKoy, G; Protonotarios, N; Crosby, A; Tsatsopoulou, A; Anastasakis, A; Coonar, A; Norman, M; Baboonian, C; Jeffery, S; McKenna, WJ				McKoy, G; Protonotarios, N; Crosby, A; Tsatsopoulou, A; Anastasakis, A; Coonar, A; Norman, M; Baboonian, C; Jeffery, S; McKenna, WJ			Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease)	LANCET			English	Article							DILATED CARDIOMYOPATHY; STRUCTURAL PROTEINS; MISSENSE MUTATIONS; EMBRYONIC HEART; LONG ARM; GENE; DYSPLASIA; MAPS; LOCUS; LOCALIZATION	Background Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an autosomal dominant heart muscle disorder that causes arrhythmia, heart failure, and sudden death. Previously we mapped the genetic locus for the triad of autosomal recessive ARVC, palmoplantar keratoderma, and woolly hair (Naxos disease) to chromosome 17q21, in which the gene for plakoglobin is encoded, This protein is a key component of desmosomes and adherens junctions, and is important for the tight adhesion of many cell types, including those in the heart and skin. Methods We studied 19 individuals with Naxos disease, as well as unaffected family members and unrelated individuals from the neighbouring Greek islands of Naxos and Miles. Gene sequence was determined by reverse transcriptase PCR from RNA isolated from the skin of an affected individual and mutations in other cases were confirmed by restriction-enzyme analysis. Findings A homozygous 2 base pair deletion in the plakoglobin gene was identified only in the 19 affected individuals. This deletion caused a frameshift and premature termination of the protein, which was shown by western blot analysis. 29 clinically unaffected family members were heterozygous for the mutation; 20 unrelated individuals from Naxos and 43 autosomal dominant ARVC probands were homozygous for the normal allele. Interpretation The finding of a deletion in plakoglobin in ARVC suggests that the proteins involved in, cell-cell adhesion play an important part in maintaining myocyte integrity, acid when junctions are disrupted, cell death, and fibrofatty replacement occur. Therefore, the discovery of a mutation in a protein with functions in maintaining cell junction integrity has important implications for other dominant forms of ARVC, related cardiomyopathies, and other cutaneous diseases.	Univ London St Georges Hosp, Sch Med, Dept Cardiol Sci, London SW17 0RE, England; Univ London St Georges Hosp, Sch Med, Dept Med Genet, London SW17 0RE, England; Yannis Protonotarios Med Ctr Naxos, Naxos 84300, Greece; Univ Athens, Dept Cardiol, Hippokrat Hosp 114, Athens 11527, Greece	St Georges University London; St Georges University London; National & Kapodistrian University of Athens	McKenna, WJ (corresponding author), Univ London St Georges Hosp, Sch Med, Dept Cardiol Sci, Cranmer Terrace, London SW17 0RE, England.		McKenna, William J/C-3243-2008; Crosby, Andrew H/E-2218-2015	McKenna, William J/0000-0001-7994-2460; Crosby, Andrew H/0000-0003-3667-9054				ABERLE H, 1995, P NATL ACAD SCI USA, V92, P6384, DOI 10.1073/pnas.92.14.6384; Ahmad F, 1998, CIRCULATION, V98, P2791, DOI 10.1161/01.CIR.98.25.2791; Bierkamp C, 1996, DEV BIOL, V180, P780, DOI 10.1006/dbio.1996.0346; Carvajal-Huerta L, 1998, J AM ACAD DERMATOL, V39, P418, DOI 10.1016/S0190-9622(98)70317-2; Coonar AS, 1998, CIRCULATION, V97, P2049, DOI 10.1161/01.CIR.97.20.2049; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; Fontaine G, 1998, CIRCULATION, V97, P1532, DOI 10.1161/01.CIR.97.16.1532; GUIRAUDON CM, 1989, EUR HEART J, V10, P95, DOI 10.1093/eurheartj/10.suppl_D.95; Haftek M, 1996, J INVEST DERMATOL, V106, P498, DOI 10.1111/1523-1747.ep12343791; Hatzfeld M, 1999, INT REV CYTOL, V186, P179; Hertig CM, 1996, J CELL SCI, V109, P11; Jongbloed RJE, 1999, HUM MUTAT, V13, P301, DOI 10.1002/(SICI)1098-1004(1999)13:4<301::AID-HUMU7>3.3.CO;2-M; KAPPRELL HP, 1987, EUR J BIOCHEM, V166, P505, DOI 10.1111/j.1432-1033.1987.tb13543.x; Koch PJ, 1998, J CELL SCI, V111, P2529; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; McGrath JA, 1997, NAT GENET, V17, P240, DOI 10.1038/ng1097-240; MCKENNA WJ, 1994, BRIT HEART J, V71, P215; North AJ, 1999, J CELL SCI, V112, P4325; Palka HL, 1997, J CELL SCI, V110, P2359; PROTONOTARIOS N, 1986, BRIT HEART J, V56, P321; PROTONOTARIOS N, 1997, ARRHYTHMOGENIC RIGHT, P454; RAMPAZZO A, 1995, HUM MOL GENET, V4, P2151, DOI 10.1093/hmg/4.11.2151; Rampazzo A, 1997, GENOMICS, V45, P259, DOI 10.1006/geno.1997.4927; RAMPAZZO A, 1994, HUM MOL GENET, V3, P959, DOI 10.1093/hmg/3.6.959; Rao B H, 1996, Indian Heart J, V48, P161; RONCALI L, 1989, EUR HEART J, V10, P97, DOI 10.1093/eurheartj/10.suppl_D.97; Ruiz P, 1996, J CELL BIOL, V135, P215, DOI 10.1083/jcb.135.1.215; Schnittler HJ, 1997, AM J PHYSIOL-HEART C, V273, pH2396, DOI 10.1152/ajpheart.1997.273.5.H2396; Severini GM, 1996, GENOMICS, V31, P193, DOI 10.1006/geno.1996.0031; Troyanovsky RB, 1996, J CELL SCI, V109, P3069; ZIMMER HG, 1994, BASIC RES CARDIOL, V89, P101	31	739	763	0	17	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 17	2000	355	9221					2119	2124		10.1016/S0140-6736(00)02379-5	http://dx.doi.org/10.1016/S0140-6736(00)02379-5			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325QD	10902626				2022-12-24	WOS:000087687100012
J	Slavkin, HC; Baum, BJ				Slavkin, HC; Baum, BJ			Relationship of dental and oral pathology to systemic illness	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CORONARY HEART-DISEASE; ADULTS 30 YEARS; MYOCARDIAL-INFARCTION; UNITED-STATES; PERIODONTAL-DISEASE; ARTERY DISEASE; RISK FACTOR; INFECTION; ATHEROSCLEROSIS; CARIES		Off Director, Bethesda, MD 20892 USA; Natl Inst Dent & Craniofacial Res, Gene Therapy & Therapeut Branch, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Slavkin, HC (corresponding author), Off Director, Bldg 31,Room 2C39,MSC-2290, Bethesda, MD 20892 USA.	SlavkinH@od31.nidcr.nih.gov			NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000336, ZIADE000336] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Albandar JM, 1999, J PERIODONTOL, V70, P13, DOI 10.1902/jop.1999.70.1.13; Anderson JL, 1999, CIRCULATION, V99, P1540, DOI 10.1161/01.CIR.99.12.1540; Atkinson J C, 1992, Clin Geriatr Med, V8, P499; Baum BJ, 1999, LANCET, V354, P12; Beck J, 1996, J PERIODONTOL, V67, P1123, DOI 10.1902/jop.1996.67.10s.1123; Beck J D, 1998, J Dent Educ, V62, P859; Berger A M, 1998, Oncol Nurs Forum, V25, P1623; Brown LJ, 1999, J AM DENT ASSOC, V130, P1637, DOI 10.14219/jada.archive.1999.0106; Dajani AS, 1997, JAMA-J AM MED ASSOC, V277, P1794, DOI 10.1001/jama.277.22.1794; Dasanayake A P, 1998, Ann Periodontol, V3, P206, DOI 10.1902/annals.1998.3.1.206; DESTEFANO F, 1993, BRIT MED J, V306, P688, DOI 10.1136/bmj.306.6879.688; Epstein SE, 1999, CIRCULATION, V100, pE20, DOI 10.1161/01.CIR.100.4.e20; Fourrier F, 1998, CRIT CARE MED, V26, P301, DOI 10.1097/00003246-199802000-00032; Fox Robert I., 1998, Current Opinion in Rheumatology, V10, P446, DOI 10.1097/00002281-199809000-00009; Gibson S, 1999, CARIES RES, V33, P101, DOI 10.1159/000016503; Grau AJ, 1997, STROKE, V28, P1724, DOI 10.1161/01.STR.28.9.1724; GREENBERG DS, 1992, LANCET, V340, P359, DOI 10.1016/0140-6736(92)91418-8; Gurfinkel E, 1999, EUR HEART J, V20, P121, DOI 10.1053/euhj.1998.1283; Hao SP, 1999, LARYNGOSCOPE, V109, P1324, DOI 10.1097/00005537-199908000-00027; Joshipura KJ, 1996, J DENT RES, V75, P1631, DOI 10.1177/00220345960750090301; Kaste LM, 1996, J DENT RES, V75, P631, DOI 10.1177/002203459607502S03; Loesche W J, 1998, Ann Periodontol, V3, P161, DOI 10.1902/annals.1998.3.1.161; Loesche WJ, 1999, CRIT REV ORAL BIOL M, V10, P245, DOI 10.1177/10454411990100030101; Loesche WJ, 1998, J AM DENT ASSOC, V129, P301, DOI 10.14219/jada.archive.1998.0204; Mattila Kimmo, 1998, P63; MATTILA KJ, 1995, CLIN INFECT DIS, V20, P588, DOI 10.1093/clinids/20.3.588; MATTILA KJ, 1993, ATHEROSCLEROSIS, V103, P205, DOI 10.1016/0021-9150(93)90263-T; MATTILA KJ, 1989, BRIT MED J, V298, P779, DOI 10.1136/bmj.298.6676.779; Mattila KJ, 2000, J DENT RES, V79, P756, DOI 10.1177/00220345000790020901; Mattila KJ, 1998, CLIN INFECT DIS, V26, P719, DOI 10.1086/514570; Meurman JH, 1997, J DENT RES, V76, P1271, DOI 10.1177/00220345970760060601; Meyer DH, 1998, CURR OPIN MICROBIOL, V1, P88, DOI 10.1016/S1369-5274(98)80147-1; Offenbacher S, 1996, J PERIODONTOL, V67, P1103, DOI 10.1902/jop.1996.67.10s.1103; Scannapieco FA, 1999, J PERIODONTOL, V70, P793, DOI 10.1902/jop.1999.70.7.793; Schussheim AE, 1999, DRUGS, V57, P283, DOI 10.2165/00003495-199957030-00002; Toljanic JA, 1999, CANCER, V85, P1843, DOI 10.1002/(SICI)1097-0142(19990415)85:8<1843::AID-CNCR26>3.3.CO;2-I; US Department of Health and Human Services, 2010, HLTH PEOPL 2010, V2; VALDEZ IH, 1993, INT J RADIAT ONCOL, V25, P41, DOI 10.1016/0360-3016(93)90143-J; Valtonen VV, 1999, AM HEART J, V138, pS431, DOI 10.1016/S0002-8703(99)70269-3; Vargas CM, 1998, J AM DENT ASSOC, V129, P1229, DOI 10.14219/jada.archive.1998.0420	40	71	71	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 13	2000	284	10					1215	1217		10.1001/jama.284.10.1215	http://dx.doi.org/10.1001/jama.284.10.1215			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	350WL	10979082				2022-12-24	WOS:000089124600001
J	Frader, JE				Frader, JE			Baby Doe blinders	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Northwestern Univ, Sch Med, Chicago, IL 60611 USA	Northwestern University	Frader, JE (corresponding author), Northwestern Univ, Sch Med, Chicago, IL 60611 USA.		Frader, Joel/A-8610-2010	Frader, Joel/0000-0001-5620-2400				PLESS JE, 1983, NEW ENGL J MED, V309, P664; 2000, EXPENDITURES PERINAT; 2000, PRETERM BIRTHS US 19; 2000, INT COMP INF MORT RA; 2000, HLTH EXPENDITURES; 2000, ADEQUACY PRENATAL CA	6	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2000	284	9					1143	1143		10.1001/jama.284.9.1143	http://dx.doi.org/10.1001/jama.284.9.1143			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	349GK	10974698				2022-12-24	WOS:000089037200019
J	Melov, S; Ravenscroft, J; Malik, S; Gill, MS; Walker, DW; Clayton, PE; Wallace, DC; Malfroy, B; Doctrow, SR; Lithgow, GJ				Melov, S; Ravenscroft, J; Malik, S; Gill, MS; Walker, DW; Clayton, PE; Wallace, DC; Malfroy, B; Doctrow, SR; Lithgow, GJ			Extension of life-span with superoxide dismutase/catalase mimetics	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; OXIDATIVE STRESS; CATALASE; OVEREXPRESSION; SCAVENGER; EUK-8	We tested the theory that reactive oxygen species cause aging. We augmented the natural antioxidant systems of Caenorhabditis elegans with small synthetic superoxide dismutase/catalase mimetics. Treatment of wild-type worms increased their mean Life-span by a mean of 44 percent, and treatment of prematurely aging worms resulted in normalization of their life-span (a 67 percent increase). It appears that oxidative stress is a major determinant of Life-span and that it can be counteracted by pharmacological intervention.	Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England; Univ Manchester, Acad Unit Child Hlth, Manchester M13 9PT, Lancs, England; Buck Inst Age Res, Novato, CA 94949 USA; Eukarion, Bedford, MA 01730 USA; Emory Univ, Ctr Mol Med, Atlanta, GA 30322 USA	University of Manchester; University of Manchester; Buck Institute for Research on Aging; Emory University	Lithgow, GJ (corresponding author), Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England.		Melov, Simon/AAC-9469-2020	Doctrow, Susan/0000-0003-0628-9960; Clayton, Peter/0000-0003-1225-4537; Melov, Simon/0000-0001-8554-2834; Gill, Matthew/0000-0003-0818-8792	NIA NIH HHS [AG-13154] Funding Source: Medline; NINDS NIH HHS [NS21328] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013154] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baker K, 1998, J PHARMACOL EXP THER, V284, P215; BEAL MF, 1995, ANN NEUROL, V38, P357, DOI 10.1002/ana.410380304; Beckmann K. B., 1997, OXIDATIVE STRESS MOL, P201; Bruce AJ, 1996, P NATL ACAD SCI USA, V93, P2312, DOI 10.1073/pnas.93.6.2312; Doctrow S R, 1997, Adv Pharmacol, V38, P247; HARRINGTON LA, 1988, MECH AGEING DEV, V43, P71, DOI 10.1016/0047-6374(88)90098-X; ISHII N, 1990, MUTAT RES, V237, P165, DOI 10.1016/0921-8734(90)90022-J; Ishii N, 1998, NATURE, V394, P694, DOI 10.1038/29331; JOHNSON TE, 1990, SCIENCE, V249, P908, DOI 10.1126/science.2392681; Lakowski B, 1996, SCIENCE, V272, P1010, DOI 10.1126/science.272.5264.1010; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; Malfroy B, 1997, CELL IMMUNOL, V177, P62, DOI 10.1006/cimm.1997.1091; Melov S, 1998, NAT GENET, V18, P159, DOI 10.1038/ng0298-159; MELOV S, UNPUB; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Rong YQ, 1999, P NATL ACAD SCI USA, V96, P9897, DOI 10.1073/pnas.96.17.9897; Sulston J, 1988, NEMATODE CAENORHABDI, P587; Sun JT, 1999, MOL CELL BIOL, V19, P216; VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605	21	712	751	3	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 1	2000	289	5484					1567	1569		10.1126/science.289.5484.1567	http://dx.doi.org/10.1126/science.289.5484.1567			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349XW	10968795				2022-12-24	WOS:000089071700051
J	Weimerskirch, H; Wilson, RP				Weimerskirch, H; Wilson, RP			Oceanic respite for wandering albatrosses	NATURE			English	Article							SEABIRDS		CNRS, CEBC, F-79360 Villiers En Bois, France; Inst Francais Rech & Technol Polaire, F-29280 Plouzane, France	Centre National de la Recherche Scientifique (CNRS)	Weimerskirch, H (corresponding author), CNRS, CEBC, F-79360 Villiers En Bois, France.		Weimerskirch, Henri/F-5562-2013; Weimerskirch, Henri/K-7306-2019	Weimerskirch, Henri/0000-0002-0457-586X				BROTHERS N, 1991, BIOL CONSERV, V55, P255, DOI 10.1016/0006-3207(91)90031-4; Hill Roger D., 1994, P227; JOUVENTIN P, 1990, NATURE, V343, P746, DOI 10.1038/343746a0; MURPHY R.C., 1936, OCEANIC BIRDS S AM, V2; Nicholls DG, 1997, EMU, V97, P240; ROBERTSON G, 1993, ALBATROSS BIOL CONSE; WEIMERSKIRCH H, 1985, EMU, V85, P22, DOI 10.1071/MU9850022; WEIMERSKIRCH H, 1994, P ROY SOC B-BIOL SCI, V255, P91, DOI 10.1098/rspb.1994.0013; Weimerskirch H, 1997, BIOL CONSERV, V79, P257, DOI 10.1016/S0006-3207(96)00084-5; Welch DW, 1999, CAN J FISH AQUAT SCI, V56, P1317, DOI 10.1139/cjfas-56-7-1317; Wilson R.P., 1992, P131	11	104	112	0	38	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 31	2000	406	6799					955	956		10.1038/35023068	http://dx.doi.org/10.1038/35023068			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	348ZW	10984040				2022-12-24	WOS:000089020200031
J	Chandler, JM; Zimmerman, SI; Girman, CJ; Martin, AR; Hawkes, W; Hebel, JR; Sloane, PD; Holder, L; Magaziner, J				Chandler, JM; Zimmerman, SI; Girman, CJ; Martin, AR; Hawkes, W; Hebel, JR; Sloane, PD; Holder, L; Magaziner, J			Low bone mineral density and risk of fracture in white female nursing home residents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MINIMUM DATA SET; HIP FRACTURE; OSTEOPOROTIC FRACTURES; ELDERLY WOMEN; OLDER-PEOPLE; PREVALENCE; FALLS; MASS; AGE	Context Low bone mineral density (BMD) is a strong risk factor for fracture in community-dwelling white women, but the relationship in white female nursing home residents, for whom fracture rates are highest, is less clear, Objective To assess the relative contribution of low BMD to fracture risk in nursing home residents. Design Prospective cohort study with baseline data collected April 1995 to June 1997, with 18 months of follow-up. Setting Forty-seven randomly selected nursing homes in Maryland. Patients A total of 1427 white female nursing home residents aged 65 years or older. Main Outcome Measure Documented osteoporotic fracture occurring during follow-up as a function of baseline BMD measurements higher vs lower than the median, and after controlling for demographic, functional, cognitive, psychosocial, and medical factors. Results A total of 223 osteoporotic fractures occurred among 180 women. Low BMD and transfer independence were significant independent risk factors for fracture in this nursing home sample (P<.001) and the 2 factors acted synergistically (P=.06) to further increase fracture risk. Compared with women whose BMD was higher than the median (0.296 g/cm(2)), those whose BMD was lower than the median had an unadjusted hazard ratio for risk of fracture of 2.1 (95% confidence interval [CI], 1.5-2.8); women who were independent in transfer had a hazard ratio of 1.6 (95% CI, 1.2-2.2) compared with women dependent in transfer. Among residents independent in transfer, those with BMD below the median had a more than 3-fold increase in fracture risk compared with those with higher BMD (unadjusted hazard ratio, 3.1; 95% CI, 2.2-4.4). Among residents dependent in transfer, those with BMD below the median had a 60% increase in fracture risk (unadjusted hazard ratio, 1.6; 95% CI, 1.1-2.3). Adjustment for covariates did not alter the BMD-fracture relationship, Conclusions Our data indicate that low BMD and independence in transfer are significant predictors of osteoporotic fracture in white female nursing home residents.	Merck Res Labs, Dept Epidemiol, Blue Bell, PA USA; Univ Maryland, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA; Univ Maryland, Med Ctr, Dept Diagnost Radiol, Baltimore, MD 21201 USA; Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC USA; Univ N Carolina, Sch Social Work, Chapel Hill, NC USA; Univ N Carolina, Dept Family Med, Chapel Hill, NC 27514 USA	Merck & Company; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Chandler, JM (corresponding author), Merck Res Labs, Dept Epidemiol, BL1-7,POB 4, West Point, PA 19486 USA.	julie_chandler@merck.com			NATIONAL INSTITUTE ON AGING [R29AG011407, R01AG008211] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AGO8211, R29 AG11407] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALEXOPOULOS GS, 1988, BIOL PSYCHIAT, V23, P271, DOI 10.1016/0006-3223(88)90038-8; BLACK DM, 1992, J BONE MINER RES, V7, P633; CALI CM, 1995, J AM GERIATR SOC, V43, P1336, DOI 10.1111/j.1532-5415.1995.tb06610.x; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CHRISCHILLES E, 1994, BONE, V15, P377, DOI 10.1016/8756-3282(94)90813-3; CUMMINGS SR, 1985, EPIDEMIOL REV, V7, P178, DOI 10.1093/oxfordjournals.epirev.a036281; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; DargentMolina P, 1996, LANCET, V348, P145, DOI 10.1016/S0140-6736(96)01440-7; DEY AN, 1997, 289 NAT CTR HLTH STA; ENSRUD KE, 1995, J BONE MINER RES, V10, P1778; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GREENLAND S, 1998, MODERN EPIDEMIOLOGY, P255; GREENSPAN SL, 1994, JAMA-J AM MED ASSOC, V271, P128, DOI 10.1001/jama.271.2.128; Greenspan SL, 1998, AM J MED, V104, P539, DOI 10.1016/S0002-9343(98)00115-6; Guo ZC, 1998, AM J EPIDEMIOL, V148, P887; HAWES C, 1995, GERONTOLOGIST, V35, P172, DOI 10.1093/geront/35.2.172; Kiely DK, 1998, J AM GERIATR SOC, V46, P551, DOI 10.1111/j.1532-5415.1998.tb01069.x; Koski K, 1996, AGE AGEING, V25, P29, DOI 10.1093/ageing/25.1.29; Lawton MP, 1998, J AM GERIATR SOC, V46, P736, DOI 10.1111/j.1532-5415.1998.tb03809.x; LOOKER AC, 1995, J BONE MINER RES, V10, P796; Magaziner J, 1997, AM J PUBLIC HEALTH, V87, P1630, DOI 10.2105/AJPH.87.10.1630; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; Martin AR, 1999, J CLIN DENSITOM, V2, P381, DOI 10.1016/S1094-6950(06)60403-4; Melton LJ, 1996, BONE, V18, pS121, DOI 10.1016/8756-3282(95)00492-0; MELTON LJ, 1992, J BONE MINER RES, V7, P1005, DOI 10.1002/jbmr.5650070902; MORRIS JN, 1990, GERONTOLOGIST, V30, P293, DOI 10.1093/geront/30.3.293; NEVITT MC, 1994, OSTEOPOROSIS INT, V4, P325, DOI 10.1007/BF01622192; ROSS PD, 1990, CALCIFIED TISSUE INT, V46, P149, DOI 10.1007/BF02555036; SEELEY DG, 1991, ANN INTERN MED, V115, P837, DOI 10.7326/0003-4819-115-11-837; STEIGER P, 1992, J BONE MINER RES, V7, P625; Takahashi M, 1999, BRIT J OBSTET GYNAEC, V106, P427, DOI 10.1111/j.1471-0528.1999.tb08295.x; TINETTI ME, 1987, J AM GERIATR SOC, V35, P644, DOI 10.1111/j.1532-5415.1987.tb04341.x; VISENTIN P, 1995, GERONTOLOGY, V41, P273; Young Y, 1997, J AM GERIATR SOC, V45, P288, DOI 10.1111/j.1532-5415.1997.tb00942.x; Zimmerman SI, 1999, OSTEOPOROSIS INT, V9, P151	35	117	118	2	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 23	2000	284	8					972	977		10.1001/jama.284.8.972	http://dx.doi.org/10.1001/jama.284.8.972			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	344PX	10944642	Bronze			2022-12-24	WOS:000088769000023
J	Limaye, AP; Corey, L; Koelle, DM; Davis, CL; Boeckh, M				Limaye, AP; Corey, L; Koelle, DM; Davis, CL; Boeckh, M			Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants	LANCET			English	Article							PATIENTS RECEIVING GANCICLOVIR; ORAL GANCICLOVIR; LIVER-TRANSPLANTATION; RENAL-TRANSPLANTATION; ANTIVIRAL DRUGS; RETINITIS; INFECTION; PROPHYLAXIS; THERAPY; ANTIGENEMIA	Background Concerns have been raised about emergence of ganciclovir resistance as a result of the advent of both routine oral ganciclovir prophylaxis and highly potent immunosuppression. We retrospectively assessed the occurrence of ganciclovir-resistant cytomegalovirus disease among transplant recipients who had received oral ganciclovir prophylaxis and highly potent immunosuppression, Methods We studied 240 recipients of liver, kidney, or pancreas transplants. Antiviral susceptibility testing of blood cytomegaloviral isolates was done when patients failed to respond to intravenous ganciclovir treatment for symptomatic cytomegalovirus infection. Portions of the UL97 gene associated with ganciclovir resistance were sequenced in cytomegalovirus isolates with phenotypic resistance to ganciclovir. Findings Ganciclovir-resistant cytomegalovirus disease developed in five (7%) of 67 seronegative recipients of cytomegalovirus-seropositive organs (D+/R-) com pared with none of 173 seropositive recipients (p=0.002). Among the 25 (10.4%) patients who developed cytomegalovirus disease within 1 year after transplantation, five had ganciclovir-resistant cytomegalovirus disease. Among D+/R-transplant recipients, ganciclovir-resistant cytomegalovirus disease was more common among the group receiving the most potent immunosuppression-ie, recipients of kidney and pancreas or pancreas alone (four of 19) compared with all other transplant recipients tone of 48, p=0.02). Ganciclovir-resistant cytomegalovirus disease was diagnosed at a median of 10 months after transplantation (range 7-12) after lengthened exposure to ganciclovir, was associated with previously described mutations of the UL97 gene, and led to serious clinical complications. Interpretation Ganciclovir-resistant cytomegalovirus is an important cause of late morbidity among D+/R- transplant recipients who have had lengthened exposure to ganciclovir and have received highly potent immunosuppression. Strategies to reduce this complication, especially among D+/R- patients, are warranted.	Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Program Infect Dis, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Limaye, AP (corresponding author), Univ Washington, Med Ctr, Dept Lab Med, Box 357110,1959 NE Pacific St, Seattle, WA 98195 USA.	limaye@u.washington.edu	Boeckh, Michael/AAA-1607-2022; Koelle, David/Q-6529-2016	Koelle, David/0000-0003-1255-9023	NCI NIH HHS [CA18029] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA018029] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alain S, 1997, TRANSPLANTATION, V63, P1533, DOI 10.1097/00007890-199705270-00031; Baldanti F, 1998, TRANSPLANTATION, V66, P324, DOI 10.1097/00007890-199808150-00008; Barbui Anna, 1999, Clin Microbiol Infect, V5, P23; BOECKH M, 1994, J CLIN MICROBIOL, V32, P832, DOI 10.1128/JCM.32.3.832-834.1994; BOIVIN G, 1993, J INFECT DIS, V168, P332, DOI 10.1093/infdis/168.2.332; Bowen EF, 1998, AIDS, V12, P605, DOI 10.1097/00002030-199806000-00009; Chou SW, 1998, J INFECT DIS, V178, P526, DOI 10.1086/515648; Chou SW, 1997, J INFECT DIS, V176, P786, DOI 10.1086/517302; Cope AV, 1997, J INFECT DIS, V176, P1484, DOI 10.1086/514145; CRUMPACKER CS, 1996, J ACQUIRED IMMUNE S1, V12, pS1; Drew WL, 1999, J INFECT DIS, V179, P1352, DOI 10.1086/314747; DREW WL, 1991, J INFECT DIS, V163, P716, DOI 10.1093/infdis/163.4.716; Erice A, 1999, CLIN MICROBIOL REV, V12, P286, DOI 10.1128/CMR.12.2.286; Gane E, 1997, LANCET, V350, P1729, DOI 10.1016/S0140-6736(97)05535-9; Goodrich J, 1997, LANCET, V350, P1718, DOI 10.1016/S0140-6736(97)22050-7; Jabs DA, 1998, J INFECT DIS, V177, P770, DOI 10.1086/514249; JABS DA, 1998, 5 C RETR OPP INF CHI; Kruger RM, 1999, TRANSPLANTATION, V68, P1272, DOI 10.1097/00007890-199911150-00010; Lowance D, 1999, NEW ENGL J MED, V340, P1462, DOI 10.1056/NEJM199905133401903; Lurain NS, 1996, TRANSPLANTATION, V62, P497, DOI 10.1097/00007890-199608270-00012; Martin DF, 1999, NEW ENGL J MED, V340, P1063, DOI 10.1056/NEJM199904083401402; Mendez JC, 1999, TRANSPLANTATION, V67, P755, DOI 10.1097/00007890-199903150-00020; RAZIS E, 1994, LEUKEMIA LYMPHOMA, V12, P477, DOI 10.3109/10428199409073791; Reusser P, 1996, BONE MARROW TRANSPL, V17, P813; Rosen HR, 1997, TRANSPLANTATION, V63, P476, DOI 10.1097/00007890-199702150-00026; Singh N, 1998, DIGEST DIS SCI, V43, P1190, DOI 10.1023/A:1018839320383; SLAVIN MA, 1993, ANTIMICROB AGENTS CH, V37, P1360, DOI 10.1128/AAC.37.6.1360; SMITH IL, 1998, 38 IKNT C ANT AG CHE; VANDENBERG AP, 1989, TRANSPLANTATION, V48, P991, DOI 10.1097/00007890-198912000-00019; WINSTON DJ, 1995, LANCET, V346, P69, DOI 10.1016/S0140-6736(95)92110-9	30	401	407	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 19	2000	356	9230					645	649		10.1016/S0140-6736(00)02607-6	http://dx.doi.org/10.1016/S0140-6736(00)02607-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346RD	10968438				2022-12-24	WOS:000088884100013
J	McQuibban, GA; Gong, JH; Tam, EM; McCulloch, CAG; Clark-Lewis, I; Overall, CM				McQuibban, GA; Gong, JH; Tam, EM; McCulloch, CAG; Clark-Lewis, I; Overall, CM			Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3	SCIENCE			English	Article							72-KDA GELATINASE; TISSUE INHIBITOR; HUMAN FIBROBLASTS; IV COLLAGENASE; METALLOPROTEINASES; ACTIVATION; BINDING; DOMAIN; PROGELATINASE; ANTAGONISTS	Tissue degradation by the matrix metalloproteinase gelatinase A is pivotal to inflammation and metastases. Recognizing the catalytic importance of substrate-binding exosites outside the catalytic domain, we screened for extracellular substrates using the gelatinase A hemopexin domain as bait in the yeast two-hybrid system. Monocyte chemoattractant protein-3 (MCP-3) was identified as a physiological substrate of gelatinase A. Cleaved MCP-3 binds to CC-chemokine receptors-1, -2, and -3, but no Longer induces calcium fluxes or promotes chemotaxis, and instead acts as a general chemokine antagonist that dampens inflammation. This suggests that matrix metalloproteinases are both effecters and regulators of the inflammatory response.	Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Biomed Res Ctr, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Oral Biol & Med Sci, Vancouver, BC V6T 1Z3, Canada; Univ Toronto, MRC, Periodontal Physiol Grp, Toronto, ON M5S 3E8, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of Toronto	Overall, CM (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada.							FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; GEARING AJH, 1994, NATURE, V370, P555, DOI 10.1038/370555a0; GomisRuth FX, 1996, J MOL BIOL, V264, P556, DOI 10.1006/jmbi.1996.0661; Gong JH, 1996, J BIOL CHEM, V271, P10521, DOI 10.1074/jbc.271.18.10521; GONG JH, 1995, J EXP MED, V181, P631, DOI 10.1084/jem.181.2.631; HOWARD EW, 1991, J BIOL CHEM, V266, P13064; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; MCQUIBBAN GA, UNPUB; NETZELARNETT S, 1993, BIOCHEMISTRY-US, V32, P6427, DOI 10.1021/bi00076a016; NGUYEN Q, 1994, BIOCHEMISTRY-US, V33, P2089, DOI 10.1021/bi00174a015; OPDENAKKER G, 1993, BIOCHEM BIOPH RES CO, V191, P535, DOI 10.1006/bbrc.1993.1251; OPENAKKER G, 1991, LYMPHOKINE CYTOK RES, V10, P317; OVERALL CM, 1991, J BIOL CHEM, V266, P14064; OVERALL CM, 1990, J BIOL CHEM, V265, P21141; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; STEFFENSEN B, 1995, J BIOL CHEM, V270, P11555, DOI 10.1074/jbc.270.19.11555; Van Damme J, 1999, Chem Immunol, V72, P42, DOI 10.1159/000058725; WALLON UM, 1997, J BIOL CHEM, V272, P747; WARD RV, 1994, BIOCHEM J, V304, P263, DOI 10.1042/bj3040263; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; YOUNG TN, 1995, J BIOL CHEM, V270, P999, DOI 10.1074/jbc.270.3.999	21	607	625	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 18	2000	289	5482					1202	1206		10.1126/science.289.5482.1202	http://dx.doi.org/10.1126/science.289.5482.1202			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346JE	10947989				2022-12-24	WOS:000088866600045
J	Rakow, NA; Suslick, KS				Rakow, NA; Suslick, KS			A colorimetric sensor array for odour visualization	NATURE			English	Article							CHEMICAL SENSORS; DENDRIMER-METALLOPORPHYRINS; ELECTRONIC NOSE; COMPLEXES; RECEPTORS; COATINGS	Array-based vapour-sensing devices are used to detect and differentiate between chemically diverse analytes. These systems- based on cross-responsive sensor elements-aim to mimic the mammalian olfactory system(1-3) by producing composite responses unique to each odorant. Previous work has concentrated on a variety of non-specific chemical interactions(4-11) to detect non-coordinating organic vapours. But the most odiferous, toxic compounds often bind readily to metal ions. Here we report a simple optical chemical sensing method that utilizes the colour change induced in an array of metalloporphyrin dyes upon ligand binding while minimizing the need for extensive signal transduction hardware. The chemoselective response of a library of immobilized vapour-sensing metalloporphyrin dyes permits the visual identification of a wide range of ligating (alcohols, amines, ethers, phosphines, phosphites, thioethers and thiols) and even weakly ligating (arenes, halocarbons and ketones) vapours. Water geometrical correlation length), and consequently a purely diffusive large-scale behaviour for the force. Therefore, we conclude that our results are certainly applicable to disordered packings such as cohesionless soils or sand piles. In contrast, for the particular case of non-random, textured packings, biased and long-range correlated q-series along the force transmission tree are likely to be encountered, thus altering the previous purely diffusive behaviour.	Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Suslick, KS (corresponding author), Univ Illinois, Dept Chem, 600 S Mathews Ave, Urbana, IL 61801 USA.		Suslick, Kenneth S/A-1841-2010	Suslick, Kenneth S/0000-0001-5422-0701				ADLER AD, 1970, J INORG NUCL CHEM, V32, P2443, DOI 10.1016/0022-1902(70)80535-8; ADLER AD, 1967, J ORG CHEM, V32, P476, DOI 10.1021/jo01288a053; AXEL R, 1995, SCI AM, V273, P154, DOI 10.1038/scientificamerican1095-154; BARLEY M, 1983, CAN J CHEM, V61, P2389, DOI 10.1139/v83-414; BARON AE, 1993, REV SCI INSTRUM, V64, P3394, DOI 10.1063/1.1144310; Bhyrappa P, 1996, J AM CHEM SOC, V118, P5708, DOI 10.1021/ja953474k; Bhyrappa P, 1999, J AM CHEM SOC, V121, P262, DOI 10.1021/ja983411c; BLAUER G, 1985, OPTICAL PROPERTIES S; Brunink JAJ, 1996, ANAL CHIM ACTA, V325, P53, DOI 10.1016/0003-2670(96)00017-7; CHOU JH, 2000, PORPHYRIN HDB, V6, P43; Crooks RM, 1998, ACCOUNTS CHEM RES, V31, P219, DOI 10.1021/ar970246h; DATTAGUPTA N, 1968, J PHARM SCI-US, V57, P300, DOI 10.1002/jps.2600570211; Di Natale C, 1998, MAT SCI ENG C-BIOMIM, V5, P209, DOI 10.1016/S0928-4931(97)00045-3; Dickinson TA, 1996, NATURE, V382, P697, DOI 10.1038/382697a0; Dryer L, 1999, TRENDS PHARMACOL SCI, V20, P413, DOI 10.1016/S0165-6147(99)01381-4; FREUND MS, 1995, P NATL ACAD SCI USA, V92, P2652, DOI 10.1073/pnas.92.7.2652; GARDNER JW, 1992, SENSOR ACTUAT B-CHEM, V6, P71, DOI 10.1016/0925-4005(92)80033-T; Gelperin A, 2000, J NEUROPHYSIOL, V83, P116, DOI 10.1152/jn.2000.83.1.116; GRATE JW, 1991, SENSOR ACTUAT B-CHEM, V3, P85, DOI 10.1016/0925-4005(91)80202-U; Heilig A, 1997, SENSOR ACTUAT B-CHEM, V43, P45, DOI 10.1016/S0925-4005(97)00096-8; LANCET D, 1993, CURR BIOL, V3, P668, DOI 10.1016/0960-9822(93)90064-U; LEE WWS, 1993, J MATER CHEM, V3, P1031, DOI 10.1039/jm9930301031; Lonergan MC, 1996, CHEM MATER, V8, P2298, DOI 10.1021/cm960036j; NAPPA M, 1978, J AM CHEM SOC, V100, P5075, DOI 10.1021/ja00484a027; SEN A, IN PRESS J AM CHEM S; Suslick KS, 1996, COMPREHENSIVE SUPRAM, V5, P141; Vaughan AA, 1996, ANAL COMMUN, V33, P393, DOI 10.1039/ac9963300393; Walt DR, 1998, ACCOUNTS CHEM RES, V31, P267, DOI 10.1021/ar970069k; Yaws C.L., 1994, HDB VAPOR PRESSURE, VVolume 3	29	1157	1227	29	682	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2000	406	6797					710	713		10.1038/35021028	http://dx.doi.org/10.1038/35021028			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963592				2022-12-24	WOS:000088767700039
J	Van Cauter, E; Leproult, R; Plat, L				Van Cauter, E; Leproult, R; Plat, L			Age-related changes in slow wave sleep and REM sleep and relationship with growth hormone and cortisol levels in healthy men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CORTICOTROPIN-RELEASING HORMONE; PRIMARY ENDOGENOUS-DEPRESSION; ELECTROENCEPHALOGRAPHIC ACTIVITY; CIRCADIAN RHYTHMICITY; GLUCOSE REGULATION; 24-HOUR PROFILE; PLASMA-CORTISOL; SECRETION; HUMANS; YOUNG	Context In young adults, sleep affects the regulation of growth hormone (GH) and cortisol. The relationship between decreased sleep quality in older adults and age-related changes in the regulation of GH and cortisol is unknown. Objective To determine the chronology of age-related changes in sleep duration and quality (sleep stages) in healthy men and whether concomitant alterations occur in GH and cortisol levels. Design and Setting Data combined from a series of studies conducted between 1985 and 1999 at 4 laboratories. Subjects A total of 149 healthy men. aged 16 to 83 years, with a mean (SD) body mass index of 24.1 (2.3) kg/m(2), without sleep complaints or histories of endocrine, psychiatric, or sleep disorders. Main Outcome Measures Twenty-four-hour profiles of plasma GH and cortisol levels and polygraphic sleep recordings. Results The mean (SEM) percentage of deep slow wave sleep decreased from 18.9% (1.3%) during early adulthood (age 16-25 years) to 3.4% (1.0%) during midlife (age 36-50 years) and was replaced by lighter sleep (stages 1 and 2) without significant increases in sleep fragmentation or decreases in rapid eye movement (REM) sleep. The transition from midlife to late life (age 71-83 years) involved no further significant decrease in slow wave sleep but an increase in time awake of 28 minutes per decade at the expense of decreases in both light non-REM sleep (-24 minutes per decade; P<.001) and REM sleep (-10 minutes per decade; P<.001). The decline in slow wave sleep from early adulthood to midlife was paralleled by a major decline in GH secretion (-372 mu g per decade; P<.001). From midlife to late life, GH secretion further declined at a slower rate (-43 mu g per decade; P<.02). Independently of age, the amount of GH secretion was significantly associated with slow wave sleep (P<.001). Increasing age was associated with an elevation of evening cortisol levels (+19.3 nmol/L per decade; P<.001) that became significant only after age 50 years, when sleep became more fragmented and REM sleep declined. A trend for an association between lower amounts of REM sleep and higher evening cortisol concentrations independent of age was detected (P<.10). Conclusions In men, age-related changes in slow wave sleep and REM sleep occur with markedly different chronologies and are each associated with specific hormonal alterations. Future studies should evaluate whether strategies to enhance sleep quality may have beneficial hormonal effects.	Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago	Van Cauter, E (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave,MC 1027, Chicago, IL 60637 USA.	evcauter@medicine.bsd.uchicago.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041814] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG011412] Funding Source: NIH RePORTER; NIA NIH HHS [AG-11412] Funding Source: Medline; NIDDK NIH HHS [DK-41814] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ASTROM C, 1995, ACTA NEUROL SCAND, V92, P281; BENCA RM, 1992, ARCH GEN PSYCHIAT, V49, P651; Bierwolf C, 1997, J NEUROENDOCRINOL, V9, P479, DOI 10.1046/j.1365-2826.1997.00605.x; Biston P, 1996, HYPERTENSION, V28, P863, DOI 10.1161/01.HYP.28.5.863; BLIWISE DL, 1994, PRINCIPLES PRACTICE, P26; Borbely AA, 1998, HORM RES, V49, P114, DOI 10.1159/000023156; BORN J, 1989, J CLIN ENDOCR METAB, V68, P904, DOI 10.1210/jcem-68-5-904; COOPER BG, 1995, SLEEP, V18, P172; Copinschi G, 1997, NEUROENDOCRINOLOGY, V66, P278, DOI 10.1159/000127249; COPINSCHI G, 1990, SLEEP, V13, P232; CORPAS E, 1993, ENDOCR REV, V14, P20, DOI 10.1210/er.14.1.20; CUNEO RC, 1992, CLIN ENDOCRINOL, V37, P387, DOI 10.1111/j.1365-2265.1992.tb02347.x; DALLMAN MF, 1993, FRONT NEUROENDOCRIN, V14, P303, DOI 10.1006/frne.1993.1010; DIJK DJ, 1995, J NEUROSCI, V15, P3526; DIJK DJ, 1989, SLEEP, V12, P500, DOI 10.1093/sleep/12.6.500; Ehlers CL, 1997, J SLEEP RES, V6, P211, DOI 10.1046/j.1365-2869.1997.00041.x; EHLERS CL, 1989, ELECTROEN CLIN NEURO, V72, P118, DOI 10.1016/0013-4694(89)90172-7; FEINBERG I, 1967, J PSYCHIAT RES, V5, P107, DOI 10.1016/0022-3956(67)90027-1; Feinberg I, 1976, NEUROBIOL AGING, P23; Frank SA, 1995, AM J PHYSIOL-ENDOC M, V269, pE1006, DOI 10.1152/ajpendo.1995.269.6.E1006; Gronfier C, 1996, SLEEP, V19, P817, DOI 10.1093/sleep/19.10.817; Gronfier C, 1997, ELECTROEN CLIN NEURO, V103, P405, DOI 10.1016/S0013-4694(97)00013-1; HO KY, 1987, J CLIN ENDOCR METAB, V64, P51, DOI 10.1210/jcem-64-1-51; HOLSBOER F, 1988, NEUROENDOCRINOLOGY, V48, P32, DOI 10.1159/000124986; JARRETT DB, 1991, BIOL PSYCHIAT, V29, P3, DOI 10.1016/0006-3223(91)90206-2; JARRETT DJ, 1988, 1 M SOC RES BIOL RHY; Kern W, 1996, J GERONTOL A-BIOL, V51, pM3, DOI 10.1093/gerona/51A.1.M3; Landolt HP, 1996, BRAIN RES, V738, P205, DOI 10.1016/S0006-8993(96)00770-6; Leproult R, 1997, SLEEP, V20, P865; LHermiteBaleriaux M, 1996, CLIN CHEM, V42, P1789; LINKOWSKI P, 1985, J CLIN ENDOCR METAB, V61, P429, DOI 10.1210/jcem-61-3-429; Linkowski P, 1998, AM J PHYSIOL-ENDOC M, V274, pE909, DOI 10.1152/ajpendo.1998.274.5.E909; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; MOURTAZAEV MS, 1995, SLEEP, V18, P557, DOI 10.1093/sleep/18.7.557; Plat L, 1999, J CLIN ENDOCR METAB, V84, P3082, DOI 10.1210/jc.84.9.3082; PRINZ PN, 1995, J CLIN NEUROPHYSIOL, V12, P139, DOI 10.1097/00004691-199503000-00004; Rechtschaffen A., 1968, MANUAL STANDARDIZED; ROSEN T, 1993, ACTA ENDOCRINOL-COP, V129, P201, DOI 10.1530/acta.0.1290201; RUBIN RT, 1990, BIOL PSYCHIAT, V27, P1065, DOI 10.1016/0006-3223(90)90044-3; RUBIN RT, 1987, ARCH GEN PSYCHIAT, V44, P328; SAINI J, 1993, HORM METAB RES, V25, P375, DOI 10.1055/s-2007-1002123; SEEMAN TE, 1994, ENDOCR REV, V15, P233, DOI 10.1210/er.15.2.233; SPATHSCHWALBE E, 1993, J CLIN ENDOCR METAB, V77, P1170, DOI 10.1210/jc.77.5.1170; SPATHSCHWALBE E, 1994, NEUROENDOCRINOLOGY, V60, P544, DOI 10.1159/000126793; Van Cauter E, 1998, SLEEP, V21, P553; VanCauter E, 1997, J CLIN INVEST, V100, P745, DOI 10.1172/JCI119587; VANCAUTER E, 1991, J CLIN INVEST, V88, P934, DOI 10.1172/JCI115396; VANCAUTER E, 1979, AM J PHYSIOL, V237, pE225, DOI 10.1152/ajpendo.1979.237.3.E255; VANCAUTER E, 1988, AM J PHYSIOL, V254, pE786, DOI 10.1152/ajpendo.1988.254.6.E786; VANCAUTER E, 1992, J CLIN ENDOCR METAB, V74, P1441, DOI 10.1210/jc.74.6.1441; VanCauter E, 1996, J CLIN ENDOCR METAB, V81, P2468, DOI 10.1210/jc.81.7.2468; VANCOEVORDEN A, 1991, AM J PHYSIOL, V260, pE651, DOI 10.1152/ajpendo.1991.260.4.E651; Vgontzas AN, 2000, J CLIN ENDOCR METAB, V85, P1151, DOI 10.1210/jc.85.3.1151; VIRASORO E, 1971, CLIN CHIM ACTA, V31, P294, DOI 10.1016/0009-8981(71)90392-5; WEBB WB, 1982, J GERONTOL, V37, P581, DOI 10.1093/geronj/37.5.581; WEITZMAN ED, 1983, J CLIN ENDOCR METAB, V56, P352, DOI 10.1210/jcem-56-2-352	57	454	458	1	43	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2000	284	7					861	868		10.1001/jama.284.7.861	http://dx.doi.org/10.1001/jama.284.7.861			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	342PM	10938176	Bronze			2022-12-24	WOS:000088654400029
J	Volchuk, A; Amherdt, M; Ravazzola, M; Brugger, B; Rivera, VM; Clackson, T; Perrelet, A; Sollner, TH; Rothman, JE; Orci, L				Volchuk, A; Amherdt, M; Ravazzola, M; Brugger, B; Rivera, VM; Clackson, T; Perrelet, A; Sollner, TH; Rothman, JE; Orci, L			Megavesicles implicated in the rapid transport of intracisternal aggregates across the Golgi stack	CELL			English	Article							ENDOPLASMIC-RETICULUM; CISTERNAL MATURATION; MEMBRANE-PROTEINS; COPI VESICLES; LIVING CELLS; APPARATUS; COMPLEX; ER; SECRETION; COATOMER	Engineered protein aggregates ranging up to 400 nm in diameter were selectively deposited within the cis-most cisternae of the Golgi stack following a 15 degrees C block. These aggregates are much larger than the standard volume of Golgi vesicles, yet they are transported across the stack within 10 min after warming the cells to 20 degrees C. Serial sectioning reveals that during the peak of anterograde transport, about 20% of the aggregates were enclosed in topologically free "megavesicles" which appear to pinch off from the rims of the cisternae. These megavesicles can explain the rapid transport of aggregates without cisternal progression on this time scale.	Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA; Univ Geneva, Sch Med, Dept Morphol, CH-1211 Geneva 4, Switzerland; ARIAD Pharmaceut Inc, Cambridge, MA 02139 USA	Memorial Sloan Kettering Cancer Center; University of Geneva; Takeda Pharmaceutical Company Ltd; Takeda Oncology	Rothman, JE (corresponding author), Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, 1275 York Ave, New York, NY 10021 USA.			Rivera, Victor/0000-0002-7258-3001				Allan RB, 1999, SCIENCE, V285, P63, DOI 10.1126/science.285.5424.63; ATTAR RM, 1992, MOL CELL BIOL, V12, P2432, DOI 10.1128/MCB.12.5.2432; Bonfanti L, 1999, MOL BIOL CELL, V10, p114A; Bonfanti L, 1998, CELL, V95, P993, DOI 10.1016/S0092-8674(00)81723-7; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; CLAUDE A, 1970, J CELL BIOL, V47, P745, DOI 10.1083/jcb.47.3.745; CLERMONT Y, 1993, ANAT REC, V235, P363, DOI 10.1002/ar.1092350305; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; DAHAN S, 1994, J CELL BIOL, V127, P1859, DOI 10.1083/jcb.127.6.1859; Denault JB, 1996, FEBS LETT, V379, P113, DOI 10.1016/0014-5793(95)01487-X; Glick BS, 1997, FEBS LETT, V414, P177, DOI 10.1016/S0014-5793(97)00984-8; Glick BS, 1998, CELL, V95, P883, DOI 10.1016/S0092-8674(00)81713-4; GREEN J, 1981, J MOL BIOL, V152, P663, DOI 10.1016/0022-2836(81)90122-4; GRIFFITHS G, 1989, J CELL BIOL, V108, P277, DOI 10.1083/jcb.108.2.277; GRIFFITHS G, 1986, SCIENCE, V234, P438, DOI 10.1126/science.2945253; HARAKUGE S, 1994, J CELL BIOL, V124, P883, DOI 10.1083/jcb.124.6.883; Hay JC, 1997, CELL, V89, P149, DOI 10.1016/S0092-8674(00)80191-9; Hay JC, 1998, J CELL BIOL, V141, P1489, DOI 10.1083/jcb.141.7.1489; Holthuis JCM, 1998, EMBO J, V17, P113, DOI 10.1093/emboj/17.1.113; JAMIESON JD, 1971, J CELL BIOL, V50, P135, DOI 10.1083/jcb.50.1.135; Lanoix J, 1999, EMBO J, V18, P4935, DOI 10.1093/emboj/18.18.4935; LEBLOND CP, 1989, ANAT REC, V224, P123, DOI 10.1002/ar.1092240204; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; MELKONIAN M, 1991, J ELECTRON MICR TECH, V17, P165, DOI 10.1002/jemt.1060170205; ORCI L, 1985, P NATL ACAD SCI USA, V82, P5385, DOI 10.1073/pnas.82.16.5385; ORCI L, 1973, J ULTRA MOL STRUCT R, V43, P270, DOI 10.1016/S0022-5320(73)80039-5; ORCI L, 1989, CELL, V56, P357, DOI 10.1016/0092-8674(89)90239-0; ORCI L, 1986, CELL, V46, P171, DOI 10.1016/0092-8674(86)90734-8; Orci L, 1998, P NATL ACAD SCI USA, V95, P2279, DOI 10.1073/pnas.95.5.2279; Orci L, 1997, CELL, V90, P335, DOI 10.1016/S0092-8674(00)80341-4; ORCI L, 2000, IN PRESS J CELL BIOL; OSTERMANN J, 1993, CELL, V75, P1015, DOI 10.1016/0092-8674(93)90545-2; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; PELHAM HRB, 1994, CELL, V79, P1125, DOI 10.1016/0092-8674(94)90002-7; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; QUINN P, 1984, J CELL BIOL, V98, P2142, DOI 10.1083/jcb.98.6.2142; RABOUILLE C, 1995, J CELL SCI, V108, P1617; Rivera VM, 2000, SCIENCE, V287, P826, DOI 10.1126/science.287.5454.826; Rollins CT, 2000, P NATL ACAD SCI USA, V97, P7096, DOI 10.1073/pnas.100101997; ROTHMAN JE, 1994, CURR BIOL, V4, P220, DOI 10.1016/S0960-9822(00)00051-8; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; SARASTE J, 1984, CELL, V38, P535, DOI 10.1016/0092-8674(84)90508-7; Scales SJ, 1997, CELL, V90, P1137, DOI 10.1016/S0092-8674(00)80379-7; SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904; SIMIONESCU N, 1976, J CELL BIOL, V70, P622, DOI 10.1083/jcb.70.3.622; SOGAARD M, 1994, CELL, V78, P937, DOI 10.1016/0092-8674(94)90270-4; Sonnichsen B, 1998, J CELL BIOL, V140, P1013, DOI 10.1083/jcb.140.5.1013; TANDLER B, 1990, J ELECTRON MICR TECH, V16, P81, DOI 10.1002/jemt.1060160110; WATERS MG, 1992, J CELL BIOL, V118, P1015, DOI 10.1083/jcb.118.5.1015	49	83	85	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 4	2000	102	3					335	348		10.1016/S0092-8674(00)00039-8	http://dx.doi.org/10.1016/S0092-8674(00)00039-8			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	342BP	10975524	Bronze			2022-12-24	WOS:000088625600009
J	Chen, YQ; Cann, MJ; Litvin, TN; Iourgenko, V; Sinclair, ML; Levin, LR; Buck, J				Chen, YQ; Cann, MJ; Litvin, TN; Iourgenko, V; Sinclair, ML; Levin, LR; Buck, J			Soluble adenylyl cyclase as an evolutionarily conserved bicarbonate sensor	SCIENCE			English	Article							SPIRULINA-PLATENSIS; SPERM; PURIFICATION; CYAC	Spermatozoa undergo a poorly understood activation process induced by bicarbonate and mediated by cyclic adenosine 3',5'-monophosphate (cAMP). It has been assumed that bicarbonate mediates its effects through changes in intracellular pH or membrane potential; however, we demonstrate here that bicarbonate directly stimulates mammalian soluble adenylyl cyclase (sAC) activity in vivo and in vitro in a pH-independent manner. sAC is most similar to adenylyl cyclases from cyanobacteria, and bicarbonate regulation of cyclase activity is conserved in these early forms of life. sAC is also expressed in other bicarbonate-responsive tissues, which suggests that bicarbonate regulation of cAMP signaling plays a fundamental role in many biological systems.	Cornell Univ, Joan & Sanford I Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA	Cornell University	Cann, MJ (corresponding author), Cornell Univ, Joan & Sanford I Weill Med Coll, Dept Pharmacol, 1300 York Ave, New York, NY 10021 USA.		Cann, Martin/G-2864-2012	Cann, Martin/0000-0001-6305-8769; Levin, Lonny/0000-0002-5204-6356				BRAUN T, 1975, P NATL ACAD SCI USA, V72, P1097, DOI 10.1073/pnas.72.3.1097; BRAUN T, 1991, METHOD ENZYMOL, V195, P130; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; CANN MJ, UNPUB; CANN MJ, COMMUNICATION; FORTE LR, 1983, MOL PHARMACOL, V24, P42; GARTY NB, 1987, FEBS LETT, V218, P148, DOI 10.1016/0014-5793(87)81036-0; Johnson LR, 1998, ESSENTIAL MED PHYSL; Kasahara M, 1999, J BIOL CHEM, V274, P15167, DOI 10.1074/jbc.274.21.15167; Kasahara M, 1997, PLANT CELL PHYSIOL, V38, P828, DOI 10.1093/oxfordjournals.pcp.a029241; LEVIN LR, 1995, J BIOL CHEM, V270, P7573, DOI 10.1074/jbc.270.13.7573; LEVINE N, 1971, J PHYSIOL-LONDON, V213, P557, DOI 10.1113/jphysiol.1971.sp009400; MITTAG TW, 1993, AM J PHYSIOL, V264, pF1060, DOI 10.1152/ajprenal.1993.264.6.F1060; OHMORI K, 1992, PLANT CELL PHYSIOL, V33, P21; Ohno S, 1997, J MOL EVOL, V44, pS23, DOI 10.1007/PL00000055; OKAMURA N, 1991, J BIOL CHEM, V266, P17754; Pitts RF, 1974, PHYSL KIDNEY BODY FL, V3rd; Scholich K, 1997, P NATL ACAD SCI USA, V94, P2915, DOI 10.1073/pnas.94.7.2915; Sinclair ML, 2000, MOL REPROD DEV, V56, P6, DOI 10.1002/(SICI)1098-2795(200005)56:1&lt;6::AID-MRD2&gt;3.0.CO;2-M; Visconti PE, 1998, J ANDROL, V19, P242	20	658	686	2	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 28	2000	289	5479					625	628		10.1126/science.289.5479.625	http://dx.doi.org/10.1126/science.289.5479.625			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	338XD	10915626				2022-12-24	WOS:000088447800055
J	Peck, JR; Waxman, D				Peck, JR; Waxman, D			Mutation and sex in a competitive world	NATURE			English	Article							DELETERIOUS MUTATIONS; SYNERGISTIC EPISTASIS; MULLERS RATCHET; SELECTION; EVOLUTION; FITNESS; RECOMBINATION; REPRODUCTION; ADAPTATION; RATES	How do deleterious mutations interact to affect fitness? The answer to this question has substantial implications for a variety of important problems in population biology, including the evolution of sex(1-3), the rate of adaptation(4,5) and the conservation of small populations(3,6-8). Here we analyse a mathematical model of competition for food in which deleterious mutations affect competitive ability. We show that, if individuals usually compete in small groups, then competition can easily lead to a type of genetic interaction known as synergistic epistasis. This means that a deleterious mutation is most damaging in a genome that already has many other deleterious mutations. We also show that competition in small groups can produce a large advantage for sexual populations, both in mean fitness and in ability to resist invasion by asexual lineages. One implication of our findings is that experimental efforts to demonstrate synergistic epistasis may not succeed unless the experiments are redesigned to make them much more naturalistic.	Univ Sussex, Ctr Study Evolut, Brighton BN1 9QG, E Sussex, England	University of Sussex	Peck, JR (corresponding author), Univ Sussex, Ctr Study Evolut, Brighton BN1 9QG, E Sussex, England.			Peck, Joel/0000-0003-0421-8739				Bell G., 1982, MASTERPIECE NATURE; BUTCHER D, 1995, GENETICS, V141, P431; CHARLESWORTH B, 1993, GENET RES, V61, P205, DOI 10.1017/S0016672300031372; CHARLESWORTH B, 1990, GENET RES, V55, P199, DOI 10.1017/S0016672300025532; Crow J.F., 1970, MATH TOPICS POPULATI; de Visser JAGM, 1998, GENET RES, V71, P39, DOI 10.1017/S0016672397003091; deVisser JAGM, 1997, GENETICS, V145, P815; Elena SF, 1997, NATURE, V390, P395, DOI 10.1038/37108; Eyre-Walker A, 1999, NATURE, V397, P344, DOI 10.1038/16915; Eyre-Walker A, 1999, GENETICS, V152, P675; Fry JD, 1999, P NATL ACAD SCI USA, V96, P574, DOI 10.1073/pnas.96.2.574; Gradshteyn I.S., 2014, TABLE INTEGRALS SERI; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; KIMURA M, 1966, GENETICS, V54, P1337; KING JL, 1967, GENETICS, V55, P483; Koelewijn HP, 1998, EVOLUTION, V52, P692, DOI 10.1111/j.1558-5646.1998.tb03694.x; KONDRASHOV AS, 1992, GENETICS, V132, P603; KONDRASHOV AS, 1995, J THEOR BIOL, V175, P583, DOI 10.1006/jtbi.1995.0167; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; KONDRASHOV AS, 1994, GENETICS, V136, P1469; Krebs CJ., 1994, ECOLOGY; Maynard Smith J., 1978, EVOLUTION SEX; NYGREN A, 1954, BOT REV, V20, P577, DOI 10.1007/BF02958805; PARKER ED, 2000, EVOL GENET, P450; Peck JR, 1997, NATURE, V387, P135, DOI 10.1038/387135a0; Peck JR, 1997, GENETICS, V145, P1171; SVED JA, 1967, GENETICS, V55, P469; Waxman D, 1999, GENETICS, V153, P1041; West SA, 1998, GENETICS, V149, P435; WILLIS JH, 1993, EVOLUTION, V47, P864, DOI 10.1111/j.1558-5646.1993.tb01240.x	30	40	40	0	13	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					399	404		10.1038/35019055	http://dx.doi.org/10.1038/35019055			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935634				2022-12-24	WOS:000088383800044
J	Johnsen, A; Andersen, V; Sunding, C; Lifjeld, JT				Johnsen, A; Andersen, V; Sunding, C; Lifjeld, JT			Female bluethroats enhance offspring immunocompetence through extra-pair copulations	NATURE			English	Article							LUSCINIA S. SVECICA; ZEBRA FINCH; PATERNITY; BIRDS; FERTILIZATIONS; SURVIVAL	Female birds frequently copulate with extra-pair males(1,2), but the adaptive value of this behaviour is poorly understood(2). Some studies have suggested that 'good genes' may be involved, where females seek to have their eggs fertilized by high-quality males without receiving any material benefits from them(3,4). Nevertheless, it remains to be shown that a genetic benefit is passed on to offspring(5,6). Here we report that nestling bluethroats, Luscinia svecica, sired by extra-pair males had a higher T-cell-mediated immune response than their maternal half-siblings raised in the same nest. The difference could not be attributed to nestling body mass, sex or hatching order, but may be an effect of paternal genotype. Extra-pair young were also more immunocompetent than their paternal half-sibs raised in the genetic father's own nest, which indicates an additional effect of maternal genotype. Our results are consistent with the idea that females engage in extra-pair copulations to obtain compatible viability genes, rather than 'good genes' per se.	Univ Oslo, Zool Museum, N-0562 Oslo, Norway	University of Oslo	Lifjeld, JT (corresponding author), Univ Wisconsin, Dept Biol Sci, Lapham Hall,POB 413, Milwaukee, WI 53201 USA.	j.t.lifjeld@toyen.uio.no	Lifjeld, Jan T/B-1978-2008	Lifjeld, Jan T/0000-0002-9172-9985; Johnsen, Arild/0000-0003-4864-6284				Andersson Malte, 1994; Anthonisen K, 1997, AUK, V114, P553; Birkhead T.R., 1998, P579, DOI 10.1016/B978-012100543-6/50039-8; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P385, DOI 10.1098/rspb.1999.0649; Brinkhof MWG, 1999, P ROY SOC B-BIOL SCI, V266, P2315, DOI 10.1098/rspb.1999.0925; Christe P, 1998, OIKOS, V83, P175, DOI 10.2307/3546559; Cunningham EJA, 2000, NATURE, V404, P74, DOI 10.1038/35003565; Gil D, 1999, SCIENCE, V286, P126, DOI 10.1126/science.286.5437.126; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Hasselquist D, 1996, NATURE, V381, P229, DOI 10.1038/381229a0; JAMIESON A, 1994, ANIM GENET, V25, P37, DOI 10.1111/j.1365-2052.1994.tb00401.x; JEFFREYS AJ, 1992, FORENSIC SCI INT, V56, P65, DOI 10.1016/0379-0738(92)90148-P; Johnsen A, 1998, BEHAV ECOL SOCIOBIOL, V43, P401, DOI 10.1007/s002650050507; Johnsen A, 1998, P ROY SOC B-BIOL SCI, V265, P1313, DOI 10.1098/rspb.1998.0435; Kempenaers B, 1996, ANIM BEHAV, V51, P1165, DOI 10.1006/anbe.1996.0118; KEMPENAERS B, 1992, NATURE, V357, P494, DOI 10.1038/357494a0; MCCORKLE F, 1980, POULTRY SCI, V59, P616, DOI 10.3382/ps.0590616; PETRIE M, 1994, NATURE, V371, P598, DOI 10.1038/371598a0; Saino N, 1997, J ANIM ECOL, V66, P827, DOI 10.2307/5998; Sheldon BC, 1997, P ROY SOC B-BIOL SCI, V264, P297, DOI 10.1098/rspb.1997.0042; Sheldon BC, 1999, NATURE, V402, P874, DOI 10.1038/47239; Westneat DF, 1997, BEHAV ECOL SOCIOBIOL, V41, P205, DOI 10.1007/s002650050381	22	172	174	0	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 20	2000	406	6793					296	299		10.1038/35018556	http://dx.doi.org/10.1038/35018556			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335PM	10917529				2022-12-24	WOS:000088251900047
J	Henney, JE				Henney, JE			Joint meeting of advisory committees	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item											Henney, JE (corresponding author), HF-1,Room 14-71,5600 Fishers Ln, Rockville, MD 20857 USA.								0	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 5	2000	284	1					33	33		10.1001/jama.284.1.33	http://dx.doi.org/10.1001/jama.284.1.33			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	328GX	10905906				2022-12-24	WOS:000087843000005
J	Kozlowski, LT; O'Connor, RJ				Kozlowski, LT; O'Connor, RJ			Official cigarette tar tests are misleading: use a two-stage, compensating test	LANCET			English	Editorial Material							CARBON-MONOXIDE EXPOSURE; LOW-YIELD CIGARETTES; SAFER SMOKING; NICOTINE; TOBACCO; SMOKERS; BRANDS		Penn State Univ, Dept Biobehav Hlth, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kozlowski, LT (corresponding author), Penn State Univ, Dept Biobehav Hlth, University Pk, PA 16802 USA.		O'Connor, Richard/A-6961-2009					Bates C, 1999, TOB CONTROL, V8, P225, DOI 10.1136/tc.8.2.225; BENOWITZ NL, 1986, JAMA-J AM MED ASSOC, V256, P241; BENOWITZ NL, 1983, NEW ENGL J MED, V309, P139, DOI 10.1056/NEJM198307213090303; Djordjevic MV, 2000, JNCI-J NATL CANCER I, V92, P106, DOI 10.1093/jnci/92.2.106; *FED TRAD COMM, 1999, TAR NIC CARB MON SMO; *FED TRAD COMM, 1997, P944509 FTC; FROST C, 1995, THORAX, V50, P1038, DOI 10.1136/thx.50.10.1038; Glantz S.A., 1996, CIGARETTE PAPERS; HENNINGFIELD JE, 1994, JAMA-J AM MED ASSOC, V272, P312, DOI 10.1001/jama.272.4.312; HERNING RI, 1981, BRIT MED J, V283, P187, DOI 10.1136/bmj.283.6285.187; Kozlowski LT, 1998, TOB CONTROL, V7, P369, DOI 10.1136/tc.7.4.369; Kozlowski LT, 2000, AM J PREV MED, V18, P339, DOI 10.1016/S0749-3797(00)00125-2; Kozlowski LT, 1998, AM J PREV MED, V15, P9, DOI 10.1016/S0749-3797(98)00004-X; KOZLOWSKI LT, 1983, NIDA RES MONOGRAPH, V48; PEELER CE, 1996, NCI SMOKING TOBACCO, V7, P1; RICKERT WS, 1983, PREV MED, V12, P682, DOI 10.1016/0091-7435(83)90226-8; *ROYAL COLL PHYS, 2000, NIC ADD BRIT REP TOB; RUSSELL MAH, 1976, BRIT MED J, V1, P1430, DOI 10.1136/bmj.1.6023.1430; RUSSELL MAH, 1974, LANCET, V1, P254; SAMET JM, 1996, NCI SMOKING TOBACCO, V7, P77; Sweeney CT, 1999, PHARMACOL BIOCHEM BE, V63, P167, DOI 10.1016/S0091-3057(98)00250-0; TOWNSEND DE, 1996, NCI SMOKING TOBACCO, V7, pCH13; WARNER KE, 1992, AM J PUBLIC HEALTH, V82, P17, DOI 10.2105/AJPH.82.1.17	23	33	38	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUN 17	2000	355	9221					2159	2161		10.1016/S0140-6736(00)02390-4	http://dx.doi.org/10.1016/S0140-6736(00)02390-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	325QD	10902645				2022-12-24	WOS:000087687100041
J	Gronbaek, M; Becker, U; Johansen, D; Gottschau, A; Schnohr, P; Hein, HO; Jensen, G; Sorensen, TIA				Gronbaek, M; Becker, U; Johansen, D; Gottschau, A; Schnohr, P; Hein, HO; Jensen, G; Sorensen, TIA			Type of alcohol consumed and mortality from all causes, coronary heart disease, and cancer	ANNALS OF INTERNAL MEDICINE			English	Article							DENSITY-LIPOPROTEIN; FRENCH PARADOX; 7 COUNTRIES; DANISH MEN; RED WINE; RISK; CONSUMPTION; WOMEN; DIET; BEER	Background: Although the J-shaped relation between alcohol intake and mortality has been reproduced in many large cohort studies, the question of whether the effects of beer, wine, and spirits differ remains controversial. Objective: To examine the relation between intake of different types of alcohol and death from all causes, coronary heart disease, and cancer. Design: Pooled cohort studies in which intake of beer, wine, and spirits; smoking status; educational level; physical activity; and body mass index were assessed at baseline. Setting: Copenhagen, Denmark. Participants: 13 064 men and 11 459 women 20 to 98 years of age. Measurements: Number of deaths and time to death from all causes, coronary heart disease, and cancer during follow-up. Results: During 257 859 person-years of follow-up, 4833 participants died. J-shaped relations were found between total alcohol intake and mortality at various levels of wine intake. Compared with nondrinken, light drinkers who avoided wine had a relative risk for death from all causes of 0.90 (95% CI, 0.82 to 0.99) and those who drank wine had a relative risk of 0.66 (CI, 0.55 to 0.77). Heavy drinkers who avoided wine were at higher risk for death from all causes than were heavy drinkers who included wine in their alcohol intake. Wine drinkers had significantly lower mortality from both coronary heart disease and cancer than did non-wine drinkers (P = 0.007 and P = 0.004, respectively). Conclusion: Wine intake may have a beneficial effect on all-cause mortality that is additive to that of alcohol. This effect may be attributable to a reduction in death from both coronary heart disease and cancer.	Copenhagen Univ Hosp, Hvidovre Hosp, Inst Prevent Med,Danish Epidemiol Sci Ctr, Copenhagen Ctr Prospect Populat Studies, Copenhagen, Denmark; Univ Copenhagen, Bispebjerg Hosp, Copenhagen, Denmark	Aarhus University; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital	Gronbaek, M (corresponding author), Kommune Hosp Copenhagen, Inst Prevent Med, DK-1399 Copenhagen, Denmark.		Becker, Ulrik/D-2657-2012	Becker, Ulrik/0000-0002-1678-7771; Gronbaek, Morten Klocker/0000-0002-8473-6474				[Anonymous], 1989, GEN LINEAR MODELS, DOI [10.1007/978-1-4899-3242-6, DOI 10.1007/978-1-4899-3242-6]; APPLEYARD M, 1989, SCAND J SOC MED S, V41, P1; BLOCK G, 1992, NUTR CANCER, V18, P1, DOI 10.1080/01635589209514201; CRIQUI MH, 1994, LANCET, V344, P1719, DOI 10.1016/S0140-6736(94)92883-5; DIEHL AK, 1988, ATHEROSCLEROSIS, V69, P145, DOI 10.1016/0021-9150(88)90008-1; DOLL R, 1994, BRIT MED J, V309, P911, DOI 10.1136/bmj.309.6959.911; FARCHI G, 1992, INT J EPIDEMIOL, V21, P74, DOI 10.1093/ije/21.1.74; FRANKEL EN, 1993, LANCET, V341, P454, DOI 10.1016/0140-6736(93)90206-V; FUCHS CS, 1995, NEW ENGL J MED, V332, P1245, DOI 10.1056/NEJM199505113321901; GRONBAEK M, 1994, BRIT MED J, V308, P302, DOI 10.1136/bmj.308.6924.302; Gronbaek M, 2000, EUR J CLIN NUTR, V54, P174, DOI 10.1038/sj.ejcn.1600919; GRONBAEK M, 1995, BRIT MED J, V310, P1165, DOI 10.1136/bmj.310.6988.1165; HEIN HO, 1993, LANCET, V341, P392, DOI 10.1016/0140-6736(93)92987-5; HEITMANN BL, 1993, INT J OBESITY, V17, P329; HERTOG MGL, 1995, ARCH INTERN MED, V155, P381, DOI 10.1001/archinte.155.4.381; HERTOG MGL, 1993, LANCET, V342, P1007, DOI 10.1016/0140-6736(93)92876-U; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Keil U, 1997, EPIDEMIOLOGY, V8, P150, DOI 10.1097/00001648-199703000-00005; KITTNER SJ, 1983, AM J EPIDEMIOL, V117, P538, DOI 10.1093/oxfordjournals.aje.a113576; KLATSKY AL, 1993, AM J CARDIOL, V71, P467, DOI 10.1016/0002-9149(93)90460-T; KLATSKY AL, 1992, ANN INTERN MED, V117, P646, DOI 10.7326/0003-4819-117-8-646; Mabeck C E, 1980, Ugeskr Laeger, V142, P257; McElduff P, 1997, BRIT MED J, V314, P1159, DOI 10.1136/bmj.314.7088.1159; Ness AR, 1997, INT J EPIDEMIOL, V26, P1, DOI 10.1093/ije/26.1.1; POIKOLAINEN K, 1995, J CLIN EPIDEMIOL, V48, P455, DOI 10.1016/0895-4356(94)00174-O; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; RENAUD SC, 1992, AM J CLIN NUTR, V55, P1012, DOI 10.1093/ajcn/55.5.1012; RIMM EB, 1995, AM J CLIN NUTR, V61, p1378S, DOI 10.1093/ajcn/61.6.1378S; Rimm EB, 1996, BRIT MED J, V312, P731, DOI 10.1136/bmj.312.7033.731; RIMM EB, 1995, BRIT MED J, V310, P555, DOI 10.1136/bmj.310.6979.555; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; ROSENBERG L, 1981, AM J PUBLIC HEALTH, V71, P82, DOI 10.2105/AJPH.71.1.82; RUF JC, 1995, ARTERIOSCL THROM VAS, V15, P140, DOI 10.1161/01.ATV.15.1.140; *SAS I, 1993, SAS STAT SOFTW GENMO; STAMPFER MJ, 1988, NEW ENGL J MED, V319, P267, DOI 10.1056/NEJM198808043190503; STLEGER AS, 1979, LANCET, V1, P1017, DOI 10.1016/S0140-6736(79)92765-X; SUH I, 1992, ANN INTERN MED, V116, P881, DOI 10.7326/0003-4819-116-11-881; Tjonneland A, 1999, AM J CLIN NUTR, V69, P49; WILSON V, 1995, BRIT MED J, V311, P1166, DOI 10.1136/bmj.311.7013.1166b; YANO K, 1977, NEW ENGL J MED, V297, P405, DOI 10.1056/NEJM197708252970801; Yuan JM, 1997, BRIT MED J, V314, P18, DOI 10.1136/bmj.314.7073.18	41	362	377	0	27	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 19	2000	133	6					411	419		10.7326/0003-4819-133-6-200009190-00008	http://dx.doi.org/10.7326/0003-4819-133-6-200009190-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354KM	10975958				2022-12-24	WOS:000089329700002
J	Beja, O; Aravind, L; Koonin, EV; Suzuki, MT; Hadd, A; Nguyen, LP; Jovanovich, S; Gates, CM; Feldman, RA; Spudich, JL; Spudich, EN; DeLong, EF				Beja, O; Aravind, L; Koonin, EV; Suzuki, MT; Hadd, A; Nguyen, LP; Jovanovich, S; Gates, CM; Feldman, RA; Spudich, JL; Spudich, EN; DeLong, EF			Bacterial rhodopsin: Evidence for a new type of phototrophy in the sea	SCIENCE			English	Article							16S RIBOSOMAL-RNA; ESCHERICHIA-COLI; PROTON RELEASE; PHYLOGENETIC DIVERSITY; MEMBRANE-VESICLES; BINDING-PROTEIN; BACTERIORHODOPSIN; TRANSDUCER; GENE; ARCHAEAL	Extremely halophilic archaea contain retinal-binding integral membrane proteins called bacteriorhodopsins that function as Light-driven proton pumps. So far, bacteriorhodopsins capable of generating a chemiosmotic membrane potential in response to Light have been demonstrated only in halophilic archaea. We describe here a type of rhodopsin derived from bacteria that was discovered through genomic analyses of naturally occuring marine bacterioplankton. The bacterial rhodopsin was encoded in the genome of an uncultivated gamma-proteobacterium and shared highest amino acid sequence similarity with archaeal rhodopsins. The protein was functionally expressed in Escherichia coli and bound retinal to form an active, Light-driven proton pump. The new rhodopsin exhibited a photochemical reaction cycle with intermediates and kinetics characteristic of archaeal proton-pumping rhodopsins. Our results demonstrate that archaeal-like rhodopsins are broadly distributed among different taxa, including members of the domain Bacteria. Our data also indicate that a previously unsuspected mode of bacterially mediated Light-driven energy generation may commonly occur in oceanic surface waters worldwide.	Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA; Amersham Pharmacia Biotech, Mol Dynam, Sunnyvale, CA 94086 USA; Univ Texas, Sch Med, Dept Microbiol & Mol Genet, Houston, TX 77030 USA	Monterey Bay Aquarium Research Institute; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Pfizer; University of Texas System	DeLong, EF (corresponding author), Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA.		Suzuki, Marcelino/D-3329-2009	Suzuki, Marcelino/0000-0003-3868-6362; Aravind, L/0000-0003-0771-253X	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027750] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG01775-02S1] Funding Source: Medline; NIGMS NIH HHS [R01GM27750] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acinas SG, 1999, APPL ENVIRON MICROB, V65, P514; Aravind L, 1998, TRENDS GENET, V14, P442, DOI 10.1016/S0168-9525(98)01553-4; Balashov SP, 1997, BIOCHEMISTRY-US, V36, P8671, DOI 10.1021/bi970744y; Baldwin JM, 1997, J MOL BIOL, V272, P144, DOI 10.1006/jmbi.1997.1240; BEJA O, IN PRESS ENV MICROBI; Bieszke JA, 1999, P NATL ACAD SCI USA, V96, P8034, DOI 10.1073/pnas.96.14.8034; Bieszke JA, 1999, BIOCHEMISTRY-US, V38, P14138, DOI 10.1021/bi9916170; BOGOMOLNI RA, 1994, P NATL ACAD SCI USA, V91, P10188, DOI 10.1073/pnas.91.21.10188; BROWN LS, 1995, J BIOL CHEM, V270, P27122, DOI 10.1074/jbc.270.45.27122; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Eilers H, 2000, APPL ENVIRON MICROB, V66, P3044, DOI 10.1128/AEM.66.7.3044-3051.2000; ELISH ME, 1988, J GEN MICROBIOL, V134, P1355; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; FUHRMAN JA, 1993, APPL ENVIRON MICROB, V59, P1294, DOI 10.1128/AEM.59.5.1294-1302.1993; Govindjee R, 1996, BIOPHYS J, V71, P1011, DOI 10.1016/S0006-3495(96)79302-5; Grigorieff N, 1996, J MOL BIOL, V259, P393, DOI 10.1006/jmbi.1996.0328; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Heberle J, 2000, BBA-BIOENERGETICS, V1458, P135, DOI 10.1016/S0005-2728(00)00064-5; Hoff WD, 1997, ANNU REV BIOPH BIOM, V26, P223, DOI 10.1146/annurev.biophys.26.1.223; Kaback H. R., 1971, METHOD ENZYMOL, V22, P99, DOI DOI 10.1016/0076-6879(71)22015-2; KEUNEN JG, 1991, PROKARYOTES, P2638; Lanyi JK, 1998, J STRUCT BIOL, V124, P164, DOI 10.1006/jsbi.1998.4044; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Mukohata Y, 1999, J BIOCHEM-TOKYO, V125, P649, DOI 10.1093/oxfordjournals.jbchem.a022332; MULLINS TD, 1995, LIMNOL OCEANOGR, V40, P148, DOI 10.4319/lo.1995.40.1.0148; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; PROSSNITZ E, 1989, J BIOL CHEM, V264, P5006; Rappe MS, 1997, LIMNOL OCEANOGR, V42, P811, DOI 10.4319/lo.1997.42.5.0811; ROBERTSON DE, 1980, BIOCHEMISTRY-US, V19, P5692, DOI 10.1021/bi00566a005; Sasaki J, 1998, BIOPHYS J, V75, P2435, DOI 10.1016/S0006-3495(98)77687-8; SCHMIDT TM, 1991, J BACTERIOL, V173, P4371, DOI 10.1128/JB.173.14.4371-4378.1991; SEIDEL R, 1995, P NATL ACAD SCI USA, V92, P3036, DOI 10.1073/pnas.92.7.3036; Shimono K, 1997, FEBS LETT, V420, P54, DOI 10.1016/S0014-5793(97)01487-7; SIPPL MJ, 1990, J MOL BIOL, V213, P859, DOI 10.1016/S0022-2836(05)80269-4; STOECKENIUS W, 1979, BIOCHIM BIOPHYS ACTA, V505, P215, DOI 10.1016/0304-4173(79)90006-5; SUZUKI M, UNPUB; Suzuki MT, 1997, APPL ENVIRON MICROB, V63, P983, DOI 10.1128/AEM.63.3.983-989.1997; YAO VJ, 1992, P NATL ACAD SCI USA, V89, P11915, DOI 10.1073/pnas.89.24.11915	39	1054	1124	11	240	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 15	2000	289	5486					1902	1906		10.1126/science.289.5486.1902	http://dx.doi.org/10.1126/science.289.5486.1902			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354XD	10988064				2022-12-24	WOS:000089355800036
J	Kato, M; Mizuno, K; Crozier, A; Fujimura, T; Ashihara, H				Kato, M; Mizuno, K; Crozier, A; Fujimura, T; Ashihara, H			Plant biotechnology - Caffeine synthase gene from tea leaves	NATURE			Unspecified	Article							BLOOD-PRESSURE; COFFEE; CORONARY; DISEASE; GREEN; RISK		Ochanomizu Univ, Fac Sci, Dept Biol, Bunkyo Ku, Tokyo 1128610, Japan; Univ Tsukuba, Inst Agr & Forest Engn, Tsukuba, Ibaraki 3058572, Japan; Univ Glasgow, Inst Biomed & Life Sci, Div Biochem & Mol Biol, Plant Prod & Human Nutr Grp, Glasgow G12 8QQ, Lanark, Scotland	Ochanomizu University; University of Tsukuba; University of Glasgow	Kato, M (corresponding author), Ochanomizu Univ, Fac Sci, Dept Biol, Bunkyo Ku, Tokyo 1128610, Japan.	a.crozier@bio.gla.ac.uk	Crozier, Alan/H-6642-2017	Crozier, Alan/0000-0001-7581-6782				Ashihara H, 1999, ADV BOT RES, V30, P117; CHOU TM, 1994, COMP BIOCHEM PHYS C, V109, P173, DOI 10.1016/0742-8413(94)00048-F; Fujiki H, 1999, J CANCER RES CLIN, V125, P589, DOI 10.1007/s004320050321; HERTOG MGL, 1993, LANCET, V342, P1007, DOI 10.1016/0140-6736(93)92876-U; James JE, 1997, LANCET, V349, P279, DOI 10.1016/S0140-6736(96)04253-5; Kato M, 1999, PLANT PHYSIOL, V120, P579, DOI 10.1104/pp.120.2.579; Lane JD, 1998, PSYCHOSOM MED, V60, P327, DOI 10.1097/00006842-199805000-00019; Leenen R, 2000, EUR J CLIN NUTR, V54, P87, DOI 10.1038/sj.ejcn.1600900; MAZZAFERA P, 1991, PHYTOCHEMISTRY, V30, P3913, DOI 10.1016/0031-9422(91)83433-L; Nurminen ML, 1999, EUR J CLIN NUTR, V53, P831, DOI 10.1038/sj.ejcn.1600899; Ross JR, 1999, ARCH BIOCHEM BIOPHYS, V367, P9, DOI 10.1006/abbi.1999.1255; STENSVOLD I, 1992, PREV MED, V21, P546, DOI 10.1016/0091-7435(92)90062-M; Vinson JA, 1998, FEBS LETT, V433, P44, DOI 10.1016/S0014-5793(98)00880-1	13	137	169	1	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 31	2000	406	6799					956	957		10.1038/35023072	http://dx.doi.org/10.1038/35023072			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	348ZW	10984041	Green Accepted			2022-12-24	WOS:000089020200032
J	Chen, FE; Ooi, C; Ha, SY; Cheung, BMY; Todd, D; Liang, R; Chan, TK; Chan, V				Chen, FE; Ooi, C; Ha, SY; Cheung, BMY; Todd, D; Liang, R; Chan, TK; Chan, V			Genetic and clinical features of hemoglobin H disease in Chinese patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEPATIC IRON OVERLOAD; ALPHA-THALASSEMIA; HYDROPS-FETALIS; MOLECULAR-BASIS; LIVER IRON; HEMOCHROMATOSIS; FORM; QUANTIFICATION; PREVALENCE; EXPRESSION	Background: Normally, one pair of each of the two alpha-globin genes, alpha 1 and alpha 2, resides on each copy of chromosome 16. In hemoglobin H disease, three of these four alpha-globin genes are affected by a deletion, a mutation, or both. We studied the alpha-globin gene abnormalities and the clinical and hematologic features of Chinese patients with hemoglobin H disease in Hong Kong. Methods: We assessed the clinical features, hematologic values, serum ferritin levels, and liver function of 114 patients with hemoglobin H disease. We also performed echocardiography and magnetic resonance imaging of the liver and examined the two pairs of alpha-globin genes. Results: Hemoglobin H disease in 87 of the 114 patients (76 percent) was due to the deletion of three of the four alpha-globin genes (--/-alpha), a combination termed the deletional type of hemoglobin H. The remaining 27 patients (24 percent) had the nondeletional type of hemoglobin H disease, in which two alpha-globin genes are deleted and a third is mutated (--/alpha alpha(T)). All 87 patients with the deletional type of hemoglobin H were double heterozygotes in whom there was a deletion of both alpha-globin genes from one chromosome, plus a deletion of the alpha 1 or alpha 2 gene from the other chromosome (--/alpha- or --/-alpha). A variety of mutated alpha-globin genes was found in the patients with nondeletional type of hemoglobin H disease. Patients with the nondeletional type of the H disease had more symptoms at a younger age, more severe hemolytic anemia, and larger spleens and were more likely to require transfusions than patients with deletional hemoglobin H disease. The severity of iron overload was not related to the genotype. Conclusions: Chinese patients in Hong Kong with the nondeletional type of hemoglobin H disease have more severe disease than those with the deletional type of the disease. Iron overload is a major cause of disability in both forms of the disease. (N Engl J Med 2000;343:544-50.) (C)2000, Massachusetts Medical Society.	Queen Mary Hosp, Univ Dept Med, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Dept Radiol, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Dept Paediat, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Chan, V (corresponding author), Queen Mary Hosp, Univ Dept Med, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.		Liang, Raymond Hin Suen/C-4346-2009; Chan, Vivian/C-4217-2009; /E-9829-2010	Chen, Frederick E./0000-0002-1455-2231; HA, Shau Yin/0000-0002-9191-8743; /0000-0001-9106-7363				AGER JAM, 1958, BMJ-BRIT MED J, V1, P929, DOI 10.1136/bmj.1.5076.929; Angelucci E, 1997, BLOOD, V90, P4736, DOI 10.1182/blood.V90.12.4736.4736_4736_4742; Bonetti MG, 1996, PEDIATR RADIOL, V26, P650, DOI 10.1007/BF01356827; Chan V, 1999, BRIT J HAEMATOL, V104, P513, DOI 10.1046/j.1365-2141.1999.01221.x; CHAN V, 1988, HEMOGLOBIN, V12, P499, DOI 10.3109/03630268808991638; Chan V, 1997, BRIT J HAEMATOL, V96, P224, DOI 10.1046/j.1365-2141.1997.d01-2017.x; CHAN V, 1985, BLOOD, V66, P224; CHAN V, 1986, BRIT J HAEMATOL, V64, P97, DOI 10.1111/j.1365-2141.1986.tb07577.x; CHEN P, 1998, 2 INT C THAL CHIN TH, P14; CHEZMAR JL, 1990, GASTROINTEST RADIOL, V15, P27, DOI 10.1007/BF01888728; Chim CS, 1998, AM J HEMATOL, V57, P160, DOI 10.1002/(SICI)1096-8652(199802)57:2<160::AID-AJH12>3.0.CO;2-G; CHUAANUSORN W, 1994, HYPERFINE INTERACT, V91, P905, DOI 10.1007/BF02064626; Cullen LM, 1998, AM J HUM GENET, V62, P1403, DOI 10.1086/301878; FUCHAROEN S, 1998, 2 INT C THAL CHIN TH, P3; GALANELLO R, 1983, J MED GENET, V20, P425, DOI 10.1136/jmg.20.6.425; GANDON Y, 1994, RADIOLOGY, V193, P533, DOI 10.1148/radiology.193.2.7972774; GOOSSENS M, 1982, NATURE, V296, P864, DOI 10.1038/296864a0; GUYADER D, 1992, J HEPATOL, V15, P304, DOI 10.1016/0168-8278(92)90060-3; HSU HC, 1990, AM J HEMATOL, V34, P287, DOI 10.1002/ajh.2830340410; Jazwinska EC, 1996, NAT GENET, V14, P249, DOI 10.1038/ng1196-249; KATTAMIS C, 1988, LANCET, V1, P442; Lau YL, 1997, NEW ENGL J MED, V336, P1298, DOI 10.1056/NEJM199705013361805; LIEBHABER SA, 1986, J BIOL CHEM, V261, P5327; LIU TC, 1994, AM J HEMATOL, V45, P293, DOI 10.1002/ajh.2830450405; Mura C, 1999, BLOOD, V93, P2502, DOI 10.1182/blood.V93.8.2502.408k27_2502_2505; Ooi GC, 1999, CLIN RADIOL, V54, P98, DOI 10.1016/S0009-9260(99)91068-1; ORKIN SH, 1981, CELL, V24, P345, DOI 10.1016/0092-8674(81)90324-X; PAGLIETTI E, 1986, BRIT J HAEMATOL, V63, P485, DOI 10.1111/j.1365-2141.1986.tb07525.x; PEERAPITTAYAMON.C, 1996, J SCI SOC THAILAND, V22, P117; PIPPARD MJ, 1979, LANCET, V2, P819; RIGAS DA, 1955, SCIENCE, V121, P372, DOI 10.1126/science.121.3141.372; Schrier SL, 1997, BLOOD, V89, P1762, DOI 10.1182/blood.V89.5.1762.1762_1762_1769; Senior R, 1990, Indian Heart J, V42, P73; SIEGELMAN ES, 1993, RADIOLOGY, V188, P637, DOI 10.1148/radiology.188.3.8351325; St Pierre TG, 1998, BBA-MOL BASIS DIS, V1407, P51, DOI 10.1016/S0925-4439(98)00026-X; Torcharus K, 1995, Southeast Asian J Trop Med Public Health, V26 Suppl 1, P275; TSO SC, 1984, SCAND J HAEMATOL, V32, P391; WEATHERALL D, 1995, MOL MED TODAY, V1, P15, DOI 10.1016/1357-4310(95)80014-X; WICKRAMASINGHE SN, 1980, BRIT J HAEMATOL, V45, P401, DOI 10.1111/j.1365-2141.1980.tb07160.x; Yaprak I, 1998, TURKISH J PEDIATR, V40, P201	40	165	181	1	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 24	2000	343	8					544	550		10.1056/NEJM200008243430804	http://dx.doi.org/10.1056/NEJM200008243430804			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346QM	10954762	Green Published, Green Submitted			2022-12-24	WOS:000088882600004
J	Satcher, D				Satcher, D			Injury: An overlooked global health concern	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article																			0	4	5	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 23	2000	284	8					950	950		10.1001/jama.284.8.950	http://dx.doi.org/10.1001/jama.284.8.950			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	344PX	10944623				2022-12-24	WOS:000088769000006
J	Zheng, N; Wang, P; Jeffrey, PD; Pavletich, NP				Zheng, N; Wang, P; Jeffrey, PD; Pavletich, NP			Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases	CELL			English	Article							GROWTH-FACTOR RECEPTOR; PROTOONCOGENE C-CBL; TYROSINE KINASE; NEGATIVE REGULATOR; SYSTEM; PHOSPHORYLATION; DEGRADATION; INSIGHTS; PRODUCT; HOMOLOG	Ubiquitin-protein ligases (E3s) regulate diverse cellular processes by mediating protein ubiquitination. The c-Cbl proto-oncogene is a RING family E3 that recognizes activated receptor tyrosine kinases, promotes their ubiquitination by a ubiquitin-conjugating enzyme (E2) and terminates signaling. The crystal structure of c-Cbl bound to a cognate E2 and a kinase peptide shows how the RING domain recruits the E2. A comparison with a HECT family E3-E2 complex indicates that a common E2 motif is recognized by the two E3 families. The structure reveals a rigid coupling between the peptide binding and the E2 binding domains and a conserved surface channel leading from the peptide to the E2 active site, suggesting that RING E3s may function as scaffolds that position the substrate and the E2 optimally for ubiquitin transfer.	Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Pavletich, NP (corresponding author), Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, 1275 York Ave, New York, NY 10021 USA.	nikola@xray2.mskcc.org		Jeffrey, Philip/0000-0002-4351-5341				ANDONIOU CE, 1994, EMBO J, V13, P4515, DOI 10.1002/j.1460-2075.1994.tb06773.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bellon SF, 1997, NAT STRUCT BIOL, V4, P586, DOI 10.1038/nsb0797-586; BLAKE TJ, 1991, ONCOGENE, V6, P653; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; COOK WJ, 1992, J BIOL CHEM, V267, P15116; Duprez E, 1999, J CELL SCI, V112, P381; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hime GR, 1997, ONCOGENE, V14, P2709, DOI 10.1038/sj.onc.1201223; HOCHESTRASSER M, 1988, UBIQUITIN BIOL CELL, P279; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kamura T, 1999, GENE DEV, V13, P2928, DOI 10.1101/gad.13.22.2928; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Lee PSW, 1999, EMBO J, V18, P3616, DOI 10.1093/emboj/18.13.3616; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Lupher ML, 1997, J BIOL CHEM, V272, P33140, DOI 10.1074/jbc.272.52.33140; Meng WY, 1999, NATURE, V398, P84, DOI 10.1038/18050; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Miyake S, 1998, P NATL ACAD SCI USA, V95, P7927, DOI 10.1073/pnas.95.14.7927; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Ota S, 2000, J BIOL CHEM, V275, P414, DOI 10.1074/jbc.275.1.414; Ota Y, 1997, SCIENCE, V276, P418, DOI 10.1126/science.276.5311.418; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Schwarz SE, 1998, J BIOL CHEM, V273, P12148, DOI 10.1074/jbc.273.20.12148; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; Suzuki T, 1999, EMBO J, V18, P6017, DOI 10.1093/emboj/18.21.6017; Xie YM, 1999, EMBO J, V18, P6832, DOI 10.1093/emboj/18.23.6832; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Yokouchi M, 1999, J BIOL CHEM, V274, P31707, DOI 10.1074/jbc.274.44.31707; YOON CH, 1995, SCIENCE, V269, P1102, DOI 10.1126/science.7652556; Yu HT, 1998, SCIENCE, V279, P1219, DOI 10.1126/science.279.5354.1219; Zachariae W, 1998, SCIENCE, V279, P1216, DOI 10.1126/science.279.5354.1216	39	696	723	2	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 18	2000	102	4					533	539		10.1016/S0092-8674(00)00057-X	http://dx.doi.org/10.1016/S0092-8674(00)00057-X			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	347BX	10966114	Bronze			2022-12-24	WOS:000088908000014
J	Jones, TD; Farlow, JO; Ruben, JA; Henderson, DM; Hillenius, WJ				Jones, TD; Farlow, JO; Ruben, JA; Henderson, DM; Hillenius, WJ			Cursoriality in bipedal archosaurs	NATURE			English	Article							HIND-LIMB FUNCTION; DINOSAURS; LOCOMOTION; EVOLUTION; CHINA	Modern birds have markedly foreshortened tails and their body mass is centred anteriorly, near the wings(1-5). To provide stability during powered flight, the avian centre of mass is far from the pelvis, which poses potential balance problems for cursorial birds. To compensate, avians adapted to running maintain the femur subhorizontally, with its distal end situated anteriorly, close to the animal's centre of mass; stride generation stems largely from parasagittal rotation of the lower leg about the knee joint(6-12). In contrast, bipedal dinosaurs had a centre of mass near the hip joint and rotated the entire hindlimb during stride generation(4-8,11-13). Here we show that these contrasting styles of cursoriality are tightly linked to longer relative total hindlimb length in cursorial birds than in bipedal dinosaurs. Surprisingly, Caudipteryx, described as a theropod dinosaur(14,15), possessed an anterior centre of mass and hindlimb proportions resembling those of cursorial birds. Accordingly, Caudipteryx probably used a running mechanism more similar to that of modern cursorial birds than to that of all other bipedal dinosaurs. These observations provide valuable clues about cursoriality in Caudipteryx, but may also have implications for interpreting the locomotory status of its ancestors.	Indiana Univ Purdue Univ, Dept Geosci, Ft Wayne, IN 46805 USA; Johns Hopkins Univ, Sch Med, Dept Cell Biol & Anat, Baltimore, MD 21205 USA; Coll Charleston, Dept Biol, Charleston, SC 29424 USA; Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA	Purdue University System; Indiana University Purdue University Fort Wayne; Johns Hopkins University; College of Charleston; Oregon State University	Jones, TD (corresponding author), Stephen F Austin State Univ, Dept Biol, Nacogdoches, TX 75962 USA.							Alexander R.M., 1989, DYNAMICS DINOSAURS O; ALEXANDER RM, 1985, ZOOL J LINN SOC-LOND, V83, P1, DOI 10.1111/j.1096-3642.1985.tb00871.x; Burnham David A., 2000, University of Kansas Paleontological Contributions New Series, V13, P1; Carrano MT, 1998, PALEOBIOLOGY, V24, P450, DOI 10.1017/S0094837300020108; FARLOW JO, IN PRESS AM ZOOL; Feduccia A., 1999, ORIGIN EVOLUTION BIR, V2; Foster John R., 1999, Journal of Vertebrate Paleontology, V19, p45A; GALTON P M, 1970, Journal of Paleontology, V44, P464; Gatesy SM, 1999, J MORPHOL, V240, P127, DOI 10.1002/(SICI)1097-4687(199905)240:2<127::AID-JMOR4>3.0.CO;2-Q; GATESY SM, 1990, PALEOBIOLOGY, V16, P170, DOI 10.1017/S0094837300009866; Gatesy SM, 1999, J MORPHOL, V240, P115, DOI 10.1002/(SICI)1097-4687(199905)240:2<115::AID-JMOR3>3.0.CO;2-Y; GATESY SM, 1991, J MORPHOL, V209, P83, DOI 10.1002/jmor.1052090107; Gatesy SM, 1999, NATURE, V399, P141, DOI 10.1038/20167; GATESY SM, 1991, J ZOOL LOND, V224, P129; Henderson DM, 1999, PALEOBIOLOGY, V25, P88; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; MANION BL, 1984, THESIS U ILLINOIS CH; NORBERG UM, 1990, VERTEBRATE FLIGHT, P1; PAUL GS, 1985, PREDATORY DINOSAURS; Pennycuick CJ, 1986, ORIGIN BIRDS EVOLUTI, P83; PERRY SF, 1990, J COMP PHYSIOL B, V159, P761, DOI 10.1007/BF00691722; Roberts TJ, 1999, AM ZOOL, V39, p65A; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2163, DOI 10.1139/e93-187; RUSSELL DA, 1970, NATL MUS NAT HIST PU, V1, P1; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Zhou Zhong-He, 2000, Vertebrata Palasiatica, V38, P111	26	53	58	0	24	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 17	2000	406	6797					716	718		10.1038/35021041	http://dx.doi.org/10.1038/35021041			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344PH	10963594	Green Published			2022-12-24	WOS:000088767700041
J	Mohler, ER				Mohler, ER			Are atherosclerotic processes involved in aortic-valve calcification?	LANCET			English	Editorial Material							BONE-FORMATION; DISEASE; CELLS		Univ Penn, Sch Med, Dept Med, Div Cardiovasc Dis, Philadelphia, PA 19104 USA	University of Pennsylvania	Mohler, ER (corresponding author), Univ Penn, Sch Med, Dept Med, Div Cardiovasc Dis, Philadelphia, PA 19104 USA.							Callister TQ, 1998, NEW ENGL J MED, V339, P1972, DOI 10.1056/NEJM199812313392703; Chan KA, 2000, LANCET, V355, P2185, DOI 10.1016/S0140-6736(00)02400-4; EDWARDS JE, 1962, CIRCULATION, V26, P17; MAHER ER, 1987, NEPHRON, V47, P119, DOI 10.1159/000184472; Mohler ER, 1998, J AM COLL CARDIOL, V31, p503A, DOI 10.1016/S0735-1097(97)88192-2; Mohler ER, 1999, J HEART VALVE DIS, V8, P254; Mohler ER, 1997, ARTERIOSCL THROM VAS, V17, P547, DOI 10.1161/01.ATV.17.3.547; Monckeberg JG, 1904, VIRCHOWS ARCH A, V176, P472, DOI 10.1007/BF02041318; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Palta S, 2000, CIRCULATION, V101, P2497, DOI 10.1161/01.CIR.101.21.2497; SARIG S, 1994, LAB INVEST, V71, P782; STRICKBERGER SA, 1987, AM J MED, V82, P953, DOI 10.1016/0002-9343(87)90157-4; WATSON KE, 1994, J CLIN INVEST, V93, P2106, DOI 10.1172/JCI117205	13	112	114	1	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 12	2000	356	9229					524	525		10.1016/S0140-6736(00)02572-1	http://dx.doi.org/10.1016/S0140-6736(00)02572-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	345MY	10950224				2022-12-24	WOS:000088820800004
J	Ross, SE; Hemati, N; Longo, KA; Bennett, CN; Lucas, PC; Erickson, RL; MacDougald, OA				Ross, SE; Hemati, N; Longo, KA; Bennett, CN; Lucas, PC; Erickson, RL; MacDougald, OA			Inhibition of adipogenesis by Wnt signaling	SCIENCE			English	Article							BINDING-PROTEIN-ALPHA; BETA-CATENIN; ADIPOCYTE DIFFERENTIATION; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; 3T3-L1 ADIPOCYTES; PPAR-GAMMA; FAT PADS; FIBROBLASTS; REGULATOR	Wnts are secreted signaling proteins that regulate developmental processes. Here we show that Wnt signaling, Likely mediated by Wnt-10b, is a molecular switch that governs adipogenesis. Wnt signaling maintains preadipocytes in an undifferentiated state through inhibition of the adipogenic transcription factors CCAAT/enhancer binding protein alpha (C/EBP alpha) and peroxisome proliferator-activated receptor gamma (PPAR gamma). When Wnt signaling in preadipocytes is prevented by overexpression of Axin or dominant-negative TCF4, these cells differentiate into adipocytes. Disruption of Wnt signaling also causes transdifferentiation of myoblasts into adipocytes in vitro, highlighting the importance of this pathway not only in adipocyte differentiation but also in mesodermal cell fate determination.	Univ Michigan, Sch Med, Dept Physiol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	MacDougald, OA (corresponding author), Univ Michigan, Sch Med, Dept Physiol, Ann Arbor, MI 48109 USA.		Erickson, Robin/AAV-3405-2020; Longo, Kenneth A/A-5631-2010	Erickson, Robin/0000-0002-3945-6158; Lucas, Peter/0000-0003-4880-7172; MacDougald, Ormond/0000-0001-6907-7960	NIDDK NIH HHS [T32-DK07245, R01-DK51563, 5P60 DK20572, T32 DK007245] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007245, P60DK020572, R01DK051563] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bafico A, 1998, ONCOGENE, V16, P2819, DOI 10.1038/sj.onc.1201797; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Cho EA, 1998, MECH DEVELOP, V77, P9; CHRISTIAN JL, 1991, DEV BIOL, V143, P230, DOI 10.1016/0012-1606(91)90073-C; CORNELIUS P, 1994, ANNU REV NUTR, V14, P99, DOI 10.1146/annurev.nu.14.070194.000531; Cossu G, 1999, EMBO J, V18, P6867, DOI 10.1093/emboj/18.24.6867; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; GREEN H, 1979, J CELL PHYSIOL, V101, P169, DOI 10.1002/jcp.1041010119; Hemati N, 1997, J BIOL CHEM, V272, P25913, DOI 10.1074/jbc.272.41.25913; Hoppler S, 1996, GENE DEV, V10, P2805, DOI 10.1101/gad.10.21.2805; JULIUS MH, UNPUB; Kikuchi A, 1999, CYTOKINE GROWTH F R, V10, P255, DOI 10.1016/S1359-6101(99)00017-9; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; LIN FT, 1993, P NATL ACAD SCI USA, V90, P9606, DOI 10.1073/pnas.90.20.9606; Lowell BB, 1999, CELL, V99, P239, DOI 10.1016/S0092-8674(00)81654-2; MACDOUGALD OA, 1995, P NATL ACAD SCI USA, V92, P9034, DOI 10.1073/pnas.92.20.9034; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Mandrup S, 1997, P NATL ACAD SCI USA, V94, P4300, DOI 10.1073/pnas.94.9.4300; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Ross SE, 1999, MOL CELL BIOL, V19, P8433; Shao DL, 1997, J BIOL CHEM, V272, P21473, DOI 10.1074/jbc.272.34.21473; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Van den Berg DJ, 1998, BLOOD, V92, P3189, DOI 10.1182/blood.V92.9.3189.421k45_3189_3202; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Young CS, 1998, MOL CELL BIOL, V18, P2474, DOI 10.1128/MCB.18.5.2474	29	1288	1370	5	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 11	2000	289	5481					950	953		10.1126/science.289.5481.950	http://dx.doi.org/10.1126/science.289.5481.950			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	343KH	10937998				2022-12-24	WOS:000088701200032
J	Burch, CL; Chao, L				Burch, CL; Chao, L			Evolvability of an RNA virus is determined by its mutational neighbourhood	NATURE			English	Article							EVOLUTION; FITNESS; PHI-6		Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Burch, CL (corresponding author), Univ Calif San Diego, Dept Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA.							Burch CL, 1999, GENETICS, V151, P921; Chao L, 1997, GENE, V205, P301, DOI 10.1016/S0378-1119(97)00405-8; CHAO L, 1992, EVOLUTION, V46, P289, DOI 10.1111/j.1558-5646.1992.tb02038.x; CHAO L, 1990, NATURE, V348, P454, DOI 10.1038/348454a0; Domingo Esteban, 1994, P161; EIGEN M, 1987, COLD SPRING HARB SYM, V52, P307, DOI 10.1101/SQB.1987.052.01.036; EIGEN M, 1996, TRENDS MICROBIOL, V4, P212; Fenster CB, 1997, TRENDS ECOL EVOL, V12, P282, DOI 10.1016/S0169-5347(97)81027-0; Fraile A, 1997, J VIROL, V71, P8316, DOI 10.1128/JVI.71.11.8316-8320.1997; HOLLAND J, 1982, SCIENCE, V215, P1577, DOI 10.1126/science.7041255; Kauffman S. A., 1993, ORIGINS ORDER; MINDICH L, 1976, VIROLOGY, V75, P218, DOI 10.1016/0042-6822(76)90020-9; Nijhuis M, 1999, AIDS, V13, P2349, DOI 10.1097/00002030-199912030-00006; Radman M, 1999, ANN NY ACAD SCI, V870, P146, DOI 10.1111/j.1749-6632.1999.tb08874.x; SCHUSTER P, 1988, B MATH BIOL, V56, P636; Sokal RR., 1995, BIOMETRY, V3; VIDAVER AK, 1973, J VIROL, V11, P799, DOI 10.1128/JVI.11.5.799-805.1973; Wagner GP, 1999, J EXP ZOOL, V285, P116, DOI 10.1002/(SICI)1097-010X(19990815)285:2<116::AID-JEZ3>3.0.CO;2-P; [No title captured]	19	214	215	2	35	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 10	2000	406	6796					625	628		10.1038/35020564	http://dx.doi.org/10.1038/35020564			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	342PF	10949302				2022-12-24	WOS:000088653800047
J	Christen, WG; Glynn, RJ; Ajani, UA; Schaumberg, DA; Buring, JE; Hennekens, CH; Manson, JE				Christen, WG; Glynn, RJ; Ajani, UA; Schaumberg, DA; Buring, JE; Hennekens, CH; Manson, JE			Smoking cessation and risk of age-related cataract in men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CIGARETTE-SMOKING; LENS OPACITIES; VITAMIN-C; ALCOHOL; PLASMA; EYE	Context Although cigarette smoking has been shown to be a risk factor for age-related cataract, data are inconclusive on the risk of cataract in individuals who quit smoking. Objective To examine the association between smoking cessation and incidence of age-related cataract. Design Prospective cohort study conducted from 1982 through 1997, with an average follow-up of 13.6 years. Setting and Participants A total of 20907 US male physicians participating in the Physicians' Health Study I who did not have a diagnosis of age-related cataract at baseline and had reported their level of smoking at baseline. Main Outcome Measures Incident age-related cataract defined as self-report confirmed by medical record review, diagnosed after study randomization and responsible for vision loss to 20/30 or worse, and surgical extraction of incident age-related cataract, in relation to smoking status and years since quitting smoking. Results At baseline, 11% were current smokers, 39% were past smokers, and 50% were never smokers. Average reported cumulative dose of smoking at baseline was approximately 2-fold greater in current than in past smokers (35.8 vs 20.5 pack-years). Two thousand seventy-four incident cases of age-related cataract and 1193 cataract extractions were confirmed during follow-up. Compared with current smokers, multivariate relative risks (RRs) of cataract in past smokers who quit smoking fewer than 10 years, 10 to fewer than 20 years, and 20 or more years before the study were 0.79 (95% confidence interval [CI], 0.64-0.98), 0.73 (95% CI, 0.61-0.88), and 0.74 (95% CI, 0.63-0.87), respectively, after adjustment for other risk factors for cataract and age at smoking inception. The RR for never smelters was 0.64 (95% CI, 0.54-0.76). The reduced risk in past smokers was principally due to a lower total cumulative dose (RR of cataract for increase of 10 pack-years of smoking, 1.07; 95% CI, 1.04-1.10). A benefit of stopping smoking independent of cumulative dose was suggested in some analyses. Results for cataract extraction were similar. Conclusion These prospective data indicate that while some smoking-related damage to the lens may be reversible, smoking cessation reduces the risk of cataract primarily by limiting total dose-related damage to the lens.	Harvard Univ, Sch Med, Div Prevent Med, Boston, MA USA; Harvard Univ, Sch Med, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Univ Miami, Sch Med, Dept Med, Miami, FL USA; Univ Miami, Sch Med, Dept Epidemiol, Miami, FL USA; Univ Miami, Sch Med, Dept Publ Hlth, Miami, FL USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Miami; University of Miami; University of Miami	Christen, WG (corresponding author), 900 Commonwealth Ave E, Boston, MA 02215 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034595] Funding Source: NIH RePORTER; NCI NIH HHS [CA 34944] Funding Source: Medline; NHLBI NIH HHS [HL 34595, HL 26490] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BUNCE GE, 1990, ANNU REV NUTR, V10, P233, DOI 10.1146/annurev.nu.10.070190.001313; CHOW CK, 1986, J AM COLL NUTR, V5, P305; CHRISTEN WG, 1992, JAMA-J AM MED ASSOC, V268, P989; Christen WG, 1996, JAMA-J AM MED ASSOC, V276, P1147, DOI 10.1001/jama.276.14.1147; CLAYTON RM, 1982, T OPHTHAL SOC UK, V102, P331; FLAYE DE, 1989, EYE, V3, P379, DOI 10.1038/eye.1989.56; HANKINSON SE, 1992, JAMA-J AM MED ASSOC, V268, P994, DOI 10.1001/jama.268.8.994; HARDING JJ, 1988, BRIT J OPHTHALMOL, V72, P809, DOI 10.1136/bjo.72.11.809; Hiller R, 1997, ARCH OPHTHALMOL-CHIC, V115, P1113, DOI 10.1001/archopht.1997.01100160283003; JACQUES PF, 1988, ARCH OPHTHALMOL-CHIC, V106, P337, DOI 10.1001/archopht.1988.01060130363022; KLEIN BEK, 1985, OPHTHALMOLOGY, V92, P1191; KLEIN BEK, 1993, AM J PREV MED, V9, P27, DOI 10.1016/S0749-3797(18)30763-3; LESKE MC, 1991, ARCH OPHTHALMOL-CHIC, V109, P244, DOI 10.1001/archopht.1991.01080020090051; MOHAN M, 1989, ARCH OPHTHALMOL-CHIC, V107, P670, DOI 10.1001/archopht.1989.01070010688028; *NAT ADV EYE COUNC, 1998, NAT ADV EYE COUNC NI; Paik DC, 2000, EXP EYE RES, V70, P73, DOI 10.1006/exer.1999.0761; RAMAKRISHNAN S, 1995, BRIT J OPHTHALMOL, V79, P202, DOI 10.1136/bjo.79.3.202; STRYKER WS, 1988, AM J EPIDEMIOL, V127, P283, DOI 10.1093/oxfordjournals.aje.a114804; TAYLOR A, 1987, FREE RADICAL BIO MED, V3, P371, DOI 10.1016/0891-5849(87)90015-3; *US DEP HHS, 1990, DHHS PUBL CDC; WEST S, 1989, ARCH OPHTHALMOL-CHIC, V107, P1166, DOI 10.1001/archopht.1989.01070020232031; WEST S, 1995, ARCH OPHTHALMOL-CHIC, V113, P1377, DOI 10.1001/archopht.1995.01100110037022	22	54	55	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2000	284	6					713	716		10.1001/jama.284.6.713	http://dx.doi.org/10.1001/jama.284.6.713			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	341JM	10927779	Bronze			2022-12-24	WOS:000088587300029
J	Insley, SJ				Insley, SJ			Long-term vocal recognition in the northern fur seal	NATURE			English	Article							FIDELITY	The ability to recognize and remember individual identities for long periods of time has important implications for the evolution of animal social behaviour, particularly complex interactions such as cooperation or mate choice(1-7). Despite this importance, there is only a single example of long-term individual recognition in nature, the 8-month retention of neighbour's song among male hooded warblers, Wilsonia citrina(7), and there is none for a nonhuman mammal. Associations between individuals spanning years, which are especially prevalent in carnivores(8), primates(9) and seabirds(10,) and evidence of mate rdelity(11,12) provide indirect support for the ability of long-term recognition. In many of these instances, however, individuals do not separate for extended periods, and thus long-term recognition, although often assumed, may be both unnecessary and nonexistent. Furthermore, site fidelity rather than individual recognition may explain many instances of mate fidelity(10). Here I show that mother-offspring pairs of a migratory otariid pinniped-the northern fur seal (Callorhinus ursinus)-not only have the ability to recognize each other's vocalizations during the course of a breeding season, but are also able to retain these memories for at least 4 years.	Univ Calif Davis, Anim Behav Grp, Davis, CA 95616 USA; Smithsonian Inst, Natl Zool Pk, Dept Zool Res, Washington, DC 20008 USA	University of California System; University of California Davis; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Insley, SJ (corresponding author), Univ Calif Davis, Anim Behav Grp, Davis, CA 95616 USA.							AMOS B, 1995, SCIENCE, V268, P1897, DOI 10.1126/science.268.5219.1897; BAKER JD, 1995, ANIM BEHAV, V50, P237, DOI 10.1006/anbe.1995.0236; Beecher M.D., 1991, P94; BLACK J, 1996, PARTNERSHIP BIRDS ST; Colgan PW, 1983, COMP SOCIAL RECOGNIT; Falls JB., 1982, ACOUSTIC COMMUNICATI, P237; Gentry R.L., 1998, BEHAV ECOLOGY NO SEA; GODARD R, 1991, NATURE, V350, P228, DOI 10.1038/350228a0; INSLEY SJ, 1992, BEHAVIOUR, V120, P103, DOI 10.1163/156853992X00237; INSLEY SJ, IN PRESS ANIMAL BEHA; LEGER DW, 1994, ANIM BEHAV, V48, P823, DOI 10.1006/anbe.1994.1306; Mateo JM, 2000, ANIM BEHAV, V59, P491, DOI 10.1006/anbe.1999.1363; REGAN T, 1995, J MAMMAL, V76, P1137; Sherman Paul W., 1997, P69; Smuts B. B., 1987, PRIMATE SOC; Stoddard Philip Kraft, 1996, P356; Uy JAC, 2000, P ROY SOC B-BIOL SCI, V267, P251, DOI 10.1098/rspb.2000.0994; [No title captured]	18	116	120	0	36	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 27	2000	406	6794					404	405		10.1038/35019064	http://dx.doi.org/10.1038/35019064			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	337WC	10935635				2022-12-24	WOS:000088383800045
J	Marszalek, JR; Liu, XR; Roberts, EA; Chui, D; Marth, JD; Williams, DS; Goldstein, LSB				Marszalek, JR; Liu, XR; Roberts, EA; Chui, D; Marth, JD; Williams, DS; Goldstein, LSB			Genetic evidence for selective transport of opsin and arrestin by kinesin-II in mammalian photoreceptors	CELL			English	Article							DOMINANT RETINITIS-PIGMENTOSA; LEFT-RIGHT ASYMMETRY; DYNEIN LIGHT-CHAIN; RETINAL DEGENERATION; TRANSGENIC MICE; RHODOPSIN GENE; OUTER SEGMENT; MUTANT MICE; OLIGOSACCHARIDE BIOSYNTHESIS; CAENORHABDITIS-ELEGANS	To test whether kinesin-II is important for transport in the mammalian photoreceptor cilium, and to identify its potential cargoes, we used Cre-loxP mutagenesis to remove the kinesin-II subunit, KIF3A, specifically from photoreceptors. Complete loss of KIF3A caused large accumulations of opsin, arrestin, and membranes within the photoreceptor inner segment, while the localization of cu-transducin was unaffected. Other membrane, organelle, and transport markers, as well as opsin processing appeared normal. Loss of KIF3A ultimately caused apoptotic photoreceptor cell death similar to a known opsin transport mutant. The data suggest that kinesin-II is required to transport opsin and arrestin from the inner to the outer segment and that blocks in this transport pathway lead to photoreceptor cell death as found in retinitis pigmentosa.	Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Goldstein, LSB (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.				NEI NIH HHS [R01 EY007042, EY07042] Funding Source: Medline; NICHD NIH HHS [N01-HD-6-2915] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD062915] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY007042] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Beech PL, 1996, J CELL SCI, V109, P889; BESHARSE JC, 1995, J NEUROCYTOL, V24, P371, DOI 10.1007/BF01189064; BLOODGOOD RA, 1992, BIOL CELL, V76, P291, DOI 10.1016/0248-4900(92)90431-Y; BOBOLA N, 1995, J BIOL CHEM, V270, P1289, DOI 10.1074/jbc.270.3.1289; CANTERA R, 1990, EXP BIOL, V48, P305; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; Chui D, 1997, CELL, V90, P157, DOI 10.1016/S0092-8674(00)80322-0; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; COLE DG, 1993, NATURE, V366, P268, DOI 10.1038/366268a0; COLLEY NJ, 1995, P NATL ACAD SCI USA, V92, P3070, DOI 10.1073/pnas.92.7.3070; DERETIC D, 1991, J CELL BIOL, V113, P1281, DOI 10.1083/jcb.113.6.1281; Deretic D, 1996, J BIOL CHEM, V271, P2279, DOI 10.1074/jbc.271.4.2279; Fariss RN, 1997, J COMP NEUROL, V387, P148, DOI 10.1002/(SICI)1096-9861(19971013)387:1<148::AID-CNE12>3.0.CO;2-Q; HUANG PC, 1993, P NATL ACAD SCI USA, V90, P8484, DOI 10.1073/pnas.90.18.8484; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; ISHIGURO S, 1987, CELL STRUCT FUNCT, V12, P141, DOI 10.1247/csf.12.141; Jeon CJ, 1998, J NEUROSCI, V18, P8936; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Le Bot N, 1998, J CELL BIOL, V143, P1559, DOI 10.1083/jcb.143.6.1559; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; LI TS, 1995, P NATL ACAD SCI USA, V92, P3551, DOI 10.1073/pnas.92.8.3551; Li TS, 1996, P NATL ACAD SCI USA, V93, P14176, DOI 10.1073/pnas.93.24.14176; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; Liu XR, 1999, J NEUROSCI, V19, P6267; Liu XR, 1997, CELL MOTIL CYTOSKEL, V37, P240, DOI 10.1002/(SICI)1097-0169(1997)37:3<240::AID-CM6>3.3.CO;2-2; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Marszalek JR, 2000, BBA-MOL CELL RES, V1496, P142, DOI 10.1016/S0167-4889(00)00015-X; Marth JD, 1996, GLYCOBIOLOGY, V6, P701, DOI 10.1093/glycob/6.7.701; Muresan V, 1997, EXP EYE RES, V64, P895, DOI 10.1006/exer.1996.0261; NIR I, 1989, EXP EYE RES, V49, P403, DOI 10.1016/0014-4835(89)90050-X; NIR I, 1990, EXP EYE RES, V51, P257, DOI 10.1016/0014-4835(90)90022-M; Nir I, 1989, Prog Clin Biol Res, V314, P251; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; OLSSON JE, 1992, NEURON, V9, P815, DOI 10.1016/0896-6273(92)90236-7; PAPERMASTER DS, 1985, INVEST OPHTH VIS SCI, V26, P1386; Pazour GJ, 1999, J CELL BIOL, V144, P473, DOI 10.1083/jcb.144.3.473; Pazour GJ, 1998, J CELL BIOL, V141, P979, DOI 10.1083/jcb.141.4.979; Piperno G, 1998, J CELL BIOL, V143, P1591, DOI 10.1083/jcb.143.6.1591; Piperno G, 1997, P NATL ACAD SCI USA, V94, P4457, DOI 10.1073/pnas.94.9.4457; Ray K, 1999, J CELL BIOL, V147, P507, DOI 10.1083/jcb.147.3.507; RIM J, 1995, BIOCHEMISTRY-US, V34, P11938, DOI 10.1021/bi00037a035; ROOF DJ, 1994, INVEST OPHTH VIS SCI, V35, P4049; Rosenbaum JL, 1999, J CELL BIOL, V144, P385, DOI 10.1083/jcb.144.3.385; Signor D, 1999, J CELL BIOL, V147, P519, DOI 10.1083/jcb.147.3.519; SUNG CH, 1994, J NEUROSCI, V14, P5818; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Takeda S, 2000, J CELL BIOL, V148, P1255, DOI 10.1083/jcb.148.6.1255; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; TROUTT LL, 1988, J NEUROSCI, V8, P2371; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Whitehead JL, 1999, EXP EYE RES, V69, P491, DOI 10.1006/exer.1999.0724	52	323	332	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 21	2000	102	2					175	187		10.1016/S0092-8674(00)00023-4	http://dx.doi.org/10.1016/S0092-8674(00)00023-4			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	337NA	10943838	Bronze			2022-12-24	WOS:000088366800008
J	Larison, JR; Likens, GE; Fitzpatrick, JW; Crock, JG				Larison, JR; Likens, GE; Fitzpatrick, JW; Crock, JG			Cadmium toxicity among wildlife in the Colorado Rocky Mountains	NATURE			English	Article							REPRODUCTION; ALUMINUM; CALCIUM; MERCURY; BIRDS; LEAD	Cadmium is known to be both extremely toxic and ubiquitous in natural environments. It occurs in almost all soils, surface waters and plants(1-3), and it is readily mobilized by human activities such as mining(4). As a result, cadmium has been named as a potential health threat to wildlife species(5); however, because it exists most commonly in the environment as a trace constituent, reported incidences of cadmium toxicity are rare. Here we have measured trace metals in the food web and tissues of white-tailed ptarmigan (Lagopus leucurus) in Colorado. Our results suggest that cadmium toxicity may be more common among natural populations of vertebrates than has been appreciated to date and that cadmium toxicity may often go undetected or unrecognized. In addition, our research shows that ingestion of even trace quantities of cadmium can influence not only the physiology and health of individual organisms, but also the demographics and the distribution of species.	Cornell Univ, Sect Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; Inst Ecosyst Studies, Millbrook, NY 12545 USA; Cornell Lab Ornithol, Ithaca, NY 14850 USA; US Geol Survey, Denver Fed Ctr, Lakewood, CO 80225 USA	Cornell University; Cary Institute of Ecosystem Studies; Cornell University; United States Department of the Interior; United States Geological Survey	Larison, JR (corresponding author), Oregon State Univ, 138 Strand Hall, Corvallis, OR 97331 USA.	larisonj@ucs.orst.edu						ANDO M, 1978, TOXICOL APPL PHARM, V46, P625, DOI 10.1016/0041-008X(78)90308-3; ARMSTRONG DM, 1987, ROCKY MOUNTAIN MAMMA; Bonnell JA, 1955, BRIT J IND MED, V12, P181; BRAUN CE, 1976, 38 COL DIV WILDL SPE; Braun CE, 1969, THESIS COLORADO STAT; BURBANK WS, 1968, GEOLOGY ORE DEPOSITS, V1, P715; CHANG LW, 1980, CADMIUM ENV, P784; CHURCH SE, 1997, 97151 US GEOL SURV; Crock J.G., 1999, REV EC GEOLOGY A, P265; CROCK JG, 1999, 9933 US GEOL SURV; Foulkes E. C., 1986, CADMIUM, P75; Friberg L., 1986, HDB TOXICOLOGY METAL, P130; Furness Robert W., 1996, P389; GOERING PL, 1986, CADMIUM HDB EXPT PHA, P189; GRAVELAND J, 1994, NATURE, V368, P446, DOI 10.1038/368446a0; HAMILTON DL, 1978, ENVIRON RES, V15, P175, DOI 10.1016/0013-9351(78)90094-4; KIDO T, 1988, ARCH ENVIRON HEALTH, V43, P213, DOI 10.1080/00039896.1988.9934935; NICHOLSON JK, 1983, J ZOOL, V200, P99, DOI 10.1111/j.1469-7998.1983.tb06111.x; NOGAWA K, 1980, CADMIUM ENV, P1; PAGE AL, 1987, LEAD MERCURY CADMIUM, P33; PETERSON AP, 1979, CHEM BIOCH BIOL CADM, P45; Quick H. F., 1947, Condor Berkeley, V49, P233, DOI 10.2307/1364181; RICHARDSON ME, 1974, J NUTR, V104, P323, DOI 10.1093/jn/104.3.323; SCHEUHAMMER AM, 1987, ENVIRON POLLUT, V46, P263, DOI 10.1016/0269-7491(87)90173-4; Scheuhammer AM, 1996, ENVIRON POLLUT, V94, P337, DOI 10.1016/S0269-7491(96)00084-X; SHACKLETTE HT, 1972, GEOLOGICAL SURVEY G, V1314; SIMKISS K, 1961, BIOL REV, V36, P321, DOI 10.1111/j.1469-185X.1961.tb01292.x; WARREN E.R., 1942, MAMMALS COLORADO THE; Wiebe KL, 1998, IBIS, V140, P14, DOI 10.1111/j.1474-919X.1998.tb04536.x; [No title captured]	30	182	193	2	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 13	2000	406	6792					181	183		10.1038/35018068	http://dx.doi.org/10.1038/35018068			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	335BA	10910356				2022-12-24	WOS:000088221100046
J	Fawcett, AJ				Fawcett, AJ			Mono-ocular occlusion for treatment of dylexia	LANCET			English	Editorial Material							MONOCULAR OCCLUSION		Univ Sheffield, Dept Psychol, Sheffield S10 2TP, S Yorkshire, England	University of Sheffield	Fawcett, AJ (corresponding author), Univ Sheffield, Dept Psychol, Sheffield S10 2TP, S Yorkshire, England.		Fawcett, Angela/AAA-6600-2021					Adams M.J., 1990, BEGINNING READ THINK; BISHOP DVM, 1989, BRIT J OPHTHALMOL, V73, P209, DOI 10.1136/bjo.73.3.209; Cornelissen PL, 1998, VISION RES, V38, P471, DOI 10.1016/S0042-6989(97)00199-5; Nicolson RI, 1999, BRIT J EDUC PSYCHOL, V69, P47, DOI 10.1348/000709999157563; Nicolson RI, 1999, LANCET, V353, P1662, DOI 10.1016/S0140-6736(98)09165-X; STEIN J, 1985, LANCET, V2, P69; Stein JF, 2000, BRAIN, V123, P164, DOI 10.1093/brain/123.1.164; Wilkins A, 1996, PERCEPTION, V25, P1372	8	2	2	1	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 8	2000	356	9224					89	90		10.1016/S0140-6736(00)02464-8	http://dx.doi.org/10.1016/S0140-6736(00)02464-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	331UG	10963240				2022-12-24	WOS:000088036600004
J	Verhagen, AM; Ekert, PG; Pakusch, M; Silke, J; Connolly, LM; Reid, GE; Moritz, RL; Simpson, RJ; Vaux, DL				Verhagen, AM; Ekert, PG; Pakusch, M; Silke, J; Connolly, LM; Reid, GE; Moritz, RL; Simpson, RJ; Vaux, DL			Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins	CELL			English	Article							PROGRAMMED CELL-DEATH; BCL-X-L; DROSOPHILA CASPASE; INHIBIT APOPTOSIS; SIGNALING COMPLEX; BACULOVIRUS IAP; CYTOCHROME-C; GENE; APAF-1; ACTIVATION	To identify proteins that bind mammalian IAP homolog A (MIHA, also known as XIAP), we used coimmunoprecipitation and 2D immobilized pH gradient/SDS PAGE, followed by electrospray ionization tandem mass spectrometry. DIABLO (direct IAP binding protein with low pi) is a novel protein that can bind MIHA and can also interact with MIHB and MIHC and the baculoviral IAP, OpIAP. The N-terminally processed, IAP-interacting form of DIABLO is concentrated in membrane fractions in healthy cells but released into the MIHA-containing cytosolic fractions upon UV irradiation. As transfection of cells with DIABLO was able to counter the protection afforded by MIHA against UV irradiation, DIABLO may promote apoptosis by binding to IAPs and preventing them from inhibiting caspases.	Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; Ludwig Inst Canc Res, Joint Prot Struct Lab, Melbourne, Vic, Australia; Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia	Walter & Eliza Hall Institute; Ludwig Institute for Cancer Research; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Vaux, DL (corresponding author), Walter & Eliza Hall Inst Med Res, PO Royal Melbourne Hosp, Melbourne, Vic 3050, Australia.		Vaux, David L/C-7249-2013; Ekert, Paul G/C-7247-2013; Silke, John/B-7622-2008; Moritz, Robert L/B-9222-2011; Ekert, Paul/Q-1842-2015	Vaux, David L/0000-0003-2703-1651; Ekert, Paul G/0000-0002-2976-8617; Silke, John/0000-0002-7611-5774; Ekert, Paul/0000-0002-2976-8617; Simpson, Richard/0000-0002-9834-0796; Reid, Gavin/0000-0002-9675-1444				Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; CROOK NE, 1993, J VIROL, V67, P2168, DOI 10.1128/JVI.67.4.2168-2174.1993; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Dorstyn L, 1999, P NATL ACAD SCI USA, V96, P4307, DOI 10.1073/pnas.96.8.4307; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Duckett CS, 1996, EMBO J, V15, P2685, DOI 10.1002/j.1460-2075.1996.tb00629.x; Ekert PG, 1999, EMBO J, V18, P330, DOI 10.1093/emboj/18.2.330; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; Hawkins CJ, 1999, P NATL ACAD SCI USA, V96, P2885, DOI 10.1073/pnas.96.6.2885; Hawkins CJ, 1996, P NATL ACAD SCI USA, V93, P13786, DOI 10.1073/pnas.93.24.13786; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; Hu YM, 1998, P NATL ACAD SCI USA, V95, P4386, DOI 10.1073/pnas.95.8.4386; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Ji H, 1997, ELECTROPHORESIS, V18, P605, DOI 10.1002/elps.1150180344; Kaiser WJ, 1998, FEBS LETT, V440, P243, DOI 10.1016/S0014-5793(98)01465-3; Liston P, 1996, NATURE, V379, P349, DOI 10.1038/379349a0; Moriishi K, 1999, P NATL ACAD SCI USA, V96, P9683, DOI 10.1073/pnas.96.17.9683; MORITZ RL, 1992, J CHROMATOGR, V599, P119; Moritz RL, 1996, ELECTROPHORESIS, V17, P907, DOI 10.1002/elps.1150170512; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Pan GH, 1998, J BIOL CHEM, V273, P5841, DOI 10.1074/jbc.273.10.5841; Reid GE, 1998, ELECTROPHORESIS, V19, P946, DOI 10.1002/elps.1150190610; ROEPSTORFF P, 1984, BIOMED MASS SPECTROM, V11, P601, DOI 10.1002/bms.1200111109; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Seshagiri S, 1997, P NATL ACAD SCI USA, V94, P13606, DOI 10.1073/pnas.94.25.13606; Uren AG, 1996, P NATL ACAD SCI USA, V93, P4974, DOI 10.1073/pnas.93.10.4974; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	34	1840	1971	4	127	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JUL 7	2000	102	1					43	53		10.1016/S0092-8674(00)00009-X	http://dx.doi.org/10.1016/S0092-8674(00)00009-X			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	332UL	10929712	Bronze			2022-12-24	WOS:000088091700007
